Citrus Sinensis ID: 021682
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 309 | 2.2.26 [Sep-21-2011] | |||||||
| Q9C5S8 | 659 | Cysteine-rich receptor-li | no | no | 0.980 | 0.459 | 0.496 | 1e-87 | |
| O65476 | 662 | Putative cysteine-rich re | no | no | 0.970 | 0.453 | 0.511 | 4e-87 | |
| Q9LDQ3 | 669 | Putative cysteine-rich re | no | no | 0.980 | 0.452 | 0.495 | 6e-87 | |
| Q8GYA4 | 669 | Cysteine-rich receptor-li | no | no | 0.967 | 0.446 | 0.5 | 8e-87 | |
| O81905 | 850 | Receptor-like serine/thre | no | no | 0.896 | 0.325 | 0.553 | 3e-86 | |
| Q9ZR08 | 852 | G-type lectin S-receptor- | no | no | 0.889 | 0.322 | 0.547 | 5e-86 | |
| Q9SXB8 | 842 | G-type lectin S-receptor- | no | no | 0.980 | 0.359 | 0.498 | 3e-85 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 0.889 | 0.326 | 0.544 | 3e-85 | |
| O81906 | 849 | G-type lectin S-receptor- | no | no | 0.970 | 0.353 | 0.506 | 2e-84 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.957 | 0.355 | 0.51 | 2e-84 |
| >sp|Q9C5S8|CRK5_ARATH Cysteine-rich receptor-like protein kinase 5 OS=Arabidopsis thaliana GN=CRK5 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 323 bits (828), Expect = 1e-87, Method: Compositional matrix adjust.
Identities = 151/304 (49%), Positives = 219/304 (72%), Gaps = 1/304 (0%)
Query: 7 QGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDY 66
+G LPNG ++AVKRLS+TS QG +EF+NEV + A+LQH NL+ +LG C +REEK+L+Y++
Sbjct: 356 KGTLPNGVQVAVKRLSKTSGQGEKEFKNEVVVVAKLQHRNLVKLLGFCLEREEKILVYEF 415
Query: 67 MPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY 126
+ NKSLD+++FD R + LDW TR II GI +G+LYL + S LTI+HRDLKA NILLD
Sbjct: 416 VSNKSLDYFLFDSRMQSQLDWTTRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDA 475
Query: 127 EMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQI 186
+MNPK++DFGMAR F D+ EA+T R+VGTYGY+ PEY G +SMK DVYS+GVL+L+I
Sbjct: 476 DMNPKVADFGMARIFEIDQTEAHTRRVVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEI 535
Query: 187 LGGKRTSCYYGPNESL-NLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCV 245
+ G++ S Y + S NL+ Y + LW +G ++ +DSS DS +++RC+ +ALLCV
Sbjct: 536 ISGRKNSSLYQMDASFGNLVTYTWRLWSDGSPLDLVDSSFRDSYQRNEIIRCIHIALLCV 595
Query: 246 QENAADRPTMLEILVMLKSETADIKTPKKPAFSVKRDNDEISECMLEANIYSVDDATITQ 305
QE+ +RPTM I+ ML + + + P+ P F + ++++ M ++++ S+D A+IT
Sbjct: 596 QEDTENRPTMSAIVQMLTTSSIALAVPQPPGFFFRSNHEQAGPSMDKSSLCSIDAASITI 655
Query: 306 PVPR 309
PR
Sbjct: 656 LAPR 659
|
Involved in multiple distinct defense responses. May function as a disease resistance (R) protein. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|O65476|CRK16_ARATH Putative cysteine-rich receptor-like protein kinase 16 OS=Arabidopsis thaliana GN=CRK16 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 321 bits (823), Expect = 4e-87, Method: Compositional matrix adjust.
Identities = 159/311 (51%), Positives = 222/311 (71%), Gaps = 11/311 (3%)
Query: 5 ICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIY 64
+ +G PNG E+AVKRLS+ S QG EEF+NEV L A+LQH NL+ +LG + EEK+L+Y
Sbjct: 349 VFKGTFPNGTEVAVKRLSKISGQGEEEFKNEVLLVAKLQHRNLVRLLGFSVEGEEKILVY 408
Query: 65 DYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL 124
+YMPNKSLD+++FD RRR LDWRTR +II G+T+G+LYL + S LTI+HRDLKA NILL
Sbjct: 409 EYMPNKSLDYFLFDHRRRGQLDWRTRYNIIRGVTRGILYLHQDSRLTIIHRDLKAGNILL 468
Query: 125 DYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLL 184
D +MNPKI+DFG+AR F D+ EA TGR+VGT+GY+PPEYV G +SMK DVYS+GVL+L
Sbjct: 469 DVDMNPKIADFGVARNFRVDQTEATTGRVVGTFGYMPPEYVANGQFSMKSDVYSFGVLIL 528
Query: 185 QILGGKRTSCYYGPNESL-NLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALL 243
+I+ GK++S ++ + S+ NL+ Y + LW N +E +D ++ +S +++RC+ ++LL
Sbjct: 529 EIIVGKKSSSFHEIDGSVGNLVTYVWRLWNNESFLELVDPAMGESYDKDEVIRCIHISLL 588
Query: 244 CVQENAADRPTMLEILVMLKSETADIKTPKKPA--FSVKRDNDEISECMLEAN------- 294
CVQEN ADRPTM + ML + + P+ P F V+ + + ++E LE
Sbjct: 589 CVQENPADRPTMSTVFQMLTNTFLTLPVPQLPGFVFRVRSEPNPLAE-RLEPGPSTTMSF 647
Query: 295 IYSVDDATITQ 305
S+DDA+IT
Sbjct: 648 ACSIDDASITS 658
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LDQ3|CRK35_ARATH Putative cysteine-rich receptor-like protein kinase 35 OS=Arabidopsis thaliana GN=CRK35 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 320 bits (821), Expect = 6e-87, Method: Compositional matrix adjust.
Identities = 153/309 (49%), Positives = 223/309 (72%), Gaps = 6/309 (1%)
Query: 7 QGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDY 66
+G+L +G E+AVKRLS+TS QG EEF+NE L ++LQH NL+ +LG C + EEK+L+Y++
Sbjct: 361 RGKLSSGPEVAVKRLSKTSGQGAEEFKNEAVLVSKLQHKNLVRLLGFCLEGEEKILVYEF 420
Query: 67 MPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY 126
+PNKSLD+++FD ++ LDW R +II GI +G+LYL + S LTI+HRDLKASNILLD
Sbjct: 421 VPNKSLDYFLFDPAKQGELDWTRRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDA 480
Query: 127 EMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQI 186
+MNPKI+DFGMAR F D+ +ANT RI GT+GY+ PEY +G +SMK DVYS+GVL+L+I
Sbjct: 481 DMNPKIADFGMARIFGVDQSQANTRRIAGTFGYMSPEYAMRGHFSMKSDVYSFGVLVLEI 540
Query: 187 LGGKRTSCYYGPNES-LNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCV 245
+ GK+ S +Y ++S NL+ +A+ LW+NG +E +D ++ +S + + RC+ +ALLCV
Sbjct: 541 ISGKKNSSFYNIDDSGSNLVTHAWRLWRNGSPLELVDPTIGESYQSSEATRCIHIALLCV 600
Query: 246 QENAADRPTMLEILVMLKSETADIKTPKKPAF-----SVKRDNDEISECMLEANIYSVDD 300
QE+ ADRP + I++ML S T + P+ P F +++D E +E + S++D
Sbjct: 601 QEDPADRPLLPAIIMMLTSSTTTLHVPRAPGFCLSGRDLEQDGVEYTESTSRSIPGSIND 660
Query: 301 ATITQPVPR 309
A+IT+ PR
Sbjct: 661 ASITEFYPR 669
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8GYA4|CRK10_ARATH Cysteine-rich receptor-like protein kinase 10 OS=Arabidopsis thaliana GN=CRK10 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 320 bits (820), Expect = 8e-87, Method: Compositional matrix adjust.
Identities = 155/310 (50%), Positives = 217/310 (70%), Gaps = 11/310 (3%)
Query: 7 QGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDY 66
+G L +G E+AVKRLS++S QG EF+NEV L A+LQH NL+ +LG C EE++L+Y+Y
Sbjct: 364 KGTLSDGTEVAVKRLSKSSGQGEVEFKNEVVLVAKLQHRNLVRLLGFCLDGEERVLVYEY 423
Query: 67 MPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY 126
+PNKSLD+++FD ++ LDW R II G+ +G+LYL + S LTI+HRDLKASNILLD
Sbjct: 424 VPNKSLDYFLFDPAKKGQLDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDA 483
Query: 127 EMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQI 186
+MNPKI+DFGMAR F D+ E NT RIVGTYGY+ PEY G YSMK DVYS+GVL+L+I
Sbjct: 484 DMNPKIADFGMARIFGLDQTEENTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEI 543
Query: 187 LGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQ 246
+ GK+ S +Y + + +L+ YA+GLW NG +E +D ++ ++ +++RC+ + LLCVQ
Sbjct: 544 ISGKKNSSFYQTDGAHDLVSYAWGLWSNGRPLELVDPAIVENCQRNEVVRCVHIGLLCVQ 603
Query: 247 ENAADRPTMLEILVMLKSETADIKTPKKPAFSVKR-------DNDEISECMLEANIYSVD 299
E+ A+RPT+ I++ML S T + P++P + D D S+ +L SVD
Sbjct: 604 EDPAERPTLSTIVLMLTSNTVTLPVPRQPGLFFQSRIGKDPLDTDTTSKSLLG----SVD 659
Query: 300 DATITQPVPR 309
DA+IT PR
Sbjct: 660 DASITDIHPR 669
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 318 bits (815), Expect = 3e-86, Method: Compositional matrix adjust.
Identities = 155/280 (55%), Positives = 202/280 (72%), Gaps = 3/280 (1%)
Query: 5 ICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIY 64
+ +G+L +GQEMAVKRLS+TS QG +EF+NEVKL ARLQH+NL+ +L C EKMLIY
Sbjct: 540 VYKGKLLDGQEMAVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIY 599
Query: 65 DYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL 124
+Y+ N SLD ++FD R L+W+ R II GI +GLLYL + S I+HRDLKASNILL
Sbjct: 600 EYLENLSLDSHLFDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILL 659
Query: 125 DYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLL 184
D M PKISDFGMAR F +DE EANT ++VGTYGY+ PEY GI+SMK DV+S+GVLLL
Sbjct: 660 DKYMTPKISDFGMARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLL 719
Query: 185 QILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWK---LMRCMQVA 241
+I+ KR +Y + LNLL + WK G+G+E ID + DSSS ++ ++RC+Q+
Sbjct: 720 EIISSKRNKGFYNSDRDLNLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIG 779
Query: 242 LLCVQENAADRPTMLEILVMLKSETADIKTPKKPAFSVKR 281
LLCVQE A DRPTM +++ML SE+ I PK P + ++R
Sbjct: 780 LLCVQERAEDRPTMSLVILMLGSESTTIPQPKAPGYCLER 819
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZR08|Y4230_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g03230 OS=Arabidopsis thaliana GN=At4g03230 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 318 bits (814), Expect = 5e-86, Method: Compositional matrix adjust.
Identities = 151/276 (54%), Positives = 202/276 (73%), Gaps = 1/276 (0%)
Query: 7 QGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDY 66
+G P QE+AVKRLSR S QGLEEF+NEV L A+LQH NL+ +LG C EEK+L+Y+Y
Sbjct: 548 KGMFPGDQEIAVKRLSRCSGQGLEEFKNEVVLIAKLQHRNLVRLLGYCVAGEEKLLLYEY 607
Query: 67 MPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY 126
MP+KSLDF+IFD + LDW+ R +II GI +GLLYL + S L I+HRDLK SNILLD
Sbjct: 608 MPHKSLDFFIFDRKLCQRLDWKMRCNIILGIARGLLYLHQDSRLRIIHRDLKTSNILLDE 667
Query: 127 EMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQI 186
EMNPKISDFG+AR F E ANT R+VGTYGY+ PEY +G++S K DV+S+GV++++
Sbjct: 668 EMNPKISDFGLARIFGGSETSANTNRVVGTYGYMSPEYALEGLFSFKSDVFSFGVVVIET 727
Query: 187 LGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQ 246
+ GKR + ++ P +SL+LL +A+ LWK G+E +D +L +S ++C+ V LLCVQ
Sbjct: 728 ISGKRNTGFHEPEKSLSLLGHAWDLWKAERGIELLDQALQESCETEGFLKCLNVGLLCVQ 787
Query: 247 ENAADRPTMLEILVML-KSETADIKTPKKPAFSVKR 281
E+ DRPTM ++ ML SE A + TPK+PAF ++R
Sbjct: 788 EDPNDRPTMSNVVFMLGSSEAATLPTPKQPAFVLRR 823
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 315 bits (807), Expect = 3e-85, Method: Compositional matrix adjust.
Identities = 151/303 (49%), Positives = 207/303 (68%)
Query: 7 QGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDY 66
+G+LP GQE+AVKRLSR S QGLEE NEV + ++LQH NL+ +LG C + EE+ML+Y+Y
Sbjct: 540 KGKLPEGQEIAVKRLSRKSGQGLEELMNEVVVISKLQHRNLVKLLGCCIEGEERMLVYEY 599
Query: 67 MPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY 126
MP KSLD Y+FD ++ +LDW+TR +I+EGI +GLLYL S L I+HRDLKASNILLD
Sbjct: 600 MPKKSLDAYLFDPMKQKILDWKTRFNIMEGICRGLLYLHRDSRLKIIHRDLKASNILLDE 659
Query: 127 EMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQI 186
+NPKISDFG+AR F +E EANT R+VGTYGY+ PEY +G +S K DV+S GV+ L+I
Sbjct: 660 NLNPKISDFGLARIFRANEDEANTRRVVGTYGYMSPEYAMEGFFSEKSDVFSLGVIFLEI 719
Query: 187 LGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQ 246
+ G+R S + +LNLL YA+ LW +GE D ++ D ++ +C+ + LLCVQ
Sbjct: 720 ISGRRNSSSHKEENNLNLLAYAWKLWNDGEAASLADPAVFDKCFEKEIEKCVHIGLLCVQ 779
Query: 247 ENAADRPTMLEILVMLKSETADIKTPKKPAFSVKRDNDEISECMLEANIYSVDDATITQP 306
E A DRP + ++ ML +E + PK+PAF V+R E + S++D ++T
Sbjct: 780 EVANDRPNVSNVIWMLTTENMSLADPKQPAFIVRRGASEAESSDQSSQKVSINDVSLTAV 839
Query: 307 VPR 309
R
Sbjct: 840 TGR 842
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 315 bits (806), Expect = 3e-85, Method: Compositional matrix adjust.
Identities = 152/279 (54%), Positives = 200/279 (71%), Gaps = 4/279 (1%)
Query: 7 QGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDY 66
+GRL +G+E+AVKRLS+ S QG +EF NEV+L A+LQH+NL+ +LG C + EKMLIY+Y
Sbjct: 535 KGRLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEY 594
Query: 67 MPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY 126
+ N SLD ++FD R L+W+ R II GI +GLLYL + S I+HRDLKASN+LLD
Sbjct: 595 LENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDK 654
Query: 127 EMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQI 186
M PKISDFGMAR F ++E EANT R+VGTYGY+ PEY GI+SMK DV+S+GVLLL+I
Sbjct: 655 NMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEI 714
Query: 187 LGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDS-SLDDSSSAW---KLMRCMQVAL 242
+ GKR +Y N LNLL + + WK G +E +D ++D SS + +++RC+Q+ L
Sbjct: 715 ISGKRNKGFYNSNRDLNLLGFVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGL 774
Query: 243 LCVQENAADRPTMLEILVMLKSETADIKTPKKPAFSVKR 281
LCVQE A DRP M ++VML SET I PK+P F + R
Sbjct: 775 LCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCIGR 813
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 312 bits (800), Expect = 2e-84, Method: Compositional matrix adjust.
Identities = 153/302 (50%), Positives = 219/302 (72%), Gaps = 2/302 (0%)
Query: 7 QGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDY 66
+G L +G+E+AVKRLS S QG++EF+NE+ L A+LQH NL+ +LG C + EEKML+Y+Y
Sbjct: 545 KGVLEDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEY 604
Query: 67 MPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY 126
MPNKSLDF++FD ++ L+DW+ R IIEGI +GLLYL S L I+HRDLK SN+LLD
Sbjct: 605 MPNKSLDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDA 664
Query: 127 EMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQI 186
EMNPKISDFGMAR F ++ EANT R+VGTYGY+ PEY +G++S+K DVYS+GVLLL+I
Sbjct: 665 EMNPKISDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEI 724
Query: 187 LGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQ 246
+ GKR + +E +L+ YA+ L+ +G E +D + + S + +RC+ VA+LCVQ
Sbjct: 725 VSGKRNTSLRS-SEHGSLIGYAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQ 783
Query: 247 ENAADRPTMLEILVMLKSETADIKTPKKPAF-SVKRDNDEISECMLEANIYSVDDATITQ 305
++AA+RP M +L+ML+S+TA + P++P F S +R++ +++ + + Y V IT
Sbjct: 784 DSAAERPNMASVLLMLESDTATLAAPRQPTFTSTRRNSIDVNFALDSSQQYIVSSNEITS 843
Query: 306 PV 307
V
Sbjct: 844 TV 845
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 312 bits (799), Expect = 2e-84, Method: Compositional matrix adjust.
Identities = 153/300 (51%), Positives = 211/300 (70%), Gaps = 4/300 (1%)
Query: 7 QGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDY 66
+G L N E+AVKRLSR S QG+EEF+NEVKL ++LQH NL+ +LG C + EEKML+Y+Y
Sbjct: 531 KGVLQNRMEIAVKRLSRNSGQGMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYEY 590
Query: 67 MPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY 126
+PNKSLD++IF +R LDW R+ I+ GI +G+LYL + S L I+HRDLKASNILLD
Sbjct: 591 LPNKSLDYFIFHEEQRAELDWPKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDS 650
Query: 127 EMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQI 186
EM PKISDFGMAR F ++ E T R+VGT+GY+ PEY +G +S+K DVYS+GVL+L+I
Sbjct: 651 EMIPKISDFGMARIFGGNQMEGCTSRVVGTFGYMAPEYAMEGQFSIKSDVYSFGVLMLEI 710
Query: 187 LGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSS-SAWKLMRCMQVALLCV 245
+ GK+ S ++ ES NL+ + + LW+NGE E ID+ +D + ++M+C+Q+ LLCV
Sbjct: 711 ITGKKNSAFH--EESSNLVGHIWDLWENGEATEIIDNLMDQETYDEREVMKCIQIGLLCV 768
Query: 246 QENAADRPTMLEILVMLKSETADIKTPKKPAF-SVKRDNDEISECMLEANIYSVDDATIT 304
QENA+DR M +++ML ++ PK PAF S +R E C+ SV+D T +
Sbjct: 769 QENASDRVDMSSVVIMLGHNATNLPNPKHPAFTSARRRGGENGACLKGQTGISVNDVTFS 828
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 309 | ||||||
| 224142427 | 327 | predicted protein [Populus trichocarpa] | 0.983 | 0.929 | 0.712 | 1e-127 | |
| 296088199 | 1130 | unnamed protein product [Vitis vinifera] | 0.987 | 0.269 | 0.686 | 1e-120 | |
| 359484771 | 781 | PREDICTED: G-type lectin S-receptor-like | 0.987 | 0.390 | 0.702 | 1e-118 | |
| 296084604 | 580 | unnamed protein product [Vitis vinifera] | 0.987 | 0.525 | 0.702 | 1e-118 | |
| 359497026 | 738 | PREDICTED: G-type lectin S-receptor-like | 0.932 | 0.390 | 0.724 | 1e-118 | |
| 224142425 | 763 | predicted protein [Populus trichocarpa] | 0.987 | 0.399 | 0.669 | 1e-117 | |
| 255565055 | 721 | conserved hypothetical protein [Ricinus | 0.977 | 0.418 | 0.650 | 1e-115 | |
| 356558668 | 909 | PREDICTED: uncharacterized protein LOC10 | 0.983 | 0.334 | 0.665 | 1e-114 | |
| 224082290 | 335 | predicted protein [Populus trichocarpa] | 0.987 | 0.910 | 0.663 | 1e-114 | |
| 224142431 | 332 | predicted protein [Populus trichocarpa] | 0.987 | 0.918 | 0.663 | 1e-113 |
| >gi|224142427|ref|XP_002324559.1| predicted protein [Populus trichocarpa] gi|222865993|gb|EEF03124.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 462 bits (1188), Expect = e-127, Method: Compositional matrix adjust.
Identities = 218/306 (71%), Positives = 260/306 (84%), Gaps = 2/306 (0%)
Query: 4 AICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLI 63
++ +G+LPNG+E+AVKRLS+TS QG EEF+NEV LT +LQHVN++ VLG C +REEKMLI
Sbjct: 24 SVYKGKLPNGKEIAVKRLSKTSTQGEEEFKNEVTLTEKLQHVNIVTVLGFCAEREEKMLI 83
Query: 64 YDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNIL 123
Y+YMPNKSLD YI+D RRY+LDWR RV IIEG+TQGLLYLQEYSN TI+HRD+K+SN+L
Sbjct: 84 YEYMPNKSLDIYIYDPIRRYMLDWRKRVQIIEGLTQGLLYLQEYSNFTIIHRDIKSSNVL 143
Query: 124 LDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLL 183
LD EMNPKISDFGMAR F KDE EANT RIVGTYGYVPPEYVRKGIYSMKYDVYS+GVLL
Sbjct: 144 LDEEMNPKISDFGMARLFRKDELEANTSRIVGTYGYVPPEYVRKGIYSMKYDVYSFGVLL 203
Query: 184 LQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALL 243
LQI+ GK+++CYYG +E+ NLLEYAY LWK+GEG+EF D SLDDS S+ KL RC+QVALL
Sbjct: 204 LQIISGKKSTCYYGADENWNLLEYAYELWKDGEGVEFFDPSLDDSFSSCKLTRCLQVALL 263
Query: 244 CVQENAADRPTMLEILVMLKSETADIKTPKKPAFSVKRDNDEISECMLEANIYSVDDATI 303
CVQEN DRP+ML+I MLK+E A I TPK+P+FS KRD +E + ++ IYSV+DATI
Sbjct: 264 CVQENPLDRPSMLKISSMLKNENAPIATPKRPSFSTKRDEEE--DSVIRNKIYSVNDATI 321
Query: 304 TQPVPR 309
+ PR
Sbjct: 322 SDLEPR 327
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296088199|emb|CBI35714.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 436 bits (1120), Expect = e-120, Method: Compositional matrix adjust.
Identities = 210/306 (68%), Positives = 253/306 (82%), Gaps = 1/306 (0%)
Query: 5 ICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIY 64
+ +G+LP GQE+AVKRLS+TSHQGLEEF+NEV LTA LQHVNL+ +LG CTQREEKMLIY
Sbjct: 825 VYKGKLPKGQEIAVKRLSKTSHQGLEEFKNEVTLTATLQHVNLVKLLGFCTQREEKMLIY 884
Query: 65 DYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL 124
+ MPNKSLDFY+FD + LLDW R+HIIEGITQGLLYLQEYS L I+HRDLKASNILL
Sbjct: 885 ECMPNKSLDFYLFDPEGQVLLDWGKRIHIIEGITQGLLYLQEYSRLRIIHRDLKASNILL 944
Query: 125 DYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLL 184
D EM PKI+DFG+AR F KDE EANTGRIVGTYGYV PEYV+KG YS+K DVYS+GVLLL
Sbjct: 945 DGEMKPKIADFGIARIFQKDENEANTGRIVGTYGYVSPEYVQKGTYSVKSDVYSFGVLLL 1004
Query: 185 QILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLC 244
QI+ GK+ +C+YG +++L+LLEYAY LWK+G+ MEF+D SLDD+ S+ KL RCMQVALLC
Sbjct: 1005 QIISGKKNTCFYGLDQNLHLLEYAYELWKDGKSMEFMDPSLDDACSSCKLTRCMQVALLC 1064
Query: 245 VQENAADRPTMLEILVMLKSETADIKTPKKPAFSVKRDNDEISECMLEAN-IYSVDDATI 303
VQEN ADRP++LE+ M+K+ETA I TP++PAF+ KRD E + I SV+ TI
Sbjct: 1065 VQENPADRPSVLEVDSMIKNETAAIATPRRPAFAAKRDEVEADGKSASGHEIGSVNVTTI 1124
Query: 304 TQPVPR 309
+Q +PR
Sbjct: 1125 SQVLPR 1130
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359484771|ref|XP_003633158.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RKS1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 431 bits (1109), Expect = e-118, Method: Compositional matrix adjust.
Identities = 217/309 (70%), Positives = 254/309 (82%), Gaps = 4/309 (1%)
Query: 5 ICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIY 64
+ +G+ G+EMAVKRLS+TS+QG EEF+NEV LTA+LQHVNL+ + G CT+ EEKMLIY
Sbjct: 473 VYKGKSQKGEEMAVKRLSKTSNQGAEEFKNEVTLTAKLQHVNLVRLQGFCTEGEEKMLIY 532
Query: 65 DYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL 124
+YMPNKSLDFY+FD RRY LDW R+ IIEGITQGLLYLQEYSN TI+HRDLKASNILL
Sbjct: 533 EYMPNKSLDFYLFDPTRRYFLDWTKRIAIIEGITQGLLYLQEYSNFTIIHRDLKASNILL 592
Query: 125 DYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLL 184
D EM PKISDFG+ARAF KDE EA+TGRIVGTYGYVPPEYVR+GIYSMKYDVYS+GVLLL
Sbjct: 593 DSEMKPKISDFGIARAFQKDEHEASTGRIVGTYGYVPPEYVRRGIYSMKYDVYSFGVLLL 652
Query: 185 QILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLC 244
QI+ +R SC YG +++LNLLEYAY LWK GEGM F+D SLDDSSS+ KLM CMQVALLC
Sbjct: 653 QIISSRRNSCTYGLSQNLNLLEYAYELWKEGEGMRFMDPSLDDSSSSCKLMACMQVALLC 712
Query: 245 VQENAADRPTMLEILVMLKSETADIKTPKKPAFSVKRDNDEIS----ECMLEANIYSVDD 300
+QEN RPTMLE+ MLKSETA + P +PAFS+K + D++S + NI SV+D
Sbjct: 713 IQENPDHRPTMLEVSSMLKSETAAMPAPLRPAFSIKSNEDKLSVNDATTSSQQNILSVND 772
Query: 301 ATITQPVPR 309
ATI+ VPR
Sbjct: 773 ATISDLVPR 781
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296084604|emb|CBI25625.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 431 bits (1108), Expect = e-118, Method: Compositional matrix adjust.
Identities = 217/309 (70%), Positives = 254/309 (82%), Gaps = 4/309 (1%)
Query: 5 ICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIY 64
+ +G+ G+EMAVKRLS+TS+QG EEF+NEV LTA+LQHVNL+ + G CT+ EEKMLIY
Sbjct: 272 VYKGKSQKGEEMAVKRLSKTSNQGAEEFKNEVTLTAKLQHVNLVRLQGFCTEGEEKMLIY 331
Query: 65 DYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL 124
+YMPNKSLDFY+FD RRY LDW R+ IIEGITQGLLYLQEYSN TI+HRDLKASNILL
Sbjct: 332 EYMPNKSLDFYLFDPTRRYFLDWTKRIAIIEGITQGLLYLQEYSNFTIIHRDLKASNILL 391
Query: 125 DYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLL 184
D EM PKISDFG+ARAF KDE EA+TGRIVGTYGYVPPEYVR+GIYSMKYDVYS+GVLLL
Sbjct: 392 DSEMKPKISDFGIARAFQKDEHEASTGRIVGTYGYVPPEYVRRGIYSMKYDVYSFGVLLL 451
Query: 185 QILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLC 244
QI+ +R SC YG +++LNLLEYAY LWK GEGM F+D SLDDSSS+ KLM CMQVALLC
Sbjct: 452 QIISSRRNSCTYGLSQNLNLLEYAYELWKEGEGMRFMDPSLDDSSSSCKLMACMQVALLC 511
Query: 245 VQENAADRPTMLEILVMLKSETADIKTPKKPAFSVKRDNDEIS----ECMLEANIYSVDD 300
+QEN RPTMLE+ MLKSETA + P +PAFS+K + D++S + NI SV+D
Sbjct: 512 IQENPDHRPTMLEVSSMLKSETAAMPAPLRPAFSIKSNEDKLSVNDATTSSQQNILSVND 571
Query: 301 ATITQPVPR 309
ATI+ VPR
Sbjct: 572 ATISDLVPR 580
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359497026|ref|XP_003635401.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410-like, partial [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 431 bits (1107), Expect = e-118, Method: Compositional matrix adjust.
Identities = 216/298 (72%), Positives = 248/298 (83%), Gaps = 10/298 (3%)
Query: 5 ICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIY 64
+ +G+LP GQE+AVKRLS+TSHQGLEEF+NEV LTA LQHVNL+ +LG CTQREEKMLIY
Sbjct: 447 VYKGKLPKGQEIAVKRLSKTSHQGLEEFKNEVTLTATLQHVNLVKLLGFCTQREEKMLIY 506
Query: 65 DYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL 124
+ MPNKSLDFY+FD RRY LDW R+ IIEGITQGLLYLQEYSN TI+HRDLKASNILL
Sbjct: 507 ECMPNKSLDFYLFDPTRRYFLDWTKRIAIIEGITQGLLYLQEYSNFTIIHRDLKASNILL 566
Query: 125 DYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLL 184
D EM PKISDFG+ARAF KDE EA+TGRIVGTYGYVPPEYVR+GIYSMKYDVYS+GVLLL
Sbjct: 567 DSEMKPKISDFGIARAFQKDEHEASTGRIVGTYGYVPPEYVRRGIYSMKYDVYSFGVLLL 626
Query: 185 QILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLC 244
QI+ +R SC YG +++LNLLEYAY LWK GEGM F+D SLDDSSS+ KLM CMQVALLC
Sbjct: 627 QIISSRRNSCTYGLSQNLNLLEYAYELWKEGEGMRFMDPSLDDSSSSCKLMACMQVALLC 686
Query: 245 VQENAADRPTMLEILVMLKSETADIKTPKKPAFSVKRDNDEISECMLEANIYSVDDAT 302
+QEN RPTMLE+ MLKSETA + P +PAFS+K + D++ SV+DAT
Sbjct: 687 IQENPDHRPTMLEVSSMLKSETAAMPAPLRPAFSIKSNEDKL----------SVNDAT 734
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224142425|ref|XP_002324558.1| predicted protein [Populus trichocarpa] gi|222865992|gb|EEF03123.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 427 bits (1099), Expect = e-117, Method: Compositional matrix adjust.
Identities = 205/306 (66%), Positives = 250/306 (81%), Gaps = 1/306 (0%)
Query: 5 ICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIY 64
+ +G LP GQE+AVK+LS++S QG +EF+NEV LTA+LQHVNL+ VLG C +REEK+LIY
Sbjct: 458 VYKGVLPGGQEIAVKKLSKSSTQGFDEFKNEVMLTAKLQHVNLVKVLGFCVEREEKVLIY 517
Query: 65 DYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL 124
+YMP KSLD Y+FD RRYLLDW+ R IIEGITQGLLYLQEYS LTI+HRDLKASNILL
Sbjct: 518 EYMPKKSLDSYLFDPIRRYLLDWKRREEIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 577
Query: 125 DYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLL 184
D +M PKISDFGMAR FTKDE EANT R+VGTYGYVPPEYVR G+YS+K DVYS+G++LL
Sbjct: 578 DGDMKPKISDFGMARIFTKDEQEANTSRLVGTYGYVPPEYVRNGVYSIKSDVYSFGIVLL 637
Query: 185 QILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLC 244
I+ GK+ YG +E+L+LLEYAY LWK+G+GME +D SLDD+ S+ KL++C+Q+ALLC
Sbjct: 638 HIISGKKNGSLYGSDETLSLLEYAYELWKDGKGMEIMDPSLDDTLSSCKLIKCLQIALLC 697
Query: 245 VQENAADRPTMLEILVMLKSETADIKTPKKPAFSVKRDNDEISEC-MLEANIYSVDDATI 303
VQEN DRP+MLE+ MLK+ETA + PK+PAFSVK D D+ + L I SVDDATI
Sbjct: 698 VQENPIDRPSMLEVSSMLKNETAIVTIPKRPAFSVKTDEDDKNRPDQLHIKICSVDDATI 757
Query: 304 TQPVPR 309
+Q V R
Sbjct: 758 SQVVGR 763
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255565055|ref|XP_002523520.1| conserved hypothetical protein [Ricinus communis] gi|223537227|gb|EEF38859.1| conserved hypothetical protein [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 420 bits (1080), Expect = e-115, Method: Compositional matrix adjust.
Identities = 199/306 (65%), Positives = 253/306 (82%), Gaps = 4/306 (1%)
Query: 7 QGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDY 66
QG+LP GQE+AVKRLS+TS+QGL+EF+NE+KLTA+LQHVNL+ +LG CT+R+EKMLIY+Y
Sbjct: 417 QGKLPRGQEIAVKRLSKTSNQGLKEFKNELKLTAKLQHVNLVRLLGYCTERKEKMLIYEY 476
Query: 67 MPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY 126
MPNKSLDFY+FD +RR L+W RVHIIEGI QGLLYLQEYSNLTI+H+D+K+SNILLD
Sbjct: 477 MPNKSLDFYLFDQKRRLELNWEKRVHIIEGIAQGLLYLQEYSNLTIIHKDIKSSNILLDS 536
Query: 127 EMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQI 186
M PKISDFGMAR F K+ EANT +IVGTYGYVPPEYV++G+YS KYDVYS+GVLLLQI
Sbjct: 537 NMKPKISDFGMARIFQKENHEANTCQIVGTYGYVPPEYVKRGVYSTKYDVYSFGVLLLQI 596
Query: 187 LGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQ 246
+ GK+ +CYYG + +LNLLEYAY W+ G G EF+D LDDS S KL+RC+QV LLCVQ
Sbjct: 597 ISGKKNTCYYGSHVNLNLLEYAYEFWETGNGKEFLDPVLDDSHSTCKLLRCLQVGLLCVQ 656
Query: 247 ENAADRPTMLEILVMLKSETADIKTPKKPAFSVKRDNDEISECMLEA---NIYSVDDATI 303
E+ DRP++L+I MLK+E I +PK+PAFSV NDEI + + ++ ++ SV+ A++
Sbjct: 657 ESPIDRPSILQICSMLKNENDIIVSPKRPAFSVT-SNDEIEKNVSKSTSQDVGSVNSASL 715
Query: 304 TQPVPR 309
++ +PR
Sbjct: 716 SELLPR 721
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356558668|ref|XP_003547625.1| PREDICTED: uncharacterized protein LOC100787480 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 418 bits (1075), Expect = e-114, Method: Compositional matrix adjust.
Identities = 203/305 (66%), Positives = 246/305 (80%), Gaps = 1/305 (0%)
Query: 5 ICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIY 64
+ +G L N QE+AVK+LS+ S QG EEF+NEV LTARLQHVNL+ +LG E++ML+Y
Sbjct: 447 VYKGILSNRQEVAVKKLSKASTQGFEEFKNEVMLTARLQHVNLVRLLGFYIDGEQQMLVY 506
Query: 65 DYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL 124
+YMPNKSLD Y+FD RRYLLDWR R++IIEGITQGLLYLQEYS LTI+HRD+KASNILL
Sbjct: 507 EYMPNKSLDSYLFDPIRRYLLDWRKRIYIIEGITQGLLYLQEYSRLTIIHRDIKASNILL 566
Query: 125 DYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLL 184
D EM PKISDFGMAR F KDE EANT +IVGTYGYV PEY KG+YS K DVYS+GVLLL
Sbjct: 567 DNEMKPKISDFGMARIFRKDELEANTSKIVGTYGYVSPEYAMKGLYSTKSDVYSFGVLLL 626
Query: 185 QILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLC 244
QI+ G+RT+C+YG +E+LNL+EYAY LWK G+GMEF D SLDDS S KL+RCMQ+ALLC
Sbjct: 627 QIVSGRRTACFYGEHENLNLMEYAYELWKEGKGMEFADPSLDDSHSTCKLLRCMQIALLC 686
Query: 245 VQENAADRPTMLEILVMLKSETADIKTPKKPAFSVKRDNDEISECMLEANIYSVDDATIT 304
VQE+A DRPT+ EI MLKS+T I P+KPAFS+ RD + ++ ++ S++DATI+
Sbjct: 687 VQEDANDRPTVKEISSMLKSDTILI-IPQKPAFSINRDEKKPNKFIMHEEKCSINDATIS 745
Query: 305 QPVPR 309
Q V R
Sbjct: 746 QVVAR 750
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224082290|ref|XP_002335492.1| predicted protein [Populus trichocarpa] gi|222834258|gb|EEE72735.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 416 bits (1070), Expect = e-114, Method: Compositional matrix adjust.
Identities = 203/306 (66%), Positives = 241/306 (78%), Gaps = 1/306 (0%)
Query: 5 ICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIY 64
+ +G+LP G E+AVKRLS +S QGLEEF+NEV LTARLQHVNL+ +LG C++R EKMLIY
Sbjct: 30 VYKGKLPRGLEIAVKRLSASSTQGLEEFKNEVSLTARLQHVNLVRLLGFCSERGEKMLIY 89
Query: 65 DYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL 124
+YMPNKSLD Y+FD RRY LDW RV IIEG+TQGLLYLQEYSN TI+HRDLK+SNILL
Sbjct: 90 EYMPNKSLDLYLFDPIRRYSLDWSKRVRIIEGVTQGLLYLQEYSNFTIIHRDLKSSNILL 149
Query: 125 DYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLL 184
D EMNPKISDFGMA+ F KD EANT RIVGTYGY+PPEY RKGIYS+KYDVYS+GV+LL
Sbjct: 150 DDEMNPKISDFGMAKLFRKDVYEANTSRIVGTYGYIPPEYARKGIYSIKYDVYSFGVVLL 209
Query: 185 QILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLC 244
Q++ GK + +Y NE LNLLEYAY LWKNG GMEFID LDDSSS KL+ CMQVALLC
Sbjct: 210 QMISGKTNTRFYSENEDLNLLEYAYDLWKNGRGMEFIDPFLDDSSSPCKLLTCMQVALLC 269
Query: 245 VQENAADRPTMLEILVMLKSETA-DIKTPKKPAFSVKRDNDEISECMLEANIYSVDDATI 303
VQEN RPTMLE MLK++ + I TP++P FS K+ D + + + S +D+ +
Sbjct: 270 VQENPDARPTMLEAFSMLKNDDSLAIATPERPGFSEKKKGDMETASSSQQVMCSFNDSQV 329
Query: 304 TQPVPR 309
+Q PR
Sbjct: 330 SQLEPR 335
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224142431|ref|XP_002324561.1| predicted protein [Populus trichocarpa] gi|222865995|gb|EEF03126.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 415 bits (1066), Expect = e-113, Method: Compositional matrix adjust.
Identities = 203/306 (66%), Positives = 240/306 (78%), Gaps = 1/306 (0%)
Query: 5 ICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIY 64
+ +G+LP G E+AVKRLS +S QGLEEF+NEV LTARLQHVNL+ +LG C++R EKMLIY
Sbjct: 27 VYKGKLPRGLEIAVKRLSASSTQGLEEFKNEVSLTARLQHVNLVRLLGFCSERGEKMLIY 86
Query: 65 DYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL 124
+YMPNKSLD Y+FD RRY LDW RV IIEG+TQGLLYLQEYSN TI+HRDLK+SNILL
Sbjct: 87 EYMPNKSLDLYLFDPIRRYSLDWSKRVRIIEGVTQGLLYLQEYSNFTIIHRDLKSSNILL 146
Query: 125 DYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLL 184
D EMNPKISDFGMA+ F KD EANT RIVGTYGY+PPEY RKGIYS+KYDVYS+GV+LL
Sbjct: 147 DDEMNPKISDFGMAKLFRKDVYEANTSRIVGTYGYIPPEYARKGIYSIKYDVYSFGVVLL 206
Query: 185 QILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLC 244
Q++ GK + +Y NE LNLLEYAY LWKNG GMEFID LDDSSS KL+ CMQVALLC
Sbjct: 207 QMISGKTNTRFYSENEDLNLLEYAYDLWKNGRGMEFIDPFLDDSSSPCKLLTCMQVALLC 266
Query: 245 VQENAADRPTMLEILVMLKSETA-DIKTPKKPAFSVKRDNDEISECMLEANIYSVDDATI 303
VQEN RPTMLE MLK++ + I TP++P FS K+ D + + S +D+ +
Sbjct: 267 VQENPDARPTMLEAFSMLKNDDSLAIATPERPGFSEKKKGDMEIASSSQQVMCSFNDSQV 326
Query: 304 TQPVPR 309
+Q PR
Sbjct: 327 SQLEPR 332
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 309 | ||||||
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.970 | 0.352 | 0.522 | 2.2e-80 | |
| TAIR|locus:2123111 | 669 | CRK34 "cysteine-rich RLK (RECE | 0.987 | 0.455 | 0.491 | 1.6e-79 | |
| TAIR|locus:2121676 | 669 | CRK10 "cysteine-rich RLK (RECE | 0.987 | 0.455 | 0.496 | 2.6e-79 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.964 | 0.351 | 0.511 | 1.4e-78 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.964 | 0.353 | 0.511 | 1.8e-78 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.977 | 0.355 | 0.503 | 4.8e-78 | |
| TAIR|locus:2121686 | 645 | CRK19 "cysteine-rich RLK (RECE | 0.987 | 0.472 | 0.496 | 1.3e-77 | |
| TAIR|locus:2093397 | 850 | CES101 "CALLUS EXPRESSION OF R | 0.970 | 0.352 | 0.501 | 1.6e-77 | |
| TAIR|locus:2121626 | 830 | CRK23 "cysteine-rich RLK (RECE | 0.987 | 0.367 | 0.478 | 5.5e-77 | |
| UNIPROTKB|O49974 | 848 | KIK1 "Serine/threonine-protein | 0.974 | 0.354 | 0.488 | 1.9e-76 |
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 807 (289.1 bits), Expect = 2.2e-80, P = 2.2e-80
Identities = 160/306 (52%), Positives = 213/306 (69%)
Query: 5 ICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIY 64
+ +G+L +GQEMAVKRLS+TS QG +EF+NEVKL ARLQH+NL+ +L C EKMLIY
Sbjct: 540 VYKGKLLDGQEMAVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIY 599
Query: 65 DYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL 124
+Y+ N SLD ++FD R L+W+ R II GI +GLLYL + S I+HRDLKASNILL
Sbjct: 600 EYLENLSLDSHLFDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILL 659
Query: 125 DYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLL 184
D M PKISDFGMAR F +DE EANT ++VGTYGY+ PEY GI+SMK DV+S+GVLLL
Sbjct: 660 DKYMTPKISDFGMARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLL 719
Query: 185 QILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWK---LMRCMQVA 241
+I+ KR +Y + LNLL + WK G+G+E ID + DSSS ++ ++RC+Q+
Sbjct: 720 EIISSKRNKGFYNSDRDLNLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIG 779
Query: 242 LLCVQENAADRPTMLEILVMLKSETADIKTPKKPAFSVKR---DNDEISECMLEANIYSV 298
LLCVQE A DRPTM +++ML SE+ I PK P + ++R D D S + ++V
Sbjct: 780 LLCVQERAEDRPTMSLVILMLGSESTTIPQPKAPGYCLERSLLDTDSSSSKQRDDESWTV 839
Query: 299 DDATIT 304
+ T++
Sbjct: 840 NQITVS 845
|
|
| TAIR|locus:2123111 CRK34 "cysteine-rich RLK (RECEPTOR-like protein kinase) 34" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 799 (286.3 bits), Expect = 1.6e-79, P = 1.6e-79
Identities = 153/311 (49%), Positives = 224/311 (72%)
Query: 5 ICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIY 64
+ +G+L +G E+AVKRLS+TS QG EEF+NE L ++LQH NL+ +LG C + EEK+L+Y
Sbjct: 359 VYRGKLSSGPEVAVKRLSKTSGQGAEEFKNEAVLVSKLQHKNLVRLLGFCLEGEEKILVY 418
Query: 65 DYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL 124
+++PNKSLD+++FD ++ LDW R +II GI +G+LYL + S LTI+HRDLKASNILL
Sbjct: 419 EFVPNKSLDYFLFDPAKQGELDWTRRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILL 478
Query: 125 DYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLL 184
D +MNPKI+DFGMAR F D+ +ANT RI GT+GY+ PEY +G +SMK DVYS+GVL+L
Sbjct: 479 DADMNPKIADFGMARIFGVDQSQANTRRIAGTFGYMSPEYAMRGHFSMKSDVYSFGVLVL 538
Query: 185 QILGGKRTSCYYGPNES-LNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALL 243
+I+ GK+ S +Y ++S NL+ +A+ LW+NG +E +D ++ +S + + RC+ +ALL
Sbjct: 539 EIISGKKNSSFYNIDDSGSNLVTHAWRLWRNGSPLELVDPTIGESYQSSEATRCIHIALL 598
Query: 244 CVQENAADRPTMLEILVMLKSETADIKTPKKPAF-----SVKRDNDEISECMLEANIYSV 298
CVQE+ ADRP + I++ML S T + P+ P F +++D E +E + S+
Sbjct: 599 CVQEDPADRPLLPAIIMMLTSSTTTLHVPRAPGFCLSGRDLEQDGVEYTESTSRSIPGSI 658
Query: 299 DDATITQPVPR 309
+DA+IT+ PR
Sbjct: 659 NDASITEFYPR 669
|
|
| TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 797 (285.6 bits), Expect = 2.6e-79, P = 2.6e-79
Identities = 153/308 (49%), Positives = 220/308 (71%)
Query: 5 ICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIY 64
+ +G L +G E+AVKRLS++S QG EF+NEV L A+LQH NL+ +LG C EE++L+Y
Sbjct: 362 VYKGTLSDGTEVAVKRLSKSSGQGEVEFKNEVVLVAKLQHRNLVRLLGFCLDGEERVLVY 421
Query: 65 DYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL 124
+Y+PNKSLD+++FD ++ LDW R II G+ +G+LYL + S LTI+HRDLKASNILL
Sbjct: 422 EYVPNKSLDYFLFDPAKKGQLDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILL 481
Query: 125 DYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLL 184
D +MNPKI+DFGMAR F D+ E NT RIVGTYGY+ PEY G YSMK DVYS+GVL+L
Sbjct: 482 DADMNPKIADFGMARIFGLDQTEENTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVL 541
Query: 185 QILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLC 244
+I+ GK+ S +Y + + +L+ YA+GLW NG +E +D ++ ++ +++RC+ + LLC
Sbjct: 542 EIISGKKNSSFYQTDGAHDLVSYAWGLWSNGRPLELVDPAIVENCQRNEVVRCVHIGLLC 601
Query: 245 VQENAADRPTMLEILVMLKSETADIKTPKKPA--FSVKRDNDEI-SECMLEANIYSVDDA 301
VQE+ A+RPT+ I++ML S T + P++P F + D + ++ ++ + SVDDA
Sbjct: 602 VQEDPAERPTLSTIVLMLTSNTVTLPVPRQPGLFFQSRIGKDPLDTDTTSKSLLGSVDDA 661
Query: 302 TITQPVPR 309
+IT PR
Sbjct: 662 SITDIHPR 669
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 790 (283.2 bits), Expect = 1.4e-78, P = 1.4e-78
Identities = 156/305 (51%), Positives = 211/305 (69%)
Query: 5 ICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIY 64
+ +G L +G+E+AVKRLS+ S QG +EF NEV+L A+LQH+NL+ +LG C + EKMLIY
Sbjct: 537 VYKGMLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIY 596
Query: 65 DYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL 124
+Y+ N SLD ++FD R L+W+ R II GI +GLLYL + S I+HRDLKASN+LL
Sbjct: 597 EYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLL 656
Query: 125 DYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLL 184
D M PKISDFGMAR F ++E EANT R+VGTYGY+ PEY GI+SMK DV+S+GVLLL
Sbjct: 657 DKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLL 716
Query: 185 QILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDS-SLDDSSSAW---KLMRCMQV 240
+I+ GKR +Y N LNLL + + WK G+ +E +D ++D SS + +++RC+Q+
Sbjct: 717 EIISGKRNKGFYNSNRDLNLLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQI 776
Query: 241 ALLCVQENAADRPTMLEILVMLKSETADIKTPKKPAFSVKRDNDEISECMLEANIYSVDD 300
LLCVQE A DRP M ++VML SET I PK+P F V R + E+ ++ D+
Sbjct: 777 GLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCVGRSSLEVDS---SSSTQRDDE 833
Query: 301 ATITQ 305
T+ Q
Sbjct: 834 CTVNQ 838
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 789 (282.8 bits), Expect = 1.8e-78, P = 1.8e-78
Identities = 156/305 (51%), Positives = 209/305 (68%)
Query: 5 ICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIY 64
+ +GRL +G+E+AVKRLS+ S QG +EF NEV+L A+LQH+NL+ +LG C + EKMLIY
Sbjct: 533 VYKGRLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIY 592
Query: 65 DYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL 124
+Y+ N SLD ++FD R L+W+ R II GI +GLLYL + S I+HRDLKASN+LL
Sbjct: 593 EYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLL 652
Query: 125 DYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLL 184
D M PKISDFGMAR F ++E EANT R+VGTYGY+ PEY GI+SMK DV+S+GVLLL
Sbjct: 653 DKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLL 712
Query: 185 QILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDS-SLDDSSSAW---KLMRCMQV 240
+I+ GKR +Y N LNLL + + WK G +E +D ++D SS + +++RC+Q+
Sbjct: 713 EIISGKRNKGFYNSNRDLNLLGFVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQI 772
Query: 241 ALLCVQENAADRPTMLEILVMLKSETADIKTPKKPAFSVKRDNDEISECMLEANIYSVDD 300
LLCVQE A DRP M ++VML SET I PK+P F + R E ++ D+
Sbjct: 773 GLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCIGRSPLEADS---SSSTQRDDE 829
Query: 301 ATITQ 305
T+ Q
Sbjct: 830 CTVNQ 834
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 785 (281.4 bits), Expect = 4.8e-78, P = 4.8e-78
Identities = 153/304 (50%), Positives = 220/304 (72%)
Query: 5 ICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIY 64
+ +G L +G+E+AVKRLS S QG++EF+NE+ L A+LQH NL+ +LG C + EEKML+Y
Sbjct: 543 VYKGVLEDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVY 602
Query: 65 DYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL 124
+YMPNKSLDF++FD ++ L+DW+ R IIEGI +GLLYL S L I+HRDLK SN+LL
Sbjct: 603 EYMPNKSLDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLL 662
Query: 125 DYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLL 184
D EMNPKISDFGMAR F ++ EANT R+VGTYGY+ PEY +G++S+K DVYS+GVLLL
Sbjct: 663 DAEMNPKISDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLL 722
Query: 185 QILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLC 244
+I+ GKR + +E +L+ YA+ L+ +G E +D + + S + +RC+ VA+LC
Sbjct: 723 EIVSGKRNTSLRS-SEHGSLIGYAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLC 781
Query: 245 VQENAADRPTMLEILVMLKSETADIKTPKKPAF-SVKRDNDEISECMLEANIYSVDDATI 303
VQ++AA+RP M +L+ML+S+TA + P++P F S +R++ +++ + + Y V I
Sbjct: 782 VQDSAAERPNMASVLLMLESDTATLAAPRQPTFTSTRRNSIDVNFALDSSQQYIVSSNEI 841
Query: 304 TQPV 307
T V
Sbjct: 842 TSTV 845
|
|
| TAIR|locus:2121686 CRK19 "cysteine-rich RLK (RECEPTOR-like protein kinase) 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 781 (280.0 bits), Expect = 1.3e-77, P = 1.3e-77
Identities = 152/306 (49%), Positives = 210/306 (68%)
Query: 5 ICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIY 64
+ +G L +G ++AVKRLS+TS QG +EFENEV + A+LQH NL+ +LG C + EEK+L+Y
Sbjct: 340 VYKGTLSSGLQVAVKRLSKTSGQGEKEFENEVVVVAKLQHRNLVKLLGYCLEGEEKILVY 399
Query: 65 DYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL 124
+++PNKSLD ++FD + LDW R II GI +G+LYL + S LTI+HRDLKA NILL
Sbjct: 400 EFVPNKSLDHFLFDSTMKMKLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILL 459
Query: 125 DYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLL 184
D +MNPKI+DFGMAR F D+ EA T R+VGTYGY+ PEY G +SMK DVYS+GVL+L
Sbjct: 460 DDDMNPKIADFGMARIFGMDQTEAMTRRVVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVL 519
Query: 185 QILGGKRTSCYYGPNESL-NLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALL 243
+I+ G + S Y +ES+ NL+ Y + LW NG E +D S D+ ++ RC+ +ALL
Sbjct: 520 EIISGMKNSSLYQMDESVGNLVTYTWRLWSNGSPSELVDPSFGDNYQTSEITRCIHIALL 579
Query: 244 CVQENAADRPTMLEILVMLKSETADIKTPKKPAFSVKRDNDEISECMLEANIYSVDDATI 303
CVQE+A DRPTM I+ ML + + P+ P F + ++ + + SVD+A+I
Sbjct: 580 CVQEDAEDRPTMSSIVQMLTTSLIALAEPRPPGFFFRSKQEQAGPSIDSSTHCSVDEASI 639
Query: 304 TQPVPR 309
T+ PR
Sbjct: 640 TRVTPR 645
|
|
| TAIR|locus:2093397 CES101 "CALLUS EXPRESSION OF RBCS 101" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 780 (279.6 bits), Expect = 1.6e-77, P = 1.6e-77
Identities = 153/305 (50%), Positives = 219/305 (71%)
Query: 5 ICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIY 64
+ +GRL +G+E+A+KRLS S QGL EF+NE L A+LQH NL+ +LG C +++EKMLIY
Sbjct: 541 VYKGRLIDGEEVAIKRLSLASGQGLVEFKNEAMLIAKLQHTNLVKLLGCCVEKDEKMLIY 600
Query: 65 DYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL 124
+YMPNKSLD+++FD R+ +LDW+ R I+EGI QGLLYL +YS L ++HRD+KA NILL
Sbjct: 601 EYMPNKSLDYFLFDPLRKIVLDWKLRFRIMEGIIQGLLYLHKYSRLKVIHRDIKAGNILL 660
Query: 125 DYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLL 184
D +MNPKISDFGMAR F E +ANT R+ GT+GY+ PEY R+G++S K DV+S+GVL+L
Sbjct: 661 DEDMNPKISDFGMARIFGAQESKANTKRVAGTFGYMSPEYFREGLFSAKSDVFSFGVLML 720
Query: 185 QILGGKRTSCYYGPNES-LNLLEYAYGLWKNGEGMEFIDSSLDDSS-SAWKLMRCMQVAL 242
+I+ G++ + ++ +E LNL+ + + L+K E ID SL DS+ +++RC+QVAL
Sbjct: 721 EIICGRKNNSFHHDSEGPLNLIVHVWNLFKENRVREVIDPSLGDSAVENPQVLRCVQVAL 780
Query: 243 LCVQENAADRPTMLEILVMLKSETAD-IKTPKKPAF--SVKRDNDEISECMLEANIYSVD 299
LCVQ+NA DRP+ML+++ M+ + + + PK+PAF R + E+ E S +
Sbjct: 781 LCVQQNADDRPSMLDVVSMIYGDGNNALSLPKEPAFYDGPPRSSPEMEVEPPEMENVSAN 840
Query: 300 DATIT 304
TIT
Sbjct: 841 RVTIT 845
|
|
| TAIR|locus:2121626 CRK23 "cysteine-rich RLK (RECEPTOR-like protein kinase) 23" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 775 (277.9 bits), Expect = 5.5e-77, P = 5.5e-77
Identities = 148/309 (47%), Positives = 211/309 (68%)
Query: 5 ICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIY 64
+ +G P+G ++AVKRLS+TS QG EFENEV + A+LQH NL+ +LG C + EEK+L+Y
Sbjct: 522 VYKGTFPSGVQVAVKRLSKTSGQGEREFENEVVVVAKLQHRNLVRLLGYCLEGEEKILVY 581
Query: 65 DYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL 124
+++ NKSLD+++FD + LDW R II GI +G+LYL + S LTI+HRDLKA NILL
Sbjct: 582 EFVHNKSLDYFLFDTTMKRQLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILL 641
Query: 125 DYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLL 184
D +MNPK++DFGMAR F D+ EANT R+VGTYGY+ PEY G +SMK DVYS+GVL+
Sbjct: 642 DADMNPKVADFGMARIFGMDQTEANTRRVVGTYGYMAPEYAMYGQFSMKSDVYSFGVLVF 701
Query: 185 QILGGKRTSCYYGPNESL-NLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALL 243
+I+ G + S Y ++S+ NL+ Y + LW NG ++ +D S D+ + RC+ +ALL
Sbjct: 702 EIISGMKNSSLYQMDDSVSNLVTYTWRLWSNGSQLDLVDPSFGDNYQTHDITRCIHIALL 761
Query: 244 CVQENAADRPTMLEILVMLKSETADIKTPKKPAFSVKRDNDEISECMLEAN---IYSVDD 300
CVQE+ DRP M I+ ML + + + PK+P F + ++++ E + + S+DD
Sbjct: 762 CVQEDVDDRPNMSAIVQMLTTSSIVLAVPKQPGFFFRGRHEQVGEVGSSVDRLALCSIDD 821
Query: 301 ATITQPVPR 309
A+IT PR
Sbjct: 822 ASITSVAPR 830
|
|
| UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)] | Back alignment and assigned GO terms |
|---|
Score = 770 (276.1 bits), Expect = 1.9e-76, P = 1.9e-76
Identities = 147/301 (48%), Positives = 209/301 (69%)
Query: 5 ICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIY 64
+ G LP G+E+AVKRL R S QGLEEF+NEV L A+LQH NL+ +LG C REEK+L+Y
Sbjct: 544 VYMGTLPGGEEVAVKRLCRNSGQGLEEFKNEVILIAKLQHRNLVRLLGCCIPREEKILVY 603
Query: 65 DYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL 124
+YMPNKSLD ++F+ ++ LLDW+ R IIEGI +GLLYL S L +VHRDLKASNILL
Sbjct: 604 EYMPNKSLDAFLFNPEKQRLLDWKKRFDIIEGIARGLLYLHRDSRLRVVHRDLKASNILL 663
Query: 125 DYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLL 184
D +M PKISDFGMAR F D+ + NT R+VGT+GY+ PEY +GI+S+K DVY +GVL+L
Sbjct: 664 DADMKPKISDFGMARMFGGDQNQFNTNRVVGTFGYMSPEYAMEGIFSVKSDVYGFGVLIL 723
Query: 185 QILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLC 244
+I+ GKR ++ +SLN+ YA+ W E ID + S S +++RC+ +ALLC
Sbjct: 724 EIITGKRAVSFHCHEDSLNIAGYAWRQWNEDNAAELIDPVIRASCSVRQVLRCIHIALLC 783
Query: 245 VQENAADRPTMLEILVMLKSETADIKTPKKPAFSVKRDNDEISECMLEANIYSVDDATIT 304
VQ++A +RP + +++ML ++++ + P+ P ++ E S+ + +S+ T+T
Sbjct: 784 VQDHADERPDIPTVILMLSNDSSSLPNPRPPTLMLRGREIESSKSSEKDRSHSIGTVTMT 843
Query: 305 Q 305
Q
Sbjct: 844 Q 844
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | gw1.XVIII.3343.1 | hypothetical protein (327 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 309 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-40 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-39 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-39 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-38 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-37 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-35 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-34 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-29 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-24 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-24 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-24 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-23 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-23 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-22 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-22 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-22 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-22 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-22 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-21 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-21 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-21 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 9e-21 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-19 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-19 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-19 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-19 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-19 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-18 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-18 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-18 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-17 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-17 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-17 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-16 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-16 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-16 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-16 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-16 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-16 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-16 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-16 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-16 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-15 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-15 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-15 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-15 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-15 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-15 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-15 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-14 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-14 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-14 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-14 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 9e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-13 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-13 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-13 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-13 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-13 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-13 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-12 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-12 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-12 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-12 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-12 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-12 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-12 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-12 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-12 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-12 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 9e-12 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-11 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-11 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-11 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-11 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-11 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-11 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-11 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 8e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 8e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-10 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-10 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-10 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-10 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-10 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-10 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 6e-10 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-10 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 8e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-09 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-09 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-09 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-09 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-09 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-09 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 9e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 9e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-08 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-08 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-08 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-08 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-08 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-08 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-08 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-08 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-08 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-08 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-07 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-07 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-07 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-07 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-07 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-07 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-07 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-07 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-07 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-07 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-06 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-06 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-06 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-06 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-06 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-06 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-06 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-06 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-06 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-05 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-05 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-05 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-05 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-05 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 8e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-04 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-04 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 0.001 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.002 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 0.002 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.003 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.003 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 0.003 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 4e-40
Identities = 76/267 (28%), Positives = 128/267 (47%), Gaps = 33/267 (12%)
Query: 5 ICQGRL-----PNGQEMAVKRLSRTSH-QGLEEFENEVKLTARLQHVNLLPVLGICTQRE 58
+ +G+L E+AVK L + Q +EEF E ++ +L H N++ +LG+CT+ E
Sbjct: 15 VYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEE 74
Query: 59 EKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLK 118
++ +YM L Y+ R + L + I +G+ YL + +HRDL
Sbjct: 75 PLYIVMEYMEGGDLLSYLRKNRPK--LSLSDLLSFALQIARGMEYL---ESKNFIHRDLA 129
Query: 119 ASNILLDYEMNPKISDFGMARAFTKDE-CEANTGRIVGTYGYVPPEYVRKGIYSMKYDVY 177
A N L+ + KISDFG++R D+ G++ ++ PE +++G ++ K DV+
Sbjct: 130 ARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL--PIRWMAPESLKEGKFTSKSDVW 187
Query: 178 SYGVLLLQI--LGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235
S+GVLL +I LG + Y + +LEY KNG + + +
Sbjct: 188 SFGVLLWEIFTLGEQ----PYPGMSNEEVLEYL----KNGYRLPQPPNCPPE-------- 231
Query: 236 RCMQVALLCVQENAADRPTMLEILVML 262
+ L C E+ DRPT E++ +L
Sbjct: 232 -LYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 4e-39
Identities = 58/178 (32%), Positives = 94/178 (52%), Gaps = 10/178 (5%)
Query: 12 NGQEMAVKRLSR-TSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNK 70
G+++A+K + + S LEE E+++ +L H N++ + G+ L+ +Y
Sbjct: 17 TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGG 76
Query: 71 SLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY-EMN 129
SL + + + L + I+ I +GL YL I+HRDLK NILLD
Sbjct: 77 SLKDLLKENEGK--LSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGK 131
Query: 130 PKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVR-KGIYSMKYDVYSYGVLLLQI 186
K++DFG+++ T D+ T IVGT Y+ PE + KG YS K D++S GV+L ++
Sbjct: 132 VKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 4e-39
Identities = 78/267 (29%), Positives = 129/267 (48%), Gaps = 32/267 (11%)
Query: 5 ICQGRL-----PNGQEMAVKRL-SRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQRE 58
+ +G L E+AVK L S Q +EEF E ++ +L H N++ +LG+CT+ E
Sbjct: 15 VYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEE 74
Query: 59 EKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLK 118
M++ +YMP L Y+ R L + I +G+ YL + +HRDL
Sbjct: 75 PLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYL---ESKNFIHRDLA 130
Query: 119 ASNILLDYEMNPKISDFGMARA-FTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVY 177
A N L+ + KISDFG++R + D + G++ ++ PE +++G ++ K DV+
Sbjct: 131 ARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESLKEGKFTSKSDVW 188
Query: 178 SYGVLLLQI--LGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235
S+GVLL +I LG + Y + +LEY K G + + +
Sbjct: 189 SFGVLLWEIFTLGEE----PYPGMSNAEVLEYL----KKGYRLPKPPNCPPE-------- 232
Query: 236 RCMQVALLCVQENAADRPTMLEILVML 262
++ L C E+ DRPT E++ +L
Sbjct: 233 -LYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 1e-38
Identities = 77/261 (29%), Positives = 111/261 (42%), Gaps = 22/261 (8%)
Query: 2 SVAICQGRLPNGQEMAVKRL--SRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREE 59
+V + G+ +AVK L + + E+++ RL H N++ ++ ++
Sbjct: 14 TVYKAK-HKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDH 72
Query: 60 KMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKA 119
L+ +Y L Y+ L I I +GL YL I+HRDLK
Sbjct: 73 LYLVMEYCEGGDLFDYLSRGGP---LSEDEAKKIALQILRGLEYLHSNG---IIHRDLKP 126
Query: 120 SNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGI-YSMKYDVYS 178
NILLD KI+DFG+A+ K T VGT Y+ PE + G Y K DV+S
Sbjct: 127 ENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGTPWYMAPEVLLGGNGYGPKVDVWS 184
Query: 179 YGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238
GV+L ++L GK + G N L L E E SS S A L++
Sbjct: 185 LGVILYELLTGK--PPFSGENILDQLQLIRRILGPPLEFDEPKWSSG--SEEAKDLIKKC 240
Query: 239 QVALLCVQENAADRPTMLEIL 259
L + + RPT EIL
Sbjct: 241 ----LNK--DPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 3e-37
Identities = 80/275 (29%), Positives = 130/275 (47%), Gaps = 41/275 (14%)
Query: 4 AICQGRLPNGQEMAVKRL-SRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKML 62
+G+ E+AVK L S + ++F E ++ +L H N++ +LG+CT+ E L
Sbjct: 14 GKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYL 73
Query: 63 IYDYMPNKSLDFYI------FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRD 116
+ +YM L Y+ F + L + + I +G+ YL ++ VHRD
Sbjct: 74 VLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL---ASKKFVHRD 130
Query: 117 LKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP-----PEYVRKGIYS 171
L A N L+ ++ KISDFG++R D+ G +P PE ++ GI++
Sbjct: 131 LAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTG-----GKLPIRWMAPESLKDGIFT 185
Query: 172 MKYDVYSYGVLLLQI--LGGKRTSCYYG-PNESLNLLEYAYGLWKNGEGMEFIDSSLDDS 228
K DV+S+GVLL +I LG + Y G NE +LEY + G + + D+
Sbjct: 186 SKSDVWSFGVLLWEIFTLGA---TPYPGLSNE--EVLEYL----RKGYRLPKPEYCPDE- 235
Query: 229 SSAWKLMRCMQVALLCVQENAADRPTMLEILVMLK 263
++LM C Q + DRPT E++ L+
Sbjct: 236 --LYELMLS------CWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 2e-35
Identities = 76/260 (29%), Positives = 121/260 (46%), Gaps = 37/260 (14%)
Query: 12 NGQEMAVKRLSR-TSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNK 70
++AVK L S + EEF E + +L H N++ +LG+CTQ E ++ +YMP
Sbjct: 27 TETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGG 86
Query: 71 SLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNP 130
L ++ + L + + + I +G+ YL + VHRDL A N L+ +
Sbjct: 87 DLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYL---ESKNFVHRDLAARNCLVTENLVV 141
Query: 131 KISDFGMARAFTKDECEANTGRIVGTYGYVP-----PEYVRKGIYSMKYDVYSYGVLLLQ 185
KISDFG++R +D+ G +P PE ++ G ++ K DV+S+GVLL +
Sbjct: 142 KISDFGLSRDIYEDDYY-----RKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWE 196
Query: 186 IL-GGKRTSCYYG--PNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVAL 242
I G++ Y G E L LLE +G + + ++LM L
Sbjct: 197 IFTLGEQP--YPGMSNEEVLELLE-------DGYRLPR---PENCPDELYELM------L 238
Query: 243 LCVQENAADRPTMLEILVML 262
C + DRPT E++ L
Sbjct: 239 QCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-34
Identities = 68/253 (26%), Positives = 110/253 (43%), Gaps = 25/253 (9%)
Query: 9 RLPNGQEMAVKRLSRTSHQGLEE-FENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYM 67
G+ +A+K + + + E E+K+ +L+H N++ + + ++ L+ +Y
Sbjct: 20 DKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYC 79
Query: 68 PNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYE 127
L + +R L + R + I L YL IVHRDLK NILLD +
Sbjct: 80 EGGDLFDLL--KKRGRLSEDEAR-FYLRQILSALEYLHS---KGIVHRDLKPENILLDED 133
Query: 128 MNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQIL 187
+ K++DFG+AR E VGT Y+ PE + Y D++S GV+L ++L
Sbjct: 134 GHVKLADFGLARQLDPGE---KLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELL 190
Query: 188 GGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDD-SSSAWKLMRCMQVALLCVQ 246
GK + G ++ L L + K G+ D S A L+R + L
Sbjct: 191 TGKPP--FPGDDQLLELFK------KIGKPKPPFPPPEWDISPEAKDLIRKL----LVK- 237
Query: 247 ENAADRPTMLEIL 259
+ R T E L
Sbjct: 238 -DPEKRLTAEEAL 249
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-29
Identities = 60/186 (32%), Positives = 96/186 (51%), Gaps = 14/186 (7%)
Query: 12 NGQEMAVK--RLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKML-IY-DYM 67
G+ MAVK LS S + LE E E+++ + LQH N++ G E+ L I+ +Y+
Sbjct: 24 TGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYV 83
Query: 68 PNKSLDFYIFDLRRRY--LLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLD 125
SL L +++ L + R + + I +GL YL IVHRD+K +NIL+D
Sbjct: 84 SGGSLS----SLLKKFGKLPEPVIRKYTRQ-ILEGLAYLHSNG---IVHRDIKGANILVD 135
Query: 126 YEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQ 185
+ K++DFG A+ E TG + GT ++ PE +R Y D++S G +++
Sbjct: 136 SDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIE 195
Query: 186 ILGGKR 191
+ GK
Sbjct: 196 MATGKP 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 3e-24
Identities = 71/259 (27%), Positives = 122/259 (47%), Gaps = 37/259 (14%)
Query: 13 GQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSL 72
GQ++AVK L S + F E + L+H NL+ +LG+ Q ++ +YM SL
Sbjct: 29 GQKVAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSL 87
Query: 73 DFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKI 132
Y+ R R ++ ++ + +G+ YL+E + VHRDL A N+L+ ++ K+
Sbjct: 88 VDYLRS-RGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKV 143
Query: 133 SDFGMARAFTKDECEANTGRIVGTYGYVP-----PEYVRKGIYSMKYDVYSYGVLLLQIL 187
SDFG+A K+ + G +P PE +R+ +S K DV+S+G+LL +I
Sbjct: 144 SDFGLA----KEASQGQDS------GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIY 193
Query: 188 GGKRTSCYYGPNESL-NLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQ 246
R Y P L +++ + + G ME + + +K+M+ C +
Sbjct: 194 SFGRVP-Y--PRIPLKDVVPHV----EKGYRMEAPEGCPPE---VYKVMK------DCWE 237
Query: 247 ENAADRPTMLEILVMLKSE 265
+ A RPT ++ L
Sbjct: 238 LDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 4e-24
Identities = 73/270 (27%), Positives = 124/270 (45%), Gaps = 39/270 (14%)
Query: 5 ICQGRL--PNGQE--MAVKRLSRTSHQGLE-EFENEVKLTARLQHVNLLPVLGICTQREE 59
+C+GRL P +E +A+K L S +F E + + H N++ + G+ T+
Sbjct: 20 VCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP 79
Query: 60 KMLIYDYMPNKSLDFYIFDLRR-RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLK 118
M+I +YM N SLD + LR V ++ GI G+ YL S + VHRDL
Sbjct: 80 VMIITEYMENGSLDKF---LRENDGKFTVGQLVGMLRGIASGMKYL---SEMNYVHRDLA 133
Query: 119 ASNILLDYEMNPKISDFGMARAF--TKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDV 176
A NIL++ + K+SDFG++R ++ G+I + PE + ++ DV
Sbjct: 134 ARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI--PIRWTAPEAIAYRKFTSASDV 191
Query: 177 YSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMR 236
+S+G+++ ++ YG E Y N + + +++D M
Sbjct: 192 WSFGIVMWEV-------MSYG--------ERPYWDMSNQDVI----KAVEDGYRLPPPMD 232
Query: 237 C----MQVALLCVQENAADRPTMLEILVML 262
C Q+ L C Q++ +RPT +I+ L
Sbjct: 233 CPSALYQLMLDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 6e-24
Identities = 56/230 (24%), Positives = 99/230 (43%), Gaps = 21/230 (9%)
Query: 30 EEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRT 89
++F E K+ +L H NL+ + G+CT++ ++ +YM N L Y+ R+ L
Sbjct: 44 DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYL--RERKGKLGTEW 101
Query: 90 RVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEAN 149
+ + + + + YL+ +HRDL A N L+ + K+SDFG+AR D+ ++
Sbjct: 102 LLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158
Query: 150 TGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAY 209
G + PPE +S K DV+S+GVL+ ++ + Y
Sbjct: 159 QGTKF-PVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMP---------------Y 202
Query: 210 GLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEIL 259
+ N E +E + + + C E DRP ++L
Sbjct: 203 ERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLL 252
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 1e-23
Identities = 65/216 (30%), Positives = 106/216 (49%), Gaps = 33/216 (15%)
Query: 15 EMAVKRL-SRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLD 73
+A+K L TS + +E +E + A + H +++ +LGIC + LI MP L
Sbjct: 38 PVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLL 96
Query: 74 FYIFD----LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMN 129
Y+ + + +YLL+W + I +G+ YL+E +VHRDL A N+L+ +
Sbjct: 97 DYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLEEKR---LVHRDLAARNVLVKTPQH 147
Query: 130 PKISDFGMARAFTKDECEANTGRIVGTYGYVP-----PEYVRKGIYSMKYDVYSYGVLLL 184
KI+DFG+A+ DE E + G VP E + IY+ K DV+SYGV +
Sbjct: 148 VKITDFGLAKLLDVDEKEYHA-----EGGKVPIKWMALESILHRIYTHKSDVWSYGVTVW 202
Query: 185 QILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGME 219
+++ G + P E + +E L + GE +
Sbjct: 203 ELMTFGAK------PYEGIPAVEIP-DLLEKGERLP 231
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 5e-23
Identities = 70/259 (27%), Positives = 118/259 (45%), Gaps = 28/259 (10%)
Query: 13 GQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQ--REEKMLIYDYMPN 69
G+++AVK L+ + Q +FE E+++ L H N++ G+C + LI +Y+P+
Sbjct: 33 GEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPS 92
Query: 70 KSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMN 129
SL Y+ R + ++ + + I +G+ YL + +HRDL A NIL++ E
Sbjct: 93 GSLRDYLQRHRDQ--INLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDL 147
Query: 130 PKISDFGMARAFT--KDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQIL 187
KISDFG+A+ KD + Y PE +R +S DV+S+GV L ++
Sbjct: 148 VKISDFGLAKVLPEDKDYYYVKEPGESPIFWYA-PECLRTSKFSSASDVWSFGVTLYELF 206
Query: 188 GGKRTSC--------YYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQ 239
S G + ++ L K GE + S D+ + LM+
Sbjct: 207 TYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDE---VYDLMK--- 260
Query: 240 VALLCVQENAADRPTMLEI 258
LC + DRP+ ++
Sbjct: 261 ---LCWEAEPQDRPSFADL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 1e-22
Identities = 78/269 (28%), Positives = 113/269 (42%), Gaps = 46/269 (17%)
Query: 9 RLPNGQEM--AVKRLSR-TSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYD 65
+ +G+E+ AVK L + G +EF E + A+L H ++ ++G+C + E ML+ +
Sbjct: 17 LMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVC-KGEPLMLVME 75
Query: 66 YMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLD 125
P L Y+ R + D + H + G+ YL+ VHRDL A N+LL
Sbjct: 76 LAPLGPLLKYLKKRREIPVSDLKELAH---QVAMGMAYLESKH---FVHRDLAARNVLLV 129
Query: 126 YEMNPKISDFGMARA--FTKDECEANTGRIVGTYGYVP-----PEYVRKGIYSMKYDVYS 178
KISDFGM+RA D A T G P PE + G +S K DV+S
Sbjct: 130 NRHQAKISDFGMSRALGAGSDYYRATTA------GRWPLKWYAPECINYGKFSSKSDVWS 183
Query: 179 YGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238
YGV L + YG YG K E + ++S C
Sbjct: 184 YGVTLWEAFS-------YG--------AKPYGEMKGAEVIAMLESGERLPRPE----ECP 224
Query: 239 Q----VALLCVQENAADRPTMLEILVMLK 263
Q + L C + DRPT E+ +
Sbjct: 225 QEIYSIMLSCWKYRPEDRPTFSELESTFR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 96.3 bits (238), Expect = 1e-22
Identities = 57/258 (22%), Positives = 106/258 (41%), Gaps = 19/258 (7%)
Query: 14 QEMAVKRLSRT---SHQGLEEFENEVKLTARLQH-VNLLPVLGICTQREEKMLIYDYMPN 69
+ +A+K L++ + +E F E+++ A L H N++ + L+ +Y+
Sbjct: 23 KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDG 82
Query: 70 KSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMN 129
SL+ + + R+ L + I+ I L YL I+HRD+K NILLD +
Sbjct: 83 GSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGR 139
Query: 130 -PKISDFGMARAFTKDECEAN----TGRIVGTYGYVPPEYVR---KGIYSMKYDVYSYGV 181
K+ DFG+A+ ++ VGT GY+ PE + S D++S G+
Sbjct: 140 VVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGI 199
Query: 182 LLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241
L ++L G + G S + + + + S L S+ +
Sbjct: 200 TLYELLTGL--PPFEGEKNSSATSQTLKIILEL--PTPSLASPLSPSNPELISKAASDLL 255
Query: 242 LLCVQENAADRPTMLEIL 259
+ ++ +R + L
Sbjct: 256 KKLLAKDPKNRLSSSSDL 273
|
Length = 384 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 2e-22
Identities = 49/146 (33%), Positives = 75/146 (51%), Gaps = 11/146 (7%)
Query: 56 QREEKM-LIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVH 114
Q EEK+ L+ +Y P L ++ + + R R + E I L YL +L I++
Sbjct: 63 QTEEKLYLVLEYAPGGELFSHL--SKEGRFSEERARFYAAE-IVLALEYLH---SLGIIY 116
Query: 115 RDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKY 174
RDLK NILLD + + K++DFG+A+ + + NT GT Y+ PE + Y
Sbjct: 117 RDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLLGKGYGKAV 174
Query: 175 DVYSYGVLLLQILGGKRTSCYYGPNE 200
D +S GVLL ++L GK +Y +
Sbjct: 175 DWWSLGVLLYEMLTGK--PPFYAEDR 198
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 6e-22
Identities = 54/185 (29%), Positives = 95/185 (51%), Gaps = 16/185 (8%)
Query: 7 QGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDY 66
+G N +A+K L ++F+ EV+ RL+H +L+ + +C+ E +I +
Sbjct: 24 EGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83
Query: 67 MPNKSLDFYIFD-----LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASN 121
M SL ++ L L+D +V +G+ YL+E + +HRDL A N
Sbjct: 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQV------AEGMAYLEEQN---SIHRDLAARN 134
Query: 122 ILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGV 181
IL+ ++ K++DFG+AR +D ++ +I Y + PE G +S K DV+S+G+
Sbjct: 135 ILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTFSTKSDVWSFGI 192
Query: 182 LLLQI 186
LL ++
Sbjct: 193 LLYEM 197
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 6e-22
Identities = 68/266 (25%), Positives = 110/266 (41%), Gaps = 35/266 (13%)
Query: 7 QGRLPNGQEMAVKRLSRTSHQGL-EEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYD 65
+G L E+AVK T L +F E ++ + H N++ ++G+C Q++ ++ +
Sbjct: 13 KGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVME 72
Query: 66 YMPNKSLDFYIFDLRRRY-LLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL 124
+P SL + LR++ L + + + G+ YL E N +HRDL A N L+
Sbjct: 73 LVPGGSLLTF---LRKKKNRLTVKKLLQMSLDAAAGMEYL-ESKN--CIHRDLAARNCLV 126
Query: 125 DYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLL 184
KISDFGM+R + G + PE + G Y+ + DV+SYG+LL
Sbjct: 127 GENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLW 186
Query: 185 QILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDS----SLDDSSSAW--KLMRCM 238
+ Y P N + E I+S +LM
Sbjct: 187 ETFSLG--DTPY-PG------------MSNQQTRERIESGYRMPAPQLCPEEIYRLM--- 228
Query: 239 QVALLCVQENAADRPTMLEILVMLKS 264
L C + +RP+ EI L+
Sbjct: 229 ---LQCWAYDPENRPSFSEIYNELQI 251
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 1e-21
Identities = 75/264 (28%), Positives = 120/264 (45%), Gaps = 33/264 (12%)
Query: 17 AVKRLSRT-SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFY 75
AVK L S E+F EVK+ +RL N+ +LG+CT +I +YM N L+ +
Sbjct: 50 AVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQF 109
Query: 76 IFDLRRRYLLD-----------WRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL 124
L++ + T +++ I G+ YL +L VHRDL N L+
Sbjct: 110 ---LQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLV 163
Query: 125 DYEMNPKISDFGMAR-AFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLL 183
KI+DFGM+R ++ D GR ++ E V G ++ K DV+++GV L
Sbjct: 164 GKNYTIKIADFGMSRNLYSSDYYRVQ-GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTL 222
Query: 184 LQILGGKRTSCYYGPNESLN---LLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQV 240
+IL T C P E L ++E A +++ ++ + ++LM
Sbjct: 223 WEIL----TLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELM----- 273
Query: 241 ALLCVQENAADRPTMLEILVMLKS 264
L C + + DRPT EI + L+
Sbjct: 274 -LECWRRDEEDRPTFREIHLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 2e-21
Identities = 68/273 (24%), Positives = 119/273 (43%), Gaps = 58/273 (21%)
Query: 17 AVKRLSRTSHQGLEE-FENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFY 75
AVK L T+ + FE E +L QH N++ G+CT+ + +++++YM + L+ +
Sbjct: 39 AVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKF 98
Query: 76 IF----DLRRRYLLDWRTR-------VHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL 124
+ D D + I I G++YL ++ VHRDL N L+
Sbjct: 99 LRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLV 155
Query: 125 DYEMNPKISDFGMAR-AFTKDECEANTGRIVGT----YGYVPPEYVRKGIYSMKYDVYSY 179
Y++ KI DFGM+R +T D R+ G ++PPE + ++ + DV+S+
Sbjct: 156 GYDLVVKIGDFGMSRDVYTTDYY-----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSF 210
Query: 180 GVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRC- 237
GV+L +I GK+ +YG + N E +E I +L++
Sbjct: 211 GVVLWEIFTYGKQP--WYGLS--------------NEEVIECITQG--------RLLQRP 246
Query: 238 -------MQVALLCVQENAADRPTMLEILVMLK 263
+ L C + + R + +I L+
Sbjct: 247 RTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 5e-21
Identities = 72/247 (29%), Positives = 119/247 (48%), Gaps = 29/247 (11%)
Query: 16 MAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFY 75
+AVK L + +EEF E + ++H NL+ +LG+CT+ +I ++M +L Y
Sbjct: 34 VAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 92
Query: 76 IFDLRR--RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKIS 133
LR R ++ +++ I+ + YL++ + +HRDL A N L+ K++
Sbjct: 93 ---LRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVA 146
Query: 134 DFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTS 193
DFG++R T D A+ G + PE + +S+K DV+++GVLL +I
Sbjct: 147 DFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEI------- 198
Query: 194 CYYG--PNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAAD 251
YG P ++ L Y L + G ME + ++LMR C Q N +D
Sbjct: 199 ATYGMSPYPGID-LSQVYELLEKGYRMERPEGC---PPKVYELMRA------CWQWNPSD 248
Query: 252 RPTMLEI 258
RP+ EI
Sbjct: 249 RPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 6e-21
Identities = 73/285 (25%), Positives = 126/285 (44%), Gaps = 60/285 (21%)
Query: 10 LPNGQEM----AVKRLSRTSHQG--LEEFENEVKLTARLQHVNLLPVLGICTQREEKMLI 63
PN + A+K L + + + +EF E +L + LQH N++ +LG+CT+ + ++
Sbjct: 28 GPNERLSATSVAIKTL-KENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCML 86
Query: 64 YDYMPNKSLDFYIF-------------DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNL 110
++Y+ + L ++ D + LD +HI I G+ YL S+
Sbjct: 87 FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYL---SSH 143
Query: 111 TIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIY 170
VHRDL A N L+ + KISDFG++R + + + ++PPE + G +
Sbjct: 144 HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKF 203
Query: 171 SMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGL-----WKNGEGMEFIDS-- 223
+ + D++S+GV+L +I ++YGL + N E +E I S
Sbjct: 204 TTESDIWSFGVVLWEI--------------------FSYGLQPYYGFSNQEVIEMIRSRQ 243
Query: 224 ----SLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKS 264
D + + LM + C E A RP +I L+S
Sbjct: 244 LLPCPEDCPARVYALM------IECWNEIPARRPRFKDIHTRLRS 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 9e-21
Identities = 61/187 (32%), Positives = 97/187 (51%), Gaps = 12/187 (6%)
Query: 13 GQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQ--REEKMLIYDYMPNK 70
G+ +AVK+L ++ + L +FE E+++ LQH N++ G+C R L+ +Y+P
Sbjct: 33 GEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYG 92
Query: 71 SLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNP 130
SL Y+ R R LD R + I +G+ YL VHRDL NIL++ E
Sbjct: 93 SLRDYLQKHRER--LDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRV 147
Query: 131 KISDFGMARAFTKDECEANTGRIVG---TYGYVPPEYVRKGIYSMKYDVYSYGVLLLQIL 187
KI DFG+ + +D+ E R G + Y PE + + +S+ DV+S+GV+L ++
Sbjct: 148 KIGDFGLTKVLPQDK-EYYKVREPGESPIFWYA-PESLTESKFSVASDVWSFGVVLYELF 205
Query: 188 GGKRTSC 194
SC
Sbjct: 206 TYSDKSC 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 5e-20
Identities = 53/182 (29%), Positives = 93/182 (51%), Gaps = 9/182 (4%)
Query: 12 NGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKS 71
+++A+K + R E+F E ++ +L H L+ + G+CT+R L++++M +
Sbjct: 27 EKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGC 85
Query: 72 LDFYIFDLR-RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNP 130
L Y LR +R T + + + +G+ YL+ + ++HRDL A N L+
Sbjct: 86 LSDY---LRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVV 139
Query: 131 KISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGK 190
K+SDFGM R D+ ++TG + PE YS K DV+S+GVL+ ++
Sbjct: 140 KVSDFGMTRFVLDDQYTSSTGTKFPVK-WSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEG 198
Query: 191 RT 192
+T
Sbjct: 199 KT 200
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 1e-19
Identities = 72/270 (26%), Positives = 131/270 (48%), Gaps = 38/270 (14%)
Query: 5 ICQGRL--PNGQEMAVK----RLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQRE 58
+C GRL P +E+ V + T Q +F +E + + H N++ + G+ T+ +
Sbjct: 20 VCSGRLKLPGKREIPVAIKTLKAGYTEKQ-RRDFLSEASIMGQFDHPNIIHLEGVVTKSK 78
Query: 59 EKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLK 118
M++ +YM N SLD ++ ++ + V ++ GI G+ YL S++ VHRDL
Sbjct: 79 PVMIVTEYMENGSLDAFLRKHDGQFTV--IQLVGMLRGIASGMKYL---SDMGYVHRDLA 133
Query: 119 ASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP-----PEYVRKGIYSMK 173
A NIL++ + K+SDFG++R D A T R G +P PE + ++
Sbjct: 134 ARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR----GGKIPIRWTAPEAIAYRKFTSA 189
Query: 174 YDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAW 232
DV+SYG+++ +++ G+R + + +E Y L + +D ++
Sbjct: 190 SDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRL----------PAPMDCPAALH 239
Query: 233 KLMRCMQVALLCVQENAADRPTMLEILVML 262
+LM L C Q++ +RP +I+ +L
Sbjct: 240 QLM------LDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-19
Identities = 71/269 (26%), Positives = 113/269 (42%), Gaps = 42/269 (15%)
Query: 8 GRLPNGQEMAVKRLSRT---SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIY 64
GR + E+ V + S Q +F E + ++ H N++ ++G+ +R + ++
Sbjct: 29 GRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILL 88
Query: 65 DYMPNKSLDFYIFDLRRR----YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKAS 120
+ M L ++ + R R L + + + +G YL+E +HRD+ A
Sbjct: 89 ELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAAR 145
Query: 121 NILLDYEMNP----KISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDV 176
N LL + P KI+DFGMAR + GR + ++PPE GI++ K DV
Sbjct: 146 NCLLTCK-GPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDV 204
Query: 177 YSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFI------DSSLDDSSS 230
+S+GVLL +I S Y P Y N E MEF+ D
Sbjct: 205 WSFGVLLWEIF-----SLGYMP----------YPGRTNQEVMEFVTGGGRLDPPKGCPGP 249
Query: 231 AWKLMRCMQVALLCVQENAADRPTMLEIL 259
+++M C Q DRP IL
Sbjct: 250 VYRIMT------DCWQHTPEDRPNFATIL 272
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 2e-19
Identities = 48/182 (26%), Positives = 93/182 (51%), Gaps = 8/182 (4%)
Query: 9 RLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMP 68
G+E+A+K + S + E+ NE+++ + +H N++ G +++E ++ ++
Sbjct: 21 HKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80
Query: 69 NKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM 128
SL + + L ++ + + +GL YL I+HRD+KA+NILL +
Sbjct: 81 GGSLK-DLLKSTNQ-TLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDG 135
Query: 129 NPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG 188
K+ DFG++ + D NT +VGT ++ PE + Y K D++S G+ +++
Sbjct: 136 EVKLIDFGLSAQLS-DTKARNT--MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAE 192
Query: 189 GK 190
GK
Sbjct: 193 GK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 3e-19
Identities = 54/175 (30%), Positives = 88/175 (50%), Gaps = 12/175 (6%)
Query: 15 EMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDF 74
++AVK L + E F E ++ +L+H L+ + +C++ E ++ +YM SL
Sbjct: 32 KVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLD 90
Query: 75 YIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISD 134
++ + L V + I +G+ YL+ +HRDL A NIL+ + KI+D
Sbjct: 91 FLKSGEGKKLR-LPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIAD 146
Query: 135 FGMARAFTKDECEANTGR---IVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQI 186
FG+AR DE A G I T PE G +++K DV+S+G+LL +I
Sbjct: 147 FGLARLIEDDEYTAREGAKFPIKWT----APEAANYGRFTIKSDVWSFGILLTEI 197
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (210), Expect = 6e-19
Identities = 52/172 (30%), Positives = 84/172 (48%), Gaps = 36/172 (20%)
Query: 35 EVKLTARLQHVNLLPVLGICTQREEK--MLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVH 92
E+KL +L+H N++ + I T + + ++++YM DL LLD V
Sbjct: 48 EIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD--------HDLTG--LLD-SPEVK 96
Query: 93 IIEG--------ITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKD 144
E + +GL YL I+HRD+K SNIL++ + K++DFG+AR +TK
Sbjct: 97 FTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153
Query: 145 ECEANTGRIVGTYGYVPPEYVRKGI------YSMKYDVYSYGVLLLQILGGK 190
T R++ T Y PPE + Y + D++S G +L ++ GK
Sbjct: 154 NSADYTNRVI-TLWYRPPE-----LLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-18
Identities = 51/181 (28%), Positives = 88/181 (48%), Gaps = 6/181 (3%)
Query: 7 QGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDY 66
+G N +AVK L + ++F E ++ +L+H L+ + +CT E ++ +
Sbjct: 24 EGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82
Query: 67 MPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY 126
M SL Y+ R L + + + G+ YL+ + +HRDL A N+L+
Sbjct: 83 MKYGSLLEYLQGGAGRAL-KLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGE 138
Query: 127 EMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQI 186
K++DFG+AR +D EA G + PE +S+K DV+S+G+LL +I
Sbjct: 139 NNICKVADFGLARVIKEDIYEAREG-AKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEI 197
Query: 187 L 187
+
Sbjct: 198 V 198
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 2e-18
Identities = 52/159 (32%), Positives = 76/159 (47%), Gaps = 11/159 (6%)
Query: 34 NEVKLTARLQHVNLLPVLGICTQREEKM-LIYDYMPNKSLDFYIFDLRRRYLLDWRTRVH 92
NE ++ L H L L Q EE M L+ D + L +++ ++ + + +
Sbjct: 49 NERRILQELNH-PFLVNLWYSFQDEENMYLVVDLLLGGDLRYHL--SQKVKFSEEQVKFW 105
Query: 93 IIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGR 152
I E I L YL I+HRD+K NILLD + + I+DF +A T D T
Sbjct: 106 ICE-IVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTS 158
Query: 153 IVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKR 191
GT GY+ PE + + YS+ D +S GV + L GKR
Sbjct: 159 TSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-18
Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 17/199 (8%)
Query: 3 VAICQGRLPNGQEM--AVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEK 60
+A C LP +M AVK L S ++F+ E +L LQH +++ G+CT+
Sbjct: 23 LAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82
Query: 61 MLIYDYMPNKSL---------DFYIFDLRRRYLLDWRT---RVHIIEGITQGLLYLQEYS 108
+++++YM + L D I T + I I G++YL +
Sbjct: 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYL---A 139
Query: 109 NLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKG 168
+L VHRDL N L+ + KI DFGM+R + GR + ++PPE +
Sbjct: 140 SLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR 199
Query: 169 IYSMKYDVYSYGVLLLQIL 187
++ + D++S+GV+L +I
Sbjct: 200 KFTTESDIWSFGVVLWEIF 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-18
Identities = 60/233 (25%), Positives = 108/233 (46%), Gaps = 27/233 (11%)
Query: 30 EEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRT 89
+EF E K+ +L H L+ + G+CT++ ++ +YM N L Y+ + +R+
Sbjct: 44 DEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRF-----Q 98
Query: 90 RVHIIE---GITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDEC 146
++E + +G+ YL+ +HRDL A N L+D + K+SDFG++R DE
Sbjct: 99 PSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155
Query: 147 EANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLE 206
++ G + PPE + +S K DV+++GVL+ ++ +L +
Sbjct: 156 TSSVGSKFPVR-WSPPEVLLYSKFSSKSDVWAFGVLMWEV---------------YSLGK 199
Query: 207 YAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEIL 259
Y + N E +E + L + + C E A +RPT ++L
Sbjct: 200 MPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 3e-18
Identities = 67/231 (29%), Positives = 103/231 (44%), Gaps = 23/231 (9%)
Query: 30 EEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRY-LLDWR 88
E+F E K+ +L H L+ + G+CTQ++ ++ ++M N L Y LR+R L
Sbjct: 44 EDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNY---LRQRQGKLSKD 100
Query: 89 TRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEA 148
+ + + + +G+ YL+ S +HRDL A N L+ K+SDFGM R DE +
Sbjct: 101 MLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157
Query: 149 NTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYA 208
++G + PPE YS K DV+S+GVL+ ++ + P E
Sbjct: 158 SSGAKF-PVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKM-----PFEK------- 204
Query: 209 YGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEIL 259
N E +E I M +V C E RPT E+L
Sbjct: 205 ---KSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELL 252
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 5e-18
Identities = 70/266 (26%), Positives = 124/266 (46%), Gaps = 31/266 (11%)
Query: 3 VAICQGRLPNGQEMAVKRLS-RTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKM 61
AIC LPN +++A+KR+ ++E EV+ ++ H N++ +E
Sbjct: 19 AAIC---LPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELW 75
Query: 62 LIYDYMPNKSLDFYIFDL-RRRY---LLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDL 117
L+ Y+ SL D+ + Y LD +++ + +GL YL +HRD+
Sbjct: 76 LVMPYLSGGSL----LDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ---IHRDI 128
Query: 118 KASNILLDYEMNPKISDFGMARAFTKDECEANTGR--IVGTYGYVPPEYV--RKGIYSMK 173
KA NILL + + KI+DFG++ + R VGT ++ PE + G Y K
Sbjct: 129 KAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHG-YDFK 187
Query: 174 YDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWK 233
D++S+G+ +++ G Y P + L L L + +E + S +++
Sbjct: 188 ADIWSFGITAIELATGAAPYSKYPPMKVLMLT-----LQNDPPSLE-TGADYKKYSKSFR 241
Query: 234 LMRCMQVALLCVQENAADRPTMLEIL 259
M ++ LC+Q++ + RPT E+L
Sbjct: 242 KM----IS-LCLQKDPSKRPTAEELL 262
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 6e-18
Identities = 56/185 (30%), Positives = 94/185 (50%), Gaps = 17/185 (9%)
Query: 8 GRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYM 67
G ++A+K L + S E F E L +LQH L+ + + TQ E +I +YM
Sbjct: 25 GYYNGHTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLVRLYAVVTQ-EPIYIITEYM 82
Query: 68 PNKSLDFYI-----FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNI 122
N SL ++ L L+D + I +G+ +++ + +HRDL+A+NI
Sbjct: 83 ENGSLVDFLKTPEGIKLTINKLIDMAAQ------IAEGMAFIERKN---YIHRDLRAANI 133
Query: 123 LLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVL 182
L+ + KI+DFG+AR +E A G + PE + G +++K DV+S+G+L
Sbjct: 134 LVSETLCCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAINYGTFTIKSDVWSFGIL 192
Query: 183 LLQIL 187
L +I+
Sbjct: 193 LTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 6e-18
Identities = 55/207 (26%), Positives = 103/207 (49%), Gaps = 18/207 (8%)
Query: 14 QEMAVKRLSRTSHQGL-EEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSL 72
Q +A+K L + L EEF++E + +RLQH N++ +LG+ T+ + +I+ Y + L
Sbjct: 36 QAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDL 95
Query: 73 DFYIF-------------DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKA 119
++ D + L+ VHI+ I G+ +L + +VH+DL
Sbjct: 96 HEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLAT 152
Query: 120 SNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSY 179
N+L+ ++N KISD G+ R + G + ++ PE + G +S+ D++SY
Sbjct: 153 RNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSY 212
Query: 180 GVLLLQILG-GKRTSCYYGPNESLNLL 205
GV+L ++ G + C Y + + ++
Sbjct: 213 GVVLWEVFSYGLQPYCGYSNQDVIEMI 239
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 7e-18
Identities = 57/197 (28%), Positives = 98/197 (49%), Gaps = 28/197 (14%)
Query: 12 NGQEMAVKR--LSRTSHQG--------LEEFENEVKLTARLQHVNLLPVLGICTQREEKM 61
G+ MAVK+ L T ++ +E++ L H+N++ LG EE +
Sbjct: 25 TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLG-FETTEEYL 83
Query: 62 LIY-DYMPNKSLDFYIFDLRRRY-LLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKA 119
I+ +Y+P S I R Y + + E + +GL YL + I+HRDLKA
Sbjct: 84 SIFLEYVPGGS----IGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKA 136
Query: 120 SNILLDYEMNPKISDFGMAR--AFTKDECEANTGRIVGTYGYVPPEYV---RKGIYSMKY 174
N+L+D + KISDFG+++ D + + + G+ ++ PE + +G YS K
Sbjct: 137 DNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ--GSVFWMAPEVIHSYSQG-YSAKV 193
Query: 175 DVYSYGVLLLQILGGKR 191
D++S G ++L++ G+R
Sbjct: 194 DIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 7e-18
Identities = 66/244 (27%), Positives = 120/244 (49%), Gaps = 41/244 (16%)
Query: 30 EEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRT 89
++F +E + + H N++ + G+ T+ + M+I +YM N +LD Y+ D +
Sbjct: 51 QDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSS--YQ 108
Query: 90 RVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEAN 149
V ++ GI G+ YL S++ VHRDL A NIL++ + K+SDFG++R D
Sbjct: 109 LVGMLRGIAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP---- 161
Query: 150 TGRIVGTYGYVP-----PEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNL 204
G + G +P PE + ++ DV+S+G+++ +++ +G
Sbjct: 162 EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS-------FG------- 207
Query: 205 LEYAYGLWKNGEGMEFID------SSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEI 258
E Y N E M+ I+ + +D S+ ++LM L C Q++ A RP ++I
Sbjct: 208 -ERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQLM------LQCWQQDRARRPRFVDI 260
Query: 259 LVML 262
+ +L
Sbjct: 261 VNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 9e-18
Identities = 53/160 (33%), Positives = 83/160 (51%), Gaps = 8/160 (5%)
Query: 33 ENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVH 92
+NE ++ L H N++ + + M++ +Y P +L YI R LLD T
Sbjct: 47 QNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQK-RCNSLLDEDT--- 102
Query: 93 IIEGITQGLLYLQEYSNLTIVHRDLKASNILLD-YEMNPKISDFGMARAFTKDECEANTG 151
I+ Q LL L I+HRDLK NILLD ++M KI DFG+++ + + +A T
Sbjct: 103 ILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS-KSKAYT- 160
Query: 152 RIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKR 191
+VGT Y+ PE Y+ K D+++ G +L ++ KR
Sbjct: 161 -VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-17
Identities = 55/177 (31%), Positives = 92/177 (51%), Gaps = 8/177 (4%)
Query: 12 NGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKS 71
N ++AVK L + ++ F E L LQH L+ + + T+ E +I +YM S
Sbjct: 29 NSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGS 87
Query: 72 L-DFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNP 130
L DF D + LL + I +G+ Y++ + +HRDL+A+N+L+ +
Sbjct: 88 LLDFLKSDEGGKVLLP--KLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMC 142
Query: 131 KISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQIL 187
KI+DFG+AR +E A G + PE + G +++K DV+S+G+LL +I+
Sbjct: 143 KIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIKSDVWSFGILLYEIV 198
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 1e-17
Identities = 55/184 (29%), Positives = 92/184 (50%), Gaps = 13/184 (7%)
Query: 14 QEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSL 72
+AVK L + + Q +EF E L + H N++ +LG+C E + +I + M L
Sbjct: 27 IRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDL 86
Query: 73 DFYIFDLRRRY----LLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL---- 124
Y+ D R LL + + I + +G +YL++ + +HRDL A N L+
Sbjct: 87 LSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKG 143
Query: 125 -DYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLL 183
D + KI DFG+AR K + G + ++ PE + G ++ + DV+S+GVL+
Sbjct: 144 YDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLM 203
Query: 184 LQIL 187
+IL
Sbjct: 204 WEIL 207
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-17
Identities = 48/196 (24%), Positives = 87/196 (44%), Gaps = 18/196 (9%)
Query: 2 SVAICQGRLPNGQEMAVKRLSRTSHQGLE-EFENEVKLTARLQHVNLLPVLGICTQREEK 60
SV C+ + G A+K ++ + L+ + E+++ + ++ G
Sbjct: 16 SVTKCRLK-NTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSS 74
Query: 61 ML--IYDYMPNKSLDFYIFDLRRRYLLDWRTRVHII----EGITQGLLYLQEYSNLTIVH 114
+ +Y SLD +++R R ++ E + +GL YL I+H
Sbjct: 75 SIGIAMEYCEGGSLDSIYKKVKKR---GGRIGEKVLGKIAESVLKGLSYLHSRK---IIH 128
Query: 115 RDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKY 174
RD+K SNILL + K+ DFG++ + G GT Y+ PE ++ YS+
Sbjct: 129 RDIKPSNILLTRKGQVKLCDFGVSGELV----NSLAGTFTGTSFYMAPERIQGKPYSITS 184
Query: 175 DVYSYGVLLLQILGGK 190
DV+S G+ LL++ +
Sbjct: 185 DVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 5e-17
Identities = 65/257 (25%), Positives = 112/257 (43%), Gaps = 29/257 (11%)
Query: 13 GQEMAVKRLS----RTSHQG--LEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDY 66
G MAVK+++ +S Q +E E++L ARL H +++ +LG + L ++
Sbjct: 25 GTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEW 84
Query: 67 MPNKSLDFYIFDLRRRY-LLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLD 125
M S + L +Y ++ E + +GL YL E I+HRD+K +N+L+D
Sbjct: 85 MAGGS----VSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLID 137
Query: 126 YE-MNPKISDFGMARAFTKDECEAN--TGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVL 182
+I+DFG A A G+++GT ++ PE +R Y DV+S G +
Sbjct: 138 STGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCV 197
Query: 183 LLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVAL 242
++++ K + + N L + + + I L V L
Sbjct: 198 IIEMATAKPP---WNAEKHSNHLALIFKI-ASATTAPSIPEHLSPGLR--------DVTL 245
Query: 243 LCVQENAADRPTMLEIL 259
C++ DRP E+L
Sbjct: 246 RCLELQPEDRPPSRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 5e-17
Identities = 77/263 (29%), Positives = 124/263 (47%), Gaps = 44/263 (16%)
Query: 10 LPNGQEMAVKRLS-----RTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKML-I 63
L +G AVK +S +T + +++ E E+ L ++LQH N++ LG T+REE L I
Sbjct: 22 LDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLG--TEREEDNLYI 79
Query: 64 Y-DYMPNKSLDFYIFDLRRRYLLDWRTRVHII---EGITQGLLYLQEYSNLTIVHRDLKA 119
+ + +P SL L ++Y I I GL YL + VHRD+K
Sbjct: 80 FLELVPGGSLA----KLLKKY--GSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKG 130
Query: 120 SNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYV-RKGIYSMKYDVYS 178
+NIL+D K++DFGMA+ + + G+ ++ PE + ++G Y + D++S
Sbjct: 131 ANILVDTNGVVKLADFGMAKQVVE---FSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWS 187
Query: 179 YGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEF--IDSSLDDSSSAWKLMR 236
G +L++ GK P S LE ++K G E I L D + +
Sbjct: 188 LGCTVLEMATGK-------PPWS--QLEGVAAVFKIGRSKELPPIPDHLSDEAKDF---- 234
Query: 237 CMQVALLCVQENAADRPTMLEIL 259
L C+Q + + RPT E+L
Sbjct: 235 ----ILKCLQRDPSLRPTAAELL 253
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 6e-17
Identities = 71/269 (26%), Positives = 131/269 (48%), Gaps = 34/269 (12%)
Query: 5 ICQGRL--PNGQE--MAVKRL-SRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREE 59
+C+GRL P +E +A+K L S + + +F +E + + H N++ + G+ T+
Sbjct: 20 VCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRP 79
Query: 60 KMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKA 119
M+I ++M N +LD ++ ++ + V ++ GI G+ YL E + VHRDL A
Sbjct: 80 VMIITEFMENGALDSFLRQNDGQFTV--IQLVGMLRGIAAGMKYLSE---MNYVHRDLAA 134
Query: 120 SNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP-----PEYVRKGIYSMKY 174
NIL++ + K+SDFG++R D + +G G +P PE + ++
Sbjct: 135 RNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLG--GKIPIRWTAPEAIAYRKFTSAS 192
Query: 175 DVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWK 233
DV+SYG+++ +++ G+R + +N +E Y L +D ++ +
Sbjct: 193 DVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRL----------PPPMDCPTALHQ 242
Query: 234 LMRCMQVALLCVQENAADRPTMLEILVML 262
LM L C Q++ RP +I+ L
Sbjct: 243 LM------LDCWQKDRNARPKFGQIVSTL 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 6e-17
Identities = 71/265 (26%), Positives = 111/265 (41%), Gaps = 51/265 (19%)
Query: 13 GQEMAVKR-----LSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYM 67
G+E+AVK+ S + + + E E++L LQH ++ G E + +YM
Sbjct: 27 GRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYM 86
Query: 68 PNKSLDFYIFDLRRRY--LLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLD 125
P S+ + + Y L + TR + + I +G+ YL +SN+ IVHRD+K +NIL D
Sbjct: 87 PGGSVKDQL----KAYGALTETVTRKYTRQ-ILEGVEYL--HSNM-IVHRDIKGANILRD 138
Query: 126 YEMNPKISDFGMARAFTKDECEANTGRIV-GTYGYVPPEYVRKGIYSMKYDVYSYGVLLL 184
N K+ DFG ++ + V GT ++ PE + Y K DV+S G ++
Sbjct: 139 SAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVV 198
Query: 185 QILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFI--------DSSLDD--SSSAWKL 234
++L K W E M I + L S A
Sbjct: 199 EMLTEKPP-------------------WAEFEAMAAIFKIATQPTNPQLPSHVSPDARNF 239
Query: 235 MRCMQVALLCVQENAADRPTMLEIL 259
+R ENA RP+ E+L
Sbjct: 240 LR------RTFVENAKKRPSAEELL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-16
Identities = 74/278 (26%), Positives = 125/278 (44%), Gaps = 49/278 (17%)
Query: 10 LPNGQEMAVKRLSR-TSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMP 68
+ + Q +A+K L + Q EF+ E L A L H N++ +LG+ TQ + ++++Y+
Sbjct: 31 MDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLN 90
Query: 69 NKSL-DFYIF-------------DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVH 114
L +F I D + LD +HI I G+ YL + VH
Sbjct: 91 QGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVH 147
Query: 115 RDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKY 174
+DL A NIL+ +++ KISD G++R + + + ++PPE + G +S
Sbjct: 148 KDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDS 207
Query: 175 DVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKL 234
D++S+GV+L +I S L Y YG + N E +E + +L
Sbjct: 208 DIWSFGVVLWEIF-------------SFGLQPY-YG-FSNQEVIEMVRKR--------QL 244
Query: 235 MRCMQ------VALL--CVQENAADRPTMLEILVMLKS 264
+ C + +L+ C QE + RP +I L+S
Sbjct: 245 LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-16
Identities = 72/275 (26%), Positives = 118/275 (42%), Gaps = 48/275 (17%)
Query: 10 LPNGQEMAVKRLSRTSHQG-LEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMP 68
+AVK L + L + +E L ++ H +++ + G C+Q +LI +Y
Sbjct: 27 RAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAK 86
Query: 69 NKSLDFYIFDLRR---RYLLDWRTR------------------VHIIEGITQGLLYLQEY 107
SL ++ + R+ YL R + I++G+ YL E
Sbjct: 87 YGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE- 145
Query: 108 SNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRK 167
+ +VHRDL A N+L+ KISDFG++R +++ + ++ E +
Sbjct: 146 --MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD 203
Query: 168 GIYSMKYDVYSYGVLLLQI--LGGKRTSCYYG--PNESLNLLEYAYGLWKNGEGMEFIDS 223
IY+ + DV+S+GVLL +I LGG + Y G P NLL K G ME ++
Sbjct: 204 HIYTTQSDVWSFGVLLWEIVTLGG---NPYPGIAPERLFNLL-------KTGYRMERPEN 253
Query: 224 SLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEI 258
S + LM C ++ RPT +I
Sbjct: 254 C---SEEMYNLML------TCWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 1e-16
Identities = 50/189 (26%), Positives = 87/189 (46%), Gaps = 26/189 (13%)
Query: 12 NGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIY-DYMP 68
G +A+K++S + L+ E+ L L+H N++ +G + + + I +Y
Sbjct: 24 TGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG-SIETSDSLYIILEYAE 82
Query: 69 NKSL-----DFYIF--DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASN 121
N SL F F L Y + + QGL YL E ++HRD+KA+N
Sbjct: 83 NGSLRQIIKKFGPFPESLVAVY----------VYQVLQGLAYLHEQG---VIHRDIKAAN 129
Query: 122 ILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGV 181
IL + K++DFG+A + + +VGT ++ PE + S D++S G
Sbjct: 130 ILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWMAPEVIEMSGASTASDIWSLGC 187
Query: 182 LLLQILGGK 190
++++L G
Sbjct: 188 TVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 1e-16
Identities = 63/214 (29%), Positives = 90/214 (42%), Gaps = 36/214 (16%)
Query: 12 NGQEMAVKRLSRTSHQGLEEFENEVKLTAR-LQHVNLLPVLGI----CT-QREEKM-LIY 64
+E A+K L + E+ VK+ L +N P GI T Q EE + +
Sbjct: 25 TNKEYAIKILDK-RQLIKEKKVKYVKIEKEVLTRLNGHP--GIIKLYYTFQDEENLYFVL 81
Query: 65 DYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL 124
+Y PN L YI R+ LD + I L YL + I+HRDLK NILL
Sbjct: 82 EYAPNGELLQYI---RKYGSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILL 135
Query: 125 DYEMNPKISDFGMARAFTKDECE------------------ANTGRIVGTYGYVPPEYVR 166
D +M+ KI+DFG A+ + VGT YV PE +
Sbjct: 136 DKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLN 195
Query: 167 KGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNE 200
+ D+++ G ++ Q+L GK + G NE
Sbjct: 196 EKPAGKSSDLWALGCIIYQMLTGK--PPFRGSNE 227
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-16
Identities = 68/256 (26%), Positives = 113/256 (44%), Gaps = 31/256 (12%)
Query: 17 AVKRLSRTSHQGLE-EFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFY 75
VK L +T + L+ EF E+ + +L H N++ +LG+C + E +I +Y L +
Sbjct: 39 LVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQF 98
Query: 76 IFDLRRRYL------LDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMN 129
+ + + L + +V + I G+ +L SN VHRDL A N L+ +
Sbjct: 99 LRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHL---SNARFVHRDLAARNCLVSSQRE 155
Query: 130 PKISDFGMARAFTKDE-CEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG 188
K+S +++ E + I ++ PE V++ +S K DV+S+GVL+ ++
Sbjct: 156 VKVSLLSLSKDVYNSEYYKLRNALI--PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
Query: 189 GKRTSCYYGPNES-LNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM-RCMQVALLCVQ 246
Y +E LN L+ EG S +KLM RC V
Sbjct: 214 QGELPFYGLSDEEVLNRLQAGKLELPVPEGC---------PSRLYKLMTRCWAV------ 258
Query: 247 ENAADRPTMLEILVML 262
N DRP+ E++ L
Sbjct: 259 -NPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-16
Identities = 53/179 (29%), Positives = 88/179 (49%), Gaps = 8/179 (4%)
Query: 15 EMAVKRLSRTSHQGLEE-FENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSL 72
++AVK L T+H E +E+K+ + L H N++ +LG CT ++I +Y L
Sbjct: 67 KVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDL 126
Query: 73 DFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKI 132
++ +R L + + +G+ +L + +HRDL A N+LL + KI
Sbjct: 127 LNFLRR-KRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKI 182
Query: 133 SDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQI--LGG 189
DFG+AR D G ++ PE + +Y+ + DV+SYG+LL +I LG
Sbjct: 183 CDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGS 241
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 3e-16
Identities = 50/202 (24%), Positives = 92/202 (45%), Gaps = 15/202 (7%)
Query: 11 PNGQEMAVKRLSRTSHQGLE-EFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPN 69
P G+ MAVK + ++ ++ + E+ + + ++ G + + +YM
Sbjct: 24 PTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDG 83
Query: 70 KSLDFYIFDLRRRYLLDWRTRV--HIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYE 127
SLD + + R+ I + +GL YL + I+HRD+K SNIL++
Sbjct: 84 GSLD----KILKEVQGRIPERILGKIAVAVLKGLTYL--HEKHKIIHRDVKPSNILVNSR 137
Query: 128 MNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQIL 187
K+ DFG++ + VGT Y+ PE ++ YS+K D++S G+ L+++
Sbjct: 138 GQIKLCDFGVSGQLVNSLAKTF----VGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELA 193
Query: 188 GGK--RTSCYYGPNESLNLLEY 207
G+ P+ LL+Y
Sbjct: 194 TGRFPYPPENDPPDGIFELLQY 215
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 3e-16
Identities = 69/271 (25%), Positives = 118/271 (43%), Gaps = 44/271 (16%)
Query: 16 MAVKRLSR-TSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDF 74
+AVK L S +F+ E L A H N++ +LG+C + L+++YM L+
Sbjct: 38 VAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNE 97
Query: 75 YIFDLRRRYL-------------------LDWRTRVHIIEGITQGLLYLQEYSNLTIVHR 115
++ R L ++ I + + G+ YL E VHR
Sbjct: 98 FLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHR 154
Query: 116 DLKASNILLDYEMNPKISDFGMAR-AFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKY 174
DL N L+ M KI+DFG++R ++ D +A+ + ++PPE + Y+ +
Sbjct: 155 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIR-WMPPESIFYNRYTTES 213
Query: 175 DVYSYGVLLLQILGGKRTSCYYG--PNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAW 232
DV++YGV+L +I YG P + E Y + ++G + D+ +
Sbjct: 214 DVWAYGVVLWEIFS-------YGMQPYYGMAHEEVIYYV-RDGNVLSCPDNC---PLELY 262
Query: 233 KLMRCMQVALLCVQENAADRPTMLEILVMLK 263
LMR LC + +DRP+ I +L+
Sbjct: 263 NLMR------LCWSKLPSDRPSFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 4e-16
Identities = 63/273 (23%), Positives = 112/273 (41%), Gaps = 66/273 (24%)
Query: 11 PNGQEMAVKRL---SRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYM 67
P G+ A+K++ + ++ E+K + ++ G + E ++ +YM
Sbjct: 24 PTGKIYALKKIHVDGDEEFR--KQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81
Query: 68 PNKSLDFYIFDLRRRYLLDWRTRVHIIEGIT--------QGLLYLQEYSNLTIVHRDLKA 119
SL DL ++ I E + +GL YL ++ I+HRD+K
Sbjct: 82 DGGSLA----DLLKKV-------GKIPEPVLAYIARQILKGLDYL--HTKRHIIHRDIKP 128
Query: 120 SNILLDYEMNPKISDFGMARAF--TKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVY 177
SN+L++ + KI+DFG+++ T D+C VGT Y+ PE ++ YS D++
Sbjct: 129 SNLLINSKGEVKIADFGISKVLENTLDQCNTF----VGTVTYMSPERIQGESYSYAADIW 184
Query: 178 SYGVLLLQILGGKRTSCYYGPNESLN---LLEY-----AYGLWKNG---EGMEFIDSSLD 226
S G+ LL+ GK + P + L++ L E +FI
Sbjct: 185 SLGLTLLECALGK---FPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFIS---- 237
Query: 227 DSSSAWKLMRCMQVALLCVQENAADRPTMLEIL 259
C+Q++ RP+ E+L
Sbjct: 238 ----------------ACLQKDPKKRPSAAELL 254
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 4e-16
Identities = 60/199 (30%), Positives = 99/199 (49%), Gaps = 35/199 (17%)
Query: 13 GQEMAVKR--LSRTSHQG-------LEEFENEVKLTARLQHVNLLPVLGICTQREEKMLI 63
G+ MAVK+ L S L+ E+ L LQH N++ LG + + + I
Sbjct: 25 GELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLG-SSLDADHLNI 83
Query: 64 Y-DYMPNKS----LDFY-IFD--LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHR 115
+ +Y+P S L+ Y F+ L R + + I +GL YL N I+HR
Sbjct: 84 FLEYVPGGSVAALLNNYGAFEETLVRNF----------VRQILKGLNYLH---NRGIIHR 130
Query: 116 DLKASNILLDYEMNPKISDFGMARAFTKDECEANTGR----IVGTYGYVPPEYVRKGIYS 171
D+K +NIL+D + KISDFG+++ + T + G+ ++ PE V++ Y+
Sbjct: 131 DIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYT 190
Query: 172 MKYDVYSYGVLLLQILGGK 190
K D++S G L++++L GK
Sbjct: 191 RKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 6e-16
Identities = 65/252 (25%), Positives = 117/252 (46%), Gaps = 26/252 (10%)
Query: 16 MAVKRL-SRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDF 74
+AVK L + + +F E+K+ +RL++ N++ +LG+C + +I +YM N L+
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106
Query: 75 YIFDLRRRYLLDWRTRVHIIEGIT-QGLLYL--------QEYSNLTIVHRDLKASNILLD 125
+ L +R + T + I ++ LLY+ + ++L VHRDL N L+
Sbjct: 107 F---LSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG 163
Query: 126 YEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQ 185
KI+DFGM+R + GR V ++ E + G ++ DV+++GV L +
Sbjct: 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWE 223
Query: 186 ILGGKRTSCYYGPNESLN---LLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVAL 242
+ T C P L+ ++E ++N ++ + S +KLM +
Sbjct: 224 MF----TLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLM------M 273
Query: 243 LCVQENAADRPT 254
C + DRPT
Sbjct: 274 RCWSRDIKDRPT 285
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 7e-16
Identities = 55/192 (28%), Positives = 91/192 (47%), Gaps = 26/192 (13%)
Query: 16 MAVKRL-SRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDF 74
+AVK L + +F EVK+ +RL+ N++ +LG+C + +I +YM N L+
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 75 YIFDLRRRYLLD-------------------WRTRVHIIEGITQGLLYLQEYSNLTIVHR 115
+ L +L D + + +H+ I G+ YL S+L VHR
Sbjct: 109 F---LSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHR 162
Query: 116 DLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYD 175
DL N L+ + KI+DFGM+R + GR V ++ E + G ++ D
Sbjct: 163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASD 222
Query: 176 VYSYGVLLLQIL 187
V+++GV L +IL
Sbjct: 223 VWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-15
Identities = 54/214 (25%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 3 VAICQGRLPNGQEM--AVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEK 60
+A C P +M AVK L + ++F+ E +L LQH +++ G+C +
Sbjct: 23 LAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82
Query: 61 MLIYDYMPNKSLDFYIF-------------DLRRRYLLDWRTRVHIIEGITQGLLYLQEY 107
+++++YM + L+ ++ + + L +HI I G++YL
Sbjct: 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL--- 139
Query: 108 SNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRK 167
++ VHRDL N L+ + KI DFGM+R + G + ++PPE +
Sbjct: 140 ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY 199
Query: 168 GIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNE 200
++ + DV+S+GV+L +I GK+ E
Sbjct: 200 RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE 233
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 1e-15
Identities = 61/267 (22%), Positives = 112/267 (41%), Gaps = 44/267 (16%)
Query: 15 EMAVKRLSR--TSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSL 72
+A+K ++ + + +E F NE + +++ +LG+ + + +++ + M L
Sbjct: 38 RVAIKTVNENASMRERIE-FLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDL 96
Query: 73 DFYIFDLR----RRYLLDWRTRVHIIE---GITQGLLYLQEYSNLTIVHRDLKASNILLD 125
Y+ R L T I+ I G+ YL VHRDL A N ++
Sbjct: 97 KSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVA 153
Query: 126 YEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQ 185
++ KI DFGM R + + G+ + ++ PE ++ G+++ K DV+S+GV+L +
Sbjct: 154 EDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWE 213
Query: 186 ILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMR--------C 237
+ L E Y N E ++F+ +
Sbjct: 214 M---------------ATLAEQPYQGLSNEEVLKFV--------IDGGHLDLPENCPDKL 250
Query: 238 MQVALLCVQENAADRPTMLEILVMLKS 264
+++ +C Q N RPT LEI+ LK
Sbjct: 251 LELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-15
Identities = 54/178 (30%), Positives = 91/178 (51%), Gaps = 7/178 (3%)
Query: 7 QGRLPNGQEMAVKRLSRTSHQGLE-EFENEVKLTARLQHVNLLPVLGICTQREEKMLIYD 65
+G L + +AVK Q L+ +F +E ++ + H N++ ++G+CTQR+ ++ +
Sbjct: 13 KGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVME 72
Query: 66 YMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLD 125
+P DF F +++ L + V G+ YL+ + +HRDL A N L+
Sbjct: 73 LVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVG 127
Query: 126 YEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLL 183
KISDFGM+R D +++G + PE + G YS + DV+SYG+LL
Sbjct: 128 ENNVLKISDFGMSRQ-EDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILL 184
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-15
Identities = 47/182 (25%), Positives = 84/182 (46%), Gaps = 11/182 (6%)
Query: 12 NGQEMAVKRLSRTSHQGLEEFEN--EVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPN 69
G+ +A+K++ E+KL L H N++ +L + + + L++++M
Sbjct: 23 TGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM-- 80
Query: 70 KSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMN 129
D Y R+ L + + QGL + + I+HRDLK N+L++ E
Sbjct: 81 -DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGV 136
Query: 130 PKISDFGMARAFTKDECEANTGRIVGTYGYVPPE-YVRKGIYSMKYDVYSYGVLLLQILG 188
K++DFG+AR+F T +V T Y PE + YS D++S G + ++L
Sbjct: 137 LKLADFGLARSFGSPV-RPYTHYVV-TRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLS 194
Query: 189 GK 190
+
Sbjct: 195 RR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 3e-15
Identities = 68/259 (26%), Positives = 118/259 (45%), Gaps = 25/259 (9%)
Query: 16 MAVKRLSRTSHQGLE-EFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDF 74
+AVK L +++ +F E+K+ +RL+ N++ +L +C + +I +YM N L+
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108
Query: 75 YIFDLR--------RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY 126
++ + + T + + I G+ YL S+L VHRDL N L+
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGK 165
Query: 127 EMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQI 186
KI+DFGM+R + GR V ++ E + G ++ DV+++GV L +I
Sbjct: 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEI 225
Query: 187 LGGKRTSCYYGPNESLN---LLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALL 243
L T C P L+ ++E +++ ++ S +KLM L
Sbjct: 226 L----TLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLM------LS 275
Query: 244 CVQENAADRPTMLEILVML 262
C + NA +RP+ EI L
Sbjct: 276 CWRRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 5e-15
Identities = 64/258 (24%), Positives = 101/258 (39%), Gaps = 41/258 (15%)
Query: 17 AVKRLSRTSHQG-LEEFENEVKLTARLQHVNLLPVLGICTQREEKML--------IYDYM 67
AVK L +++F E + L H NL+ + G+ M+ + D +
Sbjct: 27 AVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLGSLLDRL 86
Query: 68 PNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYE 127
+L ++ L D+ + I G+ YL E +HRDL A NILL +
Sbjct: 87 RKDALGHFLIST----LCDYAVQ------IANGMRYL-ESKRF--IHRDLAARNILLASD 133
Query: 128 MNPKISDFGMARAFTK-DECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQI 186
KI DFG+ RA + ++ + + + PE +R +S DV+ +GV L ++
Sbjct: 134 DKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEM 193
Query: 187 LGGKRTSCYYG--PNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLC 244
YG P L+ + + K GE +E + V L C
Sbjct: 194 FT-------YGEEPWAGLSGSQILKKIDKEGERLE----RPEACPQ-----DIYNVMLQC 237
Query: 245 VQENAADRPTMLEILVML 262
N ADRPT + L
Sbjct: 238 WAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (180), Expect = 5e-15
Identities = 54/195 (27%), Positives = 85/195 (43%), Gaps = 32/195 (16%)
Query: 12 NGQEMAVKR--LSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQRE---EKMLIY-- 64
+G+ +K LS S + E+ NEVK+ +L H N I E EK +
Sbjct: 24 DGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN------IIKYYESFEEKGKLCIV 77
Query: 65 -DYMPNKSLDFYIFDLRRRY-------LLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRD 116
+Y L I ++ +LDW + + L YL +S I+HRD
Sbjct: 78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ------LCLALKYL--HSR-KILHRD 128
Query: 117 LKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDV 176
+K NI L K+ DFG+++ + A T +VGT Y+ PE + Y+ K D+
Sbjct: 129 IKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSPELCQNKPYNYKSDI 186
Query: 177 YSYGVLLLQILGGKR 191
+S G +L ++ K
Sbjct: 187 WSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 6e-15
Identities = 50/175 (28%), Positives = 92/175 (52%), Gaps = 12/175 (6%)
Query: 13 GQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIY-DYMPNKS 71
G ++AVK + + + F E + +L+H NL+ +LG+ + + + I +YM S
Sbjct: 29 GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 86
Query: 72 LDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPK 131
L Y+ R R +L + + + + YL+ + VHRDL A N+L+ + K
Sbjct: 87 LVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAK 142
Query: 132 ISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQI 186
+SDFG+ + + + +TG++ + PE +R+ +S K DV+S+G+LL +I
Sbjct: 143 VSDFGLTKEASSTQ---DTGKL--PVKWTAPEALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 8e-15
Identities = 48/184 (26%), Positives = 90/184 (48%), Gaps = 22/184 (11%)
Query: 13 GQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSL 72
G+E+A+K++ Q E NE+ + +H N++ +E ++ +YM SL
Sbjct: 44 GKEVAIKKMRLRK-QNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSL 102
Query: 73 ----DFYIFDLRRRYLLDWRTRVHI---IEGITQGLLYLQEYSNLTIVHRDLKASNILLD 125
+ I + QGL YL + ++HRD+K+ NILL
Sbjct: 103 TDIITQNFVRM---------NEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLS 150
Query: 126 YEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQ 185
+ + K++DFG A TK++ + N+ +VGT ++ PE +++ Y K D++S G++ ++
Sbjct: 151 KDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIE 208
Query: 186 ILGG 189
+ G
Sbjct: 209 MAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 8e-15
Identities = 59/202 (29%), Positives = 104/202 (51%), Gaps = 20/202 (9%)
Query: 15 EMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSL-D 73
++AVK + + +E F E + LQH L+ + + T +E +I ++M SL D
Sbjct: 32 KVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLD 89
Query: 74 FYIFDLRRRY----LLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMN 129
F D + L+D+ + I +G+ ++++ + +HRDL+A+NIL+ +
Sbjct: 90 FLKSDEGSKQPLPKLIDFSAQ------IAEGMAFIEQRN---YIHRDLRAANILVSASLV 140
Query: 130 PKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGG 189
KI+DFG+AR +E A G + PE + G +++K DV+S+G+LL++I+
Sbjct: 141 CKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTY 199
Query: 190 KRTSCYYGPN--ESLNLLEYAY 209
R Y G + E + LE Y
Sbjct: 200 GRIP-YPGMSNPEVIRALERGY 220
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 8e-15
Identities = 57/235 (24%), Positives = 110/235 (46%), Gaps = 18/235 (7%)
Query: 33 ENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVH 92
+E+ +LQH N++ ++G+C + LI++Y+ K+L + + L W R
Sbjct: 731 SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRK 784
Query: 93 IIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGR 152
I GI + L +L + +V +L I++D + P + + C
Sbjct: 785 IAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL----CTDTKCF 839
Query: 153 IVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTS-CYYGPNESLNLLEYAYGL 211
I + YV PE + K D+Y +G++L+++L GK + +G + S ++E+A
Sbjct: 840 I--SSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGS--IVEWARYC 895
Query: 212 WKNGEGMEFIDSSL--DDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKS 264
+ + +ID S+ D S + +++ M +AL C + RP ++L L+S
Sbjct: 896 YSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLES 950
|
Length = 968 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 1e-14
Identities = 49/182 (26%), Positives = 89/182 (48%), Gaps = 13/182 (7%)
Query: 16 MAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFY 75
+AVK L S ++F E +L LQH +++ G+C + + +++++YM + L+ +
Sbjct: 38 VAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKF 97
Query: 76 I----------FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLD 125
+ + R L +HI + I G++YL ++ VHRDL N L+
Sbjct: 98 LRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVG 154
Query: 126 YEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQ 185
+ KI DFGM+R + G + ++PPE + ++ + DV+S GV+L +
Sbjct: 155 ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWE 214
Query: 186 IL 187
I
Sbjct: 215 IF 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-14
Identities = 46/179 (25%), Positives = 91/179 (50%), Gaps = 9/179 (5%)
Query: 12 NGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKS 71
+G+++AVK + Q E NEV + QH N++ + EE ++ +++ +
Sbjct: 45 SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104
Query: 72 LDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPK 131
L + R L+ + E + Q L YL ++HRD+K+ +ILL + K
Sbjct: 105 LTDIVSQTR----LNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVK 157
Query: 132 ISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGK 190
+SDFG +KD + + +VGT ++ PE + + Y + D++S G+++++++ G+
Sbjct: 158 LSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-14
Identities = 57/192 (29%), Positives = 101/192 (52%), Gaps = 21/192 (10%)
Query: 10 LPNGQEM----AVKRLSRTSH-QGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIY 64
+P G+ + A+K L+ T+ + EF +E + A + H +L+ +LG+C + L+
Sbjct: 29 VPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVT 87
Query: 65 DYMPNKSLDFYIFDLR----RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKAS 120
MP+ L Y+ + + + LL+W + I +G++YL+E +VHRDL A
Sbjct: 88 QLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEERR---LVHRDLAAR 138
Query: 121 NILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYG 180
N+L+ + KI+DFG+AR DE E N ++ E + ++ + DV+SYG
Sbjct: 139 NVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYG 198
Query: 181 VLLLQIL--GGK 190
V + +++ GGK
Sbjct: 199 VTIWELMTFGGK 210
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-14
Identities = 36/99 (36%), Positives = 58/99 (58%), Gaps = 6/99 (6%)
Query: 92 HIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTG 151
I + +GL YL Y+ I+HRD+K SNIL++ K+ DFG++ A+T
Sbjct: 107 KIAVAVVEGLTYL--YNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--ADT- 161
Query: 152 RIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGK 190
VGT Y+ PE ++ G Y++K DV+S G+ ++++ GK
Sbjct: 162 -FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-14
Identities = 52/182 (28%), Positives = 91/182 (50%), Gaps = 9/182 (4%)
Query: 30 EEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRT 89
E F E ++ +L+H L+ + + + E ++ +YM SL ++ D R L
Sbjct: 46 ESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDGEGRAL-KLPN 103
Query: 90 RVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEAN 149
V + + G+ Y++ + +HRDL+++NIL+ + KI+DFG+AR +E A
Sbjct: 104 LVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTAR 160
Query: 150 TGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPN--ESLNLLEY 207
G + PE G +++K DV+S+G+LL +++ R Y G N E L +E
Sbjct: 161 QGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP-YPGMNNREVLEQVER 218
Query: 208 AY 209
Y
Sbjct: 219 GY 220
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 6e-14
Identities = 38/129 (29%), Positives = 63/129 (48%), Gaps = 7/129 (5%)
Query: 62 LIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASN 121
L+ M L ++I+++ + R + + I GL +L IV+RDLK N
Sbjct: 70 LVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ-IICGLEHLH---QRRIVYRDLKPEN 125
Query: 122 ILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGV 181
+LLD N +ISD G+A + GR GT GY+ PE ++ +Y D ++ G
Sbjct: 126 VLLDDHGNVRISDLGLAVELK--GGKKIKGR-AGTPGYMAPEVLQGEVYDFSVDWFALGC 182
Query: 182 LLLQILGGK 190
L +++ G+
Sbjct: 183 TLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 7e-14
Identities = 51/149 (34%), Positives = 82/149 (55%), Gaps = 12/149 (8%)
Query: 54 CT-QREEKML-IYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLT 111
CT Q +E + + +Y+ L F+I R + R R + E I GL +L +
Sbjct: 63 CTFQTKEHLFFVMEYLNGGDLMFHIQSSGR--FDEARARFYAAE-IICGLQFL--HKK-G 116
Query: 112 IVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYS 171
I++RDLK N+LLD + + KI+DFGM + E +A+T GT Y+ PE ++ Y+
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST--FCGTPDYIAPEILKGQKYN 174
Query: 172 MKYDVYSYGVLLLQILGGKRTSCYYGPNE 200
D +S+GVLL ++L G+ S ++G +E
Sbjct: 175 ESVDWWSFGVLLYEMLIGQ--SPFHGEDE 201
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 7e-14
Identities = 50/179 (27%), Positives = 87/179 (48%), Gaps = 12/179 (6%)
Query: 13 GQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSL 72
GQ++AVK + + F E + +L H NL+ +LG+ ++ + M +L
Sbjct: 29 GQKVAVKNIK--CDVTAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMSKGNL 85
Query: 73 DFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKI 132
++ R R L+ + + +G+ YL+ +VHRDL A NIL+ + K+
Sbjct: 86 VNFL-RTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKV 141
Query: 133 SDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKR 191
SDFG+AR + + ++ + PE ++ +S K DV+SYGVLL ++ R
Sbjct: 142 SDFGLARVGSMG---VDNSKL--PVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGR 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 7e-14
Identities = 61/189 (32%), Positives = 98/189 (51%), Gaps = 20/189 (10%)
Query: 13 GQEMAVKRL-----SRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKML--IYD 65
G+E+A K++ S + + + E E++L LQH ++ G R EK L +
Sbjct: 27 GRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFME 86
Query: 66 YMPNKSLDFYIFDLRRRY--LLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNIL 123
YMP S+ D + Y L + TR + + I +G+ YL +SN+ IVHRD+K +NIL
Sbjct: 87 YMPGGSVK----DQLKAYGALTESVTRKYTRQ-ILEGMSYL--HSNM-IVHRDIKGANIL 138
Query: 124 LDYEMNPKISDFGMARAFTKDECEANTG--RIVGTYGYVPPEYVRKGIYSMKYDVYSYGV 181
D N K+ DFG ++ + C + TG + GT ++ PE + Y K DV+S G
Sbjct: 139 RDSAGNVKLGDFGASKRL-QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGC 197
Query: 182 LLLQILGGK 190
++++L K
Sbjct: 198 TVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 9e-14
Identities = 56/190 (29%), Positives = 92/190 (48%), Gaps = 15/190 (7%)
Query: 10 LPNGQEMAVK--RLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYM 67
L G+ MAVK R+ + ++E +E+K+ L+H NL+ G+ RE+ + +Y
Sbjct: 22 LDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81
Query: 68 PNKSLDFYIFDLRRRYLLDWR-TRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY 126
+L+ L +LD RV+ ++ + +GL YL + IVHRD+K +NI LD+
Sbjct: 82 SGGTLEEL---LEHGRILDEHVIRVYTLQ-LLEGLAYLHSHG---IVHRDIKPANIFLDH 134
Query: 127 EMNPKISDFGMAR--AFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKY---DVYSYGV 181
K+ DFG A + GT Y+ PE + G D++S G
Sbjct: 135 NGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGC 194
Query: 182 LLLQILGGKR 191
++L++ GKR
Sbjct: 195 VVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 9e-14
Identities = 57/189 (30%), Positives = 99/189 (52%), Gaps = 23/189 (12%)
Query: 10 LPNGQEM----AVKRLSR-TSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIY 64
+P G+++ A+K L TS + +E +E + A + + ++ +LGIC + LI
Sbjct: 29 IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIT 87
Query: 65 DYMPNKSLDFYIFDLRRR----YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKAS 120
MP L Y+ + + YLL+W + I +G+ YL+E +VHRDL A
Sbjct: 88 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLEERR---LVHRDLAAR 138
Query: 121 NILLDYEMNPKISDFGMARAFTKDECE--ANTGRIVGTYGYVPPEYVRKGIYSMKYDVYS 178
N+L+ + KI+DFG+A+ DE E A G++ ++ E + IY+ + DV+S
Sbjct: 139 NVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV--PIKWMALESILHRIYTHQSDVWS 196
Query: 179 YGVLLLQIL 187
YGV + +++
Sbjct: 197 YGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 69.8 bits (170), Expect = 1e-13
Identities = 49/193 (25%), Positives = 99/193 (51%), Gaps = 9/193 (4%)
Query: 13 GQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSL 72
GQE+A+K+++ E NE+ + L++ N++ L +E ++ +Y+ SL
Sbjct: 44 GQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSL 103
Query: 73 DFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKI 132
D+ +D + Q L +L ++N ++HRD+K+ N+LL + + K+
Sbjct: 104 T----DVVTETCMDEAQIAAVCRECLQALEFL--HAN-QVIHRDIKSDNVLLGMDGSVKL 156
Query: 133 SDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRT 192
+DFG T ++ + +T +VGT ++ PE V + Y K D++S G++ ++++ G+
Sbjct: 157 TDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
Query: 193 SCYYGPNESLNLL 205
P +L L+
Sbjct: 215 YLNENPLRALYLI 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-13
Identities = 53/242 (21%), Positives = 101/242 (41%), Gaps = 22/242 (9%)
Query: 21 LSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80
L+R S + + NE+ + + LQH N++ ++ +Y +L + +
Sbjct: 35 LTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTL-YDKIVRQ 93
Query: 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARA 140
+ L + + + I + Y+ + I+HRD+K NI L K+ DFG+++
Sbjct: 94 KGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKI 150
Query: 141 FTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNE 200
+ A T +VGT Y+ PE + Y+ K D+++ G +L ++L KRT +
Sbjct: 151 LGSEYSMAET--VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTF------D 202
Query: 201 SLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILV 260
+ N L + + + SS + +Q++ RPT E+L
Sbjct: 203 ATNPLNLVVKIVQGNYTPV-----VSVYSSELI-----SLVHSLLQQDPEKRPTADEVLD 252
Query: 261 ML 262
Sbjct: 253 QP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-13
Identities = 58/242 (23%), Positives = 104/242 (42%), Gaps = 29/242 (11%)
Query: 31 EFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRY------- 83
EF NE + +++ +LG+ +Q + ++I + M L Y+ LR
Sbjct: 55 EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQA 114
Query: 84 LLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTK 143
+ + + I G+ YL VHRDL A N ++ + KI DFGM R +
Sbjct: 115 PPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 171
Query: 144 DECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLN 203
+ G+ + ++ PE ++ G+++ DV+S+GV+L +I
Sbjct: 172 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------AT 216
Query: 204 LLEYAYGLWKNGEGMEFIDSS--LDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261
L E Y N + + F+ LD + ++ ++ +C Q N RP+ LEI+
Sbjct: 217 LAEQPYQGMSNEQVLRFVMEGGLLDKPDNCPDML--FELMRMCWQYNPKMRPSFLEIISS 274
Query: 262 LK 263
+K
Sbjct: 275 IK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 2e-13
Identities = 38/96 (39%), Positives = 50/96 (52%), Gaps = 7/96 (7%)
Query: 93 IIEGITQGLLYLQE-----YSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECE 147
I +TQ LL L E T++HRDLK +NI LD N K+ DFG+A+ D
Sbjct: 107 IWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF 166
Query: 148 ANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLL 183
A T VGT Y+ PE + Y K D++S G L+
Sbjct: 167 AKT--YVGTPYYMSPEQLNHMSYDEKSDIWSLGCLI 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-13
Identities = 59/245 (24%), Positives = 111/245 (45%), Gaps = 31/245 (12%)
Query: 31 EFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR-------RY 83
EF NE + +++ +LG+ ++ + +++ + M + L Y+ LR R
Sbjct: 55 EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 114
Query: 84 LLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTK 143
+ + + I G+ YL VHRDL A N ++ ++ KI DFGM R +
Sbjct: 115 PPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE 171
Query: 144 DECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLN 203
+ G+ + ++ PE ++ G+++ D++S+GV+L +I +
Sbjct: 172 TDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI---------------TS 216
Query: 204 LLEYAYGLWKNGEGMEFI--DSSLDDSSSA-WKLMRCMQVALLCVQENAADRPTMLEILV 260
L E Y N + ++F+ LD + ++ M+ +C Q N RPT LEI+
Sbjct: 217 LAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMR---MCWQFNPKMRPTFLEIVN 273
Query: 261 MLKSE 265
+LK +
Sbjct: 274 LLKDD 278
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-13
Identities = 62/189 (32%), Positives = 99/189 (52%), Gaps = 20/189 (10%)
Query: 13 GQEMAVKRL-----SRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKML--IYD 65
G+E+AVK++ S+ + + + E E++L L+H ++ G EEK L +
Sbjct: 27 GRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVE 86
Query: 66 YMPNKSLDFYIFDLRRRY--LLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNIL 123
YMP S I D + Y L + TR + + I QG+ YL +SN+ IVHRD+K +NIL
Sbjct: 87 YMPGGS----IKDQLKAYGALTENVTRRYTRQ-ILQGVSYL--HSNM-IVHRDIKGANIL 138
Query: 124 LDYEMNPKISDFGMARAFTKDECEANTG--RIVGTYGYVPPEYVRKGIYSMKYDVYSYGV 181
D N K+ DFG ++ + C + TG + GT ++ PE + Y K DV+S
Sbjct: 139 RDSAGNVKLGDFGASKRI-QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVAC 197
Query: 182 LLLQILGGK 190
++++L K
Sbjct: 198 TVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-13
Identities = 54/179 (30%), Positives = 92/179 (51%), Gaps = 9/179 (5%)
Query: 8 GRL-PNGQEMAVKRLSRTSHQGLE-EFENEVKLTARLQHVNLLPVLGICTQREEKMLIYD 65
GRL + +AVK T L+ +F E ++ + H N++ ++G+CTQ++ ++ +
Sbjct: 14 GRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 73
Query: 66 YMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLD 125
+ + DF F L + + ++E G+ YL+ +HRDL A N L+
Sbjct: 74 LV--QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVT 128
Query: 126 YEMNPKISDFGMARAFTKDECEANTGRIVGT-YGYVPPEYVRKGIYSMKYDVYSYGVLL 183
+ KISDFGM+R +D A+TG + + PE + G YS + DV+S+G+LL
Sbjct: 129 EKNVLKISDFGMSRE-EEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILL 186
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 4e-13
Identities = 73/256 (28%), Positives = 121/256 (47%), Gaps = 37/256 (14%)
Query: 12 NGQEMAVKRLSRTSHQGLEEFEN---EVKLTARLQHVNLLPVLGICTQREEKM-LIYDYM 67
+ +A+K++S + Q E++++ EV+ +L+H N + G C RE L+ +Y
Sbjct: 39 TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG-CYLREHTAWLVMEYC 97
Query: 68 PNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYE 127
+ D I ++ ++ L + I G QGL YL + +HRD+KA NILL
Sbjct: 98 LGSASD--ILEVHKKPLQEVEIAA-ICHGALQGLAYLH---SHERIHRDIKAGNILLTEP 151
Query: 128 MNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYV---RKGIYSMKYDVYSYGVLLL 184
K++DFG A AN+ VGT ++ PE + +G Y K DV+S G+ +
Sbjct: 152 GTVKLADFGSASLV----SPANS--FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 205
Query: 185 QILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDS-SLDDSSSAWKLMRCMQVALL 243
++ K P ++N + Y + +N DS +L SS+ W V
Sbjct: 206 ELAERKP------PLFNMNAMSALYHIAQN-------DSPTL--SSNDWSDYFRNFVD-S 249
Query: 244 CVQENAADRPTMLEIL 259
C+Q+ DRP+ E+L
Sbjct: 250 CLQKIPQDRPSSEELL 265
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 5e-13
Identities = 48/186 (25%), Positives = 89/186 (47%), Gaps = 16/186 (8%)
Query: 14 QEMAVK--RLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEK------MLIYD 65
++AVK +L ++ +EEF +E H N++ ++G+C + M+I
Sbjct: 28 LKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILP 87
Query: 66 YMPNKSLDFYIFDLRRRYL---LDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNI 122
+M + L ++ R L L +T + + I G+ YL SN +HRDL A N
Sbjct: 88 FMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYL---SNRNFIHRDLAARNC 144
Query: 123 LLDYEMNPKISDFGMARAFTKDECEANTGRIVGT-YGYVPPEYVRKGIYSMKYDVYSYGV 181
+L +M ++DFG+++ + GRI ++ E + +Y+ K DV+++GV
Sbjct: 145 MLREDMTVCVADFGLSKKIYSGD-YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGV 203
Query: 182 LLLQIL 187
+ +I
Sbjct: 204 TMWEIA 209
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 5e-13
Identities = 60/222 (27%), Positives = 103/222 (46%), Gaps = 32/222 (14%)
Query: 30 EEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRT 89
E F E ++ +L+H L+P+ + ++ E ++ ++M SL ++ + +YL
Sbjct: 46 EAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYL-KLPQ 103
Query: 90 RVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEAN 149
V + I G+ Y++ + +HRDL+A+NIL+ + KI+DFG+AR +E A
Sbjct: 104 LVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR 160
Query: 150 TGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG--------------------G 189
G + PE G +++K DV+S+G+LL +++ G
Sbjct: 161 QGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG 219
Query: 190 KRTSCYYGPNESLNLLEYAYGLWKNGEG----MEFIDSSLDD 227
R C G ESL+ E WK E+I S L+D
Sbjct: 220 YRMPCPQGCPESLH--ELMKLCWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 5e-13
Identities = 68/251 (27%), Positives = 117/251 (46%), Gaps = 35/251 (13%)
Query: 16 MAVKRLSRTSHQGLEEFEN---EVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSL 72
+A+K++S + Q E++++ EVK R++H N + G + L+ +Y +
Sbjct: 53 VAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSAS 112
Query: 73 DFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKI 132
D + ++ ++ L + I G QGL YL + ++HRD+KA NILL K+
Sbjct: 113 D--LLEVHKKPLQEVEIAA-ITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKL 166
Query: 133 SDFGMARAFTKDECEANTGRIVGTYGYVPPEYV---RKGIYSMKYDVYSYGVLLLQILGG 189
+DFG A + AN+ VGT ++ PE + +G Y K DV+S G+ +++
Sbjct: 167 ADFGSASIASP----ANS--FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 220
Query: 190 KRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWK-LMRCMQVALLCVQEN 248
K P ++N + Y + +N S S+ W R + C+Q+
Sbjct: 221 KP------PLFNMNAMSALYHIAQN--------ESPTLQSNEWSDYFRNFVDS--CLQKI 264
Query: 249 AADRPTMLEIL 259
DRPT E+L
Sbjct: 265 PQDRPTSEELL 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 6e-13
Identities = 54/187 (28%), Positives = 90/187 (48%), Gaps = 14/187 (7%)
Query: 9 RLPNGQEMAVKRLSRTSHQGLEEFE--NEVKLTARLQHVNLLPVLGICTQREEKMLIYDY 66
R + + A+K++ + E E +E ++ A+L ++ + + ++ +Y
Sbjct: 21 RKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80
Query: 67 MPNKSLDFYIFDLRRRYLLD---WRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNIL 123
N L + R R L + WR + I GL +L +S I+HRD+K+ N+
Sbjct: 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQI----LLGLAHL--HSK-KILHRDIKSLNLF 133
Query: 124 LDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLL 183
LD N KI D G+A+ + + ANT IVGT Y+ PE Y+ K DV++ GV+L
Sbjct: 134 LDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPELCEDKPYNEKSDVWALGVVL 191
Query: 184 LQILGGK 190
+ GK
Sbjct: 192 YECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 7e-13
Identities = 37/90 (41%), Positives = 57/90 (63%), Gaps = 5/90 (5%)
Query: 101 LLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYV 160
+L L+ N +V+RDLK +NILLD + +ISD G+A F+K + A+ VGT+GY+
Sbjct: 107 ILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYM 162
Query: 161 PPEYVRKGI-YSMKYDVYSYGVLLLQILGG 189
PE ++KG+ Y D +S G +L ++L G
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-12
Identities = 58/189 (30%), Positives = 97/189 (51%), Gaps = 20/189 (10%)
Query: 13 GQEMAVKRL-----SRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKML--IYD 65
G+E+AVK++ S + + + E E++L L H ++ G E+ L +
Sbjct: 27 GRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME 86
Query: 66 YMPNKSLDFYIFDLRRRY--LLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNIL 123
+MP S I D + Y L + TR + + I +G+ YL +SN+ IVHRD+K +NIL
Sbjct: 87 HMPGGS----IKDQLKSYGALTENVTRKYTRQ-ILEGVSYL--HSNM-IVHRDIKGANIL 138
Query: 124 LDYEMNPKISDFGMARAFTKDECEANTG--RIVGTYGYVPPEYVRKGIYSMKYDVYSYGV 181
D N K+ DFG ++ + C + TG + GT ++ PE + Y K D++S G
Sbjct: 139 RDSVGNVKLGDFGASKRL-QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGC 197
Query: 182 LLLQILGGK 190
++++L K
Sbjct: 198 TVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-12
Identities = 73/273 (26%), Positives = 116/273 (42%), Gaps = 38/273 (13%)
Query: 15 EMAVKRLSR-TSHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSL 72
+ A+KR+ S +F E+++ +L H N++ +LG C R L +Y P+ +L
Sbjct: 36 DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNL 95
Query: 73 -DF------------YIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKA 119
DF + L + +H + +G+ YL S +HRDL A
Sbjct: 96 LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAA 152
Query: 120 SNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSY 179
NIL+ KI+DFG++R + + GR+ ++ E + +Y+ DV+SY
Sbjct: 153 RNILVGENYVAKIADFGLSRG-QEVYVKKTMGRL--PVRWMAIESLNYSVYTTNSDVWSY 209
Query: 180 GVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238
GVLL +I+ G C E L Y L K L+ + LMR
Sbjct: 210 GVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK----------PLNCDDEVYDLMR-- 257
Query: 239 QVALLCVQENAADRPTMLEILVMLKSETADIKT 271
C +E +RP+ +ILV L + KT
Sbjct: 258 ----QCWREKPYERPSFAQILVSLNRMLEERKT 286
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-12
Identities = 38/93 (40%), Positives = 58/93 (62%), Gaps = 5/93 (5%)
Query: 98 TQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTY 157
T+ +L L+ N +V+RDLK +NILLD + +ISD G+A F+K + A+ VGT+
Sbjct: 104 TEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTH 159
Query: 158 GYVPPEYVRKGI-YSMKYDVYSYGVLLLQILGG 189
GY+ PE ++KG Y D +S G +L ++L G
Sbjct: 160 GYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-12
Identities = 77/274 (28%), Positives = 125/274 (45%), Gaps = 53/274 (19%)
Query: 11 PNGQEMAVKRLSRTSH-QGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMP 68
+AVK L + + L + +E+++ + +H N++ +LG+CTQ ++ +Y
Sbjct: 40 NETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAA 99
Query: 69 NKSL-DFYIFDLRRR-----YLLDWRTRVHIIEGITQ------------GLLYLQEYSNL 110
+ +L DF LR R Y R E +TQ G+ +L ++
Sbjct: 100 HGNLRDF----LRARRPPGEYASPDDPRPPE-ETLTQKDLVSFAYQVARGMEFL---ASK 151
Query: 111 TIVHRDLKASNILL--DYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKG 168
+HRDL A N+L+ D+ M KI+DFG+AR + T ++ PE +
Sbjct: 152 KCIHRDLAARNVLVTEDHVM--KIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR 209
Query: 169 IYSMKYDVYSYGVLLLQI--LGGKRTSCYYG-PNESLNLLEYAYGLWKNGEGMEFIDSSL 225
+Y+ + DV+S+GVLL +I LGG S Y G P E L + L K G ME
Sbjct: 210 VYTHQSDVWSFGVLLWEIFTLGG---SPYPGIPVEEL------FKLLKEGYRME---KPQ 257
Query: 226 DDSSSAWKLMRCMQVALLCVQENAADRPTMLEIL 259
+ + + LMR C E + RPT +++
Sbjct: 258 NCTQELYHLMRD------CWHEVPSQRPTFKQLV 285
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-12
Identities = 50/153 (32%), Positives = 79/153 (51%), Gaps = 12/153 (7%)
Query: 42 LQHVNLLP---VLGICTQREEKM-LIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGI 97
L+HV P L Q E K+ LI DY+ + +++ +R + R + E I
Sbjct: 58 LEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY--QRDNFSEDEVRFYSGEII 115
Query: 98 TQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTY 157
L L+ L IV+RD+K NILLD E + ++DFG+++ F +E + T GT
Sbjct: 116 ----LALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE-KERTYSFCGTI 170
Query: 158 GYVPPEYVR-KGIYSMKYDVYSYGVLLLQILGG 189
Y+ PE +R KG + D +S G+L+ ++L G
Sbjct: 171 EYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-12
Identities = 55/184 (29%), Positives = 91/184 (49%), Gaps = 21/184 (11%)
Query: 13 GQEMAVKRLSRTSHQGLEE-FENEVKLTARLQHVNLLPVLGICTQREEK--MLIYDYMPN 69
G+ +AVK L R Q ++ E+ + L H N++ G C+++ K LI +Y+P
Sbjct: 33 GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPL 92
Query: 70 KSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYL--QEYSNLTIVHRDLKASNILLDYE 127
SL Y+ ++ L+ + + I +G+ YL Q Y +HRDL A N+LLD +
Sbjct: 93 GSLRDYL----PKHKLNLAQLLLFAQQICEGMAYLHSQHY-----IHRDLAARNVLLDND 143
Query: 128 MNPKISDFGMARAFTKDE----CEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLL 183
KI DFG+A+A + + V Y E +++ +S DV+S+GV L
Sbjct: 144 RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA---VECLKENKFSYASDVWSFGVTL 200
Query: 184 LQIL 187
++L
Sbjct: 201 YELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-12
Identities = 48/178 (26%), Positives = 93/178 (52%), Gaps = 9/178 (5%)
Query: 13 GQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSL 72
GQE+A+K+++ E NE+ + +H N++ L +E ++ +Y+ SL
Sbjct: 44 GQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSL 103
Query: 73 DFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKI 132
D+ +D + Q L +L +SN ++HRD+K+ NILL + + K+
Sbjct: 104 T----DVVTETCMDEGQIAAVCRECLQALEFL--HSN-QVIHRDIKSDNILLGMDGSVKL 156
Query: 133 SDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGK 190
+DFG T ++ + +T +VGT ++ PE V + Y K D++S G++ ++++ G+
Sbjct: 157 TDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 3e-12
Identities = 45/139 (32%), Positives = 70/139 (50%), Gaps = 11/139 (7%)
Query: 54 CTQREEKM-LIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTI 112
C Q ++++ + +Y+ L F+I R + R R + E I GL +L E I
Sbjct: 64 CFQTKDRLFFVMEYVNGGDLMFHIQRSGR--FDEPRARFYAAE-IVLGLQFLHERG---I 117
Query: 113 VHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGR-IVGTYGYVPPEYVRKGIYS 171
++RDLK N+LLD E + KI+DFGM + + T GT Y+ PE + Y
Sbjct: 118 IYRDLKLDNVLLDSEGHIKIADFGMCK---EGILGGVTTSTFCGTPDYIAPEILSYQPYG 174
Query: 172 MKYDVYSYGVLLLQILGGK 190
D ++ GVLL ++L G+
Sbjct: 175 PAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 3e-12
Identities = 50/196 (25%), Positives = 99/196 (50%), Gaps = 9/196 (4%)
Query: 10 LPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPN 69
+ GQE+A+K+++ E NE+ + ++ N++ L +E ++ +Y+
Sbjct: 41 IATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 100
Query: 70 KSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMN 129
SL D+ +D + Q L +L +SN ++HRD+K+ NILL + +
Sbjct: 101 GSLT----DVVTETCMDEGQIAAVCRECLQALDFL--HSN-QVIHRDIKSDNILLGMDGS 153
Query: 130 PKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGG 189
K++DFG T ++ + +T +VGT ++ PE V + Y K D++S G++ ++++ G
Sbjct: 154 VKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
Query: 190 KRTSCYYGPNESLNLL 205
+ P +L L+
Sbjct: 212 EPPYLNENPLRALYLI 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 3e-12
Identities = 45/163 (27%), Positives = 79/163 (48%), Gaps = 21/163 (12%)
Query: 35 EVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHII 94
E+++ + H N++ + E ++ ++M SL+ ++ D + +
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE-------GTHIADEQFLADVA 174
Query: 95 EGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMAR--AFTKDECEANTGR 152
I G+ YL IVHRD+K SN+L++ N KI+DFG++R A T D C ++
Sbjct: 175 RQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS--- 228
Query: 153 IVGTYGYVPPEYVRKGIYSMKY-----DVYSYGVLLLQILGGK 190
VGT Y+ PE + + Y D++S GV +L+ G+
Sbjct: 229 -VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-12
Identities = 48/162 (29%), Positives = 83/162 (51%), Gaps = 16/162 (9%)
Query: 30 EEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSL-DF----YIFDLRRRYL 84
E F E ++ +L+H L+ + + ++ E ++ +YM SL DF LR L
Sbjct: 46 EAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQL 104
Query: 85 LDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKD 144
+D + I G+ Y++ + VHRDL+A+NIL+ + K++DFG+AR +
Sbjct: 105 VDMAAQ------IASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155
Query: 145 ECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQI 186
E A G + PE G +++K DV+S+G+LL ++
Sbjct: 156 EYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-12
Identities = 51/186 (27%), Positives = 95/186 (51%), Gaps = 15/186 (8%)
Query: 8 GRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKM---LIY 64
G++ +++ KRL + S + + E E+ L+ VN ++ + E K L+
Sbjct: 18 GKMYACKKLDKKRLKKKSGEKMALLEKEI-----LEKVNSPFIVNLAYAFESKTHLCLVM 72
Query: 65 DYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL 124
M L ++I+++ R L + +H IT G+L+L + IV+RD+K N+LL
Sbjct: 73 SLMNGGDLKYHIYNVGERGL-EMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLL 128
Query: 125 DYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLL 184
D + N ++SD G+A + + T R GT GY+ PE +++ YS D ++ G +
Sbjct: 129 DDQGNCRLSDLGLAVELK--DGKTITQR-AGTNGYMAPEILKEEPYSYPVDWFAMGCSIY 185
Query: 185 QILGGK 190
+++ G+
Sbjct: 186 EMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 3e-12
Identities = 44/128 (34%), Positives = 59/128 (46%), Gaps = 13/128 (10%)
Query: 65 DYMPNKSLDFYIFD-LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNIL 123
+Y L + LR R L D T I + YL N I++RDLK N+L
Sbjct: 73 EYCLGGEL----WTILRDRGLFDEYTARFYIACVVLAFEYL---HNRGIIYRDLKPENLL 125
Query: 124 LDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVR-KGIYSMKYDVYSYGVL 182
LD K+ DFG A+ K + T GT YV PE + KG Y D +S G+L
Sbjct: 126 LDSNGYVKLVDFGFAK---KLKSGQKTWTFCGTPEYVAPEIILNKG-YDFSVDYWSLGIL 181
Query: 183 LLQILGGK 190
L ++L G+
Sbjct: 182 LYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 4e-12
Identities = 33/98 (33%), Positives = 58/98 (59%), Gaps = 5/98 (5%)
Query: 93 IIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGR 152
I+ +GL YL + +HRD+KA NILL+ E K++DFG++ T + NT
Sbjct: 104 ILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-- 158
Query: 153 IVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGK 190
++GT ++ PE +++ Y+ K D++S G+ +++ GK
Sbjct: 159 VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 4e-12
Identities = 43/137 (31%), Positives = 75/137 (54%), Gaps = 9/137 (6%)
Query: 54 CTQREEKML-IYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTI 112
C Q +++ + +++ L F+I RR + R R + E IT L++L + I
Sbjct: 64 CFQTPDRLFFVMEFVNGGDLMFHIQKSRR--FDEARARFYAAE-ITSALMFLHDKG---I 117
Query: 113 VHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSM 172
++RDLK N+LLD+E + K++DFGM + + +T GT Y+ PE +++ +Y
Sbjct: 118 IYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST--FCGTPDYIAPEILQEMLYGP 175
Query: 173 KYDVYSYGVLLLQILGG 189
D ++ GVLL ++L G
Sbjct: 176 SVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 4e-12
Identities = 74/287 (25%), Positives = 129/287 (44%), Gaps = 50/287 (17%)
Query: 16 MAVKRLS-RTSHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLD 73
+AVK L + + L + +E++L + +H N++ +LG+CTQ +I +Y +L
Sbjct: 47 VAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLR 106
Query: 74 FYI-----------FDLRR--RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKAS 120
++ FD+ + L ++ V + +G+ YL+ +HRDL A
Sbjct: 107 EFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAAR 163
Query: 121 NILLDYEMNPKISDFGMARAFTKDECEANT--GRIVGTYGYVPPEYVRKGIYSMKYDVYS 178
N+L+ + KI+DFG+AR + T GR+ ++ PE + +Y+ + DV+S
Sbjct: 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRL--PVKWMAPEALFDRVYTHQSDVWS 221
Query: 179 YGVLLLQI--LGGKRTSCYYG-PNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235
+G+L+ +I LGG S Y G P E L + L + G M D + + + LM
Sbjct: 222 FGILMWEIFTLGG---SPYPGIPVEEL------FKLLREGHRM---DKPSNCTHELYMLM 269
Query: 236 RCMQVALLCVQENAADRPTMLE-------ILVMLKSETADIKTPKKP 275
R C RPT + +L + E D+ P +
Sbjct: 270 R------ECWHAVPTQRPTFKQLVEALDKVLAAVSEEYLDLSMPFEQ 310
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 5e-12
Identities = 52/182 (28%), Positives = 93/182 (51%), Gaps = 15/182 (8%)
Query: 13 GQEMAVKRL---SRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEK--MLIYDYM 67
G+++AVK L S +H + + + E+++ L H N++ GICT+ LI +++
Sbjct: 33 GEQVAVKSLKPESGGNH--IADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFL 90
Query: 68 PNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYE 127
P+ SL Y+ R + ++ + ++ I +G+ YL + VHRDL A N+L++ E
Sbjct: 91 PSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYL---GSRQYVHRDLAARNVLVESE 145
Query: 128 MNPKISDFGMARAFTKDE--CEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQ 185
KI DFG+ +A D+ + Y P ++ Y + DV+S+GV L +
Sbjct: 146 HQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFY-IASDVWSFGVTLYE 204
Query: 186 IL 187
+L
Sbjct: 205 LL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 5e-12
Identities = 45/137 (32%), Positives = 72/137 (52%), Gaps = 10/137 (7%)
Query: 56 QREEKM-LIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVH 114
Q + K+ LI DY+ L +++ +R + + RV+I E + L L L I++
Sbjct: 75 QTDTKLHLILDYVNGGELFTHLY--QREHFTESEVRVYIAEIV----LALDHLHQLGIIY 128
Query: 115 RDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGI--YSM 172
RD+K NILLD E + ++DFG+++ F +E E GT Y+ PE +R G +
Sbjct: 129 RDIKLENILLDSEGHVVLTDFGLSKEFLAEE-EERAYSFCGTIEYMAPEVIRGGSGGHDK 187
Query: 173 KYDVYSYGVLLLQILGG 189
D +S GVL ++L G
Sbjct: 188 AVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 7e-12
Identities = 38/111 (34%), Positives = 53/111 (47%), Gaps = 9/111 (8%)
Query: 85 LDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFG------MA 138
LD I I L YL + I+HRDLK NIL+D + K++DFG +
Sbjct: 90 LDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVR 146
Query: 139 RAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGG 189
R ++ E RIVGT Y+ PE + +S D +S G +L + L G
Sbjct: 147 RQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 8e-12
Identities = 53/188 (28%), Positives = 90/188 (47%), Gaps = 16/188 (8%)
Query: 10 LPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPN 69
L +A+K + + ++ E+ L + L+H N++ LG ++ + + +P
Sbjct: 30 LSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPG 89
Query: 70 KSLDFYIFDLRRRY--LLDWR-TRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLD- 125
SL LR ++ L D T + + I +GL YL + IVHRD+K N+L++
Sbjct: 90 GSLSAL---LRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNT 143
Query: 126 YEMNPKISDFGMARAFTK-DECEANTGRIVGTYGYVPPEYVRKGI--YSMKYDVYSYGVL 182
Y KISDFG ++ + C T GT Y+ PE + KG Y D++S G
Sbjct: 144 YSGVVKISDFGTSKRLAGINPC---TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCT 200
Query: 183 LLQILGGK 190
++++ GK
Sbjct: 201 IVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 9e-12
Identities = 50/181 (27%), Positives = 90/181 (49%), Gaps = 18/181 (9%)
Query: 12 NGQEMAVKRLSRTSHQGLEEFEN---EVKLTARLQHVNLLPVLGICTQREEKMLIYDYMP 68
N + +A+K++S + Q E++++ EV+ +L+H N + G + L+ +Y
Sbjct: 39 NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL 98
Query: 69 NKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM 128
+ D + ++ ++ L + + G QGL YL ++ ++HRD+KA NILL
Sbjct: 99 GSASD--LLEVHKKPLQEVEIAA-VTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPG 152
Query: 129 NPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYV---RKGIYSMKYDVYSYGVLLLQ 185
K+ DFG A AN VGT ++ PE + +G Y K DV+S G+ ++
Sbjct: 153 LVKLGDFGSASIMAP----ANX--FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 206
Query: 186 I 186
+
Sbjct: 207 L 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 9e-12
Identities = 41/128 (32%), Positives = 66/128 (51%), Gaps = 9/128 (7%)
Query: 63 IYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNI 122
I +Y S DL + LD I+ + GL YL E +HRD+KA+NI
Sbjct: 77 IMEYCGGGS----CLDLLKPGKLDETYIAFILREVLLGLEYLHEEGK---IHRDIKAANI 129
Query: 123 LLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVL 182
LL E + K++DFG++ T + NT VGT ++ PE +++ Y K D++S G+
Sbjct: 130 LLSEEGDVKLADFGVSGQLTSTMSKRNT--FVGTPFWMAPEVIKQSGYDEKADIWSLGIT 187
Query: 183 LLQILGGK 190
+++ G+
Sbjct: 188 AIELAKGE 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 1e-11
Identities = 33/94 (35%), Positives = 50/94 (53%), Gaps = 5/94 (5%)
Query: 97 ITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGT 156
I GL +L + I++RDLK N++LD E + KI+DFGM + T GT
Sbjct: 110 IAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG--GKTTRTFCGT 164
Query: 157 YGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGK 190
Y+ PE + Y D +++GVLL ++L G+
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-11
Identities = 33/88 (37%), Positives = 53/88 (60%), Gaps = 2/88 (2%)
Query: 102 LYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP 161
L L +L I++RDLK NILLD E + K++DFG+++ E +A + GT Y+
Sbjct: 109 LALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMA 166
Query: 162 PEYVRKGIYSMKYDVYSYGVLLLQILGG 189
PE V + ++ D +S+GVL+ ++L G
Sbjct: 167 PEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 48/150 (32%), Positives = 79/150 (52%), Gaps = 12/150 (8%)
Query: 53 ICT--QREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNL 110
CT +E + +++ L F+I D R L +R + E I GL +L
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDL--YRATFYAAE-IVCGLQFLHSKG-- 116
Query: 111 TIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIY 170
I++RDLK N++LD + + KI+DFGM + + A+T GT Y+ PE ++ Y
Sbjct: 117 -IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST--FCGTPDYIAPEILQGLKY 173
Query: 171 SMKYDVYSYGVLLLQILGGKRTSCYYGPNE 200
+ D +S+GVLL ++L G+ S ++G +E
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQ--SPFHGDDE 201
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 55/189 (29%), Positives = 98/189 (51%), Gaps = 23/189 (12%)
Query: 10 LPNGQEM----AVKRL-SRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIY 64
+P+G+ + A+K L TS + +E +E + A + + +LGIC + L+
Sbjct: 29 IPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQ-LVT 87
Query: 65 DYMPNKSLDFYIFDLRRR----YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKAS 120
MP L Y+ + + R LL+W + I +G+ YL+E + +VHRDL A
Sbjct: 88 QLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLEE---VRLVHRDLAAR 138
Query: 121 NILLDYEMNPKISDFGMARAFTKDECE--ANTGRIVGTYGYVPPEYVRKGIYSMKYDVYS 178
N+L+ + KI+DFG+AR DE E A+ G++ ++ E + ++ + DV+S
Sbjct: 139 NVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV--PIKWMALESILHRRFTHQSDVWS 196
Query: 179 YGVLLLQIL 187
YGV + +++
Sbjct: 197 YGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-11
Identities = 52/189 (27%), Positives = 90/189 (47%), Gaps = 15/189 (7%)
Query: 23 RTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF----D 78
R+ Q +E + + L H ++ +LGIC + L+ P SL ++
Sbjct: 47 RSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDS 105
Query: 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMA 138
L + LL+W + I +G+ YL+E+ +VHR+L A NILL + +I+DFG+A
Sbjct: 106 LDPQRLLNWCVQ------IAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVA 156
Query: 139 RAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYG 197
D+ + ++ E + G Y+ + DV+SYGV + +++ G
Sbjct: 157 DLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR 216
Query: 198 PNESLNLLE 206
P+E +LLE
Sbjct: 217 PHEVPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 2e-11
Identities = 48/193 (24%), Positives = 96/193 (49%), Gaps = 9/193 (4%)
Query: 13 GQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSL 72
GQE+A+++++ E NE+ + ++ N++ L +E ++ +Y+ SL
Sbjct: 45 GQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104
Query: 73 DFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKI 132
D+ +D + Q L +L +SN ++HRD+K+ NILL + + K+
Sbjct: 105 T----DVVTETCMDEGQIAAVCRECLQALEFL--HSN-QVIHRDIKSDNILLGMDGSVKL 157
Query: 133 SDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRT 192
+DFG T + ++ +VGT ++ PE V + Y K D++S G++ ++++ G+
Sbjct: 158 TDFGFCAQITPE--QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
Query: 193 SCYYGPNESLNLL 205
P +L L+
Sbjct: 216 YLNENPLRALYLI 228
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 67/250 (26%), Positives = 116/250 (46%), Gaps = 33/250 (13%)
Query: 16 MAVKRLSRTSHQGLEEFEN---EVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSL 72
+AVK++S + Q E++++ EVK +L+H N + G + L+ +Y +
Sbjct: 49 VAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSAS 108
Query: 73 DFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKI 132
D + ++ ++ L + I G QGL YL ++ ++HRD+KA NILL K+
Sbjct: 109 D--LLEVHKKPLQEVEIAA-ITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKL 162
Query: 133 SDFGMARAFTKDECEANTGRIVGTYGYVPPEYV---RKGIYSMKYDVYSYGVLLLQILGG 189
+DFG A + AN+ VGT ++ PE + +G Y K DV+S G+ +++
Sbjct: 163 ADFGSASKSSP----ANS--FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 216
Query: 190 KRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENA 249
K P ++N + Y + +N DS S+ R C+Q+
Sbjct: 217 KP------PLFNMNAMSALYHIAQN-------DSPTLQSNEWTDSFR--GFVDYCLQKIP 261
Query: 250 ADRPTMLEIL 259
+RP E+L
Sbjct: 262 QERPASAELL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-11
Identities = 55/196 (28%), Positives = 87/196 (44%), Gaps = 32/196 (16%)
Query: 9 RLPNGQEMAVKR--LSRTSHQGLEEFENEVKLTARLQHVNLLP-----VLG--ICTQREE 59
RL + Q A+K L S + E+ NE+++ A + H N++ + G +C
Sbjct: 21 RLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCI---- 76
Query: 60 KMLIYDYMPNKSLDFYI---FDLRRRYLLD--WRTRVHIIEGITQGLLYLQEYSNLTIVH 114
+ +Y P L I R+ WR + ++ G LQ I+H
Sbjct: 77 ---VMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG-------LQALHEQKILH 126
Query: 115 RDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKY 174
RDLK++NILL KI D G+++ K+ A T +GT Y+ PE + YS K
Sbjct: 127 RDLKSANILLVANDLVKIGDLGISKVLKKN--MAKT--QIGTPHYMAPEVWKGRPYSYKS 182
Query: 175 DVYSYGVLLLQILGGK 190
D++S G LL ++
Sbjct: 183 DIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (154), Expect = 2e-11
Identities = 35/115 (30%), Positives = 59/115 (51%), Gaps = 20/115 (17%)
Query: 35 EVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRV--- 91
E+ L L+H N++ +L + + L+++Y DL++ LD R
Sbjct: 48 EISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD--------MDLKK--YLDKRPGPLSP 97
Query: 92 ----HIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFT 142
I+ + +GL Y +S+ I+HRDLK NIL++ + K++DFG+ARAF
Sbjct: 98 NLIKSIMYQLLRGLAYC--HSHR-ILHRDLKPQNILINRDGVLKLADFGLARAFG 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-11
Identities = 51/154 (33%), Positives = 76/154 (49%), Gaps = 22/154 (14%)
Query: 54 CT--QREEKMLIYDYMPNKSLDFYI-----FDLRRRYLLDWRTRVHIIEGITQGLLYLQE 106
CT +E + +Y+ L F+I FDL R + E I GL +L
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPR-------ATFYAAE-IICGLQFLHS 114
Query: 107 YSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVR 166
IV+RDLK NILLD + + KI+DFGM + + + T GT Y+ PE +
Sbjct: 115 KG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT--FCGTPDYIAPEILL 169
Query: 167 KGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNE 200
Y+ D +S+GVLL ++L G+ S ++G +E
Sbjct: 170 GQKYNTSVDWWSFGVLLYEMLIGQ--SPFHGHDE 201
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 3e-11
Identities = 43/138 (31%), Positives = 72/138 (52%), Gaps = 9/138 (6%)
Query: 54 CTQREEKML-IYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTI 112
C Q E ++ + +Y+ L F++ R+R L + R + E I+ L YL E I
Sbjct: 64 CFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAE-ISLALNYLHERG---I 117
Query: 113 VHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSM 172
++RDLK N+LLD E + K++D+GM + + T GT Y+ PE +R Y
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTTSTFCGTPNYIAPEILRGEDYGF 175
Query: 173 KYDVYSYGVLLLQILGGK 190
D ++ GVL+ +++ G+
Sbjct: 176 SVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 35/94 (37%), Positives = 51/94 (54%), Gaps = 5/94 (5%)
Query: 97 ITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGT 156
I+ GL +L I++RDLK N++LD E + KI+DFGM + D T GT
Sbjct: 110 ISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT--FCGT 164
Query: 157 YGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGK 190
Y+ PE + Y D ++YGVLL ++L G+
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 58/199 (29%), Positives = 98/199 (49%), Gaps = 36/199 (18%)
Query: 10 LPNGQEMAVKRLSRTSHQGL-EEFENEVKLTARLQHVNLLPVLGICTQR-----EEKMLI 63
P G ++A+K++S HQ + E+K+ R +H N++ +L I + ++
Sbjct: 27 KPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIV 86
Query: 64 YDYMPNKSLDFYIFDLRRRYLLDWRTRV----HI---IEGITQGLLYLQEYSNLTIVHRD 116
+ M DL + L+ +T+ HI + I +GL Y+ +N ++HRD
Sbjct: 87 QELMET--------DLYK--LI--KTQHLSNDHIQYFLYQILRGLKYIHS-AN--VLHRD 131
Query: 117 LKASNILLDYEMNPKISDFGMARAFTKDECEANTGRI---VGTYGYVPPEYV--RKGIYS 171
LK SN+LL+ + KI DFG+AR D +TG + V T Y PE + KG Y+
Sbjct: 132 LKPSNLLLNTNCDLKICDFGLAR--IADPEHDHTGFLTEYVATRWYRAPEIMLNSKG-YT 188
Query: 172 MKYDVYSYGVLLLQILGGK 190
D++S G +L ++L +
Sbjct: 189 KAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-11
Identities = 38/122 (31%), Positives = 67/122 (54%), Gaps = 11/122 (9%)
Query: 93 IIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGR 152
I+ I +GL YL +HRD+KA+N+LL + + K++DFG+A T + + NT
Sbjct: 106 ILREILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-- 160
Query: 153 IVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLW 212
VGT ++ PE +++ Y K D++S G+ +++ G+ PN L+ + + +
Sbjct: 161 FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEP------PNSDLHPMRVLFLIP 214
Query: 213 KN 214
KN
Sbjct: 215 KN 216
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-11
Identities = 47/184 (25%), Positives = 90/184 (48%), Gaps = 16/184 (8%)
Query: 15 EMAVK--RLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEK------MLIYDY 66
++AVK +++ + +E+F +E H N++ ++G+C Q E ++I +
Sbjct: 28 KVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPF 87
Query: 67 MPNKSLDFYIFDLR---RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNIL 123
M + L ++ R L + V + I G+ YL S+ + +HRDL A N +
Sbjct: 88 MKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYL---SSKSFIHRDLAARNCM 144
Query: 124 LDYEMNPKISDFGMARAFTKDECEANTGRIVGT-YGYVPPEYVRKGIYSMKYDVYSYGVL 182
L+ MN ++DFG+++ + GRI ++ E + +Y+ K DV+S+GV
Sbjct: 145 LNENMNVCVADFGLSKKIYNGD-YYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVT 203
Query: 183 LLQI 186
+ +I
Sbjct: 204 MWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 4e-11
Identities = 55/227 (24%), Positives = 100/227 (44%), Gaps = 21/227 (9%)
Query: 35 EVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI--FDLRRRYLLDWRTRVH 92
E+ L +L H N++ L + E ++ + L I F ++R L+ RT
Sbjct: 52 EIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKR-LIPERTIWK 110
Query: 93 IIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGR 152
+ L ++ I+HRD+K +N+ + K+ D G+ R F+ A++
Sbjct: 111 YFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-- 165
Query: 153 IVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLW 212
+VGT Y+ PE + + Y+ K D++S G LL ++ + S +YG + +NL Y L
Sbjct: 166 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ--SPFYG--DKMNL----YSLC 217
Query: 213 KNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEIL 259
K E ++ D S + + C+ + RP + +L
Sbjct: 218 KKIEKCDYPPLPADHYSEELR-----DLVSRCINPDPEKRPDISYVL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-11
Identities = 64/262 (24%), Positives = 110/262 (41%), Gaps = 30/262 (11%)
Query: 8 GRLPNGQEMAVKRLS------RTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKM 61
G GQ +AVK++ + + E+ + EV L L+HVN++ LG C
Sbjct: 19 GLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTIS 78
Query: 62 LIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASN 121
+ +++P S+ L R L + I G+ YL +VHRD+K +N
Sbjct: 79 IFMEFVPGGSISSI---LNRFGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNN 132
Query: 122 ILLDYEMNPKISDFGMARAFTKDECEANTGRIV----GTYGYVPPEYVRKGIYSMKYDVY 177
++L K+ DFG AR ++ GT ++ PE + + Y K D++
Sbjct: 133 VMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIW 192
Query: 178 SYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRC 237
S G + ++ GK P S++ L + + G+ L DS SA
Sbjct: 193 SIGCTVFEMATGKP------PLASMDRLAAMFYI-GAHRGLM---PRLPDSFSA----AA 238
Query: 238 MQVALLCVQENAADRPTMLEIL 259
+ C+ + +RP+ L++L
Sbjct: 239 IDFVTSCLTRDQHERPSALQLL 260
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 5e-11
Identities = 53/189 (28%), Positives = 93/189 (49%), Gaps = 23/189 (12%)
Query: 11 PNGQEM--AVKRLSR-TSHQGLEEFENEVKLTARLQHVNLLPVLGICTQRE-EKMLIYDY 66
+GQ++ AVK L+R T + +E+F E + H N+L +LGIC E +++ Y
Sbjct: 19 SDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78
Query: 67 MPNKSLDFYIFDLRR----RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNI 122
M + L +I + L+ + +V +G+ YL ++ VHRDL A N
Sbjct: 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQV------AKGMEYL---ASKKFVHRDLAARNC 129
Query: 123 LLDYEMNPKISDFGMARAFTKDEC----EANTGRIVGTYGYVPPEYVRKGIYSMKYDVYS 178
+LD K++DFG+AR E ++ ++ E ++ ++ K DV+S
Sbjct: 130 MLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKL--PVKWMALESLQTQKFTTKSDVWS 187
Query: 179 YGVLLLQIL 187
+GVLL +++
Sbjct: 188 FGVLLWELM 196
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 5e-11
Identities = 54/231 (23%), Positives = 108/231 (46%), Gaps = 25/231 (10%)
Query: 29 LEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWR 88
+E+ + E+ + ++ + G + + +I +Y+ S DL R D
Sbjct: 46 IEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGS----ALDLLRAGPFDEF 101
Query: 89 TRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEA 148
+++ I +GL YL +HRD+KA+N+LL + + K++DFG+A T + +
Sbjct: 102 QIATMLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158
Query: 149 NTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYA 208
NT VGT ++ PE +++ Y K D++S G+ +++ G+ PN ++ +
Sbjct: 159 NT--FVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEP------PNSDMHPMRVL 210
Query: 209 YGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEIL 259
+ + KN + + S +K + C+ ++ + RPT E+L
Sbjct: 211 FLIPKNNP-----PTLTGEFSKPFK-----EFIDACLNKDPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 5e-11
Identities = 34/94 (36%), Positives = 50/94 (53%), Gaps = 5/94 (5%)
Query: 97 ITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGT 156
I GL +L I++RDLK N++LD E + KI+DFGM + D T GT
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT--FCGT 164
Query: 157 YGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGK 190
Y+ PE + Y D +++GVLL ++L G+
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 8e-11
Identities = 63/194 (32%), Positives = 91/194 (46%), Gaps = 17/194 (8%)
Query: 3 VAICQGRLPNGQEMAVKRLSRT---SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREE 59
V CQ R G+ A K+L + +G NE ++ L+ VN V+ + E
Sbjct: 16 VCACQVRA-TGKMYACKKLEKKRIKKRKGEAMALNEKQI---LEKVNSRFVVSLAYAYET 71
Query: 60 K---MLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRD 116
K L+ M L F+I+++ + R + E IT GL L IV+RD
Sbjct: 72 KDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAE-ITCGLEDLHRER---IVYRD 127
Query: 117 LKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDV 176
LK NILLD + +ISD G+A E E GR VGT GY+ PE V+ Y+ D
Sbjct: 128 LKPENILLDDYGHIRISDLGLAVEIP--EGETIRGR-VGTVGYMAPEVVKNERYTFSPDW 184
Query: 177 YSYGVLLLQILGGK 190
+ G L+ +++ GK
Sbjct: 185 WGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 8e-11
Identities = 41/138 (29%), Positives = 72/138 (52%), Gaps = 9/138 (6%)
Query: 54 CTQREEKM-LIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTI 112
C Q E ++ + +++ L F++ R+R L + R + E I+ L +L E I
Sbjct: 64 CFQTESRLFFVIEFVSGGDLMFHM--QRQRKLPEEHARFYSAE-ISLALNFLHERG---I 117
Query: 113 VHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSM 172
++RDLK N+LLD E + K++D+GM + + T GT Y+ PE +R Y
Sbjct: 118 IYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDTTSTFCGTPNYIAPEILRGEDYGF 175
Query: 173 KYDVYSYGVLLLQILGGK 190
D ++ GVL+ +++ G+
Sbjct: 176 SVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 8e-11
Identities = 46/152 (30%), Positives = 66/152 (43%), Gaps = 18/152 (11%)
Query: 113 VHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSM 172
+HRDL A NILL KI DFG+AR KD G ++ PE + +Y+
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTT 254
Query: 173 KYDVYSYGVLLLQI--LGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSS 230
+ DV+S+GVLL +I LG P + + E K G M + + +
Sbjct: 255 QSDVWSFGVLLWEIFSLGAS-------PYPGVQIDEEFCRRLKEGTRMRAPEYATPE--- 304
Query: 231 AWKLMRCMQVALLCVQENAADRPTMLEILVML 262
+ L C N DRPT E++ +L
Sbjct: 305 ------IYSIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 8e-11
Identities = 44/157 (28%), Positives = 76/157 (48%), Gaps = 9/157 (5%)
Query: 54 CTQREEKM-LIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTI 112
C Q ++ L+ +Y+ L F++ R+R L + R + E I L +L E I
Sbjct: 64 CFQTTSRLFLVIEYVNGGDLMFHM--QRQRKLPEEHARFYAAE-ICIALNFLHERG---I 117
Query: 113 VHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSM 172
++RDLK N+LLD + + K++D+GM + T GT Y+ PE +R Y
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDTTSTFCGTPNYIAPEILRGEEYGF 175
Query: 173 KYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAY 209
D ++ GVL+ +++ G+ N +N +Y +
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLF 212
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 8e-11
Identities = 46/160 (28%), Positives = 80/160 (50%), Gaps = 18/160 (11%)
Query: 35 EVKLTARLQHVNLLPVLGICTQREEKM----------LIYDYMPNKSLDFYIFDLRRRYL 84
E+K+ +L H N++ + I T +++ + L+++YM D + L L
Sbjct: 56 EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGL 110
Query: 85 LDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKD 144
+ + + HI + Q L L +HRD+K SNILL+ + K++DFG+AR + +
Sbjct: 111 VHF-SEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSE 169
Query: 145 ECEANTGRIVGTYGYVPPEYVR-KGIYSMKYDVYSYGVLL 183
E T +++ T Y PPE + + Y DV+S G +L
Sbjct: 170 ESRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCIL 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 1e-10
Identities = 49/159 (30%), Positives = 76/159 (47%), Gaps = 17/159 (10%)
Query: 42 LQHVNLLPVLGICTQREEK-MLIYDYMPNKSLDFYIFDLR-----RRYLLDWRTRVHIIE 95
L H N+LP+L +C + E ++Y YM +L ++ R L + VH+
Sbjct: 65 LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAI 124
Query: 96 GITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMAR-AFTKD-ECEA-NTGR 152
I G+ YL ++H+D+ A N ++D E+ KI+D ++R F D C N R
Sbjct: 125 QIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENR 181
Query: 153 IVGTYGYVPPEYVRKGIYSMKYDVYSYGVLL--LQILGG 189
V ++ E + YS DV+S+GVLL L LG
Sbjct: 182 PV---KWMALESLVNKEYSSASDVWSFGVLLWELMTLGQ 217
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 51/194 (26%), Positives = 89/194 (45%), Gaps = 36/194 (18%)
Query: 12 NGQEMAVKRL-SRTSHQGL-EEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPN 69
G+ +A+K++ R G+ + E+K QH ++ +L + +L+ +YMP+
Sbjct: 24 TGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMPS 83
Query: 70 KSLDFYIFDLRR-----------RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLK 118
L + D R R LL G+ Y+ I+HRDLK
Sbjct: 84 -DLSEVLRDEERPLPEAQVKSYMRMLLK-------------GVAYMHA---NGIMHRDLK 126
Query: 119 ASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYV---RKGIYSMKYD 175
+N+L+ + KI+DFG+AR F+++E + + V T Y PE + RK Y D
Sbjct: 127 PANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPELLYGARK--YDPGVD 183
Query: 176 VYSYGVLLLQILGG 189
+++ G + ++L G
Sbjct: 184 LWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 60/241 (24%), Positives = 111/241 (46%), Gaps = 33/241 (13%)
Query: 30 EEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRT 89
+E E + +L + ++ ++GIC + E ML+ + L+ ++ + +++ + +
Sbjct: 41 DELLREANVMQQLDNPYIVRMIGIC-EAESWMLVMELAELGPLNKFL--QKNKHVTE-KN 96
Query: 90 RVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEAN 149
++ ++ G+ YL+E + VHRDL A N+LL + KISDFG+++A DE
Sbjct: 97 ITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153
Query: 150 TGRIVGTYGYVP-----PEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLN 203
T+G P PE + +S K DV+S+GVL+ + G++ NE
Sbjct: 154 A----KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQ 209
Query: 204 LLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLK 263
++E +GE ME + LM+ LC +RP + + L+
Sbjct: 210 MIE-------SGERME---CPQRCPPEMYDLMK------LCWTYGVDERPGFAVVELRLR 253
Query: 264 S 264
+
Sbjct: 254 N 254
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 67/226 (29%), Positives = 110/226 (48%), Gaps = 36/226 (15%)
Query: 15 EMAVKRL-SRTSHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSL 72
++AVK L S + + L + +E+++ + +H N++ +LG CTQ +I +Y +L
Sbjct: 52 KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 111
Query: 73 DFYIFDLRR--------------RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLK 118
Y+ RR L ++ V + +G+ YL ++ +HRDL
Sbjct: 112 REYL-RARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLA 167
Query: 119 ASNILLDYEMNPKISDFGMARAFTKDECEANT--GRIVGTYGYVPPEYVRKGIYSMKYDV 176
A N+L+ + KI+DFG+AR + T GR+ ++ PE + IY+ + DV
Sbjct: 168 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL--PVKWMAPEALFDRIYTHQSDV 225
Query: 177 YSYGVLLLQI--LGGKRTSCYYG-PNESLNLLEYAYGLWKNGEGME 219
+S+GVLL +I LGG S Y G P E L + L K G M+
Sbjct: 226 WSFGVLLWEIFTLGG---SPYPGVPVEEL------FKLLKEGHRMD 262
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 45/135 (33%), Positives = 69/135 (51%), Gaps = 9/135 (6%)
Query: 56 QREEKM-LIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVH 114
Q EK+ + DY+ L F++ R R L+ R R + E + + YL +L I++
Sbjct: 66 QTAEKLYFVLDYVNGGELFFHL--QRERCFLEPRARFYAAE-VASAIGYLH---SLNIIY 119
Query: 115 RDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKY 174
RDLK NILLD + + ++DFG+ + E E T GT Y+ PE +RK Y
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGV--EPEETTSTFCGTPEYLAPEVLRKEPYDRTV 177
Query: 175 DVYSYGVLLLQILGG 189
D + G +L ++L G
Sbjct: 178 DWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-10
Identities = 38/156 (24%), Positives = 67/156 (42%), Gaps = 15/156 (9%)
Query: 35 EVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHII 94
E L + H +++ + ++ +P+ S D Y + +R L + I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 95 EGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIV 154
+ I +GL YL I+HRD+K NI ++ I D G A+ +
Sbjct: 164 KQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQ------FPVVAPAFL 214
Query: 155 GTYGYV---PPEYVRKGIYSMKYDVYSYGVLLLQIL 187
G G V PE + + Y+ K D++S G++L ++L
Sbjct: 215 GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 47/159 (29%), Positives = 80/159 (50%), Gaps = 11/159 (6%)
Query: 35 EVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHII 94
E+ L L+H N++ + + + ML+++YM +K L Y+ R LD T
Sbjct: 48 EISLMKELKHENIVRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFT 106
Query: 95 EGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANT-GRI 153
+ +G+ + E ++HRDLK N+L++ K++DFG+ARAF NT
Sbjct: 107 YQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFG---IPVNTFSNE 160
Query: 154 VGTYGYVPPEYVRKG--IYSMKYDVYSYGVLLLQILGGK 190
V T Y P+ V G YS D++S G ++ +++ G+
Sbjct: 161 VVTLWYRAPD-VLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 50/154 (32%), Positives = 76/154 (49%), Gaps = 13/154 (8%)
Query: 42 LQHVNLLP---VLGICTQREEKM-LIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGI 97
L+H+ P L Q + K+ LI DY+ L F R R+ V I G
Sbjct: 58 LEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGEL-FTHLSQRERFK---EQEVQIYSG- 112
Query: 98 TQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTY 157
+ +L L+ L I++RD+K NILLD + ++DFG+++ F +DE E GT
Sbjct: 113 -EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTI 170
Query: 158 GYVPPEYVRKGI--YSMKYDVYSYGVLLLQILGG 189
Y+ P+ VR G + D +S GVL+ ++L G
Sbjct: 171 EYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-10
Identities = 60/194 (30%), Positives = 91/194 (46%), Gaps = 17/194 (8%)
Query: 3 VAICQGRLPNGQEMAVKRLSRT---SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREE 59
V CQ R G+ A K+L + +G NE ++ L+ VN V+ + E
Sbjct: 16 VCACQVR-ATGKMYACKKLEKKRIKKRKGESMALNEKQI---LEKVNSRFVVSLAYAYET 71
Query: 60 K---MLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRD 116
K L+ M L F+I+ + + R + E I GL L + IV+RD
Sbjct: 72 KDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAE-ICCGLEDLHQER---IVYRD 127
Query: 117 LKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDV 176
LK NILLD + +ISD G+A + + GR VGT GY+ PE V+ Y+ D
Sbjct: 128 LKPENILLDDHGHIRISDLGLAVHVPEG--QTIKGR-VGTVGYMAPEVVKNERYTFSPDW 184
Query: 177 YSYGVLLLQILGGK 190
++ G LL +++ G+
Sbjct: 185 WALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 3e-10
Identities = 63/242 (26%), Positives = 113/242 (46%), Gaps = 23/242 (9%)
Query: 48 LPVLGICTQREEKML-IYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQE 106
L L C Q ++++ + +Y+ L F I R R + R+R + E +T L++L
Sbjct: 58 LTALHCCFQTKDRLFFVMEYVNGGDLMFQI--QRSRKFDEPRSRFYAAE-VTLALMFLHR 114
Query: 107 YSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVR 166
+ +++RDLK NILLD E + K++DFGM + + T GT Y+ PE ++
Sbjct: 115 HG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILN--GVTTTTFCGTPDYIAPEILQ 169
Query: 167 KGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLE------YAYGLWKNGEGMEF 220
+ Y D ++ GVL+ +++ G+ + NE +L E Y +W + E +
Sbjct: 170 ELEYGPSVDWWALGVLMYEMMAGQPP--FEADNED-DLFESILHDDVLYPVWLSKEAVSI 226
Query: 221 IDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETADIKTPKKPAFSVK 280
+ + + + + K + C+ E+A + + + + E IK P KP K
Sbjct: 227 LKAFM--TKNPNKRLGCVASQGG---EDAIKQHPFFKEIDWVLLEQRKIKPPFKPKIKTK 281
Query: 281 RD 282
RD
Sbjct: 282 RD 283
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 3e-10
Identities = 40/148 (27%), Positives = 76/148 (51%), Gaps = 34/148 (22%)
Query: 35 EVKLTARLQHVNLLPVLGICTQREEK--------MLIYDY--------MPNKSLDFYIFD 78
E+K+ L+H N++ ++ IC + L++++ + NK++ F + +
Sbjct: 61 EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSE 120
Query: 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMA 138
+++ +++ + GL Y+ + N I+HRD+KA+NIL+ + K++DFG+A
Sbjct: 121 IKK-----------VMKMLLNGLYYI--HRN-KILHRDMKAANILITKDGILKLADFGLA 166
Query: 139 RAF---TKDECEANTGRIVGTYGYVPPE 163
RAF + T R+V T Y PPE
Sbjct: 167 RAFSLSKNSKPNRYTNRVV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-10
Identities = 51/196 (26%), Positives = 99/196 (50%), Gaps = 18/196 (9%)
Query: 5 ICQG--RLPNGQEM--AVKRL-SRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREE 59
+C+G +LP+ +E+ A+ L + S + F E + H N++ + G+ T+
Sbjct: 21 LCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT 80
Query: 60 KMLIYDYMPNKSLDFYIFDLRRRY-LLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLK 118
M++ +YM N +LD + LR+ L + ++ G+ G+ YL E + VH+ L
Sbjct: 81 MMIVTEYMSNGALDSF---LRKHEGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLA 134
Query: 119 ASNILLDYEMNPKISDFGMARAFTKDECEA--NTGRIVGTYGYVPPEYVRKGIYSMKYDV 176
A +L++ ++ KIS F R +D+ EA T + PE ++ +S DV
Sbjct: 135 AHKVLVNSDLVCKISGF---RRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDV 191
Query: 177 YSYGVLLLQILG-GKR 191
+S+G+++ +++ G+R
Sbjct: 192 WSFGIVMWEVMSYGER 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 3e-10
Identities = 68/262 (25%), Positives = 121/262 (46%), Gaps = 39/262 (14%)
Query: 16 MAVKRLS-RTSHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLD 73
+AVK L + + L + +E+++ + +H N++ +LG CTQ +I +Y +L
Sbjct: 50 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 109
Query: 74 FYI-----------FDLRR--RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKAS 120
Y+ +D+ R + ++ V + +G+ YL ++ +HRDL A
Sbjct: 110 EYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAAR 166
Query: 121 NILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYG 180
N+L+ KI+DFG+AR + T ++ PE + +Y+ + DV+S+G
Sbjct: 167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 226
Query: 181 VLLLQI--LGGKRTSCYYG-PNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRC 237
VL+ +I LGG S Y G P E L + L K G M D + ++ + +MR
Sbjct: 227 VLMWEIFTLGG---SPYPGIPVEEL------FKLLKEGHRM---DKPANCTNELYMMMRD 274
Query: 238 MQVALLCVQENAADRPTMLEIL 259
C + RPT +++
Sbjct: 275 ------CWHAIPSHRPTFKQLV 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 4e-10
Identities = 47/189 (24%), Positives = 94/189 (49%), Gaps = 12/189 (6%)
Query: 15 EMAVKRLSRTSHQGL-EEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLD 73
++A+K L + + + +E E ++ +L + ++ ++G+C + E ML+ + L+
Sbjct: 24 DVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC-EAEALMLVMEMASGGPLN 82
Query: 74 FYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKIS 133
++ ++ + V ++ ++ G+ YL+ + VHRDL A N+LL + KIS
Sbjct: 83 KFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKIS 137
Query: 134 DFGMARAFTKDECEANTGRIVGTY--GYVPPEYVRKGIYSMKYDVYSYGVLLLQIL--GG 189
DFG+++A D+ R G + + PE + +S + DV+SYG+ + + G
Sbjct: 138 DFGLSKALGADD-SYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQ 196
Query: 190 KRTSCYYGP 198
K GP
Sbjct: 197 KPYKKMKGP 205
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 4e-10
Identities = 46/175 (26%), Positives = 92/175 (52%), Gaps = 12/175 (6%)
Query: 17 AVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76
A K + S + LE++ E+++ A H ++ +LG + ++ ++ P ++D +
Sbjct: 41 AAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIM 100
Query: 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFG 136
+L R L + + +V I + + L YL ++ I+HRDLKA N+LL + + K++DFG
Sbjct: 101 LELDRG-LTEPQIQV-ICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFG 155
Query: 137 MARAFTKDECEANTGRIVGTYGYVPPEYV-----RKGIYSMKYDVYSYGVLLLQI 186
++ K ++ +GT ++ PE V + Y K D++S G+ L+++
Sbjct: 156 VSAKNVKTLQRRDS--FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-10
Identities = 47/175 (26%), Positives = 88/175 (50%), Gaps = 12/175 (6%)
Query: 17 AVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76
A K + S + LE++ E+ + A H N++ +L ++ ++ ++D +
Sbjct: 34 AAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVM 93
Query: 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFG 136
+L R L + + RV + + + L YL E I+HRDLKA NIL + + K++DFG
Sbjct: 94 LELERP-LTEPQIRV-VCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFG 148
Query: 137 MARAFTKDECEANTGRIVGTYGYVPPEYV-----RKGIYSMKYDVYSYGVLLLQI 186
++ T+ ++ +GT ++ PE V + Y K DV+S G+ L+++
Sbjct: 149 VSAKNTRTIQRRDS--FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 4e-10
Identities = 54/199 (27%), Positives = 91/199 (45%), Gaps = 31/199 (15%)
Query: 12 NGQEMAVKRLSR-TSHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPN 69
A+K L S +F E+++ +L H N++ +LG C R + +Y P
Sbjct: 28 LKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPY 87
Query: 70 KSL-DFYIFDLRRRYLLDW----------------RTRVHIIEGITQGLLYLQEYSNLTI 112
+L DF LR+ +L+ + + + G+ YL E
Sbjct: 88 GNLLDF----LRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---F 140
Query: 113 VHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSM 172
+HRDL A N+L+ + KI+DFG++R + + GR+ ++ E + +Y+
Sbjct: 141 IHRDLAARNVLVGENLASKIADFGLSRG-EEVYVKKTMGRL--PVRWMAIESLNYSVYTT 197
Query: 173 KYDVYSYGVLLLQI--LGG 189
K DV+S+GVLL +I LGG
Sbjct: 198 KSDVWSFGVLLWEIVSLGG 216
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (143), Expect = 5e-10
Identities = 52/191 (27%), Positives = 89/191 (46%), Gaps = 17/191 (8%)
Query: 3 VAICQGRLPNGQEMAVKRLSRTS--HQGLEE-FENEVKLTARLQHVNLLPVLGICTQREE 59
V + + +G+ A+K LS+ E NE ++ ++H L+ + G Q +
Sbjct: 17 VMLVR-HKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG-SFQDDS 74
Query: 60 KM-LIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLK 118
+ L+ +Y+P L F R+ R + + + L YL +L IV+RDLK
Sbjct: 75 NLYLVMEYVPGGEL-FSHLRKSGRFPEPV-ARFYAAQ-VVLALEYLH---SLDIVYRDLK 128
Query: 119 ASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYS 178
N+LLD + KI+DFG A+ + T + GT Y+ PE + Y D ++
Sbjct: 129 PENLLLDSDGYIKITDFGFAK-----RVKGRTYTLCGTPEYLAPEIILSKGYGKAVDWWA 183
Query: 179 YGVLLLQILGG 189
G+L+ ++L G
Sbjct: 184 LGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (144), Expect = 5e-10
Identities = 60/208 (28%), Positives = 95/208 (45%), Gaps = 56/208 (26%)
Query: 12 NGQEMAVKRLSRTSHQGLEEFEN---------EVKLTARLQHVNLLPVLGICTQREEKML 62
G+++A+K++S F++ E+KL L+H N++ +L I
Sbjct: 24 TGRKVAIKKISNV-------FDDLIDAKRILREIKLLRHLRHENIIGLLDI--------- 67
Query: 63 IYDYMPNKSLDF---YIF------DLRR-----RYLLDWRTRVHIIEGITQGLLYLQEYS 108
P DF YI DL + + L D + + + I +GL YL +
Sbjct: 68 ---LRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQ-YFLYQILRGLKYLHS-A 122
Query: 109 NLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEAN--TGRIVGTYGYVPPEYVR 166
N ++HRDLK SNIL++ + KI DFG+AR DE E T +V T Y PE +
Sbjct: 123 N--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV-TRWYRAPELL- 178
Query: 167 KGIYSMKY----DVYSYGVLLLQILGGK 190
+ S +Y D++S G + ++L K
Sbjct: 179 --LSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 6e-10
Identities = 50/175 (28%), Positives = 79/175 (45%), Gaps = 9/175 (5%)
Query: 14 QEMAVK--RLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKS 71
Q+ A+K RL ++S +E+ E L A+++H N++ ++ +Y
Sbjct: 26 QKYAMKEIRLPKSSSA-VEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGD 84
Query: 72 LDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPK 131
L I R + I++ Q L +Q ++HRD+K+ NI L K
Sbjct: 85 LMQKIKLQRGKLF----PEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVK 140
Query: 132 ISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQI 186
+ DFG AR T A T VGT YVPPE Y+ K D++S G +L ++
Sbjct: 141 LGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 6e-10
Identities = 45/137 (32%), Positives = 68/137 (49%), Gaps = 13/137 (9%)
Query: 56 QREEKM-LIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVH 114
Q +K+ + DY+ L F++ R R + R R + E I L YL L I++
Sbjct: 66 QTADKLYFVLDYVNGGELFFHL--QRERSFPEPRARFYAAE-IASALGYLHS---LNIIY 119
Query: 115 RDLKASNILLDYEMNPKISDFGMARAFTKDECEAN--TGRIVGTYGYVPPEYVRKGIYSM 172
RDLK NILLD + + ++DFG+ K+ E + T GT Y+ PE +RK Y
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLC----KEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDR 175
Query: 173 KYDVYSYGVLLLQILGG 189
D + G +L ++L G
Sbjct: 176 TVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 6e-10
Identities = 45/177 (25%), Positives = 83/177 (46%), Gaps = 9/177 (5%)
Query: 29 LEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWR 88
+E+ + E+ + ++ + G + + +I +Y+ S DL LD
Sbjct: 46 IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDET 101
Query: 89 TRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEA 148
I+ I +GL YL +HRD+KA+N+LL K++DFG+A T + +
Sbjct: 102 QIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 158
Query: 149 NTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLL 205
N VGT ++ PE +++ Y K D++S G+ +++ G+ P + L L+
Sbjct: 159 N--TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI 213
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 6e-10
Identities = 56/194 (28%), Positives = 93/194 (47%), Gaps = 31/194 (15%)
Query: 17 AVKRLSR-TSHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSL-D 73
A+KR+ S +F E+++ +L H N++ +LG C R L +Y P+ +L D
Sbjct: 26 AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 85
Query: 74 FYIFDLRRRYLLDW----------------RTRVHIIEGITQGLLYLQEYSNLTIVHRDL 117
F LR+ +L+ + +H + +G+ YL + +HRDL
Sbjct: 86 F----LRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDL 138
Query: 118 KASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVY 177
A NIL+ KI+DFG++R + + GR+ ++ E + +Y+ DV+
Sbjct: 139 AARNILVGENYVAKIADFGLSRG-QEVYVKKTMGRL--PVRWMAIESLNYSVYTTNSDVW 195
Query: 178 SYGVLLLQI--LGG 189
SYGVLL +I LGG
Sbjct: 196 SYGVLLWEIVSLGG 209
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 7e-10
Identities = 49/194 (25%), Positives = 89/194 (45%), Gaps = 28/194 (14%)
Query: 12 NGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEK------MLI 63
+ Q++AVK L S +EEF E H N++ ++G+ + K M+I
Sbjct: 26 SFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVI 85
Query: 64 YDYMPNKSLDFYIFDLRRR-----YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLK 118
+M K D + F L R + L +T V + I G+ YL S+ +HRDL
Sbjct: 86 LPFM--KHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYL---SSKNFIHRDLA 140
Query: 119 ASNILLDYEMNPKISDFGMARA-----FTKDECEANTGRIVGTYGYVPPEYVRKGIYSMK 173
A N +L+ M ++DFG+++ + + C + ++ E + +Y+
Sbjct: 141 ARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL-----PVKWLALESLADNVYTTH 195
Query: 174 YDVYSYGVLLLQIL 187
DV+++GV + +I+
Sbjct: 196 SDVWAFGVTMWEIM 209
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 7e-10
Identities = 60/194 (30%), Positives = 91/194 (46%), Gaps = 17/194 (8%)
Query: 3 VAICQGRLPNGQEMAVKRLSRT---SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREE 59
V CQ R G+ A KRL + +G NE ++ L+ VN V+ + E
Sbjct: 16 VCACQVR-ATGKMYACKRLEKKRIKKRKGESMALNEKQI---LEKVNSQFVVNLAYAYET 71
Query: 60 K---MLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRD 116
K L+ M L F+I+++ + R + E I GL L + V+RD
Sbjct: 72 KDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAE-ILCGLEDLHREN---TVYRD 127
Query: 117 LKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDV 176
LK NILLD + +ISD G+A E E+ GR VGT GY+ PE + Y++ D
Sbjct: 128 LKPENILLDDYGHIRISDLGLAVKIP--EGESIRGR-VGTVGYMAPEVLNNQRYTLSPDY 184
Query: 177 YSYGVLLLQILGGK 190
+ G L+ +++ G+
Sbjct: 185 WGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 8e-10
Identities = 41/179 (22%), Positives = 90/179 (50%), Gaps = 9/179 (5%)
Query: 12 NGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKS 71
G+++AVK++ Q E NEV + H N++ + +E ++ +++ +
Sbjct: 46 TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105
Query: 72 LDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPK 131
L D+ ++ + + + L YL N ++HRD+K+ +ILL + K
Sbjct: 106 LT----DIVTHTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIK 158
Query: 132 ISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGK 190
+SDFG +K+ + + +VGT ++ PE + + Y + D++S G+++++++ G+
Sbjct: 159 LSDFGFCAQVSKEVPKRKS--LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 8e-10
Identities = 40/178 (22%), Positives = 89/178 (50%), Gaps = 9/178 (5%)
Query: 13 GQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSL 72
G+++AVK++ Q E NEV + QH N++ + +E ++ +++ +L
Sbjct: 44 GRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103
Query: 73 DFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKI 132
+ R ++ + + + L +L ++HRD+K+ +ILL + K+
Sbjct: 104 TDIVTHTR----MNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKL 156
Query: 133 SDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGK 190
SDFG +K+ + +VGT ++ PE + + Y + D++S G+++++++ G+
Sbjct: 157 SDFGFCAQVSKEVPRRKS--LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 8e-10
Identities = 52/189 (27%), Positives = 76/189 (40%), Gaps = 45/189 (23%)
Query: 32 FENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLD--WR- 88
F E K+ A L H ++PV IC+ + +Y MP YI + LL W+
Sbjct: 49 FLREAKIAADLIHPGIVPVYSICSDGD---PVYYTMP------YIEGYTLKSLLKSVWQK 99
Query: 89 --------------TRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISD 134
+ I I + Y+ ++HRDLK NILL I D
Sbjct: 100 ESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILD 156
Query: 135 FGMARAFTKDE-------------CEANT---GRIVGTYGYVPPEYVRKGIYSMKYDVYS 178
+G A +E C ++ G+IVGT Y+ PE + S D+Y+
Sbjct: 157 WGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYA 216
Query: 179 YGVLLLQIL 187
GV+L Q+L
Sbjct: 217 LGVILYQML 225
|
Length = 932 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 8e-10
Identities = 49/193 (25%), Positives = 89/193 (46%), Gaps = 12/193 (6%)
Query: 3 VAICQGRLPNGQEMAVKRLSRT---SHQGLEEFENEVKLTARLQHVNLLPVLGICTQ-RE 58
V+ CQ R G+ A K+L++ +G E E ++ A++ H + L Q +
Sbjct: 9 VSACQMR-ATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLAYAFQTKT 66
Query: 59 EKMLIYDYMPNKSLDFYIFDLRRRYL-LDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDL 117
+ L+ M L ++I+++ I GL +L + I++RDL
Sbjct: 67 DLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDL 123
Query: 118 KASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVY 177
K N+LLD + N +ISD G+A + ++ T GT G++ PE ++ Y D +
Sbjct: 124 KPENVLLDNDGNVRISDLGLAVELK--DGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYF 181
Query: 178 SYGVLLLQILGGK 190
+ GV L +++ +
Sbjct: 182 ALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 49/178 (27%), Positives = 81/178 (45%), Gaps = 26/178 (14%)
Query: 18 VKRLSRTSHQGLEEFENEVKLTARLQH---VNLLPVLGICTQREEKML--IYDYMPNKSL 72
V RL + H NE ++ + H + L T+ +++ L + +Y+P L
Sbjct: 39 VIRLKQEQH-----VHNEKRVLKEVSHPFIIRLF-----WTEHDQRFLYMLMEYVPGGEL 88
Query: 73 DFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKI 132
Y LR T + I L YL + IV+RDLK NILLD E + K+
Sbjct: 89 FSY---LRNSGRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKL 142
Query: 133 SDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGK 190
+DFG A+ + T + GT Y+ PE ++ ++ D ++ G+L+ ++L G
Sbjct: 143 TDFGFAK-----KLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-09
Identities = 36/94 (38%), Positives = 53/94 (56%), Gaps = 2/94 (2%)
Query: 99 QGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGR-IVGTY 157
Q LL + + ++HRD+K++NILL K+ DFG ++ + + GR GT
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYA-ATVSDDVGRTFCGTP 209
Query: 158 GYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKR 191
YV PE R+ YS K D++S GVLL ++L KR
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-09
Identities = 44/130 (33%), Positives = 65/130 (50%), Gaps = 12/130 (9%)
Query: 62 LIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASN 121
+ DY+ L +++ R R L+ R R + E I L YL +L IV+RDLK N
Sbjct: 73 FVLDYINGGELFYHL--QRERCFLEPRARFYAAE-IASALGYLH---SLNIVYRDLKPEN 126
Query: 122 ILLDYEMNPKISDFGMARAFTKDECEAN--TGRIVGTYGYVPPEYVRKGIYSMKYDVYSY 179
ILLD + + ++DFG+ K+ E N T GT Y+ PE + K Y D +
Sbjct: 127 ILLDSQGHIVLTDFGLC----KENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCL 182
Query: 180 GVLLLQILGG 189
G +L ++L G
Sbjct: 183 GAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 1e-09
Identities = 44/192 (22%), Positives = 79/192 (41%), Gaps = 33/192 (17%)
Query: 96 GITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVG 155
I + L YL L+++HRD+K SN+L++ K+ DFG++ A T G
Sbjct: 111 SIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS--VAKTIDA-G 165
Query: 156 TYGYVPPEYV-----RKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYG 210
Y+ PE + +KG Y +K DV+S G+ ++++ G+ + Y
Sbjct: 166 CKPYMAPERINPELNQKG-YDVKSDVWSLGITMIELATGR----------------FPYD 208
Query: 211 LWKNGEGMEFIDSSLDDSSSAWKLMR----CMQVALLCVQENAADRPTMLEILVMLKSET 266
WK + + +++ S + C+++N +RP E+L E
Sbjct: 209 SWKT--PFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266
Query: 267 ADIKTPKKPAFS 278
K +F
Sbjct: 267 HLSKNTDVASFV 278
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 58/201 (28%), Positives = 88/201 (43%), Gaps = 38/201 (18%)
Query: 13 GQEMAVKRLSRTSHQGLEE----FENEVKLTARLQHVNLLPVL--GICTQREEKML--IY 64
G E+A+K L RT E F E L ARL H N++ +L G +L ++
Sbjct: 3 GHEVAIK-LLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA---PPGLLFAVF 58
Query: 65 DYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLT------IVHRDLK 118
+Y+P ++L R D + G L LQ L IVHRDLK
Sbjct: 59 EYVPGRTL-------REVLAAD-----GALPAGETGRLMLQVLDALACAHNQGIVHRDLK 106
Query: 119 ASNILL---DYEMNPKISDFGMARAF--TKDECEAN---TGRIVGTYGYVPPEYVRKGIY 170
NI++ + K+ DFG+ +D A T ++GT Y PE +R
Sbjct: 107 PQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPV 166
Query: 171 SMKYDVYSYGVLLLQILGGKR 191
+ D+Y++G++ L+ L G+R
Sbjct: 167 TPNSDLYAWGLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 45/179 (25%), Positives = 89/179 (49%), Gaps = 12/179 (6%)
Query: 13 GQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSL 72
G A K + S + LE+F E+ + + +H N++ + + ++ ++ +L
Sbjct: 30 GLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGAL 89
Query: 73 DFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKI 132
D + +L R L + + R + + + L +L + ++HRDLKA NILL + + K+
Sbjct: 90 DSIMLELERG-LTEPQIRY-VCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKL 144
Query: 133 SDFGMARAFTKDECEANTGRIVGTYGYVPPEYV-----RKGIYSMKYDVYSYGVLLLQI 186
+DFG++ A K + +GT ++ PE V + Y K D++S G+ L+++
Sbjct: 145 ADFGVS-AKNKSTLQKRD-TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 2e-09
Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 2/93 (2%)
Query: 97 ITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGT 156
+ L L+ +++RDLK NILLDY+ + + DFG+ + KD+ + NT GT
Sbjct: 99 TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGT 156
Query: 157 YGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGG 189
Y+ PE + Y+ D ++ GVLL ++L G
Sbjct: 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-09
Identities = 45/178 (25%), Positives = 83/178 (46%), Gaps = 8/178 (4%)
Query: 12 NGQEMAVKRL--SRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPN 69
+G++ +K + S+ S + EE EV + + ++H N++ + ++ DY
Sbjct: 24 DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEG 83
Query: 70 KSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMN 129
L + + +R L I++ Q L L+ + I+HRD+K+ NI L +
Sbjct: 84 GDL-YKKINAQRGVLFPED---QILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT 139
Query: 130 PKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQIL 187
K+ DFG+AR A T +GT Y+ PE Y+ K D+++ G +L ++
Sbjct: 140 IKLGDFGIARVLNSTVELART--CIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMC 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-09
Identities = 43/152 (28%), Positives = 72/152 (47%), Gaps = 5/152 (3%)
Query: 35 EVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHII 94
E +L ++L H ++ +R+ +I +Y + LD + +L+ + +
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTG--KTLSENQVC 109
Query: 95 EGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIV 154
E Q LL + I+HRDLKA NI L + KI DFG++R C+ T
Sbjct: 110 EWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSR-LLMGSCDLAT-TFT 166
Query: 155 GTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQI 186
GT Y+ PE ++ Y K D++S G +L ++
Sbjct: 167 GTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 72/278 (25%), Positives = 128/278 (46%), Gaps = 43/278 (15%)
Query: 2 SVAICQGRLPNGQEMAVKRLSR-TSHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREE 59
++ I + + +AVK L + + L + +E+++ + +H N++ +LG CTQ
Sbjct: 33 AIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 92
Query: 60 KMLIYDYMPNKSLDFYI-----------FDLRR--RYLLDWRTRVHIIEGITQGLLYLQE 106
++ +Y +L Y+ FD + L ++ V + +G+ YL
Sbjct: 93 LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL-- 150
Query: 107 YSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANT--GRIVGTYGYVPPEY 164
++ +HRDL A N+L+ + KI+DFG+AR + T GR+ ++ PE
Sbjct: 151 -ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRL--PVKWMAPEA 207
Query: 165 VRKGIYSMKYDVYSYGVLLLQI--LGGKRTSCYYG-PNESLNLLEYAYGLWKNGEGMEFI 221
+ +Y+ + DV+S+GVLL +I LGG S Y G P E L + L K G M
Sbjct: 208 LFDRVYTHQSDVWSFGVLLWEIFTLGG---SPYPGIPVEEL------FKLLKEGHRM--- 255
Query: 222 DSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEIL 259
D + + + +MR C + RPT +++
Sbjct: 256 DKPANCTHELYMIMR------ECWHAVPSQRPTFKQLV 287
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-09
Identities = 27/79 (34%), Positives = 48/79 (60%), Gaps = 3/79 (3%)
Query: 112 IVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGI-Y 170
++HRD+KA+NIL+ N K+ DFG+A ++ + +T VGT ++ PE + +G Y
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGTPYWMAPEVITEGKYY 179
Query: 171 SMKYDVYSYGVLLLQILGG 189
K D++S G+ + ++ G
Sbjct: 180 DTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 49/151 (32%), Positives = 72/151 (47%), Gaps = 13/151 (8%)
Query: 62 LIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASN 121
L+ DYM L F+ R+ D R + +I E + L L+ IV+RDLK N
Sbjct: 73 LVTDYMSGGEL-FWHLQKEGRFSED-RAKFYIAELV----LALEHLHKYDIVYRDLKPEN 126
Query: 122 ILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYV--RKGIYSMKYDVYSY 179
ILLD + + DFG+++A D NT GT Y+ PE + KG Y+ D +S
Sbjct: 127 ILLDATGHIALCDFGLSKANLTDNKTTNT--FCGTTEYLAPEVLLDEKG-YTKHVDFWSL 183
Query: 180 GVLLLQILGGKRTSCYYGPNESLNLLEYAYG 210
GVL+ ++ G S +Y + A+G
Sbjct: 184 GVLVFEMCCG--WSPFYAEDTQQMYRNIAFG 212
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-09
Identities = 60/194 (30%), Positives = 90/194 (46%), Gaps = 17/194 (8%)
Query: 3 VAICQGRLPNGQEMAVKRLSRT---SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREE 59
V CQ R G+ A K+L + +G NE ++ L+ VN V+ + E
Sbjct: 16 VCACQVR-ATGKMYACKKLEKKRIKKRKGEAMALNEKRI---LEKVNSRFVVSLAYAYET 71
Query: 60 K---MLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRD 116
K L+ M L F+I+++ + R + E + GL LQ IV+RD
Sbjct: 72 KDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAE-LCCGLEDLQRER---IVYRD 127
Query: 117 LKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDV 176
LK NILLD + +ISD G+A E E GR VGT GY+ PE + Y+ D
Sbjct: 128 LKPENILLDDRGHIRISDLGLAVQIP--EGETVRGR-VGTVGYMAPEVINNEKYTFSPDW 184
Query: 177 YSYGVLLLQILGGK 190
+ G L+ +++ G+
Sbjct: 185 WGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-09
Identities = 33/102 (32%), Positives = 55/102 (53%), Gaps = 22/102 (21%)
Query: 97 ITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFG--------MARAFTKDECEA 148
+ +GL YL+E I+HRD+K SNIL++ K+ DFG MA +F
Sbjct: 108 VLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF------- 158
Query: 149 NTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGK 190
VGT Y+ PE ++ Y+++ D++S G+ L+++ G+
Sbjct: 159 -----VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-09
Identities = 51/182 (28%), Positives = 92/182 (50%), Gaps = 12/182 (6%)
Query: 12 NGQEMAVKRLSRTSHQGLEEFE--NEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPN 69
NGQ +A+K +S + +G+ F E L L+H N++ + I +E +++YM +
Sbjct: 29 NGQLVALKVISMKTEEGVP-FTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYM-H 86
Query: 70 KSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMN 129
L Y+ L + R+ + + + +GL Y+ I+HRDLK N+L+ Y
Sbjct: 87 TDLAQYMIQ-HPGGLHPYNVRLFMFQ-LLRGLAYIHGQH---ILHRDLKPQNLLISYLGE 141
Query: 130 PKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGI-YSMKYDVYSYGVLLLQILG 188
K++DFG+ARA + + +V T Y PP+ + YS D++ G + +++L
Sbjct: 142 LKLADFGLARA-KSIPSQTYSSEVV-TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQ 199
Query: 189 GK 190
G+
Sbjct: 200 GQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 4e-09
Identities = 30/75 (40%), Positives = 41/75 (54%)
Query: 113 VHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSM 172
+HRDL A NILL KI DFG+AR KD G ++ PE + +Y+
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTT 255
Query: 173 KYDVYSYGVLLLQIL 187
+ DV+S+GVLL +I
Sbjct: 256 QSDVWSFGVLLWEIF 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-09
Identities = 43/182 (23%), Positives = 91/182 (50%), Gaps = 15/182 (8%)
Query: 12 NGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKS 71
+G+ +AVK++ Q E NEV + QH N++ + +E ++ +++ +
Sbjct: 44 SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103
Query: 72 LDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNL---TIVHRDLKASNILLDYEM 128
L + TR++ + L L+ S L ++HRD+K+ +ILL ++
Sbjct: 104 LTDIVT----------HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDG 153
Query: 129 NPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG 188
K+SDFG +K+ + +VGT ++ PE + + Y + D++S G+++++++
Sbjct: 154 RVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVD 211
Query: 189 GK 190
G+
Sbjct: 212 GE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 4e-09
Identities = 30/75 (40%), Positives = 42/75 (56%)
Query: 113 VHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSM 172
+HRDL A NILL KI DFG+AR KD G ++ PE + +Y++
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 260
Query: 173 KYDVYSYGVLLLQIL 187
+ DV+S+GVLL +I
Sbjct: 261 QSDVWSFGVLLWEIF 275
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 5e-09
Identities = 41/144 (28%), Positives = 66/144 (45%), Gaps = 31/144 (21%)
Query: 51 LGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGIT----QGLLYLQE 106
+ ICT+ +M SLD Y + H++ I +GL YL
Sbjct: 74 ISICTE---------FMDGGSLDVY-----------RKIPEHVLGRIAVAVVKGLTYLW- 112
Query: 107 YSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVR 166
+L I+HRD+K SN+L++ K+ DFG++ A T VGT Y+ PE +
Sbjct: 113 --SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--IAKT--YVGTNAYMAPERIS 166
Query: 167 KGIYSMKYDVYSYGVLLLQILGGK 190
Y + DV+S G+ +++ G+
Sbjct: 167 GEQYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 5e-09
Identities = 60/210 (28%), Positives = 104/210 (49%), Gaps = 34/210 (16%)
Query: 12 NGQEMAVKRLS-RTSHQGLE-EFENEVKLTARLQ---HVNLLPVLGIC----TQREEKM- 61
+G +A+K + +T+ GL EV L RL+ H N++ ++ +C T RE K+
Sbjct: 24 SGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVT 83
Query: 62 LIYDYMPNKSLDFYIFDLRRRYL-------LDWRTRVHIIEGITQGLLYLQEYSNLTIVH 114
L+++++ DLR YL L T ++ +GL +L ++N IVH
Sbjct: 84 LVFEHVDQ--------DLRT-YLDKVPPPGLPAETIKDLMRQFLRGLDFL--HAN-CIVH 131
Query: 115 RDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKY 174
RDLK NIL+ K++DFG+AR ++ C+ +V T Y PE + + Y+
Sbjct: 132 RDLKPENILVTSGGQVKLADFGLARIYS---CQMALTPVVVTLWYRAPEVLLQSTYATPV 188
Query: 175 DVYSYGVLLLQILGGKRTSCYYGPNESLNL 204
D++S G + ++ +R + G +E+ L
Sbjct: 189 DMWSVGCIFAEMF--RRKPLFCGNSEADQL 216
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 5e-09
Identities = 53/180 (29%), Positives = 83/180 (46%), Gaps = 10/180 (5%)
Query: 11 PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNK 70
P + + KR+ S ++ ENE+ RL H N+L + I R E YM +
Sbjct: 190 PKCERLIAKRVKAGSRAAIQ-LENEILALGRLNHENILKIEEIL--RSEA---NTYMITQ 243
Query: 71 SLDFYIFDLRRRYLLDWRTRVHIIE--GITQGLLYLQEY-SNLTIVHRDLKASNILLDYE 127
DF ++ DW+ R + + I + LL EY + ++HRD+K NI L+ +
Sbjct: 244 KYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD 303
Query: 128 MNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQIL 187
+ DFG A F K+ + G VGT PE + Y D++S G++LL +L
Sbjct: 304 GKIVLGDFGTAMPFEKEREAFDYG-WVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 5e-09
Identities = 44/175 (25%), Positives = 81/175 (46%), Gaps = 32/175 (18%)
Query: 35 EVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVH-- 92
E+K+ ++H N++ ++ + + + L+ D M DL++ ++D + R+
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA--------SDLKK--VVDRKIRLTES 119
Query: 93 ----IIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAF------- 141
I+ I GL L ++ +HRDL +NI ++ + KI+DFG+AR +
Sbjct: 120 QVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSD 176
Query: 142 --TKDECEANTGRI---VGTYGYVPPEYVRKG-IYSMKYDVYSYGVLLLQILGGK 190
+KDE + V T Y PE + Y D++S G + ++L GK
Sbjct: 177 TLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 5e-09
Identities = 45/155 (29%), Positives = 76/155 (49%), Gaps = 11/155 (7%)
Query: 35 EVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDF--YIFDLRRRYLLDWRTRVH 92
E+ L LQH N++ + + Q LI++++ S+D Y+ L + +D
Sbjct: 49 EISLLKELQHPNIVCLQDVLMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMDAELVKS 105
Query: 93 IIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGR 152
+ I QG+L+ ++HRDLK N+L+D + K++DFG+ARAF T
Sbjct: 106 YLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGI-PVRVYTHE 161
Query: 153 IVGTYGYVPPEYVRKGI-YSMKYDVYSYGVLLLQI 186
+V T Y PE + YS D++S G + ++
Sbjct: 162 VV-TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEM 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 6e-09
Identities = 28/85 (32%), Positives = 46/85 (54%), Gaps = 6/85 (7%)
Query: 106 EY-SNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEY 164
EY + I++RDLK N+LLD + + K++DFG A+ T + GT Y+ PE
Sbjct: 132 EYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-----RTFTLCGTPEYLAPEV 186
Query: 165 VRKGIYSMKYDVYSYGVLLLQILGG 189
++ + D ++ GVLL + + G
Sbjct: 187 IQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 6e-09
Identities = 34/103 (33%), Positives = 55/103 (53%), Gaps = 9/103 (8%)
Query: 92 HIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTG 151
+ I + L YL+E ++HRD+K SNILLD N K+ DFG++ + +A T
Sbjct: 118 KMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLV--DSKAKT- 172
Query: 152 RIVGTYGYVPPEYV----RKGIYSMKYDVYSYGVLLLQILGGK 190
R G Y+ PE + Y ++ DV+S G+ L+++ G+
Sbjct: 173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 8e-09
Identities = 29/75 (38%), Positives = 41/75 (54%)
Query: 113 VHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSM 172
+HRDL A NILL + KI DFG+AR D G ++ PE + +Y+
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTF 295
Query: 173 KYDVYSYGVLLLQIL 187
+ DV+SYG+LL +I
Sbjct: 296 ESDVWSYGILLWEIF 310
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 8e-09
Identities = 32/87 (36%), Positives = 51/87 (58%), Gaps = 12/87 (13%)
Query: 112 IVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRI----VGTYGYVPPEYVRK 167
++HRDLK SNILL+ + K++DFG+AR+ ++ E E + V T Y PE +
Sbjct: 128 VIHRDLKPSNILLNSDCRVKLADFGLARSLSELE-ENPENPVLTDYVATRWYRAPEIL-- 184
Query: 168 GIYSMKY----DVYSYGVLLLQILGGK 190
+ S +Y D++S G +L ++L GK
Sbjct: 185 -LGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 9e-09
Identities = 53/234 (22%), Positives = 102/234 (43%), Gaps = 27/234 (11%)
Query: 35 EVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI--FDLRRRYLLD---WRT 89
E+ L +L H N++ + E ++ + L I F ++R + + W+
Sbjct: 52 EIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKY 111
Query: 90 RVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEAN 149
V + L+ + ++HRD+K +N+ + K+ D G+ R F+ A+
Sbjct: 112 FVQLCSA-------LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH 164
Query: 150 TGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAY 209
+ +VGT Y+ PE + + Y+ K D++S G LL ++ S +YG + +NL Y
Sbjct: 165 S--LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM--AALQSPFYG--DKMNL----Y 214
Query: 210 GLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLK 263
L K E ++ D S + Q+ +C+ + RP + + + K
Sbjct: 215 SLCKKIEQCDYPPLPSDHYSEELR-----QLVNMCINPDPEKRPDITYVYDVAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 9e-09
Identities = 33/95 (34%), Positives = 57/95 (60%), Gaps = 6/95 (6%)
Query: 96 GITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVG 155
+ +GL YL+E I+HRD+K SNIL++ K+ DFG++ + AN+ VG
Sbjct: 111 AVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANS--FVG 164
Query: 156 TYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGK 190
T Y+ PE ++ YS++ D++S G+ L+++ G+
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-08
Identities = 48/201 (23%), Positives = 90/201 (44%), Gaps = 30/201 (14%)
Query: 8 GRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYM 67
P + V ++ + H+ F L ++L H +L+ + G+C R+E +++ +Y+
Sbjct: 24 IVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCV-RDENIMVEEYV 82
Query: 68 PNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL-DY 126
LD ++ + L W+ V + + L YL++ +VH ++ NIL+ Y
Sbjct: 83 KFGPLDVFLHREKNNVSLHWKLDV--AKQLASALHYLED---KKLVHGNVCGKNILVARY 137
Query: 127 EMNP------KISDFGMAR-AFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKY--DVY 177
+N K+SD G+ +++E RI ++ PE +R G S+ D +
Sbjct: 138 GLNEGYVPFIKLSDPGIPITVLSREERVE---RI----PWIAPECIRNGQASLTIAADKW 190
Query: 178 SYGVLLLQILGGKRTSCYYGP 198
S+G LL+I C G
Sbjct: 191 SFGTTLLEI-------CSNGE 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 32/79 (40%), Positives = 43/79 (54%), Gaps = 2/79 (2%)
Query: 113 VHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSM 172
VHRDL A N+LL KI DFG+AR D + G ++ PE + +Y+
Sbjct: 259 VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTT 318
Query: 173 KYDVYSYGVLLLQI--LGG 189
DV+SYG+LL +I LGG
Sbjct: 319 LSDVWSYGILLWEIFSLGG 337
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 33/95 (34%), Positives = 57/95 (60%), Gaps = 6/95 (6%)
Query: 96 GITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVG 155
+ +GL YL+E I+HRD+K SNIL++ K+ DFG++ + AN+ VG
Sbjct: 111 AVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANS--FVG 164
Query: 156 TYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGK 190
T Y+ PE ++ YS++ D++S G+ L+++ G+
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 110 LTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGI 169
L +HRDLK N L+D + K++DFG+++ AN+ +VG+ Y+ PE +R
Sbjct: 120 LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---YANS--VVGSPDYMAPEVLRGKG 174
Query: 170 YSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWK 213
Y D +S G +L + L G PNE+ L+Y WK
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKY----WK 214
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 56/248 (22%), Positives = 94/248 (37%), Gaps = 72/248 (29%)
Query: 8 GRLPNGQEMAVKRLSRTSHQG-LEEFENEVKLTARL-QHVNLLPVLGICTQ--------- 56
G+ N +AVK L ++H E +E+K+ + L QH N++ +LG CT
Sbjct: 63 GKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITE 122
Query: 57 -------------REEKMLIY----DYMPNKSLDFYIFDLRRRYL--------------- 84
+ E L + + S D+ L ++Y+
Sbjct: 123 YCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYV 182
Query: 85 --------------------------LDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLK 118
LD + + QG+ +L ++ +HRD+
Sbjct: 183 EMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVA 239
Query: 119 ASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYS 178
A N+LL KI DFG+AR D G ++ PE + +Y+++ DV+S
Sbjct: 240 ARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWS 299
Query: 179 YGVLLLQI 186
YG+LL +I
Sbjct: 300 YGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 44/185 (23%), Positives = 77/185 (41%), Gaps = 46/185 (24%)
Query: 35 EVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKS---LDFYIF------DLRRRYLL 85
E+K+ +L+H N++P++ + + Y+ DL LL
Sbjct: 57 EIKILKKLKHPNVVPLID---------MAVERPDKSKRKRGSVYMVTPYMDHDLSG--LL 105
Query: 86 DWRTRVH--------IIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGM 137
+ V + + +G+ YL E I+HRD+KA+NIL+D + KI+DFG+
Sbjct: 106 E-NPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGL 161
Query: 138 ARAFTKDECEANTGRIVGTYGYV---------PPEYV---RKGIYSMKYDVYSYGVLLLQ 185
AR + G GT Y PPE + R+ Y+ D++ G + +
Sbjct: 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERR--YTTAVDIWGIGCVFAE 219
Query: 186 ILGGK 190
+ +
Sbjct: 220 MFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-08
Identities = 46/167 (27%), Positives = 78/167 (46%), Gaps = 7/167 (4%)
Query: 21 LSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80
L++ + E + EV L A+++H N++ + ++ +Y L I + +
Sbjct: 35 LTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRI-NRQ 93
Query: 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYE-MNPKISDFGMAR 139
R L + I+ Q L L+ + I+HRD+K+ NI L M K+ DFG+AR
Sbjct: 94 RGVLF---SEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIAR 150
Query: 140 AFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQI 186
A T VGT Y+ PE + Y+ K D++S G +L ++
Sbjct: 151 QLNDSMELAYT--CVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 54.1 bits (131), Expect = 2e-08
Identities = 46/174 (26%), Positives = 77/174 (44%), Gaps = 47/174 (27%)
Query: 35 EVKLTARLQHVNLLPVLGICTQREEKMLIYDYMP--------NKSLDFYIFDLRRRYLLD 86
E+KL L+H N++ +L + + L++++M +KS+
Sbjct: 52 EIKLLQELKHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVL------------ 99
Query: 87 WRTRVHI---IEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTK 143
T I + +GL YL I+HRDLK +N+L+ + K++DFG+AR+F
Sbjct: 100 --TPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSF-- 152
Query: 144 DECEANTGRI----VGTYGYVPPEYV---RKGIYSMKYDVYSYGV----LLLQI 186
+ R V T Y PE + R Y + D++S G LLL++
Sbjct: 153 ----GSPNRKMTHQVVTRWYRAPELLFGARH--YGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 47/161 (29%), Positives = 76/161 (47%), Gaps = 16/161 (9%)
Query: 99 QGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158
Q +L L E + ++HRDLK++NI L K+ DFG ++ ++ GT
Sbjct: 177 QIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPY 236
Query: 159 YVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGM 218
Y+ PE + YS K D++S GV+L ++L R + GP++ + + YG +
Sbjct: 237 YLAPELWERKRYSKKADMWSLGVILYELLTLHRP--FKGPSQREIMQQVLYGKY------ 288
Query: 219 EFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEIL 259
D SS M+ + LL +N A RPT ++L
Sbjct: 289 ---DPFPCPVSSG---MKALLDPLL--SKNPALRPTTQQLL 321
|
Length = 478 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 3e-08
Identities = 30/75 (40%), Positives = 44/75 (58%), Gaps = 3/75 (4%)
Query: 112 IVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYS 171
IVHRDL +NI+L + I+DFG+A+ K E+ +VGT Y PE V+ Y
Sbjct: 135 IVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQP-ESKLTSVVGTILYSCPEIVKNEPYG 191
Query: 172 MKYDVYSYGVLLLQI 186
K DV+++G +L Q+
Sbjct: 192 EKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 3e-08
Identities = 39/109 (35%), Positives = 55/109 (50%), Gaps = 22/109 (20%)
Query: 92 HIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMAR------AFTKDE 145
I + L YL+E L I+HRD+K SNILLD N K+ DFG++ A T+D
Sbjct: 111 KIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRD- 167
Query: 146 CEANTGRIVGTYGYVPPEYV----RKGIYSMKYDVYSYGVLLLQILGGK 190
G Y+ PE + R G Y ++ DV+S G+ L ++ GK
Sbjct: 168 --------AGCRPYMAPERIDPSARDG-YDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 3e-08
Identities = 46/176 (26%), Positives = 84/176 (47%), Gaps = 12/176 (6%)
Query: 10 LPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLI-YDYMP 68
+ G+ +A+K + E + E+ + +H N++ G R +K+ I +Y
Sbjct: 25 IATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFG-SYLRRDKLWIVMEYCG 83
Query: 69 NKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM 128
SL I+ + R L + ++ +GL YL E +HRD+K +NILL +
Sbjct: 84 GGSLQ-DIYQVTRGPLSE-LQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDG 138
Query: 129 NPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYV---RKGIYSMKYDVYSYGV 181
+ K++DFG++ T + + +GT ++ PE RKG Y K D+++ G+
Sbjct: 139 DVKLADFGVSAQLTATIAKRKS--FIGTPYWMAPEVAAVERKGGYDGKCDIWALGI 192
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 3e-08
Identities = 56/193 (29%), Positives = 91/193 (47%), Gaps = 34/193 (17%)
Query: 13 GQEMAVKRLSRTSHQGLEEFEN---------EVKLTARLQHVNLLPVLGICTQREEKMLI 63
G+++A+K+LSR F++ E++L + H N++ +L + T
Sbjct: 40 GRKVAIKKLSRP-------FQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92
Query: 64 YDY---MPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKAS 120
D D ++ + L D + ++ I +GL Y+ + I+HRDLK S
Sbjct: 93 QDVYLVTHLMGADLNNI-VKCQKLSDDHIQF-LVYQILRGLKYIH---SAGIIHRDLKPS 147
Query: 121 NILL--DYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYV-RKGIYSMKYDVY 177
NI + D E+ KI DFG+AR T DE TG V T Y PE + Y+ D++
Sbjct: 148 NIAVNEDCEL--KILDFGLARH-TDDEM---TG-YVATRWYRAPEIMLNWMHYNQTVDIW 200
Query: 178 SYGVLLLQILGGK 190
S G ++ ++L GK
Sbjct: 201 SVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 3e-08
Identities = 36/110 (32%), Positives = 57/110 (51%), Gaps = 5/110 (4%)
Query: 97 ITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGT 156
I +GL YL + I+HRD+K N+L++ KI DFG+AR DE + T +V
Sbjct: 112 ILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168
Query: 157 YGYVPPEYVRKGI-YSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLL 205
Y Y PE + Y+ D++S G + ++LG + P + L+L+
Sbjct: 169 Y-YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLI 217
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-08
Identities = 36/111 (32%), Positives = 57/111 (51%), Gaps = 5/111 (4%)
Query: 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMAR 139
R R + R R + E I L YL +S +V+RDLK N++LD + + KI+DFG+ +
Sbjct: 88 RERVFSEDRARFYGAE-IVSALDYL--HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 144
Query: 140 AFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGK 190
KD T GT Y+ PE + Y D + GV++ +++ G+
Sbjct: 145 EGIKDGATMKT--FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-08
Identities = 43/135 (31%), Positives = 66/135 (48%), Gaps = 9/135 (6%)
Query: 56 QREEKM-LIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVH 114
Q EK+ + D++ L F++ R R + R R + E I L YL ++ IV+
Sbjct: 66 QTTEKLYFVLDFVNGGELFFHL--QRERSFPEPRARFYAAE-IASALGYLH---SINIVY 119
Query: 115 RDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKY 174
RDLK NILLD + + ++DFG+ + T GT Y+ PE +RK Y
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT--FCGTPEYLAPEVIRKQPYDNTV 177
Query: 175 DVYSYGVLLLQILGG 189
D + G +L ++L G
Sbjct: 178 DWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 4e-08
Identities = 44/157 (28%), Positives = 72/157 (45%), Gaps = 6/157 (3%)
Query: 12 NGQEMAVKRL-SRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNK 70
++ VK L S Q +F E + LQH NLL LG CT+ +L+ ++ P
Sbjct: 21 TPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80
Query: 71 SLDFYIFDLRRRYLL--DWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM 128
L Y+ R+ L+ D T + I GLL+L + + +H DL N LL ++
Sbjct: 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADL 137
Query: 129 NPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYV 165
KI D+G++ K++ ++ ++ PE V
Sbjct: 138 TVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELV 174
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 4e-08
Identities = 41/161 (25%), Positives = 77/161 (47%), Gaps = 19/161 (11%)
Query: 35 EVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRR-YLLDWRTRVHI 93
E+++ +L+H NL+ ++ + +++ L+++++ + LD DL + LD
Sbjct: 50 EIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLD----DLEKYPNGLDESRVRKY 105
Query: 94 IEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRI 153
+ I +G+ + + I+HRD+K NIL+ K+ DFG AR A G +
Sbjct: 106 LFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTL------AAPGEV 156
Query: 154 ----VGTYGYVPPEYVRKGI-YSMKYDVYSYGVLLLQILGG 189
V T Y PE + Y D+++ G L+ ++L G
Sbjct: 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 5e-08
Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 5/106 (4%)
Query: 89 TRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEA 148
T H I Q L L+ + ++HRDLK N+L++ + KI DFG+AR F+++ E
Sbjct: 103 TDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGE- 161
Query: 149 NTGRI---VGTYGYVPPE-YVRKGIYSMKYDVYSYGVLLLQILGGK 190
N G + V T Y PE + Y+ DV+S G +L ++LG K
Sbjct: 162 NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 6e-08
Identities = 37/108 (34%), Positives = 52/108 (48%), Gaps = 9/108 (8%)
Query: 113 VHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSM 172
VHRDL A N+L+ KI DFG+AR +D + G ++ PE + +Y+
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT 320
Query: 173 KYDVYSYGVLLLQI--LGGKRTSCYYGPNESLNLLEYAYGLWKNGEGM 218
DV+S+G+LL +I LGG P L + E Y K G M
Sbjct: 321 LSDVWSFGILLWEIFTLGGT-------PYPELPMNEQFYNAIKRGYRM 361
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 6e-08
Identities = 42/172 (24%), Positives = 82/172 (47%), Gaps = 10/172 (5%)
Query: 35 EVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR-RYLLDWRTRVHI 93
E+ L +L H N++ L + E ++ + L I ++ + L+ RT +
Sbjct: 52 EIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERT---V 108
Query: 94 IEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRI 153
+ Q ++ + ++HRD+K +N+ + K+ D G+ R F+ A++ +
Sbjct: 109 WKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--L 166
Query: 154 VGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLL 205
VGT Y+ PE + + Y+ K D++S G LL ++ S +YG + +NL
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM--AALQSPFYG--DKMNLF 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 7e-08
Identities = 39/129 (30%), Positives = 63/129 (48%), Gaps = 8/129 (6%)
Query: 62 LIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASN 121
+ +Y+ L F++ R R + RTR + E I L YL IV+RDLK N
Sbjct: 72 FVMEYVNGGELFFHLS--RERVFSEDRTRFYGAE-IVSALDYLHSGK---IVYRDLKLEN 125
Query: 122 ILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGV 181
++LD + + KI+DFG+ + D T GT Y+ PE + Y D + GV
Sbjct: 126 LMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLAPEVLEDNDYGRAVDWWGLGV 183
Query: 182 LLLQILGGK 190
++ +++ G+
Sbjct: 184 VMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 1e-07
Identities = 38/143 (26%), Positives = 67/143 (46%), Gaps = 16/143 (11%)
Query: 65 DYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL 124
+YM SLD + I + +GL +L+E N I+HRD+K +N+L+
Sbjct: 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLV 136
Query: 125 DYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKG------IYSMKYDVYS 178
+ K+ DFG++ + N +G Y+ PE ++ G Y+++ DV+S
Sbjct: 137 NGNGQVKLCDFGVSGNLVASLAKTN----IGCQSYMAPERIKSGGPNQNPTYTVQSDVWS 192
Query: 179 YGVLLLQILGGKRTSCYYGPNES 201
G+ +L++ G Y P E+
Sbjct: 193 LGLSILEMALG----RYPYPPET 211
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 48/185 (25%), Positives = 94/185 (50%), Gaps = 18/185 (9%)
Query: 13 GQEMAVKRLS-RTSHQGLE-EFENEVKLTARLQ---HVNLLPVLGICT----QREEKM-L 62
G+ +A+KR+ +T +G+ EV + L+ H N++ + +CT RE K+ L
Sbjct: 27 GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL 86
Query: 63 IYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNI 122
+++++ ++ L Y+ D + T ++ + +GL +L + +VHRDLK NI
Sbjct: 87 VFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNI 141
Query: 123 LLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVL 182
L+ K++DFG+AR ++ + +V T Y PE + + Y+ D++S G +
Sbjct: 142 LVTSSGQIKLADFGLARIYS---FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCI 198
Query: 183 LLQIL 187
++
Sbjct: 199 FAEMF 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 1e-07
Identities = 57/194 (29%), Positives = 92/194 (47%), Gaps = 36/194 (18%)
Query: 13 GQEMAVKRLSRTSHQGL--EEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNK 70
G +AVK+LSR + + E++L ++H N++ +L + + P +
Sbjct: 42 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV------------FTPAR 89
Query: 71 SL----DFYIF------DLRRRYLLDWRTRVHI---IEGITQGLLYLQEYSNLTIVHRDL 117
SL D Y+ DL T H+ I I +GL Y+ + I+HRDL
Sbjct: 90 SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDL 146
Query: 118 KASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGI-YSMKYDV 176
K SN+ ++ + KI DFG+AR T DE TG V T Y PE + + Y+ D+
Sbjct: 147 KPSNLAVNEDCELKILDFGLAR-HTDDEM---TG-YVATRWYRAPEIMLNWMHYNQTVDI 201
Query: 177 YSYGVLLLQILGGK 190
+S G ++ ++L G+
Sbjct: 202 WSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-07
Identities = 38/116 (32%), Positives = 55/116 (47%), Gaps = 10/116 (8%)
Query: 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMA 138
L LD +I+ G LL LQ N I+HRD+K +NILL E K+ DFG++
Sbjct: 119 LICGQRLDEAMISYILYG---ALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS 175
Query: 139 RAFTKDECEANTGRIVGTYGYVPPEYVR-----KGIYSMKYDVYSYGVLLLQILGG 189
T NT VGT ++ PE + Y + DV+S G+ +++ G
Sbjct: 176 AQLTSTRLRRNTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 31/94 (32%), Positives = 52/94 (55%), Gaps = 4/94 (4%)
Query: 97 ITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGT 156
+ +GL Y+ + ++HRDLK SN+LL+ + KI DFG+AR T ++ + T +V
Sbjct: 117 LLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLART-TSEKGDFMTEYVVTR 172
Query: 157 YGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGK 190
+ P + Y+ DV+S G + ++LG K
Sbjct: 173 WYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 33/111 (29%), Positives = 54/111 (48%), Gaps = 6/111 (5%)
Query: 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMAR 139
R R + R R + E I L YL +V+RD+K N++LD + + KI+DFG+ +
Sbjct: 88 RERVFTEERARFYGAE-IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK 143
Query: 140 AFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGK 190
D T GT Y+ PE + Y D + GV++ +++ G+
Sbjct: 144 EGISDGATMKT--FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 2e-07
Identities = 31/95 (32%), Positives = 45/95 (47%), Gaps = 10/95 (10%)
Query: 92 HIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTG 151
+I+ +GL YL E N I HRD+K NILL K+ DFG++ NT
Sbjct: 117 YILRETLRGLAYLHE--NKVI-HRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTF 173
Query: 152 RIVGTYGYVPPEYV-----RKGIYSMKYDVYSYGV 181
+GT ++ PE + Y + DV+S G+
Sbjct: 174 --IGTPYWMAPEVIACDEQPDASYDARSDVWSLGI 206
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-07
Identities = 38/160 (23%), Positives = 79/160 (49%), Gaps = 11/160 (6%)
Query: 30 EEFENEVKLTARLQHVNLLPVLGICTQREEKM-LIYDYMPNKSLDFYIFDLRRRYLLDWR 88
E+F E + + H +++ ++G+ T E + ++ + P L Y+ +Y LD
Sbjct: 52 EKFLQEAYIMRQFDHPHIVKLIGVIT--ENPVWIVMELAPLGELRSYL--QVNKYSLDLA 107
Query: 89 TRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDEC-E 147
+ + ++ L YL+ + VHRD+ A N+L+ K+ DFG++R + +
Sbjct: 108 SLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYK 164
Query: 148 ANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQIL 187
A+ G++ ++ PE + ++ DV+ +GV + +IL
Sbjct: 165 ASKGKL--PIKWMAPESINFRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 34/96 (35%), Positives = 48/96 (50%), Gaps = 17/96 (17%)
Query: 100 GLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEAN------TGRI 153
GL YL E IV+RDLK N+LLD E KI+DFG+ C+ T
Sbjct: 113 GLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGL--------CKEGMGFGDRTSTF 161
Query: 154 VGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGG 189
GT ++ PE + + Y+ D + GVL+ ++L G
Sbjct: 162 CGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 34/92 (36%), Positives = 51/92 (55%), Gaps = 6/92 (6%)
Query: 100 GLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159
GL YL E I+HRDLK SN+LL + KI+DFG+AR + + T ++V T Y
Sbjct: 120 GLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKVV-TLWY 174
Query: 160 VPPEYVRKG-IYSMKYDVYSYGVLLLQILGGK 190
PE + Y+ D+++ G +L ++L K
Sbjct: 175 RAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (121), Expect = 3e-07
Identities = 37/133 (27%), Positives = 65/133 (48%), Gaps = 13/133 (9%)
Query: 12 NGQEMAVKRLSRTSHQGLEEFEN--EVKLTARLQ-HVNLLPVLGICTQREEKMLIYDYMP 68
G+ +A+K++ + + EE N EVK +L H N++ + + + +E +++YM
Sbjct: 23 TGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM- 80
Query: 69 NKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYL--QEYSNLTIVHRDLKASNILLDY 126
+L + + R+ II I QGL ++ + HRDLK N+L+
Sbjct: 81 EGNL-YQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGF-----FHRDLKPENLLVSG 134
Query: 127 EMNPKISDFGMAR 139
KI+DFG+AR
Sbjct: 135 PEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 3e-07
Identities = 51/184 (27%), Positives = 91/184 (49%), Gaps = 16/184 (8%)
Query: 13 GQEMAVKRLSRTSHQGL--EEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDY---M 67
G ++A+K+L R L + E++L ++H N++ +L + T +D+ M
Sbjct: 40 GAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVM 99
Query: 68 PNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYE 127
P D ++ L + R + ++ + +GL Y+ I+HRDLK N+ ++ +
Sbjct: 100 PFMGTDLGKL-MKHEKLSEDRIQ-FLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNED 154
Query: 128 MNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGI-YSMKYDVYSYGVLLLQI 186
KI DFG+AR T E TG +V T Y PE + + Y+ D++S G ++ ++
Sbjct: 155 CELKILDFGLARQ-TDSEM---TGYVV-TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEM 209
Query: 187 LGGK 190
L GK
Sbjct: 210 LTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-07
Identities = 56/191 (29%), Positives = 85/191 (44%), Gaps = 20/191 (10%)
Query: 12 NGQEMAVKRLSRTSHQGLEEFENEVK-LTARLQHVNLLPVLGICTQREEK-----MLIYD 65
NG + AVK L H EE E E L A H N++ G+ +++ K L+ +
Sbjct: 42 NGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLE 100
Query: 66 YMPNKSLDFYIFDLRRRYLLDW-RTRVHIIEGIT-QGLLYLQEYSNLTIVHRDLKASNIL 123
S + DL + +L R II I + L+ LQ +HRD+K +NIL
Sbjct: 101 LCNGGS----VTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNIL 156
Query: 124 LDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVR-----KGIYSMKYDVYS 178
L E K+ DFG++ T NT VGT ++ PE + Y + DV+S
Sbjct: 157 LTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFWMAPEVIACEQQLDSTYDARCDVWS 214
Query: 179 YGVLLLQILGG 189
G+ +++ G
Sbjct: 215 LGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 4e-07
Identities = 47/201 (23%), Positives = 82/201 (40%), Gaps = 46/201 (22%)
Query: 12 NGQEMAVKRLSR--TSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPN 69
+G+++A+K++ + E+K+ +H N++ + I P
Sbjct: 29 SGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI------------LRPP 76
Query: 70 KSL--DFY-IFDLRRRYLLDWRTRVHIIEG---------------ITQGLLYLQEYSNLT 111
+ D Y + DL L HII + +GL Y+ +
Sbjct: 77 GADFKDVYVVMDLMESDLH------HIIHSDQPLTEEHIRYFLYQLLRGLKYIH---SAN 127
Query: 112 IVHRDLKASNILLDYEMNPKISDFGMARA---FTKDECEANTGRIVGTYGYVPPEYVRK- 167
++HRDLK SN+L++ + +I DFGMAR + T V T Y PE +
Sbjct: 128 VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMT-EYVATRWYRAPELLLSL 186
Query: 168 GIYSMKYDVYSYGVLLLQILG 188
Y+ D++S G + ++LG
Sbjct: 187 PEYTTAIDMWSVGCIFAEMLG 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-07
Identities = 42/157 (26%), Positives = 74/157 (47%), Gaps = 9/157 (5%)
Query: 35 EVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHII 94
EV L L+H N++ + I + L+++Y+ +K L Y+ D ++ +
Sbjct: 54 EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGN--IMSMHNVKIFL 110
Query: 95 EGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIV 154
I +GL Y ++HRDLK N+L++ K++DFG+ARA K V
Sbjct: 111 YQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARA--KSVPTKTYSNEV 165
Query: 155 GTYGYVPPEYVR-KGIYSMKYDVYSYGVLLLQILGGK 190
T Y PP+ + YS + D++ G + ++ G+
Sbjct: 166 VTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-07
Identities = 55/187 (29%), Positives = 88/187 (47%), Gaps = 24/187 (12%)
Query: 14 QEMAVKRLSRTSHQGL---EEFENEVKLTARLQHVNLLPVLGICT------QREEKMLIY 64
Q++AVK+LSR Q L E++L ++H N++ +L + T E L+
Sbjct: 41 QKVAVKKLSR-PFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVT 99
Query: 65 DYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL 124
+ M DL + H+ I Q L L+ + I+HRDLK SN+ +
Sbjct: 100 NLMGA--------DLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAV 151
Query: 125 DYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGI-YSMKYDVYSYGVLL 183
+ + +I DFG+AR DE TG V T Y PE + + Y+ D++S G ++
Sbjct: 152 NEDCELRILDFGLARQ-ADDEM---TG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 206
Query: 184 LQILGGK 190
++L GK
Sbjct: 207 AELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-07
Identities = 42/157 (26%), Positives = 74/157 (47%), Gaps = 16/157 (10%)
Query: 97 ITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGT 156
+ + ++ + L VHRD+K NIL+D + +++DFG +D + VGT
Sbjct: 108 LAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAVGT 166
Query: 157 YGYVPPEYVR-----KGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGL 211
Y+ PE ++ KG Y + D +S GV + ++L G+ P + +L+E +
Sbjct: 167 PDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGET------PFYAESLVETYGKI 220
Query: 212 WKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQEN 248
+ E +F D S A L+R L+C +E+
Sbjct: 221 MNHKERFQFPAQVTDVSEDAKDLIR----RLICSREH 253
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 5e-07
Identities = 36/97 (37%), Positives = 53/97 (54%), Gaps = 13/97 (13%)
Query: 97 ITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGT 156
I +GL Y+ +VHRDLK SNIL++ + KI DFG+AR + TG V T
Sbjct: 117 ILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTG-YVST 168
Query: 157 YGYVPPEYV---RKGIYSMKYDVYSYGVLLLQILGGK 190
Y PE + +K Y ++ D++S G + ++L GK
Sbjct: 169 RYYRAPEIMLTWQK--YDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 6e-07
Identities = 36/115 (31%), Positives = 56/115 (48%), Gaps = 7/115 (6%)
Query: 77 FDLRR-RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDF 135
F L R R + R R + E I L YL +V+RDLK N++LD + + KI+DF
Sbjct: 84 FHLSRERVFSEDRARFYGAE-IVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDF 139
Query: 136 GMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGK 190
G+ + D A GT Y+ PE + Y D + GV++ +++ G+
Sbjct: 140 GLCKEGISD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 6e-07
Identities = 42/186 (22%), Positives = 82/186 (44%), Gaps = 25/186 (13%)
Query: 11 PNGQEMAVKR--LSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMP 68
P +AVK+ L S + L+ + E+ + +LQH N+LP + E ++ M
Sbjct: 23 PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82
Query: 69 NKSLDFYIFDLRRRYLLDWRTRV---HIIEGITQGLLYLQEYSNLTIVHRDLKASNILLD 125
S + DL + + + + I++ + L Y+ + +HR +KAS+ILL
Sbjct: 83 YGSCE----DLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLS 135
Query: 126 YEMNPKISDFGMARAFTKDECEANTGRIVGTYG--------YVPPEYVRKGI--YSMKYD 175
+ +S + + K R+V + ++ PE +++ + Y+ K D
Sbjct: 136 GDGKVVLSGLRYSVSMIK---HGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSD 192
Query: 176 VYSYGV 181
+YS G+
Sbjct: 193 IYSVGI 198
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 7e-07
Identities = 50/215 (23%), Positives = 97/215 (45%), Gaps = 22/215 (10%)
Query: 5 ICQGR-LPNGQEMAVKRLSRTSHQGLEEFENEVKLTARL-QHVNLLPVLGICTQR----- 57
+ +GR + GQ A+K + T + EE + E+ + + H N+ G ++
Sbjct: 22 VYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80
Query: 58 -EEKMLIYDYMPNKSLDFYIFDLRRRYLLD-WRTRVHIIEGITQGLLYLQEYSNLTIVHR 115
++ L+ ++ S+ I + + L + W +I I +GL +L ++ ++HR
Sbjct: 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREILRGLSHLHQHK---VIHR 135
Query: 116 DLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVR-----KGIY 170
D+K N+LL K+ DFG++ + NT +GT ++ PE + Y
Sbjct: 136 DIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAPEVIACDENPDATY 193
Query: 171 SMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLL 205
K D++S G+ +++ G C P +L L+
Sbjct: 194 DFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 228
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 54/199 (27%), Positives = 106/199 (53%), Gaps = 20/199 (10%)
Query: 12 NGQEMAVKRLS-RTSHQGLEEFE-NEVKLTARLQ---HVNLLPVLGIC----TQREEKM- 61
G+ +A+K++ S +G+ E+ L +L+ H N++ +L +C T RE K+
Sbjct: 23 TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLT 82
Query: 62 LIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASN 121
L+++++ ++ L Y+ + L + ++ + +G+ +L +S+ IVHRDLK N
Sbjct: 83 LVFEHV-DQDLATYLSKCPKPGLPPETIK-DLMRQLLRGVDFL--HSHR-IVHRDLKPQN 137
Query: 122 ILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGV 181
IL+ + KI+DFG+AR ++ + A T +V T Y PE + + Y+ D++S G
Sbjct: 138 ILVTSDGQVKIADFGLARIYSFE--MALTS-VVVTLWYRAPEVLLQSSYATPVDMWSVGC 194
Query: 182 LLLQILGGKRTSCYYGPNE 200
+ ++ +R + G +E
Sbjct: 195 IFAELF--RRRPLFRGTSE 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 1e-06
Identities = 52/183 (28%), Positives = 82/183 (44%), Gaps = 19/183 (10%)
Query: 12 NGQEMAVKRLS--RTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQRE----EKMLIYD 65
+G++ +K+L+ S + + E E +L ++L+H N I RE E L+Y
Sbjct: 24 DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN------IVAYRESWEGEDGLLYI 77
Query: 66 YMP-NKSLDFY-IFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNIL 123
M + D Y ++ LL V I L YL E I+HRDLK N+
Sbjct: 78 VMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVF 134
Query: 124 LDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLL 183
L K+ D G+AR A+T ++GT Y+ PE Y+ K DV++ G +
Sbjct: 135 LTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYYMSPELFSNKPYNYKSDVWALGCCV 192
Query: 184 LQI 186
++
Sbjct: 193 YEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 50/184 (27%), Positives = 89/184 (48%), Gaps = 17/184 (9%)
Query: 13 GQEMAVKRLSR--TSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDY---M 67
G+++A+K+LSR S + E+ L +QH N++ +L + T D+ M
Sbjct: 40 GEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVM 99
Query: 68 PNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYE 127
P D + L + + + +++ + GL Y+ I+HRDLK N+ ++ +
Sbjct: 100 PYMQTDLQ--KIMGHPLSEDKVQ-YLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNED 153
Query: 128 MNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGI-YSMKYDVYSYGVLLLQI 186
KI DFG+AR + TG +V T Y PE + + Y+ D++S G ++ ++
Sbjct: 154 CELKILDFGLARHADAEM----TGYVV-TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEM 208
Query: 187 LGGK 190
L GK
Sbjct: 209 LTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 28/73 (38%), Positives = 38/73 (52%), Gaps = 9/73 (12%)
Query: 112 IVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTG---RIVGTYGYVPPE-YVRK 167
I+HRDLK SN+LL+ KI DFG+AR E + ++V T Y PE +
Sbjct: 127 ILHRDLKTSNLLLNNRGILKICDFGLAR-----EYGSPLKPYTQLVVTLWYRAPELLLGA 181
Query: 168 GIYSMKYDVYSYG 180
YS D++S G
Sbjct: 182 KEYSTAIDMWSVG 194
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 31/96 (32%), Positives = 49/96 (51%), Gaps = 11/96 (11%)
Query: 101 LLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKD---ECEANTGRIVGTY 157
+L L ++ +HRD+K N+LLD + K++DFG K+ C+ VGT
Sbjct: 152 VLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT----AVGTP 207
Query: 158 GYVPPEYVRK----GIYSMKYDVYSYGVLLLQILGG 189
Y+ PE ++ G Y + D +S GV L ++L G
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 1e-06
Identities = 42/163 (25%), Positives = 77/163 (47%), Gaps = 21/163 (12%)
Query: 35 EVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHI- 93
EV L L+H N++ + I + L+++Y+ +K L ++YL D +++
Sbjct: 54 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDL--------KQYLDDCGNSINMH 104
Query: 94 -----IEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEA 148
+ + +GL Y ++HRDLK N+L++ K++DFG+ARA K
Sbjct: 105 NVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARA--KSIPTK 159
Query: 149 NTGRIVGTYGYVPPEYVRKGI-YSMKYDVYSYGVLLLQILGGK 190
V T Y PP+ + YS + D++ G + ++ G+
Sbjct: 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 38/143 (26%), Positives = 67/143 (46%), Gaps = 28/143 (19%)
Query: 62 LIYDYMP--------NKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIV 113
L+ +Y P N+ D + D+ + YL + +H + + V
Sbjct: 78 LVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH-------------QMGYV 124
Query: 114 HRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVR------K 167
HRD+K N+L+D + K++DFG A T ++ N+ VGT Y+ PE + K
Sbjct: 125 HRDIKPENVLIDRTGHIKLADFGSAARLTANK-MVNSKLPVGTPDYIAPEVLTTMNGDGK 183
Query: 168 GIYSMKYDVYSYGVLLLQILGGK 190
G Y ++ D +S GV+ +++ G+
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 1e-06
Identities = 32/113 (28%), Positives = 56/113 (49%), Gaps = 17/113 (15%)
Query: 35 EVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHII 94
E+ L L H N++ +L + + L++++ LD DL++ +D +
Sbjct: 48 EISLLKELNHPNIVRLLDVVHSENKLYLVFEF-----LDL---DLKK--YMDSSPLTGLD 97
Query: 95 EGITQGLLYLQEYSNLT------IVHRDLKASNILLDYEMNPKISDFGMARAF 141
+ + LY Q + ++HRDLK N+L+D E K++DFG+ARAF
Sbjct: 98 PPLIKSYLY-QLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAF 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 34/126 (26%), Positives = 50/126 (39%), Gaps = 4/126 (3%)
Query: 67 MPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY 126
MP D + + + R L + I + + L YL I+HRD+K NI LD
Sbjct: 165 MPKYKCDLFTY-VDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDE 220
Query: 127 EMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQI 186
N + DFG A GT PE + Y K D++S G++L ++
Sbjct: 221 PENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
Query: 187 LGGKRT 192
T
Sbjct: 281 SVKNVT 286
|
Length = 392 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 53/203 (26%), Positives = 87/203 (42%), Gaps = 54/203 (26%)
Query: 13 GQEMAVKRLSRTSHQGLEEFEN---------EVKLTARLQHVNLLPVLGICTQREEKMLI 63
GQ +A+K+LSR F+N E+ L + H N++ +L + T
Sbjct: 41 GQNVAIKKLSRP-------FQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFT-------- 85
Query: 64 YDYMPNKSLDFYIFDLRRRYL----------------LDWRTRVHIIEGITQGLLYLQEY 107
P KSL+ + + YL LD +++ + G+ +L
Sbjct: 86 ----PQKSLE----EFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH-- 135
Query: 108 SNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRK 167
+ I+HRDLK SNI++ + KI DFG+AR T T +V Y Y PE +
Sbjct: 136 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY-YRAPEVILG 191
Query: 168 GIYSMKYDVYSYGVLLLQILGGK 190
Y D++S G ++ +++ G
Sbjct: 192 MGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 2e-06
Identities = 50/185 (27%), Positives = 87/185 (47%), Gaps = 21/185 (11%)
Query: 12 NGQEMAV--KRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPN 69
NG+E+ V K L + F L +++ H++L V G+C + E +++ +++ +
Sbjct: 41 NGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEH 100
Query: 70 KSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYE-- 127
LD + + R + W+ V + + L YL+ + +VH ++ A NILL
Sbjct: 101 GPLDVCLRKEKGRVPVAWKITV--AQQLASALSYLE---DKNLVHGNVCAKNILLARLGL 155
Query: 128 ---MNP--KISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGI-YSMKYDVYSYGV 181
+P K+SD G+ +FT E RI ++ PE V G S D +S+G
Sbjct: 156 AEGTSPFIKLSDPGV--SFTALSREERVERI----PWIAPECVPGGNSLSTAADKWSFGT 209
Query: 182 LLLQI 186
LL+I
Sbjct: 210 TLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 46/159 (28%), Positives = 74/159 (46%), Gaps = 20/159 (12%)
Query: 97 ITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKD-ECEANTGRIVG 155
+ + +L + L VHRD+K N+LLD + +++DFG D ++N VG
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA--VG 165
Query: 156 TYGYVPPEYVR-----KGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYG 210
T Y+ PE ++ KG Y + D +S GV + ++L G+ P + +L+E YG
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGET------PFYAESLVE-TYG 218
Query: 211 LWKNGEGM-EFIDSSLDDSSSAWKLMRCMQVALLCVQEN 248
N + +F D S A L+R L+C E
Sbjct: 219 KIMNHKEHFQFPPDVTDVSEEAKDLIR----RLICSPET 253
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 3e-06
Identities = 42/157 (26%), Positives = 67/157 (42%), Gaps = 10/157 (6%)
Query: 35 EVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL-RRRYLLDWRTRVHI 93
EVK+ +L+H N++ + ++ L+++Y+ L+ L L
Sbjct: 50 EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLE----LLEASPGGLPPDAVRSY 105
Query: 94 IEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRI 153
I + Q + Y I+HRD+K NIL+ K+ DFG ARA T
Sbjct: 106 IWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT-DY 161
Query: 154 VGTYGYVPPE-YVRKGIYSMKYDVYSYGVLLLQILGG 189
V T Y PE V Y DV++ G ++ ++L G
Sbjct: 162 VATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 5/91 (5%)
Query: 99 QGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158
Q +L + +L IV+RDLK N+LLD + K++DFG A+ + T + GT
Sbjct: 139 QIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYTLCGTPE 193
Query: 159 YVPPEYVRKGIYSMKYDVYSYGVLLLQILGG 189
Y+ PE + + D ++ G+ + +IL G
Sbjct: 194 YIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 3e-06
Identities = 29/91 (31%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 101 LLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEAN--TGRIVGTYG 158
L L+ I++RDLK NILLD + + K++DFG+ K+ T GT
Sbjct: 110 SLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLC----KESIHEGTVTHTFCGTIE 165
Query: 159 YVPPEYVRKGIYSMKYDVYSYGVLLLQILGG 189
Y+ PE + + + D +S G L+ +L G
Sbjct: 166 YMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 40/149 (26%), Positives = 70/149 (46%), Gaps = 28/149 (18%)
Query: 54 CTQREEKML--IYDYMPNKSLDFYI--FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSN 109
C +++K L + +YMP L + +D+ ++ + V +L L +
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEV---------VLALDAIHS 160
Query: 110 LTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRI-----VGTYGYVPPEY 164
+ ++HRD+K N+LLD + K++DFG + TG + VGT Y+ PE
Sbjct: 161 MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE------TGMVRCDTAVGTPDYISPEV 214
Query: 165 VRK----GIYSMKYDVYSYGVLLLQILGG 189
++ G Y + D +S GV L ++L G
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 42/156 (26%), Positives = 72/156 (46%), Gaps = 16/156 (10%)
Query: 97 ITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGT 156
I + +L + L VHRD+K N+LLD + +++DFG +D + VGT
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG-TVQSSVAVGT 166
Query: 157 YGYVPPEYVRK-----GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGL 211
Y+ PE ++ G Y + D +S GV + ++L G+ P + +L+E +
Sbjct: 167 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGET------PFYAESLVETYGKI 220
Query: 212 WKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQE 247
+ E +F D S A L++ L+C +E
Sbjct: 221 MNHEERFQFPSHITDVSEEAKDLIQ----RLICSRE 252
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 4e-06
Identities = 46/187 (24%), Positives = 80/187 (42%), Gaps = 23/187 (12%)
Query: 9 RLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMP 68
L G+ AVK + + E+ + +H N++ G RE+ + +Y
Sbjct: 30 NLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCG 89
Query: 69 NKSL-DFY-----IFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNI 122
SL D Y + +L+ Y + QGL YL + HRD+K +NI
Sbjct: 90 GGSLQDIYHVTGPLSELQIAY---------VCRETLQGLAYLHSKGKM---HRDIKGANI 137
Query: 123 LLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYV---RKGIYSMKYDVYSY 179
LL + K++DFG+A T A +GT ++ PE + G Y+ D+++
Sbjct: 138 LLTDNGDVKLADFGVAAKITA--TIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAV 195
Query: 180 GVLLLQI 186
G+ +++
Sbjct: 196 GITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 5e-06
Identities = 42/173 (24%), Positives = 72/173 (41%), Gaps = 39/173 (22%)
Query: 62 LIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASN 121
LI +++P D +++ L + T+ +I E + L + L +HRD+K N
Sbjct: 78 LIMEFLPGG--DMMTLLMKKDTLTEEETQFYIAETV----LAIDSIHQLGFIHRDIKPDN 131
Query: 122 ILLDYEMNPKISDFGMARAFTK------------------------DECEANTGR----- 152
+LLD + + K+SDFG+ K + +A T +
Sbjct: 132 LLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQ 191
Query: 153 ----IVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNES 201
VGT Y+ PE + Y+ D +S GV++ ++L G C P E+
Sbjct: 192 LAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQET 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 5e-06
Identities = 42/185 (22%), Positives = 72/185 (38%), Gaps = 25/185 (13%)
Query: 18 VKRLSRTSH-QGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76
VK L ++ F EV+ L H N+L LG C + +L+ ++ P L Y+
Sbjct: 27 VKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYL 86
Query: 77 FDLR--RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISD 134
R + + + GLL+L + +H DL N L +++ KI D
Sbjct: 87 RSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGD 143
Query: 135 FGMARA------FTKDECEANTGRIVGTYGYVPPEYVR------KGIYSMKY-DVYSYGV 181
+G+A + +C A R + PE V K +++S GV
Sbjct: 144 YGLALEQYPEDYYITKDCHAVPLRWLA------PELVEIRGQDLLPKDQTKKSNIWSLGV 197
Query: 182 LLLQI 186
+ ++
Sbjct: 198 TMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 5e-06
Identities = 46/184 (25%), Positives = 88/184 (47%), Gaps = 20/184 (10%)
Query: 15 EMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDF 74
E+ +K L ++ E F + ++L H +L+ G+C +E +++ +Y+ SLD
Sbjct: 29 EVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDT 88
Query: 75 YIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM-----N 129
Y+ + + L++ ++ + + + L +L++ + H ++ A N+LL E N
Sbjct: 89 YL--KKNKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGN 143
Query: 130 P---KISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKG-IYSMKYDVYSYGVLLLQ 185
P K+SD G+ + T E RI +VPPE + S+ D +S+G L +
Sbjct: 144 PPFIKLSDPGI--SITVLPKEILLERI----PWVPPECIENPQNLSLAADKWSFGTTLWE 197
Query: 186 ILGG 189
I G
Sbjct: 198 IFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 6e-06
Identities = 41/140 (29%), Positives = 68/140 (48%), Gaps = 17/140 (12%)
Query: 35 EVKLTARLQHVNLLPVLGICTQREEKM--LIYDYMPNKSLDFY--IFDLR--RRYLLDWR 88
E+ L L+H N++ ++ + + +K L++DY + D + I R +R +
Sbjct: 52 EIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH---DLWQIIKFHRQAKRVSIPPS 108
Query: 89 TRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNP----KISDFGMARAFTKD 144
++ I G+ YL +SN ++HRDLK +NIL+ E KI D G+AR F
Sbjct: 109 MVKSLLWQILNGVHYL--HSNW-VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP 165
Query: 145 -ECEANTGRIVGTYGYVPPE 163
+ A+ +V T Y PE
Sbjct: 166 LKPLADLDPVVVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 7e-06
Identities = 31/96 (32%), Positives = 51/96 (53%), Gaps = 6/96 (6%)
Query: 112 IVHRDLKASNILLDYEMNP-KISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGI- 169
++HRDLK N+L+D + KI+D G+ RAF+ ++ T IV T Y PE +
Sbjct: 131 VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI-PVKSYTHEIV-TLWYRAPEVLLGSTH 188
Query: 170 YSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLL 205
YS D++S G + ++ ++ + G +E LL
Sbjct: 189 YSTPVDIWSVGCIFAEMS--RKQPLFPGDSELQQLL 222
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 7e-06
Identities = 24/80 (30%), Positives = 43/80 (53%), Gaps = 6/80 (7%)
Query: 112 IVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYS 171
I+HRD+K N+L+D + K++DFG++R +++ + VGT Y+ PE +
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK------KFVGTPDYLAPETILGVGDD 171
Query: 172 MKYDVYSYGVLLLQILGGKR 191
D +S G ++ + L G
Sbjct: 172 KMSDWWSLGCVIFEFLFGYP 191
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 9e-06
Identities = 41/163 (25%), Positives = 76/163 (46%), Gaps = 26/163 (15%)
Query: 35 EVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI---------FDLRRRYLL 85
E+ L L H N++ +L + + L+++++ ++ L ++ L + YL
Sbjct: 49 EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLF 107
Query: 86 DWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDE 145
+ QGL + + ++HRDLK N+L++ E K++DFG+ARAF
Sbjct: 108 Q----------LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV-P 153
Query: 146 CEANTGRIVGTYGYVPPEYVRKG-IYSMKYDVYSYGVLLLQIL 187
T +V T Y PE + YS D++S G + +++
Sbjct: 154 VRTYTHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 29/104 (27%), Positives = 46/104 (44%), Gaps = 27/104 (25%)
Query: 113 VHRDLKASNILLDYEMNPKISDFGMARAFTK-------------DECEANTGR------- 152
+HRD+K NIL+D + + K++DFG+ + K N
Sbjct: 123 IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQ 182
Query: 153 -------IVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGG 189
VGT Y+ PE +R Y ++ D +S GV+L ++L G
Sbjct: 183 RRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 27/79 (34%), Positives = 41/79 (51%), Gaps = 1/79 (1%)
Query: 112 IVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYS 171
IVHRD+K N+L+ + K+ DFG AR ++ AN V T Y PE + Y
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-NANYTEYVATRWYRSPELLLGAPYG 179
Query: 172 MKYDVYSYGVLLLQILGGK 190
D++S G +L ++ G+
Sbjct: 180 KAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 42/178 (23%), Positives = 80/178 (44%), Gaps = 13/178 (7%)
Query: 13 GQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSL 72
G+ A+K + + + E+ + +H N++ G +R++ + ++ SL
Sbjct: 34 GELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSL 93
Query: 73 -DFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPK 131
D Y L ++ QGL YL + +HRD+K +NILL + K
Sbjct: 94 QDIY----HVTGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVK 146
Query: 132 ISDFGMARAFTKDECEANTGRIVGTYGYVPPEYV---RKGIYSMKYDVYSYGVLLLQI 186
++DFG++ T A +GT ++ PE RKG Y+ D+++ G+ +++
Sbjct: 147 LADFGVSAQITA--TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 47/181 (25%), Positives = 84/181 (46%), Gaps = 12/181 (6%)
Query: 12 NGQEMAVKRLSRTSHQGLEEFE-NEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNK 70
NG+ +A+K + +G E L L+H N++ + I +E L+++Y+
Sbjct: 29 NGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTD 88
Query: 71 SLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYL-QEYSNLTIVHRDLKASNILLDYEMN 129
+ D L ++ + + + +GL Y+ Q Y I+HRDLK N+L+
Sbjct: 89 LCQY--MDKHPGGLHPENVKLFLFQ-LLRGLSYIHQRY----ILHRDLKPQNLLISDTGE 141
Query: 130 PKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGI-YSMKYDVYSYGVLLLQILG 188
K++DFG+ARA K V T Y PP+ + YS D++ G + ++++
Sbjct: 142 LKLADFGLARA--KSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQ 199
Query: 189 G 189
G
Sbjct: 200 G 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 39/135 (28%), Positives = 63/135 (46%), Gaps = 18/135 (13%)
Query: 62 LIYDYMPNKSLDFYIFDLRRRYLL--DWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKA 119
++ +YMP L +L Y + W R + E + L L ++ +HRD+K
Sbjct: 120 MVMEYMPGGDL----VNLMSNYDIPEKW-ARFYTAEVV----LALDAIHSMGFIHRDVKP 170
Query: 120 SNILLDYEMNPKISDFGMARAFTKD-ECEANTGRIVGTYGYVPPEYVRK----GIYSMKY 174
N+LLD + K++DFG + +T VGT Y+ PE ++ G Y +
Sbjct: 171 DNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA--VGTPDYISPEVLKSQGGDGYYGREC 228
Query: 175 DVYSYGVLLLQILGG 189
D +S GV L ++L G
Sbjct: 229 DWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-05
Identities = 33/125 (26%), Positives = 58/125 (46%), Gaps = 12/125 (9%)
Query: 86 DWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDE 145
DW +I I +GL +L + ++HRD+K N+LL K+ DFG++ +
Sbjct: 121 DWIA--YICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 175
Query: 146 CEANTGRIVGTYGYVPPEYVR-----KGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNE 200
NT +GT ++ PE + Y + D++S G+ +++ G C P
Sbjct: 176 GRRNT--FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR 233
Query: 201 SLNLL 205
+L L+
Sbjct: 234 ALFLI 238
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 42/173 (24%), Positives = 72/173 (41%), Gaps = 39/173 (22%)
Query: 62 LIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASN 121
LI +++P D +++ L + T+ +I E + L + L +HRD+K N
Sbjct: 78 LIMEFLPGG--DMMTLLMKKDTLSEEATQFYIAETV----LAIDAIHQLGFIHRDIKPDN 131
Query: 122 ILLDYEMNPKISDFGMARAFTK------------------------DECEANTGR----- 152
+LLD + + K+SDFG+ K + +A T +
Sbjct: 132 LLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQ 191
Query: 153 ----IVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNES 201
VGT Y+ PE + Y+ D +S GV++ ++L G C P E+
Sbjct: 192 LAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQET 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 42/157 (26%), Positives = 76/157 (48%), Gaps = 9/157 (5%)
Query: 35 EVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHII 94
EV L L+H N++ + I L+++Y+ + L Y+ D + ++ +
Sbjct: 53 EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYL-DNCGNLMSMHNVKIFMF 110
Query: 95 EGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIV 154
+ + +GL Y + I+HRDLK N+L++ + K++DFG+ARA K V
Sbjct: 111 Q-LLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARA--KSVPTKTYSNEV 164
Query: 155 GTYGYVPPEYVRKGI-YSMKYDVYSYGVLLLQILGGK 190
T Y PP+ + YS D++ G +L ++ G+
Sbjct: 165 VTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 31/102 (30%), Positives = 49/102 (48%), Gaps = 16/102 (15%)
Query: 101 LLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARA-------------FTKDECE 147
L YL Y IVHRDLK N+L+ + K++DFG+++ KD E
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 148 ANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGG 189
++ GT Y+ PE + + Y D ++ G++L + L G
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 2e-05
Identities = 45/164 (27%), Positives = 78/164 (47%), Gaps = 21/164 (12%)
Query: 35 EVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRY--LLDWRTRVH 92
E+ L +QH N++ + + + L+++Y LD DL++ D+
Sbjct: 51 EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEY-----LDL---DLKKHMDSSPDFAKNPR 102
Query: 93 IIEG----ITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNP-KISDFGMARAFTKDECE 147
+I+ I +G+ Y + ++HRDLK N+L+D N K++DFG+ARAF
Sbjct: 103 LIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGI-PVR 158
Query: 148 ANTGRIVGTYGYVPPEYVRKG-IYSMKYDVYSYGVLLLQILGGK 190
T +V T Y PE + YS D++S G + +++ K
Sbjct: 159 TFTHEVV-TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 46/199 (23%), Positives = 87/199 (43%), Gaps = 33/199 (16%)
Query: 13 GQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPV--------------LGICTQRE 58
+ +AVK++ T Q ++ E+K+ RL H N++ V +G T+
Sbjct: 30 DKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELN 89
Query: 59 EKMLIYDYMPNKSLDFYIFDLRR----RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVH 114
++ +YM DL L + R+ + + + +GL Y+ + ++H
Sbjct: 90 SVYIVQEYMET--------DLANVLEQGPLSEEHARLFMYQ-LLRGLKYIH---SANVLH 137
Query: 115 RDLKASNILLDYE-MNPKISDFGMARAFTKD-ECEANTGRIVGTYGYVPPEYV-RKGIYS 171
RDLK +N+ ++ E + KI DFG+AR + + T Y P + Y+
Sbjct: 138 RDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYT 197
Query: 172 MKYDVYSYGVLLLQILGGK 190
D+++ G + ++L GK
Sbjct: 198 KAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 38/158 (24%), Positives = 67/158 (42%), Gaps = 12/158 (7%)
Query: 35 EVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF--DLRRRYLLDWRTRVH 92
E + + H +++ + G T + LI +P D Y + R + D +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDI---LA 186
Query: 93 IIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGR 152
I + + + YL E I+HRD+KA NI +++ + + DFG A F D
Sbjct: 187 IERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAA-CFPVDINANKYYG 242
Query: 153 IVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGK 190
GT PE + + Y D++S G++L ++
Sbjct: 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 51/190 (26%), Positives = 85/190 (44%), Gaps = 30/190 (15%)
Query: 13 GQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKM-LIYDYMPNKS 71
G +AVK+LSR F+N+ + + LL C + + L+ + P KS
Sbjct: 46 GINVAVKKLSRP-------FQNQTHAKRAYRELVLLK----CVNHKNIISLLNVFTPQKS 94
Query: 72 LD-----FYIFDLRRRYL-------LDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKA 119
L+ + + +L L LD +++ + G+ +L I+HRDLK
Sbjct: 95 LEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKP 151
Query: 120 SNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSY 179
SNI++ + KI DFG+AR T T +V Y Y PE + Y D++S
Sbjct: 152 SNIVVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSV 208
Query: 180 GVLLLQILGG 189
G ++ +++ G
Sbjct: 209 GCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 4e-05
Identities = 31/84 (36%), Positives = 41/84 (48%), Gaps = 7/84 (8%)
Query: 112 IVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANT-GRIVGTYGYVPPEYVRKGIY 170
+ HRDLK NIL + + KI DFG+AR D A V T Y PE G +
Sbjct: 124 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC--GSF 181
Query: 171 SMKY----DVYSYGVLLLQILGGK 190
KY D++S G + ++L GK
Sbjct: 182 FSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 4e-05
Identities = 52/191 (27%), Positives = 85/191 (44%), Gaps = 32/191 (16%)
Query: 14 QEMAVKRLSR--TSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKS 71
+ +A+K+LSR + + E+ L + H N++ +L + T P KS
Sbjct: 50 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT------------PQKS 97
Query: 72 L----DFYI-FDLRRRYL-------LDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKA 119
L D YI +L L LD +++ + G+ +L I+HRDLK
Sbjct: 98 LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKP 154
Query: 120 SNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSY 179
SNI++ + KI DFG+AR T T +V Y Y PE + Y D++S
Sbjct: 155 SNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSV 211
Query: 180 GVLLLQILGGK 190
G ++ +++ G
Sbjct: 212 GCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 8e-05
Identities = 45/196 (22%), Positives = 82/196 (41%), Gaps = 45/196 (22%)
Query: 12 NGQEMAVKRLSRTSHQGLEEFEN--EVKLTARLQ-HVNLLPVLGICTQREEK-------- 60
G+ A+K + + LE+ N E++ RL H N+L ++ + R+
Sbjct: 23 TGKYYAIKCMKKHFK-SLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL 81
Query: 61 --MLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLK 118
M +Y+ + R+R L + R + + + + L ++ I HRD+K
Sbjct: 82 MDMNLYELIKG----------RKRPLPEKRVK-SYMYQLLKSLDHMHRNG---IFHRDIK 127
Query: 119 ASNILLDYEMNPKISDFGMARA------FTKDECEANTGRIVGTYGYVPPE-YVRKGIYS 171
NIL+ + K++DFG R +T+ + T Y PE + G Y
Sbjct: 128 PENILIKDD-ILKLADFGSCRGIYSKPPYTE---------YISTRWYRAPECLLTDGYYG 177
Query: 172 MKYDVYSYGVLLLQIL 187
K D+++ G + +IL
Sbjct: 178 PKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 1e-04
Identities = 46/180 (25%), Positives = 86/180 (47%), Gaps = 10/180 (5%)
Query: 14 QEMAVKRLSR--TSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYD-YMPNK 70
+ +A+K+LSR + + E+ L + H N++ +L + T ++ D Y+ +
Sbjct: 43 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVME 102
Query: 71 SLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNP 130
+D + + + L D +++ + G+ +L I+HRDLK SNI++ +
Sbjct: 103 LMDANLCQVIQMEL-DHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 158
Query: 131 KISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGK 190
KI DFG+AR T T +V Y Y PE + Y D++S G ++ +++ K
Sbjct: 159 KILDFGLAR--TAGTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 34/137 (24%), Positives = 56/137 (40%), Gaps = 40/137 (29%)
Query: 89 TRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKD---- 144
TR +I E I L + L +HRD+K N+LLD + + K+SDFG+ K
Sbjct: 103 TRFYIAETI----LAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158
Query: 145 ------------------ECEANTGRI--------------VGTYGYVPPEYVRKGIYSM 172
+ ++ + VGT Y+ PE + Y+
Sbjct: 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNK 218
Query: 173 KYDVYSYGVLLLQILGG 189
+ D +S GV++ ++L G
Sbjct: 219 ECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 31/96 (32%), Positives = 51/96 (53%), Gaps = 10/96 (10%)
Query: 99 QGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAF-TKDECEANTGRIVGTY 157
+GL + ++ ++HRDLK N+L++ K++DFG+ARAF C + V T
Sbjct: 110 KGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAE---VVTL 163
Query: 158 GYVPPEYVRKG--IYSMKYDVYSYGVLLLQILGGKR 191
Y PP+ V G +YS D++S G + ++ R
Sbjct: 164 WYRPPD-VLFGAKLYSTSIDMWSAGCIFAELANAGR 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 2e-04
Identities = 20/55 (36%), Positives = 32/55 (58%), Gaps = 4/55 (7%)
Query: 89 TRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTK 143
TR ++ E + L ++ L +HRD+K NIL+D + K+SDFG++ F K
Sbjct: 103 TRFYMAECV----LAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 3e-04
Identities = 31/125 (24%), Positives = 52/125 (41%), Gaps = 45/125 (36%)
Query: 109 NLTIVHRDLKASNILLDYEMNPKISDFGMARAF--TKD---------------------- 144
+ +HRD+K NIL+D + + K++DFG+ F T D
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178
Query: 145 -------------------ECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQ 185
C A++ +VGT Y+ PE + + Y+ D +S GV+L +
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHS--LVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236
Query: 186 ILGGK 190
+L G+
Sbjct: 237 MLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 4e-04
Identities = 39/181 (21%), Positives = 70/181 (38%), Gaps = 55/181 (30%)
Query: 57 REEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRD 116
++ + DY+P D +R + R +I E +T L ++ + +HRD
Sbjct: 73 KDNLYFVMDYIPGG--DMMSLLIRMEVFPEVLARFYIAE-LT---LAIESVHKMGFIHRD 126
Query: 117 LKASNILLDYEMNPKISDFGMARAF----------------------------------- 141
+K NIL+D + + K++DFG+ F
Sbjct: 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCG 186
Query: 142 ------------TKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGG 189
C A++ +VGT Y+ PE + + Y+ D +S GV+L ++L G
Sbjct: 187 DRLKTLEQRATKQHQRCLAHS--LVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVG 244
Query: 190 K 190
+
Sbjct: 245 Q 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.001
Identities = 45/164 (27%), Positives = 74/164 (45%), Gaps = 25/164 (15%)
Query: 35 EVKLTARLQH---VNLLPVLGICTQREEKM-LIYDYMPNKSLDFYIFDLRRRYLLDWRTR 90
E+++ +L+H VNL+ V +R+ K+ L+++Y + L+ L+ R
Sbjct: 50 EIRMLKQLKHPNLVNLIEVF----RRKRKLHLVFEYCDHTVLN----------ELEKNPR 95
Query: 91 ---VHIIEGIT-QGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDEC 146
H+I+ I Q L + +HRD+K NIL+ + K+ DFG AR T
Sbjct: 96 GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155
Query: 147 EANTGRIVGTYGYVPPEY-VRKGIYSMKYDVYSYGVLLLQILGG 189
+ V T Y PE V Y DV++ G + ++L G
Sbjct: 156 DYTD--YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.002
Identities = 42/167 (25%), Positives = 78/167 (46%), Gaps = 18/167 (10%)
Query: 35 EVKLTARLQHVNLLPVLGICTQREEKM--LIYDYMPNKSLDFYIFDLRRRYLLDWRTRVH 92
E+ L L+H N++ + + ++ L++DY + ++I R + + V
Sbjct: 48 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDL--WHIIKFHRASKAN-KKPVQ 104
Query: 93 IIEGITQGLLY-----LQEYSNLTIVHRDLKASNILLDYEMNP-----KISDFGMARAFT 142
+ G+ + LLY + ++HRDLK +NIL+ E P KI+D G AR F
Sbjct: 105 LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFN 163
Query: 143 KD-ECEANTGRIVGTYGYVPPEYVRKGI-YSMKYDVYSYGVLLLQIL 187
+ A+ +V T+ Y PE + Y+ D+++ G + ++L
Sbjct: 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 0.002
Identities = 35/131 (26%), Positives = 59/131 (45%), Gaps = 15/131 (11%)
Query: 62 LIYDYMPNKSLDFYIFDL-RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKAS 120
LI DY+ + L FDL ++ L II + + L L ++ I+H D+K
Sbjct: 86 LIMDYIKDGDL----FDLLKKEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLE 138
Query: 121 NILLD-YEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSY 179
N+L D + + D+G+ + GT Y PE ++ Y + +D ++
Sbjct: 139 NVLYDRAKDRIYLCDYGLCK------IIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAV 192
Query: 180 GVLLLQILGGK 190
GVL ++L GK
Sbjct: 193 GVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.003
Identities = 39/160 (24%), Positives = 66/160 (41%), Gaps = 22/160 (13%)
Query: 34 NEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHI 93
+E +L RL H +L +L + R L +P D Y + R L
Sbjct: 209 HEARLLRRLSHPAVLALLDV---RVVGGLTCLVLPKYRSDLYTYLGARLRPLGLAQ---- 261
Query: 94 IEGITQGLLYLQEYSNLT-IVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGR 152
+ + + LL +Y + I+HRD+K N+L++ + + DFG A C A
Sbjct: 262 VTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAA-------CFARGSW 314
Query: 153 -------IVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQ 185
I GT PE + Y+ D++S G+++ +
Sbjct: 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.003
Identities = 30/126 (23%), Positives = 50/126 (39%), Gaps = 45/126 (35%)
Query: 110 LTIVHRDLKASNILLDYEMNPKISDFGMARAF--TKDECEANTG---------------- 151
+ +HRD+K NIL+D + + K++DFG+ F T D +G
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGD 179
Query: 152 ---------------------------RIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLL 184
+VGT Y+ PE + + Y+ D +S GV+L
Sbjct: 180 PANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 239
Query: 185 QILGGK 190
++L G+
Sbjct: 240 EMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.1 bits (89), Expect = 0.003
Identities = 29/106 (27%), Positives = 52/106 (49%), Gaps = 6/106 (5%)
Query: 35 EVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHII 94
E L L+H N++ + I ++ L+++Y+ + L Y+ D L +
Sbjct: 53 EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL-DTDLKQYMDDCGG--GLSMHNVRLFL 109
Query: 95 EGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARA 140
+ +GL Y + ++HRDLK N+L+ K++DFG+ARA
Sbjct: 110 FQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARA 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 0.004
Identities = 42/192 (21%), Positives = 87/192 (45%), Gaps = 19/192 (9%)
Query: 11 PNGQEMAVK--RLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMP 68
P G + V+ L + + L+ +NEV L+ +H N++ + T +I +M
Sbjct: 23 PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82
Query: 69 NKSLDFYIFDLRRRYLLDWRTRV---HIIEGITQGLLYLQEYSNLTIVHRDLKASNILLD 125
S + L + Y + + +I+ G +GL YL + +HR++KAS+IL+
Sbjct: 83 YGSAN----SLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILIS 135
Query: 126 YEMNPKISDFGMARAFTKDECEANTGRIVGTYG-----YVPPEYVRKGI--YSMKYDVYS 178
+ +S + ++ +A + ++ PE +R+ + Y++K D+YS
Sbjct: 136 GDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYS 195
Query: 179 YGVLLLQILGGK 190
G+ ++ G+
Sbjct: 196 VGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 309 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.98 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.98 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.84 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.83 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.78 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.76 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.76 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.76 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.73 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.69 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.67 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.67 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.65 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.61 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.6 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.58 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.57 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.55 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.55 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.54 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.53 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.48 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.37 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.28 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.27 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.25 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.19 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.18 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.17 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.15 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.13 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.11 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.04 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.02 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.97 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.92 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.91 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.82 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.79 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.68 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.54 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.46 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.45 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.41 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.36 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.35 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.07 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.03 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.99 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.99 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.89 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.75 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.73 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.71 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.7 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.6 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.58 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.55 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.54 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.43 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.41 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.33 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 97.3 | |
| PLN02236 | 344 | choline kinase | 97.29 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.22 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.05 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.0 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.89 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.89 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.75 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.72 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.67 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.66 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.6 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.54 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.53 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.45 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.33 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.2 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.95 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.9 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 95.68 | |
| PF11883 | 48 | DUF3403: Domain of unknown function (DUF3403); Int | 95.56 | |
| PTZ00296 | 442 | choline kinase; Provisional | 94.82 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.75 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.53 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-47 Score=316.35 Aligned_cols=241 Identities=23% Similarity=0.319 Sum_probs=196.4
Q ss_pred ccceEEEEc-CCCcEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCC-eeEEEEeccCCCChhHHHhh
Q 021682 2 SVAICQGRL-PNGQEMAVKRLSRT-SHQGLEEFENEVKLTARLQHVNLLPVLGICTQRE-EKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 2 g~~~~~~~~-~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~ 78 (309)
|++||+... .+++-+|+|.+... .+..+.++.+|++++++.+||+||.+|+.|..+. .++|+||||.+|+|++++..
T Consensus 92 gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~ 171 (364)
T KOG0581|consen 92 GGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKR 171 (364)
T ss_pred CcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhh
Confidence 789999976 48899999999544 4556788999999999999999999999999998 59999999999999999854
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
. +.+++...-+++.++++||.|||..+ +|+||||||+|+|++..|.+||||||.+...-.. ......||..
T Consensus 172 ~---g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a~tfvGT~~ 242 (364)
T KOG0581|consen 172 V---GRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----IANTFVGTSA 242 (364)
T ss_pred c---CCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh----hccccccccc
Confidence 3 44999999999999999999999643 8999999999999999999999999998766554 3445689999
Q ss_pred CCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHH
Q 021682 159 YVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238 (309)
Q Consensus 159 y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (309)
|||||.+.+..|+.++||||||++++|+..|+.|+....... ...... ....-.+....+... ..+.++.
T Consensus 243 YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~-~~~~~L-l~~Iv~~ppP~lP~~--------~fS~ef~ 312 (364)
T KOG0581|consen 243 YMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY-LDIFEL-LCAIVDEPPPRLPEG--------EFSPEFR 312 (364)
T ss_pred ccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC-CCHHHH-HHHHhcCCCCCCCcc--------cCCHHHH
Confidence 999999999999999999999999999999999986541111 111111 111111111111111 2344899
Q ss_pred HHHhhcccCCCCCCCCHHHHHHH
Q 021682 239 QVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 239 ~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
+++..||+.||.+|||+.|++++
T Consensus 313 ~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 313 SFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred HHHHHHhcCCcccCCCHHHHhcC
Confidence 99999999999999999999976
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=321.02 Aligned_cols=262 Identities=38% Similarity=0.659 Sum_probs=223.0
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCC-eeEEEEeccCCCChhHHHhhhcc
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQRE-EKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
+.||+|.+.+|+.||||.+.....+...+|..|+.++.+++|+|+++++++|.+.+ +.+||+||+.+|+|.+.+.....
T Consensus 89 g~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~ 168 (361)
T KOG1187|consen 89 GTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKG 168 (361)
T ss_pred eEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCC
Confidence 57899999999999999886654431345999999999999999999999999988 59999999999999999865332
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccc-ccccCCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRI-VGTYGYV 160 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~-~~~~~y~ 160 (309)
. .++|..+++|+.+++.||+|||..+...|+|||||+.|||+|++.+.||+|||++........ ..... .||..|+
T Consensus 169 ~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~--~~~~~~~gt~gY~ 245 (361)
T KOG1187|consen 169 E-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDT--SVSTTVMGTFGYL 245 (361)
T ss_pred C-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcccc--ceeeecCCCCccC
Confidence 2 789999999999999999999998766799999999999999999999999999955443111 11112 7899999
Q ss_pred CccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCC-CcccH-HHHHHHH
Q 021682 161 PPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLD-DSSSA-WKLMRCM 238 (309)
Q Consensus 161 aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~ 238 (309)
+||+...+..+.++||||||+++.|+++|+.+.....+........|.+..+......+++|+.+. ..... .....+.
T Consensus 246 ~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~ 325 (361)
T KOG1187|consen 246 APEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLA 325 (361)
T ss_pred ChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHH
Confidence 999998889999999999999999999999887665545555688888899999999999999976 44443 5777899
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHhcccC
Q 021682 239 QVALLCVQENAADRPTMLEILVMLKSETA 267 (309)
Q Consensus 239 ~li~~~l~~~p~~Rpt~~ell~~L~~~~~ 267 (309)
.+..+|++.+|++||++.+++++|+.+..
T Consensus 326 ~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 326 ELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 99999999999999999999999966543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-46 Score=321.33 Aligned_cols=250 Identities=29% Similarity=0.478 Sum_probs=202.9
Q ss_pred cceEEEEcCCCcEEEEEEeecCCc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCC-eeEEEEeccCCCChhHHHhhh
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSH--QGLEEFENEVKLTARLQHVNLLPVLGICTQRE-EKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~ 79 (309)
+.||+|.++....||+|.+..... .....|..|+.+|.+++|||||++++++..+. ..++||||+++|+|.+++...
T Consensus 55 g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~ 134 (362)
T KOG0192|consen 55 GTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKK 134 (362)
T ss_pred eeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhc
Confidence 678999996444499999976532 22568999999999999999999999999887 799999999999999999653
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCc-eeecCCCCceEEeCCCC-CceeecccccccccCCccccccccccccc
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLT-IVHRDLKASNILLDYEM-NPKISDFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~g-i~H~di~p~nil~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
....+++..+..++.+|+.|+.|||++ + |+||||||+|+|++.++ ++||+|||+++...... .......||.
T Consensus 135 -~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~~~~~~GT~ 208 (362)
T KOG0192|consen 135 -RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TSMTSVAGTY 208 (362)
T ss_pred -ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc--ccccCCCCCc
Confidence 456699999999999999999999999 7 99999999999999997 99999999997765432 1122247899
Q ss_pred CCCCccccc--cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 158 GYVPPEYVR--KGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 158 ~y~aPE~~~--~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
.|||||++. ...++.++||||||+++|||+||..||..... ..........+....+... ...
T Consensus 209 ~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~~~Rp~~p~~---------~~~ 273 (362)
T KOG0192|consen 209 RWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVGGLRPPIPKE---------CPP 273 (362)
T ss_pred cccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCCCCCCCcc---------CCH
Confidence 999999999 56899999999999999999999999875443 1222222222222222221 334
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHHhcccCCCCCCC
Q 021682 236 RCMQVALLCVQENAADRPTMLEILVMLKSETADIKTPK 273 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~~~~~~ 273 (309)
.+..++.+||..||+.||++.+++..|+.+...+....
T Consensus 274 ~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~~ 311 (362)
T KOG0192|consen 274 HLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSAG 311 (362)
T ss_pred HHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcccC
Confidence 78899999999999999999999999998876555543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-46 Score=327.76 Aligned_cols=248 Identities=23% Similarity=0.329 Sum_probs=200.8
Q ss_pred ceEEEEc-CCCcEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGRL-PNGQEMAVKRLSRT---SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
.+|.+.. .+|+.||+|++.+. ....++.+.+|+++.++|+|||||+++++|++.+++|||.|+|..++|..++.
T Consensus 33 ~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~K-- 110 (592)
T KOG0575|consen 33 RCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLK-- 110 (592)
T ss_pred EEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHH--
Confidence 3566665 89999999999764 34567889999999999999999999999999999999999999999999983
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
+++.+.+..++.++.||+.|+.|||++ +|+|||||..|+|++++.++||+|||+|..+...... .....||+.|
T Consensus 111 -rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er--k~TlCGTPNY 184 (592)
T KOG0575|consen 111 -RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER--KKTLCGTPNY 184 (592)
T ss_pred -hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCcccc--cceecCCCcc
Confidence 566799999999999999999999999 9999999999999999999999999999887754322 2235799999
Q ss_pred CCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHH
Q 021682 160 VPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQ 239 (309)
Q Consensus 160 ~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (309)
+|||++.....+..+||||+||++|-||.|++||+...-.+....+.. ++-..+. ..+.+..+
T Consensus 185 IAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~-----~~Y~~P~------------~ls~~A~d 247 (592)
T KOG0575|consen 185 IAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL-----NEYSMPS------------HLSAEAKD 247 (592)
T ss_pred cChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh-----cCccccc------------ccCHHHHH
Confidence 999999999999999999999999999999999975433332222211 1100111 12236779
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHhcccCCCCCCCCCCc
Q 021682 240 VALLCVQENAADRPTMLEILVMLKSETADIKTPKKPAF 277 (309)
Q Consensus 240 li~~~l~~~p~~Rpt~~ell~~L~~~~~~~~~~~~p~~ 277 (309)
||.++|+.||.+|||+++|+..=- ....+.+...|..
T Consensus 248 LI~~lL~~~P~~Rpsl~~vL~h~F-f~~g~~p~~lp~~ 284 (592)
T KOG0575|consen 248 LIRKLLRPNPSERPSLDEVLDHPF-FKSGFTPARLPSS 284 (592)
T ss_pred HHHHHhcCCcccCCCHHHHhcCHh-hhCCCcCCCCCcc
Confidence 999999999999999999997522 1234445555553
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=308.89 Aligned_cols=236 Identities=28% Similarity=0.378 Sum_probs=189.9
Q ss_pred cceEEEEc-CCCcEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
++||+|+. .+|..||||.+.+. ....++.+..|+.+|+.++|||||.+++++..++.++||||||.||+|.+|+..
T Consensus 24 avVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~- 102 (429)
T KOG0595|consen 24 AVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRR- 102 (429)
T ss_pred EEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHH-
Confidence 46788876 47899999999766 566778899999999999999999999999999999999999999999999954
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCC------CCceeecccccccccCCccccccccc
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYE------MNPKISDFGMARAFTKDECEANTGRI 153 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~------~~~~l~Dfg~~~~~~~~~~~~~~~~~ 153 (309)
++.+++.+++.++.||+.|+++||++ +|+||||||+||+++.. -.+||+|||+|+....... ....
T Consensus 103 --~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~---a~tl 174 (429)
T KOG0595|consen 103 --RGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSM---AETL 174 (429)
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhH---HHHh
Confidence 33599999999999999999999999 89999999999999875 3589999999998875432 2334
Q ss_pred ccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHH
Q 021682 154 VGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWK 233 (309)
Q Consensus 154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
.|++.|||||++....|+.|+|+||+|+++|++++|.+||....+.+... ..-........+. ...
T Consensus 175 cGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~------~~~k~~~~~~~~~--------~~~ 240 (429)
T KOG0595|consen 175 CGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLL------YIKKGNEIVPVLP--------AEL 240 (429)
T ss_pred hCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHH------HHhccccccCchh--------hhc
Confidence 79999999999999999999999999999999999999997554444222 1111111122111 112
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 234 LMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 234 ~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
...+++++...++.+|.+|-++.+-...
T Consensus 241 s~~~~~Ll~~ll~~~~~~~~~~~~~~~~ 268 (429)
T KOG0595|consen 241 SNPLRELLISLLQRNPKDRISFEDFFDH 268 (429)
T ss_pred cCchhhhhhHHHhcCccccCchHHhhhh
Confidence 2245577778888888888777765543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=316.69 Aligned_cols=241 Identities=20% Similarity=0.276 Sum_probs=188.4
Q ss_pred CccceEEEEcCCCcEEEEEEeecCCcc-------cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChh
Q 021682 1 MSVAICQGRLPNGQEMAVKRLSRTSHQ-------GLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLD 73 (309)
Q Consensus 1 ~g~~~~~~~~~~g~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 73 (309)
||.|-.+-..++|+.||||++++.-.. ......+|+++|++|+||+||+++++|+.+...||||||++||.|.
T Consensus 185 fg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLf 264 (475)
T KOG0615|consen 185 FGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELF 264 (475)
T ss_pred eeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHH
Confidence 455666666679999999999754111 1233579999999999999999999999999999999999999999
Q ss_pred HHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCC---CCceeecccccccccCCcccccc
Q 021682 74 FYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYE---MNPKISDFGMARAFTKDECEANT 150 (309)
Q Consensus 74 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~---~~~~l~Dfg~~~~~~~~~~~~~~ 150 (309)
+.+.. .+.+.+.....++.|++.|+.|||++ ||+||||||+|||+..+ -.+||+|||+|+..+... ..
T Consensus 265 d~vv~---nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~s---fm 335 (475)
T KOG0615|consen 265 DKVVA---NKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGS---FM 335 (475)
T ss_pred HHHHh---ccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccchhhccccce---eh
Confidence 98844 44588888899999999999999999 99999999999999876 569999999999877432 34
Q ss_pred cccccccCCCCccccccCCC---CccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCC
Q 021682 151 GRIVGTYGYVPPEYVRKGIY---SMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDD 227 (309)
Q Consensus 151 ~~~~~~~~y~aPE~~~~~~~---~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (309)
....||+.|.|||++..... ..+.|+||+||++|-+++|.+||....... ...+ ....+... +..
T Consensus 336 ~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~e----QI~~G~y~------f~p 403 (475)
T KOG0615|consen 336 KTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKE----QILKGRYA------FGP 403 (475)
T ss_pred hhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHH----HHhcCccc------ccC
Confidence 45689999999999977643 347899999999999999999995432222 0111 11111111 111
Q ss_pred cccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 021682 228 SSSAWKLMRCMQVALLCVQENAADRPTMLEILVML 262 (309)
Q Consensus 228 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L 262 (309)
..-.....+..++|.+||..||++|||+.|+++.=
T Consensus 404 ~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hp 438 (475)
T KOG0615|consen 404 LQWDRISEEALDLINWMLVVDPENRPSADEALNHP 438 (475)
T ss_pred hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcCh
Confidence 22233455788999999999999999999999764
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=300.04 Aligned_cols=248 Identities=20% Similarity=0.273 Sum_probs=198.8
Q ss_pred CccceEEEEcCCCcEEEEEEeec--CCcccHHHHHHHHHHHhcCCCCCccceee-EEeeCCe-eEEEEeccCCCChhHHH
Q 021682 1 MSVAICQGRLPNGQEMAVKRLSR--TSHQGLEEFENEVKLTARLQHVNLLPVLG-ICTQREE-KMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 1 ~g~~~~~~~~~~g~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~-~~~~~~~-~~lv~e~~~~~~L~~~~ 76 (309)
||.+.-...+.+|..||.|.+.- .+...++++..|+.+|++|+|||||++++ .|..++. ++||||+|.+|+|..++
T Consensus 32 Fg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmI 111 (375)
T KOG0591|consen 32 FGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMI 111 (375)
T ss_pred chheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHH
Confidence 55554445677999999998763 35666788999999999999999999998 4555554 89999999999999998
Q ss_pred hh-hccccCCCHHHHHHHHHHHHHHHHHHhhcCCC-ceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccc
Q 021682 77 FD-LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNL-TIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIV 154 (309)
Q Consensus 77 ~~-~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~-gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~ 154 (309)
.. ...+..+++..+++++.|++.||..+|+...+ .|.||||||.|||++.+|.+||+|||+++........ ....+
T Consensus 112 k~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tf--A~S~V 189 (375)
T KOG0591|consen 112 KHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTF--AHSLV 189 (375)
T ss_pred HHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchhHH--HHhhc
Confidence 76 34567799999999999999999999995432 3899999999999999999999999999887665432 34468
Q ss_pred cccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHH
Q 021682 155 GTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKL 234 (309)
Q Consensus 155 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
||+.||+||.+.+.+|+.++||||+||++|||+..++||... + ......+...+... .-....++
T Consensus 190 GTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n-~~~L~~KI~qgd~~--------~~p~~~YS 254 (375)
T KOG0591|consen 190 GTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------N-LLSLCKKIEQGDYP--------PLPDEHYS 254 (375)
T ss_pred CCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------c-HHHHHHHHHcCCCC--------CCcHHHhh
Confidence 999999999999999999999999999999999999999643 1 11122222222111 12224567
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHHhcc
Q 021682 235 MRCMQVALLCVQENAADRPTMLEILVMLKSE 265 (309)
Q Consensus 235 ~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~ 265 (309)
..+..||..|+..||+.||+.-.+++.+.+.
T Consensus 255 ~~l~~li~~ci~vd~~~RP~t~~~v~di~~~ 285 (375)
T KOG0591|consen 255 TDLRELINMCIAVDPEQRPDTVPYVQDIQSE 285 (375)
T ss_pred hHHHHHHHHHccCCcccCCCcchHHHHHHHH
Confidence 7899999999999999999976666666654
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-45 Score=315.38 Aligned_cols=241 Identities=30% Similarity=0.460 Sum_probs=201.3
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccc
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRR 82 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 82 (309)
+.|+.|.++...+||+|.++.... ..+.|.+|++++++|+|++||+++++|..+..++||||||..|+|.+++.. ..+
T Consensus 220 G~V~~g~~~~~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~-~~~ 297 (468)
T KOG0197|consen 220 GEVWLGKWNGSTKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRT-REG 297 (468)
T ss_pred ceEEEEEEcCCCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhh-cCC
Confidence 467889998777999999976543 347888999999999999999999999998899999999999999999965 446
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCc
Q 021682 83 YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPP 162 (309)
Q Consensus 83 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 162 (309)
..+...+.+.++.|||+|++||.++ +++||||-..||||+++..+||+|||+|+....+......+ ..-+..|.||
T Consensus 298 ~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~-~kfPIkWtAP 373 (468)
T KOG0197|consen 298 GLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEG-GKFPIKWTAP 373 (468)
T ss_pred CccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeecCC-CCCCceecCH
Confidence 6699999999999999999999999 89999999999999999999999999999655544333222 2446789999
Q ss_pred cccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHH
Q 021682 163 EYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241 (309)
Q Consensus 163 E~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 241 (309)
|++..+.++.+|||||||++|||++| |+.|+......+.. +.++...+...+..++..+++++
T Consensus 374 Ea~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~----------------~~le~GyRlp~P~~CP~~vY~lM 437 (468)
T KOG0197|consen 374 EALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVL----------------ELLERGYRLPRPEGCPDEVYELM 437 (468)
T ss_pred HHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHH----------------HHHhccCcCCCCCCCCHHHHHHH
Confidence 99999999999999999999999998 77776544332211 12233334444555666899999
Q ss_pred hhcccCCCCCCCCHHHHHHHHhcc
Q 021682 242 LLCVQENAADRPTMLEILVMLKSE 265 (309)
Q Consensus 242 ~~~l~~~p~~Rpt~~ell~~L~~~ 265 (309)
..||..+|++|||++.+...|+..
T Consensus 438 ~~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 438 KSCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred HHHhhCCcccCCCHHHHHHHHHHh
Confidence 999999999999999999988865
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=304.34 Aligned_cols=236 Identities=23% Similarity=0.341 Sum_probs=194.6
Q ss_pred cceEEE-EcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 3 VAICQG-RLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 3 ~~~~~~-~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
+.||.+ ...+++.||||.+........+.+.+|+.+++..+|+|||.+++.+...+.+++||||++||+|.|.+.
T Consensus 287 G~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt---- 362 (550)
T KOG0578|consen 287 GGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVT---- 362 (550)
T ss_pred cceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhh----
Confidence 455555 456899999999976655566789999999999999999999999999999999999999999999983
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP 161 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 161 (309)
...+++.++..++.+++.||+|||.+ ||+|||||.+||+++.+|.+||+|||++..+..... .....+||+.|||
T Consensus 363 ~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR~TmVGTPYWMA 437 (550)
T KOG0578|consen 363 KTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KRSTMVGTPYWMA 437 (550)
T ss_pred cccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC--ccccccCCCCccc
Confidence 33489999999999999999999999 999999999999999999999999999977665543 3445689999999
Q ss_pred ccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHH
Q 021682 162 PEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241 (309)
Q Consensus 162 PE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 241 (309)
||+.....|.++.||||||+++.||+-|++||-...+.. .+ ......... ........+..+.+++
T Consensus 438 PEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr---Al----yLIa~ng~P-------~lk~~~klS~~~kdFL 503 (550)
T KOG0578|consen 438 PEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR---AL----YLIATNGTP-------KLKNPEKLSPELKDFL 503 (550)
T ss_pred hhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH---HH----HHHhhcCCC-------CcCCccccCHHHHHHH
Confidence 999999999999999999999999999999985422211 11 111111111 1222233344889999
Q ss_pred hhcccCCCCCCCCHHHHHHH
Q 021682 242 LLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 242 ~~~l~~~p~~Rpt~~ell~~ 261 (309)
.+||+.|+++||+|.|||+.
T Consensus 504 ~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 504 DRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred HHHhhcchhcCCCHHHHhcC
Confidence 99999999999999999975
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=290.54 Aligned_cols=249 Identities=23% Similarity=0.344 Sum_probs=197.9
Q ss_pred ccceEEEEc-CCCcEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 2 SVAICQGRL-PNGQEMAVKRLSRT-SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 2 g~~~~~~~~-~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
+.+||+++. ..++.||||++.-. -..+.+.+.+|+..++.++||||+..+..|..+..+|+||+||.+|++.+.+...
T Consensus 39 sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~ 118 (516)
T KOG0582|consen 39 SAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTY 118 (516)
T ss_pred eeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHH
Confidence 467888874 57899999999654 2334688999999999999999999999999999999999999999999999764
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccc-c-ccccccc
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEAN-T-GRIVGTY 157 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~-~-~~~~~~~ 157 (309)
-.. .+++..+..++.++++||.|||.+ |.+|||||+.||+++.+|.|+|+|||.+......+.... . ....|++
T Consensus 119 ~~~-Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp 194 (516)
T KOG0582|consen 119 YPD-GLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTP 194 (516)
T ss_pred ccc-cccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcc
Confidence 433 399999999999999999999999 999999999999999999999999998765544332211 1 4568999
Q ss_pred CCCCcccccc--CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 158 GYVPPEYVRK--GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 158 ~y~aPE~~~~--~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
+|||||++.. .+|+.|+||||||++..||.+|+.||..+.+..-. ...+.+ ....................
T Consensus 195 ~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL------l~tLqn-~pp~~~t~~~~~d~~k~~~k 267 (516)
T KOG0582|consen 195 CWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL------LLTLQN-DPPTLLTSGLDKDEDKKFSK 267 (516)
T ss_pred cccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH------HHHhcC-CCCCcccccCChHHhhhhcH
Confidence 9999999544 47999999999999999999999999766554321 111111 11111122223333344455
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 236 RCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.+.+++..||+.||.+|||+++++..
T Consensus 268 sf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 268 SFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred HHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 88899999999999999999999865
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=292.76 Aligned_cols=244 Identities=26% Similarity=0.349 Sum_probs=187.2
Q ss_pred CccceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCC--eeEEEEeccCCCChhHHHhh
Q 021682 1 MSVAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQRE--EKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 1 ~g~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~ 78 (309)
||+|...-..++|+..|||.+........+.+++|+.+|++++|||||+.++...... .++++|||+.+|+|.+++..
T Consensus 30 ~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~ 109 (313)
T KOG0198|consen 30 FGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKR 109 (313)
T ss_pred ceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHH
Confidence 3444444444569999999886553333677999999999999999999999754444 69999999999999999854
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCC-CCCceeecccccccccCC-cccccccccccc
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY-EMNPKISDFGMARAFTKD-ECEANTGRIVGT 156 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~-~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~~ 156 (309)
.+. .+++..+..++.|+++|++|||++ |++|+||||.||+++. ++.+||+|||.+...... ..........||
T Consensus 110 ~g~--~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gt 184 (313)
T KOG0198|consen 110 YGG--KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGT 184 (313)
T ss_pred cCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCC
Confidence 332 599999999999999999999998 9999999999999999 799999999998766541 111223346899
Q ss_pred cCCCCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 157 YGYVPPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 157 ~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
+.|||||++.++ ....++|||||||++.||+||.+||... ..................+. ...+.
T Consensus 185 p~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~P~ip---------~~ls~ 250 (313)
T KOG0198|consen 185 PNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSLPEIP---------DSLSD 250 (313)
T ss_pred ccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCCCCCC---------cccCH
Confidence 999999999853 3446999999999999999999998643 11122222222222222211 11333
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHHh
Q 021682 236 RCMQVALLCVQENAADRPTMLEILVMLK 263 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~Rpt~~ell~~L~ 263 (309)
+..++|.+|++.||++||||+++++..-
T Consensus 251 ~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 251 EAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred HHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 7789999999999999999999998754
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=282.90 Aligned_cols=251 Identities=18% Similarity=0.234 Sum_probs=189.1
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSH--QGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
++||+-+. ++|+-||||.+....+ ...+-.++|+++|++++|+|+|.++++|......+||+|||+..-|.++- ..
T Consensus 16 GvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTvL~eLe-~~ 94 (396)
T KOG0593|consen 16 GVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTVLHELE-RY 94 (396)
T ss_pred eEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHHHHHHH-hc
Confidence 35555554 5899999999965533 23455789999999999999999999999999999999999876665553 22
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
...++...+.++++|++.|+.|+|++ +++||||||+||+++.+|.+||||||+|+....... .....+.|.+|
T Consensus 95 --p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd--~YTDYVATRWY 167 (396)
T KOG0593|consen 95 --PNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD--NYTDYVATRWY 167 (396)
T ss_pred --cCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCCcc--hhhhhhhhhhc
Confidence 33488999999999999999999998 899999999999999999999999999987764322 23345789999
Q ss_pred CCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhC--------CCC-cc--cccc---c
Q 021682 160 VPPEYVRK-GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKN--------GEG-ME--FIDS---S 224 (309)
Q Consensus 160 ~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~-~~--~~~~---~ 224 (309)
+|||.+.| .+|....|||++||++.||++|.+.|......++.-.+....+.+.. ... .. +..+ .
T Consensus 168 RaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~e 247 (396)
T KOG0593|consen 168 RAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPE 247 (396)
T ss_pred cChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCcc
Confidence 99999988 58999999999999999999999998665444433333222221111 100 00 0000 0
Q ss_pred CCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 225 LDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 225 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.....-+.....+.+++++||+.||.+|++-++++..
T Consensus 248 pLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 248 PLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred chhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 0011111223367799999999999999999999854
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=299.73 Aligned_cols=251 Identities=21% Similarity=0.240 Sum_probs=197.1
Q ss_pred CccceEEEEcCCCcEEEEEEeecCCcccHHHH--HHHHHHHhcCC-CCCccceeeEEeeCC-eeEEEEeccCCCChhHHH
Q 021682 1 MSVAICQGRLPNGQEMAVKRLSRTSHQGLEEF--ENEVKLTARLQ-HVNLLPVLGICTQRE-EKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 1 ~g~~~~~~~~~~g~~vavK~~~~~~~~~~~~~--~~e~~~l~~l~-h~~iv~~~~~~~~~~-~~~lv~e~~~~~~L~~~~ 76 (309)
||.|..+....+|+.||||.++..-.. +++. .+|++-|++|+ |||||++.+++.+.. .+++|||||+ .+|+.++
T Consensus 23 fGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md-~NLYqLm 100 (538)
T KOG0661|consen 23 FGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMD-CNLYQLM 100 (538)
T ss_pred ceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhh-hhHHHHH
Confidence 677777777789999999999766443 3433 47999999997 999999999998877 9999999995 5899998
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccc
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGT 156 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 156 (309)
.++ +..|++..++.|+.||++||+|+|.+ |+.|||+||+|||+..+..+||+|||+|+........ +..+.|
T Consensus 101 K~R--~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPY---TeYVST 172 (538)
T KOG0661|consen 101 KDR--NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPY---TEYVST 172 (538)
T ss_pred hhc--CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccccCCCc---chhhhc
Confidence 653 67799999999999999999999998 9999999999999998999999999999877665433 334779
Q ss_pred cCCCCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcc---------c----cc
Q 021682 157 YGYVPPEYVRK-GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGME---------F----ID 222 (309)
Q Consensus 157 ~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~----~~ 222 (309)
.+|+|||++.. +.|+.+.|+|++|||++|+.+.++.|.+.+..++...+..+.+......+.+ + +.
T Consensus 173 RWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~ 252 (538)
T KOG0661|consen 173 RWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVK 252 (538)
T ss_pred ccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCC
Confidence 99999997754 5789999999999999999999999987666665544444333222211111 0 00
Q ss_pred ccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 223 SSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 223 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
+..-...-.....++.++|.+||.+||.+||||.+++++
T Consensus 253 ~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 253 PSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred CCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 000001111134578899999999999999999999987
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=296.93 Aligned_cols=238 Identities=24% Similarity=0.312 Sum_probs=193.4
Q ss_pred CccceEEEEcCCCcEEEEEEeecC---CcccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHH
Q 021682 1 MSVAICQGRLPNGQEMAVKRLSRT---SHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 1 ~g~~~~~~~~~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 76 (309)
||+|+.+....+++.+|||++.+. ...-......|-..|.+| .||.|++++..|.++..+|+|+||+++|+|-+++
T Consensus 86 YStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i 165 (604)
T KOG0592|consen 86 YSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLI 165 (604)
T ss_pred ceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHH
Confidence 577777777889999999998543 222345567788888888 8999999999999999999999999999999999
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccc---------
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECE--------- 147 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~--------- 147 (309)
...+ .+++.-.+.++.+|+.|+.|||++ ||+||||||+|||+|.+++++|+|||.|..+......
T Consensus 166 ~K~G---sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~ 239 (604)
T KOG0592|consen 166 KKYG---SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQ 239 (604)
T ss_pred HHhC---cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCccc
Confidence 6544 499999999999999999999999 9999999999999999999999999999887643222
Q ss_pred cc--ccccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccC
Q 021682 148 AN--TGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSL 225 (309)
Q Consensus 148 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (309)
.. ...++||..|.+||++.....++.+|+|+|||++|+|+.|.+||...+.--....+... +..+
T Consensus 240 a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l-------------~y~f 306 (604)
T KOG0592|consen 240 ASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL-------------DYEF 306 (604)
T ss_pred ccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh-------------cccC
Confidence 11 14578999999999999999999999999999999999999999653322211111111 1111
Q ss_pred CCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 226 DDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 226 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
....+ ....+||.++|..||.+|+|+.+|.+.
T Consensus 307 p~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 307 PEGFP----EDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred CCCCC----HHHHHHHHHHHccCccccccHHHHhhC
Confidence 11111 367799999999999999999999887
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=286.28 Aligned_cols=237 Identities=22% Similarity=0.275 Sum_probs=192.2
Q ss_pred CccceEEEEcCCCcEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 1 MSVAICQGRLPNGQEMAVKRLSRT---SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 1 ~g~~~~~~~~~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
||.|...-..++++.+|+|++++. ...+....+.|..+|.+++||+||+++..|++.+..|+|+||+.||.|...+.
T Consensus 38 fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~ 117 (357)
T KOG0598|consen 38 FGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQ 117 (357)
T ss_pred CceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHH
Confidence 566666666679999999999765 34456788999999999999999999999999999999999999999988884
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
+.+.+++..++-++.+|+.||.|||+. ||+||||||+|||++..|.++|+|||+++..-.... .+....||+
T Consensus 118 ---~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~--~t~tfcGT~ 189 (357)
T KOG0598|consen 118 ---REGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD--ATRTFCGTP 189 (357)
T ss_pred ---hcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccCCC--ccccccCCc
Confidence 344599999999999999999999999 999999999999999999999999999975444332 233468999
Q ss_pred CCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHH
Q 021682 158 GYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRC 237 (309)
Q Consensus 158 ~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (309)
.|||||++.+.+++..+|-||||+++|+|++|.+||...+.......+. .... ...+...+.+.
T Consensus 190 eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~-------~~k~---------~~~p~~ls~~a 253 (357)
T KOG0598|consen 190 EYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKIL-------KGKL---------PLPPGYLSEEA 253 (357)
T ss_pred cccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHh-------cCcC---------CCCCccCCHHH
Confidence 9999999999999999999999999999999999997554433222111 1110 01111122377
Q ss_pred HHHHhhcccCCCCCCC----CHHHHHHH
Q 021682 238 MQVALLCVQENAADRP----TMLEILVM 261 (309)
Q Consensus 238 ~~li~~~l~~~p~~Rp----t~~ell~~ 261 (309)
.+++.++|+.||+.|. .+.++...
T Consensus 254 rdll~~LL~rdp~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 254 RDLLKKLLKRDPRQRLGGPGDAEEIKRH 281 (357)
T ss_pred HHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence 8999999999999995 56665543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=293.39 Aligned_cols=235 Identities=24% Similarity=0.324 Sum_probs=187.1
Q ss_pred CccceEEEEcCCCcEEEEEEeecC----Cc-ccHHHHHHHHHHHhcCC-CCCccceeeEEeeCCeeEEEEeccCCCChhH
Q 021682 1 MSVAICQGRLPNGQEMAVKRLSRT----SH-QGLEEFENEVKLTARLQ-HVNLLPVLGICTQREEKMLIYDYMPNKSLDF 74 (309)
Q Consensus 1 ~g~~~~~~~~~~g~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (309)
||.|..+....+|+.||+|++... .. ...+.+.+|+.++++++ ||||+++++++.....+++||||+.||.|.+
T Consensus 30 fgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~ 109 (370)
T KOG0583|consen 30 FGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFD 109 (370)
T ss_pred CeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHH
Confidence 455555556678999999977553 12 23456778999999998 9999999999999999999999999999999
Q ss_pred HHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCC-CCceeecccccccccCCccccccccc
Q 021682 75 YIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYE-MNPKISDFGMARAFTKDECEANTGRI 153 (309)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~~ 153 (309)
++.. .+.+.+..+..++.|++.|++|+|++ ||+||||||+|++++.+ +++||+|||++....... ......
T Consensus 110 ~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~--~~l~t~ 181 (370)
T KOG0583|consen 110 YIVN---KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGED--GLLKTF 181 (370)
T ss_pred HHHH---cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccccccCCCC--CcccCC
Confidence 9954 44588899999999999999999999 99999999999999999 999999999998774111 123345
Q ss_pred ccccCCCCccccccCC-CC-ccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCC--CCcccccccCCCcc
Q 021682 154 VGTYGYVPPEYVRKGI-YS-MKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNG--EGMEFIDSSLDDSS 229 (309)
Q Consensus 154 ~~~~~y~aPE~~~~~~-~~-~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 229 (309)
.|++.|+|||++.+.. |+ .++||||+|+++|.|++|..||...+... .......+ .....+.
T Consensus 182 cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~-------l~~ki~~~~~~~p~~~~------- 247 (370)
T KOG0583|consen 182 CGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN-------LYRKIRKGEFKIPSYLL------- 247 (370)
T ss_pred CCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH-------HHHHHhcCCccCCCCcC-------
Confidence 7999999999999877 75 88999999999999999999997521111 11111111 1111110
Q ss_pred cHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 230 SAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 230 ~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
..++.+++.+||..||..|+|+.+++..
T Consensus 248 ----S~~~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 248 ----SPEARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred ----CHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence 3478899999999999999999999943
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=287.20 Aligned_cols=238 Identities=20% Similarity=0.285 Sum_probs=187.8
Q ss_pred cceEEEEcCCCcEEEEEEeecCCccc---HHHHHHHHHHHhcCCCCCccceeeEEee----CCeeEEEEeccCCCChhHH
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQG---LEEFENEVKLTARLQHVNLLPVLGICTQ----REEKMLIYDYMPNKSLDFY 75 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~ 75 (309)
+.||+|.+ +|+.||||.++...... .+.+.+|+.++++++||||+++++++.+ ....++||||+.+++|.++
T Consensus 34 ~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~ 112 (283)
T PHA02988 34 NSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREV 112 (283)
T ss_pred eEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHH
Confidence 46899987 78999999987543322 4677899999999999999999999876 3468999999999999999
Q ss_pred HhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccc
Q 021682 76 IFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVG 155 (309)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 155 (309)
+.. ...+++.....++.+++.++.+||+.. +++||||+|.||+++.++.+||+|||++....... ....+
T Consensus 113 l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-----~~~~~ 182 (283)
T PHA02988 113 LDK---EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-----FKNVN 182 (283)
T ss_pred Hhh---CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-----ccccC
Confidence 843 345888999999999999999999743 78899999999999999999999999987544321 12357
Q ss_pred ccCCCCcccccc--CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHH
Q 021682 156 TYGYVPPEYVRK--GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWK 233 (309)
Q Consensus 156 ~~~y~aPE~~~~--~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
+..|+|||.+.+ ..++.++|||||||++|+|++|..||......+ ............. .+...
T Consensus 183 ~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~------~~~~i~~~~~~~~---------~~~~~ 247 (283)
T PHA02988 183 FMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE------IYDLIINKNNSLK---------LPLDC 247 (283)
T ss_pred cccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhcCCCCC---------CCCcC
Confidence 889999999876 678999999999999999999999986432211 1111111111111 11122
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHHHhccc
Q 021682 234 LMRCMQVALLCVQENAADRPTMLEILVMLKSET 266 (309)
Q Consensus 234 ~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~ 266 (309)
+..+.+++.+||+.||++|||++++++.|+...
T Consensus 248 ~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 248 PLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred cHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 347889999999999999999999999998653
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=298.96 Aligned_cols=247 Identities=26% Similarity=0.426 Sum_probs=196.4
Q ss_pred cceEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
++||+|.| ...||||+++... ++..+.|++|+..+++-+|.||+-++++|..+.. .||+.||+|.+|+.++..
T Consensus 406 GtV~Rg~w--hGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv-- 480 (678)
T KOG0193|consen 406 GTVYRGRW--HGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHV-- 480 (678)
T ss_pred cceeeccc--ccceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccc--
Confidence 46899998 4569999998763 4456789999999999999999999999998877 899999999999999854
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCC
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYV 160 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 160 (309)
....|++.+.+.|+.|+++|+.|||.+ +|+|+|||..|||+.++++|||+|||++................|...||
T Consensus 481 ~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwm 557 (678)
T KOG0193|consen 481 QETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWM 557 (678)
T ss_pred hhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhh
Confidence 334599999999999999999999999 89999999999999999999999999998766554433444456788999
Q ss_pred Ccccccc---CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHH
Q 021682 161 PPEYVRK---GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRC 237 (309)
Q Consensus 161 aPE~~~~---~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (309)
|||++.. .+|++.+|||+||+++|||++|..||...........+ +.. +..+... ........++
T Consensus 558 APEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmV---------GrG--~l~pd~s-~~~s~~pk~m 625 (678)
T KOG0193|consen 558 APEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMV---------GRG--YLMPDLS-KIRSNCPKAM 625 (678)
T ss_pred cHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEe---------ccc--ccCccch-hhhccCHHHH
Confidence 9998864 36899999999999999999999999732222221111 111 1111100 0111233378
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHhcccCCC
Q 021682 238 MQVALLCVQENAADRPTMLEILVMLKSETADI 269 (309)
Q Consensus 238 ~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~~ 269 (309)
.+|+..||.+++++||++.+|+..|+.+...+
T Consensus 626 k~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 626 KRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred HHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 89999999999999999999999888775543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=295.65 Aligned_cols=250 Identities=22% Similarity=0.288 Sum_probs=199.8
Q ss_pred cceEEEEc-CCCcEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
++||+|+. .+.+.||+|.+.+. ...+...+.+|+++++.++||||+.++++|++..++++|+||+.| +|..++.+
T Consensus 16 g~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~- 93 (808)
T KOG0597|consen 16 GRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQ- 93 (808)
T ss_pred ceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHh-
Confidence 57899975 48999999998654 344566789999999999999999999999999999999999976 99998854
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
.+.++++.+..++.+++.|+.|||+. +|+|+|+||+||++..+|.+|++|||+|+..+... .......||+.|
T Consensus 94 --d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t--~vltsikGtPlY 166 (808)
T KOG0597|consen 94 --DGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT--SVLTSIKGTPLY 166 (808)
T ss_pred --ccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccCc--eeeeeccCcccc
Confidence 44499999999999999999999999 89999999999999999999999999998777643 334556899999
Q ss_pred CCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHH
Q 021682 160 VPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQ 239 (309)
Q Consensus 160 ~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (309)
||||...+.+|+..+|+|||||++||+.+|++||....-.. .. ....... ...+......+.+
T Consensus 167 mAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~------Lv-~~I~~d~----------v~~p~~~S~~f~n 229 (808)
T KOG0597|consen 167 MAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQ------LV-KSILKDP----------VKPPSTASSSFVN 229 (808)
T ss_pred cCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHH------HH-HHHhcCC----------CCCcccccHHHHH
Confidence 99999999999999999999999999999999985321111 11 1111111 1111134447889
Q ss_pred HHhhcccCCCCCCCCHHHHHHH--HhcccCCCCCCCCCCcc
Q 021682 240 VALLCVQENAADRPTMLEILVM--LKSETADIKTPKKPAFS 278 (309)
Q Consensus 240 li~~~l~~~p~~Rpt~~ell~~--L~~~~~~~~~~~~p~~~ 278 (309)
++...|..||..|.|..+++.. .++-......|..|.+.
T Consensus 230 fl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~~ 270 (808)
T KOG0597|consen 230 FLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAFD 270 (808)
T ss_pred HHHHHhhcChhhcccHHHHhcChHHhhhhhhhccccccccc
Confidence 9999999999999999999875 33333333444444443
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=266.10 Aligned_cols=251 Identities=21% Similarity=0.255 Sum_probs=195.1
Q ss_pred ceEEE-EcCCCcEEEEEEeecCCcc--cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 4 AICQG-RLPNGQEMAVKRLSRTSHQ--GLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 4 ~~~~~-~~~~g~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
+||+| +..+|+.||||.++..... -.-...+|++.|+.++|+||+.++++|.....+.||+||++ .+|...+.+
T Consensus 17 vVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~-tdLe~vIkd-- 93 (318)
T KOG0659|consen 17 VVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMP-TDLEVVIKD-- 93 (318)
T ss_pred EEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEecc-ccHHHHhcc--
Confidence 45555 5679999999999755322 12345789999999999999999999999999999999996 588888844
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCC
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYV 160 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 160 (309)
....+....+..++.++++|++|||++ .|+||||||.|++++.+|.+||+|||+++.++......... +-|.+|+
T Consensus 94 ~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~--V~TRWYR 168 (318)
T KOG0659|consen 94 KNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTHQ--VVTRWYR 168 (318)
T ss_pred cccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCcccccc--eeeeecc
Confidence 455688899999999999999999999 79999999999999999999999999999887654433332 6688999
Q ss_pred CccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCccc-----------ccccCCCc
Q 021682 161 PPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEF-----------IDSSLDDS 228 (309)
Q Consensus 161 aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~ 228 (309)
|||.+.|. .|....|+||.||++.||+-|.+-|.....-++...+....+-.....+.+. +.......
T Consensus 169 APELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~ 248 (318)
T KOG0659|consen 169 APELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNN 248 (318)
T ss_pred ChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCcccc
Confidence 99988875 7899999999999999999998887665555554444444333333333221 11111111
Q ss_pred ccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 021682 229 SSAWKLMRCMQVALLCVQENAADRPTMLEILVML 262 (309)
Q Consensus 229 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L 262 (309)
.-........+++.+||.+||.+|+|+.|++++=
T Consensus 249 lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~ 282 (318)
T KOG0659|consen 249 LFPAASSDALDLLSKMLTYNPKKRITASQALKHP 282 (318)
T ss_pred ccccccHHHHHHHHhhhccCchhcccHHHHhcch
Confidence 2223344668999999999999999999999763
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=284.75 Aligned_cols=251 Identities=23% Similarity=0.276 Sum_probs=192.4
Q ss_pred ceEEE-EcCCCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEeeC--CeeEEEEeccCCCChhHHHhh
Q 021682 4 AICQG-RLPNGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQR--EEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 4 ~~~~~-~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~ 78 (309)
.||++ +..+|+.||+|.++... +....-.-+|+.+|++|.||||+++.+..... ..+|||+|||+. +|.-++.
T Consensus 132 ~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~- 209 (560)
T KOG0600|consen 132 QVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLS- 209 (560)
T ss_pred heeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhc-
Confidence 35555 46799999999987553 33334456899999999999999999998876 589999999975 6766663
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
..+..|++.++..+..||+.||.|+|.+ ||+|||||..|||||.+|.+||+|||+|+++........+ ..+-|.+
T Consensus 210 -~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T-~rVvTLW 284 (560)
T KOG0600|consen 210 -SPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYT-SRVVTLW 284 (560)
T ss_pred -CCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCCCCcccc-cceEEee
Confidence 3455699999999999999999999999 9999999999999999999999999999988776554433 3467999
Q ss_pred CCCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHH-----hhCCCCc--ccccccCCCccc
Q 021682 159 YVPPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGL-----WKNGEGM--EFIDSSLDDSSS 230 (309)
Q Consensus 159 y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~~--~~~~~~~~~~~~ 230 (309)
|+|||++.|. .|+...|+||.|||+.||+.|++.+......++...+...-+- |...... ..+.+...-...
T Consensus 285 YRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~ 364 (560)
T KOG0600|consen 285 YRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRR 364 (560)
T ss_pred ccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccch
Confidence 9999999885 7899999999999999999999998766555544444333222 3211111 111111110000
Q ss_pred -----HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 231 -----AWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 231 -----~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
...+....+|+..+|..||.+|.||.++++.
T Consensus 365 l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 365 LRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred HHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 1112356789999999999999999999864
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=290.75 Aligned_cols=246 Identities=25% Similarity=0.380 Sum_probs=186.7
Q ss_pred ceEEEEc------CCCcEEEEEEeecCC-cccHHHHHHHHHHHhcC-CCCCccceeeEEeeCC-eeEEEEeccCCCChhH
Q 021682 4 AICQGRL------PNGQEMAVKRLSRTS-HQGLEEFENEVKLTARL-QHVNLLPVLGICTQRE-EKMLIYDYMPNKSLDF 74 (309)
Q Consensus 4 ~~~~~~~------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~-~~~lv~e~~~~~~L~~ 74 (309)
.||++.. .+++.||||.++... ......+.+|+.+++++ +||||+++++++...+ ..++||||+++|+|.+
T Consensus 22 ~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~ 101 (338)
T cd05102 22 KVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSN 101 (338)
T ss_pred eEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHH
Confidence 4666642 346789999986543 23346788999999999 8999999999887644 6899999999999999
Q ss_pred HHhhhcc-----------------------------------------------------------ccCCCHHHHHHHHH
Q 021682 75 YIFDLRR-----------------------------------------------------------RYLLDWRTRVHIIE 95 (309)
Q Consensus 75 ~~~~~~~-----------------------------------------------------------~~~~~~~~~~~~~~ 95 (309)
++..... ...+.+..+..++.
T Consensus 102 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 181 (338)
T cd05102 102 FLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSF 181 (338)
T ss_pred HHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHH
Confidence 8854221 12467788899999
Q ss_pred HHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCccccccCCCCccch
Q 021682 96 GITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYD 175 (309)
Q Consensus 96 ~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 175 (309)
|++.|+.|||+. |++||||||.||+++.++.++|+|||++............+...++..|+|||.+.+..++.++|
T Consensus 182 qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sD 258 (338)
T cd05102 182 QVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSD 258 (338)
T ss_pred HHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccC
Confidence 999999999998 89999999999999999999999999987654332222222334567899999998888999999
Q ss_pred hhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCC
Q 021682 176 VYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPT 254 (309)
Q Consensus 176 vwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt 254 (309)
||||||++|+|++ |..||........ .......+..... +...+..+.+++.+||+.||++|||
T Consensus 259 iwslG~il~el~~~g~~pf~~~~~~~~------~~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~dp~~RPs 323 (338)
T cd05102 259 VWSFGVLLWEIFSLGASPYPGVQINEE------FCQRLKDGTRMRA---------PENATPEIYRIMLACWQGDPKERPT 323 (338)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCccHH------HHHHHhcCCCCCC---------CCCCCHHHHHHHHHHccCChhhCcC
Confidence 9999999999997 9999864322111 1111111111110 1112346889999999999999999
Q ss_pred HHHHHHHHhcccC
Q 021682 255 MLEILVMLKSETA 267 (309)
Q Consensus 255 ~~ell~~L~~~~~ 267 (309)
+.++++.|+....
T Consensus 324 ~~el~~~l~~~~~ 336 (338)
T cd05102 324 FSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHHHHHHh
Confidence 9999999997654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=290.38 Aligned_cols=239 Identities=20% Similarity=0.274 Sum_probs=199.7
Q ss_pred CccceEEEEcCCCcEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCe-eEEEEeccCCCChhHHHh
Q 021682 1 MSVAICQGRLPNGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREE-KMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 1 ~g~~~~~~~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~ 77 (309)
||.+++.-+..+++.+++|.+.-. ....+....+|+.++++++|||||.+.+.|..++. .+|||+||+||++.+.+.
T Consensus 17 fG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~ 96 (426)
T KOG0589|consen 17 FGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIK 96 (426)
T ss_pred cchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHH
Confidence 677776666678899999988654 34445577899999999999999999999999887 999999999999999986
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
.. ++..+++..+..|+.|++.|+.|||++ .|+|||||+.|||++.++.|+|+|||+|+..+.... ......||+
T Consensus 97 ~~-k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~--~a~tvvGTp 170 (426)
T KOG0589|consen 97 EQ-KGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS--LASTVVGTP 170 (426)
T ss_pred HH-hhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCchh--hhheecCCC
Confidence 53 367799999999999999999999988 799999999999999999999999999988776642 233458999
Q ss_pred CCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHH
Q 021682 158 GYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRC 237 (309)
Q Consensus 158 ~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (309)
.|++||.+.+.+|..|+|||||||++|||++-+++|...+.......+. ... ....+..+..++
T Consensus 171 ~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~---------------~~~-~~Plp~~ys~el 234 (426)
T KOG0589|consen 171 YYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKIN---------------RGL-YSPLPSMYSSEL 234 (426)
T ss_pred cccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHh---------------hcc-CCCCCccccHHH
Confidence 9999999999999999999999999999999999986544333221111 111 223334455689
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHH
Q 021682 238 MQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 238 ~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
..++..||..+|+.||++.+|+..
T Consensus 235 ~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 235 RSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHHHHHHhhcCCccCCCHHHHhhC
Confidence 999999999999999999999976
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=297.11 Aligned_cols=227 Identities=27% Similarity=0.340 Sum_probs=186.3
Q ss_pred EcCCCcEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccccCC
Q 021682 9 RLPNGQEMAVKRLSRT---SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLL 85 (309)
Q Consensus 9 ~~~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~ 85 (309)
.-.+|+.+|||++.+. +......++.|+-+++.++|||++++|+++++..++|+|.||+++|-|.+++. ..+.+
T Consensus 33 h~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv---~kG~l 109 (786)
T KOG0588|consen 33 HAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLV---RKGPL 109 (786)
T ss_pred cccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHH---hhCCC
Confidence 3468999999999654 34445678999999999999999999999999999999999999999999984 45559
Q ss_pred CHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCcccc
Q 021682 86 DWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYV 165 (309)
Q Consensus 86 ~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 165 (309)
++..+.+++.||+.|+.|+|.. +|||||+||+|++++..+++||+|||+|........ .....|.++|.|||++
T Consensus 110 ~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl---LeTSCGSPHYA~PEIV 183 (786)
T KOG0588|consen 110 PEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL---LETSCGSPHYAAPEIV 183 (786)
T ss_pred CCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCCcc---ccccCCCcccCCchhh
Confidence 9999999999999999999998 799999999999999999999999999976555432 2234789999999999
Q ss_pred ccCCC-CccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHHhhc
Q 021682 166 RKGIY-SMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLC 244 (309)
Q Consensus 166 ~~~~~-~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 244 (309)
.|.+| ..++||||.|+|+|.||+|..||+..+. .....+...+...- +...+.+..+||.+|
T Consensus 184 ~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi-------r~LLlKV~~G~f~M----------Ps~Is~eaQdLLr~m 246 (786)
T KOG0588|consen 184 SGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI-------RVLLLKVQRGVFEM----------PSNISSEAQDLLRRM 246 (786)
T ss_pred cCCCCCCCccccchhHHHHHHHHhCCCCCCCccH-------HHHHHHHHcCcccC----------CCcCCHHHHHHHHHH
Confidence 99988 5789999999999999999999963211 11112222221110 011223788999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 021682 245 VQENAADRPTMLEILVM 261 (309)
Q Consensus 245 l~~~p~~Rpt~~ell~~ 261 (309)
|..||+.|.|++||++.
T Consensus 247 l~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 247 LDVDPSTRITTEEILKH 263 (786)
T ss_pred hccCccccccHHHHhhC
Confidence 99999999999999987
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=279.75 Aligned_cols=236 Identities=23% Similarity=0.322 Sum_probs=194.7
Q ss_pred CccceEEEEcCCCcEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 1 MSVAICQGRLPNGQEMAVKRLSRT---SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 1 ~g~~~~~~~~~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
||.|-.+.....|+.||||.+++. +.++.-.+.+|++++..|+||||+.+|.+|++...+.|||||..+|.|+||+.
T Consensus 66 YGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiS 145 (668)
T KOG0611|consen 66 YGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYIS 145 (668)
T ss_pred ccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHH
Confidence 344444444568999999999765 44555567899999999999999999999999999999999999999999995
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
+.+ .+++...+.++.||..|+-|+|.+ +++|||||.+||++|.|+++||+|||++..+..... ...+.|++
T Consensus 146 er~---~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kf---LqTFCGSP 216 (668)
T KOG0611|consen 146 ERG---SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKF---LQTFCGSP 216 (668)
T ss_pred Hhc---cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhccccH---HHHhcCCc
Confidence 544 499999999999999999999998 999999999999999999999999999988776543 33457899
Q ss_pred CCCCccccccCCC-CccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHH
Q 021682 158 GYVPPEYVRKGIY-SMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMR 236 (309)
Q Consensus 158 ~y~aPE~~~~~~~-~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
.|.+||+..|.+| .+..|-||||+++|-|+.|..||...+..... +....+...+.-.+ ..
T Consensus 217 LYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lv-------rQIs~GaYrEP~~P-----------Sd 278 (668)
T KOG0611|consen 217 LYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLV-------RQISRGAYREPETP-----------SD 278 (668)
T ss_pred ccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHH-------HHhhcccccCCCCC-----------ch
Confidence 9999999999888 57899999999999999999999765443321 22222222221111 14
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHHHh
Q 021682 237 CMQVALLCVQENAADRPTMLEILVMLK 263 (309)
Q Consensus 237 l~~li~~~l~~~p~~Rpt~~ell~~L~ 263 (309)
..-||++||..||+.|.|++++.....
T Consensus 279 A~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 279 ASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred HHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 558999999999999999999999874
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=287.31 Aligned_cols=233 Identities=20% Similarity=0.260 Sum_probs=183.5
Q ss_pred ceEEEE-cCCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
.||.+. ..+|+.||||+++... ......+..|+.++++++||||+++++.+..+...++||||+.+++|.+++..
T Consensus 10 ~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~- 88 (323)
T cd05571 10 KVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR- 88 (323)
T ss_pred EEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHH-
Confidence 455554 4689999999997542 23345677899999999999999999999999999999999999999888743
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
...+++..+..++.||+.|++|||+. |++||||||+||+++.++.++|+|||++........ ......|+..|
T Consensus 89 --~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y 161 (323)
T cd05571 89 --ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEY 161 (323)
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--cccceecCccc
Confidence 34589999999999999999999998 999999999999999999999999999864322211 12234689999
Q ss_pred CCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHH
Q 021682 160 VPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQ 239 (309)
Q Consensus 160 ~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (309)
+|||.+.+..++.++|||||||++|+|++|..||...+... . ........ ..+ +.....++.+
T Consensus 162 ~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~----~~~~~~~~-~~~---------p~~~~~~~~~ 224 (323)
T cd05571 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---L----FELILMEE-IRF---------PRTLSPEAKS 224 (323)
T ss_pred cChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH---H----HHHHHcCC-CCC---------CCCCCHHHHH
Confidence 99999998889999999999999999999999985422111 1 11111110 011 1112347889
Q ss_pred HHhhcccCCCCCCC-----CHHHHHHH
Q 021682 240 VALLCVQENAADRP-----TMLEILVM 261 (309)
Q Consensus 240 li~~~l~~~p~~Rp-----t~~ell~~ 261 (309)
+|.+||+.||++|| ++.++++.
T Consensus 225 li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 225 LLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred HHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 99999999999999 89999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=278.98 Aligned_cols=240 Identities=24% Similarity=0.399 Sum_probs=179.9
Q ss_pred CcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc-----------
Q 021682 13 GQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR----------- 80 (309)
Q Consensus 13 g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------- 80 (309)
+..||+|.+.... ......+.+|++++.+++||||+++++++......++||||+.+++|.+++....
T Consensus 46 ~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 125 (304)
T cd05096 46 PLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDA 125 (304)
T ss_pred ceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccc
Confidence 4479999987543 3345678899999999999999999999999999999999999999999885421
Q ss_pred -----cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccc
Q 021682 81 -----RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVG 155 (309)
Q Consensus 81 -----~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 155 (309)
....+++..+..++.|++.|+.|||+. |++|+||||+||+++.++.++|+|||++............+...+
T Consensus 126 ~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~ 202 (304)
T cd05096 126 VPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVL 202 (304)
T ss_pred cccccccccccHHHHHHHHHHHHHHHHHHHHC---CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCC
Confidence 112467788899999999999999998 899999999999999999999999999875543322222333345
Q ss_pred ccCCCCccccccCCCCccchhhhHHHHHHHHHhC--CCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHH
Q 021682 156 TYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGG--KRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWK 233 (309)
Q Consensus 156 ~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g--~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
+..|+|||.+.+..++.++||||||+++|+|+++ ..||......+ ................... .+...
T Consensus 203 ~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~------~~~~~ 273 (304)
T cd05096 203 PIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQ---VIENAGEFFRDQGRQVYLF------RPPPC 273 (304)
T ss_pred CccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHH---HHHHHHHHhhhcccccccc------CCCCC
Confidence 7789999999888899999999999999999874 45554332211 1111111111111110000 01112
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 021682 234 LMRCMQVALLCVQENAADRPTMLEILVMLKS 264 (309)
Q Consensus 234 ~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~ 264 (309)
+..+.+++.+||+.||++|||+.+|.+.|+.
T Consensus 274 ~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 274 PQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 3378899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=291.29 Aligned_cols=233 Identities=27% Similarity=0.435 Sum_probs=189.0
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccc
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRR 82 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 82 (309)
++||.|++ .++.||||.++. .-+.+++.|++|+|+|||.|.++|.....+|||||||..|.|...+. .+
T Consensus 138 GAVF~Grl-~netVAVKKV~e-------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLk---a~ 206 (904)
T KOG4721|consen 138 GAVFLGRL-HNETVAVKKVRE-------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLK---AG 206 (904)
T ss_pred cceeeeec-cCceehhHHHhh-------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHh---cc
Confidence 57999998 468899998742 23467999999999999999999999999999999999999999984 44
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCc
Q 021682 83 YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPP 162 (309)
Q Consensus 83 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 162 (309)
..+.......|..+|+.++.|||.+ .|+|||||.-||||+.+..|||+|||-++......+ .-.+.||..||||
T Consensus 207 ~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ST---kMSFaGTVaWMAP 280 (904)
T KOG4721|consen 207 RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKST---KMSFAGTVAWMAP 280 (904)
T ss_pred CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhhhh---hhhhhhhHhhhCH
Confidence 4588888999999999999999998 899999999999999999999999998876554421 1135799999999
Q ss_pred cccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCC-CCcccccccCCCcccHHHHHHHHHHH
Q 021682 163 EYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNG-EGMEFIDSSLDDSSSAWKLMRCMQVA 241 (309)
Q Consensus 163 E~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li 241 (309)
|++.+.+.+.|.||||||++|||||||..||...+..... |.-+ +...+ ..+..++.-+.-|+
T Consensus 281 EvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII---------wGVGsNsL~L-------pvPstcP~GfklL~ 344 (904)
T KOG4721|consen 281 EVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII---------WGVGSNSLHL-------PVPSTCPDGFKLLL 344 (904)
T ss_pred HHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE---------EeccCCcccc-------cCcccCchHHHHHH
Confidence 9999999999999999999999999999998654433221 1111 11111 11122233566789
Q ss_pred hhcccCCCCCCCCHHHHHHHHhcccCC
Q 021682 242 LLCVQENAADRPTMLEILVMLKSETAD 268 (309)
Q Consensus 242 ~~~l~~~p~~Rpt~~ell~~L~~~~~~ 268 (309)
++||+..|.+||++++++..|+-..++
T Consensus 345 Kqcw~sKpRNRPSFrqil~HldIa~pe 371 (904)
T KOG4721|consen 345 KQCWNSKPRNRPSFRQILLHLDIASPE 371 (904)
T ss_pred HHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence 999999999999999999999865443
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=282.48 Aligned_cols=248 Identities=19% Similarity=0.250 Sum_probs=186.5
Q ss_pred ceEEEEc-CCCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
.||++.. .+|..||+|.+.... ......+.+|++++++++||||+++++++..++..++||||+.+++|.+++..
T Consensus 20 ~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--- 96 (331)
T cd06649 20 VVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKE--- 96 (331)
T ss_pred EEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHH---
Confidence 4566654 578999999987542 33456789999999999999999999999999999999999999999998843
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP 161 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 161 (309)
...+++..+..++.+++.|+.|||+.+ +++|+||||+||+++.++.++|+|||++....... .....++..|+|
T Consensus 97 ~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~g~~~y~a 170 (331)
T cd06649 97 AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMS 170 (331)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc----cccCCCCcCcCC
Confidence 334889999999999999999999864 69999999999999999999999999986543321 223467899999
Q ss_pred ccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhC-CCCcc---------------------
Q 021682 162 PEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKN-GEGME--------------------- 219 (309)
Q Consensus 162 PE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~--------------------- 219 (309)
||.+.+..++.++|||||||++|+|++|+.||...+..+...... ...... .....
T Consensus 171 PE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (331)
T cd06649 171 PERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFG--RPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSR 248 (331)
T ss_pred HhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc--ccccccccCCccccCcccccccccccccccccc
Confidence 999998889999999999999999999999986433211100000 000000 00000
Q ss_pred -------cc----cccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 021682 220 -------FI----DSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVML 262 (309)
Q Consensus 220 -------~~----~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L 262 (309)
.. ..............++.+||.+||+.||++|||++++++..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 249 PAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred cchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 00 00000000112345788999999999999999999999764
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=302.81 Aligned_cols=238 Identities=28% Similarity=0.449 Sum_probs=198.9
Q ss_pred CCcEEEEEEeecCCcc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc-------cc
Q 021682 12 NGQEMAVKRLSRTSHQ-GLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR-------RY 83 (309)
Q Consensus 12 ~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------~~ 83 (309)
..+.||||.++..... .+++|++|++++..++|||||+++++|..++..|+|+|||..|+|.+++....+ +.
T Consensus 515 ~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~ 594 (774)
T KOG1026|consen 515 DEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQ 594 (774)
T ss_pred cceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCC
Confidence 3467999999876544 788999999999999999999999999999999999999999999999965432 22
Q ss_pred C----CCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 84 L----LDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 84 ~----~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
. +...+.+.++.||+.|+.||-++ .++||||-.+|++|.++..|||+|||+++...........+...-+.+|
T Consensus 595 ~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRW 671 (774)
T KOG1026|consen 595 DTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRW 671 (774)
T ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeec
Confidence 2 78889999999999999999998 5999999999999999999999999999887766555555455668899
Q ss_pred CCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHH
Q 021682 160 VPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238 (309)
Q Consensus 160 ~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (309)
||||.+..++++.+|||||+|+++||+++ |..|+......+ +++.. ..++ .-+.+...+.+++
T Consensus 672 MppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E---VIe~i----~~g~---------lL~~Pe~CP~~vY 735 (774)
T KOG1026|consen 672 MPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE---VIECI----RAGQ---------LLSCPENCPTEVY 735 (774)
T ss_pred CCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH---HHHHH----HcCC---------cccCCCCCCHHHH
Confidence 99999999999999999999999999998 888875443332 22221 1222 2344444566999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHhcccCC
Q 021682 239 QVALLCVQENAADRPTMLEILVMLKSETAD 268 (309)
Q Consensus 239 ~li~~~l~~~p~~Rpt~~ell~~L~~~~~~ 268 (309)
+|+..||+.+|++||+++||-..|+...+.
T Consensus 736 ~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 736 SLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred HHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 999999999999999999999999986553
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=281.08 Aligned_cols=233 Identities=18% Similarity=0.222 Sum_probs=182.5
Q ss_pred ceEEEE-cCCCcEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGR-LPNGQEMAVKRLSRT---SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
.||.+. ..+|+.||+|.++.. .......+..|+++++.++||||+++++.+..+...++||||+.+++|..++..
T Consensus 10 ~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~- 88 (323)
T cd05595 10 KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR- 88 (323)
T ss_pred EEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHH-
Confidence 455554 458999999999754 223345677899999999999999999999999999999999999999887743
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
...+++..+..++.||+.|+.|||++ |++||||||+||+++.++.++|+|||++........ ......|+..|
T Consensus 89 --~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y 161 (323)
T cd05595 89 --ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEY 161 (323)
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--ccccccCCcCc
Confidence 33589999999999999999999998 999999999999999999999999998764322211 12224688999
Q ss_pred CCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHH
Q 021682 160 VPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQ 239 (309)
Q Consensus 160 ~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (309)
+|||.+.+..++.++|||||||++|+|++|..||...+.... ....... .. . ... .....+.+
T Consensus 162 ~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~------~~~~~~~-~~-~-----~p~----~~~~~~~~ 224 (323)
T cd05595 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL------FELILME-EI-R-----FPR----TLSPEAKS 224 (323)
T ss_pred CCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH------HHHHhcC-CC-C-----CCC----CCCHHHHH
Confidence 999999888899999999999999999999999864322111 1111111 00 0 011 12336789
Q ss_pred HHhhcccCCCCCCC-----CHHHHHHH
Q 021682 240 VALLCVQENAADRP-----TMLEILVM 261 (309)
Q Consensus 240 li~~~l~~~p~~Rp-----t~~ell~~ 261 (309)
+|.+||+.||++|| ++.++++.
T Consensus 225 li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 225 LLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred HHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 99999999999998 89988764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=294.97 Aligned_cols=238 Identities=20% Similarity=0.206 Sum_probs=186.0
Q ss_pred ceEEEE-cCC-CcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh-c
Q 021682 4 AICQGR-LPN-GQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL-R 80 (309)
Q Consensus 4 ~~~~~~-~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~ 80 (309)
+||.+. ..+ ++.||+|.+..........+..|+.+++.++||||+++++++..++..++||||+.+++|.+++... .
T Consensus 82 ~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~ 161 (478)
T PTZ00267 82 AAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLK 161 (478)
T ss_pred EEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHh
Confidence 455554 334 6889999875555545567788999999999999999999999999999999999999999887542 3
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCC
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYV 160 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 160 (309)
....+++..+..++.|++.||.|||+. |++||||||+||+++.++.++|+|||++................||+.|+
T Consensus 162 ~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~ 238 (478)
T PTZ00267 162 EHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYL 238 (478)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCcccc
Confidence 345688999999999999999999998 89999999999999999999999999997654432222233346899999
Q ss_pred CccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHH
Q 021682 161 PPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQV 240 (309)
Q Consensus 161 aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 240 (309)
|||.+.+..++.++|||||||++|+|++|..||...... ........ +....+ +......+.++
T Consensus 239 aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~------~~~~~~~~-~~~~~~---------~~~~s~~~~~l 302 (478)
T PTZ00267 239 APELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR------EIMQQVLY-GKYDPF---------PCPVSSGMKAL 302 (478)
T ss_pred CHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHh-CCCCCC---------CccCCHHHHHH
Confidence 999999888999999999999999999999998542211 11111111 111100 01122368899
Q ss_pred HhhcccCCCCCCCCHHHHHH
Q 021682 241 ALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 241 i~~~l~~~p~~Rpt~~ell~ 260 (309)
|.+||+.+|++|||+++++.
T Consensus 303 i~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 303 LDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHHHhccChhhCcCHHHHHh
Confidence 99999999999999999874
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=281.58 Aligned_cols=233 Identities=18% Similarity=0.232 Sum_probs=183.0
Q ss_pred ceEEEE-cCCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
.||.+. ..+|+.||+|++.... ......+..|+++++.++||||+++++++..+...++||||+++++|..++..
T Consensus 10 ~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~- 88 (328)
T cd05593 10 KVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSR- 88 (328)
T ss_pred EEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHh-
Confidence 455554 4689999999997542 23445778899999999999999999999999999999999999999888743
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
...+++..+..++.||+.|+.|||++ |++||||||+||+++.++.++|+|||++........ ......|+..|
T Consensus 89 --~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y 161 (328)
T cd05593 89 --ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--TMKTFCGTPEY 161 (328)
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccc--ccccccCCcCc
Confidence 33588999999999999999999998 899999999999999999999999999864322211 12234688999
Q ss_pred CCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHH
Q 021682 160 VPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQ 239 (309)
Q Consensus 160 ~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (309)
+|||.+.+..++.++|||||||++|+|++|..||...+... ........ . .. .. ......+.+
T Consensus 162 ~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~------~~~~~~~~-~-~~-----~p----~~~~~~~~~ 224 (328)
T cd05593 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFELILME-D-IK-----FP----RTLSADAKS 224 (328)
T ss_pred cChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH------HHHHhccC-C-cc-----CC----CCCCHHHHH
Confidence 99999988889999999999999999999999985432211 11111110 0 00 01 112336789
Q ss_pred HHhhcccCCCCCCC-----CHHHHHHH
Q 021682 240 VALLCVQENAADRP-----TMLEILVM 261 (309)
Q Consensus 240 li~~~l~~~p~~Rp-----t~~ell~~ 261 (309)
+|.+||+.||++|| ++.++++.
T Consensus 225 li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 225 LLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 99999999999997 89999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=270.84 Aligned_cols=254 Identities=24% Similarity=0.294 Sum_probs=191.6
Q ss_pred CccceEEEEcCCCcEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeeEEee-----CCeeEEEEeccCCCChh
Q 021682 1 MSVAICQGRLPNGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQ-----REEKMLIYDYMPNKSLD 73 (309)
Q Consensus 1 ~g~~~~~~~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~ 73 (309)
||+|..+....+|+.||||.+... .....++..+|+++|+.++|+||+.+.+++.. -+.+|+|+|+| +.+|.
T Consensus 35 yGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~ 113 (359)
T KOG0660|consen 35 YGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLH 113 (359)
T ss_pred eeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHH-hhHHH
Confidence 454444455679999999998633 34456778899999999999999999999865 23689999999 56888
Q ss_pred HHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccc
Q 021682 74 FYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRI 153 (309)
Q Consensus 74 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 153 (309)
..+ ..+..+....+..+++|++.|++|+|+- +++||||||.|++++.+..+|++|||+|+...........+..
T Consensus 114 ~ii---k~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeY 187 (359)
T KOG0660|consen 114 QII---KSQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEY 187 (359)
T ss_pred HHH---HcCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeeccccCcccchhcc
Confidence 888 3444589999999999999999999998 8999999999999999999999999999887543222233445
Q ss_pred ccccCCCCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHH--------hhCCCCccccccc
Q 021682 154 VGTYGYVPPEYVRK-GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGL--------WKNGEGMEFIDSS 224 (309)
Q Consensus 154 ~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~ 224 (309)
+.|.+|.|||++.. ..|+...||||+|||+.||++|++.|.+.+.-.+...+....+- ........++...
T Consensus 188 VaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~sl 267 (359)
T KOG0660|consen 188 VATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSL 267 (359)
T ss_pred eeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhC
Confidence 77999999997754 57999999999999999999999999876665554433322111 1111111122111
Q ss_pred CCCccc------HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 225 LDDSSS------AWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 225 ~~~~~~------~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
...... +.......+|+.+||.+||.+|+|++|.++.
T Consensus 268 p~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 268 PQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred CCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 111100 1122366799999999999999999999976
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=273.88 Aligned_cols=238 Identities=22% Similarity=0.286 Sum_probs=184.1
Q ss_pred ceEEEE-cCCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
.||++. ..+|+.||+|.+.... ......+.+|+.++++++|++|+++++.+..++..++||||+.+++|..++...
T Consensus 15 ~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~ 94 (285)
T cd05631 15 EVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNM 94 (285)
T ss_pred EEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhh
Confidence 456665 4689999999986542 222345778999999999999999999999999999999999999998877432
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
....+++..+..++.|++.|+.|||+. |++||||||+||+++.++.++|+|||++........ .....|+..|
T Consensus 95 -~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~g~~~y 167 (285)
T cd05631 95 -GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET---VRGRVGTVGY 167 (285)
T ss_pred -CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe---ecCCCCCCCc
Confidence 233588999999999999999999998 899999999999999999999999999876433221 1223688999
Q ss_pred CCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHH
Q 021682 160 VPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQ 239 (309)
Q Consensus 160 ~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (309)
+|||.+.+..++.++|||||||++|+|++|+.||............ ....... ... ........+.+
T Consensus 168 ~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~---~~~~~~~-~~~---------~~~~~s~~~~~ 234 (285)
T cd05631 168 MAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV---DRRVKED-QEE---------YSEKFSEDAKS 234 (285)
T ss_pred cCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHH---HHHhhcc-ccc---------CCccCCHHHHH
Confidence 9999999989999999999999999999999998654332211111 1111100 001 11112336789
Q ss_pred HHhhcccCCCCCCCC-----HHHHHHH
Q 021682 240 VALLCVQENAADRPT-----MLEILVM 261 (309)
Q Consensus 240 li~~~l~~~p~~Rpt-----~~ell~~ 261 (309)
|+.+||+.||++||| ++++++.
T Consensus 235 li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 235 ICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred HHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 999999999999997 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=276.77 Aligned_cols=249 Identities=21% Similarity=0.276 Sum_probs=182.1
Q ss_pred ceEEEEc-CCCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
+||++.. .+++.||+|.++... ......+.+|+.++++++||||+++++++..+...++||||+.+ +|.+++...
T Consensus 20 ~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-- 96 (288)
T cd07871 20 TVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNC-- 96 (288)
T ss_pred EEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHhc--
Confidence 5677754 478999999986542 22345678899999999999999999999999999999999975 888877432
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP 161 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 161 (309)
...+++..+..++.||+.|++|||++ |++||||||+||+++.++.+||+|||++......... .....++..|+|
T Consensus 97 ~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~--~~~~~~~~~y~a 171 (288)
T cd07871 97 GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT--YSNEVVTLWYRP 171 (288)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc--ccCceecccccC
Confidence 33478889999999999999999998 9999999999999999999999999998654332211 122357889999
Q ss_pred cccccc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH-----HhhCCC----CcccccccCCCcc--
Q 021682 162 PEYVRK-GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYG-----LWKNGE----GMEFIDSSLDDSS-- 229 (309)
Q Consensus 162 PE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~----~~~~~~~~~~~~~-- 229 (309)
||.+.+ ..++.++|+||+||++|+|++|.+||...+..+.......... .|..-. ......+......
T Consensus 172 PE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (288)
T cd07871 172 PDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLI 251 (288)
T ss_pred hHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchH
Confidence 998865 4678999999999999999999999865433322211111100 011100 0000000000000
Q ss_pred --cHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021682 230 --SAWKLMRCMQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 230 --~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
......++.++|.+||+.||++|||++|+++
T Consensus 252 ~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 252 NHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred HhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0112346789999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=279.22 Aligned_cols=231 Identities=20% Similarity=0.224 Sum_probs=183.7
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
+.||++.. .+|+.||+|.+.... ....+.+.+|+.++++++||||+++++++.++...++||||+.+++|.+++..
T Consensus 15 g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 94 (291)
T cd05612 15 GRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRN 94 (291)
T ss_pred eEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHH
Confidence 35677765 479999999986432 22345688999999999999999999999999999999999999999998843
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
...+++..+..++.|++.|++|||++ |++||||+|+||+++.++.++|+|||++....... ....|++.
T Consensus 95 ---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~ 163 (291)
T cd05612 95 ---SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT-----WTLCGTPE 163 (291)
T ss_pred ---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCCc-----ccccCChh
Confidence 33588999999999999999999998 99999999999999999999999999987543321 12357889
Q ss_pred CCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHH
Q 021682 159 YVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238 (309)
Q Consensus 159 y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (309)
|+|||.+.+..++.++|||||||++|+|++|..||........ . ....... .. . +......+.
T Consensus 164 y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~------~-~~i~~~~-~~-----~----~~~~~~~~~ 226 (291)
T cd05612 164 YLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI------Y-EKILAGK-LE-----F----PRHLDLYAK 226 (291)
T ss_pred hcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------H-HHHHhCC-cC-----C----CccCCHHHH
Confidence 9999999888899999999999999999999999864322111 1 1111110 00 0 111133678
Q ss_pred HHHhhcccCCCCCCCC-----HHHHHHH
Q 021682 239 QVALLCVQENAADRPT-----MLEILVM 261 (309)
Q Consensus 239 ~li~~~l~~~p~~Rpt-----~~ell~~ 261 (309)
++|.+||+.||.+||+ ++++++.
T Consensus 227 ~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 227 DLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred HHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 9999999999999995 9998876
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=281.95 Aligned_cols=233 Identities=21% Similarity=0.238 Sum_probs=181.9
Q ss_pred ceEEEEc-CCCcEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGRL-PNGQEMAVKRLSRT---SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
.||++.. .+++.||+|.++.. .......+..|+.++++++||||+++++++..+...++||||+.+++|.+++..
T Consensus 8 ~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~- 86 (312)
T cd05585 8 KVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQR- 86 (312)
T ss_pred EEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHh-
Confidence 4566654 57899999998653 233456678899999999999999999999999999999999999999988843
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
...+++..+..++.|++.|+.|||+. |++||||||+||+++.++.++|+|||++........ ......|+..|
T Consensus 87 --~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y 159 (312)
T cd05585 87 --EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNTFCGTPEY 159 (312)
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--ccccccCCccc
Confidence 33489999999999999999999998 899999999999999999999999999865332211 12234688999
Q ss_pred CCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHH
Q 021682 160 VPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQ 239 (309)
Q Consensus 160 ~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (309)
+|||.+.+..++.++|||||||++|+|++|..||...... .......... . ..+......+.+
T Consensus 160 ~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~------~~~~~~~~~~--~---------~~~~~~~~~~~~ 222 (312)
T cd05585 160 LAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN------EMYRKILQEP--L---------RFPDGFDRDAKD 222 (312)
T ss_pred CCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH------HHHHHHHcCC--C---------CCCCcCCHHHHH
Confidence 9999999989999999999999999999999998542211 1111111110 0 011112346789
Q ss_pred HHhhcccCCCCCCCC---HHHHHHH
Q 021682 240 VALLCVQENAADRPT---MLEILVM 261 (309)
Q Consensus 240 li~~~l~~~p~~Rpt---~~ell~~ 261 (309)
+|.+||+.||++||+ +.+++..
T Consensus 223 li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 223 LLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred HHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 999999999999975 5666543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=282.46 Aligned_cols=239 Identities=20% Similarity=0.289 Sum_probs=186.6
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
+.||++.. .+|+.||||+++... ......+..|+.+++.++||||+++++++..+...++||||+++++|.+++..
T Consensus 15 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~ 94 (333)
T cd05600 15 GQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNN 94 (333)
T ss_pred eEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHH
Confidence 35677765 478999999997542 22345678899999999999999999999999999999999999999999843
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
...+++..+..++.|++.|+.+||+. |++||||+|+||+++.++.++|+|||++..... ......|++.
T Consensus 95 ---~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~~~~~gt~~ 163 (333)
T cd05600 95 ---LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPD 163 (333)
T ss_pred ---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc-----ccCCcccCcc
Confidence 33488999999999999999999998 899999999999999999999999999865433 1223468899
Q ss_pred CCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHH
Q 021682 159 YVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238 (309)
Q Consensus 159 y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (309)
|+|||.+.+..++.++|||||||++|+|++|..||......+....+ ..+... +..............++.
T Consensus 164 y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i----~~~~~~-----~~~~~~~~~~~~~s~~~~ 234 (333)
T cd05600 164 YMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENL----KYWKET-----LQRPVYDDPRFNLSDEAW 234 (333)
T ss_pred ccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHH----Hhcccc-----ccCCCCCccccccCHHHH
Confidence 99999999889999999999999999999999998643322211111 111110 000000000012234788
Q ss_pred HHHhhcccCCCCCCCCHHHHHHH
Q 021682 239 QVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 239 ~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
++|.+||..+|++|||++++++.
T Consensus 235 ~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 235 DLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHHHHHhhChhhhcCCHHHHHhC
Confidence 99999999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=284.49 Aligned_cols=237 Identities=26% Similarity=0.398 Sum_probs=183.0
Q ss_pred CCCcEEEEEEeecCC-cccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc-------
Q 021682 11 PNGQEMAVKRLSRTS-HQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR------- 81 (309)
Q Consensus 11 ~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~------- 81 (309)
.++..||||.++... ....+.+.+|+.+++.+ +||||+++++++..+...++||||+++|+|.+++.....
T Consensus 63 ~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~ 142 (375)
T cd05104 63 DAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKH 142 (375)
T ss_pred ccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccc
Confidence 356789999986442 33456788999999999 899999999999999999999999999999998854211
Q ss_pred -----------------------------------------------------------------ccCCCHHHHHHHHHH
Q 021682 82 -----------------------------------------------------------------RYLLDWRTRVHIIEG 96 (309)
Q Consensus 82 -----------------------------------------------------------------~~~~~~~~~~~~~~~ 96 (309)
...+++..+..++.|
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~q 222 (375)
T cd05104 143 EDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQ 222 (375)
T ss_pred cchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHH
Confidence 124678889999999
Q ss_pred HHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCccccccCCCCccchh
Q 021682 97 ITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDV 176 (309)
Q Consensus 97 i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 176 (309)
|+.|+.|||+. |++||||||+||+++.++.++|+|||++............+...++..|+|||.+.+..++.++||
T Consensus 223 i~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi 299 (375)
T cd05104 223 VAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDV 299 (375)
T ss_pred HHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCH
Confidence 99999999998 899999999999999999999999999876544322222222344567999999998899999999
Q ss_pred hhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCH
Q 021682 177 YSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTM 255 (309)
Q Consensus 177 wslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~ 255 (309)
|||||++|+|++ |..||....... ........+.... .+...+.++.+++.+||+.||++|||+
T Consensus 300 ~slG~~l~ellt~g~~p~~~~~~~~------~~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~RPs~ 364 (375)
T cd05104 300 WSYGILLWEIFSLGSSPYPGMPVDS------KFYKMIKEGYRML---------SPECAPSEMYDIMKSCWDADPLKRPTF 364 (375)
T ss_pred HHHHHHHHHHHhcCCCCCCCCCchH------HHHHHHHhCccCC---------CCCCCCHHHHHHHHHHccCChhHCcCH
Confidence 999999999998 888875432211 1111111111100 001112378899999999999999999
Q ss_pred HHHHHHHhcc
Q 021682 256 LEILVMLKSE 265 (309)
Q Consensus 256 ~ell~~L~~~ 265 (309)
.++++.|+++
T Consensus 365 ~eil~~l~~~ 374 (375)
T cd05104 365 KQIVQLIEQQ 374 (375)
T ss_pred HHHHHHHHhh
Confidence 9999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=282.72 Aligned_cols=231 Identities=19% Similarity=0.260 Sum_probs=183.6
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
+.||.+.. .+|+.||+|.+.... ....+.+..|+.++++++||||+++++++..++..++||||+.+++|.+++..
T Consensus 32 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 111 (329)
T PTZ00263 32 GRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRK 111 (329)
T ss_pred eEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHH
Confidence 35677765 478999999986532 23346788999999999999999999999999999999999999999988843
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
...+++..+..++.|++.|++|||++ |++||||||+||+++.++.++|+|||++....... ....|++.
T Consensus 112 ---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~ 180 (329)
T PTZ00263 112 ---AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-----FTLCGTPE 180 (329)
T ss_pred ---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-----ceecCChh
Confidence 34588999999999999999999998 89999999999999999999999999987554322 12357899
Q ss_pred CCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHH
Q 021682 159 YVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238 (309)
Q Consensus 159 y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (309)
|+|||.+.+..++.++|||||||++|+|++|..||....... ......... ..+ +......+.
T Consensus 181 y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-------~~~~i~~~~-~~~---------p~~~~~~~~ 243 (329)
T PTZ00263 181 YLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR-------IYEKILAGR-LKF---------PNWFDGRAR 243 (329)
T ss_pred hcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH-------HHHHHhcCC-cCC---------CCCCCHHHH
Confidence 999999998889999999999999999999999985432211 111111111 000 011223678
Q ss_pred HHHhhcccCCCCCCCC-----HHHHHHH
Q 021682 239 QVALLCVQENAADRPT-----MLEILVM 261 (309)
Q Consensus 239 ~li~~~l~~~p~~Rpt-----~~ell~~ 261 (309)
++|.+||+.||++||+ +++++..
T Consensus 244 ~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 244 DLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred HHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 9999999999999997 6888755
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=276.17 Aligned_cols=250 Identities=18% Similarity=0.213 Sum_probs=184.4
Q ss_pred ceEEEEc-CCCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
.||++.. .+++.||+|.+.... ......+.+|+.++++++|+||+++++++..+...++||||+.++++..+..
T Consensus 16 ~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--- 92 (287)
T cd07848 16 VVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEE--- 92 (287)
T ss_pred EEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHh---
Confidence 5677765 478899999986542 3335678899999999999999999999999999999999999877765542
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCC
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYV 160 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 160 (309)
....+++..+..++.|++.|+.|||+. |++|+||+|+||+++.++.++|+|||++......... ......++..|+
T Consensus 93 ~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~ 168 (287)
T cd07848 93 MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA-NYTEYVATRWYR 168 (287)
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc-cccccccccccC
Confidence 234588999999999999999999998 8999999999999999999999999998765432211 122346788999
Q ss_pred CccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHH--------HHHh-hCCCCcccccccCCCc---
Q 021682 161 PPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYA--------YGLW-KNGEGMEFIDSSLDDS--- 228 (309)
Q Consensus 161 aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~-~~~~~~~~~~~~~~~~--- 228 (309)
|||.+.+..++.++|+|||||++|+|++|++||......+........ ...+ ..........+.....
T Consensus 169 aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (287)
T cd07848 169 SPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSL 248 (287)
T ss_pred CcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccH
Confidence 999998888999999999999999999999998654322211111100 0000 0000000000000000
Q ss_pred ---ccHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021682 229 ---SSAWKLMRCMQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 229 ---~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
.....+..+.+++.+||+.||++|||++++++
T Consensus 249 ~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 249 ERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred HHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00112346889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=284.77 Aligned_cols=237 Identities=27% Similarity=0.413 Sum_probs=182.8
Q ss_pred CCCcEEEEEEeecCC-cccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc-------
Q 021682 11 PNGQEMAVKRLSRTS-HQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR------- 81 (309)
Q Consensus 11 ~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~------- 81 (309)
.+++.||||.++... ......+.+|+++++.+ +|+||+++++.+......++||||+.+++|.+++.....
T Consensus 66 ~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~ 145 (374)
T cd05106 66 DNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVM 145 (374)
T ss_pred cccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccc
Confidence 345689999996543 33356788999999999 899999999999999999999999999999998853211
Q ss_pred ------------------------------------------------------------ccCCCHHHHHHHHHHHHHHH
Q 021682 82 ------------------------------------------------------------RYLLDWRTRVHIIEGITQGL 101 (309)
Q Consensus 82 ------------------------------------------------------------~~~~~~~~~~~~~~~i~~~l 101 (309)
...+++..+..++.|++.|+
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL 225 (374)
T cd05106 146 ALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGM 225 (374)
T ss_pred cccccccccccccccchhcccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHH
Confidence 12467888999999999999
Q ss_pred HHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCccccccCCCCccchhhhHHH
Q 021682 102 LYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGV 181 (309)
Q Consensus 102 ~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~ 181 (309)
.|||++ |++||||||+||+++.++.++|+|||++............+...++..|+|||.+.+..++.++|||||||
T Consensus 226 ~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGv 302 (374)
T cd05106 226 DFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGI 302 (374)
T ss_pred HHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHH
Confidence 999998 99999999999999999999999999987554332222222233456799999998888999999999999
Q ss_pred HHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021682 182 LLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 182 il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
++|+|++ |..||........ ............ .+...+.++.+++.+||+.||++|||+.++++
T Consensus 303 il~ellt~G~~Pf~~~~~~~~------~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 303 LLWEIFSLGKSPYPGILVNSK------FYKMVKRGYQMS---------RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHHHHHhCCCCCCccccccHH------HHHHHHcccCcc---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999997 9999864322111 111111110000 00111247889999999999999999999999
Q ss_pred HHhcc
Q 021682 261 MLKSE 265 (309)
Q Consensus 261 ~L~~~ 265 (309)
+|+++
T Consensus 368 ~l~~~ 372 (374)
T cd05106 368 LIQRQ 372 (374)
T ss_pred HHHHH
Confidence 99875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=279.45 Aligned_cols=235 Identities=22% Similarity=0.310 Sum_probs=194.8
Q ss_pred cceEEEEc-CCCcEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRT-SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
+.||+|.. .+++.||+|++.-. .....+.+..|+.+|.+++++||.+.|+.+..+..++++||||.||++.+.+ .
T Consensus 27 G~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL---~ 103 (467)
T KOG0201|consen 27 GEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLL---K 103 (467)
T ss_pred ceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhh---c
Confidence 35777764 58999999999754 3445678899999999999999999999999999999999999999999888 3
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCC
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYV 160 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 160 (309)
.+..+.+..+..++.+++.|+.|||.. +.+|+|||+.||++..+|.+||+|||.+......... ...++||+.||
T Consensus 104 ~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r--r~tfvGTPfwM 178 (467)
T KOG0201|consen 104 SGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR--RKTFVGTPFWM 178 (467)
T ss_pred cCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhc--ccccccccccc
Confidence 444457888888899999999999999 8999999999999999999999999999776655433 35579999999
Q ss_pred CccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHH
Q 021682 161 PPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQV 240 (309)
Q Consensus 161 aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 240 (309)
|||++.+..|+.++||||||++.+||.+|.+|+....+... .-++....++.........+.++
T Consensus 179 APEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv----------------lflIpk~~PP~L~~~~S~~~kEF 242 (467)
T KOG0201|consen 179 APEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV----------------LFLIPKSAPPRLDGDFSPPFKEF 242 (467)
T ss_pred chhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE----------------EEeccCCCCCccccccCHHHHHH
Confidence 99999988999999999999999999999999865544221 11222222222223344478899
Q ss_pred HhhcccCCCCCCCCHHHHHHH
Q 021682 241 ALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 241 i~~~l~~~p~~Rpt~~ell~~ 261 (309)
+..||+.||+.||||.++++.
T Consensus 243 V~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 243 VEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred HHHHhhcCcccCcCHHHHhhh
Confidence 999999999999999999875
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=272.41 Aligned_cols=243 Identities=26% Similarity=0.454 Sum_probs=189.0
Q ss_pred cceEEEEcCC------CcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHH
Q 021682 3 VAICQGRLPN------GQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFY 75 (309)
Q Consensus 3 ~~~~~~~~~~------g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (309)
+.||+|.... ++.||+|.+.... ......+.+|+..+++++||||+++++++......+++|||+++++|.++
T Consensus 19 g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~ 98 (283)
T cd05048 19 GKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEF 98 (283)
T ss_pred CcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHH
Confidence 4667776432 2579999986543 33356788999999999999999999999988899999999999999999
Q ss_pred Hhhhcc-------------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeeccccccccc
Q 021682 76 IFDLRR-------------RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFT 142 (309)
Q Consensus 76 ~~~~~~-------------~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~ 142 (309)
+..... ...+++..++.++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++....
T Consensus 99 l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~ 175 (283)
T cd05048 99 LVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIY 175 (283)
T ss_pred HHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCcEEECCCcceeecc
Confidence 854321 14578889999999999999999998 89999999999999999999999999987554
Q ss_pred CCcccccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccc
Q 021682 143 KDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFI 221 (309)
Q Consensus 143 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (309)
............++..|+|||.+.+..++.++|||||||++|+|++ |..||......+ ....+.......
T Consensus 176 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~-------~~~~i~~~~~~~-- 246 (283)
T cd05048 176 SADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE-------VIEMIRSRQLLP-- 246 (283)
T ss_pred ccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHcCCcCC--
Confidence 3322222233356788999999988889999999999999999998 988875433211 111111111111
Q ss_pred cccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 021682 222 DSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKS 264 (309)
Q Consensus 222 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~ 264 (309)
.+...+.++.+|+.+||+.||++|||+.++++.|++
T Consensus 247 -------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 247 -------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred -------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 112233578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=269.14 Aligned_cols=240 Identities=25% Similarity=0.409 Sum_probs=193.0
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccc
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRR 82 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 82 (309)
+.||.+...+++.||+|.+..........+..|+.+++.++|+||+++++++......++||||+++++|.+++... .+
T Consensus 20 ~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~ 98 (261)
T cd05148 20 GEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSP-EG 98 (261)
T ss_pred ccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcC-CC
Confidence 46788887779999999997766656678999999999999999999999999999999999999999999998543 34
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCc
Q 021682 83 YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPP 162 (309)
Q Consensus 83 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 162 (309)
..+++..+..++.+++.|+.+||+. |++|+||+|+||+++.++.++|+|||.+.......... ....++..|+||
T Consensus 99 ~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~--~~~~~~~~~~~P 173 (261)
T cd05148 99 QVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLS--SDKKIPYKWTAP 173 (261)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCccccc--cCCCCceEecCH
Confidence 4588999999999999999999998 89999999999999999999999999987654332211 122456689999
Q ss_pred cccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHH
Q 021682 163 EYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241 (309)
Q Consensus 163 E~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 241 (309)
|.+.+..++.++|+||||+++|+|++ |..||......+ ... ........ ..+...+..+.+++
T Consensus 174 E~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~---~~~----~~~~~~~~---------~~~~~~~~~~~~~i 237 (261)
T cd05148 174 EAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE---VYD----QITAGYRM---------PCPAKCPQEIYKIM 237 (261)
T ss_pred HHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH---HHH----HHHhCCcC---------CCCCCCCHHHHHHH
Confidence 99988888999999999999999998 888885432111 111 11111100 11112234788999
Q ss_pred hhcccCCCCCCCCHHHHHHHHhc
Q 021682 242 LLCVQENAADRPTMLEILVMLKS 264 (309)
Q Consensus 242 ~~~l~~~p~~Rpt~~ell~~L~~ 264 (309)
.+||+.||++|||+.++++.|+.
T Consensus 238 ~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 238 LECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred HHHcCCCchhCcCHHHHHHHHhc
Confidence 99999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=277.03 Aligned_cols=241 Identities=20% Similarity=0.238 Sum_probs=190.5
Q ss_pred CccceEEEEcCCCcEEEEEEeecCCcc---cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 1 MSVAICQGRLPNGQEMAVKRLSRTSHQ---GLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 1 ~g~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
||.|..+-...+|+.+|+|++++.... .+.-++.|-.+|....++.||++|..|.+..++||||||++||++..++.
T Consensus 154 fGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~ 233 (550)
T KOG0605|consen 154 FGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLM 233 (550)
T ss_pred ceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHH
Confidence 677777667779999999999876433 34456789999999999999999999999999999999999999998884
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCC-------------
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKD------------- 144 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~------------- 144 (309)
....+++..++.++.+++-|+..+|+. |++||||||+|+|||..|++||+|||++......
T Consensus 234 ---~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~ 307 (550)
T KOG0605|consen 234 ---RKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQ 307 (550)
T ss_pred ---hcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhh
Confidence 445599999999999999999999999 9999999999999999999999999998443110
Q ss_pred --c-------ccc----c-------------------ccccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCC
Q 021682 145 --E-------CEA----N-------------------TGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRT 192 (309)
Q Consensus 145 --~-------~~~----~-------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p 192 (309)
. ... . ....+||+-|+|||++.+.+|....|-||||||+||||.|.+|
T Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPP 387 (550)
T KOG0605|consen 308 INLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPP 387 (550)
T ss_pred hhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCC
Confidence 0 000 0 0134699999999999999999999999999999999999999
Q ss_pred CCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCC---CHHHHHHH
Q 021682 193 SCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRP---TMLEILVM 261 (309)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~ell~~ 261 (309)
|....+.+....+..-...|.. .. ......+..|||++||. ||++|. .++||.++
T Consensus 388 F~s~tp~~T~rkI~nwr~~l~f------P~-------~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 388 FCSETPQETYRKIVNWRETLKF------PE-------EVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKH 445 (550)
T ss_pred CCCCCHHHHHHHHHHHhhhccC------CC-------cCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcC
Confidence 9876665543322211111111 10 11111477899999999 999996 57777765
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=271.20 Aligned_cols=247 Identities=24% Similarity=0.385 Sum_probs=192.9
Q ss_pred cceEEEEc------CCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHH
Q 021682 3 VAICQGRL------PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 3 ~~~~~~~~------~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 76 (309)
+.+|.+.. .++..|++|.+..........+.+|+..+++++|+||+++++++..+...++||||+.+++|.+++
T Consensus 19 g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i 98 (291)
T cd05094 19 GKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFL 98 (291)
T ss_pred CeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHH
Confidence 35666642 245668999987666555677899999999999999999999999999999999999999999998
Q ss_pred hhhc-------------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccC
Q 021682 77 FDLR-------------RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTK 143 (309)
Q Consensus 77 ~~~~-------------~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~ 143 (309)
.... ....+++..++.++.+++.|+++||++ |++|+||+|.||+++.++.++|+|||++.....
T Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~ 175 (291)
T cd05094 99 RAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYS 175 (291)
T ss_pred HhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEECCCCcccccCC
Confidence 5432 123478899999999999999999998 899999999999999999999999999876544
Q ss_pred CcccccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCccccc
Q 021682 144 DECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFID 222 (309)
Q Consensus 144 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (309)
...........++..|+|||.+.+..++.++||||||+++|+|++ |..||......+ ..............
T Consensus 176 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~~~- 247 (291)
T cd05094 176 TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------VIECITQGRVLERP- 247 (291)
T ss_pred CceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHhCCCCCCCC-
Confidence 322222223356778999999988889999999999999999998 998875432211 11111221111111
Q ss_pred ccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccCC
Q 021682 223 SSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETAD 268 (309)
Q Consensus 223 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~ 268 (309)
...+..+.+++.+||+.+|++|||+.++++.|+.+..+
T Consensus 248 --------~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 248 --------RVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred --------ccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 11233688999999999999999999999999988553
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=271.49 Aligned_cols=243 Identities=25% Similarity=0.420 Sum_probs=188.4
Q ss_pred cceEEEEcC------CCcEEEEEEeecCCcc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHH
Q 021682 3 VAICQGRLP------NGQEMAVKRLSRTSHQ-GLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFY 75 (309)
Q Consensus 3 ~~~~~~~~~------~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (309)
+.||.+... +++.||||.++..... ....+.+|+++++.++|+||+++++++..+...++||||+++++|.++
T Consensus 19 ~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 98 (280)
T cd05049 19 GKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKF 98 (280)
T ss_pred ceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHH
Confidence 356777542 3578999998765433 457889999999999999999999999999999999999999999999
Q ss_pred Hhhhc-----------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCC
Q 021682 76 IFDLR-----------RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKD 144 (309)
Q Consensus 76 ~~~~~-----------~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~ 144 (309)
+.... ....+++..+..++.+++.++.+||+. |++|+||+|+||+++.++.++|+|||++......
T Consensus 99 i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~ 175 (280)
T cd05049 99 LRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTT 175 (280)
T ss_pred HHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeEEECCcccceecccC
Confidence 85432 123478889999999999999999998 8999999999999999999999999998654332
Q ss_pred cccccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccc
Q 021682 145 ECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDS 223 (309)
Q Consensus 145 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (309)
......+...++..|+|||.+.+..++.++||||||+++|+|++ |..||......+ .. .....+.....
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~----~~~~~~~~~~~--- 245 (280)
T cd05049 176 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VI----ECITQGRLLQR--- 245 (280)
T ss_pred cceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HH----HHHHcCCcCCC---
Confidence 22111222345678999999999899999999999999999998 999875432211 11 11111111110
Q ss_pred cCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 021682 224 SLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKS 264 (309)
Q Consensus 224 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~ 264 (309)
+......+.+++.+||+.||++|||+.|+++.|++
T Consensus 246 ------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 246 ------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred ------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 01123378899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=275.38 Aligned_cols=184 Identities=23% Similarity=0.310 Sum_probs=156.4
Q ss_pred ceEEEEc-CCCcEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 4 AICQGRL-PNGQEMAVKRLSRT-SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
.||.+.. .+|+.+|+|.+... .......+..|++++++++|+||+++++++..++..++||||+.+++|.+++..
T Consensus 20 ~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--- 96 (333)
T cd06650 20 VVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--- 96 (333)
T ss_pred EEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHH---
Confidence 4566654 47889999988654 233456788999999999999999999999999999999999999999999843
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP 161 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 161 (309)
...+++..+..++.+++.|+.|||+.+ +++|+||||+||+++.++.++|+|||++....... .....++..|+|
T Consensus 97 ~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~----~~~~~~~~~y~a 170 (333)
T cd06650 97 AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMS 170 (333)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc----cccCCCCccccC
Confidence 334889999999999999999999854 79999999999999999999999999986543321 122357889999
Q ss_pred ccccccCCCCccchhhhHHHHHHHHHhCCCCCCCC
Q 021682 162 PEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYY 196 (309)
Q Consensus 162 PE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~ 196 (309)
||.+.+..++.++|+|||||++|+|++|..||...
T Consensus 171 PE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 171 PERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred HHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 99998888999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=267.86 Aligned_cols=240 Identities=22% Similarity=0.354 Sum_probs=184.6
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
+.||.+.. .+|+.||+|.+.... ......+.+|++++++++|+||+++++++......++||||+.+++|.+++...
T Consensus 9 g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~- 87 (252)
T cd05084 9 GEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE- 87 (252)
T ss_pred ccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhC-
Confidence 35677765 479999999876442 334567899999999999999999999999999999999999999999988432
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCC
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYV 160 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 160 (309)
...+++..++.++.|++.|+.|||+. |++|+||+|.||+++.++.++|+|||++.................+..|+
T Consensus 88 -~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 163 (252)
T cd05084 88 -GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWT 163 (252)
T ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeec
Confidence 33488999999999999999999998 89999999999999999999999999986543221111111112345799
Q ss_pred CccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHH
Q 021682 161 PPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQ 239 (309)
Q Consensus 161 aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (309)
|||.+.+..++.++|+||||+++|++++ |..||....... ........... ..+...+..+.+
T Consensus 164 aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-------~~~~~~~~~~~---------~~~~~~~~~~~~ 227 (252)
T cd05084 164 APEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-------TREAIEQGVRL---------PCPELCPDAVYR 227 (252)
T ss_pred CchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-------HHHHHHcCCCC---------CCcccCCHHHHH
Confidence 9999988889999999999999999997 888774322111 11111111000 111112347889
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHh
Q 021682 240 VALLCVQENAADRPTMLEILVMLK 263 (309)
Q Consensus 240 li~~~l~~~p~~Rpt~~ell~~L~ 263 (309)
++.+||+.+|++|||+.+++++|+
T Consensus 228 li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 228 LMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHcCCChhhCcCHHHHHHHHh
Confidence 999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=279.58 Aligned_cols=235 Identities=18% Similarity=0.222 Sum_probs=182.7
Q ss_pred CccceEEE-EcCCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHH
Q 021682 1 MSVAICQG-RLPNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 1 ~g~~~~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 76 (309)
||. ||.+ ...+|+.||+|.++... ......+..|+++++.++||||+++++++..+...++||||+.+++|..++
T Consensus 8 ~g~-V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l 86 (325)
T cd05594 8 FGK-VILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL 86 (325)
T ss_pred CEE-EEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHH
Confidence 344 4554 45689999999997542 233456778999999999999999999999999999999999999998887
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhh-cCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccc
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQE-YSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVG 155 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 155 (309)
.. ...+++..+..++.||+.|+.|||+ . |++||||||+||+++.++.++|+|||++......... .....|
T Consensus 87 ~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~--~~~~~g 158 (325)
T cd05594 87 SR---ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTFCG 158 (325)
T ss_pred Hh---cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc--cccccC
Confidence 43 3458999999999999999999997 5 8999999999999999999999999998643322111 122368
Q ss_pred ccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 156 TYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 156 ~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
+..|+|||.+.+..++.++|||||||++|+|++|..||........ ....... . .. ... ....
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~------~~~i~~~-~-~~-----~p~----~~~~ 221 (325)
T cd05594 159 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL------FELILME-E-IR-----FPR----TLSP 221 (325)
T ss_pred CcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH------HHHHhcC-C-CC-----CCC----CCCH
Confidence 8999999999888899999999999999999999999854322111 0011110 0 00 011 1223
Q ss_pred HHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 021682 236 RCMQVALLCVQENAADRP-----TMLEILVM 261 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~Rp-----t~~ell~~ 261 (309)
.+.+++.+||+.||++|+ ++.++++.
T Consensus 222 ~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 222 EAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred HHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 678999999999999996 89999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=280.16 Aligned_cols=246 Identities=16% Similarity=0.148 Sum_probs=178.4
Q ss_pred CccceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 1 MSVAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 1 ~g~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
||.|.......+++.||+|... ...+.+|++++++++||||+++++++..+...++|+|++. ++|..++..
T Consensus 105 ~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-- 175 (391)
T PHA03212 105 EGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCYLAA-- 175 (391)
T ss_pred CeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHHHHHh--
Confidence 3444444445689999999753 2356789999999999999999999999999999999985 678777643
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCC
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYV 160 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 160 (309)
...+++..++.++.|++.||.|||++ ||+||||||+||+++.++.++|+|||++......... ......||..|+
T Consensus 176 -~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~gt~~y~ 250 (391)
T PHA03212 176 -KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN-KYYGWAGTIATN 250 (391)
T ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccccc-ccccccCccCCC
Confidence 33488999999999999999999998 8999999999999999999999999998653322111 122346899999
Q ss_pred CccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcc----cHHHHHHHHh----------------------hC
Q 021682 161 PPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESL----NLLEYAYGLW----------------------KN 214 (309)
Q Consensus 161 aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~----~~~~~~~~~~----------------------~~ 214 (309)
|||.+.+..++.++|||||||++|+|++|..|+......... .......... ..
T Consensus 251 aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~ 330 (391)
T PHA03212 251 APELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAK 330 (391)
T ss_pred ChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHh
Confidence 999998888999999999999999999999876432221110 0000000000 00
Q ss_pred CCCcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 215 GEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
..... .............+.++.++|.+||+.||++|||++|+++.
T Consensus 331 ~~~~~-~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 331 KSSRK-PGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred ccCCC-CCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000 00000000011234478899999999999999999999964
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=266.64 Aligned_cols=240 Identities=25% Similarity=0.361 Sum_probs=189.3
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccc
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRR 82 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 82 (309)
+.||++..++++.||+|.++... ...+.+.+|+.++++++|+||+++++++...+..+++||++.+++|.+++.... +
T Consensus 20 ~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~ 97 (261)
T cd05068 20 GEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGA-G 97 (261)
T ss_pred ccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccC-C
Confidence 46888887788899999986543 335678899999999999999999999999999999999999999999985432 3
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCc
Q 021682 83 YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPP 162 (309)
Q Consensus 83 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 162 (309)
..+++..+..++.+++.|+.+||+. |++|+||+|+||+++.++.++|+|||++.......... ......+..|+||
T Consensus 98 ~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aP 173 (261)
T cd05068 98 RALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA-REGAKFPIKWTAP 173 (261)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc-cCCCcCceeccCc
Confidence 4588999999999999999999998 89999999999999999999999999987765332111 1111234579999
Q ss_pred cccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHH
Q 021682 163 EYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241 (309)
Q Consensus 163 E~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 241 (309)
|.+.+..++.++|+||||+++|+|++ |+.||....... ........... .........+.+++
T Consensus 174 E~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~---------~~~~~~~~~~~~li 237 (261)
T cd05068 174 EAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-------VLQQVDQGYRM---------PCPPGCPKELYDIM 237 (261)
T ss_pred cccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCCC---------CCCCcCCHHHHHHH
Confidence 99988889999999999999999999 888875332111 11111111100 01111234788999
Q ss_pred hhcccCCCCCCCCHHHHHHHHhc
Q 021682 242 LLCVQENAADRPTMLEILVMLKS 264 (309)
Q Consensus 242 ~~~l~~~p~~Rpt~~ell~~L~~ 264 (309)
.+||+.+|++||++.++++.|+.
T Consensus 238 ~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 238 LDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred HHHhhcCcccCCCHHHHHHHHhc
Confidence 99999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=274.83 Aligned_cols=233 Identities=23% Similarity=0.301 Sum_probs=178.8
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS---HQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
++||++.. .+++.||||.++... ....+....|..++..+ +||||+++++++..+...++||||+.+++|..++.
T Consensus 9 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~ 88 (316)
T cd05592 9 GKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQ 88 (316)
T ss_pred eEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHH
Confidence 35666654 578899999997532 23344556677777654 89999999999999999999999999999988874
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
. ...+++..+..++.|++.|+.|||+. |++||||||+||+++.++.++|+|||++....... .......|+.
T Consensus 89 ~---~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~ 160 (316)
T cd05592 89 S---SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKASTFCGTP 160 (316)
T ss_pred H---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--CccccccCCc
Confidence 3 33589999999999999999999998 89999999999999999999999999986543222 1222346899
Q ss_pred CCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHH
Q 021682 158 GYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRC 237 (309)
Q Consensus 158 ~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (309)
.|+|||.+.+..++.++|||||||++|+|++|..||...+..+ ........ .. ..+.....++
T Consensus 161 ~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~------~~~~i~~~--~~---------~~~~~~~~~~ 223 (316)
T cd05592 161 DYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE------LFDSILND--RP---------HFPRWISKEA 223 (316)
T ss_pred cccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH------HHHHHHcC--CC---------CCCCCCCHHH
Confidence 9999999998889999999999999999999999986432211 11111110 00 0111123367
Q ss_pred HHHHhhcccCCCCCCCCHH-HHHH
Q 021682 238 MQVALLCVQENAADRPTML-EILV 260 (309)
Q Consensus 238 ~~li~~~l~~~p~~Rpt~~-ell~ 260 (309)
.+++.+||+.||++||++. ++++
T Consensus 224 ~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 224 KDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred HHHHHHHccCCHHHcCCChHHHHc
Confidence 7999999999999999875 5654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=288.64 Aligned_cols=242 Identities=20% Similarity=0.237 Sum_probs=193.9
Q ss_pred eEEEEcCC-CcEEEEEEeecCCcccHHHHHHHHHHHhcCC-CCCccceeeEE-ee------CCeeEEEEeccCCCChhHH
Q 021682 5 ICQGRLPN-GQEMAVKRLSRTSHQGLEEFENEVKLTARLQ-HVNLLPVLGIC-TQ------REEKMLIYDYMPNKSLDFY 75 (309)
Q Consensus 5 ~~~~~~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~-~~------~~~~~lv~e~~~~~~L~~~ 75 (309)
||.+...+ |..||+|++-..+......+++|++++++|+ |+|||.+++.. .. ...+.|+||||.|+.|-++
T Consensus 53 VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~ 132 (738)
T KOG1989|consen 53 VYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDF 132 (738)
T ss_pred EEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHH
Confidence 55565544 4999999987778888899999999999995 99999999932 11 1257899999999999999
Q ss_pred HhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccc-----
Q 021682 76 IFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANT----- 150 (309)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~----- 150 (309)
+..+.... |.+..+++|++++++|+++||.+ ...|+|||||.+|||++.+|..||||||.+.-..........
T Consensus 133 mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve 210 (738)
T KOG1989|consen 133 MNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVE 210 (738)
T ss_pred HHHHHhcc-CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHH
Confidence 87655444 99999999999999999999998 346999999999999999999999999998655433311100
Q ss_pred -c-ccccccCCCCcccc---ccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccC
Q 021682 151 -G-RIVGTYGYVPPEYV---RKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSL 225 (309)
Q Consensus 151 -~-~~~~~~~y~aPE~~---~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (309)
. ...-|+.|+|||.+ .+.++++|+|||+|||+||-|+....||+..+... ++...+
T Consensus 211 ~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la-------------------Ilng~Y 271 (738)
T KOG1989|consen 211 EEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA-------------------ILNGNY 271 (738)
T ss_pred HHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee-------------------EEeccc
Confidence 0 12357899999965 56789999999999999999999999997543322 333444
Q ss_pred CCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccC
Q 021682 226 DDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETA 267 (309)
Q Consensus 226 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~ 267 (309)
.-.....+...|.+||+.||+.||.+||++.+++..+-.+..
T Consensus 272 ~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 272 SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 444445677799999999999999999999999999876533
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=266.23 Aligned_cols=238 Identities=27% Similarity=0.423 Sum_probs=186.2
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccc
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRR 82 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 82 (309)
++||.+.++++..+|+|.+... ......+..|++++++++||||+++++++..+...++||||+++++|.+++... .
T Consensus 18 ~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~--~ 94 (256)
T cd05114 18 GVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQR--Q 94 (256)
T ss_pred ceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhC--c
Confidence 3678888888889999988643 233467889999999999999999999999999999999999999999887532 2
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCc
Q 021682 83 YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPP 162 (309)
Q Consensus 83 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 162 (309)
..+++..+..++.+++.|+.|||+. |++|+||+|+||+++.++.++|+|||.+.......... .....++..|+||
T Consensus 95 ~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~-~~~~~~~~~y~aP 170 (256)
T cd05114 95 GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS-SSGAKFPVKWSPP 170 (256)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceec-cCCCCCchhhCCh
Confidence 3488999999999999999999998 89999999999999999999999999887554322111 1112345679999
Q ss_pred cccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHH
Q 021682 163 EYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241 (309)
Q Consensus 163 E~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 241 (309)
|.+.+..++.++|+||||+++|+|++ |+.||......+ ... ........ ..+ ......+.+++
T Consensus 171 E~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~---~~~----~i~~~~~~--~~~-------~~~~~~~~~li 234 (256)
T cd05114 171 EVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE---VVE----MISRGFRL--YRP-------KLASMTVYEVM 234 (256)
T ss_pred hhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----HHHCCCCC--CCC-------CCCCHHHHHHH
Confidence 99988888999999999999999999 888875432211 111 11111110 000 11223678999
Q ss_pred hhcccCCCCCCCCHHHHHHHHh
Q 021682 242 LLCVQENAADRPTMLEILVMLK 263 (309)
Q Consensus 242 ~~~l~~~p~~Rpt~~ell~~L~ 263 (309)
.+||+.+|++|||++++++.|.
T Consensus 235 ~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 235 YSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred HHHccCCcccCcCHHHHHHhhC
Confidence 9999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=271.31 Aligned_cols=237 Identities=26% Similarity=0.402 Sum_probs=186.4
Q ss_pred CCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc----------c
Q 021682 12 NGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR----------R 81 (309)
Q Consensus 12 ~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------~ 81 (309)
++..+|+|.+..........+..|+.++++++|+||+++++++......++||||+.+++|.+++.... .
T Consensus 34 ~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~ 113 (288)
T cd05093 34 DKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNR 113 (288)
T ss_pred cceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCC
Confidence 456689999876655556789999999999999999999999999999999999999999999885322 1
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP 161 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 161 (309)
...+++..+..++.|++.|+++||+. |++||||+|+||+++.++.++|+|||++................++..|+|
T Consensus 114 ~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 190 (288)
T cd05093 114 PAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMP 190 (288)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccC
Confidence 23489999999999999999999998 999999999999999999999999999875543322222223345678999
Q ss_pred ccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHH
Q 021682 162 PEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQV 240 (309)
Q Consensus 162 PE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 240 (309)
||.+.+..++.++|+|||||++|+|++ |..||......+ . ......+...... . ..+..+.++
T Consensus 191 PE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~------~-~~~i~~~~~~~~~-----~----~~~~~l~~l 254 (288)
T cd05093 191 PESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE------V-IECITQGRVLQRP-----R----TCPKEVYDL 254 (288)
T ss_pred HHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------H-HHHHHcCCcCCCC-----C----CCCHHHHHH
Confidence 999988889999999999999999998 888875432211 1 1111111111110 0 122368899
Q ss_pred HhhcccCCCCCCCCHHHHHHHHhcccC
Q 021682 241 ALLCVQENAADRPTMLEILVMLKSETA 267 (309)
Q Consensus 241 i~~~l~~~p~~Rpt~~ell~~L~~~~~ 267 (309)
+.+||+.||.+|||+.++++.|+++..
T Consensus 255 i~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 255 MLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred HHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=253.33 Aligned_cols=243 Identities=23% Similarity=0.234 Sum_probs=190.2
Q ss_pred cCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCC-----eeEEEEeccCCCChhHHHhhhcc-cc
Q 021682 10 LPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQRE-----EKMLIYDYMPNKSLDFYIFDLRR-RY 83 (309)
Q Consensus 10 ~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~-~~ 83 (309)
..+++.+|+|.+.....++.+..++|++..++++|||+++++++...+. ..||+++|...|+|.+.+..... +.
T Consensus 43 ~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~ 122 (302)
T KOG2345|consen 43 LSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGN 122 (302)
T ss_pred cCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCC
Confidence 4578999999998887778889999999999999999999998765443 48999999999999999876544 44
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccc-------cccccccc
Q 021682 84 LLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEA-------NTGRIVGT 156 (309)
Q Consensus 84 ~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~-------~~~~~~~~ 156 (309)
.+++.++++|+.++++|+++||+. ...+.|+||||.||+++..+.+++.|||.++...-..... .......|
T Consensus 123 ~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct 201 (302)
T KOG2345|consen 123 FVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCT 201 (302)
T ss_pred ccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCC
Confidence 799999999999999999999998 1239999999999999999999999999987654321111 11123578
Q ss_pred cCCCCcccccc---CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHH
Q 021682 157 YGYVPPEYVRK---GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWK 233 (309)
Q Consensus 157 ~~y~aPE~~~~---~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
..|.|||.+.. ...+.++|||||||++|.|+.|..||+..-....-. .................
T Consensus 202 ~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl-------------aLAv~n~q~s~P~~~~y 268 (302)
T KOG2345|consen 202 IPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL-------------ALAVQNAQISIPNSSRY 268 (302)
T ss_pred CcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE-------------EEeeeccccccCCCCCc
Confidence 89999998864 457899999999999999999999996432211000 01111111222222225
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHHHhccc
Q 021682 234 LMRCMQVALLCVQENAADRPTMLEILVMLKSET 266 (309)
Q Consensus 234 ~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~ 266 (309)
++.+.++|++||+.||.+||++.+++..++.+.
T Consensus 269 se~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 269 SEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred cHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 668999999999999999999999999988753
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=263.03 Aligned_cols=253 Identities=21% Similarity=0.248 Sum_probs=193.1
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCcc--cHHHHHHHHHHHhcCCCCC-ccceeeEEeeCC------eeEEEEeccCCCCh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSHQ--GLEEFENEVKLTARLQHVN-LLPVLGICTQRE------EKMLIYDYMPNKSL 72 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~------~~~lv~e~~~~~~L 72 (309)
++||+|+. .+|+.||+|.++-.... .-.-...|+.+|++++|+| |+.+++++...+ ..++|+||+. .+|
T Consensus 25 g~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d-~DL 103 (323)
T KOG0594|consen 25 GVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLD-RDL 103 (323)
T ss_pred eEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEeec-ccH
Confidence 36788864 58999999999755332 2345678999999999999 999999999887 7899999995 689
Q ss_pred hHHHhhhccc-cCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccc
Q 021682 73 DFYIFDLRRR-YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTG 151 (309)
Q Consensus 73 ~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 151 (309)
..++...... ..++...++.+..||+.|++|||++ ||+||||||+||++++.|.+||+|||+|+........ ..
T Consensus 104 ~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~--yt 178 (323)
T KOG0594|consen 104 KKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRT--YT 178 (323)
T ss_pred HHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchHHHhcCCccc--cc
Confidence 9998665432 4577789999999999999999999 9999999999999999999999999999866643332 22
Q ss_pred ccccccCCCCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCccc-----ccccC
Q 021682 152 RIVGTYGYVPPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEF-----IDSSL 225 (309)
Q Consensus 152 ~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~ 225 (309)
....|.+|+|||++.+. .|+...||||+||++.||+++++.|......++...+....+......+... .+...
T Consensus 179 ~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f 258 (323)
T KOG0594|consen 179 PEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPF 258 (323)
T ss_pred ccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccC
Confidence 34778899999999887 7899999999999999999999998765554444333333333222222211 11011
Q ss_pred CCc-----ccHH---HHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 226 DDS-----SSAW---KLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 226 ~~~-----~~~~---~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
..- .... ......+++.+||+++|++|.|++.++.+
T Consensus 259 ~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 259 PKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 000 0000 11367799999999999999999999986
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=276.71 Aligned_cols=234 Identities=22% Similarity=0.301 Sum_probs=177.6
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
+.||++.. .+|+.||||.+.... ......+.+|+++++.++|+||+++++++..++..++||||+.+++|....
T Consensus 88 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~---- 163 (353)
T PLN00034 88 GTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTH---- 163 (353)
T ss_pred eEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCcccccc----
Confidence 35666654 579999999986543 334567889999999999999999999999999999999999999885432
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCC
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYV 160 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 160 (309)
...+..+..++.||+.||.|||++ |++||||||+||+++.++.++|+|||++......... .....|+..|+
T Consensus 164 ---~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~--~~~~~gt~~y~ 235 (353)
T PLN00034 164 ---IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP--CNSSVGTIAYM 235 (353)
T ss_pred ---cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccccc--ccccccCcccc
Confidence 256677888999999999999998 8999999999999999999999999998765432211 12246889999
Q ss_pred Ccccccc-----CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 161 PPEYVRK-----GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 161 aPE~~~~-----~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
|||.+.. ...+.++|||||||++|+|++|+.||......+...... ....... .........
T Consensus 236 aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~----~~~~~~~---------~~~~~~~~~ 302 (353)
T PLN00034 236 SPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC----AICMSQP---------PEAPATASR 302 (353)
T ss_pred CccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH----HHhccCC---------CCCCCccCH
Confidence 9998743 233568999999999999999999986322221111110 0000000 001112234
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 236 RCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
++.++|.+||+.||++|||+.|+++.
T Consensus 303 ~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 303 EFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 78899999999999999999999975
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=283.66 Aligned_cols=250 Identities=20% Similarity=0.222 Sum_probs=194.8
Q ss_pred CccceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCC-CC-----CccceeeEEeeCCeeEEEEeccCCCChhH
Q 021682 1 MSVAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQ-HV-----NLLPVLGICTQREEKMLIYDYMPNKSLDF 74 (309)
Q Consensus 1 ~g~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (309)
||-|+-.-+..+++.||||+++.... -..+...|+.+|..|+ |. |+|+++++|...++.|||+|.+ +.+|++
T Consensus 199 FGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL-~~NLYe 276 (586)
T KOG0667|consen 199 FGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELL-STNLYE 276 (586)
T ss_pred cceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhh-hhhHHH
Confidence 78888888888999999999976543 3456778999999996 33 8999999999999999999999 569999
Q ss_pred HHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCC--CCceeecccccccccCCcccccccc
Q 021682 75 YIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYE--MNPKISDFGMARAFTKDECEANTGR 152 (309)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~--~~~~l~Dfg~~~~~~~~~~~~~~~~ 152 (309)
++... .-..+++..++.++.||+.+|.+||+. ||+|+||||+|||+... ..+||+|||.+++.......
T Consensus 277 llK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vyt----- 347 (586)
T KOG0667|consen 277 LLKNN-KFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVYT----- 347 (586)
T ss_pred HHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccccccCCccee-----
Confidence 99653 344599999999999999999999998 99999999999999764 36999999999876665432
Q ss_pred cccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhh------CCCCcccccc---
Q 021682 153 IVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWK------NGEGMEFIDS--- 223 (309)
Q Consensus 153 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~--- 223 (309)
...+..|+|||++.|.+|+.+.||||||||+.||++|.+.|...+..++...+....+... ......+++.
T Consensus 348 YiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~ 427 (586)
T KOG0667|consen 348 YIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKG 427 (586)
T ss_pred eeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCC
Confidence 2456789999999999999999999999999999999988876666555443333322100 0011111111
Q ss_pred ------------------------------cCC-------CcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 224 ------------------------------SLD-------DSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 224 ------------------------------~~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
..+ ..........+.++|.+||++||.+|+|+.+.++.
T Consensus 428 ~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~H 502 (586)
T KOG0667|consen 428 FPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNH 502 (586)
T ss_pred ceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 000 01111334467899999999999999999999986
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=278.44 Aligned_cols=249 Identities=18% Similarity=0.233 Sum_probs=190.8
Q ss_pred cceEEEEcC-C-CcEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 3 VAICQGRLP-N-GQEMAVKRLSRT---SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 3 ~~~~~~~~~-~-g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
+.||++... + +..||+|.+... .....+.+..|+.+++.++||||+++++++..+...++||||+.+++|.+++.
T Consensus 44 g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~ 123 (340)
T PTZ00426 44 GRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLR 123 (340)
T ss_pred eEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHH
Confidence 356777543 3 368999998643 22345678899999999999999999999999999999999999999999884
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
. ...+++..+..++.|++.|+.|||+. |++||||||+||+++.++.++|+|||++...... .....|++
T Consensus 124 ~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~ 192 (340)
T PTZ00426 124 R---NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-----TYTLCGTP 192 (340)
T ss_pred H---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC-----cceecCCh
Confidence 3 34589999999999999999999998 8999999999999999999999999998754322 12246889
Q ss_pred CCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHH
Q 021682 158 GYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRC 237 (309)
Q Consensus 158 ~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (309)
.|+|||.+.+..++.++|+|||||++|+|++|..||...+... .......... . +. ......+
T Consensus 193 ~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-------~~~~i~~~~~-~-~p--------~~~~~~~ 255 (340)
T PTZ00426 193 EYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL-------IYQKILEGII-Y-FP--------KFLDNNC 255 (340)
T ss_pred hhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH-------HHHHHhcCCC-C-CC--------CCCCHHH
Confidence 9999999988888999999999999999999999986432211 1111111110 0 11 1112357
Q ss_pred HHHHhhcccCCCCCCC-----CHHHHHHH--Hhcc------cCCCCCCCCCCccc
Q 021682 238 MQVALLCVQENAADRP-----TMLEILVM--LKSE------TADIKTPKKPAFSV 279 (309)
Q Consensus 238 ~~li~~~l~~~p~~Rp-----t~~ell~~--L~~~------~~~~~~~~~p~~~~ 279 (309)
.+++.+||+.||++|+ |++++++. +.+. ...+..|..|.++.
T Consensus 256 ~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~~~~ 310 (340)
T PTZ00426 256 KHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYKN 310 (340)
T ss_pred HHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCC
Confidence 7999999999999995 89999876 2211 23445666666543
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=265.86 Aligned_cols=241 Identities=26% Similarity=0.385 Sum_probs=188.4
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
++||++.. ++++.||+|.+... ......+..|++.+++++|+||+++++++..+...+++|||+.+++|.+++... .
T Consensus 20 ~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~ 97 (263)
T cd05052 20 GEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-N 97 (263)
T ss_pred ceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhC-C
Confidence 45677765 46889999998643 334567889999999999999999999999999999999999999999988542 2
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP 161 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 161 (309)
...+++..++.++.|+++++++||+. |++|+||+|+||+++.++.++|+|||++......... ......++..|+|
T Consensus 98 ~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~-~~~~~~~~~~y~a 173 (263)
T cd05052 98 RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTA 173 (263)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceee-ccCCCCCccccCC
Confidence 34588999999999999999999998 8999999999999999999999999998765433211 1111234567999
Q ss_pred ccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHH
Q 021682 162 PEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQV 240 (309)
Q Consensus 162 PE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 240 (309)
||.+.+..++.++|||||||++|+|++ |..||...+..+ ............ .+...+..+.++
T Consensus 174 PE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~---------~~~~~~~~~~~l 237 (263)
T cd05052 174 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKGYRME---------RPEGCPPKVYEL 237 (263)
T ss_pred HHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHCCCCCC---------CCCCCCHHHHHH
Confidence 999988889999999999999999998 888875432111 111111111111 111123478899
Q ss_pred HhhcccCCCCCCCCHHHHHHHHhcc
Q 021682 241 ALLCVQENAADRPTMLEILVMLKSE 265 (309)
Q Consensus 241 i~~~l~~~p~~Rpt~~ell~~L~~~ 265 (309)
+.+||+.+|++|||+.++++.|+.+
T Consensus 238 i~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 238 MRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHHccCCcccCCCHHHHHHHHHhh
Confidence 9999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=268.54 Aligned_cols=240 Identities=19% Similarity=0.257 Sum_probs=184.8
Q ss_pred ceEEEE-cCCCcEEEEEEeecCCc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTSH---QGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
+||.+. ..+|+.||+|.+..... ...+.+..|+++++.++|++|+++.+++..+...++||||+++++|..++...
T Consensus 8 ~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~ 87 (280)
T cd05608 8 EVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNV 87 (280)
T ss_pred eEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhc
Confidence 456655 45899999999865422 22356678999999999999999999999999999999999999998877432
Q ss_pred -ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 80 -RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 80 -~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
.....+++..+..++.|++.|+.|||+. |++|+||+|+||+++.++.++|+|||++......... .....|+..
T Consensus 88 ~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~g~~~ 162 (280)
T cd05608 88 DEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPG 162 (280)
T ss_pred cccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--ccccCCCcC
Confidence 2344589999999999999999999998 8999999999999999999999999998655433221 222367889
Q ss_pred CCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHH
Q 021682 159 YVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238 (309)
Q Consensus 159 y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (309)
|+|||.+.+..++.++|+|||||++|+|++|+.||...+...... ... ....... ...+...+..+.
T Consensus 163 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~--~~~-~~~~~~~----------~~~~~~~~~~~~ 229 (280)
T cd05608 163 FMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--ELK-QRILNDS----------VTYPDKFSPASK 229 (280)
T ss_pred ccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH--HHH-HhhcccC----------CCCcccCCHHHH
Confidence 999999999899999999999999999999999986433221110 000 0000000 011112334788
Q ss_pred HHHhhcccCCCCCCC-----CHHHHHHH
Q 021682 239 QVALLCVQENAADRP-----TMLEILVM 261 (309)
Q Consensus 239 ~li~~~l~~~p~~Rp-----t~~ell~~ 261 (309)
+++.+||+.||++|| |++++++.
T Consensus 230 ~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 230 SFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred HHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 999999999999999 77888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=275.10 Aligned_cols=241 Identities=20% Similarity=0.300 Sum_probs=195.5
Q ss_pred EEEEcCCCcEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcccc
Q 021682 6 CQGRLPNGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRY 83 (309)
Q Consensus 6 ~~~~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~ 83 (309)
.+.+.=+|++||||++.+. +.-....++.|++.++.++|||||++|++......+|||.|+-.+|+|.+|+-....
T Consensus 36 LArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~-- 113 (864)
T KOG4717|consen 36 LARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEE-- 113 (864)
T ss_pred hhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhc--
Confidence 3333348999999999765 344556899999999999999999999999999999999999999999999965444
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCC-CCCceeecccccccccCCcccccccccccccCCCCc
Q 021682 84 LLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY-EMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPP 162 (309)
Q Consensus 84 ~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 162 (309)
.+.+..+.+++.||+.|+.|+|+.| ++||||||+|+.+.+ -|-+||.|||++..+..... .....|+..|-||
T Consensus 114 Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k---L~TsCGSLAYSAP 187 (864)
T KOG4717|consen 114 GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK---LTTSCGSLAYSAP 187 (864)
T ss_pred cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcch---hhcccchhhccCc
Confidence 4999999999999999999999995 999999999997754 58899999999987765542 2234688899999
Q ss_pred cccccCCCC-ccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHH
Q 021682 163 EYVRKGIYS-MKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241 (309)
Q Consensus 163 E~~~~~~~~-~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 241 (309)
|++.|..|+ ++.||||||+|+|.|++|++||...+..+....+... .-..+.....++.+||
T Consensus 188 EILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDC-----------------KYtvPshvS~eCrdLI 250 (864)
T KOG4717|consen 188 EILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDC-----------------KYTVPSHVSKECRDLI 250 (864)
T ss_pred hhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcc-----------------cccCchhhhHHHHHHH
Confidence 999999885 6789999999999999999999765554433222111 1222334556899999
Q ss_pred hhcccCCCCCCCCHHHHHHH--HhcccCCCCC
Q 021682 242 LLCVQENAADRPTMLEILVM--LKSETADIKT 271 (309)
Q Consensus 242 ~~~l~~~p~~Rpt~~ell~~--L~~~~~~~~~ 271 (309)
..||..||++|.|.++|... |+....++.+
T Consensus 251 ~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT 282 (864)
T KOG4717|consen 251 QSMLVRDPKKRASLEEIVSTSWLQAGDRGLST 282 (864)
T ss_pred HHHHhcCchhhccHHHHhccccccCCCCCccc
Confidence 99999999999999999876 5555555554
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=274.30 Aligned_cols=240 Identities=19% Similarity=0.277 Sum_probs=183.2
Q ss_pred ceEEEE-cCCCcEEEEEEeecC---CcccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 4 AICQGR-LPNGQEMAVKRLSRT---SHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
.||++. ..+++.||+|.++.. .......+..|..+++++ +||||+++++++..+...++||||+++++|.+++..
T Consensus 10 ~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~ 89 (329)
T cd05588 10 KVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQR 89 (329)
T ss_pred EEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHH
Confidence 456654 457899999999754 223345678899999988 799999999999999999999999999999887743
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
...+++..+..++.|++.|+.|||++ |++||||||+||+++.++.++|+|||++........ ......|+..
T Consensus 90 ---~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~ 161 (329)
T cd05588 90 ---QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TTSTFCGTPN 161 (329)
T ss_pred ---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCC--ccccccCCcc
Confidence 34589999999999999999999998 999999999999999999999999998864222111 1223468899
Q ss_pred CCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCc--ccHHHHHHHHhhCCCCcccccccCCCcccHHHHHH
Q 021682 159 YVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNES--LNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMR 236 (309)
Q Consensus 159 y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
|+|||.+.+..++.++|+|||||++|+|++|..||...+..+. ................ . ... .....
T Consensus 162 y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~-----~p~----~~~~~ 231 (329)
T cd05588 162 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI-R-----IPR----SLSVK 231 (329)
T ss_pred ccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC-C-----CCC----CCCHH
Confidence 9999999998899999999999999999999999964333221 1111111111111110 0 011 12236
Q ss_pred HHHHHhhcccCCCCCCCC------HHHHHHH
Q 021682 237 CMQVALLCVQENAADRPT------MLEILVM 261 (309)
Q Consensus 237 l~~li~~~l~~~p~~Rpt------~~ell~~ 261 (309)
+.++|.+||+.||++|+| ++++++.
T Consensus 232 ~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 232 ASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred HHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 789999999999999997 6777654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=267.82 Aligned_cols=240 Identities=21% Similarity=0.283 Sum_probs=182.2
Q ss_pred ceEEEE-cCCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
.||++. ..+|+.||+|.+.... ......+..|++++++++||||+++++++..+...++||||+.+++|.+++...
T Consensus 8 ~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~ 87 (277)
T cd05607 8 EVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNV 87 (277)
T ss_pred EEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhc
Confidence 456665 4579999999986432 122344567999999999999999999999999999999999999998877432
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
....+++..+..++.|++.|++|||+. |++|+||+|+||+++.++.++|+|||++........ .....++..|
T Consensus 88 -~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y 160 (277)
T cd05607 88 -GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGY 160 (277)
T ss_pred -cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eeccCCCCCc
Confidence 233488889999999999999999998 999999999999999999999999999866543221 1223578899
Q ss_pred CCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHH
Q 021682 160 VPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQ 239 (309)
Q Consensus 160 ~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (309)
+|||.+.+..++.++|+|||||++|+|++|..||....... ............ .. ... ......++.+
T Consensus 161 ~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~-~~-~~~--------~~~~~~~~~~ 228 (277)
T cd05607 161 MAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--AKEELKRRTLED-EV-KFE--------HQNFTEESKD 228 (277)
T ss_pred cCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--hHHHHHHHhhcc-cc-ccc--------cccCCHHHHH
Confidence 99999988889999999999999999999999986432211 111111111110 00 000 0012336789
Q ss_pred HHhhcccCCCCCCCCHHHHHHHH
Q 021682 240 VALLCVQENAADRPTMLEILVML 262 (309)
Q Consensus 240 li~~~l~~~p~~Rpt~~ell~~L 262 (309)
++.+||+.||++|||++|+++.+
T Consensus 229 li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 229 ICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred HHHHHhccCHhhCCCCccchhhh
Confidence 99999999999999997766443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=275.14 Aligned_cols=232 Identities=21% Similarity=0.275 Sum_probs=178.4
Q ss_pred ceEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHH---hcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHH
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTS---HQGLEEFENEVKLT---ARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 76 (309)
.||.+.. .+|+.||||.++... ....+.+..|++++ +.++||||+++++++..+...++||||+.+++|...+
T Consensus 14 ~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~ 93 (324)
T cd05589 14 KVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHI 93 (324)
T ss_pred EEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHh
Confidence 5667654 579999999997542 22345666676655 5668999999999999999999999999999998776
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccc
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGT 156 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 156 (309)
. ...+++..+..++.|++.|+.|||+. |++||||||+||+++.++.+||+|||++........ ......|+
T Consensus 94 ~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~g~ 164 (324)
T cd05589 94 H----TDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD--RTSTFCGT 164 (324)
T ss_pred h----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC--cccccccC
Confidence 3 23589999999999999999999998 899999999999999999999999998764322211 12234688
Q ss_pred cCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHH
Q 021682 157 YGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMR 236 (309)
Q Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
..|+|||.+.+..++.++|+|||||++|+|++|..||......+. ....... .. . .. ......
T Consensus 165 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~------~~~i~~~-~~-~-----~p----~~~~~~ 227 (324)
T cd05589 165 PEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV------FDSIVND-EV-R-----YP----RFLSRE 227 (324)
T ss_pred ccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhC-CC-C-----CC----CCCCHH
Confidence 999999999988899999999999999999999999864322111 1111111 00 0 01 112336
Q ss_pred HHHHHhhcccCCCCCCC-----CHHHHHHH
Q 021682 237 CMQVALLCVQENAADRP-----TMLEILVM 261 (309)
Q Consensus 237 l~~li~~~l~~~p~~Rp-----t~~ell~~ 261 (309)
+.++|.+||+.||++|| ++.++++.
T Consensus 228 ~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 228 AISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred HHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 78999999999999999 67777764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=258.85 Aligned_cols=224 Identities=22% Similarity=0.287 Sum_probs=185.9
Q ss_pred CccceEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 1 MSVAICQGRLPNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 1 ~g~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
||.|-......+|..+|+|++.+.. ....+...+|..+|+.+.||+++++++.+.+...++|||||.+||-|..++.
T Consensus 57 FGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lr 136 (355)
T KOG0616|consen 57 FGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLR 136 (355)
T ss_pred cceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHH
Confidence 6777777777789999999997652 3345567899999999999999999999999999999999999999999984
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
. ...+++..++-++.+|+.|+.|||++ +|++||+||+||++|.+|.+|++|||+|+..... +-...||+
T Consensus 137 k---~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-----T~TlCGTP 205 (355)
T KOG0616|consen 137 K---SGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-----TWTLCGTP 205 (355)
T ss_pred h---cCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc-----EEEecCCc
Confidence 4 34499999999999999999999999 8999999999999999999999999999876654 22347999
Q ss_pred CCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHH
Q 021682 158 GYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRC 237 (309)
Q Consensus 158 ~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (309)
.|+|||++...++..++|=|+||+++|||+.|.+||....+......+. -.+-..+..+ ...+
T Consensus 206 eYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~-----~~~v~fP~~f------------s~~~ 268 (355)
T KOG0616|consen 206 EYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKIL-----EGKVKFPSYF------------SSDA 268 (355)
T ss_pred cccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHH-----hCcccCCccc------------CHHH
Confidence 9999999999999999999999999999999999997655522211111 1111112222 2377
Q ss_pred HHHHhhcccCCCCCC
Q 021682 238 MQVALLCVQENAADR 252 (309)
Q Consensus 238 ~~li~~~l~~~p~~R 252 (309)
.+||.++|+.|-.+|
T Consensus 269 kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 269 KDLLKKLLQVDLTKR 283 (355)
T ss_pred HHHHHHHHhhhhHhh
Confidence 899999999999998
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=267.51 Aligned_cols=241 Identities=21% Similarity=0.329 Sum_probs=185.3
Q ss_pred cceEEEEc----CCCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 3 VAICQGRL----PNGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 3 ~~~~~~~~----~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
+.||+|.+ ..+..||+|.++... ......+.+|+..+++++||||+++++++..+...++||||+.+++|.+++.
T Consensus 19 g~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 98 (266)
T cd05064 19 GELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLR 98 (266)
T ss_pred CeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHH
Confidence 34577754 346789999987543 3334578899999999999999999999999999999999999999999885
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
.. ...+++..++.++.|++.|++|||++ |++|+||+|+||+++.++.++++|||.+......... ......++.
T Consensus 99 ~~--~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~ 172 (266)
T cd05064 99 KH--EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIY-TTMSGKSPV 172 (266)
T ss_pred hC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccccccchh-cccCCCCce
Confidence 42 23588999999999999999999998 8999999999999999999999999976543222111 111123456
Q ss_pred CCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHH
Q 021682 158 GYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMR 236 (309)
Q Consensus 158 ~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
.|+|||.+.+..++.++|||||||++|++++ |..||......+ . ........... .+...+..
T Consensus 173 ~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~----~~~~~~~~~~~---------~~~~~~~~ 236 (266)
T cd05064 173 LWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---V----IKAVEDGFRLP---------APRNCPNL 236 (266)
T ss_pred eecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---H----HHHHHCCCCCC---------CCCCCCHH
Confidence 8999999988899999999999999999775 999985432211 1 11111111110 11112346
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHHHhcc
Q 021682 237 CMQVALLCVQENAADRPTMLEILVMLKSE 265 (309)
Q Consensus 237 l~~li~~~l~~~p~~Rpt~~ell~~L~~~ 265 (309)
+.+++.+||+.+|++|||+++|++.|++.
T Consensus 237 ~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 237 LHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 88999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=269.50 Aligned_cols=247 Identities=21% Similarity=0.254 Sum_probs=179.1
Q ss_pred ceEEEEcC-CCcEEEEEEeecCCc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 4 AICQGRLP-NGQEMAVKRLSRTSH-QGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 4 ~~~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
.||++... +|+.||||.++.... .....+.+|+.+++.++||||+++++++..+...++||||+. ++|.+++.. .
T Consensus 20 ~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~ 96 (303)
T cd07869 20 TVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDK--H 96 (303)
T ss_pred EEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHh--C
Confidence 56777654 789999999865432 223467789999999999999999999999999999999996 567666643 2
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP 161 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 161 (309)
...++...+..++.|++.|+.|||+. |++|+||||+||+++.++.++|+|||++........ ......++..|+|
T Consensus 97 ~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~a 171 (303)
T cd07869 97 PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH--TYSNEVVTLWYRP 171 (303)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc--cCCCCcccCCCCC
Confidence 34588889999999999999999998 999999999999999999999999999865432221 1122357889999
Q ss_pred cccccc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCC---C------cccccccCC--Ccc
Q 021682 162 PEYVRK-GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGE---G------MEFIDSSLD--DSS 229 (309)
Q Consensus 162 PE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~------~~~~~~~~~--~~~ 229 (309)
||.+.+ ..++.++|+|||||++|+|++|..||...... ............... + ..+...... ...
T Consensus 172 PE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (303)
T cd07869 172 PDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI--QDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPK 249 (303)
T ss_pred hHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHhCCCChhhccchhhccccccccccccCCc
Confidence 998865 45788999999999999999999999643221 111111111110000 0 000000000 000
Q ss_pred cH-------HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021682 230 SA-------WKLMRCMQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 230 ~~-------~~~~~l~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
.. .....+.+++.+||+.||++|||++|+++
T Consensus 250 ~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 250 NLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00 01235779999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=270.96 Aligned_cols=239 Identities=31% Similarity=0.479 Sum_probs=180.1
Q ss_pred ceEEEEcC-----CCcEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 4 AICQGRLP-----NGQEMAVKRLSRT-SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 4 ~~~~~~~~-----~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
.||+|.+. .+..|+||.++.. .....+.+.+|++.+++++||||+++++++...+..++|+||+.+++|.+++.
T Consensus 14 ~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~ 93 (259)
T PF07714_consen 14 KVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLK 93 (259)
T ss_dssp EEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHH
T ss_pred EEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccccccccccccc
Confidence 47777765 4788999999654 33346889999999999999999999999998788999999999999999985
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
.. ....+++..+..++.|++.|+.|||+. +++|++|+++||+++.++.+||+|||++...................
T Consensus 94 ~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~ 169 (259)
T PF07714_consen 94 SK-NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPL 169 (259)
T ss_dssp HT-CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGG
T ss_pred cc-ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 53 234589999999999999999999998 89999999999999999999999999987663322222223345677
Q ss_pred CCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHH
Q 021682 158 GYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMR 236 (309)
Q Consensus 158 ~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
.|+|||.+.+..++.++||||||+++||+++ |..|+..... .... ............ ...+..
T Consensus 170 ~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~------~~~~-~~~~~~~~~~~~---------~~~~~~ 233 (259)
T PF07714_consen 170 RYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN------EEII-EKLKQGQRLPIP---------DNCPKD 233 (259)
T ss_dssp GGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH------HHHH-HHHHTTEETTSB---------TTSBHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccc------cccc-ccccccccceec---------cchhHH
Confidence 8999999988889999999999999999999 6777643311 1111 111222111111 112236
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHHH
Q 021682 237 CMQVALLCVQENAADRPTMLEILVML 262 (309)
Q Consensus 237 l~~li~~~l~~~p~~Rpt~~ell~~L 262 (309)
+.+++.+||..+|++|||+.++++.|
T Consensus 234 ~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 234 IYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 88999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=265.91 Aligned_cols=240 Identities=25% Similarity=0.370 Sum_probs=189.2
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccc
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRR 82 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 82 (309)
+.||.+...+++.||+|.+.... ...+.+..|+.++++++|+||+++++.+...+..+++|||+.+++|.+++... ..
T Consensus 20 g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~ 97 (261)
T cd05072 20 GEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSD-EG 97 (261)
T ss_pred ceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHh-cC
Confidence 46788888888899999986533 24578899999999999999999999999989999999999999999988543 34
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCc
Q 021682 83 YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPP 162 (309)
Q Consensus 83 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 162 (309)
..+++..+..++.+++.|++|||+. |++|+||+|+||+++.++.++|+|||.+......... ......++..|+||
T Consensus 98 ~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aP 173 (261)
T cd05072 98 GKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-AREGAKFPIKWTAP 173 (261)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCcee-ccCCCccceecCCH
Confidence 4588889999999999999999998 8999999999999999999999999998765432211 11222456689999
Q ss_pred cccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHH
Q 021682 163 EYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241 (309)
Q Consensus 163 E~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 241 (309)
|.+.+..++.++|+||||+++|+|++ |..||....... ............ .....+..+.+++
T Consensus 174 E~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~~~~~~~~---------~~~~~~~~~~~li 237 (261)
T cd05072 174 EAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD-------VMSALQRGYRMP---------RMENCPDELYDIM 237 (261)
T ss_pred HHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH-------HHHHHHcCCCCC---------CCCCCCHHHHHHH
Confidence 99988888999999999999999998 888885432211 111111111000 0011223678999
Q ss_pred hhcccCCCCCCCCHHHHHHHHhc
Q 021682 242 LLCVQENAADRPTMLEILVMLKS 264 (309)
Q Consensus 242 ~~~l~~~p~~Rpt~~ell~~L~~ 264 (309)
.+||..+|++|||++++++.|+.
T Consensus 238 ~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 238 KTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred HHHccCCcccCcCHHHHHHHHhc
Confidence 99999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=276.52 Aligned_cols=234 Identities=24% Similarity=0.302 Sum_probs=181.4
Q ss_pred cceEEEEc-CCCcEEEEEEeecC---CcccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRT---SHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
+.||++.. .+++.||||.++.. .......+..|..++..+ +||||+++++++......++||||+.+++|.+++.
T Consensus 9 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~ 88 (320)
T cd05590 9 GKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQ 88 (320)
T ss_pred eEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHH
Confidence 35666654 57899999998753 233455677888888876 79999999999999999999999999999988874
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
. ...+++..+..++.|++.|+.|||+. |++||||||+||+++.++.++|+|||++........ ......|++
T Consensus 89 ~---~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~ 160 (320)
T cd05590 89 K---SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--TTSTFCGTP 160 (320)
T ss_pred H---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--cccccccCc
Confidence 3 33489999999999999999999998 899999999999999999999999999864322211 122346899
Q ss_pred CCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHH
Q 021682 158 GYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRC 237 (309)
Q Consensus 158 ~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (309)
.|+|||.+.+..++.++|+|||||++|+|++|+.||......+ .. ........ . .+......+
T Consensus 161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~-~~i~~~~~-~---------~~~~~~~~~ 223 (320)
T cd05590 161 DYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD------LF-EAILNDEV-V---------YPTWLSQDA 223 (320)
T ss_pred cccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH------HH-HHHhcCCC-C---------CCCCCCHHH
Confidence 9999999998889999999999999999999999986433211 11 11111110 0 011123377
Q ss_pred HHHHhhcccCCCCCCCCH------HHHHHH
Q 021682 238 MQVALLCVQENAADRPTM------LEILVM 261 (309)
Q Consensus 238 ~~li~~~l~~~p~~Rpt~------~ell~~ 261 (309)
.+++.+||+.||++||++ ++++..
T Consensus 224 ~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 224 VDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred HHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 899999999999999998 666553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=272.32 Aligned_cols=243 Identities=21% Similarity=0.303 Sum_probs=187.4
Q ss_pred CccceEEEEcCCCcEEEEEEeecCC--------------cccHHHHHHHHHHHhcCCCCCccceeeEEeeCC--eeEEEE
Q 021682 1 MSVAICQGRLPNGQEMAVKRLSRTS--------------HQGLEEFENEVKLTARLQHVNLLPVLGICTQRE--EKMLIY 64 (309)
Q Consensus 1 ~g~~~~~~~~~~g~~vavK~~~~~~--------------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~ 64 (309)
||.|..+-...+++.||||++.+.. ....++...|+.+++++.|||||+++++..+.. .+|||+
T Consensus 110 yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVl 189 (576)
T KOG0585|consen 110 YGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVL 189 (576)
T ss_pred cceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEE
Confidence 5777777777899999999996431 112357889999999999999999999987754 799999
Q ss_pred eccCCCChhHHHhhhccccC-CCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccC
Q 021682 65 DYMPNKSLDFYIFDLRRRYL-LDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTK 143 (309)
Q Consensus 65 e~~~~~~L~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~ 143 (309)
|||..|.+... ...+. +.+.++++++..++.||.|||.+ ||+||||||.|+|++.+|.+||+|||.+.....
T Consensus 190 ey~s~G~v~w~----p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~ 262 (576)
T KOG0585|consen 190 EYCSKGEVKWC----PPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQ 262 (576)
T ss_pred EeccCCccccC----CCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEEeeccceeeeccc
Confidence 99998887544 33334 89999999999999999999999 999999999999999999999999999876532
Q ss_pred Cccc---ccccccccccCCCCccccccCC----CCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCC
Q 021682 144 DECE---ANTGRIVGTYGYVPPEYVRKGI----YSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGE 216 (309)
Q Consensus 144 ~~~~---~~~~~~~~~~~y~aPE~~~~~~----~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 216 (309)
.... .......||+.|+|||.+.++. .+.+.|||++|++||-|+.|+.||-.....+ ...+
T Consensus 263 ~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~-------l~~K----- 330 (576)
T KOG0585|consen 263 GSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE-------LFDK----- 330 (576)
T ss_pred CCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH-------HHHH-----
Confidence 2111 1122358999999999887732 3678999999999999999999984321111 1111
Q ss_pred CcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcc
Q 021682 217 GMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSE 265 (309)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~ 265 (309)
+....+.-...+...+.+.+||.+||+.||+.|.++.+|.....-.
T Consensus 331 ---Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt 376 (576)
T KOG0585|consen 331 ---IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVT 376 (576)
T ss_pred ---HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceec
Confidence 1111222222223455788999999999999999999999886543
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=267.99 Aligned_cols=249 Identities=22% Similarity=0.281 Sum_probs=183.9
Q ss_pred CccceEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCC-----eeEEEEeccCCCChhH
Q 021682 1 MSVAICQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQRE-----EKMLIYDYMPNKSLDF 74 (309)
Q Consensus 1 ~g~~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~~L~~ 74 (309)
|| +||.|.. .+++.||||..-.... .-..|+++|+.+.|||||++..+|.... ...+||||++. +|.+
T Consensus 37 Fg-~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~ 110 (364)
T KOG0658|consen 37 FG-VVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYR 110 (364)
T ss_pred cc-eEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHH
Confidence 44 4555554 5789999998754322 2247899999999999999988775432 45799999974 8888
Q ss_pred HHhhh-ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCC-CCceeecccccccccCCcccccccc
Q 021682 75 YIFDL-RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYE-MNPKISDFGMARAFTKDECEANTGR 152 (309)
Q Consensus 75 ~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~ 152 (309)
++... ..+..++...++-+.+||++|++|||+. |||||||||+|+++|.+ |.+||+|||.|+..-.......
T Consensus 111 ~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epniS--- 184 (364)
T KOG0658|consen 111 VIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPNIS--- 184 (364)
T ss_pred HHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCcee---
Confidence 87542 2345578888899999999999999997 99999999999999986 8999999999987766554422
Q ss_pred cccccCCCCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCC-------CCccccccc
Q 021682 153 IVGTYGYVPPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNG-------EGMEFIDSS 224 (309)
Q Consensus 153 ~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~ 224 (309)
...+..|+|||.+.|. .|+.+.||||.||++.||+.|++-|......++...+....+..... +..++-.+.
T Consensus 185 YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ 264 (364)
T KOG0658|consen 185 YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQ 264 (364)
T ss_pred EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcc
Confidence 2567899999998875 78999999999999999999999997755555544443332221111 100111111
Q ss_pred CC-----CcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 225 LD-----DSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 225 ~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.. .-.......++++++.++|+++|.+|.|+.|++..
T Consensus 265 ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 265 IKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 11 01122234478899999999999999999999865
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=275.95 Aligned_cols=233 Identities=20% Similarity=0.260 Sum_probs=181.6
Q ss_pred ceEEEEc----CCCcEEEEEEeecC----CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHH
Q 021682 4 AICQGRL----PNGQEMAVKRLSRT----SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFY 75 (309)
Q Consensus 4 ~~~~~~~----~~g~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (309)
.||.+.. .+++.||||.++.. .......+..|+.+++.++||||+++++.+..++..++||||+.+++|.++
T Consensus 11 ~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 90 (323)
T cd05584 11 KVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMH 90 (323)
T ss_pred EEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHH
Confidence 4555543 46889999998753 122345677899999999999999999999999999999999999999888
Q ss_pred HhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccc
Q 021682 76 IFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVG 155 (309)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 155 (309)
+.. ...+.+..+..++.|++.|+.|||+. |++||||||+||+++.++.++|+|||++........ ......|
T Consensus 91 ~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g 162 (323)
T cd05584 91 LER---EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--VTHTFCG 162 (323)
T ss_pred HHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC--cccccCC
Confidence 743 34578888999999999999999998 899999999999999999999999999864332221 1222468
Q ss_pred ccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 156 TYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 156 ~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
+..|+|||.+.+..++.++|||||||++|+|++|..||...+... ........ . .. .+.....
T Consensus 163 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~------~~~~~~~~-~-~~---------~~~~~~~ 225 (323)
T cd05584 163 TIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK------TIDKILKG-K-LN---------LPPYLTP 225 (323)
T ss_pred CccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH------HHHHHHcC-C-CC---------CCCCCCH
Confidence 899999999988888999999999999999999999986433211 11111111 1 00 0111223
Q ss_pred HHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 021682 236 RCMQVALLCVQENAADRP-----TMLEILVM 261 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~Rp-----t~~ell~~ 261 (309)
.+.++|.+||+.+|++|| +++++++.
T Consensus 226 ~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 226 EARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred HHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 678999999999999999 89998774
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=274.25 Aligned_cols=233 Identities=24% Similarity=0.284 Sum_probs=182.5
Q ss_pred ceEEEEc-CCCcEEEEEEeecC---CcccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 4 AICQGRL-PNGQEMAVKRLSRT---SHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
.||++.. .+++.||||.++.. .......+..|..+++.+ +||||+++++++......++||||+.+++|..++..
T Consensus 10 ~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 89 (318)
T cd05570 10 KVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQR 89 (318)
T ss_pred EEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHH
Confidence 5677755 46889999999754 233456677888888887 799999999999999999999999999999888743
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
...+++..+..++.|++.|++|||++ |++|+||+|+||+++.++.++|+|||++........ ......|+..
T Consensus 90 ---~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~ 161 (318)
T cd05570 90 ---SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TTSTFCGTPD 161 (318)
T ss_pred ---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--cccceecCcc
Confidence 33589999999999999999999998 999999999999999999999999998864322211 1222357889
Q ss_pred CCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHH
Q 021682 159 YVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238 (309)
Q Consensus 159 y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (309)
|+|||.+.+..++.++|+|||||++|+|++|..||....... .. ........ . + +......+.
T Consensus 162 y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~------~~-~~i~~~~~-~-~--------~~~~~~~~~ 224 (318)
T cd05570 162 YIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE------LF-QSILEDEV-R-Y--------PRWLSKEAK 224 (318)
T ss_pred ccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH------HH-HHHHcCCC-C-C--------CCcCCHHHH
Confidence 999999999899999999999999999999999986432111 11 11111110 0 0 111233678
Q ss_pred HHHhhcccCCCCCCCCH-----HHHHHH
Q 021682 239 QVALLCVQENAADRPTM-----LEILVM 261 (309)
Q Consensus 239 ~li~~~l~~~p~~Rpt~-----~ell~~ 261 (309)
++|.+||+.||++|||+ .++++.
T Consensus 225 ~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 225 SILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred HHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 99999999999999999 888764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=272.56 Aligned_cols=240 Identities=20% Similarity=0.296 Sum_probs=181.9
Q ss_pred ceEEEE-cCCCcEEEEEEeecC---CcccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 4 AICQGR-LPNGQEMAVKRLSRT---SHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
.||++. ..+++.||+|.++.. .......+..|+.++.++ +||||+++++++..+...++||||+.+++|..++..
T Consensus 10 ~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~ 89 (329)
T cd05618 10 KVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR 89 (329)
T ss_pred EEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHH
Confidence 456655 457899999999754 223345677888888777 899999999999999999999999999999887743
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
...+++..+..++.|++.|+.|||++ |++||||||+||+++.++.++|+|||++........ ......|+..
T Consensus 90 ---~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~ 161 (329)
T cd05618 90 ---QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPN 161 (329)
T ss_pred ---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--ccccccCCcc
Confidence 34589999999999999999999998 899999999999999999999999999864322211 1223468899
Q ss_pred CCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCc--ccHHHHHHHHhhCCCCcccccccCCCcccHHHHHH
Q 021682 159 YVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNES--LNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMR 236 (309)
Q Consensus 159 y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
|+|||.+.+..++.++|+|||||++|+|++|..||........ ................ . .. ......
T Consensus 162 y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~-----~p----~~~~~~ 231 (329)
T cd05618 162 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-R-----IP----RSLSVK 231 (329)
T ss_pred ccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC-C-----CC----CCCCHH
Confidence 9999999998899999999999999999999999854322211 1111112121111111 1 11 112236
Q ss_pred HHHHHhhcccCCCCCCCC------HHHHHHH
Q 021682 237 CMQVALLCVQENAADRPT------MLEILVM 261 (309)
Q Consensus 237 l~~li~~~l~~~p~~Rpt------~~ell~~ 261 (309)
+.++|.+||+.||++||| +.++++.
T Consensus 232 ~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 232 AASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred HHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 779999999999999998 4666544
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=275.71 Aligned_cols=234 Identities=20% Similarity=0.285 Sum_probs=182.8
Q ss_pred cceEEEEc-CCCcEEEEEEeecC---CcccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRT---SHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
+.||++.. .+|+.||||.++.. .......+..|.+++..+ +||+|+++++++..+...++||||+++++|..++.
T Consensus 9 g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~ 88 (321)
T cd05591 9 GKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQ 88 (321)
T ss_pred eEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHH
Confidence 35677764 46899999998754 233445677888888876 89999999999999999999999999999988874
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
. ...+++..+..++.|++.|+.|||+. |++||||||+||+++.++.++|+|||++........ ......|+.
T Consensus 89 ~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~ 160 (321)
T cd05591 89 R---SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTTFCGTP 160 (321)
T ss_pred H---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc--cccccccCc
Confidence 3 33488999999999999999999998 899999999999999999999999999865332221 122345889
Q ss_pred CCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHH
Q 021682 158 GYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRC 237 (309)
Q Consensus 158 ~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (309)
.|+|||.+.+..++.++|||||||++|+|++|+.||......+ ........ .. . .+......+
T Consensus 161 ~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~------~~~~i~~~-~~--~--------~p~~~~~~~ 223 (321)
T cd05591 161 DYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD------LFESILHD-DV--L--------YPVWLSKEA 223 (321)
T ss_pred cccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH------HHHHHHcC-CC--C--------CCCCCCHHH
Confidence 9999999988889999999999999999999999986433211 11111111 10 0 011122377
Q ss_pred HHHHhhcccCCCCCCC-------CHHHHHHH
Q 021682 238 MQVALLCVQENAADRP-------TMLEILVM 261 (309)
Q Consensus 238 ~~li~~~l~~~p~~Rp-------t~~ell~~ 261 (309)
.+++.+||+.||++|| +++++++.
T Consensus 224 ~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 224 VSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred HHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 8999999999999999 88888865
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=271.46 Aligned_cols=231 Identities=23% Similarity=0.327 Sum_probs=178.5
Q ss_pred ceEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTS---HQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
.||++.. .+|+.||+|.++... .........|..++..+ .||+|+++++++..++..++||||+.+++|..++..
T Consensus 10 ~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~ 89 (316)
T cd05620 10 KVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQD 89 (316)
T ss_pred EEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHH
Confidence 4566654 578999999997542 23445667788888765 899999999999999999999999999999888743
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
...+++..+..++.|++.|++|||++ |++||||||+||+++.++.++|+|||++........ ......|+..
T Consensus 90 ---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~ 161 (316)
T cd05620 90 ---KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--RASTFCGTPD 161 (316)
T ss_pred ---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--ceeccCCCcC
Confidence 34488999999999999999999998 999999999999999999999999998764321111 1223468899
Q ss_pred CCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHH
Q 021682 159 YVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238 (309)
Q Consensus 159 y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (309)
|+|||.+.+..++.++|||||||++|+|++|..||...+... .. ...... ... . +.....++.
T Consensus 162 y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~---~~----~~~~~~-~~~-----~----~~~~~~~~~ 224 (316)
T cd05620 162 YIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE---LF----ESIRVD-TPH-----Y----PRWITKESK 224 (316)
T ss_pred ccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HH----HHHHhC-CCC-----C----CCCCCHHHH
Confidence 999999999899999999999999999999999986432211 11 111100 000 0 111233678
Q ss_pred HHHhhcccCCCCCCCCHH-HHH
Q 021682 239 QVALLCVQENAADRPTML-EIL 259 (309)
Q Consensus 239 ~li~~~l~~~p~~Rpt~~-ell 259 (309)
++|.+||+.||++||++. +++
T Consensus 225 ~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 225 DILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred HHHHHHccCCHHHcCCChHHHH
Confidence 999999999999999984 665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=264.61 Aligned_cols=242 Identities=26% Similarity=0.431 Sum_probs=187.6
Q ss_pred cceEEEEcC----CCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 3 VAICQGRLP----NGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 3 ~~~~~~~~~----~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
++||+|.+. +...||+|.++... ......+..|+.++++++|+||+++++++......+++|||+++++|.+++.
T Consensus 18 g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~ 97 (266)
T cd05033 18 GEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLR 97 (266)
T ss_pred ceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHH
Confidence 367888763 24579999986543 3345678899999999999999999999999999999999999999999985
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
.. ...+++..+..++.+++.|+.+||+. |++|+||+|.||+++.++.++|+|||++................++.
T Consensus 98 ~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~ 172 (266)
T cd05033 98 EN--DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPI 172 (266)
T ss_pred hc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCc
Confidence 42 23588999999999999999999998 89999999999999999999999999998765222211121223456
Q ss_pred CCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHH
Q 021682 158 GYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMR 236 (309)
Q Consensus 158 ~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
.|+|||.+.+..++.++|+||||+++|++++ |..||....... ............ .+...+..
T Consensus 173 ~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~~---------~~~~~~~~ 236 (266)
T cd05033 173 RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD-------VIKAVEDGYRLP---------PPMDCPSA 236 (266)
T ss_pred cccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH-------HHHHHHcCCCCC---------CCCCCCHH
Confidence 8999999988889999999999999999997 888874322111 111111110000 01112346
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHHHhcc
Q 021682 237 CMQVALLCVQENAADRPTMLEILVMLKSE 265 (309)
Q Consensus 237 l~~li~~~l~~~p~~Rpt~~ell~~L~~~ 265 (309)
+.+++.+||+.+|++||+++++++.|+++
T Consensus 237 l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 237 LYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 88999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=278.19 Aligned_cols=252 Identities=21% Similarity=0.274 Sum_probs=179.8
Q ss_pred cceEEEE-cCCCcEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCC-----eeEEEEeccCCCChhH
Q 021682 3 VAICQGR-LPNGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQRE-----EKMLIYDYMPNKSLDF 74 (309)
Q Consensus 3 ~~~~~~~-~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~~L~~ 74 (309)
+.||.+. ..+|+.||||.+... ......++.+|++++++++||||+++++++.... ..++||||+. ++|.+
T Consensus 14 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~ 92 (338)
T cd07859 14 GVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQ 92 (338)
T ss_pred eEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHHH
Confidence 3567776 457999999998643 2233456889999999999999999999875432 5799999995 67887
Q ss_pred HHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccc-cccccc
Q 021682 75 YIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECE-ANTGRI 153 (309)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~ 153 (309)
++.. ...+++..+..++.|++.|+.|||++ |++||||||+||+++.++.++|+|||++......... ......
T Consensus 93 ~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~ 166 (338)
T cd07859 93 VIKA---NDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 166 (338)
T ss_pred HHHh---cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCC
Confidence 7743 33489999999999999999999998 8999999999999999999999999998754332211 112234
Q ss_pred ccccCCCCcccccc--CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHH--------HHHhhCCCCcccc--
Q 021682 154 VGTYGYVPPEYVRK--GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYA--------YGLWKNGEGMEFI-- 221 (309)
Q Consensus 154 ~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~-- 221 (309)
.++..|+|||.+.+ ..++.++|||||||++|+|++|++||...+........... ...+........+
T Consensus 167 ~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 246 (338)
T cd07859 167 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSS 246 (338)
T ss_pred CCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHh
Confidence 68899999999865 57889999999999999999999998643321111100000 0000000000000
Q ss_pred -cccCCCccc---HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 222 -DSSLDDSSS---AWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 222 -~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
......... ......+.+++.+||+.||++|||++|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 247 MRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000000 0112367899999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=274.38 Aligned_cols=228 Identities=21% Similarity=0.259 Sum_probs=174.7
Q ss_pred ceEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHH-HHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTS---HQGLEEFENEVK-LTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
.||++.. .+|+.||+|.+.... ......+..|.. +++.++||||+++++.+..++..++||||+.+++|..++..
T Consensus 10 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 89 (323)
T cd05575 10 KVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQR 89 (323)
T ss_pred EEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHh
Confidence 5666654 589999999986532 222334445544 46778999999999999999999999999999999888743
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
...+++..+..++.||+.|+.|||++ |++||||||+||+++.++.++|+|||++........ ......|+..
T Consensus 90 ---~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~ 161 (323)
T cd05575 90 ---ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--TTSTFCGTPE 161 (323)
T ss_pred ---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--ccccccCChh
Confidence 34588999999999999999999998 999999999999999999999999998864322211 1223468899
Q ss_pred CCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHH
Q 021682 159 YVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238 (309)
Q Consensus 159 y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (309)
|+|||.+.+..++.++|||||||++|+|++|..||...+..+ ....... .. .. + .. .....+.
T Consensus 162 y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~------~~~~i~~-~~-~~-~----~~----~~~~~~~ 224 (323)
T cd05575 162 YLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE------MYDNILN-KP-LR-L----KP----NISVSAR 224 (323)
T ss_pred hcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH------HHHHHHc-CC-CC-C----CC----CCCHHHH
Confidence 999999998889999999999999999999999986432211 1111111 10 00 0 01 1133678
Q ss_pred HHHhhcccCCCCCCCCHH
Q 021682 239 QVALLCVQENAADRPTML 256 (309)
Q Consensus 239 ~li~~~l~~~p~~Rpt~~ 256 (309)
++|.+||+.||++||++.
T Consensus 225 ~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 225 HLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHHHhhcCHHhCCCCC
Confidence 999999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=278.12 Aligned_cols=239 Identities=18% Similarity=0.269 Sum_probs=180.1
Q ss_pred ceEEEE-cCCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
.||++. ..+++.||||++.... ......+..|++++++++|+||+++++++.++...++||||+++++|.+++..
T Consensus 16 ~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~- 94 (381)
T cd05626 16 EVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIR- 94 (381)
T ss_pred EEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHh-
Confidence 456664 5688999999997542 23345688999999999999999999999999999999999999999998843
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccc------------
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECE------------ 147 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~------------ 147 (309)
...+++..+..++.||+.|+.|||+. ||+||||||+||+++.++.++|+|||++.........
T Consensus 95 --~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~ 169 (381)
T cd05626 95 --MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQD 169 (381)
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccccccccccc
Confidence 33488999999999999999999998 9999999999999999999999999987533110000
Q ss_pred ---------------------------------ccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCC
Q 021682 148 ---------------------------------ANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSC 194 (309)
Q Consensus 148 ---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~ 194 (309)
.......||..|+|||.+.+..++.++|||||||++|+|++|..||.
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~ 249 (381)
T cd05626 170 SMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFL 249 (381)
T ss_pred ccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCc
Confidence 00112368999999999988889999999999999999999999996
Q ss_pred CCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHHhhc--ccCCCCCCCCHHHHHHH
Q 021682 195 YYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLC--VQENAADRPTMLEILVM 261 (309)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~--l~~~p~~Rpt~~ell~~ 261 (309)
.....+.. ............. .......++.++|.+| +..++..|||+++++..
T Consensus 250 ~~~~~~~~------~~i~~~~~~~~~~-------~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 250 APTPTETQ------LKVINWENTLHIP-------PQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred CCCHHHHH------HHHHccccccCCC-------CCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 54322111 1111100001100 0011223677888884 45566669999999986
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=272.58 Aligned_cols=232 Identities=24% Similarity=0.307 Sum_probs=179.6
Q ss_pred ceEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTS---HQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
.||++.. .+++.||||.++... .........|..+++.. +||||+++++++.++...++||||+++++|..++..
T Consensus 10 ~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~ 89 (316)
T cd05619 10 KVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQS 89 (316)
T ss_pred EEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHH
Confidence 5677765 468899999997542 23345566777888764 899999999999999999999999999999988843
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
...+++..+..++.|++.|+.|||+. |++||||||+||+++.++.++|+|||++........ ......|+..
T Consensus 90 ---~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~ 161 (316)
T cd05619 90 ---CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--KTCTFCGTPD 161 (316)
T ss_pred ---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--ceeeecCCcc
Confidence 34488999999999999999999998 899999999999999999999999999864322111 1223467899
Q ss_pred CCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHH
Q 021682 159 YVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238 (309)
Q Consensus 159 y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (309)
|+|||.+.+..++.++|||||||++|+|++|..||...+..+. . ....... .. .+......+.
T Consensus 162 y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~---~----~~i~~~~------~~----~~~~~~~~~~ 224 (316)
T cd05619 162 YIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL---F----QSIRMDN------PC----YPRWLTREAK 224 (316)
T ss_pred ccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHH---H----HHHHhCC------CC----CCccCCHHHH
Confidence 9999999988899999999999999999999999864332111 1 1111000 00 0111233678
Q ss_pred HHHhhcccCCCCCCCCHH-HHHH
Q 021682 239 QVALLCVQENAADRPTML-EILV 260 (309)
Q Consensus 239 ~li~~~l~~~p~~Rpt~~-ell~ 260 (309)
+++.+||+.||++||++. ++++
T Consensus 225 ~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 225 DILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred HHHHHHhccCHhhcCCChHHHHc
Confidence 999999999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=266.89 Aligned_cols=243 Identities=23% Similarity=0.378 Sum_probs=183.9
Q ss_pred cceEEEEc------CCCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHH
Q 021682 3 VAICQGRL------PNGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFY 75 (309)
Q Consensus 3 ~~~~~~~~------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (309)
++||.+.. .++..||+|.++... ......+.+|+.+++.++|+||+++++++..+...++||||+.+++|.++
T Consensus 20 g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 99 (277)
T cd05062 20 GMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY 99 (277)
T ss_pred CeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHH
Confidence 35676653 235779999986432 23345688999999999999999999999988999999999999999999
Q ss_pred Hhhhcc-------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccc
Q 021682 76 IFDLRR-------RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEA 148 (309)
Q Consensus 76 ~~~~~~-------~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 148 (309)
+..... ...+++..+..++.+++.|+.|||+. |++|+||+|+||+++.++.++|+|||++..........
T Consensus 100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 176 (277)
T cd05062 100 LRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 176 (277)
T ss_pred HHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEECCCCCccccCCcceee
Confidence 854322 12356788899999999999999998 89999999999999999999999999986554332221
Q ss_pred cccccccccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCC
Q 021682 149 NTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDD 227 (309)
Q Consensus 149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (309)
......++..|+|||.+.+..++.++|+||||+++|+|++ |..||....... ..............
T Consensus 177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~-------~~~~~~~~~~~~~~------ 243 (277)
T cd05062 177 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ-------VLRFVMEGGLLDKP------ 243 (277)
T ss_pred cCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHcCCcCCCC------
Confidence 1222245678999999988889999999999999999998 678875432211 11111111111110
Q ss_pred cccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 021682 228 SSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKS 264 (309)
Q Consensus 228 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~ 264 (309)
......+.+++.+||+.+|++|||+.|+++.|++
T Consensus 244 ---~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 244 ---DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred ---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1122368899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=263.00 Aligned_cols=242 Identities=29% Similarity=0.462 Sum_probs=191.2
Q ss_pred cceEEEEcCC----CcEEEEEEeecCCcc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 3 VAICQGRLPN----GQEMAVKRLSRTSHQ-GLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 3 ~~~~~~~~~~----g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
+++|++.... +..|++|.+...... ....+..|++.++.++|+|++++++++..+...++||||+++++|.+++.
T Consensus 9 g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 88 (262)
T cd00192 9 GEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLR 88 (262)
T ss_pred eEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHh
Confidence 3567776543 888999999765433 36788999999999999999999999999899999999999999999985
Q ss_pred hhcc------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccc
Q 021682 78 DLRR------RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTG 151 (309)
Q Consensus 78 ~~~~------~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 151 (309)
.... ...+++..++.++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||.+.............
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 165 (262)
T cd00192 89 KSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKT 165 (262)
T ss_pred hccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccccccccccc
Confidence 5321 35689999999999999999999998 89999999999999999999999999997765443222222
Q ss_pred ccccccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCccc
Q 021682 152 RIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSS 230 (309)
Q Consensus 152 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (309)
...++..|+|||.+....++.++|+||||+++|+|++ |..||......+ ........... ..+
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~---------~~~ 229 (262)
T cd00192 166 GGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-------VLEYLRKGYRL---------PKP 229 (262)
T ss_pred CCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCCC---------CCC
Confidence 3456788999999988888999999999999999999 588886542211 11111111111 111
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHh
Q 021682 231 AWKLMRCMQVALLCVQENAADRPTMLEILVMLK 263 (309)
Q Consensus 231 ~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~ 263 (309)
...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 230 EYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 112347889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=266.58 Aligned_cols=234 Identities=25% Similarity=0.413 Sum_probs=182.9
Q ss_pred CCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc----------
Q 021682 12 NGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR---------- 81 (309)
Q Consensus 12 ~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------- 81 (309)
++..+|+|.+..........+..|+++++.++|+||+++++++......+++|||+.+++|.+++.....
T Consensus 34 ~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~ 113 (280)
T cd05092 34 DKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGED 113 (280)
T ss_pred CceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhccccc
Confidence 4678999998766666677899999999999999999999999998899999999999999999854321
Q ss_pred --ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 82 --RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 82 --~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
...+++..+..++.|++.|++|||+. |++|+||+|+||+++.++.++|+|||++................++..|
T Consensus 114 ~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y 190 (280)
T cd05092 114 VAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 190 (280)
T ss_pred CCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccc
Confidence 13478899999999999999999998 8999999999999999999999999998655432221112223456789
Q ss_pred CCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHH
Q 021682 160 VPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238 (309)
Q Consensus 160 ~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (309)
+|||.+.+..++.++|||||||++|+|++ |.+||......+ .. ... ........ +...+..+.
T Consensus 191 ~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~---~~~-~~~~~~~~---------~~~~~~~~~ 254 (280)
T cd05092 191 MPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE---AI---ECI-TQGRELER---------PRTCPPEVY 254 (280)
T ss_pred cCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH---HH---HHH-HcCccCCC---------CCCCCHHHH
Confidence 99999988889999999999999999998 888875322211 11 111 11100000 011223678
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHhc
Q 021682 239 QVALLCVQENAADRPTMLEILVMLKS 264 (309)
Q Consensus 239 ~li~~~l~~~p~~Rpt~~ell~~L~~ 264 (309)
+++.+||+.||++||++++|++.|+.
T Consensus 255 ~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 255 AIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHHHHccCChhhCCCHHHHHHHHhC
Confidence 99999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=277.64 Aligned_cols=229 Identities=21% Similarity=0.227 Sum_probs=178.6
Q ss_pred ceEEEEc----CCCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 4 AICQGRL----PNGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 4 ~~~~~~~----~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
.||.+.. .+|+.||+|++.... ......+..|++++++++||||+++++++..+...++||||+.+++|.+++.
T Consensus 11 ~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 90 (318)
T cd05582 11 KVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLS 90 (318)
T ss_pred EEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHH
Confidence 4555442 478999999997542 2234567789999999999999999999999999999999999999988874
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
. ...+++..+..++.|++.|+.|||++ |++||||+|+||+++.++.++|+|||++........ ......|+.
T Consensus 91 ~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~g~~ 162 (318)
T cd05582 91 K---EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFCGTV 162 (318)
T ss_pred H---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--ceecccCCh
Confidence 3 34589999999999999999999998 899999999999999999999999999865433211 122346788
Q ss_pred CCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHH
Q 021682 158 GYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRC 237 (309)
Q Consensus 158 ~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (309)
.|+|||.+.+..++.++|||||||++|+|++|..||....... ........ .. . .+......+
T Consensus 163 ~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~------~~~~i~~~-~~-~---------~p~~~~~~~ 225 (318)
T cd05582 163 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE------TMTMILKA-KL-G---------MPQFLSPEA 225 (318)
T ss_pred hhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH------HHHHHHcC-CC-C---------CCCCCCHHH
Confidence 9999999988888999999999999999999999986432211 11111111 00 0 011122367
Q ss_pred HHHHhhcccCCCCCCCCHHH
Q 021682 238 MQVALLCVQENAADRPTMLE 257 (309)
Q Consensus 238 ~~li~~~l~~~p~~Rpt~~e 257 (309)
.++|.+||+.||++|||+.+
T Consensus 226 ~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 226 QSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred HHHHHHHhhcCHhHcCCCCC
Confidence 89999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=262.33 Aligned_cols=244 Identities=18% Similarity=0.276 Sum_probs=189.7
Q ss_pred ceEEEEc-CCCcEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGRL-PNGQEMAVKRLSRT---SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
.||++.. .+|+.||||.+... .......+..|+++++.++||||+++++++...+..++++||+++++|.+++...
T Consensus 17 ~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~ 96 (267)
T cd08228 17 EVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYF 96 (267)
T ss_pred eEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHh
Confidence 5677764 48899999987543 2333456889999999999999999999999999999999999999999887543
Q ss_pred c-cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 80 R-RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 80 ~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
. ....++...+..++.+++.|+.|||++ |++|+||+|+||+++.++.++|+|||++......... .....++..
T Consensus 97 ~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~ 171 (267)
T cd08228 97 KKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPY 171 (267)
T ss_pred hhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccchhHH--HhcCCCCcc
Confidence 2 234578899999999999999999998 9999999999999999999999999988765433211 122357788
Q ss_pred CCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHH
Q 021682 159 YVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238 (309)
Q Consensus 159 y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (309)
|+|||.+.+..++.++|+||||+++|+|++|+.||...... ...... ......... .........+.
T Consensus 172 ~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~~~~-~~~~~~~~~--------~~~~~~~~~~~ 238 (267)
T cd08228 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFSLCQ-KIEQCDYPP--------LPTEHYSEKLR 238 (267)
T ss_pred ccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHHHHH-HHhcCCCCC--------CChhhcCHHHH
Confidence 99999998888899999999999999999999997432211 111111 111111111 11112334788
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHhcc
Q 021682 239 QVALLCVQENAADRPTMLEILVMLKSE 265 (309)
Q Consensus 239 ~li~~~l~~~p~~Rpt~~ell~~L~~~ 265 (309)
+++.+||+.+|++|||++++++.|+++
T Consensus 239 ~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 239 ELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred HHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=263.02 Aligned_cols=238 Identities=25% Similarity=0.401 Sum_probs=185.6
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccc
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRR 82 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 82 (309)
+++|.+...++..||+|.+.... ...+.+.+|+.++++++||||+++++++......++||||+.+++|.+++....
T Consensus 18 ~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~-- 94 (256)
T cd05113 18 GVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHG-- 94 (256)
T ss_pred ceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcC--
Confidence 35688887777789999986443 334678999999999999999999999998888999999999999999885422
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCc
Q 021682 83 YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPP 162 (309)
Q Consensus 83 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 162 (309)
..+++..++.++.|++.|+.+||+. |++|+||+|.||+++.++.++|+|||.+.......... .....++..|+||
T Consensus 95 ~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~-~~~~~~~~~y~~p 170 (256)
T cd05113 95 KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPP 170 (256)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceee-cCCCccChhhCCH
Confidence 2589999999999999999999998 89999999999999999999999999886554332111 1112345679999
Q ss_pred cccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHH
Q 021682 163 EYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241 (309)
Q Consensus 163 E~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 241 (309)
|.+.+..++.++|+||||+++|+|++ |..||......+ .. ............ ......+.+++
T Consensus 171 e~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~------~~-~~~~~~~~~~~~---------~~~~~~~~~li 234 (256)
T cd05113 171 EVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE------TV-EKVSQGLRLYRP---------HLASEKVYAIM 234 (256)
T ss_pred HHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH------HH-HHHhcCCCCCCC---------CCCCHHHHHHH
Confidence 99988888999999999999999998 888875433211 11 111111111000 01234788999
Q ss_pred hhcccCCCCCCCCHHHHHHHHh
Q 021682 242 LLCVQENAADRPTMLEILVMLK 263 (309)
Q Consensus 242 ~~~l~~~p~~Rpt~~ell~~L~ 263 (309)
.+||+.+|.+|||+.+++..|+
T Consensus 235 ~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 235 YSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHHcCCCcccCCCHHHHHHhhC
Confidence 9999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=277.98 Aligned_cols=245 Identities=25% Similarity=0.378 Sum_probs=186.6
Q ss_pred ceEEEEc------CCCcEEEEEEeecCC-cccHHHHHHHHHHHhcCC-CCCccceeeEEeeCCeeEEEEeccCCCChhHH
Q 021682 4 AICQGRL------PNGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQ-HVNLLPVLGICTQREEKMLIYDYMPNKSLDFY 75 (309)
Q Consensus 4 ~~~~~~~------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (309)
+||+|.. ..+..||||.++... ....+.+..|+++++++. ||||+++++++......++||||+++++|.++
T Consensus 52 ~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~ 131 (400)
T cd05105 52 KVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNY 131 (400)
T ss_pred eEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHH
Confidence 5666653 124579999996543 334567899999999995 99999999999999999999999999999988
Q ss_pred Hhhhcc--------------------------------------------------------------------------
Q 021682 76 IFDLRR-------------------------------------------------------------------------- 81 (309)
Q Consensus 76 ~~~~~~-------------------------------------------------------------------------- 81 (309)
+.....
T Consensus 132 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (400)
T cd05105 132 LHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRP 211 (400)
T ss_pred HHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCccccc
Confidence 754210
Q ss_pred -------------------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeeccccccccc
Q 021682 82 -------------------RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFT 142 (309)
Q Consensus 82 -------------------~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~ 142 (309)
...+++..+..++.|++.|++|||+. |++|+||+|.||+++.++.++|+|||++....
T Consensus 212 ~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~~~~~kL~DfGla~~~~ 288 (400)
T cd05105 212 ASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLARDIM 288 (400)
T ss_pred ccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeCCCEEEEEeCCcceecc
Confidence 12367788899999999999999998 89999999999999999999999999987654
Q ss_pred CCcccccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccc
Q 021682 143 KDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFI 221 (309)
Q Consensus 143 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (309)
............++..|+|||.+.+..++.++|||||||++|+|++ |..||........ ............
T Consensus 289 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~------~~~~~~~~~~~~-- 360 (400)
T cd05105 289 HDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST------FYNKIKSGYRMA-- 360 (400)
T ss_pred ccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH------HHHHHhcCCCCC--
Confidence 3322222223346678999999988889999999999999999997 8888754221110 111111111110
Q ss_pred cccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhccc
Q 021682 222 DSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSET 266 (309)
Q Consensus 222 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~ 266 (309)
.....+..+.+++.+||+.||++|||+.+|.++|+...
T Consensus 361 -------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 361 -------KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred -------CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 11122347889999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=272.94 Aligned_cols=246 Identities=27% Similarity=0.404 Sum_probs=186.6
Q ss_pred ceEEEEc------CCCcEEEEEEeecCC-cccHHHHHHHHHHHhcC-CCCCccceeeEEeeC-CeeEEEEeccCCCChhH
Q 021682 4 AICQGRL------PNGQEMAVKRLSRTS-HQGLEEFENEVKLTARL-QHVNLLPVLGICTQR-EEKMLIYDYMPNKSLDF 74 (309)
Q Consensus 4 ~~~~~~~------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~ 74 (309)
+||.+.. .+++.||+|.++... ......+..|+.+++++ +|+||+++++++... ...++++||+.+++|.+
T Consensus 22 ~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~ 101 (337)
T cd05054 22 KVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSN 101 (337)
T ss_pred eEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHH
Confidence 5666642 245789999986442 22345678899999999 899999999987654 57889999999999999
Q ss_pred HHhhhcc----------------------------------------------------------ccCCCHHHHHHHHHH
Q 021682 75 YIFDLRR----------------------------------------------------------RYLLDWRTRVHIIEG 96 (309)
Q Consensus 75 ~~~~~~~----------------------------------------------------------~~~~~~~~~~~~~~~ 96 (309)
++..... ...+++..+..++.|
T Consensus 102 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~q 181 (337)
T cd05054 102 YLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQ 181 (337)
T ss_pred HHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHH
Confidence 8853211 125788999999999
Q ss_pred HHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCccccccCCCCccchh
Q 021682 97 ITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDV 176 (309)
Q Consensus 97 i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 176 (309)
++.|++|||+. |++||||||.||+++.++.++|+|||++............+...++..|+|||.+.+..++.++||
T Consensus 182 i~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 258 (337)
T cd05054 182 VARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDV 258 (337)
T ss_pred HHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccH
Confidence 99999999998 999999999999999999999999999976544332222333355678999999999999999999
Q ss_pred hhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCH
Q 021682 177 YSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTM 255 (309)
Q Consensus 177 wslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~ 255 (309)
|||||++|+|++ |..||......+. ............ .+.....++.+++.+||+.+|++|||+
T Consensus 259 ~SlGv~l~el~t~g~~p~~~~~~~~~------~~~~~~~~~~~~---------~~~~~~~~~~~l~~~cl~~~p~~RPs~ 323 (337)
T cd05054 259 WSFGVLLWEIFSLGASPYPGVQIDEE------FCRRLKEGTRMR---------APEYATPEIYSIMLDCWHNNPEDRPTF 323 (337)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCccHH------HHHHHhccCCCC---------CCccCCHHHHHHHHHHccCChhhCcCH
Confidence 999999999998 9988854222111 111111111110 011123478899999999999999999
Q ss_pred HHHHHHHhcccC
Q 021682 256 LEILVMLKSETA 267 (309)
Q Consensus 256 ~ell~~L~~~~~ 267 (309)
+++++.|+.+.+
T Consensus 324 ~ell~~l~~~~~ 335 (337)
T cd05054 324 SELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHHHHHh
Confidence 999999997654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=267.72 Aligned_cols=247 Identities=24% Similarity=0.329 Sum_probs=181.8
Q ss_pred CCCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeC--CeeEEEEeccCCCChhHHHhhhccccCCCH
Q 021682 11 PNGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQR--EEKMLIYDYMPNKSLDFYIFDLRRRYLLDW 87 (309)
Q Consensus 11 ~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 87 (309)
.+++.||+|.++... ......+.+|++++++++||||+++++++... ...+++|||+.+++|.+++.. ..+++
T Consensus 31 ~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~l~~ 106 (283)
T cd05080 31 GTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK----HKLNL 106 (283)
T ss_pred CCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHH----cCCCH
Confidence 478899999986543 23456788999999999999999999987653 368999999999999998843 23899
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccc-ccccccccCCCCccccc
Q 021682 88 RTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEAN-TGRIVGTYGYVPPEYVR 166 (309)
Q Consensus 88 ~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~ 166 (309)
..+..++.+++.|+.+||+. |++|+||+|+||+++.++.++|+|||++........... .....++..|+|||.+.
T Consensus 107 ~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~ 183 (283)
T cd05080 107 AQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183 (283)
T ss_pred HHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhc
Confidence 99999999999999999998 899999999999999999999999999876543322111 11123456799999998
Q ss_pred cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHHhhccc
Q 021682 167 KGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQ 246 (309)
Q Consensus 167 ~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 246 (309)
+..++.++||||||+++|+|++|..|+....... .................+..........+...+..+.+++.+||+
T Consensus 184 ~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 262 (283)
T cd05080 184 ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWE 262 (283)
T ss_pred ccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhc
Confidence 8888999999999999999999998875432110 000000000000000001111111111111223478899999999
Q ss_pred CCCCCCCCHHHHHHHHhcc
Q 021682 247 ENAADRPTMLEILVMLKSE 265 (309)
Q Consensus 247 ~~p~~Rpt~~ell~~L~~~ 265 (309)
.+|++|||++++++.|+.+
T Consensus 263 ~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 263 TEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred cChhhCCCHHHHHHHHHHh
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=266.22 Aligned_cols=243 Identities=28% Similarity=0.438 Sum_probs=186.9
Q ss_pred cceEEEEc-----CCCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHH
Q 021682 3 VAICQGRL-----PNGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 3 ~~~~~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 76 (309)
+.||+|.. .+++.||+|.+.... ......+..|+.++++++|+||+++++++..+...++||||+.+++|.+++
T Consensus 19 g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 98 (283)
T cd05090 19 GKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFL 98 (283)
T ss_pred cceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHH
Confidence 35787763 356889999986543 333467889999999999999999999999999999999999999999988
Q ss_pred hhhcc--------------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeeccccccccc
Q 021682 77 FDLRR--------------RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFT 142 (309)
Q Consensus 77 ~~~~~--------------~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~ 142 (309)
..... ...+++..+..++.+++.|++|||++ |++|+||+|+||+++.++.++|+|||++....
T Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 175 (283)
T cd05090 99 IMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKISDLGLSREIY 175 (283)
T ss_pred HhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCCcEEecccccccccc
Confidence 53221 23477888999999999999999998 89999999999999999999999999987654
Q ss_pred CCcccccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccc
Q 021682 143 KDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFI 221 (309)
Q Consensus 143 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (309)
............++..|+|||.+.+..++.++|+||||+++|+|++ |..||....... .. ..........
T Consensus 176 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~---~~----~~~~~~~~~~-- 246 (283)
T cd05090 176 SADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE---VI----EMVRKRQLLP-- 246 (283)
T ss_pred CCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HH----HHHHcCCcCC--
Confidence 3322222222345667999999988888999999999999999998 888875322111 11 1111111111
Q ss_pred cccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 021682 222 DSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKS 264 (309)
Q Consensus 222 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~ 264 (309)
.+......+.+++.+||+.||++||++.++++.|..
T Consensus 247 -------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 247 -------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 011122378899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=262.70 Aligned_cols=238 Identities=24% Similarity=0.405 Sum_probs=185.7
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccc
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRR 82 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 82 (309)
++||.+..+++..+|+|.+..... ....+..|++++++++|+||+++++++......++||||+++++|.+++... .
T Consensus 18 ~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~ 94 (256)
T cd05059 18 GVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRER--K 94 (256)
T ss_pred ceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhc--c
Confidence 367888877778899999864432 3457888999999999999999999999989999999999999999988532 2
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCc
Q 021682 83 YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPP 162 (309)
Q Consensus 83 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 162 (309)
..+++..++.++.|++.++++||+. |++|+||+|+||+++.++.++|+|||.+.......... .....++..|+||
T Consensus 95 ~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~y~~P 170 (256)
T cd05059 95 GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS-SQGTKFPVKWAPP 170 (256)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccc-cCCCCCCccccCH
Confidence 3588999999999999999999998 89999999999999999999999999886554322111 1111234579999
Q ss_pred cccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHH
Q 021682 163 EYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241 (309)
Q Consensus 163 E~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 241 (309)
|.+.+..++.++|+||||+++|++++ |..||......+. .......... ..+...+..+.+++
T Consensus 171 e~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-------~~~~~~~~~~---------~~~~~~~~~~~~li 234 (256)
T cd05059 171 EVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV-------VESVSAGYRL---------YRPKLAPTEVYTIM 234 (256)
T ss_pred HHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH-------HHHHHcCCcC---------CCCCCCCHHHHHHH
Confidence 99988889999999999999999998 7888864322211 1111111000 11111334788999
Q ss_pred hhcccCCCCCCCCHHHHHHHHh
Q 021682 242 LLCVQENAADRPTMLEILVMLK 263 (309)
Q Consensus 242 ~~~l~~~p~~Rpt~~ell~~L~ 263 (309)
.+||..+|++|||+.++++.|.
T Consensus 235 ~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 235 YSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred HHHhcCChhhCcCHHHHHHHhC
Confidence 9999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=263.17 Aligned_cols=239 Identities=25% Similarity=0.369 Sum_probs=184.3
Q ss_pred cceEEEEc---CCCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 3 VAICQGRL---PNGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 3 ~~~~~~~~---~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
+.||+|.+ .+++.||+|+++... ....+.+..|+.+++.+.|+||+++++++.. ...++||||+++++|.+++.
T Consensus 9 g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~ 87 (257)
T cd05116 9 GTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELGPLNKFLQ 87 (257)
T ss_pred cceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCCcHHHHHH
Confidence 36777753 468899999986443 2335678899999999999999999998764 46789999999999999884
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccc-cccccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEA-NTGRIVGT 156 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~-~~~~~~~~ 156 (309)
. ...+++..+..++.|++.|+++||++ |++|+||+|.||+++.++.++|+|||++.......... ......++
T Consensus 88 ~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~ 161 (257)
T cd05116 88 K---NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWP 161 (257)
T ss_pred h---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCC
Confidence 3 23488999999999999999999998 89999999999999999999999999987654432211 11112335
Q ss_pred cCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 157 YGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
..|+|||.+....++.++|+|||||++|+|++ |..||......+ .. .......... .+...+.
T Consensus 162 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~----~~i~~~~~~~---------~~~~~~~ 225 (257)
T cd05116 162 VKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE---VT----QMIESGERME---------CPQRCPP 225 (257)
T ss_pred ccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHHCCCCCC---------CCCCCCH
Confidence 68999999988888999999999999999998 899986432211 11 1111111111 1111234
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 021682 236 RCMQVALLCVQENAADRPTMLEILVMLKS 264 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~Rpt~~ell~~L~~ 264 (309)
++.++|.+||+.||++||++.+|.+.|++
T Consensus 226 ~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 226 EMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred HHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 78899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=256.19 Aligned_cols=276 Identities=18% Similarity=0.183 Sum_probs=204.4
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCccc--HHHHHHHHHHHhcCCCCCccceeeEEeeCC--eeEEEEeccCCCChhHHHh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSHQG--LEEFENEVKLTARLQHVNLLPVLGICTQRE--EKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~ 77 (309)
++||+|+. ++++-||+|.++...... ----.+|+.+|.+.+|||||.+-.+....+ .+|||||||+. +|..++.
T Consensus 90 GiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d 168 (419)
T KOG0663|consen 90 GVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLME 168 (419)
T ss_pred eeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHH
Confidence 46788864 589999999997543211 112468999999999999999998877654 69999999975 8988886
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
... ..|....+.-+..|++.|++|||.+ .|+|||||++|++++..|.+|++|||+|+.++..... ....+-|.
T Consensus 169 ~m~--q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~--~T~lVVTL 241 (419)
T KOG0663|consen 169 TMK--QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKP--YTPLVVTL 241 (419)
T ss_pred hcc--CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCCccc--CcceEEEe
Confidence 544 4588999999999999999999999 6999999999999999999999999999998876332 23346689
Q ss_pred CCCCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccC-----------
Q 021682 158 GYVPPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSL----------- 225 (309)
Q Consensus 158 ~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------- 225 (309)
+|+|||.+.+. .|+.+.|+||+|||+.|++++.+.|......++...+....+.....-+..+..-..
T Consensus 242 WYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~py 321 (419)
T KOG0663|consen 242 WYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPY 321 (419)
T ss_pred eecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCc
Confidence 99999999885 689999999999999999999999876666555555444433333322222211110
Q ss_pred ---CCcccHH-HHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccCCCCCCCCCCccccCCccchhh
Q 021682 226 ---DDSSSAW-KLMRCMQVALLCVQENAADRPTMLEILVMLKSETADIKTPKKPAFSVKRDNDEISE 288 (309)
Q Consensus 226 ---~~~~~~~-~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~~~~~~~p~~~~~~~~~~~~~ 288 (309)
....... ....-.+++..+|.+||++|.||+|.|+.= .-...+.|..|.++..=+....+.
T Consensus 322 n~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~--~F~e~P~p~~P~~~Pt~P~k~~~~ 386 (419)
T KOG0663|consen 322 NNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHE--YFRETPLPIDPSMFPTWPAKSEQQ 386 (419)
T ss_pred hhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccc--ccccCCCCCChhhcCCCccccccc
Confidence 0001110 224567999999999999999999998752 222345566676665444444333
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=276.02 Aligned_cols=238 Identities=18% Similarity=0.242 Sum_probs=183.1
Q ss_pred ceEEEE-cCCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
.||++. ..+|+.||+|.++... ......+..|+.+++.++|++|+++++++..+...++||||+++++|.+++...
T Consensus 16 ~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 95 (330)
T cd05601 16 EVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRY 95 (330)
T ss_pred EEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHh
Confidence 456554 4589999999997542 234456889999999999999999999999999999999999999999988543
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
...+++..+..++.|++.|+.+||+. |++||||||+||+++.++.++|+|||++......... ......|+..|
T Consensus 96 --~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y 169 (330)
T cd05601 96 --EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDY 169 (330)
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCCce-eeecccCCccc
Confidence 23589999999999999999999998 8999999999999999999999999998765433222 12223678999
Q ss_pred CCccccc------cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHH
Q 021682 160 VPPEYVR------KGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWK 233 (309)
Q Consensus 160 ~aPE~~~------~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
+|||.+. +..++.++|||||||++|+|++|..||....... .............+.. ....
T Consensus 170 ~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~~~i~~~~~~~~~~~-------~~~~ 236 (330)
T cd05601 170 IAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK------TYNNIMNFQRFLKFPE-------DPKV 236 (330)
T ss_pred cCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH------HHHHHHcCCCccCCCC-------CCCC
Confidence 9999886 4567889999999999999999999985432211 1111111111111110 1112
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 234 LMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 234 ~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
...+.++|.+||+ +|++|||+++++..
T Consensus 237 ~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 237 SSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 3467899999998 99999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=269.61 Aligned_cols=240 Identities=20% Similarity=0.277 Sum_probs=183.9
Q ss_pred ceEEEE-cCCCcEEEEEEeecCC---cccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTS---HQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
.||.+. ..+++.||+|+++... ......+..|+.++.++ +|++|+.+++++......++||||+++++|..++..
T Consensus 10 ~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 89 (327)
T cd05617 10 KVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQR 89 (327)
T ss_pred EEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHH
Confidence 455554 4578999999997542 23345678899999888 699999999999999999999999999999888743
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
...+++..+..++.|++.|+.|||++ |++||||||+||+++.++.++|+|||++........ ......|+..
T Consensus 90 ---~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~ 161 (327)
T cd05617 90 ---QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TTSTFCGTPN 161 (327)
T ss_pred ---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--ceecccCCcc
Confidence 33589999999999999999999998 999999999999999999999999998864322111 1223468899
Q ss_pred CCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHH
Q 021682 159 YVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238 (309)
Q Consensus 159 y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (309)
|+|||.+.+..++.++|+|||||++|+|++|..||........................ .+ +......+.
T Consensus 162 y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~---------p~~~~~~~~ 231 (327)
T cd05617 162 YIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI-RI---------PRFLSVKAS 231 (327)
T ss_pred cCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC-CC---------CCCCCHHHH
Confidence 99999999889999999999999999999999999654333322222222222221111 00 111123677
Q ss_pred HHHhhcccCCCCCCCCH------HHHHHH
Q 021682 239 QVALLCVQENAADRPTM------LEILVM 261 (309)
Q Consensus 239 ~li~~~l~~~p~~Rpt~------~ell~~ 261 (309)
+++.+||+.||++|+++ +++++.
T Consensus 232 ~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 232 HVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred HHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 99999999999999984 576654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=265.62 Aligned_cols=238 Identities=24% Similarity=0.291 Sum_probs=183.8
Q ss_pred ceEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
.||++.. .+++.||+|.+.... ......+.+|+.++++++|+||+++++.+..+...++||||+.+++|.+++...
T Consensus 15 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 94 (285)
T cd05605 15 EVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNM 94 (285)
T ss_pred EEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhc
Confidence 4566654 578999999986542 222345678999999999999999999999999999999999999998877432
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
....+++..+..++.|++.|+.|||+. |++|+||+|+||++++++.++|+|||++........ .....|+..|
T Consensus 95 -~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y 167 (285)
T cd05605 95 -GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET---IRGRVGTVGY 167 (285)
T ss_pred -CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc---cccccCCCCc
Confidence 234589999999999999999999998 899999999999999999999999999875432221 1223678899
Q ss_pred CCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHH
Q 021682 160 VPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQ 239 (309)
Q Consensus 160 ~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (309)
+|||.+.+..++.++|+||+|+++|++++|..||......... .......... ........+..+.+
T Consensus 168 ~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~---~~~~~~~~~~----------~~~~~~~~~~~~~~ 234 (285)
T cd05605 168 MAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR---EEVERRVKED----------QEEYSEKFSEAARS 234 (285)
T ss_pred cCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH---HHHHHHhhhc----------ccccCcccCHHHHH
Confidence 9999998888999999999999999999999998643222111 1111111100 01111123346789
Q ss_pred HHhhcccCCCCCCC-----CHHHHHHH
Q 021682 240 VALLCVQENAADRP-----TMLEILVM 261 (309)
Q Consensus 240 li~~~l~~~p~~Rp-----t~~ell~~ 261 (309)
++.+||+.||++|| +++++++.
T Consensus 235 li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 235 ICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 99999999999999 89999765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=277.87 Aligned_cols=239 Identities=22% Similarity=0.282 Sum_probs=186.4
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
+.||++.. .+|+.||||+++... ......+..|++++..++|+||+++++++..+...++||||+.+++|.+++..
T Consensus 15 g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 94 (350)
T cd05573 15 GEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIR 94 (350)
T ss_pred EEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHH
Confidence 35666654 479999999997542 23456788999999999999999999999999999999999999999998854
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCc-------------
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDE------------- 145 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~------------- 145 (309)
. ..+++..+..++.|++.||.|||+. |++||||||+||+++.++.++|+|||++.......
T Consensus 95 ~---~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~ 168 (350)
T cd05573 95 K---DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168 (350)
T ss_pred c---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccccccccccc
Confidence 3 4589999999999999999999998 99999999999999999999999999987654432
Q ss_pred --------------ccccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHH
Q 021682 146 --------------CEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGL 211 (309)
Q Consensus 146 --------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 211 (309)
.........|+..|+|||.+.+..++.++|||||||++|+|++|..||....... .....
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~------~~~~i 242 (350)
T cd05573 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE------TYNKI 242 (350)
T ss_pred ccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH------HHHHH
Confidence 0011223468899999999999999999999999999999999999986543211 11111
Q ss_pred hhCCCCcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCC-HHHHHHH
Q 021682 212 WKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPT-MLEILVM 261 (309)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt-~~ell~~ 261 (309)
........+.. .. ..+..+.++|.+||. +|++||+ ++++++.
T Consensus 243 ~~~~~~~~~p~---~~----~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 243 INWKESLRFPP---DP----PVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred hccCCcccCCC---CC----CCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 11000000000 00 023478899999998 9999999 9999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=277.13 Aligned_cols=238 Identities=20% Similarity=0.257 Sum_probs=180.0
Q ss_pred ceEEE-EcCCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQG-RLPNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
.||++ ...+|+.||||.+.... ......++.|++++++++||||+++++++.++...++||||+++++|.+++..
T Consensus 16 ~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~- 94 (377)
T cd05629 16 EVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIK- 94 (377)
T ss_pred EEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHh-
Confidence 45555 45689999999986532 22345678899999999999999999999999999999999999999998843
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccc------------
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECE------------ 147 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~------------ 147 (309)
...+++..+..++.|++.||.|||+. |++||||||+||+++.++.++|+|||++.........
T Consensus 95 --~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~ 169 (377)
T cd05629 95 --YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSN 169 (377)
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccccccccccccccccc
Confidence 34588999999999999999999998 9999999999999999999999999998533211000
Q ss_pred c---------------------------------cccccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCC
Q 021682 148 A---------------------------------NTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSC 194 (309)
Q Consensus 148 ~---------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~ 194 (309)
. ......||..|+|||.+.+..++.++|||||||++|+|++|..||.
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~ 249 (377)
T cd05629 170 KNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFC 249 (377)
T ss_pred ccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCC
Confidence 0 0001358899999999988889999999999999999999999986
Q ss_pred CCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHHhhcccCCCCCC---CCHHHHHHH
Q 021682 195 YYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADR---PTMLEILVM 261 (309)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R---pt~~ell~~ 261 (309)
.....+. ............+.+ ......++.++|.+||. +|.+| +|+.++++.
T Consensus 250 ~~~~~~~------~~~i~~~~~~~~~p~-------~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 250 SENSHET------YRKIINWRETLYFPD-------DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred CCCHHHH------HHHHHccCCccCCCC-------CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 4332111 111111001111100 00122367799999998 77775 599999886
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=296.83 Aligned_cols=249 Identities=27% Similarity=0.440 Sum_probs=200.8
Q ss_pred cceEEEEcC--CCc----EEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHH
Q 021682 3 VAICQGRLP--NGQ----EMAVKRLSRT-SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFY 75 (309)
Q Consensus 3 ~~~~~~~~~--~g~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (309)
+.||.|.+. .|. .||||.+++. +.+...+|.+|..+++++.||||+++++++......+|++|||.+|+|..+
T Consensus 706 G~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sf 785 (1025)
T KOG1095|consen 706 GEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSF 785 (1025)
T ss_pred cceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHH
Confidence 467888764 233 3899998765 466678999999999999999999999999998899999999999999999
Q ss_pred Hhhhcc----ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccc
Q 021682 76 IFDLRR----RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTG 151 (309)
Q Consensus 76 ~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 151 (309)
+.+.+. ...+.....+.++.+|++++.||+++ +++||||..+|+|++....+|++|||+|+...........+
T Consensus 786 lr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~ 862 (1025)
T KOG1095|consen 786 LRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHG 862 (1025)
T ss_pred HHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccchhHhhhhchheeccC
Confidence 966421 44588899999999999999999999 69999999999999999999999999998655544443343
Q ss_pred ccccccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCccc
Q 021682 152 RIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSS 230 (309)
Q Consensus 152 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (309)
...-+..|||||.+..+.++.|+||||||+++||+++ |..||......+.. ..+..+. +...+
T Consensus 863 ~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~-------~~~~~gg---------RL~~P 926 (1025)
T KOG1095|consen 863 EAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVL-------LDVLEGG---------RLDPP 926 (1025)
T ss_pred ccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHH-------HHHHhCC---------ccCCC
Confidence 3355679999999999999999999999999999999 88887654433321 1111111 22233
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccCCCC
Q 021682 231 AWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETADIK 270 (309)
Q Consensus 231 ~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~~~ 270 (309)
..++..+++++.+||+.+|++||++..|++.++.+.+.+.
T Consensus 927 ~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 927 SYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred CCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 3455588899999999999999999999998877655443
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=280.39 Aligned_cols=269 Identities=20% Similarity=0.253 Sum_probs=211.7
Q ss_pred CccceEEEEcCCCcEEEEEEeecC---CcccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHH
Q 021682 1 MSVAICQGRLPNGQEMAVKRLSRT---SHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 1 ~g~~~~~~~~~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 76 (309)
||.|+.+....+++.+|||++++. ..++++..+.|-+++... +||+++.++..|.+.++++.||||+.||++...
T Consensus 381 FGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~- 459 (694)
T KOG0694|consen 381 FGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHH- 459 (694)
T ss_pred CceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcEEEE-
Confidence 788988888889999999999876 466788999999998877 699999999999999999999999999984333
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccc
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGT 156 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 156 (309)
.+...+++..+.-++..++.||.|||++ ||++||||.+||++|..|.+||+|||+++.....+. .++.+.||
T Consensus 460 ---~~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~--~TsTfCGT 531 (694)
T KOG0694|consen 460 ---IHTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGD--RTSTFCGT 531 (694)
T ss_pred ---EecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCCCCC--ccccccCC
Confidence 2345599999999999999999999999 999999999999999999999999999976543333 45567899
Q ss_pred cCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHH
Q 021682 157 YGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMR 236 (309)
Q Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
+.|+|||++.+..|+...|=|+||+++|+|+.|+.||...+..+....+ ..+ ...++...+.+
T Consensus 532 pey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI------~~d-----------~~~yP~~ls~e 594 (694)
T KOG0694|consen 532 PEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSI------VND-----------EVRYPRFLSKE 594 (694)
T ss_pred hhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH------hcC-----------CCCCCCcccHH
Confidence 9999999999999999999999999999999999999765544432221 111 12333344457
Q ss_pred HHHHHhhcccCCCCCCCCH-----HHHHHH----------HhcccCCCCCCCCCCccccCCc-cchhhhhccccccc
Q 021682 237 CMQVALLCVQENAADRPTM-----LEILVM----------LKSETADIKTPKKPAFSVKRDN-DEISECMLEANIYS 297 (309)
Q Consensus 237 l~~li~~~l~~~p~~Rpt~-----~ell~~----------L~~~~~~~~~~~~p~~~~~~~~-~~~~~~~~~~~~~~ 297 (309)
..+|++++|..+|++|.-+ ++|... |+ ...+.+|=.|..+.+... -.+++++..-..++
T Consensus 595 a~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~--~r~i~PPf~P~i~~~~D~snFd~eFt~e~p~Lt 669 (694)
T KOG0694|consen 595 AIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLL--NRRIKPPFVPTIKGPEDVSNFDEEFTSEKPALT 669 (694)
T ss_pred HHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHh--hccCCCCCCcccCChhhhcccchhhhcCCCccC
Confidence 8899999999999999754 555443 22 234666666666555532 23455555444444
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=275.48 Aligned_cols=238 Identities=20% Similarity=0.262 Sum_probs=181.9
Q ss_pred ceEEEE-cCCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
.||.+. ..+|+.||||++.... ......+..|+.+++.++|+||+++++++..+...++||||+.+++|.+++..
T Consensus 16 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~- 94 (364)
T cd05599 16 EVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMK- 94 (364)
T ss_pred EEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHH-
Confidence 455554 4579999999997532 22345678899999999999999999999999999999999999999998843
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccc-----------
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEA----------- 148 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~----------- 148 (309)
...+++..+..++.|++.|+.|||+. |++||||||+||+++.++.++|+|||++..........
T Consensus 95 --~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~ 169 (364)
T cd05599 95 --KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPS 169 (364)
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccccccccccccccccc
Confidence 33589999999999999999999998 89999999999999999999999999986543211000
Q ss_pred -------------------------cccccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCccc
Q 021682 149 -------------------------NTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLN 203 (309)
Q Consensus 149 -------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~ 203 (309)
......||+.|+|||.+.+..++.++|||||||++|+|++|..||.......
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~--- 246 (364)
T cd05599 170 NFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQE--- 246 (364)
T ss_pred cccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHH---
Confidence 0011358999999999988899999999999999999999999986433211
Q ss_pred HHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCC---HHHHHHH
Q 021682 204 LLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPT---MLEILVM 261 (309)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~ell~~ 261 (309)
.............+.. .......+.++|.+|+. +|.+|++ ++++++.
T Consensus 247 ---~~~~i~~~~~~~~~~~-------~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 247 ---TYRKIINWKETLQFPD-------EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred ---HHHHHHcCCCccCCCC-------CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 1111111111111110 00123367799999997 9999998 9998874
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=257.64 Aligned_cols=245 Identities=19% Similarity=0.280 Sum_probs=191.3
Q ss_pred cceEEEEcC-CCcEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 3 VAICQGRLP-NGQEMAVKRLSRT---SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 3 ~~~~~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
+.+|++... +|+.||+|.++.. .......+..|++++++++|++++++++.+..++..++||||+++++|..++..
T Consensus 16 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 95 (267)
T cd08224 16 SVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKH 95 (267)
T ss_pred eEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHH
Confidence 356777765 8999999988642 233356788999999999999999999999999999999999999999988854
Q ss_pred h-ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccccc
Q 021682 79 L-RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 79 ~-~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
. .....+++..+..++.+++.++.+||+. |++|+||+|+||+++.++.++|+|||++......... .....++.
T Consensus 96 ~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~ 170 (267)
T cd08224 96 FKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTP 170 (267)
T ss_pred hcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccCCCcc--cceecCCc
Confidence 3 2244588999999999999999999998 9999999999999999999999999998654432211 12235778
Q ss_pred CCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHH
Q 021682 158 GYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRC 237 (309)
Q Consensus 158 ~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (309)
.|+|||.+.+..++.++|+||||+++|+|++|..||..... . .... ........... .........+
T Consensus 171 ~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~---~~~~-~~~~~~~~~~~--------~~~~~~~~~~ 237 (267)
T cd08224 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-N---LYSL-CKKIEKCDYPP--------LPADHYSEEL 237 (267)
T ss_pred cccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc-c---HHHH-HhhhhcCCCCC--------CChhhcCHHH
Confidence 89999999888899999999999999999999999843221 1 1111 11111111110 1111234478
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHhcc
Q 021682 238 MQVALLCVQENAADRPTMLEILVMLKSE 265 (309)
Q Consensus 238 ~~li~~~l~~~p~~Rpt~~ell~~L~~~ 265 (309)
.++|.+||..+|++|||+.+|+++|+.+
T Consensus 238 ~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 238 RDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred HHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 8999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=265.49 Aligned_cols=242 Identities=26% Similarity=0.435 Sum_probs=186.3
Q ss_pred ceEEEEcC------CCcEEEEEEeecCCc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHH
Q 021682 4 AICQGRLP------NGQEMAVKRLSRTSH-QGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 4 ~~~~~~~~------~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 76 (309)
+||+|... .++.||||.++.... .....+..|+.++++++||||+++++++......++++||+.+++|.+++
T Consensus 20 ~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l 99 (283)
T cd05091 20 KVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFL 99 (283)
T ss_pred eEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHH
Confidence 57777642 357899999975432 23467889999999999999999999999999999999999999999987
Q ss_pred hhhc-------------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccC
Q 021682 77 FDLR-------------RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTK 143 (309)
Q Consensus 77 ~~~~-------------~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~ 143 (309)
.... ....+++..+..++.|++.|+.+||+. |++||||||.||+++.++.++|+|||++.....
T Consensus 100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (283)
T cd05091 100 VMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYA 176 (283)
T ss_pred HhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCceEeccccccccccc
Confidence 4221 123478888999999999999999998 899999999999999999999999999876543
Q ss_pred CcccccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCccccc
Q 021682 144 DECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFID 222 (309)
Q Consensus 144 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (309)
.......+...++..|+|||.+.+..++.++|||||||++|+|++ |..||......+ .............
T Consensus 177 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------~~~~i~~~~~~~~-- 247 (283)
T cd05091 177 ADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD-------VIEMIRNRQVLPC-- 247 (283)
T ss_pred chheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHcCCcCCC--
Confidence 322222233345678999999988888999999999999999998 777875432211 1111111111111
Q ss_pred ccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 021682 223 SSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKS 264 (309)
Q Consensus 223 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~ 264 (309)
+...+..+.+++.+||+.+|++|||++++++.|+.
T Consensus 248 -------~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 248 -------PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11123367899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=278.12 Aligned_cols=238 Identities=21% Similarity=0.286 Sum_probs=179.9
Q ss_pred ceEEEE-cCCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
.||++. ..+|+.||||++.... ......+..|++++++++|+||+++++.+..++..++||||+++++|.+++..
T Consensus 16 ~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~- 94 (376)
T cd05598 16 EVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIR- 94 (376)
T ss_pred EEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHh-
Confidence 455554 4679999999986432 22345678999999999999999999999999999999999999999999843
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcc-------------
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDEC------------- 146 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~------------- 146 (309)
...+++..+..++.||+.|++|||++ ||+||||||+||+++.++.++|+|||++........
T Consensus 95 --~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~ 169 (376)
T cd05598 95 --LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQD 169 (376)
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccccccccccc
Confidence 33488899999999999999999998 999999999999999999999999998743210000
Q ss_pred ----------------------------cccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Q 021682 147 ----------------------------EANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGP 198 (309)
Q Consensus 147 ----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~ 198 (309)
........|++.|+|||.+.+..++.++|||||||++|+|++|..||.....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~ 249 (376)
T cd05598 170 SMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTP 249 (376)
T ss_pred cccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCH
Confidence 0001123688999999999998999999999999999999999999965433
Q ss_pred CCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCC---CHHHHHHH
Q 021682 199 NESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRP---TMLEILVM 261 (309)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~ell~~ 261 (309)
.+.. ............ .........+.++|.+|+ .+|++|+ |+.++++.
T Consensus 250 ~~~~------~~i~~~~~~~~~-------~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 250 AETQ------LKVINWETTLHI-------PSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred HHHH------HHHhccCccccC-------CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 2211 011100000000 000112235678888876 5999999 89999977
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=260.91 Aligned_cols=237 Identities=19% Similarity=0.276 Sum_probs=183.0
Q ss_pred cceEEEE-cCCCcEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 3 VAICQGR-LPNGQEMAVKRLSRT-SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 3 ~~~~~~~-~~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
+.||++. ..+++.||+|.+... .......+.+|++++++++||||+++++.+..++..++||||+++++|..+.
T Consensus 15 ~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~---- 90 (279)
T cd06619 15 GTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYR---- 90 (279)
T ss_pred eEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHhh----
Confidence 3567775 468999999998654 2333467889999999999999999999999999999999999999886542
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCC
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYV 160 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 160 (309)
.+++..+..++.|++.|+.|||+. |++|+||+|+||+++.++.++|+|||++....... .....++..|+
T Consensus 91 ---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~ 160 (279)
T cd06619 91 ---KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI----AKTYVGTNAYM 160 (279)
T ss_pred ---cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc----ccCCCCChhhc
Confidence 267888899999999999999998 99999999999999999999999999986543321 22236788999
Q ss_pred CccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHH
Q 021682 161 PPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQV 240 (309)
Q Consensus 161 aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 240 (309)
|||.+.+..++.++|+||||+++|+|++|..||........................... .......++.++
T Consensus 161 aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~l 232 (279)
T cd06619 161 APERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVL--------PVGQFSEKFVHF 232 (279)
T ss_pred CceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCC--------CCCcCCHHHHHH
Confidence 999998888999999999999999999999998643322211111111111111111110 001122367899
Q ss_pred HhhcccCCCCCCCCHHHHHHH
Q 021682 241 ALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 241 i~~~l~~~p~~Rpt~~ell~~ 261 (309)
+.+||+.+|++||+++++++.
T Consensus 233 i~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 233 ITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHHhhCChhhCCCHHHHhcC
Confidence 999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=271.98 Aligned_cols=228 Identities=21% Similarity=0.264 Sum_probs=173.8
Q ss_pred ceEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHH-HHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTS---HQGLEEFENEVK-LTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
.||++.. .+|+.||+|++.... ......+..|.. +++.++||||+++++.+...+..++||||+++++|...+..
T Consensus 10 ~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 89 (321)
T cd05603 10 KVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQR 89 (321)
T ss_pred EEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHH
Confidence 5677764 578999999986532 222334445544 57888999999999999999999999999999999877743
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
...+++..+..++.||+.|+.|||+. |++||||||+||+++.++.++|+|||++........ ......|+..
T Consensus 90 ---~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~ 161 (321)
T cd05603 90 ---ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--TTSTFCGTPE 161 (321)
T ss_pred ---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--ccccccCCcc
Confidence 34588889999999999999999998 899999999999999999999999998864322211 1223467899
Q ss_pred CCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHH
Q 021682 159 YVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238 (309)
Q Consensus 159 y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (309)
|+|||.+.+..++.++|||||||++|+|++|..||...+... ........ . .. .+......+.
T Consensus 162 y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~i~~~-~-~~---------~~~~~~~~~~ 224 (321)
T cd05603 162 YLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ------MYDNILHK-P-LQ---------LPGGKTVAAC 224 (321)
T ss_pred cCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH------HHHHHhcC-C-CC---------CCCCCCHHHH
Confidence 999999988889999999999999999999999985432111 11111111 0 00 1111233678
Q ss_pred HHHhhcccCCCCCCCCHH
Q 021682 239 QVALLCVQENAADRPTML 256 (309)
Q Consensus 239 ~li~~~l~~~p~~Rpt~~ 256 (309)
++|.+||+.+|++||++.
T Consensus 225 ~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 225 DLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHHHccCCHhhcCCCC
Confidence 999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=273.13 Aligned_cols=229 Identities=21% Similarity=0.248 Sum_probs=174.7
Q ss_pred ceEEEE-cCCCcEEEEEEeecCC---cccHHHHHHHHH-HHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTS---HQGLEEFENEVK-LTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
.||.+. ..+|+.||+|++.... ......+..|.. +++.++||||+++++.+..++..++||||+.+++|..++.
T Consensus 10 ~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~- 88 (325)
T cd05604 10 KVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQ- 88 (325)
T ss_pred EEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHH-
Confidence 455554 4689999999986542 222334455554 4677899999999999999999999999999999988774
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
....+++..+..++.||+.|+.|||+. |++||||||+||+++.++.++|+|||++........ ......|+..
T Consensus 89 --~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~ 161 (325)
T cd05604 89 --RERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TTTTFCGTPE 161 (325)
T ss_pred --HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--CcccccCChh
Confidence 334589999999999999999999998 999999999999999999999999999864322211 1223468899
Q ss_pred CCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHH
Q 021682 159 YVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238 (309)
Q Consensus 159 y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (309)
|+|||.+.+..++.++|||||||++|+|++|..||...+..+ ....... ... .+ .. .....+.
T Consensus 162 y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~------~~~~~~~-~~~--~~----~~----~~~~~~~ 224 (325)
T cd05604 162 YLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE------MYDNILH-KPL--VL----RP----GASLTAW 224 (325)
T ss_pred hCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH------HHHHHHc-CCc--cC----CC----CCCHHHH
Confidence 999999999889999999999999999999999986432211 1111111 100 00 01 1223677
Q ss_pred HHHhhcccCCCCCCCCHHH
Q 021682 239 QVALLCVQENAADRPTMLE 257 (309)
Q Consensus 239 ~li~~~l~~~p~~Rpt~~e 257 (309)
+++.+||+.+|.+||++.+
T Consensus 225 ~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 225 SILEELLEKDRQRRLGAKE 243 (325)
T ss_pred HHHHHHhccCHHhcCCCCC
Confidence 9999999999999998853
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=262.86 Aligned_cols=240 Identities=22% Similarity=0.294 Sum_probs=184.3
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
+.||+|.. .+|+.||+|.+..........++.|+.++++++|+||+++++++..+...++||||+.+++|.+++..
T Consensus 23 g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~--- 99 (267)
T cd06646 23 GDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHV--- 99 (267)
T ss_pred eEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHh---
Confidence 35777764 57899999999765544556788999999999999999999999999999999999999999988743
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP 161 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 161 (309)
...+++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++........ ......++..|+|
T Consensus 100 ~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~ 174 (267)
T cd06646 100 TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA--KRKSFIGTPYWMA 174 (267)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc--ccCccccCccccC
Confidence 33588999999999999999999998 899999999999999999999999999876543221 1122357789999
Q ss_pred ccccc---cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHH
Q 021682 162 PEYVR---KGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238 (309)
Q Consensus 162 PE~~~---~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (309)
||.+. ...++.++|+|||||++|+|++|..||....+..... .+.... +..+.. .........+.
T Consensus 175 PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-------~~~~~~---~~~~~~--~~~~~~~~~~~ 242 (267)
T cd06646 175 PEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-------LMSKSN---FQPPKL--KDKTKWSSTFH 242 (267)
T ss_pred HhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-------eeecCC---CCCCCC--ccccccCHHHH
Confidence 99874 3456789999999999999999999975332211100 000000 000000 00111234788
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHH
Q 021682 239 QVALLCVQENAADRPTMLEILVML 262 (309)
Q Consensus 239 ~li~~~l~~~p~~Rpt~~ell~~L 262 (309)
+++.+||+.+|++|||++++++.|
T Consensus 243 ~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 243 NFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred HHHHHHhhCChhhCcCHHHHhcCC
Confidence 999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=284.69 Aligned_cols=242 Identities=21% Similarity=0.250 Sum_probs=185.5
Q ss_pred CccceEEEEcCCCcEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCC--------eeEEEEeccCCC
Q 021682 1 MSVAICQGRLPNGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQRE--------EKMLIYDYMPNK 70 (309)
Q Consensus 1 ~g~~~~~~~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--------~~~lv~e~~~~~ 70 (309)
||.|+......+|+.||||.+... .......+..|+..+..++|++++++++.+.... ..++||||+.++
T Consensus 45 fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~g 124 (496)
T PTZ00283 45 TGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAG 124 (496)
T ss_pred CEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCC
Confidence 454444445668999999998654 2334567889999999999999999887765432 368999999999
Q ss_pred ChhHHHhhh-ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccc
Q 021682 71 SLDFYIFDL-RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEAN 149 (309)
Q Consensus 71 ~L~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 149 (309)
+|.+++... .....+++..+..++.|++.|+.|||+. |++||||||+||+++.++.++|+|||++...........
T Consensus 125 sL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~ 201 (496)
T PTZ00283 125 DLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDV 201 (496)
T ss_pred cHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEecccCeeccccccccc
Confidence 999988543 2345688999999999999999999998 899999999999999999999999999876544322222
Q ss_pred ccccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcc
Q 021682 150 TGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSS 229 (309)
Q Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (309)
.....|++.|+|||.+.+..++.++|||||||++|+|++|..||...... ...... ..+.... .
T Consensus 202 ~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~------~~~~~~-~~~~~~~---------~ 265 (496)
T PTZ00283 202 GRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME------EVMHKT-LAGRYDP---------L 265 (496)
T ss_pred cccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHH-hcCCCCC---------C
Confidence 33346899999999999988999999999999999999999998543211 111111 1111111 1
Q ss_pred cHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 230 SAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 230 ~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
+......+.+++.+||+.||++|||+.++++.
T Consensus 266 ~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 266 PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11123478899999999999999999999864
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=258.85 Aligned_cols=239 Identities=24% Similarity=0.337 Sum_probs=186.7
Q ss_pred cceEEEEcCCCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
+.||++...+++.||+|.+.... ......+.+|++++++++|+||+++++++......++||||+.+++|.+++...
T Consensus 9 g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-- 86 (250)
T cd05085 9 GEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKK-- 86 (250)
T ss_pred ceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhc--
Confidence 46788888889999999986553 233456889999999999999999999999999999999999999999887432
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP 161 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 161 (309)
...+++..+..++.+++.++.++|+. |++|+||+|+||+++.++.++|+|||++......... ......++..|+|
T Consensus 87 ~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~a 162 (250)
T cd05085 87 KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLKQIPIKWTA 162 (250)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCCCCcccccC
Confidence 23478999999999999999999998 8999999999999999999999999998654332211 1111233567999
Q ss_pred ccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHH
Q 021682 162 PEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQV 240 (309)
Q Consensus 162 PE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 240 (309)
||.+.+..++.++|+||||+++|++++ |..||....... . ............ +...+..+.++
T Consensus 163 PE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~---~----~~~~~~~~~~~~---------~~~~~~~~~~l 226 (250)
T cd05085 163 PEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ---A----REQVEKGYRMSC---------PQKCPDDVYKV 226 (250)
T ss_pred HHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH---H----HHHHHcCCCCCC---------CCCCCHHHHHH
Confidence 999988888999999999999999998 888885432111 1 111111111111 11123478899
Q ss_pred HhhcccCCCCCCCCHHHHHHHHh
Q 021682 241 ALLCVQENAADRPTMLEILVMLK 263 (309)
Q Consensus 241 i~~~l~~~p~~Rpt~~ell~~L~ 263 (309)
+.+||..+|++|||+.++++.|.
T Consensus 227 i~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 227 MQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHcccCcccCCCHHHHHHHhc
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=259.45 Aligned_cols=251 Identities=19% Similarity=0.195 Sum_probs=198.3
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
++||.+.+ .++..+|+|++.+.. .....+...|-+||+.+.||.++.+|+.|+.+...|+|||||.||+|..+.+
T Consensus 91 G~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~Lrq- 169 (459)
T KOG0610|consen 91 GTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQ- 169 (459)
T ss_pred eeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHh-
Confidence 45666665 466999999997653 3334567789999999999999999999999999999999999999998874
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcc------------
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDEC------------ 146 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~------------ 146 (309)
.+.+..+++..++-++.+++-||.|||.. ||+.|||||+||||.++|++.|+||+++..+.....
T Consensus 170 kQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~ 246 (459)
T KOG0610|consen 170 KQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGS 246 (459)
T ss_pred hCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCC
Confidence 45677799999999999999999999999 999999999999999999999999999855421000
Q ss_pred --------------------c----------------------ccccccccccCCCCccccccCCCCccchhhhHHHHHH
Q 021682 147 --------------------E----------------------ANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLL 184 (309)
Q Consensus 147 --------------------~----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ 184 (309)
. .....++||-.|+|||++.|..-+.+.|=|+||+++|
T Consensus 247 ~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflY 326 (459)
T KOG0610|consen 247 QPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLY 326 (459)
T ss_pred CcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHH
Confidence 0 0112356899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCC----HHHHHH
Q 021682 185 QILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPT----MLEILV 260 (309)
Q Consensus 185 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt----~~ell~ 260 (309)
||+.|..||...+..+....+... ...+. ..+.....+.|||+++|..||++|.. |+||.+
T Consensus 327 EmLyG~TPFKG~~~~~Tl~NIv~~--------~l~Fp-------~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 327 EMLYGTTPFKGSNNKETLRNIVGQ--------PLKFP-------EEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred HHHhCCCCcCCCCchhhHHHHhcC--------CCcCC-------CCCcchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence 999999999877665543222111 11111 11133447889999999999999988 899887
Q ss_pred H--HhcccCCCCCC
Q 021682 261 M--LKSETADIKTP 272 (309)
Q Consensus 261 ~--L~~~~~~~~~~ 272 (309)
. ++++.+.+-..
T Consensus 392 HpFF~gVnWaLir~ 405 (459)
T KOG0610|consen 392 HPFFEGVNWALIRC 405 (459)
T ss_pred CccccCCChhheec
Confidence 6 45555544433
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=259.60 Aligned_cols=240 Identities=24% Similarity=0.364 Sum_probs=187.0
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQ-GLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
+.+|.+...+++.||+|.+...... ....+..|+++++++.|+||+++++++......++|||++.+++|.+++...
T Consensus 9 g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~-- 86 (251)
T cd05041 9 GDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKK-- 86 (251)
T ss_pred ceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhc--
Confidence 4678777666999999998655332 4567899999999999999999999999999999999999999999988442
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP 161 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 161 (309)
...+++..+..++.+++.++.+||++ |++|+||+|+||+++.++.++|+|||.+.................+..|+|
T Consensus 87 ~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~ 163 (251)
T cd05041 87 KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTA 163 (251)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCC
Confidence 23478889999999999999999998 899999999999999999999999999875543221111111233567999
Q ss_pred ccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHH
Q 021682 162 PEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQV 240 (309)
Q Consensus 162 PE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 240 (309)
||.+.+..++.++|+||||+++|+|++ |..||....... ........... ..+...+..+.++
T Consensus 164 PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~-------~~~~~~~~~~~---------~~~~~~~~~~~~l 227 (251)
T cd05041 164 PEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-------TRERIESGYRM---------PAPQLCPEEIYRL 227 (251)
T ss_pred hHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH-------HHHHHhcCCCC---------CCCccCCHHHHHH
Confidence 999988889999999999999999998 777775433211 11111111100 0111123478899
Q ss_pred HhhcccCCCCCCCCHHHHHHHHh
Q 021682 241 ALLCVQENAADRPTMLEILVMLK 263 (309)
Q Consensus 241 i~~~l~~~p~~Rpt~~ell~~L~ 263 (309)
+.+||+.+|.+|||+.|+++.|+
T Consensus 228 i~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 228 MLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHhccChhhCcCHHHHHHHhh
Confidence 99999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=267.14 Aligned_cols=238 Identities=22% Similarity=0.274 Sum_probs=181.5
Q ss_pred ceEEEEc----CCCcEEEEEEeecC----CcccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhH
Q 021682 4 AICQGRL----PNGQEMAVKRLSRT----SHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDF 74 (309)
Q Consensus 4 ~~~~~~~----~~g~~vavK~~~~~----~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (309)
+||.+.. .+|+.||+|++... .....+.+..|+.+++++ .|++|+++++++..+...++||||+.+++|.+
T Consensus 15 ~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~ 94 (332)
T cd05614 15 KVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFT 94 (332)
T ss_pred EEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHH
Confidence 4565543 47899999998643 122345678899999999 59999999999999999999999999999998
Q ss_pred HHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccc
Q 021682 75 YIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIV 154 (309)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~ 154 (309)
++.. +..+++..+..++.||+.|+.|||+. |++||||||+||+++.++.++|+|||++......... ......
T Consensus 95 ~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~ 167 (332)
T cd05614 95 HLYQ---RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE-RTYSFC 167 (332)
T ss_pred HHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccccccCCC-cccccc
Confidence 8843 34589999999999999999999998 8999999999999999999999999998754332221 122346
Q ss_pred cccCCCCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHH
Q 021682 155 GTYGYVPPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWK 233 (309)
Q Consensus 155 ~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
|+..|+|||.+.+. .++.++|||||||++|+|++|..||............. ...... +... +...
T Consensus 168 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~--~~~~~~-------~~~~----~~~~ 234 (332)
T cd05614 168 GTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS--RRILKC-------DPPF----PSFI 234 (332)
T ss_pred CCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHH--HHHhcC-------CCCC----CCCC
Confidence 89999999998765 47889999999999999999999986433322211111 111110 0011 1112
Q ss_pred HHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 021682 234 LMRCMQVALLCVQENAADRP-----TMLEILVM 261 (309)
Q Consensus 234 ~~~l~~li~~~l~~~p~~Rp-----t~~ell~~ 261 (309)
...+.+++.+||+.||++|| +++++++.
T Consensus 235 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 235 GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 33678999999999999999 77888765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=261.01 Aligned_cols=241 Identities=21% Similarity=0.352 Sum_probs=184.1
Q ss_pred cceEEEEcC---CCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 3 VAICQGRLP---NGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 3 ~~~~~~~~~---~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
++||+|.+. .+..||+|.+.... ....+.+.+|+.++++++|+||+++++++.. ...++||||+++++|.+++..
T Consensus 9 g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~ 87 (257)
T cd05115 9 GCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPLNKFLSG 87 (257)
T ss_pred ccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCHHHHHHh
Confidence 357777543 45679999986553 2334678899999999999999999998764 468899999999999998743
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccc-cccccccc
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEAN-TGRIVGTY 157 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~-~~~~~~~~ 157 (309)
....+++..++.++.+++.|+.+||++ |++|+||+|+||+++.++.++|+|||++........... .....++.
T Consensus 88 --~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 162 (257)
T cd05115 88 --KKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPL 162 (257)
T ss_pred --CCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCc
Confidence 234589999999999999999999998 899999999999999999999999999875443322111 11112356
Q ss_pred CCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHH
Q 021682 158 GYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMR 236 (309)
Q Consensus 158 ~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
.|+|||.+.+..++.++|+||||+++|++++ |..||......+ ............ .+.....+
T Consensus 163 ~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~~---------~~~~~~~~ 226 (257)
T cd05115 163 KWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-------VMSFIEQGKRLD---------CPAECPPE 226 (257)
T ss_pred ccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHCCCCCC---------CCCCCCHH
Confidence 8999999988888999999999999999996 999885432211 111111111111 11122347
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHHHhcc
Q 021682 237 CMQVALLCVQENAADRPTMLEILVMLKSE 265 (309)
Q Consensus 237 l~~li~~~l~~~p~~Rpt~~ell~~L~~~ 265 (309)
+.+++.+||..+|++||++.++.+.|+..
T Consensus 227 l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 227 MYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 88999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=262.32 Aligned_cols=244 Identities=23% Similarity=0.378 Sum_probs=184.0
Q ss_pred cceEEEEcCC-Cc--EEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeeEEeeC------CeeEEEEeccCCCC
Q 021682 3 VAICQGRLPN-GQ--EMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQR------EEKMLIYDYMPNKS 71 (309)
Q Consensus 3 ~~~~~~~~~~-g~--~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~~ 71 (309)
++||+|...+ ++ .||+|.++.. .....+.+..|+.+++.++|+||+++++++... ...++++||+.+++
T Consensus 13 g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~ 92 (272)
T cd05075 13 GSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGD 92 (272)
T ss_pred ceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCc
Confidence 3678887653 33 6899988654 234456788999999999999999999977432 24689999999999
Q ss_pred hhHHHhhhc---cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccc
Q 021682 72 LDFYIFDLR---RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEA 148 (309)
Q Consensus 72 L~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 148 (309)
|.+++.... ....+++..+..++.|++.|++|||+. |++|+||||+||+++.++.++|+|||++..........
T Consensus 93 l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 169 (272)
T cd05075 93 LHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYR 169 (272)
T ss_pred HHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcccccCccccee
Confidence 988874321 234578999999999999999999998 89999999999999999999999999987654332211
Q ss_pred cccccccccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCC
Q 021682 149 NTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDD 227 (309)
Q Consensus 149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (309)
......++..|++||...+..++.++|+||||+++|+|++ |..||....... .......+......
T Consensus 170 ~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~------ 236 (272)
T cd05075 170 QGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE-------IYDYLRQGNRLKQP------ 236 (272)
T ss_pred cCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHcCCCCCCC------
Confidence 1122245668999999988889999999999999999999 788875422211 11112221111110
Q ss_pred cccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcc
Q 021682 228 SSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSE 265 (309)
Q Consensus 228 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~ 265 (309)
......+.++|.+||+.+|++|||++++++.|+..
T Consensus 237 ---~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 237 ---PDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred ---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11223678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=266.61 Aligned_cols=244 Identities=24% Similarity=0.359 Sum_probs=187.3
Q ss_pred cceEEEEcC------CCcEEEEEEeecC-CcccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhH
Q 021682 3 VAICQGRLP------NGQEMAVKRLSRT-SHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDF 74 (309)
Q Consensus 3 ~~~~~~~~~------~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (309)
+.||++... +...||+|.+... .......+..|+.+++++ +|+||+++++++..+...+++|||+.+++|..
T Consensus 26 g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~ 105 (293)
T cd05053 26 GQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRD 105 (293)
T ss_pred ccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHH
Confidence 356666542 3467999998654 233445688999999999 89999999999999999999999999999999
Q ss_pred HHhhh-------------ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccc
Q 021682 75 YIFDL-------------RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAF 141 (309)
Q Consensus 75 ~~~~~-------------~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~ 141 (309)
++... .....+++..++.++.|++.|++|||+. |++|+||+|.||+++.++.++|+|||++...
T Consensus 106 ~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 182 (293)
T cd05053 106 FLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDI 182 (293)
T ss_pred HHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcCCCeEEeCcccccccc
Confidence 98542 2234588899999999999999999998 8999999999999999999999999998765
Q ss_pred cCCcccccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCccc
Q 021682 142 TKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEF 220 (309)
Q Consensus 142 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (309)
.............++..|+|||.+.+..++.++|||||||++|++++ |..||......+ ............
T Consensus 183 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~~- 254 (293)
T cd05053 183 HHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-------LFKLLKEGYRME- 254 (293)
T ss_pred ccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH-------HHHHHHcCCcCC-
Confidence 44322212222234567999999988889999999999999999997 888875332211 111111111111
Q ss_pred ccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcc
Q 021682 221 IDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSE 265 (309)
Q Consensus 221 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~ 265 (309)
.+......+.+++.+||..+|++|||+.++++.|+.+
T Consensus 255 --------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 255 --------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred --------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 1111234788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=259.38 Aligned_cols=245 Identities=18% Similarity=0.270 Sum_probs=190.6
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
+.||++.. .+|+.||||.+.... ......+.+|+.+++.++|+||+++++++..+...+++|||+++++|.+++..
T Consensus 16 g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~ 95 (267)
T cd08229 16 SEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKH 95 (267)
T ss_pred eEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHH
Confidence 35777764 589999999886432 23345788999999999999999999999999999999999999999998854
Q ss_pred h-ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccccc
Q 021682 79 L-RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 79 ~-~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
. .....+++..++.++.+++.++.+||++ |++|+||+|+||+++.++.++|+|||++......... .....++.
T Consensus 96 ~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~ 170 (267)
T cd08229 96 FKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTP 170 (267)
T ss_pred hhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccCCcc--cccccCCc
Confidence 2 2345589999999999999999999998 9999999999999999999999999988765433221 12235788
Q ss_pred CCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHH
Q 021682 158 GYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRC 237 (309)
Q Consensus 158 ~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (309)
.|+|||.+.+..++.++|+||||+++|+|++|..||....... .... ........ ...........+
T Consensus 171 ~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~-~~~~~~~~--------~~~~~~~~~~~~ 237 (267)
T cd08229 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YSLC-KKIEQCDY--------PPLPSDHYSEEL 237 (267)
T ss_pred CccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH----HHHh-hhhhcCCC--------CCCCcccccHHH
Confidence 9999999988888999999999999999999999985322110 0000 11110000 001111234478
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHhcc
Q 021682 238 MQVALLCVQENAADRPTMLEILVMLKSE 265 (309)
Q Consensus 238 ~~li~~~l~~~p~~Rpt~~ell~~L~~~ 265 (309)
.+++.+||+.+|++|||+.+|++.+++.
T Consensus 238 ~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 238 RQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred HHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 8999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=265.50 Aligned_cols=250 Identities=22% Similarity=0.263 Sum_probs=177.5
Q ss_pred cceEEEEc--CCCcEEEEEEeecCC--cccHHHHHHHHHHHhcC---CCCCccceeeEEee-----CCeeEEEEeccCCC
Q 021682 3 VAICQGRL--PNGQEMAVKRLSRTS--HQGLEEFENEVKLTARL---QHVNLLPVLGICTQ-----REEKMLIYDYMPNK 70 (309)
Q Consensus 3 ~~~~~~~~--~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~ 70 (309)
+.||++.. .+|+.||+|.++... ......+..|+.+++.+ +||||+++++++.. ....++|||++. +
T Consensus 15 g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~ 93 (290)
T cd07862 15 GKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-Q 93 (290)
T ss_pred eEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-C
Confidence 35677764 357889999986542 22234556677776665 69999999998853 346899999996 5
Q ss_pred ChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccc
Q 021682 71 SLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANT 150 (309)
Q Consensus 71 ~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 150 (309)
+|.+++... ....+++..+..++.|++.|+.|||+. |++|+||||+||+++.++.++|+|||++....... ..
T Consensus 94 ~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~ 166 (290)
T cd07862 94 DLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---AL 166 (290)
T ss_pred CHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccceEeccCCc---cc
Confidence 888887542 233488999999999999999999998 89999999999999999999999999987654331 12
Q ss_pred cccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCc-------ccccc
Q 021682 151 GRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGM-------EFIDS 223 (309)
Q Consensus 151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~ 223 (309)
....++..|+|||.+.+..++.++|||||||++|+|++|.+||......+....+............. ..+..
T Consensus 167 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (290)
T cd07862 167 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHS 246 (290)
T ss_pred ccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccC
Confidence 23467889999999988889999999999999999999999986543322211111100000000000 00000
Q ss_pred cCCCc---ccHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021682 224 SLDDS---SSAWKLMRCMQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 224 ~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
..... ........+.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 247 KSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred CCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00000 00112346779999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=260.27 Aligned_cols=237 Identities=24% Similarity=0.300 Sum_probs=182.6
Q ss_pred ceEEEEc-CCCcEEEEEEeecCCc-----ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTSH-----QGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
.+|.+.. .+|+.||+|.+..... .....+.+|++++++++||||+++++++..+...++|+|++++++|.+++.
T Consensus 17 ~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~ 96 (263)
T cd06625 17 RVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLK 96 (263)
T ss_pred EEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHH
Confidence 4566653 5799999999865421 123567889999999999999999999999999999999999999998874
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccc-ccccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEAN-TGRIVGT 156 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~-~~~~~~~ 156 (309)
. ...++...+..++.+++.|+.+||+. |++|+||+|+||+++.++.++|+|||++........... .....++
T Consensus 97 ~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~ 170 (263)
T cd06625 97 A---YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGT 170 (263)
T ss_pred H---hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcC
Confidence 3 33488899999999999999999998 899999999999999999999999999865433211111 1223567
Q ss_pred cCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHH
Q 021682 157 YGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMR 236 (309)
Q Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
..|+|||.+.+..++.++||||||+++|++++|..||....... ............ ..+......
T Consensus 171 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~~~---------~~~~~~~~~ 235 (263)
T cd06625 171 PYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA------AIFKIATQPTNP---------QLPSHVSPD 235 (263)
T ss_pred ccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH------HHHHHhccCCCC---------CCCccCCHH
Confidence 78999999988889999999999999999999999985322111 111111110000 111122336
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 237 CMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 237 l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
+.+++.+||..+|++|||+.++++.
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 236 ARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHHHHHHHhhcCcccCCCHHHHhhC
Confidence 7899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=259.69 Aligned_cols=241 Identities=27% Similarity=0.373 Sum_probs=187.1
Q ss_pred cceEEEEcCC--C--cEEEEEEeecCCc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 3 VAICQGRLPN--G--QEMAVKRLSRTSH-QGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 3 ~~~~~~~~~~--g--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
++||++...+ + ..||||.+..... ...+.+..|+..+++++|+||+++++++.. ...++|+||+++++|.+++.
T Consensus 9 ~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~ 87 (257)
T cd05040 9 GVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLR 87 (257)
T ss_pred ccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHH
Confidence 4678876532 3 3689999976654 456788999999999999999999999888 88999999999999999885
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccc-cccccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEA-NTGRIVGT 156 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~-~~~~~~~~ 156 (309)
.... ..+++..++.++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++.......... ......++
T Consensus 88 ~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 163 (257)
T cd05040 88 KDAL-GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVP 163 (257)
T ss_pred hccc-ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCC
Confidence 5332 4589999999999999999999998 99999999999999999999999999987665432211 11123466
Q ss_pred cCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 157 YGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
..|+|||.+.+..++.++|||||||++|+|++ |..||......+ .... ......... .+...+.
T Consensus 164 ~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~---~~~~~~~~~---------~~~~~~~ 228 (257)
T cd05040 164 FAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---ILKK---IDKEGERLE---------RPEACPQ 228 (257)
T ss_pred ceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH---HHhcCCcCC---------CCccCCH
Confidence 78999999988889999999999999999998 999875322211 1111 111111000 0111234
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHHh
Q 021682 236 RCMQVALLCVQENAADRPTMLEILVMLK 263 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~Rpt~~ell~~L~ 263 (309)
.+.+++.+||+.+|++|||+.++++.|.
T Consensus 229 ~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 229 DIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 7889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=274.11 Aligned_cols=238 Identities=19% Similarity=0.261 Sum_probs=178.5
Q ss_pred ceEEE-EcCCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQG-RLPNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
.||.+ ...+|+.||||+++... ......+..|+.++.+++|++|+++++.+.++...++||||+++++|.+++..
T Consensus 16 ~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~- 94 (363)
T cd05628 16 EVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMK- 94 (363)
T ss_pred EEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHh-
Confidence 45555 45679999999997532 22345678899999999999999999999999999999999999999998843
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccc------------
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECE------------ 147 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~------------ 147 (309)
...+++..+..++.|++.|+.|||++ |++||||||+||+++.++.++|+|||++.........
T Consensus 95 --~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~ 169 (363)
T cd05628 95 --KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPS 169 (363)
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccccccccccccccccc
Confidence 34589999999999999999999998 9999999999999999999999999998654321100
Q ss_pred ---------------------ccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHH
Q 021682 148 ---------------------ANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLE 206 (309)
Q Consensus 148 ---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 206 (309)
.......||..|+|||.+.+..++.++|+|||||++|+|++|..||......+..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~---- 245 (363)
T cd05628 170 DFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETY---- 245 (363)
T ss_pred cccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHH----
Confidence 0011236899999999999989999999999999999999999999643322111
Q ss_pred HHHHHhhCCCCcccccccCCCcccHHHHHHHHHHHhhcccCCCC---CCCCHHHHHHH
Q 021682 207 YAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAA---DRPTMLEILVM 261 (309)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~---~Rpt~~ell~~ 261 (309)
........... +.+.. ....++.++|.+|+. +|+ .||+++|+++.
T Consensus 246 --~~i~~~~~~~~-~p~~~------~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 246 --KKVMNWKETLI-FPPEV------PISEKAKDLILRFCC-EWEHRIGAPGVEEIKTN 293 (363)
T ss_pred --HHHHcCcCccc-CCCcC------CCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCC
Confidence 11111000111 11110 112356678877654 344 46899999986
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=264.68 Aligned_cols=235 Identities=26% Similarity=0.382 Sum_probs=181.2
Q ss_pred cEEEEEEeecC-CcccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc-----------
Q 021682 14 QEMAVKRLSRT-SHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR----------- 80 (309)
Q Consensus 14 ~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------- 80 (309)
..||+|.++.. .......+..|+++++++ +|+||+++++++..+...++++||+.+++|.+++....
T Consensus 45 ~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 124 (334)
T cd05100 45 VTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTC 124 (334)
T ss_pred eeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccc
Confidence 46899988643 233456788999999999 89999999999999889999999999999999985432
Q ss_pred --cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 81 --RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 81 --~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
....+++..+..++.|++.|++|||+. |++|+||+|+||+++.++.++|+|||++................++..
T Consensus 125 ~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~ 201 (334)
T cd05100 125 KLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVK 201 (334)
T ss_pred cCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCce
Confidence 123477888899999999999999998 999999999999999999999999999875543222111211233467
Q ss_pred CCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHH
Q 021682 159 YVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRC 237 (309)
Q Consensus 159 y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (309)
|+|||.+.+..++.++||||||+++|+|++ |..||......+ ............. .......+
T Consensus 202 y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~~~---------~~~~~~~l 265 (334)
T cd05100 202 WMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-------LFKLLKEGHRMDK---------PANCTHEL 265 (334)
T ss_pred EcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCCCCC---------CCCCCHHH
Confidence 999999988889999999999999999998 778774332111 1111111111111 11122368
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHhcccC
Q 021682 238 MQVALLCVQENAADRPTMLEILVMLKSETA 267 (309)
Q Consensus 238 ~~li~~~l~~~p~~Rpt~~ell~~L~~~~~ 267 (309)
.+++.+||+.+|++|||+.++++.|+.+..
T Consensus 266 ~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 266 YMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred HHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=272.22 Aligned_cols=231 Identities=20% Similarity=0.235 Sum_probs=174.5
Q ss_pred ceEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHH-HHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTS---HQGLEEFENEV-KLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
+||++.. .+++.||+|++.... ......+..|. .+++.++|+||+++++++..++..++||||+.+++|.+++..
T Consensus 10 ~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 89 (325)
T cd05602 10 KVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR 89 (325)
T ss_pred EEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHh
Confidence 4566654 578899999986532 12223334444 456778999999999999999999999999999999888843
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
...+.+..+..++.||+.|+.|||+. |++||||||+||+++.++.++|+|||++........ ......|++.
T Consensus 90 ---~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~ 161 (325)
T cd05602 90 ---ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTSTFCGTPE 161 (325)
T ss_pred ---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--CcccccCCcc
Confidence 33478888899999999999999998 999999999999999999999999999864332211 1223468999
Q ss_pred CCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHH
Q 021682 159 YVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238 (309)
Q Consensus 159 y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (309)
|+|||.+.+..++.++|||||||++|+|++|..||......+. ....... . .. + .......+.
T Consensus 162 y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------~~~i~~~-~-~~-~--------~~~~~~~~~ 224 (325)
T cd05602 162 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM------YDNILNK-P-LQ-L--------KPNITNSAR 224 (325)
T ss_pred ccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH------HHHHHhC-C-cC-C--------CCCCCHHHH
Confidence 9999999998999999999999999999999999854322111 1111111 0 00 0 011223678
Q ss_pred HHHhhcccCCCCCCCCHHHHH
Q 021682 239 QVALLCVQENAADRPTMLEIL 259 (309)
Q Consensus 239 ~li~~~l~~~p~~Rpt~~ell 259 (309)
++|.+||+.+|.+||++.+.+
T Consensus 225 ~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 225 HLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred HHHHHHcccCHHHCCCCCCCH
Confidence 999999999999999987433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=267.88 Aligned_cols=244 Identities=24% Similarity=0.371 Sum_probs=186.3
Q ss_pred cceEEEEcC-CCc----EEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHH
Q 021682 3 VAICQGRLP-NGQ----EMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 3 ~~~~~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 76 (309)
+.||+|.+. +|+ .||+|.++... ....+.+..|+.+++.++|+||+++++++..+ ..+++++|+.+++|.+++
T Consensus 21 g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l 99 (316)
T cd05108 21 GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYV 99 (316)
T ss_pred ceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHH
Confidence 467888653 444 38999986543 34456788999999999999999999998765 567999999999999988
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccc
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGT 156 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 156 (309)
... ...++...++.++.|++.|++|||+. |++|+||||+||+++.++.++|+|||++.................+
T Consensus 100 ~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 174 (316)
T cd05108 100 REH--KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP 174 (316)
T ss_pred Hhc--cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccCCCcceeccCCccc
Confidence 542 23478889999999999999999998 8999999999999999999999999999876543322222222345
Q ss_pred cCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 157 YGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
..|+|||.+.+..++.++||||||+++|+|++ |..||......+ ............. +.....
T Consensus 175 ~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~~---------~~~~~~ 238 (316)
T cd05108 175 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGERLPQ---------PPICTI 238 (316)
T ss_pred eeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHhCCCCCCC---------CCCCCH
Confidence 68999999988899999999999999999997 888875432111 0111111111100 011223
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHHhcccCC
Q 021682 236 RCMQVALLCVQENAADRPTMLEILVMLKSETAD 268 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~ 268 (309)
.+.+++.+||+.+|++|||+.+++..|......
T Consensus 239 ~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 239 DVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 678999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=260.42 Aligned_cols=243 Identities=22% Similarity=0.373 Sum_probs=184.5
Q ss_pred ceEEEEcC----CCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCe------eEEEEeccCCCC
Q 021682 4 AICQGRLP----NGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQREE------KMLIYDYMPNKS 71 (309)
Q Consensus 4 ~~~~~~~~----~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------~~lv~e~~~~~~ 71 (309)
+||.|... .+..||+|.++... ......+..|+..++.++|+||+++++++..... .++++||+.+++
T Consensus 14 ~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~ 93 (273)
T cd05035 14 SVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGD 93 (273)
T ss_pred eEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCC
Confidence 56766543 24779999987542 3334678899999999999999999998766543 799999999999
Q ss_pred hhHHHhhhc---cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccc
Q 021682 72 LDFYIFDLR---RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEA 148 (309)
Q Consensus 72 L~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 148 (309)
|..++.... ....+++..+..++.|++.|+.|||+. |++|+||+|+||++++++.++|+|||++..........
T Consensus 94 l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 170 (273)
T cd05035 94 LHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYR 170 (273)
T ss_pred HHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCccceeecccccccc
Confidence 998875432 223588999999999999999999998 89999999999999999999999999987654332221
Q ss_pred cccccccccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCC
Q 021682 149 NTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDD 227 (309)
Q Consensus 149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (309)
......++..|+|||.+.+..++.++|||||||++|+|++ |..||......+ .. ...........
T Consensus 171 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~------~~-~~~~~~~~~~~------- 236 (273)
T cd05035 171 QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE------IY-DYLRHGNRLKQ------- 236 (273)
T ss_pred ccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH------HH-HHHHcCCCCCC-------
Confidence 1222234568999999988889999999999999999999 888875432211 11 11111111111
Q ss_pred cccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcc
Q 021682 228 SSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSE 265 (309)
Q Consensus 228 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~ 265 (309)
+......+.+++.+||+.||++|||+.+++..|+.+
T Consensus 237 --~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 237 --PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred --CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111233788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=269.73 Aligned_cols=238 Identities=24% Similarity=0.267 Sum_probs=191.9
Q ss_pred CccceEEEEcCCCcEEEEEEeecCCc---ccHHHHHHHHHHHhcCC-CCCccceeeEEeeCCeeEEEEeccCCCChhHHH
Q 021682 1 MSVAICQGRLPNGQEMAVKRLSRTSH---QGLEEFENEVKLTARLQ-HVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 1 ~g~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 76 (309)
||.|...-...+|+.+|+|.+.+... .+...+.+|+.+|+++. ||||+.+++++++...+++|||++.||.|.+.+
T Consensus 48 Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i 127 (382)
T KOG0032|consen 48 FGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRI 127 (382)
T ss_pred ceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHH
Confidence 44444444455799999999976533 34578999999999997 999999999999999999999999999999998
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCC----CCceeecccccccccCCcccccccc
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYE----MNPKISDFGMARAFTKDECEANTGR 152 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~----~~~~l~Dfg~~~~~~~~~~~~~~~~ 152 (309)
... .+++..+..++.|++.+++|||+. |++|+||||+|+++... +.++++|||++...... .....
T Consensus 128 ~~~----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~---~~~~~ 197 (382)
T KOG0032|consen 128 VKK----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPG---ERLHT 197 (382)
T ss_pred HHc----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCC---ceEee
Confidence 654 299999999999999999999998 99999999999999653 47999999999877762 23344
Q ss_pred cccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHH
Q 021682 153 IVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAW 232 (309)
Q Consensus 153 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (309)
..||+.|+|||.+....++..+|+||+|+++|.|++|.+||.......... ....+.. .+....-..
T Consensus 198 ~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~~~------~f~~~~w~~ 264 (382)
T KOG0032|consen 198 IVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRGDF------DFTSEPWDD 264 (382)
T ss_pred ecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcCCC------CCCCCCccc
Confidence 589999999999999999999999999999999999999996544333222 1111111 111111222
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 233 KLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 233 ~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
....+.++|++||..||..|+|+.++++.
T Consensus 265 is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 265 ISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred cCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 34477799999999999999999999996
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=264.30 Aligned_cols=235 Identities=26% Similarity=0.401 Sum_probs=182.7
Q ss_pred CCcEEEEEEeecCC-cccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccccCCCHHH
Q 021682 12 NGQEMAVKRLSRTS-HQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRT 89 (309)
Q Consensus 12 ~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 89 (309)
.+..||+|.++... ....+.+.+|+.+++++ +|+||+++++++...+..++||||+.+++|.+++.... ...+++..
T Consensus 64 ~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~ 142 (302)
T cd05055 64 AVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKR-ESFLTLED 142 (302)
T ss_pred ceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCC-CCCCCHHH
Confidence 45679999986543 33356788999999999 79999999999999999999999999999999885322 23489999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCccccccCC
Q 021682 90 RVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGI 169 (309)
Q Consensus 90 ~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 169 (309)
+..++.+++.|+.|||++ |++|+||+|+||+++.++.++|+|||++............+...++..|+|||.+.+..
T Consensus 143 ~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 219 (302)
T cd05055 143 LLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV 219 (302)
T ss_pred HHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCC
Confidence 999999999999999998 89999999999999999999999999987554332211222234567899999998888
Q ss_pred CCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHHhhcccCC
Q 021682 170 YSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQEN 248 (309)
Q Consensus 170 ~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 248 (309)
++.++|||||||++|++++ |..||......+. ............ ........+.+++.+||..+
T Consensus 220 ~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~------~~~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~ 284 (302)
T cd05055 220 YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK------FYKLIKEGYRMA---------QPEHAPAEIYDIMKTCWDAD 284 (302)
T ss_pred CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH------HHHHHHcCCcCC---------CCCCCCHHHHHHHHHHcCCC
Confidence 9999999999999999998 8888754322111 111111110000 01112237889999999999
Q ss_pred CCCCCCHHHHHHHHhcc
Q 021682 249 AADRPTMLEILVMLKSE 265 (309)
Q Consensus 249 p~~Rpt~~ell~~L~~~ 265 (309)
|++|||+.++++.|++.
T Consensus 285 p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 285 PLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred chhCcCHHHHHHHHHhh
Confidence 99999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=262.70 Aligned_cols=236 Identities=22% Similarity=0.327 Sum_probs=186.7
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
+.+|++.. .+|+.||+|.+........+.+..|+.+++.+.|+|++++++.+..+...++||||+.+++|.+++..
T Consensus 34 ~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--- 110 (296)
T cd06654 34 GTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--- 110 (296)
T ss_pred eEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHh---
Confidence 46788864 57899999998766555567788999999999999999999999999999999999999999998732
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP 161 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 161 (309)
..+++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||.+......... .....++..|+|
T Consensus 111 -~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~a 184 (296)
T cd06654 111 -TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMA 184 (296)
T ss_pred -cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccccc--cCcccCCccccC
Confidence 2378889999999999999999998 8999999999999999999999999988654332211 122357889999
Q ss_pred ccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHH
Q 021682 162 PEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241 (309)
Q Consensus 162 PE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 241 (309)
||.+.+..++.++|+|||||++|+|++|..||....... ......... ... ...+......+.+++
T Consensus 185 PE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~------~~~~~~~~~-~~~-------~~~~~~~~~~l~~li 250 (296)
T cd06654 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNG-TPE-------LQNPEKLSAIFRDFL 250 (296)
T ss_pred HHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH------hHHHHhcCC-CCC-------CCCccccCHHHHHHH
Confidence 999988888999999999999999999999985432211 000111110 000 001112334678999
Q ss_pred hhcccCCCCCCCCHHHHHHH
Q 021682 242 LLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 242 ~~~l~~~p~~Rpt~~ell~~ 261 (309)
.+||..+|++|||++++++.
T Consensus 251 ~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 251 NRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred HHHCcCCcccCcCHHHHhhC
Confidence 99999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=254.34 Aligned_cols=237 Identities=22% Similarity=0.264 Sum_probs=187.8
Q ss_pred cceEEEEc-CCCcEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
+.+|++.. .+|+.|++|.+... .......+..|++++++++|||++++++.+..+...++||||+.+++|.+++...
T Consensus 14 ~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 93 (256)
T cd08529 14 GVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQ 93 (256)
T ss_pred eEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHh
Confidence 35777765 47899999998643 3445677889999999999999999999999999999999999999999998543
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
....++...+..++.+++.|+.+||+. |++|+||+|+||+++.++.++|+|||++......... .....++..|
T Consensus 94 -~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y 167 (256)
T cd08529 94 -RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF--ANTIVGTPYY 167 (256)
T ss_pred -cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccch--hhccccCccc
Confidence 245688999999999999999999998 8999999999999999999999999988765443221 1223577889
Q ss_pred CCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHH
Q 021682 160 VPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQ 239 (309)
Q Consensus 160 ~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (309)
+|||...+..++.++|+||||+++++|++|..||....... .... ........ ........+.+
T Consensus 168 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~-~~~~~~~~---------~~~~~~~~~~~ 231 (256)
T cd08529 168 LSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA------LILK-IIRGVFPP---------VSQMYSQQLAQ 231 (256)
T ss_pred cCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH------HHHH-HHcCCCCC---------CccccCHHHHH
Confidence 99999988888999999999999999999999986433111 1111 11111111 11122347889
Q ss_pred HHhhcccCCCCCCCCHHHHHHH
Q 021682 240 VALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 240 li~~~l~~~p~~Rpt~~ell~~ 261 (309)
++.+||+.+|++||++.++++.
T Consensus 232 ~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 232 LIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred HHHHHccCCcccCcCHHHHhhC
Confidence 9999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=267.53 Aligned_cols=250 Identities=21% Similarity=0.312 Sum_probs=181.8
Q ss_pred ceEEEEc-CCCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
.||++.. .+++.||+|.++... ......+.+|+.++++++|+||+++++++..+...++||||+.+ +|..++...
T Consensus 21 ~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-- 97 (309)
T cd07872 21 TVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDC-- 97 (309)
T ss_pred EEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHHhc--
Confidence 5677754 478899999986543 22334677899999999999999999999999999999999975 777776432
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP 161 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 161 (309)
+..+++..+..++.|++.|+.|||+. |++||||+|+||+++.++.++|+|||++......... .....++..|+|
T Consensus 98 ~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~a 172 (309)
T cd07872 98 GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT--YSNEVVTLWYRP 172 (309)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCccc--cccccccccccC
Confidence 33478889999999999999999998 9999999999999999999999999998654332211 122356889999
Q ss_pred cccccc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH-----HhhCCCCc-ccc--c-ccCC----C
Q 021682 162 PEYVRK-GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYG-----LWKNGEGM-EFI--D-SSLD----D 227 (309)
Q Consensus 162 PE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~-~~~--~-~~~~----~ 227 (309)
||.+.+ ..++.++|||||||++|+|++|.+||...+..+.......... .|...... .+. . +... .
T Consensus 173 PE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (309)
T cd07872 173 PDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLI 252 (309)
T ss_pred CHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchh
Confidence 998865 4678999999999999999999999965544332221111100 00000000 000 0 0000 0
Q ss_pred cccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 228 SSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 228 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
........++.++|.+||+.||++|||++|+++.
T Consensus 253 ~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 253 NHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 0001123467899999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=263.11 Aligned_cols=245 Identities=24% Similarity=0.358 Sum_probs=188.6
Q ss_pred ceEEEEcCC-----CcEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeeEEee-CCeeEEEEeccCCCChhHHH
Q 021682 4 AICQGRLPN-----GQEMAVKRLSRT-SHQGLEEFENEVKLTARLQHVNLLPVLGICTQ-REEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 4 ~~~~~~~~~-----g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~~ 76 (309)
.||+|...+ ++.|++|.+... .......+..|+.++++++|+||+++++++.. +...+++++|+.+++|.+++
T Consensus 21 ~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l 100 (280)
T cd05043 21 RIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFL 100 (280)
T ss_pred eEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHH
Confidence 577777654 788999988644 23345678899999999999999999998766 46789999999999999998
Q ss_pred hhhccc-----cCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccc
Q 021682 77 FDLRRR-----YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTG 151 (309)
Q Consensus 77 ~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 151 (309)
...... ..+++..++.++.+++.|+.|||+. |++|+||+|+||+++.++.++|+|||+++............
T Consensus 101 ~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 177 (280)
T cd05043 101 QQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD 177 (280)
T ss_pred HhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCC
Confidence 654322 4588999999999999999999998 89999999999999999999999999987554332211111
Q ss_pred ccccccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCccc
Q 021682 152 RIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSS 230 (309)
Q Consensus 152 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (309)
...++..|+|||.+.+..++.++||||||+++|++++ |..||......+ ............ ..
T Consensus 178 ~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~~---------~~ 241 (280)
T cd05043 178 NENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE-------MAAYLKDGYRLA---------QP 241 (280)
T ss_pred CCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHcCCCCC---------CC
Confidence 2245667999999988889999999999999999998 999885432211 111111111100 01
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccC
Q 021682 231 AWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETA 267 (309)
Q Consensus 231 ~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~ 267 (309)
...+..+.+++.+||..+|++|||+.++++.|+.+..
T Consensus 242 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 242 INCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1123468899999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=269.55 Aligned_cols=234 Identities=21% Similarity=0.241 Sum_probs=179.0
Q ss_pred cceEEEEc-CCCcEEEEEEeecC---CcccHHHHHHHHHHHhcCCCC-CccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRT---SHQGLEEFENEVKLTARLQHV-NLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
+.||++.. .+++.||||++... .....+.+..|.+++..+.|+ +|+.+++++...+..++||||+.+++|.+++.
T Consensus 14 g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~ 93 (324)
T cd05587 14 GKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ 93 (324)
T ss_pred eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHH
Confidence 35666654 47889999998753 233456778899999999655 58888999998899999999999999988874
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
. ...+++..+..++.||+.|+.|||+. |++||||||+||+++.++.++|+|||++........ ......|+.
T Consensus 94 ~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~ 165 (324)
T cd05587 94 Q---VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK--TTRTFCGTP 165 (324)
T ss_pred H---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC--ceeeecCCc
Confidence 3 33488999999999999999999998 999999999999999999999999998864322111 122346889
Q ss_pred CCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHH
Q 021682 158 GYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRC 237 (309)
Q Consensus 158 ~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (309)
.|+|||.+.+..++.++|+|||||++|+|++|+.||......+ . ..... ... .. . +......+
T Consensus 166 ~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~---~~~i~-~~~-~~-----~----~~~~~~~~ 228 (324)
T cd05587 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---L---FQSIM-EHN-VS-----Y----PKSLSKEA 228 (324)
T ss_pred cccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---H---HHHHH-cCC-CC-----C----CCCCCHHH
Confidence 9999999999889999999999999999999999986432211 1 11111 110 00 0 11122367
Q ss_pred HHHHhhcccCCCCCCCCH-----HHHHHH
Q 021682 238 MQVALLCVQENAADRPTM-----LEILVM 261 (309)
Q Consensus 238 ~~li~~~l~~~p~~Rpt~-----~ell~~ 261 (309)
.+++.+||+.||++|++. +++++.
T Consensus 229 ~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 229 VSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred HHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 899999999999999986 566543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=260.97 Aligned_cols=241 Identities=22% Similarity=0.258 Sum_probs=183.8
Q ss_pred CccceEEEEcCCCcEEEEEEeecCCc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 1 MSVAICQGRLPNGQEMAVKRLSRTSH---QGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 1 ~g~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
||.++......+++.||+|.+..... .....+..|+.++++++|++++.+++.+..+...++||||+.+++|.+++.
T Consensus 13 ~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~ 92 (285)
T cd05630 13 FGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY 92 (285)
T ss_pred CeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHH
Confidence 45554444456899999999865422 223456789999999999999999999999999999999999999998875
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
... ...+++..+..++.|++.|+.|||+. |++|+||+|+||+++.++.++|+|||++........ .....|+.
T Consensus 93 ~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~g~~ 165 (285)
T cd05630 93 HMG-EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTV 165 (285)
T ss_pred Hhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc---ccCCCCCc
Confidence 422 33488999999999999999999998 999999999999999999999999999865433221 12236789
Q ss_pred CCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHH
Q 021682 158 GYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRC 237 (309)
Q Consensus 158 ~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (309)
.|+|||.+.+..++.++|+||+|+++|+|++|..||............. ...... ... . .......+
T Consensus 166 ~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~---~~~~~~-~~~-~--------~~~~~~~~ 232 (285)
T cd05630 166 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE---RLVKEV-QEE-Y--------SEKFSPDA 232 (285)
T ss_pred cccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHH---hhhhhh-hhh-c--------CccCCHHH
Confidence 9999999988889999999999999999999999986432211111111 110000 000 0 01122367
Q ss_pred HHHHhhcccCCCCCCCC-----HHHHHHH
Q 021682 238 MQVALLCVQENAADRPT-----MLEILVM 261 (309)
Q Consensus 238 ~~li~~~l~~~p~~Rpt-----~~ell~~ 261 (309)
.+++.+||+.||++||| ++|+++.
T Consensus 233 ~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 233 RSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred HHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 89999999999999999 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=262.07 Aligned_cols=241 Identities=25% Similarity=0.408 Sum_probs=183.4
Q ss_pred ceEEEEcC------CCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHH
Q 021682 4 AICQGRLP------NGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 4 ~~~~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 76 (309)
.||++... ++..||+|.+.... ......+..|+.++++++|+||+++++++......++||||+.+++|.+++
T Consensus 21 ~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i 100 (277)
T cd05036 21 EVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFL 100 (277)
T ss_pred cEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHH
Confidence 56777653 46789999886443 333456888999999999999999999998888899999999999999998
Q ss_pred hhhcc----ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCC---CceeecccccccccCCccccc
Q 021682 77 FDLRR----RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM---NPKISDFGMARAFTKDECEAN 149 (309)
Q Consensus 77 ~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~---~~~l~Dfg~~~~~~~~~~~~~ 149 (309)
..... ...+++..+..++.||+.++.|||+. |++|+||+|+||+++.++ .++|+|||++...........
T Consensus 101 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~ 177 (277)
T cd05036 101 RENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRK 177 (277)
T ss_pred HHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEeccCccccccCCccceec
Confidence 55332 12488899999999999999999998 899999999999998765 589999999876533222111
Q ss_pred ccccccccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCc
Q 021682 150 TGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDS 228 (309)
Q Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (309)
......+..|+|||.+.+..++.++|||||||++|+|++ |..||....... . ............
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~----~~~~~~~~~~~~-------- 242 (277)
T cd05036 178 GGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---V----MEFVTGGGRLDP-------- 242 (277)
T ss_pred CCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---H----HHHHHcCCcCCC--------
Confidence 222234568999999988889999999999999999997 888885432211 1 111111111110
Q ss_pred ccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHh
Q 021682 229 SSAWKLMRCMQVALLCVQENAADRPTMLEILVMLK 263 (309)
Q Consensus 229 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~ 263 (309)
+...+..+.+++.+||+.+|++|||+.+|++.|+
T Consensus 243 -~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 243 -PKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1112347789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=264.30 Aligned_cols=244 Identities=25% Similarity=0.386 Sum_probs=187.2
Q ss_pred ceEEEEcC------CCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHH
Q 021682 4 AICQGRLP------NGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 4 ~~~~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 76 (309)
.||+|... ....+++|.+.... .....++..|+.+++.++||||+++++.+..+...++++||+.+++|.+++
T Consensus 15 ~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 94 (290)
T cd05045 15 KVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFL 94 (290)
T ss_pred ceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHH
Confidence 57777642 23578999886543 334567889999999999999999999999999999999999999999987
Q ss_pred hhhc---------------------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecc
Q 021682 77 FDLR---------------------RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDF 135 (309)
Q Consensus 77 ~~~~---------------------~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Df 135 (309)
.... ....+++..++.++.|++.|+.+||+. |++|+||+|+||+++.++.++|+||
T Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nill~~~~~~kl~df 171 (290)
T cd05045 95 RESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDF 171 (290)
T ss_pred HhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheEEEcCCCcEEeccc
Confidence 5321 123478889999999999999999998 8999999999999999999999999
Q ss_pred cccccccCCcccccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhC
Q 021682 136 GMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKN 214 (309)
Q Consensus 136 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 214 (309)
|++................++..|+|||.+.+..++.++||||||+++|+|++ |..||....+.. .+.....
T Consensus 172 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~ 244 (290)
T cd05045 172 GLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER-------LFNLLKT 244 (290)
T ss_pred cccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHhC
Confidence 99875543322211222345668999999888888999999999999999998 888885432211 1111111
Q ss_pred CCCcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhccc
Q 021682 215 GEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSET 266 (309)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~ 266 (309)
.... ..+......+.+++.+||+.+|++||++.++++.|+++.
T Consensus 245 ~~~~---------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 245 GYRM---------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred CCCC---------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 1100 011112347889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=279.57 Aligned_cols=247 Identities=17% Similarity=0.228 Sum_probs=174.5
Q ss_pred ceEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeC--------CeeEEEEeccCCCChhH
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQR--------EEKMLIYDYMPNKSLDF 74 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~ 74 (309)
+||++.. .+++.||||.+.... .....|+.+++.++|+||+++++++... ..+++||||+.+ ++.+
T Consensus 81 ~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l~~ 155 (440)
T PTZ00036 81 VVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHK 155 (440)
T ss_pred EEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCc-cHHH
Confidence 5677754 578999999885432 2345799999999999999998876432 246799999975 6666
Q ss_pred HHhh-hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCC-CceeecccccccccCCcccccccc
Q 021682 75 YIFD-LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM-NPKISDFGMARAFTKDECEANTGR 152 (309)
Q Consensus 75 ~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~ 152 (309)
++.. ......+++..++.++.||+.||+|||+. ||+||||||+||+++.++ .+||+|||++......... ..
T Consensus 156 ~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~---~~ 229 (440)
T PTZ00036 156 YMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS---VS 229 (440)
T ss_pred HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccchhccCCCCc---cc
Confidence 6543 23345689999999999999999999998 899999999999998765 6999999999765432211 12
Q ss_pred cccccCCCCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH-----Hhh--CCCCccc----
Q 021682 153 IVGTYGYVPPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYG-----LWK--NGEGMEF---- 220 (309)
Q Consensus 153 ~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~-----~~~--~~~~~~~---- 220 (309)
..+++.|+|||.+.+. .++.++|||||||++|+|++|.+||......+.......... .+. .......
T Consensus 230 ~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~ 309 (440)
T PTZ00036 230 YICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPD 309 (440)
T ss_pred CCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCc
Confidence 3578899999988664 689999999999999999999999865433222111111000 000 0000000
Q ss_pred -ccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 221 -IDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 221 -~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.........+...+.++.+||.+||+.||.+|||+.|+++.
T Consensus 310 ~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 310 VKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred cCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00000000111123478899999999999999999999865
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=258.94 Aligned_cols=238 Identities=20% Similarity=0.280 Sum_probs=183.1
Q ss_pred ceEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccc
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRR 82 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 82 (309)
.+|.+. ..+++.||+|.++.........+.+|+.+++.++||||+++++.+..+...++||||+++++|.+++.. .
T Consensus 24 ~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~ 100 (267)
T cd06645 24 DVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHV---T 100 (267)
T ss_pred EEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHh---c
Confidence 456665 457999999998766555556788899999999999999999999999999999999999999998743 3
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCc
Q 021682 83 YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPP 162 (309)
Q Consensus 83 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 162 (309)
..+++..+..++.|++.++.|||+. |++|+||+|+||+++.++.++|+|||.+........ ......|+..|+||
T Consensus 101 ~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aP 175 (267)
T cd06645 101 GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA--KRKSFIGTPYWMAP 175 (267)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCccc--ccccccCcccccCh
Confidence 3589999999999999999999998 899999999999999999999999999865543221 12234678899999
Q ss_pred cccc---cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHH
Q 021682 163 EYVR---KGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQ 239 (309)
Q Consensus 163 E~~~---~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (309)
|.+. ...++.++|+|||||++|+|++|..||....+.... ............... ....+..+.+
T Consensus 176 E~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~------~~~~~~~~~~~~~~~------~~~~~~~~~~ 243 (267)
T cd06645 176 EVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL------FLMTKSNFQPPKLKD------KMKWSNSFHH 243 (267)
T ss_pred hhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH------HhhhccCCCCCcccc------cCCCCHHHHH
Confidence 9874 445788999999999999999999997543221110 000000000000000 0012236789
Q ss_pred HHhhcccCCCCCCCCHHHHHHH
Q 021682 240 VALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 240 li~~~l~~~p~~Rpt~~ell~~ 261 (309)
++.+||+.+|++|||++++++.
T Consensus 244 li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 244 FVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred HHHHHccCCchhCcCHHHHhcC
Confidence 9999999999999999999853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=258.24 Aligned_cols=235 Identities=27% Similarity=0.394 Sum_probs=187.1
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccc
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRR 82 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 82 (309)
++||.+.. .|+.||+|.++.... ..+++..|+.++++++|+||+++++++......++||||+++++|.+++.... .
T Consensus 20 g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~ 96 (256)
T cd05039 20 GDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRG-R 96 (256)
T ss_pred ceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcC-C
Confidence 46788875 589999999975544 46788999999999999999999999998889999999999999999885422 2
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCc
Q 021682 83 YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPP 162 (309)
Q Consensus 83 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 162 (309)
..+++..+..++.|++.|+.+||+. |++|+||+|.||+++.++.++|+|||.+........ ....+..|+||
T Consensus 97 ~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-----~~~~~~~~~ap 168 (256)
T cd05039 97 AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-----SGKLPVKWTAP 168 (256)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc-----cCCCcccccCc
Confidence 3589999999999999999999998 899999999999999999999999999876533221 12345679999
Q ss_pred cccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHH
Q 021682 163 EYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241 (309)
Q Consensus 163 E~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 241 (309)
|.+....++.++|+||||+++|++++ |..||......+ ............ .+...+..+.++|
T Consensus 169 e~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~~---------~~~~~~~~~~~li 232 (256)
T cd05039 169 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPHVEKGYRME---------APEGCPPEVYKVM 232 (256)
T ss_pred hhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHhcCCCCC---------CccCCCHHHHHHH
Confidence 99988888999999999999999997 888875432211 111111111111 0111234788999
Q ss_pred hhcccCCCCCCCCHHHHHHHHhc
Q 021682 242 LLCVQENAADRPTMLEILVMLKS 264 (309)
Q Consensus 242 ~~~l~~~p~~Rpt~~ell~~L~~ 264 (309)
.+||..+|++|||+++++.+|++
T Consensus 233 ~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 233 KDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred HHHhccChhhCcCHHHHHHHHhc
Confidence 99999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=273.43 Aligned_cols=237 Identities=19% Similarity=0.222 Sum_probs=181.4
Q ss_pred ceEEEE-cCCCcEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGR-LPNGQEMAVKRLSRT---SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
.||.+. ..+|+.||+|.+... .......+..|+.+++.++||||+++++++..+...++||||+++++|.+++..
T Consensus 58 ~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~- 136 (370)
T cd05596 58 EVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSN- 136 (370)
T ss_pred EEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHh-
Confidence 456665 457999999998643 222344577899999999999999999999999999999999999999988743
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
..+++..+..++.|++.|+.|||+. |++||||||+||+++.++.++|+|||++......... ......|++.|
T Consensus 137 ---~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~-~~~~~~gt~~y 209 (370)
T cd05596 137 ---YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV-RCDTAVGTPDY 209 (370)
T ss_pred ---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc-cCCCCCCCcCe
Confidence 2378888999999999999999998 8999999999999999999999999998765432211 12234689999
Q ss_pred CCccccccC----CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 160 VPPEYVRKG----IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 160 ~aPE~~~~~----~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
+|||.+.+. .++.++|+|||||++|+|++|..||....... .............+. .....+.
T Consensus 210 ~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~i~~~~~~~~~~-------~~~~~s~ 276 (370)
T cd05596 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TYSKIMDHKNSLTFP-------DDIEISK 276 (370)
T ss_pred ECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH------HHHHHHcCCCcCCCC-------CcCCCCH
Confidence 999988653 37889999999999999999999986432211 111111111111111 1111234
Q ss_pred HHHHHHhhcccCCCCC--CCCHHHHHHH
Q 021682 236 RCMQVALLCVQENAAD--RPTMLEILVM 261 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~--Rpt~~ell~~ 261 (309)
.+.++|.+||+.+|++ |+|++++++.
T Consensus 277 ~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 277 QAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred HHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 7789999999999987 9999999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=276.15 Aligned_cols=238 Identities=19% Similarity=0.285 Sum_probs=179.0
Q ss_pred ceEEEE-cCCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
.||++. ..+++.||+|.+.... ......+..|+.++++++|+||+++++.+..+...++||||+++++|.+++..
T Consensus 16 ~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~- 94 (382)
T cd05625 16 EVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIR- 94 (382)
T ss_pred EEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHh-
Confidence 456665 4688999999986542 22345688999999999999999999999999999999999999999988843
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcc-------------
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDEC------------- 146 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~------------- 146 (309)
...+++..+..++.||+.|+.|||++ ||+||||||+||+++.++.++|+|||++........
T Consensus 95 --~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~ 169 (382)
T cd05625 95 --MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQD 169 (382)
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccccccccccc
Confidence 33588999999999999999999998 899999999999999999999999998743210000
Q ss_pred --------------------------------cccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCC
Q 021682 147 --------------------------------EANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSC 194 (309)
Q Consensus 147 --------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~ 194 (309)
........||+.|+|||.+.+..++.++|||||||++|+|++|.+||.
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~ 249 (382)
T cd05625 170 SMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFL 249 (382)
T ss_pred cccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCC
Confidence 000112358899999999998899999999999999999999999996
Q ss_pred CCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCC---HHHHHHH
Q 021682 195 YYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPT---MLEILVM 261 (309)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~ell~~ 261 (309)
.....+. ............. ........++.++|.+|+ .+|++|++ ++++++.
T Consensus 250 ~~~~~~~------~~~i~~~~~~~~~-------p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 250 AQTPLET------QMKVINWQTSLHI-------PPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred CCCHHHH------HHHHHccCCCcCC-------CCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence 5332211 1111110000110 001112236678888876 59999997 8888764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=262.31 Aligned_cols=238 Identities=23% Similarity=0.402 Sum_probs=178.5
Q ss_pred cEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc---------cc
Q 021682 14 QEMAVKRLSRT-SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR---------RY 83 (309)
Q Consensus 14 ~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------~~ 83 (309)
..||+|.++.. .......+.+|++++++++|+|++++++++..+...++||||+.+++|.+++..... ..
T Consensus 45 ~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 124 (295)
T cd05097 45 VLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIP 124 (295)
T ss_pred eEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCC
Confidence 35899998654 333456789999999999999999999999999999999999999999998854221 12
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCcc
Q 021682 84 LLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPE 163 (309)
Q Consensus 84 ~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 163 (309)
.+++..++.++.+++.|++|||+. |++|+||+|+||+++.++.++|+|||++............+...++..|+|||
T Consensus 125 ~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 201 (295)
T cd05097 125 SVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWE 201 (295)
T ss_pred cccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChh
Confidence 367888999999999999999998 89999999999999999999999999986544332222222334567899999
Q ss_pred ccccCCCCccchhhhHHHHHHHHHh--CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHH
Q 021682 164 YVRKGIYSMKYDVYSYGVLLLQILG--GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241 (309)
Q Consensus 164 ~~~~~~~~~~~DvwslG~il~~ll~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 241 (309)
.+.+..++.++|+||||+++|+|++ +..||......+ ........+.......... .+...+..+.+++
T Consensus 202 ~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li 272 (295)
T cd05097 202 SILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ---VIENTGEFFRNQGRQIYLS------QTPLCPSPVFKLM 272 (295)
T ss_pred hhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH---HHHHHHHhhhhccccccCC------CCCCCCHHHHHHH
Confidence 9988889999999999999999998 455654322211 1111111111111111110 0111234788999
Q ss_pred hhcccCCCCCCCCHHHHHHHHh
Q 021682 242 LLCVQENAADRPTMLEILVMLK 263 (309)
Q Consensus 242 ~~~l~~~p~~Rpt~~ell~~L~ 263 (309)
.+||+.+|++|||++++++.|+
T Consensus 273 ~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 273 MRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHcCCCchhCcCHHHHHHHHh
Confidence 9999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=263.60 Aligned_cols=242 Identities=25% Similarity=0.418 Sum_probs=185.0
Q ss_pred ceEEEEcC------CCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHH
Q 021682 4 AICQGRLP------NGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 4 ~~~~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 76 (309)
.||++... ++..||+|.+.... ......+..|+.++++++||||+++++++..+...++++||+.+++|.+++
T Consensus 20 ~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 99 (288)
T cd05050 20 RVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFL 99 (288)
T ss_pred cEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHH
Confidence 56666542 57889999986543 334567889999999999999999999999999999999999999999998
Q ss_pred hhhc-------------------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccc
Q 021682 77 FDLR-------------------RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGM 137 (309)
Q Consensus 77 ~~~~-------------------~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~ 137 (309)
.... ....+++..++.++.+++.|+.+||+. |++|+||+|+||+++.++.++|+|||+
T Consensus 100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 176 (288)
T cd05050 100 RHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGL 176 (288)
T ss_pred HHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhheEecCCCceEECcccc
Confidence 5421 112467888999999999999999998 899999999999999999999999999
Q ss_pred cccccCCcccccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCC
Q 021682 138 ARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGE 216 (309)
Q Consensus 138 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 216 (309)
+.................+..|+|||.+.+..++.++|||||||++|+|++ |..||......+ .. .......
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~------~~-~~~~~~~ 249 (288)
T cd05050 177 SRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE------VI-YYVRDGN 249 (288)
T ss_pred ceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH------HH-HHHhcCC
Confidence 865443322111222234567999999988889999999999999999997 777764322211 11 1111111
Q ss_pred CcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 021682 217 GMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKS 264 (309)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~ 264 (309)
... .+...+.++.+++.+||+.+|++|||+.|+++.|++
T Consensus 250 ~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 250 VLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred CCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 111 011123478899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=256.53 Aligned_cols=238 Identities=21% Similarity=0.288 Sum_probs=186.5
Q ss_pred ceEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccc
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRR 82 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 82 (309)
.+|++.. .+++.+++|.+........+.+..|+.++++++||||+++++.+..+...+++|||+.+++|.+++... .
T Consensus 18 ~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~--~ 95 (262)
T cd06613 18 DVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVT--R 95 (262)
T ss_pred EEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhh--c
Confidence 4666654 468899999998765556788999999999999999999999999999999999999999999887442 2
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCc
Q 021682 83 YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPP 162 (309)
Q Consensus 83 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 162 (309)
..+++..+..++.|++.++.+||+. |++|+||+|+||+++.++.++|+|||.+........ ......++..|+||
T Consensus 96 ~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~P 170 (262)
T cd06613 96 GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA--KRKSFIGTPYWMAP 170 (262)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhh--ccccccCCccccCc
Confidence 4588999999999999999999998 899999999999999999999999999865543221 11223567789999
Q ss_pred cccccC---CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHH
Q 021682 163 EYVRKG---IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQ 239 (309)
Q Consensus 163 E~~~~~---~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (309)
|.+.+. .++.++|+||||+++|+|++|..||........ . .......... .........+..+.+
T Consensus 171 e~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~---~---~~~~~~~~~~------~~~~~~~~~~~~~~~ 238 (262)
T cd06613 171 EVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA---L---FLISKSNFPP------PKLKDKEKWSPVFHD 238 (262)
T ss_pred hhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH---H---HHHHhccCCC------ccccchhhhhHHHHH
Confidence 998776 788999999999999999999999854332111 1 0000000000 001112234457889
Q ss_pred HHhhcccCCCCCCCCHHHHHH
Q 021682 240 VALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 240 li~~~l~~~p~~Rpt~~ell~ 260 (309)
++.+||..+|.+|||+++++.
T Consensus 239 li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 239 FIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HHHHHcCCChhhCCCHHHHhc
Confidence 999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=264.48 Aligned_cols=248 Identities=25% Similarity=0.385 Sum_probs=183.6
Q ss_pred ceEEEEc-----CCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeC--CeeEEEEeccCCCChhHHH
Q 021682 4 AICQGRL-----PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQR--EEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 4 ~~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~~ 76 (309)
.||.+.. .+++.||+|.+..........+..|++++++++|+||+++++++... ...++|+||+++++|.+++
T Consensus 19 ~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 98 (284)
T cd05081 19 SVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYL 98 (284)
T ss_pred eEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHH
Confidence 4666653 46889999998766655567889999999999999999999976543 4689999999999999998
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccc-ccccccc
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEA-NTGRIVG 155 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~-~~~~~~~ 155 (309)
... ...+++..+..++.|++.|+++||+. |++|+||+|+||+++.++.++|+|||++.......... ......+
T Consensus 99 ~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 173 (284)
T cd05081 99 QKH--RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGES 173 (284)
T ss_pred Hhc--CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCC
Confidence 432 33488999999999999999999998 99999999999999999999999999987654332211 1111123
Q ss_pred ccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCc---------ccHHHHHHHHhhCCCCcccccccCC
Q 021682 156 TYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNES---------LNLLEYAYGLWKNGEGMEFIDSSLD 226 (309)
Q Consensus 156 ~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (309)
+..|+|||.+.+..++.++|+||||+++|+|++|..++......-. ............... .
T Consensus 174 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~ 244 (284)
T cd05081 174 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNG---------R 244 (284)
T ss_pred ceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCC---------c
Confidence 4469999999888889999999999999999998766432211000 000000000011000 0
Q ss_pred CcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcc
Q 021682 227 DSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSE 265 (309)
Q Consensus 227 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~ 265 (309)
..........+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 245 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 245 LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 001111233688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=261.12 Aligned_cols=241 Identities=24% Similarity=0.408 Sum_probs=180.7
Q ss_pred CCcEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc--------c
Q 021682 12 NGQEMAVKRLSRT-SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR--------R 82 (309)
Q Consensus 12 ~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------~ 82 (309)
++..||+|.+... .......+..|+.+++.++|+||+++++++..+...++||||+.+++|.+++..... .
T Consensus 45 ~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 124 (296)
T cd05095 45 QPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124 (296)
T ss_pred ceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccc
Confidence 3557899998754 333456889999999999999999999999999999999999999999998855321 1
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCc
Q 021682 83 YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPP 162 (309)
Q Consensus 83 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 162 (309)
..+++..+..++.|++.|+++||+. |++|+||||+||+++.++.++|+|||++............+...++..|++|
T Consensus 125 ~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p 201 (296)
T cd05095 125 VTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSW 201 (296)
T ss_pred cccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCH
Confidence 2467788999999999999999998 8999999999999999999999999998755433222222223446789999
Q ss_pred cccccCCCCccchhhhHHHHHHHHHh--CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHH
Q 021682 163 EYVRKGIYSMKYDVYSYGVLLLQILG--GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQV 240 (309)
Q Consensus 163 E~~~~~~~~~~~DvwslG~il~~ll~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 240 (309)
|...+..++.++|+|||||++|+|++ |..||......+. .................. . +...+..+.++
T Consensus 202 e~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~-~-----~~~~~~~~~~l 272 (296)
T cd05095 202 ESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV---IENTGEFFRDQGRQVYLP-K-----PALCPDSLYKL 272 (296)
T ss_pred HHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHH---HHHHHHHHhhccccccCC-C-----CCCCCHHHHHH
Confidence 98888889999999999999999998 6677643322111 111111111111111110 0 11122478899
Q ss_pred HhhcccCCCCCCCCHHHHHHHHhc
Q 021682 241 ALLCVQENAADRPTMLEILVMLKS 264 (309)
Q Consensus 241 i~~~l~~~p~~Rpt~~ell~~L~~ 264 (309)
+.+||+.||++|||+.+|++.|+.
T Consensus 273 i~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 273 MLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHcCCCcccCCCHHHHHHHHhC
Confidence 999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=259.10 Aligned_cols=242 Identities=23% Similarity=0.394 Sum_probs=186.4
Q ss_pred ceEEEEcC------CCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHH
Q 021682 4 AICQGRLP------NGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 4 ~~~~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 76 (309)
.||.+... ++..||+|.+.... ......+.+|+.+++.++|+||+++++++..+...++||||+.+++|.+++
T Consensus 21 ~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l 100 (277)
T cd05032 21 MVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYL 100 (277)
T ss_pred eEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHH
Confidence 46766543 34789999986443 233456889999999999999999999999999999999999999999998
Q ss_pred hhhcc-------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccc
Q 021682 77 FDLRR-------RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEAN 149 (309)
Q Consensus 77 ~~~~~-------~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 149 (309)
..... ...+++..+..++.|++.|+.|||+. |++|+||+|+||+++.++.++|+|||++...........
T Consensus 101 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~ 177 (277)
T cd05032 101 RSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRK 177 (277)
T ss_pred HhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEECCcccchhhccCccccc
Confidence 54322 22367888999999999999999998 899999999999999999999999999876544332222
Q ss_pred ccccccccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCc
Q 021682 150 TGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDS 228 (309)
Q Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (309)
.....++..|+|||.+.+..++.++|||||||++|++++ |..||......+ ...............
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~------ 244 (277)
T cd05032 178 GGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE-------VLKFVIDGGHLDLPE------ 244 (277)
T ss_pred CCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH-------HHHHHhcCCCCCCCC------
Confidence 233356778999999988889999999999999999998 888875322211 111111111111111
Q ss_pred ccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 021682 229 SSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKS 264 (309)
Q Consensus 229 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~ 264 (309)
..+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 245 ---~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 245 ---NCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred ---CCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 113478899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=272.62 Aligned_cols=248 Identities=21% Similarity=0.266 Sum_probs=181.3
Q ss_pred ceEEEE-cCCCcEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCC-----eeEEEEeccCCCChhHH
Q 021682 4 AICQGR-LPNGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQRE-----EKMLIYDYMPNKSLDFY 75 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~ 75 (309)
.||++. ..+|+.||||.+... .......+.+|+++++.++|+||+++++++.... ..++|+||+. ++|...
T Consensus 15 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~ 93 (372)
T cd07853 15 VVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKI 93 (372)
T ss_pred EEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHH
Confidence 566665 458999999998643 2233457889999999999999999999998776 7899999996 567666
Q ss_pred HhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccc
Q 021682 76 IFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVG 155 (309)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 155 (309)
+. ....+++..+..++.|++.|+.|||+. |++||||||+||+++.++.++|+|||++......... ......+
T Consensus 94 ~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~~ 166 (372)
T cd07853 94 IV---SPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK-HMTQEVV 166 (372)
T ss_pred Hh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecccCccc-cCCCCCc
Confidence 63 334589999999999999999999998 8999999999999999999999999998754432211 1222356
Q ss_pred ccCCCCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHH----------------HHHhhC-CCC
Q 021682 156 TYGYVPPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYA----------------YGLWKN-GEG 217 (309)
Q Consensus 156 ~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~----------------~~~~~~-~~~ 217 (309)
+..|+|||.+.+. .++.++|||||||++|+|++|+.||......+....+... ...+.. ...
T Consensus 167 ~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 246 (372)
T cd07853 167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHK 246 (372)
T ss_pred CCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCC
Confidence 8899999998774 4789999999999999999999999654433221111100 000000 000
Q ss_pred cccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 218 MEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
........ ........++.++|.+||+.||++|||++|+++.
T Consensus 247 ~~~~~~~~--~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 247 PPSLPVLY--TLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred CCchHHhc--ccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000000 0001123467899999999999999999999975
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=256.03 Aligned_cols=246 Identities=23% Similarity=0.336 Sum_probs=180.5
Q ss_pred cceEEEEcC---CCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 3 VAICQGRLP---NGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 3 ~~~~~~~~~---~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
+.||+|... ++..+|+|.++... ......+.+|+.++++++||||+++++++......++||||+++++|.+++..
T Consensus 9 g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 88 (269)
T cd05087 9 GKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRS 88 (269)
T ss_pred ceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHH
Confidence 357888653 34679999886543 23345688899999999999999999999988889999999999999999854
Q ss_pred hcc--ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccc
Q 021682 79 LRR--RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGT 156 (309)
Q Consensus 79 ~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 156 (309)
... ....++..+..++.|++.|+.|||+. |++|+||||+||+++.++.++|+|||.+................++
T Consensus 89 ~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~ 165 (269)
T cd05087 89 CRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVP 165 (269)
T ss_pred hhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCc
Confidence 322 23456777888999999999999998 8999999999999999999999999998654332221122223467
Q ss_pred cCCCCccccccC-------CCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCc
Q 021682 157 YGYVPPEYVRKG-------IYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDS 228 (309)
Q Consensus 157 ~~y~aPE~~~~~-------~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (309)
..|+|||.+.+. .++.++|+||||+++|+|++ |..||......+. .. .... ........+.....
T Consensus 166 ~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~---~~~~-~~~~~~~~~~~~~~ 238 (269)
T cd05087 166 LRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LT---YTVR-EQQLKLPKPRLKLP 238 (269)
T ss_pred ccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HH---HHhh-cccCCCCCCccCCC
Confidence 789999987542 35789999999999999996 9999854332211 11 1111 11111111111111
Q ss_pred ccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHh
Q 021682 229 SSAWKLMRCMQVALLCVQENAADRPTMLEILVMLK 263 (309)
Q Consensus 229 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~ 263 (309)
....+.+++.+|| .+|++|||+++|+..|+
T Consensus 239 ----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 239 ----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred ----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1225678999998 68999999999999886
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=257.53 Aligned_cols=239 Identities=24% Similarity=0.379 Sum_probs=185.8
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccc
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRR 82 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 82 (309)
+.||++..+++..||+|.+..... ..+.+.+|+.++++++|++++++++++. ....+++|||+.+++|.+++... ..
T Consensus 20 ~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~-~~ 96 (260)
T cd05070 20 GEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDG-EG 96 (260)
T ss_pred ceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHHHHHHhc-CC
Confidence 367888877888999999865433 3567899999999999999999999875 45678999999999999988542 23
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCc
Q 021682 83 YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPP 162 (309)
Q Consensus 83 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 162 (309)
..+++..++.++.+++.|+++||+. |++|+||+|+||+++.++.++|+|||.+.......... .....++..|+||
T Consensus 97 ~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aP 172 (260)
T cd05070 97 RALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA-RQGAKFPIKWTAP 172 (260)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccccc-ccCCCCCccccCh
Confidence 3478999999999999999999998 89999999999999999999999999987654322111 1112345679999
Q ss_pred cccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHH
Q 021682 163 EYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241 (309)
Q Consensus 163 E~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 241 (309)
|.+.+..++.++|+||||+++|+|++ |..||......+ .. ......... ..+...+..+.+++
T Consensus 173 E~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~------~~-~~~~~~~~~---------~~~~~~~~~~~~li 236 (260)
T cd05070 173 EAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE------VL-EQVERGYRM---------PCPQDCPISLHELM 236 (260)
T ss_pred HHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH------HH-HHHHcCCCC---------CCCCcCCHHHHHHH
Confidence 99988888999999999999999999 888885432211 11 111111100 11112234788999
Q ss_pred hhcccCCCCCCCCHHHHHHHHhc
Q 021682 242 LLCVQENAADRPTMLEILVMLKS 264 (309)
Q Consensus 242 ~~~l~~~p~~Rpt~~ell~~L~~ 264 (309)
.+||+.+|++|||++++++.|+.
T Consensus 237 ~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 237 LQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHcccCcccCcCHHHHHHHHhc
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=262.46 Aligned_cols=250 Identities=20% Similarity=0.244 Sum_probs=184.0
Q ss_pred ceEEEEc-CCCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
.||.+.. .+|+.+|+|.+.... .....++..|++++++++||||+++++.+..++..++||||+++++|.+++...
T Consensus 16 ~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~-- 93 (308)
T cd06615 16 VVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-- 93 (308)
T ss_pred EEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhc--
Confidence 4566654 578899999986542 333466889999999999999999999999999999999999999999998433
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP 161 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 161 (309)
..+++..+..++.|+++|+.|||+.+ +++|+||+|+||+++.++.++|+|||++....... .....++..|+|
T Consensus 94 -~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~a 166 (308)
T cd06615 94 -GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMS 166 (308)
T ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc----cccCCCCcCccC
Confidence 44889999999999999999999743 89999999999999999999999999876443221 222457889999
Q ss_pred ccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCC---c--c----------------c
Q 021682 162 PEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEG---M--E----------------F 220 (309)
Q Consensus 162 PE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~--~----------------~ 220 (309)
||.+.+..++.++|+||||+++|+|++|..||...+.................... . . .
T Consensus 167 PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (308)
T cd06615 167 PERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYI 246 (308)
T ss_pred hhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHH
Confidence 99998888899999999999999999999998543221110000000000000000 0 0 0
Q ss_pred ccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 021682 221 IDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVML 262 (309)
Q Consensus 221 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L 262 (309)
................+.+++.+||..+|++|||++++++..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 247 VNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred hcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 000000000001334688999999999999999999999763
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=262.31 Aligned_cols=240 Identities=27% Similarity=0.404 Sum_probs=181.5
Q ss_pred CcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc--------cc
Q 021682 13 GQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR--------RY 83 (309)
Q Consensus 13 g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------~~ 83 (309)
+..||+|.+.... ....+.+..|++++++++|+||+++++++..+...+++||++.+++|..++..... ..
T Consensus 46 ~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 125 (296)
T cd05051 46 PVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125 (296)
T ss_pred ceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCC
Confidence 3568999987543 33456788999999999999999999999998999999999999999999854321 12
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCcc
Q 021682 84 LLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPE 163 (309)
Q Consensus 84 ~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 163 (309)
.+++..++.++.|++.|+++||+. |++|+||+|+||+++.++.++|+|||++............+...++..|+|||
T Consensus 126 ~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 202 (296)
T cd05051 126 SLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWE 202 (296)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHc---CccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHH
Confidence 588999999999999999999998 89999999999999999999999999986544332222233345567899999
Q ss_pred ccccCCCCccchhhhHHHHHHHHHh--CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHH
Q 021682 164 YVRKGIYSMKYDVYSYGVLLLQILG--GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241 (309)
Q Consensus 164 ~~~~~~~~~~~DvwslG~il~~ll~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 241 (309)
.+.+..++.++|||||||++|+|++ +..||..... ..........+.......... .+...+.++.+++
T Consensus 203 ~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li 273 (296)
T cd05051 203 SVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD---QQVIENAGHFFRDDGRQIYLP------RPPNCPKDIYELM 273 (296)
T ss_pred HhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh---HHHHHHHHhccccccccccCC------CccCCCHHHHHHH
Confidence 9988889999999999999999998 5566543221 111111111111111111111 1111234788999
Q ss_pred hhcccCCCCCCCCHHHHHHHHhc
Q 021682 242 LLCVQENAADRPTMLEILVMLKS 264 (309)
Q Consensus 242 ~~~l~~~p~~Rpt~~ell~~L~~ 264 (309)
.+||+.||++|||+.+|++.|+.
T Consensus 274 ~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 274 LECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HHHhccChhcCCCHHHHHHHhcC
Confidence 99999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=258.24 Aligned_cols=235 Identities=23% Similarity=0.260 Sum_probs=183.9
Q ss_pred eEEEE-cCCCcEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccc
Q 021682 5 ICQGR-LPNGQEMAVKRLSRT-SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRR 82 (309)
Q Consensus 5 ~~~~~-~~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 82 (309)
+|.+. ..+++.+|+|.++.. .....+.+..|+.+++.++|+||+++++.+..+...+++|||+++++|.+++.. ...
T Consensus 16 v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~ 94 (255)
T cd08219 16 ALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKL-QRG 94 (255)
T ss_pred EEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHh-ccC
Confidence 44444 458999999998643 334456788999999999999999999999999999999999999999888743 234
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCc
Q 021682 83 YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPP 162 (309)
Q Consensus 83 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 162 (309)
..+++..+..++.+++.|+.+||+. |++|+||+|+||+++.++.++|+|||.+......... .....++..|+||
T Consensus 95 ~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~aP 169 (255)
T cd08219 95 KLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY--ACTYVGTPYYVPP 169 (255)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccccc--cccccCCccccCH
Confidence 4578999999999999999999998 8999999999999999999999999998655432211 1224578889999
Q ss_pred cccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHHh
Q 021682 163 EYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVAL 242 (309)
Q Consensus 163 E~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 242 (309)
|.+.+..++.++|+||||+++|+|++|..||...+... .... ...+..... +......+.+++.
T Consensus 170 E~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~-~~~~~~~~~---------~~~~~~~~~~li~ 233 (255)
T cd08219 170 EIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN------LILK-VCQGSYKPL---------PSHYSYELRSLIK 233 (255)
T ss_pred HHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH------HHHH-HhcCCCCCC---------CcccCHHHHHHHH
Confidence 99988889999999999999999999999985432211 1111 111111111 1112336789999
Q ss_pred hcccCCCCCCCCHHHHHHH
Q 021682 243 LCVQENAADRPTMLEILVM 261 (309)
Q Consensus 243 ~~l~~~p~~Rpt~~ell~~ 261 (309)
+||+.||++|||+.+++..
T Consensus 234 ~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 234 QMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHhCCcccCCCHHHHhhc
Confidence 9999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=257.47 Aligned_cols=240 Identities=26% Similarity=0.398 Sum_probs=187.8
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccc
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRR 82 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 82 (309)
++||++..++++.||||.+.... .....+.+|+.++++++|+||+++++++..+...++|||++++++|.+++... ..
T Consensus 20 ~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~-~~ 97 (261)
T cd05034 20 GEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSG-EG 97 (261)
T ss_pred eEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhcc-cc
Confidence 46788887788899999986543 34577899999999999999999999999888999999999999999988542 23
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCc
Q 021682 83 YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPP 162 (309)
Q Consensus 83 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 162 (309)
..+++..+..++.+++.|+.+||++ |++|+||+|+||+++.++.++|+|||.+.......... .....++..|+||
T Consensus 98 ~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~y~~P 173 (261)
T cd05034 98 KKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA-REGAKFPIKWTAP 173 (261)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhhhh-hhccCCCccccCH
Confidence 4588999999999999999999998 89999999999999999999999999987654322111 1112345689999
Q ss_pred cccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHH
Q 021682 163 EYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241 (309)
Q Consensus 163 E~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 241 (309)
|.+.+..++.++|+||||+++|++++ |+.||....... .. .. ....... ..+...+..+.+++
T Consensus 174 E~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~---~~-~~~~~~~---------~~~~~~~~~~~~~i 237 (261)
T cd05034 174 EAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VL---EQ-VERGYRM---------PRPPNCPEELYDLM 237 (261)
T ss_pred HHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH---HH-HHcCCCC---------CCCCCCCHHHHHHH
Confidence 99988888999999999999999998 898885322111 11 11 1111000 00011134788999
Q ss_pred hhcccCCCCCCCCHHHHHHHHhc
Q 021682 242 LLCVQENAADRPTMLEILVMLKS 264 (309)
Q Consensus 242 ~~~l~~~p~~Rpt~~ell~~L~~ 264 (309)
.+||+.+|++|||++++++.|+.
T Consensus 238 ~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 238 LQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHHcccCcccCCCHHHHHHHHhc
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=262.00 Aligned_cols=252 Identities=23% Similarity=0.264 Sum_probs=182.3
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
+.+|++.. .+|+.||||.++... ......+.+|+.++++++||||+++++++..+...++||||+. ++|.+++...
T Consensus 14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~ 92 (285)
T cd07861 14 GVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSL 92 (285)
T ss_pred eEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcC
Confidence 45777765 479999999986432 2234678899999999999999999999999999999999997 5787877554
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
..+..+++..+..++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++........ ......++..|
T Consensus 93 ~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y 167 (285)
T cd07861 93 PKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR--VYTHEVVTLWY 167 (285)
T ss_pred CCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc--cccCCcccccc
Confidence 4445689999999999999999999998 899999999999999999999999999865443221 11223567889
Q ss_pred CCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH-----HHhhCCCCc----ccccccCCC--
Q 021682 160 VPPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAY-----GLWKNGEGM----EFIDSSLDD-- 227 (309)
Q Consensus 160 ~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~----~~~~~~~~~-- 227 (309)
+|||.+.+. .++.++|+|||||++|+|++|++||................ ..|...... ..+......
T Consensus 168 ~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (285)
T cd07861 168 RAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSL 247 (285)
T ss_pred cChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchh
Confidence 999987654 56889999999999999999999986432211100000000 000000000 000000000
Q ss_pred -cccHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021682 228 -SSSAWKLMRCMQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 228 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
........++.++|.+||+.||++|||+.+++.
T Consensus 248 ~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 248 RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000012346779999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=264.38 Aligned_cols=237 Identities=25% Similarity=0.375 Sum_probs=183.2
Q ss_pred CCcEEEEEEeecC-CcccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc--------
Q 021682 12 NGQEMAVKRLSRT-SHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR-------- 81 (309)
Q Consensus 12 ~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------- 81 (309)
++..||+|.+... .......+..|+.+++.+ +||||+++++++......+++|||+.+++|.+++.....
T Consensus 46 ~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 125 (304)
T cd05101 46 EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 125 (304)
T ss_pred cceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccc
Confidence 3557999998644 234456788999999999 899999999999999999999999999999999865321
Q ss_pred -----ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccc
Q 021682 82 -----RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGT 156 (309)
Q Consensus 82 -----~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 156 (309)
...+++..+..++.|++.|+.|||+. |++|+||||+||+++.++.++|+|||.+................++
T Consensus 126 ~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~ 202 (304)
T cd05101 126 IARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLP 202 (304)
T ss_pred cccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCC
Confidence 23477888999999999999999998 9999999999999999999999999998766443322222222445
Q ss_pred cCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 157 YGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
..|+|||.+.+..++.++||||||+++|++++ |..||...... .. ........... .+.....
T Consensus 203 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~-~~~~~~~~~~~---------~~~~~~~ 266 (304)
T cd05101 203 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE------EL-FKLLKEGHRMD---------KPANCTN 266 (304)
T ss_pred ceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH------HH-HHHHHcCCcCC---------CCCCCCH
Confidence 68999999988889999999999999999998 77776432211 11 11111111111 0112234
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHHhcccC
Q 021682 236 RCMQVALLCVQENAADRPTMLEILVMLKSETA 267 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~ 267 (309)
.+.+++.+||+.+|++|||+.++++.|+++..
T Consensus 267 ~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 267 ELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred HHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 78899999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=261.72 Aligned_cols=236 Identities=22% Similarity=0.367 Sum_probs=186.4
Q ss_pred cceEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 3 VAICQGR-LPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 3 ~~~~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
+.+|++. ..+|+.||+|.+........+.+.+|+..++.++|+|++++++++..+...++|+||+.+++|..++..
T Consensus 33 g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--- 109 (296)
T cd06655 33 GTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE--- 109 (296)
T ss_pred eEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHh---
Confidence 3567775 468999999998765555567888999999999999999999999999999999999999999988732
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP 161 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 161 (309)
..+++..+..++.+++.++.+||+. |++|+||+|+||+++.++.++|+|||++......... .....++..|+|
T Consensus 110 -~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~a 183 (296)
T cd06655 110 -TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMA 183 (296)
T ss_pred -cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccccc--CCCcCCCccccC
Confidence 2488999999999999999999998 9999999999999999999999999988654433211 122357789999
Q ss_pred ccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHH
Q 021682 162 PEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241 (309)
Q Consensus 162 PE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 241 (309)
||.+.+..++.++|+|||||++|++++|..||........ . ....... ... . ..+......+.++|
T Consensus 184 PE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~---~---~~~~~~~-~~~-~------~~~~~~~~~~~~li 249 (296)
T cd06655 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA---L---YLIATNG-TPE-L------QNPEKLSPIFRDFL 249 (296)
T ss_pred cchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---H---HHHHhcC-Ccc-c------CCcccCCHHHHHHH
Confidence 9999888889999999999999999999999854332111 1 0111110 000 0 01111233678999
Q ss_pred hhcccCCCCCCCCHHHHHHH
Q 021682 242 LLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 242 ~~~l~~~p~~Rpt~~ell~~ 261 (309)
.+||..+|++|||+.++++.
T Consensus 250 ~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 250 NRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred HHHhhcChhhCCCHHHHhhC
Confidence 99999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=256.21 Aligned_cols=239 Identities=26% Similarity=0.388 Sum_probs=186.4
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccc
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRR 82 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 82 (309)
+.||.+..++++.||+|.+.... ....++..|+.++++++|+|++++++++. ....+++||++.+++|.+++... .+
T Consensus 20 g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~-~~ 96 (260)
T cd05067 20 GEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTP-EG 96 (260)
T ss_pred ceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhc-CC
Confidence 36788888889999999986443 34568899999999999999999999874 45689999999999999887542 24
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCc
Q 021682 83 YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPP 162 (309)
Q Consensus 83 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 162 (309)
..+++..+..++.+++.|+++||+. |++|+||+|+||+++.++.++|+|||.+......... ......++..|+||
T Consensus 97 ~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~p 172 (260)
T cd05067 97 IKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT-AREGAKFPIKWTAP 172 (260)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc-cccCCcccccccCH
Confidence 4588899999999999999999998 8999999999999999999999999998665432211 11122456789999
Q ss_pred cccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHH
Q 021682 163 EYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241 (309)
Q Consensus 163 E~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 241 (309)
|.+.+..++.++|+||||+++|++++ |..||......+ . ........... .....+.++.+++
T Consensus 173 e~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~----~~~~~~~~~~~---------~~~~~~~~~~~li 236 (260)
T cd05067 173 EAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE---V----IQNLERGYRMP---------RPDNCPEELYELM 236 (260)
T ss_pred HHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH---H----HHHHHcCCCCC---------CCCCCCHHHHHHH
Confidence 99988888999999999999999998 999985432211 1 11111111111 0111233788999
Q ss_pred hhcccCCCCCCCCHHHHHHHHhc
Q 021682 242 LLCVQENAADRPTMLEILVMLKS 264 (309)
Q Consensus 242 ~~~l~~~p~~Rpt~~ell~~L~~ 264 (309)
.+||..+|++|||+++++..|+.
T Consensus 237 ~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 237 RLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHHccCChhhCCCHHHHHHHhhc
Confidence 99999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=259.49 Aligned_cols=244 Identities=25% Similarity=0.358 Sum_probs=183.6
Q ss_pred cceEEEEcC-CCc----EEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHH
Q 021682 3 VAICQGRLP-NGQ----EMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 3 ~~~~~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 76 (309)
++||++.+. +|+ .|++|.+.... ......+..|+..++++.||||+++++++.. ...++++|++.+++|.+++
T Consensus 21 ~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~~~~gsL~~~l 99 (279)
T cd05111 21 GTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQLSPLGSLLDHV 99 (279)
T ss_pred cceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEeCCCCcHHHHH
Confidence 357888753 455 47777764332 2233567778888999999999999998764 4577899999999999998
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccc
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGT 156 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 156 (309)
... ...+++..+..++.|++.|+.|||+. |++|+||+|+||+++.++.++|+|||.+................++
T Consensus 100 ~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 174 (279)
T cd05111 100 RQH--RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTP 174 (279)
T ss_pred Hhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCc
Confidence 532 34589999999999999999999998 8999999999999999999999999998765433222222233466
Q ss_pred cCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 157 YGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
..|+|||.+.+..++.++||||||+++|++++ |..||....... ....+..+..... +. ....
T Consensus 175 ~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~~--~~-------~~~~ 238 (279)
T cd05111 175 IKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-------VPDLLEKGERLAQ--PQ-------ICTI 238 (279)
T ss_pred ccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHCCCcCCC--CC-------CCCH
Confidence 78999999988889999999999999999998 988875432211 1111111111110 00 1123
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHHhcccCC
Q 021682 236 RCMQVALLCVQENAADRPTMLEILVMLKSETAD 268 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~ 268 (309)
.+.+++.+||..||++|||+.|+++.|..+..+
T Consensus 239 ~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 239 DVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 567899999999999999999999999887553
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=255.75 Aligned_cols=240 Identities=23% Similarity=0.336 Sum_probs=185.7
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccc
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRR 82 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 82 (309)
++||.+...++..||+|.++... .....+..|++++++++|+||+++++++.. ...++||||+.+++|.+++... ..
T Consensus 20 ~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~-~~ 96 (262)
T cd05071 20 GEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-MG 96 (262)
T ss_pred CcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCCCcHHHHHhhc-cc
Confidence 46788887777789999986533 234678999999999999999999998754 5678999999999999998542 23
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCc
Q 021682 83 YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPP 162 (309)
Q Consensus 83 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 162 (309)
..+++..+..++.+++.|+++||+. |++|+||+|+||+++.++.++|+|||.+.......... .....++..|+||
T Consensus 97 ~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~-~~~~~~~~~y~~P 172 (262)
T cd05071 97 KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA-RQGAKFPIKWTAP 172 (262)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccccc-ccCCcccceecCH
Confidence 4578899999999999999999998 89999999999999999999999999987554332211 1123456689999
Q ss_pred cccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHH
Q 021682 163 EYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241 (309)
Q Consensus 163 E~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 241 (309)
|...+..++.++|+||||+++|++++ |..||....... ....... .. ........+..+.+++
T Consensus 173 E~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~------~~~~~~~-~~---------~~~~~~~~~~~l~~li 236 (262)
T cd05071 173 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------VLDQVER-GY---------RMPCPPECPESLHDLM 236 (262)
T ss_pred hHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH------HHHHHhc-CC---------CCCCccccCHHHHHHH
Confidence 99988889999999999999999999 787875432111 0111111 00 0011122334788999
Q ss_pred hhcccCCCCCCCCHHHHHHHHhcc
Q 021682 242 LLCVQENAADRPTMLEILVMLKSE 265 (309)
Q Consensus 242 ~~~l~~~p~~Rpt~~ell~~L~~~ 265 (309)
.+||+.+|++|||+.++++.|+..
T Consensus 237 ~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 237 CQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred HHHccCCcccCCCHHHHHHHHHHh
Confidence 999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=257.48 Aligned_cols=232 Identities=19% Similarity=0.298 Sum_probs=177.0
Q ss_pred cceEEEEcCC-------------CcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCC
Q 021682 3 VAICQGRLPN-------------GQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPN 69 (309)
Q Consensus 3 ~~~~~~~~~~-------------g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 69 (309)
+.||+|.+.. ...|++|.+..........+.+|+.+++.++||||+++++++..+...++||||+.+
T Consensus 9 ~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 88 (262)
T cd05077 9 TQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEF 88 (262)
T ss_pred ceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccC
Confidence 4678886532 235899988655444556788899999999999999999999988889999999999
Q ss_pred CChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCC-------ceeeccccccccc
Q 021682 70 KSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMN-------PKISDFGMARAFT 142 (309)
Q Consensus 70 ~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~-------~~l~Dfg~~~~~~ 142 (309)
++|..++.. ....+++..+..++.|+++|++|||+. |++|+||+|+||+++.++. ++++|||++....
T Consensus 89 ~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~ 163 (262)
T cd05077 89 GPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVL 163 (262)
T ss_pred CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCCCCCcccc
Confidence 999888743 234589999999999999999999998 8999999999999987664 8999999875443
Q ss_pred CCcccccccccccccCCCCccccc-cCCCCccchhhhHHHHHHHHH-hCCCCCCCCCCCCcccHHHHHHHHhhCCCCccc
Q 021682 143 KDECEANTGRIVGTYGYVPPEYVR-KGIYSMKYDVYSYGVLLLQIL-GGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEF 220 (309)
Q Consensus 143 ~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~~ll-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (309)
.. ....++..|+|||.+. +..++.++|||||||++|+|+ .|..|+......+ . ...... .. ..
T Consensus 164 ~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~----~---~~~~~~-~~-~~ 228 (262)
T cd05077 164 SR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE----K---ERFYEG-QC-ML 228 (262)
T ss_pred Cc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH----H---HHHHhc-Cc-cC
Confidence 22 1235677899999886 456889999999999999998 4777764322111 0 011111 00 00
Q ss_pred ccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHh
Q 021682 221 IDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLK 263 (309)
Q Consensus 221 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~ 263 (309)
. . .....+.+++.+||+.||.+||++.+|++.++
T Consensus 229 ~-----~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 229 V-----T----PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred C-----C----CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0 0 11236789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=261.60 Aligned_cols=249 Identities=22% Similarity=0.288 Sum_probs=176.0
Q ss_pred ceEEEE-cCCCcEEEEEEeecCC--cccHHHHHHHHHHHhcC---CCCCccceeeEEeeC-----CeeEEEEeccCCCCh
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTS--HQGLEEFENEVKLTARL---QHVNLLPVLGICTQR-----EEKMLIYDYMPNKSL 72 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L 72 (309)
.||++. ..+|+.||+|.++... .........|+.+++.+ +||||+++++++... ...+++||++.+ +|
T Consensus 15 ~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l 93 (288)
T cd07863 15 TVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DL 93 (288)
T ss_pred EEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEccccc-CH
Confidence 456665 4589999999986542 22223456677776655 799999999987642 358999999974 78
Q ss_pred hHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccc
Q 021682 73 DFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGR 152 (309)
Q Consensus 73 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 152 (309)
..++... ....+++..+..++.|++.|+.|||+. |++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 94 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~ 166 (288)
T cd07863 94 RTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA---LTP 166 (288)
T ss_pred HHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccccccCccc---CCC
Confidence 7776432 233489999999999999999999998 899999999999999999999999999875543221 122
Q ss_pred cccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcc-------cccccC
Q 021682 153 IVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGME-------FIDSSL 225 (309)
Q Consensus 153 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~ 225 (309)
..++..|+|||.+.+..++.++|||||||++|+|++|.+||......+................... .+....
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (288)
T cd07863 167 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRG 246 (288)
T ss_pred ccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCC
Confidence 3578899999999888899999999999999999999999864433221111111000000000000 000000
Q ss_pred C---CcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021682 226 D---DSSSAWKLMRCMQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 226 ~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
. ..........+.++|.+||+.||++|||+.+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 247 PRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 0001112346789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=249.60 Aligned_cols=229 Identities=26% Similarity=0.325 Sum_probs=180.5
Q ss_pred CCCcEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccccCCCHH
Q 021682 11 PNGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWR 88 (309)
Q Consensus 11 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 88 (309)
.+|+.+|+|++... +..+.+.+++|+++-+.|+||||+++.+........+||+|++.|+.|-.-+.. +-.+++.
T Consensus 34 ~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~---R~~ySEa 110 (355)
T KOG0033|consen 34 TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA---REFYSEA 110 (355)
T ss_pred cchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHH---HHHHHHH
Confidence 57889999987543 444678899999999999999999999999999999999999999988654422 3447888
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCC---CCCceeecccccccccCCcccccccccccccCCCCcccc
Q 021682 89 TRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY---EMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYV 165 (309)
Q Consensus 89 ~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~---~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 165 (309)
.+-....||++++.|+|.+ ||+|||+||+|+++-. ..-+||+|||++...+.. .......||+.|+|||++
T Consensus 111 ~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g---~~~~G~~GtP~fmaPEvv 184 (355)
T KOG0033|consen 111 DASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG---EAWHGFAGTPGYLSPEVL 184 (355)
T ss_pred HHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeCCc---cccccccCCCcccCHHHh
Confidence 8999999999999999999 9999999999999954 345999999999887732 223345899999999999
Q ss_pred ccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHHhhcc
Q 021682 166 RKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCV 245 (309)
Q Consensus 166 ~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 245 (309)
...+++..+|||+.|+++|-|+.|.+||-..+.... ......+... .+...-....++..+|+++||
T Consensus 185 rkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rl-------ye~I~~g~yd------~~~~~w~~is~~Ak~LvrrML 251 (355)
T KOG0033|consen 185 KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL-------YEQIKAGAYD------YPSPEWDTVTPEAKSLIRRML 251 (355)
T ss_pred hcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHH-------HHHHhccccC------CCCcccCcCCHHHHHHHHHHh
Confidence 999999999999999999999999999843222211 1111111110 011111122346779999999
Q ss_pred cCCCCCCCCHHHHHHH
Q 021682 246 QENAADRPTMLEILVM 261 (309)
Q Consensus 246 ~~~p~~Rpt~~ell~~ 261 (309)
..||++|.|+.|.++.
T Consensus 252 ~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 252 TVNPKKRITADEALKH 267 (355)
T ss_pred ccChhhhccHHHHhCC
Confidence 9999999999998865
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=251.68 Aligned_cols=230 Identities=27% Similarity=0.353 Sum_probs=179.5
Q ss_pred cCCCcEEEEEEeecC-----Cc---ccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 10 LPNGQEMAVKRLSRT-----SH---QGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 10 ~~~g~~vavK~~~~~-----~~---~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
..+|+.+|+|++... +. ..++.-..|+.+|+++ .||+|+.+.++++.+..+++|+|.|+.|-|.|++..
T Consensus 39 k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts-- 116 (411)
T KOG0599|consen 39 KETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTS-- 116 (411)
T ss_pred cccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhh--
Confidence 357889999988432 11 1234456899999998 799999999999999999999999999999999954
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCC
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYV 160 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 160 (309)
...+++...+.+..|+.+++.|||.+ +|+||||||+||++++|.+++|+|||+++........ ....||++|+
T Consensus 117 -~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~~l~~GekL---relCGTPgYL 189 (411)
T KOG0599|consen 117 -KVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFACQLEPGEKL---RELCGTPGYL 189 (411)
T ss_pred -heeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceeeccCCchhH---HHhcCCCccc
Confidence 44499999999999999999999999 8999999999999999999999999999877665433 2347999999
Q ss_pred Ccccccc------CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHH
Q 021682 161 PPEYVRK------GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKL 234 (309)
Q Consensus 161 aPE~~~~------~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
|||.+.. .+|+...|+|++|+++|.|+.|.+||-.. .+ +.. .+....++..- ....=...+
T Consensus 190 APEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR---kQ---mlM-LR~ImeGkyqF------~speWadis 256 (411)
T KOG0599|consen 190 APETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR---KQ---MLM-LRMIMEGKYQF------RSPEWADIS 256 (411)
T ss_pred ChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH---HH---HHH-HHHHHhccccc------CCcchhhcc
Confidence 9998854 46788999999999999999999998311 10 111 11111111110 011111123
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 235 MRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 235 ~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
....++|.+||+.||.+|.|++|++..
T Consensus 257 ~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 257 ATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred ccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 356799999999999999999999865
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=255.87 Aligned_cols=241 Identities=27% Similarity=0.403 Sum_probs=184.0
Q ss_pred cceEEEEcC----CCcEEEEEEeecCCc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 3 VAICQGRLP----NGQEMAVKRLSRTSH-QGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 3 ~~~~~~~~~----~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
+.||+|.+. ++..||+|.+..... .....+..|+.+++.+.|+||+++++++. ....++||||+.+++|.+++.
T Consensus 9 g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~ 87 (257)
T cd05060 9 GSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLK 87 (257)
T ss_pred eeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHH
Confidence 356666532 237899999875533 24567889999999999999999999876 456899999999999999985
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccc-ccccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEAN-TGRIVGT 156 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~-~~~~~~~ 156 (309)
.. ..+++..+..++.|++.++++||.. |++|+||+|+||+++.++.++|+|||.+........... .....++
T Consensus 88 ~~---~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~ 161 (257)
T cd05060 88 KR---REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWP 161 (257)
T ss_pred hC---CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCcccc
Confidence 43 2589999999999999999999998 899999999999999999999999999876644322111 1111234
Q ss_pred cCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 157 YGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
..|+|||.+.+..++.++|+||||+++|++++ |..||...+..+ .. .......... .+.....
T Consensus 162 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~----~~~~~~~~~~---------~~~~~~~ 225 (257)
T cd05060 162 LKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VI----AMLESGERLP---------RPEECPQ 225 (257)
T ss_pred ccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HH----HHHHcCCcCC---------CCCCCCH
Confidence 57999999988889999999999999999998 899885432211 11 1111111111 1111223
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHHhccc
Q 021682 236 RCMQVALLCVQENAADRPTMLEILVMLKSET 266 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~ 266 (309)
.+.+++.+||..+|++|||+.++++.|++..
T Consensus 226 ~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 226 EIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 7889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=265.37 Aligned_cols=252 Identities=19% Similarity=0.249 Sum_probs=180.6
Q ss_pred ceEEEEc-CCCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
+||.+.. .+|+.||+|.+.... ......+.+|+.+++.++||||+++++++..++..++||||+++++|.+++....
T Consensus 15 ~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~ 94 (327)
T cd08227 15 TVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHF 94 (327)
T ss_pred EEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhc
Confidence 4666654 589999999986542 2334567889999999999999999999999999999999999999999885432
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccc-----ccccccc
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEA-----NTGRIVG 155 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~-----~~~~~~~ 155 (309)
...+++..+..++.|++.|++|||+. |++|+||||+||+++.++.++++||+............ ......+
T Consensus 95 -~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (327)
T cd08227 95 -MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVK 170 (327)
T ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccc
Confidence 23488999999999999999999998 89999999999999999999999997653322111100 0112245
Q ss_pred ccCCCCcccccc--CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhh-------------------C
Q 021682 156 TYGYVPPEYVRK--GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWK-------------------N 214 (309)
Q Consensus 156 ~~~y~aPE~~~~--~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------~ 214 (309)
+..|+|||.+.+ ..++.++|||||||++|+|++|..||......... ......... .
T Consensus 171 ~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (327)
T cd08227 171 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKLNGTVPCLLDTTTIPAEELTMKPSRS 248 (327)
T ss_pred eecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH--HHHhcCCccccccccchhhhhcccCCccc
Confidence 677999999876 45889999999999999999999998643221100 000000000 0
Q ss_pred CCCccccc--------c----cCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 215 GEGMEFID--------S----SLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 215 ~~~~~~~~--------~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
........ . .............+.+++.+||+.||++|||++++++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 249 GANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred CCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 00000000 0 00000111234478899999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=255.99 Aligned_cols=238 Identities=25% Similarity=0.414 Sum_probs=185.1
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccc
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRR 82 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 82 (309)
+.||++...+++.+|+|.+.... .....+..|++++++++||+++++++++......++|+||+.+++|.+++... .
T Consensus 18 g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~ 94 (256)
T cd05112 18 GLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQ--R 94 (256)
T ss_pred ceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhC--c
Confidence 36788887778899999986443 23467889999999999999999999999988999999999999999887432 2
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCc
Q 021682 83 YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPP 162 (309)
Q Consensus 83 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 162 (309)
..+++..+..++.+++.++++||+. |++|+||+|+||+++.++.++|+|||.+.......... .....++..|+||
T Consensus 95 ~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~~~aP 170 (256)
T cd05112 95 GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS-STGTKFPVKWSSP 170 (256)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcccc-cCCCccchhhcCH
Confidence 3478899999999999999999998 89999999999999999999999999886554332111 1112345689999
Q ss_pred cccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHH
Q 021682 163 EYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241 (309)
Q Consensus 163 E~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 241 (309)
|.+.+..++.++|+||||+++|++++ |..||....... .. ...... .....+.. ....+.+++
T Consensus 171 e~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~~-~~~~~~--~~~~~~~~-------~~~~~~~l~ 234 (256)
T cd05112 171 EVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE------VV-ETINAG--FRLYKPRL-------ASQSVYELM 234 (256)
T ss_pred hHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH------HH-HHHhCC--CCCCCCCC-------CCHHHHHHH
Confidence 99988888999999999999999998 888875322111 11 111111 01111110 124788999
Q ss_pred hhcccCCCCCCCCHHHHHHHHh
Q 021682 242 LLCVQENAADRPTMLEILVMLK 263 (309)
Q Consensus 242 ~~~l~~~p~~Rpt~~ell~~L~ 263 (309)
.+||+.+|++|||+.++++.|.
T Consensus 235 ~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 235 QHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred HHHcccChhhCCCHHHHHHhhC
Confidence 9999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=270.86 Aligned_cols=247 Identities=18% Similarity=0.177 Sum_probs=182.0
Q ss_pred cceEEEEc---CCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 3 VAICQGRL---PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 3 ~~~~~~~~---~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
+.||.+.. .+++.||+|.+... ....+|++++++++|+||+++++++......++|||++. ++|..++.
T Consensus 106 g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~-- 177 (392)
T PHA03207 106 GEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYVD-- 177 (392)
T ss_pred eEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHHH--
Confidence 35666643 35678999987543 234679999999999999999999999999999999995 57777772
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
....+++..++.++.||+.|+.|||++ |++||||||+||+++.++.++|+|||++................|+..|
T Consensus 178 -~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y 253 (392)
T PHA03207 178 -RSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLET 253 (392)
T ss_pred -hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCc
Confidence 334589999999999999999999998 9999999999999999999999999998765543322223335689999
Q ss_pred CCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCC-----------------ccccc
Q 021682 160 VPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEG-----------------MEFID 222 (309)
Q Consensus 160 ~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~ 222 (309)
+|||.+.+..++.++|||||||++|+|++|+.||........................ .....
T Consensus 254 ~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (392)
T PHA03207 254 NSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLR 333 (392)
T ss_pred cCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhccccc
Confidence 9999999889999999999999999999999998654433221111111111100000 00000
Q ss_pred ccCCCcc---cHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 223 SSLDDSS---SAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 223 ~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
....... ......++.++|.+||..||++|||+.|++..
T Consensus 334 ~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 334 PPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred CCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000 00123467799999999999999999999976
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=267.36 Aligned_cols=233 Identities=21% Similarity=0.247 Sum_probs=178.7
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS---HQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
+.||++.. .+++.||||.++... ......+..|..++..+ .|++|+++++++...+..++||||+.+++|..++.
T Consensus 14 g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~ 93 (323)
T cd05616 14 GKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQ 93 (323)
T ss_pred eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHH
Confidence 35677654 478899999987542 22334566778888777 68899999999999999999999999999988874
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
. ...+++..+..++.|++.|+.|||++ |++||||||+||+++.++.++|+|||++........ ......|++
T Consensus 94 ~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~ 165 (323)
T cd05616 94 Q---VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTKTFCGTP 165 (323)
T ss_pred H---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC--ccccCCCCh
Confidence 3 33488999999999999999999998 899999999999999999999999999865332211 122346889
Q ss_pred CCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHH
Q 021682 158 GYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRC 237 (309)
Q Consensus 158 ~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (309)
.|+|||.+.+..++.++|+|||||++|+|++|..||....... ... . ...... . .+.....++
T Consensus 166 ~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---~~~---~-i~~~~~-~---------~p~~~s~~~ 228 (323)
T cd05616 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQ---S-IMEHNV-A---------YPKSMSKEA 228 (323)
T ss_pred hhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH---HHH---H-HHhCCC-C---------CCCcCCHHH
Confidence 9999999999999999999999999999999999986432211 111 1 111110 0 011123377
Q ss_pred HHHHhhcccCCCCCCCCH-----HHHHH
Q 021682 238 MQVALLCVQENAADRPTM-----LEILV 260 (309)
Q Consensus 238 ~~li~~~l~~~p~~Rpt~-----~ell~ 260 (309)
.+++.+||+.+|++|++. .++++
T Consensus 229 ~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 229 VAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred HHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 899999999999999984 66654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=263.05 Aligned_cols=249 Identities=24% Similarity=0.376 Sum_probs=187.6
Q ss_pred cceEEEEcC-CCc--EEEEEEeecC-CcccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 3 VAICQGRLP-NGQ--EMAVKRLSRT-SHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 3 ~~~~~~~~~-~g~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
+.||++... +|. .+++|.++.. .....+.+..|+.+++++ +||||+++++++......++++||+++++|.+++.
T Consensus 16 g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 95 (297)
T cd05089 16 GQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLR 95 (297)
T ss_pred ceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHH
Confidence 357777654 343 4788888643 333456788999999999 79999999999998889999999999999999985
Q ss_pred hhc-------------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCC
Q 021682 78 DLR-------------RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKD 144 (309)
Q Consensus 78 ~~~-------------~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~ 144 (309)
... ....+++..++.++.|++.|+++||+. |++|+||||+||+++.++.++|+|||++......
T Consensus 96 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 172 (297)
T cd05089 96 KSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEVY 172 (297)
T ss_pred hccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEECCcCCCccccce
Confidence 422 123478899999999999999999998 9999999999999999999999999987532211
Q ss_pred cccccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccc
Q 021682 145 ECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDS 223 (309)
Q Consensus 145 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (309)
. .......+..|+|||.+.+..++.++|||||||++|+|++ |..||......+ . ..........
T Consensus 173 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~---~----~~~~~~~~~~----- 237 (297)
T cd05089 173 V---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE---L----YEKLPQGYRM----- 237 (297)
T ss_pred e---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---H----HHHHhcCCCC-----
Confidence 1 1111123457999999988888999999999999999997 999985432211 1 1111111000
Q ss_pred cCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccCCCCCCC
Q 021682 224 SLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETADIKTPK 273 (309)
Q Consensus 224 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~~~~~~ 273 (309)
..+......+.+++.+||+.+|.+|||++++++.|+.+.+...+.-
T Consensus 238 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~~ 283 (297)
T cd05089 238 ----EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAYV 283 (297)
T ss_pred ----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcccc
Confidence 0111123478899999999999999999999999988877655443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=266.00 Aligned_cols=227 Identities=22% Similarity=0.296 Sum_probs=174.8
Q ss_pred ceEEEE-cCCCcEEEEEEeecC---CcccHHHHHHHHHHHhcCC-CCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 4 AICQGR-LPNGQEMAVKRLSRT---SHQGLEEFENEVKLTARLQ-HVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
.||.+. ..+|+.||||+++.. .......+..|..+++.+. |++|+++++++..++..++||||+++++|..++..
T Consensus 15 ~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~ 94 (323)
T cd05615 15 KVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQ 94 (323)
T ss_pred EEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHH
Confidence 455554 458999999998753 2233456778888888884 67788899999999999999999999999888743
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
...+++..+..++.|++.|+.|||++ |++||||||+||+++.++.++|+|||++........ ......|+..
T Consensus 95 ---~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~--~~~~~~gt~~ 166 (323)
T cd05615 95 ---VGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV--TTRTFCGTPD 166 (323)
T ss_pred ---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCCc--cccCccCCcc
Confidence 33489999999999999999999998 899999999999999999999999999865332211 1222358899
Q ss_pred CCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHH
Q 021682 159 YVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238 (309)
Q Consensus 159 y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (309)
|+|||.+.+..++.++|+|||||++|+|++|..||....... .. ...... . ..+ +......+.
T Consensus 167 y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~---~~i~~~-~-~~~---------p~~~~~~~~ 229 (323)
T cd05615 167 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE---LF---QSIMEH-N-VSY---------PKSLSKEAV 229 (323)
T ss_pred ccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH---HH---HHHHhC-C-CCC---------CccCCHHHH
Confidence 999999988889999999999999999999999986432211 11 111111 0 000 111223678
Q ss_pred HHHhhcccCCCCCCCCH
Q 021682 239 QVALLCVQENAADRPTM 255 (309)
Q Consensus 239 ~li~~~l~~~p~~Rpt~ 255 (309)
+++.+||+.+|++|++.
T Consensus 230 ~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 230 SICKGLMTKHPSKRLGC 246 (323)
T ss_pred HHHHHHcccCHhhCCCC
Confidence 99999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=263.17 Aligned_cols=237 Identities=24% Similarity=0.386 Sum_probs=182.2
Q ss_pred CCcEEEEEEeecCC-cccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc--------
Q 021682 12 NGQEMAVKRLSRTS-HQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR-------- 81 (309)
Q Consensus 12 ~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------- 81 (309)
.+..||+|.++... ......+..|+.+++++ +||||+++++++..+...+++|||+.+++|.+++.....
T Consensus 43 ~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~ 122 (314)
T cd05099 43 QTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFD 122 (314)
T ss_pred cceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCccccccc
Confidence 35679999986542 33456788999999999 699999999999988899999999999999999855321
Q ss_pred -----ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccc
Q 021682 82 -----RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGT 156 (309)
Q Consensus 82 -----~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 156 (309)
...+++..+..++.|++.|+.|||+. |++|+||+|+||+++.++.++|+|||.+................++
T Consensus 123 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~ 199 (314)
T cd05099 123 ITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLP 199 (314)
T ss_pred ccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCC
Confidence 23478889999999999999999998 9999999999999999999999999998765432221111112334
Q ss_pred cCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 157 YGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
..|+|||.+.+..++.++|+||||+++|++++ |..||......+ ............. +.....
T Consensus 200 ~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~~~---------~~~~~~ 263 (314)
T cd05099 200 VKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE-------LFKLLREGHRMDK---------PSNCTH 263 (314)
T ss_pred ccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCCCC---------CCCCCH
Confidence 57999999988889999999999999999998 788874332211 1111111111111 111233
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHHhcccC
Q 021682 236 RCMQVALLCVQENAADRPTMLEILVMLKSETA 267 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~ 267 (309)
++.+++.+||..+|++|||+.++++.|++...
T Consensus 264 ~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 264 ELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 77899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=260.07 Aligned_cols=245 Identities=23% Similarity=0.395 Sum_probs=185.0
Q ss_pred cceEEEEcC------CCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHH
Q 021682 3 VAICQGRLP------NGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFY 75 (309)
Q Consensus 3 ~~~~~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (309)
+.||+|... .+..||+|.+.... ......+.+|+.+++.++|+||+++++++......++||||+.+++|.++
T Consensus 20 g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~ 99 (288)
T cd05061 20 GMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSY 99 (288)
T ss_pred cEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHH
Confidence 357777532 35579999886443 22344678899999999999999999999988899999999999999999
Q ss_pred Hhhhcc-------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccc
Q 021682 76 IFDLRR-------RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEA 148 (309)
Q Consensus 76 ~~~~~~-------~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 148 (309)
+..... .....+..+..++.|++.|+.|||+. |++|+||||+||+++.++.++|+|||++..........
T Consensus 100 l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~ 176 (288)
T cd05061 100 LRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR 176 (288)
T ss_pred HHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEECcCCcccccccccccc
Confidence 864321 22345677889999999999999998 89999999999999999999999999987544332222
Q ss_pred cccccccccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCC
Q 021682 149 NTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDD 227 (309)
Q Consensus 149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (309)
......++..|+|||.+.+..++.++|+|||||++|+|++ |..||......+ . .............
T Consensus 177 ~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~------~-~~~~~~~~~~~~~------ 243 (288)
T cd05061 177 KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ------V-LKFVMDGGYLDQP------ 243 (288)
T ss_pred ccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH------H-HHHHHcCCCCCCC------
Confidence 2222345678999999988889999999999999999998 677875322211 1 1111111111110
Q ss_pred cccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhccc
Q 021682 228 SSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSET 266 (309)
Q Consensus 228 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~ 266 (309)
......+.+++.+||+.+|++|||+.++++.|++..
T Consensus 244 ---~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 244 ---DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred ---CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 011237889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=259.73 Aligned_cols=242 Identities=27% Similarity=0.426 Sum_probs=186.0
Q ss_pred ceEEEEcC-------CCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHH
Q 021682 4 AICQGRLP-------NGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFY 75 (309)
Q Consensus 4 ~~~~~~~~-------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (309)
.||.+... +++.||+|.+.... ......+.+|+.+++.++||||+++++++..+...++||||+++++|.++
T Consensus 10 ~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~ 89 (269)
T cd05044 10 EVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSY 89 (269)
T ss_pred eEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHH
Confidence 56777653 23679999886543 33466788999999999999999999999988899999999999999999
Q ss_pred Hhhhc----cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCC-----CceeecccccccccCCcc
Q 021682 76 IFDLR----RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM-----NPKISDFGMARAFTKDEC 146 (309)
Q Consensus 76 ~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~-----~~~l~Dfg~~~~~~~~~~ 146 (309)
+.... ....+++..+..++.+++.+++|||+. +++|+||+|+||+++.++ .++|+|||++........
T Consensus 90 l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~ 166 (269)
T cd05044 90 LRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDY 166 (269)
T ss_pred HHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcccccccccccc
Confidence 85432 223478899999999999999999998 899999999999999877 899999999865543322
Q ss_pred cccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccC
Q 021682 147 EANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSL 225 (309)
Q Consensus 147 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (309)
....+...++..|+|||.+.+..++.++||||||+++|+|++ |..||......+ ... ........
T Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~------~~~-~~~~~~~~------- 232 (269)
T cd05044 167 YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE------VLQ-HVTAGGRL------- 232 (269)
T ss_pred cccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH------HHH-HHhcCCcc-------
Confidence 222223345678999999988889999999999999999998 898875322111 111 11111100
Q ss_pred CCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 021682 226 DDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKS 264 (309)
Q Consensus 226 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~ 264 (309)
......+..+.++|.+||+.+|++|||+.++++.|+.
T Consensus 233 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 233 --QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred --CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1111223477899999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=257.79 Aligned_cols=242 Identities=25% Similarity=0.428 Sum_probs=184.9
Q ss_pred cceEEEEcC-CC---cEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 3 VAICQGRLP-NG---QEMAVKRLSRT-SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 3 ~~~~~~~~~-~g---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
+.+|+|... +| ..||||.+... .......+..|+.++++++||||+++++++..+...++||||+.+++|.+++.
T Consensus 18 g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 97 (269)
T cd05065 18 GEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLR 97 (269)
T ss_pred CeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHh
Confidence 467777654 33 35999998654 34445689999999999999999999999999999999999999999999885
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccc---
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIV--- 154 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~--- 154 (309)
.. ...+++..++.++.|++.|+.+||++ |++|+||+|+||+++.++.++|+|||.+................
T Consensus 98 ~~--~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 172 (269)
T cd05065 98 QN--DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGK 172 (269)
T ss_pred hC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccCccccccccccCCC
Confidence 42 33588999999999999999999998 99999999999999999999999999987554332211111111
Q ss_pred cccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHH
Q 021682 155 GTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWK 233 (309)
Q Consensus 155 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
.+..|+|||.+.+..++.++|||||||++|++++ |..||......+ ... ........ . .+...
T Consensus 173 ~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~----~i~~~~~~-----~----~~~~~ 236 (269)
T cd05065 173 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VIN----AIEQDYRL-----P----PPMDC 236 (269)
T ss_pred cceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHH----HHHcCCcC-----C----CcccC
Confidence 2347999999988889999999999999999886 888875332211 111 11111000 0 00112
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHHHhcc
Q 021682 234 LMRCMQVALLCVQENAADRPTMLEILVMLKSE 265 (309)
Q Consensus 234 ~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~ 265 (309)
+..+.+++.+||+.+|++||++++++..|++.
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 237 PTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 33678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=262.15 Aligned_cols=251 Identities=20% Similarity=0.281 Sum_probs=181.6
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
+.||.+.. .+++.||+|.++... ......+.+|+.++++++|+||+++++++..+...++||||+. ++|..++...
T Consensus 20 g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~- 97 (301)
T cd07873 20 ATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDC- 97 (301)
T ss_pred EEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHhc-
Confidence 35677764 478999999986442 3334567789999999999999999999999999999999997 5787777432
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCC
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYV 160 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 160 (309)
...+++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++......... .....++..|+
T Consensus 98 -~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~ 171 (301)
T cd07873 98 -GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT--YSNEVVTLWYR 171 (301)
T ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc--ccccceeeccc
Confidence 33588999999999999999999998 9999999999999999999999999998654332211 12235678999
Q ss_pred CccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH-----HHhhC---CCCccccc-ccCCC---
Q 021682 161 PPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAY-----GLWKN---GEGMEFID-SSLDD--- 227 (309)
Q Consensus 161 aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~-----~~~~~---~~~~~~~~-~~~~~--- 227 (309)
|||.+.+. .++.++||||||+++|+|++|.+||...+..+......... ..|.. ........ +....
T Consensus 172 ~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (301)
T cd07873 172 PPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCL 251 (301)
T ss_pred CcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccH
Confidence 99987654 57889999999999999999999986543322111111000 00100 00000000 00000
Q ss_pred -cccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 228 -SSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 228 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.........+.++|.+||+.||.+|||++|+++.
T Consensus 252 ~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 252 HNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred HhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0001123367899999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=263.82 Aligned_cols=248 Identities=26% Similarity=0.401 Sum_probs=186.0
Q ss_pred cceEEEEc-CCCcE--EEEEEeecC-CcccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 3 VAICQGRL-PNGQE--MAVKRLSRT-SHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 3 ~~~~~~~~-~~g~~--vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
++||++.. .+|.. +|+|.++.. .......+..|+.++.++ +|+||+++++++..++..++||||+++++|.+++.
T Consensus 21 g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 100 (303)
T cd05088 21 GQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR 100 (303)
T ss_pred ceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHH
Confidence 35677764 35554 577776543 233445788899999999 89999999999999999999999999999999885
Q ss_pred hhc-------------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCC
Q 021682 78 DLR-------------RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKD 144 (309)
Q Consensus 78 ~~~-------------~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~ 144 (309)
... ....+++..++.++.|++.|+++||+. |++||||+|+||+++.++.++|+|||++......
T Consensus 101 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 177 (303)
T cd05088 101 KSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 177 (303)
T ss_pred hcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcEEeCccccCcccchh
Confidence 432 123578999999999999999999998 9999999999999999999999999988532211
Q ss_pred cccccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccc
Q 021682 145 ECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDS 223 (309)
Q Consensus 145 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (309)
. .......+..|+|||.+.+..++.++|||||||++|+|++ |..||......+ .. ..........
T Consensus 178 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~-~~~~~~~~~~---- 243 (303)
T cd05088 178 V---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LY-EKLPQGYRLE---- 243 (303)
T ss_pred h---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH------HH-HHHhcCCcCC----
Confidence 1 1111233567999999988888999999999999999998 999885432211 11 1111110000
Q ss_pred cCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccCCCCCC
Q 021682 224 SLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETADIKTP 272 (309)
Q Consensus 224 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~~~~~ 272 (309)
.+......+.+++.+||+.+|++|||++++++.|+.+.+.-.+.
T Consensus 244 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~ 287 (303)
T cd05088 244 -----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 287 (303)
T ss_pred -----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhh
Confidence 00112236789999999999999999999999998776555443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=268.55 Aligned_cols=234 Identities=23% Similarity=0.247 Sum_probs=175.2
Q ss_pred ceEEEE-cCCCcEEEEEEeecCC---cccHHHHHHHHHHHhcC---CCCCccceeeEEeeCCeeEEEEeccCCCChhHHH
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTS---HQGLEEFENEVKLTARL---QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 76 (309)
.||.+. ..+|+.||||++.... .........|..++... .||+|+.+++.+..+...++||||+.+++|.+++
T Consensus 8 ~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l 87 (330)
T cd05586 8 QVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHL 87 (330)
T ss_pred EEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHH
Confidence 456665 4579999999986432 12223445566666554 6999999999999999999999999999998887
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccc
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGT 156 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 156 (309)
.. ...+++..+..++.||+.|++|||++ |++||||||+||+++.++.++|+|||++........ ......|+
T Consensus 88 ~~---~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt 159 (330)
T cd05586 88 QK---EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--TTNTFCGT 159 (330)
T ss_pred Hh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--CccCccCC
Confidence 43 34589999999999999999999998 899999999999999999999999999865332211 12234688
Q ss_pred cCCCCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 157 YGYVPPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 157 ~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
..|+|||.+.+. .++.++|||||||++|+|++|..||......+ .......... .+.. . ....
T Consensus 160 ~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~-------~~~~i~~~~~-~~~~----~----~~~~ 223 (330)
T cd05586 160 TEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ-------MYRNIAFGKV-RFPK----N----VLSD 223 (330)
T ss_pred ccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH-------HHHHHHcCCC-CCCC----c----cCCH
Confidence 999999988654 47899999999999999999999985432111 1111111110 1100 0 1223
Q ss_pred HHHHHHhhcccCCCCCCC----CHHHHHHH
Q 021682 236 RCMQVALLCVQENAADRP----TMLEILVM 261 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~Rp----t~~ell~~ 261 (309)
.+.++|.+||+.||++|| ++.++++.
T Consensus 224 ~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 224 EGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred HHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 677999999999999998 67777763
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=258.10 Aligned_cols=244 Identities=24% Similarity=0.353 Sum_probs=185.8
Q ss_pred cceEEEEc-CCCc----EEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHH
Q 021682 3 VAICQGRL-PNGQ----EMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 3 ~~~~~~~~-~~g~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 76 (309)
++||+|.+ .+|+ .||+|.++... ......+..|+.+++.+.|+||+++++++... ..+++++++++++|.+++
T Consensus 21 g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~~~~~~g~l~~~l 99 (279)
T cd05109 21 GTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVTQLMPYGCLLDYV 99 (279)
T ss_pred ceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEEEcCCCCCHHHHH
Confidence 46788864 3555 48999986543 33456788999999999999999999998754 577999999999999888
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccc
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGT 156 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 156 (309)
... ...+++..+..++.|++.|++|||++ |++|+||+|+||+++.++.++|+|||++................++
T Consensus 100 ~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~ 174 (279)
T cd05109 100 REN--KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVP 174 (279)
T ss_pred hhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccc
Confidence 432 33588999999999999999999998 8999999999999999999999999998766533222112122345
Q ss_pred cCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 157 YGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
..|+|||...+..++.++|||||||++|+|++ |..||....... ............. ......
T Consensus 175 ~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~~---------~~~~~~ 238 (279)
T cd05109 175 IKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE-------IPDLLEKGERLPQ---------PPICTI 238 (279)
T ss_pred hhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHCCCcCCC---------CccCCH
Confidence 68999999988889999999999999999998 888875322111 1111111111110 111233
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHHhcccCC
Q 021682 236 RCMQVALLCVQENAADRPTMLEILVMLKSETAD 268 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~ 268 (309)
.+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 239 ~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 239 DVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 678999999999999999999999999877443
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=257.92 Aligned_cols=242 Identities=26% Similarity=0.405 Sum_probs=183.4
Q ss_pred cceEEEEcC-CCc--EEEEEEeecC-CcccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 3 VAICQGRLP-NGQ--EMAVKRLSRT-SHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 3 ~~~~~~~~~-~g~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
+.||++... +|. .+++|.++.. .......+..|+++++++ .||||+++++++......++||||+++++|.+++.
T Consensus 9 g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~ 88 (270)
T cd05047 9 GQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR 88 (270)
T ss_pred ceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHH
Confidence 367777654 444 4688888643 334456788999999999 89999999999999999999999999999999985
Q ss_pred hhc-------------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCC
Q 021682 78 DLR-------------RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKD 144 (309)
Q Consensus 78 ~~~-------------~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~ 144 (309)
... ....+++..+..++.+++.|++|||+. |++|+||+|+||+++.++.++|+|||++......
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~ 165 (270)
T cd05047 89 KSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 165 (270)
T ss_pred hccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCCCccccchh
Confidence 422 123478899999999999999999998 9999999999999999999999999987532211
Q ss_pred cccccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccc
Q 021682 145 ECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDS 223 (309)
Q Consensus 145 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (309)
. .......+..|+|||.+.+..++.++|+||||+++|+|++ |..||......+ .. ...........
T Consensus 166 ~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~------~~-~~~~~~~~~~~--- 232 (270)
T cd05047 166 V---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LY-EKLPQGYRLEK--- 232 (270)
T ss_pred h---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH------HH-HHHhCCCCCCC---
Confidence 1 1111123557999999988888999999999999999997 999885432111 11 11111111110
Q ss_pred cCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhccc
Q 021682 224 SLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSET 266 (309)
Q Consensus 224 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~ 266 (309)
.......+.+++.+||..+|.+|||+.++++.|+.+.
T Consensus 233 ------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 233 ------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ------CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 1112236789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=257.12 Aligned_cols=240 Identities=28% Similarity=0.399 Sum_probs=183.4
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCcccHH--HHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSHQGLE--EFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~~~~~--~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
++||++.. .+++.||+|.+......... ....|+.++++++|+||+++++++......++|||++.+++|.+++.
T Consensus 13 g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~-- 90 (260)
T PF00069_consen 13 GTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQ-- 90 (260)
T ss_dssp EEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHH--
T ss_pred EEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccccccccccccc--
Confidence 45677765 46778999999776543322 33459999999999999999999999999999999999989999985
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
....++...+..++.|+++|+.+||+. |++|+||+|+||+++.++.++|+|||.+....... .......++..|
T Consensus 91 -~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~~y 164 (260)
T PF00069_consen 91 -KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN--ENFNPFVGTPEY 164 (260)
T ss_dssp -HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT--SEBSSSSSSGGG
T ss_pred -ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc--cccccccccccc
Confidence 344589999999999999999999998 99999999999999999999999999987542211 123334678899
Q ss_pred CCccccc-cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHH
Q 021682 160 VPPEYVR-KGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238 (309)
Q Consensus 160 ~aPE~~~-~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (309)
.|||.+. +...+.++|+||||+++|+|++|..||......+.............. .. . . ........+.
T Consensus 165 ~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~---~~----~-~--~~~~~~~~l~ 234 (260)
T PF00069_consen 165 MAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLP---SS----S-Q--QSREKSEELR 234 (260)
T ss_dssp SCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHH---HH----T-T--SHTTSHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccc---cc----c-c--ccchhHHHHH
Confidence 9999998 778899999999999999999999998644111111111111000000 00 0 0 0000014888
Q ss_pred HHHhhcccCCCCCCCCHHHHHH
Q 021682 239 QVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 239 ~li~~~l~~~p~~Rpt~~ell~ 260 (309)
+++.+||+.||++|||++++++
T Consensus 235 ~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 235 DLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHHHHSSSSGGGSTTHHHHHT
T ss_pred HHHHHHccCChhHCcCHHHHhc
Confidence 9999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=257.73 Aligned_cols=240 Identities=22% Similarity=0.263 Sum_probs=183.1
Q ss_pred CccceEEEE-cCCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHH
Q 021682 1 MSVAICQGR-LPNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 1 ~g~~~~~~~-~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 76 (309)
||. ||++. ..+|+.||+|.+.... ......+..|++++++++|++++.+.+.+..++..++||||+.+++|.+++
T Consensus 13 ~g~-vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 91 (285)
T cd05632 13 FGE-VCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHI 91 (285)
T ss_pred CeE-EEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHH
Confidence 454 55554 4689999999986542 223345778999999999999999999999999999999999999998887
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccc
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGT 156 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 156 (309)
.... ...+++..+..++.|++.|+.|||+. |++|+||+|+||+++.++.++|+|||++........ .....|+
T Consensus 92 ~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~~~~~g~ 164 (285)
T cd05632 92 YNMG-NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES---IRGRVGT 164 (285)
T ss_pred HHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc---ccCCCCC
Confidence 5432 33589999999999999999999998 899999999999999999999999998865432211 1223678
Q ss_pred cCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHH
Q 021682 157 YGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMR 236 (309)
Q Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
..|+|||.+.+..++.++|+||||+++|+|++|..||........ ........... ...+ .......
T Consensus 165 ~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~---~~~~~~~~~~~--~~~~--------~~~~~~~ 231 (285)
T cd05632 165 VGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK---REEVDRRVLET--EEVY--------SAKFSEE 231 (285)
T ss_pred cCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhhhcc--cccc--------CccCCHH
Confidence 999999999888899999999999999999999999864322111 11111111110 0001 1112236
Q ss_pred HHHHHhhcccCCCCCCCC-----HHHHHHH
Q 021682 237 CMQVALLCVQENAADRPT-----MLEILVM 261 (309)
Q Consensus 237 l~~li~~~l~~~p~~Rpt-----~~ell~~ 261 (309)
+.+|+.+||+.||++||| +.+++..
T Consensus 232 ~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 232 AKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred HHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 779999999999999999 7787764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=257.98 Aligned_cols=238 Identities=21% Similarity=0.305 Sum_probs=184.0
Q ss_pred cceEEEEcC-CCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 3 VAICQGRLP-NGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 3 ~~~~~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
+.+|++... ++..+++|.+..........+..|+++++.++|+|++++++++..+...++|+||+.+++|..++.. .
T Consensus 19 g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~--~ 96 (282)
T cd06643 19 GKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--L 96 (282)
T ss_pred eEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHh--c
Confidence 356777654 6788899998766555567788999999999999999999999999999999999999999887643 2
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP 161 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 161 (309)
...+++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++........ ......++..|+|
T Consensus 97 ~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~a 171 (282)
T cd06643 97 ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RRDSFIGTPYWMA 171 (282)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc--ccccccccccccC
Confidence 34589999999999999999999998 999999999999999999999999999865433221 1222457889999
Q ss_pred ccccc-----cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHH
Q 021682 162 PEYVR-----KGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMR 236 (309)
Q Consensus 162 PE~~~-----~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
||.+. +..++.++|+|||||++|+|++|.+||........ .... ........ ..+.....+
T Consensus 172 PE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------~~~~-~~~~~~~~-------~~~~~~~~~ 237 (282)
T cd06643 172 PEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV------LLKI-AKSEPPTL-------AQPSRWSSE 237 (282)
T ss_pred HhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH------HHHH-hhcCCCCC-------CCccccCHH
Confidence 99874 34567899999999999999999999854322111 1111 11000000 011112347
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 237 CMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 237 l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
+.++|.+||+.+|.+|||++++++.
T Consensus 238 ~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 238 FKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcC
Confidence 8899999999999999999998855
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=254.74 Aligned_cols=239 Identities=24% Similarity=0.373 Sum_probs=184.6
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccc
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRR 82 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 82 (309)
+.||.+....+..||+|.+.... ...+.+.+|++++++++|++++++++++. ....+++|||+.+++|.+++... ..
T Consensus 20 ~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~-~~ 96 (260)
T cd05069 20 GEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEG-DG 96 (260)
T ss_pred CeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHHHhhC-CC
Confidence 36788887777789999886443 33467889999999999999999999875 45678999999999999988542 23
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCc
Q 021682 83 YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPP 162 (309)
Q Consensus 83 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 162 (309)
..+++..+..++.+++.|+.|||+. |++|+||+|+||+++.++.++|+|||.+.......... .....++..|+||
T Consensus 97 ~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~~P 172 (260)
T cd05069 97 KYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA-RQGAKFPIKWTAP 172 (260)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcccc-cCCCccchhhCCH
Confidence 4478899999999999999999998 89999999999999999999999999987654332111 1122456679999
Q ss_pred cccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHH
Q 021682 163 EYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241 (309)
Q Consensus 163 E~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 241 (309)
|...+...+.++|+||||+++|+|++ |..||......+ ........... ..+...+..+.+++
T Consensus 173 e~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~---------~~~~~~~~~~~~li 236 (260)
T cd05069 173 EAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE-------VLEQVERGYRM---------PCPQGCPESLHELM 236 (260)
T ss_pred HHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCC---------CCCcccCHHHHHHH
Confidence 99988888999999999999999999 888875422111 11111111100 01112234788999
Q ss_pred hhcccCCCCCCCCHHHHHHHHhc
Q 021682 242 LLCVQENAADRPTMLEILVMLKS 264 (309)
Q Consensus 242 ~~~l~~~p~~Rpt~~ell~~L~~ 264 (309)
.+||..||++||+++++++.|+.
T Consensus 237 ~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 237 KLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHccCCcccCcCHHHHHHHHhc
Confidence 99999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=254.44 Aligned_cols=245 Identities=20% Similarity=0.294 Sum_probs=176.4
Q ss_pred ceEEEEcC---CCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGRLP---NGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~~~---~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
+||+|... ....+|+|.+.... ......+.+|+..++.++|+||+++++.+......++||||+.+++|.+++...
T Consensus 10 ~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~ 89 (269)
T cd05042 10 KVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSN 89 (269)
T ss_pred eEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhc
Confidence 46766543 34568888775443 233456788999999999999999999999999999999999999999998653
Q ss_pred cc--ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccccc
Q 021682 80 RR--RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 80 ~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
.. ....++.....++.||+.|++|||++ |++|+||||.||+++.++.++|+|||++................++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 166 (269)
T cd05042 90 RGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPL 166 (269)
T ss_pred cccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcc
Confidence 32 23356778889999999999999998 89999999999999999999999999886543322111122234566
Q ss_pred CCCCcccccc-------CCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcc
Q 021682 158 GYVPPEYVRK-------GIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSS 229 (309)
Q Consensus 158 ~y~aPE~~~~-------~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (309)
.|+|||.+.. ..++.++|||||||++|+|++ |..||......+ ....... ........+....
T Consensus 167 ~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~~-~~~~~~~~~~~~~-- 237 (269)
T cd05042 167 RWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ------VLKQVVR-EQDIKLPKPQLDL-- 237 (269)
T ss_pred cccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH------HHHHHhh-ccCccCCCCcccc--
Confidence 7999998643 356789999999999999998 777775332111 1111111 1111111111111
Q ss_pred cHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHh
Q 021682 230 SAWKLMRCMQVALLCVQENAADRPTMLEILVMLK 263 (309)
Q Consensus 230 ~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~ 263 (309)
.....+.+++..|| .||++|||+++|++.|.
T Consensus 238 --~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 238 --KYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred --cCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 12235667888888 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=270.14 Aligned_cols=245 Identities=25% Similarity=0.371 Sum_probs=186.3
Q ss_pred cceEEEEc------CCCcEEEEEEeecCC-cccHHHHHHHHHHHhcCC-CCCccceeeEEeeCCeeEEEEeccCCCChhH
Q 021682 3 VAICQGRL------PNGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQ-HVNLLPVLGICTQREEKMLIYDYMPNKSLDF 74 (309)
Q Consensus 3 ~~~~~~~~------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (309)
+.||++.+ .+++.||||.++... ....+.++.|++++.++. ||||+++++.+..+...++||||+.+++|.+
T Consensus 51 G~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~ 130 (401)
T cd05107 51 GRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVD 130 (401)
T ss_pred eeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHH
Confidence 34677764 245689999997542 233457889999999996 9999999999999899999999999999999
Q ss_pred HHhhhcc-------------------------------------------------------------------------
Q 021682 75 YIFDLRR------------------------------------------------------------------------- 81 (309)
Q Consensus 75 ~~~~~~~------------------------------------------------------------------------- 81 (309)
++.....
T Consensus 131 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (401)
T cd05107 131 YLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYE 210 (401)
T ss_pred HHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcC
Confidence 9854211
Q ss_pred ----------------------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccc
Q 021682 82 ----------------------RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMAR 139 (309)
Q Consensus 82 ----------------------~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~ 139 (309)
...+++..+..++.|++.|+.|||+. |++|+||+|.||+++.++.++|+|||++.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl~~~~~~kL~DfGla~ 287 (401)
T cd05107 211 SPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLICEGKLVKICDFGLAR 287 (401)
T ss_pred CchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEEeCCCEEEEEecCcce
Confidence 12356677888999999999999998 89999999999999999999999999987
Q ss_pred cccCCcccccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCc
Q 021682 140 AFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGM 218 (309)
Q Consensus 140 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (309)
...............++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+. .......+...
T Consensus 288 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~------~~~~~~~~~~~ 361 (401)
T cd05107 288 DIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ------FYNAIKRGYRM 361 (401)
T ss_pred ecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH------HHHHHHcCCCC
Confidence 5433222112222346778999999988888999999999999999998 8888754322111 11111111111
Q ss_pred ccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcc
Q 021682 219 EFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSE 265 (309)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~ 265 (309)
. .+......+.+++.+||..+|++||++++|++.|+..
T Consensus 362 ~---------~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 362 A---------KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred C---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 0 0111234788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=253.62 Aligned_cols=235 Identities=21% Similarity=0.304 Sum_probs=186.6
Q ss_pred cceEEEEcC-CCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 3 VAICQGRLP-NGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 3 ~~~~~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
+.+|++... +++.|++|.++.... .+.+.+|++++++++|+||+++++.+..+...++++|++.+++|.+++...
T Consensus 17 ~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~-- 92 (256)
T cd06612 17 GSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKIT-- 92 (256)
T ss_pred eEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhC--
Confidence 356788765 489999999865433 678999999999999999999999999999999999999999999988432
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP 161 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 161 (309)
+..+++..+..++.+++.++.+||+. |++|+||+|+||+++.++.++|+|||++........ ......++..|+|
T Consensus 93 ~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~ 167 (256)
T cd06612 93 NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--KRNTVIGTPFWMA 167 (256)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc--ccccccCCccccC
Confidence 34589999999999999999999998 899999999999999999999999999876544321 1222357789999
Q ss_pred ccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHH
Q 021682 162 PEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241 (309)
Q Consensus 162 PE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 241 (309)
||.+.+..++.++||||||+++|+|++|..||......... ..... .... ....+......+.+++
T Consensus 168 PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-------~~~~~-~~~~------~~~~~~~~~~~~~~~i 233 (256)
T cd06612 168 PEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-------FMIPN-KPPP------TLSDPEKWSPEFNDFV 233 (256)
T ss_pred HHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh-------hhhcc-CCCC------CCCchhhcCHHHHHHH
Confidence 99998888899999999999999999999998643222110 00000 0000 0111112334788999
Q ss_pred hhcccCCCCCCCCHHHHHH
Q 021682 242 LLCVQENAADRPTMLEILV 260 (309)
Q Consensus 242 ~~~l~~~p~~Rpt~~ell~ 260 (309)
.+||+.+|++|||++++++
T Consensus 234 ~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 234 KKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred HHHHhcChhhCcCHHHHhc
Confidence 9999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=261.41 Aligned_cols=235 Identities=20% Similarity=0.336 Sum_probs=184.4
Q ss_pred ceEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccc
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRR 82 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 82 (309)
.+|++.. .+++.||||.+........+.+..|+..+++++|+||+++++.+..++..++||||+++++|.+++..
T Consensus 37 ~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---- 112 (292)
T cd06658 37 IVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTH---- 112 (292)
T ss_pred EEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhc----
Confidence 4666654 47899999998765555567788999999999999999999999999999999999999999888732
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCc
Q 021682 83 YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPP 162 (309)
Q Consensus 83 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 162 (309)
..+++..+..++.+++.++.+||+. |++|+||+|.||+++.++.++|+|||++......... .....++..|+||
T Consensus 113 ~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~--~~~~~~~~~y~aP 187 (292)
T cd06658 113 TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKSLVGTPYWMAP 187 (292)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc--CceeecCccccCH
Confidence 2478899999999999999999998 8999999999999999999999999998654332211 1223578899999
Q ss_pred cccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHHh
Q 021682 163 EYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVAL 242 (309)
Q Consensus 163 E~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 242 (309)
|.+.+..++.++|+||||+++|++++|..||....... ..... ... ....... .......+.+++.
T Consensus 188 E~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~~~~----~~~-----~~~~~~~--~~~~~~~~~~li~ 253 (292)
T cd06658 188 EVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ---AMRRI----RDN-----LPPRVKD--SHKVSSVLRGFLD 253 (292)
T ss_pred HHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH----Hhc-----CCCcccc--ccccCHHHHHHHH
Confidence 99988888999999999999999999999985432211 11110 000 0000000 1112336779999
Q ss_pred hcccCCCCCCCCHHHHHHH
Q 021682 243 LCVQENAADRPTMLEILVM 261 (309)
Q Consensus 243 ~~l~~~p~~Rpt~~ell~~ 261 (309)
+||..+|++|||++++++.
T Consensus 254 ~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 254 LMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHccCChhHCcCHHHHhhC
Confidence 9999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=268.28 Aligned_cols=247 Identities=22% Similarity=0.248 Sum_probs=178.0
Q ss_pred ceEEEEc-CCCcEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCC------eeEEEEeccCCCChhH
Q 021682 4 AICQGRL-PNGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQRE------EKMLIYDYMPNKSLDF 74 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~~L~~ 74 (309)
.||.+.. .+|+.||+|.+... .......+.+|+.+++.++||||+++++++.... ..++||||+.+ ++..
T Consensus 36 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~ 114 (359)
T cd07876 36 IVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQ 114 (359)
T ss_pred EEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHH
Confidence 4566654 57999999998643 2333456788999999999999999999886543 47999999975 5555
Q ss_pred HHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccc
Q 021682 75 YIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIV 154 (309)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~ 154 (309)
.+. ..++...+..++.|++.|+.|||+. |++||||||+||+++.++.++|+|||++....... ......
T Consensus 115 ~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~ 183 (359)
T cd07876 115 VIH-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF---MMTPYV 183 (359)
T ss_pred HHh-----ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCccccccCc---cCCCCc
Confidence 542 2378888999999999999999998 99999999999999999999999999986543321 122236
Q ss_pred cccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHH----------------HHHHHhhCC-CC
Q 021682 155 GTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLE----------------YAYGLWKNG-EG 217 (309)
Q Consensus 155 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~----------------~~~~~~~~~-~~ 217 (309)
++..|+|||.+.+..++.++|||||||++|+|++|..||...+..+...... ......... ..
T Consensus 184 ~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (359)
T cd07876 184 VTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQY 263 (359)
T ss_pred ccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCC
Confidence 7889999999999899999999999999999999999997543321110000 000000000 00
Q ss_pred c-----ccccccC---CCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 021682 218 M-----EFIDSSL---DDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVML 262 (309)
Q Consensus 218 ~-----~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L 262 (309)
. +.+.... ...........+.++|.+||+.||++|||+.|+++.-
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 264 PGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred CCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 0 0000000 0001111234678999999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=261.33 Aligned_cols=249 Identities=25% Similarity=0.376 Sum_probs=187.9
Q ss_pred cceEEEEcC-----CCcEEEEEEeecCCcc-cHHHHHHHHHHHhcCCCCCccceeeEEee--CCeeEEEEeccCCCChhH
Q 021682 3 VAICQGRLP-----NGQEMAVKRLSRTSHQ-GLEEFENEVKLTARLQHVNLLPVLGICTQ--REEKMLIYDYMPNKSLDF 74 (309)
Q Consensus 3 ~~~~~~~~~-----~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~ 74 (309)
+.||++.+. +++.||||.++..... ....+..|+++++.++|+||+++++++.. ....+++|||+++++|.+
T Consensus 18 ~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~ 97 (284)
T cd05038 18 GKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRD 97 (284)
T ss_pred eeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHH
Confidence 356777642 4789999999755432 45789999999999999999999999877 557899999999999999
Q ss_pred HHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccc-ccccc
Q 021682 75 YIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEA-NTGRI 153 (309)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~-~~~~~ 153 (309)
++.... ..+++..+..++.+++.|+++||+. |++|+||+|+||+++.++.++|+|||.+.......... .....
T Consensus 98 ~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 172 (284)
T cd05038 98 YLQRHR--DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPG 172 (284)
T ss_pred HHHhCc--cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCC
Confidence 985432 2488999999999999999999998 89999999999999999999999999987665322211 11112
Q ss_pred ccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcc--------cHHHHHHHHhhCCCCcccccccC
Q 021682 154 VGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESL--------NLLEYAYGLWKNGEGMEFIDSSL 225 (309)
Q Consensus 154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~ 225 (309)
.++..|++||...+..++.++|+||||+++|+|++|..|+......... ..............
T Consensus 173 ~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 243 (284)
T cd05038 173 ESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGE--------- 243 (284)
T ss_pred CCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCC---------
Confidence 3456799999998888899999999999999999999887432211100 00111111111111
Q ss_pred CCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcc
Q 021682 226 DDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSE 265 (309)
Q Consensus 226 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~ 265 (309)
....+.....++.+++.+||+.+|++|||+.|++++|+++
T Consensus 244 ~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 244 RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 0011112234788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=261.85 Aligned_cols=188 Identities=23% Similarity=0.336 Sum_probs=148.8
Q ss_pred cceEEEEcC---CCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEee--CCeeEEEEeccCCCChhHHHh
Q 021682 3 VAICQGRLP---NGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQ--REEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 3 ~~~~~~~~~---~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~ 77 (309)
++||++... +++.||+|.+.... ....+.+|+.++++++||||+++++++.. +...+++|||+. ++|.+++.
T Consensus 15 g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~ 91 (317)
T cd07868 15 GHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIK 91 (317)
T ss_pred eEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-CCHHHHHH
Confidence 467777643 56889999986442 23456789999999999999999998854 457899999985 47777664
Q ss_pred hhc------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEe----CCCCCceeecccccccccCCccc
Q 021682 78 DLR------RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL----DYEMNPKISDFGMARAFTKDECE 147 (309)
Q Consensus 78 ~~~------~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~----~~~~~~~l~Dfg~~~~~~~~~~~ 147 (309)
... ....+++..+..++.|++.|+.|||++ |++||||||+||++ +.++.+||+|||++.........
T Consensus 92 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~ 168 (317)
T cd07868 92 FHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP 168 (317)
T ss_pred hcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCcc
Confidence 321 123588899999999999999999998 89999999999999 45678999999999765433211
Q ss_pred -ccccccccccCCCCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCC
Q 021682 148 -ANTGRIVGTYGYVPPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYY 196 (309)
Q Consensus 148 -~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~ 196 (309)
.......++..|+|||.+.+. .++.++|+||+||++|+|++|.+||...
T Consensus 169 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 169 LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 122334678899999988764 5789999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=257.36 Aligned_cols=240 Identities=19% Similarity=0.259 Sum_probs=183.8
Q ss_pred cceEEEEcC-CCcEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 3 VAICQGRLP-NGQEMAVKRLSRT-SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 3 ~~~~~~~~~-~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
+.+|++... +|+.||+|.++.. .......+.+|+.++++++|+||+++++.+..++..++||||+++++|..++....
T Consensus 15 g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~ 94 (286)
T cd06622 15 GSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGV 94 (286)
T ss_pred eEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhcc
Confidence 356677654 8999999988654 33345678899999999999999999999999999999999999999988875432
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCC
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYV 160 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 160 (309)
....+++..+..++.+++.|+.|||+.+ |++|+||+|+||+++.++.++|+|||.+....... .....++..|+
T Consensus 95 ~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~ 168 (286)
T cd06622 95 ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL----AKTNIGCQSYM 168 (286)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc----cccCCCccCcc
Confidence 2346899999999999999999999743 89999999999999999999999999886543221 11234677899
Q ss_pred CccccccCC------CCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHH
Q 021682 161 PPEYVRKGI------YSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKL 234 (309)
Q Consensus 161 aPE~~~~~~------~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
|||.+.+.. ++.++|+|||||++|+|++|..||......... ... ........ ...+....
T Consensus 169 aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~~-~~~~~~~~---------~~~~~~~~ 235 (286)
T cd06622 169 APERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF---AQL-SAIVDGDP---------PTLPSGYS 235 (286)
T ss_pred CcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH---HHH-HHHhhcCC---------CCCCcccC
Confidence 999885543 478999999999999999999998543221111 110 00111110 11111234
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 235 MRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 235 ~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
..+.+++.+||+.+|++||+++++++.
T Consensus 236 ~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 236 DDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 478899999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=255.93 Aligned_cols=236 Identities=24% Similarity=0.368 Sum_probs=182.6
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCcc---------cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCCh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSHQ---------GLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSL 72 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 72 (309)
+.+|.|.. .+++.||+|.+...... ..+.+..|+.++++++||||+++++++......++++||+++++|
T Consensus 14 ~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 93 (267)
T cd06628 14 GSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSV 93 (267)
T ss_pred eEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCH
Confidence 35677754 47899999988654322 124678899999999999999999999999999999999999999
Q ss_pred hHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccc----
Q 021682 73 DFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEA---- 148 (309)
Q Consensus 73 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~---- 148 (309)
.+++.. ...++...+..++.+++.|+.+||+. |++|+||+|+||+++.++.++|+|||.+..........
T Consensus 94 ~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 167 (267)
T cd06628 94 AALLNN---YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNG 167 (267)
T ss_pred HHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccc
Confidence 998843 34588889999999999999999998 89999999999999999999999999987664321111
Q ss_pred cccccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCc
Q 021682 149 NTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDS 228 (309)
Q Consensus 149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (309)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||....... .. .. ....... .
T Consensus 168 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~---~~-~~~~~~~---------~ 231 (267)
T cd06628 168 ARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ---AI---FK-IGENASP---------E 231 (267)
T ss_pred cccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH---HH---HH-HhccCCC---------c
Confidence 1112346788999999988888999999999999999999999986432111 11 11 0010000 1
Q ss_pred ccHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021682 229 SSAWKLMRCMQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 229 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
.+......+.++|.+||+.+|.+||++.++++
T Consensus 232 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 232 IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 11122347889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=269.84 Aligned_cols=237 Identities=19% Similarity=0.230 Sum_probs=179.1
Q ss_pred ceEEEE-cCCCcEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGR-LPNGQEMAVKRLSRT---SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
.||.+. ..+++.||+|.+... .......+.+|+.+++.++||||+++++++..+...++||||+.+++|.+++..
T Consensus 58 ~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~- 136 (370)
T cd05621 58 EVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN- 136 (370)
T ss_pred EEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh-
Confidence 455555 457899999998642 222345678899999999999999999999999999999999999999998842
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
..+++..+..++.||+.|++|||+. |++||||||+||+++.++.+||+|||++........ .......||+.|
T Consensus 137 ---~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~-~~~~~~~gt~~Y 209 (370)
T cd05621 137 ---YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM-VRCDTAVGTPDY 209 (370)
T ss_pred ---cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecccCCc-eecccCCCCccc
Confidence 2378889999999999999999998 899999999999999999999999999876543221 112234689999
Q ss_pred CCccccccC----CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 160 VPPEYVRKG----IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 160 ~aPE~~~~~----~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
+|||.+.+. .++.++|+|||||++|+|++|..||....... .............+. .......
T Consensus 210 ~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~------~~~~i~~~~~~~~~p-------~~~~~s~ 276 (370)
T cd05621 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG------TYSKIMDHKNSLNFP-------EDVEISK 276 (370)
T ss_pred CCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCcccCCC-------CcccCCH
Confidence 999998654 36789999999999999999999996432211 111111111111111 1111233
Q ss_pred HHHHHHhhcccCCCCC--CCCHHHHHHH
Q 021682 236 RCMQVALLCVQENAAD--RPTMLEILVM 261 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~--Rpt~~ell~~ 261 (309)
.+.+++.+||+.++.. |+|+.++++.
T Consensus 277 ~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 277 HAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 6778999999855543 8999999987
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=268.01 Aligned_cols=246 Identities=22% Similarity=0.244 Sum_probs=177.7
Q ss_pred ceEEEE-cCCCcEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeeEEeeC------CeeEEEEeccCCCChhH
Q 021682 4 AICQGR-LPNGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQR------EEKMLIYDYMPNKSLDF 74 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~~L~~ 74 (309)
+||++. ..+++.||||.+... .......+.+|+.+++.++|+||+++++++... ...++||||+.+ +|..
T Consensus 39 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~ 117 (364)
T cd07875 39 IVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQ 117 (364)
T ss_pred EEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCCC-CHHH
Confidence 456665 457899999998653 233345678899999999999999999887543 357999999965 6666
Q ss_pred HHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccc
Q 021682 75 YIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIV 154 (309)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~ 154 (309)
.+. ..++...+..++.|++.|+.|||++ |++||||||+||+++.++.++|+|||++....... ......
T Consensus 118 ~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~---~~~~~~ 186 (364)
T cd07875 118 VIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYV 186 (364)
T ss_pred HHH-----hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCccccCCCC---cccCCc
Confidence 552 1377888999999999999999998 99999999999999999999999999987543322 122236
Q ss_pred cccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHH----------------HHHhhC-CCC
Q 021682 155 GTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYA----------------YGLWKN-GEG 217 (309)
Q Consensus 155 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~----------------~~~~~~-~~~ 217 (309)
++..|+|||.+.+..++.++|||||||++|+|++|+.||...+..+....+... ...... ...
T Consensus 187 ~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (364)
T cd07875 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKY 266 (364)
T ss_pred ccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCc
Confidence 788999999999989999999999999999999999999654332211111000 000000 000
Q ss_pred cc-----cccccC---CCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 218 ME-----FIDSSL---DDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 218 ~~-----~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.. .+.... ...........+.++|.+||+.||++|||++++++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 267 AGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred CCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 000000 001111123467899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=258.89 Aligned_cols=236 Identities=22% Similarity=0.329 Sum_probs=186.8
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
+.+|++.. .+|+.||+|.+........+.+..|+.+++.++|+||+++++++..+...++||||+++++|.+++..
T Consensus 33 g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--- 109 (297)
T cd06656 33 GTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--- 109 (297)
T ss_pred eEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHh---
Confidence 46788864 58999999999766555567788999999999999999999999999999999999999999998732
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP 161 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 161 (309)
..+++..+..++.+++.++.+||+. |++|+||+|+||+++.++.++|+|||.+......... .....++..|+|
T Consensus 110 -~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~a 183 (297)
T cd06656 110 -TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMA 183 (297)
T ss_pred -CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCccC--cCcccCCccccC
Confidence 3478889999999999999999998 8999999999999999999999999988654433211 122357889999
Q ss_pred ccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHH
Q 021682 162 PEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241 (309)
Q Consensus 162 PE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 241 (309)
||.+.+..++.++|+||||+++|++++|..||...+....... .... . ......+......+.+++
T Consensus 184 PE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~------~~~~-~-------~~~~~~~~~~~~~~~~li 249 (297)
T cd06656 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATN-G-------TPELQNPERLSAVFRDFL 249 (297)
T ss_pred HHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee------eccC-C-------CCCCCCccccCHHHHHHH
Confidence 9999888889999999999999999999999854332211100 0000 0 000001112234678999
Q ss_pred hhcccCCCCCCCCHHHHHHH
Q 021682 242 LLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 242 ~~~l~~~p~~Rpt~~ell~~ 261 (309)
.+||+.+|++|||++++++.
T Consensus 250 ~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 250 NRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred HHHccCChhhCcCHHHHhcC
Confidence 99999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=258.05 Aligned_cols=238 Identities=22% Similarity=0.321 Sum_probs=184.0
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
+.||++.. .+|+.|++|.+..........+..|+.+++.++|+||+++++.+..+...++||||+.+++|..++...
T Consensus 26 g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-- 103 (292)
T cd06644 26 GKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLEL-- 103 (292)
T ss_pred eEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhh--
Confidence 35677765 468999999997766666778889999999999999999999999999999999999999998876432
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP 161 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 161 (309)
...+++..+..++.|++.++.+||+. |++|+||+|+||+++.++.++|+|||++........ ......++..|+|
T Consensus 104 ~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~a 178 (292)
T cd06644 104 DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ--RRDSFIGTPYWMA 178 (292)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccccc--ccceecCCccccC
Confidence 33488999999999999999999998 999999999999999999999999998765333211 1122357789999
Q ss_pred ccccc-----cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHH
Q 021682 162 PEYVR-----KGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMR 236 (309)
Q Consensus 162 PE~~~-----~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
||.+. ...++.++|+|||||++|+|++|..||....... .... ......... ..+......
T Consensus 179 PE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~~~-~~~~~~~~~-------~~~~~~~~~ 244 (292)
T cd06644 179 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLK-IAKSEPPTL-------SQPSKWSME 244 (292)
T ss_pred ceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH------HHHH-HhcCCCccC-------CCCcccCHH
Confidence 99874 3446789999999999999999999985432211 1111 111100000 011122336
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 237 CMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 237 l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
+.+++.+||+.+|++||+++++++.
T Consensus 245 ~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 245 FRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred HHHHHHHHhcCCcccCcCHHHHhcC
Confidence 7899999999999999999999863
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=257.43 Aligned_cols=237 Identities=22% Similarity=0.313 Sum_probs=185.2
Q ss_pred ceEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccc
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRR 82 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 82 (309)
.||++.. .+++.||+|.+........+.+..|++++++++|+||+++++++..+...++||||+++++|.+++... .
T Consensus 20 ~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~ 97 (280)
T cd06611 20 KVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLEL--E 97 (280)
T ss_pred eEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHh--c
Confidence 5677765 478999999997766666678889999999999999999999999999999999999999999988543 3
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCc
Q 021682 83 YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPP 162 (309)
Q Consensus 83 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 162 (309)
..+++..+..++.|++.++.|||+. |++|+||+|+||+++.++.++|+|||.+........ ......++..|+||
T Consensus 98 ~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~P 172 (280)
T cd06611 98 RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ--KRDTFIGTPYWMAP 172 (280)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc--ccceeecchhhcCH
Confidence 3589999999999999999999998 899999999999999999999999998765433221 12224578899999
Q ss_pred cccc-----cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHH
Q 021682 163 EYVR-----KGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRC 237 (309)
Q Consensus 163 E~~~-----~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (309)
|.+. ...++.++|+||||+++|+|++|..||...+... .. ..+.......+ ..+......+
T Consensus 173 E~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~---~~----~~~~~~~~~~~-------~~~~~~~~~~ 238 (280)
T cd06611 173 EVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR---VL----LKILKSEPPTL-------DQPSKWSSSF 238 (280)
T ss_pred HHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH---HH----HHHhcCCCCCc-------CCcccCCHHH
Confidence 9874 3346789999999999999999999986432211 11 11111111000 0011122367
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHH
Q 021682 238 MQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 238 ~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.+++.+||+.+|++|||++++++.
T Consensus 239 ~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 239 NDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHHHHHHhccChhhCcCHHHHhcC
Confidence 899999999999999999999865
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=260.09 Aligned_cols=235 Identities=22% Similarity=0.351 Sum_probs=184.6
Q ss_pred ceEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccc
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRR 82 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 82 (309)
.+|++.. .+++.||+|.+..........+.+|+.+++.+.|||++++++++..++..++|+||+++++|..++..
T Consensus 36 ~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~---- 111 (297)
T cd06659 36 IVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ---- 111 (297)
T ss_pred eEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhh----
Confidence 4566654 57899999998765555567788999999999999999999999999999999999999999887632
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCc
Q 021682 83 YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPP 162 (309)
Q Consensus 83 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 162 (309)
..+++..+..++.|++.|+.+||+. |++|+||+|.||+++.++.++|+|||++......... .....++..|+||
T Consensus 112 ~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~--~~~~~~~~~y~aP 186 (297)
T cd06659 112 TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAP 186 (297)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccccc--ccceecCccccCH
Confidence 3488999999999999999999998 8999999999999999999999999998654432211 1224578899999
Q ss_pred cccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHHh
Q 021682 163 EYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVAL 242 (309)
Q Consensus 163 E~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 242 (309)
|.+.+..++.++|+|||||++|+|++|..||......+. .. ......... .. ........+.+++.
T Consensus 187 E~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---~~----~~~~~~~~~-~~------~~~~~~~~l~~~i~ 252 (297)
T cd06659 187 EVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA---MK----RLRDSPPPK-LK------NAHKISPVLRDFLE 252 (297)
T ss_pred HHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HH----HHhccCCCC-cc------ccCCCCHHHHHHHH
Confidence 999888889999999999999999999999864322111 11 111110000 00 00112236789999
Q ss_pred hcccCCCCCCCCHHHHHHH
Q 021682 243 LCVQENAADRPTMLEILVM 261 (309)
Q Consensus 243 ~~l~~~p~~Rpt~~ell~~ 261 (309)
+||+.+|++|||++++++.
T Consensus 253 ~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 253 RMLTREPQERATAQELLDH 271 (297)
T ss_pred HHhcCCcccCcCHHHHhhC
Confidence 9999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=263.09 Aligned_cols=236 Identities=26% Similarity=0.381 Sum_probs=180.9
Q ss_pred CcEEEEEEeecCC-cccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc---------
Q 021682 13 GQEMAVKRLSRTS-HQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR--------- 81 (309)
Q Consensus 13 g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------- 81 (309)
+..+|+|.+.... ......+..|+++++.+ +|+||+++++++..+...++||||+.+++|.+++.....
T Consensus 50 ~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~ 129 (307)
T cd05098 50 VTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNP 129 (307)
T ss_pred cceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCccccccccc
Confidence 4579999987542 33445688899999999 899999999999999999999999999999999865321
Q ss_pred ----ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccccc
Q 021682 82 ----RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 82 ----~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
...+++..++.++.|++.|++|||+. |++|+||+|+||+++.++.++|+|||.+................++.
T Consensus 130 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~ 206 (307)
T cd05098 130 TQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPV 206 (307)
T ss_pred ccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCcc
Confidence 12478889999999999999999998 99999999999999999999999999986554322111111123346
Q ss_pred CCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHH
Q 021682 158 GYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMR 236 (309)
Q Consensus 158 ~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
.|+|||.+.+..++.++|+|||||++|+|++ |..||......+ ............ .+.....+
T Consensus 207 ~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~~---------~~~~~~~~ 270 (307)
T cd05098 207 KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-------LFKLLKEGHRMD---------KPSNCTNE 270 (307)
T ss_pred ceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH-------HHHHHHcCCCCC---------CCCcCCHH
Confidence 7999999988888999999999999999998 778874322111 111111111111 11112347
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHHHhcccC
Q 021682 237 CMQVALLCVQENAADRPTMLEILVMLKSETA 267 (309)
Q Consensus 237 l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~ 267 (309)
+.+++.+||..+|++|||+.++++.|+.+.+
T Consensus 271 ~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 271 LYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred HHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 7899999999999999999999999988644
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=255.81 Aligned_cols=243 Identities=21% Similarity=0.311 Sum_probs=187.0
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
+.||++.. .+|+.||+|.+.... ......+..|+++++.++|+||+++++.+......++||||+++++|.+++..
T Consensus 19 g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-- 96 (284)
T cd06620 19 GSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKK-- 96 (284)
T ss_pred eEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHh--
Confidence 45666654 478999999886543 33457888999999999999999999999999999999999999999988743
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCC
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYV 160 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 160 (309)
...+++..+..++.+++.++.|||+.+ |++|+||+|+||+++.++.++|+|||++....... .....++..|+
T Consensus 97 -~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~----~~~~~~~~~~~ 169 (284)
T cd06620 97 -GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI----ADTFVGTSTYM 169 (284)
T ss_pred -ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc----cCccccCcccC
Confidence 335899999999999999999999754 89999999999999999999999999875432221 12346788999
Q ss_pred CccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcc-----cHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 161 PPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESL-----NLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 161 aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
|||.+.+..++.++|+|||||++|++++|..||......... ............ ....+ .......
T Consensus 170 aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~--------~~~~~~~ 240 (284)
T cd06620 170 SPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE-PPPRL--------PSSDFPE 240 (284)
T ss_pred CHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc-cCCCC--------CchhcCH
Confidence 999998888899999999999999999999998654332110 011111111111 00000 0011234
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHHh
Q 021682 236 RCMQVALLCVQENAADRPTMLEILVMLK 263 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~Rpt~~ell~~L~ 263 (309)
.+.+++.+||+.||++|||+.|++++..
T Consensus 241 ~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 241 DLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 6889999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=255.05 Aligned_cols=241 Identities=22% Similarity=0.355 Sum_probs=180.7
Q ss_pred CCCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeC--CeeEEEEeccCCCChhHHHhhhccccCCCH
Q 021682 11 PNGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQR--EEKMLIYDYMPNKSLDFYIFDLRRRYLLDW 87 (309)
Q Consensus 11 ~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 87 (309)
.+++.||+|.++... ......+.+|+.++++++|+|++++++++... ...++||||+++++|.+++... ...+++
T Consensus 31 ~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~ 108 (284)
T cd05079 31 NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRN--KNKINL 108 (284)
T ss_pred CccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhc--cCCCCH
Confidence 468899999986543 33446789999999999999999999988775 5689999999999999988432 234789
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccc-ccccccccccCCCCccccc
Q 021682 88 RTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECE-ANTGRIVGTYGYVPPEYVR 166 (309)
Q Consensus 88 ~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~ 166 (309)
..+..++.+++.|+++||++ |++|+||+|+||+++.++.++|+|||++......... .......++..|+|||.+.
T Consensus 109 ~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~ 185 (284)
T cd05079 109 KQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185 (284)
T ss_pred HHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhc
Confidence 99999999999999999998 9999999999999999999999999998765433221 1122234567899999988
Q ss_pred cCCCCccchhhhHHHHHHHHHhCCCCCCCCCC--------CCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHH
Q 021682 167 KGIYSMKYDVYSYGVLLLQILGGKRTSCYYGP--------NESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238 (309)
Q Consensus 167 ~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (309)
+..++.++||||||+++|+|+++..|...... ..................... ........+.
T Consensus 186 ~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~ 256 (284)
T cd05079 186 QSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLP---------RPPNCPEEVY 256 (284)
T ss_pred cCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCccCC---------CCCCCCHHHH
Confidence 88889999999999999999998765421100 000000011111111111110 0111234788
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHhcc
Q 021682 239 QVALLCVQENAADRPTMLEILVMLKSE 265 (309)
Q Consensus 239 ~li~~~l~~~p~~Rpt~~ell~~L~~~ 265 (309)
+++.+||+.+|++|||+.++++.|+.+
T Consensus 257 ~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 257 QLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=254.12 Aligned_cols=239 Identities=26% Similarity=0.412 Sum_probs=184.8
Q ss_pred ceEEEE-cCCCcEEEEEEeecCC------cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHH
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTS------HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 76 (309)
.+|.+. ..+|+.||+|.++... ......++.|++++++++|+||+++++++...+..++|+||+.+++|.+++
T Consensus 15 ~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l 94 (268)
T cd06630 15 SCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLL 94 (268)
T ss_pred EEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHH
Confidence 456665 3689999999986432 113467889999999999999999999999999999999999999999988
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCC-CceeecccccccccCCccc--cccccc
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM-NPKISDFGMARAFTKDECE--ANTGRI 153 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~-~~~l~Dfg~~~~~~~~~~~--~~~~~~ 153 (309)
.. ...+++..+..++.|++.|+.+||++ |++|+||+|.||+++.++ .++|+|||.+......... ...+..
T Consensus 95 ~~---~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 168 (268)
T cd06630 95 SK---YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQL 168 (268)
T ss_pred HH---hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCcccccc
Confidence 43 33588999999999999999999998 999999999999998776 5999999998765543211 112233
Q ss_pred ccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHH
Q 021682 154 VGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWK 233 (309)
Q Consensus 154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
.++..|+|||.+.+..++.++|+||+|++++++++|..||............ ...... ......+...
T Consensus 169 ~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~~---------~~~~~~~~~~ 236 (268)
T cd06630 169 LGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI---FKIASA---------TTAPSIPEHL 236 (268)
T ss_pred ccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHH---HHHhcc---------CCCCCCchhh
Confidence 5788999999998888899999999999999999999998643332211111 110000 0111222233
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021682 234 LMRCMQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 234 ~~~l~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
...+.+++.+||+.+|++|||+.++++
T Consensus 237 ~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 237 SPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 457889999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=253.57 Aligned_cols=239 Identities=29% Similarity=0.456 Sum_probs=185.1
Q ss_pred cceEEEEcC-C----CcEEEEEEeecCCcc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHH
Q 021682 3 VAICQGRLP-N----GQEMAVKRLSRTSHQ-GLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 3 ~~~~~~~~~-~----g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 76 (309)
+.+|.+... . +..||+|.++..... ....+..|+..++.++|+||+++++++...+..+++||++++++|.+++
T Consensus 13 g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~ 92 (258)
T smart00219 13 GEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYL 92 (258)
T ss_pred cceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHH
Confidence 356666654 3 388999999655433 5678899999999999999999999999999999999999999999988
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccc
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGT 156 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 156 (309)
..... ..+++..+..++.|++.|+++||+. |++|+||+|+||+++.++.++|+|||.+............ ...++
T Consensus 93 ~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~-~~~~~ 167 (258)
T smart00219 93 RKNRP-KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKK-GGKLP 167 (258)
T ss_pred Hhhhh-ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceecccccccccc-cCCCc
Confidence 54222 2289999999999999999999998 8999999999999999999999999998766544221111 22367
Q ss_pred cCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 157 YGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
..|+|||.+.+..++.++|+||||+++++|++ |.+||....... .. ........... ....+.
T Consensus 168 ~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~------~~-~~~~~~~~~~~---------~~~~~~ 231 (258)
T smart00219 168 IRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE------VL-EYLKKGYRLPK---------PENCPP 231 (258)
T ss_pred ccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH------HH-HHHhcCCCCCC---------CCcCCH
Confidence 88999999988888999999999999999998 777765421111 11 11111111110 111334
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHH
Q 021682 236 RCMQVALLCVQENAADRPTMLEILVML 262 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~Rpt~~ell~~L 262 (309)
.+.+++.+||..+|++|||+.++++.|
T Consensus 232 ~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 232 EIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 788999999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=252.94 Aligned_cols=240 Identities=22% Similarity=0.275 Sum_probs=187.0
Q ss_pred CccceEEEEcCCCcEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 1 MSVAICQGRLPNGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 1 ~g~~~~~~~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
||.+.......+++.|++|.+... .......+.+|++++++++|+||+++++++......+++|||+.+++|.+++..
T Consensus 13 ~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~ 92 (256)
T cd08221 13 FGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVR 92 (256)
T ss_pred CceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHh
Confidence 343433334467999999988654 234456788999999999999999999999999999999999999999998854
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
.. ...+++..+..++.+++.++.+||+. |++|+||+|+||+++.++.++|+|||.+........ ......++..
T Consensus 93 ~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~~~~~~~~~~ 166 (256)
T cd08221 93 QK-GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--MAETVVGTPY 166 (256)
T ss_pred cc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc--cccccCCCcc
Confidence 32 34588999999999999999999998 899999999999999999999999999876544332 1223467889
Q ss_pred CCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHH
Q 021682 159 YVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238 (309)
Q Consensus 159 y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (309)
|.|||.+.+..++.++|+||||+++|+|++|..||......+ ..... ..+..... .......+.
T Consensus 167 y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~~~~-~~~~~~~~---------~~~~~~~~~ 230 (256)
T cd08221 167 YMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN------LVVKI-VQGNYTPV---------VSVYSSELI 230 (256)
T ss_pred ccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH------HHHHH-HcCCCCCC---------ccccCHHHH
Confidence 999999988888999999999999999999999985422211 11111 11111110 112234688
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHH
Q 021682 239 QVALLCVQENAADRPTMLEILVML 262 (309)
Q Consensus 239 ~li~~~l~~~p~~Rpt~~ell~~L 262 (309)
+++.+||..+|++|||++++++.+
T Consensus 231 ~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 231 SLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred HHHHHHcccCcccCCCHHHHhhCc
Confidence 999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=269.08 Aligned_cols=247 Identities=17% Similarity=0.157 Sum_probs=176.9
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
+.||++.. ..++.||||.... ..+.+|++++++++|+||+++++++..+...++||+++. ++|..++.. .
T Consensus 183 G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~--~ 253 (461)
T PHA03211 183 GCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGA--R 253 (461)
T ss_pred eEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHh--c
Confidence 35677765 4688999996422 235689999999999999999999999999999999995 677777643 2
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP 161 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 161 (309)
...+++..++.++.|++.||.|||+. ||+||||||+||+++.++.++|+|||++................||..|+|
T Consensus 254 ~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~A 330 (461)
T PHA03211 254 LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNA 330 (461)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcC
Confidence 33589999999999999999999998 899999999999999999999999999876543322222223468999999
Q ss_pred ccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCccc-HHHHHHHHhhC-----CCCccccc-------------
Q 021682 162 PEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLN-LLEYAYGLWKN-----GEGMEFID------------- 222 (309)
Q Consensus 162 PE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~~------------- 222 (309)
||.+.+..++.++|||||||++|+|++|..++-......... ........... ........
T Consensus 331 PE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 410 (461)
T PHA03211 331 PEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAAR 410 (461)
T ss_pred HHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhc
Confidence 999999899999999999999999999876542221111000 00000000000 00000000
Q ss_pred -ccCCCccc-----HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 223 -SSLDDSSS-----AWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 223 -~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
........ ......+.+||.+||+.||++|||+.|+++.
T Consensus 411 ~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 411 NRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred ccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000000 0112367799999999999999999999975
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=254.00 Aligned_cols=234 Identities=21% Similarity=0.291 Sum_probs=186.2
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
+.+|.+.. .+++.||+|.+.... ......+..|+.+++++.|+||+++++++..+...++||||+.+++|.+++..
T Consensus 18 ~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~-- 95 (277)
T cd06640 18 GEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA-- 95 (277)
T ss_pred eEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhc--
Confidence 46788765 468999999987543 33456788999999999999999999999999999999999999999988732
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCC
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYV 160 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 160 (309)
..++...+..++.+++.++++||+. |++|+||+|+||+++.++.++|+|||++........ ......++..|+
T Consensus 96 --~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~ 168 (277)
T cd06640 96 --GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFWM 168 (277)
T ss_pred --CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--ccccccCccccc
Confidence 3478889999999999999999998 899999999999999999999999999866543321 112235677899
Q ss_pred CccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHH
Q 021682 161 PPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQV 240 (309)
Q Consensus 161 aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 240 (309)
|||.+.+..++.++|+||||+++|+|++|..||....+.... . . . ...............+.++
T Consensus 169 apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---~---~-~---------~~~~~~~~~~~~~~~~~~l 232 (277)
T cd06640 169 APEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL---F---L-I---------PKNNPPTLTGEFSKPFKEF 232 (277)
T ss_pred CHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh---h---h-h---------hcCCCCCCchhhhHHHHHH
Confidence 999998888899999999999999999999998543222110 0 0 0 0000111222344578899
Q ss_pred HhhcccCCCCCCCCHHHHHHH
Q 021682 241 ALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 241 i~~~l~~~p~~Rpt~~ell~~ 261 (309)
+.+||+.+|++|||++++++.
T Consensus 233 i~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 233 IDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred HHHHcccCcccCcCHHHHHhC
Confidence 999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=272.62 Aligned_cols=246 Identities=28% Similarity=0.372 Sum_probs=192.6
Q ss_pred ceEEEEcCC--C---cEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHH
Q 021682 4 AICQGRLPN--G---QEMAVKRLSRT---SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFY 75 (309)
Q Consensus 4 ~~~~~~~~~--g---~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (309)
.||.|.+.- + ..||+|..+.. .......+++|++++++++||||+++||+......+++|||+|.||+|.++
T Consensus 172 eV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~ 251 (474)
T KOG0194|consen 172 EVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDY 251 (474)
T ss_pred EEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHH
Confidence 467776642 2 22899988742 355567899999999999999999999999999999999999999999999
Q ss_pred HhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccc
Q 021682 76 IFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVG 155 (309)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 155 (309)
+..... .++......++.+.+.|++|||++ +++||||-.+|+|++.++.+|++|||++...... ........-
T Consensus 252 L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~--~~~~~~~kl 324 (474)
T KOG0194|consen 252 LKKNKK--SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQY--VMKKFLKKL 324 (474)
T ss_pred HHhCCC--CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCcce--eeccccccC
Confidence 954332 589999999999999999999999 8999999999999999999999999998654411 111112245
Q ss_pred ccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHh-hCCCCcccccccCCCcccHHH
Q 021682 156 TYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLW-KNGEGMEFIDSSLDDSSSAWK 233 (309)
Q Consensus 156 ~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 233 (309)
+..|+|||.+....++.++||||||+++||+++ |..||......+ ..... ..+.... .+...
T Consensus 325 PirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~-------v~~kI~~~~~r~~---------~~~~~ 388 (474)
T KOG0194|consen 325 PIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE-------VKAKIVKNGYRMP---------IPSKT 388 (474)
T ss_pred cceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH-------HHHHHHhcCccCC---------CCCCC
Confidence 679999999999999999999999999999998 777875433321 11111 1111111 11133
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccCCCCCC
Q 021682 234 LMRCMQVALLCVQENAADRPTMLEILVMLKSETADIKTP 272 (309)
Q Consensus 234 ~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~~~~~ 272 (309)
+..+..++.+||..+|++|||+.++.+.|+.+.....++
T Consensus 389 p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~ 427 (474)
T KOG0194|consen 389 PKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF 427 (474)
T ss_pred HHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence 446778888999999999999999999999887665543
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=254.68 Aligned_cols=241 Identities=26% Similarity=0.429 Sum_probs=184.9
Q ss_pred ceEEEEcC-C---CcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 4 AICQGRLP-N---GQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 4 ~~~~~~~~-~---g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
.||+|... + +..+|+|.++... ......+..|+.++++++||||+++++++..+...++||||+++++|.+++..
T Consensus 19 ~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 98 (267)
T cd05066 19 EVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRK 98 (267)
T ss_pred ceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHh
Confidence 56777642 2 3379999886542 33456788999999999999999999999999999999999999999999853
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccc-cccccccc
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEAN-TGRIVGTY 157 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~-~~~~~~~~ 157 (309)
. ...+++..+..++.|++.|+++||+. |++|+||+|+||+++.++.++|+|||.+........... .....++.
T Consensus 99 ~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 173 (267)
T cd05066 99 H--DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 173 (267)
T ss_pred c--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccce
Confidence 2 23578899999999999999999998 899999999999999999999999999876544322111 11112345
Q ss_pred CCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHH
Q 021682 158 GYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMR 236 (309)
Q Consensus 158 ~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
.|+|||.+.+..++.++|+||||+++|++++ |..||......+. . ........ . . .....+..
T Consensus 174 ~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~---~----~~~~~~~~--~---~----~~~~~~~~ 237 (267)
T cd05066 174 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV---I----KAIEEGYR--L---P----APMDCPAA 237 (267)
T ss_pred eecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH---H----HHHhCCCc--C---C----CCCCCCHH
Confidence 7999999988889999999999999999886 9988754332211 1 11111100 0 0 01112346
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHHHhcc
Q 021682 237 CMQVALLCVQENAADRPTMLEILVMLKSE 265 (309)
Q Consensus 237 l~~li~~~l~~~p~~Rpt~~ell~~L~~~ 265 (309)
+.+++.+||+.+|++|||+.++++.|++.
T Consensus 238 ~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 238 LHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 78999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=254.96 Aligned_cols=238 Identities=23% Similarity=0.344 Sum_probs=184.3
Q ss_pred cceEEEEcCCCcEEEEEEeecCC------cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHH
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTS------HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 76 (309)
+.||++...+|+.+|+|.+.... ......+.+|++++++++|+||+++++++..+...++++||+.+++|.+++
T Consensus 14 ~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 93 (265)
T cd06631 14 GTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSIL 93 (265)
T ss_pred eEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHH
Confidence 35788877789999999886432 112356888999999999999999999999999999999999999999998
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcc----cccccc
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDEC----EANTGR 152 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~----~~~~~~ 152 (309)
... ..+++..+..++.|++.++++||+. |++|+||+|+||+++.++.++|+|||.+........ ......
T Consensus 94 ~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 167 (265)
T cd06631 94 NRF---GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKS 167 (265)
T ss_pred Hhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccc
Confidence 432 3478999999999999999999998 899999999999999999999999999875432111 111122
Q ss_pred cccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHH
Q 021682 153 IVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAW 232 (309)
Q Consensus 153 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (309)
..++..|+|||.+.+..++.++|+||||+++|++++|..||...+.... .. ......... +.. +..
T Consensus 168 ~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~---~~---~~~~~~~~~----~~~----~~~ 233 (265)
T cd06631 168 MHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA---MF---YIGAHRGLM----PRL----PDS 233 (265)
T ss_pred cCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH---HH---HhhhccCCC----CCC----CCC
Confidence 3578899999999888889999999999999999999999864322111 00 000000000 001 112
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021682 233 KLMRCMQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 233 ~~~~l~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
....+.++|.+||+.+|++|||+.++++
T Consensus 234 ~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 234 FSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 2347889999999999999999999985
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=255.00 Aligned_cols=235 Identities=21% Similarity=0.315 Sum_probs=186.2
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
+.+|++.. .+|+.||+|.+.... ......+..|+++++.++|+|++++++++..+...++|+||+.+++|.+++...
T Consensus 15 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~- 93 (274)
T cd06609 15 GEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG- 93 (274)
T ss_pred eEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc-
Confidence 35677765 478999999986543 334567889999999999999999999999999999999999999999887432
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCC
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYV 160 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 160 (309)
.+++..+..++.|++.++.+||+. |++|+||+|+||+++.++.++|+|||++........ ......++..|+
T Consensus 94 ---~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~ 165 (274)
T cd06609 94 ---KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS--KRNTFVGTPFWM 165 (274)
T ss_pred ---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc--ccccccCCcccc
Confidence 589999999999999999999998 899999999999999999999999999876654321 122245778899
Q ss_pred CccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHH
Q 021682 161 PPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQV 240 (309)
Q Consensus 161 aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 240 (309)
|||.+.+..++.++|+||||+++|+|++|..||....... ..... ........ ... ..+..+.++
T Consensus 166 ~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~------~~~~~-~~~~~~~~-----~~~---~~~~~~~~~ 230 (274)
T cd06609 166 APEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR------VLFLI-PKNNPPSL-----EGN---KFSKPFKDF 230 (274)
T ss_pred ChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH------HHHHh-hhcCCCCC-----ccc---ccCHHHHHH
Confidence 9999988889999999999999999999999986433211 11111 11100110 000 023468899
Q ss_pred HhhcccCCCCCCCCHHHHHHH
Q 021682 241 ALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 241 i~~~l~~~p~~Rpt~~ell~~ 261 (309)
+.+||..+|++|||++++++.
T Consensus 231 l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 231 VSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred HHHHhhCChhhCcCHHHHhhC
Confidence 999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=254.71 Aligned_cols=242 Identities=26% Similarity=0.434 Sum_probs=186.1
Q ss_pred cceEEEEcC-CCc---EEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 3 VAICQGRLP-NGQ---EMAVKRLSRT-SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 3 ~~~~~~~~~-~g~---~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
+.||++... +++ .+|+|.+... .....+.+..|++++++++|+|++++++++......++||||+.+++|.+++.
T Consensus 19 g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 98 (268)
T cd05063 19 GEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLR 98 (268)
T ss_pred ccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHH
Confidence 467888754 333 6999998654 23345678899999999999999999999999999999999999999999884
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccc-cccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANT-GRIVGT 156 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~-~~~~~~ 156 (309)
.. ...+++..+..++.+++.|+.+||+. |++|+||+|.||+++.++.++|+|||++............ .....+
T Consensus 99 ~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 173 (268)
T cd05063 99 DH--DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIP 173 (268)
T ss_pred hc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcC
Confidence 32 34588999999999999999999998 8999999999999999999999999998765433221111 111234
Q ss_pred cCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 157 YGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
..|+|||.+.+..++.++|+|||||++|++++ |..||......+ ............ .....+.
T Consensus 174 ~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~-------~~~~i~~~~~~~---------~~~~~~~ 237 (268)
T cd05063 174 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE-------VMKAINDGFRLP---------APMDCPS 237 (268)
T ss_pred ceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH-------HHHHHhcCCCCC---------CCCCCCH
Confidence 57999999988888999999999999999997 999985332111 111111111000 0111234
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHHhcc
Q 021682 236 RCMQVALLCVQENAADRPTMLEILVMLKSE 265 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~Rpt~~ell~~L~~~ 265 (309)
.+.+++.+||+.+|++||++.++++.|+++
T Consensus 238 ~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 238 AVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 678999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=252.85 Aligned_cols=234 Identities=25% Similarity=0.378 Sum_probs=181.2
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEe-eCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICT-QREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
+.+|++.. .|..||+|.++.. ...+.+..|+.++++++|++++++++++. .+...++++||+++++|.+++... .
T Consensus 20 ~~v~~~~~-~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~ 95 (256)
T cd05082 20 GDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-G 95 (256)
T ss_pred CeEEEEEE-cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhc-C
Confidence 35777765 5888999998543 23467889999999999999999998754 456789999999999999988542 2
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP 161 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 161 (309)
...+++..+..++.+++.++++||++ |++|+||+|+||+++.++.++|+|||++....... ....++..|+|
T Consensus 96 ~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~a 167 (256)
T cd05082 96 RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTA 167 (256)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC-----CCCccceeecC
Confidence 33478899999999999999999998 99999999999999999999999999886443321 11234567999
Q ss_pred ccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHH
Q 021682 162 PEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQV 240 (309)
Q Consensus 162 PE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 240 (309)
||.+.+..++.++|||||||++|+|++ |..||......+ . ........... .....+..+.++
T Consensus 168 PE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~----~~~~~~~~~~~---------~~~~~~~~~~~l 231 (256)
T cd05082 168 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---V----VPRVEKGYKMD---------APDGCPPVVYDV 231 (256)
T ss_pred HHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHhcCCCCC---------CCCCCCHHHHHH
Confidence 999988889999999999999999997 888875322111 1 11111111111 111123478899
Q ss_pred HhhcccCCCCCCCCHHHHHHHHhc
Q 021682 241 ALLCVQENAADRPTMLEILVMLKS 264 (309)
Q Consensus 241 i~~~l~~~p~~Rpt~~ell~~L~~ 264 (309)
+.+||+.+|++|||+.++++.|+.
T Consensus 232 i~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 232 MKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred HHHHhcCChhhCcCHHHHHHHHhc
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=255.61 Aligned_cols=242 Identities=21% Similarity=0.315 Sum_probs=185.3
Q ss_pred cceEEEEcCC----CcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 3 VAICQGRLPN----GQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 3 ~~~~~~~~~~----g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
+.||.|...+ ...||||...... ....+.+.+|+.+++++.|+||+++++++.. ...++||||+++++|.+++.
T Consensus 20 g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~ 98 (270)
T cd05056 20 GDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQ 98 (270)
T ss_pred eeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHH
Confidence 3677776532 2468999886554 4455688999999999999999999998875 45789999999999999985
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
.. ...+++..++.++.+++.|+.+||+. |++|+||+|+||+++.++.++|+|||++.......... .....++.
T Consensus 99 ~~--~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~ 172 (270)
T cd05056 99 VN--KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYK-ASKGKLPI 172 (270)
T ss_pred hC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeeccccccee-cCCCCccc
Confidence 42 23488999999999999999999998 89999999999999999999999999987654432111 11223456
Q ss_pred CCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHH
Q 021682 158 GYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMR 236 (309)
Q Consensus 158 ~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
.|+|||.+.+..++.++||||||+++|++++ |..||......+. . ........... ....+..
T Consensus 173 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---~----~~~~~~~~~~~---------~~~~~~~ 236 (270)
T cd05056 173 KWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV---I----GRIENGERLPM---------PPNCPPT 236 (270)
T ss_pred cccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH---H----HHHHcCCcCCC---------CCCCCHH
Confidence 7999999888888999999999999999986 9999854332211 1 11111111111 1112347
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHHHhcccC
Q 021682 237 CMQVALLCVQENAADRPTMLEILVMLKSETA 267 (309)
Q Consensus 237 l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~ 267 (309)
+.+++.+||..+|++|||+.++++.|++..+
T Consensus 237 ~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 237 LYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 8899999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=253.53 Aligned_cols=240 Identities=23% Similarity=0.344 Sum_probs=182.9
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
++||+|.. .++..||+|.+........+.+.+|+.++++++|+||+++++++..+...++|+||+.+++|.+++.....
T Consensus 22 g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 101 (268)
T cd06624 22 GIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWG 101 (268)
T ss_pred eEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcc
Confidence 45788864 47888999998766655667899999999999999999999999999999999999999999998854322
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCC-CCCceeecccccccccCCcccccccccccccCCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY-EMNPKISDFGMARAFTKDECEANTGRIVGTYGYV 160 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 160 (309)
....+...+..++.|++.|++|||+. |++|+||+|.||+++. ++.++|+|||.+........ ......++..|+
T Consensus 102 ~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~ 176 (268)
T cd06624 102 PLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CTETFTGTLQYM 176 (268)
T ss_pred cCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC--ccccCCCCcccc
Confidence 21127788889999999999999998 9999999999999976 67899999998865533221 111235688999
Q ss_pred CccccccC--CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHH
Q 021682 161 PPEYVRKG--IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238 (309)
Q Consensus 161 aPE~~~~~--~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (309)
|||.+.+. .++.++|+||||+++|+|++|..||........ ......... . ....+......+.
T Consensus 177 aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~~~--~---------~~~~~~~~~~~~~ 242 (268)
T cd06624 177 APEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGMFK--I---------HPEIPESLSAEAK 242 (268)
T ss_pred ChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhhhc--c---------CCCCCcccCHHHH
Confidence 99988654 378899999999999999999999854322110 000000000 0 0011112334788
Q ss_pred HHHhhcccCCCCCCCCHHHHHHH
Q 021682 239 QVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 239 ~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
+++.+||+.+|++|||+.+++..
T Consensus 243 ~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 243 NFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred HHHHHHcCCCchhCCCHHHHHhC
Confidence 99999999999999999999863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=263.88 Aligned_cols=246 Identities=26% Similarity=0.399 Sum_probs=183.8
Q ss_pred ceEEEE------cCCCcEEEEEEeecCC-cccHHHHHHHHHHHhcC-CCCCccceeeEEeeC-CeeEEEEeccCCCChhH
Q 021682 4 AICQGR------LPNGQEMAVKRLSRTS-HQGLEEFENEVKLTARL-QHVNLLPVLGICTQR-EEKMLIYDYMPNKSLDF 74 (309)
Q Consensus 4 ~~~~~~------~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~ 74 (309)
+||++. ..+++.||||.++... ......+..|+.++.++ +|+||+++++++... ...++||||+++++|.+
T Consensus 22 ~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~ 101 (343)
T cd05103 22 QVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSN 101 (343)
T ss_pred eEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHH
Confidence 566664 2467899999997543 23345688999999999 789999999987654 46789999999999999
Q ss_pred HHhhhcc----------------------------------------------------------------ccCCCHHHH
Q 021682 75 YIFDLRR----------------------------------------------------------------RYLLDWRTR 90 (309)
Q Consensus 75 ~~~~~~~----------------------------------------------------------------~~~~~~~~~ 90 (309)
++..... ...+++..+
T Consensus 102 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (343)
T cd05103 102 YLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDL 181 (343)
T ss_pred HHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHH
Confidence 8854210 123677888
Q ss_pred HHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCccccccCCC
Q 021682 91 VHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIY 170 (309)
Q Consensus 91 ~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 170 (309)
..++.|+++|++|||+. |++|+||||+||+++.++.++|+|||++............+...++..|+|||.+.+..+
T Consensus 182 ~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 258 (343)
T cd05103 182 ICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 258 (343)
T ss_pred HHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCC
Confidence 89999999999999998 999999999999999999999999999876543322222222345667999999988889
Q ss_pred CccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHHhhcccCCC
Q 021682 171 SMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENA 249 (309)
Q Consensus 171 ~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 249 (309)
+.++|+||||+++|++++ |..||........ . ......+..... +.....++.+++.+||+.+|
T Consensus 259 ~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~---~~~~~~~~~~~~---------~~~~~~~~~~~~~~cl~~~p 323 (343)
T cd05103 259 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---F---CRRLKEGTRMRA---------PDYTTPEMYQTMLDCWHGEP 323 (343)
T ss_pred CchhhHHHHHHHHHHHHHCCCCCCCCccccHH---H---HHHHhccCCCCC---------CCCCCHHHHHHHHHHccCCh
Confidence 999999999999999997 8888754322111 0 111111111110 01122367899999999999
Q ss_pred CCCCCHHHHHHHHhcccC
Q 021682 250 ADRPTMLEILVMLKSETA 267 (309)
Q Consensus 250 ~~Rpt~~ell~~L~~~~~ 267 (309)
++|||+.++++.|+.+.+
T Consensus 324 ~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 324 SQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred hhCcCHHHHHHHHHHHHh
Confidence 999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=269.84 Aligned_cols=238 Identities=19% Similarity=0.269 Sum_probs=179.6
Q ss_pred ceEEEE-cCCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
.||.+. ..+|+.||||+++... ......+..|+.++.+++|++|+++++.+..+...++||||+++++|.+++..
T Consensus 16 ~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~- 94 (360)
T cd05627 16 EVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMK- 94 (360)
T ss_pred EEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHh-
Confidence 455554 4579999999997532 23345778899999999999999999999999999999999999999998843
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccc------------
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECE------------ 147 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~------------ 147 (309)
...+++..+..++.|++.|+.|||+. |++||||||+||+++.++.++|+|||++.........
T Consensus 95 --~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~ 169 (360)
T cd05627 95 --KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPS 169 (360)
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCcc
Confidence 34489999999999999999999998 9999999999999999999999999998644221100
Q ss_pred ---------------------ccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHH
Q 021682 148 ---------------------ANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLE 206 (309)
Q Consensus 148 ---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 206 (309)
.......||..|+|||++.+..++.++|+|||||++|+|++|..||.........
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~---- 245 (360)
T cd05627 170 DFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETY---- 245 (360)
T ss_pred cccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHHHH----
Confidence 0011236889999999999999999999999999999999999998643322111
Q ss_pred HHHHHhhCCCCcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCC---HHHHHHH
Q 021682 207 YAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPT---MLEILVM 261 (309)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~ell~~ 261 (309)
........... +.+. .....++.++|.+|+ .||++|++ ++++++.
T Consensus 246 --~~i~~~~~~~~-~p~~------~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 246 --RKVMNWKETLV-FPPE------VPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred --HHHHcCCCcee-cCCC------CCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 11111000011 1110 012236778888877 49999985 6777765
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=241.26 Aligned_cols=236 Identities=22% Similarity=0.292 Sum_probs=191.5
Q ss_pred CccceEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHH
Q 021682 1 MSVAICQGRL-PNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 1 ~g~~~~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 76 (309)
|| .||.++. +++--||+|++.+.. .....++.+|+++.+.|+||||+++|++|.++...||++||..+|.+...+
T Consensus 35 FG-~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L 113 (281)
T KOG0580|consen 35 FG-NVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDL 113 (281)
T ss_pred cc-cEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHH
Confidence 67 5566654 578889999986542 333467899999999999999999999999999999999999999998887
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccc
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGT 156 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 156 (309)
.. ++...+++.....+..|++.|+.|+|.. +|+||||||+|++++..+.+|++|||.+....... .....||
T Consensus 114 ~~-~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~k----R~tlcgt 185 (281)
T KOG0580|consen 114 QE-GRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSNK----RKTLCGT 185 (281)
T ss_pred Hh-cccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecCCCC----ceeeecc
Confidence 53 3455689999999999999999999998 89999999999999999999999999987655332 2334689
Q ss_pred cCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHH
Q 021682 157 YGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMR 236 (309)
Q Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
.-|.+||...+...+...|+|++|++.|+++.|.+||......+....+... ++.. +...+..
T Consensus 186 ~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~----------~~~~-------p~~is~~ 248 (281)
T KOG0580|consen 186 LDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV----------DLKF-------PSTISGG 248 (281)
T ss_pred cccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc----------cccC-------CcccChh
Confidence 9999999999999999999999999999999999999765533322222111 1111 1122236
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHHH
Q 021682 237 CMQVALLCVQENAADRPTMLEILVML 262 (309)
Q Consensus 237 l~~li~~~l~~~p~~Rpt~~ell~~L 262 (309)
..|+|.+|+..+|.+|.+..|+++.-
T Consensus 249 a~dlI~~ll~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 249 AADLISRLLVKNPIERLALTEVMDHP 274 (281)
T ss_pred HHHHHHHHhccCccccccHHHHhhhH
Confidence 77999999999999999999998764
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=255.65 Aligned_cols=234 Identities=21% Similarity=0.318 Sum_probs=184.7
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
+.||+|.. .+|+.||+|.+.... ....+.+..|++++++++|+||+++++++..+...++|+||+.+++|.+++.
T Consensus 18 ~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~--- 94 (277)
T cd06642 18 GEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK--- 94 (277)
T ss_pred eeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhh---
Confidence 46788864 468899999986443 3345678899999999999999999999999999999999999999988873
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCC
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYV 160 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 160 (309)
...+++..+..++.+++.|+.|||++ |++|+||+|+||+++.++.++|+|||++........ ......++..|+
T Consensus 95 -~~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~ 168 (277)
T cd06642 95 -PGPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFWM 168 (277)
T ss_pred -cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch--hhhcccCccccc
Confidence 23488899999999999999999998 899999999999999999999999999865543221 112235778899
Q ss_pred CccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHH
Q 021682 161 PPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQV 240 (309)
Q Consensus 161 aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 240 (309)
|||.+.+..++.++|+||||+++|+|++|..|+........ .. ...... ...........+.++
T Consensus 169 aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~~----~~~~~~---------~~~~~~~~~~~~~~l 232 (277)
T cd06642 169 APEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV---LF----LIPKNS---------PPTLEGQYSKPFKEF 232 (277)
T ss_pred CHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH---Hh----hhhcCC---------CCCCCcccCHHHHHH
Confidence 99999888889999999999999999999999753322110 00 000000 001111223468899
Q ss_pred HhhcccCCCCCCCCHHHHHHH
Q 021682 241 ALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 241 i~~~l~~~p~~Rpt~~ell~~ 261 (309)
+.+||+.+|++|||+.++++.
T Consensus 233 i~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 233 VEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred HHHHccCCcccCcCHHHHHHh
Confidence 999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=252.60 Aligned_cols=239 Identities=23% Similarity=0.352 Sum_probs=185.7
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccc
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRR 82 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 82 (309)
+.||.+..+++..+|+|.+... ....+.+.+|++++++++|+||+++++++.. ...+++|||+.+++|.+++... ..
T Consensus 20 ~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~-~~ 96 (260)
T cd05073 20 GEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSD-EG 96 (260)
T ss_pred eEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhC-Cc
Confidence 4678888777888999988643 2345678899999999999999999999887 6789999999999999998542 23
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCc
Q 021682 83 YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPP 162 (309)
Q Consensus 83 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 162 (309)
...++..+..++.+++.|+.+||+. |++|+||+|+||+++.++.++|+|||.+......... ......++..|+||
T Consensus 97 ~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~y~~P 172 (260)
T cd05073 97 SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-AREGAKFPIKWTAP 172 (260)
T ss_pred cccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCcc-cccCCcccccccCH
Confidence 4578888999999999999999998 8999999999999999999999999988654432211 11122345679999
Q ss_pred cccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHH
Q 021682 163 EYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241 (309)
Q Consensus 163 E~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 241 (309)
|.+....++.++|+||||+++|++++ |..||........ ........... .....+..+.+++
T Consensus 173 E~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~-------~~~~~~~~~~~---------~~~~~~~~~~~~i 236 (260)
T cd05073 173 EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV-------IRALERGYRMP---------RPENCPEELYNIM 236 (260)
T ss_pred hHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH-------HHHHhCCCCCC---------CcccCCHHHHHHH
Confidence 99988888999999999999999998 8888854322111 11111111111 1112234788999
Q ss_pred hhcccCCCCCCCCHHHHHHHHhc
Q 021682 242 LLCVQENAADRPTMLEILVMLKS 264 (309)
Q Consensus 242 ~~~l~~~p~~Rpt~~ell~~L~~ 264 (309)
.+||+.+|++||++.++++.|+.
T Consensus 237 ~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 237 MRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHHcccCcccCcCHHHHHHHHhc
Confidence 99999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=282.40 Aligned_cols=249 Identities=22% Similarity=0.238 Sum_probs=187.4
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
+.||++.. .+|+.||||.+.... .....++.+|++++++++||||+++++++..++..++||||++|++|.+++..
T Consensus 16 G~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s 95 (932)
T PRK13184 16 GEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKS 95 (932)
T ss_pred EEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHH
Confidence 46777764 479999999986542 22345788999999999999999999999999999999999999999998854
Q ss_pred hcc--------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcc----
Q 021682 79 LRR--------RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDEC---- 146 (309)
Q Consensus 79 ~~~--------~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~---- 146 (309)
... ....+...++.++.|++.|++|||+. |++||||||+||+++.++.++|+|||++........
T Consensus 96 ~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~ 172 (932)
T PRK13184 96 VWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172 (932)
T ss_pred hhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCcceecccccccccc
Confidence 211 12345667888999999999999998 899999999999999999999999999976521110
Q ss_pred ------------cccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhC
Q 021682 147 ------------EANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKN 214 (309)
Q Consensus 147 ------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 214 (309)
....+...||+.|+|||.+.+..++.++|||||||++|+|++|..||........ . .. .....
T Consensus 173 l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki---~-~~-~~i~~ 247 (932)
T PRK13184 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI---S-YR-DVILS 247 (932)
T ss_pred cccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh---h-hh-hhccC
Confidence 0011224689999999999998999999999999999999999999854222110 0 00 00000
Q ss_pred CCCcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCC-CHHHHHHHHhcccCC
Q 021682 215 GEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRP-TMLEILVMLKSETAD 268 (309)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-t~~ell~~L~~~~~~ 268 (309)
..........+..+.+++.+||+.||++|| +++++++.|+...+.
T Consensus 248 ---------P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 248 ---------PIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred ---------hhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 000000011233678999999999999995 678888888776543
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=266.57 Aligned_cols=246 Identities=22% Similarity=0.246 Sum_probs=177.3
Q ss_pred ceEEEE-cCCCcEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeeEEeeC------CeeEEEEeccCCCChhH
Q 021682 4 AICQGR-LPNGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQR------EEKMLIYDYMPNKSLDF 74 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~~L~~ 74 (309)
+||.+. ..+++.||||.+... .......+.+|+.+++.++|+||+++++++... ...++||||+.+ ++..
T Consensus 32 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~ 110 (355)
T cd07874 32 IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQ 110 (355)
T ss_pred EEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhcc-cHHH
Confidence 456664 357899999998653 223345677899999999999999999987643 357999999975 5655
Q ss_pred HHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccc
Q 021682 75 YIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIV 154 (309)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~ 154 (309)
.+. ..++...+..++.|++.||.|||+. |++||||||+||+++.++.++|+|||++....... ......
T Consensus 111 ~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~ 179 (355)
T cd07874 111 VIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYV 179 (355)
T ss_pred HHh-----hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcccccCCCcc---ccCCcc
Confidence 542 1378888999999999999999998 99999999999999999999999999987543322 122246
Q ss_pred cccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHH----------------HHHHhhCC-CC
Q 021682 155 GTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEY----------------AYGLWKNG-EG 217 (309)
Q Consensus 155 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~----------------~~~~~~~~-~~ 217 (309)
++..|+|||.+.+..++.++|||||||++|+|++|..||...+..+....... ........ ..
T Consensus 180 ~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (355)
T cd07874 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKY 259 (355)
T ss_pred ccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCcc
Confidence 78999999999988899999999999999999999999864332111110000 00000000 00
Q ss_pred -----ccccccc-C--CCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 218 -----MEFIDSS-L--DDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 218 -----~~~~~~~-~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
...+... . ...........+.++|.+||+.||++|||+.|+++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 260 AGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred ccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000000 0 001111123467899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=256.31 Aligned_cols=250 Identities=20% Similarity=0.256 Sum_probs=183.1
Q ss_pred cceEEEEcC-CCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 3 VAICQGRLP-NGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 3 ~~~~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
+.+|++... +|+.||+|.+.... ....+.+.+|+.++++++|+|++++++++..+...++||||+++++|..+..
T Consensus 15 ~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~-- 92 (286)
T cd07847 15 GVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEK-- 92 (286)
T ss_pred eEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHh--
Confidence 456777654 69999999886542 2234567899999999999999999999999999999999999988877653
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
....+++..+..++.|++.++.+||+. |++|+||+|.||+++.++.++|+|||++......... .....++..|
T Consensus 93 -~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~ 166 (286)
T cd07847 93 -NPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD--YTDYVATRWY 166 (286)
T ss_pred -CCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCccc--ccCccccccc
Confidence 233489999999999999999999998 8999999999999999999999999998765443211 1223567889
Q ss_pred CCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH--------HhhCCCCc-ccccccCCCcc
Q 021682 160 VPPEYVRK-GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYG--------LWKNGEGM-EFIDSSLDDSS 229 (309)
Q Consensus 160 ~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~-~~~~~~~~~~~ 229 (309)
+|||.+.+ ..++.++|+||||+++|+|++|..||......+.......... .+...... ....+......
T Consensus 167 ~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (286)
T cd07847 167 RAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETRE 246 (286)
T ss_pred CCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCccccc
Confidence 99998866 4578899999999999999999999865433221111110000 00000000 00000000000
Q ss_pred c-----HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021682 230 S-----AWKLMRCMQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 230 ~-----~~~~~~l~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
+ ......+.+++.+||+.+|++|||+.|++.
T Consensus 247 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 247 PLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred CHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0 012346889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=252.58 Aligned_cols=230 Identities=20% Similarity=0.366 Sum_probs=177.5
Q ss_pred cceEEEEcCCCc-----------EEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCC
Q 021682 3 VAICQGRLPNGQ-----------EMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKS 71 (309)
Q Consensus 3 ~~~~~~~~~~g~-----------~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 71 (309)
+.||+|...+.. .|++|.+...... ...+.+|+.++++++|+||+++++++.. ...++||||+.+++
T Consensus 9 ~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~ 86 (259)
T cd05037 9 TNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGP 86 (259)
T ss_pred ceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCc
Confidence 456888765333 5788887554333 5788899999999999999999999887 67899999999999
Q ss_pred hhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCC-------CceeecccccccccCC
Q 021682 72 LDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM-------NPKISDFGMARAFTKD 144 (309)
Q Consensus 72 L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~-------~~~l~Dfg~~~~~~~~ 144 (309)
|.+++.... ..+++..+..++.|++.|++|||++ |++|+||+|+||+++.++ .++|+|||++......
T Consensus 87 L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~~ 161 (259)
T cd05037 87 LDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSR 161 (259)
T ss_pred HHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCcccccccc
Confidence 999985432 2588999999999999999999998 899999999999999887 7999999998654331
Q ss_pred cccccccccccccCCCCccccccC--CCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccc
Q 021682 145 ECEANTGRIVGTYGYVPPEYVRKG--IYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFI 221 (309)
Q Consensus 145 ~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (309)
....++..|+|||.+.+. .++.++|+||||+++|++++ |..|+......... ..+.......
T Consensus 162 ------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~-------~~~~~~~~~~-- 226 (259)
T cd05037 162 ------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE-------RFYQDQHRLP-- 226 (259)
T ss_pred ------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH-------HHHhcCCCCC--
Confidence 122456789999998776 78899999999999999999 56666543221110 0111100000
Q ss_pred cccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHh
Q 021682 222 DSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLK 263 (309)
Q Consensus 222 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~ 263 (309)
... ...+.+++.+||..+|.+|||+.++++.|+
T Consensus 227 -----~~~----~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 227 -----MPD----CAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -----CCC----chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 147889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=253.56 Aligned_cols=241 Identities=24% Similarity=0.360 Sum_probs=178.9
Q ss_pred ceEEEEcC----CCcEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeeEEe-eCCeeEEEEeccCCCChhHHHh
Q 021682 4 AICQGRLP----NGQEMAVKRLSRT-SHQGLEEFENEVKLTARLQHVNLLPVLGICT-QREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 4 ~~~~~~~~----~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
.||+|... ++..||+|.+... .......+..|+.+++.++||||+++++++. .+...++++||+.+++|.+++.
T Consensus 10 ~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 89 (262)
T cd05058 10 CVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIR 89 (262)
T ss_pred eEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHH
Confidence 56777642 3457999988543 3334567889999999999999999999765 4556889999999999999985
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccc--cccccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECE--ANTGRIVG 155 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~ 155 (309)
.. .....+..+..++.+++.|+.|||+. |++|+||+|+||+++.++.++|+|||++......... .......+
T Consensus 90 ~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 164 (262)
T cd05058 90 SE--THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKL 164 (262)
T ss_pred hc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcC
Confidence 32 22356777888999999999999998 8999999999999999999999999998654332111 11112245
Q ss_pred ccCCCCccccccCCCCccchhhhHHHHHHHHHhC-CCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHH
Q 021682 156 TYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGG-KRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKL 234 (309)
Q Consensus 156 ~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
+..|+|||.+.+..++.++||||||+++|+|++| .+||..... ........ ...... .+...+
T Consensus 165 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~------~~~~~~~~-~~~~~~---------~~~~~~ 228 (262)
T cd05058 165 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS------FDITVYLL-QGRRLL---------QPEYCP 228 (262)
T ss_pred CccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHh-cCCCCC---------CCCcCC
Confidence 6689999999888899999999999999999995 555532211 11111111 111000 001112
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHHhcc
Q 021682 235 MRCMQVALLCVQENAADRPTMLEILVMLKSE 265 (309)
Q Consensus 235 ~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~ 265 (309)
..+.+++.+||+.+|++||++.++++.|++.
T Consensus 229 ~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 229 DPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 3678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=251.87 Aligned_cols=234 Identities=24% Similarity=0.356 Sum_probs=183.9
Q ss_pred cceEEEEcC-CCcEEEEEEeecCC-----cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHH
Q 021682 3 VAICQGRLP-NGQEMAVKRLSRTS-----HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 3 ~~~~~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 76 (309)
+.+|+|... +++.|++|.+.... ......+..|+.+++.++|+||+++++++..+...++++||+++++|.+++
T Consensus 14 ~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 93 (258)
T cd06632 14 GSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLL 93 (258)
T ss_pred ceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHH
Confidence 467888765 79999999986543 224467889999999999999999999999999999999999999999988
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccc
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGT 156 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 156 (309)
.. ...+++..+..++.|++.++++||+. |++|+||+|+||+++.++.++|+|||.+....... ......++
T Consensus 94 ~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~~~~~~~~ 164 (258)
T cd06632 94 KK---YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---FAKSFKGS 164 (258)
T ss_pred Hh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccccc---cccccCCC
Confidence 43 33488999999999999999999998 89999999999999999999999999886654332 12234578
Q ss_pred cCCCCccccccCC-CCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 157 YGYVPPEYVRKGI-YSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 157 ~~y~aPE~~~~~~-~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
..|++||.+.... ++.++|+||||+++|++++|+.||....... ..... ........+ +.....
T Consensus 165 ~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~------~~~~~-~~~~~~~~~--------~~~~~~ 229 (258)
T cd06632 165 PYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA------AVFKI-GRSKELPPI--------PDHLSD 229 (258)
T ss_pred cceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH------HHHHH-HhcccCCCc--------CCCcCH
Confidence 8899999887665 8999999999999999999999986433111 11111 110001111 111234
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHH
Q 021682 236 RCMQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
.+.+++.+||+.+|++|||+.+++.
T Consensus 230 ~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 230 EAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HHHHHHHHHhhcCcccCcCHHHHhc
Confidence 6789999999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=259.50 Aligned_cols=240 Identities=18% Similarity=0.195 Sum_probs=178.7
Q ss_pred ceEEEE-cCCCcEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGR-LPNGQEMAVKRLSRT---SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
.||.+. ..+++.||+|.+.+. .......+.+|+.+++.++|++|+++++++..+.+.++||||+.+++|.+++...
T Consensus 16 ~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~ 95 (331)
T cd05597 16 EVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKF 95 (331)
T ss_pred EEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHh
Confidence 445555 457999999998653 2233456888999999999999999999999999999999999999999988432
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
...+++..+..++.||+.|++|||++ |++||||||+||+++.++.++|+|||++......... ......|+..|
T Consensus 96 --~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y 169 (331)
T cd05597 96 --EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV-QSNVAVGTPDY 169 (331)
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc-cccceeccccc
Confidence 33488999999999999999999998 8999999999999999999999999998654432211 11223589999
Q ss_pred CCcccccc-----CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHH
Q 021682 160 VPPEYVRK-----GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKL 234 (309)
Q Consensus 160 ~aPE~~~~-----~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
+|||.+.+ ..++.++|||||||++|+|++|..||......+ .............+... ....+
T Consensus 170 ~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~------~~~~i~~~~~~~~~~~~------~~~~~ 237 (331)
T cd05597 170 ISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHKEHFQFPPD------VTDVS 237 (331)
T ss_pred cCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH------HHHHHHcCCCcccCCCc------cCCCC
Confidence 99999863 356789999999999999999999985432211 11111111111111100 01123
Q ss_pred HHHHHHHhhcccCCCC--CCCCHHHHHHH
Q 021682 235 MRCMQVALLCVQENAA--DRPTMLEILVM 261 (309)
Q Consensus 235 ~~l~~li~~~l~~~p~--~Rpt~~ell~~ 261 (309)
..+.+++.+||..+++ .|++++++++.
T Consensus 238 ~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 238 EEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 4677899998865433 37899999887
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=255.58 Aligned_cols=221 Identities=21% Similarity=0.321 Sum_probs=169.8
Q ss_pred cEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccccCCCHHHHHHH
Q 021682 14 QEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHI 93 (309)
Q Consensus 14 ~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ 93 (309)
..|++|.+..........+.+|+.++++++||||+++++++..+...++||||+.+++|..++.. ....+++..+..+
T Consensus 45 ~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i 122 (274)
T cd05076 45 LRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITV 122 (274)
T ss_pred eeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHH
Confidence 45889988655444456788899999999999999999999999999999999999999888743 2345888999999
Q ss_pred HHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCC-------CceeecccccccccCCcccccccccccccCCCCccccc
Q 021682 94 IEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM-------NPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVR 166 (309)
Q Consensus 94 ~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~-------~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 166 (309)
+.|++.|++|||++ |++|+||||+||+++..+ .++++|||.+...... ....++..|+|||.+.
T Consensus 123 ~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~ 193 (274)
T cd05076 123 AQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVP 193 (274)
T ss_pred HHHHHHHHHHHHcC---CccCCCCCcccEEEeccCcccCccceeeecCCccccccccc------cccccCCcccCchhhc
Confidence 99999999999998 899999999999997643 3799999987543221 1124677899999886
Q ss_pred c-CCCCccchhhhHHHHHHHHH-hCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHHhhc
Q 021682 167 K-GIYSMKYDVYSYGVLLLQIL-GGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLC 244 (309)
Q Consensus 167 ~-~~~~~~~DvwslG~il~~ll-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 244 (309)
+ ..++.++|+||||+++|+++ +|..||......+. .... .... . .... ....+.++|.+|
T Consensus 194 ~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---~~~~----~~~~--~-----~~~~----~~~~~~~li~~c 255 (274)
T cd05076 194 GGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK---ERFY----EKKH--R-----LPEP----SCKELATLISQC 255 (274)
T ss_pred CCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH---HHHH----Hhcc--C-----CCCC----CChHHHHHHHHH
Confidence 5 56789999999999999985 68888754322211 1110 0000 0 0000 112678999999
Q ss_pred ccCCCCCCCCHHHHHHHHh
Q 021682 245 VQENAADRPTMLEILVMLK 263 (309)
Q Consensus 245 l~~~p~~Rpt~~ell~~L~ 263 (309)
|+.+|++|||+.++++.|+
T Consensus 256 l~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 256 LTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred cccChhhCcCHHHHHHhhC
Confidence 9999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=283.48 Aligned_cols=246 Identities=19% Similarity=0.240 Sum_probs=182.1
Q ss_pred CccceEEEEcCCCcEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeeEEee--CCeeEEEEeccCCCChhHHH
Q 021682 1 MSVAICQGRLPNGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQ--REEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 1 ~g~~~~~~~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~~ 76 (309)
||.|+......+++.||+|.+... .......+..|+.++++++||||++++++|.. ...++|||||+.+++|.+++
T Consensus 26 FGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL 105 (1021)
T PTZ00266 26 FGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNI 105 (1021)
T ss_pred CeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHH
Confidence 455444444567889999998654 23345678899999999999999999998854 35789999999999999988
Q ss_pred hhhc-cccCCCHHHHHHHHHHHHHHHHHHhhcC----CCceeecCCCCceEEeCC-----------------CCCceeec
Q 021682 77 FDLR-RRYLLDWRTRVHIIEGITQGLLYLQEYS----NLTIVHRDLKASNILLDY-----------------EMNPKISD 134 (309)
Q Consensus 77 ~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~----~~gi~H~di~p~nil~~~-----------------~~~~~l~D 134 (309)
.... ....+++..++.++.||+.||.|||+.. ..+|+|+||||+|||++. .+.++|+|
T Consensus 106 ~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsD 185 (1021)
T PTZ00266 106 QKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGD 185 (1021)
T ss_pred HHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEcc
Confidence 5422 2345899999999999999999999852 136999999999999964 23489999
Q ss_pred ccccccccCCcccccccccccccCCCCcccccc--CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHh
Q 021682 135 FGMARAFTKDECEANTGRIVGTYGYVPPEYVRK--GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLW 212 (309)
Q Consensus 135 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 212 (309)
||++........ .....|++.|+|||++.+ ..++.++|||||||++|+|++|..||....... . .....
T Consensus 186 FGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~-----q-li~~l 256 (1021)
T PTZ00266 186 FGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFS-----Q-LISEL 256 (1021)
T ss_pred CCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHH-----H-HHHHH
Confidence 999876543221 223468999999998854 457899999999999999999999985432211 1 11111
Q ss_pred hCCCCcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHH--HHhcc
Q 021682 213 KNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILV--MLKSE 265 (309)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~--~L~~~ 265 (309)
....... .. .....+.+||.+||+.+|.+|||+.+++. .+...
T Consensus 257 k~~p~lp------i~----~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 257 KRGPDLP------IK----GKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred hcCCCCC------cC----CCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 1111000 00 11247889999999999999999999994 44433
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=251.02 Aligned_cols=240 Identities=23% Similarity=0.310 Sum_probs=186.1
Q ss_pred cceEEEEcC-CCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 3 VAICQGRLP-NGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 3 ~~~~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
+.+|++... +++.||+|.+.... .....++.+|++++++++||||+++++.+..+...++++|++.+++|.+++....
T Consensus 15 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 94 (265)
T cd06605 15 GVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQ 94 (265)
T ss_pred eEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHcc
Confidence 346666554 78999999987653 3445678899999999999999999999999999999999999999999885432
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhh-cCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQE-YSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~-~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
..+++..+..++.+++.++.+||+ . |++|+||+|+||+++.++.++|+|||.+......... ...++..|
T Consensus 95 --~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~----~~~~~~~y 165 (265)
T cd06605 95 --GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK----TFVGTSSY 165 (265)
T ss_pred --CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh----cccCChhc
Confidence 558899999999999999999999 6 9999999999999999999999999988655332211 14577889
Q ss_pred CCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHH
Q 021682 160 VPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQ 239 (309)
Q Consensus 160 ~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (309)
+|||.+.+..++.++|+||||+++|++++|..||........ ........ .......... .......+.+
T Consensus 166 ~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~-~~~~~~~~~~--------~~~~~~~~~~ 235 (265)
T cd06605 166 MAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQY-IVNEPPPRLP--------SGKFSPDFQD 235 (265)
T ss_pred cCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHH-HhcCCCCCCC--------hhhcCHHHHH
Confidence 999999888899999999999999999999999854322111 11111111 1111111100 0013346889
Q ss_pred HHhhcccCCCCCCCCHHHHHHH
Q 021682 240 VALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 240 li~~~l~~~p~~Rpt~~ell~~ 261 (309)
+|.+||..+|++|||+.+++..
T Consensus 236 li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 236 FVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred HHHHHcCCCchhCcCHHHHhhC
Confidence 9999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=253.77 Aligned_cols=243 Identities=26% Similarity=0.374 Sum_probs=185.8
Q ss_pred cceEEEEcC-CCc----EEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHH
Q 021682 3 VAICQGRLP-NGQ----EMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 3 ~~~~~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 76 (309)
+++|++... +|+ .||+|.+.... ......+.+|+..+++++|+||+++++++.. ...++|+||+.+++|.+++
T Consensus 21 g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l 99 (279)
T cd05057 21 GTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYV 99 (279)
T ss_pred ccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHH
Confidence 356777643 343 58999886553 3345678899999999999999999999887 6889999999999999988
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccc
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGT 156 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 156 (309)
... ...+++..+..++.|++.|++|||+. |++|+||+|+||+++.++.++|+|||.+................++
T Consensus 100 ~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~ 174 (279)
T cd05057 100 RNH--KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVP 174 (279)
T ss_pred Hhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCccc
Confidence 542 33488999999999999999999998 9999999999999999999999999998765533221111112235
Q ss_pred cCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 157 YGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
..|+|||.+....++.++|+||||+++|++++ |..||......+ . ........... .+.....
T Consensus 175 ~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~-~~~~~~~~~~~---------~~~~~~~ 238 (279)
T cd05057 175 IKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE------I-PDLLEKGERLP---------QPPICTI 238 (279)
T ss_pred ccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH------H-HHHHhCCCCCC---------CCCCCCH
Confidence 67999999988888999999999999999998 999985432211 1 11111111100 0011123
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHHhcccC
Q 021682 236 RCMQVALLCVQENAADRPTMLEILVMLKSETA 267 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~ 267 (309)
.+.+++.+||..+|.+|||+.++++.|+....
T Consensus 239 ~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 239 DVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 67799999999999999999999999998744
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=258.22 Aligned_cols=242 Identities=26% Similarity=0.405 Sum_probs=182.7
Q ss_pred cceEEEEc-CCCc----EEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHH
Q 021682 3 VAICQGRL-PNGQ----EMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 3 ~~~~~~~~-~~g~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 76 (309)
+.||++.. .+|+ .||+|.+.... ......+.+|+.+++.++|+||+++++++..+ ..+++++|+++++|.+++
T Consensus 21 g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~ 99 (303)
T cd05110 21 GTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYV 99 (303)
T ss_pred ccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHH
Confidence 46788865 3454 47888886543 22334688999999999999999999998754 467899999999999887
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccc
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGT 156 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 156 (309)
... ...+++..+..++.|++.|+.|||++ |++|+||+|+||+++.++.+||+|||++................++
T Consensus 100 ~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~ 174 (303)
T cd05110 100 HEH--KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMP 174 (303)
T ss_pred Hhc--ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccCcccccccCCCccc
Confidence 432 33478889999999999999999998 8999999999999999999999999999765433222222223456
Q ss_pred cCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 157 YGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
..|+|||.+.+..++.++||||||+++|++++ |..||....... ............. ......
T Consensus 175 ~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~~---------~~~~~~ 238 (303)
T cd05110 175 IKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-------IPDLLEKGERLPQ---------PPICTI 238 (303)
T ss_pred cccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHCCCCCCC---------CCCCCH
Confidence 78999999988889999999999999999997 888875322111 1111111111100 011223
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHHhccc
Q 021682 236 RCMQVALLCVQENAADRPTMLEILVMLKSET 266 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~ 266 (309)
.+.+++.+||..+|++||+++++++.|+.+.
T Consensus 239 ~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 239 DVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 6789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=269.86 Aligned_cols=234 Identities=24% Similarity=0.310 Sum_probs=189.9
Q ss_pred CccceEEEEcCCCcEEEEEEeecCCc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 1 MSVAICQGRLPNGQEMAVKRLSRTSH---QGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 1 ~g~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
||.|.|+....+.+.||||.+.-... .-++++.+|++.|.+++|||+|.+-+++..+.+.+||||||- |+-.|++.
T Consensus 39 FGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl-GSAsDlle 117 (948)
T KOG0577|consen 39 FGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDLLE 117 (948)
T ss_pred cceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-ccHHHHHH
Confidence 88899998889999999999875543 346778899999999999999999999999999999999996 57878773
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
...+++.+..+..++.+.+.||+|||+. +.+|||||..||++++.|.|||+|||.+..... .+.++||+
T Consensus 118 --VhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P------AnsFvGTP 186 (948)
T KOG0577|consen 118 --VHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP------ANSFVGTP 186 (948)
T ss_pred --HHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc------hhcccCCc
Confidence 4566799999999999999999999998 899999999999999999999999999865444 33468999
Q ss_pred CCCCccccc---cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHH
Q 021682 158 GYVPPEYVR---KGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKL 234 (309)
Q Consensus 158 ~y~aPE~~~---~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
.|||||++. .+.|+.++||||||++..+|...++|.-..+- ... ..+......+.+ . ...-+
T Consensus 187 ywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA------MSA-LYHIAQNesPtL-------q-s~eWS 251 (948)
T KOG0577|consen 187 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSA-LYHIAQNESPTL-------Q-SNEWS 251 (948)
T ss_pred cccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH------HHH-HHHHHhcCCCCC-------C-CchhH
Confidence 999999874 46899999999999999999999988533211 111 112222111111 1 12223
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 235 MRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 235 ~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
..++.++..||+.-|.+|||.++++..
T Consensus 252 ~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 252 DYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred HHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 468899999999999999999998764
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=251.85 Aligned_cols=232 Identities=21% Similarity=0.352 Sum_probs=176.3
Q ss_pred cceEEEEcC-C-------CcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhH
Q 021682 3 VAICQGRLP-N-------GQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDF 74 (309)
Q Consensus 3 ~~~~~~~~~-~-------g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (309)
+.||++... . ...||+|.+........+.+.+|+.+++.+.|||++++++++..+...++||||+.+++|..
T Consensus 9 ~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~ 88 (258)
T cd05078 9 TKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDT 88 (258)
T ss_pred hhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHH
Confidence 356776542 2 33488888865544455678899999999999999999999999889999999999999999
Q ss_pred HHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCC--------ceeecccccccccCCcc
Q 021682 75 YIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMN--------PKISDFGMARAFTKDEC 146 (309)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~--------~~l~Dfg~~~~~~~~~~ 146 (309)
++... ...+++..+..++.|++.|++|||+. |++|+||||+||+++.++. ++++|||.+......
T Consensus 89 ~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~-- 161 (258)
T cd05078 89 YLKKN--KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK-- 161 (258)
T ss_pred HHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccccccccCCc--
Confidence 98542 23588999999999999999999998 9999999999999987765 589999987543321
Q ss_pred cccccccccccCCCCccccccC-CCCccchhhhHHHHHHHHHhCC-CCCCCCCCCCcccHHHHHHHHhhCCCCccccccc
Q 021682 147 EANTGRIVGTYGYVPPEYVRKG-IYSMKYDVYSYGVLLLQILGGK-RTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSS 224 (309)
Q Consensus 147 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (309)
....++..|+|||.+.+. .++.++|+||||+++|++++|. .|+....... .. ..... ...+
T Consensus 162 ----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~------~~-~~~~~--~~~~---- 224 (258)
T cd05078 162 ----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK------KL-QFYED--RHQL---- 224 (258)
T ss_pred ----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH------HH-HHHHc--cccC----
Confidence 123567789999998764 5789999999999999999985 5543222111 00 00110 0000
Q ss_pred CCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHh
Q 021682 225 LDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLK 263 (309)
Q Consensus 225 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~ 263 (309)
. .....++.+++.+||+.||++|||++++++.|+
T Consensus 225 -~----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 225 -P----APKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -C----CCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 011236789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=249.56 Aligned_cols=235 Identities=24% Similarity=0.312 Sum_probs=183.1
Q ss_pred ceEEEEc-CCCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
.+|.+.. .+++.+|+|.+.... ......+..|++++++++|+|++++++.+..+...++||||+++++|.+++...
T Consensus 15 ~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~- 93 (256)
T cd08220 15 IVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKR- 93 (256)
T ss_pred EEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHh-
Confidence 4565543 588999999986542 334567889999999999999999999999899999999999999999998542
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCC-CceeecccccccccCCcccccccccccccCC
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM-NPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
.+..+++..+..++.+++.++.+||++ |++|+||+|.||+++.++ .++|+|||.+......... ....++..|
T Consensus 94 ~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~y 167 (256)
T cd08220 94 CNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA---YTVVGTPCY 167 (256)
T ss_pred cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccc---cccccCCcc
Confidence 234588999999999999999999998 999999999999998654 5799999998765443221 123577899
Q ss_pred CCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHH
Q 021682 160 VPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQ 239 (309)
Q Consensus 160 ~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (309)
+|||.+.+..++.++|+||||+++|+|++|..||...+... .. .. ........+. ......+.+
T Consensus 168 ~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~---~~-~~~~~~~~~~---------~~~~~~l~~ 231 (256)
T cd08220 168 ISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA---LV---LK-IMSGTFAPIS---------DRYSPDLRQ 231 (256)
T ss_pred cCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH---HH---HH-HHhcCCCCCC---------CCcCHHHHH
Confidence 99999988888999999999999999999999985432211 11 11 1111111111 112336889
Q ss_pred HHhhcccCCCCCCCCHHHHHHH
Q 021682 240 VALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 240 li~~~l~~~p~~Rpt~~ell~~ 261 (309)
++.+||+.+|++|||++++++.
T Consensus 232 li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 232 LILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred HHHHHccCChhhCCCHHHHhhC
Confidence 9999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=265.98 Aligned_cols=238 Identities=20% Similarity=0.226 Sum_probs=178.7
Q ss_pred ceEEEE-cCCCcEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGR-LPNGQEMAVKRLSRT---SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
.||++. ..+++.||+|++... .......+.+|+.+++.++||||+++++.+..+...++||||+.+++|.+++..
T Consensus 58 ~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~- 136 (371)
T cd05622 58 EVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN- 136 (371)
T ss_pred EEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh-
Confidence 455555 457899999998643 222345577899999999999999999999999999999999999999988743
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
..+++..+..++.||+.|+.|||++ |++||||||+||+++.++.++|+|||++......... ......||+.|
T Consensus 137 ---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~-~~~~~~gt~~y 209 (371)
T cd05622 137 ---YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPDY 209 (371)
T ss_pred ---cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcc-cccCcccCccc
Confidence 2378888999999999999999998 8999999999999999999999999998765432211 12234689999
Q ss_pred CCccccccCC----CCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 160 VPPEYVRKGI----YSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 160 ~aPE~~~~~~----~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
+|||.+.+.. ++.++|||||||++|+|++|..||...+.. ..............+.. ......
T Consensus 210 ~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~~~~~~~~-------~~~~s~ 276 (371)
T cd05622 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMNHKNSLTFPD-------DNDISK 276 (371)
T ss_pred cCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH------HHHHHHHcCCCcccCCC-------cCCCCH
Confidence 9999986543 788999999999999999999998643221 11111111111111111 111233
Q ss_pred HHHHHHhhcccCCCCC--CCCHHHHHHHH
Q 021682 236 RCMQVALLCVQENAAD--RPTMLEILVML 262 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~--Rpt~~ell~~L 262 (309)
.+.++|.+||..++.. |++++++++..
T Consensus 277 ~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 277 EAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred HHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 6779999999843332 78999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=262.20 Aligned_cols=240 Identities=22% Similarity=0.250 Sum_probs=186.0
Q ss_pred ccceEEEEcCCCcEEEEEEee--cCCcccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 2 SVAICQGRLPNGQEMAVKRLS--RTSHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 2 g~~~~~~~~~~g~~vavK~~~--~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
|..||+....+.+.+|+|.+. ..+.+..+-+.+|+..|.+| .|.+||+++++-..++.+|||||+- ..+|..++..
T Consensus 374 SSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G-d~DL~kiL~k 452 (677)
T KOG0596|consen 374 SSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG-DIDLNKILKK 452 (677)
T ss_pred cceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc-cccHHHHHHh
Confidence 356788887667788888654 33566678899999999999 6999999999999999999999976 5689888854
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
... ..+.-.++.++.||+.|+.++|+. ||+|.||||.|+++. .|.+||+|||+|..+.............||..
T Consensus 453 ~~~--~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~N 526 (677)
T KOG0596|consen 453 KKS--IDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVN 526 (677)
T ss_pred ccC--CCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhcccCccccceeeccccCccc
Confidence 322 233347888999999999999998 999999999999985 67899999999999988877777777899999
Q ss_pred CCCccccccC-----------CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCC
Q 021682 159 YVPPEYVRKG-----------IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDD 227 (309)
Q Consensus 159 y~aPE~~~~~-----------~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (309)
||+||++... +.+.++||||||||+|+|+.|++||+.+.. ...........+.-.++.+-..
T Consensus 527 YMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-----~~aKl~aI~~P~~~Iefp~~~~-- 599 (677)
T KOG0596|consen 527 YMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-----QIAKLHAITDPNHEIEFPDIPE-- 599 (677)
T ss_pred ccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-----HHHHHHhhcCCCccccccCCCC--
Confidence 9999988432 256899999999999999999999863211 1111111111111112211111
Q ss_pred cccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 228 SSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 228 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
..++.++++.||++||.+|||..+||+.
T Consensus 600 ------~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 600 ------NDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ------chHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 1138899999999999999999999975
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=254.09 Aligned_cols=242 Identities=23% Similarity=0.336 Sum_probs=184.4
Q ss_pred ceEEEEcC------CCcEEEEEEeecCCcc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHH
Q 021682 4 AICQGRLP------NGQEMAVKRLSRTSHQ-GLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 4 ~~~~~~~~------~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 76 (309)
.||.+..+ +.+.|++|.+...... ....+..|++++++++|+||+++++++......++||||+++++|.+++
T Consensus 20 ~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i 99 (275)
T cd05046 20 EVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFL 99 (275)
T ss_pred EEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHH
Confidence 45666542 3567999988654333 3567899999999999999999999999888999999999999999998
Q ss_pred hhhcccc------CCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccc
Q 021682 77 FDLRRRY------LLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANT 150 (309)
Q Consensus 77 ~~~~~~~------~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 150 (309)
....... .+++..+..++.|++.+++|||+. |++|+||+|+||+++.++.++++|||++........ ...
T Consensus 100 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~-~~~ 175 (275)
T cd05046 100 RATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEY-YKL 175 (275)
T ss_pred HhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcccccccccCcccc-ccc
Confidence 6543221 589999999999999999999998 899999999999999999999999998764432211 112
Q ss_pred cccccccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcc
Q 021682 151 GRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSS 229 (309)
Q Consensus 151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (309)
....++..|+|||.+.+..++.++||||||+++|++++ |..||....... .. ........... .
T Consensus 176 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~------~~-~~~~~~~~~~~--------~ 240 (275)
T cd05046 176 RNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE------VL-NRLQAGKLELP--------V 240 (275)
T ss_pred CCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH------HH-HHHHcCCcCCC--------C
Confidence 22345678999999888888999999999999999998 777874322111 11 11111111100 0
Q ss_pred cHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 021682 230 SAWKLMRCMQVALLCVQENAADRPTMLEILVMLKS 264 (309)
Q Consensus 230 ~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~ 264 (309)
....+..+.+++.+||+.+|++|||+.++++.|++
T Consensus 241 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 241 PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 11122378899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=249.83 Aligned_cols=245 Identities=19% Similarity=0.285 Sum_probs=175.6
Q ss_pred ceEEEEcCCCc---EEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGRLPNGQ---EMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~~~~g~---~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
.||++...++. .+++|.+.... ......+.+|+.+++.++||||+++++.+......++||||+.+++|.+++...
T Consensus 10 ~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 89 (268)
T cd05086 10 KVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQE 89 (268)
T ss_pred eEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhh
Confidence 46777543333 45667665432 334567899999999999999999999999988999999999999999988543
Q ss_pred c-cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 80 R-RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 80 ~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
. .....+...+..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||++................++..
T Consensus 90 ~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 166 (268)
T cd05086 90 QWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR 166 (268)
T ss_pred hcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCccc
Confidence 2 223467777889999999999999998 899999999999999999999999998753222111111122356788
Q ss_pred CCCcccccc-------CCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCccc
Q 021682 159 YVPPEYVRK-------GIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSS 230 (309)
Q Consensus 159 y~aPE~~~~-------~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (309)
|+|||.+.. ..++.++||||||+++|+|++ |..||...... ........ .......++.....
T Consensus 167 y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~~-~~~~~~~~~~~~~~-- 237 (268)
T cd05086 167 WLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR------EVLNHVIK-DQQVKLFKPQLELP-- 237 (268)
T ss_pred ccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHh-hcccccCCCccCCC--
Confidence 999998743 235788999999999999997 45666432221 11111111 11122222222211
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHh
Q 021682 231 AWKLMRCMQVALLCVQENAADRPTMLEILVMLK 263 (309)
Q Consensus 231 ~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~ 263 (309)
....+.+++..|| .+|++|||++++++.|.
T Consensus 238 --~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 238 --YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred --CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 2236778999999 67999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=249.47 Aligned_cols=236 Identities=21% Similarity=0.279 Sum_probs=182.1
Q ss_pred ceEEEE-cCCCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEee-CCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQ-REEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
.+|.+. ..+++.||+|.+.... ....+.+..|++++++++|+|++++++.+.. +...++++||+++++|.+++...
T Consensus 15 ~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~ 94 (257)
T cd08223 15 EVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQ 94 (257)
T ss_pred EEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHh
Confidence 355554 4578899999986542 3345578899999999999999999988764 44689999999999999888542
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
....+++..+..++.+++.++.+||+. |++|+||+|+||+++.++.++|+|||++........ ......++..|
T Consensus 95 -~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y 168 (257)
T cd08223 95 -KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTLIGTPYY 168 (257)
T ss_pred -cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccCC--ccccccCCcCc
Confidence 234589999999999999999999998 899999999999999999999999999876543322 12234578899
Q ss_pred CCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHH
Q 021682 160 VPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQ 239 (309)
Q Consensus 160 ~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (309)
+|||.+.+..++.++|+||||++++++++|+.||...+.. ........ .... ..+......+.+
T Consensus 169 ~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~------~~~~~~~~-~~~~---------~~~~~~~~~~~~ 232 (257)
T cd08223 169 MSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN------SLVYRIIE-GKLP---------PMPKDYSPELGE 232 (257)
T ss_pred cChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHh-cCCC---------CCccccCHHHHH
Confidence 9999998888899999999999999999999988532211 11111111 1110 111123347889
Q ss_pred HHhhcccCCCCCCCCHHHHHHH
Q 021682 240 VALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 240 li~~~l~~~p~~Rpt~~ell~~ 261 (309)
++.+||+.+|++|||+.+++..
T Consensus 233 li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 233 LIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred HHHHHhccCcccCCCHHHHhcC
Confidence 9999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=255.73 Aligned_cols=251 Identities=21% Similarity=0.249 Sum_probs=183.6
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCcc-----cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHH
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSHQ-----GLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 76 (309)
+.+|+|.. .+|+.||||.++..... ....+..|++++++++|+||+++++++......++||||+ +++|..++
T Consensus 14 ~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i 92 (298)
T cd07841 14 AVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVI 92 (298)
T ss_pred cEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHH
Confidence 36788865 47899999999765322 2345678999999999999999999999999999999999 88999988
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccc
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGT 156 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 156 (309)
.... ..+++..+..++.|+++|+.+||+. |++|+||+|+||+++.++.++|+|||++......... .....++
T Consensus 93 ~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~ 165 (298)
T cd07841 93 KDKS--IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK--MTHQVVT 165 (298)
T ss_pred hccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc--ccccccc
Confidence 4322 3589999999999999999999998 8999999999999999999999999998765443211 1223457
Q ss_pred cCCCCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH-----HHhhC-CCCcccccccCCCcc
Q 021682 157 YGYVPPEYVRK-GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAY-----GLWKN-GEGMEFIDSSLDDSS 229 (309)
Q Consensus 157 ~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~-----~~~~~-~~~~~~~~~~~~~~~ 229 (309)
..|+|||.+.+ ..++.++|+|||||++|+|++|.++|......+......... ..+.. ...............
T Consensus 166 ~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (298)
T cd07841 166 RWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPT 245 (298)
T ss_pred eeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCc
Confidence 78999998855 456889999999999999999987775433221111110000 00000 000011000000011
Q ss_pred -----cHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 230 -----SAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 230 -----~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.......+.++|.+||+.+|++|||+.|++..
T Consensus 246 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 246 PLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred chhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 11224578899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=254.96 Aligned_cols=248 Identities=20% Similarity=0.243 Sum_probs=183.7
Q ss_pred ceEEEEc-CCCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
.+|++.. .+|+.||+|.+.... ......+..|+.++++++|+||+++++++..+...++|+||+ +++|.+++...
T Consensus 15 ~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~- 92 (286)
T cd07832 15 IVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDE- 92 (286)
T ss_pred EEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhc-
Confidence 5677764 579999999987553 333567889999999999999999999999999999999999 99999887543
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCC
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYV 160 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 160 (309)
...+++..++.++.|++.++.+||+. |++|+||+|+||+++.++.++|+|||.+........ .......++..|+
T Consensus 93 -~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~ 167 (286)
T cd07832 93 -ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLYSHQVATRWYR 167 (286)
T ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-CccccccCccccc
Confidence 24589999999999999999999998 899999999999999999999999999876544321 1122246788999
Q ss_pred CccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHH--------hhCCC----Cccc-ccccCC
Q 021682 161 PPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGL--------WKNGE----GMEF-IDSSLD 226 (309)
Q Consensus 161 aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~~----~~~~-~~~~~~ 226 (309)
|||.+.+. .++.++||||+|+++|+|++|.++|........ ....... |.... .... ......
T Consensus 168 aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (286)
T cd07832 168 APELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ---LAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKP 244 (286)
T ss_pred CceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH---HHHHHHHcCCCChHHHhhccCcchhhcccCCCCCc
Confidence 99988654 468999999999999999999877754322111 1111110 00000 0000 000000
Q ss_pred C---cccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 227 D---SSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 227 ~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
. .........+.++|.+||+.+|++|||+++++..
T Consensus 245 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 245 IPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred chHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 0001123578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=248.93 Aligned_cols=237 Identities=24% Similarity=0.337 Sum_probs=188.4
Q ss_pred ceEEEEcC-CCcEEEEEEeecCCc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 4 AICQGRLP-NGQEMAVKRLSRTSH-QGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 4 ~~~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
.+|++... +|+.|++|.+..... .....+..|+..+++++|+|++++++++..+...++|+||+.+++|.+++...
T Consensus 16 ~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-- 93 (264)
T cd06623 16 VVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKV-- 93 (264)
T ss_pred EEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHc--
Confidence 45666654 699999999876543 44678999999999999999999999999999999999999999999998543
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhh-cCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQE-YSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYV 160 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~-~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 160 (309)
..+++..+..++.|++.++.+||+ . |++|+||+|+||+++.++.++|+|||.+......... .....++..|+
T Consensus 94 -~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~ 167 (264)
T cd06623 94 -GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ--CNTFVGTVTYM 167 (264)
T ss_pred -CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCCc--ccceeeccccc
Confidence 458999999999999999999999 8 8999999999999999999999999998765443222 12235778999
Q ss_pred CccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHH-HHHHHHH
Q 021682 161 PPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAW-KLMRCMQ 239 (309)
Q Consensus 161 aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~ 239 (309)
|||.+....++.++|+||||+++|+|++|..||............. ... ....... ... .+..+.+
T Consensus 168 ~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~---~~~-~~~~~~~---------~~~~~~~~l~~ 234 (264)
T cd06623 168 SPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ---AIC-DGPPPSL---------PAEEFSPEFRD 234 (264)
T ss_pred CHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHH---HHh-cCCCCCC---------CcccCCHHHHH
Confidence 9999988888999999999999999999999986554311111111 111 1111110 111 2347889
Q ss_pred HHhhcccCCCCCCCCHHHHHHH
Q 021682 240 VALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 240 li~~~l~~~p~~Rpt~~ell~~ 261 (309)
+|.+||..+|++|||+.++++.
T Consensus 235 li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 235 FISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHHHHccCChhhCCCHHHHHhC
Confidence 9999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=251.84 Aligned_cols=235 Identities=22% Similarity=0.362 Sum_probs=179.0
Q ss_pred ceEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCCccceeeEEeeC------CeeEEEEeccCCCChhHH
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLTARL-QHVNLLPVLGICTQR------EEKMLIYDYMPNKSLDFY 75 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~------~~~~lv~e~~~~~~L~~~ 75 (309)
.||+|.. .+++.||+|.+.... .....+..|+.+++++ +|+||+++++++... ...+++|||+.+++|.++
T Consensus 21 ~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~ 99 (272)
T cd06637 21 QVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL 99 (272)
T ss_pred EEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHH
Confidence 5677764 578999999986543 3456788999999998 799999999998753 468999999999999998
Q ss_pred HhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccc
Q 021682 76 IFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVG 155 (309)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 155 (309)
+... ....+++..+..++.|++.|++|||++ |++|+||+|+||+++.++.++|+|||++........ ......|
T Consensus 100 l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~g 173 (272)
T cd06637 100 IKNT-KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIG 173 (272)
T ss_pred HHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCceecccccc--cCCcccc
Confidence 8542 234588999999999999999999998 899999999999999999999999999865433221 1223467
Q ss_pred ccCCCCccccc-----cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCccc
Q 021682 156 TYGYVPPEYVR-----KGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSS 230 (309)
Q Consensus 156 ~~~y~aPE~~~-----~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (309)
+..|+|||.+. +..++.++|+|||||++|+|++|..||........ ...... ....... .
T Consensus 174 ~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~------~~~~~~-~~~~~~~--------~ 238 (272)
T cd06637 174 TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA------LFLIPR-NPAPRLK--------S 238 (272)
T ss_pred cccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH------HHHHhc-CCCCCCC--------C
Confidence 88999999875 33578899999999999999999999854322111 011111 1111110 0
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021682 231 AWKLMRCMQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 231 ~~~~~~l~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
......+.+++.+||..+|.+|||+.+++.
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 239 KKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 112236789999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=261.20 Aligned_cols=176 Identities=21% Similarity=0.250 Sum_probs=145.4
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
+.||++.. .+++.||+|..... ....|+.++++++|+||+++++++......++|+|++. ++|.+++.. .
T Consensus 80 g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~--~ 150 (357)
T PHA03209 80 GRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYLTK--R 150 (357)
T ss_pred eEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcHHHHHHh--c
Confidence 35677765 46788999975332 23468999999999999999999999999999999995 577777643 3
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP 161 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 161 (309)
...+++..+..++.||+.|+.|||+. |++||||||+||+++.++.++|+|||++........ .....|+..|+|
T Consensus 151 ~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~a 224 (357)
T PHA03209 151 SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA---FLGLAGTVETNA 224 (357)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCcc---cccccccccccC
Confidence 34589999999999999999999998 899999999999999999999999999864332211 122357899999
Q ss_pred ccccccCCCCccchhhhHHHHHHHHHhCCCCC
Q 021682 162 PEYVRKGIYSMKYDVYSYGVLLLQILGGKRTS 193 (309)
Q Consensus 162 PE~~~~~~~~~~~DvwslG~il~~ll~g~~p~ 193 (309)
||.+.+..++.++|||||||++|+|+++..++
T Consensus 225 PE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 225 PEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred CeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 99999888999999999999999999865443
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=251.43 Aligned_cols=237 Identities=20% Similarity=0.268 Sum_probs=181.8
Q ss_pred ceEEEE-cCCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
.||.+. ..+|+.||+|.+.... ......+..|++++++++||||+++++.+...+..++||||+++++|.+++...
T Consensus 8 ~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 87 (277)
T cd05577 8 EVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNV 87 (277)
T ss_pred eEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHc
Confidence 455554 4579999999986532 223445678999999999999999999999999999999999999999888543
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
. ...+++..+..++.|++.++.+||+. |++|+||+|+||+++.++.++|+|||.+........ .....++..|
T Consensus 88 ~-~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y 160 (277)
T cd05577 88 G-EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGTPGY 160 (277)
T ss_pred C-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc---cccccCCCCc
Confidence 2 23589999999999999999999998 999999999999999999999999998865443211 1223567789
Q ss_pred CCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHH
Q 021682 160 VPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQ 239 (309)
Q Consensus 160 ~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (309)
+|||.+.+..++.++|+||||+++|+|++|..||............. ..... . ....+......+.+
T Consensus 161 ~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~-~---------~~~~~~~~~~~~~~ 227 (277)
T cd05577 161 MAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK---RRTLE-M---------AVEYPDKFSPEAKD 227 (277)
T ss_pred CCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH---hcccc-c---------cccCCccCCHHHHH
Confidence 99999988888999999999999999999999986543321111110 00000 0 00011112347889
Q ss_pred HHhhcccCCCCCCC-----CHHHHHH
Q 021682 240 VALLCVQENAADRP-----TMLEILV 260 (309)
Q Consensus 240 li~~~l~~~p~~Rp-----t~~ell~ 260 (309)
+|.+||+.+|++|| ++.+++.
T Consensus 228 li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 228 LCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred HHHHHccCChhHccCCCcccHHHHHh
Confidence 99999999999999 7777875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=251.14 Aligned_cols=239 Identities=22% Similarity=0.268 Sum_probs=184.6
Q ss_pred CccceEEEEcCCCcEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 1 MSVAICQGRLPNGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 1 ~g~~~~~~~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
||.++......+|+.||+|.+... .......+.+|+.++++++|+||+++++++...+..++|+||+.+++|.+++..
T Consensus 13 ~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~ 92 (256)
T cd08218 13 FGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINA 92 (256)
T ss_pred ceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHh
Confidence 344433334468899999998643 233446788999999999999999999999999999999999999999888743
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
. ....+++..+..++.|++.++.+||+. |++|+||+|+||+++.++.++|+|||.+......... .....++..
T Consensus 93 ~-~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~ 166 (256)
T cd08218 93 Q-RGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL--ARTCIGTPY 166 (256)
T ss_pred c-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh--hhhccCCcc
Confidence 2 233478899999999999999999998 8999999999999999999999999998655432211 122357788
Q ss_pred CCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHH
Q 021682 159 YVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238 (309)
Q Consensus 159 y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (309)
|+|||.+.+..++.++|+||||++++++++|..||...+.. ...... ..+.... .+......+.
T Consensus 167 ~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~-~~~~~~~---------~~~~~~~~~~ 230 (256)
T cd08218 167 YLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK------NLVLKI-IRGSYPP---------VSSHYSYDLR 230 (256)
T ss_pred ccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH------HHHHHH-hcCCCCC---------CcccCCHHHH
Confidence 99999998888899999999999999999999998532211 111111 1111111 1111234788
Q ss_pred HHHhhcccCCCCCCCCHHHHHHH
Q 021682 239 QVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 239 ~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
++|.+||+.+|++||++.++++.
T Consensus 231 ~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 231 NLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred HHHHHHhhCChhhCcCHHHHhhC
Confidence 99999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=253.51 Aligned_cols=236 Identities=20% Similarity=0.315 Sum_probs=185.0
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
+++|++.. .+++.|++|.+........+.+.+|+.+++.+.|+||+++++++..++..++++||+.+++|.+++..
T Consensus 33 g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--- 109 (285)
T cd06648 33 GIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH--- 109 (285)
T ss_pred eEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh---
Confidence 45677764 57899999998655544556788999999999999999999999999999999999999999998743
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP 161 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 161 (309)
..++...+..++.+++.++++||+. |++||||+|+||+++.++.++|+|||.+......... .....++..|+|
T Consensus 110 -~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~y~a 183 (285)
T cd06648 110 -TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMA 183 (285)
T ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc--cccccCCccccC
Confidence 3488899999999999999999998 8999999999999999999999999987654432211 122357889999
Q ss_pred ccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHH
Q 021682 162 PEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241 (309)
Q Consensus 162 PE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 241 (309)
||.+.+..++.++|+||||+++|+|++|..||....+.. ... .. ..... .... ........+.+++
T Consensus 184 PE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~---~~~---~~-~~~~~-~~~~------~~~~~~~~l~~li 249 (285)
T cd06648 184 PEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ---AMK---RI-RDNLP-PKLK------NLHKVSPRLRSFL 249 (285)
T ss_pred HHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH---HHH---HH-HhcCC-CCCc------ccccCCHHHHHHH
Confidence 999988888999999999999999999999985422211 111 11 11100 0000 0111234788999
Q ss_pred hhcccCCCCCCCCHHHHHHH
Q 021682 242 LLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 242 ~~~l~~~p~~Rpt~~ell~~ 261 (309)
.+||+.+|++|||+.++++.
T Consensus 250 ~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 250 DRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred HHHcccChhhCcCHHHHccC
Confidence 99999999999999999963
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=254.78 Aligned_cols=248 Identities=19% Similarity=0.211 Sum_probs=178.8
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
+.+|++.. .+|+.||+|.++... ......+..|+.++++++|+||+++++++.+....++++||+.+ +|.+++..
T Consensus 14 ~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~- 91 (284)
T cd07839 14 GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDS- 91 (284)
T ss_pred eEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCCC-CHHHHHHh-
Confidence 35677765 479999999986542 22235677899999999999999999999999999999999964 67666533
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
....+++..++.++.||++|+.+||+. |++|+||+|+||+++.++.++|+|||++......... .....++..|
T Consensus 92 -~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y 165 (284)
T cd07839 92 -CNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC--YSAEVVTLWY 165 (284)
T ss_pred -cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC--cCCCccccCC
Confidence 234589999999999999999999998 8999999999999999999999999998754432211 1223567899
Q ss_pred CCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHH-----------hhCCCCccccccc---
Q 021682 160 VPPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGL-----------WKNGEGMEFIDSS--- 224 (309)
Q Consensus 160 ~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~--- 224 (309)
+|||.+.+. .++.++|||||||++|+|++|..|+........ ........ .............
T Consensus 166 ~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (284)
T cd07839 166 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPAT 243 (284)
T ss_pred cChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH--HHHHHHHHhCCCChHHhHHhhhcccccccCCCCCc
Confidence 999988664 468999999999999999999888533222111 11110000 0000000000000
Q ss_pred CC-CcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021682 225 LD-DSSSAWKLMRCMQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 225 ~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
.. ..........+.++|.+||+.||.+|||+++++.
T Consensus 244 ~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 244 TSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred chhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00 0001112347789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=255.28 Aligned_cols=230 Identities=23% Similarity=0.296 Sum_probs=182.4
Q ss_pred ceEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
.+|.+.. .+++.||+|.+.... ......+..|+++++++.||||+++++++..+...++||||+.+++|.+++..
T Consensus 16 ~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~- 94 (290)
T cd05580 16 RVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRK- 94 (290)
T ss_pred EEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHH-
Confidence 5666654 478999999986532 23346788999999999999999999999999999999999999999998843
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
...++...+..++.|++.|+.+||+. |++|+||+|.||+++.++.++|+|||++...... .....++..|
T Consensus 95 --~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y 164 (290)
T cd05580 95 --SGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----TYTLCGTPEY 164 (290)
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----CCCCCCCccc
Confidence 34589999999999999999999998 9999999999999999999999999998765443 1223578899
Q ss_pred CCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHH
Q 021682 160 VPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQ 239 (309)
Q Consensus 160 ~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (309)
+|||.+.+...+.++|+||||+++|+|++|..||...+.. .. ........ .. ... .....+.+
T Consensus 165 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~-~~~~~~~~-~~-----~~~----~~~~~l~~ 227 (290)
T cd05580 165 LAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI------QI-YEKILEGK-VR-----FPS----FFSPDAKD 227 (290)
T ss_pred cChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH------HH-HHHHhcCC-cc-----CCc----cCCHHHHH
Confidence 9999998888899999999999999999999998543311 10 11111111 00 011 11347889
Q ss_pred HHhhcccCCCCCCC-----CHHHHHHH
Q 021682 240 VALLCVQENAADRP-----TMLEILVM 261 (309)
Q Consensus 240 li~~~l~~~p~~Rp-----t~~ell~~ 261 (309)
+|.+||+.||.+|+ +++|+++.
T Consensus 228 li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 228 LIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred HHHHHccCCHHHccCcccCCHHHHHcC
Confidence 99999999999999 88888754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=247.30 Aligned_cols=244 Identities=24% Similarity=0.374 Sum_probs=188.2
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
+.+|++.. .++..+|+|++.... ......+.+|++.++.++|+|++++++.+..++..++|+|++.+++|.+++....
T Consensus 15 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~ 94 (267)
T cd06610 15 AVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSY 94 (267)
T ss_pred eEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhc
Confidence 36788874 478899999986442 3355778999999999999999999999999999999999999999999986543
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccc--cccccccccC
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEA--NTGRIVGTYG 158 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~--~~~~~~~~~~ 158 (309)
....+++..+..++.|++.|+++||+. |++|+||+|+||+++.++.++|+|||++.......... ......++..
T Consensus 95 ~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (267)
T cd06610 95 PRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPC 171 (267)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChh
Confidence 335689999999999999999999998 99999999999999999999999999987665432221 1223357889
Q ss_pred CCCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHH
Q 021682 159 YVPPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRC 237 (309)
Q Consensus 159 y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (309)
|+|||.+... .++.++|+||||+++|+|++|..||......... ...... .... +... .........+
T Consensus 172 y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~------~~~~~~-~~~~-~~~~---~~~~~~~~~~ 240 (267)
T cd06610 172 WMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVL------MLTLQN-DPPS-LETG---ADYKKYSKSF 240 (267)
T ss_pred hcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhH------HHHhcC-CCCC-cCCc---cccccccHHH
Confidence 9999988776 7899999999999999999999998644332211 011111 0000 0000 0011223467
Q ss_pred HHHHhhcccCCCCCCCCHHHHHH
Q 021682 238 MQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 238 ~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
.+++.+||+.||++|||++++++
T Consensus 241 ~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 241 RKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred HHHHHHHcCCChhhCcCHHHHhh
Confidence 89999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=250.60 Aligned_cols=235 Identities=23% Similarity=0.315 Sum_probs=176.7
Q ss_pred ceEEEEc-CCCcEEEEEEeecCC-----cccHHHHHHHHHHHhcCCCCCccceeeEEee--CCeeEEEEeccCCCChhHH
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTS-----HQGLEEFENEVKLTARLQHVNLLPVLGICTQ--REEKMLIYDYMPNKSLDFY 75 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~ 75 (309)
.+|++.. .+|+.||+|.+.... ......+.+|+.++++++|+||+++++++.. +...++++||+.+++|.++
T Consensus 17 ~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~ 96 (266)
T cd06651 17 RVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQ 96 (266)
T ss_pred EEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHH
Confidence 5677654 578999999886432 1233568889999999999999999998865 3578899999999999988
Q ss_pred HhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcc-cccccccc
Q 021682 76 IFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDEC-EANTGRIV 154 (309)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~ 154 (309)
+.. ...+++.....++.|++.++++||+. |++|+||+|+||+++.++.++|+|||++........ ........
T Consensus 97 l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 170 (266)
T cd06651 97 LKA---YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT 170 (266)
T ss_pred HHH---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCC
Confidence 843 23478889999999999999999988 899999999999999999999999999865432111 11112235
Q ss_pred cccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHH
Q 021682 155 GTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKL 234 (309)
Q Consensus 155 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
++..|+|||.+.+..++.++|+|||||++|++++|+.||....... .......... ....+....
T Consensus 171 ~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~------~~~~~~~~~~---------~~~~~~~~~ 235 (266)
T cd06651 171 GTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA------AIFKIATQPT---------NPQLPSHIS 235 (266)
T ss_pred ccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH------HHHHHhcCCC---------CCCCchhcC
Confidence 7788999999988888999999999999999999999986432211 1111111000 011112223
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHH
Q 021682 235 MRCMQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 235 ~~l~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
..+.+++ +||..+|++|||++|++.
T Consensus 236 ~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 236 EHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 3566777 788899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=257.05 Aligned_cols=240 Identities=21% Similarity=0.212 Sum_probs=185.7
Q ss_pred cceEEEEcC-CCcEEEEEEeecCCc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 3 VAICQGRLP-NGQEMAVKRLSRTSH---QGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 3 ~~~~~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
+.+|.+... +++.||+|.+..... .....+..|+++++.++|+||+++++.+..+...++||||+.+++|.+++..
T Consensus 15 g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 94 (316)
T cd05574 15 GRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQR 94 (316)
T ss_pred EEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHh
Confidence 356777654 689999999876532 2445788999999999999999999999999999999999999999998753
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccc-----------
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECE----------- 147 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~----------- 147 (309)
.....+++..+..++.|++.+++|||+. |++|+||+|+||+++.++.++|+|||++.........
T Consensus 95 -~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 170 (316)
T cd05574 95 -QPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRR 170 (316)
T ss_pred -CCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccccccccccccccccc
Confidence 2345689999999999999999999998 8999999999999999999999999988654322110
Q ss_pred ----------------ccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHH
Q 021682 148 ----------------ANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGL 211 (309)
Q Consensus 148 ----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 211 (309)
.......|+..|+|||.+.+..++.++||||||+++|+|++|..||...+.... ....
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~------~~~~ 244 (316)
T cd05574 171 SSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET------FSNI 244 (316)
T ss_pred ccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH------HHHH
Confidence 011123578889999999888889999999999999999999999864332211 1111
Q ss_pred hhCCCCcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCC----HHHHHHH
Q 021682 212 WKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPT----MLEILVM 261 (309)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt----~~ell~~ 261 (309)
.... ............+.+++.+||+.+|++||| ++++++.
T Consensus 245 ~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 245 LKKE---------VTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred hcCC---------ccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 1100 000001113447889999999999999999 8888774
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=254.76 Aligned_cols=245 Identities=22% Similarity=0.255 Sum_probs=181.2
Q ss_pred CCCcEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccccCCCHH
Q 021682 11 PNGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWR 88 (309)
Q Consensus 11 ~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 88 (309)
.+|+.||||.++.. .......+..|+++++.++|+||+++++++..+...+++|||+.+++|.+++... ....+++.
T Consensus 23 ~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~-~~~~~~~~ 101 (314)
T cd08216 23 PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTH-FPEGLPEL 101 (314)
T ss_pred CCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHh-cccCCCHH
Confidence 37999999998754 3445678999999999999999999999999999999999999999999988543 23348889
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccc-----ccccccccccCCCCcc
Q 021682 89 TRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECE-----ANTGRIVGTYGYVPPE 163 (309)
Q Consensus 89 ~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE 163 (309)
.+..++.|++.|++|||+. |++|+||+|+||+++.++.++++||+.+......... .......++..|+|||
T Consensus 102 ~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE 178 (314)
T cd08216 102 AIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPE 178 (314)
T ss_pred HHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHH
Confidence 9999999999999999998 8999999999999999999999999987654322111 0111234567899999
Q ss_pred cccc--CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhh---C-C-------CCcc----c----cc
Q 021682 164 YVRK--GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWK---N-G-------EGME----F----ID 222 (309)
Q Consensus 164 ~~~~--~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~---~-~-------~~~~----~----~~ 222 (309)
.+.+ ..++.++|+|||||++|+|++|..||........ .......... . . .... . ..
T Consensus 179 ~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (314)
T cd08216 179 VLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNR 256 (314)
T ss_pred HhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchhhhcCCcCcccccccccchh
Confidence 9865 3578899999999999999999999864322111 1111000000 0 0 0000 0 00
Q ss_pred ccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 223 SSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 223 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
..............+.+++.+||+.||++|||++++++.
T Consensus 257 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 257 DSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 001111122234578899999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=249.64 Aligned_cols=232 Identities=26% Similarity=0.384 Sum_probs=181.1
Q ss_pred ceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcccc
Q 021682 4 AICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRY 83 (309)
Q Consensus 4 ~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~ 83 (309)
.||.+.. +++.||+|.++... ..+.+.+|+.++++++|+|++++++++..+ ..++||||+.+++|.+++... ...
T Consensus 21 ~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~-~~~ 95 (254)
T cd05083 21 AVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTR-GRA 95 (254)
T ss_pred ceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhc-CcC
Confidence 5677764 78899999986432 346788999999999999999999998754 478999999999999998543 233
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCcc
Q 021682 84 LLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPE 163 (309)
Q Consensus 84 ~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 163 (309)
.+++..+..++.|++.|+.+||+. |++||||+|+||+++.++.++|+|||++....... .....+..|+|||
T Consensus 96 ~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~y~~pe 167 (254)
T cd05083 96 LVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-----DNSKLPVKWTAPE 167 (254)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC-----CCCCCCceecCHH
Confidence 578899999999999999999998 99999999999999999999999999886543221 1123356799999
Q ss_pred ccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHHh
Q 021682 164 YVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVAL 242 (309)
Q Consensus 164 ~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 242 (309)
.+.+..++.++|+||||+++|+|++ |..||......+ ............ .....+..+.+++.
T Consensus 168 ~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~~---------~~~~~~~~~~~li~ 231 (254)
T cd05083 168 ALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-------VKECVEKGYRME---------PPEGCPADVYVLMT 231 (254)
T ss_pred HhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH-------HHHHHhCCCCCC---------CCCcCCHHHHHHHH
Confidence 9988889999999999999999997 888885432211 111111111111 01112347789999
Q ss_pred hcccCCCCCCCCHHHHHHHHhc
Q 021682 243 LCVQENAADRPTMLEILVMLKS 264 (309)
Q Consensus 243 ~~l~~~p~~Rpt~~ell~~L~~ 264 (309)
+||+.+|++|||+.++++.|++
T Consensus 232 ~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 232 SCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHcCCChhhCcCHHHHHHHHcc
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=247.38 Aligned_cols=235 Identities=21% Similarity=0.288 Sum_probs=184.1
Q ss_pred ceEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
.+|.+.. .+++.||+|.+.... ....+.+..|+.+++.++|+||+++++++..+...++++||+++++|.+++..
T Consensus 8 ~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~- 86 (262)
T cd05572 8 RVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRD- 86 (262)
T ss_pred EEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhh-
Confidence 4666665 458999999986543 23346788999999999999999999999999999999999999999998843
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
...++...+..++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||.+....... ......++..|
T Consensus 87 --~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~ 158 (262)
T cd05572 87 --RGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEY 158 (262)
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCcCc
Confidence 23488999999999999999999998 89999999999999999999999999987654432 11223567899
Q ss_pred CCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHH
Q 021682 160 VPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQ 239 (309)
Q Consensus 160 ~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (309)
++||.+.+..++.++|+||||+++|++++|..||....... ............... .+......+.+
T Consensus 159 ~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~---------~~~~~~~~~~~ 225 (262)
T cd05572 159 VAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEIYNDILKGNGKLE---------FPNYIDKAAKD 225 (262)
T ss_pred cChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHHHHHHhccCCCCC---------CCcccCHHHHH
Confidence 99999888888999999999999999999999986543211 111111110011111 11111347889
Q ss_pred HHhhcccCCCCCCCC-----HHHHHH
Q 021682 240 VALLCVQENAADRPT-----MLEILV 260 (309)
Q Consensus 240 li~~~l~~~p~~Rpt-----~~ell~ 260 (309)
++.+||+.+|++||| ++|+++
T Consensus 226 ~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 226 LIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHccCChhhCcCCcccCHHHHhc
Confidence 999999999999999 888876
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=256.52 Aligned_cols=188 Identities=23% Similarity=0.336 Sum_probs=147.9
Q ss_pred cceEEEEcC---CCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEee--CCeeEEEEeccCCCChhHHHh
Q 021682 3 VAICQGRLP---NGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQ--REEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 3 ~~~~~~~~~---~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~ 77 (309)
+.||++... ++..||+|.+.... ....+.+|+.++++++||||+++++++.. +...++|+||+.+ +|.+++.
T Consensus 15 g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~ 91 (317)
T cd07867 15 GHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIK 91 (317)
T ss_pred eeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-cHHHHHH
Confidence 357777653 45789999986543 23457789999999999999999998854 4578999999965 6666653
Q ss_pred hh------ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEe----CCCCCceeecccccccccCCccc
Q 021682 78 DL------RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL----DYEMNPKISDFGMARAFTKDECE 147 (309)
Q Consensus 78 ~~------~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~----~~~~~~~l~Dfg~~~~~~~~~~~ 147 (309)
.. .....+++..+..++.|++.|+.|||+. |++|+||||+||++ +.++.++|+|||++.........
T Consensus 92 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~ 168 (317)
T cd07867 92 FHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP 168 (317)
T ss_pred hhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCccc
Confidence 21 1223578889999999999999999998 89999999999999 45678999999999765433221
Q ss_pred -ccccccccccCCCCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCC
Q 021682 148 -ANTGRIVGTYGYVPPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYY 196 (309)
Q Consensus 148 -~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~ 196 (309)
.......++..|+|||.+.+. .++.++|||||||++|+|++|.+||...
T Consensus 169 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 169 LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 122234678899999988764 5789999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=256.37 Aligned_cols=241 Identities=17% Similarity=0.197 Sum_probs=181.7
Q ss_pred ceEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
.+|.+.. .+++.||+|.+.... ......+.+|+++++.++|+||+++++.+..+...++||||+++++|.+++..
T Consensus 16 ~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~- 94 (305)
T cd05609 16 AVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKN- 94 (305)
T ss_pred eEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHH-
Confidence 4566654 478899999987543 23345778999999999999999999999999999999999999999999843
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccc------------
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECE------------ 147 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~------------ 147 (309)
...+++..+..++.+++.|++|||+. |++|+||+|.||+++.++.++|+|||++.........
T Consensus 95 --~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~ 169 (305)
T cd05609 95 --IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169 (305)
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchh
Confidence 33488999999999999999999998 8999999999999999999999999987642111000
Q ss_pred -ccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCC
Q 021682 148 -ANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLD 226 (309)
Q Consensus 148 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (309)
.......++..|+|||.+.+..++.++|+||||+++|++++|..||......+ .. ......... .+..
T Consensus 170 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~------~~-~~~~~~~~~---~~~~- 238 (305)
T cd05609 170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE------LF-GQVISDDIE---WPEG- 238 (305)
T ss_pred hccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HH-HHHHhcccC---CCCc-
Confidence 00112346778999999988888999999999999999999999985322211 11 111111000 0000
Q ss_pred CcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 021682 227 DSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKS 264 (309)
Q Consensus 227 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~ 264 (309)
....+..+.+++.+||+.+|++|||..++.+.|+.
T Consensus 239 ---~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 239 ---DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred ---cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 01123367899999999999999997666666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=256.45 Aligned_cols=252 Identities=21% Similarity=0.267 Sum_probs=181.1
Q ss_pred ceEEEEc-CCCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
+||.+.. .+|+.||+|.+.... ....+.+++|+.+++.++||||+++++++..+...++|+||+.++++.+++....
T Consensus 15 ~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~ 94 (328)
T cd08226 15 SVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYF 94 (328)
T ss_pred eEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhc
Confidence 4666654 589999999986432 3335678899999999999999999999999999999999999999998885432
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccc-----ccccccc
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEA-----NTGRIVG 155 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~-----~~~~~~~ 155 (309)
...+++..+..++.|++.|++|||+. |++|+||||+||+++.++.++++||+.+.......... ......+
T Consensus 95 -~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (328)
T cd08226 95 -PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTS 170 (328)
T ss_pred -ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccC
Confidence 23488899999999999999999998 89999999999999999999999997543222111100 0011124
Q ss_pred ccCCCCccccccC--CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH----------------H------
Q 021682 156 TYGYVPPEYVRKG--IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYG----------------L------ 211 (309)
Q Consensus 156 ~~~y~aPE~~~~~--~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~----------------~------ 211 (309)
+..|+|||.+.+. .++.++|||||||++|+|++|..||......... ...... .
T Consensus 171 ~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (328)
T cd08226 171 VLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML--LQKLKGPPYSPLDITTFPCEESRMKNSQS 248 (328)
T ss_pred ccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH--HHHhcCCCCCCccccccchhhhhhccchh
Confidence 5679999998763 4789999999999999999999998643321110 000000 0
Q ss_pred -hhC---------CCCcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 212 -WKN---------GEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 212 -~~~---------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
+.. ......................+.+++.+||+.||++|||++++++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 249 GVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 000 00000000011111223345678899999999999999999999865
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=259.63 Aligned_cols=245 Identities=22% Similarity=0.271 Sum_probs=175.4
Q ss_pred ceEEEE-cCCCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEeeC------CeeEEEEeccCCCChhH
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQR------EEKMLIYDYMPNKSLDF 74 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~~L~~ 74 (309)
.||++. ..+++.||||.+.... ......+.+|++++++++|+||+++++++... ...+++++++ +++|..
T Consensus 30 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~ 108 (343)
T cd07878 30 SVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNN 108 (343)
T ss_pred EEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHH
Confidence 456664 4688999999986532 22345677899999999999999999887543 3578999988 678877
Q ss_pred HHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccc
Q 021682 75 YIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIV 154 (309)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~ 154 (309)
++. ...+++..+..++.|++.|+.|||+. |++||||||+||+++.++.++|+|||++...... .....
T Consensus 109 ~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-----~~~~~ 176 (343)
T cd07878 109 IVK----CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTGYV 176 (343)
T ss_pred HHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccceecCCC-----cCCcc
Confidence 762 23489999999999999999999998 9999999999999999999999999998754332 12236
Q ss_pred cccCCCCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH--------HHhhCCCCcccccccC
Q 021682 155 GTYGYVPPEYVRK-GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAY--------GLWKNGEGMEFIDSSL 225 (309)
Q Consensus 155 ~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~ 225 (309)
++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+..+......... ..........+.....
T Consensus 177 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (343)
T cd07878 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLP 256 (343)
T ss_pred ccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccc
Confidence 7889999999876 467899999999999999999999986433221111000000 0000000000000000
Q ss_pred CCccc------HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 226 DDSSS------AWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 226 ~~~~~------~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
..... ......+.++|.+||+.||++|||++|+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 257 HMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred cccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 0012256799999999999999999999975
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=254.46 Aligned_cols=247 Identities=21% Similarity=0.265 Sum_probs=183.5
Q ss_pred ceEEEEcC-CCcEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 4 AICQGRLP-NGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 4 ~~~~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
.+|++..+ +++.||+|.++.. .....+.+..|++++++++|+||+++++++..++..++|+||+.++++..+..
T Consensus 16 ~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~--- 92 (288)
T cd07833 16 VVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEA--- 92 (288)
T ss_pred eEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHh---
Confidence 56777654 6899999988654 23345788999999999999999999999999999999999998877765542
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCC
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYV 160 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 160 (309)
....+++..+..++.+++.++.+||+. |++|+||+|+||+++.++.++|+|||.+......... ......++..|+
T Consensus 93 ~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~~ 168 (288)
T cd07833 93 SPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS-PLTDYVATRWYR 168 (288)
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc-cccCcccccCCc
Confidence 234488999999999999999999998 8999999999999999999999999998765543321 122245678899
Q ss_pred CccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhC-----------CCC---cccccccC
Q 021682 161 PPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKN-----------GEG---MEFIDSSL 225 (309)
Q Consensus 161 aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~-----------~~~---~~~~~~~~ 225 (309)
|||.+.+. .++.++|+||||+++|+|++|.+||......+. .......+.. ... ..+.....
T Consensus 169 ~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (288)
T cd07833 169 APELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQ---LYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQ 245 (288)
T ss_pred CCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHHhhhcccCccccccccCCCCC
Confidence 99998877 788999999999999999999998864322211 1111110000 000 00000000
Q ss_pred CC----cccHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021682 226 DD----SSSAWKLMRCMQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 226 ~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
.. ..+...+.++.++|++||..+|++|||+++++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 246 PESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00 001112457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=249.17 Aligned_cols=240 Identities=21% Similarity=0.303 Sum_probs=183.9
Q ss_pred ceEEEEcC--CCcEEEEEEeecC----------CcccHHHHHHHHHHHhc-CCCCCccceeeEEeeCCeeEEEEeccCCC
Q 021682 4 AICQGRLP--NGQEMAVKRLSRT----------SHQGLEEFENEVKLTAR-LQHVNLLPVLGICTQREEKMLIYDYMPNK 70 (309)
Q Consensus 4 ~~~~~~~~--~g~~vavK~~~~~----------~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 70 (309)
.+|++... +++.+|+|.+... .......+..|+.++.+ ++|+||+++++++..+...+++|||+.++
T Consensus 15 ~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 94 (269)
T cd08528 15 CVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGA 94 (269)
T ss_pred eEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCCC
Confidence 56777654 4788999987532 12233456678887765 69999999999999999999999999999
Q ss_pred ChhHHHhhh-ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccc
Q 021682 71 SLDFYIFDL-RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEAN 149 (309)
Q Consensus 71 ~L~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 149 (309)
+|.+++... .....+++..++.++.+++.++.+||+.. |++|+||+|.||+++.++.++|+|||.+....... .
T Consensus 95 ~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~---~ 169 (269)
T cd08528 95 PLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---K 169 (269)
T ss_pred cHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecccceeeccccc---c
Confidence 999887542 23455889999999999999999999632 89999999999999999999999999987654432 2
Q ss_pred ccccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcc
Q 021682 150 TGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSS 229 (309)
Q Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (309)
.....++..|++||.+.+..++.++|+||||+++|++++|..||....... .. ............
T Consensus 170 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~---~~----~~~~~~~~~~~~-------- 234 (269)
T cd08528 170 LTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS---LA----TKIVEAVYEPLP-------- 234 (269)
T ss_pred cccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH---HH----HHHhhccCCcCC--------
Confidence 223467889999999988888999999999999999999999975322111 11 111111111100
Q ss_pred cHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHh
Q 021682 230 SAWKLMRCMQVALLCVQENAADRPTMLEILVMLK 263 (309)
Q Consensus 230 ~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~ 263 (309)
.......+.+++.+||+.||++|||+.|+..+++
T Consensus 235 ~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 235 EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 0112347889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=258.00 Aligned_cols=242 Identities=17% Similarity=0.197 Sum_probs=179.9
Q ss_pred CccceEEEE-cCCCcEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHH
Q 021682 1 MSVAICQGR-LPNGQEMAVKRLSRT---SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 1 ~g~~~~~~~-~~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 76 (309)
||. ||++. ..+++.||+|.+... .......+.+|..++..++|++|+++++++..++..++||||+.+++|..++
T Consensus 14 fg~-V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l 92 (331)
T cd05624 14 FGE-VAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLL 92 (331)
T ss_pred CeE-EEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHH
Confidence 344 45554 457899999998653 2223455788999999999999999999999999999999999999999998
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccc
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGT 156 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 156 (309)
... ...+++..+..++.|++.|+.|||+. |++||||||+||+++.++.++|+|||++......... ......|+
T Consensus 93 ~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt 166 (331)
T cd05624 93 SKF--EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV-QSSVAVGT 166 (331)
T ss_pred HHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce-eeccccCC
Confidence 542 23588999999999999999999998 9999999999999999999999999998765433221 11224689
Q ss_pred cCCCCcccccc-----CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccH
Q 021682 157 YGYVPPEYVRK-----GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSA 231 (309)
Q Consensus 157 ~~y~aPE~~~~-----~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (309)
..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+..+ .............+ .... .
T Consensus 167 ~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~~~~~~~~~-p~~~-----~ 234 (331)
T cd05624 167 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHEERFQF-PSHI-----T 234 (331)
T ss_pred cccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH------HHHHHHcCCCcccC-CCcc-----c
Confidence 99999998865 457889999999999999999999985432211 11111111111111 0000 1
Q ss_pred HHHHHHHHHHhhcccCCCCC--CCCHHHHHHH
Q 021682 232 WKLMRCMQVALLCVQENAAD--RPTMLEILVM 261 (309)
Q Consensus 232 ~~~~~l~~li~~~l~~~p~~--Rpt~~ell~~ 261 (309)
..+..+.+++.+||...++. |++++++++.
T Consensus 235 ~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 235 DVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred cCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 12347789999999876554 4688888865
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=263.73 Aligned_cols=242 Identities=25% Similarity=0.407 Sum_probs=193.2
Q ss_pred CCCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccccCCCHHH
Q 021682 11 PNGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRT 89 (309)
Q Consensus 11 ~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 89 (309)
..+.+||||.++... ...+..|..|+++|.+++||||+.++++|..++.+|+++||+++|+|..++....... +....
T Consensus 560 eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt-~~t~~ 638 (807)
T KOG1094|consen 560 EGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPT-AETAP 638 (807)
T ss_pred cCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcc-cccch
Confidence 356899999998764 3446889999999999999999999999999999999999999999999996653332 45566
Q ss_pred HHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCccccccCC
Q 021682 90 RVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGI 169 (309)
Q Consensus 90 ~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 169 (309)
...++.||+.|++||.+. +++||||.+.|++++.++++|++|||+++-..........+..+-+.+|+|+|.+..++
T Consensus 639 ~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgk 715 (807)
T KOG1094|consen 639 GVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGK 715 (807)
T ss_pred hHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhcc
Confidence 777999999999999999 89999999999999999999999999998666665555566667788999999999999
Q ss_pred CCccchhhhHHHHHHHHHh--CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHHhhcccC
Q 021682 170 YSMKYDVYSYGVLLLQILG--GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQE 247 (309)
Q Consensus 170 ~~~~~DvwslG~il~~ll~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 247 (309)
++.++|+|+||+++||+++ ...||...... ..++.... +......+. ..+.+..++..+++++.+||..
T Consensus 716 FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e---~vven~~~-~~~~~~~~~-----~l~~P~~cp~~lyelml~Cw~~ 786 (807)
T KOG1094|consen 716 FTTASDVWAFGVTLWEVFMLCREQPYSQLTDE---QVVENAGE-FFRDQGRQV-----VLSRPPACPQGLYELMLRCWRR 786 (807)
T ss_pred ccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---HHHHhhhh-hcCCCCcce-----eccCCCcCcHHHHHHHHHHhch
Confidence 9999999999999999865 66776432211 12222211 222222222 2223334455888999999999
Q ss_pred CCCCCCCHHHHHHHHhcc
Q 021682 248 NAADRPTMLEILVMLKSE 265 (309)
Q Consensus 248 ~p~~Rpt~~ell~~L~~~ 265 (309)
+.++|||++++...|+..
T Consensus 787 es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 787 ESEQRPSFEQLHLFLQED 804 (807)
T ss_pred hhhcCCCHHHHHHHHHHh
Confidence 999999999999988764
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=271.66 Aligned_cols=246 Identities=17% Similarity=0.197 Sum_probs=171.5
Q ss_pred ceEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCC------CCccceeeEEeeC-CeeEEEEeccCCCChhHH
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQH------VNLLPVLGICTQR-EEKMLIYDYMPNKSLDFY 75 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~ 75 (309)
.||++. ..+++.||||+++.... .......|+.+++.++| .+++.+++++..+ .+.|+||+++ +++|.++
T Consensus 144 ~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~ 221 (467)
T PTZ00284 144 KVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDW 221 (467)
T ss_pred EEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc-CCCHHHH
Confidence 456664 45789999999964322 23345667777766644 4588888888765 4789999988 6678777
Q ss_pred HhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCC----------------Cceeecccccc
Q 021682 76 IFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM----------------NPKISDFGMAR 139 (309)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~----------------~~~l~Dfg~~~ 139 (309)
+.. ...+++..+..++.||+.||.|||+.. ||+||||||+||+++.++ .+||+|||.+.
T Consensus 222 l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~ 296 (467)
T PTZ00284 222 IMK---HGPFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCC 296 (467)
T ss_pred HHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccc
Confidence 743 345899999999999999999999732 899999999999998765 48999999875
Q ss_pred cccCCcccccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH----HhhC-
Q 021682 140 AFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYG----LWKN- 214 (309)
Q Consensus 140 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~----~~~~- 214 (309)
..... .....||..|+|||.+.+..++.++|||||||++|+|++|+.||...+..+....+....+ .|..
T Consensus 297 ~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~ 371 (467)
T PTZ00284 297 DERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGR 371 (467)
T ss_pred cCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhh
Confidence 32221 2234689999999999999999999999999999999999999965443222211111100 0000
Q ss_pred ---CCCccccc------ccCC-----------CcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 215 ---GEGMEFID------SSLD-----------DSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 215 ---~~~~~~~~------~~~~-----------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.....++. +... ..........+.+||.+||++||++|||++|+++.
T Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~H 438 (467)
T PTZ00284 372 CGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTH 438 (467)
T ss_pred ccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcC
Confidence 00000000 0000 00001123457799999999999999999999974
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=250.72 Aligned_cols=237 Identities=23% Similarity=0.334 Sum_probs=186.7
Q ss_pred cceEEEEcC-CCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 3 VAICQGRLP-NGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 3 ~~~~~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
+.+|.+..+ +++.|++|.+..... ....+..|++.+++++|+|++++++.+..+...++++||+.+++|.+++....
T Consensus 33 ~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~- 110 (286)
T cd06614 33 GEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF- 110 (286)
T ss_pred eEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhc-
Confidence 457888765 689999999976544 45678899999999999999999999999999999999999999999985432
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP 161 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 161 (309)
..+++..+..++.+++.++.+||+. |++|+||+|+||+++.++.++|+|||.+........ ......++..|+|
T Consensus 111 -~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~ 184 (286)
T cd06614 111 -VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--KRNSVVGTPYWMA 184 (286)
T ss_pred -cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh--hhccccCCcccCC
Confidence 3589999999999999999999998 999999999999999999999999998765443221 1122346788999
Q ss_pred ccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHH
Q 021682 162 PEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241 (309)
Q Consensus 162 PE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 241 (309)
||.+.+..++.++|+||||+++|+|++|..||........ .. .......... .........+.++|
T Consensus 185 PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~---~~----~~~~~~~~~~-------~~~~~~~~~l~~li 250 (286)
T cd06614 185 PEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA---LF----LITTKGIPPL-------KNPEKWSPEFKDFL 250 (286)
T ss_pred HhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH---HH----HHHhcCCCCC-------cchhhCCHHHHHHH
Confidence 9999888889999999999999999999999853322111 10 0111100000 00111234788999
Q ss_pred hhcccCCCCCCCCHHHHHHH
Q 021682 242 LLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 242 ~~~l~~~p~~Rpt~~ell~~ 261 (309)
.+||+.+|.+|||+.+++..
T Consensus 251 ~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 251 NKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred HHHhccChhhCcCHHHHhhC
Confidence 99999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=249.76 Aligned_cols=233 Identities=22% Similarity=0.247 Sum_probs=183.6
Q ss_pred ceEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
.+|++.. .+|+.||+|.+.... ......+.+|++++++++||||+++++.+..+...++|+||+.+++|.+++...
T Consensus 15 ~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 94 (258)
T cd05578 15 KVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK 94 (258)
T ss_pred eEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhc
Confidence 4566654 479999999987542 234568899999999999999999999999999999999999999999988432
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
..+++..+..++.++++++.+||++ |++|+||+|+||+++.++.++|+|||.+....... ......++..|
T Consensus 95 ---~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~y 165 (258)
T cd05578 95 ---VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGY 165 (258)
T ss_pred ---CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc---cccccCCChhh
Confidence 4588999999999999999999998 89999999999999999999999999987654432 12223577889
Q ss_pred CCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHH
Q 021682 160 VPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQ 239 (309)
Q Consensus 160 ~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (309)
+|||.+.+..++.++|+||||+++|++++|..||........ .... ..... .. ...+...+..+.+
T Consensus 166 ~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~~~-~~~~~--~~--------~~~~~~~~~~~~~ 231 (258)
T cd05578 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR---DQIR-AKQET--AD--------VLYPATWSTEAID 231 (258)
T ss_pred cCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH---HHHH-HHhcc--cc--------ccCcccCcHHHHH
Confidence 999999888889999999999999999999999865443211 1111 11110 00 0111112357889
Q ss_pred HHhhcccCCCCCCCCH--HHHH
Q 021682 240 VALLCVQENAADRPTM--LEIL 259 (309)
Q Consensus 240 li~~~l~~~p~~Rpt~--~ell 259 (309)
+|.+||+.||.+||++ +|++
T Consensus 232 ~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 232 AINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred HHHHHccCChhHcCCccHHHHh
Confidence 9999999999999999 6655
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=243.63 Aligned_cols=239 Identities=27% Similarity=0.382 Sum_probs=189.4
Q ss_pred cceEEEEcC-CCcEEEEEEeecCCc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeC--CeeEEEEeccCCCChhHHHh
Q 021682 3 VAICQGRLP-NGQEMAVKRLSRTSH--QGLEEFENEVKLTARLQHVNLLPVLGICTQR--EEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 3 ~~~~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~ 77 (309)
+.+|.+... +++.|++|.+..... ...+.+.+|+..+++++|+||+++++.+... ...++++|++.+++|.+++.
T Consensus 14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 93 (260)
T cd06606 14 GSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLK 93 (260)
T ss_pred eEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHH
Confidence 467888765 799999999866542 4467889999999999999999999999988 88999999999999999985
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
... .+++..+..++.+++.++++||+. |++|+||+|+||+++.++.++|+|||.+................++.
T Consensus 94 ~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 167 (260)
T cd06606 94 KFG---KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTP 167 (260)
T ss_pred HcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCc
Confidence 432 689999999999999999999998 89999999999999999999999999987665543211122345788
Q ss_pred CCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHH
Q 021682 158 GYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRC 237 (309)
Q Consensus 158 ~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (309)
.|+|||.+.+...+.++|+||||+++++|++|..||...+ ................. .+......+
T Consensus 168 ~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~---------~~~~~~~~l 233 (260)
T cd06606 168 YWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGSSGEPPE---------IPEHLSEEA 233 (260)
T ss_pred cccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccccCCCcC---------CCcccCHHH
Confidence 9999999988888999999999999999999999986544 11111111111011111 111124478
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHH
Q 021682 238 MQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 238 ~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.+++.+||+.+|++|||+.++++.
T Consensus 234 ~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 234 KDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred HHHHHHhCcCChhhCCCHHHHhhC
Confidence 899999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=254.14 Aligned_cols=250 Identities=20% Similarity=0.263 Sum_probs=181.2
Q ss_pred cceEEEEcC-CCcEEEEEEeecCCc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 3 VAICQGRLP-NGQEMAVKRLSRTSH--QGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 3 ~~~~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
+.+|++..+ +|+.||+|.+..... ...+.+.+|+++++.++|+||+++++++..+...++|+||+.+++|..+...
T Consensus 15 ~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~- 93 (286)
T cd07846 15 GMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKY- 93 (286)
T ss_pred eEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhc-
Confidence 356777764 689999998754422 2345688999999999999999999999999999999999999888876532
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
...+++..+..++.|++.+++|||+. |++|+||+|+||+++.++.++|+|||++........ ......++..|
T Consensus 94 --~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y 166 (286)
T cd07846 94 --PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYTDYVATRWY 166 (286)
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc--ccCcccceeec
Confidence 33489999999999999999999998 899999999999999999999999999865443321 12223567899
Q ss_pred CCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHH--------hhCC------CCccccccc
Q 021682 160 VPPEYVRK-GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGL--------WKNG------EGMEFIDSS 224 (309)
Q Consensus 160 ~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~------~~~~~~~~~ 224 (309)
+|||.+.+ ..++.++||||||+++|+|++|.+||......+........... .... .........
T Consensus 167 ~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (286)
T cd07846 167 RAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIE 246 (286)
T ss_pred cCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcc
Confidence 99998865 34678999999999999999999888543221110000000000 0000 000000000
Q ss_pred CCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021682 225 LDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 225 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
............+.+++.+||+.+|++|||+.++++
T Consensus 247 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 247 PLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000001122457889999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=246.49 Aligned_cols=239 Identities=25% Similarity=0.359 Sum_probs=184.9
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCcc--cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSHQ--GLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
+.+|++.. .+++.|++|.++..... ....+..|+.++++++|+||+++++++......++|+||+.+++|.+++..
T Consensus 14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~- 92 (264)
T cd06626 14 GKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEH- 92 (264)
T ss_pred cEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhh-
Confidence 35677764 47899999998765443 567889999999999999999999999999999999999999999998843
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccc--cccccccc
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEAN--TGRIVGTY 157 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~--~~~~~~~~ 157 (309)
+..+++..+..++.+++.++.+||+. |++|+||+|+||+++.++.++|+|||.+........... .....++.
T Consensus 93 --~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
T cd06626 93 --GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTP 167 (264)
T ss_pred --cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCc
Confidence 33478889999999999999999998 899999999999999999999999999876544322111 11235678
Q ss_pred CCCCccccccCC---CCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHH
Q 021682 158 GYVPPEYVRKGI---YSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKL 234 (309)
Q Consensus 158 ~y~aPE~~~~~~---~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
.|+|||.+.+.. .+.++||||||+++|++++|..||....... ..... ........ +.. .....
T Consensus 168 ~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-----~~~~~-~~~~~~~~-~~~------~~~~~ 234 (264)
T cd06626 168 AYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-----QIMFH-VGAGHKPP-IPD------SLQLS 234 (264)
T ss_pred CccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-----HHHHH-HhcCCCCC-CCc------ccccC
Confidence 999999987765 7899999999999999999999986432111 11100 11111011 110 01113
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHH
Q 021682 235 MRCMQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 235 ~~l~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
..+.+++.+||+.+|++|||+++++.
T Consensus 235 ~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 235 PEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhc
Confidence 36779999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=247.93 Aligned_cols=242 Identities=24% Similarity=0.327 Sum_probs=182.5
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCc----------ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCC
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSH----------QGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKS 71 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~----------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 71 (309)
+.||.|.. .+|+.||+|.++.... ...+.+..|+.++++++|+|++++++++......++||||+.+++
T Consensus 15 ~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 94 (272)
T cd06629 15 GRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGS 94 (272)
T ss_pred eEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCc
Confidence 36788764 4789999998853211 012457789999999999999999999999999999999999999
Q ss_pred hhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccc
Q 021682 72 LDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTG 151 (309)
Q Consensus 72 L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 151 (309)
|.+++... ..++...+..++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||.+.............
T Consensus 95 L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 168 (272)
T cd06629 95 IGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNM 168 (272)
T ss_pred HHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccccccccccccccc
Confidence 99988433 4588899999999999999999998 89999999999999999999999999986544322111122
Q ss_pred ccccccCCCCccccccCC--CCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcc
Q 021682 152 RIVGTYGYVPPEYVRKGI--YSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSS 229 (309)
Q Consensus 152 ~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (309)
...++..|+|||.+.... ++.++|+||||+++|++++|..||...... ..............+. ...
T Consensus 169 ~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~-----~~~ 237 (272)
T cd06629 169 SMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI------AAMFKLGNKRSAPPIP-----PDV 237 (272)
T ss_pred cccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH------HHHHHhhccccCCcCC-----ccc
Confidence 235778999999887654 789999999999999999999997432111 1111111111111111 111
Q ss_pred cHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 230 SAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 230 ~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
....+..+.+++.+||..+|++|||++++++.
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 238 SMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 11223478899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=251.85 Aligned_cols=236 Identities=22% Similarity=0.346 Sum_probs=186.5
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
+.+|++.. .+++.||+|.+........+.+.+|+.++++++|||++++++.+..++..++|+||+++++|.+++..
T Consensus 33 g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--- 109 (293)
T cd06647 33 GTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--- 109 (293)
T ss_pred eEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhh---
Confidence 46788864 47899999998655555567788999999999999999999999999999999999999999998742
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP 161 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 161 (309)
..+++..+..++.+++.|+.+||++ |++|+||+|+||+++.++.++|+|||++........ ......++..|++
T Consensus 110 -~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~~ 183 (293)
T cd06647 110 -TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMA 183 (293)
T ss_pred -cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--ccccccCChhhcC
Confidence 2378889999999999999999998 999999999999999999999999998765443322 1222357788999
Q ss_pred ccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHH
Q 021682 162 PEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241 (309)
Q Consensus 162 PE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 241 (309)
||.+.+..++.++|+||||+++|++++|..||............ .... .............+.+++
T Consensus 184 PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~------~~~~--------~~~~~~~~~~~~~l~~li 249 (293)
T cd06647 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATNG--------TPELQNPEKLSAIFRDFL 249 (293)
T ss_pred chhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh------hcCC--------CCCCCCccccCHHHHHHH
Confidence 99998888899999999999999999999998654332211100 0000 000011112234688999
Q ss_pred hhcccCCCCCCCCHHHHHHH
Q 021682 242 LLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 242 ~~~l~~~p~~Rpt~~ell~~ 261 (309)
.+||..+|++||++++++.+
T Consensus 250 ~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 250 NRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred HHHccCChhhCcCHHHHhcC
Confidence 99999999999999999977
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=246.78 Aligned_cols=247 Identities=23% Similarity=0.317 Sum_probs=185.2
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeC--CeeEEEEeccCCCChhHHHhh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSH-QGLEEFENEVKLTARLQHVNLLPVLGICTQR--EEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~ 78 (309)
+.+|.+.. .+++.||+|.+..... ....++.+|++++++++|+||+++++++... ..+++||||+++++|.+++..
T Consensus 15 ~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 94 (287)
T cd06621 15 GSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKK 94 (287)
T ss_pred eEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHH
Confidence 35677765 5789999999875432 3456788999999999999999999988653 368999999999999888743
Q ss_pred h-ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccccc
Q 021682 79 L-RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 79 ~-~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
. .....++...+..++.+++.+++|||+. |++|+||+|+||+++.++.++|+|||++........ ....++.
T Consensus 95 ~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~ 167 (287)
T cd06621 95 VKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA----GTFTGTS 167 (287)
T ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccccccc----ccccCCc
Confidence 2 2344578899999999999999999998 999999999999999999999999999765433211 1234677
Q ss_pred CCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHH
Q 021682 158 GYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRC 237 (309)
Q Consensus 158 ~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (309)
.|+|||.+.+..++.++|+||||+++|+|++|..||....... ....... ........... .... .........+
T Consensus 168 ~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~-~~~~~~~~~~~-~~~~--~~~~~~~~~~ 242 (287)
T cd06621 168 FYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP-LGPIELL-SYIVNMPNPEL-KDEP--GNGIKWSEEF 242 (287)
T ss_pred cccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC-CChHHHH-HHHhcCCchhh-ccCC--CCCCchHHHH
Confidence 8999999988889999999999999999999999986543311 1111111 11111111111 1110 1011124478
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHH
Q 021682 238 MQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 238 ~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.+++.+||+.+|++|||+.|++..
T Consensus 243 ~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 243 KDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred HHHHHHHcCCCcccCCCHHHHHhC
Confidence 899999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=254.33 Aligned_cols=255 Identities=21% Similarity=0.240 Sum_probs=182.0
Q ss_pred cceEEEEcC---CCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeC--CeeEEEEeccCCCChhH
Q 021682 3 VAICQGRLP---NGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQR--EEKMLIYDYMPNKSLDF 74 (309)
Q Consensus 3 ~~~~~~~~~---~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~ 74 (309)
+.+|++... +++.||+|.+.... ......+..|+.++++++||||+++++++... ...++||||+++ ++.+
T Consensus 14 g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~ 92 (316)
T cd07842 14 GRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQ 92 (316)
T ss_pred EEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCCc-CHHH
Confidence 456777653 58999999987632 33346778899999999999999999999888 789999999975 5666
Q ss_pred HHhhhcc--ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCC----CCCceeecccccccccCCccc-
Q 021682 75 YIFDLRR--RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY----EMNPKISDFGMARAFTKDECE- 147 (309)
Q Consensus 75 ~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~----~~~~~l~Dfg~~~~~~~~~~~- 147 (309)
++..... ...+++..++.++.|++.|+.|||+. |++|+||+|+||+++. ++.++|+|||++.........
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 169 (316)
T cd07842 93 IIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPL 169 (316)
T ss_pred HHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccc
Confidence 5543222 23588999999999999999999998 8999999999999999 899999999998765443221
Q ss_pred ccccccccccCCCCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCccc------HHHHHHHHhhC------
Q 021682 148 ANTGRIVGTYGYVPPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLN------LLEYAYGLWKN------ 214 (309)
Q Consensus 148 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~------~~~~~~~~~~~------ 214 (309)
.......++..|+|||.+.+. .++.++|+||||+++++|++|++||.......... ........+..
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 249 (316)
T cd07842 170 ADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDW 249 (316)
T ss_pred cccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHH
Confidence 112223567889999987664 57899999999999999999999997544433110 00000000000
Q ss_pred ------CCCcc----cccccCC-CcccH------HHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 215 ------GEGME----FIDSSLD-DSSSA------WKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 215 ------~~~~~----~~~~~~~-~~~~~------~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
..... ....... ..... .....+.+++.+||+.||++|||+.|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 250 PDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000 0000000 00000 122368899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=248.53 Aligned_cols=240 Identities=22% Similarity=0.289 Sum_probs=184.5
Q ss_pred ceEEEE-cCCCcEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeeEEee--CCeeEEEEeccCCCChhHHHhh
Q 021682 4 AICQGR-LPNGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQ--REEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
.+|++. ..+|+.||+|.+... .....+++..|++++++++|+||+++++++.. +...+++|||+.+++|.+++..
T Consensus 15 ~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~ 94 (265)
T cd08217 15 TVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQK 94 (265)
T ss_pred EEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHH
Confidence 566665 457899999998654 23345678899999999999999999997754 4468999999999999998855
Q ss_pred h-ccccCCCHHHHHHHHHHHHHHHHHHhhcC--CCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccc
Q 021682 79 L-RRRYLLDWRTRVHIIEGITQGLLYLQEYS--NLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVG 155 (309)
Q Consensus 79 ~-~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 155 (309)
. .....+++..++.++.+++.|+.+||..+ ..+++|+||+|+||+++.++.++|+|||++......... .....+
T Consensus 95 ~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~--~~~~~~ 172 (265)
T cd08217 95 CKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF--AKTYVG 172 (265)
T ss_pred HhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCCccc--cccccc
Confidence 3 22456899999999999999999999321 228999999999999999999999999998766543321 122357
Q ss_pred ccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 156 TYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 156 ~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
+..|+|||.+.+..++.++|+||||+++++|++|..||...+... .. ......... ..+.....
T Consensus 173 ~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~----~~~~~~~~~---------~~~~~~~~ 236 (265)
T cd08217 173 TPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---LA----SKIKEGKFR---------RIPYRYSS 236 (265)
T ss_pred CCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH---HH----HHHhcCCCC---------CCccccCH
Confidence 889999999988888999999999999999999999986533111 11 111111111 11112334
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 236 RCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.+.+++.+||+.+|++|||+.+|++.
T Consensus 237 ~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 237 ELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhhC
Confidence 78899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=247.79 Aligned_cols=237 Identities=22% Similarity=0.269 Sum_probs=179.0
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC-----cccHHHHHHHHHHHhcCCCCCccceeeEEeeC--CeeEEEEeccCCCChhH
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS-----HQGLEEFENEVKLTARLQHVNLLPVLGICTQR--EEKMLIYDYMPNKSLDF 74 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~ 74 (309)
+.||.+.. .+|+.||||.+.... ......+..|+.+++++.|+||+++++++..+ ..++++|||+++++|.+
T Consensus 16 g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~ 95 (265)
T cd06652 16 GRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKD 95 (265)
T ss_pred eEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHH
Confidence 35677765 468999999875321 12345788899999999999999999988763 46889999999999999
Q ss_pred HHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccc-cccccc
Q 021682 75 YIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECE-ANTGRI 153 (309)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~ 153 (309)
++... ..+++..+..++.+++.++.+||++ |++|+||+|+||+++.++.++|+|||.+......... ......
T Consensus 96 ~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~ 169 (265)
T cd06652 96 QLKSY---GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSV 169 (265)
T ss_pred HHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccccccccccccccccC
Confidence 88432 3478888999999999999999998 8999999999999999999999999988654321111 111223
Q ss_pred ccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHH
Q 021682 154 VGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWK 233 (309)
Q Consensus 154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
.++..|+|||.+.+..++.++|+||||+++|+|++|+.||....... ......... .....+...
T Consensus 170 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~---------~~~~~~~~~ 234 (265)
T cd06652 170 TGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA------AIFKIATQP---------TNPVLPPHV 234 (265)
T ss_pred CCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH------HHHHHhcCC---------CCCCCchhh
Confidence 57789999999988888999999999999999999999985321111 111111000 011122233
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 234 LMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 234 ~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
...+.++|.+||. +|++|||++++++.
T Consensus 235 ~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 235 SDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred CHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 4467899999995 99999999999853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=251.25 Aligned_cols=235 Identities=22% Similarity=0.353 Sum_probs=177.8
Q ss_pred ceEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCCccceeeEEee------CCeeEEEEeccCCCChhHH
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLTARL-QHVNLLPVLGICTQ------REEKMLIYDYMPNKSLDFY 75 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~------~~~~~lv~e~~~~~~L~~~ 75 (309)
.+|.+.. .+++.||+|.+.... .....+..|+.+++++ +|+||+++++++.. ....+++|||+.+++|.++
T Consensus 31 ~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~ 109 (282)
T cd06636 31 QVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDL 109 (282)
T ss_pred EEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHH
Confidence 4566654 578999999986543 3346788899999998 79999999998853 4578999999999999998
Q ss_pred HhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccc
Q 021682 76 IFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVG 155 (309)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 155 (309)
+... ....+++..+..++.|++.|++|||+. |++|+||+|+||+++.++.++|+|||++........ ......+
T Consensus 110 ~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~ 183 (282)
T cd06636 110 VKNT-KGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIG 183 (282)
T ss_pred HHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhhhhcccc--CCCcccc
Confidence 8542 234578888999999999999999998 899999999999999999999999999865432211 1222457
Q ss_pred ccCCCCccccc-----cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCccc
Q 021682 156 TYGYVPPEYVR-----KGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSS 230 (309)
Q Consensus 156 ~~~y~aPE~~~-----~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (309)
+..|+|||.+. ...++.++|+|||||++|+|++|..||........... .... .... ...
T Consensus 184 ~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~------~~~~-~~~~--------~~~ 248 (282)
T cd06636 184 TPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL------IPRN-PPPK--------LKS 248 (282)
T ss_pred cccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh------HhhC-CCCC--------Ccc
Confidence 88999999875 34578899999999999999999999854322111110 0000 0000 001
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021682 231 AWKLMRCMQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 231 ~~~~~~l~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
...+..+.++|.+||+.||.+|||+.|+++
T Consensus 249 ~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 249 KKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred cccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 112347889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=252.37 Aligned_cols=247 Identities=22% Similarity=0.286 Sum_probs=178.0
Q ss_pred ceEEEEcC-CCcEEEEEEeecCCc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 4 AICQGRLP-NGQEMAVKRLSRTSH-QGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 4 ~~~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
.||++... +++.||||.+..... .....+.+|++++++++|+||+++++++..+...++||||+.+ +|.+++...
T Consensus 20 ~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~-- 96 (291)
T cd07844 20 TVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDC-- 96 (291)
T ss_pred EEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-CHHHHHHhC--
Confidence 57887754 789999999865432 2234567899999999999999999999999999999999975 888877432
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP 161 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 161 (309)
...+++..+..++.|+++|+.|||+. |++|+||+|+||+++.++.++|+|||++......... .....++..|+|
T Consensus 97 ~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~a 171 (291)
T cd07844 97 GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT--YSNEVVTLWYRP 171 (291)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCcc--ccccccccccCC
Confidence 23588999999999999999999998 8999999999999999999999999988644322111 111245778999
Q ss_pred cccccc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCC---CC------cc-------ccccc
Q 021682 162 PEYVRK-GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNG---EG------ME-------FIDSS 224 (309)
Q Consensus 162 PE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~------~~-------~~~~~ 224 (309)
||.+.+ ..++.++||||+|+++|+|++|..||....... ............. .. .. .....
T Consensus 172 PE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (291)
T cd07844 172 PDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE--DQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPR 249 (291)
T ss_pred cHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHhcCCCChhhhhhhhhccccccccccccCCh
Confidence 998865 457899999999999999999999985433111 1111111100000 00 00 00000
Q ss_pred CC-Cc-ccHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021682 225 LD-DS-SSAWKLMRCMQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 225 ~~-~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
.. .. ........+.+++.+||+.+|++|||+.++++
T Consensus 250 ~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 250 PLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00 00 00001146779999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=249.53 Aligned_cols=244 Identities=22% Similarity=0.356 Sum_probs=182.7
Q ss_pred cceEEEEc----CCCcEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCC------eeEEEEeccCCC
Q 021682 3 VAICQGRL----PNGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQRE------EKMLIYDYMPNK 70 (309)
Q Consensus 3 ~~~~~~~~----~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~ 70 (309)
+.||++.. .+++.||||.+... .....+++..|++++++++||||+++++++.... ..+++++|+.++
T Consensus 13 g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 92 (273)
T cd05074 13 GSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHG 92 (273)
T ss_pred CCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCC
Confidence 36777754 25789999998654 2334567889999999999999999999876532 247889999999
Q ss_pred ChhHHHhhhc---cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccc
Q 021682 71 SLDFYIFDLR---RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECE 147 (309)
Q Consensus 71 ~L~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~ 147 (309)
+|..++.... ....++...+..++.|++.|++|||+. |++|+||+|+||+++.++.++|+|||.+.........
T Consensus 93 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~ 169 (273)
T cd05074 93 DLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYY 169 (273)
T ss_pred cHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcccccccccCCcce
Confidence 9988764321 122478889999999999999999998 8999999999999999999999999998765432221
Q ss_pred ccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCC
Q 021682 148 ANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLD 226 (309)
Q Consensus 148 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (309)
.......++..|++||.+.+..++.++|||||||++|+|++ |.+||......+ .............
T Consensus 170 ~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~~~------ 236 (273)
T cd05074 170 RQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE-------IYNYLIKGNRLKQ------ 236 (273)
T ss_pred ecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH-------HHHHHHcCCcCCC------
Confidence 11122234567999999988888999999999999999999 788875332211 1111111111100
Q ss_pred CcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcc
Q 021682 227 DSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSE 265 (309)
Q Consensus 227 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~ 265 (309)
.......+.+++.+||+.+|++|||+.++++.|+++
T Consensus 237 ---~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 237 ---PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 011234788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=265.96 Aligned_cols=241 Identities=25% Similarity=0.378 Sum_probs=199.1
Q ss_pred cceEEEEcC-CCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 3 VAICQGRLP-NGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 3 ~~~~~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
+-||.|.|+ -...||||-++... ...+.|..|+.+++.++|||+|+++++|..+..+|||+|||..|+|.+|+.+..
T Consensus 281 GeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecn- 358 (1157)
T KOG4278|consen 281 GEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECN- 358 (1157)
T ss_pred cceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhc-
Confidence 458899886 46779999996554 467899999999999999999999999999999999999999999999996643
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP 161 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 161 (309)
+..++....+.++.||..|+.||..+ +++||||-..|+++.++..+|++|||+++.+..+......+ ..-+..|.|
T Consensus 359 r~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAG-AKFPIKWTA 434 (1157)
T KOG4278|consen 359 RSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTA 434 (1157)
T ss_pred hhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCceecccC-ccCcccccC
Confidence 44578888899999999999999998 79999999999999999999999999999888765544333 234678999
Q ss_pred ccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHH
Q 021682 162 PEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQV 240 (309)
Q Consensus 162 PE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 240 (309)
||-+....++-++|||+||++|||+.| |-.|+...+. ..++..+.. ...+..+..++.+.++|
T Consensus 435 PEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl-------SqVY~LLEk---------gyRM~~PeGCPpkVYeL 498 (1157)
T KOG4278|consen 435 PESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-------SQVYGLLEK---------GYRMDGPEGCPPKVYEL 498 (1157)
T ss_pred cccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH-------HHHHHHHhc---------cccccCCCCCCHHHHHH
Confidence 999988899999999999999999998 7777654322 222333333 33333344455588999
Q ss_pred HhhcccCCCCCCCCHHHHHHHHhcc
Q 021682 241 ALLCVQENAADRPTMLEILVMLKSE 265 (309)
Q Consensus 241 i~~~l~~~p~~Rpt~~ell~~L~~~ 265 (309)
++.||+++|++||++.|+-+.++.+
T Consensus 499 MraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 499 MRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred HHHHhcCCcccCccHHHHHHHHHHH
Confidence 9999999999999999999988655
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=247.58 Aligned_cols=237 Identities=23% Similarity=0.343 Sum_probs=180.6
Q ss_pred ceEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCCccceeeEEeeCC------eeEEEEeccCCCChhHH
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLTARL-QHVNLLPVLGICTQRE------EKMLIYDYMPNKSLDFY 75 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~------~~~lv~e~~~~~~L~~~ 75 (309)
.+|.+.. .+++.+++|.+..... ..+.+..|+.+++++ .|+||+++++++.... ..++||||+.+++|.++
T Consensus 21 ~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 99 (275)
T cd06608 21 KVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDL 99 (275)
T ss_pred EEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHH
Confidence 4677765 4788999999865543 346789999999999 7999999999987644 48999999999999988
Q ss_pred Hhhhc-cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccc
Q 021682 76 IFDLR-RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIV 154 (309)
Q Consensus 76 ~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~ 154 (309)
+.... ....+++..+..++.|++.|+.|||+. |++|+||+|+||+++.++.++|+|||.+........ ......
T Consensus 100 ~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~ 174 (275)
T cd06608 100 VKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLG--RRNTFI 174 (275)
T ss_pred HHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCccceecccchh--hhcCcc
Confidence 75432 245689999999999999999999998 899999999999999999999999999865443221 122345
Q ss_pred cccCCCCcccccc-----CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcc
Q 021682 155 GTYGYVPPEYVRK-----GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSS 229 (309)
Q Consensus 155 ~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (309)
++..|+|||.+.. ..++.++||||||+++|++++|..||....... .... ....... ....
T Consensus 175 ~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~-~~~~~~~-------~~~~ 240 (275)
T cd06608 175 GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR------ALFK-IPRNPPP-------TLKS 240 (275)
T ss_pred ccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH------HHHH-hhccCCC-------CCCc
Confidence 7889999998753 346788999999999999999999985322111 0111 1111000 0111
Q ss_pred cHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021682 230 SAWKLMRCMQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 230 ~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
.......+.+++.+||..||++|||++++++
T Consensus 241 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 241 PENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1123347889999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=251.03 Aligned_cols=250 Identities=20% Similarity=0.228 Sum_probs=180.9
Q ss_pred cceEEEEcC-CCcEEEEEEeecCCc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeC--CeeEEEEeccCCCChhHHHh
Q 021682 3 VAICQGRLP-NGQEMAVKRLSRTSH--QGLEEFENEVKLTARLQHVNLLPVLGICTQR--EEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 3 ~~~~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~ 77 (309)
+.||++..+ +++.||+|.++.... .....+.+|+.++++++||||+++++++..+ ...++|+||+. ++|.+++.
T Consensus 19 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~ 97 (293)
T cd07843 19 GVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLME 97 (293)
T ss_pred eEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC-cCHHHHHH
Confidence 356777764 689999999875432 2233567899999999999999999998877 78999999997 48888774
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
.. ...+++..+..++.|++.|++|||+. |++|+||+|+||+++.++.++|+|||.+......... .....++.
T Consensus 98 ~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~ 170 (293)
T cd07843 98 TM--KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP--YTQLVVTL 170 (293)
T ss_pred hc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCCccc--cccccccc
Confidence 42 23589999999999999999999998 8999999999999999999999999988765543211 22235678
Q ss_pred CCCCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHH--------HHHhhC------CCCccccc
Q 021682 158 GYVPPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYA--------YGLWKN------GEGMEFID 222 (309)
Q Consensus 158 ~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~~------~~~~~~~~ 222 (309)
.|+|||.+.+. .++.++|+||||+++|+|++|.+||......+........ +..+.. ........
T Consensus 171 ~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (293)
T cd07843 171 WYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPY 250 (293)
T ss_pred cccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccc
Confidence 89999988764 4688999999999999999999998654332211111000 000000 00000000
Q ss_pred ccCCCcccHH-HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021682 223 SSLDDSSSAW-KLMRCMQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 223 ~~~~~~~~~~-~~~~l~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
.......... ....+.++|.+||+.+|++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 251 NQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000011111 2346789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=249.81 Aligned_cols=239 Identities=22% Similarity=0.273 Sum_probs=185.0
Q ss_pred ceEEEEcC-CCcEEEEEEeecCCc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGRLP-NGQEMAVKRLSRTSH---QGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
.+|.+... +|+.|++|.+..... .....+.+|++++++++|+||+++++.+..+...++++||+.+++|.+++...
T Consensus 8 ~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 87 (265)
T cd05579 8 RVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENV 87 (265)
T ss_pred EEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHc
Confidence 57777765 599999999865432 34567889999999999999999999999999999999999999999988543
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcc------ccccccc
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDEC------EANTGRI 153 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~------~~~~~~~ 153 (309)
. .+++..+..++.|++.++++||+. |++|+||+|+||+++.++.++|+|||++........ .......
T Consensus 88 ~---~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~ 161 (265)
T cd05579 88 G---SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRI 161 (265)
T ss_pred C---CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCc
Confidence 2 589999999999999999999998 899999999999999999999999998865443211 0112233
Q ss_pred ccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHH
Q 021682 154 VGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWK 233 (309)
Q Consensus 154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
.++..|++||.......+.++|+||||+++|++++|..||......+ .. ........ ... .. ...
T Consensus 162 ~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~-~~~~~~~~-~~~-----~~--~~~ 226 (265)
T cd05579 162 VGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE------IF-QNILNGKI-EWP-----ED--VEV 226 (265)
T ss_pred ccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH------HH-HHHhcCCc-CCC-----cc--ccC
Confidence 56788999999888888999999999999999999999985433211 11 11111000 000 00 002
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHHHh
Q 021682 234 LMRCMQVALLCVQENAADRPTMLEILVMLK 263 (309)
Q Consensus 234 ~~~l~~li~~~l~~~p~~Rpt~~ell~~L~ 263 (309)
...+.+++.+||+.+|++|||+.++.+.|+
T Consensus 227 ~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 227 SDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred CHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 347789999999999999999966665554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=251.07 Aligned_cols=248 Identities=18% Similarity=0.198 Sum_probs=180.0
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
+.+|++.. .+|+.||||.+.... ......+.+|++++++++||||+++++++..+...++||||+. ++|..++...
T Consensus 14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~ 92 (284)
T cd07860 14 GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDAS 92 (284)
T ss_pred eEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhC
Confidence 45677764 479999999886442 2234578899999999999999999999999999999999996 5787777432
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
....+++..+..++.+++.|++|||.. |++|+||+|+||+++.++.++|+|||++......... .....++..|
T Consensus 93 -~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y 166 (284)
T cd07860 93 -PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWY 166 (284)
T ss_pred -CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc--cccccccccc
Confidence 244588999999999999999999998 8999999999999999999999999998655432211 1222457789
Q ss_pred CCccccccCC-CCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCC---------Cc---ccccccCC
Q 021682 160 VPPEYVRKGI-YSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGE---------GM---EFIDSSLD 226 (309)
Q Consensus 160 ~aPE~~~~~~-~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~~---~~~~~~~~ 226 (309)
+|||.+.+.. ++.++|+||||+++|+|++|..||...+..+.. ........... .. ..+.....
T Consensus 167 ~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (284)
T cd07860 167 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL---FRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWAR 243 (284)
T ss_pred cCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH---HHHHHHhCCCChhhhhhhhHHHHHHhhcccccc
Confidence 9999886644 588899999999999999999998643221111 00000000000 00 00000000
Q ss_pred Cc---ccHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021682 227 DS---SSAWKLMRCMQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 227 ~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
.. ........+.++|.+||+.||++|||+++++.
T Consensus 244 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 244 QDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred cCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00 00112236779999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=250.31 Aligned_cols=236 Identities=19% Similarity=0.280 Sum_probs=183.8
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
+.+|++.. .+|+.||||.+..........+.+|+.+++.++|+|++++++.+..++..++||||+++++|.+++..
T Consensus 34 g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--- 110 (292)
T cd06657 34 GIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH--- 110 (292)
T ss_pred eEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhc---
Confidence 35677765 57999999998654444566788999999999999999999999999999999999999999887632
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP 161 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 161 (309)
..+++..+..++.|++.++++||+. |++|+||+|.||+++.++.++|+|||.+......... .....++..|+|
T Consensus 111 -~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~~ 184 (292)
T cd06657 111 -TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMA 184 (292)
T ss_pred -CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccccc--ccccccCccccC
Confidence 2478899999999999999999998 8999999999999999999999999987654432211 122357788999
Q ss_pred ccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHH
Q 021682 162 PEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241 (309)
Q Consensus 162 PE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 241 (309)
||.+.+..++.++|+||+|+++|+|++|..||....... ......... ...+.. .......+.+++
T Consensus 185 pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~---~~~~~~~~~-----~~~~~~------~~~~~~~l~~li 250 (292)
T cd06657 185 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMKMIRDNL-----PPKLKN------LHKVSPSLKGFL 250 (292)
T ss_pred HHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhhC-----CcccCC------cccCCHHHHHHH
Confidence 999888888999999999999999999999985422211 111111000 000000 011223677999
Q ss_pred hhcccCCCCCCCCHHHHHHH
Q 021682 242 LLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 242 ~~~l~~~p~~Rpt~~ell~~ 261 (309)
.+||+.+|.+||++++++..
T Consensus 251 ~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 251 DRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred HHHHhCCcccCcCHHHHhcC
Confidence 99999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=246.99 Aligned_cols=235 Identities=22% Similarity=0.351 Sum_probs=183.0
Q ss_pred cceEEEEc-CCCcEEEEEEeecC-CcccHHHHHHHHHHHhcCC---CCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRT-SHQGLEEFENEVKLTARLQ---HVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
+.+|++.. .+|+.||+|.++.. .......+..|+.++++++ |+|++++++++..+...++||||+.+++|.+++.
T Consensus 15 g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 94 (277)
T cd06917 15 GAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMK 94 (277)
T ss_pred ceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHH
Confidence 45677764 57899999998654 3344567888999999986 9999999999999999999999999999998873
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
. ..+++..+..++.+++.++.+||+. |++|+||+|+||+++.++.++|+|||.+......... .....|+.
T Consensus 95 ~----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~ 165 (277)
T cd06917 95 A----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK--RSTFVGTP 165 (277)
T ss_pred c----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc--cccccCCc
Confidence 2 2588999999999999999999998 8999999999999999999999999998765543321 22235788
Q ss_pred CCCCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHH
Q 021682 158 GYVPPEYVRK-GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMR 236 (309)
Q Consensus 158 ~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
.|+|||.+.+ ..++.++|+||||+++|+|++|..||......... ......... ..... .....
T Consensus 166 ~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~-------~~~~~~~~~-----~~~~~---~~~~~ 230 (277)
T cd06917 166 YWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM-------MLIPKSKPP-----RLEDN---GYSKL 230 (277)
T ss_pred ceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh-------hccccCCCC-----CCCcc---cCCHH
Confidence 9999998765 45688999999999999999999998643221110 000000000 01110 02347
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 237 CMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 237 l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
+.+++.+||+.||++|||+.+++..
T Consensus 231 ~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 231 LREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred HHHHHHHHcCCCcccCcCHHHHhhC
Confidence 8899999999999999999999864
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=249.63 Aligned_cols=239 Identities=22% Similarity=0.286 Sum_probs=178.6
Q ss_pred ceEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCCccceeeEEe-----eCCeeEEEEeccCCCChhHHH
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLTARL-QHVNLLPVLGICT-----QREEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~ 76 (309)
.||++.. .+|+.+|+|.+.... .....+..|+.+++.+ +|+||+++++++. .+...++||||+++++|.+++
T Consensus 33 ~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 111 (286)
T cd06638 33 KVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLV 111 (286)
T ss_pred EEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHH
Confidence 4676654 578999999885432 2235678899999999 7999999999874 345789999999999999887
Q ss_pred hhh-ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccc
Q 021682 77 FDL-RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVG 155 (309)
Q Consensus 77 ~~~-~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 155 (309)
... .....+++..+..++.|++.|+.+||+. +++|+||+|+||+++.++.++|+|||++......... .....+
T Consensus 112 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~ 186 (286)
T cd06638 112 KGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVG 186 (286)
T ss_pred HHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCceeecccCCCc--cccccC
Confidence 532 2344588899999999999999999998 8999999999999999999999999998765432211 122357
Q ss_pred ccCCCCcccccc-----CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCccc
Q 021682 156 TYGYVPPEYVRK-----GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSS 230 (309)
Q Consensus 156 ~~~y~aPE~~~~-----~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (309)
+..|+|||.+.. ..++.++|+||+||++|+|++|..||......... ............. +
T Consensus 187 ~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~-------~~~~~~~~~~~~~-------~ 252 (286)
T cd06638 187 TPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL-------FKIPRNPPPTLHQ-------P 252 (286)
T ss_pred CCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH-------hhccccCCCcccC-------C
Confidence 889999998753 34688999999999999999999998543221110 0000000001000 0
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 021682 231 AWKLMRCMQVALLCVQENAADRPTMLEILVML 262 (309)
Q Consensus 231 ~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L 262 (309)
......+.+++.+||+.+|++|||+.|+++.+
T Consensus 253 ~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 253 ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred CCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 11123688999999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=243.03 Aligned_cols=237 Identities=23% Similarity=0.355 Sum_probs=187.9
Q ss_pred cceEEEEcC-CCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 3 VAICQGRLP-NGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 3 ~~~~~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
+.+|++... +++.|++|.+..........+.+|++.+++++|++++++++++..+...++++||+.+++|.+++...
T Consensus 14 ~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~-- 91 (253)
T cd05122 14 GEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKST-- 91 (253)
T ss_pred eEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhc--
Confidence 467777764 78999999997665445678999999999999999999999999999999999999999999987442
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP 161 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 161 (309)
...+++..+..++.+++.++.+||.. |++|+||+|+||+++.++.++|+|||.+........ .....++..|+|
T Consensus 92 ~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~ 165 (253)
T cd05122 92 NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTMVGTPYWMA 165 (253)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc---ccceecCCcccC
Confidence 24589999999999999999999997 899999999999999999999999998876554331 223457889999
Q ss_pred ccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHH
Q 021682 162 PEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241 (309)
Q Consensus 162 PE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 241 (309)
||.+.+...+.++|+||||+++|+|++|..||...+... .... ............ ......+.++|
T Consensus 166 PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~----~~~~~~~~~~~~-------~~~~~~~~~~i 231 (253)
T cd05122 166 PEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK---ALFK----IATNGPPGLRNP-------EKWSDEFKDFL 231 (253)
T ss_pred HHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH---HHHH----HHhcCCCCcCcc-------cccCHHHHHHH
Confidence 999988888999999999999999999999985432211 1111 111111111110 00134788999
Q ss_pred hhcccCCCCCCCCHHHHHHH
Q 021682 242 LLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 242 ~~~l~~~p~~Rpt~~ell~~ 261 (309)
.+||+.||++|||+.++++.
T Consensus 232 ~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 232 KKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred HHHccCChhhCCCHHHHhcC
Confidence 99999999999999999853
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=251.39 Aligned_cols=252 Identities=22% Similarity=0.283 Sum_probs=179.4
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCcc--cHHHHHHHHHHHhcCCCCCccceeeEEeeC--CeeEEEEeccCCCChhHHHh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSHQ--GLEEFENEVKLTARLQHVNLLPVLGICTQR--EEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~ 77 (309)
++||++.. .+|+.||+|.++..... ....+.+|+.++++++|+||+++++++... ...++||||+.+ +|.+++.
T Consensus 21 ~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~ 99 (309)
T cd07845 21 GIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLD 99 (309)
T ss_pred EEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCCC-CHHHHHH
Confidence 35677765 57999999998654321 223456899999999999999999998755 468999999964 7877774
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
.. ...+++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||.+......... .....++.
T Consensus 100 ~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~--~~~~~~~~ 172 (309)
T cd07845 100 NM--PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP--MTPKVVTL 172 (309)
T ss_pred hc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCccCC--CCcccccc
Confidence 32 24589999999999999999999998 8999999999999999999999999998765443211 11224567
Q ss_pred CCCCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH-----HhhCC---CCcccc--cccCC
Q 021682 158 GYVPPEYVRK-GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYG-----LWKNG---EGMEFI--DSSLD 226 (309)
Q Consensus 158 ~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~---~~~~~~--~~~~~ 226 (309)
.|+|||.+.+ ..++.++|+||||+++|+|++|.+||...+..+.......... .|... .....+ .....
T Consensus 173 ~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (309)
T cd07845 173 WYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPY 252 (309)
T ss_pred cccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCC
Confidence 8999998865 4578999999999999999999999864433222111111000 00000 000000 00000
Q ss_pred Cc---ccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 021682 227 DS---SSAWKLMRCMQVALLCVQENAADRPTMLEILVML 262 (309)
Q Consensus 227 ~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L 262 (309)
.. ........+.++|.+||+.||++|||+++++..-
T Consensus 253 ~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~ 291 (309)
T cd07845 253 NNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESS 291 (309)
T ss_pred CchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 00 0001234677999999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=248.76 Aligned_cols=250 Identities=21% Similarity=0.265 Sum_probs=184.1
Q ss_pred cceEEEEcC-CCcEEEEEEeecCCc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 3 VAICQGRLP-NGQEMAVKRLSRTSH-QGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 3 ~~~~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
+.+|++... +|+.||||.++.... .....+..|+.++++++|+||+++++++...+..++||||+.+ +|.+++....
T Consensus 14 ~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~ 92 (284)
T cd07836 14 ATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHG 92 (284)
T ss_pred eEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcC
Confidence 357888764 789999999875532 2345677899999999999999999999999999999999975 7888775544
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCC
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYV 160 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 160 (309)
....+++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||.+......... .....++..|+
T Consensus 93 ~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~y~ 167 (284)
T cd07836 93 VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT--FSNEVVTLWYR 167 (284)
T ss_pred CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc--ccccccccccc
Confidence 445689999999999999999999998 8999999999999999999999999998654332211 11234677899
Q ss_pred CccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHH--------HHHhhCCCCcccccccCC-----
Q 021682 161 PPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYA--------YGLWKNGEGMEFIDSSLD----- 226 (309)
Q Consensus 161 aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~----- 226 (309)
+||.+.+. .++.++|+||||+++|++++|..||...+..+........ +..+.. ...+......
T Consensus 168 ~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 245 (284)
T cd07836 168 APDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ--LPEYKPTFPRYPPQD 245 (284)
T ss_pred ChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc--CchhcccccCCChHH
Confidence 99987654 5688999999999999999999998654432211111100 000000 0000000000
Q ss_pred -CcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021682 227 -DSSSAWKLMRCMQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 227 -~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
..........+.+++.+||+.||.+|||+.++++
T Consensus 246 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 246 LQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred HHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0001122346789999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=256.71 Aligned_cols=246 Identities=22% Similarity=0.250 Sum_probs=177.7
Q ss_pred ceEEEE-cCCCcEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeeEEeeC------CeeEEEEeccCCCChhH
Q 021682 4 AICQGR-LPNGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQR------EEKMLIYDYMPNKSLDF 74 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~~L~~ 74 (309)
.||.+. ..+|+.||||.+... .......+..|+.++++++|+||+++++++... ...++||||+. ++|.+
T Consensus 31 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~ 109 (353)
T cd07850 31 IVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQ 109 (353)
T ss_pred EEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccC-CCHHH
Confidence 455554 458999999998643 233345677899999999999999999987643 35799999996 47777
Q ss_pred HHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccc
Q 021682 75 YIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIV 154 (309)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~ 154 (309)
.+.. . ++...+..++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 110 ~~~~---~--l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~ 178 (353)
T cd07850 110 VIQM---D--LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYV 178 (353)
T ss_pred HHhh---c--CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccceeCCCCCC---CCCCc
Confidence 6632 1 78889999999999999999998 999999999999999999999999999876543321 12235
Q ss_pred cccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHH---------------HHH-HhhCCC--
Q 021682 155 GTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEY---------------AYG-LWKNGE-- 216 (309)
Q Consensus 155 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~---------------~~~-~~~~~~-- 216 (309)
++..|+|||.+.+..++.++|||||||++|+|++|..||...+.......+.. ... ......
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (353)
T cd07850 179 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKY 258 (353)
T ss_pred ccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCC
Confidence 67889999999998999999999999999999999999864432111110000 000 000000
Q ss_pred ----Cccccccc----CCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 217 ----GMEFIDSS----LDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 217 ----~~~~~~~~----~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
..+.+... ............+.++|.+||+.||++|||+.|+++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 259 AGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred CCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000 0000011234467899999999999999999999976
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=246.77 Aligned_cols=236 Identities=17% Similarity=0.167 Sum_probs=176.2
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCcc---cHHHHHHHHHH-HhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSHQ---GLEEFENEVKL-TARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~~---~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
+.+|++.. .+|+.||+|.++..... ....+..|..+ .....|+|++++++++..++..++|+||+.+++|.+++.
T Consensus 10 ~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 89 (260)
T cd05611 10 GSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIK 89 (260)
T ss_pred eeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHH
Confidence 35677754 57899999998654321 12233444444 345589999999999999999999999999999999884
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
. ...+++..+..++.|++.|+.+||+. |++|+||+|.||+++.++.++|+|||++..... .....++.
T Consensus 90 ~---~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~~~ 157 (260)
T cd05611 90 T---LGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVGTP 157 (260)
T ss_pred H---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc------cccCCCCc
Confidence 3 33588999999999999999999998 899999999999999999999999998865332 12235678
Q ss_pred CCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHH
Q 021682 158 GYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRC 237 (309)
Q Consensus 158 ~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (309)
.|++||.+.+..++.++|+||||+++|++++|..||........ . ......... ............+
T Consensus 158 ~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~----~~~~~~~~~------~~~~~~~~~~~~~ 224 (260)
T cd05611 158 DYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV---F----DNILSRRIN------WPEEVKEFCSPEA 224 (260)
T ss_pred CccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH---H----HHHHhcccC------CCCcccccCCHHH
Confidence 89999999887789999999999999999999999854322111 1 111111000 0000111123478
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHh
Q 021682 238 MQVALLCVQENAADRPTMLEILVMLK 263 (309)
Q Consensus 238 ~~li~~~l~~~p~~Rpt~~ell~~L~ 263 (309)
.+++.+||+.+|++|||+.++.+.|.
T Consensus 225 ~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 225 VDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred HHHHHHHccCCHHHccCCCcHHHHHc
Confidence 89999999999999998876666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=245.63 Aligned_cols=234 Identities=21% Similarity=0.219 Sum_probs=174.9
Q ss_pred ceEEEEc-CCCcEEEEEEeecCCc---ccHHHHHHHHHHH---hcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHH
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTSH---QGLEEFENEVKLT---ARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~~---~~~~~~~~e~~~l---~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 76 (309)
.||++.. .+|+.||+|.+..... .....+..|..++ ....|++++.+++.+..++..++||||+.+++|.+++
T Consensus 9 ~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i 88 (279)
T cd05633 9 EVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL 88 (279)
T ss_pred EEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHH
Confidence 5666654 5789999998865421 1122333444333 3347999999999999889999999999999999887
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccc
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGT 156 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 156 (309)
.. ...+++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++....... .....++
T Consensus 89 ~~---~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~ 158 (279)
T cd05633 89 SQ---HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGT 158 (279)
T ss_pred Hh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----ccCcCCC
Confidence 43 33489999999999999999999998 89999999999999999999999999986443221 1123578
Q ss_pred cCCCCccccc-cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 157 YGYVPPEYVR-KGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 157 ~~y~aPE~~~-~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
..|+|||.+. +..++.++|+||+||++|+|++|..||......... ........ .....+.....
T Consensus 159 ~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----~~~~~~~~----------~~~~~~~~~~~ 224 (279)
T cd05633 159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----EIDRMTLT----------VNVELPDSFSP 224 (279)
T ss_pred cCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH----HHHHHhhc----------CCcCCccccCH
Confidence 8999999886 456789999999999999999999998644332211 11111000 00111122334
Q ss_pred HHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 021682 236 RCMQVALLCVQENAADRP-----TMLEILVM 261 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~Rp-----t~~ell~~ 261 (309)
++.++|.+||..||++|| |++++++.
T Consensus 225 ~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 225 ELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred HHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 788999999999999999 69999885
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=253.67 Aligned_cols=240 Identities=18% Similarity=0.203 Sum_probs=178.4
Q ss_pred ceEEEEc-CCCcEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGRL-PNGQEMAVKRLSRT---SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
.||++.. .+++.||+|.+.+. .......+..|+.++..++|++|+++++.+..+...++||||+.+++|.+++...
T Consensus 16 ~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~ 95 (332)
T cd05623 16 EVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKF 95 (332)
T ss_pred EEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHh
Confidence 4566654 46888999998642 1223345788999999999999999999999999999999999999999998542
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
...+++..+..++.|++.|+.+||+. |++||||||+||+++.++.++|+|||++......... ......|+..|
T Consensus 96 --~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~-~~~~~~gt~~y 169 (332)
T cd05623 96 --EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-QSSVAVGTPDY 169 (332)
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCCcc-eecccccCccc
Confidence 33588999999999999999999998 8999999999999999999999999998654322211 12224689999
Q ss_pred CCccccc-----cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHH
Q 021682 160 VPPEYVR-----KGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKL 234 (309)
Q Consensus 160 ~aPE~~~-----~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
+|||.+. ...++.++|+|||||++|+|++|+.||...+..+ .............+.. ......
T Consensus 170 ~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~~~~~~~~~p~------~~~~~s 237 (332)
T cd05623 170 ISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHKERFQFPA------QVTDVS 237 (332)
T ss_pred cCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH------HHHHHhCCCccccCCC------ccccCC
Confidence 9999885 3457889999999999999999999985432211 1111111111111100 001123
Q ss_pred HHHHHHHhhcccCCCCC--CCCHHHHHHH
Q 021682 235 MRCMQVALLCVQENAAD--RPTMLEILVM 261 (309)
Q Consensus 235 ~~l~~li~~~l~~~p~~--Rpt~~ell~~ 261 (309)
..+.+++.+||..+++. |++++++++.
T Consensus 238 ~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 238 EDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 46779999988765444 6899999877
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=248.34 Aligned_cols=241 Identities=24% Similarity=0.322 Sum_probs=178.7
Q ss_pred ceEEEEc-CCCcEEEEEEeecCC-cccHHHHHHHHHHHhcCC-CCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh--
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQ-HVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD-- 78 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-- 78 (309)
.||++.. .+|+.||+|.+.... ......+..|+.++.++. |+||+++++++..+...+++||++. .++.++...
T Consensus 19 ~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~-~~l~~l~~~~~ 97 (288)
T cd06616 19 TVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD-ISLDKFYKYVY 97 (288)
T ss_pred EEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-CCHHHHHHHHH
Confidence 4566654 578999999986543 334567889999999995 9999999999998889999999985 455544321
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
......+++..+..++.+++.|++|||+.. |++||||+|+||+++.++.++|+|||++......... ....++..
T Consensus 98 ~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~ 172 (288)
T cd06616 98 EVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK---TRDAGCRP 172 (288)
T ss_pred HhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccCCcc---ccccCccC
Confidence 122355899999999999999999999744 8999999999999999999999999998655432211 12256788
Q ss_pred CCCccccccC---CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 159 YVPPEYVRKG---IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 159 y~aPE~~~~~---~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
|+|||.+.+. .++.++|+||||+++|+|++|..||.... ......... ....... .........+.
T Consensus 173 y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~-~~~~~~~-----~~~~~~~~~~~ 241 (288)
T cd06616 173 YMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQV-VKGDPPI-----LSNSEEREFSP 241 (288)
T ss_pred ccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhh-cCCCCCc-----CCCcCCCccCH
Confidence 9999998765 68899999999999999999999986432 111111111 1111111 11111122344
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 236 RCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.+.+++.+||+.+|++|||+++++..
T Consensus 242 ~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 242 SFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 78899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=247.74 Aligned_cols=238 Identities=23% Similarity=0.289 Sum_probs=179.5
Q ss_pred ceEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCCccceeeEEeeC-----CeeEEEEeccCCCChhHHH
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLTARL-QHVNLLPVLGICTQR-----EEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~ 76 (309)
.+|++.. .+|+.+|+|.+.... .....+..|+.+++++ +|+|++++++++... ...++||||+++++|.+++
T Consensus 37 ~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~ 115 (291)
T cd06639 37 KVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV 115 (291)
T ss_pred EEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHH
Confidence 5677665 578999999986432 2345678899999998 899999999998754 3589999999999999887
Q ss_pred hhh-ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccc
Q 021682 77 FDL-RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVG 155 (309)
Q Consensus 77 ~~~-~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 155 (309)
... .....+++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||.+......... .....+
T Consensus 116 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~ 190 (291)
T cd06639 116 KGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVG 190 (291)
T ss_pred HHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeecccchhccccccc--ccCccC
Confidence 532 2344589999999999999999999998 8999999999999999999999999998655432211 122357
Q ss_pred ccCCCCccccccC-----CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCccc
Q 021682 156 TYGYVPPEYVRKG-----IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSS 230 (309)
Q Consensus 156 ~~~y~aPE~~~~~-----~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (309)
+..|+|||.+... .++.++|+|||||++|+|++|+.||........ ... +.......... .
T Consensus 191 ~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~------~~~-~~~~~~~~~~~-------~ 256 (291)
T cd06639 191 TPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT------LFK-IPRNPPPTLLH-------P 256 (291)
T ss_pred CccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH------HHH-HhcCCCCCCCc-------c
Confidence 7889999987543 357899999999999999999999864322111 111 11111111100 1
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 231 AWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 231 ~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
......+.++|.+||+.+|++||++.++++.
T Consensus 257 ~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 257 EKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred cccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1123368899999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=247.01 Aligned_cols=234 Identities=21% Similarity=0.314 Sum_probs=183.9
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
+.||++.. .+++.||||.+.... ......+.+|+..+++++|+||+++++++..+...++||||+.+++|..++.
T Consensus 18 ~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~--- 94 (277)
T cd06641 18 GEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE--- 94 (277)
T ss_pred eEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHh---
Confidence 46777764 578999999875432 3334678899999999999999999999999999999999999999998873
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCC
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYV 160 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 160 (309)
...+++..+..++.+++.++.+||+. |++|+||+|+||+++.++.++|+|||++........ ......++..|+
T Consensus 95 -~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~ 168 (277)
T cd06641 95 -PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNTFVGTPFWM 168 (277)
T ss_pred -cCCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh--hhccccCCcccc
Confidence 23478999999999999999999998 999999999999999999999999998865543221 122235678899
Q ss_pred CccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHH
Q 021682 161 PPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQV 240 (309)
Q Consensus 161 aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 240 (309)
|||.+.+..++.++|+|||||++|++++|..||....... .... ...... . .. .......+.++
T Consensus 169 ~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------~~~~-~~~~~~-~----~~----~~~~~~~~~~~ 232 (277)
T cd06641 169 APEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK------VLFL-IPKNNP-P----TL----EGNYSKPLKEF 232 (277)
T ss_pred ChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH------HHHH-HhcCCC-C----CC----CcccCHHHHHH
Confidence 9999988888999999999999999999999985432211 0100 111110 0 01 11123468899
Q ss_pred HhhcccCCCCCCCCHHHHHHH
Q 021682 241 ALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 241 i~~~l~~~p~~Rpt~~ell~~ 261 (309)
+.+||+.+|++||++.++++.
T Consensus 233 i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 233 VEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HHHHccCChhhCcCHHHHHhC
Confidence 999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=283.63 Aligned_cols=247 Identities=23% Similarity=0.392 Sum_probs=188.4
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
+.||+|.. .+|..||||.+...... ...|++.+++++||||+++++++..+...++||||+++++|.+++.
T Consensus 704 g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~---- 775 (968)
T PLN00113 704 GASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR---- 775 (968)
T ss_pred eeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh----
Confidence 46788875 58999999998643321 2356889999999999999999999999999999999999999983
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP 161 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 161 (309)
.+++..+..++.+++.|++|||..+.++++||||||+||+++.++..++. ++.+..... .....++..|+|
T Consensus 776 --~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~a 846 (968)
T PLN00113 776 --NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFISSAYVA 846 (968)
T ss_pred --cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc------CCCccccccccC
Confidence 17888999999999999999996656699999999999999988877764 444322211 112257889999
Q ss_pred ccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCC--CcccHHHHHHHHH
Q 021682 162 PEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLD--DSSSAWKLMRCMQ 239 (309)
Q Consensus 162 PE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~ 239 (309)
||.+.+..++.++|||||||++|||++|+.||..... .......+.............+++... .........++.+
T Consensus 847 PE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 925 (968)
T PLN00113 847 PETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMN 925 (968)
T ss_pred cccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHH
Confidence 9999988999999999999999999999999843221 222233333332222222233333322 1233445567889
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHhcccC
Q 021682 240 VALLCVQENAADRPTMLEILVMLKSETA 267 (309)
Q Consensus 240 li~~~l~~~p~~Rpt~~ell~~L~~~~~ 267 (309)
++.+||+.+|++|||++|+++.|+++..
T Consensus 926 l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 926 LALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred HHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 9999999999999999999999998755
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=250.69 Aligned_cols=233 Identities=25% Similarity=0.313 Sum_probs=178.0
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
+.+|.+.. .+|+.||+|.+.... ......+.+|+++++.++||||+++++++..+...++|+||+. +++.+++..
T Consensus 29 g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~ 107 (307)
T cd06607 29 GAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEV 107 (307)
T ss_pred eEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHH
Confidence 35677764 479999999986432 2234568899999999999999999999999999999999997 466666532
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
....+++..+..++.|++.++.|||+. |++|+||+|+||+++.++.++|+|||++...... ....++..
T Consensus 108 --~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~------~~~~~~~~ 176 (307)
T cd06607 108 --HKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA------NSFVGTPY 176 (307)
T ss_pred --cccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC------CCccCCcc
Confidence 233589999999999999999999998 8999999999999999999999999988654322 12356778
Q ss_pred CCCccccc---cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 159 YVPPEYVR---KGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 159 y~aPE~~~---~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
|+|||.+. ...++.++||||||+++|+|++|..||...+... ..... ....... ........
T Consensus 177 y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~------~~~~~-~~~~~~~--------~~~~~~~~ 241 (307)
T cd06607 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHI-AQNDSPT--------LSSNDWSD 241 (307)
T ss_pred ccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH------HHHHH-hcCCCCC--------CCchhhCH
Confidence 99999874 3567889999999999999999999975322111 11110 0000000 01112334
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHH
Q 021682 236 RCMQVALLCVQENAADRPTMLEILVML 262 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~Rpt~~ell~~L 262 (309)
.+.+++.+||+.+|++|||+.+++...
T Consensus 242 ~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 242 YFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 688999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=249.69 Aligned_cols=237 Identities=25% Similarity=0.298 Sum_probs=180.6
Q ss_pred ceEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
.+|++.. .+|+.||+|.+.... ......+..|++++++++|+|++++++++..+...++||||+.+ ++.+.+..
T Consensus 40 ~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~- 117 (317)
T cd06635 40 AVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEV- 117 (317)
T ss_pred EEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCC-CHHHHHHH-
Confidence 5677764 578999999986442 22345688899999999999999999999999999999999975 67666533
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
....+++..+..++.+++.++.+||+. |++|+||+|+||+++.++.++|+|||++...... ....++..|
T Consensus 118 -~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~y 187 (317)
T cd06635 118 -HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA------NSFVGTPYW 187 (317)
T ss_pred -hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc------ccccCCccc
Confidence 234588999999999999999999998 8999999999999999999999999987543321 123577889
Q ss_pred CCccccc---cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHH
Q 021682 160 VPPEYVR---KGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMR 236 (309)
Q Consensus 160 ~aPE~~~---~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
+|||.+. ...++.++|+|||||++|+|++|..||....... .. ..+....... .........
T Consensus 188 ~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~------~~-~~~~~~~~~~--------~~~~~~~~~ 252 (317)
T cd06635 188 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------AL-YHIAQNESPT--------LQSNEWSDY 252 (317)
T ss_pred cChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH------HH-HHHHhccCCC--------CCCccccHH
Confidence 9999873 4567899999999999999999999975321111 01 1111111000 011112336
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHHHhcccC
Q 021682 237 CMQVALLCVQENAADRPTMLEILVMLKSETA 267 (309)
Q Consensus 237 l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~ 267 (309)
+.+++.+||+.+|++|||+.++++.+.....
T Consensus 253 l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 253 FRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred HHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 7899999999999999999999987665433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=249.37 Aligned_cols=251 Identities=20% Similarity=0.243 Sum_probs=180.8
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
+.+|++.. .+|+.||+|.+.... ......+.+|++++++++|+|++++++++..+...+++|||+. ++|..++...
T Consensus 13 ~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~ 91 (283)
T cd07835 13 GVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSS 91 (283)
T ss_pred eEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhC
Confidence 45788765 479999999986543 2223567889999999999999999999999999999999995 6888887432
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
. ...+++..+..++.|++.++++||+. |++|+||+|+||+++.++.++|+|||.+......... .....++..|
T Consensus 92 ~-~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~ 165 (283)
T cd07835 92 P-LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT--YTHEVVTLWY 165 (283)
T ss_pred C-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc--cCccccccCC
Confidence 2 23589999999999999999999998 8999999999999999999999999998654332211 1122457889
Q ss_pred CCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH-----HhhC-CCCccc---cccc---CC
Q 021682 160 VPPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYG-----LWKN-GEGMEF---IDSS---LD 226 (309)
Q Consensus 160 ~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~-----~~~~-~~~~~~---~~~~---~~ 226 (309)
+|||.+.+. .++.++|+||||+++|+|++|.+||...+............. .|.. .....+ +... ..
T Consensus 166 ~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (283)
T cd07835 166 RAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDL 245 (283)
T ss_pred CCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccch
Confidence 999987664 568899999999999999999999864332111100000000 0000 000000 0000 00
Q ss_pred CcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021682 227 DSSSAWKLMRCMQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 227 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
..........+.++|.+||+.+|++|||++++++
T Consensus 246 ~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 246 SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0001112247889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=258.49 Aligned_cols=242 Identities=21% Similarity=0.335 Sum_probs=197.3
Q ss_pred cceEEEEcCC---Cc--EEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHH
Q 021682 3 VAICQGRLPN---GQ--EMAVKRLSRT-SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 3 ~~~~~~~~~~---g~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 76 (309)
+.||.|.+-+ |+ .||||.-+.+ ...+.+.|+.|..+++++.||||++++++|.+ ...+||||+++-|-|..|+
T Consensus 403 GdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmEL~~~GELr~yL 481 (974)
T KOG4257|consen 403 GDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVMELAPLGELREYL 481 (974)
T ss_pred cceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEecccchhHHHHH
Confidence 4678888743 33 3788876653 45568899999999999999999999999885 4689999999999999999
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccc
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGT 156 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 156 (309)
.. +...++......+++||+.|++|||+. .++||||-..||++....-+||+|||+++........... ...-+
T Consensus 482 q~--nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS-~~kLP 555 (974)
T KOG4257|consen 482 QQ--NKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKAS-RGKLP 555 (974)
T ss_pred Hh--ccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhccccchhhcc-ccccc
Confidence 54 344589999999999999999999999 8999999999999999999999999999887665433222 23456
Q ss_pred cCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 157 YGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
..|||||-+....++.++|||-||+++||+++ |..||..-...+ ....++.......++.++.
T Consensus 556 IKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD----------------VI~~iEnGeRlP~P~nCPp 619 (974)
T KOG4257|consen 556 IKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD----------------VIGHIENGERLPCPPNCPP 619 (974)
T ss_pred eeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc----------------eEEEecCCCCCCCCCCCCh
Confidence 78999999999999999999999999999987 888986543333 2223333444555666677
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHHhcccC
Q 021682 236 RCMQVALLCVQENAADRPTMLEILVMLKSETA 267 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~ 267 (309)
.|+.+..+||.++|.+||++.++...|+.+.+
T Consensus 620 ~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 620 ALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred HHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 99999999999999999999999988755443
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=287.99 Aligned_cols=240 Identities=24% Similarity=0.305 Sum_probs=193.5
Q ss_pred CccceEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 1 MSVAICQGRLPNGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 1 ~g~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
||-|.-++..++|+..|+|.++..+ ......+.+|+.++..++|||+|+.|++-...+..+|.||||.+|+|.+.+.
T Consensus 1248 fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~- 1326 (1509)
T KOG4645|consen 1248 FGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLE- 1326 (1509)
T ss_pred eeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHH-
Confidence 5666666667899999999886543 3334567899999999999999999999999999999999999999999984
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcc--cccccccccc
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDEC--EANTGRIVGT 156 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~ 156 (309)
.+...++.....+..|++.|++|||++ ||+||||||.||+++.+|.+|++|||.|........ .......+||
T Consensus 1327 --~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT 1401 (1509)
T KOG4645|consen 1327 --HGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGT 1401 (1509)
T ss_pred --hcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCC
Confidence 344478888888999999999999998 999999999999999999999999999987765521 1223346899
Q ss_pred cCCCCccccccCC---CCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHH
Q 021682 157 YGYVPPEYVRKGI---YSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWK 233 (309)
Q Consensus 157 ~~y~aPE~~~~~~---~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
+.|||||.+.+.. -..++|||||||++.||.||+.||...+.. +....+...+..+++... .
T Consensus 1402 ~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne------~aIMy~V~~gh~Pq~P~~---------l 1466 (1509)
T KOG4645|consen 1402 PMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE------WAIMYHVAAGHKPQIPER---------L 1466 (1509)
T ss_pred chhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch------hHHHhHHhccCCCCCchh---------h
Confidence 9999999997643 467899999999999999999998644332 223334444444444332 3
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 234 LMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 234 ~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
+.+-.++|..||+.||+.|.++.||++.
T Consensus 1467 s~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1467 SSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred hHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 3466799999999999999999988865
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=244.07 Aligned_cols=237 Identities=22% Similarity=0.268 Sum_probs=184.2
Q ss_pred cceEEEEcC-CCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 3 VAICQGRLP-NGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 3 ~~~~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
+.+|++..+ +|..||+|.+.... ....+.+.+|+.++++++|+||+++++.+..+...++|+||+.+++|.+++...
T Consensus 14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 93 (257)
T cd08225 14 GKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQ 93 (257)
T ss_pred ceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhc
Confidence 467887764 68999999986542 234567889999999999999999999999999999999999999999988542
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCC-ceeecccccccccCCcccccccccccccC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMN-PKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~-~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
....+++..+..++.+++.|+.+||+. +++|+||+|.||+++.++. ++|+|||.+......... .....++..
T Consensus 94 -~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~ 167 (257)
T cd08225 94 -RGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL--AYTCVGTPY 167 (257)
T ss_pred -cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCccc--ccccCCCcc
Confidence 233478999999999999999999998 8999999999999998864 699999988765433211 122357888
Q ss_pred CCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHH
Q 021682 159 YVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238 (309)
Q Consensus 159 y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (309)
|+|||.+.+..++.++|+||||++++++++|..||....... ...... ....... .......+.
T Consensus 168 ~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~-~~~~~~~---------~~~~~~~~~ 231 (257)
T cd08225 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ------LVLKIC-QGYFAPI---------SPNFSRDLR 231 (257)
T ss_pred ccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHh-cccCCCC---------CCCCCHHHH
Confidence 999999988888999999999999999999999985332111 111111 1111110 111223788
Q ss_pred HHHhhcccCCCCCCCCHHHHHHH
Q 021682 239 QVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 239 ~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
+++.+||..+|++|||+.+++..
T Consensus 232 ~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 232 SLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred HHHHHHhccChhhCcCHHHHhhC
Confidence 99999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=247.83 Aligned_cols=247 Identities=21% Similarity=0.233 Sum_probs=184.0
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSH--QGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
+.+|++.. .+|+.+++|.+..... .....+..|+.++++++|++|+++++++..+...++|+||+.+ ++..++...
T Consensus 13 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~ 91 (283)
T cd05118 13 GVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDR 91 (283)
T ss_pred ceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhh
Confidence 35677765 4799999999865432 2456788899999999999999999999999999999999975 777776432
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
...+++..+..++.+++.++.+||+. |++|+||+|+||+++.++.++|+|||.+........ ......++..|
T Consensus 92 --~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~ 164 (283)
T cd05118 92 --QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR--PYTHYVVTRWY 164 (283)
T ss_pred --cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc--cccCccCcccc
Confidence 24589999999999999999999998 899999999999999999999999999876654331 11223567789
Q ss_pred CCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCC---CCc-----------cccccc
Q 021682 160 VPPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNG---EGM-----------EFIDSS 224 (309)
Q Consensus 160 ~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~-----------~~~~~~ 224 (309)
+|||.+.+. .++.++|+||||+++|++++|+.||...+..+..... ....... ... .+....
T Consensus 165 ~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (283)
T cd05118 165 RAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKI---FRTLGTPDPEVWPKFTSLARNYKFSFPKKA 241 (283)
T ss_pred cCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHcCCCchHhcccchhhhhhhhhhhcccc
Confidence 999988776 7889999999999999999999998654332211111 1110000 000 000000
Q ss_pred CC--CcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021682 225 LD--DSSSAWKLMRCMQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 225 ~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
.. .........++.++|.+||+.||.+||++++++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 242 GMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred ccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00 0011123457889999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=251.66 Aligned_cols=250 Identities=17% Similarity=0.180 Sum_probs=190.4
Q ss_pred CccceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCC--CC----CccceeeEEeeCCeeEEEEeccCCCChhH
Q 021682 1 MSVAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQ--HV----NLLPVLGICTQREEKMLIYDYMPNKSLDF 74 (309)
Q Consensus 1 ~g~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~----~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (309)
||.|+---+..++..||||+++.. ...+++.+-|+++|.++. .| .++++.++|+..++.|||+|.+ |.++.+
T Consensus 102 FGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~d 179 (415)
T KOG0671|consen 102 FGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFD 179 (415)
T ss_pred ccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-ChhHHH
Confidence 566664444446899999999654 445678889999999993 22 3777888999999999999998 678999
Q ss_pred HHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCC--------------------CCCceeec
Q 021682 75 YIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY--------------------EMNPKISD 134 (309)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~--------------------~~~~~l~D 134 (309)
++.. +.-.+++...++.+++|+++++++||+. +++|.||||+||++.+ +..++++|
T Consensus 180 Flk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vID 255 (415)
T KOG0671|consen 180 FLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVID 255 (415)
T ss_pred Hhcc-CCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEe
Confidence 9854 3455699999999999999999999999 8999999999999932 33489999
Q ss_pred ccccccccCCcccccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhC
Q 021682 135 FGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKN 214 (309)
Q Consensus 135 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 214 (309)
||.|+.-.... ...+.|..|.|||++.+-+++.++||||+||||+|+.+|...|...+..+....++...+....
T Consensus 256 FGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~ 330 (415)
T KOG0671|consen 256 FGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPS 330 (415)
T ss_pred cCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcH
Confidence 99997654433 3346789999999999999999999999999999999999999887766655544443321111
Q ss_pred CCC-----cccc-----c------------------cc-CCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 215 GEG-----MEFI-----D------------------SS-LDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 215 ~~~-----~~~~-----~------------------~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.-. .+++ + +. ........+...|.||+++||.+||.+|+|+.|+++.
T Consensus 331 ~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 331 RMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred HHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcC
Confidence 000 0000 0 00 0112223355689999999999999999999999864
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=238.25 Aligned_cols=237 Identities=21% Similarity=0.273 Sum_probs=187.4
Q ss_pred ceEEEEc-CCCcEEEEEEeecCCc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTSH--QGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
.+|++.. ++++.||+|.+..... .....+..|++.++.++|+|++++.+.+..+...++|+|++++++|.+++....
T Consensus 15 ~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 94 (258)
T cd08215 15 KVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQK 94 (258)
T ss_pred EEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhh
Confidence 5566654 4789999999875532 456678899999999999999999999999999999999999999999885432
Q ss_pred -cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 81 -RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 81 -~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
....+++..+..++.+++.++.+||+. |++|+||+|+||+++.++.++|+|||.+........ ......++..|
T Consensus 95 ~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y 169 (258)
T cd08215 95 KEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD--LAKTVVGTPYY 169 (258)
T ss_pred ccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCcc--eecceeeeecc
Confidence 135689999999999999999999998 999999999999999999999999999876544331 12234678899
Q ss_pred CCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHH
Q 021682 160 VPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQ 239 (309)
Q Consensus 160 ~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (309)
+|||...+..++.++|+||+|+++++|++|..||...+... .. ..........+ +......+.+
T Consensus 170 ~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~-~~~~~~~~~~~---------~~~~~~~~~~ 233 (258)
T cd08215 170 LSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE------LA-LKILKGQYPPI---------PSQYSSELRN 233 (258)
T ss_pred cChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH------HH-HHHhcCCCCCC---------CCCCCHHHHH
Confidence 99999888888999999999999999999999985443211 11 11111111111 1112347889
Q ss_pred HHhhcccCCCCCCCCHHHHHHH
Q 021682 240 VALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 240 li~~~l~~~p~~Rpt~~ell~~ 261 (309)
++.+||..+|++|||+.++++.
T Consensus 234 ~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 234 LVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred HHHHHcCCChhhCcCHHHHhcC
Confidence 9999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=242.44 Aligned_cols=236 Identities=24% Similarity=0.272 Sum_probs=187.0
Q ss_pred cceEEEE-cCCCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 3 VAICQGR-LPNGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 3 ~~~~~~~-~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
+.+|++. ..+|+.+|+|.+.... ......+..|++++++++|+||+++++++..+...++|+||+++++|..++...
T Consensus 14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~ 93 (256)
T cd08530 14 GSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKR 93 (256)
T ss_pred eeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHH
Confidence 3566664 4578999999986542 334567788999999999999999999999999999999999999999988552
Q ss_pred c-cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 80 R-RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 80 ~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
. .+..+++..+..++.+++.|+++||+. |++|+||+|.||+++.++.++|+|||.+....... .....++..
T Consensus 94 ~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~----~~~~~~~~~ 166 (256)
T cd08530 94 KKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNM----AKTQIGTPH 166 (256)
T ss_pred HhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccCC----cccccCCcc
Confidence 2 235588899999999999999999998 89999999999999999999999999987665441 112356789
Q ss_pred CCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHH
Q 021682 159 YVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238 (309)
Q Consensus 159 y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (309)
|+|||.+.+..++.++|+||||+++|++++|..||...+... ........... .........+.
T Consensus 167 ~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~---------~~~~~~~~~~~ 230 (256)
T cd08530 167 YMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD-------LRYKVQRGKYP---------PIPPIYSQDLQ 230 (256)
T ss_pred ccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhcCCCC---------CCchhhCHHHH
Confidence 999999988888999999999999999999999986433211 11111111111 11123345788
Q ss_pred HHHhhcccCCCCCCCCHHHHHHH
Q 021682 239 QVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 239 ~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
+++.+||+.+|++|||+.++++.
T Consensus 231 ~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 231 NFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred HHHHHHcCCCcccCCCHHHHhcC
Confidence 99999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=248.60 Aligned_cols=249 Identities=18% Similarity=0.190 Sum_probs=178.6
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC--cccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCe-----eEEEEeccCCCChh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS--HQGLEEFENEVKLTARL-QHVNLLPVLGICTQREE-----KMLIYDYMPNKSLD 73 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~-----~~lv~e~~~~~~L~ 73 (309)
+.||++.. .+|+.||||.+.... ......+.+|+.+++.+ +|+||+++++++..... .++||||+.+ +|.
T Consensus 15 g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~ 93 (295)
T cd07837 15 GKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLK 93 (295)
T ss_pred eEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHH
Confidence 45788875 479999999876542 22345678899999999 56999999999877665 8999999975 788
Q ss_pred HHHhhhcc--ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCC-CCCceeecccccccccCCcccccc
Q 021682 74 FYIFDLRR--RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY-EMNPKISDFGMARAFTKDECEANT 150 (309)
Q Consensus 74 ~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~-~~~~~l~Dfg~~~~~~~~~~~~~~ 150 (309)
+++..... ...+++..++.++.||+.|+.|||+. |++|+||+|+||+++. ++.++|+|||++......... .
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~--~ 168 (295)
T cd07837 94 KFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS--Y 168 (295)
T ss_pred HHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecccceecCCCccc--c
Confidence 87754322 34589999999999999999999998 8999999999999998 889999999998654332211 1
Q ss_pred cccccccCCCCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCc------cc---
Q 021682 151 GRIVGTYGYVPPEYVRK-GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGM------EF--- 220 (309)
Q Consensus 151 ~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~~--- 220 (309)
....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||........... ........... ..
T Consensus 169 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 245 (295)
T cd07837 169 THEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLH---IFKLLGTPTEQVWPGVSKLRDW 245 (295)
T ss_pred CCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH---HHHHhCCCChhhCcchhhccch
Confidence 12245778999998765 4578999999999999999999999864332211110 00100000000 00
Q ss_pred --ccccC---CCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021682 221 --IDSSL---DDSSSAWKLMRCMQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 221 --~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
..... .....+.....+.++|.+||..||++|||+++++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 246 HEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00000 00000113346889999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=261.41 Aligned_cols=235 Identities=23% Similarity=0.335 Sum_probs=182.8
Q ss_pred cceEEEEc-CCCcEEEEEEee----cCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCe--eEEEEeccCCCChhHH
Q 021682 3 VAICQGRL-PNGQEMAVKRLS----RTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREE--KMLIYDYMPNKSLDFY 75 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~----~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--~~lv~e~~~~~~L~~~ 75 (309)
.+||+|.. .+|-.||=-.++ ...+...++|..|+.+|+.|+|+||+++|+++.+... +.+|+|++.+|+|..|
T Consensus 54 KtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y 133 (632)
T KOG0584|consen 54 KTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREY 133 (632)
T ss_pred eeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHH
Confidence 35777753 356666522221 1234556899999999999999999999999987654 8899999999999999
Q ss_pred HhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCC-CCceeecccccccccCCcccccccccc
Q 021682 76 IFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYE-MNPKISDFGMARAFTKDECEANTGRIV 154 (309)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~~~ 154 (309)
+...++ ++...+..|+.||++||.|||++ .+.|+|||||.+||||+.+ |.|||+|+|+|......... ...
T Consensus 134 ~kk~~~---vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ak----svI 205 (632)
T KOG0584|consen 134 RKKHRR---VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHAK----SVI 205 (632)
T ss_pred HHHhcc---CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccccc----eec
Confidence 865444 88889999999999999999997 5689999999999999876 88999999999876554322 257
Q ss_pred cccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHH
Q 021682 155 GTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKL 234 (309)
Q Consensus 155 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
||+.|||||.+. ..|+...||||||++++||+|+..||.-.... ...+++...+.-+..+. .-..
T Consensus 206 GTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~------AQIYKKV~SGiKP~sl~--------kV~d 270 (632)
T KOG0584|consen 206 GTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP------AQIYKKVTSGIKPAALS--------KVKD 270 (632)
T ss_pred cCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH------HHHHHHHHcCCCHHHhh--------ccCC
Confidence 999999999986 78899999999999999999999997533221 22233333222222111 1123
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 235 MRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 235 ~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.++.+||.+||.. .++|||+.|||..
T Consensus 271 Pevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 271 PEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred HHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 3788999999999 9999999999964
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=254.83 Aligned_cols=252 Identities=21% Similarity=0.286 Sum_probs=181.0
Q ss_pred ceEEEEc-CCCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEee----CCeeEEEEeccCCCChhHHH
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQ----REEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~~ 76 (309)
.+|.+.. .+|+.||+|.+.... ......+..|+.++++++|+||+++++++.. ....++||||+. ++|..++
T Consensus 20 ~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~ 98 (334)
T cd07855 20 VVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHII 98 (334)
T ss_pred EEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHh
Confidence 5677764 579999999986542 2345677889999999999999999988753 346899999995 5787776
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccc--ccccccc
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECE--ANTGRIV 154 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~ 154 (309)
. ....+++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++......... .......
T Consensus 99 ~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 172 (334)
T cd07855 99 H---SDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172 (334)
T ss_pred c---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCccccccc
Confidence 3 334489999999999999999999998 8999999999999999999999999998665433221 1112346
Q ss_pred cccCCCCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHH--------hhCCCCccccc---
Q 021682 155 GTYGYVPPEYVRK-GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGL--------WKNGEGMEFID--- 222 (309)
Q Consensus 155 ~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~--- 222 (309)
++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+............+. ...........
T Consensus 173 ~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 252 (334)
T cd07855 173 ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLP 252 (334)
T ss_pred ccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcc
Confidence 7889999998765 45789999999999999999999998654332211111100000 00000000000
Q ss_pred ccCCCc---ccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 021682 223 SSLDDS---SSAWKLMRCMQVALLCVQENAADRPTMLEILVML 262 (309)
Q Consensus 223 ~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L 262 (309)
...... .....+..+.++|.+||+.+|++|||+++++..-
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 253 RKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred cCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 000000 0011245788999999999999999999999863
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=246.73 Aligned_cols=238 Identities=20% Similarity=0.293 Sum_probs=176.2
Q ss_pred ceEEEEc-CCCcEEEEEEeecCC-cccHHHHHHHHHH-HhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh-
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTS-HQGLEEFENEVKL-TARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL- 79 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~- 79 (309)
.||++.. .+|+.||+|.++... ......+..|+.. ++.+.|+||+++++++..+...+++|||++ ++|.+++...
T Consensus 16 ~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~ 94 (283)
T cd06617 16 VVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVY 94 (283)
T ss_pred EEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhc
Confidence 5677664 479999999987543 2233455556665 556689999999999999999999999996 5787776542
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
.....+++..++.++.|++.|+.|||++. +++|+||+|+||+++.++.++|+|||.+........ .....++..|
T Consensus 95 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y 169 (283)
T cd06617 95 DKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA---KTIDAGCKPY 169 (283)
T ss_pred cCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccccc---cccccCCccc
Confidence 23456899999999999999999999854 799999999999999999999999999875533211 1223567889
Q ss_pred CCcccccc----CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 160 VPPEYVRK----GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 160 ~aPE~~~~----~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
+|||.+.+ ..++.++|+|||||++|+|++|..||...... . ....... ......+.. ...+.
T Consensus 170 ~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~---~~~~~~~-~~~~~~~~~--------~~~~~ 235 (283)
T cd06617 170 MAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP--F---QQLKQVV-EEPSPQLPA--------EKFSP 235 (283)
T ss_pred cChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC--H---HHHHHHH-hcCCCCCCc--------cccCH
Confidence 99998865 34688999999999999999999998532211 1 1111111 111111110 11234
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 236 RCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.+.++|.+||..+|++|||+.++++.
T Consensus 236 ~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 236 EFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 78899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=245.86 Aligned_cols=249 Identities=18% Similarity=0.207 Sum_probs=177.2
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC-cccHHHHHHHHHHHhcC-CCCCccceeeEEeeC--CeeEEEEeccCCCChhHHHh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS-HQGLEEFENEVKLTARL-QHVNLLPVLGICTQR--EEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~ 77 (309)
+.+|++.. .+++.||+|.++... .........|+..++++ .|+|++++++++.++ +..++||||+.+ ++.+.+.
T Consensus 13 ~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~ 91 (282)
T cd07831 13 SEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIK 91 (282)
T ss_pred ceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCCc-cHHHHHH
Confidence 35777764 578999999986542 22223445788888888 499999999999887 789999999974 7766664
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
. ....+++..+..++.|++.|+.+||+. |++|+||+|+||+++. +.++|+|||.+......... ....++.
T Consensus 92 ~--~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~---~~~~~~~ 162 (282)
T cd07831 92 G--RKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY---TEYISTR 162 (282)
T ss_pred h--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCCc---CCCCCCc
Confidence 3 234589999999999999999999998 8999999999999999 99999999998755433211 1235678
Q ss_pred CCCCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHH--------HHHhhCCCCcccccccCC--
Q 021682 158 GYVPPEYVRK-GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYA--------YGLWKNGEGMEFIDSSLD-- 226 (309)
Q Consensus 158 ~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~-- 226 (309)
.|+|||.+.. ..++.++|+|||||++|+|++|.+||...+..+........ ...........+..+...
T Consensus 163 ~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (282)
T cd07831 163 WYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGT 242 (282)
T ss_pred ccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccc
Confidence 9999997644 45688999999999999999999998654332211100000 000000000000000000
Q ss_pred --CcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 227 --DSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 227 --~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.......+..+.++|.+||+.+|++|||++++++.
T Consensus 243 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 243 GLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00011234588999999999999999999999863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=248.86 Aligned_cols=252 Identities=20% Similarity=0.280 Sum_probs=176.3
Q ss_pred ceEEEEc-CCCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCC--------eeEEEEeccCCCCh
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQRE--------EKMLIYDYMPNKSL 72 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--------~~~lv~e~~~~~~L 72 (309)
.||++.. .+|+.||||.+.... ......+..|++++++++||||+++++++.... ..++||||+.+ +|
T Consensus 27 ~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l 105 (310)
T cd07865 27 EVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DL 105 (310)
T ss_pred EEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCCc-CH
Confidence 5677764 479999999886442 222345678999999999999999999887654 45999999964 77
Q ss_pred hHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccc--ccc
Q 021682 73 DFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECE--ANT 150 (309)
Q Consensus 73 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~--~~~ 150 (309)
.+.+.. ....+++..++.++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++......... ...
T Consensus 106 ~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 180 (310)
T cd07865 106 AGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY 180 (310)
T ss_pred HHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCc
Confidence 776632 233589999999999999999999998 8999999999999999999999999998765433221 111
Q ss_pred cccccccCCCCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHh-----hCCCCccccccc
Q 021682 151 GRIVGTYGYVPPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLW-----KNGEGMEFIDSS 224 (309)
Q Consensus 151 ~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~ 224 (309)
....++..|+|||.+.+. .++.++|+||||+++|+|++|..||................... .........+..
T Consensus 181 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (310)
T cd07865 181 TNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKM 260 (310)
T ss_pred cCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhc
Confidence 223567789999987664 46889999999999999999999986543221111111110000 000000000000
Q ss_pred -CCCc---------ccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 225 -LDDS---------SSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 225 -~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.... ........+.++|.+||..||++|||++++++.
T Consensus 261 ~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 261 ELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred cCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0000 000012356799999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=261.04 Aligned_cols=237 Identities=20% Similarity=0.306 Sum_probs=185.9
Q ss_pred ceEEEEcC-CCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccc
Q 021682 4 AICQGRLP-NGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRR 82 (309)
Q Consensus 4 ~~~~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 82 (309)
.||++..+ ++-.-|-|++...+....+.++-|+++|....||+|+++++.+..++.++|+.|||.||-.+..+...++
T Consensus 47 KVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r- 125 (1187)
T KOG0579|consen 47 KVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGR- 125 (1187)
T ss_pred hhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhcc-
Confidence 45666654 3444567888777777889999999999999999999999999999999999999999999888755444
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCc
Q 021682 83 YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPP 162 (309)
Q Consensus 83 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 162 (309)
.+.+.++.-+++|++.||.|||++ +|+|||||..||+++-+|.++|+|||.+...... ......+.||++||||
T Consensus 126 -~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--~qkRDsFIGTPYWMAP 199 (1187)
T KOG0579|consen 126 -VLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--RQKRDSFIGTPYWMAP 199 (1187)
T ss_pred -ccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhH--HhhhccccCCcccccc
Confidence 499999999999999999999999 8999999999999999999999999988544332 2234457899999999
Q ss_pred cccc-----cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHH
Q 021682 163 EYVR-----KGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRC 237 (309)
Q Consensus 163 E~~~-----~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (309)
|+.. ..+|+.++||||||+.+.+|..+.+|-... +....... .....-..++ .+..-...+
T Consensus 200 EVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel------npMRVllK-iaKSePPTLl-------qPS~Ws~~F 265 (1187)
T KOG0579|consen 200 EVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL------NPMRVLLK-IAKSEPPTLL-------QPSHWSRSF 265 (1187)
T ss_pred hheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc------chHHHHHH-HhhcCCCccc-------CcchhhhHH
Confidence 9764 457899999999999999999999884322 11211111 1111111111 111122367
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHH
Q 021682 238 MQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 238 ~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.|++.+||..||..||++.+|++.
T Consensus 266 ~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 266 SDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred HHHHHHHHhcCCccCCCHHHHhhC
Confidence 899999999999999999999875
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=246.38 Aligned_cols=251 Identities=22% Similarity=0.263 Sum_probs=182.6
Q ss_pred cceEEEEcC-CCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEeeC--CeeEEEEeccCCCChhHHHh
Q 021682 3 VAICQGRLP-NGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQR--EEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 3 ~~~~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~ 77 (309)
+.+|++... +|+.||+|.+.... ......+..|++++++++|+|++++++++... ...++|+||+.+ +|..++.
T Consensus 13 ~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~ 91 (287)
T cd07840 13 GQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLD 91 (287)
T ss_pred eEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccc-cHHHHHh
Confidence 467888754 68999999997653 33345688899999999999999999999888 789999999974 7877764
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
.. ...+++..++.++.++++|+++||+. |++|+||+|+||+++.++.++|+|||.+......... ......++.
T Consensus 92 ~~--~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~ 165 (287)
T cd07840 92 SP--EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA-DYTNRVITL 165 (287)
T ss_pred cc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc-ccccccccc
Confidence 32 24589999999999999999999998 8999999999999999999999999998766543321 112234577
Q ss_pred CCCCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCccc--------cccc----
Q 021682 158 GYVPPEYVRK-GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEF--------IDSS---- 224 (309)
Q Consensus 158 ~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~---- 224 (309)
.|+|||.+.+ ..++.++||||||+++|+|++|..||........................... ....
T Consensus 166 ~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (287)
T cd07840 166 WYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYK 245 (287)
T ss_pred ccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccch
Confidence 8999997765 45789999999999999999999998654432211111110000000000000 0000
Q ss_pred --CCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021682 225 --LDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 225 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
............+.+++.+||+.+|++|||++++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 246 RRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000000001447889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=246.45 Aligned_cols=248 Identities=23% Similarity=0.279 Sum_probs=177.0
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCc-ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSH-QGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
+.||.+.. .+|+.||+|.+..... .....+.+|+.+++.++|+||+++++++..+...++|+||+. +++..++..
T Consensus 19 ~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-- 95 (291)
T cd07870 19 ATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQ-- 95 (291)
T ss_pred EEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHh--
Confidence 35677754 4789999999865432 223467789999999999999999999999999999999996 566665532
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCC
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYV 160 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 160 (309)
....+.+..+..++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++......... .....++..|+
T Consensus 96 ~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~ 170 (291)
T cd07870 96 HPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT--YSSEVVTLWYR 170 (291)
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC--CCCcccccccc
Confidence 223477888889999999999999998 8999999999999999999999999988654322111 12234678999
Q ss_pred CccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhh-----------C-CC-CcccccccCC
Q 021682 161 PPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWK-----------N-GE-GMEFIDSSLD 226 (309)
Q Consensus 161 aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-----------~-~~-~~~~~~~~~~ 226 (309)
|||.+.+. .++.++|+||||+++|+|++|..||....... ......+..+. . .. ..........
T Consensus 171 aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (291)
T cd07870 171 PPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF--EQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKP 248 (291)
T ss_pred CCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH--HHHHHHHHHcCCCChhhhhhhhhcccccchhccccCC
Confidence 99988654 57889999999999999999999986433211 11111111000 0 00 0000000000
Q ss_pred Ccc-----cHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021682 227 DSS-----SAWKLMRCMQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 227 ~~~-----~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
... .......+.+++.+||+.||++|||+.+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 249 QQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000 0001246779999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=263.12 Aligned_cols=238 Identities=24% Similarity=0.398 Sum_probs=193.7
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
++||+|+. .+...+|||.+........+.+.+|+..-++|+|.|||+.++.+..++++-|.||-.+||+|.+++.. .
T Consensus 589 G~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrs--k 666 (1226)
T KOG4279|consen 589 GTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRS--K 666 (1226)
T ss_pred eEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHh--c
Confidence 46788875 46677899999888888889999999999999999999999999999999999999999999999843 3
Q ss_pred ccCC--CHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeC-CCCCceeecccccccccCCcccccccccccccC
Q 021682 82 RYLL--DWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLD-YEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 82 ~~~~--~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
.+++ .+.+.-.+..||++||+|||.+ .|+|||||-+|++++ ..|.+||+|||-++....- ...+..+.||..
T Consensus 667 WGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TETFTGTLQ 741 (1226)
T KOG4279|consen 667 WGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTETFTGTLQ 741 (1226)
T ss_pred cCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccC--Cccccccccchh
Confidence 4445 7888888999999999999999 699999999999995 5799999999988655432 234555789999
Q ss_pred CCCccccccC--CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHH
Q 021682 159 YVPPEYVRKG--IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMR 236 (309)
Q Consensus 159 y~aPE~~~~~--~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
|||||++..+ +|..++|||||||++.||.||++||...+.... ..+.- ..+ ...+..+...+.+
T Consensus 742 YMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--------AMFkV----Gmy--KvHP~iPeelsae 807 (1226)
T KOG4279|consen 742 YMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--------AMFKV----GMY--KVHPPIPEELSAE 807 (1226)
T ss_pred hhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--------hhhhh----cce--ecCCCCcHHHHHH
Confidence 9999998765 689999999999999999999999954333221 00000 011 1223444556668
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 237 CMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 237 l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
...+|.+|+.++|.+||+|.++++-
T Consensus 808 ak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 808 AKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred HHHHHHHHcCCCcccCccHHHhccC
Confidence 8899999999999999999999864
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=234.86 Aligned_cols=239 Identities=19% Similarity=0.296 Sum_probs=182.3
Q ss_pred ccceEEEEcCCCcEEEEEEeecCC-cccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 2 SVAICQGRLPNGQEMAVKRLSRTS-HQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 2 g~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
|.|+-.....+|...|||.+..+. ..+..++..++.++.+- .+|+||+.+++|..+..+.+.||.| +..+..++..
T Consensus 106 G~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s~C~ekLlkr- 183 (391)
T KOG0983|consen 106 GQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-STCAEKLLKR- 183 (391)
T ss_pred cceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-HHHHHHHHHH-
Confidence 444444444579999999997764 44456777888877666 5999999999999999999999999 4567777643
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
...++++..+-++...+++||.||-.+| ||+|||+||+||++|..|++||+|||++....... ......|-+.|
T Consensus 184 -ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk---AhtrsAGC~~Y 257 (391)
T KOG0983|consen 184 -IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK---AHTRSAGCAAY 257 (391)
T ss_pred -hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc---ccccccCCccc
Confidence 3455999999999999999999999999 99999999999999999999999999986554433 33344788899
Q ss_pred CCcccccc---CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHH
Q 021682 160 VPPEYVRK---GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMR 236 (309)
Q Consensus 160 ~aPE~~~~---~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
||||.+.. ..|+-.+||||||+.++||.||+.||...+.. ....-. ..+++. ..++.. ...+..
T Consensus 258 MaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--Fe~ltk---vln~eP--P~L~~~------~gFSp~ 324 (391)
T KOG0983|consen 258 MAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--FEVLTK---VLNEEP--PLLPGH------MGFSPD 324 (391)
T ss_pred cCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--HHHHHH---HHhcCC--CCCCcc------cCcCHH
Confidence 99998854 46788999999999999999999998653221 111111 111111 111111 012347
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 237 CMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 237 l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
+.+++..||+.|+.+||...++++.
T Consensus 325 F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 325 FQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred HHHHHHHHhhcCcccCcchHHHhcC
Confidence 8899999999999999999999875
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=237.38 Aligned_cols=234 Identities=24% Similarity=0.346 Sum_probs=185.7
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSH--QGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
+.+|.+.. .+++.|++|.+..... ...+.+.+|++++++++|++++++++++..++..+++||++++++|.+++...
T Consensus 14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~ 93 (254)
T cd06627 14 GVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKF 93 (254)
T ss_pred eEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhc
Confidence 46777754 4788999999976543 45678899999999999999999999999999999999999999999988443
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
..+++..+..++.+++.++.+||+. |++|+||+|.||+++.++.++|+|||.+......... .....++..|
T Consensus 94 ---~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y 165 (254)
T cd06627 94 ---GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYW 165 (254)
T ss_pred ---cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc--ccccccchhh
Confidence 4589999999999999999999998 8999999999999999999999999998766543321 1223578899
Q ss_pred CCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHH
Q 021682 160 VPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQ 239 (309)
Q Consensus 160 ~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (309)
+|||...+...+.++|+|++|+++|+|++|..||...... ...... ....... + +......+.+
T Consensus 166 ~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~------~~~~~~-~~~~~~~-~--------~~~~~~~~~~ 229 (254)
T cd06627 166 MAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM------AALFRI-VQDDHPP-L--------PEGISPELKD 229 (254)
T ss_pred cCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHH-hccCCCC-C--------CCCCCHHHHH
Confidence 9999988877889999999999999999999998543211 101111 1111111 1 1112347789
Q ss_pred HHhhcccCCCCCCCCHHHHHH
Q 021682 240 VALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 240 li~~~l~~~p~~Rpt~~ell~ 260 (309)
++.+||..+|++|||+.+++.
T Consensus 230 ~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 230 FLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred HHHHHHhCChhhCcCHHHHhc
Confidence 999999999999999999984
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=256.98 Aligned_cols=235 Identities=23% Similarity=0.318 Sum_probs=190.4
Q ss_pred CccceEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 1 MSVAICQGRLPNGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 1 ~g~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
|+.|-.+....+|..||||.+.+.. ...++.+..|+++++.++||||++++.+......+|+||||+.++.+.+++..
T Consensus 69 f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~ 148 (596)
T KOG0586|consen 69 FAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVK 148 (596)
T ss_pred eEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHh
Confidence 4555666666789999999997653 33445688999999999999999999999999999999999999999999965
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
..+ ..+..+..++.|+..|++|||++ +|+|||||.+|++++.+.++||+|||++.++.... ......|++.
T Consensus 149 ~gr---~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~---~lqt~cgspp 219 (596)
T KOG0586|consen 149 HGR---MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL---MLQTFCGSPP 219 (596)
T ss_pred ccc---chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecccc---cccccCCCCC
Confidence 444 55688899999999999999999 89999999999999999999999999998876433 2334578999
Q ss_pred CCCccccccCCC-CccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHH
Q 021682 159 YVPPEYVRKGIY-SMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRC 237 (309)
Q Consensus 159 y~aPE~~~~~~~-~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (309)
|.|||++.+..+ .+..|+||+|+++|.|++|..||+...-.+..... +........ ....++
T Consensus 220 yAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv---------------l~gk~rIp~--~ms~dc 282 (596)
T KOG0586|consen 220 YAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV---------------LRGKYRIPF--YMSCDC 282 (596)
T ss_pred ccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchh---------------eeeeecccc--eeechh
Confidence 999999999876 68899999999999999999999754443322111 111111111 112266
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHH
Q 021682 238 MQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 238 ~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.++|+++|..+|.+|++.+++...
T Consensus 283 e~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 283 EDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred HHHHHHhhccCccccCCHHHhhhh
Confidence 799999999999999999999876
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=270.34 Aligned_cols=247 Identities=25% Similarity=0.393 Sum_probs=198.6
Q ss_pred cceEEEEcC-C---CcEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 3 VAICQGRLP-N---GQEMAVKRLSRT-SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 3 ~~~~~~~~~-~---g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
+-||.|+++ . ...||||-++.. ....+..|..|+.++-++.||||+++.++......+.||+|||++|+|+.++.
T Consensus 643 GEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR 722 (996)
T KOG0196|consen 643 GEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLR 722 (996)
T ss_pred cceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHh
Confidence 357888875 2 356999999765 34456789999999999999999999999999999999999999999999995
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccc-ccccccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECE-ANTGRIVGT 156 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~ 156 (309)
... +.|...++..++..|+.+++||-.. |++||||-.+|||++.|..+|++|||+++....+... ..+....-+
T Consensus 723 ~~D--GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIP 797 (996)
T KOG0196|consen 723 QND--GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIP 797 (996)
T ss_pred hcC--CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccc
Confidence 433 3488888999999999999999988 9999999999999999999999999999876554321 112222346
Q ss_pred cCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 157 YGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
.+|.|||.+...+++.++||||+|+++||.++ |..|+- +...+.... .++....-..+..++.
T Consensus 798 iRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYW--dmSNQdVIk--------------aIe~gyRLPpPmDCP~ 861 (996)
T KOG0196|consen 798 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW--DMSNQDVIK--------------AIEQGYRLPPPMDCPA 861 (996)
T ss_pred eeecChhHhhhcccCchhhccccceEEEEecccCCCccc--ccchHHHHH--------------HHHhccCCCCCCCCcH
Confidence 79999999999999999999999999999887 888863 222222111 1222333334444566
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHHhcccCCCC
Q 021682 236 RCMQVALLCVQENAADRPTMLEILVMLKSETADIK 270 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~~~ 270 (309)
.|.+|+..||+.|-.+||++.+|+..|.++.....
T Consensus 862 aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 862 ALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred HHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence 89999999999999999999999999998865443
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=251.97 Aligned_cols=252 Identities=24% Similarity=0.291 Sum_probs=185.1
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCC-----eeEEEEeccCCCChhH
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQRE-----EKMLIYDYMPNKSLDF 74 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~~L~~ 74 (309)
+.+|++.. .+|+.||||.+.... ....+.+..|+.+++.++|+||+++++++.... ..+++|||+. ++|.+
T Consensus 14 ~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~ 92 (330)
T cd07834 14 GVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHK 92 (330)
T ss_pred eEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHH
Confidence 35677765 468999999986543 334567889999999999999999999987765 7899999997 47877
Q ss_pred HHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccc-cccccc
Q 021682 75 YIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECE-ANTGRI 153 (309)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~ 153 (309)
++.. ...+++..+..++.+++.|+++||+. |++|+||+|.||+++.++.++|+|||.+......... ......
T Consensus 93 ~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~ 166 (330)
T cd07834 93 VIKS---PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEY 166 (330)
T ss_pred HHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeeccccccccccccc
Confidence 7743 33689999999999999999999998 8999999999999999999999999999766543210 112223
Q ss_pred ccccCCCCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHH--------hhCCCCccccccc
Q 021682 154 VGTYGYVPPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGL--------WKNGEGMEFIDSS 224 (309)
Q Consensus 154 ~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~ 224 (309)
.++..|+|||.+.+. .++.++|+||||+++|+|++|.+||...+..+....+...... ........++...
T Consensus 167 ~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (330)
T cd07834 167 VVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSL 246 (330)
T ss_pred ccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhc
Confidence 568889999999887 7899999999999999999999998654432211111100000 0000000010000
Q ss_pred CCCc------ccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 225 LDDS------SSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 225 ~~~~------~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.... ........+.++|.+||+.+|++|||+++++..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 247 PKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred ccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0000 001123467899999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=253.16 Aligned_cols=256 Identities=23% Similarity=0.274 Sum_probs=180.2
Q ss_pred cceEEEE-cCCCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeC-----CeeEEEEeccCCCChhHH
Q 021682 3 VAICQGR-LPNGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQR-----EEKMLIYDYMPNKSLDFY 75 (309)
Q Consensus 3 ~~~~~~~-~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~ 75 (309)
+.||.+. ..+|+.||||.++... ......+..|+.++++++|+||+++++++... ...++|+||+.+ +|..+
T Consensus 19 g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~ 97 (336)
T cd07849 19 GMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKL 97 (336)
T ss_pred eEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhccc-CHHHH
Confidence 4577775 4579999999986432 23345678899999999999999999886544 357999999964 77666
Q ss_pred HhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccc-cccccc
Q 021682 76 IFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEA-NTGRIV 154 (309)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~-~~~~~~ 154 (309)
+. ...+++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++.......... ......
T Consensus 98 ~~----~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 170 (336)
T cd07849 98 IK----TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYV 170 (336)
T ss_pred Hh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcC
Confidence 52 23489999999999999999999998 89999999999999999999999999987654322111 112235
Q ss_pred cccCCCCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHH--------HHHhhCCCCcccccc--
Q 021682 155 GTYGYVPPEYVRK-GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYA--------YGLWKNGEGMEFIDS-- 223 (309)
Q Consensus 155 ~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~-- 223 (309)
++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+........... ............+..
T Consensus 171 ~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (336)
T cd07849 171 ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLP 250 (336)
T ss_pred cCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcC
Confidence 7889999998654 46789999999999999999999998543221110000000 000000000000000
Q ss_pred -cCCCc---ccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--Hhccc
Q 021682 224 -SLDDS---SSAWKLMRCMQVALLCVQENAADRPTMLEILVM--LKSET 266 (309)
Q Consensus 224 -~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~--L~~~~ 266 (309)
..... ........+.+++.+||+.+|++|||+.++++. ++...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 251 FKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred cCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 00000 001123468899999999999999999999987 55443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=245.90 Aligned_cols=237 Identities=25% Similarity=0.291 Sum_probs=179.9
Q ss_pred cceEEEEc-CCCcEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRT---SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
+.+|.|.. .+++.||+|.+... ......++.+|+++++.++|+|++++++++..+...++||||+. +++.+.+..
T Consensus 29 g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~ 107 (308)
T cd06634 29 GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEV 107 (308)
T ss_pred EEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHH
Confidence 35677764 57889999988643 22334567889999999999999999999999999999999996 577666533
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
....+++..+..++.+++.++.+||+. |++|+||+|+||+++.++.++|+|||++...... ....++..
T Consensus 108 --~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~ 176 (308)
T cd06634 108 --HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTPY 176 (308)
T ss_pred --cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc------ccccCCcc
Confidence 234488999999999999999999998 8999999999999999999999999988654322 12356788
Q ss_pred CCCccccc---cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 159 YVPPEYVR---KGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 159 y~aPE~~~---~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
|+|||.+. ...++.++|||||||++|+|++|..||......+. . .......... ........
T Consensus 177 y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~-~~~~~~~~~~--------~~~~~~~~ 241 (308)
T cd06634 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------L-YHIAQNESPA--------LQSGHWSE 241 (308)
T ss_pred ccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH------H-HHHhhcCCCC--------cCcccccH
Confidence 99999874 34578899999999999999999998743221110 0 1111111111 01112234
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHHhccc
Q 021682 236 RCMQVALLCVQENAADRPTMLEILVMLKSET 266 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~ 266 (309)
.+.++|.+||+.+|++|||+++++....-..
T Consensus 242 ~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 242 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred HHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 6789999999999999999999998755443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=252.75 Aligned_cols=250 Identities=22% Similarity=0.314 Sum_probs=178.3
Q ss_pred cceEEEE-cCCCcEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeeEEeeC-----CeeEEEEeccCCCChhH
Q 021682 3 VAICQGR-LPNGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQR-----EEKMLIYDYMPNKSLDF 74 (309)
Q Consensus 3 ~~~~~~~-~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~ 74 (309)
+++|.+. ..+|+.||||.+... .......+..|+.+++.++|+||+++++++... ...++|+||+. ++|.+
T Consensus 19 ~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~ 97 (337)
T cd07858 19 GIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQ 97 (337)
T ss_pred eEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHH
Confidence 3556665 457999999998653 233345677899999999999999999987644 35799999995 67877
Q ss_pred HHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccc
Q 021682 75 YIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIV 154 (309)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~ 154 (309)
++.. ...+++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++........ ......
T Consensus 98 ~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~ 169 (337)
T cd07858 98 IIRS---SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD--FMTEYV 169 (337)
T ss_pred HHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccccCCCcc--cccccc
Confidence 7743 34589999999999999999999998 899999999999999999999999999876543321 112235
Q ss_pred cccCCCCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH--------HHhhCCCCccccc---
Q 021682 155 GTYGYVPPEYVRK-GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAY--------GLWKNGEGMEFID--- 222 (309)
Q Consensus 155 ~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~--- 222 (309)
++..|+|||.+.+ ..++.++|+|||||++|+|++|.+||...+............ .............
T Consensus 170 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (337)
T cd07858 170 VTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLP 249 (337)
T ss_pred cccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcC
Confidence 6789999998765 468899999999999999999999986432211110000000 0000000000000
Q ss_pred ccCCC---cccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 223 SSLDD---SSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 223 ~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
..... ........++.++|.+||+.+|++|||++++++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 250 YTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred cccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00000 0001123467899999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=239.06 Aligned_cols=227 Identities=20% Similarity=0.238 Sum_probs=170.7
Q ss_pred ceEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTSHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
.||.+. ..+|+.+|+|.+....... .|+.....+ +|+|++++++.+..++..++||||+++++|.+++...
T Consensus 31 ~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~-- 103 (267)
T PHA03390 31 KVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE-- 103 (267)
T ss_pred EEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhc--
Confidence 344544 4578999999986542211 122222222 7999999999999999999999999999999998432
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCC-CceeecccccccccCCcccccccccccccCCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM-NPKISDFGMARAFTKDECEANTGRIVGTYGYV 160 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 160 (309)
..+++..+..++.|+++|+.+||+. |++|+||+|.||+++.++ .++|+|||.+....... ...++..|+
T Consensus 104 -~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~------~~~~~~~y~ 173 (267)
T PHA03390 104 -GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS------CYDGTLDYF 173 (267)
T ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc------cCCCCCccc
Confidence 3689999999999999999999998 899999999999999988 99999999886543221 125688999
Q ss_pred CccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHH
Q 021682 161 PPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQV 240 (309)
Q Consensus 161 aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 240 (309)
|||.+.+..++.++|+||+|+++|+|++|..||....... ....... ... ...... .......+.++
T Consensus 174 aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~-~~~--~~~~~~---------~~~~~~~~~~l 240 (267)
T PHA03390 174 SPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLL-KRQ--QKKLPF---------IKNVSKNANDF 240 (267)
T ss_pred ChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHH-Hhh--cccCCc---------ccccCHHHHHH
Confidence 9999988889999999999999999999999986332221 1111111 100 000010 11233478899
Q ss_pred HhhcccCCCCCCCC-HHHHHH
Q 021682 241 ALLCVQENAADRPT-MLEILV 260 (309)
Q Consensus 241 i~~~l~~~p~~Rpt-~~ell~ 260 (309)
|.+||+.+|.+||+ ++++++
T Consensus 241 i~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 241 VQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHhccChhhCCchHHHHhc
Confidence 99999999999996 598874
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=249.62 Aligned_cols=250 Identities=19% Similarity=0.209 Sum_probs=180.9
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCccc--------------HHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEecc
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSHQG--------------LEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYM 67 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 67 (309)
++||++.. .+|+.||||.++...... ...+..|++++++++|+||+++++++..+...++|||++
T Consensus 23 g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 102 (335)
T PTZ00024 23 GKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM 102 (335)
T ss_pred eeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCCcEEEEEecc
Confidence 35777764 479999999986542211 124678999999999999999999999999999999999
Q ss_pred CCCChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcc-
Q 021682 68 PNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDEC- 146 (309)
Q Consensus 68 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~- 146 (309)
. ++|.+++.. ...+++.....++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||.+........
T Consensus 103 ~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~ 175 (335)
T PTZ00024 103 A-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYS 175 (335)
T ss_pred c-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCccceeeccccccc
Confidence 6 588887743 34488999999999999999999998 999999999999999999999999999876541110
Q ss_pred -----------cccccccccccCCCCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhC
Q 021682 147 -----------EANTGRIVGTYGYVPPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKN 214 (309)
Q Consensus 147 -----------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 214 (309)
........++..|+|||.+.+. .++.++|+|||||++|+|++|.+||...+..+.. .........
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~---~~i~~~~~~ 252 (335)
T PTZ00024 176 DTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL---GRIFELLGT 252 (335)
T ss_pred ccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCC
Confidence 0111122457789999988764 4688999999999999999999998654332211 111111110
Q ss_pred CC---Cccc--------ccccCCC---cccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 021682 215 GE---GMEF--------IDSSLDD---SSSAWKLMRCMQVALLCVQENAADRPTMLEILVML 262 (309)
Q Consensus 215 ~~---~~~~--------~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L 262 (309)
.. +... ....... .........+.++|.+||+.+|++|||+++++..-
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 253 PNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred CchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 00 0000 0000000 00011234678999999999999999999999753
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=241.36 Aligned_cols=234 Identities=20% Similarity=0.322 Sum_probs=189.9
Q ss_pred eEEE-EcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcccc
Q 021682 5 ICQG-RLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRY 83 (309)
Q Consensus 5 ~~~~-~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~ 83 (309)
|+++ +..+|+.||||.+.. +.+.+.+.+|+.++++...+++|++|+.+.....+++|||||..|+..+.+. .+++
T Consensus 49 V~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R--~R~K 124 (502)
T KOG0574|consen 49 VHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMR--ARRK 124 (502)
T ss_pred HHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHH--HhcC
Confidence 3444 345899999999854 3457889999999999999999999999988889999999999999999984 3566
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCcc
Q 021682 84 LLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPE 163 (309)
Q Consensus 84 ~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 163 (309)
.+.+..+..++...+++|.|||.. .-+|||||..||+++-+|..||+|||.+........ ..+...||+.|||||
T Consensus 125 ~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPE 199 (502)
T KOG0574|consen 125 PLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPE 199 (502)
T ss_pred CccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHH--hhCccccCcccccHH
Confidence 799999999999999999999998 689999999999999999999999999876554332 233458999999999
Q ss_pred ccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHHhh
Q 021682 164 YVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALL 243 (309)
Q Consensus 164 ~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 243 (309)
++..-.|+.++||||||+...+|..|++|+...-+......+ ...+...-..+..-+.++-+++++
T Consensus 200 VI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI--------------PT~PPPTF~KPE~WS~~F~DFi~~ 265 (502)
T KOG0574|consen 200 VIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI--------------PTKPPPTFKKPEEWSSEFNDFIRS 265 (502)
T ss_pred HHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec--------------cCCCCCCCCChHhhhhHHHHHHHH
Confidence 999999999999999999999999999998644332211100 001111112223334578899999
Q ss_pred cccCCCCCCCCHHHHHHH
Q 021682 244 CVQENAADRPTMLEILVM 261 (309)
Q Consensus 244 ~l~~~p~~Rpt~~ell~~ 261 (309)
||..+|++|.|+.++++.
T Consensus 266 CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 266 CLIKKPEERKTALRLCEH 283 (502)
T ss_pred HhcCCHHHHHHHHHHhhh
Confidence 999999999999999875
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=245.85 Aligned_cols=251 Identities=22% Similarity=0.250 Sum_probs=178.1
Q ss_pred cceEEEEcC-CCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCC----------eeEEEEeccCC
Q 021682 3 VAICQGRLP-NGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQRE----------EKMLIYDYMPN 69 (309)
Q Consensus 3 ~~~~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----------~~~lv~e~~~~ 69 (309)
+.||+|..+ +|+.||+|.++... ......+..|++++++++|||++++++++.... ..++|+||+.+
T Consensus 21 g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~ 100 (302)
T cd07864 21 GQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH 100 (302)
T ss_pred EEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc
Confidence 467788764 68999999986542 233456778999999999999999999887654 78999999976
Q ss_pred CChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccc
Q 021682 70 KSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEAN 149 (309)
Q Consensus 70 ~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 149 (309)
++...+... ...+++..+..++.|++.|++|||+. |++|+||+|+||+++.++.++|+|||.+......... .
T Consensus 101 -~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~-~ 173 (302)
T cd07864 101 -DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR-P 173 (302)
T ss_pred -cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCcccccccccCCccc-c
Confidence 666665332 33589999999999999999999998 9999999999999999999999999998655433211 1
Q ss_pred ccccccccCCCCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCccc--------
Q 021682 150 TGRIVGTYGYVPPEYVRK-GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEF-------- 220 (309)
Q Consensus 150 ~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 220 (309)
.....++..|+|||.+.+ ..++.++|||||||++|+|++|++||...+..+....+...............
T Consensus 174 ~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T cd07864 174 YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNT 253 (302)
T ss_pred cccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccc
Confidence 111245678999998765 35688999999999999999999998643322211111111000000000000
Q ss_pred ccccCCC-----cccHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021682 221 IDSSLDD-----SSSAWKLMRCMQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 221 ~~~~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
.+..... ......+..+.+++.+||+.+|++|||+++++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 254 MKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred cccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000000 000012347889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=259.64 Aligned_cols=238 Identities=26% Similarity=0.352 Sum_probs=193.0
Q ss_pred cceEEEEcC--CCc--EEEEEEeecCCcc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 3 VAICQGRLP--NGQ--EMAVKRLSRTSHQ-GLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 3 ~~~~~~~~~--~g~--~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
+||++|.|. +|+ .||||+++..... ..+.|..|+.++.+|+|+|++++|++..+ ...-||||+++.|+|.+.+.
T Consensus 124 gvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLr 202 (1039)
T KOG0199|consen 124 GVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLR 202 (1039)
T ss_pred eeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHh
Confidence 356777764 454 4799999765433 56789999999999999999999999887 66789999999999999986
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccc-cccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANT-GRIVGT 156 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~-~~~~~~ 156 (309)
. .....|.......++.||+.|+.||.++ +++||||-..|+++-....+||+|||+.+..+........ ....-.
T Consensus 203 k-a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvP 278 (1039)
T KOG0199|consen 203 K-AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVP 278 (1039)
T ss_pred h-ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCc
Confidence 6 4556688899999999999999999999 8999999999999999999999999999887765544332 223345
Q ss_pred cCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 157 YGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
..|.|||.+....++.++|||++|+++|||++ |+.||......... +.++....-..++.++.
T Consensus 279 fAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL----------------~~iD~~erLpRPk~cse 342 (1039)
T KOG0199|consen 279 FAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQIL----------------KNIDAGERLPRPKYCSE 342 (1039)
T ss_pred ccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHH----------------HhccccccCCCCCCChH
Confidence 68999999999999999999999999999998 78888654332221 12222333344455667
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 236 RCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
+++++++.||..+|++|||+..|.+.
T Consensus 343 dIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 343 DIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred HHHHHHHHhccCCccccccHHHHHHh
Confidence 99999999999999999999999743
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=240.03 Aligned_cols=234 Identities=23% Similarity=0.237 Sum_probs=174.5
Q ss_pred ceEEEEc-CCCcEEEEEEeecCCcc---cHHHHHHHHH---HHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHH
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTSHQ---GLEEFENEVK---LTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~~~---~~~~~~~e~~---~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 76 (309)
.||.+.. .+|+.||+|.+...... ....+..|.. .++...|++|+.+++.+..+...++||||+.+++|.+++
T Consensus 9 ~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l 88 (278)
T cd05606 9 EVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL 88 (278)
T ss_pred EEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHH
Confidence 5666654 57899999998654211 1122333433 344457999999999999999999999999999998887
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccc
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGT 156 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 156 (309)
.. ...+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++....... .....|+
T Consensus 89 ~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~~~~~~~ 158 (278)
T cd05606 89 SQ---HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGT 158 (278)
T ss_pred Hh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----CcCcCCC
Confidence 43 34589999999999999999999998 89999999999999999999999999986543321 1223578
Q ss_pred cCCCCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 157 YGYVPPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 157 ~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
..|+|||.+.+. .++.++|+||+|+++|+|++|..||.......... ....... .... .+...+.
T Consensus 159 ~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~-~~~~---------~~~~~s~ 224 (278)
T cd05606 159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLT-MAVE---------LPDSFSP 224 (278)
T ss_pred cCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH----HHHHhhc-cCCC---------CCCcCCH
Confidence 899999998754 67899999999999999999999986432222111 0011000 0000 0111234
Q ss_pred HHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 021682 236 RCMQVALLCVQENAADRP-----TMLEILVM 261 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~Rp-----t~~ell~~ 261 (309)
.+.+++.+||..+|++|| ++.++++.
T Consensus 225 ~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 225 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred HHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 788999999999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=244.39 Aligned_cols=232 Identities=25% Similarity=0.320 Sum_probs=177.0
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSH---QGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
+.+|.|.. .+|+.|++|.+..... .....+..|+++++.++|+|++++++++..+...++||||+. +++.+++..
T Consensus 35 g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~ 113 (313)
T cd06633 35 GAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEV 113 (313)
T ss_pred eEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHh
Confidence 35677764 4789999999865422 233567889999999999999999999999999999999996 467666532
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
....+++..+..++.|++.++.|||+. |++|+||+|+||+++.++.++|+|||++..... .....++..
T Consensus 114 --~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~------~~~~~~~~~ 182 (313)
T cd06633 114 --HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP------ANSFVGTPY 182 (313)
T ss_pred --cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC------CCCcccccc
Confidence 234588999999999999999999998 899999999999999999999999998754322 122357889
Q ss_pred CCCccccc---cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 159 YVPPEYVR---KGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 159 y~aPE~~~---~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
|+|||.+. ...++.++|+||||+++|+|++|..||...+.... .. .. ......... ......
T Consensus 183 y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~---~~---~~-~~~~~~~~~--------~~~~~~ 247 (313)
T cd06633 183 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LY---HI-AQNDSPTLQ--------SNEWTD 247 (313)
T ss_pred ccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH---HH---HH-HhcCCCCCC--------ccccCH
Confidence 99999874 35678899999999999999999999754322111 11 00 001111110 111223
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 236 RCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.+.+++.+||+.+|.+|||+.+++..
T Consensus 248 ~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 248 SFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 67899999999999999999999965
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=245.09 Aligned_cols=252 Identities=19% Similarity=0.223 Sum_probs=178.2
Q ss_pred cceEEEEcC-CCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 3 VAICQGRLP-NGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 3 ~~~~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
+.+|++... +|+.||+|.+.... ......+..|++++++++|+||+++++++..+...++||||+. ++|.+++...
T Consensus 16 ~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~ 94 (294)
T PLN00009 16 GVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSS 94 (294)
T ss_pred EEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhC
Confidence 467888754 78999999886432 2234567889999999999999999999999999999999996 4777766332
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCC-CCCceeecccccccccCCcccccccccccccC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY-EMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
....+++..+..++.||+.|+.+||++ |++|+||+|+||+++. ++.++|+|||++......... .....++..
T Consensus 95 -~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~ 168 (294)
T PLN00009 95 -PDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT--FTHEVVTLW 168 (294)
T ss_pred -CCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCccc--cccCceeec
Confidence 233367888899999999999999998 8999999999999985 456899999998654432211 122356788
Q ss_pred CCCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH-----HHhhCCCC-ccc---ccccCCC-
Q 021682 159 YVPPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAY-----GLWKNGEG-MEF---IDSSLDD- 227 (309)
Q Consensus 159 y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~-~~~---~~~~~~~- 227 (309)
|+|||.+.+. .++.++|+||||+++|+|++|.+||......+......... ..|..... ... .......
T Consensus 169 y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (294)
T PLN00009 169 YRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKD 248 (294)
T ss_pred ccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCC
Confidence 9999988664 57899999999999999999999986533221111000000 00000000 000 0000000
Q ss_pred --cccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 228 --SSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 228 --~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.........+.+++.+||+.+|++||++.++++.
T Consensus 249 ~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 249 LATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred HHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011123467899999999999999999999863
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=238.66 Aligned_cols=235 Identities=23% Similarity=0.280 Sum_probs=178.2
Q ss_pred ceEEEEc-CCCcEEEEEEeecC-----CcccHHHHHHHHHHHhcCCCCCccceeeEEeeC--CeeEEEEeccCCCChhHH
Q 021682 4 AICQGRL-PNGQEMAVKRLSRT-----SHQGLEEFENEVKLTARLQHVNLLPVLGICTQR--EEKMLIYDYMPNKSLDFY 75 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~ 75 (309)
.+|.+.. .+|+.||+|.+... .......+++|++++++++|+||+++++++... ...++++||+++++|.++
T Consensus 17 ~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~ 96 (264)
T cd06653 17 EVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQ 96 (264)
T ss_pred EEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHH
Confidence 5677754 57999999987532 123345788999999999999999999988664 468899999999999988
Q ss_pred HhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccc-ccccccc
Q 021682 76 IFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECE-ANTGRIV 154 (309)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~ 154 (309)
+.. ...+++..+..++.+++.|+.+||++ |++|+||+|+||+++.++.++|+|||++......... .......
T Consensus 97 ~~~---~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 170 (264)
T cd06653 97 LKA---YGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT 170 (264)
T ss_pred HHH---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccC
Confidence 743 23478889999999999999999998 8999999999999999999999999998754321110 1112235
Q ss_pred cccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHH
Q 021682 155 GTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKL 234 (309)
Q Consensus 155 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
++..|+|||.+.+..++.++|+|||||++|++++|+.||....... ......... .....+....
T Consensus 171 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~---------~~~~~p~~~~ 235 (264)
T cd06653 171 GTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA------AIFKIATQP---------TKPMLPDGVS 235 (264)
T ss_pred CcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH------HHHHHHcCC---------CCCCCCcccC
Confidence 7889999999988888999999999999999999999985321111 111111110 0111122233
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHH
Q 021682 235 MRCMQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 235 ~~l~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
..+.+++.+||+ +|..|||+.+++.
T Consensus 236 ~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 236 DACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHHHHHHHHHhc-CcccCccHHHHhc
Confidence 478899999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=244.59 Aligned_cols=234 Identities=24% Similarity=0.293 Sum_probs=183.5
Q ss_pred ceEEEEc-CCCcEEEEEEeecC---CcccHHHHHHHHHHHhcCC-CCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 4 AICQGRL-PNGQEMAVKRLSRT---SHQGLEEFENEVKLTARLQ-HVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
.+|++.. .+|+.||+|++... .......+..|+.++++++ |+||+++++++..+...++|||++.+++|.+++..
T Consensus 16 ~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 95 (280)
T cd05581 16 TVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRK 95 (280)
T ss_pred EEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHH
Confidence 5677765 47999999998653 2233456788999999998 99999999999999999999999999999998844
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccc-----------
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECE----------- 147 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~----------- 147 (309)
...+++..+..++.|++.++.+||+. |++|+||+|+||+++.++.++|+|||++.........
T Consensus 96 ---~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~ 169 (280)
T cd05581 96 ---YGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNID 169 (280)
T ss_pred ---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCcccc
Confidence 33599999999999999999999998 8999999999999999999999999998765443221
Q ss_pred -------ccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCccc
Q 021682 148 -------ANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEF 220 (309)
Q Consensus 148 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (309)
.......++..|+|||......++.++|+||||++++++++|..||....... . ...... . .
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~---~~~~~~-~-~--- 238 (280)
T cd05581 170 SQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL---T---FQKILK-L-E--- 238 (280)
T ss_pred ccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH---H---HHHHHh-c-C---
Confidence 11223456789999999888888999999999999999999999986543111 1 111110 0 0
Q ss_pred ccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCH----HHHHH
Q 021682 221 IDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTM----LEILV 260 (309)
Q Consensus 221 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~----~ell~ 260 (309)
...+......+.+++.+||+.+|++|||+ +++++
T Consensus 239 ------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 239 ------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred ------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 00111113478899999999999999999 88764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=252.25 Aligned_cols=249 Identities=20% Similarity=0.245 Sum_probs=175.6
Q ss_pred ceEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeC--------------CeeEEEEeccC
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQR--------------EEKMLIYDYMP 68 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--------------~~~~lv~e~~~ 68 (309)
.||.+.. .+|+.||+|.+..........+.+|++++++++||||+++++++... ...++|+||+.
T Consensus 20 ~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~ 99 (342)
T cd07854 20 LVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME 99 (342)
T ss_pred EEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc
Confidence 5677754 57999999998766655667788999999999999999998776543 35789999996
Q ss_pred CCChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCC-CCCceeecccccccccCCccc
Q 021682 69 NKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY-EMNPKISDFGMARAFTKDECE 147 (309)
Q Consensus 69 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~-~~~~~l~Dfg~~~~~~~~~~~ 147 (309)
++|.+++. ...+++..++.++.|+++|+.|||+. |++|+||+|+||+++. ++.++|+|||.+.........
T Consensus 100 -~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~ 171 (342)
T cd07854 100 -TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSH 171 (342)
T ss_pred -ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECCcccceecCCcccc
Confidence 57877763 23488999999999999999999998 8999999999999975 557899999998654322111
Q ss_pred c-cccccccccCCCCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH--------HHhhCCCC
Q 021682 148 A-NTGRIVGTYGYVPPEYVRK-GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAY--------GLWKNGEG 217 (309)
Q Consensus 148 ~-~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~ 217 (309)
. ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||......+......... ..... ..
T Consensus 172 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 250 (342)
T cd07854 172 KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLN-VI 250 (342)
T ss_pred ccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhh-hh
Confidence 1 1112346778999997654 467889999999999999999999986443222111100000 00000 00
Q ss_pred ccccc-ccCCCc-----ccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 218 MEFID-SSLDDS-----SSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 218 ~~~~~-~~~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
..... ...... .......++.+++.+||+.||++|||+++++..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 251 PSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred hhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 00000 000000 001123467899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=237.26 Aligned_cols=217 Identities=17% Similarity=0.102 Sum_probs=166.2
Q ss_pred ccceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 2 SVAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 2 g~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
|.+.......+|+.||+|.+..... ...|...+....||||+++++++......+++|||+.+++|.+++...
T Consensus 7 ~~v~~~~~~~~~~~~~~K~i~~~~~-----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-- 79 (237)
T cd05576 7 DKVLLVMDTRTQQTFILKGLRKSSE-----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF-- 79 (237)
T ss_pred ceEEEEEEccCCcEEEEEeecchhh-----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh--
Confidence 4444444456899999999865432 233445555567999999999999999999999999999999888443
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP 161 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 161 (309)
..+++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.++++|||.+........ ...++..|+|
T Consensus 80 -~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~y~a 150 (237)
T cd05576 80 -LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCD-----GEAVENMYCA 150 (237)
T ss_pred -cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccccc-----cCCcCccccC
Confidence 3488999999999999999999998 899999999999999999999999998755443211 1234667999
Q ss_pred ccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHH
Q 021682 162 PEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241 (309)
Q Consensus 162 PE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 241 (309)
||...+..++.++|+||+|+++|+|++|..|+....... .... ....+......+.++|
T Consensus 151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~~~---------~~~~~~~~~~~~~~li 209 (237)
T cd05576 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NTHT---------TLNIPEWVSEEARSLL 209 (237)
T ss_pred CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------cccc---------ccCCcccCCHHHHHHH
Confidence 999988888999999999999999999998764221100 0000 0001112234688999
Q ss_pred hhcccCCCCCCCCH
Q 021682 242 LLCVQENAADRPTM 255 (309)
Q Consensus 242 ~~~l~~~p~~Rpt~ 255 (309)
.+||+.||++|||+
T Consensus 210 ~~~l~~dp~~R~~~ 223 (237)
T cd05576 210 QQLLQFNPTERLGA 223 (237)
T ss_pred HHHccCCHHHhcCC
Confidence 99999999999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=257.02 Aligned_cols=254 Identities=23% Similarity=0.292 Sum_probs=192.3
Q ss_pred cceEEEE-cCCCcEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCC------eeEEEEeccCCCChhH
Q 021682 3 VAICQGR-LPNGQEMAVKRLSRT-SHQGLEEFENEVKLTARLQHVNLLPVLGICTQRE------EKMLIYDYMPNKSLDF 74 (309)
Q Consensus 3 ~~~~~~~-~~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~~L~~ 74 (309)
+.||+|+ ..+|+.||||.++.. ....+++...|++++++++|+|||+++++-+... ...+|||||.||+|..
T Consensus 27 g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~ 106 (732)
T KOG4250|consen 27 GNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRK 106 (732)
T ss_pred ceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHH
Confidence 3578888 568999999999765 4556788999999999999999999998865543 4689999999999999
Q ss_pred HHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCC--C--CceeecccccccccCCcccccc
Q 021682 75 YIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYE--M--NPKISDFGMARAFTKDECEANT 150 (309)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~--~--~~~l~Dfg~~~~~~~~~~~~~~ 150 (309)
.+.+......+++..++.++..++.|+.|||++ ||+||||||.||++... | ..||+|||.|+....+. ..
T Consensus 107 ~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s---~~ 180 (732)
T KOG4250|consen 107 VLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS---LF 180 (732)
T ss_pred HhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccccccCCCCC---ee
Confidence 998888888899999999999999999999988 99999999999999543 3 38999999998766654 34
Q ss_pred cccccccCCCCccccc-cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCc-ccHHHHHHHHhhC---------CCCcc
Q 021682 151 GRIVGTYGYVPPEYVR-KGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNES-LNLLEYAYGLWKN---------GEGME 219 (309)
Q Consensus 151 ~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~---------~~~~~ 219 (309)
....||..|++||.+. ...++...|.|||||++|++.||..||.+...... ....+.....-.. ++.+-
T Consensus 181 ~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv 260 (732)
T KOG4250|consen 181 TSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPV 260 (732)
T ss_pred eeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCce
Confidence 4568999999999998 48899999999999999999999999976444322 1122211111111 11111
Q ss_pred ccccc--CCCcccHHHHHHHHHHHhhcccCCCCCCC--CHHHHHHHH
Q 021682 220 FIDSS--LDDSSSAWKLMRCMQVALLCVQENAADRP--TMLEILVML 262 (309)
Q Consensus 220 ~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rp--t~~ell~~L 262 (309)
-.... ............+-..+..+|..+|++|- ...+.-..+
T Consensus 261 ~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~ 307 (732)
T KOG4250|consen 261 EWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEV 307 (732)
T ss_pred eeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHH
Confidence 11111 12223333444666788889999999998 544444443
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=238.16 Aligned_cols=229 Identities=23% Similarity=0.275 Sum_probs=179.5
Q ss_pred ceEEEEc-CCCcEEEEEEeecCCc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTSH---QGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
.+|.+.. .+++.||+|.+..... .....+..|+.++++++|+||+++++.+..+...++|||++.+++|.+++...
T Consensus 8 ~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~ 87 (250)
T cd05123 8 KVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKE 87 (250)
T ss_pred EEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhc
Confidence 4566654 3689999999875432 23457889999999999999999999999999999999999999999988433
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
..+++..+..++.|++.++.+||+. |++|+||+|+||+++.++.++|+|||.+........ ......++..|
T Consensus 88 ---~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~ 159 (250)
T cd05123 88 ---GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTFCGTPEY 159 (250)
T ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCC--cccCCcCCccc
Confidence 3488999999999999999999998 899999999999999999999999999866544321 12233567889
Q ss_pred CCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHH
Q 021682 160 VPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQ 239 (309)
Q Consensus 160 ~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (309)
++||...+...+.++|+||||+++|++++|..||...+... ....... ... ..+......+.+
T Consensus 160 ~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~------~~~~~~~--~~~---------~~~~~~~~~l~~ 222 (250)
T cd05123 160 LAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE------IYEKILK--DPL---------RFPEFLSPEARD 222 (250)
T ss_pred cChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHhc--CCC---------CCCCCCCHHHHH
Confidence 99999988888999999999999999999999985433211 1111110 000 011111347789
Q ss_pred HHhhcccCCCCCCCCHHH
Q 021682 240 VALLCVQENAADRPTMLE 257 (309)
Q Consensus 240 li~~~l~~~p~~Rpt~~e 257 (309)
++.+||..||++|||+.+
T Consensus 223 ~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 223 LISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHhcCCHhhCCCccc
Confidence 999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=241.72 Aligned_cols=250 Identities=22% Similarity=0.220 Sum_probs=182.9
Q ss_pred cceEEEEcC-CCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 3 VAICQGRLP-NGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 3 ~~~~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
+.+|.+... +++.||+|.+.... ......+..|+.++++++|++++++++++......++|+|++. ++|.+++...
T Consensus 13 ~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~ 91 (282)
T cd07829 13 GVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKR 91 (282)
T ss_pred ceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhh
Confidence 356777654 69999999987653 3334677889999999999999999999999899999999997 5898888543
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
. ..+++..+..++.+++.++.+||++ |++|+||+|+||+++.++.++|+|||.+......... .....++..|
T Consensus 92 ~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~ 164 (282)
T cd07829 92 P--GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT--YTHEVVTLWY 164 (282)
T ss_pred c--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCccc--cCccccCcCc
Confidence 2 3589999999999999999999998 8999999999999999999999999998765433221 1122456789
Q ss_pred CCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHH--------HHHHhhCCC-CcccccccCCC--
Q 021682 160 VPPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEY--------AYGLWKNGE-GMEFIDSSLDD-- 227 (309)
Q Consensus 160 ~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~~-~~~~~~~~~~~-- 227 (309)
+|||.+.+. .++.++|+||||+++|++++|.+||......+....... .+..+.... ....+......
T Consensus 165 ~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (282)
T cd07829 165 RAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDL 244 (282)
T ss_pred CChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccch
Confidence 999988766 788999999999999999999998854332211111100 000000000 00000000000
Q ss_pred -cccHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021682 228 -SSSAWKLMRCMQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 228 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
.........+.++|.+||+.+|++||++++++.
T Consensus 245 ~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 245 EKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred HHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000111347889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=239.66 Aligned_cols=250 Identities=21% Similarity=0.271 Sum_probs=178.9
Q ss_pred cceEEEEcC-CCcEEEEEEeecCCcc--cHHHHHHHHHHHhcC---CCCCccceeeEEeeCCe-----eEEEEeccCCCC
Q 021682 3 VAICQGRLP-NGQEMAVKRLSRTSHQ--GLEEFENEVKLTARL---QHVNLLPVLGICTQREE-----KMLIYDYMPNKS 71 (309)
Q Consensus 3 ~~~~~~~~~-~g~~vavK~~~~~~~~--~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~-----~~lv~e~~~~~~ 71 (309)
+.+|.+..+ +|+.||+|.++..... ....+..|+.+++++ .|+|++++++++..... .+++||++.+ +
T Consensus 13 ~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~-~ 91 (287)
T cd07838 13 GTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-D 91 (287)
T ss_pred eEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhccc-C
Confidence 467888765 5899999999644222 234556677776655 69999999999987766 9999999964 7
Q ss_pred hhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccc
Q 021682 72 LDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTG 151 (309)
Q Consensus 72 L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 151 (309)
|.+++.... ...+++..+..++.|++.|+++||+. |++|+||+|+||+++.++.++|+|||.+........ ..
T Consensus 92 l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~---~~ 164 (287)
T cd07838 92 LATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA---LT 164 (287)
T ss_pred HHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcceeccCCcc---cc
Confidence 888774422 23589999999999999999999998 899999999999999999999999999866543321 11
Q ss_pred ccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH-----HHhhCCCC--ccccccc
Q 021682 152 RIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAY-----GLWKNGEG--MEFIDSS 224 (309)
Q Consensus 152 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~--~~~~~~~ 224 (309)
...++..|+|||.+.+..++.++|+|||||++|+|++|.+||......+......... ..+..... ...+...
T Consensus 165 ~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (287)
T cd07838 165 SVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSY 244 (287)
T ss_pred cccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccc
Confidence 2246788999999988889999999999999999999999886433222111110000 00000000 0000000
Q ss_pred CCC---cccHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021682 225 LDD---SSSAWKLMRCMQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 225 ~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
... .........+.++|.+||+.||++||++++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 245 TPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 010 111123456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=248.88 Aligned_cols=251 Identities=22% Similarity=0.255 Sum_probs=179.2
Q ss_pred cceEEEEcC-CCcEEEEEEeecC--CcccHHHHHHHHHHHhcC-CCCCccceeeEEeeC--CeeEEEEeccCCCChhHHH
Q 021682 3 VAICQGRLP-NGQEMAVKRLSRT--SHQGLEEFENEVKLTARL-QHVNLLPVLGICTQR--EEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 3 ~~~~~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~~ 76 (309)
+.+|+|... +|+.||+|.+... .......+..|+.+++++ +|+||+++++++... ...++||||+. ++|..++
T Consensus 21 ~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~ 99 (337)
T cd07852 21 GIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVI 99 (337)
T ss_pred eeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHH
Confidence 357888754 6899999988542 233345677899999999 999999999988643 36899999996 5887776
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccc---cccccc
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECE---ANTGRI 153 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~---~~~~~~ 153 (309)
.. + .+++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||.+......... ......
T Consensus 100 ~~---~-~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~ 172 (337)
T cd07852 100 RA---N-ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDY 172 (337)
T ss_pred hc---C-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcc
Confidence 32 2 578888999999999999999998 9999999999999999999999999998765433221 112234
Q ss_pred ccccCCCCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH--------HHhhCCCCcccccc-
Q 021682 154 VGTYGYVPPEYVRK-GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAY--------GLWKNGEGMEFIDS- 223 (309)
Q Consensus 154 ~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~- 223 (309)
.++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||......+......... ..+.......+++.
T Consensus 173 ~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (337)
T cd07852 173 VATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSL 252 (337)
T ss_pred cccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhc
Confidence 57889999998755 457889999999999999999999986433322111110000 00000000000000
Q ss_pred --cC---CCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 224 --SL---DDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 224 --~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.. ...........+.++|.+||+.+|++|||+.++++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 253 PSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred ccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00 000001123478899999999999999999999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=238.83 Aligned_cols=251 Identities=20% Similarity=0.195 Sum_probs=181.1
Q ss_pred cceEEEEcC-CCcEEEEEEeecCCc-ccHHHHHHHHHHHhcCC-CCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 3 VAICQGRLP-NGQEMAVKRLSRTSH-QGLEEFENEVKLTARLQ-HVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 3 ~~~~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
+.+|+|... +++.|+||.+..... ........|+..+++++ |+|++++++++..+...++||||+ +++|.+++...
T Consensus 13 g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~ 91 (283)
T cd07830 13 GSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDR 91 (283)
T ss_pred eEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhc
Confidence 467888764 688999999865432 22234557899999998 999999999999999999999999 77888877432
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
. ...+++..+..++.|++.++.+||++ |++|+||+|+||+++.++.++|+|||.+........ .....++..|
T Consensus 92 ~-~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~ 164 (283)
T cd07830 92 K-GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP---YTDYVSTRWY 164 (283)
T ss_pred c-cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC---cCCCCCcccc
Confidence 2 34589999999999999999999998 899999999999999999999999999875543221 1223567889
Q ss_pred CCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHH----------HHHHhhCCCCcccccccCCCc
Q 021682 160 VPPEYVRK-GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEY----------AYGLWKNGEGMEFIDSSLDDS 228 (309)
Q Consensus 160 ~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~ 228 (309)
+|||.+.. ..++.++|+||||+++++|++|.+||......+....... .............+.......
T Consensus 165 ~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (283)
T cd07830 165 RAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTS 244 (283)
T ss_pred cCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccccccccccc
Confidence 99998754 4578999999999999999999999865433221111000 000000000000000000000
Q ss_pred c---cHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 229 S---SAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 229 ~---~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
. .......+.++|++||+.+|++|||++|++..
T Consensus 245 ~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 245 LHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred HHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0 00113478899999999999999999999753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=239.32 Aligned_cols=241 Identities=22% Similarity=0.245 Sum_probs=181.6
Q ss_pred ceEEEEc----CCCcEEEEEEeecCC----cccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhH
Q 021682 4 AICQGRL----PNGQEMAVKRLSRTS----HQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDF 74 (309)
Q Consensus 4 ~~~~~~~----~~g~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (309)
.+|.+.. .+++.||||.++... ......+..|+.++.++ .|++|+++++.+..+...++||||+.+++|.+
T Consensus 15 ~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 94 (288)
T cd05583 15 KVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFT 94 (288)
T ss_pred eEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHH
Confidence 4666543 367889999986432 22345678899999999 69999999999999999999999999999988
Q ss_pred HHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccc
Q 021682 75 YIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIV 154 (309)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~ 154 (309)
++.. ...+++..+..++.|++.++.+||+. |++|+||+|.||+++.++.++|+|||++......... ......
T Consensus 95 ~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~ 167 (288)
T cd05583 95 HLYQ---REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFC 167 (288)
T ss_pred HHhh---cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccccccccc-cccccc
Confidence 8743 33488899999999999999999998 8999999999999999999999999988654433211 112235
Q ss_pred cccCCCCccccccCC--CCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHH
Q 021682 155 GTYGYVPPEYVRKGI--YSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAW 232 (309)
Q Consensus 155 ~~~~y~aPE~~~~~~--~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (309)
++..|++||.+.+.. .+.++|+||||+++|+|++|..||...+.... ............ .. .+..
T Consensus 168 ~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~-------~~----~~~~ 234 (288)
T cd05583 168 GTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISRRILKSK-------PP----FPKT 234 (288)
T ss_pred CCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHHHHHccC-------CC----CCcc
Confidence 688999999987654 68899999999999999999999854322111 111111111110 00 0111
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 021682 233 KLMRCMQVALLCVQENAADRPTMLEILVMLKS 264 (309)
Q Consensus 233 ~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~ 264 (309)
....+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 235 ~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 235 MSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred cCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 22367899999999999999999888877764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=232.96 Aligned_cols=248 Identities=19% Similarity=0.214 Sum_probs=181.5
Q ss_pred EcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCCccceeeEEeeC----CeeEEEEeccCCCChhHHHhhhcccc
Q 021682 9 RLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARL-QHVNLLPVLGICTQR----EEKMLIYDYMPNKSLDFYIFDLRRRY 83 (309)
Q Consensus 9 ~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~ 83 (309)
...+|+++|+|++. +....++|++.--.. .|||||.+++++++. ..+.+|||+|+||.|...+.+.+ ..
T Consensus 83 ~k~T~ekfALKvL~-----Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g-~~ 156 (400)
T KOG0604|consen 83 HKRTQEKFALKVLL-----DSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRG-DQ 156 (400)
T ss_pred eccchhhhHHHHHh-----cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcc-cc
Confidence 34588888988873 234556788775554 799999999998764 35789999999999988886543 45
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCC---CCCceeecccccccccCCcccccccccccccCCC
Q 021682 84 LLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY---EMNPKISDFGMARAFTKDECEANTGRIVGTYGYV 160 (309)
Q Consensus 84 ~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~---~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 160 (309)
.+.+..+-.+..||+.|+.|||+. +|.||||||+|++.+. |-.+||+|||+|+....... ......|+.|.
T Consensus 157 afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~---L~TPc~TPyYv 230 (400)
T KOG0604|consen 157 AFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGD---LMTPCFTPYYV 230 (400)
T ss_pred cchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccccCCCcc---ccCCccccccc
Confidence 599999999999999999999999 8999999999999975 45699999999986554322 22235689999
Q ss_pred CccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHH
Q 021682 161 PPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQV 240 (309)
Q Consensus 161 aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 240 (309)
|||++...+|+...|+||+|+++|-|++|.+||...-. .....-.. .+ ...+ .-+ +....=...+....++
T Consensus 231 aPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg-~aispgMk-~r-I~~g-qy~-----FP~pEWs~VSe~aKdl 301 (400)
T KOG0604|consen 231 APEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-LAISPGMK-RR-IRTG-QYE-----FPEPEWSCVSEAAKDL 301 (400)
T ss_pred CHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC-ccCChhHH-hH-hhcc-Ccc-----CCChhHhHHHHHHHHH
Confidence 99999989999999999999999999999999954322 21111100 00 0000 001 1111112345567799
Q ss_pred HhhcccCCCCCCCCHHHHHHHHhcccCCCCCCCCCCcc
Q 021682 241 ALLCVQENAADRPTMLEILVMLKSETADIKTPKKPAFS 278 (309)
Q Consensus 241 i~~~l~~~p~~Rpt~~ell~~L~~~~~~~~~~~~p~~~ 278 (309)
|+.+|..+|.+|.|++++++.=.- ...-..|-.|..-
T Consensus 302 IR~LLkt~PteRlTI~~~m~hpwi-~~~~~vp~tpl~t 338 (400)
T KOG0604|consen 302 IRKLLKTEPTERLTIEEVMDHPWI-NQYEAVPQTPLST 338 (400)
T ss_pred HHHHhcCCchhheeHHHhhcCchh-cccccCCCCCchh
Confidence 999999999999999999987542 2334444444443
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=241.34 Aligned_cols=239 Identities=22% Similarity=0.318 Sum_probs=176.3
Q ss_pred cceEEEEcC-CCcEEEEEEeecCCc-ccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 3 VAICQGRLP-NGQEMAVKRLSRTSH-QGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 3 ~~~~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
+.+|++..+ +|+.||||.++.... .....+..|+.++.+. .|+||+++++++..+...+++|||+. +++..+....
T Consensus 29 ~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~l~~~~ 107 (296)
T cd06618 29 GQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS-TCLDKLLKRI 107 (296)
T ss_pred eEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC-cCHHHHHHHh
Confidence 357888765 499999999975432 2334556677766666 59999999999999999999999985 4676666432
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
...+++..+..++.+++.++.|||+.+ |++|+||+|+||+++.++.++|+|||++......... ....++..|
T Consensus 108 --~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~---~~~~~~~~y 180 (296)
T cd06618 108 --QGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---TRSAGCAAY 180 (296)
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCCCcc---cCCCCCccc
Confidence 235889999999999999999999743 8999999999999999999999999998654432211 122467789
Q ss_pred CCccccccCC----CCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 160 VPPEYVRKGI----YSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 160 ~aPE~~~~~~----~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
+|||.+.+.. ++.++|+||||+++|+|++|..||...... .... ........... .. ......
T Consensus 181 ~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~-~~~~~~~~~~~-~~------~~~~~~ 247 (296)
T cd06618 181 MAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVL-TKILQEEPPSL-PP------NEGFSP 247 (296)
T ss_pred cCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHH-HHHhcCCCCCC-CC------CCCCCH
Confidence 9999986543 788999999999999999999998532111 1111 11111111110 00 001234
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHH
Q 021682 236 RCMQVALLCVQENAADRPTMLEILVML 262 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~Rpt~~ell~~L 262 (309)
++.+++.+||..||++|||+++++..-
T Consensus 248 ~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 248 DFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 788999999999999999999998763
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=235.95 Aligned_cols=239 Identities=22% Similarity=0.285 Sum_probs=182.5
Q ss_pred cCCCcEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccccCCCHH
Q 021682 10 LPNGQEMAVKRLSRTSHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWR 88 (309)
Q Consensus 10 ~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 88 (309)
+.+|..+|||++.+.....+.+..+|++++.+. .|+||+++++||+++..+|||||-|.||+|-..+. .++.+++.
T Consensus 100 i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~---~~~~F~E~ 176 (463)
T KOG0607|consen 100 IQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQ---KRKHFNER 176 (463)
T ss_pred eccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHH---HhhhccHH
Confidence 468999999999888888899999999999999 59999999999999999999999999999988884 34559999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCC---ceeecccccccccCCccc-----ccccccccccCCC
Q 021682 89 TRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMN---PKISDFGMARAFTKDECE-----ANTGRIVGTYGYV 160 (309)
Q Consensus 89 ~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~---~~l~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~ 160 (309)
.+..+...|+.||.|||.+ ||.|||+||+||+-...+. +||+||+++......... .......|+..||
T Consensus 177 EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfM 253 (463)
T KOG0607|consen 177 EASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFM 253 (463)
T ss_pred HHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhc
Confidence 9999999999999999999 9999999999999976554 899999887544322211 1222456888999
Q ss_pred Cccccc---c--CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcc------cHHHHH--HHHhhCCCCcccccccCCC
Q 021682 161 PPEYVR---K--GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESL------NLLEYA--YGLWKNGEGMEFIDSSLDD 227 (309)
Q Consensus 161 aPE~~~---~--~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~------~~~~~~--~~~~~~~~~~~~~~~~~~~ 227 (309)
|||+.. + ..|+.+.|.||||+|+|-|++|.+||......+-. ...... ..-..++ --++.+.
T Consensus 254 APEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEG-kYeFPdk---- 328 (463)
T KOG0607|consen 254 APEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEG-KYEFPDK---- 328 (463)
T ss_pred chhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhcc-CCcCChh----
Confidence 999653 2 35789999999999999999999999654332211 001000 0000000 0111111
Q ss_pred cccHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021682 228 SSSAWKLMRCMQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 228 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
.=...+.+..+++..+|..++.+|.++.++++
T Consensus 329 -dWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 329 -DWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred -hhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 01123346678999999999999999999998
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=259.04 Aligned_cols=229 Identities=23% Similarity=0.258 Sum_probs=160.3
Q ss_pred cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc--ccCCCHHHHHHHHHHHHHHHHHHh
Q 021682 28 GLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR--RYLLDWRTRVHIIEGITQGLLYLQ 105 (309)
Q Consensus 28 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh 105 (309)
....+.+|+.++++++|+||+++++++......++|++++. ++|..++..... ........+..++.||+.||.|||
T Consensus 206 ~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH 284 (501)
T PHA03210 206 AAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH 284 (501)
T ss_pred HHHHHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 34568899999999999999999999999999999999985 466666533211 112335667789999999999999
Q ss_pred hcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCccccccCCCCccchhhhHHHHHHH
Q 021682 106 EYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQ 185 (309)
Q Consensus 106 ~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ 185 (309)
++ ||+||||||+||+++.++.+||+|||++......... ......|+..|+|||.+.+..++.++|||||||++|+
T Consensus 285 ~~---gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e 360 (501)
T PHA03210 285 DK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLD 360 (501)
T ss_pred hC---CeecCCCCHHHEEECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHH
Confidence 98 9999999999999999999999999999765433221 1222468999999999999899999999999999999
Q ss_pred HHhCCCC-CCCCCCCCcccHHHHHHHHh-hCCCCc-------cccccc----CCCccc-----HHHHHHHHHHHhhcccC
Q 021682 186 ILGGKRT-SCYYGPNESLNLLEYAYGLW-KNGEGM-------EFIDSS----LDDSSS-----AWKLMRCMQVALLCVQE 247 (309)
Q Consensus 186 ll~g~~p-~~~~~~~~~~~~~~~~~~~~-~~~~~~-------~~~~~~----~~~~~~-----~~~~~~l~~li~~~l~~ 247 (309)
|++|..+ +................... ...... .++... ...... ......+.++|.+||++
T Consensus 361 ll~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~ 440 (501)
T PHA03210 361 MLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTF 440 (501)
T ss_pred HHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhcc
Confidence 9998754 33222211111111100000 000000 000000 000000 00123567889999999
Q ss_pred CCCCCCCHHHHHHH
Q 021682 248 NAADRPTMLEILVM 261 (309)
Q Consensus 248 ~p~~Rpt~~ell~~ 261 (309)
||++|||+.|+++.
T Consensus 441 DP~~Rpsa~elL~h 454 (501)
T PHA03210 441 DWHLRPGAAELLAL 454 (501)
T ss_pred CcccCcCHHHHhhC
Confidence 99999999999864
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=244.16 Aligned_cols=252 Identities=21% Similarity=0.291 Sum_probs=175.9
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCcc--cHHHHHHHHHHHhcCCCCCccceeeEEeeC--------CeeEEEEeccCCCC
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSHQ--GLEEFENEVKLTARLQHVNLLPVLGICTQR--------EEKMLIYDYMPNKS 71 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~~ 71 (309)
+.+|.+.. .+|+.||||.+...... ....+.+|++++++++|+||+++++++... ...++|+||+.+ +
T Consensus 22 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~ 100 (311)
T cd07866 22 GEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-D 100 (311)
T ss_pred EEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCCc-C
Confidence 46777765 47899999998654322 234567899999999999999999887543 346999999965 5
Q ss_pred hhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccc--
Q 021682 72 LDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEAN-- 149 (309)
Q Consensus 72 L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~-- 149 (309)
+...+.. ....+++..+..++.|+++|+.+||+. |++|+||+|+||+++.++.++|+|||++...........
T Consensus 101 l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 175 (311)
T cd07866 101 LSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG 175 (311)
T ss_pred HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccC
Confidence 6555532 234589999999999999999999998 899999999999999999999999999876543221111
Q ss_pred -------ccccccccCCCCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH--------Hhh
Q 021682 150 -------TGRIVGTYGYVPPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYG--------LWK 213 (309)
Q Consensus 150 -------~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~--------~~~ 213 (309)
.....++..|+|||.+.+. .++.++||||||+++|+|++|.+||................. .+.
T Consensus 176 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (311)
T cd07866 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWR 255 (311)
T ss_pred CcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhh
Confidence 1123457789999987654 578999999999999999999999864333221111111000 000
Q ss_pred CCCCcc--cccccCCCcc---cHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021682 214 NGEGME--FIDSSLDDSS---SAWKLMRCMQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 214 ~~~~~~--~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
...... .......... .......+.++|.+||+.||++|||+.+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 256 SLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred hcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 000000 0000000000 0011246789999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=237.72 Aligned_cols=238 Identities=23% Similarity=0.253 Sum_probs=179.2
Q ss_pred ceEEEEc----CCCcEEEEEEeecCC----cccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhH
Q 021682 4 AICQGRL----PNGQEMAVKRLSRTS----HQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDF 74 (309)
Q Consensus 4 ~~~~~~~----~~g~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (309)
.+|.+.. .+|+.||+|.++... ....+.+..|+++++++ +|++|+++++.+..+...++|+||+++++|.+
T Consensus 15 ~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 94 (290)
T cd05613 15 KVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFT 94 (290)
T ss_pred eEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHH
Confidence 4566553 478999999987532 22345678899999999 69999999999999999999999999999999
Q ss_pred HHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccc
Q 021682 75 YIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIV 154 (309)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~ 154 (309)
++.. ...+++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++......... ......
T Consensus 95 ~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~ 167 (290)
T cd05613 95 HLSQ---RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFC 167 (290)
T ss_pred HHHH---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceeccccccc-cccccc
Confidence 8843 33488899999999999999999998 8999999999999999999999999998765432211 112235
Q ss_pred cccCCCCccccccC--CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHH
Q 021682 155 GTYGYVPPEYVRKG--IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAW 232 (309)
Q Consensus 155 ~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (309)
++..|+|||.+.+. ..+.++||||||+++|+|++|..||...+.... ............ .. .+..
T Consensus 168 ~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~~--~~---------~~~~ 234 (290)
T cd05613 168 GTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISRRILKSE--PP---------YPQE 234 (290)
T ss_pred CCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHHHhhccC--CC---------CCcc
Confidence 78899999988653 467899999999999999999999854222111 111111111110 00 0111
Q ss_pred HHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 021682 233 KLMRCMQVALLCVQENAADRP-----TMLEILVM 261 (309)
Q Consensus 233 ~~~~l~~li~~~l~~~p~~Rp-----t~~ell~~ 261 (309)
....+.+++.+||+.+|++|| ++++++..
T Consensus 235 ~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 235 MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 233678999999999999997 77777764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=242.49 Aligned_cols=245 Identities=22% Similarity=0.300 Sum_probs=176.3
Q ss_pred ceEEEE-cCCCcEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeeEEee-CCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGR-LPNGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQ-REEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
.+|++. ..+|+.||+|.+... .......+..|++++++++||||+++.+++.. ....++++||+ +++|..++.
T Consensus 25 ~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~-- 101 (328)
T cd07856 25 LVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLT-- 101 (328)
T ss_pred EEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHh--
Confidence 456664 458999999987543 22345678889999999999999999998865 45789999998 568877763
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
...++...+..++.|+++|+.+||+. |++|+||+|+||+++.++.++|+|||.+....... ....++..|
T Consensus 102 --~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~y 171 (328)
T cd07856 102 --SRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQM-----TGYVSTRYY 171 (328)
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCCCc-----CCCcccccc
Confidence 23478888899999999999999998 89999999999999999999999999886433211 123467789
Q ss_pred CCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHH--------HHHhhCCCCcccccccCC-Ccc
Q 021682 160 VPPEYVRK-GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYA--------YGLWKNGEGMEFIDSSLD-DSS 229 (309)
Q Consensus 160 ~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~-~~~ 229 (309)
+|||.+.+ ..++.++|+||||+++|+|++|.+||............... ...+......+++..... ...
T Consensus 172 ~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (328)
T cd07856 172 RAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPV 251 (328)
T ss_pred cCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCC
Confidence 99998765 56789999999999999999999998644321111100000 000000001111100000 000
Q ss_pred c-----HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 230 S-----AWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 230 ~-----~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
+ ......+.++|.+||+.+|++|||+++++..
T Consensus 252 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 252 PFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred cHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 0123478899999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=245.36 Aligned_cols=251 Identities=22% Similarity=0.262 Sum_probs=177.2
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCC------eeEEEEeccCCCChh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQRE------EKMLIYDYMPNKSLD 73 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~~L~ 73 (309)
+.+|+|.. .+|+.||||.+.... ......+..|+.++++++|+||+++++++.... ..++|+||+. .+|.
T Consensus 29 g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~ 107 (342)
T cd07879 29 GSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQ 107 (342)
T ss_pred eEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEecccc-cCHH
Confidence 35677764 579999999986532 223456789999999999999999999886542 4689999985 4665
Q ss_pred HHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccc
Q 021682 74 FYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRI 153 (309)
Q Consensus 74 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 153 (309)
.+. ...+++..+..++.|++.|+++||+. |++||||+|+||+++.++.++|+|||++...... ....
T Consensus 108 ~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~-----~~~~ 174 (342)
T cd07879 108 KIM-----GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGY 174 (342)
T ss_pred HHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC-----CCCc
Confidence 553 22488999999999999999999998 8999999999999999999999999998654321 1123
Q ss_pred ccccCCCCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHH--------HHHhhCCCCccccccc
Q 021682 154 VGTYGYVPPEYVRK-GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYA--------YGLWKNGEGMEFIDSS 224 (309)
Q Consensus 154 ~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~ 224 (309)
.++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+........... ...+............
T Consensus 175 ~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (342)
T cd07879 175 VVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSL 254 (342)
T ss_pred eeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhc
Confidence 56788999998866 45789999999999999999999998643221111000000 0000000000000000
Q ss_pred ---CCCcc---cHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--HhcccC
Q 021682 225 ---LDDSS---SAWKLMRCMQVALLCVQENAADRPTMLEILVM--LKSETA 267 (309)
Q Consensus 225 ---~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~--L~~~~~ 267 (309)
..... .......+.++|.+||+.||++|||+++++.. ++...+
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 255 PKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred CCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 00000 00122367899999999999999999999965 666543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=244.24 Aligned_cols=249 Identities=21% Similarity=0.252 Sum_probs=177.0
Q ss_pred ceEEEE-cCCCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCC------eeEEEEeccCCCChhH
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQRE------EKMLIYDYMPNKSLDF 74 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~~L~~ 74 (309)
.||.+. ..+|+.||||.+.... ......+..|+.++++++|+||+++++++..+. ..++|||++ +++|.+
T Consensus 30 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~ 108 (343)
T cd07880 30 TVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGK 108 (343)
T ss_pred EEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHH
Confidence 456664 5589999999985432 223456889999999999999999999887654 358999998 678887
Q ss_pred HHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccc
Q 021682 75 YIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIV 154 (309)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~ 154 (309)
++. ...+++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 109 ~~~----~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~-----~~~~ 176 (343)
T cd07880 109 LMK----HEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM-----TGYV 176 (343)
T ss_pred HHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccccccccCc-----cccc
Confidence 763 23489999999999999999999998 89999999999999999999999999986543321 1235
Q ss_pred cccCCCCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHH--------HHHHhhCCCCcccccccC
Q 021682 155 GTYGYVPPEYVRK-GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEY--------AYGLWKNGEGMEFIDSSL 225 (309)
Q Consensus 155 ~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~ 225 (309)
++..|+|||.+.+ ..++.++|+||||+++|++++|..||...+.......... ....+.......+.....
T Consensus 177 ~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (343)
T cd07880 177 VTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLP 256 (343)
T ss_pred cCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhcc
Confidence 6788999998866 3578899999999999999999999864332111100000 000000000000000000
Q ss_pred CC------cccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--Hhcc
Q 021682 226 DD------SSSAWKLMRCMQVALLCVQENAADRPTMLEILVM--LKSE 265 (309)
Q Consensus 226 ~~------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~--L~~~ 265 (309)
.. .........+.++|.+||+.||++|||+.+++.. ++..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 257 RFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred ccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 00 0001122367899999999999999999999943 4444
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=226.67 Aligned_cols=236 Identities=23% Similarity=0.253 Sum_probs=186.0
Q ss_pred cceEEEEcC-CCcEEEEEEeecCCccc-HHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 3 VAICQGRLP-NGQEMAVKRLSRTSHQG-LEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 3 ~~~~~~~~~-~g~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
+.+|++... +|+.||+|.+....... ...+..|++.+++++|++++++++++..+...++++|++.+++|..++....
T Consensus 3 g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~ 82 (244)
T smart00220 3 GKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRG 82 (244)
T ss_pred eEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhcc
Confidence 367777765 58999999997654444 6789999999999999999999999999999999999999989999885432
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCC
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYV 160 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 160 (309)
.++...+..++.+++.++.+||+. |++|+||+|.||+++.++.++|+|||.+....... ......++..|+
T Consensus 83 ---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~ 153 (244)
T smart00220 83 ---RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYM 153 (244)
T ss_pred ---CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCC
Confidence 288899999999999999999998 89999999999999999999999999987665432 122335678899
Q ss_pred CccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHH
Q 021682 161 PPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQV 240 (309)
Q Consensus 161 aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 240 (309)
+||...+..++.++|+|+||++++++++|..||....... ............. .... ......+.++
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~------~~~~~~~~~~~~~-~~~~------~~~~~~~~~~ 220 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL------ELFKKIGKPKPPF-PPPE------WKISPEAKDL 220 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH------HHHHHHhccCCCC-cccc------ccCCHHHHHH
Confidence 9999988888999999999999999999999985421111 1111111111100 0000 0022378899
Q ss_pred HhhcccCCCCCCCCHHHHHH
Q 021682 241 ALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 241 i~~~l~~~p~~Rpt~~ell~ 260 (309)
+.+||..+|++||++.++++
T Consensus 221 i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 221 IRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHccCCchhccCHHHHhh
Confidence 99999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=243.86 Aligned_cols=245 Identities=22% Similarity=0.273 Sum_probs=174.3
Q ss_pred ceEEEE-cCCCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEeeC------CeeEEEEeccCCCChhH
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQR------EEKMLIYDYMPNKSLDF 74 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~~L~~ 74 (309)
.+|.+. ..+|+.||+|.+.... ......+.+|+.++++++|+||+++++++... ...+++++++ +++|.+
T Consensus 32 ~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~ 110 (345)
T cd07877 32 SVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNN 110 (345)
T ss_pred EEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHH
Confidence 456665 4689999999986532 22345677899999999999999999987643 3468888887 678877
Q ss_pred HHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccc
Q 021682 75 YIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIV 154 (309)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~ 154 (309)
++. ...+++..+..++.|++.|++|||+. |++|+||+|+||+++.++.++|+|||++...... .....
T Consensus 111 ~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~-----~~~~~ 178 (345)
T cd07877 111 IVK----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYV 178 (345)
T ss_pred HHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEeccccccccccc-----ccccc
Confidence 763 22488999999999999999999998 8999999999999999999999999998654322 11235
Q ss_pred cccCCCCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHH--------HHHhhCCCCcccc---c
Q 021682 155 GTYGYVPPEYVRK-GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYA--------YGLWKNGEGMEFI---D 222 (309)
Q Consensus 155 ~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~---~ 222 (309)
++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+........... ...+.......++ .
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (345)
T cd07877 179 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 258 (345)
T ss_pred cCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhc
Confidence 6788999998866 46788999999999999999999998543322111100000 0000000000000 0
Q ss_pred ccCCCcc---cHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 223 SSLDDSS---SAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 223 ~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
....... .......+.++|.+||+.||.+|||+.+++..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 259 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred ccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000000 00123367899999999999999999999976
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=235.97 Aligned_cols=253 Identities=24% Similarity=0.311 Sum_probs=189.1
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhc--CCCCCccceeeEEeeCC----eeEEEEeccCCCChhHHH
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTAR--LQHVNLLPVLGICTQRE----EKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~~----~~~lv~e~~~~~~L~~~~ 76 (309)
++||+|.+ +++.||||++... ..+.+.+|-++.+. ++|+||+++++.-.... .++||++|.+.|+|.+++
T Consensus 224 g~V~KaqL-~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL 299 (534)
T KOG3653|consen 224 GCVWKAQL-DNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYL 299 (534)
T ss_pred ceeehhhc-cCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHH
Confidence 46899988 5699999999643 45677788777665 58999999998866554 789999999999999999
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhc------CCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccc
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEY------SNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANT 150 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~------~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 150 (309)
.. ..++|....+++..++.||+|||+. ++++|+|||||..|||+.+++++.|+|||+|..+.........
T Consensus 300 ~~----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~ 375 (534)
T KOG3653|consen 300 KA----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDT 375 (534)
T ss_pred Hh----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcch
Confidence 43 3389999999999999999999974 4578999999999999999999999999999888766555555
Q ss_pred cccccccCCCCccccccCC-C-----CccchhhhHHHHHHHHHhCCCCCCCCCCCCccc----------HHHHHHHH-hh
Q 021682 151 GRIVGTYGYVPPEYVRKGI-Y-----SMKYDVYSYGVLLLQILGGKRTSCYYGPNESLN----------LLEYAYGL-WK 213 (309)
Q Consensus 151 ~~~~~~~~y~aPE~~~~~~-~-----~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~----------~~~~~~~~-~~ 213 (309)
...+||.+|||||++.+.- + -.+.||||+|.++||+++.-.-+......+..- -.+..+.. ..
T Consensus 376 ~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~ 455 (534)
T KOG3653|consen 376 HGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVR 455 (534)
T ss_pred hhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHh
Confidence 5578999999999997642 2 246899999999999998754432211111110 01111111 12
Q ss_pred CCCCcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccC
Q 021682 214 NGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETA 267 (309)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~ 267 (309)
+.....+.+..... ....-+.+.+..||..||+-|.|+.=+-+.+..+..
T Consensus 456 kK~RP~~p~~W~~h----~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 456 KKQRPKIPDAWRKH----AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred hccCCCChhhhhcC----ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 22222333322222 233467899999999999999999999888877643
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=243.22 Aligned_cols=246 Identities=23% Similarity=0.276 Sum_probs=177.6
Q ss_pred cceEEEEcC-CCcEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCe------eEEEEeccCCCChh
Q 021682 3 VAICQGRLP-NGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREE------KMLIYDYMPNKSLD 73 (309)
Q Consensus 3 ~~~~~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------~~lv~e~~~~~~L~ 73 (309)
+.+|.+... +++.||+|.+... .......+..|+.++++++|+|++++.+++..+.. .++|+|++ +++|.
T Consensus 29 g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~ 107 (343)
T cd07851 29 GQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLN 107 (343)
T ss_pred eEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHH
Confidence 467777654 6899999998643 22234567789999999999999999987765544 89999998 56898
Q ss_pred HHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccc
Q 021682 74 FYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRI 153 (309)
Q Consensus 74 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 153 (309)
+++.. ..+++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||.+...... ....
T Consensus 108 ~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-----~~~~ 175 (343)
T cd07851 108 NIVKC----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGY 175 (343)
T ss_pred HHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccccccccc-----ccCC
Confidence 88732 3489999999999999999999998 8999999999999999999999999998755332 1123
Q ss_pred ccccCCCCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHH--------HHHhhCCCCccccccc
Q 021682 154 VGTYGYVPPEYVRK-GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYA--------YGLWKNGEGMEFIDSS 224 (309)
Q Consensus 154 ~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~ 224 (309)
.++..|+|||.+.+ ..++.++||||||+++|++++|+.||............... ...+.......+....
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (343)
T cd07851 176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSL 255 (343)
T ss_pred cccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhc
Confidence 56778999998765 36789999999999999999999998643322111100000 0000000000000000
Q ss_pred C---CCcc---cHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 225 L---DDSS---SAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 225 ~---~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
. .... .......+.++|.+||+.+|++|||+.+|+..
T Consensus 256 ~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 256 PQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred cccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0 0000 00124478899999999999999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=239.79 Aligned_cols=252 Identities=23% Similarity=0.248 Sum_probs=175.7
Q ss_pred cceEEEEcC-C--CcEEEEEEeecCC--cccHHHHHHHHHHHhcC-CCCCccceeeEEeeC----CeeEEEEeccCCCCh
Q 021682 3 VAICQGRLP-N--GQEMAVKRLSRTS--HQGLEEFENEVKLTARL-QHVNLLPVLGICTQR----EEKMLIYDYMPNKSL 72 (309)
Q Consensus 3 ~~~~~~~~~-~--g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~----~~~~lv~e~~~~~~L 72 (309)
+.+|.+... + ++.||+|.+.... ....+.+..|+.+++++ .|+||+++++.+... ...+++++++. ++|
T Consensus 14 g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L 92 (332)
T cd07857 14 GIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADL 92 (332)
T ss_pred eEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCH
Confidence 356777653 4 7899999986432 22345678899999999 599999999875432 45789999985 578
Q ss_pred hHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccc--ccc
Q 021682 73 DFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECE--ANT 150 (309)
Q Consensus 73 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~--~~~ 150 (309)
.+++. ....+++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||.+......... ...
T Consensus 93 ~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 166 (332)
T cd07857 93 HQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM 166 (332)
T ss_pred HHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccc
Confidence 77773 344589999999999999999999998 8999999999999999999999999998755432211 112
Q ss_pred cccccccCCCCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHH--------HHHhhCCCCcccc
Q 021682 151 GRIVGTYGYVPPEYVRK-GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYA--------YGLWKNGEGMEFI 221 (309)
Q Consensus 151 ~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~ 221 (309)
....++..|+|||.+.+ ..++.++|+||+|+++|++++|.+||...+........... ...+.........
T Consensus 167 ~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (332)
T cd07857 167 TEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYI 246 (332)
T ss_pred cCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHH
Confidence 23467889999998765 46789999999999999999999998643321111000000 0000000000000
Q ss_pred ---cccCCC---cccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 222 ---DSSLDD---SSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 222 ---~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
...... .........+.+++.+||+.||++|||+.+++..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 247 RSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000 0000113478899999999999999999999855
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=231.60 Aligned_cols=242 Identities=15% Similarity=0.140 Sum_probs=166.2
Q ss_pred ceEEEEcCC----CcEEEEEEeecCCcccH-H----------HHHHHHHHHhcCCCCCccceeeEEeeCC----eeEEEE
Q 021682 4 AICQGRLPN----GQEMAVKRLSRTSHQGL-E----------EFENEVKLTARLQHVNLLPVLGICTQRE----EKMLIY 64 (309)
Q Consensus 4 ~~~~~~~~~----g~~vavK~~~~~~~~~~-~----------~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~ 64 (309)
.||++...+ +..+|+|.......... + ....+...+..+.|++++.+++.+.... ..++++
T Consensus 27 ~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~ 106 (294)
T PHA02882 27 CVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILL 106 (294)
T ss_pred eEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEecCCceEEEEEE
Confidence 567777543 45667775432221110 0 1122334456678999999998765443 346788
Q ss_pred eccCCCChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCC
Q 021682 65 DYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKD 144 (309)
Q Consensus 65 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~ 144 (309)
+++. .++.+.+.. ....++..+..++.|++.|+.|||+. |++||||||+||+++.++.++|+|||++......
T Consensus 107 ~~~~-~~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~ 179 (294)
T PHA02882 107 EKLV-ENTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIH 179 (294)
T ss_pred ehhc-cCHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcEEEEEcCCceeeccC
Confidence 8774 456655532 22357788899999999999999998 8999999999999999999999999998765432
Q ss_pred ccc-----ccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHH--HHHHhhCCCC
Q 021682 145 ECE-----ANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEY--AYGLWKNGEG 217 (309)
Q Consensus 145 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~ 217 (309)
... .......||..|+|||...+..++.++|||||||++|+|++|..||.............. ..........
T Consensus 180 ~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (294)
T PHA02882 180 GKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKI 259 (294)
T ss_pred CcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhhhhh
Confidence 111 111223689999999999999999999999999999999999999975533221111100 0111111100
Q ss_pred cccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHh
Q 021682 218 MEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLK 263 (309)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~ 263 (309)
. + . . ....+.+++..|++.+|++||+++++++.|+
T Consensus 260 -~-~----~-~----~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 260 -K-I----K-N----ANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred -c-c----C-C----CCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 0 0 0 0 1236889999999999999999999998763
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=248.84 Aligned_cols=230 Identities=22% Similarity=0.197 Sum_probs=176.4
Q ss_pred CccceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 1 MSVAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 1 ~g~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
||++-|-....+++..++|++..... +..+|+.++... +|+||+++.+.+.++.+.++|||.+.++-+.+.+...
T Consensus 335 ~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~ 410 (612)
T KOG0603|consen 335 FSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSK 410 (612)
T ss_pred ccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhc
Confidence 34444555567889999999865522 234677776666 7999999999999999999999999998776665322
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEe-CCCCCceeecccccccccCCcccccccccccccC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL-DYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~-~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
. .....+..|+.+|+.|+.|||.+ |++||||||+||++ +..++++|+|||.+...... .....-|..
T Consensus 411 ~----~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-----~~tp~~t~~ 478 (612)
T KOG0603|consen 411 P----EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-----CDTPALTLQ 478 (612)
T ss_pred c----hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh-----hcccchhhc
Confidence 2 22266677999999999999998 99999999999999 58899999999998765554 111234778
Q ss_pred CCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHH
Q 021682 159 YVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238 (309)
Q Consensus 159 y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (309)
|.|||......+++++|+||||+++|+|++|+.||...... ........ ....+...+....
T Consensus 479 y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------~ei~~~i~------------~~~~s~~vS~~AK 540 (612)
T KOG0603|consen 479 YVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------IEIHTRIQ------------MPKFSECVSDEAK 540 (612)
T ss_pred ccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------HHHHHhhc------------CCccccccCHHHH
Confidence 99999999999999999999999999999999998654332 00111111 1112234445788
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHhc
Q 021682 239 QVALLCVQENAADRPTMLEILVMLKS 264 (309)
Q Consensus 239 ~li~~~l~~~p~~Rpt~~ell~~L~~ 264 (309)
+||.+||+.||.+||++.++...=-.
T Consensus 541 dLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 541 DLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHHHHhccCChhhCcChhhhccCcch
Confidence 99999999999999999999876443
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=231.32 Aligned_cols=236 Identities=22% Similarity=0.244 Sum_probs=177.3
Q ss_pred ceEEEEc-CCCcEEEEEEeecC-----CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 4 AICQGRL-PNGQEMAVKRLSRT-----SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
.||++.. ..+..+++|.++.. .......+..|+.++++++||||+++++++......++|+||+.+++|.+++.
T Consensus 15 ~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~ 94 (260)
T cd08222 15 TVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLE 94 (260)
T ss_pred eEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHH
Confidence 4566654 34555667766432 12233456678999999999999999999998889999999999999998875
Q ss_pred hh-ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccc
Q 021682 78 DL-RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGT 156 (309)
Q Consensus 78 ~~-~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 156 (309)
.. .....+++..++.++.|++.|+.+||+. |++|+||+|+||+++. +.++|+|||.+......... .....++
T Consensus 95 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~~--~~~~~~~ 168 (260)
T cd08222 95 ELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCDL--ATTFTGT 168 (260)
T ss_pred HHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecCCCccc--ccCCCCC
Confidence 42 2345689999999999999999999998 9999999999999975 56999999988665433221 2223567
Q ss_pred cCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHH
Q 021682 157 YGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMR 236 (309)
Q Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
..|+|||.+.+..++.++|+||||+++|+|++|..||..... ...... ...... ...+.....+
T Consensus 169 ~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~-~~~~~~---------~~~~~~~~~~ 232 (260)
T cd08222 169 PYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVLR-IVEGPT---------PSLPETYSRQ 232 (260)
T ss_pred cCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHH-HHcCCC---------CCCcchhcHH
Confidence 889999998888889999999999999999999999853211 111111 111111 1112233447
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 237 CMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 237 l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
+.+++.+||+.+|++||++.++++.
T Consensus 233 ~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 233 LNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred HHHHHHHHhcCChhhCcCHHHHhhC
Confidence 8899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=254.89 Aligned_cols=236 Identities=22% Similarity=0.303 Sum_probs=180.3
Q ss_pred ccceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 2 SVAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 2 g~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
|++||+|.+ +|+.||||.+... ......+|+..|+.- +|||||++|+.-.++...||..|.|. .+|.+++....
T Consensus 523 Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~sL~dlie~~~ 597 (903)
T KOG1027|consen 523 GTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CSLQDLIESSG 597 (903)
T ss_pred CcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hhHHHHHhccc
Confidence 789999998 7899999988543 234567899999988 79999999998888889999999995 69999996531
Q ss_pred cccCCCH-HHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCC---C--CCceeecccccccccCCcccc-ccccc
Q 021682 81 RRYLLDW-RTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY---E--MNPKISDFGMARAFTKDECEA-NTGRI 153 (309)
Q Consensus 81 ~~~~~~~-~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~---~--~~~~l~Dfg~~~~~~~~~~~~-~~~~~ 153 (309)
....... ...+.++.|+++|+++||+. +|+||||||+||+|+. + ..++|+|||+++......... .....
T Consensus 598 ~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~ 674 (903)
T KOG1027|consen 598 LDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGG 674 (903)
T ss_pred cchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCC
Confidence 1111111 34577899999999999998 8999999999999976 2 458999999998887654432 23455
Q ss_pred ccccCCCCccccccCCCCccchhhhHHHHHHHHHhC-CCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHH
Q 021682 154 VGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGG-KRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAW 232 (309)
Q Consensus 154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (309)
.||.+|+|||.+.....+.++|||||||++|+.++| ..||+..-.. .............+.+...
T Consensus 675 sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--------~~NIl~~~~~L~~L~~~~d------ 740 (903)
T KOG1027|consen 675 SGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--------QANILTGNYTLVHLEPLPD------ 740 (903)
T ss_pred CCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh--------hhhhhcCccceeeeccCch------
Confidence 789999999999998888899999999999999985 8998643221 1122222222222211111
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 233 KLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 233 ~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
. +..+||.+|+..+|..||+|.+|+..
T Consensus 741 ~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 741 C--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred H--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 1 56699999999999999999999854
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=227.54 Aligned_cols=245 Identities=21% Similarity=0.276 Sum_probs=185.2
Q ss_pred CccceEEEEcCCCcEEEEEEeecCC-cccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 1 MSVAICQGRLPNGQEMAVKRLSRTS-HQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 1 ~g~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
||+|--....++|+..|||.++... ..+..++..|.+...+- +.|+||++|+.+..++-.+|.||+|. .+|+.+-..
T Consensus 77 fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~SlDklYk~ 155 (361)
T KOG1006|consen 77 FGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-ISLDKLYKR 155 (361)
T ss_pred chhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-hhHHHHHHH
Confidence 4555444556789999999997654 35677888898876665 89999999999999999999999994 577654321
Q ss_pred --hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccc
Q 021682 79 --LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGT 156 (309)
Q Consensus 79 --~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 156 (309)
......+++..+-.+....+.||.||-... .++|||+||+||+++..|.+||||||++......... +...|-
T Consensus 156 vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAk---T~daGC 230 (361)
T KOG1006|consen 156 VYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAK---TVDAGC 230 (361)
T ss_pred HHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHHHh---hhccCC
Confidence 123445899999999999999999999876 7999999999999999999999999998654443322 223577
Q ss_pred cCCCCcccccc--CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHH
Q 021682 157 YGYVPPEYVRK--GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKL 234 (309)
Q Consensus 157 ~~y~aPE~~~~--~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
..|+|||.+.. ..++-++|+||||+++||+.||..|+..++. ... .......+....+.. ........
T Consensus 231 rpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfe----ql~~Vv~gdpp~l~~----~~~~~~~s 300 (361)
T KOG1006|consen 231 RPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFE----QLCQVVIGDPPILLF----DKECVHYS 300 (361)
T ss_pred ccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHH----HHHHHHcCCCCeecC----cccccccC
Confidence 78999998864 3589999999999999999999999865433 111 112222222222221 12223345
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 235 MRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 235 ~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
..++.+|..||..|-++||.+.+++.+
T Consensus 301 ~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 301 FSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HHHHHHHHHHhhcccccCcchhhhhcC
Confidence 588999999999999999999999864
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=238.54 Aligned_cols=232 Identities=22% Similarity=0.259 Sum_probs=185.2
Q ss_pred cCCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccccCCC
Q 021682 10 LPNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLD 86 (309)
Q Consensus 10 ~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 86 (309)
..+|+.+|+|.+.+.. ........+|-.+|.+++.++||.+-..|++...+|+|+..|+||+|...+...+. ..++
T Consensus 207 raTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~-~gF~ 285 (591)
T KOG0986|consen 207 RATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGN-PGFD 285 (591)
T ss_pred ecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCC-CCCc
Confidence 3588999999875442 23345667899999999999999998889999999999999999999998876554 4599
Q ss_pred HHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCccccc
Q 021682 87 WRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVR 166 (309)
Q Consensus 87 ~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 166 (309)
+..+.-++.+|+.+|.+||.. +|+.||+||.||++|+.|+++|+|+|+|..+...... ...+||.+|||||++.
T Consensus 286 e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~---~~rvGT~GYMAPEvl~ 359 (591)
T KOG0986|consen 286 EQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI---RGRVGTVGYMAPEVLQ 359 (591)
T ss_pred hHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCCcc---ccccCcccccCHHHHc
Confidence 999999999999999999999 8999999999999999999999999999877765432 2238999999999999
Q ss_pred cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHHhhccc
Q 021682 167 KGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQ 246 (309)
Q Consensus 167 ~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 246 (309)
+..|+...|-|||||++|+|+.|+.||...........+... . ... ....+...+.++.+|.+..|+
T Consensus 360 ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr--~--~~~---------~~ey~~kFS~eakslc~~LL~ 426 (591)
T KOG0986|consen 360 NEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRR--T--LED---------PEEYSDKFSEEAKSLCEGLLT 426 (591)
T ss_pred CCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHH--H--hcc---------hhhcccccCHHHHHHHHHHHc
Confidence 999999999999999999999999999654443322222111 0 001 111222334477899999999
Q ss_pred CCCCCCC-----CHHHHHHH
Q 021682 247 ENAADRP-----TMLEILVM 261 (309)
Q Consensus 247 ~~p~~Rp-----t~~ell~~ 261 (309)
.||++|. .++++.+.
T Consensus 427 Kdp~~RLGcrg~ga~evk~H 446 (591)
T KOG0986|consen 427 KDPEKRLGCRGEGAQEVKEH 446 (591)
T ss_pred cCHHHhccCCCcCcchhhhC
Confidence 9999985 45566553
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=208.37 Aligned_cols=250 Identities=20% Similarity=0.227 Sum_probs=192.5
Q ss_pred ceEEEE-cCCCcEEEEEEeecCCc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTSH--QGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
+|++++ +++++-||+|.++-.++ ..-....+|+-+|+.++|.||++++++...++..-+|+|||. .+|..+....
T Consensus 17 tvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cd-qdlkkyfdsl- 94 (292)
T KOG0662|consen 17 TVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSL- 94 (292)
T ss_pred eeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh-HHHHHHHHhc-
Confidence 456665 56899999999875532 224567889999999999999999999999999999999995 5888887443
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCC
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYV 160 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 160 (309)
++.++...++.+..|++.++.++|++ ++.|||+||+|.+++.||.+||+|||+++.++-..... +...-|.+|.
T Consensus 95 -ng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvrcy--saevvtlwyr 168 (292)
T KOG0662|consen 95 -NGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY--SAEVVTLWYR 168 (292)
T ss_pred -CCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceEee--eceeeeeecc
Confidence 44589999999999999999999998 79999999999999999999999999998777654322 2235688999
Q ss_pred CccccccC-CCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCccc---ccccCCCcccH----
Q 021682 161 PPEYVRKG-IYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEF---IDSSLDDSSSA---- 231 (309)
Q Consensus 161 aPE~~~~~-~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~---- 231 (309)
+|.++.+. -|+...|+||.||++.|+.. |++.|...+..++...+.+..+...+.++... .+....+..+.
T Consensus 169 ppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattsw 248 (292)
T KOG0662|consen 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSW 248 (292)
T ss_pred CcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchH
Confidence 99998886 57999999999999999986 67777766666655555555554444444322 22222221111
Q ss_pred -----HHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 232 -----WKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 232 -----~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.....=.+++++.|.-+|..|.++++.++.
T Consensus 249 sqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 249 SQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred HHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 111234689999999999999999998753
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=254.15 Aligned_cols=237 Identities=25% Similarity=0.366 Sum_probs=188.6
Q ss_pred CcEEEEEEeecC-CcccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc-----cc---
Q 021682 13 GQEMAVKRLSRT-SHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR-----RR--- 82 (309)
Q Consensus 13 g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-----~~--- 82 (309)
...||||.++.. ...+.+.++.|+++++.+ .|+||+.+++.+..++..++|+||+..|+|..++...+ ..
T Consensus 328 ~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~ 407 (609)
T KOG0200|consen 328 YVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGV 407 (609)
T ss_pred eEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCC
Confidence 467999998765 345678899999999999 79999999999999889999999999999999996654 01
Q ss_pred -----cCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccc-ccccc
Q 021682 83 -----YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTG-RIVGT 156 (309)
Q Consensus 83 -----~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~-~~~~~ 156 (309)
..+.....+.++.||+.|++||++. .++||||-.+||+++.+..+|++|||+++...........+ ...-+
T Consensus 408 ~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP 484 (609)
T KOG0200|consen 408 FPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLP 484 (609)
T ss_pred CccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccc
Confidence 2388889999999999999999999 79999999999999999999999999998655443332111 11135
Q ss_pred cCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 157 YGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
..|||||.+....++.++||||||+++||+++ |..|+....... ........+... ..+.....
T Consensus 485 ~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~------~l~~~l~~G~r~---------~~P~~c~~ 549 (609)
T KOG0200|consen 485 VKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE------ELLEFLKEGNRM---------EQPEHCSD 549 (609)
T ss_pred eeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH------HHHHHHhcCCCC---------CCCCCCCH
Confidence 57999999999999999999999999999998 778875422111 112233333332 23333455
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHHhcccC
Q 021682 236 RCMQVALLCVQENAADRPTMLEILVMLKSETA 267 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~ 267 (309)
+++++++.||+.+|++||++.++.+.++....
T Consensus 550 eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 550 EIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred HHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 88899999999999999999999999998543
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=242.40 Aligned_cols=235 Identities=22% Similarity=0.287 Sum_probs=184.1
Q ss_pred ceEEEEc-CCCcEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 4 AICQGRL-PNGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
+||-|.. ++|+.||||++.+. .....+++++|+.+|+++.||.||.+...|++.+.+++|||-+. |++-+++.. .
T Consensus 579 ~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-GDMLEMILS-s 656 (888)
T KOG4236|consen 579 TVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-GDMLEMILS-S 656 (888)
T ss_pred eeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-chHHHHHHH-h
Confidence 4566654 69999999999654 23344789999999999999999999999999999999999995 466565533 3
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCC---CCceeecccccccccCCccccccccccccc
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYE---MNPKISDFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~---~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
+.+.+++..-..++.||+.||+|||-+ +|+|+||||+||++... -.+||+|||+|+.++..... ...+||+
T Consensus 657 EkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR---rsVVGTP 730 (888)
T KOG4236|consen 657 EKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR---RSVVGTP 730 (888)
T ss_pred hcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhhh---hhhcCCc
Confidence 345589888889999999999999999 89999999999999764 46999999999998876433 3348999
Q ss_pred CCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHH
Q 021682 158 GYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRC 237 (309)
Q Consensus 158 ~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (309)
.|+|||++.+..|+..-|+||.|+|+|--++|..||... .+....++.+.-......+. ......
T Consensus 731 AYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp~PW~-------------eis~~A 795 (888)
T KOG4236|consen 731 AYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPPNPWS-------------EISPEA 795 (888)
T ss_pred cccCHHHHhhccccccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCCCchh-------------hcCHHH
Confidence 999999999999999999999999999999999998432 22112222111111111111 123366
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHH
Q 021682 238 MQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 238 ~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.++|..+|+.+-++|-|.+..+..
T Consensus 796 idlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 796 IDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred HHHHHHHHHHHHHHhcchHhhccc
Confidence 799999999999999998876654
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-31 Score=229.35 Aligned_cols=251 Identities=18% Similarity=0.151 Sum_probs=184.3
Q ss_pred CccceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCC-----C---CCccceeeEEeeC----CeeEEEEeccC
Q 021682 1 MSVAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQ-----H---VNLLPVLGICTQR----EEKMLIYDYMP 68 (309)
Q Consensus 1 ~g~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~~iv~~~~~~~~~----~~~~lv~e~~~ 68 (309)
||+||.+-+..+.+.||+|+.+.. ....+..+.|+++|++++ | .+||+++++|... .++|||+|++
T Consensus 91 FSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL- 168 (590)
T KOG1290|consen 91 FSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL- 168 (590)
T ss_pred cceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-
Confidence 889999988889999999999543 344577889999999883 2 2799999999753 4899999999
Q ss_pred CCChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCC---------------------
Q 021682 69 NKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYE--------------------- 127 (309)
Q Consensus 69 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~--------------------- 127 (309)
|.+|-.++... .-..++...+..|+.|++.||.|||..+ ||+|.||||+|||+..+
T Consensus 169 GdnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~ 245 (590)
T KOG1290|consen 169 GDNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKM 245 (590)
T ss_pred hhHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchhhhhhhhccccccCCCC
Confidence 56777776543 3445899999999999999999999998 99999999999999000
Q ss_pred --------------------------------------------------------------------------------
Q 021682 128 -------------------------------------------------------------------------------- 127 (309)
Q Consensus 128 -------------------------------------------------------------------------------- 127 (309)
T Consensus 246 s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~ 325 (590)
T KOG1290|consen 246 SPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDS 325 (590)
T ss_pred CcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccccchhhccccccc
Confidence
Q ss_pred -----------------------------------------------------------------CCceeeccccccccc
Q 021682 128 -----------------------------------------------------------------MNPKISDFGMARAFT 142 (309)
Q Consensus 128 -----------------------------------------------------------------~~~~l~Dfg~~~~~~ 142 (309)
-++||+|||-|+...
T Consensus 326 ~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~ 405 (590)
T KOG1290|consen 326 NENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVH 405 (590)
T ss_pred ccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEEEeeccchhhhh
Confidence 013444555444333
Q ss_pred CCcccccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH-----------H-
Q 021682 143 KDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAY-----------G- 210 (309)
Q Consensus 143 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~-----------~- 210 (309)
...+ ....|..|+|||++.+..|+..+||||++|++|||.||...|.+...........-.. .
T Consensus 406 khFT-----~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~i 480 (590)
T KOG1290|consen 406 KHFT-----EDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKI 480 (590)
T ss_pred hhhc-----hhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHH
Confidence 2211 1234678999999999999999999999999999999999997665544332211111 1
Q ss_pred HhhCCCCcccccccC-------------------CCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 211 LWKNGEGMEFIDSSL-------------------DDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 211 ~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.........++.... .-..+.....++.+++.-||+++|++||||.++++.
T Consensus 481 a~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~h 550 (590)
T KOG1290|consen 481 ALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKH 550 (590)
T ss_pred HhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcC
Confidence 122223334443321 112234456688899999999999999999999976
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=250.15 Aligned_cols=252 Identities=26% Similarity=0.343 Sum_probs=205.8
Q ss_pred cceEEEEc-CCCc----EEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHH
Q 021682 3 VAICQGRL-PNGQ----EMAVKRLSRT-SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 3 ~~~~~~~~-~~g~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 76 (309)
+.||+|.| ..|+ +||+|++... ..+....+.+|+.++.++.|||++++++++..+. .-||++|++.|+|.+++
T Consensus 710 GtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyv 788 (1177)
T KOG1025|consen 710 GTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYV 788 (1177)
T ss_pred eeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHH
Confidence 45788876 4454 4789987554 4555678999999999999999999999998765 77899999999999999
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccc
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGT 156 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 156 (309)
.. .+..+.....+.|.+||++|+.|||.+ +++||||-.+||||.....+|+.|||++.....+..........-.
T Consensus 789 r~--hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~p 863 (1177)
T KOG1025|consen 789 RE--HRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVP 863 (1177)
T ss_pred HH--hhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccC
Confidence 65 444588889999999999999999998 8999999999999999999999999999888777666555555567
Q ss_pred cCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 157 YGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
+.|+|-|.+....++.++||||||+++||++| |..|+......+. ..+++...+-+.++-...
T Consensus 864 ikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI----------------~dlle~geRLsqPpiCti 927 (1177)
T KOG1025|consen 864 IKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI----------------PDLLEKGERLSQPPICTI 927 (1177)
T ss_pred cHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh----------------hHHHhccccCCCCCCccH
Confidence 78999999999999999999999999999998 8888765433332 222333333445555666
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHHhcccCCCCCCCCCC
Q 021682 236 RCMQVALLCVQENAADRPTMLEILVMLKSETADIKTPKKPA 276 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~~~~~~~p~ 276 (309)
++.-++.+||..|+..||+++++...+.+...++..-..++
T Consensus 928 DVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpqryl~i~ 968 (1177)
T KOG1025|consen 928 DVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQRYLVIQ 968 (1177)
T ss_pred HHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcceEeeeh
Confidence 88899999999999999999999999988776665544444
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-33 Score=227.36 Aligned_cols=228 Identities=20% Similarity=0.226 Sum_probs=184.2
Q ss_pred CccceEEEEcCCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 1 MSVAICQGRLPNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 1 ~g~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
||.|+.-....+|+.+|+|++++.. .+.+.--..|-++|+..+||++..+-..|.....+|+||||..||.|...+.
T Consensus 181 FGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLs 260 (516)
T KOG0690|consen 181 FGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLS 260 (516)
T ss_pred cceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehh
Confidence 7888877777899999999997653 3334455678899999999999999889999999999999999999987773
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
+...+++...+.+-..|+.||.|||++ +|+.||+|.+|+++|++|.+|++|||+.+.--.... .+..+.||+
T Consensus 261 ---rer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~--t~kTFCGTP 332 (516)
T KOG0690|consen 261 ---RERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGD--TTKTFCGTP 332 (516)
T ss_pred ---hhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcccccc--eeccccCCh
Confidence 344589999999999999999999998 899999999999999999999999999864333222 234568999
Q ss_pred CCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHH
Q 021682 158 GYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRC 237 (309)
Q Consensus 158 ~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (309)
.|+|||++....|..+.|-|.+|+++|+|++|+.||...++......+... +-.... ....+.
T Consensus 333 EYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e-----d~kFPr------------~ls~eA 395 (516)
T KOG0690|consen 333 EYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME-----DLKFPR------------TLSPEA 395 (516)
T ss_pred hhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh-----hccCCc------------cCCHHH
Confidence 999999999999999999999999999999999999765554433222211 111111 111256
Q ss_pred HHHHhhcccCCCCCCC
Q 021682 238 MQVALLCVQENAADRP 253 (309)
Q Consensus 238 ~~li~~~l~~~p~~Rp 253 (309)
..|+.-+|..||.+|.
T Consensus 396 ktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 396 KTLLSGLLKKDPKKRL 411 (516)
T ss_pred HHHHHHHhhcChHhhc
Confidence 6888899999999994
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=223.95 Aligned_cols=256 Identities=20% Similarity=0.234 Sum_probs=181.8
Q ss_pred cceEEEE-cCC----CcEEEEEEeecCCcc-c-HHHHHHHHHHHhcCCCCCccceeeEEee-CCeeEEEEeccCCCChhH
Q 021682 3 VAICQGR-LPN----GQEMAVKRLSRTSHQ-G-LEEFENEVKLTARLQHVNLLPVLGICTQ-REEKMLIYDYMPNKSLDF 74 (309)
Q Consensus 3 ~~~~~~~-~~~----g~~vavK~~~~~~~~-~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~ 74 (309)
+.||++. .++ .+.+|||.++...+. . ....-+|+..++.++|+|++.+..+|.. +..+++++||.+. +|..
T Consensus 38 G~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~ 116 (438)
T KOG0666|consen 38 GKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWH 116 (438)
T ss_pred ceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhhh-hHHH
Confidence 3467774 332 236899998654211 1 2344579999999999999999998877 7799999999975 6777
Q ss_pred HHhhh--ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCC----CCceeecccccccccCCcccc
Q 021682 75 YIFDL--RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYE----MNPKISDFGMARAFTKDECEA 148 (309)
Q Consensus 75 ~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~----~~~~l~Dfg~~~~~~~~~~~~ 148 (309)
.+... .....++...+..+++||+.++.|||+++ |+||||||.||++..+ |.+||+|+|+++.+.......
T Consensus 117 II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl 193 (438)
T KOG0666|consen 117 IIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPL 193 (438)
T ss_pred HHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeecccHHHHhhcccccc
Confidence 66432 23456889999999999999999999996 9999999999999877 899999999999876553322
Q ss_pred -cccccccccCCCCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCccc------HHHHHHHH---hhCCCC
Q 021682 149 -NTGRIVGTYGYVPPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLN------LLEYAYGL---WKNGEG 217 (309)
Q Consensus 149 -~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~------~~~~~~~~---~~~~~~ 217 (309)
.....+-|.+|+|||.+.|. .|+.+.|||+.|||+.||++..+.|...+...... .+...... .....+
T Consensus 194 ~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~W 273 (438)
T KOG0666|consen 194 ASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDW 273 (438)
T ss_pred ccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccc
Confidence 23344668999999999885 68999999999999999999999886433322111 11111111 111111
Q ss_pred ccc---------ccc---cCCCc--ccHH------HHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 021682 218 MEF---------IDS---SLDDS--SSAW------KLMRCMQVALLCVQENAADRPTMLEILVML 262 (309)
Q Consensus 218 ~~~---------~~~---~~~~~--~~~~------~~~~l~~li~~~l~~~p~~Rpt~~ell~~L 262 (309)
..+ +.. ..... .... ......+|+.++|++||-+|.|+++.++..
T Consensus 274 p~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 274 PDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred hhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 110 000 00000 0000 011356899999999999999999999874
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-31 Score=251.24 Aligned_cols=130 Identities=22% Similarity=0.319 Sum_probs=113.3
Q ss_pred ceEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
.||++.. .+++.||||+++... ......+..|+.+++.++|+||+++++++......++||||+.+++|.+++..
T Consensus 19 ~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~- 97 (669)
T cd05610 19 KVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHI- 97 (669)
T ss_pred EEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHh-
Confidence 4666655 479999999986542 22346788999999999999999999999999999999999999999998843
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccc
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMAR 139 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~ 139 (309)
...+++..++.++.||+.||.|||.. ||+|+||||+||+++.++.++|+|||++.
T Consensus 98 --~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 98 --YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 23478899999999999999999998 99999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=252.03 Aligned_cols=181 Identities=25% Similarity=0.321 Sum_probs=129.1
Q ss_pred eEEEEeccCCCChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccc
Q 021682 60 KMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMAR 139 (309)
Q Consensus 60 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~ 139 (309)
.||=||||+..++.+++.+.... -.....++++.+|++|++|+|++ |++||||||.|||+++++.|||+|||+++
T Consensus 671 LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt 745 (1351)
T KOG1035|consen 671 LYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLAT 745 (1351)
T ss_pred EEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHHHhC---ceeeccCCcceeEEcCCCCeeecccccch
Confidence 46779999988888777432211 15778899999999999999999 99999999999999999999999999998
Q ss_pred ccc------CC----------cccccccccccccCCCCccccccC---CCCccchhhhHHHHHHHHHhCCCCCCCCCCCC
Q 021682 140 AFT------KD----------ECEANTGRIVGTYGYVPPEYVRKG---IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNE 200 (309)
Q Consensus 140 ~~~------~~----------~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~ 200 (309)
... .. ......+...||..|+|||.+.+. .|+.|+|+||||++++||+. ||...
T Consensus 746 ~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts---- 818 (1351)
T KOG1035|consen 746 DLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTS---- 818 (1351)
T ss_pred hhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCch----
Confidence 721 00 001123356899999999999765 49999999999999999984 34321
Q ss_pred cccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021682 201 SLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
+..... ...+..+..... +. ........=.++|++||+.||.+||||.|||+
T Consensus 819 -MERa~i-L~~LR~g~iP~~--~~----f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 819 -MERASI-LTNLRKGSIPEP--AD----FFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred -HHHHHH-HHhcccCCCCCC--cc----cccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 111111 112223222222 01 11111123348999999999999999999985
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-33 Score=238.74 Aligned_cols=252 Identities=18% Similarity=0.190 Sum_probs=190.3
Q ss_pred CccceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCC------CCccceeeEEeeCCeeEEEEeccCCCChhH
Q 021682 1 MSVAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQH------VNLLPVLGICTQREEKMLIYDYMPNKSLDF 74 (309)
Q Consensus 1 ~g~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (309)
||+||-+-...-|+.||||++..+... ...=..|+++|++|+. -|+++++-.|...+++|||||.+ ..+|.+
T Consensus 445 Fs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRe 522 (752)
T KOG0670|consen 445 FSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLRE 522 (752)
T ss_pred eeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhh-hchHHH
Confidence 677777777777889999999765322 1233579999999952 28999999999999999999988 679999
Q ss_pred HHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCC-CCceeecccccccccCCccccccccc
Q 021682 75 YIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYE-MNPKISDFGMARAFTKDECEANTGRI 153 (309)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~~ 153 (309)
.+...+....+....+..++.|++-||..|-.+ ||+|.||||+|||++++ ..+||||||.|...+.+.... .
T Consensus 523 vLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~eneitP----Y 595 (752)
T KOG0670|consen 523 VLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFGSASFASENEITP----Y 595 (752)
T ss_pred HHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCccccccccccccH----H
Confidence 998888888899999999999999999999988 99999999999999876 568999999997766553221 2
Q ss_pred ccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHH-----hhCCCC-----------
Q 021682 154 VGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGL-----WKNGEG----------- 217 (309)
Q Consensus 154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~----------- 217 (309)
+-+-.|.|||++.|.+|+...|+||.||+||||.||...|................+. +..+..
T Consensus 596 LVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf 675 (752)
T KOG0670|consen 596 LVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNF 675 (752)
T ss_pred HHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccce
Confidence 3355899999999999999999999999999999999988654433322211111111 000000
Q ss_pred ----------------cccccc-----------cCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 218 ----------------MEFIDS-----------SLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 218 ----------------~~~~~~-----------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
+..+.+ .-...........|.+|+.+||..||++|.|..+.|..
T Consensus 676 ~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 676 LYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKH 746 (752)
T ss_pred EEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcC
Confidence 000000 00122223445688999999999999999999998853
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=223.47 Aligned_cols=251 Identities=24% Similarity=0.287 Sum_probs=184.4
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhc--CCCCCccceeeEEeeCC----eeEEEEeccCCCChhHHH
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTAR--LQHVNLLPVLGICTQRE----EKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~~----~~~lv~e~~~~~~L~~~~ 76 (309)
+-||+|.| -|+.||||++...+. ..+.+|.++.+. |+|+||+.+++.-..++ +++||++|.+.|+|.||+
T Consensus 225 GEVwrG~w-rGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL 300 (513)
T KOG2052|consen 225 GEVWRGRW-RGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYL 300 (513)
T ss_pred cceeeccc-cCCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHH
Confidence 45789998 589999999965443 456677777765 59999999998866554 689999999999999999
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhc-----CCCceeecCCCCceEEeCCCCCceeecccccccccCCccc--cc
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEY-----SNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECE--AN 149 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~-----~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~--~~ 149 (309)
.. ..++....++++..++.||++||.. .++.|.|||||..||+|.+|+.+.|+|+|+|......... ..
T Consensus 301 ~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~ 376 (513)
T KOG2052|consen 301 NR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIP 376 (513)
T ss_pred hh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCC
Confidence 43 4488999999999999999999963 3467999999999999999999999999999665543222 23
Q ss_pred ccccccccCCCCccccccCC------CCccchhhhHHHHHHHHHhC----------CCCCCCCCCCCcccHHHHHHHHhh
Q 021682 150 TGRIVGTYGYVPPEYVRKGI------YSMKYDVYSYGVLLLQILGG----------KRTSCYYGPNESLNLLEYAYGLWK 213 (309)
Q Consensus 150 ~~~~~~~~~y~aPE~~~~~~------~~~~~DvwslG~il~~ll~g----------~~p~~~~~~~~~~~~~~~~~~~~~ 213 (309)
.+...||.+|||||++...- .-..+||||||.++||+.-. +.||...-+.+..... ..
T Consensus 377 ~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~ee------Mr 450 (513)
T KOG2052|consen 377 PNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEE------MR 450 (513)
T ss_pred CCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHH------Hh
Confidence 44568999999999986532 12469999999999998643 2455333222211100 01
Q ss_pred CCCCcccccccC-CCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccC
Q 021682 214 NGEGMEFIDSSL-DDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETA 267 (309)
Q Consensus 214 ~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~ 267 (309)
+---.+.+++.. ..=.+......+.++++.||..||.-|-|+--+.+.|.++.+
T Consensus 451 kVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 451 KVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred cceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 111111111111 122233455678899999999999999999999999988754
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-32 Score=230.73 Aligned_cols=257 Identities=23% Similarity=0.296 Sum_probs=199.7
Q ss_pred CccceEEEEcCCCcEEEEEEeecC---CcccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHH
Q 021682 1 MSVAICQGRLPNGQEMAVKRLSRT---SHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 1 ~g~~~~~~~~~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 76 (309)
||.|..+.+..+.+.+|||++++. .+.+.+.-+.|-++|... +-|.++++...|.+-..+|+||||+.||+|-..+
T Consensus 362 FGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhi 441 (683)
T KOG0696|consen 362 FGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHI 441 (683)
T ss_pred cceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHH
Confidence 788888888888999999999865 345567777888888877 6889999999999999999999999999998888
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccc
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGT 156 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 156 (309)
++.+. +.+..+.-++..|+-+|-+||++ ||+.||||.+||+++..|.+||+|||+.+..-.... .+....||
T Consensus 442 QQ~Gk---FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~--TTkTFCGT 513 (683)
T KOG0696|consen 442 QQVGK---FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGV--TTKTFCGT 513 (683)
T ss_pred HHhcc---cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccccCCc--ceeeecCC
Confidence 55444 88899999999999999999999 999999999999999999999999999865433322 24456899
Q ss_pred cCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHH
Q 021682 157 YGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMR 236 (309)
Q Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
+.|+|||++...+|..++|-|++|+++|||+.|++||+..+..+....+ .+. ..+.+...+.+
T Consensus 514 PdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI-------~eh----------nvsyPKslSkE 576 (683)
T KOG0696|consen 514 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAI-------MEH----------NVSYPKSLSKE 576 (683)
T ss_pred CcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-------HHc----------cCcCcccccHH
Confidence 9999999999999999999999999999999999999765444322211 111 22333444447
Q ss_pred HHHHHhhcccCCCCCCCC----HH-HHHHH--H------hcccCCCCCCCCCCccccCC
Q 021682 237 CMQVALLCVQENAADRPT----ML-EILVM--L------KSETADIKTPKKPAFSVKRD 282 (309)
Q Consensus 237 l~~li~~~l~~~p~~Rpt----~~-ell~~--L------~~~~~~~~~~~~p~~~~~~~ 282 (309)
.+++....|..+|.+|.. .+ ++... + .-+...+.+|-+|...-++.
T Consensus 577 Av~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~k~~r~ 635 (683)
T KOG0696|consen 577 AVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPKIKCGRD 635 (683)
T ss_pred HHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCccccCCc
Confidence 788999999999999842 22 22211 1 11223567777777655443
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=239.97 Aligned_cols=239 Identities=21% Similarity=0.325 Sum_probs=188.9
Q ss_pred ccceEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCCccceeeEEee-----CCeeEEEEeccCCCChhH
Q 021682 2 SVAICQGR-LPNGQEMAVKRLSRTSHQGLEEFENEVKLTARL-QHVNLLPVLGICTQ-----REEKMLIYDYMPNKSLDF 74 (309)
Q Consensus 2 g~~~~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~ 74 (309)
++.||++. .++|+.+|+|+.....+ ..+.++.|+++|+.+ .|||++.+++++.. ++.++||||||.+|+..|
T Consensus 32 ygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTD 110 (953)
T KOG0587|consen 32 YGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTD 110 (953)
T ss_pred ceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHH
Confidence 35667775 35899999999865544 346788999999998 79999999998864 457999999999999999
Q ss_pred HHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccc
Q 021682 75 YIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIV 154 (309)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~ 154 (309)
++.... +..+.+..+..++..++.|+.+||.+ .++|||||-.||+++.++.+||+|||.+....... ...+...
T Consensus 111 LVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~--grRnT~i 184 (953)
T KOG0587|consen 111 LVKNTK-GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTV--GRRNTFI 184 (953)
T ss_pred HHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeeeccc--ccccCcC
Confidence 997654 66789999999999999999999998 69999999999999999999999999987655433 3345568
Q ss_pred cccCCCCccccccC-----CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcc
Q 021682 155 GTYGYVPPEYVRKG-----IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSS 229 (309)
Q Consensus 155 ~~~~y~aPE~~~~~-----~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (309)
||+.|||||++... .|+..+|+||||++..||-.|.+|+...-+.-.... -.-.+.+....
T Consensus 185 GtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~--------------IpRNPPPkLkr 250 (953)
T KOG0587|consen 185 GTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFL--------------IPRNPPPKLKR 250 (953)
T ss_pred CCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhcc--------------CCCCCCccccc
Confidence 99999999988643 467899999999999999999999754322221100 00111122222
Q ss_pred cHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 230 SAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 230 ~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
+..-..++-++|..||..|.+.||+..++++.
T Consensus 251 p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 251 PKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred hhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 33345578899999999999999999999864
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-32 Score=234.50 Aligned_cols=237 Identities=18% Similarity=0.180 Sum_probs=189.4
Q ss_pred CccceEEEEcCCCcEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 1 MSVAICQGRLPNGQEMAVKRLSRT---SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 1 ~g~~~~~~~~~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
||-|-......+...+|+|++++. +....+-...|-+++...+.|.|+++|-.|.++..+|++||-|-||.+...+.
T Consensus 433 FGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLr 512 (732)
T KOG0614|consen 433 FGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILR 512 (732)
T ss_pred cceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhh
Confidence 455555444322233788988654 23334456788999999999999999999999999999999999999988884
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
+ ++.|+..+...++..+++|+.|||++ ||+.|||||+|++++.+|.+||.|||+|+..+.....+ .+.||+
T Consensus 513 d---Rg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTw---TFcGTp 583 (732)
T KOG0614|consen 513 D---RGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTW---TFCGTP 583 (732)
T ss_pred h---cCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccCCcee---eecCCc
Confidence 4 44599999999999999999999999 89999999999999999999999999999888765433 357999
Q ss_pred CCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHH
Q 021682 158 GYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRC 237 (309)
Q Consensus 158 ~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (309)
.|.|||++.+..-+.++|.|+||+++|||++|.+||...++....+.+......+. .+.. .....
T Consensus 584 EYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~---~Pr~------------I~k~a 648 (732)
T KOG0614|consen 584 EYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIE---FPRR------------ITKTA 648 (732)
T ss_pred ccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhh---cccc------------cchhH
Confidence 99999999999999999999999999999999999987777665554443322221 1111 11245
Q ss_pred HHHHhhcccCCCCCCCC-----HHHHHHH
Q 021682 238 MQVALLCVQENAADRPT-----MLEILVM 261 (309)
Q Consensus 238 ~~li~~~l~~~p~~Rpt-----~~ell~~ 261 (309)
.++++++...+|.+|.. +.++...
T Consensus 649 ~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 649 TDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred HHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 68999999999999976 6666655
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-32 Score=221.53 Aligned_cols=254 Identities=22% Similarity=0.273 Sum_probs=189.6
Q ss_pred CccceEEEEcCCCcEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCC-----eeEEEEeccCCCChh
Q 021682 1 MSVAICQGRLPNGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQRE-----EKMLIYDYMPNKSLD 73 (309)
Q Consensus 1 ~g~~~~~~~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~~L~ 73 (309)
||+||...+-++|+.||+|.+... .-.+..++..|+++|..++|.|++..+++..-.. .+|+++|+|. .+|.
T Consensus 66 FGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQ-SDLH 144 (449)
T KOG0664|consen 66 FGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQ-SDLH 144 (449)
T ss_pred eeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHH-hhhh
Confidence 677777777789999999998654 2334567889999999999999999988765432 3678889884 5787
Q ss_pred HHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccc
Q 021682 74 FYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRI 153 (309)
Q Consensus 74 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 153 (309)
..+ .....++.+.+.-+++||+.+++|||+- ||+||||||.|.+++.|-.+||+|||+++......... ....
T Consensus 145 KII---VSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~h-MTqE 217 (449)
T KOG0664|consen 145 KII---VSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLN-MTHE 217 (449)
T ss_pred hee---ccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchhhhhh-hHHH
Confidence 776 4555688899999999999999999998 99999999999999999999999999998665443332 2234
Q ss_pred ccccCCCCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHH-----------------hhCC
Q 021682 154 VGTYGYVPPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGL-----------------WKNG 215 (309)
Q Consensus 154 ~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~-----------------~~~~ 215 (309)
+-|..|.|||++.|. .|+...||||.||++.|++..+..|...++.+....+-...+. +...
T Consensus 218 VVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~ 297 (449)
T KOG0664|consen 218 VVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAG 297 (449)
T ss_pred HHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccC
Confidence 568899999999885 6899999999999999999999888777766655433222111 0000
Q ss_pred CCcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 021682 216 EGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVML 262 (309)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L 262 (309)
....-+.-....+.......+.+.++.+++.+||.+|.+.++.+..+
T Consensus 298 ~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 298 LRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred CCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 00000011111122222233556889999999999999999998875
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=244.36 Aligned_cols=239 Identities=22% Similarity=0.236 Sum_probs=188.2
Q ss_pred CccceEEEEcCCCcEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 1 MSVAICQGRLPNGQEMAVKRLSRT---SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 1 ~g~~~~~~~~~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
||-|.......+++.+|+|++++- -......|.+|-.++..-..+=|+.+.-.|.++.++|+||||++||+|-.++.
T Consensus 88 FGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlS 167 (1317)
T KOG0612|consen 88 FGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLS 167 (1317)
T ss_pred cceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHHHh
Confidence 677777777788999999999762 23345778899999998889999999999999999999999999999988875
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
... .+++..++.++..|+-|+..+|+. |++||||||+||++|.+|++||+|||.+..+..++.. .....+|||
T Consensus 168 k~~---~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V-~s~~aVGTP 240 (1317)
T KOG0612|consen 168 KFD---RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV-RSSVAVGTP 240 (1317)
T ss_pred hcC---CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcCCCCcE-EeccccCCC
Confidence 444 499999999999999999999999 9999999999999999999999999998776655433 233458999
Q ss_pred CCCCccccc----c-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCC-CCcccccccCCCcccH
Q 021682 158 GYVPPEYVR----K-GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNG-EGMEFIDSSLDDSSSA 231 (309)
Q Consensus 158 ~y~aPE~~~----~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 231 (309)
-|++||++. + +.|....|-||+|+++|||+.|..||.... .+ ..++..... ....|.+ . .
T Consensus 241 DYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------lv-eTY~KIm~hk~~l~FP~-~------~ 306 (1317)
T KOG0612|consen 241 DYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------LV-ETYGKIMNHKESLSFPD-E------T 306 (1317)
T ss_pred CccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH------HH-HHHHHHhchhhhcCCCc-c------c
Confidence 999999884 2 468899999999999999999999985321 11 122222222 2222221 1 1
Q ss_pred HHHHHHHHHHhhcccCCCCCCCC---HHHHHHH
Q 021682 232 WKLMRCMQVALLCVQENAADRPT---MLEILVM 261 (309)
Q Consensus 232 ~~~~~l~~li~~~l~~~p~~Rpt---~~ell~~ 261 (309)
..+....+||++.+. +|+.|-. ++++...
T Consensus 307 ~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 307 DVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred ccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 134467788888776 6788877 8888876
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=200.34 Aligned_cols=189 Identities=23% Similarity=0.330 Sum_probs=155.0
Q ss_pred ccceEEEEcCCCcEEEEEEeecC-CcccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh-
Q 021682 2 SVAICQGRLPNGQEMAVKRLSRT-SHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD- 78 (309)
Q Consensus 2 g~~~~~~~~~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~- 78 (309)
|.+.-.....+|+..|+|.+... ..+...++.+|+.+..+. .+|+++.+|+.......+++.||.|. .+|+.+-..
T Consensus 60 G~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~-tSldkfy~~v 138 (282)
T KOG0984|consen 60 GVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD-TSLDKFYRKV 138 (282)
T ss_pred chhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh-hhHHHHHHHH
Confidence 44444445579999999999765 345566788888887665 79999999999888889999999995 578776533
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
...+..+++..+-+++..+++|+.|||++- .++|||+||+||+++..|.+|+||||++......... +...|-..
T Consensus 139 ~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAk---t~daGCkp 213 (282)
T KOG0984|consen 139 LKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAK---TMDAGCKP 213 (282)
T ss_pred HhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhhhHH---HHhcCCCc
Confidence 456777999999999999999999999975 7999999999999999999999999998765554322 22356678
Q ss_pred CCCcccccc----CCCCccchhhhHHHHHHHHHhCCCCCCCC
Q 021682 159 YVPPEYVRK----GIYSMKYDVYSYGVLLLQILGGKRTSCYY 196 (309)
Q Consensus 159 y~aPE~~~~----~~~~~~~DvwslG~il~~ll~g~~p~~~~ 196 (309)
|+|||.+.. ..|+-++||||||+.+.||.+++.|+..+
T Consensus 214 YmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 214 YMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred cCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 999998854 36899999999999999999999998654
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=220.16 Aligned_cols=240 Identities=25% Similarity=0.370 Sum_probs=177.5
Q ss_pred eEEE-EcCCCcEEEEEEee--cCCccc-----HHHHHHHHHHHhcCCCCCccceeeEEeeCC-eeEEEEeccCCCChhHH
Q 021682 5 ICQG-RLPNGQEMAVKRLS--RTSHQG-----LEEFENEVKLTARLQHVNLLPVLGICTQRE-EKMLIYDYMPNKSLDFY 75 (309)
Q Consensus 5 ~~~~-~~~~g~~vavK~~~--~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~~~L~~~ 75 (309)
||++ ++...+.||||+-. +..... ..-..+|.++-+.|.||.||++|++|.-+. .+|-|.|||+|.+|+.|
T Consensus 479 VyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFY 558 (775)
T KOG1151|consen 479 VYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFY 558 (775)
T ss_pred HHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHH
Confidence 3444 45678999999753 221111 123457899999999999999999997654 68999999999999999
Q ss_pred HhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCC---CCCceeecccccccccCCccccc---
Q 021682 76 IFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY---EMNPKISDFGMARAFTKDECEAN--- 149 (309)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~---~~~~~l~Dfg~~~~~~~~~~~~~--- 149 (309)
+. ....+++..++.|+.||+.||.||.+. ...|+|.||||.||++.. .|.+||+|||+++.+........
T Consensus 559 LK---QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGm 634 (775)
T KOG1151|consen 559 LK---QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGM 634 (775)
T ss_pred HH---hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccce
Confidence 84 455589999999999999999999986 458999999999999954 47799999999998865544322
Q ss_pred --ccccccccCCCCccccccC----CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccc
Q 021682 150 --TGRIVGTYGYVPPEYVRKG----IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDS 223 (309)
Q Consensus 150 --~~~~~~~~~y~aPE~~~~~----~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (309)
+....||.+|++||++.-+ +++.+.||||+|+|+|.++-|+.||+...... ..+.. ...+.... .++ .+
T Consensus 635 eLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ--dILqe-NTIlkAtE-VqF-P~ 709 (775)
T KOG1151|consen 635 ELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ--DILQE-NTILKATE-VQF-PP 709 (775)
T ss_pred eeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH--HHHhh-hchhccee-ccC-CC
Confidence 3455799999999988543 56899999999999999999999996432211 11111 01111111 111 11
Q ss_pred cCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 021682 224 SLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEIL 259 (309)
Q Consensus 224 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell 259 (309)
. +....+..++|++||++--++|....++.
T Consensus 710 K------PvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 710 K------PVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred C------CccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 1 12233667999999999999999887764
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=202.60 Aligned_cols=238 Identities=20% Similarity=0.289 Sum_probs=175.4
Q ss_pred eEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCC-CCCccceeeEEeeCC--eeEEEEeccCCCChhHHHhhhc
Q 021682 5 ICQGR-LPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQ-HVNLLPVLGICTQRE--EKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 5 ~~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
|+.|. ..+.++++||++++.. ...+.+|+++|..|. ||||++++++..++. ...|++|+.++.++..+- .
T Consensus 54 VFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly---~ 127 (338)
T KOG0668|consen 54 VFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLY---P 127 (338)
T ss_pred HhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHh---h
Confidence 45564 3578999999997643 357899999999995 999999999987654 689999999988776554 1
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCC-CCceeecccccccccCCcccccccccccccCC
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYE-MNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
. +....+..++.++++||.|+|+. ||.|||+||+|++++.. ..++|+|||+|.++...... +..+.+..|
T Consensus 128 t---l~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eY---nVRVASRyf 198 (338)
T KOG0668|consen 128 T---LTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYF 198 (338)
T ss_pred h---hchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCCcee---eeeeehhhc
Confidence 1 56667888999999999999999 99999999999999874 66999999999887765432 223567789
Q ss_pred CCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCC-CCCCCCcccHHHHHHHH------h------------------h
Q 021682 160 VPPEYVRK-GIYSMKYDVYSYGVLLLQILGGKRTSC-YYGPNESLNLLEYAYGL------W------------------K 213 (309)
Q Consensus 160 ~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~-~~~~~~~~~~~~~~~~~------~------------------~ 213 (309)
..||.+.. ..++.+-|+|||||++..|+..+.||- ..+..++...+....+. . .
T Consensus 199 KGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~ 278 (338)
T KOG0668|consen 199 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHS 278 (338)
T ss_pred CCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccc
Confidence 99998865 467999999999999999999988873 23332332222221110 0 0
Q ss_pred CCCCcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 214 NGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
...+..++.+. .......+..+++.++|.+|-.+|+|+.|....
T Consensus 279 rk~w~~Fi~~~----n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 279 RKPWSRFINSE----NQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred cccHHHhCCcc----ccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 01111222111 111123477799999999999999999998753
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=212.37 Aligned_cols=251 Identities=22% Similarity=0.341 Sum_probs=176.3
Q ss_pred EEEE-cCCCcEEEEEEeecCCc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeC--------CeeEEEEeccCCCChhH
Q 021682 6 CQGR-LPNGQEMAVKRLSRTSH--QGLEEFENEVKLTARLQHVNLLPVLGICTQR--------EEKMLIYDYMPNKSLDF 74 (309)
Q Consensus 6 ~~~~-~~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~ 74 (309)
|+++ .++|+.||+|.+..... .--....+|+++|..++|+|++.++++|... ..+++||.+|+. +|.-
T Consensus 34 FkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaG 112 (376)
T KOG0669|consen 34 FKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAG 112 (376)
T ss_pred HHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHH
Confidence 3443 45788899986533211 1123456799999999999999999887542 358999999975 6777
Q ss_pred HHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccc--ccccc
Q 021682 75 YIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECE--ANTGR 152 (309)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~ 152 (309)
++.+ ....++...+..+..++..+|.|+|.. .|+|||+|+.|++|+.+|.++|+|||+++.+...... .....
T Consensus 113 lLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytn 187 (376)
T KOG0669|consen 113 LLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTN 187 (376)
T ss_pred HhcC--ccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCccc
Confidence 7643 234589999999999999999999998 7999999999999999999999999999766543222 22233
Q ss_pred cccccCCCCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHH-----hhCCCCccccccc--
Q 021682 153 IVGTYGYVPPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGL-----WKNGEGMEFIDSS-- 224 (309)
Q Consensus 153 ~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~-- 224 (309)
.+-|.+|++||.+.|. .+.++.|+|..||++.+|+++.+-+...........+....+- |..-.-..+..+.
T Consensus 188 rvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ 267 (376)
T KOG0669|consen 188 RVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIEL 267 (376)
T ss_pred ceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccC
Confidence 4568899999988775 6899999999999999999998876543332222222222111 2211111111111
Q ss_pred --CCCccc---------HHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 021682 225 --LDDSSS---------AWKLMRCMQVALLCVQENAADRPTMLEILVML 262 (309)
Q Consensus 225 --~~~~~~---------~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L 262 (309)
+..... -.......+++.++|..||.+|+++++++..-
T Consensus 268 ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 268 EPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred CCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 000000 00112567999999999999999999998763
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=207.67 Aligned_cols=280 Identities=20% Similarity=0.272 Sum_probs=201.3
Q ss_pred ceEEEEcCCCcEEEEEEeecC---CcccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGRLPNGQEMAVKRLSRT---SHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~~~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
|+.....++.+-+|+|++++. .+.+.+-...|-.+..+. +||+++.+...|.++..+++|.||.+||+|-....
T Consensus 266 vl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhmq-- 343 (593)
T KOG0695|consen 266 VLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ-- 343 (593)
T ss_pred hhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeehh--
Confidence 344444568899999998764 444555566666666665 89999999999999999999999999999976653
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
+...++++.++.+...|+-|+.|||+. ||+.||||.+|++++..|.+||+|+|+.+....... .++.+.||+.|
T Consensus 344 -rqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~~gd--~tstfcgtpny 417 (593)
T KOG0695|consen 344 -RQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGD--TTSTFCGTPNY 417 (593)
T ss_pred -hhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCCCCc--ccccccCCCcc
Confidence 333499999999999999999999999 999999999999999999999999999875444333 24456899999
Q ss_pred CCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCC-cccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHH
Q 021682 160 VPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNE-SLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238 (309)
Q Consensus 160 ~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (309)
+|||++.+..|....|-|+||+++++|+.|+.||..-+... ..+...+........++. +. .+.+. +..
T Consensus 418 iapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir-ip-----rslsv----kas 487 (593)
T KOG0695|consen 418 IAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR-IP-----RSLSV----KAS 487 (593)
T ss_pred cchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc-cc-----ceeeh----hhH
Confidence 99999999999999999999999999999999996433221 122233333322222211 11 11111 444
Q ss_pred HHHhhcccCCCCCCC------CHHHHHH----------HHhcccCCCCCCCCCCcc-ccCCccchhhhhccccccccCCc
Q 021682 239 QVALLCVQENAADRP------TMLEILV----------MLKSETADIKTPKKPAFS-VKRDNDEISECMLEANIYSVDDA 301 (309)
Q Consensus 239 ~li~~~l~~~p~~Rp------t~~ell~----------~L~~~~~~~~~~~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~ 301 (309)
.+++..|..||.+|. .++++.. +|+ +++ ..+|-.|... ...--..+.+++...-++++++.
T Consensus 488 ~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~le-qk~-v~ppf~p~i~~d~~l~~fd~qft~e~~qltpdd~ 565 (593)
T KOG0695|consen 488 HVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLE-QKQ-VLPPFQPQITDDYGLDNFDTQFTSEPVQLTPDDE 565 (593)
T ss_pred HHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHh-hcc-cCCCCCCccccccCccccccccccCCcccCCCCH
Confidence 778889999999984 2344432 233 222 3444444432 22233457778877778887776
Q ss_pred cc
Q 021682 302 TI 303 (309)
Q Consensus 302 ~~ 303 (309)
++
T Consensus 566 d~ 567 (593)
T KOG0695|consen 566 DA 567 (593)
T ss_pred HH
Confidence 54
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=199.12 Aligned_cols=204 Identities=30% Similarity=0.460 Sum_probs=173.0
Q ss_pred cceEEEEcC-CCcEEEEEEeecCCcc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 3 VAICQGRLP-NGQEMAVKRLSRTSHQ-GLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 3 ~~~~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
+.+|++... +|+.+++|.+...... ..+.+.+|++.++.++|++++++++++......++++|++.+++|.+++....
T Consensus 7 ~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~ 86 (215)
T cd00180 7 GTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENE 86 (215)
T ss_pred eEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhcc
Confidence 467888764 4899999999755432 35678999999999999999999999999899999999999899999885431
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCC-CCCceeecccccccccCCcccccccccccccCC
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY-EMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
..++...+..++.+++.++.+||+. |++|+||+|.||+++. ++.++|+||+.+........ ......+...|
T Consensus 87 --~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~ 159 (215)
T cd00180 87 --GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAY 159 (215)
T ss_pred --CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCCCCc
Confidence 3488899999999999999999998 9999999999999999 89999999999876544321 12223567789
Q ss_pred CCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHH
Q 021682 160 VPPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238 (309)
Q Consensus 160 ~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (309)
++||..... ..+.++|+|++|++++++ ..+.
T Consensus 160 ~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------~~~~ 191 (215)
T cd00180 160 MAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------PELK 191 (215)
T ss_pred cChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------HHHH
Confidence 999998776 778999999999999998 2677
Q ss_pred HHHhhcccCCCCCCCCHHHHHHH
Q 021682 239 QVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 239 ~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
+++.+|++.+|++||++.+++..
T Consensus 192 ~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 192 DLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHhhCCcccCcCHHHHhhC
Confidence 99999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=222.39 Aligned_cols=195 Identities=20% Similarity=0.330 Sum_probs=162.8
Q ss_pred CccceEEEEcCCCcEEEEEEeecCCcc---cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 1 MSVAICQGRLPNGQEMAVKRLSRTSHQ---GLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 1 ~g~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
||-|-.....++...+|+|.+++.+.- ...-.+.|-.||..-..+-||++|-.|.+...+|+||+|++||++-.++.
T Consensus 642 FGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLI 721 (1034)
T KOG0608|consen 642 FGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLI 721 (1034)
T ss_pred cceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHH
Confidence 676767777777888899988765422 23446789999999999999999999999999999999999999999886
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcc--------cc-
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDEC--------EA- 148 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~--------~~- 148 (309)
..+ .|++..++.++.++..|+.+.|.. |++||||||+|||||.+|.+||+|||++.-+.-... ..
T Consensus 722 rmg---IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~R 795 (1034)
T KOG0608|consen 722 RMG---IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHR 795 (1034)
T ss_pred Hhc---cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceeccccccccCCCccc
Confidence 544 499999999999999999999999 999999999999999999999999999854311000 00
Q ss_pred -------------------------------cccccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 021682 149 -------------------------------NTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYG 197 (309)
Q Consensus 149 -------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~ 197 (309)
.....+||+.|+|||++....++...|-||.|+|||+|+.|++||....
T Consensus 796 qDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~t 875 (1034)
T KOG0608|consen 796 QDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADT 875 (1034)
T ss_pred cccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCC
Confidence 0013469999999999999999999999999999999999999997666
Q ss_pred CCCc
Q 021682 198 PNES 201 (309)
Q Consensus 198 ~~~~ 201 (309)
+.+.
T Consensus 876 p~~t 879 (1034)
T KOG0608|consen 876 PGET 879 (1034)
T ss_pred CCcc
Confidence 5543
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-30 Score=214.49 Aligned_cols=242 Identities=21% Similarity=0.276 Sum_probs=187.3
Q ss_pred ceEEEEc------CCCcEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeeEEeeC-CeeEEEEeccCCCChhHH
Q 021682 4 AICQGRL------PNGQEMAVKRLSRT-SHQGLEEFENEVKLTARLQHVNLLPVLGICTQR-EEKMLIYDYMPNKSLDFY 75 (309)
Q Consensus 4 ~~~~~~~------~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~ 75 (309)
.+|+|.| ++.+.|-+|-++.. +.-....+..|.-.+..+.|||+.++.+++..+ ...++++.++.-|+|..+
T Consensus 299 ri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~F 378 (563)
T KOG1024|consen 299 RIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSF 378 (563)
T ss_pred heeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHH
Confidence 4677744 44566777766544 333456777888888889999999999987665 467888999988999999
Q ss_pred Hh-----hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccc
Q 021682 76 IF-----DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANT 150 (309)
Q Consensus 76 ~~-----~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 150 (309)
+. +......+...+...++.|++.|++|||.. |++|.||-.+|++|++.-.+||+|=.+++...........
T Consensus 379 L~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLG 455 (563)
T KOG1024|consen 379 LQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLG 455 (563)
T ss_pred HHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEeccchhccccCcccccccC
Confidence 96 223344566778888999999999999998 9999999999999999999999999888766544433222
Q ss_pred cccccccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcc
Q 021682 151 GRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSS 229 (309)
Q Consensus 151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (309)
...-.+..||+||.+.+..++..+|+||||+++|||++ |+.|+...++.+.. ....++. +...
T Consensus 456 DnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~-------~ylkdGy---------RlaQ 519 (563)
T KOG1024|consen 456 DNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME-------HYLKDGY---------RLAQ 519 (563)
T ss_pred CCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH-------HHHhccc---------eecC
Confidence 22345678999999999999999999999999999998 88887666555421 2222222 2223
Q ss_pred cHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 021682 230 SAWKLMRCMQVALLCVQENAADRPTMLEILVMLKS 264 (309)
Q Consensus 230 ~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~ 264 (309)
+..++.+|..++.-||...|++||+++++...|..
T Consensus 520 P~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 520 PFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 33455589999999999999999999999998875
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=225.56 Aligned_cols=246 Identities=17% Similarity=0.123 Sum_probs=148.2
Q ss_pred cceEEEEcC-C----CcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeE------EeeCCeeEEEEeccCCCC
Q 021682 3 VAICQGRLP-N----GQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGI------CTQREEKMLIYDYMPNKS 71 (309)
Q Consensus 3 ~~~~~~~~~-~----g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~------~~~~~~~~lv~e~~~~~~ 71 (309)
+.||+|... + ++.||+|.+..... .+....+ .+....+.++..++.. ...+...++|+||+.+++
T Consensus 146 G~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~LV~ey~~~gs 221 (566)
T PLN03225 146 GVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGEST 221 (566)
T ss_pred eEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceEEEEEecCCCc
Confidence 367788764 5 78999998754322 1111211 1122222222222111 234567899999999999
Q ss_pred hhHHHhhhcc-----------------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCC-CCCceee
Q 021682 72 LDFYIFDLRR-----------------RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY-EMNPKIS 133 (309)
Q Consensus 72 L~~~~~~~~~-----------------~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~-~~~~~l~ 133 (309)
|.+++..... +.......+..++.|++.||.|||+. ||+||||||+||+++. ++.+||+
T Consensus 222 L~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~NILl~~~~~~~KL~ 298 (566)
T PLN03225 222 LADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQNIIFSEGSGSFKII 298 (566)
T ss_pred HHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHHEEEeCCCCcEEEE
Confidence 9988754221 01112344667999999999999998 8999999999999986 5789999
Q ss_pred cccccccccCCcccccccccccccCCCCccccccC----------------------CCCccchhhhHHHHHHHHHhCCC
Q 021682 134 DFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKG----------------------IYSMKYDVYSYGVLLLQILGGKR 191 (309)
Q Consensus 134 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~DvwslG~il~~ll~g~~ 191 (309)
|||++......... ......+++.|+|||.+... .++.++|||||||++|+|+++..
T Consensus 299 DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~ 377 (566)
T PLN03225 299 DLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNL 377 (566)
T ss_pred eCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcC
Confidence 99999754332211 22334678899999965322 23345699999999999998655
Q ss_pred CCCCCCCCCcccHHHHH------HHHhhCCCCcccccccCCCcc--cHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 192 TSCYYGPNESLNLLEYA------YGLWKNGEGMEFIDSSLDDSS--SAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 192 p~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
++.. +........ ...|....... ......... .........+||.+||+.||++|||++++++.
T Consensus 378 ~~~~----~~~~~~~~l~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 378 RSDS----NLIQFNRQLKRNDYDLVAWRKLVEPR-ASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred CCch----HHHHHHHHHHhcCCcHHHHHHhhccc-cchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhCC
Confidence 4321 000000000 00111000000 000000000 00011234589999999999999999999986
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=207.46 Aligned_cols=238 Identities=25% Similarity=0.262 Sum_probs=175.8
Q ss_pred CCcEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCC------eeEEEEeccCCCChhHHHhhhcccc
Q 021682 12 NGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQRE------EKMLIYDYMPNKSLDFYIFDLRRRY 83 (309)
Q Consensus 12 ~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~ 83 (309)
.++.||+|.+... ......+...|...+..++|+||++++.+|.-.. .+|+|||+|. .+|...+. .
T Consensus 40 ~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~-~nl~~vi~-----~ 113 (369)
T KOG0665|consen 40 LGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMD-ANLCQVIL-----M 113 (369)
T ss_pred ccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhh-hHHHHHHH-----H
Confidence 6889999976433 2233456678999999999999999999986543 5799999995 68877763 2
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCcc
Q 021682 84 LLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPE 163 (309)
Q Consensus 84 ~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 163 (309)
.++=.++..+++|++.|+++||+. ||+||||||+||++..+..+|+.|||++...... ...+....+..|.|||
T Consensus 114 elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~---~~mtpyVvtRyyrape 187 (369)
T KOG0665|consen 114 ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD---FMMTPYVVTRYYRAPE 187 (369)
T ss_pred hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccCcc---cccCchhheeeccCch
Confidence 266678899999999999999999 9999999999999999999999999999754443 1233346678999999
Q ss_pred ccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHH----------------hh-CC-----CCccc-
Q 021682 164 YVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGL----------------WK-NG-----EGMEF- 220 (309)
Q Consensus 164 ~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~----------------~~-~~-----~~~~~- 220 (309)
++.+..+.+.+||||+||++.+|+.|...|...+..+....+....+. .. .. ...+.
T Consensus 188 vil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~f 267 (369)
T KOG0665|consen 188 VILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELF 267 (369)
T ss_pred heeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhC
Confidence 999988999999999999999999999888754444433222111110 00 00 00111
Q ss_pred ccccCC--CcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 221 IDSSLD--DSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 221 ~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.+.... ...+......+.+++.+||..||++|.+++++|..
T Consensus 268 pD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 268 PDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred CcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 111111 11122334467799999999999999999999986
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-29 Score=198.47 Aligned_cols=282 Identities=16% Similarity=0.209 Sum_probs=206.7
Q ss_pred CccceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCCccceeeE-EeeCCeeEEEEeccCCCChhHHHhh
Q 021682 1 MSVAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARL-QHVNLLPVLGI-CTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 1 ~g~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~-~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
||......+..+.+.+++|.+.... .....|.+|...--.| .|.||+..|++ |...+.+++++||++.|+|...+..
T Consensus 37 FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~ 115 (378)
T KOG1345|consen 37 FGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEA 115 (378)
T ss_pred eeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCc
Confidence 5666666666788999999985442 3356788888776667 58899998865 5666788899999999999888733
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCC--CCceeecccccccccCCcccccccccccc
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYE--MNPKISDFGMARAFTKDECEANTGRIVGT 156 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~--~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 156 (309)
..+-+.....++.|+++|+.|||+. +++|||||.+||+|-.. -++||+|||.....+..... ....
T Consensus 116 ----~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~-----~~~~ 183 (378)
T KOG1345|consen 116 ----AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKY-----LEYV 183 (378)
T ss_pred ----ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCceehh-----hhhh
Confidence 3477888899999999999999999 89999999999999532 47999999998765543222 1235
Q ss_pred cCCCCccccccC-----CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccH
Q 021682 157 YGYVPPEYVRKG-----IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSA 231 (309)
Q Consensus 157 ~~y~aPE~~~~~-----~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (309)
-.|.+||.+... ...+.+|+|.||+++|++++|..||. .........+.+..|..+......+..-
T Consensus 184 ~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ---ka~~~d~~Y~~~~~w~~rk~~~~P~~F~------ 254 (378)
T KOG1345|consen 184 NNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ---KASIMDKPYWEWEQWLKRKNPALPKKFN------ 254 (378)
T ss_pred cccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch---hhhccCchHHHHHHHhcccCccCchhhc------
Confidence 578899976432 23688999999999999999999986 3333445566667777666654332211
Q ss_pred HHHHHHHHHHhhcccCCCCCC---CCHHHHHHHHhcccCCCCCCCCCCccccCCccchhh--hhccccccccCCccccC
Q 021682 232 WKLMRCMQVALLCVQENAADR---PTMLEILVMLKSETADIKTPKKPAFSVKRDNDEISE--CMLEANIYSVDDATITQ 305 (309)
Q Consensus 232 ~~~~~l~~li~~~l~~~p~~R---pt~~ell~~L~~~~~~~~~~~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 305 (309)
.....++.+.++-|..++++| -++......+..+ ..+.+.+.|-.++.-..|..+. +....-+.|++.++.+.
T Consensus 255 ~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E-~~i~t~k~~ee~~~tn~d~~S~iysrq~~~~~sg~~~kp~~ 332 (378)
T KOG1345|consen 255 PFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE-KLIKTVKRPEEDYYTNIDTASKIYSRQTATSSSGEPQKPSA 332 (378)
T ss_pred ccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH-hhhccccChhhccccccCCcchhhhcCcCcCCCCCcCCCCc
Confidence 122367788999999999999 6666666666554 4588999999998887777766 33334455555555443
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=216.22 Aligned_cols=241 Identities=19% Similarity=0.192 Sum_probs=155.6
Q ss_pred CCcEEEEEEeecCCcccHHH--------------HHHHHHHHhcCCCCCc-----cceeeEEee--------CCeeEEEE
Q 021682 12 NGQEMAVKRLSRTSHQGLEE--------------FENEVKLTARLQHVNL-----LPVLGICTQ--------REEKMLIY 64 (309)
Q Consensus 12 ~g~~vavK~~~~~~~~~~~~--------------~~~e~~~l~~l~h~~i-----v~~~~~~~~--------~~~~~lv~ 64 (309)
.++.||||.+........+. ...|+.++.+++|.++ +.++++|.. ....++|+
T Consensus 185 ~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~ 264 (507)
T PLN03224 185 KKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVW 264 (507)
T ss_pred cCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEE
Confidence 46789999986543222222 2346666777765544 556666543 24679999
Q ss_pred eccCCCChhHHHhhhcc---------------------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEE
Q 021682 65 DYMPNKSLDFYIFDLRR---------------------RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNIL 123 (309)
Q Consensus 65 e~~~~~~L~~~~~~~~~---------------------~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil 123 (309)
||+.+++|.+++..... ...+++..+..++.|++.++.|||+. +++|+||||.||+
T Consensus 265 Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NIL 341 (507)
T PLN03224 265 KFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLL 341 (507)
T ss_pred EcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEE
Confidence 99999999998853210 11245677889999999999999998 8999999999999
Q ss_pred eCCCCCceeecccccccccCCcccccccccccccCCCCccccccCC----------------------CCccchhhhHHH
Q 021682 124 LDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGI----------------------YSMKYDVYSYGV 181 (309)
Q Consensus 124 ~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----------------------~~~~~DvwslG~ 181 (309)
++.++.++|+|||++......... ......+++.|+|||.+.... ...+.|+||+||
T Consensus 342 l~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGv 420 (507)
T PLN03224 342 VTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGV 420 (507)
T ss_pred ECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHH
Confidence 999999999999998654332111 111123478999999875322 123479999999
Q ss_pred HHHHHHhCCC-CCCCCCCCCcc-cHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHHhhcccCCC---CCCCCHH
Q 021682 182 LLLQILGGKR-TSCYYGPNESL-NLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENA---ADRPTML 256 (309)
Q Consensus 182 il~~ll~g~~-p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p---~~Rpt~~ 256 (309)
++++|+++.. |+......... .........|....... ...+..........+++.+||..+| .+|+|++
T Consensus 421 il~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~-----~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~ 495 (507)
T PLN03224 421 LLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK-----YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVG 495 (507)
T ss_pred HHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC-----CCcccccccChHHHHHHHHHhccCCCCcccCCCHH
Confidence 9999999874 55322111110 00001111111111110 0111111223467799999999766 6899999
Q ss_pred HHHHH
Q 021682 257 EILVM 261 (309)
Q Consensus 257 ell~~ 261 (309)
|+++.
T Consensus 496 eaL~H 500 (507)
T PLN03224 496 QALSH 500 (507)
T ss_pred HHhCC
Confidence 99864
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-27 Score=209.60 Aligned_cols=184 Identities=23% Similarity=0.294 Sum_probs=154.5
Q ss_pred CccceEEEEcCCCcEEEEEEeecCC--------cccHHHHHHHHHHHhcCC---CCCccceeeEEeeCCeeEEEEecc-C
Q 021682 1 MSVAICQGRLPNGQEMAVKRLSRTS--------HQGLEEFENEVKLTARLQ---HVNLLPVLGICTQREEKMLIYDYM-P 68 (309)
Q Consensus 1 ~g~~~~~~~~~~g~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~-~ 68 (309)
||-|..+-..++...|+||.+.+.. +......-.|+.+|..++ |+||++++++|++++.+||+||.- +
T Consensus 574 yGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~ 653 (772)
T KOG1152|consen 574 YGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGE 653 (772)
T ss_pred cceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCC
Confidence 5677777777788899999886542 111223447999999996 999999999999999999999976 4
Q ss_pred CCChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccc
Q 021682 69 NKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEA 148 (309)
Q Consensus 69 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 148 (309)
+.+|.+++.. ...+.+..+..++.|++.++++||++ ||+|||||-+|+.++.+|-+||+|||.+.......
T Consensus 654 gIDLFd~IE~---kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgsaa~~ksgp--- 724 (772)
T KOG1152|consen 654 GIDLFDFIEF---KPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSGP--- 724 (772)
T ss_pred Ccchhhhhhc---cCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccchhhhcCCC---
Confidence 5688888843 34489999999999999999999999 99999999999999999999999999987665543
Q ss_pred cccccccccCCCCccccccCCC-CccchhhhHHHHHHHHHhCCCCCC
Q 021682 149 NTGRIVGTYGYVPPEYVRKGIY-SMKYDVYSYGVLLLQILGGKRTSC 194 (309)
Q Consensus 149 ~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~ll~g~~p~~ 194 (309)
...++||..|.|||++.|.+| ....|||+||+++|.++....||.
T Consensus 725 -fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 725 -FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred -cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 334679999999999999877 567899999999999998888863
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-27 Score=231.54 Aligned_cols=197 Identities=16% Similarity=0.132 Sum_probs=135.8
Q ss_pred cCCC-CCccceeeEE-------eeCCeeEEEEeccCCCChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCce
Q 021682 41 RLQH-VNLLPVLGIC-------TQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTI 112 (309)
Q Consensus 41 ~l~h-~~iv~~~~~~-------~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi 112 (309)
.++| +||..++++| .....++.++|++ +++|.+++.. ....+++..+..++.||+.||.|||++ ||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---gI 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHSQ---GI 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 4445 5777777766 2234577888987 5699999853 234589999999999999999999998 99
Q ss_pred eecCCCCceEEeCCC-------------------CCceeecccccccccCCcc--------------cccccccccccCC
Q 021682 113 VHRDLKASNILLDYE-------------------MNPKISDFGMARAFTKDEC--------------EANTGRIVGTYGY 159 (309)
Q Consensus 113 ~H~di~p~nil~~~~-------------------~~~~l~Dfg~~~~~~~~~~--------------~~~~~~~~~~~~y 159 (309)
+||||||+|||++.. +.+|++|||++........ ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 999999999999653 4456666666543211000 0001113578889
Q ss_pred CCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHH
Q 021682 160 VPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQ 239 (309)
Q Consensus 160 ~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (309)
+|||.+.+..++.++|||||||++|||++|.+|+.... ......... ...+. .........+
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~~~~~~~--------~~~~~-----~~~~~~~~~~ 243 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTMSSLRHR--------VLPPQ-----ILLNWPKEAS 243 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHHHHHHHh--------hcChh-----hhhcCHHHHH
Confidence 99999999999999999999999999999887753210 000000000 00000 0111224568
Q ss_pred HHhhcccCCCCCCCCHHHHHHH
Q 021682 240 VALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 240 li~~~l~~~p~~Rpt~~ell~~ 261 (309)
++.+||+.+|.+|||+.|+++.
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHhCCCChhhCcChHHHhhc
Confidence 8899999999999999999864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.7e-26 Score=186.17 Aligned_cols=186 Identities=30% Similarity=0.423 Sum_probs=156.6
Q ss_pred cceEEEEcC-CCcEEEEEEeecCCcc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 3 VAICQGRLP-NGQEMAVKRLSRTSHQ-GLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 3 ~~~~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
+.+|++... +++.+|+|.+...... ....+..|++.+++++|+|++++++++......++++|++.+++|.+++....
T Consensus 13 ~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~ 92 (225)
T smart00221 13 GKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKG 92 (225)
T ss_pred eEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcc
Confidence 357778765 4899999999765544 56788999999999999999999999998889999999999989999884422
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCC
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYV 160 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 160 (309)
. .+++..+..++.+++.++.+||+. |++|+||+|.||+++.++.++|+|||.+......... ......++..|+
T Consensus 93 ~--~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~~ 166 (225)
T smart00221 93 G--KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LLKTVKGTPFYL 166 (225)
T ss_pred c--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-cccceeccCCcC
Confidence 1 178899999999999999999998 8999999999999999999999999998766544211 112235677899
Q ss_pred Ccccc-ccCCCCccchhhhHHHHHHHHHhCCCCCC
Q 021682 161 PPEYV-RKGIYSMKYDVYSYGVLLLQILGGKRTSC 194 (309)
Q Consensus 161 aPE~~-~~~~~~~~~DvwslG~il~~ll~g~~p~~ 194 (309)
+||.+ ....++.++|+|+||++++++++|+.||.
T Consensus 167 ~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 167 APEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred CHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 99988 66677889999999999999999999984
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=182.96 Aligned_cols=167 Identities=19% Similarity=0.119 Sum_probs=122.9
Q ss_pred CChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccc
Q 021682 70 KSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEAN 149 (309)
Q Consensus 70 ~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 149 (309)
|+|.+++.. .+..+++..++.++.|++.|+.|||++ + ||+||+++.++.+++ ||.+.......
T Consensus 1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc----
Confidence 578888843 244599999999999999999999998 5 999999999999998 99886554321
Q ss_pred ccccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcc
Q 021682 150 TGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSS 229 (309)
Q Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (309)
..|+..|+|||.+.+..++.++|||||||++|+|++|+.||....... .............. .. ....
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~------~~-~~~~ 131 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPADD------PR-DRSN 131 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhccCC------cc-cccc
Confidence 157899999999999999999999999999999999999985332211 11111111111000 00 0001
Q ss_pred cHHHH--HHHHHHHhhcccCCCCCCCCHHHHHHHHhcc
Q 021682 230 SAWKL--MRCMQVALLCVQENAADRPTMLEILVMLKSE 265 (309)
Q Consensus 230 ~~~~~--~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~ 265 (309)
..... ..+.+++.+||..+|++|||+.++++.+...
T Consensus 132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 11112 2588999999999999999999999988654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.9e-26 Score=192.44 Aligned_cols=239 Identities=22% Similarity=0.319 Sum_probs=171.4
Q ss_pred CCcEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccccCCCHHHH
Q 021682 12 NGQEMAVKRLSRTSHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTR 90 (309)
Q Consensus 12 ~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~ 90 (309)
.++.||+|.+...+. ..++..|+++|..+ .+.||+++.+.+..++.+++|+||++.....++.. . ++...+
T Consensus 63 ~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~---~---l~~~~i 134 (418)
T KOG1167|consen 63 KRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYR---S---LSLAEI 134 (418)
T ss_pred ccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHHh---c---CCHHHH
Confidence 578899999865533 35788999999999 69999999999999999999999999998888862 2 678899
Q ss_pred HHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCC-CCceeecccccccccCCc-------------cc---------
Q 021682 91 VHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYE-MNPKISDFGMARAFTKDE-------------CE--------- 147 (309)
Q Consensus 91 ~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~-~~~~l~Dfg~~~~~~~~~-------------~~--------- 147 (309)
..+++.++.||+++|.+ ||+||||||+|++++.. +.-.|+|||++....... ..
T Consensus 135 ~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~ 211 (418)
T KOG1167|consen 135 RWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQ 211 (418)
T ss_pred HHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCccccc
Confidence 99999999999999999 99999999999999764 667899999997211000 00
Q ss_pred --------------------ccccccccccCCCCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCC-CCCCcccHH
Q 021682 148 --------------------ANTGRIVGTYGYVPPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYY-GPNESLNLL 205 (309)
Q Consensus 148 --------------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~-~~~~~~~~~ 205 (309)
.......||++|.|||++... ..+++.||||.|+++..+++++.||-.. +..+....+
T Consensus 212 ~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei 291 (418)
T KOG1167|consen 212 SVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEI 291 (418)
T ss_pred ccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHH
Confidence 000123589999999988664 5689999999999999999999998432 222211111
Q ss_pred HHHHH---------------HhhCCCCcc----------c-ccccCCCc--------ccHHHHHHHHHHHhhcccCCCCC
Q 021682 206 EYAYG---------------LWKNGEGME----------F-IDSSLDDS--------SSAWKLMRCMQVALLCVQENAAD 251 (309)
Q Consensus 206 ~~~~~---------------~~~~~~~~~----------~-~~~~~~~~--------~~~~~~~~l~~li~~~l~~~p~~ 251 (309)
....+ .|....... . ........ .....+..+++++.+||+.||.+
T Consensus 292 ~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~k 371 (418)
T KOG1167|consen 292 ATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQK 371 (418)
T ss_pred HHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhh
Confidence 11100 011000000 0 00000000 01112337789999999999999
Q ss_pred CCCHHHHHHH
Q 021682 252 RPTMLEILVM 261 (309)
Q Consensus 252 Rpt~~ell~~ 261 (309)
|.|+++.|..
T Consensus 372 RitAEeALkH 381 (418)
T KOG1167|consen 372 RITAEDALKH 381 (418)
T ss_pred cccHHHHhcC
Confidence 9999999854
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.8e-26 Score=201.95 Aligned_cols=237 Identities=22% Similarity=0.263 Sum_probs=183.0
Q ss_pred ceEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccc
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRR 82 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 82 (309)
.||+++ ..+|+..|+|+++-....+..-+..|+-+++..+||||+.+++.+......++.||||.+|+|.+.- .-.
T Consensus 30 dvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy---~~T 106 (829)
T KOG0576|consen 30 DVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIY---HVT 106 (829)
T ss_pred chhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCccccee---eec
Confidence 456665 4689999999998777777778889999999999999999999999999999999999999998865 234
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCc
Q 021682 83 YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPP 162 (309)
Q Consensus 83 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 162 (309)
+++.+.++-.++....++++|||++ |-+|||||-.||+++..|.+|++|||.+..++.... ....+.||+.||||
T Consensus 107 gplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati~--KrksfiGtpywmap 181 (829)
T KOG0576|consen 107 GPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA--KRKSFIGTPYWMAP 181 (829)
T ss_pred ccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhhh--hhhcccCCccccch
Confidence 5589999999999999999999999 889999999999999999999999999876655432 23346899999999
Q ss_pred ccc---ccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHH
Q 021682 163 EYV---RKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQ 239 (309)
Q Consensus 163 E~~---~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (309)
|+. ..+.|...+|||++|+..-++-..++|--. .. .......... .. +++.-.... ..-...+.+
T Consensus 182 Evaaverkggynqlcdiwa~gitAiel~eLqpplfd-----lh--pmr~l~LmTk-S~---~qpp~lkDk-~kws~~fh~ 249 (829)
T KOG0576|consen 182 EVAAVERKGGYNQLCDIWALGITAIELGELQPPLFD-----LH--PMRALFLMTK-SG---FQPPTLKDK-TKWSEFFHN 249 (829)
T ss_pred hHHHHHhcccccccccccccccchhhhhhcCCcccc-----cc--hHHHHHHhhc-cC---CCCCcccCC-ccchHHHHH
Confidence 976 346789999999999999999877776311 10 0111111111 00 111111111 112235779
Q ss_pred HHhhcccCCCCCCCCHHHHHH
Q 021682 240 VALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 240 li~~~l~~~p~~Rpt~~ell~ 260 (309)
+++.||..+|++|||++.+++
T Consensus 250 fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 250 FVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred HHHHHhcCCCccCCChhhhee
Confidence 999999999999999998765
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-24 Score=202.41 Aligned_cols=237 Identities=16% Similarity=0.227 Sum_probs=167.2
Q ss_pred eEEEEcCCCcEEEEEEeecCC-cccHHHHHHHHHHHh--cCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 5 ICQGRLPNGQEMAVKRLSRTS-HQGLEEFENEVKLTA--RLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 5 ~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~--~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
+.++..++|. |+||++-+.. ......++++++-++ .+++||++++.-+...+...|||-+|... +|+|.+ ..
T Consensus 39 v~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh-nLyDRl---ST 113 (1431)
T KOG1240|consen 39 VARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVKH-NLYDRL---ST 113 (1431)
T ss_pred hhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHhh-hhhhhh---cc
Confidence 3455556777 9999886553 334455555544443 45899999998888888888999999965 788887 44
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccc-c----cccccc
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEAN-T----GRIVGT 156 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~-~----~~~~~~ 156 (309)
+..+.....++++.|++.|+.-+|.. ||||||||.+||+++.-+++.|+||...+.......... . .....-
T Consensus 114 RPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRR 190 (1431)
T KOG1240|consen 114 RPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRR 190 (1431)
T ss_pred chHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCce
Confidence 55688888899999999999999999 999999999999999999999999987655433222111 1 112334
Q ss_pred cCCCCccccccC----------C-CCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCccccccc
Q 021682 157 YGYVPPEYVRKG----------I-YSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSS 224 (309)
Q Consensus 157 ~~y~aPE~~~~~----------~-~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (309)
.+|+|||.+... + .+++-||||+||++.||++ |+++|... +...+... ........++..
T Consensus 191 tCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~aYr~~--~~~~~e~~Le~I 262 (1431)
T KOG1240|consen 191 TCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLAYRSG--NADDPEQLLEKI 262 (1431)
T ss_pred eeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHhHhcc--CccCHHHHHHhC
Confidence 589999987431 1 4678999999999999998 67777421 11111100 000000111111
Q ss_pred CCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcc
Q 021682 225 LDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSE 265 (309)
Q Consensus 225 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~ 265 (309)
+...++++|..|++.||++|.+++++|+..++.
T Consensus 263 --------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 263 --------EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred --------cCccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 112677999999999999999999999985443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=7e-24 Score=170.78 Aligned_cols=238 Identities=21% Similarity=0.320 Sum_probs=177.2
Q ss_pred ccceEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 2 SVAICQGRLPNGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 2 g~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
|+-.|+|+|+ |-.++.|+++... ..-...|.+|...|+-+.||||+.+++.|..+.+..++..||+.++|+..+..
T Consensus 203 sgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe- 280 (448)
T KOG0195|consen 203 SGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHE- 280 (448)
T ss_pred Cccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhc-
Confidence 5677999994 5667778775432 22234688999999999999999999999999999999999999999999854
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceee--cccccccccCCccccccccccccc
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKIS--DFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~--Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
.....++..++.+++..++.+++|||+.. +-+.--.+....+++|++.+.+|. |--++.. ..+ ....+
T Consensus 281 ~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsfq--------e~g-r~y~p 350 (448)
T KOG0195|consen 281 QTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ--------EVG-RAYSP 350 (448)
T ss_pred CccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeeee--------ccc-cccCc
Confidence 33445677889999999999999999974 224444688999999998877654 3222110 111 23467
Q ss_pred CCCCccccccCCC---CccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHH
Q 021682 158 GYVPPEYVRKGIY---SMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKL 234 (309)
Q Consensus 158 ~y~aPE~~~~~~~---~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
.|++||.+...+. -.++|+|||++++||+.|...||....+.+..-.+. -..+....++...
T Consensus 351 awmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia---------------leglrv~ippgis 415 (448)
T KOG0195|consen 351 AWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA---------------LEGLRVHIPPGIS 415 (448)
T ss_pred ccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh---------------hccccccCCCCcc
Confidence 8999999977654 367999999999999999999997665554321111 1112222333333
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHHhccc
Q 021682 235 MRCMQVALLCVQENAADRPTMLEILVMLKSET 266 (309)
Q Consensus 235 ~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~ 266 (309)
.-+..++.-|+..||.+||.+..++-.||++.
T Consensus 416 ~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 416 RHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred HHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 46778899999999999999999999999863
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.1e-21 Score=167.33 Aligned_cols=250 Identities=16% Similarity=0.108 Sum_probs=179.4
Q ss_pred cceEEEEcCC--CcEEEEEEeecCCcccHHHHHHHHHHHhcCC----CCCccceeeEE-eeCCeeEEEEeccCCCChhHH
Q 021682 3 VAICQGRLPN--GQEMAVKRLSRTSHQGLEEFENEVKLTARLQ----HVNLLPVLGIC-TQREEKMLIYDYMPNKSLDFY 75 (309)
Q Consensus 3 ~~~~~~~~~~--g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~----h~~iv~~~~~~-~~~~~~~lv~e~~~~~~L~~~ 75 (309)
+.||.+...+ ...+|+|............+..|..++..+. ..++..+++.. ..+...++||+.+ |.+|.++
T Consensus 32 G~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl 110 (322)
T KOG1164|consen 32 GAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDL 110 (322)
T ss_pred ceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-CccHHHH
Confidence 3456665433 2578999876653333237888999988886 35888999988 4777889999988 7899998
Q ss_pred HhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCC-----CCceeecccccc--cccCCccc-
Q 021682 76 IFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYE-----MNPKISDFGMAR--AFTKDECE- 147 (309)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~-----~~~~l~Dfg~~~--~~~~~~~~- 147 (309)
..... ...++..++..++.|++.+|.++|+. |++||||||.|+++... ..+.|.|||+++ ........
T Consensus 111 ~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~ 186 (322)
T KOG1164|consen 111 RKRNP-PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGN 186 (322)
T ss_pred HHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcc
Confidence 74443 56699999999999999999999999 99999999999999765 358999999998 33222111
Q ss_pred -----ccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCccccc
Q 021682 148 -----ANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFID 222 (309)
Q Consensus 148 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (309)
.......||..|.++....+...+.+.|+||++.++.+++.|..||..................... ..
T Consensus 187 ~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~---~~--- 260 (322)
T KOG1164|consen 187 LRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLT---DR--- 260 (322)
T ss_pred cccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhcc---cc---
Confidence 1122356999999999999999999999999999999999999998554433322111111111000 00
Q ss_pred ccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccCCC
Q 021682 223 SSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETADI 269 (309)
Q Consensus 223 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~~ 269 (309)
.... ....+.++...+-..+..++|....+...|+......
T Consensus 261 ---~~~~---~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 261 ---FGDL---KPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred ---ccCC---ChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 0111 1224455555666689999999999999987664443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.7e-23 Score=189.42 Aligned_cols=215 Identities=20% Similarity=0.221 Sum_probs=157.9
Q ss_pred HHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCc
Q 021682 32 FENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLT 111 (309)
Q Consensus 32 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~g 111 (309)
+..|+-+-..++|+|++..+..+.......-+||||++ +|..++.. ...+....+..++.|++.|++|+|+. |
T Consensus 368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~~---G 440 (601)
T KOG0590|consen 368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHSM---G 440 (601)
T ss_pred hhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHhc---C
Confidence 34555566678999998877666555544445999998 88888733 34577888889999999999999999 9
Q ss_pred eeecCCCCceEEeCCCCCceeecccccccccCCccc--ccccccccccCCCCccccccCCCC-ccchhhhHHHHHHHHHh
Q 021682 112 IVHRDLKASNILLDYEMNPKISDFGMARAFTKDECE--ANTGRIVGTYGYVPPEYVRKGIYS-MKYDVYSYGVLLLQILG 188 (309)
Q Consensus 112 i~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~ll~ 188 (309)
+.|+|+|++|++++.+|.+|++|||.+......... .......|+..|+|||.+.+..|. ...||||.|+++..|.+
T Consensus 441 iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~ 520 (601)
T KOG0590|consen 441 LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMIL 520 (601)
T ss_pred ceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEec
Confidence 999999999999999999999999998766544332 333445789999999999998885 46899999999999999
Q ss_pred CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 189 GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 189 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
|+.||......+... ... ... ...-............+.....+|.+||+.+|.+|.|+++|++.
T Consensus 521 ~~~~Wk~a~~~~~~~-~~~-----~~~--~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 521 GRFPWKVAKKSDNSF-KTN-----NYS--DQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred CCCccccccccccch-hhh-----ccc--cccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 999997655544321 000 000 00000000111111223356789999999999999999999864
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.3e-21 Score=152.75 Aligned_cols=274 Identities=16% Similarity=0.157 Sum_probs=204.6
Q ss_pred ceEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCC-CCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQ-HVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
.+|.|. ..+|+.||||+-+..... .++.-|.++...|+ ...|..+..+..+..+-.+||+.+ |.+|.++..-..+
T Consensus 30 dIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~R 106 (341)
T KOG1163|consen 30 DIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFCSR 106 (341)
T ss_pred heeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHHHHHHHHhh
Confidence 355554 468999999997554332 35677888888885 557778888888888899999998 7899998755444
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCC---CCceeecccccccccCCcccc-----ccccc
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYE---MNPKISDFGMARAFTKDECEA-----NTGRI 153 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~---~~~~l~Dfg~~~~~~~~~~~~-----~~~~~ 153 (309)
+ ++..+++.++-|++.-++|+|.+ +++||||||+|++..-+ ..+.|+|||+++.+....... .....
T Consensus 107 ~--ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~l 181 (341)
T KOG1163|consen 107 R--FTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNL 181 (341)
T ss_pred h--hhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCcc
Confidence 3 89999999999999999999999 79999999999999643 568899999998876543322 12345
Q ss_pred ccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHH
Q 021682 154 VGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWK 233 (309)
Q Consensus 154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
.||.+|.+-....+...+..-|+=|+|.++.++.-|..||.........+..+.....-.......++...
T Consensus 182 tGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G~--------- 252 (341)
T KOG1163|consen 182 TGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKGF--------- 252 (341)
T ss_pred ceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhCCC---------
Confidence 68999999988888888999999999999999999999998766665555444443333222222222221
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccCCCCCCCCCCccccCCccchhhhhcccc
Q 021682 234 LMRCMQVALLCVQENAADRPTMLEILVMLKSETADIKTPKKPAFSVKRDNDEISECMLEAN 294 (309)
Q Consensus 234 ~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 294 (309)
+.++.-.+..|-..--++-|...-+.+.+.-+-..+.-.-.=+|+|...-+.++++-++..
T Consensus 253 P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~lkqk~~q~~~~~~ 313 (341)
T KOG1163|consen 253 PAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTMLKQKSQQSGRSRD 313 (341)
T ss_pred cHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHHHHHHhhcccCCCc
Confidence 2256667788888888899999999999887766666666667777655554554444443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-19 Score=157.87 Aligned_cols=250 Identities=22% Similarity=0.282 Sum_probs=181.5
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcc---cHHHHHHHHHHHhcCCCC-CccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQ---GLEEFENEVKLTARLQHV-NLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
+.+|.+... ..+++|.+...... ....+..|+..+..+.|+ +++.+.+++......+++++++.++++.+++..
T Consensus 14 ~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 91 (384)
T COG0515 14 GEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKK 91 (384)
T ss_pred eEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHh
Confidence 456666654 78899998765322 367788999999999888 799999999777778999999999999866532
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCC-CceeecccccccccCCcccc----ccccc
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM-NPKISDFGMARAFTKDECEA----NTGRI 153 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~-~~~l~Dfg~~~~~~~~~~~~----~~~~~ 153 (309)
......+.......+..+++.++.++|+. |++|||+||+||+++..+ .++++|||.+.......... .....
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~ 168 (384)
T COG0515 92 IGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTS 168 (384)
T ss_pred cccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcccccccccccc
Confidence 21112588899999999999999999999 899999999999999988 69999999987554433221 23445
Q ss_pred ccccCCCCcccccc---CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCccc
Q 021682 154 VGTYGYVPPEYVRK---GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSS 230 (309)
Q Consensus 154 ~~~~~y~aPE~~~~---~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (309)
.++..|++||.+.+ .......|+|++|+++++++.|..||...... ................ ...........
T Consensus 169 ~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 244 (384)
T COG0515 169 VGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP-SLASPLSPSNP 244 (384)
T ss_pred ccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc-ccccccCcccc
Confidence 78999999999987 57789999999999999999999996543321 0011111111111111 00000000000
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 231 AWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 231 ~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
......+.+++..|+..+|..|.+..+....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 245 ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 2223467799999999999999998887764
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.1e-21 Score=156.72 Aligned_cols=261 Identities=16% Similarity=0.156 Sum_probs=190.1
Q ss_pred ceEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTSHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
+++.|. +-+++.||||.-...+. .-++..|++..+.| ..++|..+|-|...+.+-.||+|++ |.+|.|+..-.++
T Consensus 43 ~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~CgR 119 (449)
T KOG1165|consen 43 VLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDLCGR 119 (449)
T ss_pred eeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHHhcC
Confidence 455564 34899999999755543 45789999999998 6889999999999888899999998 7899998865554
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCC-----CCceeecccccccccCCcccc-----ccc
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYE-----MNPKISDFGMARAFTKDECEA-----NTG 151 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~-----~~~~l~Dfg~~~~~~~~~~~~-----~~~ 151 (309)
+ |+..++..++.|++.-+.++|++ .++.|||||+|+||... ..+.++|||+|+.+....+.. ...
T Consensus 120 ~--FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~K 194 (449)
T KOG1165|consen 120 R--FSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHK 194 (449)
T ss_pred c--ccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCcccccc
Confidence 4 99999999999999999999999 69999999999999653 348899999999886654432 233
Q ss_pred ccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccH
Q 021682 152 RIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSA 231 (309)
Q Consensus 152 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (309)
...||.+||+-....|...+..-|+=+||-+++++|-|..||....-.......+.+-..-.......++..
T Consensus 195 SLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc~g-------- 266 (449)
T KOG1165|consen 195 SLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVLCEG-------- 266 (449)
T ss_pred ccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHHHhc--------
Confidence 456999999999999999999999999999999999999999765444433222222111111111111111
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccCCCCCCCCCCccccC
Q 021682 232 WKLMRCMQVALLCVQENAADRPTMLEILVMLKSETADIKTPKKPAFSVKR 281 (309)
Q Consensus 232 ~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~~~~~~~p~~~~~~ 281 (309)
.+.++..-++..-..+-.+-|..+-+...+......+-.--.=.|+|-.
T Consensus 267 -~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~~ 315 (449)
T KOG1165|consen 267 -FPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWMG 315 (449)
T ss_pred -CHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccccccccc
Confidence 1224444444455567777799888888776665554444444444433
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.5e-20 Score=164.75 Aligned_cols=218 Identities=22% Similarity=0.293 Sum_probs=162.0
Q ss_pred HhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCC
Q 021682 39 TARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLK 118 (309)
Q Consensus 39 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~ 118 (309)
|+.+.|.|+.++++.+.++...++|.+||..|+|.|.+.. ....+++.....+...+++++.|+|... ..+|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 4678999999999999999999999999999999999854 3445888889999999999999999874 34999999
Q ss_pred CceEEeCCCCCceeecccccccccCCcccccccccccccCCCCccccccCC-------CCccchhhhHHHHHHHHHhCCC
Q 021682 119 ASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGI-------YSMKYDVYSYGVLLLQILGGKR 191 (309)
Q Consensus 119 p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~DvwslG~il~~ll~g~~ 191 (309)
..|++++....+||+|||+.....................|.|||.+.+.. .+.++|+||+|++++|+++...
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 999999999999999999986654311111111123456899999987641 3677999999999999999999
Q ss_pred CCCCCCCCCcc-cHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccC
Q 021682 192 TSCYYGPNESL-NLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETA 267 (309)
Q Consensus 192 p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~ 267 (309)
||......... ..+.+... .....+.+...... .....+..++..||..+|++||+++.+...++....
T Consensus 157 ~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred ccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 98654333322 12222111 11222222211111 222267899999999999999999999999987644
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.5e-20 Score=160.94 Aligned_cols=149 Identities=17% Similarity=0.227 Sum_probs=110.3
Q ss_pred cceEEEEcC--CCcEEEEEEeecC-----CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHH
Q 021682 3 VAICQGRLP--NGQEMAVKRLSRT-----SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFY 75 (309)
Q Consensus 3 ~~~~~~~~~--~g~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (309)
++||++... +++.||||.+... .......+.+|+++|++++|++++..+.. .+..++||||+.|++|...
T Consensus 32 g~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LVmE~~~G~~L~~~ 108 (365)
T PRK09188 32 STVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLVRGWTEGVPLHLA 108 (365)
T ss_pred EEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEEEEccCCCCHHHh
Confidence 356777543 6788899986432 12235678999999999999999863322 2357999999999988622
Q ss_pred HhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCC-CCceEEeCCCCCceeecccccccccCCccccc-----
Q 021682 76 IFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDL-KASNILLDYEMNPKISDFGMARAFTKDECEAN----- 149 (309)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di-~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~----- 149 (309)
... . ...++.++++++.+||+. |++|||| ||+||+++.++.++|+|||++...........
T Consensus 109 ----~~~---~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~ 175 (365)
T PRK09188 109 ----RPH---G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYE 175 (365)
T ss_pred ----Ccc---c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhh
Confidence 111 1 146788999999999998 9999999 99999999999999999999987654432211
Q ss_pred -ccccccccCCCCcccccc
Q 021682 150 -TGRIVGTYGYVPPEYVRK 167 (309)
Q Consensus 150 -~~~~~~~~~y~aPE~~~~ 167 (309)
.....++..|+|||.+..
T Consensus 176 d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 176 DLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred hhhhhhccCccCCcccCCh
Confidence 123456778999998854
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.5e-20 Score=153.57 Aligned_cols=219 Identities=19% Similarity=0.218 Sum_probs=133.9
Q ss_pred ceEEE-EcCCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCC----------CCCccceeeEEee---------CC--
Q 021682 4 AICQG-RLPNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQ----------HVNLLPVLGICTQ---------RE-- 58 (309)
Q Consensus 4 ~~~~~-~~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~----------h~~iv~~~~~~~~---------~~-- 58 (309)
++|.+ +..+|+.+|||++.... ....+.+++|.-....+. |-.++..++.... ..
T Consensus 27 ~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~~~~~~~~~~~ 106 (288)
T PF14531_consen 27 IVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGKPPFFERGPGQ 106 (288)
T ss_dssp EEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS-SEEEECETT
T ss_pred EEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCCCcceecCCCC
Confidence 44555 45689999999875432 334566777765555532 2233333333221 11
Q ss_pred ------eeEEEEeccCCCChhHHHhhhccc----cCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCC
Q 021682 59 ------EKMLIYDYMPNKSLDFYIFDLRRR----YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM 128 (309)
Q Consensus 59 ------~~~lv~e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~ 128 (309)
+.+++|+-+ .++|.+++...... ..+.......+..|+++.+++||.. |++|+||+|+|++++.+|
T Consensus 107 ~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi~~~nfll~~~G 182 (288)
T PF14531_consen 107 SIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDIKPENFLLDQDG 182 (288)
T ss_dssp EEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEE-TTS
T ss_pred ccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecccceeeEEEcCCC
Confidence 246788887 46888876432211 2233445566779999999999999 999999999999999999
Q ss_pred CceeecccccccccCCcccccccccccccCCCCccccccC--------CCCccchhhhHHHHHHHHHhCCCCCCCCCCCC
Q 021682 129 NPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKG--------IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNE 200 (309)
Q Consensus 129 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--------~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~ 200 (309)
.+.|+||+.....+..... ...+..|.|||..... .++.+.|.|+||+++|.|+++..||+......
T Consensus 183 ~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~ 257 (288)
T PF14531_consen 183 GVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEA 257 (288)
T ss_dssp -EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGS
T ss_pred CEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccc
Confidence 9999999876544432211 2335679999976432 46888999999999999999999987543322
Q ss_pred cccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHHhhcccCCCCCC
Q 021682 201 SLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADR 252 (309)
Q Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 252 (309)
.... .+ ..+. ..++.+..||..+|+.||++|
T Consensus 258 ~~~~---------------~f-----~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 258 DPEW---------------DF-----SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp TSGG---------------GG-----TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred cccc---------------cc-----hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 1111 11 1222 455578899999999999988
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.8e-20 Score=148.40 Aligned_cols=156 Identities=13% Similarity=0.143 Sum_probs=113.1
Q ss_pred CccceEEEEcCCCcEEEEEEeecCCcccHH---H------HHHHHHHHhcCCCCCccceeeEEeeC--------CeeEEE
Q 021682 1 MSVAICQGRLPNGQEMAVKRLSRTSHQGLE---E------FENEVKLTARLQHVNLLPVLGICTQR--------EEKMLI 63 (309)
Q Consensus 1 ~g~~~~~~~~~~g~~vavK~~~~~~~~~~~---~------~~~e~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv 63 (309)
||.|+. ... ++..+|||++.+....... . ++.|++.+.+++|++|..+.+++... ...+||
T Consensus 44 f~~v~l-~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lv 121 (232)
T PRK10359 44 DTKVSL-IDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIML 121 (232)
T ss_pred ceEEEE-Eec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEE
Confidence 455554 333 5778999999755332222 2 67899999999999999998886543 357899
Q ss_pred EeccCCCChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccC
Q 021682 64 YDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTK 143 (309)
Q Consensus 64 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~ 143 (309)
|||++|.+|.++.. ++. ....+++.++..+|.. |++|||++|.|++++.+| ++|+|||.......
T Consensus 122 mEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e 186 (232)
T PRK10359 122 IEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQ 186 (232)
T ss_pred EEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-EEEEECCCcccccc
Confidence 99999999977631 222 2455889999999998 999999999999999988 99999997654321
Q ss_pred CcccccccccccccCCCCccccccCCCCccchhhhHHHHHHHHH
Q 021682 144 DECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQIL 187 (309)
Q Consensus 144 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll 187 (309)
.... ........+..++|+|+||+.+..+.
T Consensus 187 ~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 187 RKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred hhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 1100 00223334557899999998877654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.1e-19 Score=143.25 Aligned_cols=130 Identities=18% Similarity=0.176 Sum_probs=98.2
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcc--c------------------------HHHHHHHHHHHhcCCCCCccceeeEEee
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQ--G------------------------LEEFENEVKLTARLQHVNLLPVLGICTQ 56 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~--~------------------------~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 56 (309)
+.||.+...+|+.||||+++..... . ....+.|++.+.++.++++.....+...
T Consensus 11 ~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~~p~~~~~~ 90 (190)
T cd05147 11 ANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIPCPEPILLK 90 (190)
T ss_pred eEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCcEEEec
Confidence 4678888778999999999754211 1 0122459999999988777544433222
Q ss_pred CCeeEEEEeccCCCChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHH-hhcCCCceeecCCCCceEEeCCCCCceeecc
Q 021682 57 REEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYL-QEYSNLTIVHRDLKASNILLDYEMNPKISDF 135 (309)
Q Consensus 57 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l-h~~~~~gi~H~di~p~nil~~~~~~~~l~Df 135 (309)
. .+|||||++++++..... ....++...+..++.|++.++.++ |+. |++||||||.||+++ ++.++|+||
T Consensus 91 -~-~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~~~v~LiDF 161 (190)
T cd05147 91 -S-HVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-DGKLYIIDV 161 (190)
T ss_pred -C-CEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-CCcEEEEEc
Confidence 2 379999998877654432 223588899999999999999999 677 899999999999998 578999999
Q ss_pred cccccc
Q 021682 136 GMARAF 141 (309)
Q Consensus 136 g~~~~~ 141 (309)
|++...
T Consensus 162 G~a~~~ 167 (190)
T cd05147 162 SQSVEH 167 (190)
T ss_pred cccccC
Confidence 998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=5e-18 Score=136.69 Aligned_cols=131 Identities=20% Similarity=0.247 Sum_probs=99.7
Q ss_pred cceEEEEcCCCcEEEEEEeecCCccc--------------------------HHHHHHHHHHHhcCCCCCccceeeEEee
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQG--------------------------LEEFENEVKLTARLQHVNLLPVLGICTQ 56 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~--------------------------~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 56 (309)
+.||.+...+|+.||||+++...... ...+..|++.+.++.++++.....+...
T Consensus 11 ~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 90 (190)
T cd05145 11 ANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVPVPEPILLK 90 (190)
T ss_pred cEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCCCceEEEec
Confidence 46788877689999999987652110 1224578899999998887554443332
Q ss_pred CCeeEEEEeccCCCChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhh-cCCCceeecCCCCceEEeCCCCCceeecc
Q 021682 57 REEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQE-YSNLTIVHRDLKASNILLDYEMNPKISDF 135 (309)
Q Consensus 57 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~~~gi~H~di~p~nil~~~~~~~~l~Df 135 (309)
. .++||||++++++..... ....++......++.+++.++.++|+ . |++|+||||.||+++ ++.++|+||
T Consensus 91 ~--~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~~~~~liDF 161 (190)
T cd05145 91 K--NVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-DGKPYIIDV 161 (190)
T ss_pred C--CEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-CCCEEEEEc
Confidence 2 479999998875543321 12346778889999999999999999 7 999999999999998 889999999
Q ss_pred ccccccc
Q 021682 136 GMARAFT 142 (309)
Q Consensus 136 g~~~~~~ 142 (309)
|++....
T Consensus 162 G~a~~~~ 168 (190)
T cd05145 162 SQAVELD 168 (190)
T ss_pred ccceecC
Confidence 9986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2e-18 Score=146.23 Aligned_cols=198 Identities=19% Similarity=0.213 Sum_probs=135.8
Q ss_pred CCCCccceeeEEee---------------------------CCeeEEEEeccCCCChhHHHhhhccccCCCHHHHHHHHH
Q 021682 43 QHVNLLPVLGICTQ---------------------------REEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIE 95 (309)
Q Consensus 43 ~h~~iv~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~ 95 (309)
+|||||.+..+|.+ +...|+||...+ .+|..++.... .+.....-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~----~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH----RSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC----CchHHHHHHHH
Confidence 69999999876633 235789998875 58988885432 45556777899
Q ss_pred HHHHHHHHHhhcCCCceeecCCCCceEEeCCC----CCceeecccccccccCCccccc----ccccccccCCCCcccccc
Q 021682 96 GITQGLLYLQEYSNLTIVHRDLKASNILLDYE----MNPKISDFGMARAFTKDECEAN----TGRIVGTYGYVPPEYVRK 167 (309)
Q Consensus 96 ~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~----~~~~l~Dfg~~~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~ 167 (309)
|+++|+.|||.+ |+.|||+|.+||++.-+ -.++++|||.+-.....+.+.. .-..-|...-||||+..-
T Consensus 349 QlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 999999999998 99999999999999432 3588999998743332211111 111236678899998854
Q ss_pred CC------CCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHH
Q 021682 168 GI------YSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241 (309)
Q Consensus 168 ~~------~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 241 (309)
.+ .-.++|.|..|.+.||+++...||...+..-..... +. + ......+...+..+.+++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~-Yq----------e----~qLPalp~~vpp~~rqlV 490 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT-YQ----------E----SQLPALPSRVPPVARQLV 490 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh-hh----------h----hhCCCCcccCChHHHHHH
Confidence 32 136899999999999999999998653222211111 10 0 001112222333778999
Q ss_pred hhcccCCCCCCCCHHHHHHHHh
Q 021682 242 LLCVQENAADRPTMLEILVMLK 263 (309)
Q Consensus 242 ~~~l~~~p~~Rpt~~ell~~L~ 263 (309)
...|+.||++|++..=....|.
T Consensus 491 ~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHhcCCccccCCccHHHhHHH
Confidence 9999999999998776665554
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=7.7e-18 Score=159.94 Aligned_cols=179 Identities=16% Similarity=0.126 Sum_probs=140.2
Q ss_pred ceEEEEcCCCcEEEEEEeecCCc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 4 AICQGRLPNGQEMAVKRLSRTSH---QGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 4 ~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
.||.|.-.+|+.||||+-++... .-..+++..++ + + --+.|..+...+...+..+||++|.+.|+|.+++.
T Consensus 713 ~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk-~-~-~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N--- 786 (974)
T KOG1166|consen 713 SVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLK-P-Q-MLPSIMHISSAHVFQNASVLVSEYSPYGTLLDLIN--- 786 (974)
T ss_pred EEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhc-h-h-hhcchHHHHHHHccCCcceeeeeccccccHHHhhc---
Confidence 46777766799999999866532 12233443333 1 1 13356666666666777889999999999999984
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCC-------CCCceeecccccccccCCccccccccc
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY-------EMNPKISDFGMARAFTKDECEANTGRI 153 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~-------~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 153 (309)
..+..++..+..++.|++..+..||.. ||+||||||+|+++.. +-.++|+|||.+..+..-.........
T Consensus 787 ~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~ 863 (974)
T KOG1166|consen 787 TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAV 863 (974)
T ss_pred cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeee
Confidence 566689999999999999999999999 8999999999999942 345999999999766544333333345
Q ss_pred ccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCC
Q 021682 154 VGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKR 191 (309)
Q Consensus 154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~ 191 (309)
..|-.+-++|...|.+|+.++|.|+|+.+++-||.|+.
T Consensus 864 ~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 864 WHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 67889999999999999999999999999999999974
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.9e-17 Score=132.04 Aligned_cols=174 Identities=14% Similarity=0.083 Sum_probs=124.6
Q ss_pred CccceEEEEcCCCcEEEEEEeecCCc----ccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHH
Q 021682 1 MSVAICQGRLPNGQEMAVKRLSRTSH----QGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFY 75 (309)
Q Consensus 1 ~g~~~~~~~~~~g~~vavK~~~~~~~----~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (309)
||++.+++. .+.+++.+.+....- -....+..|+++|++| .++++++++++ +..+++|+|+.|.+|...
T Consensus 15 f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~ 88 (218)
T PRK12274 15 FGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQR 88 (218)
T ss_pred cceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhh
Confidence 677776665 688888877754422 1123578999999999 45789989886 346899999999888644
Q ss_pred HhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCC-CCceEEeCCCCCceeecccccccccCCccc----cc-
Q 021682 76 IFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDL-KASNILLDYEMNPKISDFGMARAFTKDECE----AN- 149 (309)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di-~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~----~~- 149 (309)
.. . ....++.+++.++.++|.+ |++|+|| +|.||+++.++.++|+|||++......... ..
T Consensus 89 ~~---~-------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~r 155 (218)
T PRK12274 89 PP---R-------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLARE 155 (218)
T ss_pred hh---h-------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHH
Confidence 31 1 1134678899999999999 9999999 799999999999999999999754433211 00
Q ss_pred ------ccccccccCCCCccccccC-CCC-ccchhhhHHHHHHHHHhCCCCC
Q 021682 150 ------TGRIVGTYGYVPPEYVRKG-IYS-MKYDVYSYGVLLLQILGGKRTS 193 (309)
Q Consensus 150 ------~~~~~~~~~y~aPE~~~~~-~~~-~~~DvwslG~il~~ll~g~~p~ 193 (309)
......++.++.|+..... ..+ ...+-++.|+.+|.++|++.+.
T Consensus 156 Dl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 156 DLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred HHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 1112345667777644332 223 4456669999999999998775
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.76 E-value=8.4e-19 Score=153.54 Aligned_cols=172 Identities=23% Similarity=0.295 Sum_probs=129.4
Q ss_pred eeEEEEeccCCCChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeeccccc
Q 021682 59 EKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMA 138 (309)
Q Consensus 59 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~ 138 (309)
+.+|.|++|...+|.+++.........++.....++.|++.++.| + |.+|+|++|.||++..+..++|+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999766666667888899999999999999 4 8999999999999999999999999998
Q ss_pred ccccCCc----ccccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhh
Q 021682 139 RAFTKDE----CEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWK 213 (309)
Q Consensus 139 ~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~ 213 (309)
....... ....+....||..|++||.+.+..|+.++|||+||++++|++. -...+..... ..-..
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t----------~~d~r 473 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIAT----------LTDIR 473 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHh----------hhhhh
Confidence 7655443 2223455689999999999999999999999999999999997 2222211100 01111
Q ss_pred CCCCcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCH
Q 021682 214 NGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTM 255 (309)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~ 255 (309)
.+.+...+ ......=..|+.+++...|.+||++
T Consensus 474 ~g~ip~~~---------~~d~p~e~~ll~~lls~~p~~RP~~ 506 (516)
T KOG1033|consen 474 DGIIPPEF---------LQDYPEEYTLLQQLLSPSPEERPSA 506 (516)
T ss_pred cCCCChHH---------hhcCcHHHHHHHHhcCCCcccCchH
Confidence 11111110 1111133489999999999999943
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.8e-18 Score=154.38 Aligned_cols=216 Identities=20% Similarity=0.226 Sum_probs=165.6
Q ss_pred CCCcEEEEEEeecCCcc--cHHHHHHHHHHHhcCC-CCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccccCCCH
Q 021682 11 PNGQEMAVKRLSRTSHQ--GLEEFENEVKLTARLQ-HVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDW 87 (309)
Q Consensus 11 ~~g~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 87 (309)
+.|+.+|+|++++.... .....+.|..++...+ ||.++.+...+..+...+++.++..++.+...+ .....+.+
T Consensus 20 da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l---~~~~~f~~ 96 (612)
T KOG0603|consen 20 DAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRL---SKEVMFDE 96 (612)
T ss_pred cccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhcc---ccCCchHH
Confidence 46788899988765321 1225567788888885 999999999999999999999999998886655 33344777
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCcccccc
Q 021682 88 RTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRK 167 (309)
Q Consensus 88 ~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 167 (309)
.....+...++-++.++|+. |++++|+|++||+++.+|.+++.|||+++..-..... .|+..|||||++.
T Consensus 97 ~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~------cgt~eymApEI~~- 166 (612)
T KOG0603|consen 97 LDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA------CGTYEYRAPEIIN- 166 (612)
T ss_pred HHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc------ccchhhhhhHhhh-
Confidence 77888888999999999999 9999999999999999999999999998765443221 5799999999997
Q ss_pred CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHHhhcccC
Q 021682 168 GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQE 247 (309)
Q Consensus 168 ~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 247 (309)
.....+|-||+|++.++|++|..||.. +.. ..... .....+......+.+++.+++..
T Consensus 167 -gh~~a~D~ws~gvl~felltg~~pf~~----~~~------~~Il~-----------~~~~~p~~l~~~a~~~~~~l~~r 224 (612)
T KOG0603|consen 167 -GHLSAADWWSFGVLAFELLTGTLPFGG----DTM------KRILK-----------AELEMPRELSAEARSLFRQLFKR 224 (612)
T ss_pred -ccCCcccchhhhhhHHHHhhCCCCCch----HHH------HHHhh-----------hccCCchhhhHHHHHHHHHHHhh
Confidence 457889999999999999999999865 111 11111 01122233444677999999999
Q ss_pred CCCCCCCH--HHHHHH
Q 021682 248 NAADRPTM--LEILVM 261 (309)
Q Consensus 248 ~p~~Rpt~--~ell~~ 261 (309)
+|.+|.-. ..+.+.
T Consensus 225 ~p~nrLg~~~~~~~ei 240 (612)
T KOG0603|consen 225 NPENRLGAGPDGVDEI 240 (612)
T ss_pred CHHHHhccCcchhHHH
Confidence 99999654 344444
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=5.6e-16 Score=125.67 Aligned_cols=123 Identities=21% Similarity=0.216 Sum_probs=93.3
Q ss_pred ceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcC-----CCCCccceeeEEeeCC---e-eEEEEec--cCCCCh
Q 021682 4 AICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARL-----QHVNLLPVLGICTQRE---E-KMLIYDY--MPNKSL 72 (309)
Q Consensus 4 ~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~---~-~~lv~e~--~~~~~L 72 (309)
+||. .-.++.. +||++..........+.+|+.+++++ .||||+++++++.++. . +.+|+|| +.+++|
T Consensus 17 ~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL 94 (210)
T PRK10345 17 KCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITL 94 (210)
T ss_pred EEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhH
Confidence 4564 3345554 69988665444567889999999999 5799999999999874 3 3478999 557899
Q ss_pred hHHHhhhccccCCCHHHHHHHHHHHHHHH-HHHhhcCCCceeecCCCCceEEeCCC----CCceeecccc
Q 021682 73 DFYIFDLRRRYLLDWRTRVHIIEGITQGL-LYLQEYSNLTIVHRDLKASNILLDYE----MNPKISDFGM 137 (309)
Q Consensus 73 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l-~~lh~~~~~gi~H~di~p~nil~~~~----~~~~l~Dfg~ 137 (309)
.+++.+. .+++. ..++.+++.++ +|||++ +|+|+||||+||+++.+ +.++|+|++.
T Consensus 95 ~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 95 TEFAEQC----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred HHHHHcc----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 9998431 25555 34567777777 999998 89999999999999743 3799999543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.67 E-value=6.7e-16 Score=128.14 Aligned_cols=129 Identities=18% Similarity=0.185 Sum_probs=96.0
Q ss_pred cceEEEE--cCCCcEEEEEEeecCCcc------------------------cHHHHHHHHHHHhcCCCC--CccceeeEE
Q 021682 3 VAICQGR--LPNGQEMAVKRLSRTSHQ------------------------GLEEFENEVKLTARLQHV--NLLPVLGIC 54 (309)
Q Consensus 3 ~~~~~~~--~~~g~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~h~--~iv~~~~~~ 54 (309)
+.||++. ..+|+.||||.++..... ....+..|+..++++.+. .+..+++.
T Consensus 42 g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~i~~p~~~~~- 120 (237)
T smart00090 42 ANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAGVPVPKPIAW- 120 (237)
T ss_pred eeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCeeeEe-
Confidence 4678886 578999999998754210 012356899999999653 23344432
Q ss_pred eeCCeeEEEEeccCCCChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCc-eeecCCCCceEEeCCCCCceee
Q 021682 55 TQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLT-IVHRDLKASNILLDYEMNPKIS 133 (309)
Q Consensus 55 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~g-i~H~di~p~nil~~~~~~~~l~ 133 (309)
. ..++||||+.+.+|..... ............++.|++.++.+||.. | ++|+||+|+||+++ ++.++|+
T Consensus 121 --~-~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NIli~-~~~i~Li 190 (237)
T smart00090 121 --R-RNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNILVH-DGKVVII 190 (237)
T ss_pred --c-CceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhEEEE-CCCEEEE
Confidence 2 3479999999888765431 222355666788999999999999998 8 99999999999999 8899999
Q ss_pred ccccccccc
Q 021682 134 DFGMARAFT 142 (309)
Q Consensus 134 Dfg~~~~~~ 142 (309)
|||.+....
T Consensus 191 DFg~a~~~~ 199 (237)
T smart00090 191 DVSQSVELD 199 (237)
T ss_pred EChhhhccC
Confidence 999876433
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=9.6e-16 Score=125.61 Aligned_cols=126 Identities=19% Similarity=0.239 Sum_probs=102.9
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcc--------cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhH
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQ--------GLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDF 74 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (309)
+.||.|.. +|..|++|........ ....+..|+.++..+.|+++.....++......+++|||++|++|.+
T Consensus 10 ~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~ 88 (211)
T PRK14879 10 AEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKD 88 (211)
T ss_pred EEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHH
Confidence 56899986 7888999986543211 12357789999999999998887777777778899999999999998
Q ss_pred HHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeeccccccc
Q 021682 75 YIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARA 140 (309)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~ 140 (309)
++... .. ....++.+++.++.++|+. |++|+|++|.||+++ ++.++|+|||.+..
T Consensus 89 ~~~~~------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 89 LINSN------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred HHHhc------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 87431 11 7788999999999999998 899999999999998 78899999998753
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.9e-15 Score=122.71 Aligned_cols=123 Identities=23% Similarity=0.305 Sum_probs=97.4
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcc--------cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhH
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQ--------GLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDF 74 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (309)
++||+|.+ +|..|++|........ ...++..|++++..++|+++.....++......++||||++|++|.+
T Consensus 8 ~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~ 86 (199)
T TIGR03724 8 AIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKD 86 (199)
T ss_pred EEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHH
Confidence 56899985 6789999986543211 12456789999999988876665555566667789999999999988
Q ss_pred HHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeeccccccc
Q 021682 75 YIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARA 140 (309)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~ 140 (309)
.+..... .++.+++.++.++|+. |++|+|++|.||+++ ++.++++|||.+..
T Consensus 87 ~~~~~~~----------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 87 VIEEGND----------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred HHhhcHH----------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 7632110 7788999999999998 999999999999998 88999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.5e-14 Score=127.60 Aligned_cols=173 Identities=16% Similarity=0.208 Sum_probs=131.2
Q ss_pred cceEE--EEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 3 VAICQ--GRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 3 ~~~~~--~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
..+|. .+..++.+|.|+..+.......+..++.++.|+.++||+|+++++.++.+.+.|||+|-+. .|..++.+..
T Consensus 25 ~a~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~ 102 (690)
T KOG1243|consen 25 EALWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG 102 (690)
T ss_pred cccccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH
Confidence 34554 3445899999999876655445678889999999999999999999999999999999874 6777774433
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCC
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYV 160 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 160 (309)
...+..-++||+.||.|||..+ +++|++|.-+.|+|+..|.+||++|.+......... .......-..|.
T Consensus 103 ------~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~ 172 (690)
T KOG1243|consen 103 ------KEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFD 172 (690)
T ss_pred ------HHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhccc
Confidence 4556677899999999999766 899999999999999999999999988754333221 011111122455
Q ss_pred CccccccCCCCccchhhhHHHHHHHHHhC
Q 021682 161 PPEYVRKGIYSMKYDVYSYGVLLLQILGG 189 (309)
Q Consensus 161 aPE~~~~~~~~~~~DvwslG~il~~ll~g 189 (309)
.|+.+.... ...|.|.|||++++++.|
T Consensus 173 ~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 173 DPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 665542222 456999999999999998
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.3e-15 Score=143.00 Aligned_cols=139 Identities=23% Similarity=0.315 Sum_probs=108.4
Q ss_pred HHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccc-------------cccccccccCCCCccc
Q 021682 98 TQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEA-------------NTGRIVGTYGYVPPEY 164 (309)
Q Consensus 98 ~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~-------------~~~~~~~~~~y~aPE~ 164 (309)
+.+++|+|+. ||+|+|+||+|.+|+.-|.+|++|||+++......... ......||+.|+|||+
T Consensus 153 vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV 229 (1205)
T KOG0606|consen 153 VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV 229 (1205)
T ss_pred hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhh
Confidence 6789999998 99999999999999999999999999987654322211 1123368999999999
Q ss_pred cccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHHhhc
Q 021682 165 VRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLC 244 (309)
Q Consensus 165 ~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 244 (309)
+..+.|....|=|++|+++|+.+.|..||....+.+....+......|.++ +.....+..++|.++
T Consensus 230 ilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~--------------dea~p~Ea~dli~~L 295 (1205)
T KOG0606|consen 230 ILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE--------------DEALPPEAQDLIEQL 295 (1205)
T ss_pred hhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc--------------CcCCCHHHHHHHHHH
Confidence 999999999999999999999999999997766655544443333333332 111222778999999
Q ss_pred ccCCCCCCC
Q 021682 245 VQENAADRP 253 (309)
Q Consensus 245 l~~~p~~Rp 253 (309)
|+.+|.+|-
T Consensus 296 L~qnp~~Rl 304 (1205)
T KOG0606|consen 296 LRQNPLCRL 304 (1205)
T ss_pred HHhChHhhc
Confidence 999999994
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.5e-14 Score=117.38 Aligned_cols=123 Identities=15% Similarity=0.159 Sum_probs=93.2
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcc----------------------cHHHHHHHHHHHhcCCCCC--ccceeeEEeeCC
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQ----------------------GLEEFENEVKLTARLQHVN--LLPVLGICTQRE 58 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~----------------------~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~ 58 (309)
+.+|++...+|+.||||++...... .......|+..+..+.+++ +..+++. .
T Consensus 29 g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~~~~~~----~ 104 (198)
T cd05144 29 SDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVPKPIDW----N 104 (198)
T ss_pred eEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCCceeec----C
Confidence 3578888878999999987643210 1123567888888887763 4444432 3
Q ss_pred eeEEEEeccCCCChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeeccccc
Q 021682 59 EKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMA 138 (309)
Q Consensus 59 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~ 138 (309)
..++||||+++++|..... ......++.+++.++.++|+. |++|+||+|.||+++.++.++|+|||.+
T Consensus 105 ~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~~~~~~~liDfg~~ 172 (198)
T cd05144 105 RHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVDDDEKIYIIDWPQM 172 (198)
T ss_pred CceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEcCCCcEEEEECCcc
Confidence 4589999999998865531 023456888999999999998 9999999999999999999999999988
Q ss_pred ccc
Q 021682 139 RAF 141 (309)
Q Consensus 139 ~~~ 141 (309)
...
T Consensus 173 ~~~ 175 (198)
T cd05144 173 VST 175 (198)
T ss_pred ccC
Confidence 543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=5.7e-15 Score=122.62 Aligned_cols=204 Identities=18% Similarity=0.194 Sum_probs=138.2
Q ss_pred HHhcCCCCCccceeeEEeeCC-----eeEEEEeccCCCChhHHHhhhc-cccCCCHHHHHHHHHHHHHHHHHHhhcCCCc
Q 021682 38 LTARLQHVNLLPVLGICTQRE-----EKMLIYDYMPNKSLDFYIFDLR-RRYLLDWRTRVHIIEGITQGLLYLQEYSNLT 111 (309)
Q Consensus 38 ~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~g 111 (309)
.|-++-|.||+++..++.+.. ...+++|||..|++..++.+.. ....+......+|+.||+.||.|||+. .+.
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCc
Confidence 345566999999998886543 4688899999999999996633 345577788889999999999999996 568
Q ss_pred eeecCCCCceEEeCCCCCceeecc--cccccccCCcccccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHhC
Q 021682 112 IVHRDLKASNILLDYEMNPKISDF--GMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGG 189 (309)
Q Consensus 112 i~H~di~p~nil~~~~~~~~l~Df--g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g 189 (309)
++|+++..+.|++..+|-+|++-- ......-............+.++|.+||.-.-...+..+|||+||+...+|-.+
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 999999999999999998886421 111111111111112223456789999986666778899999999999999877
Q ss_pred CCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 190 KRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 190 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
........... ....... .....+... .=++++.+|++-.|..||++++++..
T Consensus 279 Eiq~tnseS~~--~~ee~ia------~~i~~len~-----------lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 279 EIQSTNSESKV--EVEENIA------NVIIGLENG-----------LQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred eeccCCCccee--ehhhhhh------hheeeccCc-----------cccCcCcccccCCCCCCcchhhhhcC
Confidence 65422111111 0000000 000000101 11267889999999999999998754
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.9e-14 Score=131.70 Aligned_cols=122 Identities=20% Similarity=0.289 Sum_probs=97.0
Q ss_pred cceEEEEcCCCcEEEEEEeecCC--------cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhH
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTS--------HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDF 74 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (309)
++||++.+. +..+++|...... ....+++..|+++++.++|++++.+..++......++||||+++++|.+
T Consensus 347 g~Vy~~~~~-~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~ 425 (535)
T PRK09605 347 ADIKKGEYL-GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKD 425 (535)
T ss_pred EEEEEEeec-CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHH
Confidence 467888764 4445555432211 1123567899999999999999888777777777899999999999988
Q ss_pred HHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeeccccccc
Q 021682 75 YIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARA 140 (309)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~ 140 (309)
++. ....++.+++.++.+||+. |++||||||.||++ .++.++|+|||++..
T Consensus 426 ~l~-----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 426 VLE-----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred HHH-----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 873 3456889999999999998 99999999999999 678899999998854
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=7.1e-16 Score=143.29 Aligned_cols=233 Identities=23% Similarity=0.289 Sum_probs=169.2
Q ss_pred CcEEEEEEeecCC--cccHHHHHHHHHHHhcCC-CCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccccCCCHHH
Q 021682 13 GQEMAVKRLSRTS--HQGLEEFENEVKLTARLQ-HVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRT 89 (309)
Q Consensus 13 g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 89 (309)
...+|+|.+.... .........|..+-+.+. |.|++.+++........+++.++..++++.+.+.. ......+...
T Consensus 46 ~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~-~~~~~~~~~~ 124 (601)
T KOG0590|consen 46 ESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISH-PDSTGTSSSS 124 (601)
T ss_pred cceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCccccccccccccc-CCccCCCCcc
Confidence 3446666665443 222344556777777775 99999999999999999999999999988777621 1111355566
Q ss_pred HHHHHHHHHHHHHHHh-hcCCCceeecCCCCceEEeCCCC-CceeecccccccccC-Cccccccccccc-ccCCCCcccc
Q 021682 90 RVHIIEGITQGLLYLQ-EYSNLTIVHRDLKASNILLDYEM-NPKISDFGMARAFTK-DECEANTGRIVG-TYGYVPPEYV 165 (309)
Q Consensus 90 ~~~~~~~i~~~l~~lh-~~~~~gi~H~di~p~nil~~~~~-~~~l~Dfg~~~~~~~-~~~~~~~~~~~~-~~~y~aPE~~ 165 (309)
.-.++.|+..++.|+| .. ++.|+||+|+|.+++.++ .++++|||+|..+.. .+.........| +..|+|||..
T Consensus 125 ~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~ 201 (601)
T KOG0590|consen 125 ASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHL 201 (601)
T ss_pred hhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccc
Confidence 7778999999999999 66 899999999999999999 999999999988776 444444445567 9999999998
Q ss_pred ccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHHhhc
Q 021682 166 RKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLC 244 (309)
Q Consensus 166 ~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 244 (309)
.+. ...+..|+||.|+++..+++|..|+.......... ..|....... .............+++.++
T Consensus 202 ~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~------~~~~~~~~~~------~~~~~~~~~~~~~~~l~k~ 269 (601)
T KOG0590|consen 202 SGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY------SSWKSNKGRF------TQLPWNSISDQAHDLLHKI 269 (601)
T ss_pred cchhhcCCCcccccccccccccccCCCCccccccccccc------eeeccccccc------ccCccccCChhhhhccccc
Confidence 884 44788999999999999999999986554444210 1111111110 0011111122556889999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 021682 245 VQENAADRPTMLEILVM 261 (309)
Q Consensus 245 l~~~p~~Rpt~~ell~~ 261 (309)
+..+|+.|.+.+++...
T Consensus 270 l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 270 LKENPSNRLSIEELKLD 286 (601)
T ss_pred ccCCchhcccccccccc
Confidence 99999999999988643
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.54 E-value=9.6e-14 Score=115.48 Aligned_cols=125 Identities=18% Similarity=0.166 Sum_probs=92.7
Q ss_pred ceEEEEcCCCcEEEEEEeecCC-------------cccHHHHHHHHHHHhcCCCCCc--cceeeEEeeCC----eeEEEE
Q 021682 4 AICQGRLPNGQEMAVKRLSRTS-------------HQGLEEFENEVKLTARLQHVNL--LPVLGICTQRE----EKMLIY 64 (309)
Q Consensus 4 ~~~~~~~~~g~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i--v~~~~~~~~~~----~~~lv~ 64 (309)
++|.... ++..++||.+.... .....++..|++++.+++|+++ +.++++..... ..++||
T Consensus 47 tv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~ 125 (239)
T PRK01723 47 TTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILI 125 (239)
T ss_pred cEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEE
Confidence 3444444 47889999885321 1223567889999999988775 66676644332 235999
Q ss_pred eccCC-CChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeeccccccc
Q 021682 65 DYMPN-KSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARA 140 (309)
Q Consensus 65 e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~ 140 (309)
|++++ .+|.+++.. ..++.. .+.+++.++.+||.. ||+|+||+|.||+++.++.++|+|||.+..
T Consensus 126 e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 126 ERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred EecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 99987 688887632 124443 356899999999999 999999999999999989999999998754
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.53 E-value=9.6e-14 Score=107.10 Aligned_cols=124 Identities=20% Similarity=0.202 Sum_probs=100.9
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCC--CCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQH--VNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
..+|++... ++.+++|....... ...+..|+..++.+++ .++++++.+....+..++++||+.+..+..+
T Consensus 12 ~~v~~~~~~-~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~----- 83 (155)
T cd05120 12 NRVYLLGTK-DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV----- 83 (155)
T ss_pred cceEEEEec-CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC-----
Confidence 467777764 47899999865433 4678899999999966 5888888888877889999999988766432
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccc
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMAR 139 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~ 139 (309)
+......++.+++.+++.+|..+..+++|+|++|.||++++.+.++++||+.+.
T Consensus 84 -----~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 84 -----SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred -----CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence 445566788899999999998755589999999999999998999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.48 E-value=3.2e-13 Score=108.47 Aligned_cols=126 Identities=20% Similarity=0.228 Sum_probs=86.7
Q ss_pred cceEEEEcCCCcEEEEEEeecCCccc--HHH----------------------HHHHHHHHhcCCCCC--ccceeeEEee
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQG--LEE----------------------FENEVKLTARLQHVN--LLPVLGICTQ 56 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~--~~~----------------------~~~e~~~l~~l~h~~--iv~~~~~~~~ 56 (309)
+.||.+...+|+.||||+++...... ... ...|.+.+.++.+.+ +.++++.
T Consensus 11 g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~--- 87 (187)
T cd05119 11 ADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVPKPIDL--- 87 (187)
T ss_pred eeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCCceEec---
Confidence 46788887789999999986542111 111 135566666664332 4444433
Q ss_pred CCeeEEEEeccCCCChhH-HHhhhccccCCCHHHHHHHHHHHHHHHHHHhh-cCCCceeecCCCCceEEeCCCCCceeec
Q 021682 57 REEKMLIYDYMPNKSLDF-YIFDLRRRYLLDWRTRVHIIEGITQGLLYLQE-YSNLTIVHRDLKASNILLDYEMNPKISD 134 (309)
Q Consensus 57 ~~~~~lv~e~~~~~~L~~-~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~~~gi~H~di~p~nil~~~~~~~~l~D 134 (309)
...++||||++++.+.. .+.... .. .....++.+++.++.++|. . |++|+||+|+||+++ ++.++|+|
T Consensus 88 -~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-~~~~~liD 157 (187)
T cd05119 88 -NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-DGKVYIID 157 (187)
T ss_pred -CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-CCcEEEEE
Confidence 23589999999854321 111111 11 5677889999999999999 6 899999999999999 88999999
Q ss_pred ccccccc
Q 021682 135 FGMARAF 141 (309)
Q Consensus 135 fg~~~~~ 141 (309)
||.+...
T Consensus 158 fg~a~~~ 164 (187)
T cd05119 158 VPQAVEI 164 (187)
T ss_pred Ccccccc
Confidence 9988543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.37 E-value=3e-12 Score=115.58 Aligned_cols=132 Identities=20% Similarity=0.260 Sum_probs=85.3
Q ss_pred ceEEEEcCCCcEEEEEEeecCCcccHH----------------------------------------HHHHHHHHHhcC-
Q 021682 4 AICQGRLPNGQEMAVKRLSRTSHQGLE----------------------------------------EFENEVKLTARL- 42 (309)
Q Consensus 4 ~~~~~~~~~g~~vavK~~~~~~~~~~~----------------------------------------~~~~e~~~l~~l- 42 (309)
-||+|.+.+|+.||||+.++....... .+..|++.+.++
T Consensus 132 QVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~Ea~n~~~~~ 211 (437)
T TIGR01982 132 QVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRREAANASELG 211 (437)
T ss_pred heEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHHHHHHHHHHH
Confidence 589999999999999998654211100 123344444433
Q ss_pred ---CCCCccceeeEE-eeCCeeEEEEeccCCCChhHHHhhhccccCCCHHHHHHHHHHHHH-HHHHHhhcCCCceeecCC
Q 021682 43 ---QHVNLLPVLGIC-TQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQ-GLLYLQEYSNLTIVHRDL 117 (309)
Q Consensus 43 ---~h~~iv~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~-~l~~lh~~~~~gi~H~di 117 (309)
++.+-+.+-.++ ......+|||||++|.+|.++......+ .+ ...++..++. .+..+|.. |++|+|+
T Consensus 212 ~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~~---~~~ia~~~~~~~l~ql~~~---g~~H~D~ 283 (437)
T TIGR01982 212 ENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--LD---RKALAENLARSFLNQVLRD---GFFHADL 283 (437)
T ss_pred HhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--CC---HHHHHHHHHHHHHHHHHhC---CceeCCC
Confidence 222222222222 2234578999999999998876321111 22 2345555554 35667776 9999999
Q ss_pred CCceEEeCCCCCceeecccccccccC
Q 021682 118 KASNILLDYEMNPKISDFGMARAFTK 143 (309)
Q Consensus 118 ~p~nil~~~~~~~~l~Dfg~~~~~~~ 143 (309)
+|.||+++.++.++++|||++.....
T Consensus 284 hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 284 HPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred CcccEEECCCCcEEEEeCCCeeECCH
Confidence 99999999999999999999865543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.28 E-value=8.7e-11 Score=93.79 Aligned_cols=96 Identities=16% Similarity=0.169 Sum_probs=71.2
Q ss_pred HHHHHHhcCC--CCCccceeeEEeeCCeeEEEEeccCCCChhH-HHhhhccccCCCHHHHHHHHHHHHHHHHHH-hhcCC
Q 021682 34 NEVKLTARLQ--HVNLLPVLGICTQREEKMLIYDYMPNKSLDF-YIFDLRRRYLLDWRTRVHIIEGITQGLLYL-QEYSN 109 (309)
Q Consensus 34 ~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~-~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l-h~~~~ 109 (309)
.|++.|+++. .-++..++++ ..-+|||||+.+..+.. .+. ...++......+..+++.++..+ |..
T Consensus 75 kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~~-- 144 (197)
T cd05146 75 KEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKEC-- 144 (197)
T ss_pred HHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHhC--
Confidence 8999999984 3466667765 34579999997643321 221 11244556677788999999988 777
Q ss_pred CceeecCCCCceEEeCCCCCceeecccccccc
Q 021682 110 LTIVHRDLKASNILLDYEMNPKISDFGMARAF 141 (309)
Q Consensus 110 ~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~ 141 (309)
|++||||++.||+++ ++.+.|+|||.+...
T Consensus 145 -glVHGDLs~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 145 -NLVHADLSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred -CeecCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence 999999999999996 577999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.27 E-value=5.3e-12 Score=113.06 Aligned_cols=224 Identities=18% Similarity=0.191 Sum_probs=159.6
Q ss_pred CCCcEEEEEEeec--CCcccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccccCCCH
Q 021682 11 PNGQEMAVKRLSR--TSHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDW 87 (309)
Q Consensus 11 ~~g~~vavK~~~~--~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 87 (309)
.++..+|+|.-+. ..+.....-.+|+...+++ .|++.++.+..+...+..++-+|.+. .+|..+.. .....++.
T Consensus 141 ~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~~-~sl~~~~~--~~~~~~p~ 217 (524)
T KOG0601|consen 141 ESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELCG-ESLQSYCH--TPCNFLPD 217 (524)
T ss_pred cCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeeecccc-chhHHhhh--cccccCCc
Confidence 4788899997433 2333334445667666777 69999998999999999999999984 67777763 33444777
Q ss_pred HHHHHHHHHHHH----HHHHHhhcCCCceeecCCCCceEEeCCC-CCceeecccccccccCCcccccc---cccccccCC
Q 021682 88 RTRVHIIEGITQ----GLLYLQEYSNLTIVHRDLKASNILLDYE-MNPKISDFGMARAFTKDECEANT---GRIVGTYGY 159 (309)
Q Consensus 88 ~~~~~~~~~i~~----~l~~lh~~~~~gi~H~di~p~nil~~~~-~~~~l~Dfg~~~~~~~~~~~~~~---~~~~~~~~y 159 (309)
..++..+.+... |+.++|+. +++|-|++|.||+...+ ..++++|||+...++........ ....+...|
T Consensus 218 ~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y 294 (524)
T KOG0601|consen 218 NLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIY 294 (524)
T ss_pred hhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceE
Confidence 788888888888 99999998 89999999999999999 88999999998877765432221 123677899
Q ss_pred CCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCC---CCCCcccHHHHHHHHhhCCC-CcccccccCCCcccHHHHH
Q 021682 160 VPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYY---GPNESLNLLEYAYGLWKNGE-GMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 160 ~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~---~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 235 (309)
++||...+ -++...|+|++|.++.+..++....... .+... .... ..++++. ...
T Consensus 295 ~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~-----------r~~~ip~e~~~~---------~s~ 353 (524)
T KOG0601|consen 295 AAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL-----------RQGYIPLEFCEG---------GSS 353 (524)
T ss_pred eChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc-----------ccccCchhhhcC---------cch
Confidence 99999855 4588899999999999888775543211 11110 0000 0111111 112
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 236 RCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
++...+.+|++.+|-.|++++.+...
T Consensus 354 ~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 354 SLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred hhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 55568889999999999999887754
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.25 E-value=3.3e-11 Score=95.05 Aligned_cols=121 Identities=19% Similarity=0.155 Sum_probs=85.4
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCcc-ceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLL-PVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
..+|+... .|+.|++|....... ....+..|+..++.+.+.+++ +++.+.. ...++||||++|.++....
T Consensus 12 ~~vy~~~~-~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~~~~----- 82 (170)
T cd05151 12 NKNYRVEV-ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELLTED----- 82 (170)
T ss_pred CceEEEEE-CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcccccc-----
Confidence 35677765 478899999754432 223467899999988554444 4554432 3457999999998775320
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcC--CCceeecCCCCceEEeCCCCCceeecccccc
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYS--NLTIVHRDLKASNILLDYEMNPKISDFGMAR 139 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~--~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~ 139 (309)
. .....+.+++.+++.||... ..+++|+|++|.||+++ ++.++++||+.+.
T Consensus 83 ---~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 83 ---F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ---c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 1 11235678999999999873 22369999999999998 6789999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.19 E-value=3e-11 Score=110.60 Aligned_cols=77 Identities=18% Similarity=0.204 Sum_probs=52.5
Q ss_pred CCeeEEEEeccCCCChhHHHhhhccc---cCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCC----C
Q 021682 57 REEKMLIYDYMPNKSLDFYIFDLRRR---YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM----N 129 (309)
Q Consensus 57 ~~~~~lv~e~~~~~~L~~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~----~ 129 (309)
....+|||||+.|+.+.++..-...+ ..+....+..++.|++ .. |++|+|++|.||+++.++ .
T Consensus 233 st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------~~---GffHaDpHPGNIlv~~~g~~~~~ 302 (537)
T PRK04750 233 CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------RD---GFFHADMHPGNIFVSYDPPENPR 302 (537)
T ss_pred CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------hC---CeeeCCCChHHeEEecCCCCCCe
Confidence 34568999999999997753111111 1122333333344433 33 899999999999999888 8
Q ss_pred ceeecccccccccC
Q 021682 130 PKISDFGMARAFTK 143 (309)
Q Consensus 130 ~~l~Dfg~~~~~~~ 143 (309)
++++|||+......
T Consensus 303 i~llDFGivg~l~~ 316 (537)
T PRK04750 303 YIALDFGIVGSLNK 316 (537)
T ss_pred EEEEecceEEECCH
Confidence 99999999876544
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.18 E-value=3.2e-10 Score=87.82 Aligned_cols=121 Identities=19% Similarity=0.227 Sum_probs=88.7
Q ss_pred eEEEEcCCCcEEEEEEeecCC---c-----ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHH
Q 021682 5 ICQGRLPNGQEMAVKRLSRTS---H-----QGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 5 ~~~~~~~~g~~vavK~~~~~~---~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 76 (309)
++.+.+ -|.++++|.=.++. + -...+..+|++++.+++--.|.-.+-+..+.....|+|||.+|..|.+++
T Consensus 12 i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l 90 (204)
T COG3642 12 IYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDAL 90 (204)
T ss_pred EEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHH
Confidence 445544 35557777532221 1 12345678999999987666666666666777788999999999999888
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeeccccccc
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARA 140 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~ 140 (309)
... ...++..+...+.-||.. ||+||||.++||++...+ +.++|||++..
T Consensus 91 ~~~----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 91 EEA----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred Hhc----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 433 245677788888999998 999999999999996554 99999999853
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.17 E-value=9.6e-10 Score=97.24 Aligned_cols=217 Identities=19% Similarity=0.240 Sum_probs=149.8
Q ss_pred CccceEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEee----CCeeEEEEeccCC-CChhH
Q 021682 1 MSVAICQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQ----REEKMLIYDYMPN-KSLDF 74 (309)
Q Consensus 1 ~g~~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~-~~L~~ 74 (309)
|+.+-|+... .+|..+++|++.............-++..+++.|.|+|++.++|.. +..+++|++|.++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 4556677765 4899999999955444444455667889999999999999888763 3468999999975 46666
Q ss_pred HHhhhc------------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeeccccccccc
Q 021682 75 YIFDLR------------RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFT 142 (309)
Q Consensus 75 ~~~~~~------------~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~ 142 (309)
+-.... .+...++..+|.++.|+..||.++|+. |+.-+-|.+.+|+++...++++...|......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence 543321 233467899999999999999999998 99999999999999988889998887765544
Q ss_pred CCcccccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCccccc
Q 021682 143 KDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFID 222 (309)
Q Consensus 143 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (309)
.+... -+.+ ..+-|.--||.+++.|.+|....- ..+.. ....
T Consensus 445 ~d~~~----------------~le~---~Qq~D~~~lG~ll~aLAt~~~ns~---~~d~~--~~s~-------------- 486 (655)
T KOG3741|consen 445 EDPTE----------------PLES---QQQNDLRDLGLLLLALATGTENSN---RTDST--QSSH-------------- 486 (655)
T ss_pred CCCCc----------------chhH---HhhhhHHHHHHHHHHHhhcccccc---cccch--HHHH--------------
Confidence 43211 1111 245689999999999999864310 00000 0000
Q ss_pred ccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 021682 223 SSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVML 262 (309)
Q Consensus 223 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L 262 (309)
..........++++++......++++ -++.+++.+.
T Consensus 487 ---~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 487 ---LTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred ---HHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 00111223346667777777777776 6777777664
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.4e-10 Score=89.37 Aligned_cols=124 Identities=24% Similarity=0.243 Sum_probs=80.2
Q ss_pred eEEEEcCCCcEEEEEEeecCC--------------c------------ccHHHHHHHHHHHhcCCCC--CccceeeEEee
Q 021682 5 ICQGRLPNGQEMAVKRLSRTS--------------H------------QGLEEFENEVKLTARLQHV--NLLPVLGICTQ 56 (309)
Q Consensus 5 ~~~~~~~~g~~vavK~~~~~~--------------~------------~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~ 56 (309)
||.|...+|..||||+.+... . ......+.|++.|.++... ++.+++++.
T Consensus 2 Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-- 79 (188)
T PF01163_consen 2 VYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-- 79 (188)
T ss_dssp EEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE--
T ss_pred EEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe--
Confidence 788988899999999885310 0 0123466899999999655 466676552
Q ss_pred CCeeEEEEeccC--CCChhHHHhhhccccCCCHHHHHHHHHHHHHHHHH-HhhcCCCceeecCCCCceEEeCCCCCceee
Q 021682 57 REEKMLIYDYMP--NKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLY-LQEYSNLTIVHRDLKASNILLDYEMNPKIS 133 (309)
Q Consensus 57 ~~~~~lv~e~~~--~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~-lh~~~~~gi~H~di~p~nil~~~~~~~~l~ 133 (309)
.-+|||||++ |..+..+.... +.......++.+++..+.. +|.. |++|||+++.||+++.+ .+.++
T Consensus 80 --~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 --RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp --TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE-
T ss_pred --CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEE
Confidence 2369999998 66665543211 1123445667777774444 5676 99999999999999877 89999
Q ss_pred cccccccc
Q 021682 134 DFGMARAF 141 (309)
Q Consensus 134 Dfg~~~~~ 141 (309)
|||.+...
T Consensus 149 Df~qav~~ 156 (188)
T PF01163_consen 149 DFGQAVDS 156 (188)
T ss_dssp -GTTEEET
T ss_pred ecCcceec
Confidence 99987543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.13 E-value=9.4e-10 Score=84.98 Aligned_cols=131 Identities=20% Similarity=0.289 Sum_probs=95.6
Q ss_pred eEEEEcCCCcEEEEEEe-ecC-------CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCC-CChhHH
Q 021682 5 ICQGRLPNGQEMAVKRL-SRT-------SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPN-KSLDFY 75 (309)
Q Consensus 5 ~~~~~~~~g~~vavK~~-~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~~L~~~ 75 (309)
++.+.+ .|+...||.= .+. ..-.+.+.+.|++.|.+++--.|.-..-++.+...-.|+|||++| .++.++
T Consensus 23 v~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~ 101 (229)
T KOG3087|consen 23 VPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDF 101 (229)
T ss_pred Eeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHH
Confidence 456665 6888888843 221 122345678999999998766776666667777777899999976 477888
Q ss_pred HhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCC---ceeeccccccc
Q 021682 76 IFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMN---PKISDFGMARA 140 (309)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~---~~l~Dfg~~~~ 140 (309)
+.........++ ....++..|.+.+.-||.. +++||||..+||++..++. +.++|||++..
T Consensus 102 i~~~~~~~~~d~-~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 102 ILSTMEDESEDE-GLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred HHHHccCcccch-hHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 865444333332 2367888899999999999 8999999999999976543 48999999854
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.11 E-value=2.6e-09 Score=90.01 Aligned_cols=130 Identities=18% Similarity=0.201 Sum_probs=93.0
Q ss_pred eEEEEcCCCcEEEEEEeecCCc-----------ccHHHHHHHHHHHhcCCCCC--ccceeeEEee-----CCeeEEEEec
Q 021682 5 ICQGRLPNGQEMAVKRLSRTSH-----------QGLEEFENEVKLTARLQHVN--LLPVLGICTQ-----REEKMLIYDY 66 (309)
Q Consensus 5 ~~~~~~~~g~~vavK~~~~~~~-----------~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~-----~~~~~lv~e~ 66 (309)
+++..+ +|+.+.||......- .....+..|...+.++..-+ ...++++.+. ....++|||+
T Consensus 38 vvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~ 116 (268)
T PRK15123 38 TLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITED 116 (268)
T ss_pred EEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEee
Confidence 445555 678999997743321 11124678888888884333 3445556543 2357899999
Q ss_pred cCCC-ChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCC-------CCCceeeccccc
Q 021682 67 MPNK-SLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY-------EMNPKISDFGMA 138 (309)
Q Consensus 67 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~-------~~~~~l~Dfg~~ 138 (309)
+++. +|.+++.+.. ....+......++.+++..+.-||.. |++|+|+++.||+++. +..+.|+||+.+
T Consensus 117 l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~ 192 (268)
T PRK15123 117 LAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA 192 (268)
T ss_pred CCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence 9875 7888874321 22345667778999999999999999 9999999999999975 457899999976
Q ss_pred c
Q 021682 139 R 139 (309)
Q Consensus 139 ~ 139 (309)
.
T Consensus 193 ~ 193 (268)
T PRK15123 193 Q 193 (268)
T ss_pred c
Confidence 4
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.04 E-value=3.9e-09 Score=91.39 Aligned_cols=212 Identities=15% Similarity=0.122 Sum_probs=138.4
Q ss_pred eeEEEEeccCCC-ChhHHHhh---hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeec
Q 021682 59 EKMLIYDYMPNK-SLDFYIFD---LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISD 134 (309)
Q Consensus 59 ~~~lv~e~~~~~-~L~~~~~~---~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~D 134 (309)
...++|+.+.+. ...++..- ........|...+.++..++.+.+.||.. |..-||+.++|+++...+.+.|.|
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVd 160 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVD 160 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEc
Confidence 367888887653 23333221 22344577899999999999999999998 999999999999999999999998
Q ss_pred ccccccccCCcccccccccccccCCCCccccc-----cCCCCccchhhhHHHHHHHHHhC-CCCCCCCCCCCcc-cHH--
Q 021682 135 FGMARAFTKDECEANTGRIVGTYGYVPPEYVR-----KGIYSMKYDVYSYGVLLLQILGG-KRTSCYYGPNESL-NLL-- 205 (309)
Q Consensus 135 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~~ll~g-~~p~~~~~~~~~~-~~~-- 205 (309)
=+........ ....+.+|.+.|.+||... +-.-+...|.|.||+++|+++.| +.||........- ...
T Consensus 161 sDsfqi~~ng---~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~ 237 (637)
T COG4248 161 SDSFQINANG---TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET 237 (637)
T ss_pred ccceeeccCC---ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh
Confidence 6654433222 2344567889999999765 23446789999999999999986 8888643322111 111
Q ss_pred HHHHHHhh--CCCCcccccccCCCccc-HHHHHHHHHHHhhcccC--CCCCCCCHHHHHHHHhcccCCCCCCCCCCcc
Q 021682 206 EYAYGLWK--NGEGMEFIDSSLDDSSS-AWKLMRCMQVALLCVQE--NAADRPTMLEILVMLKSETADIKTPKKPAFS 278 (309)
Q Consensus 206 ~~~~~~~~--~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~--~p~~Rpt~~ell~~L~~~~~~~~~~~~p~~~ 278 (309)
......+. .........+ ..+.+ .....++..+..+|+.. ++.-|||++..+..|....+.+.+=..-..-
T Consensus 238 ~Ia~g~f~ya~~~~~g~~p~--P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v~a~H 313 (637)
T COG4248 238 DIAHGRFAYASDQRRGLKPP--PRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTVSAMH 313 (637)
T ss_pred hhhcceeeechhccCCCCCC--CCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhhcccc
Confidence 11111111 1111111111 11111 11233566777788765 3668999999999998887777766555443
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.02 E-value=3e-09 Score=87.61 Aligned_cols=133 Identities=15% Similarity=0.211 Sum_probs=93.7
Q ss_pred cceEEEEcCCCcEEEEEEeecCCc-ccHHHHHHHHHHHhcCCC--CCccceeeEEeeC---CeeEEEEeccCCCChhHHH
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSH-QGLEEFENEVKLTARLQH--VNLLPVLGICTQR---EEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~---~~~~lv~e~~~~~~L~~~~ 76 (309)
..+|+....+|+.+++|....... .....+..|+++++.+.+ ..+.+++.+.... +..++|||+++|.++...+
T Consensus 12 n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~ 91 (223)
T cd05154 12 NLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRL 91 (223)
T ss_pred ceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCC
Confidence 356777766678999999754322 235678899999999965 3456677776653 2568999999998876543
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhcC------------------------------------------------
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYS------------------------------------------------ 108 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~------------------------------------------------ 108 (309)
.. ..++......++.+++.++..||+..
T Consensus 92 ~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (223)
T cd05154 92 LR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAH 167 (223)
T ss_pred CC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhh
Confidence 10 12455555666666666666666421
Q ss_pred -----CCceeecCCCCceEEeCC--CCCceeecccccc
Q 021682 109 -----NLTIVHRDLKASNILLDY--EMNPKISDFGMAR 139 (309)
Q Consensus 109 -----~~gi~H~di~p~nil~~~--~~~~~l~Dfg~~~ 139 (309)
...++|+|+++.||+++. ++.+.++||+.+.
T Consensus 168 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 168 LPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred CCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 246799999999999998 5668899998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.97 E-value=9.1e-10 Score=98.93 Aligned_cols=223 Identities=17% Similarity=0.138 Sum_probs=150.9
Q ss_pred CCCcEEEEEEeecCCcccHHH--HHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccccCCCH
Q 021682 11 PNGQEMAVKRLSRTSHQGLEE--FENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDW 87 (309)
Q Consensus 11 ~~g~~vavK~~~~~~~~~~~~--~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 87 (309)
.++..+++|.+.+......++ -..|+.+...+ .|.+++..+..+....+.++=-|||+++++...+ .-...+++
T Consensus 289 ~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~---~~~~~~d~ 365 (524)
T KOG0601|consen 289 EGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRS---VTSQMLDE 365 (524)
T ss_pred CCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhh---HHHHhcCc
Confidence 467778888776543322222 23455555555 6888888887777777777888999998887665 22334777
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCC-CCceeecccccccccCCcccccccccccccCCC--Cccc
Q 021682 88 RTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYE-MNPKISDFGMARAFTKDECEANTGRIVGTYGYV--PPEY 164 (309)
Q Consensus 88 ~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~--aPE~ 164 (309)
...+.+..|++.++.++|+. .++|+|++|.||++..+ +..+++||+.......... ......++. ++..
T Consensus 366 ~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~-----~~~~~~r~~p~~~~~ 437 (524)
T KOG0601|consen 366 DPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG-----VFHHIDRLYPIAEIL 437 (524)
T ss_pred chhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccccceecc-----cccccccccccchhh
Confidence 88899999999999999988 89999999999999886 7788999988754221111 111222333 5555
Q ss_pred cccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHHhhc
Q 021682 165 VRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLC 244 (309)
Q Consensus 165 ~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 244 (309)
.....+..++|+++||.-+.+..++....... ..+..+............ ..+..+.+.+
T Consensus 438 ~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~------------------~~~~~i~~~~~p~~~~~~--~~~q~~~kv~ 497 (524)
T KOG0601|consen 438 LEDYPHLSKADIFSLGLSVDEAITGSPLSESG------------------VQSLTIRSGDTPNLPGLK--LQLQVLLKVM 497 (524)
T ss_pred ccccccccccccccccccccccccCcccCccc------------------ccceeeecccccCCCchH--Hhhhhhhhhh
Confidence 56667889999999999999998886542110 011111111111111111 3566788889
Q ss_pred ccCCCCCCCCHHHHHHHHhc
Q 021682 245 VQENAADRPTMLEILVMLKS 264 (309)
Q Consensus 245 l~~~p~~Rpt~~ell~~L~~ 264 (309)
+..++..||.+.++....+-
T Consensus 498 ~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 498 INPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred cCCccccchhhhhhcccchh
Confidence 99999999999998876554
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.3e-08 Score=83.74 Aligned_cols=122 Identities=20% Similarity=0.184 Sum_probs=86.9
Q ss_pred cceEEEEcCCCcEEEEEEeecCC----------------------cccHHHHHHHHHHHhcCCCC--CccceeeEEeeCC
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTS----------------------HQGLEEFENEVKLTARLQHV--NLLPVLGICTQRE 58 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~----------------------~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~~ 58 (309)
+.||.+...+|.++|||.-+... .-.+...++|++.|.+|... .+..++++ +
T Consensus 105 sdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP~P~~~----n 180 (304)
T COG0478 105 SDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVPKPIAW----N 180 (304)
T ss_pred ceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCCCcccc----c
Confidence 46899998899999999753210 11233467899999999544 67777765 3
Q ss_pred eeEEEEeccCCCChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeeccccc
Q 021682 59 EKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMA 138 (309)
Q Consensus 59 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~ 138 (309)
.-++|||+++|..|...- +.......++..|++-+..+-.. |++|||+++-||+++++|.+.++||-.+
T Consensus 181 RHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~dg~~~vIDwPQ~ 249 (304)
T COG0478 181 RHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTEDGDIVVIDWPQA 249 (304)
T ss_pred cceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecCCCEEEEeCccc
Confidence 356999999987664432 12223344555555555555555 8999999999999999999999999765
Q ss_pred c
Q 021682 139 R 139 (309)
Q Consensus 139 ~ 139 (309)
.
T Consensus 250 v 250 (304)
T COG0478 250 V 250 (304)
T ss_pred c
Confidence 4
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=3.4e-10 Score=103.28 Aligned_cols=154 Identities=19% Similarity=0.240 Sum_probs=102.9
Q ss_pred HHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccc----c---ccccccccCCCCcccc
Q 021682 93 IIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEA----N---TGRIVGTYGYVPPEYV 165 (309)
Q Consensus 93 ~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~----~---~~~~~~~~~y~aPE~~ 165 (309)
=+.+++.|+.++|... +++|++|.|++|.++.++.+||+.|+++.......... . .........|.|||.+
T Consensus 104 nl~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~ 181 (700)
T KOG2137|consen 104 NLGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL 181 (700)
T ss_pred hhhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence 3445668999999876 89999999999999999999999998875444321110 0 1111234579999999
Q ss_pred ccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHHhhc
Q 021682 166 RKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLC 244 (309)
Q Consensus 166 ~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 244 (309)
.+...+.++|+||+|+++|.+.. |..-+...+........... .....+ ..+...+.++.+=+.++
T Consensus 182 ~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~------~~~~~~-------~~s~~~p~el~~~l~k~ 248 (700)
T KOG2137|consen 182 LGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNL------LNAGAF-------GYSNNLPSELRESLKKL 248 (700)
T ss_pred ccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcc------cccccc-------cccccCcHHHHHHHHHH
Confidence 88888999999999999999984 44443322222211111000 000000 11122334777888899
Q ss_pred ccCCCCCCCCHHHHHHH
Q 021682 245 VQENAADRPTMLEILVM 261 (309)
Q Consensus 245 l~~~p~~Rpt~~ell~~ 261 (309)
+..++..||++.++...
T Consensus 249 l~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 249 LNGDSAVRPTLDLLLSI 265 (700)
T ss_pred hcCCcccCcchhhhhcc
Confidence 99999999988877654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.82 E-value=2.7e-09 Score=101.44 Aligned_cols=193 Identities=18% Similarity=0.161 Sum_probs=132.9
Q ss_pred CCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEE
Q 021682 44 HVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNIL 123 (309)
Q Consensus 44 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil 123 (309)
+|.++.....+......+|+++++.+++|...+.... ..+....+..+..+..+..+||+. .+.|+|++|.|++
T Consensus 863 ~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l 936 (1205)
T KOG0606|consen 863 SPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLL 936 (1205)
T ss_pred CCceecccCCCCCCCCcchhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccc---hhhcccccccchh
Confidence 4444444444445567899999999999987774332 355666677777888999999987 5899999999999
Q ss_pred eCCCCCceeecccccccccCCcc---------------------c--------ccccccccccCCCCccccccCCCCccc
Q 021682 124 LDYEMNPKISDFGMARAFTKDEC---------------------E--------ANTGRIVGTYGYVPPEYVRKGIYSMKY 174 (309)
Q Consensus 124 ~~~~~~~~l~Dfg~~~~~~~~~~---------------------~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~ 174 (309)
...++..++.||+.....+.... . .......+|+.|.+||...+......+
T Consensus 937 ~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~a 1016 (1205)
T KOG0606|consen 937 IAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAA 1016 (1205)
T ss_pred hcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcc
Confidence 99999999999984322211000 0 001234688999999999999889999
Q ss_pred hhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCC
Q 021682 175 DVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPT 254 (309)
Q Consensus 175 DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt 254 (309)
|.|++|+++++.++|.+||....+......+.. ... +.. ...........+++...+..+|.+|..
T Consensus 1017 d~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~----------~~~--~~p--~g~~~~s~~aq~~~~~ll~~~~~qr~~ 1082 (1205)
T KOG0606|consen 1017 DWWSSGVCLFEVLTGIPPFNAETPQQIFENILN----------RDI--PWP--EGPEEGSYEAQDLINRLLTEEPTQRLG 1082 (1205)
T ss_pred hhhhhhhhhhhhhcCCCCCCCcchhhhhhcccc----------CCC--CCC--CCccccChhhhhhhhhhhccCchhccC
Confidence 999999999999999999865433332211100 000 000 111122235668888889999999977
Q ss_pred HH
Q 021682 255 ML 256 (309)
Q Consensus 255 ~~ 256 (309)
+.
T Consensus 1083 a~ 1084 (1205)
T KOG0606|consen 1083 AK 1084 (1205)
T ss_pred cc
Confidence 76
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.79 E-value=8.4e-08 Score=78.11 Aligned_cols=106 Identities=22% Similarity=0.262 Sum_probs=82.2
Q ss_pred HHHHHHHHHHHhcCC--CCCccceeeEEeeCC----eeEEEEeccCCC-ChhHHHhhhccccCCCHHHHHHHHHHHHHHH
Q 021682 29 LEEFENEVKLTARLQ--HVNLLPVLGICTQRE----EKMLIYDYMPNK-SLDFYIFDLRRRYLLDWRTRVHIIEGITQGL 101 (309)
Q Consensus 29 ~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~----~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 101 (309)
..+...|...+..|. .-.+..++++..... ..++|+|.+++. +|.+++..... .+......++.+++..+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence 456778888887774 334556677666532 458999999874 78888744222 55667788999999999
Q ss_pred HHHhhcCCCceeecCCCCceEEeCCCC---Cceeeccccccc
Q 021682 102 LYLQEYSNLTIVHRDLKASNILLDYEM---NPKISDFGMARA 140 (309)
Q Consensus 102 ~~lh~~~~~gi~H~di~p~nil~~~~~---~~~l~Dfg~~~~ 140 (309)
+-||.. |++|+|+++.|||++.++ .+.++||+.+..
T Consensus 132 ~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 132 AKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999 999999999999999887 799999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.1e-07 Score=86.82 Aligned_cols=82 Identities=15% Similarity=0.178 Sum_probs=55.1
Q ss_pred eeCCeeEEEEeccCCCChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeec
Q 021682 55 TQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISD 134 (309)
Q Consensus 55 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~D 134 (309)
+......|+|||+.|..+.+...... ..++... ++..++.+.-..--.+ |+.|.|.+|.||+++.+|.+.+.|
T Consensus 236 e~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~---ia~~~~~~f~~q~~~d--gffHaDpHpGNi~v~~~g~i~~lD 308 (517)
T COG0661 236 EYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKE---LAELLVRAFLRQLLRD--GFFHADPHPGNILVRSDGRIVLLD 308 (517)
T ss_pred hccCCcEEEEEeeCCEecccHHHHHh--cCCCHHH---HHHHHHHHHHHHHHhc--CccccCCCccceEEecCCcEEEEc
Confidence 33456789999999999988753222 2244333 2333333221111112 899999999999999999999999
Q ss_pred ccccccccC
Q 021682 135 FGMARAFTK 143 (309)
Q Consensus 135 fg~~~~~~~ 143 (309)
||+......
T Consensus 309 fGi~g~l~~ 317 (517)
T COG0661 309 FGIVGRLDP 317 (517)
T ss_pred CcceecCCH
Confidence 999866544
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.54 E-value=9e-07 Score=72.23 Aligned_cols=127 Identities=18% Similarity=0.230 Sum_probs=86.6
Q ss_pred ceEEEEcCCCcEEEEEEeecCCcc-------------------cHH-----HHHHHHHHHhcCC--CCCccceeeEEeeC
Q 021682 4 AICQGRLPNGQEMAVKRLSRTSHQ-------------------GLE-----EFENEVKLTARLQ--HVNLLPVLGICTQR 57 (309)
Q Consensus 4 ~~~~~~~~~g~~vavK~~~~~~~~-------------------~~~-----~~~~e~~~l~~l~--h~~iv~~~~~~~~~ 57 (309)
.||.|.-.++..||+|+++..... ++. -.++|+.-|+++. +-.+.+.+.+..+
T Consensus 63 ~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~~n- 141 (268)
T COG1718 63 NVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFRNN- 141 (268)
T ss_pred EEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCCceeecCC-
Confidence 578887778999999999643211 111 1347888888883 5566777776553
Q ss_pred CeeEEEEeccCCCCh-hHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeeccc
Q 021682 58 EEKMLIYDYMPNKSL-DFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFG 136 (309)
Q Consensus 58 ~~~~lv~e~~~~~~L-~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg 136 (309)
.|||||+...-. .-.+. ...+.......+..++++.+.-|-... |++|+||+.-||++. .+.+.++|++
T Consensus 142 ---VLvMEfIg~~g~pAP~Lk----Dv~~e~~e~~~~~~~~v~~~~~l~~~a--~LVHgDLSEyNiL~~-~~~p~iID~~ 211 (268)
T COG1718 142 ---VLVMEFIGDDGLPAPRLK----DVPLELEEAEGLYEDVVEYMRRLYKEA--GLVHGDLSEYNILVH-DGEPYIIDVS 211 (268)
T ss_pred ---eEEEEeccCCCCCCCCcc----cCCcCchhHHHHHHHHHHHHHHHHHhc--CcccccchhhheEEE-CCeEEEEECc
Confidence 599999954311 11111 111223356667778888888877743 899999999999998 8889999999
Q ss_pred ccccc
Q 021682 137 MARAF 141 (309)
Q Consensus 137 ~~~~~ 141 (309)
.+...
T Consensus 212 QaV~~ 216 (268)
T COG1718 212 QAVTI 216 (268)
T ss_pred ccccc
Confidence 88543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.46 E-value=7.6e-06 Score=65.83 Aligned_cols=124 Identities=16% Similarity=0.150 Sum_probs=88.9
Q ss_pred CCcEEEEEEeecC---C---cccHHHHHHHHHHHhcCC--CCCccceeeEEeeC----CeeEEEEeccCC-CChhHHHhh
Q 021682 12 NGQEMAVKRLSRT---S---HQGLEEFENEVKLTARLQ--HVNLLPVLGICTQR----EEKMLIYDYMPN-KSLDFYIFD 78 (309)
Q Consensus 12 ~g~~vavK~~~~~---~---~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~----~~~~lv~e~~~~-~~L~~~~~~ 78 (309)
+|+.+-+|.-... + +.....+..|+..|.+|. .-.+.+++...... ...+||+|-+.+ .+|.+++.+
T Consensus 40 ~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~ 119 (216)
T PRK09902 40 NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTEDMAGFISIADWYAQ 119 (216)
T ss_pred CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEeCCCCccHHHHHhc
Confidence 4567888876421 1 345678999999999884 33355555222121 246899997753 578777633
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCC--ceeecccccc
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMN--PKISDFGMAR 139 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~--~~l~Dfg~~~ 139 (309)
. .....+......++.+++.+++-||.. |+.|+|+.+.||+++.++. +.++||.-+.
T Consensus 120 ~-~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 120 H-AVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred C-CcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 2 122356677788999999999999999 9999999999999987777 9999997654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.5e-06 Score=70.12 Aligned_cols=66 Identities=21% Similarity=0.265 Sum_probs=50.7
Q ss_pred eeEEEEeccCCCChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeeccccc
Q 021682 59 EKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMA 138 (309)
Q Consensus 59 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~ 138 (309)
..+++|||++|..|.++.. ++. .+...+.+++.-+|.. |++|||++|.|++++.+ .++++|++..
T Consensus 117 ~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~-~i~iID~~~k 181 (229)
T PF06176_consen 117 SYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN-GIRIIDTQGK 181 (229)
T ss_pred EEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC-cEEEEECccc
Confidence 4678999999988866531 222 2345567788999998 99999999999999855 4999999754
Q ss_pred c
Q 021682 139 R 139 (309)
Q Consensus 139 ~ 139 (309)
.
T Consensus 182 ~ 182 (229)
T PF06176_consen 182 R 182 (229)
T ss_pred c
Confidence 3
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.41 E-value=2.4e-06 Score=78.09 Aligned_cols=79 Identities=15% Similarity=0.201 Sum_probs=53.9
Q ss_pred CeeEEEEeccCCCChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCC----CCCceee
Q 021682 58 EEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY----EMNPKIS 133 (309)
Q Consensus 58 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~----~~~~~l~ 133 (309)
....|+|||++|..++|.-.-...+ ++.. .++..+.++...+--.+ |++|+|-+|.||++.. ++.+.+.
T Consensus 275 t~RVLtME~~~G~~i~Dl~~i~~~g--i~~~---~i~~~l~~~~~~qIf~~--GffHaDPHPGNilv~~~~~~~~~ivll 347 (538)
T KOG1235|consen 275 TKRVLTMEYVDGIKINDLDAIDKRG--ISPH---DILNKLVEAYLEQIFKT--GFFHADPHPGNILVRPNPEGDEEIVLL 347 (538)
T ss_pred cceEEEEEecCCccCCCHHHHHHcC--CCHH---HHHHHHHHHHHHHHHhc--CCccCCCCCCcEEEecCCCCCccEEEE
Confidence 4578999999998887764322222 4443 34444444444333233 8999999999999984 5679999
Q ss_pred cccccccccC
Q 021682 134 DFGMARAFTK 143 (309)
Q Consensus 134 Dfg~~~~~~~ 143 (309)
|||+......
T Consensus 348 DhGl~~~is~ 357 (538)
T KOG1235|consen 348 DHGLYAVISH 357 (538)
T ss_pred cccccccccH
Confidence 9999765544
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.36 E-value=1.1e-05 Score=66.50 Aligned_cols=130 Identities=12% Similarity=0.135 Sum_probs=75.2
Q ss_pred ceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCC--CccceeeEEeeCCeeEEEEeccCCCC-hhHHH----
Q 021682 4 AICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHV--NLLPVLGICTQREEKMLIYDYMPNKS-LDFYI---- 76 (309)
Q Consensus 4 ~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~~~~~lv~e~~~~~~-L~~~~---- 76 (309)
.+|+. .|..+++|...... .......|.+.++.+..- .+.+++++...++...+|||+++|.. +...+
T Consensus 16 ~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~~~~~~~~ 90 (226)
T TIGR02172 16 ESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFSRIISDNP 90 (226)
T ss_pred ceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchhhhhcCCH
Confidence 45652 25567889876533 335578899999888533 35678888877778889999998863 21111
Q ss_pred ----------hhh---ccc---cCCCHHHHH-HHHH----------HHHH-HHHHHhhc-CCCceeecCCCCceEEeCCC
Q 021682 77 ----------FDL---RRR---YLLDWRTRV-HIIE----------GITQ-GLLYLQEY-SNLTIVHRDLKASNILLDYE 127 (309)
Q Consensus 77 ----------~~~---~~~---~~~~~~~~~-~~~~----------~i~~-~l~~lh~~-~~~gi~H~di~p~nil~~~~ 127 (309)
... -+. ......... .+.. .+.. ...+|... ....++|||++|.||+++.+
T Consensus 91 ~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~Nii~~~~ 170 (226)
T TIGR02172 91 SRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIGNLITSGK 170 (226)
T ss_pred HHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCCcEEEcCC
Confidence 000 000 011111100 0100 0111 11222211 12367999999999999988
Q ss_pred CCceeecccccc
Q 021682 128 MNPKISDFGMAR 139 (309)
Q Consensus 128 ~~~~l~Dfg~~~ 139 (309)
+ +.++||+.+.
T Consensus 171 ~-~~iIDwe~a~ 181 (226)
T TIGR02172 171 G-TYWIDLGDFG 181 (226)
T ss_pred C-cEEEechhcC
Confidence 8 9999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.35 E-value=6e-06 Score=69.10 Aligned_cols=69 Identities=12% Similarity=0.085 Sum_probs=48.3
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHH
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFY 75 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (309)
..||+... ++..+.||...... ...+..|+++++.+ .+-.+.+++++...++..++||++++|.++...
T Consensus 13 ~~v~~~~~-~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 13 ATVYRLDG-KNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred CeEEEEcC-CCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 34666654 35788888875433 34567889888887 344566678777766678899999998877643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.07 E-value=5.8e-05 Score=62.37 Aligned_cols=69 Identities=17% Similarity=0.232 Sum_probs=46.2
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCC--CccceeeEEee---CCeeEEEEeccCCCChhH
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHV--NLLPVLGICTQ---REEKMLIYDYMPNKSLDF 74 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~---~~~~~lv~e~~~~~~L~~ 74 (309)
..+|.....+ ..+++|..... .....+..|+.+++.+... .+..++.+... ....+++|++++|..+..
T Consensus 11 n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~ 84 (239)
T PF01636_consen 11 NRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDD 84 (239)
T ss_dssp SEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHH
T ss_pred eeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccccc
Confidence 3467776655 68999997543 3456778888888887422 35566664433 235789999999987777
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.03 E-value=2.9e-05 Score=75.74 Aligned_cols=197 Identities=20% Similarity=0.200 Sum_probs=129.7
Q ss_pred HHHHHHHHHhcCCCCCccceeeEEeeCCeeE----EEEeccCCCChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhh
Q 021682 31 EFENEVKLTARLQHVNLLPVLGICTQREEKM----LIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQE 106 (309)
Q Consensus 31 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~----lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~ 106 (309)
..+.|.+.+.+..|+|++.++.+........ +..+++...++...+.. -..++..+.+.+..++.++++++|+
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~---v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS---VGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh---ccccCHHHHHHHHHHHhhhHHHHHH
Confidence 3456677788889999999998876654333 33467777777766643 4448889999999999999999999
Q ss_pred cCCCceeecCCCCc---eEEeCCCCCceee--cccccccccCCcccccccccccccCCCCccccccCCCC--ccchhhhH
Q 021682 107 YSNLTIVHRDLKAS---NILLDYEMNPKIS--DFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYS--MKYDVYSY 179 (309)
Q Consensus 107 ~~~~gi~H~di~p~---nil~~~~~~~~l~--Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~--~~~Dvwsl 179 (309)
. .+.|.-+..+ +...+..+.+..+ ||+............. ...+..+.++|.......+ ...|+|++
T Consensus 305 ~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 305 L---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS---DLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred h---ccceeEEecccccccccCccceeecchhhhcccccCCCcccchh---hcCccccccccccccccchhhhhhHHHHH
Confidence 7 3444444444 3344455555555 7877655444322111 1334567788877665444 44799999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 021682 180 GVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEIL 259 (309)
Q Consensus 180 G~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell 259 (309)
|.....+..|..+........ .+.+.. .. ..+.+.+.+|+..++++|+++.+++
T Consensus 379 gll~~~~~~~~~i~~~~~~~~------------------~~l~~~----~~----~~~~d~~~~~~~~~~~~Rl~~~~ll 432 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKSAVPV------------------SLLDVL----ST----SELLDALPKCLDEDSEERLSALELL 432 (1351)
T ss_pred HHHHhhhhhcCcccccccchh------------------hhhccc----cc----hhhhhhhhhhcchhhhhccchhhhh
Confidence 999999988876532111000 001000 00 0456788899999999999999999
Q ss_pred HHH
Q 021682 260 VML 262 (309)
Q Consensus 260 ~~L 262 (309)
...
T Consensus 433 ~~~ 435 (1351)
T KOG1035|consen 433 THP 435 (1351)
T ss_pred hch
Confidence 775
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.99 E-value=3.3e-05 Score=61.71 Aligned_cols=105 Identities=20% Similarity=0.142 Sum_probs=79.9
Q ss_pred HHHHHHHhcCCC-CCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCc
Q 021682 33 ENEVKLTARLQH-VNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLT 111 (309)
Q Consensus 33 ~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~g 111 (309)
..|.-+++.+++ +++.+++|+|-. .+|.|+...+++...-.....-...+|..+.+++.++++.+.+|+......
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357888888854 699999999843 578899976655321000011223689999999999999999999865546
Q ss_pred eeecCCCCceEEeCCCCCceeecccccccc
Q 021682 112 IVHRDLKASNILLDYEMNPKISDFGMARAF 141 (309)
Q Consensus 112 i~H~di~p~nil~~~~~~~~l~Dfg~~~~~ 141 (309)
+.-.|++++|+-+++++++|++|.+.....
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888999999999999999999999876443
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.99 E-value=6.6e-05 Score=58.27 Aligned_cols=118 Identities=20% Similarity=0.236 Sum_probs=79.7
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccc-eeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLP-VLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~-~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
++||.+.+. |..+|+|+-+.. +.+..+..|+++|..+.-.++.+ +|.+..+ .+.|||+.|..|.......
T Consensus 36 s~Vyl~~~~-~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~L~~~~~~~-- 106 (201)
T COG2112 36 SVVYLGEWR-GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRPLGKLEIGG-- 106 (201)
T ss_pred cEEEEeecc-CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcchhhhhhcc--
Confidence 578999884 568999987543 45678999999999997766654 4444333 2559999998887765211
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCC-CceEEeCCCCCceeeccccccc
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLK-ASNILLDYEMNPKISDFGMARA 140 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~-p~nil~~~~~~~~l~Dfg~~~~ 140 (309)
+...+.. +++..--|... ||-|+-|+ |...++..++.+.|+||+.|..
T Consensus 107 ----~rk~l~~----vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 107 ----DRKHLLR----VLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred ----cHHHHHH----HHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 2223333 44443334444 89999998 4444454555899999998863
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.0001 Score=62.17 Aligned_cols=131 Identities=15% Similarity=0.138 Sum_probs=70.5
Q ss_pred ceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCc-cceeeEEeeCCeeEEEEeccCCCChhHH-------
Q 021682 4 AICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNL-LPVLGICTQREEKMLIYDYMPNKSLDFY------- 75 (309)
Q Consensus 4 ~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~~L~~~------- 75 (309)
.+|+.. .+|+.+++|........-.-....|.++++.+....+ .+++.... .++|+||++|..+...
T Consensus 11 ~~y~~~-~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~~~~~~~~ 85 (256)
T TIGR02721 11 RSWRIE-HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLDQFVALDL 85 (256)
T ss_pred CeEEEE-eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccccccCchh
Confidence 345554 3577888987644322211135778889888854333 34444432 3689999998665421
Q ss_pred -------Hhhh---c-cccCCCHH-HHHHHHHHH---------HHHHHHHhhc-----CCCceeecCCCCceEEeCCCCC
Q 021682 76 -------IFDL---R-RRYLLDWR-TRVHIIEGI---------TQGLLYLQEY-----SNLTIVHRDLKASNILLDYEMN 129 (309)
Q Consensus 76 -------~~~~---~-~~~~~~~~-~~~~~~~~i---------~~~l~~lh~~-----~~~gi~H~di~p~nil~~~~~~ 129 (309)
+.+. . ....++.. .+..+..++ ...+..+... ....++|+|+.|.||+++.++
T Consensus 86 ~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~~~~~- 164 (256)
T TIGR02721 86 LLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVVTPQG- 164 (256)
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEEeCCC-
Confidence 1000 0 01111111 111111111 1112222111 123589999999999999877
Q ss_pred ceeeccccccc
Q 021682 130 PKISDFGMARA 140 (309)
Q Consensus 130 ~~l~Dfg~~~~ 140 (309)
+.|+||+.+..
T Consensus 165 ~~lIDwE~a~~ 175 (256)
T TIGR02721 165 LKLIDWEYASD 175 (256)
T ss_pred CEEEeccccCc
Confidence 78999987743
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00018 Score=59.82 Aligned_cols=30 Identities=27% Similarity=0.351 Sum_probs=24.9
Q ss_pred CceeecCCCCceEEeCCCCCceeecccccc
Q 021682 110 LTIVHRDLKASNILLDYEMNPKISDFGMAR 139 (309)
Q Consensus 110 ~gi~H~di~p~nil~~~~~~~~l~Dfg~~~ 139 (309)
.+++|||+.+.|++++.++..-++||+.+.
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 469999999999999866555699998763
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00054 Score=55.10 Aligned_cols=114 Identities=17% Similarity=0.239 Sum_probs=76.2
Q ss_pred CCCcEEEEEEeecCC----------------cccHHHHHHHHHHHhcCC------CCCccceeeEEeeCCeeEEEEeccC
Q 021682 11 PNGQEMAVKRLSRTS----------------HQGLEEFENEVKLTARLQ------HVNLLPVLGICTQREEKMLIYDYMP 68 (309)
Q Consensus 11 ~~g~~vavK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~~~~~lv~e~~~ 68 (309)
++.....||+..... .....+...|+.....+. +.+|.+++++.+++....+|+|.+.
T Consensus 21 P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~ 100 (199)
T PF10707_consen 21 PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIR 100 (199)
T ss_pred CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEE
Confidence 355667889886544 122345566666655554 8899999999999999999999775
Q ss_pred C------CChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCC----Cceeecc
Q 021682 69 N------KSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM----NPKISDF 135 (309)
Q Consensus 69 ~------~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~----~~~l~Df 135 (309)
+ .+|.+++ ....++. . +...+-+-..+|-.. +|+.+|++|+||++..+. .+.|+|-
T Consensus 101 d~dG~~s~TL~~~l----~~~~~~~-~---~~~~L~~f~~~l~~~---~Iv~~dl~~~NIv~~~~~~~~~~lvlIDG 166 (199)
T PF10707_consen 101 DADGNISPTLEDYL----KEGGLTE-E---LRQALDEFKRYLLDH---HIVIRDLNPHNIVVQRRDSGEFRLVLIDG 166 (199)
T ss_pred CCCCCcCccHHHHH----HcCCccH-H---HHHHHHHHHHHHHHc---CCeecCCCcccEEEEecCCCceEEEEEeC
Confidence 3 3566665 2223454 2 333344556666666 699999999999996532 4666663
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00063 Score=66.99 Aligned_cols=59 Identities=17% Similarity=0.351 Sum_probs=40.6
Q ss_pred cEEEEEEeecCC-cccHHHHHHHHHHHhcCC-CCCc--cceeeEEeeC---CeeEEEEeccCCCCh
Q 021682 14 QEMAVKRLSRTS-HQGLEEFENEVKLTARLQ-HVNL--LPVLGICTQR---EEKMLIYDYMPNKSL 72 (309)
Q Consensus 14 ~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i--v~~~~~~~~~---~~~~lv~e~~~~~~L 72 (309)
..+++|+..... ......+..|+++++.+. |.++ .+++.++.+. +..++|||+++|..+
T Consensus 66 ~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~~ 131 (822)
T PLN02876 66 KRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRIF 131 (822)
T ss_pred eeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCccc
Confidence 367777754322 223457889999999984 6654 6777777654 357899999988653
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00055 Score=56.85 Aligned_cols=30 Identities=27% Similarity=0.434 Sum_probs=26.2
Q ss_pred CceeecCCCCceEEeCC-CCCceeecccccc
Q 021682 110 LTIVHRDLKASNILLDY-EMNPKISDFGMAR 139 (309)
Q Consensus 110 ~gi~H~di~p~nil~~~-~~~~~l~Dfg~~~ 139 (309)
.+++|+|+.+.||+++. ++.+.++||..+.
T Consensus 170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 47999999999999997 5779999998763
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00051 Score=59.59 Aligned_cols=128 Identities=16% Similarity=0.177 Sum_probs=87.1
Q ss_pred ceEEEEcCCCcEEEEEEeecCC----------------------cccH----HHHHHHHHHHhcCCCCCccceeeEEeeC
Q 021682 4 AICQGRLPNGQEMAVKRLSRTS----------------------HQGL----EEFENEVKLTARLQHVNLLPVLGICTQR 57 (309)
Q Consensus 4 ~~~~~~~~~g~~vavK~~~~~~----------------------~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 57 (309)
.||.+...+|..+|||+++... ...+ --.+.|++-|++|....|.-.--+...
T Consensus 159 NVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP~PePIlLk- 237 (520)
T KOG2270|consen 159 NVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIPCPEPILLK- 237 (520)
T ss_pred eeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCCCCCceeee-
Confidence 5888888899999999885321 0011 124578888998876665433322222
Q ss_pred CeeEEEEeccCCCChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccc
Q 021682 58 EEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGM 137 (309)
Q Consensus 58 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~ 137 (309)
.-.|||+|+....... -......+....+..+-.+++.-+.-|.+.| +++|.||+--|+++. +|.+.++|-+.
T Consensus 238 -~hVLVM~FlGrdgw~a---PkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh-dG~lyiIDVSQ 310 (520)
T KOG2270|consen 238 -NHVLVMEFLGRDGWAA---PKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH-DGKLYIIDVSQ 310 (520)
T ss_pred -cceEeeeeccCCCCcC---cccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE-CCEEEEEEccc
Confidence 2468999995322110 1112334666677888888888888888877 899999999999984 67799999876
Q ss_pred cc
Q 021682 138 AR 139 (309)
Q Consensus 138 ~~ 139 (309)
+.
T Consensus 311 SV 312 (520)
T KOG2270|consen 311 SV 312 (520)
T ss_pred cc
Confidence 64
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00064 Score=58.79 Aligned_cols=31 Identities=32% Similarity=0.410 Sum_probs=26.9
Q ss_pred CCceeecCCCCceEEeCCC----CCceeecccccc
Q 021682 109 NLTIVHRDLKASNILLDYE----MNPKISDFGMAR 139 (309)
Q Consensus 109 ~~gi~H~di~p~nil~~~~----~~~~l~Dfg~~~ 139 (309)
..++||+|+.+.||+++.+ +.+.++||+.+.
T Consensus 178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 3479999999999999985 889999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00015 Score=65.32 Aligned_cols=73 Identities=16% Similarity=0.147 Sum_probs=52.6
Q ss_pred CccceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeC-CeeEEEEeccCCCChhHHHh
Q 021682 1 MSVAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQR-EEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 1 ~g~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~ 77 (309)
||...+.+....|..+ ..-+.-.+ ...++.....+++.+.|+++...+++.... ....+|+|++ +.+|.+.+.
T Consensus 1 ~~a~~~~a~~~~~~~c-~nglplt~--~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~ 74 (725)
T KOG1093|consen 1 FGAFTFFAQEKPGDVC-SNGLPLTP--NSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILK 74 (725)
T ss_pred CCceEEehhcCCCccc-cCCCcCCC--cHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHH
Confidence 6777888877777654 33332222 235677888999999999999998876543 3578999998 578888873
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00067 Score=58.44 Aligned_cols=131 Identities=13% Similarity=0.136 Sum_probs=72.3
Q ss_pred eEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCC--ccceee------EEeeCCeeEEEEeccCCCChhH--
Q 021682 5 ICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVN--LLPVLG------ICTQREEKMLIYDYMPNKSLDF-- 74 (309)
Q Consensus 5 ~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~------~~~~~~~~~lv~e~~~~~~L~~-- 74 (309)
+|+-.. ++..+++|.... .....+..|++++..+.+.+ +.+++. +...++..++|+++++|..+..
T Consensus 30 ~y~v~~-~~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~G~~~~~~~ 105 (296)
T cd05153 30 NYFVTT-DSGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLAGEHLTRPT 105 (296)
T ss_pred eEEEEe-CCCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCCCCCCCCCC
Confidence 555544 345688898754 23456777888887774322 344433 1233445689999999876532
Q ss_pred --HHhhh----------cccc--------CCCHHHH----------HHHHHHHHHHHHHHhh----cCCCceeecCCCCc
Q 021682 75 --YIFDL----------RRRY--------LLDWRTR----------VHIIEGITQGLLYLQE----YSNLTIVHRDLKAS 120 (309)
Q Consensus 75 --~~~~~----------~~~~--------~~~~~~~----------~~~~~~i~~~l~~lh~----~~~~gi~H~di~p~ 120 (309)
..... .... ...+... ......+..++..+.. ....+++|+|+.|.
T Consensus 106 ~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~ 185 (296)
T cd05153 106 AAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGVIHADLFRD 185 (296)
T ss_pred HHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcCCccCcCcc
Confidence 11000 0000 0010000 0011112233444432 11247999999999
Q ss_pred eEEeCCCCCceeecccccc
Q 021682 121 NILLDYEMNPKISDFGMAR 139 (309)
Q Consensus 121 nil~~~~~~~~l~Dfg~~~ 139 (309)
|++++.++.+.|+||+.+.
T Consensus 186 Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 186 NVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred cEEEeCCceEEEeehhhhc
Confidence 9999987767899998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.43 E-value=6e-05 Score=69.25 Aligned_cols=151 Identities=19% Similarity=0.149 Sum_probs=103.4
Q ss_pred HHHHHHHHHHhcCCCCC-ccceeeEEeeCCeeEEEEeccCCC-ChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhc
Q 021682 30 EEFENEVKLTARLQHVN-LLPVLGICTQREEKMLIYDYMPNK-SLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEY 107 (309)
Q Consensus 30 ~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 107 (309)
.....++++|.+++||| .+..++-++.+...+++++++.++ +-.... ......+...+....+..-.+.++++|+.
T Consensus 278 l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~ 355 (829)
T KOG0576|consen 278 LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHSS 355 (829)
T ss_pred hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccC--ChhhHhhhhhhhhhhhhhhcccccccccc
Confidence 34567889999999999 666666666667889999998765 221111 11122233444444555556678888875
Q ss_pred CCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCccccccCCCCccchhhhHHHHHHHHH
Q 021682 108 SNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQIL 187 (309)
Q Consensus 108 ~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll 187 (309)
--+|+| ||+.. ++..++.||+......... ......+++.++|||......+..+.|+|++|.-.-++-
T Consensus 356 ---~~~~~d----~~l~s-~~~~~~~~~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~a 424 (829)
T KOG0576|consen 356 ---YKVHRD----NILGS-EEEVKLLDFAVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMA 424 (829)
T ss_pred ---cccCcc----ccccc-ccccccccccCCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcC
Confidence 236777 66654 4678999998876555443 233457899999999999999999999999998666666
Q ss_pred hCCCCC
Q 021682 188 GGKRTS 193 (309)
Q Consensus 188 ~g~~p~ 193 (309)
-|.+|-
T Consensus 425 p~~pPr 430 (829)
T KOG0576|consen 425 PGLPPR 430 (829)
T ss_pred CCCCCC
Confidence 666654
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0038 Score=53.85 Aligned_cols=65 Identities=14% Similarity=0.080 Sum_probs=43.5
Q ss_pred eEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCC-C--CCccceeeEEeeC---CeeEEEEeccCCCCh
Q 021682 5 ICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQ-H--VNLLPVLGICTQR---EEKMLIYDYMPNKSL 72 (309)
Q Consensus 5 ~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h--~~iv~~~~~~~~~---~~~~lv~e~~~~~~L 72 (309)
+|+-...+| .+++|..+.. .....+..|.+.|+.|. + ..+.++++++..+ +..+||||++++.++
T Consensus 30 vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 30 LWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSV 100 (297)
T ss_pred EEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEec
Confidence 344433334 5677875431 12357889999999884 2 4678888877543 568999999988654
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0043 Score=55.42 Aligned_cols=65 Identities=11% Similarity=0.022 Sum_probs=42.7
Q ss_pred ceEEEEcCCC-cEEEEEEeecC----C---cccHHHHHHHHHHHhcCC---CCCccceeeEEeeCCeeEEEEeccCCC
Q 021682 4 AICQGRLPNG-QEMAVKRLSRT----S---HQGLEEFENEVKLTARLQ---HVNLLPVLGICTQREEKMLIYDYMPNK 70 (309)
Q Consensus 4 ~~~~~~~~~g-~~vavK~~~~~----~---~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~~ 70 (309)
.||+....+| +.|+||.-.+. . +...++...|.+.|+.+. ..++.+++.+. ....++|||++++.
T Consensus 41 ~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~lVME~L~~~ 116 (401)
T PRK09550 41 LVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVTVMEDLSDH 116 (401)
T ss_pred EEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEEEEecCCCc
Confidence 3577766666 58999975321 1 234567778888888762 23566677663 35578999999763
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.00083 Score=54.84 Aligned_cols=30 Identities=33% Similarity=0.496 Sum_probs=21.2
Q ss_pred ceeecCCCCceEEe-CCCCCceeeccccccc
Q 021682 111 TIVHRDLKASNILL-DYEMNPKISDFGMARA 140 (309)
Q Consensus 111 gi~H~di~p~nil~-~~~~~~~l~Dfg~~~~ 140 (309)
.++|+|+.+.||++ +.++.++|+||..+..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 58999999999999 8889999999987743
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0029 Score=55.80 Aligned_cols=122 Identities=16% Similarity=0.238 Sum_probs=68.3
Q ss_pred CcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCc-cceeeEEeeCCeeEEEEeccCCCChhHH-------H--------
Q 021682 13 GQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNL-LPVLGICTQREEKMLIYDYMPNKSLDFY-------I-------- 76 (309)
Q Consensus 13 g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~~L~~~-------~-------- 76 (309)
++.|++|..........+ ...|..+++.+...++ .++++.+..+ .|.+|+++.++... .
T Consensus 65 ~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~~l~~~~l~~~~~~~~ia~~L~ 139 (344)
T PLN02236 65 GRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHARTLSAADLRDPEISALIAAKLR 139 (344)
T ss_pred CCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCCCCCHHHcCChHHHHHHHHHHH
Confidence 468899987654433333 3678888888854444 3466665433 57899987666421 0
Q ss_pred --hhhc-ccc--CCCHHHHHHHHHHH-----------------HHHHHHH----hh-cCCCceeecCCCCceEEeCC-CC
Q 021682 77 --FDLR-RRY--LLDWRTRVHIIEGI-----------------TQGLLYL----QE-YSNLTIVHRDLKASNILLDY-EM 128 (309)
Q Consensus 77 --~~~~-~~~--~~~~~~~~~~~~~i-----------------~~~l~~l----h~-~~~~gi~H~di~p~nil~~~-~~ 128 (309)
+... ... ......+..+..++ ...+..| .. .....++|+|+++.||++++ ++
T Consensus 140 ~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~ 219 (344)
T PLN02236 140 EFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQEIGFCHNDLQYGNIMIDEETR 219 (344)
T ss_pred HHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCC
Confidence 0000 000 11122222332111 1112222 11 12236899999999999986 46
Q ss_pred Cceeecccccc
Q 021682 129 NPKISDFGMAR 139 (309)
Q Consensus 129 ~~~l~Dfg~~~ 139 (309)
.+.++||..+.
T Consensus 220 ~~~lID~Eya~ 230 (344)
T PLN02236 220 AITIIDYEYAS 230 (344)
T ss_pred cEEEEeehhcc
Confidence 79999998774
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0038 Score=53.90 Aligned_cols=119 Identities=14% Similarity=0.223 Sum_probs=72.7
Q ss_pred CcEEEEEEeec--CCcccHHHHHHHHHHHhcCCC--CCccceeeEEeeCC--eeEEEEeccCCCChhHHHhhhccccCCC
Q 021682 13 GQEMAVKRLSR--TSHQGLEEFENEVKLTARLQH--VNLLPVLGICTQRE--EKMLIYDYMPNKSLDFYIFDLRRRYLLD 86 (309)
Q Consensus 13 g~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 86 (309)
+++++|. ... ...........|+++++.+.- .-+...++.|..+. ..+.||+|++|..+..... .
T Consensus 48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~--------~ 118 (321)
T COG3173 48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALP--------P 118 (321)
T ss_pred CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCC--------c
Confidence 6777777 321 223344567788888888743 33444566666655 5689999998843322110 0
Q ss_pred HHHHHHHHH-HHHHHHHHHhhcC-------------------------------------------------------CC
Q 021682 87 WRTRVHIIE-GITQGLLYLQEYS-------------------------------------------------------NL 110 (309)
Q Consensus 87 ~~~~~~~~~-~i~~~l~~lh~~~-------------------------------------------------------~~ 110 (309)
......++. .++..|+.||+-. ..
T Consensus 119 ~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~ 198 (321)
T COG3173 119 ESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPP 198 (321)
T ss_pred ccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCc
Confidence 000011111 3344444444321 24
Q ss_pred ceeecCCCCceEEeCCCCCceeeccccccc
Q 021682 111 TIVHRDLKASNILLDYEMNPKISDFGMARA 140 (309)
Q Consensus 111 gi~H~di~p~nil~~~~~~~~l~Dfg~~~~ 140 (309)
.++|||+++.|++++.++-+-+.||+++..
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 689999999999999988888999998854
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.024 Score=49.44 Aligned_cols=31 Identities=26% Similarity=0.327 Sum_probs=25.7
Q ss_pred CCceeecCCCCceEEeCCCCCceeecccccc
Q 021682 109 NLTIVHRDLKASNILLDYEMNPKISDFGMAR 139 (309)
Q Consensus 109 ~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~ 139 (309)
..|+||+|+.+.||+++.+...-++||+.+.
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 3489999999999999866555799998764
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.022 Score=49.33 Aligned_cols=31 Identities=29% Similarity=0.382 Sum_probs=26.9
Q ss_pred CCceeecCCCCceEEeCCCCCceeecccccc
Q 021682 109 NLTIVHRDLKASNILLDYEMNPKISDFGMAR 139 (309)
Q Consensus 109 ~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~ 139 (309)
..+++|+|+++.|++++.++.+.++||+.+.
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 3589999999999999988767899998763
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.00047 Score=69.57 Aligned_cols=158 Identities=15% Similarity=-0.012 Sum_probs=107.2
Q ss_pred HHHHHHhcCCCCCccceeeEEee--CCeeEEEEeccCCCChhHHHhhhccccCCCHHHHHHHHHHH-HHHHHHHhhcCC-
Q 021682 34 NEVKLTARLQHVNLLPVLGICTQ--REEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGI-TQGLLYLQEYSN- 109 (309)
Q Consensus 34 ~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i-~~~l~~lh~~~~- 109 (309)
.|...++...|+++...+.-... +...+.+++++.+|.+...+.......+..........+++ .....-+|++.+
T Consensus 1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence 34444555678877665543332 22467889999999998888654333222222223333443 444555555432
Q ss_pred -CceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHh
Q 021682 110 -LTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG 188 (309)
Q Consensus 110 -~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~ 188 (309)
.-.+|.++++-|.++..+-.++++++|+.+...... ...+...+++.|+.|+....-.++.++|+|..|+-+|....
T Consensus 1358 g~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~--sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL--SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred CccchhhhhhhhccceecCCcccccccccccccCchH--hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence 236899999999999999999999999987322221 22444577888999999888888888999999999999988
Q ss_pred CCCCC
Q 021682 189 GKRTS 193 (309)
Q Consensus 189 g~~p~ 193 (309)
|..+|
T Consensus 1436 ~n~~f 1440 (2724)
T KOG1826|consen 1436 GNAYF 1440 (2724)
T ss_pred ccHHH
Confidence 87664
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.0012 Score=56.45 Aligned_cols=121 Identities=12% Similarity=0.090 Sum_probs=79.1
Q ss_pred cceEEEEcCCCcEEEEEEeec----------CC--------cc----cHHHHHHHHHHHhcCC-CC-CccceeeEEeeCC
Q 021682 3 VAICQGRLPNGQEMAVKRLSR----------TS--------HQ----GLEEFENEVKLTARLQ-HV-NLLPVLGICTQRE 58 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~----------~~--------~~----~~~~~~~e~~~l~~l~-h~-~iv~~~~~~~~~~ 58 (309)
+.+|.+...+|+..++|+-+- +. .+ ++-...+|+..++.|. |. .+.+.+++.
T Consensus 106 SDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfpVPkpiD~~---- 181 (465)
T KOG2268|consen 106 SDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFPVPKPIDHN---- 181 (465)
T ss_pred cceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCCCCCccccc----
Confidence 357888888899999995421 00 00 1223457888888884 33 345555543
Q ss_pred eeEEEEeccCCCChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeeccccc
Q 021682 59 EKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMA 138 (309)
Q Consensus 59 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~ 138 (309)
.-|+|||++.+..|...-. .-+..+ +...+...+.-|-.+ |++|||..-=||++..++.++++||-..
T Consensus 182 RH~Vvmelv~g~Pl~~v~~------v~d~~~---ly~~lm~~Iv~la~~---GlIHgDFNEFNimv~dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 182 RHCVVMELVDGYPLRQVRH------VEDPPT---LYDDLMGLIVRLANH---GLIHGDFNEFNIMVKDDDKIVVIDFPQM 249 (465)
T ss_pred ceeeHHHhhcccceeeeee------cCChHH---HHHHHHHHHHHHHHc---CceecccchheeEEecCCCEEEeechHh
Confidence 3578999999887754321 122223 333344444555555 9999999999999999999999999654
Q ss_pred c
Q 021682 139 R 139 (309)
Q Consensus 139 ~ 139 (309)
.
T Consensus 250 v 250 (465)
T KOG2268|consen 250 V 250 (465)
T ss_pred h
Confidence 3
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.056 Score=47.30 Aligned_cols=67 Identities=10% Similarity=0.139 Sum_probs=41.1
Q ss_pred ceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCC--Ccccee---e--EEeeCCeeEEEEeccCCCC
Q 021682 4 AICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHV--NLLPVL---G--ICTQREEKMLIYDYMPNKS 71 (309)
Q Consensus 4 ~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~---~--~~~~~~~~~lv~e~~~~~~ 71 (309)
.+|.-...+|+.+++|+.+... .....+..|++.+..|... .++... + +...++..+.|+++++|..
T Consensus 40 ~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 40 RVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred eEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 3566666678889999885332 3456677788887766321 222222 1 2233456788999998754
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.02 Score=49.03 Aligned_cols=57 Identities=19% Similarity=0.301 Sum_probs=37.0
Q ss_pred CCCcEEEEEEeecCCcccHHHHHHHHHHHhcC---CCCCccceeeEEeeCCeeEEEEeccCCC
Q 021682 11 PNGQEMAVKRLSRTSHQGLEEFENEVKLTARL---QHVNLLPVLGICTQREEKMLIYDYMPNK 70 (309)
Q Consensus 11 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 70 (309)
.+++.+.||.-. ......+..|++-|+.| ..-.+.+++++.......+||+||++.+
T Consensus 38 ~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 38 TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 578889999875 23345788888888877 3446778999888877789999999765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.023 Score=48.42 Aligned_cols=30 Identities=30% Similarity=0.518 Sum_probs=24.6
Q ss_pred CceeecCCCCceEEeCCCCC-ceeecccccc
Q 021682 110 LTIVHRDLKASNILLDYEMN-PKISDFGMAR 139 (309)
Q Consensus 110 ~gi~H~di~p~nil~~~~~~-~~l~Dfg~~~ 139 (309)
..++|+|+++.||+++.++. .-|+||+.+.
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 35899999999999987555 4589998774
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.027 Score=46.05 Aligned_cols=163 Identities=21% Similarity=0.302 Sum_probs=93.6
Q ss_pred CCcEEEEEEeecCCcccHHHHHHHHHHHhcC---CCCCccceeeEEeeCCeeEEEEeccCCCChhHH--------Hhh--
Q 021682 12 NGQEMAVKRLSRTSHQGLEEFENEVKLTARL---QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFY--------IFD-- 78 (309)
Q Consensus 12 ~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~--------~~~-- 78 (309)
...++.||+-. ......|..|+.-|..| +.-.+.+++.+.....+.++|+||++-+.++.. +..
T Consensus 38 g~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d~~~~~~~GqqLA~LH 114 (286)
T COG3001 38 GTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLDAHSAFILGQQLARLH 114 (286)
T ss_pred CCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCCchhHHHHHHHHHHHH
Confidence 45667787742 23346788888877777 345678889888888899999999988666511 000
Q ss_pred -hccc---------------cCCCH---------HHHHHHHH--------------HHHHHHHHHhhcCC--CceeecCC
Q 021682 79 -LRRR---------------YLLDW---------RTRVHIIE--------------GITQGLLYLQEYSN--LTIVHRDL 117 (309)
Q Consensus 79 -~~~~---------------~~~~~---------~~~~~~~~--------------~i~~~l~~lh~~~~--~gi~H~di 117 (309)
-... .+-.+ ++++.+.. .++..+.-+-..|. +.++||||
T Consensus 115 ~~~~~~~fG~d~dn~iG~t~QpN~W~~~Wa~FfaeqRig~qlqlar~rg~~f~did~~~~~v~elL~~hqpqPsLlHGDL 194 (286)
T COG3001 115 QWGGQAQFGLDFDNYIGTTPQPNTWQRRWATFFAEQRIGWQLQLARERGLTFGDIDAIVEKIQELLADHQPQPSLLHGDL 194 (286)
T ss_pred hhcCccccCcccccccCCCCCCCCCcchHHHHHHHhhhhHHHHHHHHhCCCccCHHHHHHHHHHHHhcCCCCcceeeccc
Confidence 0000 00000 11111111 12233333333333 57999999
Q ss_pred CCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCccccccC--------CCCccchhhhHHHHH
Q 021682 118 KASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKG--------IYSMKYDVYSYGVLL 183 (309)
Q Consensus 118 ~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--------~~~~~~DvwslG~il 183 (309)
...|+.+..+| ..+.|- |+..+............|. .+||+..+. .+....++|.|=.++
T Consensus 195 W~gN~a~~~~G-Pv~fDP--A~y~GDrE~Dlam~elFgg---fp~efy~gY~sv~PL~~G~~eRk~iYqLY~ll 262 (286)
T COG3001 195 WSGNCAFGKDG-PVIFDP--ACYWGDRECDLAMLELFGG---FPPEFYDGYQSVSPLPAGYLERKPIYQLYHLL 262 (286)
T ss_pred ccccccccCCC-Ceeecc--ccccCCcccceehhhhhcC---CcHHHHHhhhccCCCCCchHHHhHHHHHHHHH
Confidence 99999999999 666554 4455555444333333333 467766542 234556677654333
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.016 Score=50.76 Aligned_cols=30 Identities=27% Similarity=0.367 Sum_probs=25.6
Q ss_pred ceeecCCCCceEEeCC-CCCceeeccccccc
Q 021682 111 TIVHRDLKASNILLDY-EMNPKISDFGMARA 140 (309)
Q Consensus 111 gi~H~di~p~nil~~~-~~~~~l~Dfg~~~~ 140 (309)
-+||+|+.+.||++++ ++.++++||..+..
T Consensus 183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 3799999999999975 57899999988754
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.026 Score=49.31 Aligned_cols=106 Identities=16% Similarity=0.113 Sum_probs=72.5
Q ss_pred CeeEEEEeccCCCChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccc
Q 021682 58 EEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGM 137 (309)
Q Consensus 58 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~ 137 (309)
...|++|++- |+++. ..+.....++..++++.+..+.-+.... ..-|||+.-.||+++ +|++.|+||-+
T Consensus 299 ~y~yl~~kdh-gt~is-------~ik~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfkl 367 (488)
T COG5072 299 LYLYLHFKDH-GTPIS-------IIKADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKL 367 (488)
T ss_pred eEEEEEEecC-Cceee-------eeecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeee
Confidence 3567788875 45552 2334567788889988888888887765 688999999999999 99999999998
Q ss_pred cccccCCcccccccccccccCCCCccccccCCCCccchhhhHHHH
Q 021682 138 ARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVL 182 (309)
Q Consensus 138 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~i 182 (309)
++......... -...--|..+.|.. +.+-+||-+.-.
T Consensus 368 sRl~~~q~~is-------y~rldhp~lF~G~d-d~QFeIYrlMr~ 404 (488)
T COG5072 368 SRLSYSQGIIS-------YNRLDHPDLFNGVD-DYQFEIYRLMRR 404 (488)
T ss_pred eecccCCceee-------ccccCchhhhcCcc-ceeeeHHHHHHH
Confidence 87433322111 11233455555443 677788875433
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.07 Score=46.24 Aligned_cols=28 Identities=29% Similarity=0.344 Sum_probs=24.7
Q ss_pred CceeecCCCCceEEeCCCCCceeeccccc
Q 021682 110 LTIVHRDLKASNILLDYEMNPKISDFGMA 138 (309)
Q Consensus 110 ~gi~H~di~p~nil~~~~~~~~l~Dfg~~ 138 (309)
.+++|||+.+.|++++. +.+.++||+.+
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccc
Confidence 48999999999999987 67889999865
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.017 Score=46.88 Aligned_cols=87 Identities=17% Similarity=0.125 Sum_probs=59.8
Q ss_pred HHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 021682 30 EEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSN 109 (309)
Q Consensus 30 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 109 (309)
.-+..+++++.++. .|+++.. .+...+.++.|.|..... ... .++..-++++.-+|+. +
T Consensus 103 ~~y~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy~~~i------------~~~----N~i~agi~~L~~fH~~-~ 161 (308)
T PF07387_consen 103 ALYFNKYRVFARMH--GILRLKN--DNNYKYGVILERCYKIKI------------NFS----NFITAGIKDLMDFHSE-N 161 (308)
T ss_pred hhhhhhhhHHHHhh--heeEeec--CCCceeEEEEeeccCccc------------chh----HHHHHhHHHHHHhhcc-C
Confidence 45677888888775 5666652 233457788898854211 111 1222235678888865 3
Q ss_pred CceeecCCCCceEEeCCCCCceeecccc
Q 021682 110 LTIVHRDLKASNILLDYEMNPKISDFGM 137 (309)
Q Consensus 110 ~gi~H~di~p~nil~~~~~~~~l~Dfg~ 137 (309)
.+.+|||..|+||+-|+.|-+||.|-+.
T Consensus 162 ~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 162 QHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred CCeecCCCChhheeecCCCCEEecChhh
Confidence 4899999999999999999999999864
|
The function of this family is unknown. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.33 E-value=0.091 Score=45.61 Aligned_cols=31 Identities=26% Similarity=0.295 Sum_probs=27.6
Q ss_pred CCceeecCCCCceEEeCCCCCceeecccccc
Q 021682 109 NLTIVHRDLKASNILLDYEMNPKISDFGMAR 139 (309)
Q Consensus 109 ~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~ 139 (309)
..++||+|+.++|++++.++.+.++||..+.
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 3489999999999999999899999998764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.094 Score=46.17 Aligned_cols=30 Identities=27% Similarity=0.316 Sum_probs=24.7
Q ss_pred CceeecCCCCceEEeCCCCCceeeccccccc
Q 021682 110 LTIVHRDLKASNILLDYEMNPKISDFGMARA 140 (309)
Q Consensus 110 ~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~ 140 (309)
..++|||+.+.||+++.++ ++++|+.++..
T Consensus 192 ~~llHGDl~~gNi~~~~~~-~~~iD~e~~~~ 221 (370)
T TIGR01767 192 ETLLHGDLHSGSIFVSEHE-TKVIDPEFAFY 221 (370)
T ss_pred ceeeeccCCcccEEEcCCC-CEEEcCccccc
Confidence 4789999999999997654 78999986643
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.95 E-value=0.14 Score=44.80 Aligned_cols=132 Identities=19% Similarity=0.258 Sum_probs=73.1
Q ss_pred eEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCC--ccce--------eeEEeeCCeeEEEEeccCCCChhH
Q 021682 5 ICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVN--LLPV--------LGICTQREEKMLIYDYMPNKSLDF 74 (309)
Q Consensus 5 ~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~--------~~~~~~~~~~~lv~e~~~~~~L~~ 74 (309)
+|.-...+|+. ++|+.... ....++..|...+..|.... +... +.........+-|++|++|..+..
T Consensus 41 ~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~~~~~ 117 (331)
T COG2334 41 NFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGRPLER 117 (331)
T ss_pred eEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCcCcCC
Confidence 45555556665 99998655 34567778888888773111 1111 111121136778899999887762
Q ss_pred -H-----------H---hhhcccc---------CCCHHH-------------HHHHHHHHHHHHHHHhhc----CCCc--
Q 021682 75 -Y-----------I---FDLRRRY---------LLDWRT-------------RVHIIEGITQGLLYLQEY----SNLT-- 111 (309)
Q Consensus 75 -~-----------~---~~~~~~~---------~~~~~~-------------~~~~~~~i~~~l~~lh~~----~~~g-- 111 (309)
. + ....++. ...+.. ......++...+..+... ...+
T Consensus 118 ~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp~~~~ 197 (331)
T COG2334 118 DDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLPALGD 197 (331)
T ss_pred CCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCCcccc
Confidence 1 0 0000010 111110 011222333334433332 1223
Q ss_pred -eeecCCCCceEEeCCCCC-ceeecccccc
Q 021682 112 -IVHRDLKASNILLDYEMN-PKISDFGMAR 139 (309)
Q Consensus 112 -i~H~di~p~nil~~~~~~-~~l~Dfg~~~ 139 (309)
++|+|+.|.||+++.+.. +.++||+-+.
T Consensus 198 ~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 198 QIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 999999999999998874 8899998663
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.90 E-value=0.06 Score=48.23 Aligned_cols=29 Identities=21% Similarity=0.359 Sum_probs=24.3
Q ss_pred CceeecCCCCceEEeCCCCCceeecccccc
Q 021682 110 LTIVHRDLKASNILLDYEMNPKISDFGMAR 139 (309)
Q Consensus 110 ~gi~H~di~p~nil~~~~~~~~l~Dfg~~~ 139 (309)
..++|||+++.||+++.++ .+++|..++.
T Consensus 230 ~~L~HGDl~~g~i~~~~~~-~~~id~ef~~ 258 (418)
T PLN02756 230 QALVHGDLHTGSVMVTPDS-TQVIDPEFAF 258 (418)
T ss_pred cceeecCCCCCcEEEcCCC-ceEecchhhc
Confidence 5789999999999998765 8888877653
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=95.68 E-value=0.13 Score=41.45 Aligned_cols=111 Identities=23% Similarity=0.326 Sum_probs=70.0
Q ss_pred cceEEEEcCCCcEEEEEEeec---CCc------------------ccHHHHHHHHHHHhcC---CCCCc--cceeeEEee
Q 021682 3 VAICQGRLPNGQEMAVKRLSR---TSH------------------QGLEEFENEVKLTARL---QHVNL--LPVLGICTQ 56 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~---~~~------------------~~~~~~~~e~~~l~~l---~h~~i--v~~~~~~~~ 56 (309)
+.|++... +|+.+|||+++. ... ...+.|..|-+...+| .+.++ ++.+++..-
T Consensus 52 ~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L 130 (207)
T PF13095_consen 52 GYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGREGLWAVKCHGYLLL 130 (207)
T ss_pred eEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccccCceEEEeeEEEEE
Confidence 56788887 688999999421 100 1123456676665555 45566 788887632
Q ss_pred C------------------CeeEEEEeccCCCChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCC
Q 021682 57 R------------------EEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLK 118 (309)
Q Consensus 57 ~------------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~ 118 (309)
. ....||.||..... .+.... +.+|.+-+..+|.. ||+-+|++
T Consensus 131 ~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~~----~~~~~~dl~~~~k~---gI~~~Dv~ 191 (207)
T PF13095_consen 131 TEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIRD----IPQMLRDLKILHKL---GIVPRDVK 191 (207)
T ss_pred chHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchhH----HHHHHHHHHHHHHC---CeeeccCc
Confidence 2 12356777665432 122222 44566677788888 99999999
Q ss_pred CceEEeCCCCCceeeccccc
Q 021682 119 ASNILLDYEMNPKISDFGMA 138 (309)
Q Consensus 119 p~nil~~~~~~~~l~Dfg~~ 138 (309)
+.|.. + =+|+|||.+
T Consensus 192 ~~ny~---~--G~lvDfs~~ 206 (207)
T PF13095_consen 192 PRNYR---G--GKLVDFSSS 206 (207)
T ss_pred ccccc---C--CEEEecccC
Confidence 99986 3 378899854
|
|
| >PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins | Back alignment and domain information |
|---|
Probab=95.56 E-value=0.0069 Score=36.27 Aligned_cols=44 Identities=32% Similarity=0.416 Sum_probs=36.2
Q ss_pred cCCCCCCCCCCccccCCccchhhhhccc--cccccCCccccCCCCC
Q 021682 266 TADIKTPKKPAFSVKRDNDEISECMLEA--NIYSVDDATITQPVPR 309 (309)
Q Consensus 266 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 309 (309)
...++.||.|.|+.++...+.+.++... ..+|.|..|++-...|
T Consensus 3 ~~~LP~PKqPgF~~~r~~~e~~sSss~~~~~~~SvNevTiT~l~~R 48 (48)
T PF11883_consen 3 TATLPQPKQPGFFTGRSPSETDSSSSKQRDESCSVNEVTITMLEAR 48 (48)
T ss_pred cccCCCCCCCCEEeEcCCCCcCCCcccccCCCCCeeeEEEEeEecC
Confidence 4568999999999999887777666665 6899999999877665
|
; GO: 0004674 protein serine/threonine kinase activity |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.82 E-value=0.23 Score=45.35 Aligned_cols=28 Identities=25% Similarity=0.432 Sum_probs=23.7
Q ss_pred ceeecCCCCceEEeCCCCCceeecccccc
Q 021682 111 TIVHRDLKASNILLDYEMNPKISDFGMAR 139 (309)
Q Consensus 111 gi~H~di~p~nil~~~~~~~~l~Dfg~~~ 139 (309)
.+||+|+.+.||+.+.+ .++|+||..+.
T Consensus 285 VfCHNDl~~~NiL~~~~-~l~LIDfEYAg 312 (442)
T PTZ00296 285 VFCHNDLQENNIINTNK-CLRLIDFEYSG 312 (442)
T ss_pred eEEeCCCCccceeecCC-CEEEEeecccc
Confidence 58999999999987654 49999998764
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.75 E-value=0.81 Score=46.49 Aligned_cols=31 Identities=32% Similarity=0.462 Sum_probs=25.5
Q ss_pred CceeecCCCCceEEeCCCC--Cce-eeccccccc
Q 021682 110 LTIVHRDLKASNILLDYEM--NPK-ISDFGMARA 140 (309)
Q Consensus 110 ~gi~H~di~p~nil~~~~~--~~~-l~Dfg~~~~ 140 (309)
.+++|+|+.+.||+++.++ .+. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 3799999999999998775 454 899987743
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.53 E-value=0.31 Score=43.66 Aligned_cols=29 Identities=31% Similarity=0.266 Sum_probs=24.1
Q ss_pred CceeecCCCCceEEeCCCCCceeecccccc
Q 021682 110 LTIVHRDLKASNILLDYEMNPKISDFGMAR 139 (309)
Q Consensus 110 ~gi~H~di~p~nil~~~~~~~~l~Dfg~~~ 139 (309)
..+||.|+.+.||+.+. +.+.++||..+.
T Consensus 227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEecC-CCEEEEEecccc
Confidence 36899999999998754 559999998774
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 309 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-38 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 6e-38 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-34 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-34 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-30 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-30 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-30 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-29 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-19 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-19 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-19 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-19 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-19 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-18 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-18 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-18 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-18 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-18 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-18 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-17 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-17 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-17 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-16 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-16 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-16 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-16 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-16 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-16 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-16 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-16 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-16 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-16 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-16 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 7e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 7e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-16 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 9e-16 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 9e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-15 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-15 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-15 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-14 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-14 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-14 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-14 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-14 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-14 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-14 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 9e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 9e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-13 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-13 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-13 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 6e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-12 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-12 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-12 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-12 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 8e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 8e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 8e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 8e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 9e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 9e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-11 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-11 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-11 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-11 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-11 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-11 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-11 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-11 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-11 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-11 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-11 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-11 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-11 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-11 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-11 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-11 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-11 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-11 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-11 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-11 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 7e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 7e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 7e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 7e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 7e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 7e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 7e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 8e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 9e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-10 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-10 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-10 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-10 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-10 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-10 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-10 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-10 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-10 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-10 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-10 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-10 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-10 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-10 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-10 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-10 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-10 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-10 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 8e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-10 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 8e-10 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 8e-10 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 9e-10 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 9e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 9e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 9e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-09 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-09 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-09 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-09 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-09 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-09 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-09 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-09 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-09 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-09 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-09 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-09 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-09 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-09 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-09 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-09 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-09 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-09 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-09 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-09 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-09 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-09 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-09 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-09 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-09 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-09 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-09 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-09 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-09 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-09 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-09 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-09 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 7e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 7e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-09 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 8e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 9e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-08 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-08 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-08 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 7e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 7e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 7e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 7e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 8e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 8e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 8e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 9e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 9e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 9e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 9e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 9e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 9e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 9e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 9e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-07 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-07 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-07 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-07 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-07 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-07 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 6e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 6e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-07 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 6e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-07 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-07 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 7e-07 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-07 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 7e-07 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-07 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-07 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-07 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 7e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-07 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 7e-07 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 8e-07 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 8e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 8e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 9e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 9e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 9e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 9e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 9e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 9e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 9e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-06 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-06 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-06 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-06 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-06 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-06 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-06 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-06 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-06 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-06 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-06 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-06 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-06 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-06 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-06 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-06 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-06 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-06 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-06 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-06 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-06 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-06 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-06 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 6e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 6e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 7e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 7e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 7e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 8e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 8e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 9e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-05 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-05 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-05 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-05 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-05 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-05 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-05 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-05 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 6e-05 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 7e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 7e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 8e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 8e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 8e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 8e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 9e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 9e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 9e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 9e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 9e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-04 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-04 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-04 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-04 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-04 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-04 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-04 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-04 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-04 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-04 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 6e-04 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 309 bits (795), Expect = e-106
Identities = 90/265 (33%), Positives = 142/265 (53%), Gaps = 13/265 (4%)
Query: 8 GRLPNGQEMAVKRLS----RTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLI 63
G + N +AVK+L+ T+ + ++F+ E+K+ A+ QH NL+ +LG + ++ L+
Sbjct: 50 GYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLV 108
Query: 64 YDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNIL 123
Y YMPN SL + L L W R I +G G+ +L E +HRD+K++NIL
Sbjct: 109 YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANIL 165
Query: 124 LDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLL 183
LD KISDFG+ARA K T RIVGT Y+ PE +R G + K D+YS+GV+L
Sbjct: 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVL 224
Query: 184 LQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGME-FIDSSLDDSSSAWKLMRCMQVAL 242
L+I+ G + + LL+ + + +E +ID ++D+ S + VA
Sbjct: 225 LEIITGLPAVDEHREPQ--LLLDIKEEIEDEEKTIEDYIDKKMNDADST-SVEAMYSVAS 281
Query: 243 LCVQENAADRPTMLEILVMLKSETA 267
C+ E RP + ++ +L+ TA
Sbjct: 282 QCLHEKKNKRPDIKKVQQLLQEMTA 306
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 304 bits (781), Expect = e-103
Identities = 93/262 (35%), Positives = 147/262 (56%), Gaps = 5/262 (1%)
Query: 8 GRLPNGQEMAVKRLSRTSHQGLE-EFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDY 66
GRL +G +AVKRL QG E +F+ EV++ + H NLL + G C E++L+Y Y
Sbjct: 49 GRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 108
Query: 67 MPNKSLDFYIFDLRR-RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLD 125
M N S+ + + + LDW R I G +GL YL ++ + I+HRD+KA+NILLD
Sbjct: 109 MANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD 168
Query: 126 YEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQ 185
E + DFG+A+ + T + GT G++ PEY+ G S K DV+ YGV+LL+
Sbjct: 169 EEFEAVVGDFGLAKLMDYKDTHVTT-AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLE 227
Query: 186 ILGGKRTSCYYGP--NESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALL 243
++ G+R ++ + LL++ GL K + +D L + ++ + +QVALL
Sbjct: 228 LITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALL 287
Query: 244 CVQENAADRPTMLEILVMLKSE 265
C Q + +RP M E++ ML+ +
Sbjct: 288 CTQSSPMERPKMSEVVRMLEGD 309
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 277 bits (711), Expect = 8e-93
Identities = 90/257 (35%), Positives = 148/257 (57%), Gaps = 4/257 (1%)
Query: 8 GRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYM 67
G L +G ++A+KR + S QG+EEFE E++ + +H +L+ ++G C +R E +LIY YM
Sbjct: 58 GVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM 117
Query: 68 PNKSLDFYIFDLRRRYL-LDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY 126
N +L +++ + + W R+ I G +GL YL + I+HRD+K+ NILLD
Sbjct: 118 ENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDE 174
Query: 127 EMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQI 186
PKI+DFG+++ T+ + + + GT GY+ PEY KG + K DVYS+GV+L ++
Sbjct: 175 NFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEV 234
Query: 187 LGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQ 246
L + P E +NL E+A NG+ + +D +L D L + A+ C+
Sbjct: 235 LCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLA 294
Query: 247 ENAADRPTMLEILVMLK 263
++ DRP+M ++L L+
Sbjct: 295 LSSEDRPSMGDVLWKLE 311
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 4e-72
Identities = 62/290 (21%), Positives = 109/290 (37%), Gaps = 36/290 (12%)
Query: 5 ICQGR-------LPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQ- 56
+GR + +AVK Q + E EV ++H N+L +G +
Sbjct: 32 KARGRFGCVWKAQLLNEYVAVKIFPIQDKQS-WQNEYEVYSLPGMKHENILQFIGAEKRG 90
Query: 57 ---REEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYL-------QE 106
+ LI + SL ++ + ++ W HI E + +GL YL ++
Sbjct: 91 TSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIAETMARGLAYLHEDIPGLKD 146
Query: 107 YSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVR 166
I HRD+K+ N+LL + I+DFG+A F + +T VGT Y+ PE +
Sbjct: 147 GHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLE 206
Query: 167 KGI-----YSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGM--- 218
I ++ D+Y+ G++L ++ + L E G + E M
Sbjct: 207 GAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI-GQHPSLEDMQEV 265
Query: 219 ---EFIDSSLDDSSSAWKLMRCM-QVALLCVQENAADRPTMLEILVMLKS 264
+ L D M + + C +A R + + +
Sbjct: 266 VVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 2e-57
Identities = 54/307 (17%), Positives = 106/307 (34%), Gaps = 40/307 (13%)
Query: 12 NGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICT-----QREEKMLIYDY 66
+ + +AVK S + Q E + ++H N+ + R E +L+ +Y
Sbjct: 35 DERPVAVKVFSFANRQNFIN-EKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEY 93
Query: 67 MPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYL------QEYSNLTIVHRDLKAS 120
PN SL Y+ + DW + + +T+GL YL ++ I HRDL +
Sbjct: 94 YPNGSLXKYL----SLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSR 149
Query: 121 NILLDYEMNPKISDFGMARAFT------KDECEANTGRIVGTYGYVPPEYVRKGI----- 169
N+L+ + ISDFG++ T E + VGT Y+ PE + +
Sbjct: 150 NVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDX 209
Query: 170 --YSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDD 227
+ D+Y+ G++ +I + + + + + +
Sbjct: 210 ESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMA-FQTEVGNHPTFEDMQVLVSRE 268
Query: 228 S---------SSAWKLMRCM-QVALLCVQENAADRPTMLEILVMLKSETADIKTPKKPAF 277
+R + + C ++A R T + + K +
Sbjct: 269 KQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSP 328
Query: 278 SVKRDND 284
+ +
Sbjct: 329 TAHHHHH 335
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 5e-53
Identities = 65/256 (25%), Positives = 118/256 (46%), Gaps = 22/256 (8%)
Query: 12 NGQEMAVKRL--SRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPN 69
+G ++AVK L + + EF EV + RL+H N++ +G TQ ++ +Y+
Sbjct: 59 HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR 118
Query: 70 KSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMN 129
SL + R LD R R+ + + +G+ YL N IVHR+LK+ N+L+D +
Sbjct: 119 GSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYT 177
Query: 130 PKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGG 189
K+ DFG++R K ++ GT ++ PE +R + K DVYS+GV+L ++
Sbjct: 178 VKVCDFGLSR--LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATL 235
Query: 190 KRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWK-LMRCMQVALLCVQEN 248
++ P +LN + + + +E + + ++ C
Sbjct: 236 QQ------PWGNLNPAQVVAAVGFKCKRLEIP----RNLNPQVAAIIE------GCWTNE 279
Query: 249 AADRPTMLEILVMLKS 264
RP+ I+ +L+
Sbjct: 280 PWKRPSFATIMDLLRP 295
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 6e-50
Identities = 73/265 (27%), Positives = 121/265 (45%), Gaps = 35/265 (13%)
Query: 12 NGQEMAVKRL----SRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYM 67
G E+AVK Q +E E KL A L+H N++ + G+C + L+ ++
Sbjct: 29 IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFA 88
Query: 68 PNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYE 127
L + + V+ I +G+ YL + + + I+HRDLK+SNIL+ +
Sbjct: 89 RGGPL----NRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQK 144
Query: 128 MNP--------KISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSY 179
+ KI+DFG+AR + + + G Y ++ PE +R ++S DV+SY
Sbjct: 145 VENGDLSNKILKITDFGLAREWHRTTKMSAA----GAYAWMAPEVIRASMFSKGSDVWSY 200
Query: 180 GVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQ 239
GVLL ++L G+ P ++ L AYG+ N + I S+ + + KLM
Sbjct: 201 GVLLWELLTGEV------PFRGIDGLAVAYGVAMNKLALP-IPSTCPEPFA--KLME--- 248
Query: 240 VALLCVQENAADRPTMLEILVMLKS 264
C + RP+ IL L +
Sbjct: 249 ---DCWNPDPHSRPSFTNILDQLTT 270
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 6e-48
Identities = 58/261 (22%), Positives = 104/261 (39%), Gaps = 33/261 (12%)
Query: 12 NGQEMAVKRL--SRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEK--MLIYDYM 67
G ++ VK L S + +F E H N+LPVLG C LI +M
Sbjct: 32 QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWM 91
Query: 68 PNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYE 127
P SL + + +++D V + +G+ +L I L + ++++D +
Sbjct: 92 PYGSLYNVLHE-GTNFVVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDED 149
Query: 128 MNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRK---GIYSMKYDVYSYGVLLL 184
M +IS + +F + GR+ +V PE ++K D++S+ VLL
Sbjct: 150 MTARISMADVKFSFQ------SPGRM-YAPAWVAPEALQKKPEDTNRRSADMWSFAVLLW 202
Query: 185 QILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAW-KLMRCMQVALL 243
+++ + P L+ +E + G S KLM+ +
Sbjct: 203 ELVTREV------PFADLSNMEIGMKVALEGLRPTIP----PGISPHVSKLMK------I 246
Query: 244 CVQENAADRPTMLEILVMLKS 264
C+ E+ A RP I+ +L+
Sbjct: 247 CMNEDPAKRPKFDMIVPILEK 267
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 6e-48
Identities = 56/267 (20%), Positives = 107/267 (40%), Gaps = 28/267 (10%)
Query: 12 NGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKS 71
+++A+K++ S + F E++ +R+ H N++ + G C L+ +Y S
Sbjct: 30 RAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGS 85
Query: 72 LDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMN-P 130
L + + +QG+ YL ++HRDLK N+LL
Sbjct: 86 LYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVL 145
Query: 131 KISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGK 190
KI DFG A + + + G+ ++ PE YS K DV+S+G++L +++ +
Sbjct: 146 KICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRR 200
Query: 191 RTSCYYGPNESLNLLEYAY-GLWKNGEGMEFIDSSLDDSSSAWK-LMRCMQVALLCVQEN 248
+ P + + + NG I + + LM C ++
Sbjct: 201 K------PFDEIGGPAFRIMWAVHNGTRPPLI----KNLPKPIESLMTR------CWSKD 244
Query: 249 AADRPTMLEILVMLKSETADIKTPKKP 275
+ RP+M EI+ ++ +P
Sbjct: 245 PSQRPSMEEIVKIMTHLMRYFPGADEP 271
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-47
Identities = 57/273 (20%), Positives = 112/273 (41%), Gaps = 47/273 (17%)
Query: 11 PNGQEMAVKRLSRTSHQG-------LEEFENEVKLTARLQHVNLLPVLGICTQREEKMLI 63
+ +A+K L +G +EF+ EV + + L H N++ + G+ ++
Sbjct: 42 KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN--PPRMV 99
Query: 64 YDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNIL 123
+++P L + L + + + W ++ ++ I G+ Y+Q N IVHRDL++ NI
Sbjct: 100 MEFVPCGDLYHRL--LDKAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIF 156
Query: 124 LD-----YEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPE--YVRKGIYSMKYDV 176
L + K++DFG+++ ++G + ++ PE + Y+ K D
Sbjct: 157 LQSLDENAPVCAKVADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADT 211
Query: 177 YSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGM-----EFIDSSLDDSSSA 231
YS+ ++L IL G+ P + + + + EG+ E L
Sbjct: 212 YSFAMILYTILTGEG------PFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLR----- 260
Query: 232 WKLMRCMQVALLCVQENAADRPTMLEILVMLKS 264
++ LC + RP I+ L
Sbjct: 261 -NVIE------LCWSGDPKKRPHFSYIVKELSE 286
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 2e-47
Identities = 62/273 (22%), Positives = 113/273 (41%), Gaps = 32/273 (11%)
Query: 5 ICQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLI 63
+ G+ M +K L R + F EVK+ L+H N+L +G+ + + I
Sbjct: 26 AIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI 85
Query: 64 YDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNIL 123
+Y+ +L I + + W RV + I G+ YL ++ I+HRDL + N L
Sbjct: 86 TEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYL---HSMNIIHRDLNSHNCL 140
Query: 124 LDYEMNPKISDFGMARAFTKDECEANTGR------------IVGTYGYVPPEYVRKGIYS 171
+ N ++DFG+AR ++ + R +VG ++ PE + Y
Sbjct: 141 VRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYD 200
Query: 172 MKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSA 231
K DV+S+G++L +I+G Y P +GL G + + S
Sbjct: 201 EKVDVFSFGIVLCEIIGRVNADPDYLPRTM------DFGLNVRGFLDRYCPPNCPPSFF- 253
Query: 232 WKLMRCMQVALLCVQENAADRPTMLEILVMLKS 264
+ + C + RP+ +++ L++
Sbjct: 254 -------PITVRCCDLDPEKRPSFVKLEHWLET 279
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 7e-46
Identities = 60/256 (23%), Positives = 119/256 (46%), Gaps = 24/256 (9%)
Query: 15 EMAVKRL--SRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSL 72
++AVK L + + Q L+ F+NEV + + +HVN+L +G T + ++ + SL
Sbjct: 48 DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSL 106
Query: 73 DFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKI 132
++ + + + + I +G+ YL + I+HRDLK++NI L + KI
Sbjct: 107 YHHLHASETK--FEMKKLIDIARQTARGMDYL-HAKS--IIHRDLKSNNIFLHEDNTVKI 161
Query: 133 SDFGMARAFTKDECEANTGRIVGTYGYVPPEYVR---KGIYSMKYDVYSYGVLLLQILGG 189
DFG+A ++ ++ G+ ++ PE +R YS + DVY++G++L +++ G
Sbjct: 162 GDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTG 221
Query: 190 KRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWK-LMRCMQVALLCVQEN 248
+ P ++N + + G + + K LM C+++
Sbjct: 222 QL------PYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMA------ECLKKK 269
Query: 249 AADRPTMLEILVMLKS 264
+RP+ IL ++
Sbjct: 270 RDERPSFPRILAEIEE 285
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 5e-44
Identities = 51/265 (19%), Positives = 104/265 (39%), Gaps = 35/265 (13%)
Query: 14 QEMAVKRL--SRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKS 71
E+A++ + R + L+ F+ EV + +H N++ +G C +I ++
Sbjct: 56 GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRT 115
Query: 72 LDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPK 131
L + + +LD I + I +G+ YL I+H+DLK+ N+ D
Sbjct: 116 LYSVV--RDAKIVLDVNKTRQIAQEIVKGMGYL-HAKG--ILHKDLKSKNVFYD-NGKVV 169
Query: 132 ISDFGMARAFTKDECEANTGRI---VGTYGYVPPEYVR---------KGIYSMKYDVYSY 179
I+DFG+ + ++ G ++ PE +R K +S DV++
Sbjct: 170 ITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFAL 229
Query: 180 GVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQ 239
G + ++ + P ++ + + G GM+ S + ++
Sbjct: 230 GTIWYELHAREW------PFKTQPAEAIIWQM---GTGMKPNLSQIGMGKEISDILL--- 277
Query: 240 VALLCVQENAADRPTMLEILVMLKS 264
C +RPT +++ ML+
Sbjct: 278 ---FCWAFEQEERPTFTKLMDMLEK 299
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 1e-41
Identities = 72/288 (25%), Positives = 113/288 (39%), Gaps = 39/288 (13%)
Query: 12 NGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQ----REEKMLIYDYM 67
G+++AVK T+ + E E+ T ++H N+L + + + LI DY
Sbjct: 59 RGEKVAVKVFF-TTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYH 117
Query: 68 PNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYL-----QEYSNLTIVHRDLKASNI 122
N SL +D + LD ++ + + GL +L I HRDLK+ NI
Sbjct: 118 ENGSL----YDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNI 173
Query: 123 LLDYEMNPKISDFGMARAF---TKDECEANTGRIVGTYGYVPPE------YVRKGIYSMK 173
L+ I+D G+A F T + R VGT Y+PPE +
Sbjct: 174 LVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR-VGTKRYMPPEVLDESLNRNHFQSYIM 232
Query: 174 YDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSS---- 229
D+YS+G++L ++ C G L Y + + + +
Sbjct: 233 ADMYSFGLILWEVA----RRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSF 288
Query: 230 -SAWKLMRCM-QVALL---CVQENAADRPTMLEILVMLK--SETADIK 270
+ W C+ Q+ L C N A R T L + L SE+ DIK
Sbjct: 289 PNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQDIK 336
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-40
Identities = 61/287 (21%), Positives = 102/287 (35%), Gaps = 51/287 (17%)
Query: 12 NGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEK----MLIYDYM 67
G+ +AVK + + E E+ T L+H N+L + LI Y
Sbjct: 30 QGENVAVKIF-SSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYH 88
Query: 68 PNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYL-----QEYSNLTIVHRDLKASNI 122
SL +D + LD + + I+ I GL +L I HRDLK+ NI
Sbjct: 89 EMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNI 144
Query: 123 LLDYEMNPKISDFGMARAFTKDECEANTGRI--VGTYGYVPPE------YVRKGIYSMKY 174
L+ I+D G+A ++ + + G VGT Y+ PE V +
Sbjct: 145 LVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRV 204
Query: 175 DVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSA--- 231
D++++G++L ++ N + + + + D S +D
Sbjct: 205 DIWAFGLVLWEVA----RRMV--SNGIVEDYKPPF------YDVVPNDPSFEDMRKVVCV 252
Query: 232 ----------WKLMRCMQV--ALL--CVQENAADRPTMLEILVMLKS 264
W + L+ C +N + R T L I L
Sbjct: 253 DQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-40
Identities = 66/279 (23%), Positives = 101/279 (36%), Gaps = 35/279 (12%)
Query: 12 NGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEK----MLIYDYM 67
G+E+AVK S + E E+ T L+H N+L + + L+ DY
Sbjct: 64 RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 122
Query: 68 PNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYL-----QEYSNLTIVHRDLKASNI 122
+ SL FD RY + + + GL +L I HRDLK+ NI
Sbjct: 123 EHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNI 178
Query: 123 LLDYEMNPKISDFGMARAF---TKDECEANTGRIVGTYGYVPPEYVRKGI------YSMK 173
L+ I+D G+A T A R VGT Y+ PE + I +
Sbjct: 179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR-VGTKRYMAPEVLDDSINMKHFESFKR 237
Query: 174 YDVYSYGVLLLQIL----GGKRTSCYYGPNESLNLLEYAYGLWKNGEGME----FIDSSL 225
D+Y+ G++ +I G Y P L + + + + I +
Sbjct: 238 ADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRW 297
Query: 226 DDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKS 264
+ + + M+ C N A R T L I L
Sbjct: 298 QSCEALRVMAKIMR---ECWYANGAARLTALRIKKTLSQ 333
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-35
Identities = 66/274 (24%), Positives = 108/274 (39%), Gaps = 48/274 (17%)
Query: 6 CQGRL-PNGQEMAVKRL-SRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLI 63
GRL + +AVK +F E ++ + H N++ ++G+CTQ++ ++
Sbjct: 131 FSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190
Query: 64 YDYMPNKSLDFYIFDLR-RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNI 122
+ + + LR L +T + ++ G+ YL E +HRDL A N
Sbjct: 191 MELVQGGDFLTF---LRTEGARLRVKTLLQMVGDAAAGMEYL-ESKC--CIHRDLAARNC 244
Query: 123 LLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP-----PEYVRKGIYSMKYDVY 177
L+ + KISDFGM+R A+ G VP PE + G YS + DV+
Sbjct: 245 LVTEKNVLKISDFGMSREEADGVYAASGGL-----RQVPVKWTAPEALNYGRYSSESDVW 299
Query: 178 SYGVLLLQIL-GGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSS------LDDSSS 230
S+G+LL + G P Y N + EF++ +
Sbjct: 300 SFGILLWETFSLGAS------P----------YPNLSNQQTREFVEKGGRLPCPELCPDA 343
Query: 231 AWKLMRCMQVALLCVQENAADRPTMLEILVMLKS 264
++LM C RP+ I L+S
Sbjct: 344 VFRLM------EQCWAYEPGQRPSFSTIYQELQS 371
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 6e-33
Identities = 69/271 (25%), Positives = 113/271 (41%), Gaps = 46/271 (16%)
Query: 6 CQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYD 65
G N ++A+K + R E+F E ++ +L H L+ + G+C ++ L+ +
Sbjct: 25 HLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE 83
Query: 66 YMPNKSLDFYIFDLR-RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL 124
+M + L Y LR +R L T + + + +G+ YL ++HRDL A N L+
Sbjct: 84 FMEHGCLSDY---LRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRDLAARNCLV 137
Query: 125 DYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP-----PEYVRKGIYSMKYDVYSY 179
K+SDFGM R D+ ++TG P PE YS K DV+S+
Sbjct: 138 GENQVIKVSDFGMTRFVLDDQYTSSTG------TKFPVKWASPEVFSFSRYSSKSDVWSF 191
Query: 180 GVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSL------DDSSSAWK 233
GVL+ ++ G + Y N E +E I + S+ ++
Sbjct: 192 GVLMWEVFS-------EG--------KIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQ 236
Query: 234 LMRCMQVALLCVQENAADRPTMLEILVMLKS 264
+M C +E DRP +L L
Sbjct: 237 IM------NHCWRERPEDRPAFSRLLRQLAE 261
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-32
Identities = 64/264 (24%), Positives = 113/264 (42%), Gaps = 34/264 (12%)
Query: 6 CQGRLPN-GQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIY 64
+G +AVK L + +EEF E + ++H NL+ +LG+CT+ +I
Sbjct: 237 YEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295
Query: 65 DYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL 124
++M +L Y+ + R + +++ I+ + YL++ + +HR+L A N L+
Sbjct: 296 EFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLV 351
Query: 125 DYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLL 184
K++DFG++R T D A+ G + PE + +S+K DV+++GVLL
Sbjct: 352 GENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLW 410
Query: 185 QILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSL------DDSSSAWKLMRCM 238
+I YG Y + E ++ ++LM
Sbjct: 411 EIAT-------YG--------MSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM--- 452
Query: 239 QVALLCVQENAADRPTMLEILVML 262
C Q N +DRP+ EI
Sbjct: 453 ---RACWQWNPSDRPSFAEIHQAF 473
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-32
Identities = 60/268 (22%), Positives = 111/268 (41%), Gaps = 44/268 (16%)
Query: 6 CQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYD 65
++AVK + + +E F E + LQH L+ + + T+ E +I +
Sbjct: 205 WMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 262
Query: 66 YMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLD 125
+M SL ++ + I +G+ ++++ + +HRDL+A+NIL+
Sbjct: 263 FMAKGSLLDFLKS-DEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVS 318
Query: 126 YEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP-----PEYVRKGIYSMKYDVYSYG 180
+ KI+DFG+AR +E A G P PE + G +++K DV+S+G
Sbjct: 319 ASLVCKIADFGLARVIEDNEYTAREG------AKFPIKWTAPEAINFGSFTIKSDVWSFG 372
Query: 181 VLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSS------LDDSSSAWKL 234
+LL++I+ YG Y N E + ++ + + +
Sbjct: 373 ILLMEIVT-------YG--------RIPYPGMSNPEVIRALERGYRMPRPENCPEELYNI 417
Query: 235 MRCMQVALLCVQENAADRPTMLEILVML 262
M + C + +RPT I +L
Sbjct: 418 M------MRCWKNRPEERPTFEYIQSVL 439
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-32
Identities = 62/265 (23%), Positives = 109/265 (41%), Gaps = 34/265 (12%)
Query: 6 CQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYD 65
G +A+K L + E F E ++ +L+H L+ + + ++ E ++ +
Sbjct: 284 WMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341
Query: 66 YMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLD 125
YM SL ++ L V + I G+ Y+ E N VHRDL+A+NIL+
Sbjct: 342 YMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYV-ERMN--YVHRDLRAANILVG 397
Query: 126 YEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQ 185
+ K++DFG+AR +E A G + PE G +++K DV+S+G+LL +
Sbjct: 398 ENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTE 456
Query: 186 ILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSS------LDDSSSAWKLMRCMQ 239
+ G Y N E ++ ++ + S LM
Sbjct: 457 LTT-------KG--------RVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLM---- 497
Query: 240 VALLCVQENAADRPTMLEILVMLKS 264
C ++ +RPT + L+
Sbjct: 498 --CQCWRKEPEERPTFEYLQAFLED 520
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-32
Identities = 60/265 (22%), Positives = 109/265 (41%), Gaps = 34/265 (12%)
Query: 6 CQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYD 65
G +A+K L + E F E ++ +L+H L+ + + ++ E ++ +
Sbjct: 201 WMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258
Query: 66 YMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLD 125
YM SL ++ L V + I G+ Y++ + VHRDL+A+NIL+
Sbjct: 259 YMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVG 314
Query: 126 YEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQ 185
+ K++DFG+AR +E A G + PE G +++K DV+S+G+LL +
Sbjct: 315 ENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTE 373
Query: 186 ILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSS------LDDSSSAWKLMRCMQ 239
+ G Y N E ++ ++ + S LM
Sbjct: 374 LTT-------KG--------RVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLM---- 414
Query: 240 VALLCVQENAADRPTMLEILVMLKS 264
C ++ +RPT + L+
Sbjct: 415 --CQCWRKEPEERPTFEYLQAFLED 437
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-32
Identities = 77/300 (25%), Positives = 138/300 (46%), Gaps = 48/300 (16%)
Query: 6 CQGRL--PNGQEM--AVKRL-SRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEK 60
C GRL P+ +E+ A+K L + + +F E + + H N++ + G+ T+ +
Sbjct: 62 CSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV 121
Query: 61 MLIYDYMPNKSLDFYIFDLR-RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKA 119
M++ +YM N SLD + LR V ++ GI G+ YL S++ VHRDL A
Sbjct: 122 MIVTEYMENGSLDSF---LRKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAA 175
Query: 120 SNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP-----PEYVRKGIYSMKY 174
NIL++ + K+SDFG+ R D A T G +P PE + ++
Sbjct: 176 RNILINSNLVCKVSDFGLGRVLEDDPEAAYT----TRGGKIPIRWTSPEAIAYRKFTSAS 231
Query: 175 DVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSS------LDDS 228
DV+SYG++L +++ YG E Y N + ++ +D +D
Sbjct: 232 DVWSYGIVLWEVMS-------YG--------ERPYWEMSNQDVIKAVDEGYRLPPPMDCP 276
Query: 229 SSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETADIKTPKKPAFSVKRDNDEISE 288
++ ++LM L C Q++ +RP +I+ +L + + K + R ++ + +
Sbjct: 277 AALYQLM------LDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLD 330
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 7e-32
Identities = 66/269 (24%), Positives = 114/269 (42%), Gaps = 46/269 (17%)
Query: 6 CQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYD 65
G+ ++A+K + + +EF E K+ L H L+ + G+CT++ +I +
Sbjct: 41 KYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99
Query: 66 YMPNKSLDFYIFDLR-RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL 124
YM N L Y LR R+ + + + + + + + YL + +HRDL A N L+
Sbjct: 100 YMANGCLLNY---LREMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLAARNCLV 153
Query: 125 DYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP-----PEYVRKGIYSMKYDVYSY 179
+ + K+SDFG++R DE ++ G P PE + +S K D++++
Sbjct: 154 NDQGVVKVSDFGLSRYVLDDEYTSSVG------SKFPVRWSPPEVLMYSKFSSKSDIWAF 207
Query: 180 GVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSS--LDD----SSSAWK 233
GVL+ +I G + Y + N E E I L S +
Sbjct: 208 GVLMWEIYS-------LG--------KMPYERFTNSETAEHIAQGLRLYRPHLASEKVYT 252
Query: 234 LMRCMQVALLCVQENAADRPTMLEILVML 262
+M C E A +RPT +L +
Sbjct: 253 IM------YSCWHEKADERPTFKILLSNI 275
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 8e-32
Identities = 61/271 (22%), Positives = 112/271 (41%), Gaps = 46/271 (16%)
Query: 6 CQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYD 65
G+ ++AVK + + +EF E + +L H L+ G+C++ ++ +
Sbjct: 25 KLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83
Query: 66 YMPNKSLDFYIFDLR-RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL 124
Y+ N L Y LR L+ + + + +G+ +L + +HRDL A N L+
Sbjct: 84 YISNGCLLNY---LRSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIHRDLAARNCLV 137
Query: 125 DYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP-----PEYVRKGIYSMKYDVYSY 179
D ++ K+SDFGM R D+ ++ G P PE YS K DV+++
Sbjct: 138 DRDLCVKVSDFGMTRYVLDDQYVSSVG------TKFPVKWSAPEVFHYFKYSSKSDVWAF 191
Query: 180 GVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSL------DDSSSAWK 233
G+L+ ++ G + Y L+ N E + + S + ++
Sbjct: 192 GILMWEVFS-------LG--------KMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQ 236
Query: 234 LMRCMQVALLCVQENAADRPTMLEILVMLKS 264
+M C E RPT ++L ++
Sbjct: 237 IM------YSCWHELPEKRPTFQQLLSSIEP 261
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-31
Identities = 62/265 (23%), Positives = 113/265 (42%), Gaps = 30/265 (11%)
Query: 12 NGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEK--MLIYDYMPN 69
G+ +AVK+L ++ + L +FE E+++ LQH N++ G+C + LI +Y+P
Sbjct: 38 TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPY 97
Query: 70 KSLDFYIFDLRR-RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM 128
SL Y L++ + +D + I +G+ YL +HRDL NIL++ E
Sbjct: 98 GSLRDY---LQKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENEN 151
Query: 129 NPKISDFGMARAFTKDECEANTGRIVGTYGYVP-----PEYVRKGIYSMKYDVYSYGVLL 183
KI DFG+ + +D+ V G P PE + + +S+ DV+S+GV+L
Sbjct: 152 RVKIGDFGLTKVLPQDKEFF----KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVL 207
Query: 184 LQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSS------LDDSSSAWKLMRC 237
++ S + G +E + ++ + +M
Sbjct: 208 YELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIM-- 265
Query: 238 MQVALLCVQENAADRPTMLEILVML 262
C N RP+ ++ + +
Sbjct: 266 ----TECWNNNVNQRPSFRDLALRV 286
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-31
Identities = 63/282 (22%), Positives = 109/282 (38%), Gaps = 48/282 (17%)
Query: 6 CQGRLPNGQEM---AVKRL--SRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEK 60
+G + + AVK L +E E + +L + ++ ++GIC E
Sbjct: 34 KKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESW 92
Query: 61 MLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKAS 120
ML+ + L+ Y L++ + + + ++ ++ G+ YL VHRDL A
Sbjct: 93 MLVMEMAELGPLNKY---LQQNRHVKDKNIIELVHQVSMGMKYL---EESNFVHRDLAAR 146
Query: 121 NILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP-----PEYVRKGIYSMKYD 175
N+LL + KISDFG+++A DE G P PE + +S K D
Sbjct: 147 NVLLVTQHYAKISDFGLSKALRADENYYKAQTH----GKWPVKWYAPECINYYKFSSKSD 202
Query: 176 VYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSS------LDDSS 229
V+S+GVL+ + YG + Y K E ++
Sbjct: 203 VWSFGVLMWEAFS-------YG--------QKPYRGMKGSEVTAMLEKGERMGCPAGCPR 247
Query: 230 SAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETADIKT 271
+ LM LC + +RP + + L++ D+
Sbjct: 248 EMYDLM------NLCWTYDVENRPGFAAVELRLRNYYYDVVN 283
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-31
Identities = 62/265 (23%), Positives = 113/265 (42%), Gaps = 30/265 (11%)
Query: 12 NGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEK--MLIYDYMPN 69
G+ +AVK+L ++ + L +FE E+++ LQH N++ G+C + LI +Y+P
Sbjct: 69 TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPY 128
Query: 70 KSLDFYIFDLRR-RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM 128
SL Y L++ + +D + I +G+ YL +HRDL NIL++ E
Sbjct: 129 GSLRDY---LQKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENEN 182
Query: 129 NPKISDFGMARAFTKDECEANTGRIVGTYGYVP-----PEYVRKGIYSMKYDVYSYGVLL 183
KI DFG+ + +D+ V G P PE + + +S+ DV+S+GV+L
Sbjct: 183 RVKIGDFGLTKVLPQDKEYY----KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVL 238
Query: 184 LQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSS------LDDSSSAWKLMRC 237
++ S + G +E + ++ + +M
Sbjct: 239 YELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIM-- 296
Query: 238 MQVALLCVQENAADRPTMLEILVML 262
C N RP+ ++ + +
Sbjct: 297 ----TECWNNNVNQRPSFRDLALRV 317
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-31
Identities = 66/283 (23%), Positives = 116/283 (40%), Gaps = 48/283 (16%)
Query: 4 AICQGRLPNGQEM--AVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKM 61
A C LP +M AVK L S ++F+ E +L LQH +++ G+CT+ +
Sbjct: 60 AECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119
Query: 62 LIYDYMPNKSLDFYIFDLRRRYLLDWRTR------------VHIIEGITQGLLYLQEYSN 109
++++YM + L+ ++ L + + + G++YL +
Sbjct: 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AG 176
Query: 110 LTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP-----PEY 164
L VHRDL N L+ + KI DFGM+R D + R VG +P PE
Sbjct: 177 LHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYR-VGGRTMLPIRWMPPES 231
Query: 165 VRKGIYSMKYDVYSYGVLLLQI--LGGKRTSCYYG-PNESLNLLEYAYGLWKNGEGMEFI 221
+ ++ + DV+S+GV+L +I G +Y N ++ G +E
Sbjct: 232 ILYRKFTTESDVWSFGVVLWEIFTYGK---QPWYQLSNT--EAIDCI----TQGRELE-- 280
Query: 222 DSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKS 264
+ +MR C Q R ++ ++ L++
Sbjct: 281 -RPRACPPEVYAIMR------GCWQREPQQRHSIKDVHARLQA 316
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 5e-31
Identities = 47/269 (17%), Positives = 100/269 (37%), Gaps = 61/269 (22%)
Query: 17 AVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76
+K L + E F + ++L H +L+ G+C +E +L+ +++ SLD Y
Sbjct: 44 LLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTY- 102
Query: 77 FDLRR-RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNP----- 130
L++ + ++ ++ + + + + +L+E + ++H ++ A NILL E +
Sbjct: 103 --LKKNKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNP 157
Query: 131 ---KISDFGMARAFTKDECEANTGRIVGTYGYVP-----PEYVRKG-IYSMKYDVYSYGV 181
K+SD G++ + PE + ++ D +S+G
Sbjct: 158 PFIKLSDPGISITVLPKD-----------ILQERIPWVPPECIENPKNLNLATDKWSFGT 206
Query: 182 LLLQILGGKRTSCYYG--PNESLNLLEYAYGLWKNGEGMEFIDS----SLDDSSSAWKLM 235
L +I C G P + ++F + ++ L+
Sbjct: 207 TLWEI-------CSGGDKP----------LSALDSQRKLQFYEDRHQLPAPKAAELANLI 249
Query: 236 RCMQVALLCVQENAADRPTMLEILVMLKS 264
C+ RP+ I+ L S
Sbjct: 250 ------NNCMDYEPDHRPSFRAIIRDLNS 272
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-31
Identities = 66/262 (25%), Positives = 111/262 (42%), Gaps = 32/262 (12%)
Query: 17 AVKRL-SRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEK--MLIYDYMPNKSLD 73
AVK L + Q ++ E+ + L H +++ G C L+ +Y+P SL
Sbjct: 64 AVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLR 123
Query: 74 FYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKIS 133
Y+ R+ + + + I +G+ YL +HRDL A N+LLD + KI
Sbjct: 124 DYL----PRHSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIG 176
Query: 134 DFGMARAFTKDECEANTGRIVGTYGYVP-----PEYVRKGIYSMKYDVYSYGVLLLQILG 188
DFG+A+A + V G P PE +++ + DV+S+GV L ++L
Sbjct: 177 DFGLAKAVPEGHEYYR----VREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232
Query: 189 GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSS--LDD----SSSAWKLMRCMQVAL 242
+S P + L L+ A G E ++ L + + LM
Sbjct: 233 HCDSSQ-SPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLM------K 285
Query: 243 LCVQENAADRPTMLEILVMLKS 264
C + A+ RPT ++ +LK+
Sbjct: 286 NCWETEASFRPTFENLIPILKT 307
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-31
Identities = 73/274 (26%), Positives = 124/274 (45%), Gaps = 48/274 (17%)
Query: 6 CQGRL--PNGQEM--AVKRL-SRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEK 60
C GRL P +++ A+K L + + + +F +E + + H N++ + G+ T+
Sbjct: 66 CYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA 125
Query: 61 MLIYDYMPNKSLDFYIFDLR-RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKA 119
M++ +YM N SLD + LR V ++ G+ G+ YL + L VHRDL A
Sbjct: 126 MIVTEYMENGSLDTF---LRTHDGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAA 179
Query: 120 SNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP-----PEYVRKGIYSMKY 174
N+L+D + K+SDFG++R D A T T G +P PE + +S
Sbjct: 180 RNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT----TTGGKIPIRWTAPEAIAFRTFSSAS 235
Query: 175 DVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSL------DDS 228
DV+S+GV++ ++L YG E Y N + + ++
Sbjct: 236 DVWSFGVVMWEVLA-------YG--------ERPYWNMTNRDVISSVEEGYRLPAPMGCP 280
Query: 229 SSAWKLMRCMQVALLCVQENAADRPTMLEILVML 262
+ +LM L C ++ A RP +I+ +L
Sbjct: 281 HALHQLM------LDCWHKDRAQRPRFSQIVSVL 308
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-30
Identities = 66/283 (23%), Positives = 118/283 (41%), Gaps = 35/283 (12%)
Query: 12 NGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEK--MLIYDYMPN 69
G +AVK+L + +F+ E+++ L ++ G+ + L+ +Y+P+
Sbjct: 51 TGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPS 110
Query: 70 KSLDFYIFDLRR-RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM 128
L + L+R R LD + I +G+ YL VHRDL A NIL++ E
Sbjct: 111 GCLRDF---LQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEA 164
Query: 129 NPKISDFGMARAFTKDECEANTGRIVGTYGYVP-----PEYVRKGIYSMKYDVYSYGVLL 183
+ KI+DFG+A+ D+ +V G P PE + I+S + DV+S+GV+L
Sbjct: 165 HVKIADFGLAKLLPLDKDYY----VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVL 220
Query: 184 LQI--LGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSS------LDDSSSAWKLM 235
++ K E L ++ + +E ++ + +LM
Sbjct: 221 YELFTYCDKS---CSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELM 277
Query: 236 RCMQVALLCVQENAADRPTMLEILVMLKSETADIKTPKKPAFS 278
LC + DRP+ + L + + + AF+
Sbjct: 278 ------KLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFT 314
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-30
Identities = 57/269 (21%), Positives = 113/269 (42%), Gaps = 34/269 (12%)
Query: 12 NGQEMAVKRL-SRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEK--MLIYDYMP 68
G+++AVK L + + + + E+++ L H N++ GICT+ LI +++P
Sbjct: 49 TGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP 108
Query: 69 NKSLDFYIFDLRR-RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYE 127
+ SL Y L + + ++ + ++ I +G+ YL VHRDL A N+L++ E
Sbjct: 109 SGSLKEY---LPKNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESE 162
Query: 128 MNPKISDFGMARAFTKDECEANTGRIVGTYGYVP-----PEYVRKGIYSMKYDVYSYGVL 182
KI DFG+ +A D+ V P PE + + + + DV+S+GV
Sbjct: 163 HQVKIGDFGLTKAIETDKEYYT----VKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVT 218
Query: 183 LLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSS------LDDSSSAWKLM 235
L ++L L ++ +G + + + ++LM
Sbjct: 219 LHELLTYCDSD--SSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLM 276
Query: 236 RCMQVALLCVQENAADRPTMLEILVMLKS 264
C + ++R + ++ ++
Sbjct: 277 ------RKCWEFQPSNRTSFQNLIEGFEA 299
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-30
Identities = 63/290 (21%), Positives = 114/290 (39%), Gaps = 61/290 (21%)
Query: 4 AICQGRLPNGQEM--AVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKM 61
A C P +M AVK L + ++F+ E +L LQH +++ G+C + +
Sbjct: 34 AECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 93
Query: 62 LIYDYMPNKSLDFYIFDLRRRYLLDWRTR-------------VHIIEGITQGLLYLQEYS 108
++++YM + L+ ++ ++ + +HI I G++YL +
Sbjct: 94 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---A 150
Query: 109 NLTIVHRDLKASNILLDYEMNPKISDFGMARA-FTKDECEANTGRIVGTYGYVP-----P 162
+ VHRDL N L+ + KI DFGM+R ++ D +P P
Sbjct: 151 SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH------TMLPIRWMPP 204
Query: 163 EYVRKGIYSMKYDVYSYGVLLLQI--LGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEF 220
E + ++ + DV+S+GV+L +I G ++ N E +E
Sbjct: 205 ESIMYRKFTTESDVWSFGVILWEIFTYGK---QPWFQ--------------LSNTEVIEC 247
Query: 221 IDS--SLDD----SSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKS 264
I L+ + +M C Q R + EI +L +
Sbjct: 248 ITQGRVLERPRVCPKEVYDVML------GCWQREPQQRLNIKEIYKILHA 291
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-30
Identities = 62/273 (22%), Positives = 112/273 (41%), Gaps = 54/273 (19%)
Query: 6 CQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEK-MLIY 64
G G ++AVK + + + F E + +L+H NL+ +LG+ + + ++
Sbjct: 210 MLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266
Query: 65 DYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL 124
+YM SL Y+ R R +L + + + + YL+ + VHRDL A N+L+
Sbjct: 267 EYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLV 322
Query: 125 DYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP-----PEYVRKGIYSMKYDVYSY 179
+ K+SDFG+ + + G +P PE +R+ +S K DV+S+
Sbjct: 323 SEDNVAKVSDFGLTK----EASSTQDT------GKLPVKWTAPEALREKKFSTKSDVWSF 372
Query: 180 GVLLLQI--LGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSS------LDDSSSA 231
G+LL +I G P Y + + ++ +
Sbjct: 373 GILLWEIYSFGRV-------P----------YPRIPLKDVVPRVEKGYKMDAPDGCPPAV 415
Query: 232 WKLMRCMQVALLCVQENAADRPTMLEILVMLKS 264
+ +M C +AA RPT L++ L+
Sbjct: 416 YDVM------KNCWHLDAATRPTFLQLREQLEH 442
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-30
Identities = 64/274 (23%), Positives = 114/274 (41%), Gaps = 44/274 (16%)
Query: 6 CQGRL--PNGQEM--AVKRLSR-TSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEK 60
G L +G+++ AVK L+R T + +F E + H N+L +LGIC + E
Sbjct: 42 YHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 101
Query: 61 -MLIYDYMPNKSLDFYIFDLR-RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLK 118
+++ YM + L + +R + + + + +G+ YL ++ VHRDL
Sbjct: 102 PLVVLPYMKHGDLRNF---IRNETHNPTVKDLIGFGLQVAKGMKYL---ASKKFVHRDLA 155
Query: 119 ASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP-----PEYVRKGIYSMK 173
A N +LD + K++DFG+AR E + + T +P E ++ ++ K
Sbjct: 156 ARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK---TGAKLPVKWMALESLQTQKFTTK 212
Query: 174 YDVYSYGVLLLQI--LGGKRTSCYYG--PNESLNLLEYAYGLWKNGEGMEFIDSSLDDSS 229
DV+S+GVLL ++ G Y + L G +
Sbjct: 213 SDVWSFGVLLWELMTRGAPP---YPDVNTFDITVYLL-------QGRRLL---QPEYCPD 259
Query: 230 SAWKLMRCMQVALLCVQENAADRPTMLEILVMLK 263
+++M L C A RP+ E++ +
Sbjct: 260 PLYEVM------LKCWHPKAEMRPSFSELVSRIS 287
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-30
Identities = 68/272 (25%), Positives = 110/272 (40%), Gaps = 50/272 (18%)
Query: 6 CQGRLPNGQEM--AVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLI 63
+G + AVK L + +EEF E + ++H NL+ +LG+CT+ +I
Sbjct: 30 YEGVW-KKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87
Query: 64 YDYMPNKSLDFYIFDLR--RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASN 121
++M +L Y LR R + +++ I+ + YL +HRDL A N
Sbjct: 88 TEFMTYGNLLDY---LRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRDLAARN 141
Query: 122 ILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP-----PEYVRKGIYSMKYDV 176
L+ K++DFG++R T D A+ G P PE + +S+K DV
Sbjct: 142 CLVGENHLVKVADFGLSRLMTGDTYTAHAG------AKFPIKWTAPESLAYNKFSIKSDV 195
Query: 177 YSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSL------DDSSS 230
+++GVLL +I YG Y + E ++
Sbjct: 196 WAFGVLLWEIAT-------YG--------MSPYPGIDLSQVYELLEKDYRMERPEGCPEK 240
Query: 231 AWKLMRCMQVALLCVQENAADRPTMLEILVML 262
++LM C Q N +DRP+ EI
Sbjct: 241 VYELM------RACWQWNPSDRPSFAEIHQAF 266
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 2e-30
Identities = 70/291 (24%), Positives = 119/291 (40%), Gaps = 62/291 (21%)
Query: 4 AICQGRLPNGQEM--AVKRL-SRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEK 60
G P Q A+K L + EEF +E L ARLQH N++ +LG+ T+ +
Sbjct: 28 GHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL 87
Query: 61 MLIYDYMPNKSLDFYIFDLRRRYLLDWRTR-------------VHIIEGITQGLLYLQEY 107
+I+ Y + L ++ + VH++ I G+ YL
Sbjct: 88 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL--- 144
Query: 108 SNLTIVHRDLKASNILLDYEMNPKISDFGMARA-FTKDECEANTGRIVGTYGYVP----- 161
S+ +VH+DL N+L+ ++N KISD G+ R + D + +P
Sbjct: 145 SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN------SLLPIRWMA 198
Query: 162 PEYVRKGIYSMKYDVYSYGVLLLQI--LGGKRTSCYYGPNESLNLLEYAYGLWKNGEGME 219
PE + G +S+ D++SYGV+L ++ G + Y G + N + +E
Sbjct: 199 PEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP---YCG--------------YSNQDVVE 241
Query: 220 FIDS--SLDD----SSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKS 264
I + L + + LM + C E + RP +I L++
Sbjct: 242 MIRNRQVLPCPDDCPAWVYALM------IECWNEFPSRRPRFKDIHSRLRA 286
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-30
Identities = 62/260 (23%), Positives = 107/260 (41%), Gaps = 48/260 (18%)
Query: 17 AVKRL-SRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFY 75
A+K L TS + +E +E + A + + ++ +LGIC LI MP L Y
Sbjct: 48 AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDY 106
Query: 76 IFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDF 135
+ + + + ++ I +G+ YL++ +VHRDL A N+L+ + KI+DF
Sbjct: 107 V--REHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDF 161
Query: 136 GMARAFTKDECEANTGRIVGTYGYVP-----PEYVRKGIYSMKYDVYSYGVLLLQI--LG 188
G+A+ +E E + G VP E + IY+ + DV+SYGV + ++ G
Sbjct: 162 GLAKLLGAEEKEYHAEG-----GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 216
Query: 189 GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSS--LDD----SSSAWKLMRCMQVAL 242
K P Y E ++ L + + +M
Sbjct: 217 SK-------P----------YDGIPASEISSILEKGERLPQPPICTIDVYMIM------R 253
Query: 243 LCVQENAADRPTMLEILVML 262
C +A RP E+++
Sbjct: 254 KCWMIDADSRPKFRELIIEF 273
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-30
Identities = 66/277 (23%), Positives = 108/277 (38%), Gaps = 52/277 (18%)
Query: 6 CQGRLPNGQEM---AVKRL-SRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKM 61
QG ++ A+K L T EE E ++ +L + ++ ++G+C E M
Sbjct: 27 RQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 85
Query: 62 LIYDYMPNKSLDFYIFDLR-RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKAS 120
L+ + L + L +R + ++ ++ G+ YL VHRDL A
Sbjct: 86 LVMEMAGGGPLHKF---LVGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRDLAAR 139
Query: 121 NILLDYEMNPKISDFGMARAFTKDECE--ANTGRIVGTYGYVP-----PEYVRKGIYSMK 173
N+LL KISDFG+++A D+ A + G P PE + +S +
Sbjct: 140 NVLLVNRHYAKISDFGLSKALGADDSYYTARSA------GKWPLKWYAPECINFRKFSSR 193
Query: 174 YDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSS------LDD 227
DV+SYGV + + L YG + Y K E M FI+ +
Sbjct: 194 SDVWSYGVTMWEALS-------YG--------QKPYKKMKGPEVMAFIEQGKRMECPPEC 238
Query: 228 SSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKS 264
+ LM C DRP L + +++
Sbjct: 239 PPELYALM------SDCWIYKWEDRPDFLTVEQRMRA 269
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-30
Identities = 70/272 (25%), Positives = 120/272 (44%), Gaps = 48/272 (17%)
Query: 6 CQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYD 65
G ++AVK L + + F E L +LQH L+ + + TQ E +I +
Sbjct: 30 WMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87
Query: 66 YMPNKSLDFYIFDLR--RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNIL 123
YM N SL + L+ L + + I +G+ +++E + +HRDL+A+NIL
Sbjct: 88 YMENGSLVDF---LKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANIL 141
Query: 124 LDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP-----PEYVRKGIYSMKYDVYS 178
+ ++ KI+DFG+AR +E A G P PE + G +++K DV+S
Sbjct: 142 VSDTLSCKIADFGLARLIEDNEYTAREG------AKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 179 YGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSS------LDDSSSAW 232
+G+LL +I+ +G Y N E ++ ++ + +
Sbjct: 196 FGILLTEIVT-------HG--------RIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY 240
Query: 233 KLMRCMQVALLCVQENAADRPTMLEILVMLKS 264
+LM LC +E DRPT + +L+
Sbjct: 241 QLM------RLCWKERPEDRPTFDYLRSVLED 266
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-30
Identities = 71/288 (24%), Positives = 108/288 (37%), Gaps = 54/288 (18%)
Query: 4 AICQGRLPNGQEM--AVKRL-SRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEK 60
G + + AVK L S Q +F E + ++ H N++ +G+ Q +
Sbjct: 49 GQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108
Query: 61 MLIYDYMPNKSLDFYIFDLRRRYL----LDWRTRVHIIEGITQGLLYLQEYSNLTIVHRD 116
++ + M L ++ + R R L +H+ I G YL +HRD
Sbjct: 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL---EENHFIHRD 165
Query: 117 LKASNILLDYE---MNPKISDFGMARAFTKDECEANTGRIVGTYGYVP-----PEYVRKG 168
+ A N LL KI DFGMAR + G +P PE +G
Sbjct: 166 IAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC-----AMLPVKWMPPEAFMEG 220
Query: 169 IYSMKYDVYSYGVLLLQI--LGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDS--S 224
I++ K D +S+GVLL +I LG Y N E +EF+ S
Sbjct: 221 IFTSKTDTWSFGVLLWEIFSLGY---MPYPS--------------KSNQEVLEFVTSGGR 263
Query: 225 LDD----SSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETAD 268
+D +++M C Q DRP IL ++ T D
Sbjct: 264 MDPPKNCPGPVYRIMT------QCWQHQPEDRPNFAIILERIEYCTQD 305
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 8e-30
Identities = 68/260 (26%), Positives = 120/260 (46%), Gaps = 44/260 (16%)
Query: 17 AVKRL-SRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFY 75
A+K L + + + +F E + + H N++ + G+ ++ + M+I +YM N +LD +
Sbjct: 77 AIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKF 136
Query: 76 IFDLR-RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISD 134
LR + V ++ GI G+ YL + VHRDL A NIL++ + K+SD
Sbjct: 137 ---LREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSD 190
Query: 135 FGMARAFTKDECEANTGRIVGTYGYVP-----PEYVRKGIYSMKYDVYSYGVLLLQILGG 189
FG++R D T G G +P PE + ++ DV+S+G+++ +++
Sbjct: 191 FGLSRVLEDDPEATYTTS--G--GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT- 245
Query: 190 KRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSS------LDDSSSAWKLMRCMQVALL 243
YG E Y N E M+ I+ +D S+ ++LM +
Sbjct: 246 ------YG--------ERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLM------MQ 285
Query: 244 CVQENAADRPTMLEILVMLK 263
C Q+ A RP +I+ +L
Sbjct: 286 CWQQERARRPKFADIVSILD 305
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-29
Identities = 63/274 (22%), Positives = 115/274 (41%), Gaps = 44/274 (16%)
Query: 6 CQGRL--PNGQEM--AVKRLSR-TSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEK 60
G L +G+++ AVK L+R T + +F E + H N+L +LGIC + E
Sbjct: 106 YHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 165
Query: 61 -MLIYDYMPNKSLDFYIFDLR-RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLK 118
+++ YM + L + +R + + + + +G+ +L ++ VHRDL
Sbjct: 166 PLVVLPYMKHGDLRNF---IRNETHNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLA 219
Query: 119 ASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP-----PEYVRKGIYSMK 173
A N +LD + K++DFG+AR E ++ + T +P E ++ ++ K
Sbjct: 220 ARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK---TGAKLPVKWMALESLQTQKFTTK 276
Query: 174 YDVYSYGVLLLQI--LGGKRTSCYYG--PNESLNLLEYAYGLWKNGEGMEFIDSSLDDSS 229
DV+S+GVLL ++ G Y + L G +
Sbjct: 277 SDVWSFGVLLWELMTRGAPP---YPDVNTFDITVYLL-------QGRRLL---QPEYCPD 323
Query: 230 SAWKLMRCMQVALLCVQENAADRPTMLEILVMLK 263
+++M L C A RP+ E++ +
Sbjct: 324 PLYEVM------LKCWHPKAEMRPSFSELVSRIS 351
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-29
Identities = 71/288 (24%), Positives = 108/288 (37%), Gaps = 54/288 (18%)
Query: 4 AICQGRLPNGQEM--AVKRL-SRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEK 60
G + + AVK L S Q +F E + ++ H N++ +G+ Q +
Sbjct: 90 GQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149
Query: 61 MLIYDYMPNKSLDFYIFDLRRRYL----LDWRTRVHIIEGITQGLLYLQEYSNLTIVHRD 116
++ + M L ++ + R R L +H+ I G YL +HRD
Sbjct: 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL---EENHFIHRD 206
Query: 117 LKASNILLDYE---MNPKISDFGMARAFTKDECEANTGRIVGTYGYVP-----PEYVRKG 168
+ A N LL KI DFGMAR + G +P PE +G
Sbjct: 207 IAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGC-----AMLPVKWMPPEAFMEG 261
Query: 169 IYSMKYDVYSYGVLLLQI--LGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDS--S 224
I++ K D +S+GVLL +I LG Y N E +EF+ S
Sbjct: 262 IFTSKTDTWSFGVLLWEIFSLGY---MPYPS--------------KSNQEVLEFVTSGGR 304
Query: 225 LDD----SSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETAD 268
+D +++M C Q DRP IL ++ T D
Sbjct: 305 MDPPKNCPGPVYRIMT------QCWQHQPEDRPNFAIILERIEYCTQD 346
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-29
Identities = 62/274 (22%), Positives = 111/274 (40%), Gaps = 58/274 (21%)
Query: 6 CQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEK-MLIY 64
G G ++AVK + + + F E + +L+H NL+ +LG+ + + ++
Sbjct: 38 MLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94
Query: 65 DYMPNKSLDFYIFDLR--RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNI 122
+YM SL Y LR R +L + + + + YL VHRDL A N+
Sbjct: 95 EYMAKGSLVDY---LRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNV 148
Query: 123 LLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP-----PEYVRKGIYSMKYDVY 177
L+ + K+SDFG+ + + G +P PE +R+ +S K DV+
Sbjct: 149 LVSEDNVAKVSDFGLTK----EASSTQDT------GKLPVKWTAPEALREKKFSTKSDVW 198
Query: 178 SYGVLLLQI--LGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSL------DDSS 229
S+G+LL +I G P Y + + ++
Sbjct: 199 SFGILLWEIYSFGRV-------P----------YPRIPLKDVVPRVEKGYKMDAPDGCPP 241
Query: 230 SAWKLMRCMQVALLCVQENAADRPTMLEILVMLK 263
+ +++M C +AA RP+ L++ L+
Sbjct: 242 AVYEVM------KNCWHLDAAMRPSFLQLREQLE 269
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 65/276 (23%), Positives = 109/276 (39%), Gaps = 50/276 (18%)
Query: 6 CQGRLPNGQEM---AVKRL-SRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKM 61
QG ++ A+K L T EE E ++ +L + ++ ++G+C E M
Sbjct: 353 RQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALM 411
Query: 62 LIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASN 121
L+ + L ++ R + ++ ++ G+ YL+E VHR+L A N
Sbjct: 412 LVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARN 466
Query: 122 ILLDYEMNPKISDFGMARAFTKDECE--ANTGRIVGTYGYVP-----PEYVRKGIYSMKY 174
+LL KISDFG+++A D+ A + G P PE + +S +
Sbjct: 467 VLLVNRHYAKISDFGLSKALGADDSYYTARSA------GKWPLKWYAPECINFRKFSSRS 520
Query: 175 DVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSS------LDDS 228
DV+SYGV + + L YG + Y K E M FI+ +
Sbjct: 521 DVWSYGVTMWEALS-------YG--------QKPYKKMKGPEVMAFIEQGKRMECPPECP 565
Query: 229 SSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKS 264
+ LM C DRP L + +++
Sbjct: 566 PELYALM------SDCWIYKWEDRPDFLTVEQRMRA 595
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-29
Identities = 70/284 (24%), Positives = 118/284 (41%), Gaps = 46/284 (16%)
Query: 4 AICQGRLPNGQEM--AVKRL-SRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEK 60
+ +G + + E A+K + S + EF NE + +++ +LG+ +Q +
Sbjct: 44 GVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 103
Query: 61 MLIYDYMPNKSLDFYIFDLRRRYL-------LDWRTRVHIIEGITQGLLYLQEYSNLTIV 113
++I + M L Y+ LR + + I G+ YL + V
Sbjct: 104 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL---NANKFV 160
Query: 114 HRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP-----PEYVRKG 168
HRDL A N ++ + KI DFGM R D E + R G G +P PE ++ G
Sbjct: 161 HRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYR-KGGKGLLPVRWMSPESLKDG 215
Query: 169 IYSMKYDVYSYGVLLLQI--LGGKRTSCYYG--PNESLNLLEYAYGLWKNGEGMEFIDSS 224
+++ DV+S+GV+L +I L Y G + L + G ++
Sbjct: 216 VFTTYSDVWSFGVVLWEIATLAE---QPYQGLSNEQVLRFV-------MEGGLLD---KP 262
Query: 225 LDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETAD 268
+ ++LMR +C Q N RP+ LEI+ +K E
Sbjct: 263 DNCPDMLFELMR------MCWQYNPKMRPSFLEIISSIKEEMEP 300
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-28
Identities = 56/276 (20%), Positives = 106/276 (38%), Gaps = 51/276 (18%)
Query: 6 CQGRL--PNGQEM--AVKRL-SRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEK 60
QG P + A+K + TS E+F E + H +++ ++G+ T+
Sbjct: 32 HQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPV 90
Query: 61 MLIYDYMPNKSLDFYIFDLR-RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKA 119
+I + L + L+ R+Y LD + + ++ L YL + VHRD+ A
Sbjct: 91 WIIMELCTLGELRSF---LQVRKYSLDLASLILYAYQLSTALAYL---ESKRFVHRDIAA 144
Query: 120 SNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP-----PEYVRKGIYSMKY 174
N+L+ K+ DFG++R + G +P PE + ++
Sbjct: 145 RNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK------GKLPIKWMAPESINFRRFTSAS 198
Query: 175 DVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSS------LDDS 228
DV+ +GV + +IL +G + KN + + I++ +
Sbjct: 199 DVWMFGVCMWEILM-------HG--------VKPFQGVKNNDVIGRIENGERLPMPPNCP 243
Query: 229 SSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKS 264
+ + LM C + + RP E+ L +
Sbjct: 244 PTLYSLM------TKCWAYDPSRRPRFTELKAQLST 273
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-28
Identities = 55/276 (19%), Positives = 106/276 (38%), Gaps = 51/276 (18%)
Query: 6 CQGRL--PNGQEM--AVKRLSR-TSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEK 60
+G G+++ AVK + + E+F +E + L H +++ ++GI + E
Sbjct: 29 YEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPT 87
Query: 61 MLIYDYMPNKSLDFYIFDLRR-RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKA 119
+I + P L Y L R + L T V I + + YL+ + VHRD+
Sbjct: 88 WIIMELYPYGELGHY---LERNKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAV 141
Query: 120 SNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP-----PEYVRKGIYSMKY 174
NIL+ K+ DFG++R ++ + +P PE + ++
Sbjct: 142 RNILVASPECVKLGDFGLSRYIEDEDYYKASV------TRLPIKWMSPESINFRRFTTAS 195
Query: 175 DVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSS------LDDS 228
DV+ + V + +IL +G + + +N + + ++
Sbjct: 196 DVWMFAVCMWEILS-------FG--------KQPFFWLENKDVIGVLEKGDRLPKPDLCP 240
Query: 229 SSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKS 264
+ LM C + +DRP E++ L
Sbjct: 241 PVLYTLM------TRCWDYDPSDRPRFTELVCSLSD 270
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-28
Identities = 59/306 (19%), Positives = 115/306 (37%), Gaps = 49/306 (16%)
Query: 4 AICQGRLPNGQEMAVKRL--SRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEK- 60
A + + ++AVK L + +EEF E H ++ ++G+ + K
Sbjct: 42 AQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101
Query: 61 -----MLIYDYMPNKSLDFYIFDLR---RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTI 112
M+I +M + L ++ R + L +T V + I G+ YL S+
Sbjct: 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYL---SSRNF 158
Query: 113 VHRDLKASNILLDYEMNPKISDFGMARA-FTKDECEANTGRIVGTYGYVP-----PEYVR 166
+HRDL A N +L +M ++DFG++R ++ D +P E +
Sbjct: 159 IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCA------SKLPVKWLALESLA 212
Query: 167 KGIYSMKYDVYSYGVLLLQI--LGGKRTSCYYG--PNESLNLLEYAYGLWKNGEGMEFID 222
+Y++ DV+++GV + +I G + Y G E N L G ++
Sbjct: 213 DNLYTVHSDVWAFGVTMWEIMTRGQ---TPYAGIENAEIYNYLI-------GGNRLK--- 259
Query: 223 SSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETADIKTPKKPAFSVKRD 282
+ + LM C + RP+ + + L++ + + +
Sbjct: 260 QPPECMEEVYDLMYQ------CWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPLYIN 313
Query: 283 NDEISE 288
+
Sbjct: 314 IERAHH 319
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-28
Identities = 61/279 (21%), Positives = 115/279 (41%), Gaps = 48/279 (17%)
Query: 4 AICQGRLPNGQEMAVKRLSR--TSHQGLEEFENEVKLTARLQHVNLLPVLGICTQRE--- 58
+ ++AVK + +S + +EEF +E H N++ +LG+C +
Sbjct: 53 GNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112
Query: 59 --EKMLIYDYMPNKSLDFYIFDLRRR---YLLDWRTRVHIIEGITQGLLYLQEYSNLTIV 113
+ M+I +M L Y+ R + +T + + I G+ YL SN +
Sbjct: 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL---SNRNFL 169
Query: 114 HRDLKASNILLDYEMNPKISDFGMARA-FTKDECEANTGRIVGTYGYVP-----PEYVRK 167
HRDL A N +L +M ++DFG+++ ++ D +P E +
Sbjct: 170 HRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRI------AKMPVKWIAIESLAD 223
Query: 168 GIYSMKYDVYSYGVLLLQI--LGGKRTSCYYG--PNESLNLLEYAYGLWKNGEGMEFIDS 223
+Y+ K DV+++GV + +I G + Y G +E + L +G ++
Sbjct: 224 RVYTSKSDVWAFGVTMWEIATRGM---TPYPGVQNHEMYDYLL-------HGHRLK---Q 270
Query: 224 SLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVML 262
D +++M C + + DRPT + + L
Sbjct: 271 PEDCLDELYEIMYS------CWRTDPLDRPTFSVLRLQL 303
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-28
Identities = 59/279 (21%), Positives = 102/279 (36%), Gaps = 52/279 (18%)
Query: 6 CQGRL--PNGQEM--AVKRL---SRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQRE 58
+G P+G+ + AVK L + + +++F EV L H NL+ + G+
Sbjct: 35 RRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P 93
Query: 59 EKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLK 118
++ + P SL + + + T + +G+ YL E +HRDL
Sbjct: 94 PMKMVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAEGMGYL-ESKRF--IHRDLA 148
Query: 119 ASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP-----PEYVRKGIYSMK 173
A N+LL KI DFG+ RA +++ VP PE ++ +S
Sbjct: 149 ARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH----RKVPFAWCAPESLKTRTFSHA 204
Query: 174 YDVYSYGVLLLQIL-GGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSS-------L 225
D + +GV L ++ G+ P + + + ID
Sbjct: 205 SDTWMFGVTLWEMFTYGQE------P----------WIGLNGSQILHKIDKEGERLPRPE 248
Query: 226 DDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKS 264
D + +M + C DRPT + + L
Sbjct: 249 DCPQDIYNVM------VQCWAHKPEDRPTFVALRDFLLE 281
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-28
Identities = 61/260 (23%), Positives = 107/260 (41%), Gaps = 48/260 (18%)
Query: 17 AVKRL-SRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFY 75
A+K L TS + +E +E + A + + ++ +LGIC LI MP L Y
Sbjct: 48 AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDY 106
Query: 76 IFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDF 135
+ + + + ++ I +G+ YL++ +VHRDL A N+L+ + KI+DF
Sbjct: 107 V--REHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDF 161
Query: 136 GMARAFTKDECEANTGRIVGTYGYVP-----PEYVRKGIYSMKYDVYSYGVLLLQI--LG 188
G+A+ +E E + G VP E + IY+ + DV+SYGV + ++ G
Sbjct: 162 GLAKLLGAEEKEYHAEG-----GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 216
Query: 189 GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSS------LDDSSSAWKLMRCMQVAL 242
K P Y E ++ + + +M +
Sbjct: 217 SK-------P----------YDGIPASEISSILEKGERLPQPPICTIDVYMIM------V 253
Query: 243 LCVQENAADRPTMLEILVML 262
C +A RP E+++
Sbjct: 254 KCWMIDADSRPKFRELIIEF 273
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 7e-28
Identities = 58/278 (20%), Positives = 106/278 (38%), Gaps = 55/278 (19%)
Query: 6 CQGRL--PNGQEM--AVKRL-SRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEK 60
QG P M A+K + TS E+F E + H +++ ++G+ T+
Sbjct: 407 HQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPV 465
Query: 61 MLIYDYMPNKSLDFYIFDLR-RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKA 119
+I + L + L+ R++ LD + + ++ L YL + VHRD+ A
Sbjct: 466 WIIMELCTLGELRSF---LQVRKFSLDLASLILYAYQLSTALAYL---ESKRFVHRDIAA 519
Query: 120 SNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP-----PEYVRKGIYSMKY 174
N+L+ K+ DFG++R + G +P PE + ++
Sbjct: 520 RNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK------GKLPIKWMAPESINFRRFTSAS 573
Query: 175 DVYSYGVLLLQI--LGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDS--SLDD--- 227
DV+ +GV + +I G K P + KN + + I++ L
Sbjct: 574 DVWMFGVCMWEILMHGVK-------P----------FQGVKNNDVIGRIENGERLPMPPN 616
Query: 228 -SSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKS 264
+ + LM C + + RP E+ L +
Sbjct: 617 CPPTLYSLM------TKCWAYDPSRRPRFTELKAQLST 648
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 8e-28
Identities = 74/297 (24%), Positives = 119/297 (40%), Gaps = 66/297 (22%)
Query: 4 AICQGRLPNGQEM--AVKRL-SRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEK 60
A G LP AVK L S +F+ E L A + N++ +LG+C +
Sbjct: 66 ARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 125
Query: 61 MLIYDYMPNKSLDFYIFDLRRR------------------------YLLDWRTRVHIIEG 96
L+++YM L+ + LR L ++ I
Sbjct: 126 CLLFEYMAYGDLNEF---LRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQ 182
Query: 97 ITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMAR-AFTKDECEANTGRIVG 155
+ G+ YL S VHRDL N L+ M KI+DFG++R ++ D +A+
Sbjct: 183 VAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGN---- 235
Query: 156 TYGYVP-----PEYVRKGIYSMKYDVYSYGVLLLQI--LGGKRTSCYYG-PNESLNLLEY 207
+P PE + Y+ + DV++YGV+L +I G YYG +E ++ Y
Sbjct: 236 --DAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL---QPYYGMAHE--EVIYY 288
Query: 208 AYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKS 264
++G + + + LMR LC + ADRP+ I +L+
Sbjct: 289 V----RDGNILA---CPENCPLELYNLMR------LCWSKLPADRPSFCSIHRILQR 332
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-28
Identities = 67/271 (24%), Positives = 112/271 (41%), Gaps = 38/271 (14%)
Query: 4 AICQGRLPNGQEMAVKRLSR-TSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREE-KM 61
+ N + A+K LSR T Q +E F E L L H N+L ++GI E
Sbjct: 40 GEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99
Query: 62 LIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASN 121
++ YM + L +I +R + + + +G+ YL + VHRDL A N
Sbjct: 100 VLLPYMCHGDLLQFIRSPQRN--PTVKDLISFGLQVARGMEYL---AEQKFVHRDLAARN 154
Query: 122 ILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP-----PEYVRKGIYSMKYDV 176
+LD K++DFG+AR E + + +P E ++ ++ K DV
Sbjct: 155 CMLDESFTVKVADFGLARDILDREYYSVQQ---HRHARLPVKWTALESLQTYRFTTKSDV 211
Query: 177 YSYGVLLLQI--LGGKRTSCYYG--PNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAW 232
+S+GVLL ++ G Y P + + L L E+ SL +
Sbjct: 212 WSFGVLLWELLTRGA---PPYRHIDPFDLTHFLAQGRRL----PQPEYCPDSL------Y 258
Query: 233 KLMRCMQVALLCVQENAADRPTMLEILVMLK 263
++M C + + A RPT ++ ++
Sbjct: 259 QVM------QQCWEADPAVRPTFRVLVGEVE 283
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-27
Identities = 77/286 (26%), Positives = 121/286 (42%), Gaps = 61/286 (21%)
Query: 6 CQGRL-PNGQEM--AVKRL-SRTSHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEK 60
+ R+ +G M A+KR+ S +F E+++ +L H N++ +LG C R
Sbjct: 42 LKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 101
Query: 61 MLIYDYMPNKSLDFYIFDLRRR----------------YLLDWRTRVHIIEGITQGLLYL 104
L +Y P+ +L + LR+ L + +H + +G+ YL
Sbjct: 102 YLAIEYAPHGNLLDF---LRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 158
Query: 105 QEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP--- 161
S +HRDL A NIL+ KI+DFG++R ++ T G +P
Sbjct: 159 ---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTM------GRLPVRW 207
Query: 162 --PEYVRKGIYSMKYDVYSYGVLLLQI--LGGKRTSCYYG-PNESLNLLEYAYGLWKNGE 216
E + +Y+ DV+SYGVLL +I LGG + Y G L Y G
Sbjct: 208 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG---TPYCGMTCAEL------YEKLPQGY 258
Query: 217 GMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVML 262
+E L+ + LMR C +E +RP+ +ILV L
Sbjct: 259 RLE---KPLNCDDEVYDLMR------QCWREKPYERPSFAQILVSL 295
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-27
Identities = 51/260 (19%), Positives = 100/260 (38%), Gaps = 48/260 (18%)
Query: 17 AVKRL-SRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFY 75
+K + ++ Q + + + L H +++ +LG+C L+ Y+P SL +
Sbjct: 46 CIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDH 104
Query: 76 IFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDF 135
+ + R L + ++ I +G+ YL +VHR+L A N+LL +++DF
Sbjct: 105 V--RQHRGALGPQLLLNWGVQIAKGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADF 159
Query: 136 GMARAFTKDECEANTGRIVGTYGYVP-----PEYVRKGIYSMKYDVYSYGVLLLQI--LG 188
G+A D+ + P E + G Y+ + DV+SYGV + ++ G
Sbjct: 160 GVADLLPPDDKQLLYSE-----AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFG 214
Query: 189 GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSS------LDDSSSAWKLMRCMQVAL 242
+ P Y + E + ++ + + +M +
Sbjct: 215 AE-------P----------YAGLRLAEVPDLLEKGERLAQPQICTIDVYMVM------V 251
Query: 243 LCVQENAADRPTMLEILVML 262
C + RPT E+
Sbjct: 252 KCWMIDENIRPTFKELANEF 271
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 7e-27
Identities = 63/287 (21%), Positives = 114/287 (39%), Gaps = 52/287 (18%)
Query: 4 AICQGRLPNGQEM--AVKRL-SRTSHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREE 59
A G + + M AVK L E +E+K+ + L H+N++ +LG CT
Sbjct: 42 ATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101
Query: 60 KMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEG---------------ITQGLLYL 104
++I +Y L ++ R ++ + + + + +G+ +L
Sbjct: 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL 161
Query: 105 QEYSNLTIVHRDLKASNILLDYEMNPKISDFGMAR-AFTKDECEANTGRIVGTYGYVP-- 161
++ +HRDL A NILL + KI DFG+AR +P
Sbjct: 162 ---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN------ARLPVK 212
Query: 162 ---PEYVRKGIYSMKYDVYSYGVLLLQI--LGGKRTSCYYGPNESLNLLEYAYGLWKNGE 216
PE + +Y+ + DV+SYG+ L ++ LG S Y G + K G
Sbjct: 213 WMAPESIFNCVYTFESDVWSYGIFLWELFSLGS---SPYPGMPVDSKFYKMI----KEGF 265
Query: 217 GMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLK 263
M + + + + +M+ C + RPT +I+ +++
Sbjct: 266 RMLSPEHA---PAEMYDIMK------TCWDADPLKRPTFKQIVQLIE 303
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 70/282 (24%), Positives = 122/282 (43%), Gaps = 51/282 (18%)
Query: 5 ICQGRLPNGQEMAVKRL-SRTSHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKML 62
I + + +AVK L + + L + +E+++ + +H N++ +LG CTQ +
Sbjct: 59 IDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV 118
Query: 63 IYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEG-------------ITQGLLYLQEYSN 109
I +Y +L Y+ R + + E + +G+ YL ++
Sbjct: 119 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---AS 175
Query: 110 LTIVHRDLKASNILLDYEMNPKISDFGMAR-AFTKDECEANTGRIVGTYGYVP-----PE 163
+HRDL A N+L+ KI+DFG+AR D + T G +P PE
Sbjct: 176 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN------GRLPVKWMAPE 229
Query: 164 YVRKGIYSMKYDVYSYGVLLLQI--LGGKRTSCYYG-PNESLNLLEYAYGLWKNGEGMEF 220
+ +Y+ + DV+S+GVL+ +I LGG S Y G P E L + K G M+
Sbjct: 230 ALFDRVYTHQSDVWSFGVLMWEIFTLGG---SPYPGIPVE--ELFKLL----KEGHRMDK 280
Query: 221 IDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVML 262
+ ++ + +MR C + RPT +++ L
Sbjct: 281 PANCTNE---LYMMMR------DCWHAVPSQRPTFKQLVEDL 313
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-26
Identities = 72/285 (25%), Positives = 124/285 (43%), Gaps = 57/285 (20%)
Query: 5 ICQGRLPNGQEMAVKRL-SRTSHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKML 62
I + + +AVK L + + L + +E+++ + +H N++ +LG CTQ +
Sbjct: 105 IDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV 164
Query: 63 IYDYMPNKSLDFYIFDLRRR----------------YLLDWRTRVHIIEGITQGLLYLQE 106
I +Y +L Y LR R + ++ V + +G+ YL
Sbjct: 165 IVEYASKGNLREY---LRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL-- 219
Query: 107 YSNLTIVHRDLKASNILLDYEMNPKISDFGMAR-AFTKDECEANTGRIVGTYGYVP---- 161
++ +HRDL A N+L+ KI+DFG+AR D + T G +P
Sbjct: 220 -ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN------GRLPVKWM 272
Query: 162 -PEYVRKGIYSMKYDVYSYGVLLLQI--LGGKRTSCYYG-PNESLNLLEYAYGLWKNGEG 217
PE + +Y+ + DV+S+GVL+ +I LGG S Y G P E L + K G
Sbjct: 273 APEALFDRVYTHQSDVWSFGVLMWEIFTLGG---SPYPGIPVE--ELFKLL----KEGHR 323
Query: 218 MEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVML 262
M+ + ++ + +MR C + RPT +++ L
Sbjct: 324 MD---KPANCTNELYMMMRD------CWHAVPSQRPTFKQLVEDL 359
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 55/275 (20%), Positives = 99/275 (36%), Gaps = 46/275 (16%)
Query: 9 RLPNGQEMAVK--RLSRTSHQGLEEFENEVKLTARLQHVNLL---------PVLGICTQR 57
+ A+K RL E+ EVK A+L+H ++
Sbjct: 26 NKVDDCNYAIKRIRLPNRELA-REKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84
Query: 58 EEKMLIY---DYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVH 114
K+ +Y ++L ++ + +HI I + + +L ++H
Sbjct: 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMH 141
Query: 115 RDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGR----------IVGTYGYVPPEY 164
RDLK SNI + K+ DFG+ A +DE E VGT Y+ PE
Sbjct: 142 RDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQ 201
Query: 165 VRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSS 224
+ YS K D++S G++L ++L P + +N +F
Sbjct: 202 IHGNSYSHKVDIFSLGLILFELL---------YPFSTQMERVRTLTDVRNL---KFPPLF 249
Query: 225 LDDSSSAWKLMRCMQVALLCVQENAADRPTMLEIL 259
+ +++ M + + +RP + I+
Sbjct: 250 TQKYPCEYVMVQDM------LSPSPMERPEAINII 278
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-26
Identities = 75/295 (25%), Positives = 117/295 (39%), Gaps = 62/295 (21%)
Query: 4 AICQGRLPNGQEM--AVKRL-SRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEK 60
A AVK L S L + +E + ++ H +++ + G C+Q
Sbjct: 42 ATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101
Query: 61 MLIYDYMPNKSL---------------------DFYIFDLRRRYLLDWRTRVHIIEGITQ 99
+LI +Y SL + D L + I+Q
Sbjct: 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQ 161
Query: 100 GLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMAR-AFTKDECEANTGRIVGTYG 158
G+ YL + + +VHRDL A NIL+ KISDFG++R + +D + G
Sbjct: 162 GMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQ------G 212
Query: 159 YVP-----PEYVRKGIYSMKYDVYSYGVLLLQI--LGGKRTSCYYG--PNESLNLLEYAY 209
+P E + IY+ + DV+S+GVLL +I LGG + Y G P NLL
Sbjct: 213 RIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG---NPYPGIPPERLFNLL---- 265
Query: 210 GLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKS 264
K G ME D+ ++ ++LM C ++ RP +I L+
Sbjct: 266 ---KTGHRMERPDNCSEE---MYRLMLQ------CWKQEPDKRPVFADISKDLEK 308
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-26
Identities = 67/288 (23%), Positives = 112/288 (38%), Gaps = 48/288 (16%)
Query: 4 AICQGRLPNGQEM--AVKRL-SRTSHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREE 59
A G + AVK L S E +E+K+ + L QH N++ +LG CT
Sbjct: 65 ATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124
Query: 60 KMLIYDYMPNKSLDFYIFDLRRRYLLDWRTR-----------VHIIEGITQGLLYLQEYS 108
++I +Y L ++ R D +H + QG+ +L +
Sbjct: 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL---A 181
Query: 109 NLTIVHRDLKASNILLDYEMNPKISDFGMAR-AFTKDECEANTGRIVGTYGYVP-----P 162
+ +HRD+ A N+LL KI DFG+AR +P P
Sbjct: 182 SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN------ARLPVKWMAP 235
Query: 163 EYVRKGIYSMKYDVYSYGVLLLQI--LGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEF 220
E + +Y+++ DV+SYG+LL +I LG + Y G + + K+G M
Sbjct: 236 ESIFDCVYTVQSDVWSYGILLWEIFSLGL---NPYPGILVNSKFYKLV----KDGYQMAQ 288
Query: 221 IDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETAD 268
+ + + +M+ C RPT +I L+ + +
Sbjct: 289 PAFA---PKNIYSIMQ------ACWALEPTHRPTFQQICSFLQEQAQE 327
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 7e-26
Identities = 66/285 (23%), Positives = 112/285 (39%), Gaps = 51/285 (17%)
Query: 4 AICQGRLPNGQEM--AVKRL-SRTSHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREE 59
A G AVK L +H +E+K+ + H+N++ +LG CT+
Sbjct: 46 ADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 105
Query: 60 -KMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEG-------------ITQGLLYLQ 105
M+I ++ +L Y+ R ++ + + + +G+ +L
Sbjct: 106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL- 164
Query: 106 EYSNLTIVHRDLKASNILLDYEMNPKISDFGMAR-AFTKDECEANTGRIVGTYGYVP--- 161
++ +HRDL A NILL + KI DFG+AR + + +P
Sbjct: 165 --ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD------ARLPLKW 216
Query: 162 --PEYVRKGIYSMKYDVYSYGVLLLQI--LGGKRTSCYYGPNESLNLLEYAYGLWKNGEG 217
PE + +Y+++ DV+S+GVLL +I LG S Y G K G
Sbjct: 217 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA---SPYPGVKIDEEFCRRL----KEGTR 269
Query: 218 MEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVML 262
M D + + ++ M C + RPT E++ L
Sbjct: 270 MRAPDYT---TPEMYQTML------DCWHGEPSQRPTFSELVEHL 305
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-25
Identities = 75/271 (27%), Positives = 121/271 (44%), Gaps = 51/271 (18%)
Query: 17 AVKRL-SRTSHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDF 74
AVK L S + + L + +E+++ + +H N++ +LG CTQ +I +Y +L
Sbjct: 105 AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 164
Query: 75 YIFDLRRRYLLDWRTRVHIIEG-------------ITQGLLYLQEYSNLTIVHRDLKASN 121
Y+ R L H E + +G+ YL ++ +HRDL A N
Sbjct: 165 YLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARN 221
Query: 122 ILLDYEMNPKISDFGMAR-AFTKDECEANTGRIVGTYGYVP-----PEYVRKGIYSMKYD 175
+L+ + KI+DFG+AR D + T G +P PE + IY+ + D
Sbjct: 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTN------GRLPVKWMAPEALFDRIYTHQSD 275
Query: 176 VYSYGVLLLQI--LGGKRTSCYYG-PNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAW 232
V+S+GVLL +I LGG S Y G P E L + L K G M+ + ++ +
Sbjct: 276 VWSFGVLLWEIFTLGG---SPYPGVPVEEL------FKLLKEGHRMDKPSNCTNE---LY 323
Query: 233 KLMRCMQVALLCVQENAADRPTMLEILVMLK 263
+MR C + RPT +++ L
Sbjct: 324 MMMR------DCWHAVPSQRPTFKQLVEDLD 348
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-25
Identities = 61/267 (22%), Positives = 106/267 (39%), Gaps = 48/267 (17%)
Query: 9 RLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVN-------------LLPVLGICT 55
+G+ +KR+ + E+ E EVK A+L HVN +
Sbjct: 32 HRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNS 87
Query: 56 QREEKMLIY---DYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTI 112
R + ++ ++ +L+ +I + RR LD + + E IT+G+ Y+ +
Sbjct: 88 SRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALELFEQITKGVDYIHS---KKL 143
Query: 113 VHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSM 172
++RDLK SNI L KI DFG+ + D + GT Y+ PE + Y
Sbjct: 144 INRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG-KRTR--SKGTLRYMSPEQISSQDYGK 200
Query: 173 KYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAW 232
+ D+Y+ G++L ++L T E+ ++G I
Sbjct: 201 EVDLYALGLILAELLHVCDT-----AFETSKFFTDL----RDGI----ISDIF--DKKEK 245
Query: 233 KLMRCMQVALLCVQENAADRPTMLEIL 259
L++ + + + DRP EIL
Sbjct: 246 TLLQKL------LSKKPEDRPNTSEIL 266
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-25
Identities = 57/279 (20%), Positives = 101/279 (36%), Gaps = 57/279 (20%)
Query: 12 NGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLL----------PVLGICTQREEKM 61
+ + A+K++ T + L +EV L A L H ++ + T ++K
Sbjct: 30 DSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKS 88
Query: 62 LIY---DYMPNKSLDFYIFDL--RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRD 116
++ +Y N +L +DL + I + L Y+ I+HRD
Sbjct: 89 TLFIQMEYCENGTL----YDLIHSENLNQQRDEYWRLFRQILEALSYIHS---QGIIHRD 141
Query: 117 LKASNILLDYEMNPKISDFGMARAFTKDECEANTGRI------------VGTYGYVPPEY 164
LK NI +D N KI DFG+A+ + +GT YV E
Sbjct: 142 LKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEV 201
Query: 165 VR-KGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKN-GEGMEFID 222
+ G Y+ K D+YS G++ +++ Y + + + + K
Sbjct: 202 LDGTGHYNEKIDMYSLGIIFFEMI--------YPFSTGMERVN----ILKKLRSVSIEFP 249
Query: 223 SSLDD--SSSAWKLMRCMQVALLCVQENAADRPTMLEIL 259
DD K++R + + + RP +L
Sbjct: 250 PDFDDNKMKVEKKIIRLL----IDH--DPNKRPGARTLL 282
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-25
Identities = 48/256 (18%), Positives = 101/256 (39%), Gaps = 32/256 (12%)
Query: 12 NGQEMAVK--RLSRTSHQGLEEFENEVKLTARLQHVNLLPVLG--ICTQREEKML--IYD 65
E+A + + + + F+ E ++ LQH N++ T + +K + + +
Sbjct: 50 TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE 109
Query: 66 YMPNKSLDFYIFDLRRRY-LLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL 124
M + +L +R+ ++ + I +GL +L I+HRDLK NI +
Sbjct: 110 LMTSGTL----KTYLKRFKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFI 164
Query: 125 DYEM-NPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLL 183
+ KI D G+A +A ++GT ++ PE + Y DVY++G+ +
Sbjct: 165 TGPTGSVKIGDLGLATLKRASFAKA----VIGTPEFMAPEMYEEK-YDESVDVYAFGMCM 219
Query: 184 LQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALL 243
L++ + + Y +G D ++
Sbjct: 220 LEMATSEYPYSECQNAAQI------YRRVTSGVKPASFDKVAIPE--------VKEIIEG 265
Query: 244 CVQENAADRPTMLEIL 259
C+++N +R ++ ++L
Sbjct: 266 CIRQNKDERYSIKDLL 281
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-25
Identities = 56/276 (20%), Positives = 98/276 (35%), Gaps = 53/276 (19%)
Query: 7 QGRLPNGQEMAVKR--LSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIY 64
Q Q A+K L +Q L+ + NE+ +LQ I +Y
Sbjct: 74 QVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ----HSDKIIR-------LY 122
Query: 65 DYMPNKSLDFYI---------FD-LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVH 114
DY Y+ L+++ +D R + + + + + ++ IVH
Sbjct: 123 DYEITDQ-YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVH 178
Query: 115 RDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPE----------- 163
DLK +N L+ + K+ DFG+A D VG Y+PPE
Sbjct: 179 SDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSREN 237
Query: 164 YVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDS 223
K S K DV+S G +L + GK + ++ L + I+
Sbjct: 238 GKSKSKISPKSDVWSLGCILYYMTYGKTP--FQQIINQISKLH------AIIDPNHEIEF 289
Query: 224 SLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEIL 259
+++C C++ + R ++ E+L
Sbjct: 290 PDIPEKDLQDVLKC------CLKRDPKQRISIPELL 319
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 71/297 (23%), Positives = 118/297 (39%), Gaps = 57/297 (19%)
Query: 4 AICQGRLPNGQEM--AVKRL-SRTSHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREE 59
A G G + AVK L + E +E+K+ +L H N++ +LG CT
Sbjct: 64 ATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123
Query: 60 KMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEG--------------------ITQ 99
LI++Y L Y+ R ++ D + + +
Sbjct: 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAK 183
Query: 100 GLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMAR-AFTKDECEANTGRIVGTYG 158
G+ +L + VHRDL A N+L+ + KI DFG+AR +
Sbjct: 184 GMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGN------A 234
Query: 159 YVP-----PEYVRKGIYSMKYDVYSYGVLLLQI--LGGKRTSCYYGPNESLNLLEYAYGL 211
+P PE + +GIY++K DV+SYG+LL +I LG + Y G N +
Sbjct: 235 RLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV---NPYPGIPVDANFYKLI--- 288
Query: 212 WKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETAD 268
+NG M+ + + + +M+ C ++ RP+ + L + AD
Sbjct: 289 -QNGFKMDQPFYA---TEEIYIIMQ------SCWAFDSRKRPSFPNLTSFLGCQLAD 335
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 2e-24
Identities = 57/276 (20%), Positives = 99/276 (35%), Gaps = 53/276 (19%)
Query: 7 QGRLPNGQEMAVKR--LSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIY 64
Q Q A+K L +Q L+ + NE+ +LQ I +Y
Sbjct: 27 QVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ----HSDKIIR-------LY 75
Query: 65 DYMPNKSLDFYI---------FD-LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVH 114
DY Y+ L+++ +D R + + + + + ++ IVH
Sbjct: 76 DYEITDQ-YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVH 131
Query: 115 RDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPE----------- 163
DLK +N L+ + K+ DFG+A D VGT Y+PPE
Sbjct: 132 SDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN 190
Query: 164 YVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDS 223
K S K DV+S G +L + GK + ++ L + I+
Sbjct: 191 GKSKSKISPKSDVWSLGCILYYMTYGKTP--FQQIINQISKLH------AIIDPNHEIEF 242
Query: 224 SLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEIL 259
+++C C++ + R ++ E+L
Sbjct: 243 PDIPEKDLQDVLKC------CLKRDPKQRISIPELL 272
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 3e-24
Identities = 51/259 (19%), Positives = 104/259 (40%), Gaps = 34/259 (13%)
Query: 12 NGQEMAVKRLSRTSHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNK 70
+ +++AVKR+ + EV+L +H N++ R+ + + +
Sbjct: 47 DNRDVAVKRILPECFSFAD---REVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-A 102
Query: 71 SLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL-----D 125
+L Y+ ++ + + +++ T GL +L L IVHRDLK NIL+
Sbjct: 103 TLQEYV--EQKDFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAH 157
Query: 126 YEMNPKISDFGMARAFTKDECE-ANTGRIVGTYGYVPPEYVR---KGIYSMKYDVYSYGV 181
++ ISDFG+ + + + GT G++ PE + K + D++S G
Sbjct: 158 GKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGC 217
Query: 182 LLLQILGGKRTSCYYGPNES-LNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQV 240
+ ++ + + N+L A L + + + A +L+ M
Sbjct: 218 VFYYVISEGSHP-FGKSLQRQANILLGACSL-------DCLHPEKHEDVIARELIEKM-- 267
Query: 241 ALLCVQENAADRPTMLEIL 259
+ + + RP+ +L
Sbjct: 268 --IAM--DPQKRPSAKHVL 282
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 3e-24
Identities = 57/276 (20%), Positives = 99/276 (35%), Gaps = 53/276 (19%)
Query: 7 QGRLPNGQEMAVKR--LSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIY 64
Q Q A+K L +Q L+ + NE+ +LQ I +Y
Sbjct: 46 QVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ----HSDKIIR-------LY 94
Query: 65 DYMPNKSLDFYI---------FD-LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVH 114
DY Y+ L+++ +D R + + + + + ++ IVH
Sbjct: 95 DYEITDQ-YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVH 150
Query: 115 RDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPE----------- 163
DLK +N L+ + K+ DFG+A D VGT Y+PPE
Sbjct: 151 SDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN 209
Query: 164 YVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDS 223
K S K DV+S G +L + GK + ++ L + I+
Sbjct: 210 GKSKSKISPKSDVWSLGCILYYMTYGKTP--FQQIINQISKLH------AIIDPNHEIEF 261
Query: 224 SLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEIL 259
+++C C++ + R ++ E+L
Sbjct: 262 PDIPEKDLQDVLKC------CLKRDPKQRISIPELL 291
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 4e-24
Identities = 47/232 (20%), Positives = 89/232 (38%), Gaps = 34/232 (14%)
Query: 41 RLQHVNLLPVLGICTQREEKMLIY---DYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGI 97
R+ + +G K+ +Y ++L ++ + +HI I
Sbjct: 114 RMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQI 173
Query: 98 TQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTG------ 151
+ + +L + ++HRDLK SNI + K+ DFG+ A +DE E
Sbjct: 174 AEAVEFL---HSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 230
Query: 152 ----RIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEY 207
VGT Y+ PE + YS K D++S G++L ++L T E + ++
Sbjct: 231 ATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ-----MERVRIITD 285
Query: 208 AYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEIL 259
+N +F +++ M + + +RP +I+
Sbjct: 286 V----RNL---KFPLLFTQKYPQEHMMVQDM------LSPSPTERPEATDII 324
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 4e-24
Identities = 53/253 (20%), Positives = 97/253 (38%), Gaps = 24/253 (9%)
Query: 9 RLPNGQEMAVK--RLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDY 66
+G++ +K +SR S + EE EV + A ++H N++ + ++ DY
Sbjct: 45 STEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY 104
Query: 67 MPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY 126
L I + + I L ++ + I+HRD+K+ NI L
Sbjct: 105 CEGGDLFKRINAQKGVLF-QEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTK 160
Query: 127 EMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQI 186
+ ++ DFG+AR A +GT Y+ PE Y+ K D+++ G +L ++
Sbjct: 161 DGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEICENKPYNNKSDIWALGCVLYEL 218
Query: 187 LGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQ 246
K E+ ++ +G + S L+ +
Sbjct: 219 CTLKH------AFEAGSMKN-LVLKIISGS-FPPVSLHY--SYDLRSLVS------QLFK 262
Query: 247 ENAADRPTMLEIL 259
N DRP++ IL
Sbjct: 263 RNPRDRPSVNSIL 275
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 8e-24
Identities = 62/258 (24%), Positives = 103/258 (39%), Gaps = 25/258 (9%)
Query: 9 RLPNGQEMAVK--RLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKML--IY 64
R +G+ + K + + +EV L L+H N++ R L +
Sbjct: 27 RKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 86
Query: 65 DYMPNKSLDFYIFDLRR-RYLLDWRTRVHIIEGITQGLLYL--QEYSNLTIVHRDLKASN 121
+Y L I + R LD + ++ +T L + T++HRDLK +N
Sbjct: 87 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPAN 146
Query: 122 ILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGV 181
+ LD + N K+ DFG+AR D A T VGT Y+ PE + + Y+ K D++S G
Sbjct: 147 VFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYMSPEQMNRMSYNEKSDIWSLGC 204
Query: 182 LLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241
LL ++ P + + E L +F S +++ M
Sbjct: 205 LLYELCALMP------PFTAFSQKE----LAGKIREGKFRRIPYRYSDELNEIITRM--- 251
Query: 242 LLCVQENAADRPTMLEIL 259
+ RP++ EIL
Sbjct: 252 ---LNLKDYHRPSVEEIL 266
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-23
Identities = 53/255 (20%), Positives = 107/255 (41%), Gaps = 22/255 (8%)
Query: 9 RLPNGQEMAVKRL---SRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYD 65
L +G +A+K++ + + E+ L +L H N++ + E ++ +
Sbjct: 53 CLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 112
Query: 66 YMPNKSLDFYIFDLRRRY-LLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL 124
L I +++ L+ RT + L ++ ++HRD+K +N+ +
Sbjct: 113 LADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFI 169
Query: 125 DYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLL 184
K+ D G+ R F+ A++ +VGT Y+ PE + + Y+ K D++S G LL
Sbjct: 170 TATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHENGYNFKSDIWSLGCLLY 227
Query: 185 QILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLC 244
++ + +YG +L Y L K E ++ D S + Q+ +C
Sbjct: 228 EMAALQSP--FYGDKMNL------YSLCKKIEQCDYPPLPSDHYSEELR-----QLVNMC 274
Query: 245 VQENAADRPTMLEIL 259
+ + RP + +
Sbjct: 275 INPDPEKRPDVTYVY 289
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-23
Identities = 46/186 (24%), Positives = 81/186 (43%), Gaps = 15/186 (8%)
Query: 10 LPNGQEMAVKRLSRTS--HQGLEE-FENEVKLTARLQHVNLLPVLGICTQREEKMLIYDY 66
+ A K + ++ E E+ + L H +++ G + ++ +
Sbjct: 63 ADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL 122
Query: 67 MPNKSLDFYIFDL--RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL 124
+SL +L RR+ L + R + + I G YL ++HRDLK N+ L
Sbjct: 123 CRRRSL----LELHKRRKALTEPEAR-YYLRQIVLGCQYLHRNR---VIHRDLKLGNLFL 174
Query: 125 DYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLL 184
+ ++ KI DFG+A D + GT Y+ PE + K +S + DV+S G ++
Sbjct: 175 NEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMY 232
Query: 185 QILGGK 190
+L GK
Sbjct: 233 TLLVGK 238
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 94.1 bits (235), Expect = 9e-23
Identities = 51/184 (27%), Positives = 89/184 (48%), Gaps = 10/184 (5%)
Query: 10 LPNGQEMAVKRLSRTS--HQGLEE-FENEVKLTARLQHVNLLPVLGICTQREEKMLIYDY 66
+ G E+A+K + + + G+ + +NEVK+ +L+H ++L + L+ +
Sbjct: 33 IHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEM 92
Query: 67 MPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY 126
N + R + + R H + I G+LYL + I+HRDL SN+LL
Sbjct: 93 CHNGEM-NRYLKNRVKPFSENEAR-HFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTR 147
Query: 127 EMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQI 186
MN KI+DFG+A + T + GT Y+ PE + + ++ DV+S G + +
Sbjct: 148 NMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEIATRSAHGLESDVWSLGCMFYTL 205
Query: 187 LGGK 190
L G+
Sbjct: 206 LIGR 209
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 1e-22
Identities = 47/164 (28%), Positives = 85/164 (51%), Gaps = 9/164 (5%)
Query: 29 LEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWR 88
L+ FE EV +++L H N++ ++ + + + L+ +Y+ +L YI L
Sbjct: 55 LKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVD 111
Query: 89 TRVHIIEGITQGLLYLQEYS-NLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECE 147
T ++ I G+ +++ ++ IVHRD+K NIL+D KI DFG+A+A + +
Sbjct: 112 TAINFTNQILDGI----KHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSL 166
Query: 148 ANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKR 191
T ++GT Y PE + D+YS G++L ++L G+
Sbjct: 167 TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEP 210
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 1e-22
Identities = 46/186 (24%), Positives = 81/186 (43%), Gaps = 15/186 (8%)
Query: 10 LPNGQEMAVKRLSRTS--HQGLEE-FENEVKLTARLQHVNLLPVLGICTQREEKMLIYDY 66
+ A K + ++ E E+ + L H +++ G + ++ +
Sbjct: 37 ADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL 96
Query: 67 MPNKSLDFYIFDL--RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL 124
+SL +L RR+ L + R + + I G YL ++HRDLK N+ L
Sbjct: 97 CRRRSL----LELHKRRKALTEPEAR-YYLRQIVLGCQYLHRNR---VIHRDLKLGNLFL 148
Query: 125 DYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLL 184
+ ++ KI DFG+A D + GT Y+ PE + K +S + DV+S G ++
Sbjct: 149 NEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMY 206
Query: 185 QILGGK 190
+L GK
Sbjct: 207 TLLVGK 212
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-22
Identities = 57/266 (21%), Positives = 97/266 (36%), Gaps = 32/266 (12%)
Query: 9 RLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKM----LIY 64
L +G A+KR+ Q EE + E + H N+L ++ C + L+
Sbjct: 50 GLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLL 109
Query: 65 DYMPNKSLDFYIFDLRRR-YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNIL 123
+ +L I L+ + L + ++ GI +GL + HRDLK +NIL
Sbjct: 110 PFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNIL 166
Query: 124 LDYEMNPKISDFGMARAFTKDECEANTGRIV-------GTYGYVPPEYV---RKGIYSMK 173
L E P + D G + + T Y PE + +
Sbjct: 167 LGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDER 226
Query: 174 YDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWK 233
DV+S G +L ++ GP + + + L + I S SS+ W+
Sbjct: 227 TDVWSLGCVLYAMM------FGEGPYDMVFQKGDSVALAVQNQ--LSIPQSPRHSSALWQ 278
Query: 234 LMRCMQVALLCVQENAADRPTMLEIL 259
L+ M + + RP + +L
Sbjct: 279 LLNSM------MTVDPHQRPHIPLLL 298
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 94.7 bits (235), Expect = 2e-22
Identities = 29/282 (10%), Positives = 64/282 (22%), Gaps = 52/282 (18%)
Query: 13 GQEMAVKRL---SRTSHQGLEEFENEVKLTARLQHVN------------LLPVLGICTQR 57
++ A+K + S LE ARL + + + +Q
Sbjct: 87 LEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQP 146
Query: 58 EEKMLIYDYMPNKSLDFYI-----------------FDLRRRYLLDWRTRVHIIEGITQG 100
L ++ + F R + + +
Sbjct: 147 PFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRL 206
Query: 101 LLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYV 160
LQ +VH N+ + + + D Y
Sbjct: 207 AANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVG-----TRGPASSVPVTYA 258
Query: 161 PPEYV--RKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGM 218
P E++ ++ + + G+ + ++ +G + +
Sbjct: 259 PREFLNASTATFTHALNAWQLGLSIYRVWCLFLP---FGLVTPGIKGSWKRPSLRVPGTD 315
Query: 219 EFIDSSLDD-SSSAWKLMRCMQVALLCVQENAADRPTMLEIL 259
S L+ L + R LE +
Sbjct: 316 SLAFGSCTPLPDFVKTLIGRF----LNF--DRRRRLLPLEAM 351
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 3e-22
Identities = 46/185 (24%), Positives = 74/185 (40%), Gaps = 18/185 (9%)
Query: 17 AVKRLSRTSHQG----LEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIY----DYMP 68
AVK L R F E + A L H ++ V + +Y+
Sbjct: 41 AVKVL-RADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVD 99
Query: 69 NKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYS-NLTIVHRDLKASNILLDYE 127
+L + + + + +I Q L +S I+HRD+K +NI++
Sbjct: 100 GVTLRDIV---HTEGPMTPKRAIEVIADACQAL----NFSHQNGIIHRDVKPANIMISAT 152
Query: 128 MNPKISDFGMARAFTKDECE-ANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQI 186
K+ DFG+ARA T ++GT Y+ PE R + DVYS G +L ++
Sbjct: 153 NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEV 212
Query: 187 LGGKR 191
L G+
Sbjct: 213 LTGEP 217
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 5e-22
Identities = 50/186 (26%), Positives = 83/186 (44%), Gaps = 10/186 (5%)
Query: 10 LPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIY-DYMP 68
L N +A+K + + + E+ L L+H N++ LG + I+ + +P
Sbjct: 44 LSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG-SFSENGFIKIFMEQVP 102
Query: 69 NKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLD-YE 127
SL + + +T + I +GL YL + IVHRD+K N+L++ Y
Sbjct: 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYS 159
Query: 128 MNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGI--YSMKYDVYSYGVLLLQ 185
KISDFG ++ T GT Y+ PE + KG Y D++S G +++
Sbjct: 160 GVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIE 217
Query: 186 ILGGKR 191
+ GK
Sbjct: 218 MATGKP 223
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 9e-22
Identities = 48/195 (24%), Positives = 83/195 (42%), Gaps = 23/195 (11%)
Query: 12 NGQEMAVKRLSRTSHQG-LEEFENEVKLTARLQH---VNLLPVLGICTQREEKMLIYDYM 67
G A+K + S ++ E ++ +L H V L + T R K+LI ++
Sbjct: 33 TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH-KVLIMEFC 91
Query: 68 PNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL--- 124
P SL + + Y L + ++ + G+ +L+E IVHR++K NI+
Sbjct: 92 PCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIG 148
Query: 125 -DYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGI--------YSMKYD 175
D + K++DFG AR DE + + + GT Y+ P+ + + Y D
Sbjct: 149 EDGQSVYKLTDFGAARELEDDE-QFVS--LYGTEEYLHPDMYERAVLRKDHQKKYGATVD 205
Query: 176 VYSYGVLLLQILGGK 190
++S GV G
Sbjct: 206 LWSIGVTFYHAATGS 220
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-21
Identities = 45/185 (24%), Positives = 74/185 (40%), Gaps = 24/185 (12%)
Query: 17 AVKRLSRTSHQG----LEEFENEVKLTARLQHVNLLPV--LGICTQREEKMLIY---DYM 67
A+K + + + E + RLQ +++P+ G E +Y +
Sbjct: 63 ALKLM-SETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFG-----EIDGQLYVDMRLI 116
Query: 68 PNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYS-NLTIVHRDLKASNILLDY 126
L + RR+ L V I+ I L + + HRD+K NIL+
Sbjct: 117 NGVDLAAML---RRQGPLAPPRAVAIVRQIGSAL----DAAHAAGATHRDVKPENILVSA 169
Query: 127 EMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQI 186
+ + DFG+A A T DE G VGT Y+ PE + + + D+Y+ +L +
Sbjct: 170 DDFAYLVDFGIASATT-DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYEC 228
Query: 187 LGGKR 191
L G
Sbjct: 229 LTGSP 233
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 2e-21
Identities = 48/195 (24%), Positives = 82/195 (42%), Gaps = 23/195 (11%)
Query: 12 NGQEMAVKRLSRTSHQGLEE-FENEVKLTARLQH---VNLLPVLGICTQREEKMLIYDYM 67
G A+K + S + E ++ +L H V L + T R K+LI ++
Sbjct: 33 TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH-KVLIMEFC 91
Query: 68 PNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL--- 124
P SL + + Y L + ++ + G+ +L+E IVHR++K NI+
Sbjct: 92 PCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIG 148
Query: 125 -DYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGI--------YSMKYD 175
D + K++DFG AR DE + + + GT Y+ P+ + + Y D
Sbjct: 149 EDGQSVYKLTDFGAARELEDDE-QFVS--LYGTEEYLHPDMYERAVLRKDHQKKYGATVD 205
Query: 176 VYSYGVLLLQILGGK 190
++S GV G
Sbjct: 206 LWSIGVTFYHAATGS 220
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 92.4 bits (229), Expect = 5e-21
Identities = 47/189 (24%), Positives = 77/189 (40%), Gaps = 16/189 (8%)
Query: 13 GQEMAVKRLSRTSHQGLEE-FENEVKLTARLQHVN---LLPVLGICTQREEKMLIY---D 65
G+++A+K+ + E + E+++ +L H N V + L +
Sbjct: 39 GEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAME 98
Query: 66 YMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLD 125
Y L Y+ L ++ I+ L YL E I+HRDLK NI+L
Sbjct: 99 YCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQ 155
Query: 126 YEMNP---KISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVL 182
KI D G A+ + E VGT Y+ PE + + Y++ D +S+G L
Sbjct: 156 PGPQRLIHKIIDLGYAKELDQGEL-CTE--FVGTLQYLAPELLEQKKYTVTVDYWSFGTL 212
Query: 183 LLQILGGKR 191
+ + G R
Sbjct: 213 AFECITGFR 221
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-20
Identities = 50/187 (26%), Positives = 82/187 (43%), Gaps = 23/187 (12%)
Query: 12 NGQEMAVKRLSRT--SHQGLEE-FENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMP 68
+ +A+K L + G+E EV++ + L+H N+L + G LI +Y P
Sbjct: 33 SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP 92
Query: 69 NKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM 128
++ + + + RT +I E + L Y ++HRD+K N+LL
Sbjct: 93 LGTVYREL--QKLSKFDEQRTATYITE-LANALSYCHSKR---VIHRDIKPENLLLGSAG 146
Query: 129 NPKISDFGMARAFTKDE-----CEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLL 183
KI+DFG + C GT Y+PPE + ++ K D++S GVL
Sbjct: 147 ELKIADFGWS-VHAPSSRRTDLC--------GTLDYLPPEMIEGRMHDEKVDLWSLGVLC 197
Query: 184 LQILGGK 190
+ L GK
Sbjct: 198 YEFLVGK 204
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 90.1 bits (223), Expect = 1e-20
Identities = 36/291 (12%), Positives = 80/291 (27%), Gaps = 74/291 (25%)
Query: 13 GQEMAVKRLSRT---SHQGLEEFENEVKLTARLQHV----------------NLLPVLGI 53
G+ V T +++ + EV L+ + +L+
Sbjct: 98 GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 157
Query: 54 CT--------QREEKMLIYDYMPNKSLDFYIF------DLRRRYLLDWRTRVHIIEGITQ 99
+ + + P + F L R+ + + +
Sbjct: 158 KKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIR 217
Query: 100 GLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159
L L Y +VH L+ +I+LD ++ F + G+
Sbjct: 218 LLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA------RVVSSVSRGF 268
Query: 160 VPPEYV-----------RKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYA 208
PPE R+ + + +D ++ G+++ I P L +
Sbjct: 269 EPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL------PITKDAALGGS 322
Query: 209 YGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEIL 259
++++ + + L+ L DR L+ +
Sbjct: 323 EWIFRSCKNI---------PQPVRALLEGF----LRY--PKEDRLLPLQAM 358
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 2e-20
Identities = 42/186 (22%), Positives = 72/186 (38%), Gaps = 22/186 (11%)
Query: 12 NGQEMAVKRLSRTSHQGLEE-FENEVKLTARLQHVNLLPVL--GICTQREEKMLIY---D 65
NG+ + +K L + + E + A + H +++ + T R + Y +
Sbjct: 105 NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVME 164
Query: 66 YMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLD 125
Y+ +SL + + L + + I L YL +V+ DLK NI+L
Sbjct: 165 YVGGQSLK----RSKGQKL-PVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLT 216
Query: 126 YEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQ 185
E K+ D G G + GT G+ PE VR G ++ D+Y+ G L
Sbjct: 217 -EEQLKLIDLGAVSRINS------FGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAA 268
Query: 186 ILGGKR 191
+
Sbjct: 269 LTLDLP 274
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-20
Identities = 45/187 (24%), Positives = 78/187 (41%), Gaps = 21/187 (11%)
Query: 12 NGQEMAVKRLSRTSHQGLEEFE-NEVKLTARLQHVNLLPVLGICTQREEKMLIY-DYMPN 69
G + AVK++ LE F E+ A L ++P+ G + + I+ + +
Sbjct: 82 TGFQCAVKKVR------LEVFRVEELVACAGLSSPRIVPLYG-AVREGPWVNIFMELLEG 134
Query: 70 KSLDFYIFDLRRRY-LLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM 128
S + L ++ L ++ + +GL YL I+H D+KA N+LL +
Sbjct: 135 GS----LGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDG 187
Query: 129 NP-KISDFGMARAFTKDECEANTGR---IVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLL 184
+ + DFG A D + I GT ++ PE V K D++S ++L
Sbjct: 188 SRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMML 247
Query: 185 QILGGKR 191
+L G
Sbjct: 248 HMLNGCH 254
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 89.3 bits (221), Expect = 3e-20
Identities = 34/287 (11%), Positives = 73/287 (25%), Gaps = 67/287 (23%)
Query: 13 GQEMAVKRLS---RTSHQGLEEFENEVKLTARLQHV----------------NLLPVLGI 53
G+ V R +++ + EV L+ + +L+
Sbjct: 103 GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 162
Query: 54 CT--------QREEKMLIYDYMPNKSLDFYIF------DLRRRYLLDWRTRVHIIEGITQ 99
+ + + P + F L R+ + + +
Sbjct: 163 KKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIR 222
Query: 100 GLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159
L L Y +VH L+ +I+LD ++ F + GR
Sbjct: 223 LLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD-GASAVSPIGRGFAPPET 278
Query: 160 VPPEYVR-----KGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKN 214
+ + + +D ++ G+ + I
Sbjct: 279 TAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP--NTDDAAL------------- 323
Query: 215 GEGMEFIDSSLDDSSSAWK--LMRCMQVALLCVQENAADRPTMLEIL 259
G E+I S + + L ++ DR L+ +
Sbjct: 324 -GGSEWIFRSCKNIPQPVRALLEGFLRY-------PKEDRLLPLQAM 362
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 4e-20
Identities = 47/196 (23%), Positives = 87/196 (44%), Gaps = 30/196 (15%)
Query: 12 NGQEMAVKRLSRT-----------------SHQGLEEFENEVKLTARLQHVNLLPVLGIC 54
+ + A+K+ ++ ++F+NE+++ +++ L GI
Sbjct: 53 DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGII 112
Query: 55 TQREEKMLIYDYMPNKSLDFYI-----FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSN 109
T +E +IY+YM N S+ + D + + II+ + Y+ ++
Sbjct: 113 TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYI--HNE 170
Query: 110 LTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYV--RK 167
I HRD+K SNIL+D K+SDFG + + D+ + GTY ++PPE+
Sbjct: 171 KNICHRDVKPSNILMDKNGRVKLSDFGES-EYMVDK-KIKG--SRGTYEFMPPEFFSNES 226
Query: 168 GIYSMKYDVYSYGVLL 183
K D++S G+ L
Sbjct: 227 SYNGAKVDIWSLGICL 242
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 6e-20
Identities = 47/186 (25%), Positives = 84/186 (45%), Gaps = 21/186 (11%)
Query: 12 NGQEMAVKRLSRT--SHQGLEE-FENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMP 68
N MA+K L ++ +G+E E+++ + L+H N+L + R+ L+ ++ P
Sbjct: 38 NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAP 97
Query: 69 NKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM 128
L + + + R+ + E + L Y E ++HRD+K N+L+ Y+
Sbjct: 98 RGELYKEL--QKHGRFDEQRSATFMEE-LADALHYCHERK---VIHRDIKPENLLMGYKG 151
Query: 129 NPKISDFGMA----RAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLL 184
KI+DFG + + C GT Y+PPE + + K D++ GVL
Sbjct: 152 ELKIADFGWSVHAPSLRRRTMC--------GTLDYLPPEMIEGKTHDEKVDLWCAGVLCY 203
Query: 185 QILGGK 190
+ L G
Sbjct: 204 EFLVGM 209
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 1e-19
Identities = 51/272 (18%), Positives = 95/272 (34%), Gaps = 41/272 (15%)
Query: 9 RLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQ-HVNLLPVLGICTQREEKM------ 61
+ +G+E A+KRL + EV +L H N++ + +E+
Sbjct: 49 DVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAE 108
Query: 62 -LIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKAS 120
L+ + L ++ + R L T + I + + ++ I+HRDLK
Sbjct: 109 FLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH-RQKPPIIHRDLKVE 167
Query: 121 NILLDYEMNPKISDFGMARAFTKDECEANTGRI----------VGTYGYVPPEYV---RK 167
N+LL + K+ DFG A + + + + T Y PE +
Sbjct: 168 NLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSN 227
Query: 168 GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDD 227
K D+++ G +L + P E L G +
Sbjct: 228 FPIGEKQDIWALGCILYLLC------FRQHPFEDGAKLRIVNGKYSIPPHDTQ------- 274
Query: 228 SSSAWKLMRCMQVALLCVQENAADRPTMLEIL 259
+ L+R M +Q N +R ++ E++
Sbjct: 275 YTVFHSLIRAM------LQVNPEERLSIAEVV 300
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 2e-19
Identities = 42/181 (23%), Positives = 75/181 (41%), Gaps = 14/181 (7%)
Query: 13 GQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSL 72
G+ K ++ +NE+ + +L H L+ + + E +LI +++ L
Sbjct: 76 GRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL 135
Query: 73 DFYIFD--LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNP 130
FD Y + ++ + +GL ++ E +IVH D+K NI+ + +
Sbjct: 136 ----FDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKAS 188
Query: 131 --KISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG 188
KI DFG+A DE T + PE V + D+++ GVL +L
Sbjct: 189 SVKIIDFGLATKLNPDEIVKV---TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS 245
Query: 189 G 189
G
Sbjct: 246 G 246
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 2e-19
Identities = 40/181 (22%), Positives = 69/181 (38%), Gaps = 14/181 (7%)
Query: 13 GQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSL 72
G A K + E E++ + L+H L+ + E ++IY++M L
Sbjct: 182 GNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL 241
Query: 73 DFYIFD--LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNP 130
F+ + V + + +GL ++ E VH DLK NI+ + +
Sbjct: 242 ----FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSN 294
Query: 131 --KISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG 188
K+ DFG+ + + GT + PE D++S GVL +L
Sbjct: 295 ELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS 351
Query: 189 G 189
G
Sbjct: 352 G 352
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-19
Identities = 45/186 (24%), Positives = 82/186 (44%), Gaps = 14/186 (7%)
Query: 13 GQEMAVK-----RLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYM 67
GQ+ AVK + + + E+ + E + L+H +++ +L + +++++M
Sbjct: 49 GQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFM 108
Query: 68 PNKSLDFYIFDL-RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY 126
L F I ++ H + I + L Y + I+HRD+K +LL
Sbjct: 109 DGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLAS 165
Query: 127 EMNP---KISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLL 183
+ N K+ FG+A + A VGT ++ PE V++ Y DV+ GV+L
Sbjct: 166 KENSAPVKLGGFGVAIQLGESGLVAGG--RVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
Query: 184 LQILGG 189
+L G
Sbjct: 224 FILLSG 229
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 7e-19
Identities = 43/259 (16%), Positives = 83/259 (32%), Gaps = 47/259 (18%)
Query: 12 NGQEMAVK--RLSRTSHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIY-DYM 67
+G+ AVK + EV ++ QH + + + + + +
Sbjct: 81 DGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ-AWEEGGILYLQTELC 139
Query: 68 PNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYE 127
SL + L + + ++ + L +L +VH D+K +NI L
Sbjct: 140 -GPSLQQHCEA-WGASLPEAQVWGYLRD-TLLALAHLHSQG---LVHLDVKPANIFLGPR 193
Query: 128 MNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQIL 187
K+ DFG+ G Y+ PE ++ Y DV+S G+ +L++
Sbjct: 194 GRCKLGDFGLLVELGTAGA-GEV--QEGDPRYMAPELLQGS-YGTAADVFSLGLTILEVA 249
Query: 188 GGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDD-------SSSAWKLMRCMQV 240
L GEG + + SS ++
Sbjct: 250 CNME-------------------LPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLV---- 286
Query: 241 ALLCVQENAADRPTMLEIL 259
+ ++ + R T +L
Sbjct: 287 --MMLEPDPKLRATAEALL 303
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 1e-18
Identities = 53/283 (18%), Positives = 93/283 (32%), Gaps = 61/283 (21%)
Query: 12 NGQEMAVKRLSRTSHQGLEEFENEVK-LTARLQHVNLLPVLGICTQREEKMLIYDYMPNK 70
G+ +AVKR+ + E+K LT H N++ T + + N
Sbjct: 38 QGRPVAVKRMLIDFC---DIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NL 93
Query: 71 SLDFYI----FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY 126
+L + L + ++ I G+ +L L I+HRDLK NIL+
Sbjct: 94 NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVST 150
Query: 127 EMNP-------------KISDFGMARAFTKDEC--EANTGRIVGTYGYVPPEYVRKGI-- 169
ISDFG+ + + N GT G+ PE + +
Sbjct: 151 SSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNL 210
Query: 170 -----YSMKYDVYSYGVLLLQILGGKRTSCYYGPNES--------LNLLEYAYGLWKNGE 216
+ D++S G + IL + + +L E ++
Sbjct: 211 QTKRRLTRSIDIFSMGCVFYYILSKGKHP-FGDKYSRESNIIRGIFSLDEMKCLHDRS-- 267
Query: 217 GMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEIL 259
+ A L+ M + + RPT +++L
Sbjct: 268 ----------LIAEATDLISQM----IDH--DPLKRPTAMKVL 294
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-18
Identities = 43/154 (27%), Positives = 72/154 (46%), Gaps = 10/154 (6%)
Query: 54 CTQREEKM-LIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTI 112
+ ++ + L+ M L F+I+ + + + R + E I GL L I
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLEDLHR---ERI 307
Query: 113 VHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSM 172
V+RDLK NILLD + +ISD G+A + + VGT GY+ PE V+ Y+
Sbjct: 308 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTF 364
Query: 173 KYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLE 206
D ++ G LL +++ G+ S + + + E
Sbjct: 365 SPDWWALGCLLYEMIAGQ--SPFQQRKKKIKREE 396
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-18
Identities = 33/175 (18%), Positives = 68/175 (38%), Gaps = 15/175 (8%)
Query: 13 GQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSL 72
+ K + + + E+ + +H N+L + EE ++I++++ +
Sbjct: 30 KKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDI 88
Query: 73 DFYIFD--LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNP 130
F+ + L+ R V + + + L +L I H D++ NI+ +
Sbjct: 89 ----FERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSS 141
Query: 131 --KISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLL 183
KI +FG AR + + Y PE + + S D++S G L+
Sbjct: 142 TIKIIEFGQARQLKPGD-NFRL--LFTAPEYYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 3e-18
Identities = 46/175 (26%), Positives = 80/175 (45%), Gaps = 14/175 (8%)
Query: 13 GQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSL 72
G ++A K + + EE +NE+ + +L H NL+ + + + +L+ +Y+ L
Sbjct: 114 GLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173
Query: 73 DFYIFD--LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNP 130
FD + Y L + ++ I +G+ ++ + + I+H DLK NIL
Sbjct: 174 ----FDRIIDESYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAK 226
Query: 131 --KISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLL 183
KI DFG+AR + E GT ++ PE V S D++S GV+
Sbjct: 227 QIKIIDFGLARRYKPREKLKV---NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 6e-18
Identities = 71/256 (27%), Positives = 107/256 (41%), Gaps = 33/256 (12%)
Query: 12 NGQEMAVKRLSR---TSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMP 68
GQE AVK +S+ E EV+L +L H N++ + + L+ +
Sbjct: 50 TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYT 109
Query: 69 NKSLDFYIFD-LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL--- 124
L FD + R II + G+ Y+ + IVHRDLK N+LL
Sbjct: 110 GGEL----FDEIISRKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESK 162
Query: 125 DYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLL 184
+ N +I DFG++ F + +GT Y+ PE V G Y K DV+S GV+L
Sbjct: 163 SKDANIRIIDFGLSTHFEASK---KMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILY 218
Query: 185 QILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDD-SSSAWKLMRCMQVALL 243
+L G + G NE ++L+ + G+ F S SA L+R M L
Sbjct: 219 ILLSGCPP--FNGANEY-DILKKV----EKGK-YTFELPQWKKVSESAKDLIRKM----L 266
Query: 244 CVQENAADRPTMLEIL 259
+ R + + L
Sbjct: 267 TY--VPSMRISARDAL 280
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 8e-18
Identities = 63/255 (24%), Positives = 104/255 (40%), Gaps = 32/255 (12%)
Query: 12 NGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPN 69
E A+K + +T S + EV + L H N++ + + L+ +
Sbjct: 61 THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKG 120
Query: 70 KSLDFYIFD-LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL---D 125
L FD + R + II+ + G+ YL + IVHRDLK N+LL +
Sbjct: 121 GEL----FDEIIHRMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKE 173
Query: 126 YEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQ 185
+ KI DFG++ F + +GT Y+ PE V + Y K DV+S GV+L
Sbjct: 174 KDALIKIVDFGLSAVFENQK---KMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFI 229
Query: 186 ILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDD-SSSAWKLMRCMQVALLC 244
+L G + G + +L + G+ F + S A L++ M L
Sbjct: 230 LLAGYPP--FGGQTDQ-EILRKV----EKGK-YTFDSPEWKNVSEGAKDLIKQM----LQ 277
Query: 245 VQENAADRPTMLEIL 259
++ R + + L
Sbjct: 278 F--DSQRRISAQQAL 290
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 9e-18
Identities = 35/156 (22%), Positives = 69/156 (44%), Gaps = 11/156 (7%)
Query: 54 CTQREEKM-LIYDYMPNKSLDFYIFDL--RRRYLLDWRTRVHIIEGITQGLLYLQEYSNL 110
+ + + L+ M + ++I+++ + R + + I GL +L +
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ-IVSGLEHLHQ---R 308
Query: 111 TIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIY 170
I++RDLK N+LLD + N +ISD G+A + + GT G++ PE + Y
Sbjct: 309 NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG--YAGTPGFMAPELLLGEEY 366
Query: 171 SMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLE 206
D ++ GV L +++ + + E + E
Sbjct: 367 DFSVDYFALGVTLYEMIAAR--GPFRARGEKVENKE 400
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 9e-18
Identities = 47/183 (25%), Positives = 79/183 (43%), Gaps = 12/183 (6%)
Query: 12 NGQEMAVKRLS-RTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNK 70
+G E +K ++ S +E+ E E+++ L H N++ + + ++ +
Sbjct: 46 SGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGG 105
Query: 71 SL-DFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL---DY 126
L + + R L +++ + L Y +VH+DLK NIL
Sbjct: 106 ELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSP 162
Query: 127 EMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQI 186
KI DFG+A F DE N GT Y+ PE V K + K D++S GV++ +
Sbjct: 163 HSPIKIIDFGLAELFKSDEHSTN---AAGTALYMAPE-VFKRDVTFKCDIWSAGVVMYFL 218
Query: 187 LGG 189
L G
Sbjct: 219 LTG 221
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 1e-17
Identities = 43/191 (22%), Positives = 82/191 (42%), Gaps = 16/191 (8%)
Query: 3 VAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKML 62
V I + A K++ + + ++ F+ E+++ L H N++ + + L
Sbjct: 25 VKIAVQK-GTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYL 83
Query: 63 IYDYMPNKSLDFYIFD-LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASN 121
+ + L F+ + + + I++ + + Y + L + HRDLK N
Sbjct: 84 VMELCTGGEL----FERVVHKRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPEN 136
Query: 122 ILL---DYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYS 178
L + K+ DFG+A F + VGT YV P+ V +G+Y + D +S
Sbjct: 137 FLFLTDSPDSPLKLIDFGLAARFKPGKMMRT---KVGTPYYVSPQ-VLEGLYGPECDEWS 192
Query: 179 YGVLLLQILGG 189
GV++ +L G
Sbjct: 193 AGVMMYVLLCG 203
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 1e-17
Identities = 54/187 (28%), Positives = 84/187 (44%), Gaps = 19/187 (10%)
Query: 12 NGQEMAVKRLSRTSHQGLEEFE---NEVKLTARLQH---VNLLPVLGICT-QREEKM-LI 63
+E A+K L + + E + +RL H V L T Q +EK+
Sbjct: 54 TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-----FTFQDDEKLYFG 108
Query: 64 YDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNIL 123
Y N L YI + + TR + E I L YL I+HRDLK NIL
Sbjct: 109 LSYAKNGELLKYI--RKIGSFDETCTRFYTAE-IVSALEYLHG---KGIIHRDLKPENIL 162
Query: 124 LDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLL 183
L+ +M+ +I+DFG A+ + + +A VGT YV PE + + D+++ G ++
Sbjct: 163 LNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCII 222
Query: 184 LQILGGK 190
Q++ G
Sbjct: 223 YQLVAGL 229
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 1e-17
Identities = 45/182 (24%), Positives = 85/182 (46%), Gaps = 12/182 (6%)
Query: 11 PNGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIY-DYMP 68
P+G MA K + + E+++ ++ G + ++ I ++M
Sbjct: 56 PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG-AFYSDGEISICMEHMD 114
Query: 69 NKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM 128
SLD L++ + + + + +GL YL I+HRD+K SNIL++
Sbjct: 115 GGSLDQV---LKKAGRIPEQILGKVSIAVIKGLTYL--REKHKIMHRDVKPSNILVNSRG 169
Query: 129 NPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG 188
K+ DFG++ AN+ VGT Y+ PE ++ YS++ D++S G+ L+++
Sbjct: 170 EIKLCDFGVSGQLIDS--MANS--FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV 225
Query: 189 GK 190
G+
Sbjct: 226 GR 227
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-17
Identities = 50/182 (27%), Positives = 76/182 (41%), Gaps = 21/182 (11%)
Query: 13 GQEMAVK------RLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDY 66
G E A K + EE E EV + ++ H N++ + + R + +LI +
Sbjct: 37 GLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILEL 96
Query: 67 MPNKSLDFYIFD-LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLD 125
+ L FD L ++ L I+ I G+ YL I H DLK NI+L
Sbjct: 97 VSGGEL----FDFLAQKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLL 149
Query: 126 YEMNP----KISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGV 181
+ P K+ DFG+A N I GT +V PE V ++ D++S GV
Sbjct: 150 DKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGV 206
Query: 182 LL 183
+
Sbjct: 207 IT 208
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-17
Identities = 55/182 (30%), Positives = 82/182 (45%), Gaps = 21/182 (11%)
Query: 13 GQEMAVK----RLSRTSHQGL--EEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDY 66
G E A K R SR S +G+ EE E EV + ++ H N++ + + R + +LI +
Sbjct: 37 GLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILEL 96
Query: 67 MPNKSLDFYIFD-LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLD 125
+ L FD L ++ L I+ I G+ YL I H DLK NI+L
Sbjct: 97 VSGGEL----FDFLAQKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLL 149
Query: 126 YEMNP----KISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGV 181
+ P K+ DFG+A N I GT +V PE V ++ D++S GV
Sbjct: 150 DKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGV 206
Query: 182 LL 183
+
Sbjct: 207 IT 208
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-17
Identities = 55/185 (29%), Positives = 89/185 (48%), Gaps = 19/185 (10%)
Query: 12 NGQEMAVKRLSRTSHQG--LEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPN 69
QE AVK +++ S + EV+L +L H N++ + I ++ +
Sbjct: 46 TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTG 105
Query: 70 KSLDFYIFD--LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL--- 124
L FD ++R+ + II+ + G+ Y+ + IVHRDLK NILL
Sbjct: 106 GEL----FDEIIKRKRFSE-HDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESK 157
Query: 125 DYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLL 184
+ + + KI DFG++ F ++ +GT Y+ PE V +G Y K DV+S GV+L
Sbjct: 158 EKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILY 213
Query: 185 QILGG 189
+L G
Sbjct: 214 ILLSG 218
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 4e-17
Identities = 42/139 (30%), Positives = 68/139 (48%), Gaps = 12/139 (8%)
Query: 54 CTQREEKM-LIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTI 112
+K+ I D M L +++ + + R + E I GL ++ +
Sbjct: 260 AFHTPDKLSFILDLMNGGDLHYHLS--QHGVFSEADMRFYAAE-IILGLEHMHN---RFV 313
Query: 113 VHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGI-YS 171
V+RDLK +NILLD + +ISD G+A D + VGT+GY+ PE ++KG+ Y
Sbjct: 314 VYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQKGVAYD 369
Query: 172 MKYDVYSYGVLLLQILGGK 190
D +S G +L ++L G
Sbjct: 370 SSADWFSLGCMLFKLLRGH 388
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-17
Identities = 44/179 (24%), Positives = 90/179 (50%), Gaps = 9/179 (5%)
Query: 12 NGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKS 71
GQE+A+++++ E NE+ + ++ N++ L +E ++ +Y+ S
Sbjct: 44 TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS 103
Query: 72 LDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPK 131
L D+ +D + Q L +L ++HRD+K+ NILL + + K
Sbjct: 104 LT----DVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVK 156
Query: 132 ISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGK 190
++DFG T ++ + +T +VGT ++ PE V + Y K D++S G++ ++++ G+
Sbjct: 157 LTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 79.6 bits (196), Expect = 5e-17
Identities = 61/241 (25%), Positives = 92/241 (38%), Gaps = 37/241 (15%)
Query: 35 EVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHII 94
V L RL + EEK L D Y L +L+ + +
Sbjct: 146 PVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQ---- 201
Query: 95 EGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIV 154
+ +G+ +L ++ +HRDL A NILL + KI DFG+AR KD G
Sbjct: 202 --VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD-- 254
Query: 155 GTYGYVP-----PEYVRKGIYSMKYDVYSYGVLLLQI--LGGKRTSCYYGPNESLNLLEY 207
+P PE + +Y+++ DV+S+GVLL +I LG S Y G
Sbjct: 255 ---ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA---SPYPGVKIDEEFCRR 308
Query: 208 AYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETA 267
K G M D + + ++ M C + RPT E++ L +
Sbjct: 309 ----LKEGTRMRAPDYTTPE---MYQTML------DCWHGEPSQRPTFSELVEHLGNLLQ 355
Query: 268 D 268
Sbjct: 356 A 356
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 2e-04
Identities = 28/135 (20%), Positives = 54/135 (40%), Gaps = 13/135 (9%)
Query: 16 MAVKRL-SRTSHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEK-MLIYDYMPNKSL 72
+AVK L +H +E+K+ + H+N++ +LG CT+ M+I ++ +L
Sbjct: 55 VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 114
Query: 73 DFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKI 132
Y+ R + T+G + Q + + DLK + +
Sbjct: 115 STYL----------RSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSAS 164
Query: 133 SDFGMARAFTKDECE 147
S F ++ + E E
Sbjct: 165 SGFVEEKSLSDVEEE 179
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 9e-17
Identities = 57/297 (19%), Positives = 100/297 (33%), Gaps = 66/297 (22%)
Query: 12 NGQEMAVK-----RLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDY 66
A+K ++ + + + +E + EV+L +L H N+ + + + L+ +
Sbjct: 50 TRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMEL 109
Query: 67 MPNKSLDFYIFDLRRRYLLDWRTRV----------------------------------- 91
L + V
Sbjct: 110 CHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKL 169
Query: 92 --HIIEGITQGLLYLQEYSNLTIVHRDLKASNILL--DYEMNPKISDFGMARAFTKDECE 147
+I+ I L YL I HRD+K N L + K+ DFG+++ F K
Sbjct: 170 ISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNG 226
Query: 148 ANTGR--IVGTYGYVPPEYVRKGI--YSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLN 203
G GT +V PE + Y K D +S GVLL +L G + G N++ +
Sbjct: 227 EYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP--FPGVNDA-D 283
Query: 204 LLEYAYGLWKNGEGMEFIDSSLDD-SSSAWKLMRCMQVALLCVQENAADRPTMLEIL 259
+ N + + F + + + S A L+ + L N +R + L
Sbjct: 284 TISQV----LNKK-LCFENPNYNVLSPLARDLLSNL----LNR--NVDERFDAMRAL 329
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-16
Identities = 45/173 (26%), Positives = 89/173 (51%), Gaps = 9/173 (5%)
Query: 12 NGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKS 71
+G+++AVK + Q E NEV + QH N++ + EE ++ +++ +
Sbjct: 69 SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGA 128
Query: 72 LDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPK 131
L D+ + L+ + E + Q L YL ++HRD+K+ +ILL + K
Sbjct: 129 LT----DIVSQVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVK 181
Query: 132 ISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLL 184
+SDFG +KD + + +VGT ++ PE + + +Y+ + D++S G++++
Sbjct: 182 LSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRSLYATEVDIWSLGIMVI 232
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-16
Identities = 72/258 (27%), Positives = 114/258 (44%), Gaps = 38/258 (14%)
Query: 12 NGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIY---DY 66
QE AVK +++ ++ EV+L +L H N++ + I E+ Y +
Sbjct: 46 TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL---EDSSSFYIVGEL 102
Query: 67 MPNKSLDFYIFD-LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL- 124
L FD + +R II+ + G+ Y+ + IVHRDLK NILL
Sbjct: 103 YTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLE 155
Query: 125 --DYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVL 182
+ + + KI DFG++ F ++ +GT Y+ PE V +G Y K DV+S GV+
Sbjct: 156 SKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVI 211
Query: 183 LLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDD-SSSAWKLMRCMQVA 241
L +L G +YG NE ++L+ + G+ F S A L+R M
Sbjct: 212 LYILLSGTPP--FYGKNEY-DILKRV----ETGK-YAFDLPQWRTISDDAKDLIRKM--- 260
Query: 242 LLCVQENAADRPTMLEIL 259
L + + R T + L
Sbjct: 261 -LTF--HPSLRITATQCL 275
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 2e-16
Identities = 52/182 (28%), Positives = 79/182 (43%), Gaps = 21/182 (11%)
Query: 13 GQEMAVK-----RLSRTSHQG-LEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDY 66
G+E A K RLS + EE E EV + ++H N++ + I + + +LI +
Sbjct: 30 GKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILEL 89
Query: 67 MPNKSLDFYIFD-LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLD 125
+ L FD L + L ++ I G+ YL I H DLK NI+L
Sbjct: 90 VSGGEL----FDFLAEKESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLL 142
Query: 126 YEMNP----KISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGV 181
+ P K+ DFG+A N I GT +V PE V ++ D++S GV
Sbjct: 143 DKNVPNPRIKLIDFGIAHKIEAGNEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGV 199
Query: 182 LL 183
+
Sbjct: 200 IT 201
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 3e-16
Identities = 50/184 (27%), Positives = 87/184 (47%), Gaps = 18/184 (9%)
Query: 13 GQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNK 70
G E A K ++ S + ++ E E ++ +LQH N++ + + L++D +
Sbjct: 31 GLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG 90
Query: 71 SLDFYIFD--LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM 128
L F+ + R + + H I+ I + + Y IVHR+LK N+LL +
Sbjct: 91 EL----FEDIVAREFYSEADAS-HCIQQILESIAYCHS---NGIVHRNLKPENLLLASKA 142
Query: 129 NP---KISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQ 185
K++DFG+A D + GT GY+ PE ++K YS D+++ GV+L
Sbjct: 143 KGAAVKLADFGLAIEV-NDSEAWHG--FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYI 199
Query: 186 ILGG 189
+L G
Sbjct: 200 LLVG 203
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-16
Identities = 42/207 (20%), Positives = 70/207 (33%), Gaps = 49/207 (23%)
Query: 9 RLPNGQEMAVKRLSRT------SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKML 62
R+ + +A+K + + EV L ++ G+
Sbjct: 64 RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF--S--GVIR------- 112
Query: 63 IYDYMPNKSLDFYI-----------FD-LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNL 110
+ D+ F + FD + R L + + + +
Sbjct: 113 LLDWFERPD-SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG-- 169
Query: 111 TIVHRDLKASNILLDYE-MNPKISDFGMARAFTKDE-----CEANTGRIVGTYGYVPPEY 164
++HRD+K NIL+D K+ DFG A KD GT Y PPE+
Sbjct: 170 -VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD--------GTRVYSPPEW 219
Query: 165 VRKGIYS-MKYDVYSYGVLLLQILGGK 190
+R Y V+S G+LL ++ G
Sbjct: 220 IRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 76.6 bits (188), Expect = 5e-16
Identities = 31/245 (12%), Positives = 66/245 (26%), Gaps = 27/245 (11%)
Query: 12 NGQEMAVKRLSRTSHQGLEEFENEVKLTARLQ---HVNLLPVLGICTQREEKMLIYDYMP 68
N Q+ +K + EF +L RL+ + + +L+ +
Sbjct: 94 NKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYS 150
Query: 69 NKSLDFYIFDLRRRY--LLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY 126
+L I + ++ + + + + + I+H D+K N +L
Sbjct: 151 YGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGN 207
Query: 127 EMNP-----------KISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYD 175
+ D G + T G+ E + ++ + D
Sbjct: 208 GFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQID 267
Query: 176 VYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLD----DSSSA 231
+ + +L G L EF L+ +
Sbjct: 268 YFGVAATVYCMLFGTYMK-VKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPS 326
Query: 232 WKLMR 236
L+R
Sbjct: 327 LDLLR 331
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 7e-16
Identities = 50/178 (28%), Positives = 87/178 (48%), Gaps = 18/178 (10%)
Query: 13 GQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNK 70
G E A K ++ S + ++ E E ++ +LQH N++ + + L++D +
Sbjct: 54 GLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG 113
Query: 71 SLDFYIFD--LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM 128
L F+ + R + + H I+ I + + Y IVHR+LK N+LL +
Sbjct: 114 EL----FEDIVAREFYSEADAS-HCIQQILESIAYCHS---NGIVHRNLKPENLLLASKA 165
Query: 129 NP---KISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLL 183
K++DFG+A ++ EA G GT GY+ PE ++K YS D+++ GV+L
Sbjct: 166 KGAAVKLADFGLAIEV--NDSEAWHG-FAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 7e-16
Identities = 44/173 (25%), Positives = 81/173 (46%), Gaps = 10/173 (5%)
Query: 10 LPNGQEMAVKRLSRTSHQG-LEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMP 68
+ +A+K + + +E+ + E+ + ++ + G + + +I +Y+
Sbjct: 44 NRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 103
Query: 69 NKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM 128
S DL LD I+ I +GL YL +HRD+KA+N+LL
Sbjct: 104 GGSAL----DLLEPGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHG 156
Query: 129 NPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGV 181
K++DFG+A T + + NT VGT ++ PE +++ Y K D++S G+
Sbjct: 157 EVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQSAYDSKADIWSLGI 207
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-15
Identities = 50/182 (27%), Positives = 76/182 (41%), Gaps = 21/182 (11%)
Query: 13 GQEMAVKRL------SRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDY 66
G + A K + S E+ E EV + +QH N++ + + + + +LI +
Sbjct: 36 GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95
Query: 67 MPNKSLDFYIFD-LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLD 125
+ L FD L + L ++ I G+ YL L I H DLK NI+L
Sbjct: 96 VAGGEL----FDFLAEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLL 148
Query: 126 YEMNP----KISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGV 181
P KI DFG+A N I GT +V PE V ++ D++S GV
Sbjct: 149 DRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 182 LL 183
+
Sbjct: 206 IT 207
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-15
Identities = 66/294 (22%), Positives = 113/294 (38%), Gaps = 43/294 (14%)
Query: 13 GQEMAVKRLSRTSHQGLEE-FENEVKLTARLQHVNLLPVLGICTQREEKMLIY---DYMP 68
+ +AVK + E + E+ + L H N++ G R E + Y +Y
Sbjct: 32 EEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH---RREGNIQYLFLEYCS 88
Query: 69 NKSLDFYIFD--LRRRYLLDWRTRVH---IIEGITQGLLYLQEYS-NLTIVHRDLKASNI 122
L FD + + + ++ G+ Y + I HRD+K N+
Sbjct: 89 GGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV--------VYLHGIGITHRDIKPENL 136
Query: 123 LLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYS-MKYDVYSYGV 181
LLD N KISDFG+A F + E ++ GT YV PE +++ + DV+S G+
Sbjct: 137 LLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGI 196
Query: 182 LLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241
+L +L G P + + Y WK + +++ S+ L+ +
Sbjct: 197 VLTAMLAG------ELPWDQPSDSCQEYSDWKEKK--TYLNPWKKIDSAPLALLHKI--- 245
Query: 242 LLCVQENAADRPTMLEILV---MLKSETADIKTPKKPAFSVKRDNDEISECMLE 292
L N + R T+ +I K K P+ + V S+ +
Sbjct: 246 -LVE--NPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQS 296
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-15
Identities = 69/266 (25%), Positives = 118/266 (44%), Gaps = 43/266 (16%)
Query: 12 NGQEMAVKRLSR-------------TSHQGLEEFENEVKLTARLQHVNLLPVLGICTQRE 58
E A+K + + + EE NE+ L L H N++ + + ++
Sbjct: 60 GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKK 119
Query: 59 EKMLIYDYMPNKSLDFYIFD-LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDL 117
L+ ++ L F+ + R+ D +I++ I G+ YL + IVHRD+
Sbjct: 120 YFYLVTEFYEGGEL----FEQIINRHKFDECDAANIMKQILSGICYLHK---HNIVHRDI 172
Query: 118 KASNILL---DYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKY 174
K NILL + +N KI DFG++ F+KD +GT Y+ PE V K Y+ K
Sbjct: 173 KPENILLENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPE-VLKKKYNEKC 228
Query: 175 DVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDD-SSSAWK 233
DV+S GV++ +L G + G N+ ++++ + G+ F + + S A +
Sbjct: 229 DVWSCGVIMYILLCGYPP--FGGQNDQ-DIIKKV----EKGK-YYFDFNDWKNISDEAKE 280
Query: 234 LMRCMQVALLCVQENAADRPTMLEIL 259
L++ M L + R T E L
Sbjct: 281 LIKLM----LTY--DYNKRCTAEEAL 300
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-15
Identities = 53/258 (20%), Positives = 100/258 (38%), Gaps = 35/258 (13%)
Query: 13 GQEMAVKRLSRTSHQGLEEFENEVKLTARLQ-HVNLLPVLGICTQREEKMLIYDYMPNKS 71
Q AVK +S+ + E+ + H N++ + + + L+ + +
Sbjct: 36 NQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92
Query: 72 LDFYIFD--LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL---DY 126
L F+ ++++ + +I+ + + ++ + + +VHRDLK N+L +
Sbjct: 93 L----FERIKKKKHFSE-TEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDEND 144
Query: 127 EMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQI 186
+ KI DFG AR D T T Y PE + + Y D++S GV+L +
Sbjct: 145 NLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAPELLNQNGYDESCDLWSLGVILYTM 202
Query: 187 LGGKRTSCY---YGPNESLNLLEYAYGLWKNGEG-MEFIDSSLDD-SSSAWKLMRCMQVA 241
L G + SL + K +G F + + S A L++ +
Sbjct: 203 LSG-----QVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGL--- 254
Query: 242 LLCVQENAADRPTMLEIL 259
L V + R M +
Sbjct: 255 -LTV--DPNKRLKMSGLR 269
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-15
Identities = 50/177 (28%), Positives = 78/177 (44%), Gaps = 19/177 (10%)
Query: 13 GQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSL 72
E AVK + ++ EE E L QH N++ + + + ++ + M L
Sbjct: 47 NMEFAVKIIDKSKRDPTEEIE---ILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL 103
Query: 73 DFYIFD--LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL-DYEMN 129
D LR+++ + ++ IT+ + YL +VHRDLK SNIL D N
Sbjct: 104 ----LDKILRQKFFSEREAS-AVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGN 155
Query: 130 P---KISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLL 183
P +I DFG A+ + T T +V PE + + Y D++S GVLL
Sbjct: 156 PESIRICDFGFAKQLRAENGLLMT--PCYTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 2e-15
Identities = 47/182 (25%), Positives = 79/182 (43%), Gaps = 17/182 (9%)
Query: 13 GQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSL 72
G+ A+K + ++ ENE+ + +++H N++ + I L+ + L
Sbjct: 34 GKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGEL 93
Query: 73 DFYIFD--LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL---DYE 127
FD L R + + +I+ + + YL E IVHRDLK N+L +
Sbjct: 94 ----FDRILERGVYTE-KDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEEN 145
Query: 128 MNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQIL 187
I+DFG+++ GT GYV PE + + YS D +S GV+ +L
Sbjct: 146 SKIMITDFGLSKMEQ----NGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILL 201
Query: 188 GG 189
G
Sbjct: 202 CG 203
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-15
Identities = 47/178 (26%), Positives = 85/178 (47%), Gaps = 17/178 (9%)
Query: 13 GQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNK 70
GQE A ++ S + ++ E E ++ L+H N++ + ++ LI+D +
Sbjct: 36 GQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGG 95
Query: 71 SLDFYIFD--LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL---D 125
L F+ + R Y + H I+ I + +L+ + + +VHR+LK N+LL
Sbjct: 96 EL----FEDIVAREYYSE-ADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKL 147
Query: 126 YEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLL 183
K++DFG+A ++ GT GY+ PE +RK Y D+++ GV+L
Sbjct: 148 KGAAVKLADFGLAIEVEGEQQAWFG--FAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 2e-15
Identities = 39/190 (20%), Positives = 76/190 (40%), Gaps = 22/190 (11%)
Query: 4 AICQGRLPNGQEMAVKR--LSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKM 61
A P G+ + V+R L S++ + + E+ ++ H N++P E
Sbjct: 46 ARY---KPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102
Query: 62 LIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHI---IEGITQGLLYLQEYSNLTIVHRDLK 118
++ +M S DL + +D + I ++G+ + L Y+ VHR +K
Sbjct: 103 VVTSFMAYGSA----KDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVK 155
Query: 119 ASNILLDYEMNPKISDFGMARAFTKDECEANT-----GRIVGTYGYVPPEYVRKGI--YS 171
AS+IL+ + +S + V ++ PE +++ + Y
Sbjct: 156 ASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYD 215
Query: 172 MKYDVYSYGV 181
K D+YS G+
Sbjct: 216 AKSDIYSVGI 225
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-15
Identities = 44/206 (21%), Positives = 73/206 (35%), Gaps = 47/206 (22%)
Query: 9 RLPNGQEMAVKRLSRT------SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKML 62
RL + ++A+K + R EV L ++ P G+
Sbjct: 52 RLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP--GVIR------- 102
Query: 63 IYDYMPNKSLDFYI-----------FD-LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNL 110
+ D+ + F + FD + + L + + +
Sbjct: 103 LLDWFETQE-GFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG-- 159
Query: 111 TIVHRDLKASNILLDYEMNP-KISDFGMARAFTKDE-----CEANTGRIVGTYGYVPPEY 164
+VHRD+K NIL+D K+ DFG A DE GT Y PPE+
Sbjct: 160 -VVHRDIKDENILIDLRRGCAKLIDFGSG-ALLHDEPYTDFD--------GTRVYSPPEW 209
Query: 165 VRKGIYS-MKYDVYSYGVLLLQILGG 189
+ + Y + V+S G+LL ++ G
Sbjct: 210 ISRHQYHALPATVWSLGILLYDMVCG 235
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 3e-15
Identities = 41/148 (27%), Positives = 71/148 (47%), Gaps = 10/148 (6%)
Query: 54 CTQREEKM-LIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTI 112
Q +++ + +Y L F++ R R + R R + E I L YL +S +
Sbjct: 216 SFQTHDRLCFVMEYANGGELFFHLS--RERVFSEDRARFYGAE-IVSALDYL--HSEKNV 270
Query: 113 VHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSM 172
V+RDLK N++LD + + KI+DFG+ + KD T GT Y+ PE + Y
Sbjct: 271 VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPEVLEDNDYGR 328
Query: 173 KYDVYSYGVLLLQILGGKRTSCYYGPNE 200
D + GV++ +++ G+ +Y +
Sbjct: 329 AVDWWGLGVVMYEMMCGR--LPFYNQDH 354
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 4e-15
Identities = 53/195 (27%), Positives = 85/195 (43%), Gaps = 29/195 (14%)
Query: 13 GQEMAVKRLSRTSHQGL---------EEFENEVKLTARL-QHVNLLPVLGICTQREEKML 62
+E AVK + T E EV + ++ H N++ + L
Sbjct: 42 CKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 101
Query: 63 IYDYMPNKSLDFYIFD--LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKAS 120
++D M L FD + L + TR I+ + + + L + L IVHRDLK
Sbjct: 102 VFDLMKKGEL----FDYLTEKVTLSEKETR-KIMRALLEVICALHK---LNIVHRDLKPE 153
Query: 121 NILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGI------YSMKY 174
NILLD +MN K++DFG + E + + GT Y+ PE + + Y +
Sbjct: 154 NILLDDDMNIKLTDFGFSCQLDPGE-KLRE--VCGTPSYLAPEIIECSMNDNHPGYGKEV 210
Query: 175 DVYSYGVLLLQILGG 189
D++S GV++ +L G
Sbjct: 211 DMWSTGVIMYTLLAG 225
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 5e-15
Identities = 41/140 (29%), Positives = 67/140 (47%), Gaps = 13/140 (9%)
Query: 56 QREEKM-LIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVH 114
Q EE M ++ D + L +++ + + + ++ I E + L YLQ I+H
Sbjct: 85 QDEEDMFMVVDLLLGGDLRYHL--QQNVHFKEETVKLFICE-LVMALDYLQNQR---IIH 138
Query: 115 RDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGI---YS 171
RD+K NILLD + I+DF +A ++ + T + GT Y+ PE YS
Sbjct: 139 RDMKPDNILLDEHGHVHITDFNIAAMLPRET-QITT--MAGTKPYMAPEMFSSRKGAGYS 195
Query: 172 MKYDVYSYGVLLLQILGGKR 191
D +S GV ++L G+R
Sbjct: 196 FAVDWWSLGVTAYELLRGRR 215
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 6e-15
Identities = 49/201 (24%), Positives = 81/201 (40%), Gaps = 40/201 (19%)
Query: 11 PNGQEMAVKRLSRTS-HQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMP 68
P+GQ MAVKR+ T + ++ ++ + R ++ G + + + + M
Sbjct: 45 PSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS 104
Query: 69 NKSLDFYIFDLRRRYLLDWRTRV-------HIIEGITQGLLYLQEYSNLTIVHRDLKASN 121
FY +Y+ V I + L +L NL I+HRD+K SN
Sbjct: 105 TSFDKFY------KYVYSVLDDVIPEEILGKITLATVKALNHL--KENLKIIHRDIKPSN 156
Query: 122 ILLDYEMNPKISDFG--------MARAFTKDECEANTGRIVGTYGYVPPE----YVRKGI 169
ILLD N K+ DFG +A+ G Y+ PE +
Sbjct: 157 ILLDRSGNIKLCDFGISGQLVDSIAKTRD-----------AGCRPYMAPERIDPSASRQG 205
Query: 170 YSMKYDVYSYGVLLLQILGGK 190
Y ++ DV+S G+ L ++ G+
Sbjct: 206 YDVRSDVWSLGITLYELATGR 226
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 7e-15
Identities = 44/180 (24%), Positives = 75/180 (41%), Gaps = 19/180 (10%)
Query: 13 GQEMAVK--RLSRTSHQGLEEFENEVKLTARLQHV-NLLPVLGICTQREEKMLIYDYMPN 69
GQE A K + R E +E+ + + ++ + + E +LI +Y
Sbjct: 54 GQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAG 113
Query: 70 KSLDFYIFDL---RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL-- 124
+ F L ++ + +I+ I +G+ YL + IVH DLK NILL
Sbjct: 114 GEI----FSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSS 166
Query: 125 -DYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLL 183
+ KI DFGM+R I+GT Y+ PE + + D+++ G++
Sbjct: 167 IYPLGDIKIVDFGMSRKIGHACELRE---IMGTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 7e-15
Identities = 43/186 (23%), Positives = 85/186 (45%), Gaps = 11/186 (5%)
Query: 11 PNGQEMAVKRLSRTS-HQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMP 68
P+GQ MAVKR+ T Q + ++ ++ R + G + + + + M
Sbjct: 30 PSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD 89
Query: 69 NKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM 128
FY + + + I I + L +L +S L+++HRD+K SN+L++
Sbjct: 90 TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL--HSKLSVIHRDVKPSNVLINALG 147
Query: 129 NPKISDFGMARAFTKDECEANTGRIVGTYGYVPPE----YVRKGIYSMKYDVYSYGVLLL 184
K+ DFG++ D+ + G Y+ PE + + YS+K D++S G+ ++
Sbjct: 148 QVKMCDFGISGYLV-DDVAKDI--DAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMI 204
Query: 185 QILGGK 190
++ +
Sbjct: 205 ELAILR 210
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 8e-15
Identities = 38/148 (25%), Positives = 68/148 (45%), Gaps = 11/148 (7%)
Query: 54 CTQREEKM-LIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTI 112
Q +++ + +Y L F++ R R + R R + E I L YL +
Sbjct: 73 AFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSALEYLHS---RDV 126
Query: 113 VHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSM 172
V+RD+K N++LD + + KI+DFG+ + D T GT Y+ PE + Y
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEVLEDNDYGR 184
Query: 173 KYDVYSYGVLLLQILGGKRTSCYYGPNE 200
D + GV++ +++ G+ +Y +
Sbjct: 185 AVDWWGLGVVMYEMMCGR--LPFYNQDH 210
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 9e-15
Identities = 65/256 (25%), Positives = 108/256 (42%), Gaps = 41/256 (16%)
Query: 13 GQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNK 70
G+E+A+K + +T + L++ EV++ L H N++ + + + LI +Y
Sbjct: 40 GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGG 99
Query: 71 SLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNP 130
+ Y+ + + + R I + Y + IVHRDLKA N+LLD +MN
Sbjct: 100 EVFDYL--VAHGRMKEKEAR-SKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNI 153
Query: 131 KISDFGMARAFTKDE-----CEANTGRIVGTYGYVPPEYVRKGIYS-MKYDVYSYGVLLL 184
KI+DFG + FT C G Y PE + Y + DV+S GV+L
Sbjct: 154 KIADFGFSNEFTVGGKLDAFC--------GAPPYAAPELFQGKKYDGPEVDVWSLGVILY 205
Query: 185 QILGGKRTSCYYGPNESLNLLEYAYGLWKN-GEGMEFIDSSLDDSSSAWKLMRCMQVALL 243
++ P + NL E L + G I + S+ L++ L
Sbjct: 206 TLV------SGSLPFDGQNLKE----LRERVLRGKYRIPFYM--STDCENLLKRF----L 249
Query: 244 CVQENAADRPTMLEIL 259
+ N R T+ +I+
Sbjct: 250 VL--NPIKRGTLEQIM 263
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 1e-14
Identities = 61/258 (23%), Positives = 104/258 (40%), Gaps = 40/258 (15%)
Query: 13 GQEMAVKRLSRTSHQGLEE-FENEVKLTARLQHVNLLPVLGICTQREEKMLIY---DYMP 68
+ +AVK + E + E+ + L H N++ G R E + Y +Y
Sbjct: 32 EEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH---RREGNIQYLFLEYCS 88
Query: 69 NKSLDFYIFD--LRRRYLLDWRTRVH---IIEGITQGLLYLQEYS-NLTIVHRDLKASNI 122
L FD + + + ++ G+ Y + I HRD+K N+
Sbjct: 89 GGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV--------VYLHGIGITHRDIKPENL 136
Query: 123 LLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYS-MKYDVYSYGV 181
LLD N KISDFG+A F + E ++ GT YV PE +++ + DV+S G+
Sbjct: 137 LLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGI 196
Query: 182 LLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241
+L +L G P + + Y WK + +++ S+ L+ +
Sbjct: 197 VLTAMLAG------ELPWDQPSDSCQEYSDWKEKK--TYLNPWKKIDSAPLALLHKI--- 245
Query: 242 LLCVQENAADRPTMLEIL 259
L N + R T+ +I
Sbjct: 246 -LVE--NPSARITIPDIK 260
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-14
Identities = 42/207 (20%), Positives = 75/207 (36%), Gaps = 51/207 (24%)
Query: 9 RLPNGQEMAVKRLSRT--------SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEK 60
+E+ VK + + L + E+ + +R++H N I
Sbjct: 45 DKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHAN------IIK----- 93
Query: 61 MLIYDYMPNKSLDFYI-----------FD-LRRRYLLDWRTRVHIIEGITQGLLYLQEYS 108
+ D N+ F + F + R LD +I + + YL+
Sbjct: 94 --VLDIFENQG-FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD 150
Query: 109 NLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDE-----CEANTGRIVGTYGYVPPE 163
I+HRD+K NI++ + K+ DFG A + + C GT Y PE
Sbjct: 151 ---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC--------GTIEYCAPE 199
Query: 164 YVRKGIYS-MKYDVYSYGVLLLQILGG 189
+ Y + +++S GV L ++
Sbjct: 200 VLMGNPYRGPELEMWSLGVTLYTLVFE 226
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-14
Identities = 49/188 (26%), Positives = 80/188 (42%), Gaps = 28/188 (14%)
Query: 13 GQEMAVKRLSRTS--------HQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLI 63
G E AVK + T+ + E E + ++ H +++ ++ L+
Sbjct: 119 GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178
Query: 64 YDYMPNKSLDFYIFD--LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASN 121
+D M L FD + L + TR I+ + + + +L IVHRDLK N
Sbjct: 179 FDLMRKGEL----FDYLTEKVALSEKETR-SIMRSLLEAVSFLHA---NNIVHRDLKPEN 230
Query: 122 ILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPE------YVRKGIYSMKYD 175
ILLD M ++SDFG + E + + GT GY+ PE Y + D
Sbjct: 231 ILLDDNMQIRLSDFGFSCHLEPGE-KLRE--LCGTPGYLAPEILKCSMDETHPGYGKEVD 287
Query: 176 VYSYGVLL 183
+++ GV+L
Sbjct: 288 LWACGVIL 295
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-14
Identities = 44/172 (25%), Positives = 84/172 (48%), Gaps = 13/172 (7%)
Query: 12 NGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKS 71
GQ +A+K++ L+E E+ + + +++ G + + ++ +Y S
Sbjct: 53 TGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGS 110
Query: 72 LDFYIFDL--RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMN 129
+ D+ R L I++ +GL YL +HRD+KA NILL+ E +
Sbjct: 111 VS----DIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGH 163
Query: 130 PKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGV 181
K++DFG+A T + NT ++GT ++ PE +++ Y+ D++S G+
Sbjct: 164 AKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVIQEIGYNCVADIWSLGI 213
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-14
Identities = 58/276 (21%), Positives = 101/276 (36%), Gaps = 46/276 (16%)
Query: 12 NGQEMAVKRLSRTSHQGLEEFENEVKLTARLQ-HVNLLPVLGICTQREEKMLIYDYMPNK 70
QE AVK + + EV++ + Q H N+L ++ + + L+++ M
Sbjct: 37 TSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGG 96
Query: 71 SLDFYIFD-LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMN 129
S+ + +R + +++ + L +L N I HRDLK NIL ++
Sbjct: 97 SI----LSHIHKRRHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQ 149
Query: 130 P---KISDFGMARAFTKDECEANTGR-----IVGTYGYVPPEYVRKG-----IYSMKYDV 176
KI DF + + + G+ Y+ PE V IY + D+
Sbjct: 150 VSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDL 209
Query: 177 YSYGVLLLQILGGKRTSCY---YGPNESLNLLEYAYGLWKNGEGM---------EFIDSS 224
+S GV+L +L G Y G S + + EF D
Sbjct: 210 WSLGVILYILLSG-----YPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKD 264
Query: 225 LDD-SSSAWKLMRCMQVALLCVQENAADRPTMLEIL 259
S +A L+ + L +A R + ++L
Sbjct: 265 WAHISCAAKDLISKL----LVR--DAKQRLSAAQVL 294
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-14
Identities = 58/267 (21%), Positives = 105/267 (39%), Gaps = 48/267 (17%)
Query: 13 GQEMAVKRLSR--------TSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIY 64
+++A++ +S+ E E+++ +L H ++ + E+ ++
Sbjct: 160 CKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVL 218
Query: 65 DYMPNKSLDFYIFD--LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNI 122
+ M L FD + + L + + + + YL E I+HRDLK N+
Sbjct: 219 ELMEGGEL----FDKVVGNKRLKEATCK-LYFYQMLLAVQYLHE---NGIIHRDLKPENV 270
Query: 123 LL---DYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPE---YVRKGIYSMKYDV 176
LL + + KI+DFG ++ + T + GT Y+ PE V Y+ D
Sbjct: 271 LLSSQEEDCLIKITDFGHSK-ILGETSLMRT--LCGTPTYLAPEVLVSVGTAGYNRAVDC 327
Query: 177 YSYGVLLLQILGGKRTSCY---YGPNESLNLLEYAYGLWKNGEGMEFIDSSLDD-SSSAW 232
+S GV+L L G Y ++L + +G+ FI + S A
Sbjct: 328 WSLGVILFICLSG-----YPPFSEHRTQVSLKD----QITSGK-YNFIPEVWAEVSEKAL 377
Query: 233 KLMRCMQVALLCVQENAADRPTMLEIL 259
L++ + L V + R T E L
Sbjct: 378 DLVKKL----LVV--DPKARFTTEEAL 398
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-14
Identities = 43/138 (31%), Positives = 73/138 (52%), Gaps = 9/138 (6%)
Query: 54 CTQREEKM-LIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTI 112
C Q E ++ + +Y+ L F++ R+R L + R + E I+ L YL E I
Sbjct: 78 CFQTESRLFFVIEYVNGGDLMFHMQ--RQRKLPEEHARFYSAE-ISLALNYLHE---RGI 131
Query: 113 VHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSM 172
++RDLK N+LLD E + K++D+GM + + +T GT Y+ PE +R Y
Sbjct: 132 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYIAPEILRGEDYGF 189
Query: 173 KYDVYSYGVLLLQILGGK 190
D ++ GVL+ +++ G+
Sbjct: 190 SVDWWALGVLMFEMMAGR 207
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 71.4 bits (176), Expect = 2e-14
Identities = 36/137 (26%), Positives = 62/137 (45%), Gaps = 23/137 (16%)
Query: 35 EVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHII 94
E+ L L H N++ +L + + L+++++ DL++ +D I
Sbjct: 52 EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ--------DLKK--FMDASALTGIP 101
Query: 95 EG--------ITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDEC 146
+ QGL + + ++HRDLK N+L++ E K++DFG+ARAF
Sbjct: 102 LPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPV 157
Query: 147 EANTGRIVGTYGYVPPE 163
T +V T Y PE
Sbjct: 158 RTYTHEVV-TLWYRAPE 173
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 2e-14
Identities = 42/148 (28%), Positives = 74/148 (50%), Gaps = 11/148 (7%)
Query: 54 CTQREEKM-LIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTI 112
Q E K+ LI D++ L + + + + ++ E + L +L L I
Sbjct: 94 AFQTEGKLYLILDFLRGGDLFTRLS--KEVMFTEEDVKFYLAE-LALALDHLHS---LGI 147
Query: 113 VHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSM 172
++RDLK NILLD E + K++DFG+++ E +A + GT Y+ PE V + ++
Sbjct: 148 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVVNRRGHTQ 205
Query: 173 KYDVYSYGVLLLQILGGKRTSCYYGPNE 200
D +S+GVL+ ++L G + G +
Sbjct: 206 SADWWSFGVLMFEMLTGT--LPFQGKDR 231
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 72.4 bits (177), Expect = 2e-14
Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 11/148 (7%)
Query: 54 CTQREEKM-LIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTI 112
C Q +++ + +Y+ L ++I + + + E I GL +LQ I
Sbjct: 410 CFQTMDRLYFVMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAE-IAIGLFFLQS---KGI 463
Query: 113 VHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSM 172
++RDLK N++LD E + KI+DFGM + D T GT Y+ PE + Y
Sbjct: 464 IYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDYIAPEIIAYQPYGK 521
Query: 173 KYDVYSYGVLLLQILGGKRTSCYYGPNE 200
D +++GVLL ++L G+ + + G +E
Sbjct: 522 SVDWWAFGVLLYEMLAGQ--APFEGEDE 547
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 3e-14
Identities = 52/213 (24%), Positives = 75/213 (35%), Gaps = 61/213 (28%)
Query: 10 LPNGQEMAVKRLSRTSHQGLEEFEN----EVKLTARLQH---VNLLPVLGICTQREEKML 62
AVK L + + + E E++L RL+H + L+ VL EEK
Sbjct: 27 SETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVL----YNEEKQK 82
Query: 63 IY--------------DYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYS 108
+Y D +P K Y +I+G+ EY
Sbjct: 83 MYMVMEYCVCGMQEMLDSVPEKRFPV---CQAHGYF------CQLIDGL--------EYL 125
Query: 109 -NLTIVHRDLKASNILLDYEMNPKISDFGMA---RAFTKDE-----CEANTGRIVGTYGY 159
+ IVH+D+K N+LL KIS G+A F D+ G+ +
Sbjct: 126 HSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ--------GSPAF 177
Query: 160 VPPEYVR--KGIYSMKYDVYSYGVLLLQILGGK 190
PPE K D++S GV L I G
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 3e-14
Identities = 49/196 (25%), Positives = 83/196 (42%), Gaps = 35/196 (17%)
Query: 10 LPNGQEMAVKRLSRT---SHQGLEEFENEVKLTARLQH---VNLLPVLGICTQREEKMLI 63
G ++AVK L+R S + + + E++ +H + L V+
Sbjct: 33 QLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI------STPTDF 86
Query: 64 Y---DYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKAS 120
+ +Y+ L YI R ++ + + I + Y +VHRDLK
Sbjct: 87 FMVMEYVSGGELFDYICKHGR---VEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPE 140
Query: 121 NILLDYEMNPKISDFGMARAFTKDE-----CEANTGRIVGTYGYVPPEYVRKGIYS-MKY 174
N+LLD MN KI+DFG++ + E C G+ Y PE + +Y+ +
Sbjct: 141 NVLLDAHMNAKIADFGLSNMMSDGEFLRTSC--------GSPNYAAPEVISGRLYAGPEV 192
Query: 175 DVYSYGVLLLQILGGK 190
D++S GV+L +L G
Sbjct: 193 DIWSCGVILYALLCGT 208
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-14
Identities = 43/138 (31%), Positives = 73/138 (52%), Gaps = 9/138 (6%)
Query: 54 CTQREEKM-LIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTI 112
C Q E ++ + +Y+ L F++ R+R L + R + E I+ L YL E I
Sbjct: 121 CFQTESRLFFVIEYVNGGDLMFHMQ--RQRKLPEEHARFYSAE-ISLALNYLHE---RGI 174
Query: 113 VHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSM 172
++RDLK N+LLD E + K++D+GM + + +T GT Y+ PE +R Y
Sbjct: 175 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYIAPEILRGEDYGF 232
Query: 173 KYDVYSYGVLLLQILGGK 190
D ++ GVL+ +++ G+
Sbjct: 233 SVDWWALGVLMFEMMAGR 250
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 71.0 bits (175), Expect = 3e-14
Identities = 38/148 (25%), Positives = 70/148 (47%), Gaps = 11/148 (7%)
Query: 54 CTQREEKM-LIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTI 112
Q K+ LI +Y+ L + R ++ ++ E I+ L +L + I
Sbjct: 89 AFQTGGKLYLILEYLSGGELFMQLE--REGIFMEDTACFYLAE-ISMALGHLHQ---KGI 142
Query: 113 VHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSM 172
++RDLK NI+L+++ + K++DFG+ + D +T GT Y+ PE + + ++
Sbjct: 143 IYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEYMAPEILMRSGHNR 200
Query: 173 KYDVYSYGVLLLQILGGKRTSCYYGPNE 200
D +S G L+ +L G + G N
Sbjct: 201 AVDWWSLGALMYDMLTGA--PPFTGENR 226
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 4e-14
Identities = 45/148 (30%), Positives = 70/148 (47%), Gaps = 11/148 (7%)
Query: 54 CTQREEKM-LIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTI 112
Q +K+ + DY+ L +++ R R L+ R R + E I L YL L I
Sbjct: 107 SFQTADKLYFVLDYINGGELFYHL--QRERCFLEPRARFYAAE-IASALGYLHS---LNI 160
Query: 113 VHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSM 172
V+RDLK NILLD + + ++DFG+ + + +T GT Y+ PE + K Y
Sbjct: 161 VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST--FCGTPEYLAPEVLHKQPYDR 218
Query: 173 KYDVYSYGVLLLQILGGKRTSCYYGPNE 200
D + G +L ++L G +Y N
Sbjct: 219 TVDWWCLGAVLYEMLYGL--PPFYSRNT 244
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 4e-14
Identities = 43/148 (29%), Positives = 77/148 (52%), Gaps = 11/148 (7%)
Query: 54 CTQREEKM-LIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTI 112
C Q +++ + +++ L F+I + R + R R + E I L++L + I
Sbjct: 92 CFQTPDRLFFVMEFVNGGDLMFHIQ--KSRRFDEARARFYAAE-IISALMFLHD---KGI 145
Query: 113 VHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSM 172
++RDLK N+LLD+E + K++DFGM + + T GT Y+ PE +++ +Y
Sbjct: 146 IYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT--FCGTPDYIAPEILQEMLYGP 203
Query: 173 KYDVYSYGVLLLQILGGKRTSCYYGPNE 200
D ++ GVLL ++L G + + NE
Sbjct: 204 AVDWWAMGVLLYEMLCGH--APFEAENE 229
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 5e-14
Identities = 38/141 (26%), Positives = 64/141 (45%), Gaps = 27/141 (19%)
Query: 35 EVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHII 94
E+ L L+H N++ + + + L++++M N DL++ +D RT +
Sbjct: 53 EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN--------DLKK--YMDSRTVGNTP 102
Query: 95 EGIT------------QGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFT 142
G+ QGL + E I+HRDLK N+L++ K+ DFG+ARAF
Sbjct: 103 RGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159
Query: 143 KDECEANTGRIVGTYGYVPPE 163
+ +V T Y P+
Sbjct: 160 -IPVNTFSSEVV-TLWYRAPD 178
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 5e-14
Identities = 26/75 (34%), Positives = 44/75 (58%), Gaps = 5/75 (6%)
Query: 112 IVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVR--KGI 169
I+HRD+K SN+L+ + + KI+DFG++ F + + VGT ++ PE + + I
Sbjct: 158 IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSN--TVGTPAFMAPESLSETRKI 215
Query: 170 YS-MKYDVYSYGVLL 183
+S DV++ GV L
Sbjct: 216 FSGKALDVWAMGVTL 230
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 7e-14
Identities = 47/148 (31%), Positives = 74/148 (50%), Gaps = 11/148 (7%)
Query: 54 CTQREEKM-LIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTI 112
Q +E + + +Y+ L ++I R + E I GL +L I
Sbjct: 86 TFQTKENLFFVMEYLNGGDLMYHIQ--SCHKFDLSRATFYAAE-IILGLQFLHS---KGI 139
Query: 113 VHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSM 172
V+RDLK NILLD + + KI+DFGM + + + NT GT Y+ PE + Y+
Sbjct: 140 VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPEILLGQKYNH 197
Query: 173 KYDVYSYGVLLLQILGGKRTSCYYGPNE 200
D +S+GVLL ++L G+ S ++G +E
Sbjct: 198 SVDWWSFGVLLYEMLIGQ--SPFHGQDE 223
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 7e-14
Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 11/148 (7%)
Query: 54 CTQREEKM-LIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTI 112
C Q +++ + +Y+ L ++I + + + E I GL +LQ I
Sbjct: 89 CFQTMDRLYFVMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAE-IAIGLFFLQS---KGI 142
Query: 113 VHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSM 172
++RDLK N++LD E + KI+DFGM + D T GT Y+ PE + Y
Sbjct: 143 IYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDYIAPEIIAYQPYGK 200
Query: 173 KYDVYSYGVLLLQILGGKRTSCYYGPNE 200
D +++GVLL ++L G+ + + G +E
Sbjct: 201 SVDWWAFGVLLYEMLAGQ--APFEGEDE 226
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 7e-14
Identities = 33/137 (24%), Positives = 66/137 (48%), Gaps = 24/137 (17%)
Query: 35 EVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHII 94
E+ L L H N++ ++ + L++++M DL++ +LD + +
Sbjct: 69 EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK--------DLKK--VLD-ENKTGLQ 117
Query: 95 EG--------ITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDEC 146
+ + +G+ + ++ I+HRDLK N+L++ + K++DFG+ARAF
Sbjct: 118 DSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFG-IPV 173
Query: 147 EANTGRIVGTYGYVPPE 163
+ T +V T Y P+
Sbjct: 174 RSYTHEVV-TLWYRAPD 189
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 1e-13
Identities = 40/137 (29%), Positives = 64/137 (46%), Gaps = 24/137 (17%)
Query: 35 EVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHII 94
E+KL L H N++ +L + L++D+M DL ++ + +
Sbjct: 62 EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET--------DLEV--IIK-DNSLVLT 110
Query: 95 EG--------ITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDEC 146
QGL YL ++ I+HRDLK +N+LLD K++DFG+A++F
Sbjct: 111 PSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPN 166
Query: 147 EANTGRIVGTYGYVPPE 163
A T ++V T Y PE
Sbjct: 167 RAYTHQVV-TRWYRAPE 182
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-13
Identities = 47/282 (16%), Positives = 93/282 (32%), Gaps = 66/282 (23%)
Query: 9 RLPNGQEMAVKR--LSRTSHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIY- 64
+ +G A+KR + EV A L QH +++ ++ MLI
Sbjct: 32 KRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFS-AWAEDDHMLIQN 90
Query: 65 DYMPNKSLDFYIFDLRRRY-LLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNIL 123
+Y SL I + R ++ + +GL Y+ S +VH D+K SNI
Sbjct: 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIF 147
Query: 124 LDYEMNP-------------------KISDFGMARAFTKDECEANTGRIVGTYGYVPPEY 164
+ P KI D G + G ++ E
Sbjct: 148 ISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS----PQV--EEGDSRFLANEV 201
Query: 165 VRKGI-YSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDS 223
+++ + K D+++ + ++ G + L +NG+ I
Sbjct: 202 LQENYTHLPKADIFALALTVVCAAGAEP-------------------LPRNGDQWHEIRQ 242
Query: 224 S----LDD--SSSAWKLMRCMQVALLCVQENAADRPTMLEIL 259
+ S +L++ + + + RP+ + ++
Sbjct: 243 GRLPRIPQVLSQEFTELLK------VMIHPDPERRPSAMALV 278
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-13
Identities = 31/85 (36%), Positives = 46/85 (54%), Gaps = 14/85 (16%)
Query: 112 IVHRDLKASNILLDYEMNPKISDFGMARAFTKDE-----CEANTGRIVGTYGYVPPEYVR 166
IVHRDLK N+LLD +N KI+DFG++ T C G+ Y PE +
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC--------GSPNYAAPEVIN 180
Query: 167 KGIYS-MKYDVYSYGVLLLQILGGK 190
+Y+ + DV+S G++L +L G+
Sbjct: 181 GKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-13
Identities = 46/178 (25%), Positives = 79/178 (44%), Gaps = 18/178 (10%)
Query: 11 PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNK 70
+ A+K L +T + + E+ + RL H N++ + I E L+ + +
Sbjct: 76 GTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGG 133
Query: 71 SLDFYIFD--LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL---D 125
L FD + + Y + R ++ I + + YL E IVHRDLK N+L
Sbjct: 134 EL----FDRIVEKGYYSE-RDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPA 185
Query: 126 YEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLL 183
+ KI+DFG+++ + GT GY PE +R Y + D++S G++
Sbjct: 186 PDAPLKIADFGLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-13
Identities = 31/104 (29%), Positives = 51/104 (49%), Gaps = 10/104 (9%)
Query: 92 HIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTG 151
+ I + L YL ++HRD+K SNILLD K+ DFG++ D+ + +
Sbjct: 128 KMTVAIVKALYYL--KEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS- 184
Query: 152 RIVGTYGYVPPE-----YVRKGIYSMKYDVYSYGVLLLQILGGK 190
G Y+ PE K Y ++ DV+S G+ L+++ G+
Sbjct: 185 --AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 2e-13
Identities = 30/137 (21%), Positives = 61/137 (44%), Gaps = 24/137 (17%)
Query: 35 EVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHII 94
E+ L L+H N++ + + ++ L++++ DL++ D +
Sbjct: 51 EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ--------DLKK--YFD-SCNGDLD 99
Query: 95 EG--------ITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDEC 146
+ +GL + + ++HRDLK N+L++ K+++FG+ARAF
Sbjct: 100 PEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFG-IPV 155
Query: 147 EANTGRIVGTYGYVPPE 163
+ +V T Y PP+
Sbjct: 156 RCYSAEVV-TLWYRPPD 171
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-13
Identities = 41/148 (27%), Positives = 66/148 (44%), Gaps = 34/148 (22%)
Query: 35 EVKLTARLQHVNLLPVLGICTQREEKM--------LIYDYMPNKSLDFYIFDLRRRYLLD 86
E+K+ L+H N++ ++ IC + L++D+ + DL LL
Sbjct: 66 EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH--------DLAG--LLS 115
Query: 87 WRTRVHIIEG--------ITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMA 138
V + GL Y+ I+HRD+KA+N+L+ + K++DFG+A
Sbjct: 116 -NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA 171
Query: 139 RAF---TKDECEANTGRIVGTYGYVPPE 163
RAF + T R+V T Y PPE
Sbjct: 172 RAFSLAKNSQPNRYTNRVV-TLWYRPPE 198
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-13
Identities = 43/176 (24%), Positives = 86/176 (48%), Gaps = 14/176 (7%)
Query: 12 NGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKM-LIYDYMPNK 70
G A K + S + LE++ E+++ A H ++ +LG + K+ ++ ++ P
Sbjct: 43 TGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLG-AYYHDGKLWIMIEFCPGG 101
Query: 71 SLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNP 130
++D + +L R L + + + L +L I+HRDLKA N+L+ E +
Sbjct: 102 AVDAIMLELDRG--LTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDI 156
Query: 131 KISDFGMARAFTKDECEANTGRIVGTYGYVPPEYV-----RKGIYSMKYDVYSYGV 181
+++DFG++ K + ++ +GT ++ PE V + Y K D++S G+
Sbjct: 157 RLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGI 210
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 3e-13
Identities = 31/85 (36%), Positives = 46/85 (54%), Gaps = 14/85 (16%)
Query: 112 IVHRDLKASNILLDYEMNPKISDFGMARAFTKDE-----CEANTGRIVGTYGYVPPEYVR 166
+VHRDLK N+LLD MN KI+DFG++ + E C G+ Y PE +
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC--------GSPNYAAPEVIS 188
Query: 167 KGIYS-MKYDVYSYGVLLLQILGGK 190
+Y+ + D++S GV+L +L G
Sbjct: 189 GRLYAGPEVDIWSSGVILYALLCGT 213
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 67.5 bits (166), Expect = 4e-13
Identities = 35/137 (25%), Positives = 64/137 (46%), Gaps = 24/137 (17%)
Query: 35 EVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHII 94
E+ + L+H N++ + + ++ +L+++++ DL++ LLD +
Sbjct: 50 EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ--------DLKK--LLD-VCEGGLE 98
Query: 95 EG--------ITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDEC 146
+ G+ Y + ++HRDLK N+L++ E KI+DFG+ARAF
Sbjct: 99 SVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFG-IPV 154
Query: 147 EANTGRIVGTYGYVPPE 163
T IV T Y P+
Sbjct: 155 RKYTHEIV-TLWYRAPD 170
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 4e-13
Identities = 36/137 (26%), Positives = 61/137 (44%), Gaps = 24/137 (17%)
Query: 35 EVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHII 94
EV L L+H N++ + I + L+++Y+ DL++ LD I
Sbjct: 50 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK--------DLKQ--YLD-DCGNIIN 98
Query: 95 EG--------ITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDEC 146
+ +GL Y ++HRDLK N+L++ K++DFG+ARA +
Sbjct: 99 MHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKS-IPT 154
Query: 147 EANTGRIVGTYGYVPPE 163
+ +V T Y PP+
Sbjct: 155 KTYDNEVV-TLWYRPPD 170
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 5e-13
Identities = 45/193 (23%), Positives = 81/193 (41%), Gaps = 28/193 (14%)
Query: 13 GQEMAVKRLSR--------TSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIY 64
+++A+K +S+ E E+++ +L H ++ + E+ ++
Sbjct: 35 CKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVL 93
Query: 65 DYMPNKSLDFYIFD--LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNI 122
+ M L FD + + L + + + + YL E I+HRDLK N+
Sbjct: 94 ELMEGGEL----FDKVVGNKRLKEATCK-LYFYQMLLAVQYLHE---NGIIHRDLKPENV 145
Query: 123 LL---DYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPE---YVRKGIYSMKYDV 176
LL + + KI+DFG ++ + T + GT Y+ PE V Y+ D
Sbjct: 146 LLSSQEEDCLIKITDFGHSK-ILGETSLMRT--LCGTPTYLAPEVLVSVGTAGYNRAVDC 202
Query: 177 YSYGVLLLQILGG 189
+S GV+L L G
Sbjct: 203 WSLGVILFICLSG 215
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 8e-13
Identities = 60/296 (20%), Positives = 124/296 (41%), Gaps = 44/296 (14%)
Query: 4 AICQGRLPNGQEMAVKRLS-RTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKML 62
A C P +++A+KR++ ++E E++ ++ H N++ ++E L
Sbjct: 34 AYC---APKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90
Query: 63 IYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIE---------GITQGLLYLQEYSNLTIV 113
+ + S+ D+ + + + +++ + +GL YL + +
Sbjct: 91 VMKLLSGGSV----LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QI 143
Query: 114 HRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGR---IVGTYGYVPPEYVRKGI- 169
HRD+KA NILL + + +I+DFG++ VGT ++ PE + +
Sbjct: 144 HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRG 203
Query: 170 YSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNG----EGMEFIDSSL 225
Y K D++S+G+ +++ G Y P + L L +N E L
Sbjct: 204 YDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL------QNDPPSLETGVQDKEML 257
Query: 226 DDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETADIKTPKKPAFSVKR 281
+++ M ++ LC+Q++ RPT E +L+ + + K F ++
Sbjct: 258 KKYGKSFRKM----IS-LCLQKDPEKRPTAAE---LLRHKF--FQKAKNKEFLQEK 303
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-12
Identities = 41/140 (29%), Positives = 59/140 (42%), Gaps = 26/140 (18%)
Query: 35 EVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHII 94
EV L LQH N++ + + LI++Y N DL++ +D V +
Sbjct: 83 EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN--------DLKK--YMDKNPDVSMR 132
Query: 95 EG------ITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNP-----KISDFGMARAFTK 143
+ G+ + +S +HRDLK N+LL KI DFG+ARAF
Sbjct: 133 VIKSFLYQLINGVNFC--HSR-RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG- 188
Query: 144 DECEANTGRIVGTYGYVPPE 163
T I+ T Y PPE
Sbjct: 189 IPIRQFTHEII-TLWYRPPE 207
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-12
Identities = 37/140 (26%), Positives = 63/140 (45%), Gaps = 12/140 (8%)
Query: 56 QREEKM-LIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVH 114
Q + + L+ DY L + R + R ++ E + + + L VH
Sbjct: 144 QDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEE-MARFYLAE-MVIAIDSVH---QLHYVH 198
Query: 115 RDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVR-----KGI 169
RD+K NIL+D + +++DFG +D + VGT Y+ PE ++ KG
Sbjct: 199 RDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAVGTPDYISPEILQAMEGGKGR 257
Query: 170 YSMKYDVYSYGVLLLQILGG 189
Y + D +S GV + ++L G
Sbjct: 258 YGPECDWWSLGVCMYEMLYG 277
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-12
Identities = 38/175 (21%), Positives = 69/175 (39%), Gaps = 27/175 (15%)
Query: 92 HIIEGITQGLLYLQEYSNLTIVHRDLKASNILL---DYEMNPKISDFGMARAFTKDECEA 148
I+ I + +L I HRD+K N+L + + K++DFG A+ +
Sbjct: 132 EIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNAL 186
Query: 149 NTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCY---YGPNESLNLL 205
T T YV PE + Y D++S GV++ +L G + Y +
Sbjct: 187 QT--PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG-----FPPFYSNTGQ-AIS 238
Query: 206 EYAYGLWKNGEGMEFIDSSLDD-SSSAWKLMRCMQVALLCVQENAADRPTMLEIL 259
+ G+ F + + S A +L+R + L + +R T+ + +
Sbjct: 239 PGMKRRIRLGQ-YGFPNPEWSEVSEDAKQLIRLL----LKT--DPTERLTITQFM 286
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 28/95 (29%), Positives = 43/95 (45%), Gaps = 9/95 (9%)
Query: 92 HIIEGITQGLLYLQEYSNLTIVHRDLKASNILL---DYEMNPKISDFGMARAFTKDECEA 148
I++ I + + YL + I HRD+K N+L K++DFG A+ T
Sbjct: 165 EIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SL 220
Query: 149 NTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLL 183
T T YV PE + Y D++S GV++
Sbjct: 221 TT--PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 43/202 (21%), Positives = 85/202 (42%), Gaps = 36/202 (17%)
Query: 6 CQGRLPNGQEMAVKRLSRTSHQGLEEFEN-EVKLTARLQHVNLLPVLGICTQREEKM--- 61
Q +L E+A+K++ + + F+N E+++ ++H N++ + +K
Sbjct: 57 FQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111
Query: 62 ---LIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEG--------ITQGLLYLQEYSNL 110
L+ +Y+P + R + + + + + L Y+ ++
Sbjct: 112 FLNLVLEYVPE--------TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SI 160
Query: 111 TIVHRDLKASNILLDYEMNP-KISDFGMARAFTKDECEANTGRIVGTYGYVPPE-YVRKG 168
I HRD+K N+LLD K+ DFG A+ E N I Y Y PE
Sbjct: 161 GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG--EPNVSYICSRY-YRAPELIFGAT 217
Query: 169 IYSMKYDVYSYGVLLLQILGGK 190
Y+ D++S G ++ +++ G+
Sbjct: 218 NYTTNIDIWSTGCVMAELMQGQ 239
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 46/156 (29%), Positives = 76/156 (48%), Gaps = 16/156 (10%)
Query: 56 QREEKM-LIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVH 114
Q E K+ LI DY+ L ++ +R + ++++ E I L +L + L I++
Sbjct: 129 QTETKLHLILDYINGGELFTHLS--QRERFTEHEVQIYVGE-IVLALEHLHK---LGIIY 182
Query: 115 RDLKASNILLDYEMNPKISDFGMARAFTKDECE-ANTGRIVGTYGYVPPE---YVRKGIY 170
RD+K NILLD + ++DFG+++ F DE E A GT Y+ P+ G +
Sbjct: 183 RDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD--FCGTIEYMAPDIVRGGDSG-H 239
Query: 171 SMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLE 206
D +S GVL+ ++L G S + E + E
Sbjct: 240 DKAVDWWSLGVLMYELLTGA--SPFTVDGEKNSQAE 273
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 50/203 (24%), Positives = 89/203 (43%), Gaps = 37/203 (18%)
Query: 6 CQGRL-PNGQEMAVKRLSRTSHQGLEEFEN-EVKLTARLQHVNLLPVLGICTQREEKM-- 61
Q +L +G+ +A+K++ + + F+N E+++ +L H N++ + EK
Sbjct: 71 YQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 125
Query: 62 ----LIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEG--------ITQGLLYLQEYSN 109
L+ DY+P + R R + + + + L Y+ +
Sbjct: 126 VYLNLVLDYVPE--------TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---S 174
Query: 110 LTIVHRDLKASNILLDYEMNP-KISDFGMARAFTKDECEANTGRIVGTYGYVPPEYV-RK 167
I HRD+K N+LLD + K+ DFG A+ + E N I Y Y PE +
Sbjct: 175 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRY-YRAPELIFGA 231
Query: 168 GIYSMKYDVYSYGVLLLQILGGK 190
Y+ DV+S G +L ++L G+
Sbjct: 232 TDYTSSIDVWSAGCVLAELLLGQ 254
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 3e-12
Identities = 43/179 (24%), Positives = 83/179 (46%), Gaps = 25/179 (13%)
Query: 12 NGQEMAVKRLSRTSHQGLEEFENE-VKLTA--------RLQHVNLLPVLGICTQREEKML 62
G+ +A+K+ LE +++ VK A +L+H NL+ +L +C +++ L
Sbjct: 49 TGRIVAIKKF-------LESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL 101
Query: 63 IYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNI 122
+++++ + ++ + +L L + ++ + I G+ + ++ I+HRD+K NI
Sbjct: 102 VFEFV-DHTILDDL-ELFPNGLDYQVVQKYLFQ-IINGIGFCHSHN---IIHRDIKPENI 155
Query: 123 LLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEY-VRKGIYSMKYDVYSYG 180
L+ K+ DFG AR E + T Y PE V Y DV++ G
Sbjct: 156 LVSQSGVVKLCDFGFARTLA-APGEVYDDEVA-TRWYRAPELLVGDVKYGKAVDVWAIG 212
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 3e-12
Identities = 39/144 (27%), Positives = 64/144 (44%), Gaps = 21/144 (14%)
Query: 35 EVKLTARLQHVNLLPVLGICTQREEK--MLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVH 92
E+ L L+H N++ + + ++ L++DY D + R + V
Sbjct: 68 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA---EHDLWHIIKFHRASKANKKPVQ 124
Query: 93 IIEG--------ITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNP----KISDFGMARA 140
+ G I G+ YL ++N ++HRDLK +NIL+ E KI+D G AR
Sbjct: 125 LPRGMVKSLLYQILDGIHYL--HAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
Query: 141 FTK-DECEANTGRIVGTYGYVPPE 163
F + A+ +V T+ Y PE
Sbjct: 182 FNSPLKPLADLDPVVVTFWYRAPE 205
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-12
Identities = 50/176 (28%), Positives = 82/176 (46%), Gaps = 18/176 (10%)
Query: 12 NGQEMAVKRLSRTSHQGLEEFE---NEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMP 68
N + +A+K++S + Q E+++ EV+ +L+H N + G + L+ +Y
Sbjct: 78 NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL 137
Query: 69 NKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM 128
+ D + L + G QGL YL ++ ++HRD+KA NILL
Sbjct: 138 GSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPG 191
Query: 129 NPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYV---RKGIYSMKYDVYSYGV 181
K+ DFG A AN+ VGT ++ PE + +G Y K DV+S G+
Sbjct: 192 LVKLGDFGSASIMAP----ANS--FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 241
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 6e-12
Identities = 51/194 (26%), Positives = 83/194 (42%), Gaps = 32/194 (16%)
Query: 11 PNGQEMAVKRLSRTSHQGLEEFEN---------EVKLTARLQHVN---LLPVLGICTQRE 58
+ +A+K+LSR F+N E+ L + H N LL V E
Sbjct: 85 VLDRNVAIKKLSRP-------FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE 137
Query: 59 EKMLIYDYMPNKSLDFYIFDLRR--RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRD 116
E +Y M + +L + + LD +++ + G+ +L + I+HRD
Sbjct: 138 EFQDVYLVM-----ELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRD 189
Query: 117 LKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDV 176
LK SNI++ + KI DFG+AR T T V T Y PE + Y D+
Sbjct: 190 LKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPY-VVTRYYRAPEVILGMGYKENVDI 246
Query: 177 YSYGVLLLQILGGK 190
+S G ++ +++ K
Sbjct: 247 WSVGCIMGEMVRHK 260
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 6e-12
Identities = 41/186 (22%), Positives = 80/186 (43%), Gaps = 24/186 (12%)
Query: 12 NGQEMAVKRLSRTSHQGLEEFE---NEVKLTARLQH---VNLLPVLGICTQREEKM-LIY 64
+G A+K L + L++ E NE ++ + V L + + ++
Sbjct: 65 SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE----FSFKDNSNLYMVM 120
Query: 65 DYMPNKSLDFYIFDLRR-RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNIL 123
+Y+ + + LRR + R + + I YL L +++RDLK N+L
Sbjct: 121 EYVAGGEMFSH---LRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLL 173
Query: 124 LDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLL 183
+D + +++DFG A+ + T + GT + PE + Y+ D ++ GVL+
Sbjct: 174 IDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLI 228
Query: 184 LQILGG 189
++ G
Sbjct: 229 YEMAAG 234
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 1e-11
Identities = 28/75 (37%), Positives = 37/75 (49%), Gaps = 6/75 (8%)
Query: 112 IVHRDLKASNILLD--YEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGI 169
I HRDLK N LLD KI DFG +++ + + VGT Y+ PE + +
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS--TVGTPAYIAPEVLLRQE 193
Query: 170 YS-MKYDVYSYGVLL 183
Y DV+S GV L
Sbjct: 194 YDGKIADVWSCGVTL 208
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 1e-11
Identities = 35/142 (24%), Positives = 56/142 (39%), Gaps = 14/142 (9%)
Query: 56 QREEKM-LIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVH 114
Q E + L+ +Y L + R + R ++ E I + + VH
Sbjct: 131 QDENYLYLVMEYYVGGDLLTLLSKFGERIPAE-MARFYLAE-IVMAIDSVHRLG---YVH 185
Query: 115 RDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPE-------YVRK 167
RD+K NILLD + +++DFG D + VGT Y+ PE
Sbjct: 186 RDIKPDNILLDRCGHIRLADFGSCLKLRADG-TVRSLVAVGTPDYLSPEILQAVGGGPGT 244
Query: 168 GIYSMKYDVYSYGVLLLQILGG 189
G Y + D ++ GV ++ G
Sbjct: 245 GSYGPECDWWALGVFAYEMFYG 266
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 2e-11
Identities = 29/129 (22%), Positives = 55/129 (42%), Gaps = 8/129 (6%)
Query: 35 EVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHII 94
E+++ +L+H NL+ +L + ++ L+++Y R + + I
Sbjct: 52 EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYC---DHTVLHELDRYQRGVPEHLVKSIT 108
Query: 95 EGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIV 154
Q + + +++ +HRD+K NIL+ K+ DFG AR T + +
Sbjct: 109 WQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLT-GPSDYYDDEVA 164
Query: 155 GTYGYVPPE 163
T Y PE
Sbjct: 165 -TRWYRSPE 172
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-11
Identities = 47/198 (23%), Positives = 84/198 (42%), Gaps = 40/198 (20%)
Query: 11 PNGQEMAVKRLSRTSHQGLEEFEN---------EVKLTARLQHVNLLPVLGICT--QREE 59
+ +A+K+LSR F+N E+ L + H N++ +L + T + E
Sbjct: 48 ILERNVAIKKLSRP-------FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 100
Query: 60 KM----LIYDYMPNKSLDFYIFDLR---RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTI 112
+ ++ + M +L + L R +++ + G+ +L I
Sbjct: 101 EFQDVYIVMELMD--------ANLCQVIQMELDHERMS-YLLYQMLCGIKHLHSAG---I 148
Query: 113 VHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSM 172
+HRDLK SNI++ + KI DFG+AR T V T Y PE + Y
Sbjct: 149 IHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPY-VVTRYYRAPEVILGMGYKE 205
Query: 173 KYDVYSYGVLLLQILGGK 190
D++S G ++ +++ G
Sbjct: 206 NVDIWSVGCIMGEMIKGG 223
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-11
Identities = 35/132 (26%), Positives = 60/132 (45%), Gaps = 12/132 (9%)
Query: 62 LIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASN 121
++ +YMP L + + + + R + E + L + + +HRD+K N
Sbjct: 146 MVMEYMPGGDL-VNL--MSNYDVPEKWARFYTAE-VVLALDAIHS---MGFIHRDVKPDN 198
Query: 122 ILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVR----KGIYSMKYDVY 177
+LLD + K++DFG K+ VGT Y+ PE ++ G Y + D +
Sbjct: 199 MLLDKSGHLKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWW 257
Query: 178 SYGVLLLQILGG 189
S GV L ++L G
Sbjct: 258 SVGVFLYEMLVG 269
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 3e-11
Identities = 44/206 (21%), Positives = 82/206 (39%), Gaps = 43/206 (20%)
Query: 11 PNGQEMAVKRLSRTSHQGLEEFEN---------EVKLTARLQHVNLLPVLGICTQREEKM 61
+ +A+K++ + E+K+ RL H N++ V I ++
Sbjct: 34 DCDKRVAIKKIV---------LTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQL 84
Query: 62 LIYDYMPNKSLDFYIF------DL----RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLT 111
+ YI DL + LL+ R + + +GL Y+ +
Sbjct: 85 TDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHAR-LFMYQLLRGLKYIHSAN--- 140
Query: 112 IVHRDLKASNILLDYE-MNPKISDFGMARAFTKDECEAN--TGRIVGTYGYVPPEYVRKG 168
++HRDLK +N+ ++ E + KI DFG+AR + +V T Y P +
Sbjct: 141 VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV-TKWYRSPRLL--- 196
Query: 169 IYSMKY----DVYSYGVLLLQILGGK 190
+ Y D+++ G + ++L GK
Sbjct: 197 LSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 61.0 bits (149), Expect = 6e-11
Identities = 44/162 (27%), Positives = 70/162 (43%), Gaps = 32/162 (19%)
Query: 35 EVKLTARLQ---HVNLLPVLGICTQREEK-----MLIYDYMPNKSLDFYIFDLRRRYLLD 86
EV L RL+ H N++ ++ +C L+++++ DLR LD
Sbjct: 61 EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ--------DLRT--YLD 110
Query: 87 WRTRVHIIEG--------ITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMA 138
+ +GL +L IVHRDLK NIL+ K++DFG+A
Sbjct: 111 KAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLA 167
Query: 139 RAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYG 180
R ++ A T +V T Y PE + + Y+ D++S G
Sbjct: 168 RIYSYQ--MALTPVVV-TLWYRAPEVLLQSTYATPVDMWSVG 206
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 61.0 bits (149), Expect = 8e-11
Identities = 50/186 (26%), Positives = 86/186 (46%), Gaps = 24/186 (12%)
Query: 12 NGQEMAVKRLSRTSHQGLEEFE---NEVKLTARLQH---VNLLPVLGICTQREEKM-LIY 64
NG+ A+K L + L++ E +E + + + H + + Q +++ +I
Sbjct: 30 NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW----GTFQDAQQIFMIM 85
Query: 65 DYMPNKSLDFYIFDLRR-RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNIL 123
DY+ L LR+ + + + + E + L YL I++RDLK NIL
Sbjct: 86 DYIEGGELFSL---LRKSQRFPNPVAKFYAAE-VCLALEYLHS---KDIIYRDLKPENIL 138
Query: 124 LDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLL 183
LD + KI+DFG A+ T + GT Y+ PE V Y+ D +S+G+L+
Sbjct: 139 LDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILI 193
Query: 184 LQILGG 189
++L G
Sbjct: 194 YEMLAG 199
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 9e-11
Identities = 42/203 (20%), Positives = 81/203 (39%), Gaps = 31/203 (15%)
Query: 6 CQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVN---LLPVLGICTQREEK- 60
G+ G +A+K++ + E + ++ A L H N L +R+ +
Sbjct: 40 QLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHHPNIVQLQSYFYTLGERDRRD 98
Query: 61 ---MLIYDYMPNKSLDFYIFDLRR--RYLLDWRTRVHIIEG------ITQGLLYLQEYSN 109
++ +Y+P+ L R R + I + + + L S
Sbjct: 99 IYLNVVMEYVPD--------TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS- 149
Query: 110 LTIVHRDLKASNILLDYEMNP-KISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKG 168
+ + HRD+K N+L++ K+ DFG A+ + E N I Y Y PE +
Sbjct: 150 VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS--EPNVAYICSRY-YRAPELIFGN 206
Query: 169 I-YSMKYDVYSYGVLLLQILGGK 190
Y+ D++S G + +++ G+
Sbjct: 207 QHYTTAVDIWSVGCIFAEMMLGE 229
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 1e-10
Identities = 41/162 (25%), Positives = 70/162 (43%), Gaps = 32/162 (19%)
Query: 35 EVKLTARLQ---HVNLLPVLGICTQREEK-----MLIYDYMPNKSLDFYIFDLRRRYLLD 86
EV + L+ H N++ + +CT L+++++ DL LD
Sbjct: 61 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ--------DLTT--YLD 110
Query: 87 WRTRVHIIEG--------ITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMA 138
+ + +GL +L + +VHRDLK NIL+ K++DFG+A
Sbjct: 111 KVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLA 167
Query: 139 RAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYG 180
R ++ A T +V T Y PE + + Y+ D++S G
Sbjct: 168 RIYSFQ--MALTSVVV-TLWYRAPEVLLQSSYATPVDLWSVG 206
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 47/199 (23%), Positives = 88/199 (44%), Gaps = 43/199 (21%)
Query: 11 PNGQEMAVKRLSRTSHQGLEEFEN---------EVKLTARLQHVNLLPVLGICT--QREE 59
+G+++A+K+LSR F++ E+ L +QH N++ +L + T
Sbjct: 47 RSGEKVAIKKLSRP-------FQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 99
Query: 60 KM----LIYDYMPNKSLDFYIFDLR---RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTI 112
L+ +M DL+ + + + +++ + +GL Y+ +
Sbjct: 100 NFYDFYLVMPFMQT--------DLQKIMGLKFSEEKIQ-YLVYQMLKGLKYIHSAG---V 147
Query: 113 VHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYV-RKGIYS 171
VHRDLK N+ ++ + KI DFG+AR + V T Y PE + Y+
Sbjct: 148 VHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG-----YVVTRWYRAPEVILSWMHYN 202
Query: 172 MKYDVYSYGVLLLQILGGK 190
D++S G ++ ++L GK
Sbjct: 203 QTVDIWSVGCIMAEMLTGK 221
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 3e-10
Identities = 54/204 (26%), Positives = 91/204 (44%), Gaps = 48/204 (23%)
Query: 11 PNGQEMAVKRLSRTSHQGLEEFEN---------EVKLTARLQHVNLLPVLGICT-QREEK 60
N +A+K++S FE+ E+K+ R +H N++ + I E+
Sbjct: 50 LNKVRVAIKKISP--------FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101
Query: 61 M----LIYDYMPNKSLDFYIFDLRR----RYLLDWRTRVHIIEGITQGLLYLQEYSNLTI 112
M ++ D M DL + ++L + + + I +GL Y+ +N +
Sbjct: 102 MKDVYIVQDLMET--------DLYKLLKTQHLSNDHIC-YFLYQILRGLKYIHS-AN--V 149
Query: 113 VHRDLKASNILLDYEMNPKISDFGMARAFTKDECEAN--TGRIVGTYGYVPPEYVRKGIY 170
+HRDLK SN+LL+ + KI DFG+AR D T V T Y PE + +
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY-VATRWYRAPEIM---LN 205
Query: 171 SMKY----DVYSYGVLLLQILGGK 190
S Y D++S G +L ++L +
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 3e-10
Identities = 51/207 (24%), Positives = 80/207 (38%), Gaps = 34/207 (16%)
Query: 5 ICQGRLPNGQEMAVKRLSRTSHQGLEE--FEN---------EVKLTARLQHVNLLPVLGI 53
+C G G +A+KR+ T G + E++L H N+L + I
Sbjct: 38 VCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97
Query: 54 CT-QREEKM----LIYDYMPNKSLDFY-IFDLRRRYLLDWRTRVHIIEGITQGLLYLQEY 107
E M L+ + M D + +R + + + + I GL L E
Sbjct: 98 FVHFEEPAMHKLYLVTELMRT---DLAQVIHDQRIVISPQHIQ-YFMYHILLGLHVLHE- 152
Query: 108 SNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRK 167
+ +VHRDL NILL + I DF +AR T D T V Y PE V
Sbjct: 153 AG--VVHRDLHPGNILLADNNDITICDFNLAREDTAD--ANKTHY-VTHRWYRAPELV-- 205
Query: 168 GIYSMKY----DVYSYGVLLLQILGGK 190
+ + D++S G ++ ++ K
Sbjct: 206 -MQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 4e-10
Identities = 47/200 (23%), Positives = 87/200 (43%), Gaps = 44/200 (22%)
Query: 11 PNGQEMAVKRLSRTSHQGLEEFEN---------EVKLTARLQHVNLLPVLGICTQREEKM 61
G ++A+K+L R F++ E++L ++H N++ +L + T E
Sbjct: 48 RTGAKVAIKKLYRP-------FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 100
Query: 62 ------LIYDYMPNKSLDFYIFDL----RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLT 111
L+ +M DL + L + R + ++ + +GL Y+
Sbjct: 101 DFTDFYLVMPFMGT--------DLGKLMKHEKLGEDRIQ-FLVYQMLKGLRYIHAAG--- 148
Query: 112 IVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYV-RKGIY 170
I+HRDLK N+ ++ + KI DFG+AR + V T Y PE + Y
Sbjct: 149 IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY-----VVTRWYRAPEVILNWMRY 203
Query: 171 SMKYDVYSYGVLLLQILGGK 190
+ D++S G ++ +++ GK
Sbjct: 204 TQTVDIWSVGCIMAEMITGK 223
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 9e-10
Identities = 31/139 (22%), Positives = 59/139 (42%), Gaps = 24/139 (17%)
Query: 62 LIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQ--------GLLYLQEYSNLTIV 113
+I +Y+P+ L + R+ I + + ++ +L I
Sbjct: 115 VIMEYVPD--------TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGIC 163
Query: 114 HRDLKASNILLDYEMNP-KISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGI-YS 171
HRD+K N+L++ + N K+ DFG A+ E + I + Y PE + Y+
Sbjct: 164 HRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS--EPSVAYICSRF-YRAPELMLGATEYT 220
Query: 172 MKYDVYSYGVLLLQILGGK 190
D++S G + +++ GK
Sbjct: 221 PSIDLWSIGCVFGELILGK 239
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-09
Identities = 52/200 (26%), Positives = 89/200 (44%), Gaps = 44/200 (22%)
Query: 11 PNGQEMAVKRLSRTSHQGLEEFEN---------EVKLTARLQHVNLLPVLGICT--QREE 59
G +AVK+LSR F++ E++L ++H N++ +L + T + E
Sbjct: 52 KTGLRVAVKKLSRP-------FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 104
Query: 60 KM----LIYDYMPNKSLDFYIFDL----RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLT 111
+ L+ M DL + + L D + +I I +GL Y+
Sbjct: 105 EFNDVYLVTHLMGA--------DLNNIVKCQKLTDDHVQ-FLIYQILRGLKYIHSAD--- 152
Query: 112 IVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYV-RKGIY 170
I+HRDLK SN+ ++ + KI DFG+AR + V T Y PE + Y
Sbjct: 153 IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY-----VATRWYRAPEIMLNWMHY 207
Query: 171 SMKYDVYSYGVLLLQILGGK 190
+ D++S G ++ ++L G+
Sbjct: 208 NQTVDIWSVGCIMAELLTGR 227
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-09
Identities = 27/94 (28%), Positives = 46/94 (48%), Gaps = 10/94 (10%)
Query: 93 IIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGR 152
I I +GL +L ++ ++HRD+K N+LL K+ DFG++ + NT
Sbjct: 134 ICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-- 188
Query: 153 IVGTYGYVPPEYVR-----KGIYSMKYDVYSYGV 181
+GT ++ PE + Y K D++S G+
Sbjct: 189 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGI 222
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 2e-09
Identities = 36/175 (20%), Positives = 71/175 (40%), Gaps = 44/175 (25%)
Query: 11 PNGQEMAVKRLSRTSHQGLEEFEN---------EVKLTARLQHVNLLPVLGICTQREEKM 61
+ +A+K++ R FE+ E+ + RL H +++ VL I ++ +
Sbjct: 76 LEKRVVAIKKILR-------VFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEK 128
Query: 62 -----LIYDYMPNKSLDFYIFDLRR-----RYLLDWRTRVHI---IEGITQGLLYLQEYS 108
++ + + D ++ YL T +HI + + G+ Y+
Sbjct: 129 FDELYVVLEIADS--------DFKKLFRTPVYL----TELHIKTLLYNLLVGVKYVHSAG 176
Query: 109 NLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPE 163
I+HRDLK +N L++ + + K+ DFG+AR E + I +
Sbjct: 177 ---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 5e-09
Identities = 45/207 (21%), Positives = 83/207 (40%), Gaps = 47/207 (22%)
Query: 11 PNGQEMAVKRLSRTSHQGLEEFEN---------EVKLTARLQHVNLLPVLGICT-QREEK 60
P G+ +A+K++ F+ E+K+ +H N++ + I E
Sbjct: 34 PTGEIVAIKKIEP--------FDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFEN 85
Query: 61 M----LIYDYMPNKSLDFYIFDL----RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTI 112
+I + M DL + L D + + I + + L SN +
Sbjct: 86 FNEVYIIQELMQT--------DLHRVISTQMLSDDHIQ-YFIYQTLRAVKVLHG-SN--V 133
Query: 113 VHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTY--GYV------PPEY 164
+HRDLK SN+L++ + K+ DFG+AR + + + + +V PE
Sbjct: 134 IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEV 193
Query: 165 V-RKGIYSMKYDVYSYGVLLLQILGGK 190
+ YS DV+S G +L ++ +
Sbjct: 194 MLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 8e-09
Identities = 33/177 (18%), Positives = 70/177 (39%), Gaps = 38/177 (21%)
Query: 11 PNGQEMAVKRLSRTSHQGLEEFEN---------EVKLTARLQHVNLLPVLGICT-QREEK 60
+ +A+K+++R FE+ E+ + RL+ ++ + + K
Sbjct: 49 NTEKNVAIKKVNRM-------FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLK 101
Query: 61 M----LIYDYMPNKSLDFYIFDLRR-----RYLLDWRTRVHIIEGITQGLLYLQEYSNLT 111
++ + + DL++ +L + + I+ + G ++ E S
Sbjct: 102 FDELYIVLEIADS--------DLKKLFKTPIFLTEEHIK-TILYNLLLGENFIHE-SG-- 149
Query: 112 IVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKG 168
I+HRDLK +N LL+ + + K+ DFG+AR ++ + P K
Sbjct: 150 IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKK 206
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 8e-09
Identities = 42/188 (22%), Positives = 86/188 (45%), Gaps = 24/188 (12%)
Query: 11 PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQ-HVNLLPVLGICTQREEKM--LIYDYM 67
N +++ VK L + + + E+K+ L+ N++ + I + L+++++
Sbjct: 59 TNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 115
Query: 68 PNKSLDFYIFDLRRRY--LLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLD 125
N D ++ Y L D+ R ++ E I + L Y I+HRD+K N+++D
Sbjct: 116 NNT-------DFKQLYQTLTDYDIRFYMYE-ILKALDYCHSMG---IMHRDVKPHNVMID 164
Query: 126 YE-MNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPE-YVRKGIYSMKYDVYSYGVLL 183
+E ++ D+G+A + + R+ Y + PE V +Y D++S G +L
Sbjct: 165 HEHRKLRLIDWGLAEFY--HPGQEYNVRVASRY-FKGPELLVDYQMYDYSLDMWSLGCML 221
Query: 184 LQILGGKR 191
++ K
Sbjct: 222 ASMIFRKE 229
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 6e-08
Identities = 17/178 (9%), Positives = 46/178 (25%), Gaps = 40/178 (22%)
Query: 17 AVKRL---SRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLD 73
A+ + L+E + +R+ + VL + R +++ +++ SL
Sbjct: 60 ALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQ 119
Query: 74 FYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKIS 133
++ + ++ + + S + +S
Sbjct: 120 ----EVADTSPSPVGA-IRAMQSLAAAADAAHRAG---VALSIDHPSRVR--------VS 163
Query: 134 DFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKR 191
G + +P + D+ G L +L +
Sbjct: 164 IDGDVV--------------LAYPATMPDANPQD-------DIRGIGASLYALLVNRW 200
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 29/99 (29%), Positives = 46/99 (46%), Gaps = 20/99 (20%)
Query: 112 IVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPP--------E 163
++HRD+K SNILL+ E + K++DFG++R+F N + +
Sbjct: 130 LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTD 189
Query: 164 YV-----R-------KGIYSMKYDVYSYGVLLLQILGGK 190
YV R Y+ D++S G +L +IL GK
Sbjct: 190 YVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 8e-07
Identities = 22/95 (23%), Positives = 35/95 (36%), Gaps = 30/95 (31%)
Query: 92 HIIEGITQGLLYLQEYSNLTIVHRDLKASNILL---DYEMNPKISDFGMARAFTKDECEA 148
I++ I + + YL + I HRD+K N+L K++DFG A
Sbjct: 121 EIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA---------- 167
Query: 149 NTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLL 183
E Y D++S GV++
Sbjct: 168 -------------KE-TTGEKYDKSCDMWSLGVIM 188
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 1e-05
Identities = 24/105 (22%), Positives = 46/105 (43%), Gaps = 13/105 (12%)
Query: 92 HIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNP------KISDFGMARAFTKDE 145
I + + GL Y+ + I+H D+K N+L++ +P KI+D G A + +
Sbjct: 135 QISKQLLLGLDYM--HRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-CWYDEH 191
Query: 146 CEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGK 190
+ T Y PE + + D++S L+ +++ G
Sbjct: 192 Y----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 3e-05
Identities = 15/59 (25%), Positives = 22/59 (37%), Gaps = 2/59 (3%)
Query: 84 LLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFT 142
L T I+ +T L + L HRDL N+LL K+ ++ T
Sbjct: 157 LSSLATAKSILHQLTASLAVAEAS--LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSST 213
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.0 bits (95), Expect = 5e-04
Identities = 48/290 (16%), Positives = 91/290 (31%), Gaps = 88/290 (30%)
Query: 51 LGICTQREEKM-----LIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQ 105
L C E + L+Y PN + R + + + R+H I+ + LL +
Sbjct: 189 LKNCNSPETVLEMLQKLLYQIDPN-------WTSRSDHSSNIKLRIHSIQAELRRLLKSK 241
Query: 106 EYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAF---------TKDECEANTGRIVGT 156
Y N +V +++ + AF T+ + + T
Sbjct: 242 PYENCLLVLLNVQNAKAW---------------NAFNLSCKILLTTRFKQVTDF-LSAAT 285
Query: 157 YGYVPPEYVRKGIY---SMKYDVYSYGVLLLQILGGK-----RTSCYYGP---------- 198
++ ++ + LLL+ L + R P
Sbjct: 286 TTHISLDHHSMTLTPDEVKS--------LLLKYLDCRPQDLPREVLTTNPRRLSIIAESI 337
Query: 199 NESLNLLEYAYGLWKNGEGMEF---IDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTM 255
+ L + WK+ + I+SSL+ A R M L + A PT+
Sbjct: 338 RDGLATWDN----WKHVNCDKLTTIIESSLNVLEPA--EYRKMFDRLSVFPPS-AHIPTI 390
Query: 256 -LEIL--VMLKSETADI--KTPKKPAFSVKRDNDEISECMLEANIYSVDD 300
L ++ ++KS+ + K K V++ E + S+
Sbjct: 391 LLSLIWFDVIKSDVMVVVNKLHKYSL--VEKQPKE--------STISIPS 430
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 6e-04
Identities = 29/100 (29%), Positives = 46/100 (46%), Gaps = 16/100 (16%)
Query: 97 ITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNP--KISDFGMARAFTKDECEANTGRIV 154
+ LL+L L+I+H DLK NILL KI DFG + C+ + +
Sbjct: 166 MCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-------CQLG--QRI 215
Query: 155 GTY----GYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGK 190
Y Y PE + Y + D++S G +L+++ G+
Sbjct: 216 YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 309 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.83 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.68 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.5 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.33 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.17 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.9 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.75 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.63 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.42 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.36 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.27 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.12 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.05 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.98 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.8 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.74 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.72 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.63 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.4 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.37 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.36 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.35 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.06 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.0 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.98 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.91 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.73 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.67 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.42 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.28 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 90.98 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 90.3 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 87.32 | |
| 2lic_A | 35 | Vitellogenin; lipid transport; HET: SEP; NMR {Apis | 81.74 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-53 Score=368.99 Aligned_cols=247 Identities=23% Similarity=0.381 Sum_probs=193.2
Q ss_pred cceEEEEcC------CCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHH
Q 021682 3 VAICQGRLP------NGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 3 ~~~~~~~~~------~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 76 (309)
++||+|.+. +++.||||.++.......+.|.+|++++++++|||||+++++|.++...+||||||++|+|.+++
T Consensus 55 G~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l 134 (329)
T 4aoj_A 55 GKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFL 134 (329)
T ss_dssp EEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHH
T ss_pred cEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHH
Confidence 467888753 58899999998777777788999999999999999999999999999999999999999999998
Q ss_pred hhhc------------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCC
Q 021682 77 FDLR------------RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKD 144 (309)
Q Consensus 77 ~~~~------------~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~ 144 (309)
.... ....+++..++.++.|++.|+.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 135 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~ 211 (329)
T 4aoj_A 135 RSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 211 (329)
T ss_dssp HTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred HhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEEEcccccceeccCC
Confidence 6532 134589999999999999999999998 8999999999999999999999999999866544
Q ss_pred cccccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccc
Q 021682 145 ECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDS 223 (309)
Q Consensus 145 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (309)
..........||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+ .. .....+.....
T Consensus 212 ~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~----~~i~~g~~~~~--- 281 (329)
T 4aoj_A 212 DYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE---AI----DCITQGRELER--- 281 (329)
T ss_dssp --------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH---HH----HHHHHTCCCCC---
T ss_pred CcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH---HH----HHHHcCCCCCC---
Confidence 33333344578999999999999999999999999999999998 899986432211 11 11111111111
Q ss_pred cCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccCC
Q 021682 224 SLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETAD 268 (309)
Q Consensus 224 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~ 268 (309)
+...+.++.+|+.+||+.||++|||++||++.|+.+.+.
T Consensus 282 ------p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 282 ------PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp ------CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ------cccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 111234788999999999999999999999999988664
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=365.59 Aligned_cols=246 Identities=24% Similarity=0.383 Sum_probs=200.8
Q ss_pred cceEEEEcC------CCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHH
Q 021682 3 VAICQGRLP------NGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 3 ~~~~~~~~~------~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 76 (309)
+.||+|.+. +|+.||||.++.......+.|.+|++++++++|||||++++++.+++..+||||||++|+|.+++
T Consensus 27 G~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l 106 (299)
T 4asz_A 27 GKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFL 106 (299)
T ss_dssp CCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHH
T ss_pred cEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHH
Confidence 456777653 57889999998777767788999999999999999999999999999999999999999999999
Q ss_pred hhhc----------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcc
Q 021682 77 FDLR----------RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDEC 146 (309)
Q Consensus 77 ~~~~----------~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 146 (309)
.... ....+++..+..++.|++.|+.|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 107 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 183 (299)
T 4asz_A 107 RAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDY 183 (299)
T ss_dssp HHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGC
T ss_pred HhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEECCcccceecCCCCc
Confidence 6532 234689999999999999999999998 899999999999999999999999999986654433
Q ss_pred cccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccC
Q 021682 147 EANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSL 225 (309)
Q Consensus 147 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (309)
........||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+ .. .....+.....
T Consensus 184 ~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~----~~i~~~~~~~~----- 251 (299)
T 4asz_A 184 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VI----ECITQGRVLQR----- 251 (299)
T ss_dssp EEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HH----HHHHHTCCCCC-----
T ss_pred eeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HH----HHHHcCCCCCC-----
Confidence 333334568999999999999999999999999999999998 899986432211 11 11122221111
Q ss_pred CCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccC
Q 021682 226 DDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETA 267 (309)
Q Consensus 226 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~ 267 (309)
+...+.++.+|+.+||+.||++|||+++|.+.|+++.+
T Consensus 252 ----p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 252 ----PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11123478899999999999999999999999998754
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-52 Score=359.03 Aligned_cols=245 Identities=26% Similarity=0.421 Sum_probs=197.4
Q ss_pred cceEEEEc------CCCcEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHH
Q 021682 3 VAICQGRL------PNGQEMAVKRLSRT-SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFY 75 (309)
Q Consensus 3 ~~~~~~~~------~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (309)
+.||+|.+ .+++.||||.++.. .....+.|.+|+.++++++|||||++++++..+...+||||||++|+|.++
T Consensus 40 G~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~ 119 (308)
T 4gt4_A 40 GKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEF 119 (308)
T ss_dssp CEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHH
T ss_pred cEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHH
Confidence 36788876 35789999999754 334567899999999999999999999999999999999999999999999
Q ss_pred Hhhhcc-------------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeeccccccccc
Q 021682 76 IFDLRR-------------RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFT 142 (309)
Q Consensus 76 ~~~~~~-------------~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~ 142 (309)
+..... ...+++..+..++.||+.|+.|||++ +++||||||+|||++.++.+||+|||+++...
T Consensus 120 L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~ 196 (308)
T 4gt4_A 120 LVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVY 196 (308)
T ss_dssp HHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCSCCBCGGG
T ss_pred HHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCCEEECCcccceecc
Confidence 854321 34589999999999999999999998 89999999999999999999999999998765
Q ss_pred CCcccccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccc
Q 021682 143 KDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFI 221 (309)
Q Consensus 143 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (309)
........+...||+.|+|||.+.+..++.++|||||||++|||+| |..||......+ . ......+.....
T Consensus 197 ~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~---~----~~~i~~~~~~~~- 268 (308)
T 4gt4_A 197 AADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---V----VEMIRNRQVLPC- 268 (308)
T ss_dssp GGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---H----HHHHHTTCCCCC-
T ss_pred CCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHHcCCCCCC-
Confidence 4443333445578999999999999999999999999999999998 899986433211 1 112222222211
Q ss_pred cccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhccc
Q 021682 222 DSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSET 266 (309)
Q Consensus 222 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~ 266 (309)
+...+..+.+|+.+||+.||++|||++||++.|+...
T Consensus 269 --------p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 269 --------PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp --------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred --------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 1122347889999999999999999999999998653
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-52 Score=353.88 Aligned_cols=249 Identities=22% Similarity=0.351 Sum_probs=189.9
Q ss_pred cceEEEEcCCCcEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 3 VAICQGRLPNGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
++||+|.++ ..||||+++.. .....+.|.+|+.++++++|||||++++++.. +..+||||||++|+|.+++..
T Consensus 50 G~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~-- 124 (307)
T 3omv_A 50 GTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHV-- 124 (307)
T ss_dssp SEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHT--
T ss_pred cEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhh--
Confidence 468899874 36999998654 34456789999999999999999999998865 568999999999999999853
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCC
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYV 160 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 160 (309)
....+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+|+...............||+.|+
T Consensus 125 ~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ym 201 (307)
T 3omv_A 125 QETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWM 201 (307)
T ss_dssp SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSC
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCcc
Confidence 234599999999999999999999998 89999999999999999999999999997665433333334457999999
Q ss_pred Ccccccc---CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHH
Q 021682 161 PPEYVRK---GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRC 237 (309)
Q Consensus 161 aPE~~~~---~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (309)
|||++.+ ..++.++|||||||++|||++|+.||....... ........+....... ......+..+
T Consensus 202 APE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~------~~~~~~~~~~~~p~~~-----~~~~~~~~~l 270 (307)
T 3omv_A 202 APEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD------QIIFMVGRGYASPDLS-----KLYKNCPKAM 270 (307)
T ss_dssp CHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHTTCCCCCST-----TSCTTSCHHH
T ss_pred CHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH------HHHHHHhcCCCCCCcc-----cccccchHHH
Confidence 9999864 358999999999999999999999996433221 1111111111111110 1111223478
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHhcccCCCC
Q 021682 238 MQVALLCVQENAADRPTMLEILVMLKSETADIK 270 (309)
Q Consensus 238 ~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~~~ 270 (309)
.+|+.+||+.||++|||+.||++.|+.+..+++
T Consensus 271 ~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 271 KRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp HHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 899999999999999999999999998766653
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-52 Score=361.43 Aligned_cols=236 Identities=20% Similarity=0.283 Sum_probs=191.9
Q ss_pred cceEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 3 VAICQGR-LPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 3 ~~~~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
++||++. ..+|+.||||++........+.+.+|++++++++|||||++++++.+++.+|||||||++|+|.+++..
T Consensus 88 G~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~--- 164 (346)
T 4fih_A 88 GIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH--- 164 (346)
T ss_dssp CEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHH---
T ss_pred eEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHc---
Confidence 3556665 468999999999766555667789999999999999999999999999999999999999999998843
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP 161 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 161 (309)
..+++..+..++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||++......... .....||+.|+|
T Consensus 165 -~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~--~~~~~GTp~YmA 238 (346)
T 4fih_A 165 -TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMA 238 (346)
T ss_dssp -SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC--BCCCCSCGGGCC
T ss_pred -CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc--ccccccCcCcCC
Confidence 3489999999999999999999999 8999999999999999999999999999876543322 234579999999
Q ss_pred ccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHH
Q 021682 162 PEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241 (309)
Q Consensus 162 PE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 241 (309)
||++.+..++.++|||||||++|+|++|.+||......+ ... ......... .......+.++.+||
T Consensus 239 PEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~----~i~~~~~~~-------~~~~~~~s~~~~dli 304 (346)
T 4fih_A 239 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMK----MIRDNLPPR-------LKNLHKVSPSLKGFL 304 (346)
T ss_dssp HHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHH----HHHHSSCCC-------CSCGGGSCHHHHHHH
T ss_pred HHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHH----HHHcCCCCC-------CCccccCCHHHHHHH
Confidence 999999999999999999999999999999996432211 111 111111000 011112234788999
Q ss_pred hhcccCCCCCCCCHHHHHHH
Q 021682 242 LLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 242 ~~~l~~~p~~Rpt~~ell~~ 261 (309)
.+||+.||++|||++|+++.
T Consensus 305 ~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 305 DRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp HHHSCSSTTTSCCHHHHTTC
T ss_pred HHHcCCChhHCcCHHHHhcC
Confidence 99999999999999999874
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-52 Score=357.49 Aligned_cols=247 Identities=19% Similarity=0.216 Sum_probs=193.0
Q ss_pred ceEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccc
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRR 82 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 82 (309)
+||++. ..+|+.||||+++.... ..+|+.++++++|||||++++++.+++.+|||||||+||+|.+++...
T Consensus 73 ~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~--- 144 (336)
T 4g3f_A 73 EVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQM--- 144 (336)
T ss_dssp EEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHH---
T ss_pred EEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHc---
Confidence 456665 46899999999975432 246999999999999999999999999999999999999999998543
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCC-CceeecccccccccCCccc---ccccccccccC
Q 021682 83 YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM-NPKISDFGMARAFTKDECE---ANTGRIVGTYG 158 (309)
Q Consensus 83 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~-~~~l~Dfg~~~~~~~~~~~---~~~~~~~~~~~ 158 (309)
..+++..+..++.||+.||.|||++ ||+||||||+|||++.+| .+||+|||+++........ .......||+.
T Consensus 145 ~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~ 221 (336)
T 4g3f_A 145 GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTET 221 (336)
T ss_dssp SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGG
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCcc
Confidence 3599999999999999999999998 899999999999999987 5999999999876543221 11233469999
Q ss_pred CCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHH
Q 021682 159 YVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238 (309)
Q Consensus 159 y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (309)
|+|||++.+..++.++|||||||++|+|++|++||......+....+. ....... ..+...+..+.
T Consensus 222 YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~------~~~~~~~--------~~~~~~s~~~~ 287 (336)
T 4g3f_A 222 HMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA------SEPPPIR--------EIPPSCAPLTA 287 (336)
T ss_dssp GCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHH------HSCCGGG--------GSCTTSCHHHH
T ss_pred ccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH------cCCCCch--------hcCccCCHHHH
Confidence 999999999999999999999999999999999997544433221111 1110000 01111234788
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHhcccCCCCCCCCC
Q 021682 239 QVALLCVQENAADRPTMLEILVMLKSETADIKTPKKP 275 (309)
Q Consensus 239 ~li~~~l~~~p~~Rpt~~ell~~L~~~~~~~~~~~~p 275 (309)
++|.+||+.||++|||+.||++.|.........-+-|
T Consensus 288 ~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hP 324 (336)
T 4g3f_A 288 QAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSP 324 (336)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSC
T ss_pred HHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCC
Confidence 9999999999999999999999987766554443444
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=358.05 Aligned_cols=235 Identities=23% Similarity=0.287 Sum_probs=191.5
Q ss_pred CccceEEE-EcCCCcEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHH
Q 021682 1 MSVAICQG-RLPNGQEMAVKRLSRT---SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 1 ~g~~~~~~-~~~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 76 (309)
||. ||++ ...+|+.||||++.+. .....+.+.+|++++++++||||+++++++.+++.+|||||||+||+|.+++
T Consensus 45 fg~-V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i 123 (311)
T 4aw0_A 45 FST-VVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI 123 (311)
T ss_dssp TEE-EEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHH
T ss_pred CeE-EEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHH
Confidence 444 5555 4568999999999753 2344678999999999999999999999999999999999999999999998
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccc
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGT 156 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 156 (309)
.. ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++...............||
T Consensus 124 ~~---~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GT 197 (311)
T 4aw0_A 124 RK---IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 197 (311)
T ss_dssp HH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSC
T ss_pred HH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccC
Confidence 54 34599999999999999999999999 8999999999999999999999999999877654433344456899
Q ss_pred cCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHH
Q 021682 157 YGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMR 236 (309)
Q Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
+.|+|||++.+..++.++|||||||++|+|++|.+||...+.. ......... .. .+ .. ..+.+
T Consensus 198 p~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------~~~~~i~~~-~~-~~-----p~----~~s~~ 260 (311)
T 4aw0_A 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG------LIFAKIIKL-EY-DF-----PE----KFFPK 260 (311)
T ss_dssp GGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHT-CC-CC-----CT----TCCHH
T ss_pred cccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHcC-CC-CC-----Cc----ccCHH
Confidence 9999999999999999999999999999999999999543211 111111111 11 11 11 12236
Q ss_pred HHHHHhhcccCCCCCCCCHHHHH
Q 021682 237 CMQVALLCVQENAADRPTMLEIL 259 (309)
Q Consensus 237 l~~li~~~l~~~p~~Rpt~~ell 259 (309)
+.+||.+||+.||++|||++|++
T Consensus 261 ~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 261 ARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp HHHHHHHHSCSSGGGSTTSGGGT
T ss_pred HHHHHHHHccCCHhHCcChHHHc
Confidence 88999999999999999999864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-52 Score=362.00 Aligned_cols=236 Identities=21% Similarity=0.255 Sum_probs=191.0
Q ss_pred ceEEEE-cCCCcEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 4 AICQGR-LPNGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
+||++. ..+|+.||||++... .....+.+.+|++++++++|||||++++++.+++.+|||||||+||+|.+++...
T Consensus 39 ~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~- 117 (350)
T 4b9d_A 39 KAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQ- 117 (350)
T ss_dssp CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHT-
T ss_pred EEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHc-
Confidence 456664 568999999999754 3445678999999999999999999999999999999999999999999998542
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCC
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYV 160 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 160 (309)
.+..+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||+++....... ......||+.|+
T Consensus 118 ~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~GT~~Ym 192 (350)
T 4b9d_A 118 KGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE--LARACIGTPYYL 192 (350)
T ss_dssp TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH--HHHHHHSCCTTC
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCcc--cccccCCCcccc
Confidence 344578999999999999999999998 999999999999999999999999999976543221 123347999999
Q ss_pred CccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHH
Q 021682 161 PPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQV 240 (309)
Q Consensus 161 aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 240 (309)
|||++.+..++.++|||||||++|+|++|+.||...+.. ........ ...... +...+.++.+|
T Consensus 193 APE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~------~~~~~i~~-~~~~~~---------~~~~s~~~~~l 256 (350)
T 4b9d_A 193 SPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK------NLVLKIIS-GSFPPV---------SLHYSYDLRSL 256 (350)
T ss_dssp CHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHH-TCCCCC---------CTTSCHHHHHH
T ss_pred CHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHHHHc-CCCCCC---------CccCCHHHHHH
Confidence 999999999999999999999999999999999643221 11111111 111111 11123478899
Q ss_pred HhhcccCCCCCCCCHHHHHHH
Q 021682 241 ALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 241 i~~~l~~~p~~Rpt~~ell~~ 261 (309)
|.+||+.||++|||++|+++.
T Consensus 257 i~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 257 VSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp HHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999874
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-51 Score=362.59 Aligned_cols=235 Identities=20% Similarity=0.299 Sum_probs=191.6
Q ss_pred ceEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccc
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRR 82 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 82 (309)
+||++. ..+|+.||||.+........+.+.+|+.+|++++|||||++++++.+++.+|||||||+||+|.+++..
T Consensus 166 ~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~---- 241 (423)
T 4fie_A 166 IVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH---- 241 (423)
T ss_dssp EEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH----
T ss_pred EEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhc----
Confidence 456665 468999999999876666677899999999999999999999999999999999999999999998842
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCc
Q 021682 83 YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPP 162 (309)
Q Consensus 83 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 162 (309)
..+++..+..++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||++........ ......||+.|+||
T Consensus 242 ~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~GTp~YmAP 316 (423)
T 4fie_A 242 TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAP 316 (423)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--CBCCCEECTTTCCH
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc--cccccccCcCcCCH
Confidence 3489999999999999999999999 999999999999999999999999999987654332 23345799999999
Q ss_pred cccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHHh
Q 021682 163 EYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVAL 242 (309)
Q Consensus 163 E~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 242 (309)
|++.+..|+.++|||||||++|+|++|.+||......+ ... ......... +. .....+..+.+||.
T Consensus 317 Evl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~----~i~~~~~~~-~~------~~~~~s~~~~dli~ 382 (423)
T 4fie_A 317 ELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMK----MIRDNLPPR-LK------NLHKVSPSLKGFLD 382 (423)
T ss_dssp HHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHH----HHHHSCCCC-CS------CTTSSCHHHHHHHH
T ss_pred HHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHH----HHHcCCCCC-Cc------ccccCCHHHHHHHH
Confidence 99999999999999999999999999999995432211 111 111111100 00 00112237889999
Q ss_pred hcccCCCCCCCCHHHHHHH
Q 021682 243 LCVQENAADRPTMLEILVM 261 (309)
Q Consensus 243 ~~l~~~p~~Rpt~~ell~~ 261 (309)
+||+.||++|||++|+++.
T Consensus 383 ~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 383 RLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp HHSCSSTTTSCCHHHHTTC
T ss_pred HHcCCChhHCcCHHHHhcC
Confidence 9999999999999999874
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-50 Score=340.99 Aligned_cols=234 Identities=21% Similarity=0.320 Sum_probs=184.4
Q ss_pred cceEEEEc-CCCcEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeeEEee----CCeeEEEEeccCCCChhHH
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQ----REEKMLIYDYMPNKSLDFY 75 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~ 75 (309)
++||+|.. .+|+.||+|.+... .....+.+.+|++++++++|||||++++++.. +..++||||||++|+|.++
T Consensus 40 g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~ 119 (290)
T 3fpq_A 40 KTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTY 119 (290)
T ss_dssp EEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHH
T ss_pred cEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHH
Confidence 35677764 57999999998654 34456789999999999999999999999865 3468999999999999999
Q ss_pred HhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCc--eeecCCCCceEEeCC-CCCceeecccccccccCCcccccccc
Q 021682 76 IFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLT--IVHRDLKASNILLDY-EMNPKISDFGMARAFTKDECEANTGR 152 (309)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~g--i~H~di~p~nil~~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~ 152 (309)
+.. ...+++..+..++.||+.||.|||++ | |+||||||+|||++. ++.+||+|||+|+...... ...
T Consensus 120 l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~~----~~~ 189 (290)
T 3fpq_A 120 LKR---FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKA 189 (290)
T ss_dssp HHH---HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTTS----BEE
T ss_pred HHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCCc----cCC
Confidence 854 34599999999999999999999998 6 999999999999985 7899999999997543322 233
Q ss_pred cccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHH
Q 021682 153 IVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAW 232 (309)
Q Consensus 153 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (309)
..||+.|+|||++.+ .++.++|||||||++|+|++|+.||...... ...............++ ..
T Consensus 190 ~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~------~~~~~~i~~~~~~~~~~--------~~ 254 (290)
T 3fpq_A 190 VIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKPASFD--------KV 254 (290)
T ss_dssp SCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCCCGGGG--------GC
T ss_pred cccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH------HHHHHHHHcCCCCCCCC--------cc
Confidence 579999999998865 6899999999999999999999998532211 11112222221111111 11
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 233 KLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 233 ~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.+.++.+||.+||+.||++|||++|+++.
T Consensus 255 ~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 255 AIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 12368899999999999999999999863
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-51 Score=342.76 Aligned_cols=232 Identities=22% Similarity=0.313 Sum_probs=177.3
Q ss_pred cceEEEE-cCCCcEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 3 VAICQGR-LPNGQEMAVKRLSRT---SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 3 ~~~~~~~-~~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
++||++. ..+|+.||||++.+. ......++.+|++++++++||||+++++++.+++..++||||+ +|+|.+++..
T Consensus 27 g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~ 105 (275)
T 3hyh_A 27 GKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQ 105 (275)
T ss_dssp CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHH
T ss_pred eEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHH
Confidence 3566665 468999999999754 2334567999999999999999999999999999999999999 6788888843
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
...+++..+..++.||+.|++|||++ ||+||||||+||+++.++.+||+|||++........ .....||+.
T Consensus 106 ---~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~---~~~~~GT~~ 176 (275)
T 3hyh_A 106 ---RDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF---LKTSCGSPN 176 (275)
T ss_dssp ---SCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC------------------CT
T ss_pred ---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCCc---cCCeeECcc
Confidence 34599999999999999999999998 999999999999999999999999999976544321 223579999
Q ss_pred CCCccccccCCC-CccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHH
Q 021682 159 YVPPEYVRKGIY-SMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRC 237 (309)
Q Consensus 159 y~aPE~~~~~~~-~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (309)
|+|||++.+..+ +.++|||||||++|+|++|+.||..... ......... ... . + . ...+.++
T Consensus 177 Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~------~~~~~~i~~-~~~-~-~----p----~~~s~~~ 239 (275)
T 3hyh_A 177 YAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI------PVLFKNISN-GVY-T-L----P----KFLSPGA 239 (275)
T ss_dssp TSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHH-TCC-C-C----C----TTSCHHH
T ss_pred cCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHc-CCC-C-C----C----CCCCHHH
Confidence 999999988876 5799999999999999999999954211 111111111 110 0 0 1 1122377
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHH
Q 021682 238 MQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 238 ~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.++|.+||+.||++|||++|+++.
T Consensus 240 ~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 240 AGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred HHHHHHHccCChhHCcCHHHHHcC
Confidence 899999999999999999999874
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-50 Score=348.83 Aligned_cols=247 Identities=26% Similarity=0.381 Sum_probs=195.6
Q ss_pred cceEEEEcC------CCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCC-CCccceeeEEeeC-CeeEEEEeccCCCChh
Q 021682 3 VAICQGRLP------NGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQH-VNLLPVLGICTQR-EEKMLIYDYMPNKSLD 73 (309)
Q Consensus 3 ~~~~~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~ 73 (309)
+.||+|.+. +++.||||.++... ......+..|++++++++| ||||+++++|..+ ..++||||||++|+|.
T Consensus 78 G~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~ 157 (353)
T 4ase_A 78 GQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLS 157 (353)
T ss_dssp EEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHH
T ss_pred eEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHH
Confidence 356777642 34689999997653 3345679999999999965 8999999998764 5689999999999999
Q ss_pred HHHhhhcc-------------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeeccccccc
Q 021682 74 FYIFDLRR-------------RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARA 140 (309)
Q Consensus 74 ~~~~~~~~-------------~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~ 140 (309)
+++..... ...+++..+..++.||+.|+.|||++ +++||||||+|||++.++.+||+|||+++.
T Consensus 158 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~vKi~DFGlar~ 234 (353)
T 4ase_A 158 TYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARD 234 (353)
T ss_dssp HHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSC
T ss_pred HHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccceeeCCCCCEEECcchhhhh
Confidence 99965322 34588999999999999999999999 899999999999999999999999999987
Q ss_pred ccCCcccccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcc
Q 021682 141 FTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGME 219 (309)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (309)
..........+...||+.|+|||.+.+..++.++|||||||++|||+| |..||......+. .......+....
T Consensus 235 ~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~------~~~~i~~g~~~~ 308 (353)
T 4ase_A 235 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEGTRMR 308 (353)
T ss_dssp TTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH------HHHHHHHTCCCC
T ss_pred cccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH------HHHHHHcCCCCC
Confidence 655444334445678999999999999999999999999999999998 8999865433221 111222222111
Q ss_pred cccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccC
Q 021682 220 FIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETA 267 (309)
Q Consensus 220 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~ 267 (309)
. +...+.++.+++.+||+.||++|||++||++.|+.+.+
T Consensus 309 ~---------p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 309 A---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp C---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C---------CccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 1 11123478899999999999999999999999988754
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=344.03 Aligned_cols=232 Identities=21% Similarity=0.224 Sum_probs=178.6
Q ss_pred ceEEEEc----CCCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 4 AICQGRL----PNGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 4 ~~~~~~~----~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
+||.+.. .+++.||||+++... .....++..|++++++++||||+++++++.+++.+|||||||+||+|.+++.
T Consensus 39 ~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~ 118 (304)
T 3ubd_A 39 KVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLS 118 (304)
T ss_dssp EEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHH
T ss_pred EEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHH
Confidence 5666643 367899999996542 2334568889999999999999999999999999999999999999999985
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
. ...+++..+..++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||+++........ .....||+
T Consensus 119 ~---~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~--~~~~~GT~ 190 (304)
T 3ubd_A 119 K---EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTV 190 (304)
T ss_dssp H---HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-----CC--CCSCCCCG
T ss_pred h---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccCCCcc--ccccccCc
Confidence 4 34599999999999999999999999 9999999999999999999999999999765433221 23357999
Q ss_pred CCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHH
Q 021682 158 GYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRC 237 (309)
Q Consensus 158 ~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (309)
.|+|||++.+..++.++|||||||++|+|++|+.||...+..+ ......... . .+ . ...+.++
T Consensus 191 ~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~------~~~~i~~~~-~-~~-----p----~~~s~~~ 253 (304)
T 3ubd_A 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE------TMTMILKAK-L-GM-----P----QFLSPEA 253 (304)
T ss_dssp GGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCC-C-CC-----C----TTSCHHH
T ss_pred ccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH------HHHHHHcCC-C-CC-----C----CcCCHHH
Confidence 9999999999999999999999999999999999996432211 111111111 0 11 1 1123378
Q ss_pred HHHHhhcccCCCCCCCC-----HHHHHH
Q 021682 238 MQVALLCVQENAADRPT-----MLEILV 260 (309)
Q Consensus 238 ~~li~~~l~~~p~~Rpt-----~~ell~ 260 (309)
.+||.+||+.||++||| ++|+++
T Consensus 254 ~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 254 QSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp HHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred HHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 89999999999999998 467775
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-49 Score=337.38 Aligned_cols=255 Identities=23% Similarity=0.230 Sum_probs=186.9
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCC----eeEEEEeccCCCChhHHHhh
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQRE----EKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~ 78 (309)
++||+|.+ +|+.||||+++.... .....+.|+..+.+++||||+++++++..++ .++||||||++|+|.+++..
T Consensus 17 G~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~ 94 (303)
T 3hmm_A 17 GEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR 94 (303)
T ss_dssp SEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH
T ss_pred eEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHh
Confidence 46789987 689999999965432 1223345666677889999999999998754 57999999999999999843
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhc-----CCCceeecCCCCceEEeCCCCCceeecccccccccCCccc--cccc
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEY-----SNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECE--ANTG 151 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~-----~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~--~~~~ 151 (309)
..+++..+..++.|++.|++|||++ +.+||+||||||+|||++.++.+||+|||+++........ ....
T Consensus 95 ----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~ 170 (303)
T 3hmm_A 95 ----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN 170 (303)
T ss_dssp ----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC--
T ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecc
Confidence 2488999999999999999999976 3458999999999999999999999999999766543322 1223
Q ss_pred ccccccCCCCccccccC------CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCc--------ccHHHHHHHHhhCCCC
Q 021682 152 RIVGTYGYVPPEYVRKG------IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNES--------LNLLEYAYGLWKNGEG 217 (309)
Q Consensus 152 ~~~~~~~y~aPE~~~~~------~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~--------~~~~~~~~~~~~~~~~ 217 (309)
...||+.|+|||++.+. .++.++|||||||++|||++|.+|+........ ................
T Consensus 171 ~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 250 (303)
T 3hmm_A 171 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL 250 (303)
T ss_dssp ---CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCC
T ss_pred cccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccC
Confidence 35799999999998764 357899999999999999999887753322111 0011111111111111
Q ss_pred cccccccCC-CcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccC
Q 021682 218 MEFIDSSLD-DSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETA 267 (309)
Q Consensus 218 ~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~ 267 (309)
++... ...+......+.+|+.+||+.||++|||+.||++.|+.+.+
T Consensus 251 ----rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 251 ----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp ----CCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 11111 11223345578899999999999999999999999987643
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=331.08 Aligned_cols=237 Identities=21% Similarity=0.275 Sum_probs=176.2
Q ss_pred ceEEEE-cCCCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCC------------eeEEEEeccCC
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQRE------------EKMLIYDYMPN 69 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------------~~~lv~e~~~~ 69 (309)
+||++. ..+|+.||||.++... ....+.+.+|++++++++|||||++++++...+ .+|+|||||.+
T Consensus 20 ~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~g 99 (299)
T 4g31_A 20 VVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRK 99 (299)
T ss_dssp EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCS
T ss_pred EEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCC
Confidence 566665 4589999999987543 334567899999999999999999999987544 37999999999
Q ss_pred CChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccc-
Q 021682 70 KSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEA- 148 (309)
Q Consensus 70 ~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~- 148 (309)
++|.+++.........++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++.........
T Consensus 100 g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~ 176 (299)
T 4g31_A 100 ENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 176 (299)
T ss_dssp CCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCCCC-----------
T ss_pred CcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEccCccceecCCCccccc
Confidence 99999996544444466777899999999999999999 99999999999999999999999999998765432211
Q ss_pred ---------cccccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcc
Q 021682 149 ---------NTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGME 219 (309)
Q Consensus 149 ---------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (309)
......||+.|+|||++.+..++.++|||||||++|+|++ ||... .... ............
T Consensus 177 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~-----~~~~-~~~~~~~~~~~p- 246 (299)
T 4g31_A 177 VLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ-----MERV-RTLTDVRNLKFP- 246 (299)
T ss_dssp ---------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH-----HHHH-HHHHHHHTTCCC-
T ss_pred cccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc-----cHHH-HHHHHHhcCCCC-
Confidence 1223469999999999999999999999999999999996 55311 1111 111111111111
Q ss_pred cccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 220 FIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 220 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.........+.+||.+||+.||++|||+.|+++.
T Consensus 247 --------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 247 --------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp --------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1112223356789999999999999999999873
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=334.79 Aligned_cols=253 Identities=20% Similarity=0.255 Sum_probs=184.5
Q ss_pred CccceEEEE-cCCCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEeeC------CeeEEEEeccCCCC
Q 021682 1 MSVAICQGR-LPNGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQR------EEKMLIYDYMPNKS 71 (309)
Q Consensus 1 ~g~~~~~~~-~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~~ 71 (309)
|| +||++. ..+|+.||||+++... ......+.+|+++|++++||||+++++++... ..+|||||||. |+
T Consensus 67 fG-~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~ 144 (398)
T 4b99_A 67 YG-VVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SD 144 (398)
T ss_dssp SC-EEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EE
T ss_pred Ce-EEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CC
Confidence 45 556665 5689999999996542 33456788999999999999999999987643 57899999996 67
Q ss_pred hhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcc--ccc
Q 021682 72 LDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDEC--EAN 149 (309)
Q Consensus 72 L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~--~~~ 149 (309)
|.+++. ....+++..+..++.||+.||.|||++ ||+||||||+||+++.++.+||+|||++........ ...
T Consensus 145 L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~ 218 (398)
T 4b99_A 145 LHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYF 218 (398)
T ss_dssp HHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCC
T ss_pred HHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeecccCccccccc
Confidence 888884 345699999999999999999999998 999999999999999999999999999976543221 122
Q ss_pred ccccccccCCCCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCC--------ccc
Q 021682 150 TGRIVGTYGYVPPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEG--------MEF 220 (309)
Q Consensus 150 ~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~ 220 (309)
.....||+.|+|||++.+. .++.++||||+||++|+|++|++||...+..+....+............ ...
T Consensus 219 ~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~ 298 (398)
T 4b99_A 219 MTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAY 298 (398)
T ss_dssp CCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHH
T ss_pred cccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhh
Confidence 3345799999999998775 5689999999999999999999999654332222211111100000000 000
Q ss_pred ccccCCC-ccc-----HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 221 IDSSLDD-SSS-----AWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 221 ~~~~~~~-~~~-----~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
+...... ..+ .....++.+||.+||+.||++|||++|+++.
T Consensus 299 ~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 299 IQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp HHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000 000 0112367899999999999999999999985
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=319.27 Aligned_cols=262 Identities=34% Similarity=0.578 Sum_probs=221.5
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc-c
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR-R 81 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~ 81 (309)
+.||++..++|+.||||.+........+.+.+|+.++++++||||+++++++..++..++||||+.+++|.+++.... .
T Consensus 53 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 132 (321)
T 2qkw_B 53 GKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLP 132 (321)
T ss_dssp SEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCC
T ss_pred eeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCC
Confidence 468899888899999999877666667889999999999999999999999999999999999999999998885432 2
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP 161 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 161 (309)
...+++..++.++.|++.|+.|||++ |++|+||||+||+++.++.+||+|||++................|+..|+|
T Consensus 133 ~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~a 209 (321)
T 2qkw_B 133 TMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYID 209 (321)
T ss_dssp SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCC
T ss_pred ccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccC
Confidence 33589999999999999999999998 999999999999999999999999999876543332222333468999999
Q ss_pred ccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHH
Q 021682 162 PEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241 (309)
Q Consensus 162 PE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 241 (309)
||.+.+..++.++||||||+++|+|++|+.||....+.+......+..............++.............+.+++
T Consensus 210 PE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 289 (321)
T 2qkw_B 210 PEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTA 289 (321)
T ss_dssp HHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHH
T ss_pred HHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHH
Confidence 99998889999999999999999999999999776666666665555555555555666666666666677788999999
Q ss_pred hhcccCCCCCCCCHHHHHHHHhcccC
Q 021682 242 LLCVQENAADRPTMLEILVMLKSETA 267 (309)
Q Consensus 242 ~~~l~~~p~~Rpt~~ell~~L~~~~~ 267 (309)
.+||+.||++|||++++++.|+....
T Consensus 290 ~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 290 VKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 99999999999999999999997754
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=341.90 Aligned_cols=237 Identities=20% Similarity=0.234 Sum_probs=190.6
Q ss_pred ceEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccc
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRR 82 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 82 (309)
+||++. ..+|+.||||.+........+.+.+|+.+|+.++||||++++++|.++..++||||||.||+|.+++.. ..
T Consensus 172 ~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~--~~ 249 (573)
T 3uto_A 172 VVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EH 249 (573)
T ss_dssp EEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTC--TT
T ss_pred EEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHH--hC
Confidence 456664 468999999999876666677899999999999999999999999999999999999999999998843 33
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCC--CCceeecccccccccCCcccccccccccccCCC
Q 021682 83 YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYE--MNPKISDFGMARAFTKDECEANTGRIVGTYGYV 160 (309)
Q Consensus 83 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~--~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 160 (309)
..+++..+..++.||+.||.|||++ ||+||||||+||+++.+ +.+||+|||++........ .....||+.|+
T Consensus 250 ~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~---~~~~~GT~~y~ 323 (573)
T 3uto_A 250 NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFA 323 (573)
T ss_dssp SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE---EEEECSSGGGC
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc---eeeeEECcccc
Confidence 4589999999999999999999999 89999999999999854 8899999999987654332 22347999999
Q ss_pred CccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHH
Q 021682 161 PPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQV 240 (309)
Q Consensus 161 aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 240 (309)
|||++.+..++.++|||||||++|+|++|.+||......+ .. ......... + ........+..+.+|
T Consensus 324 APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~------~~-~~i~~~~~~-~-----~~~~~~~~s~~~~dl 390 (573)
T 3uto_A 324 APEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------TL-RNVKSCDWN-M-----DDSAFSGISEDGKDF 390 (573)
T ss_dssp CHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HH-HHHHTTCCC-C-----CSGGGTTSCHHHHHH
T ss_pred CHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HH-HHHHhCCCC-C-----CcccccCCCHHHHHH
Confidence 9999999999999999999999999999999996432211 11 111111110 0 001111123367899
Q ss_pred HhhcccCCCCCCCCHHHHHHH
Q 021682 241 ALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 241 i~~~l~~~p~~Rpt~~ell~~ 261 (309)
|.+||+.||++|||++|+++.
T Consensus 391 i~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 391 IRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp HHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999974
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=317.00 Aligned_cols=181 Identities=22% Similarity=0.309 Sum_probs=151.0
Q ss_pred ceEEEEc----CCCcEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 4 AICQGRL----PNGQEMAVKRLSRTSHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 4 ~~~~~~~----~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
+||++.. .+++.||||.+.... ...++.+|+++|+.+ +||||+++++++.+++++++||||+++++|.+++.
T Consensus 36 ~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~- 112 (361)
T 4f9c_A 36 SVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN- 112 (361)
T ss_dssp EEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT-
T ss_pred EEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHc-
Confidence 4566642 367899999986543 345788999999998 69999999999999999999999999999998872
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCC-CCceeecccccccccCCccc----------
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYE-MNPKISDFGMARAFTKDECE---------- 147 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~-~~~~l~Dfg~~~~~~~~~~~---------- 147 (309)
.+++..+..++.||+.||+|||++ ||+||||||+|||++.+ +.+||+|||+|+........
T Consensus 113 -----~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~ 184 (361)
T 4f9c_A 113 -----SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQ 184 (361)
T ss_dssp -----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC-----
T ss_pred -----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccccccccccccc
Confidence 288999999999999999999999 99999999999999876 79999999999755432110
Q ss_pred ----------------ccccccccccCCCCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCC
Q 021682 148 ----------------ANTGRIVGTYGYVPPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCY 195 (309)
Q Consensus 148 ----------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~ 195 (309)
.......||+.|+|||++.+. .++.++||||+||++|+|++|+.||..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 185 QERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp ---------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred ccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 011234699999999998775 589999999999999999999999853
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=312.52 Aligned_cols=251 Identities=25% Similarity=0.377 Sum_probs=188.2
Q ss_pred cceEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
++||++.. +|+.||||++.... ......+.+|++++++++||||+++++++..+...++||||+.+++|.+++....
T Consensus 51 g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 129 (309)
T 3p86_A 51 GTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSG 129 (309)
T ss_dssp EEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTT
T ss_pred eEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcC
Confidence 46788876 68999999986553 3334678899999999999999999999999999999999999999999986544
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCc--eeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLT--IVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~g--i~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
....+++..++.++.|++.|++|||+. | ++||||||+||+++.++.++|+|||++........ ......|++.
T Consensus 130 ~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~--~~~~~~gt~~ 204 (309)
T 3p86_A 130 AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL--SSKSAAGTPE 204 (309)
T ss_dssp HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC-------------------CCT
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcccccccc--ccccCCCCcc
Confidence 344589999999999999999999998 8 99999999999999999999999999875443321 1223468999
Q ss_pred CCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHH
Q 021682 159 YVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238 (309)
Q Consensus 159 y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (309)
|+|||.+.+..++.++|||||||++|+|++|..||......+ .............. +......+.
T Consensus 205 y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~------~~~~~~~~~~~~~~---------~~~~~~~l~ 269 (309)
T 3p86_A 205 WMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ------VVAAVGFKCKRLEI---------PRNLNPQVA 269 (309)
T ss_dssp TSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH------HHHHHHHSCCCCCC---------CTTSCHHHH
T ss_pred ccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhcCCCCCC---------CccCCHHHH
Confidence 999999999999999999999999999999999986432211 11111111111111 111223788
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHhcccCCCCCCCC
Q 021682 239 QVALLCVQENAADRPTMLEILVMLKSETADIKTPKK 274 (309)
Q Consensus 239 ~li~~~l~~~p~~Rpt~~ell~~L~~~~~~~~~~~~ 274 (309)
++|.+||+.||++|||++++++.|+...+...+|+.
T Consensus 270 ~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~~ 305 (309)
T 3p86_A 270 AIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPN 305 (309)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHC-------
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999999998876665544
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=331.86 Aligned_cols=237 Identities=21% Similarity=0.206 Sum_probs=184.0
Q ss_pred CccceEEEEcCCCcEEEEEEeecCC---cccHHHHH---HHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhH
Q 021682 1 MSVAICQGRLPNGQEMAVKRLSRTS---HQGLEEFE---NEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDF 74 (309)
Q Consensus 1 ~g~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~---~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (309)
||.|...-...+|+.||||++.+.. ........ .++.+++.++||||++++++|.++..+||||||+.||+|.+
T Consensus 202 fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~ 281 (689)
T 3v5w_A 202 FGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHY 281 (689)
T ss_dssp SEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHH
T ss_pred CeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHH
Confidence 4555444455689999999996531 12223333 34667778899999999999999999999999999999999
Q ss_pred HHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccc
Q 021682 75 YIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIV 154 (309)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~ 154 (309)
++.. ...+++..+..++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||+|....... .....
T Consensus 282 ~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~----~~t~~ 351 (689)
T 3v5w_A 282 HLSQ---HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASV 351 (689)
T ss_dssp HHHH---HCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC----CCSCC
T ss_pred HHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecCCCC----CCCcc
Confidence 9854 34599999999999999999999998 99999999999999999999999999998765432 23357
Q ss_pred cccCCCCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHH
Q 021682 155 GTYGYVPPEYVRK-GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWK 233 (309)
Q Consensus 155 ~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
||+.|+|||++.+ ..++.++|+|||||++|+|++|.+||......+..... ........ .+ +...
T Consensus 352 GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~---~~i~~~~~--~~---------p~~~ 417 (689)
T 3v5w_A 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---RMTLTMAV--EL---------PDSF 417 (689)
T ss_dssp SCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHH---HHHHHCCC--CC---------CTTS
T ss_pred CCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HhhcCCCC--CC---------CccC
Confidence 9999999999864 57999999999999999999999999654333321111 11111110 00 1112
Q ss_pred HHHHHHHHhhcccCCCCCCCC-----HHHHHHH
Q 021682 234 LMRCMQVALLCVQENAADRPT-----MLEILVM 261 (309)
Q Consensus 234 ~~~l~~li~~~l~~~p~~Rpt-----~~ell~~ 261 (309)
+.++.+||.+||+.||++|++ ++|+++.
T Consensus 418 S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 418 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 237889999999999999998 7888764
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=309.18 Aligned_cols=262 Identities=35% Similarity=0.593 Sum_probs=213.2
Q ss_pred cceEEEEcCCCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc-
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR- 80 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~- 80 (309)
+.||++...+|+.||||.+.... ......+..|++++++++||||+++++++..+...++||||+.+++|.+++....
T Consensus 44 g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 123 (326)
T 3uim_A 44 GKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPE 123 (326)
T ss_dssp SEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCST
T ss_pred cEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccc
Confidence 46788888889999999986543 2223468999999999999999999999999999999999999999999986533
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCC
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYV 160 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 160 (309)
....+++..+..++.|++.|+.|||+.+..|++|+||||+||+++.++.++|+|||++......... ......|+..|+
T Consensus 124 ~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~ 202 (326)
T 3uim_A 124 SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHI 202 (326)
T ss_dssp TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSC-EECCCCSCGGGC
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCccccc-ccccccCCcCcc
Confidence 2345899999999999999999999986668999999999999999999999999999766543322 222345899999
Q ss_pred CccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCC--CCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHH
Q 021682 161 PPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYG--PNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238 (309)
Q Consensus 161 aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (309)
|||.+.+..++.++||||||+++|+|++|..||.... .........+..............+..............+.
T Consensus 203 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 282 (326)
T 3uim_A 203 APEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLI 282 (326)
T ss_dssp CHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHH
T ss_pred CHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHH
Confidence 9999988889999999999999999999999985211 12222334444444455555566666666677777888999
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHhcc
Q 021682 239 QVALLCVQENAADRPTMLEILVMLKSE 265 (309)
Q Consensus 239 ~li~~~l~~~p~~Rpt~~ell~~L~~~ 265 (309)
+++.+||+.||++|||+++++++|++.
T Consensus 283 ~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 283 QVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp HHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 999999999999999999999999874
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=301.48 Aligned_cols=236 Identities=22% Similarity=0.338 Sum_probs=190.7
Q ss_pred cceEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 3 VAICQGR-LPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 3 ~~~~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
+.||++. ..+|+.||||.+........+.+.+|+.++++++||||+++++++..+...++||||+.+++|.+++..
T Consensus 34 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--- 110 (297)
T 3fxz_A 34 GTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--- 110 (297)
T ss_dssp EEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH---
T ss_pred eEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhh---
Confidence 3567775 468999999999776666678899999999999999999999999999999999999999999998843
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP 161 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 161 (309)
..+++..+..++.|++.|+.|||+. |++||||||+||+++.++.++|+|||++......... .....|++.|+|
T Consensus 111 -~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~a 184 (297)
T 3fxz_A 111 -TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMA 184 (297)
T ss_dssp -SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC--BCCCCSCGGGCC
T ss_pred -cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc--cCCccCCcCccC
Confidence 2489999999999999999999998 9999999999999999999999999998765543322 233468999999
Q ss_pred ccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHH
Q 021682 162 PEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241 (309)
Q Consensus 162 PE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 241 (309)
||.+.+..++.++|||||||++|+|++|..||....... .......... .. ...+......+.++|
T Consensus 185 PE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~~~~~~-~~-------~~~~~~~~~~~~~li 250 (297)
T 3fxz_A 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNGT-PE-------LQNPEKLSAIFRDFL 250 (297)
T ss_dssp HHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHHCS-CC-------CSCGGGSCHHHHHHH
T ss_pred hhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCC-CC-------CCCccccCHHHHHHH
Confidence 999999999999999999999999999999985432211 1111111110 00 011112234688999
Q ss_pred hhcccCCCCCCCCHHHHHHH
Q 021682 242 LLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 242 ~~~l~~~p~~Rpt~~ell~~ 261 (309)
.+||+.||++|||++|+++.
T Consensus 251 ~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 251 NRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp HHHSCSSTTTSCCHHHHTTC
T ss_pred HHHccCChhHCcCHHHHhhC
Confidence 99999999999999999864
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=301.90 Aligned_cols=248 Identities=23% Similarity=0.380 Sum_probs=197.4
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
+.||++.. .+|+.||+|.+..........+.+|++++++++||||+++++++..+...++||||+.+++|.+++...
T Consensus 24 g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-- 101 (310)
T 3s95_A 24 GQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSM-- 101 (310)
T ss_dssp EEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHC--
T ss_pred EEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhc--
Confidence 35666654 579999999987766667788999999999999999999999999999999999999999999998542
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccc------------
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEAN------------ 149 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~------------ 149 (309)
...+++..+..++.|++.|++|||+. |++|+||||+||+++.++.++|+|||++...........
T Consensus 102 ~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (310)
T 3s95_A 102 DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKK 178 (310)
T ss_dssp CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-------------------
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccccccccccccccccccc
Confidence 34589999999999999999999998 899999999999999999999999999976644322110
Q ss_pred ccccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccH--HHHHHHHhhCCCCcccccccCCC
Q 021682 150 TGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNL--LEYAYGLWKNGEGMEFIDSSLDD 227 (309)
Q Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 227 (309)
.....||+.|+|||.+.+..++.++||||||+++|+|++|..|+........... ........ ...
T Consensus 179 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~ 246 (310)
T 3s95_A 179 RYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY------------CPP 246 (310)
T ss_dssp -CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHT------------CCT
T ss_pred ccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccccc------------CCC
Confidence 1134689999999999999999999999999999999999999865433322111 11110000 001
Q ss_pred cccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccCCCCC
Q 021682 228 SSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETADIKT 271 (309)
Q Consensus 228 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~~~~ 271 (309)
. .+..+.+++.+||+.||++|||++++++.|+.+...+..
T Consensus 247 ~----~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~ 286 (310)
T 3s95_A 247 N----CPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG 286 (310)
T ss_dssp T----CCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred C----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence 1 112677999999999999999999999999988665443
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=305.92 Aligned_cols=232 Identities=25% Similarity=0.353 Sum_probs=187.2
Q ss_pred ceEEEE-cCCCcEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 4 AICQGR-LPNGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
.||.+. ..+|+.||||++... .....+.+.+|++++++++||||+++++++..+...++||||+.+++|.+++...
T Consensus 30 ~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~- 108 (328)
T 3fe3_A 30 KVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH- 108 (328)
T ss_dssp EEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHH-
T ss_pred EEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHc-
Confidence 456665 468999999999754 3445667889999999999999999999999999999999999999999998543
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCC
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYV 160 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 160 (309)
..+++..+..++.|++.|+.|||+. |++||||||+||+++.++.+||+|||++........ .....|++.|+
T Consensus 109 --~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~ 180 (328)
T 3fe3_A 109 --GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDAFCGAPPYA 180 (328)
T ss_dssp --CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG---GGTTSSSGGGC
T ss_pred --CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc---cccccCCccee
Confidence 3489999999999999999999998 999999999999999999999999999976554322 23346899999
Q ss_pred CccccccCCCC-ccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHH
Q 021682 161 PPEYVRKGIYS-MKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQ 239 (309)
Q Consensus 161 aPE~~~~~~~~-~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (309)
|||.+.+..+. .++|||||||++|+|++|..||......+ ........... .+...+..+.+
T Consensus 181 aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~i~~~~~~-----------~p~~~s~~~~~ 243 (328)
T 3fe3_A 181 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE------LRERVLRGKYR-----------IPFYMSTDCEN 243 (328)
T ss_dssp CHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCCC-----------CCTTSCHHHHH
T ss_pred CcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCCC-----------CCCCCCHHHHH
Confidence 99999887764 79999999999999999999986432111 11111111110 00112236789
Q ss_pred HHhhcccCCCCCCCCHHHHHHH
Q 021682 240 VALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 240 li~~~l~~~p~~Rpt~~ell~~ 261 (309)
++.+||+.||++|||++|+++.
T Consensus 244 li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 244 LLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HHHHHCCSSTTTSCCHHHHTTC
T ss_pred HHHHHCCCChhHCcCHHHHhcC
Confidence 9999999999999999999976
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=295.67 Aligned_cols=258 Identities=33% Similarity=0.492 Sum_probs=203.4
Q ss_pred cceEEEEcCCCcEEEEEEeecC----CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 3 VAICQGRLPNGQEMAVKRLSRT----SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
+.||++.. +++.||||.+... .....+.+.+|+.++++++||||+++++++..+...++||||+++++|.+++..
T Consensus 45 g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 123 (307)
T 2nru_A 45 GVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC 123 (307)
T ss_dssp EEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHT
T ss_pred eEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHh
Confidence 46788886 7899999998653 233457889999999999999999999999999999999999999999999866
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
......+++..++.++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++................|+..
T Consensus 124 ~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~ 200 (307)
T 2nru_A 124 LDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTA 200 (307)
T ss_dssp GGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGG
T ss_pred ccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcC
Confidence 55556699999999999999999999998 999999999999999999999999999876554333222334568999
Q ss_pred CCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHH
Q 021682 159 YVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238 (309)
Q Consensus 159 y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (309)
|+|||.+.+ .++.++||||||+++|+|++|..||................. .........++... ..........+.
T Consensus 201 y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~l~ 277 (307)
T 2nru_A 201 YMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIE-DEEKTIEDYIDKKM-NDADSTSVEAMY 277 (307)
T ss_dssp GCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHH-TTSCCHHHHSCSSC-SCCCHHHHHHHH
T ss_pred cCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhh-hhhhhhhhhccccc-cccchHHHHHHH
Confidence 999998865 478999999999999999999999976544333222211111 11111122222222 233455667899
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHhcccC
Q 021682 239 QVALLCVQENAADRPTMLEILVMLKSETA 267 (309)
Q Consensus 239 ~li~~~l~~~p~~Rpt~~ell~~L~~~~~ 267 (309)
+++.+||+.||++|||++++++.|+.+.+
T Consensus 278 ~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 278 SVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 99999999999999999999999998754
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=295.15 Aligned_cols=258 Identities=21% Similarity=0.247 Sum_probs=198.7
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCC--eeEEEEeccCCCChhHHHhh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQRE--EKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~ 78 (309)
+.||++.. .+|+.||||+++... ....+.+.+|++++++++||||+++++++.... ..++||||+.+++|.+++..
T Consensus 23 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 102 (319)
T 4euu_A 23 ANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE 102 (319)
T ss_dssp EEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHS
T ss_pred eEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHH
Confidence 35677765 469999999997543 344677889999999999999999999988765 78999999999999999976
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEe----CCCCCceeecccccccccCCcccccccccc
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL----DYEMNPKISDFGMARAFTKDECEANTGRIV 154 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~----~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~ 154 (309)
......+++..++.++.|++.|+.|||+. |++|+||||+||++ +.++.+||+|||++........ .....
T Consensus 103 ~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~ 176 (319)
T 4euu_A 103 PSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLY 176 (319)
T ss_dssp GGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCC---BCCCC
T ss_pred hccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCc---eeecc
Confidence 55555599999999999999999999999 99999999999999 7778899999999976654332 22246
Q ss_pred cccCCCCccccc--------cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHH-HHHHhhCCCCccc-----
Q 021682 155 GTYGYVPPEYVR--------KGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEY-AYGLWKNGEGMEF----- 220 (309)
Q Consensus 155 ~~~~y~aPE~~~--------~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~----- 220 (309)
|+..|+|||.+. +..++.++|||||||++|+|++|..||.............. .............
T Consensus 177 gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 256 (319)
T 4euu_A 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAEN 256 (319)
T ss_dssp SCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTT
T ss_pred cCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccC
Confidence 899999999886 46789999999999999999999999975544333222221 1111111100000
Q ss_pred ----c--cccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhccc
Q 021682 221 ----I--DSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSET 266 (309)
Q Consensus 221 ----~--~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~ 266 (309)
. ...............+.++|.+||+.||++|||++|+++......
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 257 GPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp CCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred CccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 0 001122344556678889999999999999999999999988654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=301.64 Aligned_cols=240 Identities=23% Similarity=0.288 Sum_probs=186.7
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
+.||++.. .+|+.||||++.... ....+.+.+|+.+++.++||||+++++++..+...++||||+.+++|.+++.
T Consensus 21 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~--- 97 (323)
T 3tki_A 21 GEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--- 97 (323)
T ss_dssp EEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSB---
T ss_pred EEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHh---
Confidence 35666654 589999999986543 2234668899999999999999999999999999999999999999988873
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCC
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYV 160 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 160 (309)
....+++..+..++.|++.|+.|||+. |++||||||+||+++.++.++|+|||++................|++.|+
T Consensus 98 ~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 174 (323)
T 3tki_A 98 PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174 (323)
T ss_dssp TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGS
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCcc
Confidence 344599999999999999999999998 99999999999999999999999999997655433333333457899999
Q ss_pred CccccccCCC-CccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHH
Q 021682 161 PPEYVRKGIY-SMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQ 239 (309)
Q Consensus 161 aPE~~~~~~~-~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (309)
|||.+.+..+ +.++|||||||++|+|++|..||......... ...+...... . .........+.+
T Consensus 175 aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~------~~~~~~~~~~--~------~~~~~~~~~~~~ 240 (323)
T 3tki_A 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE------YSDWKEKKTY--L------NPWKKIDSAPLA 240 (323)
T ss_dssp CHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH------HHHHHTTCTT--S------TTGGGSCHHHHH
T ss_pred CcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH------HHHHhccccc--C------CccccCCHHHHH
Confidence 9999987765 77899999999999999999999654332211 1111111110 0 001112336779
Q ss_pred HHhhcccCCCCCCCCHHHHHHHH
Q 021682 240 VALLCVQENAADRPTMLEILVML 262 (309)
Q Consensus 240 li~~~l~~~p~~Rpt~~ell~~L 262 (309)
+|.+||+.||++|||++|+++.-
T Consensus 241 li~~~L~~dP~~R~t~~eil~h~ 263 (323)
T 3tki_A 241 LLHKILVENPSARITIPDIKKDR 263 (323)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCT
T ss_pred HHHHHccCChhhCcCHHHHhhCh
Confidence 99999999999999999998763
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=307.37 Aligned_cols=246 Identities=24% Similarity=0.363 Sum_probs=194.5
Q ss_pred cceEEEEc--------CCCcEEEEEEeecCC-cccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCCh
Q 021682 3 VAICQGRL--------PNGQEMAVKRLSRTS-HQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSL 72 (309)
Q Consensus 3 ~~~~~~~~--------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 72 (309)
+.||.+.. .++..||||.++... ......+..|+.+++++ +||||+++++++..+...++||||+.+++|
T Consensus 95 g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L 174 (370)
T 2psq_A 95 GQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 174 (370)
T ss_dssp SEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred eeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCH
Confidence 35666653 356689999997653 33456789999999999 899999999999999999999999999999
Q ss_pred hHHHhhhcc-------------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccc
Q 021682 73 DFYIFDLRR-------------RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMAR 139 (309)
Q Consensus 73 ~~~~~~~~~-------------~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~ 139 (309)
.+++..... ...+++..++.++.||+.||.|||++ |++||||||+||+++.++.+||+|||++.
T Consensus 175 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 251 (370)
T 2psq_A 175 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR 251 (370)
T ss_dssp HHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCSSCE
T ss_pred HHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEECCCCCEEEccccCCc
Confidence 999865331 23478899999999999999999998 99999999999999999999999999997
Q ss_pred cccCCcccccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCc
Q 021682 140 AFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGM 218 (309)
Q Consensus 140 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (309)
...............+++.|+|||.+.+..++.++|||||||++|+|++ |..||......+ .. .........
T Consensus 252 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~---~~----~~~~~~~~~ 324 (370)
T 2psq_A 252 DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---LF----KLLKEGHRM 324 (370)
T ss_dssp ETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HH----HHHHTTCCC
T ss_pred ccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH----HHHhcCCCC
Confidence 6654333222333456788999999999999999999999999999999 999986543222 11 111111111
Q ss_pred ccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccC
Q 021682 219 EFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETA 267 (309)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~ 267 (309)
. .+......+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 325 ~---------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 325 D---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp C---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1 111123378899999999999999999999999998753
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=293.33 Aligned_cols=242 Identities=24% Similarity=0.366 Sum_probs=194.6
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccc
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRR 82 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 82 (309)
+.||++...++..||+|.++.... ..+.+.+|++++++++||||+++++++..+...++||||+++++|.+++... +
T Consensus 22 g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~ 98 (268)
T 3sxs_A 22 GVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSH--G 98 (268)
T ss_dssp EEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHH--G
T ss_pred ceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHc--C
Confidence 367888888888999999965443 4577899999999999999999999999999999999999999999998543 3
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCc
Q 021682 83 YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPP 162 (309)
Q Consensus 83 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 162 (309)
..+++..++.++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++.......... .....++..|+||
T Consensus 99 ~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aP 174 (268)
T 3sxs_A 99 KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS-SVGTKFPVKWSAP 174 (268)
T ss_dssp GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE-CCSCCCCGGGCCH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhhc-ccCCCcCcccCCH
Confidence 3489999999999999999999998 99999999999999999999999999997655443222 2223456789999
Q ss_pred cccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHH
Q 021682 163 EYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241 (309)
Q Consensus 163 E~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 241 (309)
|.+.+..++.++||||||+++|+|++ |..||....... .... ........ . +...+..+.+++
T Consensus 175 E~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~-~~~~~~~~--~-------~~~~~~~l~~li 238 (268)
T 3sxs_A 175 EVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE------VVLK-VSQGHRLY--R-------PHLASDTIYQIM 238 (268)
T ss_dssp HHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HHHH-HHTTCCCC--C-------CTTSCHHHHHHH
T ss_pred HHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH------HHHH-HHcCCCCC--C-------CCcChHHHHHHH
Confidence 99998889999999999999999998 999985432211 1111 11111100 0 011123688999
Q ss_pred hhcccCCCCCCCCHHHHHHHHhcccC
Q 021682 242 LLCVQENAADRPTMLEILVMLKSETA 267 (309)
Q Consensus 242 ~~~l~~~p~~Rpt~~ell~~L~~~~~ 267 (309)
.+||+.||++|||+.++++.|+.+.+
T Consensus 239 ~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 239 YSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp HHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred HHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 99999999999999999999998755
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=301.97 Aligned_cols=256 Identities=21% Similarity=0.266 Sum_probs=192.7
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCC----eeEEEEeccCCCChhHHHhh
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQRE----EKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~ 78 (309)
+.||++.. .|+.||||++.... ........|+.++++++||||+++++++.... ..++||||+.+++|.+++..
T Consensus 38 g~Vy~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 115 (322)
T 3soc_A 38 GCVWKAQL-LNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA 115 (322)
T ss_dssp CEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH
T ss_pred eEEEEEEE-CCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHh
Confidence 46788876 48999999996543 23445667899999999999999999998754 47999999999999999843
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhc-------CCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccc
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEY-------SNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTG 151 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~-------~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 151 (309)
..+++..+..++.|++.|+.|||+. +..|++|+||||+||+++.++.+||+|||++.............
T Consensus 116 ----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~ 191 (322)
T 3soc_A 116 ----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTH 191 (322)
T ss_dssp ----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCT
T ss_pred ----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccc
Confidence 2389999999999999999999986 23479999999999999999999999999997765544333333
Q ss_pred ccccccCCCCccccccC-----CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHH---------HHHHHhhCCCC
Q 021682 152 RIVGTYGYVPPEYVRKG-----IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLE---------YAYGLWKNGEG 217 (309)
Q Consensus 152 ~~~~~~~y~aPE~~~~~-----~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~---------~~~~~~~~~~~ 217 (309)
...||..|+|||.+.+. .++.++|||||||++|+|++|..||............. ...........
T Consensus 192 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (322)
T 3soc_A 192 GQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKK 271 (322)
T ss_dssp TCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCC
T ss_pred cCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccC
Confidence 45789999999998763 45678899999999999999999987543322211111 11111111111
Q ss_pred cccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccC
Q 021682 218 MEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETA 267 (309)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~ 267 (309)
...+.. ..........+.++|.+||+.||++|||++++++.|+.+.+
T Consensus 272 ~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 272 RPVLRD---YWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp CCCCCG---GGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCccc---cccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 111111 01122344568899999999999999999999999987643
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=292.70 Aligned_cols=260 Identities=16% Similarity=0.120 Sum_probs=203.6
Q ss_pred cceEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 3 VAICQGR-LPNGQEMAVKRLSRTSHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 3 ~~~~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
+.||++. ..+|+.||||.+..... ...+.+|+.+++++ +|++++++++++..+...++||||+ +++|.+++...
T Consensus 24 g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~- 99 (298)
T 1csn_A 24 GVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLC- 99 (298)
T ss_dssp CEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT-
T ss_pred EEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHh-
Confidence 4677776 46899999999865432 34678899999999 8999999999999999999999999 89999998543
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCC-----ceeecccccccccCCccc-----ccc
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMN-----PKISDFGMARAFTKDECE-----ANT 150 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~-----~~l~Dfg~~~~~~~~~~~-----~~~ 150 (309)
+..+++..+..++.|++.|+.|||++ |++||||||+||+++.++. ++|+|||++......... ...
T Consensus 100 -~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 175 (298)
T 1csn_A 100 -GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 175 (298)
T ss_dssp -TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCC
T ss_pred -ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCc
Confidence 33489999999999999999999998 9999999999999987766 999999999776543221 112
Q ss_pred cccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCccc
Q 021682 151 GRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSS 230 (309)
Q Consensus 151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (309)
....|+..|+|||.+.+..++.++||||||+++|+|++|+.||............................ .
T Consensus 176 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~--- 247 (298)
T 1csn_A 176 KNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC-----A--- 247 (298)
T ss_dssp CCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHT-----T---
T ss_pred cCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHH-----h---
Confidence 34468999999999999899999999999999999999999997654443332222221111111111110 0
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccCCCCCCCCCCccc
Q 021682 231 AWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETADIKTPKKPAFSV 279 (309)
Q Consensus 231 ~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~~~~~~~p~~~~ 279 (309)
..+..+.+++.+||+.||++|||+++|++.|+.+...........++|
T Consensus 248 -~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw 295 (298)
T 1csn_A 248 -GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDW 295 (298)
T ss_dssp -TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGG
T ss_pred -hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCcccc
Confidence 112378899999999999999999999999999988777666655665
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=294.98 Aligned_cols=242 Identities=25% Similarity=0.392 Sum_probs=194.1
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccc
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRR 82 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 82 (309)
+.||++...+++.||+|.+.... ...+.+.+|++++++++||||+++++++..+...++||||+++++|.+++.. ..
T Consensus 24 g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~ 100 (269)
T 4hcu_A 24 GLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT--QR 100 (269)
T ss_dssp CEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHT--TT
T ss_pred cEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHh--cC
Confidence 46788888789999999996543 3457799999999999999999999999999999999999999999999843 33
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCc
Q 021682 83 YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPP 162 (309)
Q Consensus 83 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 162 (309)
..+++..++.++.|++.|+.+||+. |++|+||||+||+++.++.++|+|||++......... ......++..|+||
T Consensus 101 ~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aP 176 (269)
T 4hcu_A 101 GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASP 176 (269)
T ss_dssp TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH-STTSTTCCGGGCCH
T ss_pred cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccccc-cccCcccccccCCH
Confidence 4589999999999999999999998 8999999999999999999999999999765443221 12223567789999
Q ss_pred cccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHH
Q 021682 163 EYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241 (309)
Q Consensus 163 E~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 241 (309)
|.+.+..++.++||||||+++|+|++ |..||......+ .. ......... ..+......+.+++
T Consensus 177 E~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~------~~-~~~~~~~~~---------~~~~~~~~~~~~li 240 (269)
T 4hcu_A 177 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------VV-EDISTGFRL---------YKPRLASTHVYQIM 240 (269)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HH-HHHHTTCCC---------CCCTTSCHHHHHHH
T ss_pred HHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH------HH-HHHhcCccC---------CCCCcCCHHHHHHH
Confidence 99998999999999999999999999 899985432211 11 111111100 00111123688999
Q ss_pred hhcccCCCCCCCCHHHHHHHHhcccC
Q 021682 242 LLCVQENAADRPTMLEILVMLKSETA 267 (309)
Q Consensus 242 ~~~l~~~p~~Rpt~~ell~~L~~~~~ 267 (309)
.+||+.||++|||++++++.|+.+.+
T Consensus 241 ~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 241 NHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHccCCcccCcCHHHHHHHHHHHHH
Confidence 99999999999999999999987654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=296.40 Aligned_cols=236 Identities=22% Similarity=0.354 Sum_probs=190.8
Q ss_pred cceEEEEcC-CCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 3 VAICQGRLP-NGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 3 ~~~~~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
+.||++... +|+.||||.+........+.+.+|+.++++++||||+++++++..+...++||||+.+++|.+++..
T Consensus 59 g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--- 135 (321)
T 2c30_A 59 GIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--- 135 (321)
T ss_dssp EEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT---
T ss_pred eEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh---
Confidence 356777654 8999999999877666778899999999999999999999999999999999999999999998732
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP 161 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 161 (309)
..+++..+..++.|++.|+.|||+. |++|+||||+||+++.++.++|+|||++......... .....|+..|+|
T Consensus 136 -~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~a 209 (321)
T 2c30_A 136 -VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMA 209 (321)
T ss_dssp -CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC--BCCCCSCGGGCC
T ss_pred -cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc--cccccCCccccC
Confidence 3489999999999999999999998 9999999999999999999999999998765543221 223468999999
Q ss_pred ccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHH
Q 021682 162 PEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241 (309)
Q Consensus 162 PE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 241 (309)
||.+.+..++.++||||||+++|+|++|..||....... .. ........... ......+..+.++|
T Consensus 210 PE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~---~~----~~~~~~~~~~~-------~~~~~~~~~l~~li 275 (321)
T 2c30_A 210 PEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---AM----KRLRDSPPPKL-------KNSHKVSPVLRDFL 275 (321)
T ss_dssp HHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HH----HHHHHSSCCCC-------TTGGGSCHHHHHHH
T ss_pred HhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH----HHHhcCCCCCc-------CccccCCHHHHHHH
Confidence 999998889999999999999999999999985432211 11 11111111110 00111233688999
Q ss_pred hhcccCCCCCCCCHHHHHHH
Q 021682 242 LLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 242 ~~~l~~~p~~Rpt~~ell~~ 261 (309)
.+||+.||++|||++++++.
T Consensus 276 ~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 276 ERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHSCSSTTTSCCHHHHHTS
T ss_pred HHHccCChhhCcCHHHHhcC
Confidence 99999999999999999975
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=311.03 Aligned_cols=243 Identities=23% Similarity=0.346 Sum_probs=192.7
Q ss_pred cceEEEEcC-CCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 3 VAICQGRLP-NGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 3 ~~~~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
+.||+|... +|+.||||.++... ......+.+|++++++++||||+++++++..+...++||||+++++|.+++...
T Consensus 128 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~- 206 (377)
T 3cbl_A 128 GEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE- 206 (377)
T ss_dssp EEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHH-
T ss_pred CeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhc-
Confidence 467888764 79999999987542 333456889999999999999999999999989999999999999999998543
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCC
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYV 160 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 160 (309)
+..+++..+..++.|++.|++|||++ |++||||+|+||+++.++.+||+|||++............+...++..|+
T Consensus 207 -~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~ 282 (377)
T 3cbl_A 207 -GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT 282 (377)
T ss_dssp -GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGS
T ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcC
Confidence 33489999999999999999999998 89999999999999999999999999987644332222222234577899
Q ss_pred CccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHH
Q 021682 161 PPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQ 239 (309)
Q Consensus 161 aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (309)
|||.+.+..++.++|||||||++|+|++ |..||......+ .......+..... +...+..+.+
T Consensus 283 aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~~---------~~~~~~~l~~ 346 (377)
T 3cbl_A 283 APEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-------TREFVEKGGRLPC---------PELCPDAVFR 346 (377)
T ss_dssp CHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH-------HHHHHHTTCCCCC---------CTTCCHHHHH
T ss_pred CHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCCCC---------CCCCCHHHHH
Confidence 9999998889999999999999999998 999986432211 1111111111111 1112337889
Q ss_pred HHhhcccCCCCCCCCHHHHHHHHhccc
Q 021682 240 VALLCVQENAADRPTMLEILVMLKSET 266 (309)
Q Consensus 240 li~~~l~~~p~~Rpt~~ell~~L~~~~ 266 (309)
++.+||+.||++|||++++++.|+.+.
T Consensus 347 li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 347 LMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 999999999999999999999998764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=302.13 Aligned_cols=236 Identities=23% Similarity=0.261 Sum_probs=186.7
Q ss_pred ceEEEE-cCCCcEEEEEEeecCCc------ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHH
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTSH------QGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 76 (309)
+||++. ..+|+.||+|.++.... ...+.+.+|+.++++++||||+++++++..+...++||||+.+++|.+++
T Consensus 27 ~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l 106 (361)
T 2yab_A 27 IVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL 106 (361)
T ss_dssp EEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHH
T ss_pred EEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHH
Confidence 456665 45799999999976432 23578999999999999999999999999999999999999999999998
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCC----CceeecccccccccCCcccccccc
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM----NPKISDFGMARAFTKDECEANTGR 152 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~----~~~l~Dfg~~~~~~~~~~~~~~~~ 152 (309)
.. ...+++..+..++.||+.|+.|||++ |++|+||||+||+++.++ .++|+|||++........ ...
T Consensus 107 ~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~---~~~ 177 (361)
T 2yab_A 107 AQ---KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKN 177 (361)
T ss_dssp TT---CSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCC---CCC
T ss_pred Hh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCc---ccc
Confidence 43 34589999999999999999999998 999999999999998876 799999999976554321 223
Q ss_pred cccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHH
Q 021682 153 IVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAW 232 (309)
Q Consensus 153 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (309)
..||+.|+|||.+.+..++.++|+|||||++|+|++|..||......+ .. ........ . +.. .....
T Consensus 178 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~------~~-~~i~~~~~-~-~~~----~~~~~ 244 (361)
T 2yab_A 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TL-ANITAVSY-D-FDE----EFFSQ 244 (361)
T ss_dssp CCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HH-HHHHTTCC-C-CCH----HHHTT
T ss_pred CCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH------HH-HHHHhcCC-C-CCc----hhccC
Confidence 468999999999998899999999999999999999999985432111 11 11111110 0 000 00011
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 233 KLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 233 ~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.+..+.++|.+||..||++|||++|+++.
T Consensus 245 ~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 245 TSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 22367899999999999999999999864
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=296.70 Aligned_cols=259 Identities=13% Similarity=0.096 Sum_probs=200.0
Q ss_pred cceEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 3 VAICQGR-LPNGQEMAVKRLSRTSHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 3 ~~~~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
+.||.+. ..+|+.||||.+..... ...+..|+++++++ +|+||+++++++..+...++||||+ +++|.+++...
T Consensus 23 g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~- 98 (330)
T 2izr_A 23 GELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLC- 98 (330)
T ss_dssp TSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT-
T ss_pred ceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHc-
Confidence 3567776 46899999999865432 34688999999999 9999999999999999999999999 89999998543
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCC-----ceeecccccccccCCcccc-----cc
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMN-----PKISDFGMARAFTKDECEA-----NT 150 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~-----~~l~Dfg~~~~~~~~~~~~-----~~ 150 (309)
...+++..++.++.|++.|+.|||+. |++||||||+||+++.++. ++|+|||++.......... ..
T Consensus 99 -~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~ 174 (330)
T 2izr_A 99 -DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREH 174 (330)
T ss_dssp -TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCC
T ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCcccccccc
Confidence 34599999999999999999999998 9999999999999998887 9999999998654432211 12
Q ss_pred cccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCccc
Q 021682 151 GRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSS 230 (309)
Q Consensus 151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (309)
....||+.|+|||.+.+..++.++|||||||++|+|++|..||......+................. ... ...
T Consensus 175 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~-~~~----~~~-- 247 (330)
T 2izr_A 175 KSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI-EVL----CEN-- 247 (330)
T ss_dssp CCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH-HHH----TTT--
T ss_pred CCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH-HHH----hcc--
Confidence 3457899999999999999999999999999999999999999765444332222221111000000 000 000
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccCCCCCCCCCCccc
Q 021682 231 AWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETADIKTPKKPAFSV 279 (309)
Q Consensus 231 ~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~~~~~~~p~~~~ 279 (309)
.+ .+.+++.+||+.||.+||++++|++.|+.+...........++|
T Consensus 248 --~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw 293 (330)
T 2izr_A 248 --FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDW 293 (330)
T ss_dssp --CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTT
T ss_pred --Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccC
Confidence 12 78899999999999999999999999987766554444434444
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=294.14 Aligned_cols=253 Identities=23% Similarity=0.355 Sum_probs=190.4
Q ss_pred cceEEEE-----cCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeC--CeeEEEEeccCCCChhHH
Q 021682 3 VAICQGR-----LPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQR--EEKMLIYDYMPNKSLDFY 75 (309)
Q Consensus 3 ~~~~~~~-----~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~ 75 (309)
++||.+. ..+|+.||||.+........+.+.+|++++++++||||+++++++... ...++||||+.+++|.++
T Consensus 24 g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 103 (295)
T 3ugc_A 24 GSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDY 103 (295)
T ss_dssp EEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHH
T ss_pred EEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHH
Confidence 4567775 347899999999876666677899999999999999999999998653 468999999999999999
Q ss_pred HhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccc-ccccccc
Q 021682 76 IFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECE-ANTGRIV 154 (309)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~ 154 (309)
+... ...+++..+..++.|++.|+.|||+. |++|+||||+||+++.++.++|+|||++......... .......
T Consensus 104 l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 178 (295)
T 3ugc_A 104 LQKH--KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGE 178 (295)
T ss_dssp HHHC--GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTT
T ss_pred HHhc--ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCC
Confidence 8543 33489999999999999999999998 9999999999999999999999999999766543221 1122234
Q ss_pred cccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCC--------C-CcccHHHHHHHHhhCCCCcccccccC
Q 021682 155 GTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGP--------N-ESLNLLEYAYGLWKNGEGMEFIDSSL 225 (309)
Q Consensus 155 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~--------~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (309)
++..|+|||.+.+..++.++||||||+++|+|++|..|+..... . ....................
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 252 (295)
T 3ugc_A 179 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP------ 252 (295)
T ss_dssp CGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCC------
T ss_pred CccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcCC------
Confidence 67789999999999999999999999999999999988753210 0 00000001111111111111
Q ss_pred CCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccCCC
Q 021682 226 DDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETADI 269 (309)
Q Consensus 226 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~~ 269 (309)
.+...+..+.+++.+||+.||++|||++++++.|+.+.+.+
T Consensus 253 ---~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 253 ---RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp ---CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred ---CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 11122347889999999999999999999999999886654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=302.45 Aligned_cols=256 Identities=24% Similarity=0.329 Sum_probs=198.9
Q ss_pred cceEEEEc--------CCCcEEEEEEeecC-CcccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCCh
Q 021682 3 VAICQGRL--------PNGQEMAVKRLSRT-SHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSL 72 (309)
Q Consensus 3 ~~~~~~~~--------~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 72 (309)
+.||++.. .++..||||+++.. .......+.+|+++++++ +||||+++++++..++..++||||+.+++|
T Consensus 83 g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L 162 (382)
T 3tt0_A 83 GQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 162 (382)
T ss_dssp EEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred eEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcH
Confidence 35666653 23467999999755 334457789999999999 999999999999999999999999999999
Q ss_pred hHHHhhhcc-------------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccc
Q 021682 73 DFYIFDLRR-------------RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMAR 139 (309)
Q Consensus 73 ~~~~~~~~~-------------~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~ 139 (309)
.+++..... ...+++..++.++.|++.||.|||+. |++||||||+||+++.++.+||+|||++.
T Consensus 163 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DFG~a~ 239 (382)
T 3tt0_A 163 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR 239 (382)
T ss_dssp HHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSCSCCC
T ss_pred HHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEEcCCCcEEEcccCccc
Confidence 999865432 23589999999999999999999998 99999999999999999999999999997
Q ss_pred cccCCcccccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCc
Q 021682 140 AFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGM 218 (309)
Q Consensus 140 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (309)
...............++..|+|||.+.+..++.++|||||||++|+|++ |..||......+ ...........
T Consensus 240 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~-------~~~~~~~~~~~ 312 (382)
T 3tt0_A 240 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-------LFKLLKEGHRM 312 (382)
T ss_dssp CSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------HHHHHHTTCCC
T ss_pred ccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCC
Confidence 6654433233333456789999999999999999999999999999999 999985432111 11222222111
Q ss_pred ccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccCCCCCCCCCCc
Q 021682 219 EFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETADIKTPKKPAF 277 (309)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~~~~~~~p~~ 277 (309)
... ......+.+++.+||+.||++|||++++++.|+.+.........+.+
T Consensus 313 ~~~---------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~ 362 (382)
T 3tt0_A 313 DKP---------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYY 362 (382)
T ss_dssp CCC---------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC----
T ss_pred CCC---------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCCCC
Confidence 111 11223788999999999999999999999999998775555544444
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=301.32 Aligned_cols=246 Identities=26% Similarity=0.409 Sum_probs=191.0
Q ss_pred cceEEEEcC----CCcEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 3 VAICQGRLP----NGQEMAVKRLSRT-SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 3 ~~~~~~~~~----~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
+.||++... .+..||||.++.. .......+..|+.++++++||||+++++++..+...++||||+.+++|.+++.
T Consensus 63 g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 142 (325)
T 3kul_A 63 GEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR 142 (325)
T ss_dssp EEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHH
T ss_pred cEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHH
Confidence 356777653 3445999999765 34445678999999999999999999999999999999999999999999984
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccc-cccccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEA-NTGRIVGT 156 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~-~~~~~~~~ 156 (309)
.. ...+++..+..++.|++.|+.|||+. |++||||||+||+++.++.++|+|||++.......... ......++
T Consensus 143 ~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t 217 (325)
T 3kul_A 143 TH--DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIP 217 (325)
T ss_dssp TT--TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CC
T ss_pred hc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCc
Confidence 32 34589999999999999999999998 89999999999999999999999999997765432211 12223456
Q ss_pred cCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 157 YGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
..|+|||.+.+..++.++||||||+++|+|++ |..||......+ .. .......... .+...+.
T Consensus 218 ~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~------~~-~~~~~~~~~~---------~~~~~~~ 281 (325)
T 3kul_A 218 IRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD------VI-SSVEEGYRLP---------APMGCPH 281 (325)
T ss_dssp GGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH------HH-HHHHTTCCCC---------CCTTCCH
T ss_pred ccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH------HH-HHHHcCCCCC---------CCCCcCH
Confidence 78999999998899999999999999999999 999985432211 11 1111111111 1111233
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHHhcccCCC
Q 021682 236 RCMQVALLCVQENAADRPTMLEILVMLKSETADI 269 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~~ 269 (309)
.+.+++.+||+.||++|||++++++.|+.+....
T Consensus 282 ~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 282 ALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 7889999999999999999999999999886543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=298.01 Aligned_cols=233 Identities=18% Similarity=0.225 Sum_probs=186.7
Q ss_pred ceEEEE-cCCCcEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGR-LPNGQEMAVKRLSRT---SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
.||.+. ..+|+.||||.++.. .......+..|+.+++.++||||+++++++......++||||+.+++|..++..
T Consensus 20 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~- 98 (337)
T 1o6l_A 20 KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR- 98 (337)
T ss_dssp EEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-
T ss_pred EEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHh-
Confidence 455554 458999999999754 233467788999999999999999999999999999999999999999988854
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
...+++..++.++.||+.||.|||++ |++||||||+||+++.+|.+||+|||++........ ......||+.|
T Consensus 99 --~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y 171 (337)
T 1o6l_A 99 --ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEY 171 (337)
T ss_dssp --HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC--CBCCCEECGGG
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC--cccccccChhh
Confidence 33489999999999999999999998 999999999999999999999999999875333221 12334789999
Q ss_pred CCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHH
Q 021682 160 VPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQ 239 (309)
Q Consensus 160 ~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (309)
+|||.+.+..++.++|+|||||++|+|++|..||...+.. .......... . .+ . ...+..+.+
T Consensus 172 ~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i~~~~-~-~~-----p----~~~s~~~~~ 234 (337)
T 1o6l_A 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFELILMEE-I-RF-----P----RTLSPEAKS 234 (337)
T ss_dssp CCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCC-C-CC-----C----TTSCHHHHH
T ss_pred CChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH------HHHHHHHcCC-C-CC-----C----CCCCHHHHH
Confidence 9999999989999999999999999999999998542211 1111111111 0 00 1 112237889
Q ss_pred HHhhcccCCCCCCC-----CHHHHHHH
Q 021682 240 VALLCVQENAADRP-----TMLEILVM 261 (309)
Q Consensus 240 li~~~l~~~p~~Rp-----t~~ell~~ 261 (309)
+|.+||+.||++|| +++|+++.
T Consensus 235 li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 235 LLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 99999999999999 99999875
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=289.77 Aligned_cols=249 Identities=23% Similarity=0.321 Sum_probs=190.4
Q ss_pred cceEEEE-cCCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 3 VAICQGR-LPNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 3 ~~~~~~~-~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
+.||.+. ..+++.||+|.+.... ......+.+|+.++++++||||+++++++..+...++||||+++++|.+++..
T Consensus 25 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~ 104 (294)
T 4eqm_A 25 STVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES 104 (294)
T ss_dssp EEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH
T ss_pred EEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHh
Confidence 3466665 4589999999986542 33356788999999999999999999999999999999999999999999854
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
. ..+++..+..++.|++.|+.|||+. |++||||||+||+++.++.++|+|||++......... ......|++.
T Consensus 105 ~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~ 177 (294)
T 4eqm_A 105 H---GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT-QTNHVLGTVQ 177 (294)
T ss_dssp H---CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC--------------CCS
T ss_pred c---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccccccc-ccCccccCcc
Confidence 3 3589999999999999999999998 9999999999999999999999999999765433211 2233468999
Q ss_pred CCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHH
Q 021682 159 YVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238 (309)
Q Consensus 159 y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (309)
|+|||.+.+..++.++||||||+++|+|++|..||..... .......... ..... ...... ..+..+.
T Consensus 178 y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~-~~~~~-~~~~~~----~~~~~l~ 245 (294)
T 4eqm_A 178 YFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA------VSIAIKHIQD-SVPNV-TTDVRK----DIPQSLS 245 (294)
T ss_dssp SCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH------HHHHHHHHSS-CCCCH-HHHSCT----TSCHHHH
T ss_pred ccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhhc-cCCCc-chhccc----CCCHHHH
Confidence 9999999999999999999999999999999999854321 1111111111 11111 000111 1223788
Q ss_pred HHHhhcccCCCCCCC-CHHHHHHHHhcccCCCC
Q 021682 239 QVALLCVQENAADRP-TMLEILVMLKSETADIK 270 (309)
Q Consensus 239 ~li~~~l~~~p~~Rp-t~~ell~~L~~~~~~~~ 270 (309)
++|.+||+.||++|| +++++.+.|+.......
T Consensus 246 ~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 246 NVILRATEKDKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp HHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred HHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence 999999999999998 99999999998765443
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=295.42 Aligned_cols=251 Identities=18% Similarity=0.210 Sum_probs=186.9
Q ss_pred cceEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
++||++...+|+.||+|.+.... ......+.+|++++++++||||+++++++..+...++||||+.+ +|.+++..
T Consensus 35 g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-- 111 (311)
T 3niz_A 35 GVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDE-- 111 (311)
T ss_dssp CEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHHT--
T ss_pred eEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHHh--
Confidence 46788887789999999986542 22346788999999999999999999999999999999999975 77777643
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCC
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYV 160 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 160 (309)
....+++..+..++.|++.|+.|||+. |++||||||+||+++.++.+||+|||++......... .....++..|+
T Consensus 112 ~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~ 186 (311)
T 3niz_A 112 NKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS--YTHEVVTLWYR 186 (311)
T ss_dssp CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-----CCCCCCTTC
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCccc--ccCCcccCCcC
Confidence 334589999999999999999999998 9999999999999999999999999999765433222 22246799999
Q ss_pred Ccccccc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcc-------------cccccCC
Q 021682 161 PPEYVRK-GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGME-------------FIDSSLD 226 (309)
Q Consensus 161 aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~ 226 (309)
|||.+.+ ..++.++|||||||++|+|++|..||......+....+.............. .+.....
T Consensus 187 aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (311)
T 3niz_A 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPW 266 (311)
T ss_dssp CHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCH
T ss_pred CHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcH
Confidence 9999876 5689999999999999999999999976544443222221111111110000 0000000
Q ss_pred CcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 227 DSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 227 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.........++.++|.+||+.||++|||++|+++.
T Consensus 267 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 267 SSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00001122467899999999999999999999973
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=305.24 Aligned_cols=247 Identities=26% Similarity=0.395 Sum_probs=193.2
Q ss_pred cceEEEE------cCCCcEEEEEEeecCC-cccHHHHHHHHHHHhcC-CCCCccceeeEEeeCC-eeEEEEeccCCCChh
Q 021682 3 VAICQGR------LPNGQEMAVKRLSRTS-HQGLEEFENEVKLTARL-QHVNLLPVLGICTQRE-EKMLIYDYMPNKSLD 73 (309)
Q Consensus 3 ~~~~~~~------~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~-~~~lv~e~~~~~~L~ 73 (309)
++||++. ..+++.||||.++... ......+.+|+++++++ +||||+++++++.... ..++||||+.+++|.
T Consensus 36 g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~ 115 (359)
T 3vhe_A 36 GQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLS 115 (359)
T ss_dssp EEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHH
T ss_pred ceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHH
Confidence 4567774 3467899999997643 33456789999999999 7999999999988755 489999999999999
Q ss_pred HHHhhhcc---------------------------------------------------------------ccCCCHHHH
Q 021682 74 FYIFDLRR---------------------------------------------------------------RYLLDWRTR 90 (309)
Q Consensus 74 ~~~~~~~~---------------------------------------------------------------~~~~~~~~~ 90 (309)
+++..... ...+++..+
T Consensus 116 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 195 (359)
T 3vhe_A 116 TYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHL 195 (359)
T ss_dssp HHHHTTTTSBCSCC------------------------------------------------------CTTTTCBCHHHH
T ss_pred HHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchhccccCHHHH
Confidence 99865322 122889999
Q ss_pred HHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCccccccCCC
Q 021682 91 VHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIY 170 (309)
Q Consensus 91 ~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 170 (309)
+.++.|++.|++|||++ |++||||||+||+++.++.++|+|||++................++..|+|||.+.+..+
T Consensus 196 ~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 272 (359)
T 3vhe_A 196 ICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 272 (359)
T ss_dssp HHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCC
Confidence 99999999999999999 999999999999999999999999999976654433333444567889999999999999
Q ss_pred CccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHHhhcccCCC
Q 021682 171 SMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENA 249 (309)
Q Consensus 171 ~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 249 (309)
+.++|||||||++|+|++ |..||......... ............ +......+.+++.+||+.||
T Consensus 273 ~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~------~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dP 337 (359)
T 3vhe_A 273 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF------CRRLKEGTRMRA---------PDYTTPEMYQTMLDCWHGEP 337 (359)
T ss_dssp CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH------HHHHHHTCCCCC---------CTTCCHHHHHHHHHHTCSSG
T ss_pred CchhhhhhHHHHHHHHHhcCCCCCCccchhHHH------HHHHHcCCCCCC---------CCCCCHHHHHHHHHHccCCh
Confidence 999999999999999998 99998654332211 111111111111 11122378899999999999
Q ss_pred CCCCCHHHHHHHHhcccC
Q 021682 250 ADRPTMLEILVMLKSETA 267 (309)
Q Consensus 250 ~~Rpt~~ell~~L~~~~~ 267 (309)
++|||++++++.|+.+.+
T Consensus 338 ~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 338 SQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp GGSCCHHHHHHHHHHHHH
T ss_pred hhCCCHHHHHHHHHHHHH
Confidence 999999999999987653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=301.59 Aligned_cols=250 Identities=26% Similarity=0.406 Sum_probs=193.0
Q ss_pred cceEEEEc------CCCcEEEEEEeecC-CcccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhH
Q 021682 3 VAICQGRL------PNGQEMAVKRLSRT-SHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDF 74 (309)
Q Consensus 3 ~~~~~~~~------~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (309)
+.||++.. .+++.||||.+... .......+.+|+.+++++ +||||+++++++..++..++||||+++++|.+
T Consensus 59 g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~ 138 (344)
T 1rjb_A 59 GKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLN 138 (344)
T ss_dssp EEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHH
T ss_pred ceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHH
Confidence 35677763 35678999999754 334457899999999999 89999999999999999999999999999999
Q ss_pred HHhhhccc--------------------cCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeec
Q 021682 75 YIFDLRRR--------------------YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISD 134 (309)
Q Consensus 75 ~~~~~~~~--------------------~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~D 134 (309)
++...... ..+++..++.++.||+.|+.|||+. |++|+||||+||+++.++.++|+|
T Consensus 139 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~D 215 (344)
T 1rjb_A 139 YLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICD 215 (344)
T ss_dssp HHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGEEEETTTEEEECC
T ss_pred HHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEEcCCCcEEeCC
Confidence 98653321 3378999999999999999999998 999999999999999999999999
Q ss_pred ccccccccCCcccccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhh
Q 021682 135 FGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWK 213 (309)
Q Consensus 135 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~ 213 (309)
||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||......... .....
T Consensus 216 fg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~------~~~~~ 289 (344)
T 1rjb_A 216 FGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF------YKLIQ 289 (344)
T ss_dssp CGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH------HHHHH
T ss_pred CccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHH------HHHHh
Confidence 999976654433333344567788999999988899999999999999999998 99998654332211 11111
Q ss_pred CCCCcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccCCCC
Q 021682 214 NGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETADIK 270 (309)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~~~ 270 (309)
...... .+...+..+.+++.+||+.||++|||+.++++.|+.+.....
T Consensus 290 ~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 290 NGFKMD---------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp TTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred cCCCCC---------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 111111 111123478899999999999999999999999998866443
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=298.11 Aligned_cols=246 Identities=26% Similarity=0.374 Sum_probs=195.1
Q ss_pred cceEEEEc------CCCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHH
Q 021682 3 VAICQGRL------PNGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFY 75 (309)
Q Consensus 3 ~~~~~~~~------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (309)
+.||++.. .+++.||||.++... ......+.+|++++++++||||+++++++..+...++||||+.+++|.++
T Consensus 37 g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 116 (314)
T 2ivs_A 37 GKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGF 116 (314)
T ss_dssp SEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHH
T ss_pred eeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHH
Confidence 35666653 356899999997543 34457789999999999999999999999999999999999999999999
Q ss_pred Hhhhcc---------------------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeec
Q 021682 76 IFDLRR---------------------RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISD 134 (309)
Q Consensus 76 ~~~~~~---------------------~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~D 134 (309)
+..... ...+++..++.++.|++.|+.|||++ |++|+||||+||+++.++.++|+|
T Consensus 117 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~NIli~~~~~~kl~D 193 (314)
T 2ivs_A 117 LRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISD 193 (314)
T ss_dssp HHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTEEEECC
T ss_pred HHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccchheEEEcCCCCEEEcc
Confidence 865332 23488999999999999999999998 899999999999999999999999
Q ss_pred ccccccccCCcccccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhh
Q 021682 135 FGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWK 213 (309)
Q Consensus 135 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~ 213 (309)
||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||........ . ....
T Consensus 194 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~----~~~~ 266 (314)
T 2ivs_A 194 FGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL---F----NLLK 266 (314)
T ss_dssp CTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---H----HHHH
T ss_pred ccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---H----HHhh
Confidence 999976654433323333456788999999998889999999999999999999 9999865433221 1 1111
Q ss_pred CCCCcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccC
Q 021682 214 NGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETA 267 (309)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~ 267 (309)
....... +...+..+.+++.+||+.||++|||++++++.|+++..
T Consensus 267 ~~~~~~~---------~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 267 TGHRMER---------PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp TTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCcCCC---------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1111111 11123478899999999999999999999999998754
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=291.72 Aligned_cols=236 Identities=22% Similarity=0.286 Sum_probs=186.6
Q ss_pred ceEEEEc-CCCcEEEEEEeecCCc------ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHH
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTSH------QGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 76 (309)
.||++.. .+|+.||+|.+..... ...+.+.+|+.++++++||||+++++++..+...++||||+.+++|.+++
T Consensus 26 ~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 105 (326)
T 2y0a_A 26 VVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105 (326)
T ss_dssp EEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHH
T ss_pred EEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHH
Confidence 5666654 5799999999875432 24678999999999999999999999999999999999999999999998
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCC----CceeecccccccccCCcccccccc
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM----NPKISDFGMARAFTKDECEANTGR 152 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~----~~~l~Dfg~~~~~~~~~~~~~~~~ 152 (309)
.. ...+++..+..++.|++.|+.|||+. |++|+||||+||+++.++ .++|+|||++........ ...
T Consensus 106 ~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~ 176 (326)
T 2y0a_A 106 AE---KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKN 176 (326)
T ss_dssp TT---SSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSC---CCC
T ss_pred Hh---cCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCc---ccc
Confidence 43 34589999999999999999999998 999999999999999877 799999999976643321 223
Q ss_pred cccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHH
Q 021682 153 IVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAW 232 (309)
Q Consensus 153 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (309)
..|++.|+|||.+.+..++.++|||||||++|+|++|..||......+ ........ .. .+ .......
T Consensus 177 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~~~~~-~~-~~-----~~~~~~~ 243 (326)
T 2y0a_A 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLANVSAV-NY-EF-----EDEYFSN 243 (326)
T ss_dssp CCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHHHT-CC-CC-----CHHHHTT
T ss_pred ccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH------HHHHHHhc-CC-Cc-----Ccccccc
Confidence 468999999999998899999999999999999999999985422111 11111110 00 00 0000011
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 233 KLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 233 ~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.+..+.++|.+||+.||++|||++++++.
T Consensus 244 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 12367899999999999999999999974
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=298.81 Aligned_cols=249 Identities=25% Similarity=0.400 Sum_probs=194.8
Q ss_pred cceEEEEcC------CCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHH
Q 021682 3 VAICQGRLP------NGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFY 75 (309)
Q Consensus 3 ~~~~~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (309)
+.||++... +++.||||.++... ......+.+|+.++++++||||+++++++..+...++||||+.+++|.++
T Consensus 61 g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 140 (343)
T 1luf_A 61 GRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEF 140 (343)
T ss_dssp CEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHH
T ss_pred eeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHH
Confidence 467777653 45899999997653 33456789999999999999999999999999999999999999999999
Q ss_pred Hhhhcc---------------------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeec
Q 021682 76 IFDLRR---------------------RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISD 134 (309)
Q Consensus 76 ~~~~~~---------------------~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~D 134 (309)
+..... ...+++..++.++.||+.|+.|||++ |++|+||||+||+++.++.++|+|
T Consensus 141 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~D 217 (343)
T 1luf_A 141 LRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIAD 217 (343)
T ss_dssp HHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECC
T ss_pred HHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEECCCCeEEEee
Confidence 865321 25689999999999999999999998 999999999999999999999999
Q ss_pred ccccccccCCcccccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhh
Q 021682 135 FGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWK 213 (309)
Q Consensus 135 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~ 213 (309)
||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||...... . ......
T Consensus 218 fg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~------~-~~~~~~ 290 (343)
T 1luf_A 218 FGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE------E-VIYYVR 290 (343)
T ss_dssp CSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------H-HHHHHH
T ss_pred cCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChH------H-HHHHHh
Confidence 999976654332222333467889999999998899999999999999999999 99898543211 1 111122
Q ss_pred CCCCcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccCCCC
Q 021682 214 NGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETADIK 270 (309)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~~~ 270 (309)
....... +...+..+.+++.+||+.||++|||+.++++.|+.+.+...
T Consensus 291 ~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 291 DGNILAC---------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp TTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred CCCcCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 2221111 11122378899999999999999999999999999866543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=291.97 Aligned_cols=241 Identities=24% Similarity=0.385 Sum_probs=193.6
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccc
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRR 82 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 82 (309)
++||.+...++..||||.++... ...+.+.+|++++++++|+||+++++++..+...++||||+.+++|.+++... .
T Consensus 38 g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~ 114 (283)
T 3gen_A 38 GVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM--R 114 (283)
T ss_dssp EEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCG--G
T ss_pred ceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHh--c
Confidence 36788888888899999997543 34577899999999999999999999999999999999999999999998542 3
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCc
Q 021682 83 YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPP 162 (309)
Q Consensus 83 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 162 (309)
..+++..+..++.|++.|+.+||++ |++|+||||+||+++.++.++|+|||++......... ......++..|+||
T Consensus 115 ~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aP 190 (283)
T 3gen_A 115 HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPP 190 (283)
T ss_dssp GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH-STTSTTSCGGGCCH
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccccc-cccCCccCcccCCH
Confidence 3489999999999999999999998 9999999999999999999999999999765443221 12223457789999
Q ss_pred cccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHH
Q 021682 163 EYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241 (309)
Q Consensus 163 E~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 241 (309)
|.+.+..++.++||||||+++|+|++ |..||....... . ........... . +......+.+++
T Consensus 191 E~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~------~-~~~~~~~~~~~-~--------~~~~~~~l~~li 254 (283)
T 3gen_A 191 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------T-AEHIAQGLRLY-R--------PHLASEKVYTIM 254 (283)
T ss_dssp HHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH------H-HHHHHTTCCCC-C--------CTTCCHHHHHHH
T ss_pred HHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH------H-HHHHhcccCCC-C--------CCcCCHHHHHHH
Confidence 99998899999999999999999998 999986433211 1 11111111100 0 011123788999
Q ss_pred hhcccCCCCCCCCHHHHHHHHhccc
Q 021682 242 LLCVQENAADRPTMLEILVMLKSET 266 (309)
Q Consensus 242 ~~~l~~~p~~Rpt~~ell~~L~~~~ 266 (309)
.+||+.||++|||++++++.|+.+.
T Consensus 255 ~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 255 YSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp HHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHccCChhHCcCHHHHHHHHHHHh
Confidence 9999999999999999999998764
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=301.58 Aligned_cols=238 Identities=22% Similarity=0.270 Sum_probs=189.0
Q ss_pred cceEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 3 VAICQGR-LPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 3 ~~~~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
+.||++. ..+|+.||+|+++.......+.+.+|++++++++||||+++++++......++||||+++++|.+++.. .
T Consensus 103 g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~--~ 180 (373)
T 2x4f_A 103 GQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIID--E 180 (373)
T ss_dssp -CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHH--T
T ss_pred EEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHh--c
Confidence 3567765 468999999999876666677899999999999999999999999999999999999999999888753 2
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEe--CCCCCceeecccccccccCCcccccccccccccCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL--DYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~--~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
...+++..+..++.||+.||.|||+. |++||||||+||++ +.++.+||+|||++........ .....|++.|
T Consensus 181 ~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y 254 (373)
T 2x4f_A 181 SYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LKVNFGTPEF 254 (373)
T ss_dssp GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---CCCCCSSCTT
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---cccccCCCcE
Confidence 33489999999999999999999998 89999999999999 5667899999999976654332 2223689999
Q ss_pred CCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHH
Q 021682 160 VPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQ 239 (309)
Q Consensus 160 ~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (309)
+|||.+.+..++.++|||||||++|+|++|..||......+ ........ ... + ...........+.+
T Consensus 255 ~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~------~~~~i~~~-~~~-~-----~~~~~~~~~~~~~~ 321 (373)
T 2x4f_A 255 LAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE------TLNNILAC-RWD-L-----EDEEFQDISEEAKE 321 (373)
T ss_dssp CCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHT-CCC-S-----CSGGGTTSCHHHHH
T ss_pred eChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhc-cCC-C-----ChhhhccCCHHHHH
Confidence 99999988889999999999999999999999985432211 11111111 000 0 00001112347889
Q ss_pred HHhhcccCCCCCCCCHHHHHHH
Q 021682 240 VALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 240 li~~~l~~~p~~Rpt~~ell~~ 261 (309)
+|.+||+.||++|||++|+++.
T Consensus 322 li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 322 FISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHcCCChhhCCCHHHHhcC
Confidence 9999999999999999999974
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=306.82 Aligned_cols=247 Identities=27% Similarity=0.402 Sum_probs=193.1
Q ss_pred cceEEEEc------CCCcEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHH
Q 021682 3 VAICQGRL------PNGQEMAVKRLSRT-SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFY 75 (309)
Q Consensus 3 ~~~~~~~~------~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (309)
+.||++.+ .+++.||||.++.. .......+..|+.++++++||||+++++++..+...++||||+.+++|.++
T Consensus 85 g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~ 164 (367)
T 3l9p_A 85 GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSF 164 (367)
T ss_dssp SCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHH
T ss_pred EEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHH
Confidence 45677763 35778999999654 344456788999999999999999999999999999999999999999999
Q ss_pred Hhhhcc----ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCC---CceeecccccccccCCcccc
Q 021682 76 IFDLRR----RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM---NPKISDFGMARAFTKDECEA 148 (309)
Q Consensus 76 ~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~---~~~l~Dfg~~~~~~~~~~~~ 148 (309)
+..... ...+++..++.++.|++.|+.|||++ |++||||||+||+++.++ .+||+|||++..........
T Consensus 165 l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~ 241 (367)
T 3l9p_A 165 LRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR 241 (367)
T ss_dssp HHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCT
T ss_pred HHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECCCccccccccccccc
Confidence 865431 24588999999999999999999999 899999999999999555 49999999997654333222
Q ss_pred cccccccccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCC
Q 021682 149 NTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDD 227 (309)
Q Consensus 149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (309)
......+++.|+|||.+.+..++.++|||||||++|+|++ |..||......+ .............
T Consensus 242 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~-------~~~~i~~~~~~~~------- 307 (367)
T 3l9p_A 242 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-------VLEFVTSGGRMDP------- 307 (367)
T ss_dssp TCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------HHHHHHTTCCCCC-------
T ss_pred cCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCCCC-------
Confidence 3334567889999999999999999999999999999998 999985432211 1111111111111
Q ss_pred cccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccCC
Q 021682 228 SSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETAD 268 (309)
Q Consensus 228 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~ 268 (309)
+...+..+.+|+.+||+.||++|||+.++++.|+...+.
T Consensus 308 --~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 308 --PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp --CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred --CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 111223688999999999999999999999999877554
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=297.41 Aligned_cols=249 Identities=20% Similarity=0.353 Sum_probs=181.2
Q ss_pred cceEEEEcCC-Cc---EEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCee------EEEEeccCCC
Q 021682 3 VAICQGRLPN-GQ---EMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEK------MLIYDYMPNK 70 (309)
Q Consensus 3 ~~~~~~~~~~-g~---~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~------~lv~e~~~~~ 70 (309)
+.||++.... ++ .||||.++.. .....+.+.+|++++++++||||+++++++...... ++||||+.++
T Consensus 37 g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~ 116 (323)
T 3qup_A 37 GSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHG 116 (323)
T ss_dssp EEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTC
T ss_pred eEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCC
Confidence 4677777543 32 7999998754 344567899999999999999999999999877654 9999999999
Q ss_pred ChhHHHhhhcc---ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccc
Q 021682 71 SLDFYIFDLRR---RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECE 147 (309)
Q Consensus 71 ~L~~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~ 147 (309)
+|.+++..... ...+++..+..++.|++.|+.|||++ |++||||||+||+++.++.++|+|||++.........
T Consensus 117 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~ 193 (323)
T 3qup_A 117 DLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY 193 (323)
T ss_dssp BHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred cHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEEeeccccccccccccc
Confidence 99999854332 22589999999999999999999999 9999999999999999999999999999766543322
Q ss_pred ccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCC
Q 021682 148 ANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLD 226 (309)
Q Consensus 148 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (309)
.......++..|+|||.+.+..++.++|||||||++|+|++ |..||......+. .. ..........
T Consensus 194 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~---~~----~~~~~~~~~~------ 260 (323)
T 3qup_A 194 RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI---YN----YLIGGNRLKQ------ 260 (323)
T ss_dssp -------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HH----HHHTTCCCCC------
T ss_pred cccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH---HH----HHhcCCCCCC------
Confidence 22223356778999999999999999999999999999999 8999865433221 11 1111111111
Q ss_pred CcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccCCCC
Q 021682 227 DSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETADIK 270 (309)
Q Consensus 227 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~~~ 270 (309)
....+..+.+++.+||+.||++|||+.++++.|+.+.....
T Consensus 261 ---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 261 ---PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp ---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred ---CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 11122378899999999999999999999999998866543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=290.48 Aligned_cols=251 Identities=22% Similarity=0.349 Sum_probs=191.2
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccc
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRR 82 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 82 (309)
+.||++.. .++.||||.+... ...+.+..|++++++++||||+++++++.+ ..++||||+++++|.+++......
T Consensus 22 g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~ 96 (307)
T 2eva_A 22 GVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPL 96 (307)
T ss_dssp SEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBHHHHHHCSSSE
T ss_pred ceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCHHHHHhccCCC
Confidence 46788876 5789999998543 345788999999999999999999998774 478999999999999998654444
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCC-ceeecccccccccCCcccccccccccccCCCC
Q 021682 83 YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMN-PKISDFGMARAFTKDECEANTGRIVGTYGYVP 161 (309)
Q Consensus 83 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~-~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 161 (309)
..++...++.++.|++.|+.|||+.+..|++|+||||+||+++.++. +||+|||++....... ....|+..|+|
T Consensus 97 ~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~a 171 (307)
T 2eva_A 97 PYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM-----TNNKGSAAWMA 171 (307)
T ss_dssp ECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------------CCTTSSC
T ss_pred CccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc-----ccCCCCCceEC
Confidence 45788999999999999999999954348999999999999998887 7999999986543321 22358999999
Q ss_pred ccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHH
Q 021682 162 PEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241 (309)
Q Consensus 162 PE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 241 (309)
||.+.+..++.++||||||+++|+|++|+.||....... ....+. .......... ...+..+.+++
T Consensus 172 PE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~-~~~~~~~~~~---------~~~~~~l~~li 237 (307)
T 2eva_A 172 PEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA----FRIMWA-VHNGTRPPLI---------KNLPKPIESLM 237 (307)
T ss_dssp HHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH----HHHHHH-HHTTCCCCCB---------TTCCHHHHHHH
T ss_pred hhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH----HHHHHH-HhcCCCCCcc---------cccCHHHHHHH
Confidence 999999899999999999999999999999986433221 111111 1111111111 11223688999
Q ss_pred hhcccCCCCCCCCHHHHHHHHhcccCCCCCCCCCCc
Q 021682 242 LLCVQENAADRPTMLEILVMLKSETADIKTPKKPAF 277 (309)
Q Consensus 242 ~~~l~~~p~~Rpt~~ell~~L~~~~~~~~~~~~p~~ 277 (309)
.+||+.||++|||++++++.|+.+...++....|..
T Consensus 238 ~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~~ 273 (307)
T 2eva_A 238 TRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQ 273 (307)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCCC
T ss_pred HHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCccc
Confidence 999999999999999999999998877766655543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=299.82 Aligned_cols=237 Identities=24% Similarity=0.317 Sum_probs=186.2
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
+.||++.. .+|+.||+|.+.... ....+.+.+|+.++++++||||+++++++..+...++||||+.+++|.+++..
T Consensus 43 g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~- 121 (362)
T 2bdw_A 43 SVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA- 121 (362)
T ss_dssp EEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTT-
T ss_pred eEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHH-
Confidence 35666654 579999999997543 33456788999999999999999999999999999999999999999888843
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCC---CceeecccccccccCCcccccccccccc
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM---NPKISDFGMARAFTKDECEANTGRIVGT 156 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~---~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 156 (309)
...+++..+..++.||+.|+.|||++ |++|+||||+||+++.++ .+||+|||++........ .....||
T Consensus 122 --~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt 193 (362)
T 2bdw_A 122 --REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGT 193 (362)
T ss_dssp --CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS---CCCSCSC
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc---cccCCCC
Confidence 34589999999999999999999998 999999999999998654 599999999976553321 2234689
Q ss_pred cCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHH
Q 021682 157 YGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMR 236 (309)
Q Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
+.|+|||.+.+..++.++|||||||++|+|++|.+||...+.. .. ......+... +. .......+..
T Consensus 194 ~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~------~~-~~~i~~~~~~-~~-----~~~~~~~~~~ 260 (362)
T 2bdw_A 194 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------RL-YAQIKAGAYD-YP-----SPEWDTVTPE 260 (362)
T ss_dssp TTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HH-HHHHHHTCCC-CC-----TTGGGGSCHH
T ss_pred ccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------HH-HHHHHhCCCC-CC-----cccccCCCHH
Confidence 9999999999889999999999999999999999998542211 11 1111111100 00 0000112347
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 237 CMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 237 l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
+.++|.+||+.||++|||+.++++.
T Consensus 261 ~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 261 AKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcC
Confidence 8899999999999999999999875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=295.46 Aligned_cols=248 Identities=24% Similarity=0.380 Sum_probs=196.2
Q ss_pred cceEEEEc------CCCcEEEEEEeecCC-cccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhH
Q 021682 3 VAICQGRL------PNGQEMAVKRLSRTS-HQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDF 74 (309)
Q Consensus 3 ~~~~~~~~------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (309)
+.||++.. .+++.||||.++... ....+.+.+|+.+++++ +||||+++++++..+...++||||+.+++|.+
T Consensus 37 g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 116 (313)
T 1t46_A 37 GKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLN 116 (313)
T ss_dssp EEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHH
T ss_pred cceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHH
Confidence 35677752 467899999997553 33457889999999999 99999999999999999999999999999999
Q ss_pred HHhhhcc---------------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccc
Q 021682 75 YIFDLRR---------------RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMAR 139 (309)
Q Consensus 75 ~~~~~~~---------------~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~ 139 (309)
++..... ...+++..++.++.|++.|+.+||+. |++|+||||+||+++.++.++|+|||++.
T Consensus 117 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 193 (313)
T 1t46_A 117 FLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLAR 193 (313)
T ss_dssp HHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETTTEEEECCCGGGS
T ss_pred HHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEcCCCCEEEccccccc
Confidence 9865332 22489999999999999999999998 99999999999999999999999999997
Q ss_pred cccCCcccccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCc
Q 021682 140 AFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGM 218 (309)
Q Consensus 140 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (309)
...............++..|+|||.+.+..++.++||||||+++|+|++ |..||........ .. .........
T Consensus 194 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~---~~~~~~~~~ 267 (313)
T 1t46_A 194 DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK---FY---KMIKEGFRM 267 (313)
T ss_dssp CTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH---HH---HHHHHTCCC
T ss_pred cccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH---HH---HHhccCCCC
Confidence 7655443333334457788999999988899999999999999999998 9999865432221 11 111111000
Q ss_pred ccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccCC
Q 021682 219 EFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETAD 268 (309)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~ 268 (309)
..+...+..+.+++.+||+.||++|||++++++.|+++...
T Consensus 268 ---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 268 ---------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 00111234788999999999999999999999999987543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=295.69 Aligned_cols=231 Identities=22% Similarity=0.285 Sum_probs=184.4
Q ss_pred ceEEEE-cCCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
.||.+. ..+|+.||||.+.... ......+.+|+.+++.++||||+++++++..+...++||||+ +++|.+++...
T Consensus 24 ~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~ 102 (336)
T 3h4j_B 24 KVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEK 102 (336)
T ss_dssp EEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHH
T ss_pred EEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHc
Confidence 456665 4789999999986531 223467899999999999999999999999999999999999 67888887443
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
..+++..+..++.|++.|+.|||+. |++||||||+||+++.++.+||+|||++........ .....|++.|
T Consensus 103 ---~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~---~~~~~gt~~y 173 (336)
T 3h4j_B 103 ---KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF---LKTSCGSPNY 173 (336)
T ss_dssp ---CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT---TCCCTTSTTT
T ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc---cccccCCcCc
Confidence 3489999999999999999999999 999999999999999999999999999976544322 2234689999
Q ss_pred CCccccccCCC-CccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHH
Q 021682 160 VPPEYVRKGIY-SMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238 (309)
Q Consensus 160 ~aPE~~~~~~~-~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (309)
+|||.+.+..+ +.++|||||||++|+|++|..||...........+ ... ....+...+..+.
T Consensus 174 ~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i----------------~~~-~~~~p~~~s~~~~ 236 (336)
T 3h4j_B 174 AAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV----------------NSC-VYVMPDFLSPGAQ 236 (336)
T ss_dssp SCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC----------------CSS-CCCCCTTSCHHHH
T ss_pred CCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH----------------HcC-CCCCcccCCHHHH
Confidence 99999988776 68999999999999999999999643322211100 000 0011111234778
Q ss_pred HHHhhcccCCCCCCCCHHHHHHH
Q 021682 239 QVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 239 ~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
++|.+||+.||.+|||++|+++.
T Consensus 237 ~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 237 SLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp HHHHTTSCSSGGGSCCHHHHTTC
T ss_pred HHHHHHcCCChhHCcCHHHHHhC
Confidence 99999999999999999999875
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=301.45 Aligned_cols=254 Identities=18% Similarity=0.212 Sum_probs=187.5
Q ss_pred ceEEEEc-CCCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
.||++.. .+|+.||||.+.... ......+.+|+.++++++||||+++++++..++..++||||+.+++|.+++...
T Consensus 42 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~- 120 (389)
T 3gni_B 42 TVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTH- 120 (389)
T ss_dssp EEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHT-
T ss_pred EEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhh-
Confidence 5677765 489999999997542 334567889999999999999999999999999999999999999999998543
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccc-----cccccccc
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECE-----ANTGRIVG 155 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~-----~~~~~~~~ 155 (309)
....+++..+..++.||+.|+.|||++ |++||||||+||+++.++.++|+|||.+......... .......|
T Consensus 121 ~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~g 197 (389)
T 3gni_B 121 FMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197 (389)
T ss_dssp CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTT
T ss_pred cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccc
Confidence 234589999999999999999999998 8999999999999999999999999987654322111 11222367
Q ss_pred ccCCCCcccccc--CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHH-HHHhhC------CC----------
Q 021682 156 TYGYVPPEYVRK--GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYA-YGLWKN------GE---------- 216 (309)
Q Consensus 156 ~~~y~aPE~~~~--~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~~~------~~---------- 216 (309)
+..|+|||.+.+ ..++.++|||||||++|+|++|..||............... ...... ..
T Consensus 198 t~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (389)
T 3gni_B 198 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVA 277 (389)
T ss_dssp TGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------------------------
T ss_pred cccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccccccccccccccccccc
Confidence 889999999987 57899999999999999999999999654443322111000 000000 00
Q ss_pred ---Ccccc---------cccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 217 ---GMEFI---------DSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 217 ---~~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
..... ...............+.+||.+||+.||++|||++|+++.
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 278 NSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ----------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00000 0000001111223468899999999999999999999976
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=306.06 Aligned_cols=237 Identities=24% Similarity=0.287 Sum_probs=186.8
Q ss_pred ceEEEE-cCCCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
+||++. ..+|+.||+|.+.... ....+.+.+|+.++++++||||+++++++..+...++||||+.+++|.+.+..
T Consensus 26 ~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~-- 103 (444)
T 3soa_A 26 VVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVA-- 103 (444)
T ss_dssp EEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHH--
T ss_pred EEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHH--
Confidence 456664 5689999999987543 33456788999999999999999999999999999999999999999888854
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeC---CCCCceeecccccccccCCccccccccccccc
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLD---YEMNPKISDFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~---~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
...+++..+..++.||+.|+.|||++ |++||||||+||+++ .++.+||+|||++......... .....||+
T Consensus 104 -~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~--~~~~~gt~ 177 (444)
T 3soa_A 104 -REYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA--WFGFAGTP 177 (444)
T ss_dssp -CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCB--CCCSCSCG
T ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCce--eecccCCc
Confidence 34599999999999999999999999 999999999999998 4578999999999765543222 22346899
Q ss_pred CCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHH
Q 021682 158 GYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRC 237 (309)
Q Consensus 158 ~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (309)
.|+|||.+.+..++.++|||||||++|+|++|.+||...+... .. .....+... +..+. ....+..+
T Consensus 178 ~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~---~~----~~i~~~~~~-~~~~~-----~~~~s~~~ 244 (444)
T 3soa_A 178 GYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR---LY----QQIKAGAYD-FPSPE-----WDTVTPEA 244 (444)
T ss_dssp GGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HH----HHHHHTCCC-CCTTT-----TTTSCHHH
T ss_pred ccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH---HH----HHHHhCCCC-CCccc-----cccCCHHH
Confidence 9999999999899999999999999999999999985422111 11 111111110 00000 01122378
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHH
Q 021682 238 MQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 238 ~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.++|.+||+.||++|||+.|+++.
T Consensus 245 ~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 245 KDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHcCCChhHCCCHHHHhcC
Confidence 899999999999999999999975
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=289.70 Aligned_cols=249 Identities=18% Similarity=0.205 Sum_probs=183.3
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
+.||++.. .+|+.||||.+.... ......+.+|+.++++++||||+++++++..+...++||||+.+ ++.+.+..
T Consensus 16 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~- 93 (292)
T 3o0g_A 16 GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDS- 93 (292)
T ss_dssp SEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHH-
T ss_pred eEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHh-
Confidence 35666654 579999999997543 23346788999999999999999999999999999999999976 55554432
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
....+++..+..++.|++.|+.|||++ |++||||||+||+++.++.++|+|||++......... .....+|..|
T Consensus 94 -~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~t~~y 167 (292)
T 3o0g_A 94 -CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--YSAEVVTLWY 167 (292)
T ss_dssp -TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC--CCSCCSCGGG
T ss_pred -CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc--ccCCccccCC
Confidence 234599999999999999999999999 9999999999999999999999999999765433222 2234678999
Q ss_pred CCccccccCC-CCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhC---CCCccccc------------c
Q 021682 160 VPPEYVRKGI-YSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKN---GEGMEFID------------S 223 (309)
Q Consensus 160 ~aPE~~~~~~-~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~------------~ 223 (309)
+|||.+.+.. ++.++|||||||++|+|++|..|+.... ............... ........ .
T Consensus 168 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (292)
T 3o0g_A 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPAT 245 (292)
T ss_dssp CCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS--SHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTT
T ss_pred cChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCC--CHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCC
Confidence 9999987765 7999999999999999998887753221 111111111111111 00000000 0
Q ss_pred cCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 224 SLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 224 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.............+.++|.+||+.||++|||++|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 246 TSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00001111233477899999999999999999999864
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=295.39 Aligned_cols=237 Identities=17% Similarity=0.202 Sum_probs=187.3
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
+.||++.. .+|+.||+|.+.... .....+.+|+.+++.++||||+++++++......++||||+.+++|.+++.. .
T Consensus 19 g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~--~ 95 (321)
T 1tki_A 19 GIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINT--S 95 (321)
T ss_dssp EEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTS--S
T ss_pred eEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHh--c
Confidence 35666654 578999999986443 3456788999999999999999999999999999999999999999998843 2
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCC--CCCceeecccccccccCCcccccccccccccCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY--EMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~--~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
...+++..+..++.|++.|+.|||+. |++||||||+||+++. ++.++|+|||++........ .....+++.|
T Consensus 96 ~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y 169 (321)
T 1tki_A 96 AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPEY 169 (321)
T ss_dssp SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE---EEEEESCGGG
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc---cccccCChhh
Confidence 34589999999999999999999998 9999999999999987 78999999999976654322 2234689999
Q ss_pred CCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHH
Q 021682 160 VPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQ 239 (309)
Q Consensus 160 ~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (309)
+|||.+.+..++.++|||||||++|+|++|..||...... ............. ........+..+.+
T Consensus 170 ~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~~~~~-------~~~~~~~~s~~~~~ 236 (321)
T 1tki_A 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIENIMNAEYTF-------DEEAFKEISIEAMD 236 (321)
T ss_dssp SCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCCCC-------CHHHHTTSCHHHHH
T ss_pred cCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH------HHHHHHHcCCCCC-------ChhhhccCCHHHHH
Confidence 9999998888899999999999999999999998542211 1111111111000 00000112347889
Q ss_pred HHhhcccCCCCCCCCHHHHHHH
Q 021682 240 VALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 240 li~~~l~~~p~~Rpt~~ell~~ 261 (309)
+|.+||+.||++|||+.|+++.
T Consensus 237 li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 237 FVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHcCCChhHCcCHHHHhcC
Confidence 9999999999999999999985
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=309.01 Aligned_cols=242 Identities=24% Similarity=0.358 Sum_probs=193.3
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccc
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRR 82 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 82 (309)
+.||+|..++++.||||.++... ...+.+.+|+.++++++||||+++++++. ....++||||+.+++|.+++... ..
T Consensus 202 g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~ 278 (454)
T 1qcf_A 202 GEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSD-EG 278 (454)
T ss_dssp EEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSH-HH
T ss_pred eEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhc-cC
Confidence 46789988889999999997543 45788999999999999999999999986 56789999999999999998543 22
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCc
Q 021682 83 YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPP 162 (309)
Q Consensus 83 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 162 (309)
..+++..+..++.|++.|+.|||++ |++||||||+||+++.++.+||+|||++.......... .....++..|+||
T Consensus 279 ~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~~~~~y~aP 354 (454)
T 1qcf_A 279 SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA-REGAKFPIKWTAP 354 (454)
T ss_dssp HTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHT-TCSSSSCGGGSCH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceec-cCCCcccccccCH
Confidence 3488899999999999999999998 89999999999999999999999999997654322111 1223457789999
Q ss_pred cccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHH
Q 021682 163 EYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241 (309)
Q Consensus 163 E~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 241 (309)
|.+....++.++||||||+++|+|++ |..||......+ .. .....+.... .+...+..+.+++
T Consensus 355 E~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~---~~----~~i~~~~~~~---------~~~~~~~~l~~li 418 (454)
T 1qcf_A 355 EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VI----RALERGYRMP---------RPENCPEELYNIM 418 (454)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HH----HHHHHTCCCC---------CCTTSCHHHHHHH
T ss_pred HHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHHcCCCCC---------CCCCCCHHHHHHH
Confidence 99998899999999999999999999 999986432211 11 1111111111 1111234788999
Q ss_pred hhcccCCCCCCCCHHHHHHHHhcccC
Q 021682 242 LLCVQENAADRPTMLEILVMLKSETA 267 (309)
Q Consensus 242 ~~~l~~~p~~Rpt~~ell~~L~~~~~ 267 (309)
.+||+.||++|||+++|++.|+.+..
T Consensus 419 ~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 419 MRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred HHHccCChhHCcCHHHHHHHHHHHHh
Confidence 99999999999999999999998754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=309.23 Aligned_cols=250 Identities=22% Similarity=0.341 Sum_probs=192.8
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccc
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRR 82 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 82 (309)
+.||+|..+++..||||.++... ...+.+.+|++++++++||||+++++++.. +..++||||+.+++|.+++... .+
T Consensus 198 g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~-~~ 274 (452)
T 1fmk_A 198 GEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TG 274 (452)
T ss_dssp CEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHH-HH
T ss_pred eEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhc-CC
Confidence 46889988888889999997543 345789999999999999999999999876 6789999999999999998532 23
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCc
Q 021682 83 YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPP 162 (309)
Q Consensus 83 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 162 (309)
..+++..+..++.|++.|+.|||++ |++||||+|+||+++.++.+||+|||++......... ......++..|+||
T Consensus 275 ~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~~~~y~aP 350 (452)
T 1fmk_A 275 KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAP 350 (452)
T ss_dssp TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCcee-cccCCcccccccCH
Confidence 4589999999999999999999998 8999999999999999999999999999765433221 11223467789999
Q ss_pred cccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHH
Q 021682 163 EYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241 (309)
Q Consensus 163 E~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 241 (309)
|.+.+..++.++||||||+++|+|++ |..||......+ .......+.... .+...+..+.+++
T Consensus 351 E~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-------~~~~i~~~~~~~---------~~~~~~~~l~~li 414 (452)
T 1fmk_A 351 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYRMP---------CPPECPESLHDLM 414 (452)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCCCC---------CCTTSCHHHHHHH
T ss_pred hHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCCC---------CCCCCCHHHHHHH
Confidence 99998899999999999999999999 899985432211 111111111111 1112234788999
Q ss_pred hhcccCCCCCCCCHHHHHHHHhcccCCCCCCCCC
Q 021682 242 LLCVQENAADRPTMLEILVMLKSETADIKTPKKP 275 (309)
Q Consensus 242 ~~~l~~~p~~Rpt~~ell~~L~~~~~~~~~~~~p 275 (309)
.+||+.||++|||+++|++.|+.+.....+...|
T Consensus 415 ~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~~~ 448 (452)
T 1fmk_A 415 CQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 448 (452)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCC
T ss_pred HHHccCChhhCcCHHHHHHHHHHHhccCCccccc
Confidence 9999999999999999999999876655444444
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=296.28 Aligned_cols=237 Identities=22% Similarity=0.220 Sum_probs=176.4
Q ss_pred ceEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccc
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRR 82 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 82 (309)
+||.+. ..+|+.||||.+..... ....+.+|+.++++++||||+++++++..+...++||||+.+++|.+++...
T Consensus 35 ~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--- 110 (361)
T 3uc3_A 35 VARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNA--- 110 (361)
T ss_dssp SEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH---
T ss_pred EEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhc---
Confidence 455555 45899999999975433 3467889999999999999999999999999999999999999999988543
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCC--ceeecccccccccCCcccccccccccccCCC
Q 021682 83 YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMN--PKISDFGMARAFTKDECEANTGRIVGTYGYV 160 (309)
Q Consensus 83 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 160 (309)
..+++..+..++.|++.|++|||++ |++||||||+||+++.++. +||+|||++....... ......||+.|+
T Consensus 111 ~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~ 184 (361)
T 3uc3_A 111 GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYI 184 (361)
T ss_dssp SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC------------------CTTS
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccC---CCCCCcCCCCcC
Confidence 3499999999999999999999998 9999999999999987765 9999999986433222 122346899999
Q ss_pred CccccccCCCCcc-chhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHH
Q 021682 161 PPEYVRKGIYSMK-YDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQ 239 (309)
Q Consensus 161 aPE~~~~~~~~~~-~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (309)
|||.+.+..+..+ +|||||||++|+|++|+.||............ .......... + ......+..+.+
T Consensus 185 aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~--~~~~~~~~~~--~-------~~~~~~s~~~~~ 253 (361)
T 3uc3_A 185 APEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKT--IQRILSVKYS--I-------PDDIRISPECCH 253 (361)
T ss_dssp CHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHH--HHHHHTTCCC--C-------CTTSCCCHHHHH
T ss_pred ChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHH--HHHHhcCCCC--C-------CCcCCCCHHHHH
Confidence 9999988877655 89999999999999999999654433322111 1111111100 0 000011237789
Q ss_pred HHhhcccCCCCCCCCHHHHHHH
Q 021682 240 VALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 240 li~~~l~~~p~~Rpt~~ell~~ 261 (309)
+|.+||+.||++|||++|+++.
T Consensus 254 li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 254 LISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp HHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHccCChhHCcCHHHHHhC
Confidence 9999999999999999999986
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=299.36 Aligned_cols=243 Identities=24% Similarity=0.382 Sum_probs=183.8
Q ss_pred cceEEEEc-CCCcE----EEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHH
Q 021682 3 VAICQGRL-PNGQE----MAVKRLSRT-SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 3 ~~~~~~~~-~~g~~----vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 76 (309)
+.||++.. .+|+. ||+|.+... .......+.+|+.++++++||||+++++++..+. .++|++++.+++|.+++
T Consensus 29 g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l 107 (327)
T 3poz_A 29 GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV 107 (327)
T ss_dssp EEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHH
T ss_pred eEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHH
Confidence 46777764 45554 577777543 3345678999999999999999999999998764 77899999999999998
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccc
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGT 156 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 156 (309)
... ...+++..++.++.|++.|+.|||+. |++||||||+||+++.++.+||+|||++................++
T Consensus 108 ~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t 182 (327)
T 3poz_A 108 REH--KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182 (327)
T ss_dssp HHS--TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCC
T ss_pred Hhc--CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCcc
Confidence 542 34589999999999999999999998 8999999999999999999999999999876554433333334567
Q ss_pred cCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 157 YGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
..|+|||.+.+..++.++|||||||++|+|++ |..||........ . .......... .+.....
T Consensus 183 ~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~----~~~~~~~~~~---------~~~~~~~ 246 (327)
T 3poz_A 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---S----SILEKGERLP---------QPPICTI 246 (327)
T ss_dssp GGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---H----HHHHTTCCCC---------CCTTBCH
T ss_pred ccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH---H----HHHHcCCCCC---------CCccCCH
Confidence 89999999999999999999999999999999 9999865433221 1 1111111111 1111233
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHHhcccC
Q 021682 236 RCMQVALLCVQENAADRPTMLEILVMLKSETA 267 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~ 267 (309)
.+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 247 ~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 247 DVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp HHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 78899999999999999999999999987654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=300.66 Aligned_cols=238 Identities=20% Similarity=0.227 Sum_probs=188.7
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
+.||++.. .+|+.||+|.+..........+.+|+.++++++||||+++++++..+...++||||+.+++|.+++.. .
T Consensus 65 g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~--~ 142 (387)
T 1kob_A 65 GVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA--E 142 (387)
T ss_dssp EEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTC--T
T ss_pred EEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHh--h
Confidence 35666654 57999999999776655667889999999999999999999999999999999999999999998843 2
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCC--CCCceeecccccccccCCcccccccccccccCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY--EMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~--~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
...+++..+..++.||+.||.|||++ |++||||||+||+++. ++.++|+|||++........ .....||+.|
T Consensus 143 ~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y 216 (387)
T 1kob_A 143 DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEF 216 (387)
T ss_dssp TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC---EEEECSSGGG
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCcc---eeeeccCCCc
Confidence 34589999999999999999999998 9999999999999974 46799999999976654322 2223689999
Q ss_pred CCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHH
Q 021682 160 VPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQ 239 (309)
Q Consensus 160 ~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (309)
+|||.+.+..++.++|||||||++|+|++|..||...... ......... ... +... .....+..+.+
T Consensus 217 ~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~------~~~~~i~~~-~~~--~~~~----~~~~~s~~~~~ 283 (387)
T 1kob_A 217 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL------ETLQNVKRC-DWE--FDED----AFSSVSPEAKD 283 (387)
T ss_dssp CCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHHC-CCC--CCSS----TTTTSCHHHHH
T ss_pred cCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH------HHHHHHHhC-CCC--CCcc----ccccCCHHHHH
Confidence 9999999988999999999999999999999998643211 111111111 100 0000 00112337889
Q ss_pred HHhhcccCCCCCCCCHHHHHHH
Q 021682 240 VALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 240 li~~~l~~~p~~Rpt~~ell~~ 261 (309)
+|.+||+.||++|||++++++.
T Consensus 284 li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 284 FIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp HHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHcCCChhHCcCHHHHhhC
Confidence 9999999999999999999975
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=296.67 Aligned_cols=234 Identities=20% Similarity=0.289 Sum_probs=186.0
Q ss_pred ceEEEE-cCCCcEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGR-LPNGQEMAVKRLSRT---SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
.||.+. ..+|+.||+|.+... .......+.+|+.+++.++||||+++++++.+....++||||+.+++|..++..
T Consensus 30 ~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~- 108 (384)
T 4fr4_A 30 KVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQ- 108 (384)
T ss_dssp CEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHT-
T ss_pred EEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHh-
Confidence 455554 567999999998653 233457788999999999999999999999999999999999999999998843
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
...+++..+..++.||+.|+.|||+. ||+||||||+||+++.++.++|+|||++....... ......||+.|
T Consensus 109 --~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~---~~~~~~gt~~Y 180 (384)
T 4fr4_A 109 --NVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET---QITTMAGTKPY 180 (384)
T ss_dssp --TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC---CBCCCCSCGGG
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCCC---ceeccCCCccc
Confidence 44599999999999999999999998 99999999999999999999999999997654432 12334789999
Q ss_pred CCcccccc---CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHH
Q 021682 160 VPPEYVRK---GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMR 236 (309)
Q Consensus 160 ~aPE~~~~---~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
+|||.+.+ ..++.++|+|||||++|+|++|..||............... .... .. .+...+..
T Consensus 181 ~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~---~~~~--~~---------~p~~~s~~ 246 (384)
T 4fr4_A 181 MAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF---ETTV--VT---------YPSAWSQE 246 (384)
T ss_dssp CCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH---HHCC--CC---------CCTTSCHH
T ss_pred cCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH---hhcc--cC---------CCCcCCHH
Confidence 99999864 45889999999999999999999999654443322211111 1110 00 01112237
Q ss_pred HHHHHhhcccCCCCCCCC-HHHHHH
Q 021682 237 CMQVALLCVQENAADRPT-MLEILV 260 (309)
Q Consensus 237 l~~li~~~l~~~p~~Rpt-~~ell~ 260 (309)
+.++|.+||+.||++||+ ++++++
T Consensus 247 ~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 247 MVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred HHHHHHHHhcCCHhHhcccHHHHHc
Confidence 889999999999999998 788775
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=288.02 Aligned_cols=250 Identities=22% Similarity=0.333 Sum_probs=191.1
Q ss_pred cceEEEE-----cCCCcEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeeEEeeC--CeeEEEEeccCCCChhH
Q 021682 3 VAICQGR-----LPNGQEMAVKRLSRT-SHQGLEEFENEVKLTARLQHVNLLPVLGICTQR--EEKMLIYDYMPNKSLDF 74 (309)
Q Consensus 3 ~~~~~~~-----~~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~ 74 (309)
+.||.+. ..+|+.||||.+... .......+.+|+.++++++||||+++++++..+ ...++||||+.+++|.+
T Consensus 35 g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~ 114 (302)
T 4e5w_A 35 GKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKE 114 (302)
T ss_dssp EEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHH
T ss_pred eEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHH
Confidence 3567776 357999999998754 344567899999999999999999999999876 56899999999999999
Q ss_pred HHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccc-cccccc
Q 021682 75 YIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECE-ANTGRI 153 (309)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~ 153 (309)
++... ...+++..++.++.|++.|+.+||+. |++|+||||+||+++.++.++|+|||++......... ......
T Consensus 115 ~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 189 (302)
T 4e5w_A 115 YLPKN--KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDR 189 (302)
T ss_dssp HHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCT
T ss_pred HHHhc--cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCC
Confidence 98443 34489999999999999999999998 9999999999999999999999999999776544321 122334
Q ss_pred ccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCC--------CCCcccHHHHHHHHhhCCCCcccccccC
Q 021682 154 VGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYG--------PNESLNLLEYAYGLWKNGEGMEFIDSSL 225 (309)
Q Consensus 154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (309)
.++..|+|||.+.+..++.++||||||+++|+|++|..|+.... +.....................
T Consensus 190 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 263 (302)
T 4e5w_A 190 DSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLP------ 263 (302)
T ss_dssp TCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCC------
T ss_pred CCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCCC------
Confidence 67788999999999889999999999999999999998753210 1111111111112222211111
Q ss_pred CCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhccc
Q 021682 226 DDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSET 266 (309)
Q Consensus 226 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~ 266 (309)
.+...+..+.+++.+||+.||++|||++++++.|+.+.
T Consensus 264 ---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 264 ---CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp ---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 11122347889999999999999999999999998764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=298.91 Aligned_cols=260 Identities=20% Similarity=0.232 Sum_probs=198.3
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCC--eeEEEEeccCCCChhHHHhh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQRE--EKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~ 78 (309)
+.||++.. .+|+.||||++.... ....+.+.+|++++++++||||+++++++.... ..++||||+.+++|.+++..
T Consensus 23 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 102 (396)
T 4eut_A 23 ANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE 102 (396)
T ss_dssp EEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTS
T ss_pred eEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHh
Confidence 35677764 469999999997543 344677889999999999999999999988765 78999999999999999866
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEe----CCCCCceeecccccccccCCcccccccccc
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL----DYEMNPKISDFGMARAFTKDECEANTGRIV 154 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~----~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~ 154 (309)
......+++..++.++.|++.|+.|||+. |++||||||+||++ +.++.+||+|||++........ .....
T Consensus 103 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~---~~~~~ 176 (396)
T 4eut_A 103 PSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLY 176 (396)
T ss_dssp GGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGG---SSCSS
T ss_pred hhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCc---ccccc
Confidence 55555599999999999999999999999 99999999999999 7777899999999976554322 22346
Q ss_pred cccCCCCcccccc--------CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHH-HHHHHhhCCCCccc-----
Q 021682 155 GTYGYVPPEYVRK--------GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLE-YAYGLWKNGEGMEF----- 220 (309)
Q Consensus 155 ~~~~y~aPE~~~~--------~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~----- 220 (309)
|+..|+|||.+.+ ..++.++|||||||++|+|++|..||............. ..............
T Consensus 177 gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 256 (396)
T 4eut_A 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAEN 256 (396)
T ss_dssp SCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTT
T ss_pred CCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccC
Confidence 8999999998865 456789999999999999999999997544433222221 11111110000000
Q ss_pred ----c--cccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccCC
Q 021682 221 ----I--DSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETAD 268 (309)
Q Consensus 221 ----~--~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~ 268 (309)
. ...............+.+++.+||+.||++|||++++++.++.+...
T Consensus 257 ~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 257 GPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp CCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred CCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 0 00112233355667888999999999999999999999999887654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=299.90 Aligned_cols=233 Identities=22% Similarity=0.292 Sum_probs=182.6
Q ss_pred ceEEEE-cCCCcEEEEEEeecC---CcccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 4 AICQGR-LPNGQEMAVKRLSRT---SHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
.||.+. ..+|+.||||+++.. .......+..|..+++.+ +||||+++++++..+...++||||+.+++|..++..
T Consensus 38 ~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~ 117 (353)
T 3txo_A 38 KVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQK 117 (353)
T ss_dssp EEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH
T ss_pred EEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHH
Confidence 456665 457999999999754 234456788999999988 799999999999999999999999999999998854
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
. ..+++..++.++.||+.||.|||++ |++||||||+||+++.++.+||+|||++........ ......||+.
T Consensus 118 ~---~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~--~~~~~~gt~~ 189 (353)
T 3txo_A 118 S---RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV--TTATFCGTPD 189 (353)
T ss_dssp H---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-----------CCGG
T ss_pred c---CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecccCCc--cccccCCCcC
Confidence 3 3499999999999999999999998 999999999999999999999999999875332221 2233468999
Q ss_pred CCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHH
Q 021682 159 YVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238 (309)
Q Consensus 159 y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (309)
|+|||.+.+..++.++|+|||||++|+|++|..||...+..+ ........... .+......+.
T Consensus 190 y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~------~~~~i~~~~~~-----------~p~~~~~~~~ 252 (353)
T 3txo_A 190 YIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD------LFEAILNDEVV-----------YPTWLHEDAT 252 (353)
T ss_dssp GCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCCC-----------CCTTSCHHHH
T ss_pred eEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH------HHHHHHcCCCC-----------CCCCCCHHHH
Confidence 999999998889999999999999999999999996432211 11111111100 0111223678
Q ss_pred HHHhhcccCCCCCCCCH------HHHHHH
Q 021682 239 QVALLCVQENAADRPTM------LEILVM 261 (309)
Q Consensus 239 ~li~~~l~~~p~~Rpt~------~ell~~ 261 (309)
++|.+||+.||++||++ +++++.
T Consensus 253 ~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 253 GILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp HHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred HHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 99999999999999998 777764
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=293.05 Aligned_cols=257 Identities=23% Similarity=0.320 Sum_probs=194.0
Q ss_pred cceEEEE-----cCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEe--eCCeeEEEEeccCCCChhHH
Q 021682 3 VAICQGR-----LPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICT--QREEKMLIYDYMPNKSLDFY 75 (309)
Q Consensus 3 ~~~~~~~-----~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~~~L~~~ 75 (309)
+.||++. ..+++.||||.+........+.+.+|++++++++|+||+++++++. .....++||||+++++|.++
T Consensus 37 g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 116 (327)
T 3lxl_A 37 GSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDF 116 (327)
T ss_dssp EEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHH
T ss_pred eEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHH
Confidence 4567776 3578999999998776666778999999999999999999999886 44578999999999999999
Q ss_pred HhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccc-ccccccc
Q 021682 76 IFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECE-ANTGRIV 154 (309)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~ 154 (309)
+... ...+++..++.++.|++.|+.+||+. |++|+||||+||+++.++.++|+|||++......... .......
T Consensus 117 l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 191 (327)
T 3lxl_A 117 LQRH--RARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQ 191 (327)
T ss_dssp HHHH--GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCC
T ss_pred HHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCC
Confidence 8543 23489999999999999999999998 9999999999999999999999999999876543322 1222345
Q ss_pred cccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCC--------CcccHHHHHHHHhhCCCCcccccccCC
Q 021682 155 GTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPN--------ESLNLLEYAYGLWKNGEGMEFIDSSLD 226 (309)
Q Consensus 155 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (309)
++..|+|||.+.+..++.++||||||+++|+|++|..||...... ..................
T Consensus 192 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 262 (327)
T 3lxl_A 192 SPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQR--------- 262 (327)
T ss_dssp SCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCC---------
T ss_pred ccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcccC---------
Confidence 778899999999988999999999999999999999987532110 000011111111111111
Q ss_pred CcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccCCCCCCC
Q 021682 227 DSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETADIKTPK 273 (309)
Q Consensus 227 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~~~~~~ 273 (309)
...+...+..+.++|.+||+.||++|||++++++.|+.+........
T Consensus 263 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 309 (327)
T 3lxl_A 263 LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCE 309 (327)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--------
T ss_pred CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCcc
Confidence 11112223478899999999999999999999999998766544433
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=303.11 Aligned_cols=237 Identities=23% Similarity=0.355 Sum_probs=188.5
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
+.||.+.. .+|+.||||++.... ......+.+|+.+++.++||||+++++++......++||||+.+++|.+++.
T Consensus 30 g~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~- 108 (476)
T 2y94_A 30 GKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYIC- 108 (476)
T ss_dssp SCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTT-
T ss_pred eEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHH-
Confidence 35666654 589999999996542 2345678999999999999999999999999999999999999999999984
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
....+++..+..++.||+.|+.|||+. |++||||||+||+++.++.+||+|||++........ .....|++.
T Consensus 109 --~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~ 180 (476)
T 2y94_A 109 --KNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPN 180 (476)
T ss_dssp --SSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC---BCCCCSCST
T ss_pred --hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcccccc---ccccCCCcC
Confidence 344599999999999999999999998 999999999999999999999999999976554321 223468999
Q ss_pred CCCccccccCCC-CccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHH
Q 021682 159 YVPPEYVRKGIY-SMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRC 237 (309)
Q Consensus 159 y~aPE~~~~~~~-~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (309)
|+|||.+.+..+ +.++|||||||++|+|++|..||....... . ......+... .. ......+
T Consensus 181 y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~---~----~~~i~~~~~~------~p----~~~s~~~ 243 (476)
T 2y94_A 181 YAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT---L----FKKICDGIFY------TP----QYLNPSV 243 (476)
T ss_dssp TCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH---H----HHHHHTTCCC------CC----TTCCHHH
T ss_pred eEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH---H----HHHHhcCCcC------CC----ccCCHHH
Confidence 999999988765 689999999999999999999986432211 1 1111111100 00 1112367
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHH--Hhcc
Q 021682 238 MQVALLCVQENAADRPTMLEILVM--LKSE 265 (309)
Q Consensus 238 ~~li~~~l~~~p~~Rpt~~ell~~--L~~~ 265 (309)
.++|.+||+.||++|||++++++. +...
T Consensus 244 ~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 244 ISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred HHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 899999999999999999999984 4443
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=291.55 Aligned_cols=240 Identities=21% Similarity=0.298 Sum_probs=187.1
Q ss_pred cceEEEE-cCCCcEEEEEEeecC-----CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHH
Q 021682 3 VAICQGR-LPNGQEMAVKRLSRT-----SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 3 ~~~~~~~-~~~g~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 76 (309)
++||++. ..+|+.||||++... .....+.+.+|+.++++++||||+++++++..+...++||||+.+++|.+++
T Consensus 38 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l 117 (351)
T 3c0i_A 38 SVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEI 117 (351)
T ss_dssp EEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHH
T ss_pred EEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHH
Confidence 3567775 458999999998642 1224678999999999999999999999999999999999999999998877
Q ss_pred hhhc-cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCC---ceeecccccccccCCcccccccc
Q 021682 77 FDLR-RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMN---PKISDFGMARAFTKDECEANTGR 152 (309)
Q Consensus 77 ~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~---~~l~Dfg~~~~~~~~~~~~~~~~ 152 (309)
.... .+..+++..+..++.||+.|+.|||++ |++||||||+||+++.++. +||+|||++........ ....
T Consensus 118 ~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~ 192 (351)
T 3c0i_A 118 VKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--VAGG 192 (351)
T ss_dssp HHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSC--BCCC
T ss_pred HHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCe--eecC
Confidence 5432 344589999999999999999999998 9999999999999987655 99999999976654322 1223
Q ss_pred cccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHH
Q 021682 153 IVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAW 232 (309)
Q Consensus 153 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (309)
..||+.|+|||.+.+..++.++|||||||++|+|++|..||.... . . ............ .. .....
T Consensus 193 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~---~-~~~~i~~~~~~~--~~----~~~~~ 258 (351)
T 3c0i_A 193 RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----E---R-LFEGIIKGKYKM--NP----RQWSH 258 (351)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----H---H-HHHHHHHTCCCC--CH----HHHTT
T ss_pred CcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----H---H-HHHHHHcCCCCC--Cc----ccccc
Confidence 468999999999999889999999999999999999999985421 1 1 111111111100 00 00001
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 233 KLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 233 ~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.+..+.++|.+||+.||++|||+.++++.
T Consensus 259 ~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 259 ISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 23478899999999999999999999874
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=290.98 Aligned_cols=252 Identities=21% Similarity=0.217 Sum_probs=192.2
Q ss_pred ceEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEee----CCeeEEEEeccCCCChhHHHhh
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQ----REEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
.||++.. .+|+.||||.+........+.+.+|+.++++++||||+++++++.. ....++||||+.+++|.+++..
T Consensus 44 ~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 123 (317)
T 2buj_A 44 YVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIER 123 (317)
T ss_dssp EEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHH
T ss_pred EEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHH
Confidence 5666654 6899999999977766677889999999999999999999999863 3478999999999999998865
Q ss_pred hc-cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccc-------cc
Q 021682 79 LR-RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEA-------NT 150 (309)
Q Consensus 79 ~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~-------~~ 150 (309)
.. .+..+++..++.++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++.......... ..
T Consensus 124 ~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 200 (317)
T 2buj_A 124 LKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDW 200 (317)
T ss_dssp HHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHH
T ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhccccccccccccccccc
Confidence 32 345689999999999999999999998 99999999999999999999999999886543221110 01
Q ss_pred cccccccCCCCccccccCC---CCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCC
Q 021682 151 GRIVGTYGYVPPEYVRKGI---YSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDD 227 (309)
Q Consensus 151 ~~~~~~~~y~aPE~~~~~~---~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (309)
....|+..|+|||.+.+.. ++.++||||||+++|+|++|..||......... ... ...... . .
T Consensus 201 ~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~----~~~~~~--~-------~ 266 (317)
T 2buj_A 201 AAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-VAL----AVQNQL--S-------I 266 (317)
T ss_dssp HHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-HHH----HHHCC-----------C
T ss_pred ccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch-hhH----HhhccC--C-------C
Confidence 1235688999999987654 688999999999999999999998431111100 000 011100 0 0
Q ss_pred cccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccCCCCCC
Q 021682 228 SSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETADIKTP 272 (309)
Q Consensus 228 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~~~~~ 272 (309)
.........+.++|.+||+.||++|||++++++.|+.+..+.+.+
T Consensus 267 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~ 311 (317)
T 2buj_A 267 PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ 311 (317)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC-
T ss_pred CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCC
Confidence 001112337889999999999999999999999999886554443
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=302.03 Aligned_cols=245 Identities=26% Similarity=0.436 Sum_probs=182.2
Q ss_pred cceEEEEcC----CCcEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 3 VAICQGRLP----NGQEMAVKRLSRT-SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 3 ~~~~~~~~~----~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
+.||+|... ++..||||.++.. .......+.+|+.++++++||||+++++++..+...++||||+++++|.+++.
T Consensus 59 g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~ 138 (373)
T 2qol_A 59 GEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR 138 (373)
T ss_dssp SEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHH
T ss_pred eEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHH
Confidence 467888753 5788999999754 33445679999999999999999999999999999999999999999999985
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccc-cccccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEA-NTGRIVGT 156 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~-~~~~~~~~ 156 (309)
. ....+++..+..++.|++.|+.|||+. |++||||||+||+++.++.+||+|||++.......... ......++
T Consensus 139 ~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~ 213 (373)
T 2qol_A 139 K--HDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIP 213 (373)
T ss_dssp T--TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----------------------
T ss_pred h--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcC
Confidence 3 234589999999999999999999998 89999999999999999999999999997665432211 11122356
Q ss_pred cCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 157 YGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
..|+|||.+.+..++.++||||||+++|+|++ |..||......+ .. .......... .+...+.
T Consensus 214 ~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~---~~----~~i~~~~~~~---------~~~~~~~ 277 (373)
T 2qol_A 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD---VI----KAVDEGYRLP---------PPMDCPA 277 (373)
T ss_dssp CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH---HH----HHHHTTEECC---------CCTTCBH
T ss_pred CCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHHcCCCCC---------CCccccH
Confidence 78999999999999999999999999999998 999985432111 11 1111111000 0111234
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHHhcccCC
Q 021682 236 RCMQVALLCVQENAADRPTMLEILVMLKSETAD 268 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~ 268 (309)
.+.+++.+||+.||++|||++++++.|+.+...
T Consensus 278 ~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 278 ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 788999999999999999999999999887543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=291.18 Aligned_cols=230 Identities=21% Similarity=0.275 Sum_probs=185.9
Q ss_pred ceEEEE-cCCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
.||.+. ..+|+.||+|+++... ....+.+.+|+.+++.++||||+++++++.+....++||||+.+++|.+++..
T Consensus 21 ~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~- 99 (318)
T 1fot_A 21 RVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK- 99 (318)
T ss_dssp EEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-
T ss_pred EEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHH-
Confidence 455555 4589999999997542 23456788999999999999999999999999999999999999999999854
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
...+++..+..++.||+.|+.|||++ |++||||||+||+++.+|.+||+|||++...... .....||+.|
T Consensus 100 --~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-----~~~~~gt~~y 169 (318)
T 1fot_A 100 --SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDY 169 (318)
T ss_dssp --TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-----BCCCCSCTTT
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc-----cccccCCccc
Confidence 34589999999999999999999998 9999999999999999999999999999765432 2234689999
Q ss_pred CCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHH
Q 021682 160 VPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQ 239 (309)
Q Consensus 160 ~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (309)
+|||.+.+..++.++|+|||||++|+|++|..||...+. ............ .+ . ......+.+
T Consensus 170 ~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~~~--~~-----p----~~~~~~~~~ 232 (318)
T 1fot_A 170 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKILNAEL--RF-----P----PFFNEDVKD 232 (318)
T ss_dssp CCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHCCC--CC-----C----TTSCHHHHH
T ss_pred cCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCC--CC-----C----CCCCHHHHH
Confidence 999999999999999999999999999999999854321 111111111110 00 0 112237889
Q ss_pred HHhhcccCCCCCCC-----CHHHHHHH
Q 021682 240 VALLCVQENAADRP-----TMLEILVM 261 (309)
Q Consensus 240 li~~~l~~~p~~Rp-----t~~ell~~ 261 (309)
+|.+||+.||++|| +++++++.
T Consensus 233 li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 233 LLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp HHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 99999999999999 89999864
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=284.50 Aligned_cols=238 Identities=24% Similarity=0.451 Sum_probs=184.3
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCccc-------HHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhH
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSHQG-------LEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDF 74 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (309)
+.||++.. .+++.||||.+....... .+.+.+|+.++++++||||+++++++.... ++||||+.+++|.+
T Consensus 33 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~ 110 (287)
T 4f0f_A 33 GLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYH 110 (287)
T ss_dssp SCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHH
T ss_pred eeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEecCCCCHHH
Confidence 35677764 589999999986543221 267889999999999999999999987664 69999999999988
Q ss_pred HHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCc--eeecCCCCceEEeCCCCC-----ceeecccccccccCCccc
Q 021682 75 YIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLT--IVHRDLKASNILLDYEMN-----PKISDFGMARAFTKDECE 147 (309)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~g--i~H~di~p~nil~~~~~~-----~~l~Dfg~~~~~~~~~~~ 147 (309)
++.. ....+++..++.++.|++.|+.|||+. | ++|+||||+||+++.++. ++|+|||++......
T Consensus 111 ~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~~--- 182 (287)
T 4f0f_A 111 RLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS--- 182 (287)
T ss_dssp HHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSSC---
T ss_pred HHhc--ccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCCCCcccccccc---
Confidence 8743 344589999999999999999999998 8 999999999999988776 999999998644332
Q ss_pred ccccccccccCCCCccccc--cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccC
Q 021682 148 ANTGRIVGTYGYVPPEYVR--KGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSL 225 (309)
Q Consensus 148 ~~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (309)
.....|+..|+|||.+. ...++.++|||||||++|+|++|..||........ ...............
T Consensus 183 --~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~----- 251 (287)
T 4f0f_A 183 --VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI----KFINMIREEGLRPTI----- 251 (287)
T ss_dssp --EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH----HHHHHHHHSCCCCCC-----
T ss_pred --ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH----HHHHHHhccCCCCCC-----
Confidence 22346899999999984 45578999999999999999999999965433221 111111111111111
Q ss_pred CCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcc
Q 021682 226 DDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSE 265 (309)
Q Consensus 226 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~ 265 (309)
+...+..+.+++.+||+.||++|||++++++.|+++
T Consensus 252 ----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 252 ----PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ----CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 111233788999999999999999999999999863
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=291.29 Aligned_cols=253 Identities=22% Similarity=0.250 Sum_probs=186.7
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
+.||++.. .+|+.||||.++... ......+.+|+.++++++||||+++++++..++..++||||+. ++|.+++....
T Consensus 19 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~ 97 (317)
T 2pmi_A 19 ATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRT 97 (317)
T ss_dssp CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHH
T ss_pred EEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhcc
Confidence 35677764 479999999997543 3345678899999999999999999999999999999999997 58988875432
Q ss_pred c---ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccccc
Q 021682 81 R---RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 81 ~---~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
. ...+++..+..++.|++.|+.|||+. |++||||||+||+++.++.+||+|||++......... .....++.
T Consensus 98 ~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~t~ 172 (317)
T 2pmi_A 98 VGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT--FSSEVVTL 172 (317)
T ss_dssp SSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCC--CCCCCSCC
T ss_pred ccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecCCCccc--CCCCcccc
Confidence 1 23588999999999999999999998 9999999999999999999999999999765433221 22346799
Q ss_pred CCCCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCccc-----ccccC----C-
Q 021682 158 GYVPPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEF-----IDSSL----D- 226 (309)
Q Consensus 158 ~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~----~- 226 (309)
.|+|||.+.+. .++.++|||||||++|+|++|..||......+....+............... ..... .
T Consensus 173 ~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (317)
T 2pmi_A 173 WYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPR 252 (317)
T ss_dssp TTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCC
T ss_pred cccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccch
Confidence 99999998764 6799999999999999999999998643322211111111000000000000 00000 0
Q ss_pred -------CcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 227 -------DSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 227 -------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
..........+.++|.+||+.||++|||++|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 253 DLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 00000123478899999999999999999999864
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=309.82 Aligned_cols=243 Identities=25% Similarity=0.360 Sum_probs=195.1
Q ss_pred cceEEEEcC-CCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 3 VAICQGRLP-NGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 3 ~~~~~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
+.||+|... +++.||||.++... ...+.+.+|+.++++++||||+++++++..+...++||||+.+++|.+++... .
T Consensus 234 g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~-~ 311 (495)
T 1opk_A 234 GEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-N 311 (495)
T ss_dssp SSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHS-C
T ss_pred eEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhc-C
Confidence 467788765 58999999996543 35678999999999999999999999999999999999999999999998543 2
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP 161 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 161 (309)
...+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++......... ......++..|+|
T Consensus 312 ~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~~~~y~a 387 (495)
T 1opk_A 312 RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTA 387 (495)
T ss_dssp TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE-CCTTCCCCGGGCC
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCcee-ecCCCcCCcceeC
Confidence 34589999999999999999999998 8999999999999999999999999999765443221 1222345678999
Q ss_pred ccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHH
Q 021682 162 PEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQV 240 (309)
Q Consensus 162 PE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 240 (309)
||.+.+..++.++|||||||++|+|++ |..||......+ ... ........ ..+...+..+.+|
T Consensus 388 PE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~~~----~~~~~~~~---------~~~~~~~~~l~~l 451 (495)
T 1opk_A 388 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYE----LLEKDYRM---------ERPEGCPEKVYEL 451 (495)
T ss_dssp HHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHH----HHHTTCCC---------CCCTTCCHHHHHH
T ss_pred HhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHHcCCCC---------CCCCCCCHHHHHH
Confidence 999998889999999999999999999 899986543322 111 11111111 1111223478899
Q ss_pred HhhcccCCCCCCCCHHHHHHHHhcccC
Q 021682 241 ALLCVQENAADRPTMLEILVMLKSETA 267 (309)
Q Consensus 241 i~~~l~~~p~~Rpt~~ell~~L~~~~~ 267 (309)
|.+||+.||++|||+.+|++.|+.+..
T Consensus 452 i~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 452 MRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred HHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 999999999999999999999998743
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=293.44 Aligned_cols=238 Identities=21% Similarity=0.283 Sum_probs=180.0
Q ss_pred cceEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCC--CCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQH--VNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
+.||++...+++.||||.+.... ....+.+.+|+.++++++| +||+++++++..+...++|||+ .+++|.+++..
T Consensus 23 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~ 101 (343)
T 3dbq_A 23 SKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK 101 (343)
T ss_dssp EEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHH
T ss_pred eEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC-CCCCHHHHHHh
Confidence 45788888889999999987543 3345678899999999976 9999999999999999999995 57899999854
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
...+++..+..++.|++.||.|||+. |++||||||+||+++ ++.+||+|||++................||+.
T Consensus 102 ---~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~ 174 (343)
T 3dbq_A 102 ---KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVN 174 (343)
T ss_dssp ---SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCS
T ss_pred ---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcC
Confidence 34589999999999999999999998 899999999999996 67899999999976654433323334578999
Q ss_pred CCCcccccc-----------CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCC
Q 021682 159 YVPPEYVRK-----------GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDD 227 (309)
Q Consensus 159 y~aPE~~~~-----------~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (309)
|+|||.+.+ ..++.++|||||||++|+|++|..||..... ................+.
T Consensus 175 y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~------ 243 (343)
T 3dbq_A 175 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAIIDPNHEIEFP------ 243 (343)
T ss_dssp SCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHHHCTTSCCCCC------
T ss_pred cCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HHHHHHHHhcCCcccCCc------
Confidence 999999865 5678999999999999999999999853211 111111111111111111
Q ss_pred cccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 021682 228 SSSAWKLMRCMQVALLCVQENAADRPTMLEILVML 262 (309)
Q Consensus 228 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L 262 (309)
......+.++|.+||+.||++|||+.|+++.-
T Consensus 244 ---~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 244 ---DIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp ---CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ---ccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 11123678999999999999999999999763
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=287.02 Aligned_cols=242 Identities=25% Similarity=0.375 Sum_probs=193.5
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccc
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRR 82 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 82 (309)
+.||.+...+++.||+|.+..... ..+.+.+|++++++++||||+++++++..+...++||||+++++|.+++... .
T Consensus 22 g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~ 98 (267)
T 3t9t_A 22 GLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQ--R 98 (267)
T ss_dssp EEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHT--T
T ss_pred eeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhC--c
Confidence 467888877889999999975533 4578999999999999999999999999999999999999999999998542 3
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCc
Q 021682 83 YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPP 162 (309)
Q Consensus 83 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 162 (309)
..+++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++......... ......++..|+||
T Consensus 99 ~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aP 174 (267)
T 3t9t_A 99 GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASP 174 (267)
T ss_dssp TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH-STTSTTCCGGGCCH
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccccc-ccccccccccccCh
Confidence 4588999999999999999999998 8999999999999999999999999998765432211 12223567789999
Q ss_pred cccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHH
Q 021682 163 EYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241 (309)
Q Consensus 163 E~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 241 (309)
|.+.+..++.++||||||+++|+|++ |..||......+ . ........... .+......+.+++
T Consensus 175 E~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~-~~~i~~~~~~~---------~~~~~~~~l~~li 238 (267)
T 3t9t_A 175 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------V-VEDISTGFRLY---------KPRLASTHVYQIM 238 (267)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------H-HHHHHTTCCCC---------CCTTSCHHHHHHH
T ss_pred hhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH------H-HHHHhcCCcCC---------CCccCcHHHHHHH
Confidence 99998889999999999999999999 899885432111 1 11111111100 0111233788999
Q ss_pred hhcccCCCCCCCCHHHHHHHHhcccC
Q 021682 242 LLCVQENAADRPTMLEILVMLKSETA 267 (309)
Q Consensus 242 ~~~l~~~p~~Rpt~~ell~~L~~~~~ 267 (309)
.+||+.||++|||++++++.|+.+.+
T Consensus 239 ~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 239 NHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999988643
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=292.52 Aligned_cols=246 Identities=23% Similarity=0.373 Sum_probs=193.7
Q ss_pred cceEEEEcC------CCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHH
Q 021682 3 VAICQGRLP------NGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFY 75 (309)
Q Consensus 3 ~~~~~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (309)
+.||++... +++.||||.+.... ......+.+|+.++++++||||+++++++..+...++||||+.+++|.++
T Consensus 39 g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 118 (322)
T 1p4o_A 39 GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY 118 (322)
T ss_dssp SEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHH
T ss_pred eEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHH
Confidence 456776543 47889999997543 33456788999999999999999999999999999999999999999999
Q ss_pred Hhhhcc-------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccc
Q 021682 76 IFDLRR-------RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEA 148 (309)
Q Consensus 76 ~~~~~~-------~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 148 (309)
+..... ...+++..++.++.|++.|+.+||++ |++||||||+||+++.++.++|+|||++..........
T Consensus 119 l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~ 195 (322)
T 1p4o_A 119 LRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 195 (322)
T ss_dssp HHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEE
T ss_pred HHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEECcCccccccccccccc
Confidence 865332 13468899999999999999999998 99999999999999999999999999987654433222
Q ss_pred cccccccccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCC
Q 021682 149 NTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDD 227 (309)
Q Consensus 149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (309)
......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...... . .............
T Consensus 196 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~-~~~~~~~~~~~~~------- 261 (322)
T 1p4o_A 196 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------Q-VLRFVMEGGLLDK------- 261 (322)
T ss_dssp GGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH------H-HHHHHHTTCCCCC-------
T ss_pred cccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH------H-HHHHHHcCCcCCC-------
Confidence 2333456788999999998889999999999999999999 88887543211 1 1111111111111
Q ss_pred cccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccC
Q 021682 228 SSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETA 267 (309)
Q Consensus 228 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~ 267 (309)
....+..+.+++.+||+.||++|||+.++++.|+....
T Consensus 262 --~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 262 --PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp --CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred --CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 11123368899999999999999999999999998755
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=290.94 Aligned_cols=247 Identities=23% Similarity=0.311 Sum_probs=189.3
Q ss_pred CCCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeC--CeeEEEEeccCCCChhHHHhhhccccCCCH
Q 021682 11 PNGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQR--EEKMLIYDYMPNKSLDFYIFDLRRRYLLDW 87 (309)
Q Consensus 11 ~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 87 (309)
.+|+.||||+++... ......+.+|++++++++||||+++++++... ...++||||+.+++|.+++.. ..+++
T Consensus 58 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~ 133 (318)
T 3lxp_A 58 GTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR----HSIGL 133 (318)
T ss_dssp -CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGG----SCCCH
T ss_pred CCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhh----CCCCH
Confidence 378999999997653 34467789999999999999999999999874 578999999999999999843 23899
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccc-ccccccccccCCCCccccc
Q 021682 88 RTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECE-ANTGRIVGTYGYVPPEYVR 166 (309)
Q Consensus 88 ~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~ 166 (309)
..++.++.|++.|+.+||+. |++|+||||+||+++.++.++|+|||++......... .......++..|+|||.+.
T Consensus 134 ~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 210 (318)
T 3lxp_A 134 AQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 210 (318)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhc
Confidence 99999999999999999999 8999999999999999999999999999776543221 1122345777899999999
Q ss_pred cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCC--------CcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHH
Q 021682 167 KGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPN--------ESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238 (309)
Q Consensus 167 ~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (309)
+..++.++||||||+++|+|++|..||...... .................. ...+...+..+.
T Consensus 211 ~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~l~ 281 (318)
T 3lxp_A 211 EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGER---------LPRPDKCPAEVY 281 (318)
T ss_dssp HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCC---------CCCCTTCCHHHH
T ss_pred CCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccC---------CCCCccccHHHH
Confidence 988999999999999999999999997532110 000000111111111111 111112234788
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHHhcccCCCCCCC
Q 021682 239 QVALLCVQENAADRPTMLEILVMLKSETADIKTPK 273 (309)
Q Consensus 239 ~li~~~l~~~p~~Rpt~~ell~~L~~~~~~~~~~~ 273 (309)
++|.+||+.||++|||++++++.|+.+.+.+..+.
T Consensus 282 ~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~ 316 (318)
T 3lxp_A 282 HLMKNCWETEASFRPTFENLIPILKTVHEKYQGQA 316 (318)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC--
T ss_pred HHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCC
Confidence 99999999999999999999999998877665544
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=297.56 Aligned_cols=240 Identities=20% Similarity=0.283 Sum_probs=183.6
Q ss_pred ceEEEE-cCCCcEEEEEEeecCC---cccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTS---HQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
.||.+. ..+|+.||||++++.. ......+..|..++.++ +||||+++++++.++...++||||+.+++|..++..
T Consensus 67 ~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~ 146 (396)
T 4dc2_A 67 KVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR 146 (396)
T ss_dssp EEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH
T ss_pred EEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHH
Confidence 456665 4578999999997642 22345678899999887 899999999999999999999999999999988854
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
. ..+++..+..++.||+.||.|||++ ||+||||||+||+++.++.+||+|||++........ ......||+.
T Consensus 147 ~---~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~--~~~~~~gt~~ 218 (396)
T 4dc2_A 147 Q---RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPN 218 (396)
T ss_dssp H---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--CBCCCCBCGG
T ss_pred c---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecccCCC--ccccccCCcc
Confidence 3 3499999999999999999999999 999999999999999999999999999975332221 2333578999
Q ss_pred CCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcc--cHHHHHHHHhhCCCCcccccccCCCcccHHHHHH
Q 021682 159 YVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESL--NLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMR 236 (309)
Q Consensus 159 y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
|+|||++.+..++.++|+|||||++|+|++|..||......+.. ............... .+ +......
T Consensus 219 Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~~---------p~~~s~~ 288 (396)
T 4dc2_A 219 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RI---------PRSLSVK 288 (396)
T ss_dssp GCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC-CC---------CTTSCHH
T ss_pred cCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc-CC---------CCcCCHH
Confidence 99999999999999999999999999999999999644332211 111111111111110 00 1112237
Q ss_pred HHHHHhhcccCCCCCCCCH------HHHHHH
Q 021682 237 CMQVALLCVQENAADRPTM------LEILVM 261 (309)
Q Consensus 237 l~~li~~~l~~~p~~Rpt~------~ell~~ 261 (309)
+.+||.+||+.||++||++ +|+++.
T Consensus 289 ~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 289 AASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp HHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred HHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 8899999999999999995 666654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=288.31 Aligned_cols=248 Identities=18% Similarity=0.240 Sum_probs=183.7
Q ss_pred cceEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
+.||++...+|+.||+|.+.... ......+.+|+.++++++||||+++++++..+...++|||++.+ +|.+++...
T Consensus 16 g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~- 93 (288)
T 1ob3_A 16 GVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVC- 93 (288)
T ss_dssp EEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHTS-
T ss_pred EEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHhc-
Confidence 46788877889999999986543 22346788999999999999999999999999999999999975 888877432
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCC
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYV 160 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 160 (309)
...+++..+..++.|++.|+.|||++ |++||||||+||+++.++.+||+|||++......... .....++..|+
T Consensus 94 -~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~t~~y~ 167 (288)
T 1ob3_A 94 -EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--YTHEIVTLWYR 167 (288)
T ss_dssp -TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTC
T ss_pred -ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccccc--ccccccccccc
Confidence 34589999999999999999999998 9999999999999999999999999999765432211 22236789999
Q ss_pred CccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCC---CCcc-----cccccCC-----
Q 021682 161 PPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNG---EGME-----FIDSSLD----- 226 (309)
Q Consensus 161 aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~-----~~~~~~~----- 226 (309)
|||.+.+. .++.++|||||||++|+|++|..||......+. ........... .... ..+....
T Consensus 168 aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (288)
T 1ob3_A 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ---LMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPL 244 (288)
T ss_dssp CHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCC
T ss_pred CchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHHCCCChhhchhhhcccccccccccccCc
Confidence 99998764 589999999999999999999999864322211 11111111110 0000 0000000
Q ss_pred --CcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 227 --DSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 227 --~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
..........+.++|.+||+.||++|||++|+++.
T Consensus 245 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 245 PWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp CGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00001123477899999999999999999999863
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=292.88 Aligned_cols=241 Identities=19% Similarity=0.185 Sum_probs=169.1
Q ss_pred ceEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHHhcCC-CCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQ-HVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
.||++.. .+|+.||||.+... ....+..|+.+++.+. ||||+++++++.++...++||||+.+++|.+++..
T Consensus 26 ~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--- 99 (325)
T 3kn6_A 26 ICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKK--- 99 (325)
T ss_dssp EEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH---
T ss_pred EEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHh---
Confidence 5666654 57999999999643 3467789999999996 99999999999999999999999999999999854
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCC---CceeecccccccccCCcccccccccccccC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM---NPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~---~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
...+++..+..++.|++.|+.|||++ |++||||||+||+++.++ .++|+|||++......... .....++..
T Consensus 100 ~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~ 174 (325)
T 3kn6_A 100 KKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP--LKTPCFTLH 174 (325)
T ss_dssp CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---------------
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc--ccccCCCcC
Confidence 34599999999999999999999998 999999999999998765 7999999999765433221 223467899
Q ss_pred CCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHH
Q 021682 159 YVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238 (309)
Q Consensus 159 y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (309)
|+|||.+.+..++.++|||||||++|+|++|..||...+.................+... .........+..+.
T Consensus 175 y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~------~~~~~~~~~s~~~~ 248 (325)
T 3kn6_A 175 YAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS------FEGEAWKNVSQEAK 248 (325)
T ss_dssp ---------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC------CCSHHHHTSCHHHH
T ss_pred ccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC------CCcccccCCCHHHH
Confidence 999999999999999999999999999999999997544432222222222222221111 00011111234788
Q ss_pred HHHhhcccCCCCCCCCHHHHHHH
Q 021682 239 QVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 239 ~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
++|.+||+.||++|||++++++.
T Consensus 249 ~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 249 DLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHHHHHHCCCTTTCCCTTTSTTC
T ss_pred HHHHHHCCCChhHCCCHHHHhcC
Confidence 99999999999999999999865
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=295.33 Aligned_cols=246 Identities=27% Similarity=0.407 Sum_probs=192.7
Q ss_pred cceEEEEcC-CC-----cEEEEEEeecCC-cccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhH
Q 021682 3 VAICQGRLP-NG-----QEMAVKRLSRTS-HQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDF 74 (309)
Q Consensus 3 ~~~~~~~~~-~g-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (309)
+.||++... +| +.||+|.+.... ....+.+.+|+.+++++ +||||+++++++..+...++||||+.+++|.+
T Consensus 60 g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~ 139 (333)
T 2i1m_A 60 GKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLN 139 (333)
T ss_dssp EEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHH
T ss_pred cceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHH
Confidence 356777643 33 479999997553 33457789999999999 89999999999999999999999999999999
Q ss_pred HHhhhcc-----------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccC
Q 021682 75 YIFDLRR-----------RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTK 143 (309)
Q Consensus 75 ~~~~~~~-----------~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~ 143 (309)
++..... ...+++..++.++.|++.|+.|||+. |++|+||||+||+++.++.++|+|||++.....
T Consensus 140 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 216 (333)
T 2i1m_A 140 FLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 216 (333)
T ss_dssp HHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGG
T ss_pred HHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCCeEEECcccccccccc
Confidence 9865331 33578999999999999999999998 999999999999999999999999999976654
Q ss_pred CcccccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCccccc
Q 021682 144 DECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFID 222 (309)
Q Consensus 144 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (309)
...........++..|+|||.+.+..++.++||||||+++|+|++ |..||......... ...........
T Consensus 217 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~------~~~~~~~~~~~--- 287 (333)
T 2i1m_A 217 DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF------YKLVKDGYQMA--- 287 (333)
T ss_dssp CTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH------HHHHHHTCCCC---
T ss_pred ccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH------HHHHhcCCCCC---
Confidence 433323334456788999999988899999999999999999998 88898643322211 11111111100
Q ss_pred ccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhccc
Q 021682 223 SSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSET 266 (309)
Q Consensus 223 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~ 266 (309)
.+...+..+.+++.+||+.||++|||++++++.|+.+.
T Consensus 288 ------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 288 ------QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 01111237889999999999999999999999998764
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=288.62 Aligned_cols=238 Identities=22% Similarity=0.266 Sum_probs=184.4
Q ss_pred cceEEEEcC-CCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCC----------------------
Q 021682 3 VAICQGRLP-NGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQRE---------------------- 58 (309)
Q Consensus 3 ~~~~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---------------------- 58 (309)
+.||++... +|+.||||+++... ....+.+.+|++++++++||||+++++++....
T Consensus 20 g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (332)
T 3qd2_B 20 GVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPL 99 (332)
T ss_dssp SEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC------------
T ss_pred eEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccc
Confidence 456777654 89999999997543 335678999999999999999999999886543
Q ss_pred -----------------------------------eeEEEEeccCCCChhHHHhhhccccCCCHHHHHHHHHHHHHHHHH
Q 021682 59 -----------------------------------EKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLY 103 (309)
Q Consensus 59 -----------------------------------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 103 (309)
..++||||+.+++|.+++.........++..++.++.|++.|+.|
T Consensus 100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~ 179 (332)
T 3qd2_B 100 SSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEF 179 (332)
T ss_dssp --------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHH
T ss_pred cCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHH
Confidence 379999999999999999765555556777889999999999999
Q ss_pred HhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccc----------ccccccccccCCCCccccccCCCCcc
Q 021682 104 LQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECE----------ANTGRIVGTYGYVPPEYVRKGIYSMK 173 (309)
Q Consensus 104 lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~ 173 (309)
||++ |++||||||+||+++.++.+||+|||++......... .......||+.|+|||.+.+..++.+
T Consensus 180 LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 256 (332)
T 3qd2_B 180 LHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHK 256 (332)
T ss_dssp HHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTH
T ss_pred HHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcch
Confidence 9998 9999999999999999999999999999776543211 11223468999999999999999999
Q ss_pred chhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCC
Q 021682 174 YDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRP 253 (309)
Q Consensus 174 ~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 253 (309)
+|||||||++|+|++|..|+. ... ........... ..........+.++|.+||+.||++||
T Consensus 257 ~Di~slG~il~el~~~~~~~~--------~~~-~~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp 318 (332)
T 3qd2_B 257 VDIFSLGLILFELLYSFSTQM--------ERV-RIITDVRNLKF---------PLLFTQKYPQEHMMVQDMLSPSPTERP 318 (332)
T ss_dssp HHHHHHHHHHHHHHSCCCCHH--------HHH-HHHHHHHTTCC---------CHHHHHHCHHHHHHHHHHHCSSGGGSC
T ss_pred hhHHHHHHHHHHHHHcCCChh--------HHH-HHHHHhhccCC---------CcccccCChhHHHHHHHHccCCCCcCC
Confidence 999999999999999876531 000 11111111111 111122334678999999999999999
Q ss_pred CHHHHHHH
Q 021682 254 TMLEILVM 261 (309)
Q Consensus 254 t~~ell~~ 261 (309)
|++|+++.
T Consensus 319 s~~~~l~~ 326 (332)
T 3qd2_B 319 EATDIIEN 326 (332)
T ss_dssp CHHHHHHS
T ss_pred CHHHHhhc
Confidence 99999863
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=286.25 Aligned_cols=240 Identities=20% Similarity=0.279 Sum_probs=185.5
Q ss_pred cceEEEEcC-CC-------cEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhH
Q 021682 3 VAICQGRLP-NG-------QEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDF 74 (309)
Q Consensus 3 ~~~~~~~~~-~g-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (309)
+.||++... ++ ..||+|.+........+.+.+|+.++++++||||+++++++..+...++||||+.+++|.+
T Consensus 22 g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 101 (289)
T 4fvq_A 22 TKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDT 101 (289)
T ss_dssp EEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHH
T ss_pred ceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHH
Confidence 356777543 34 4799999977666677889999999999999999999999999999999999999999999
Q ss_pred HHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCC--------ceeecccccccccCCcc
Q 021682 75 YIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMN--------PKISDFGMARAFTKDEC 146 (309)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~--------~~l~Dfg~~~~~~~~~~ 146 (309)
++... ...+++..++.++.|++.|+.|||++ |++||||||+||+++.++. ++|+|||++......
T Consensus 102 ~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-- 174 (289)
T 4fvq_A 102 YLKKN--KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK-- 174 (289)
T ss_dssp HHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH--
T ss_pred HHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeeccCcccccccCc--
Confidence 98543 33489999999999999999999999 8999999999999998887 999999998544322
Q ss_pred cccccccccccCCCCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccC
Q 021682 147 EANTGRIVGTYGYVPPEYVRK-GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSL 225 (309)
Q Consensus 147 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (309)
....++..|+|||.+.+ ..++.++||||||+++|+|++|..|+... .. ..................
T Consensus 175 ----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~--~~---~~~~~~~~~~~~~~~~~~---- 241 (289)
T 4fvq_A 175 ----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA--LD---SQRKLQFYEDRHQLPAPK---- 241 (289)
T ss_dssp ----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTT--SC---HHHHHHHHHTTCCCCCCS----
T ss_pred ----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccc--cc---hHHHHHHhhccCCCCCCC----
Confidence 12357888999999987 67899999999999999999965443211 11 111111111111111100
Q ss_pred CCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccCCCC
Q 021682 226 DDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETADIK 270 (309)
Q Consensus 226 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~~~ 270 (309)
...+.+++.+||+.||++|||++++++.|+.+..+-.
T Consensus 242 --------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~ 278 (289)
T 4fvq_A 242 --------AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278 (289)
T ss_dssp --------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred --------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 1257799999999999999999999999998765433
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=286.67 Aligned_cols=236 Identities=28% Similarity=0.417 Sum_probs=178.2
Q ss_pred cceEEEEcCCCcEEEEEEeecCC----cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTS----HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
+.||++.. +|+.||||.++... ....+.+.+|+++++.++||||+++++++..+...++||||+.+++|.+++.
T Consensus 21 g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~- 98 (271)
T 3dtc_A 21 GKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS- 98 (271)
T ss_dssp EEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHT-
T ss_pred eEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhh-
Confidence 46788876 58999999986542 2335678899999999999999999999999999999999999999998873
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCc---eeecCCCCceEEeCC--------CCCceeecccccccccCCccc
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLT---IVHRDLKASNILLDY--------EMNPKISDFGMARAFTKDECE 147 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~g---i~H~di~p~nil~~~--------~~~~~l~Dfg~~~~~~~~~~~ 147 (309)
...+++..++.++.|++.|+.+||++ | ++|+||||+||+++. ++.++|+|||++........
T Consensus 99 ---~~~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~- 171 (271)
T 3dtc_A 99 ---GKRIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK- 171 (271)
T ss_dssp ---SSCCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC----------
T ss_pred ---cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccccccCcceEEccCCcccccccccc-
Confidence 33589999999999999999999998 7 899999999999986 67899999999875544322
Q ss_pred ccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCC
Q 021682 148 ANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDD 227 (309)
Q Consensus 148 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (309)
....|+..|+|||.+.+..++.++||||||+++|+|++|..||..... ...............
T Consensus 172 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~-------- 234 (271)
T 3dtc_A 172 ---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG------LAVAYGVAMNKLALP-------- 234 (271)
T ss_dssp -------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH------HHHHHHHHTSCCCCC--------
T ss_pred ---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHhhhcCCCCCC--------
Confidence 123678999999999998999999999999999999999999854321 111111111111111
Q ss_pred cccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcc
Q 021682 228 SSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSE 265 (309)
Q Consensus 228 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~ 265 (309)
.+...+..+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 235 -~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 235 -IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred -CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 1111223788999999999999999999999999863
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=294.05 Aligned_cols=230 Identities=17% Similarity=0.196 Sum_probs=186.3
Q ss_pred ceEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
.||.+.. .+|+.||||++.... ....+.+.+|+++++.++||||+++++++.++...++||||+.+++|.+++...
T Consensus 56 ~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~ 135 (350)
T 1rdq_E 56 RVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI 135 (350)
T ss_dssp EEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH
T ss_pred EEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHc
Confidence 4666654 589999999996542 234567889999999999999999999999999999999999999999998543
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
..+++..++.++.||+.||.|||++ |++||||||+||+++.++.++|+|||++...... .....||+.|
T Consensus 136 ---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-----~~~~~gt~~y 204 (350)
T 1rdq_E 136 ---GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEA 204 (350)
T ss_dssp ---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-----BCCCEECGGG
T ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC-----cccccCCccc
Confidence 3489999999999999999999998 9999999999999999999999999999765432 1234689999
Q ss_pred CCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHH
Q 021682 160 VPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQ 239 (309)
Q Consensus 160 ~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (309)
+|||.+.+..++.++|+|||||++|+|++|..||...... ........ ... .+ . ...+..+.+
T Consensus 205 ~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i~~-~~~-~~-----p----~~~~~~~~~ 267 (350)
T 1rdq_E 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI------QIYEKIVS-GKV-RF-----P----SHFSSDLKD 267 (350)
T ss_dssp CCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHH-CCC-CC-----C----TTCCHHHHH
T ss_pred cCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH------HHHHHHHc-CCC-CC-----C----CCCCHHHHH
Confidence 9999999999999999999999999999999998543211 11111111 111 00 1 112237889
Q ss_pred HHhhcccCCCCCCCC-----HHHHHHH
Q 021682 240 VALLCVQENAADRPT-----MLEILVM 261 (309)
Q Consensus 240 li~~~l~~~p~~Rpt-----~~ell~~ 261 (309)
+|.+||+.||++||+ ++++++.
T Consensus 268 li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 268 LLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 999999999999998 8998865
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=282.24 Aligned_cols=260 Identities=15% Similarity=0.136 Sum_probs=199.4
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEE-eeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGIC-TQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
+.||++.. .+|+.||||++..... ...+..|+.+++.++|++++..+.++ ..+...++||||+ +++|.+++...
T Consensus 23 g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~- 98 (296)
T 3uzp_A 23 GDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFC- 98 (296)
T ss_dssp EEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT-
T ss_pred eEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhh-
Confidence 35777764 6899999999865433 24688999999999888876666555 5567889999999 88999998532
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeC---CCCCceeecccccccccCCcccc-----cccc
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLD---YEMNPKISDFGMARAFTKDECEA-----NTGR 152 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~---~~~~~~l~Dfg~~~~~~~~~~~~-----~~~~ 152 (309)
...+++..++.++.|++.|+.|||++ |++|+||||+||+++ .++.++|+|||++.......... ....
T Consensus 99 -~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~ 174 (296)
T 3uzp_A 99 -SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 174 (296)
T ss_dssp -TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCC
T ss_pred -ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccc
Confidence 33589999999999999999999998 999999999999994 78899999999997765443211 1233
Q ss_pred cccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHH
Q 021682 153 IVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAW 232 (309)
Q Consensus 153 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (309)
..|+..|+|||.+.+..++.++|||||||++|+|++|+.||........................... .. .
T Consensus 175 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~----~ 245 (296)
T 3uzp_A 175 LTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL-----CK----G 245 (296)
T ss_dssp CCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH-----TT----T
T ss_pred cccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHH-----Hh----h
Confidence 46899999999999989999999999999999999999999765544433333322221111100000 00 1
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccCCCCCCCCCCccc
Q 021682 233 KLMRCMQVALLCVQENAADRPTMLEILVMLKSETADIKTPKKPAFSV 279 (309)
Q Consensus 233 ~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~~~~~~~p~~~~ 279 (309)
.+..+.+++.+||+.||++|||++++++.|+.+......+....++|
T Consensus 246 ~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw 292 (296)
T 3uzp_A 246 YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDW 292 (296)
T ss_dssp SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGG
T ss_pred CCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcccccccc
Confidence 12378899999999999999999999999999877776665555655
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=295.66 Aligned_cols=248 Identities=24% Similarity=0.346 Sum_probs=192.9
Q ss_pred cceEEEEc--------CCCcEEEEEEeecCC-cccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCCh
Q 021682 3 VAICQGRL--------PNGQEMAVKRLSRTS-HQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSL 72 (309)
Q Consensus 3 ~~~~~~~~--------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 72 (309)
+.||++.. .+++.||||.++... ......+.+|+++++++ +||||+++++++..++..++||||+.+++|
T Consensus 49 g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 128 (334)
T 2pvf_A 49 GQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 128 (334)
T ss_dssp CEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBH
T ss_pred eeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcH
Confidence 45677754 357889999997543 34456789999999999 899999999999999999999999999999
Q ss_pred hHHHhhhcc-------------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccc
Q 021682 73 DFYIFDLRR-------------RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMAR 139 (309)
Q Consensus 73 ~~~~~~~~~-------------~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~ 139 (309)
.+++..... ...+++..++.++.|++.|+.|||+. |++|+||||+||+++.++.+||+|||++.
T Consensus 129 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~ 205 (334)
T 2pvf_A 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR 205 (334)
T ss_dssp HHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred HHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEEcCCCCEEEccccccc
Confidence 999865332 22488999999999999999999998 99999999999999999999999999997
Q ss_pred cccCCcccccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCc
Q 021682 140 AFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGM 218 (309)
Q Consensus 140 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (309)
...............++..|+|||.+.+..++.++||||||+++|+|++ |..||......+ ...........
T Consensus 206 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~~~~~~~~~ 278 (334)
T 2pvf_A 206 DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-------LFKLLKEGHRM 278 (334)
T ss_dssp ECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------HHHHHHHTCCC
T ss_pred cccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH-------HHHHHhcCCCC
Confidence 6654432222333456788999999988889999999999999999999 999985432211 11111111111
Q ss_pred ccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccCCC
Q 021682 219 EFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETADI 269 (309)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~~ 269 (309)
.. +......+.+++.+||+.||++|||++++++.|+++....
T Consensus 279 ~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 279 DK---------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320 (334)
T ss_dssp CC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CC---------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 11 1112237889999999999999999999999999886543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=295.91 Aligned_cols=245 Identities=24% Similarity=0.376 Sum_probs=183.9
Q ss_pred cceEEEEc-CCCcEE----EEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHH
Q 021682 3 VAICQGRL-PNGQEM----AVKRLSRT-SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 3 ~~~~~~~~-~~g~~v----avK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 76 (309)
+.||++.. .+|+.| |+|.+... .......+.+|+.++++++||||+++++++..+. .++|++++.+++|.+++
T Consensus 29 g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l 107 (327)
T 3lzb_A 29 GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV 107 (327)
T ss_dssp EEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHH
T ss_pred eEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHH
Confidence 45677764 466655 66666433 3445678999999999999999999999998765 78899999999999998
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccc
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGT 156 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 156 (309)
... ...+++..++.++.|++.|+.|||++ |++||||||+||+++.++.++|+|||++................++
T Consensus 108 ~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t 182 (327)
T 3lzb_A 108 REH--KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182 (327)
T ss_dssp HHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC----------------CCC
T ss_pred Hhc--CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCcc
Confidence 543 34589999999999999999999998 8999999999999999999999999999876544333333334567
Q ss_pred cCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 157 YGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
..|+|||.+.+..++.++|||||||++|+|++ |..||......+.. . ......... .+.....
T Consensus 183 ~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~---~----~~~~~~~~~---------~~~~~~~ 246 (327)
T 3lzb_A 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---S----ILEKGERLP---------QPPICTI 246 (327)
T ss_dssp GGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---H----HHHTTCCCC---------CCTTBCH
T ss_pred ccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH---H----HHHcCCCCC---------CCccCCH
Confidence 78999999999999999999999999999999 99998654332211 1 111111111 1111223
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHHhcccCCC
Q 021682 236 RCMQVALLCVQENAADRPTMLEILVMLKSETADI 269 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~~ 269 (309)
.+.+++.+||+.||++|||+.|+++.|+.+....
T Consensus 247 ~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 247 DVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 6889999999999999999999999999886543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=292.58 Aligned_cols=240 Identities=21% Similarity=0.259 Sum_probs=184.3
Q ss_pred cceEEEEc-CCCcEEEEEEeecC--CcccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRT--SHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
+.||++.. .+|+.||||+++.. .......+..|+.+++++ .||||+++++++......++||||+.+++|.+++..
T Consensus 43 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 122 (327)
T 3lm5_A 43 AVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLP 122 (327)
T ss_dssp EEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSS
T ss_pred eEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHH
Confidence 35666654 57999999998754 344467889999999999 579999999999999999999999999999888743
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCC---CCCceeecccccccccCCccccccccccc
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY---EMNPKISDFGMARAFTKDECEANTGRIVG 155 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~---~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 155 (309)
.....+++..++.++.|++.|+.+||+. |++||||+|+||+++. ++.++|+|||++........ .....|
T Consensus 123 -~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~g 195 (327)
T 3lm5_A 123 -ELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE---LREIMG 195 (327)
T ss_dssp -CC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC------------CC
T ss_pred -hcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeCccccccCCccc---cccccC
Confidence 2235589999999999999999999998 9999999999999988 78999999999976544322 223468
Q ss_pred ccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 156 TYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 156 ~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
++.|+|||.+.+..++.++||||||+++|+|++|..||......+. . ...... .. ... .........
T Consensus 196 t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~---~~i~~~-~~-~~~-----~~~~~~~~~ 262 (327)
T 3lm5_A 196 TPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET---Y---LNISQV-NV-DYS-----EETFSSVSQ 262 (327)
T ss_dssp CGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H---HHHHHT-CC-CCC-----TTTTTTSCH
T ss_pred CcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH---H---HHHHhc-cc-ccC-----chhhcccCH
Confidence 9999999999999999999999999999999999999854322111 1 111110 00 000 000111223
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHH
Q 021682 236 RCMQVALLCVQENAADRPTMLEILVML 262 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~Rpt~~ell~~L 262 (309)
.+.++|.+||+.||++|||++++++.-
T Consensus 263 ~~~~li~~~L~~dP~~Rpt~~~ll~h~ 289 (327)
T 3lm5_A 263 LATDFIQSLLVKNPEKRPTAEICLSHS 289 (327)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHTTCG
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhCCH
Confidence 678999999999999999999998763
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=285.03 Aligned_cols=246 Identities=24% Similarity=0.265 Sum_probs=184.2
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhc--CCCCCccceeeEEeeC----CeeEEEEeccCCCChhHHH
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTAR--LQHVNLLPVLGICTQR----EEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~----~~~~lv~e~~~~~~L~~~~ 76 (309)
+.||++.. +|+.||||++... ....+..|.+++.. ++||||+++++++... ...++||||+.+++|.+++
T Consensus 22 g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l 97 (301)
T 3q4u_A 22 GEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL 97 (301)
T ss_dssp EEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHH
T ss_pred cEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHH
Confidence 45788876 7999999998643 23445556666555 7999999999986543 4689999999999999998
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHh--------hcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccc
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQ--------EYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEA 148 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh--------~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 148 (309)
. ...+++..++.++.|++.|+.||| +. |++||||||+||+++.++.+||+|||++..........
T Consensus 98 ~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 170 (301)
T 3q4u_A 98 Q----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQL 170 (301)
T ss_dssp T----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEE
T ss_pred h----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeCCCeeecccccccc
Confidence 3 235899999999999999999999 66 99999999999999999999999999997655433221
Q ss_pred --cccccccccCCCCccccccC------CCCccchhhhHHHHHHHHHhC----------CCCCCCCCCCCcccHHHHHHH
Q 021682 149 --NTGRIVGTYGYVPPEYVRKG------IYSMKYDVYSYGVLLLQILGG----------KRTSCYYGPNESLNLLEYAYG 210 (309)
Q Consensus 149 --~~~~~~~~~~y~aPE~~~~~------~~~~~~DvwslG~il~~ll~g----------~~p~~~~~~~~~~~~~~~~~~ 210 (309)
......||+.|+|||.+.+. .++.++|||||||++|+|++| ..||............ ...
T Consensus 171 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~--~~~ 248 (301)
T 3q4u_A 171 DVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED--MRK 248 (301)
T ss_dssp ECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHH--HHH
T ss_pred cccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhh--hhH
Confidence 12234689999999999776 445799999999999999999 7777543333222111 111
Q ss_pred Hhh-CCCCcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcc
Q 021682 211 LWK-NGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSE 265 (309)
Q Consensus 211 ~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~ 265 (309)
... ........ ...........+.+++.+||+.||++|||++++++.|+++
T Consensus 249 ~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 249 VVCVDQQRPNIP----NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp HHTTSCCCCCCC----GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhccCCCCCCC----hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 111 11111111 1112234556889999999999999999999999999875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=294.44 Aligned_cols=244 Identities=23% Similarity=0.358 Sum_probs=187.3
Q ss_pred cceEEEEc-CCCcE----EEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHH
Q 021682 3 VAICQGRL-PNGQE----MAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 3 ~~~~~~~~-~~g~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 76 (309)
+.||++.. .+|+. ||+|.+.... ......+.+|+.++++++||||+++++++. +...++||||+.+++|.+++
T Consensus 27 g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l 105 (325)
T 3kex_A 27 GTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHV 105 (325)
T ss_dssp CEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHH
T ss_pred ceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHH
Confidence 45777764 45665 7777764432 333456778999999999999999999986 45688999999999999988
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccc
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGT 156 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 156 (309)
... ...+++..+..++.|++.|+.|||+. |++||||||+||+++.++.++|+|||++................++
T Consensus 106 ~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~ 180 (325)
T 3kex_A 106 RQH--RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP 180 (325)
T ss_dssp HSS--GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CC
T ss_pred HHc--cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCc
Confidence 542 34588899999999999999999999 8999999999999999999999999999876654433333445677
Q ss_pred cCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 157 YGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
..|+|||.+.+..++.++|||||||++|+|++ |..||......+.. ............. ....
T Consensus 181 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~~~~~~~~---------~~~~ 244 (325)
T 3kex_A 181 IKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP-------DLLEKGERLAQPQ---------ICTI 244 (325)
T ss_dssp TTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHH-------HHHHTTCBCCCCT---------TBCT
T ss_pred ccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHH-------HHHHcCCCCCCCC---------cCcH
Confidence 89999999998999999999999999999999 99998654332211 1111111111100 0112
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHHhcccCC
Q 021682 236 RCMQVALLCVQENAADRPTMLEILVMLKSETAD 268 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~ 268 (309)
.+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 245 ~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 245 DVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp TTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 567899999999999999999999999887543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=287.44 Aligned_cols=243 Identities=25% Similarity=0.356 Sum_probs=193.9
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
+.||.+.. .+++.||+|.+... ....+.+.+|++++++++||||+++++++..+...++||||+.+++|.+++... .
T Consensus 27 g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~ 104 (288)
T 3kfa_A 27 GEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-N 104 (288)
T ss_dssp CSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHC-C
T ss_pred eeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhc-c
Confidence 35666665 46899999999644 345678899999999999999999999999999999999999999999998542 3
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP 161 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 161 (309)
...+++..++.++.+++.|+.+||+. |++|+||+|+||+++.++.++|+|||.+......... ......++..|+|
T Consensus 105 ~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~a 180 (288)
T 3kfa_A 105 RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTA 180 (288)
T ss_dssp TTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSE-EETTEEECGGGCC
T ss_pred cCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCccc-cccCCccccCcCC
Confidence 44589999999999999999999999 8999999999999999999999999999766543322 2223356778999
Q ss_pred ccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHH
Q 021682 162 PEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQV 240 (309)
Q Consensus 162 PE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 240 (309)
||.+.+..++.++||||||+++|+|++ |..||........ ... ........ .+...+..+.++
T Consensus 181 PE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~---~~~----~~~~~~~~---------~~~~~~~~l~~l 244 (288)
T 3kfa_A 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---YEL----LEKDYRME---------RPEGCPEKVYEL 244 (288)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HHH----HHTTCCCC---------CCTTCCHHHHHH
T ss_pred hhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH----HhccCCCC---------CCCCCCHHHHHH
Confidence 999998899999999999999999999 9999865433221 111 11111111 111122478899
Q ss_pred HhhcccCCCCCCCCHHHHHHHHhcccC
Q 021682 241 ALLCVQENAADRPTMLEILVMLKSETA 267 (309)
Q Consensus 241 i~~~l~~~p~~Rpt~~ell~~L~~~~~ 267 (309)
+.+||+.||++|||++++++.|+.+..
T Consensus 245 i~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 245 MRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 999999999999999999999987643
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=302.87 Aligned_cols=236 Identities=25% Similarity=0.374 Sum_probs=189.2
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCC-eeEEEEeccCCCChhHHHhhhcc
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQRE-EKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
+.||+|.. +|+.||||.++... ..+.+.+|+.++++++||||+++++++.... ..++||||+.+++|.+++... .
T Consensus 207 g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~-~ 282 (450)
T 1k9a_A 207 GDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-G 282 (450)
T ss_dssp EEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHH-C
T ss_pred eeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhc-C
Confidence 35788887 48899999996543 4578999999999999999999999987665 789999999999999998643 2
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP 161 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 161 (309)
...+++..++.++.|++.|++|||++ |++||||+|+||+++.++.+||+|||++....... ....++..|+|
T Consensus 283 ~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-----~~~~~~~~y~a 354 (450)
T 1k9a_A 283 RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTA 354 (450)
T ss_dssp TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC-----------CCCTTTSC
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-----cCCCCCcceeC
Confidence 33478999999999999999999998 89999999999999999999999999987543221 11246788999
Q ss_pred ccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHH
Q 021682 162 PEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQV 240 (309)
Q Consensus 162 PE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 240 (309)
||.+.+..++.++||||||+++|+|++ |..||......+.. . ....+.... .+...+..+.++
T Consensus 355 PE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~---~----~i~~~~~~~---------~p~~~~~~l~~l 418 (450)
T 1k9a_A 355 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---P----RVEKGYKMD---------APDGCPPAVYDV 418 (450)
T ss_dssp HHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH---H----HHHTTCCCC---------CCTTCCHHHHHH
T ss_pred HHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---H----HHHcCCCCC---------CCCcCCHHHHHH
Confidence 999999999999999999999999998 99998755443321 1 111111111 111223478899
Q ss_pred HhhcccCCCCCCCCHHHHHHHHhccc
Q 021682 241 ALLCVQENAADRPTMLEILVMLKSET 266 (309)
Q Consensus 241 i~~~l~~~p~~Rpt~~ell~~L~~~~ 266 (309)
+.+||+.||++|||+.++++.|+.+.
T Consensus 419 i~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 419 MKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 99999999999999999999998764
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=287.39 Aligned_cols=247 Identities=27% Similarity=0.374 Sum_probs=192.7
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccc
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRR 82 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 82 (309)
+.||.+...+++.||||.+.... ...+.+.+|++++++++||||+++++++.. +..++||||+.+++|.+++... ..
T Consensus 27 g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~-~~ 103 (279)
T 1qpc_A 27 GEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SG 103 (279)
T ss_dssp EEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSH-HH
T ss_pred eEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCCCCHHHHHhcC-CC
Confidence 46788888888899999996543 346789999999999999999999999864 5688999999999999998542 22
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCc
Q 021682 83 YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPP 162 (309)
Q Consensus 83 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 162 (309)
..+++..+..++.|++.|+.+||++ |++|+||+|+||+++.++.++|+|||++.......... .....++..|+||
T Consensus 104 ~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aP 179 (279)
T 1qpc_A 104 IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA-REGAKFPIKWTAP 179 (279)
T ss_dssp HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC-CTTCCCCTTTSCH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCccccc-ccCCCCccCccCh
Confidence 3589999999999999999999998 99999999999999999999999999997665432221 2223467789999
Q ss_pred cccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHH
Q 021682 163 EYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241 (309)
Q Consensus 163 E~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 241 (309)
|.+.+..++.++||||||+++|+|++ |..||......+ .. .......... .+...+..+.+++
T Consensus 180 E~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~~-~~~~~~~~~~---------~~~~~~~~l~~li 243 (279)
T 1qpc_A 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE------VI-QNLERGYRMV---------RPDNCPEELYQLM 243 (279)
T ss_dssp HHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HH-HHHHTTCCCC---------CCTTCCHHHHHHH
T ss_pred hhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH------HH-HHHhcccCCC---------CcccccHHHHHHH
Confidence 99988889999999999999999999 888885432211 11 1111111110 0111234788999
Q ss_pred hhcccCCCCCCCCHHHHHHHHhcccCCCCCC
Q 021682 242 LLCVQENAADRPTMLEILVMLKSETADIKTP 272 (309)
Q Consensus 242 ~~~l~~~p~~Rpt~~ell~~L~~~~~~~~~~ 272 (309)
.+||+.||++|||++++++.|+.........
T Consensus 244 ~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 274 (279)
T 1qpc_A 244 RLCWKERPEDRPTFDYLRSVLEDFFTATEGQ 274 (279)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHHHC---
T ss_pred HHHhccChhhCCCHHHHHHHHHHHHHhccCC
Confidence 9999999999999999999999876554443
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=281.07 Aligned_cols=239 Identities=23% Similarity=0.295 Sum_probs=188.0
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
+.||.+.. .+|+.||||.+.... ....+.+.+|+.+++.++||||+++++++..+...++||||+.+++|.+++.
T Consensus 21 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~--- 97 (276)
T 2yex_A 21 GEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--- 97 (276)
T ss_dssp SEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSB---
T ss_pred cEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHh---
Confidence 35677765 479999999987542 3345788999999999999999999999999999999999999999988873
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCC
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYV 160 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 160 (309)
....+++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||.+................|+..|+
T Consensus 98 ~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 174 (276)
T 2yex_A 98 PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174 (276)
T ss_dssp TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGC
T ss_pred hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCcc
Confidence 334589999999999999999999998 99999999999999999999999999987654332222233456889999
Q ss_pred CccccccCCC-CccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHH
Q 021682 161 PPEYVRKGIY-SMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQ 239 (309)
Q Consensus 161 aPE~~~~~~~-~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (309)
|||.+.+..+ +.++||||||+++|+|++|..||......... ...+...... .. ........+.+
T Consensus 175 aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~~~~~~--~~------~~~~~~~~~~~ 240 (276)
T 2yex_A 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE------YSDWKEKKTY--LN------PWKKIDSAPLA 240 (276)
T ss_dssp CGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH------HHHHHTTCTT--ST------TGGGSCHHHHH
T ss_pred ChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH------HHHhhhcccc--cC------chhhcCHHHHH
Confidence 9999987665 77899999999999999999998654332211 1111111110 00 01112336789
Q ss_pred HHhhcccCCCCCCCCHHHHHHH
Q 021682 240 VALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 240 li~~~l~~~p~~Rpt~~ell~~ 261 (309)
+|.+||+.||++|||++++++.
T Consensus 241 li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 241 LLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHCCCCchhCCCHHHHhcC
Confidence 9999999999999999999864
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=287.86 Aligned_cols=240 Identities=20% Similarity=0.291 Sum_probs=185.1
Q ss_pred ceEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTS---HQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
.||.+.. .+|+.||||+++... ......+..|..+++++ +||||+++++++..+...++||||+.+++|.+++..
T Consensus 24 ~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~ 103 (345)
T 3a8x_A 24 KVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR 103 (345)
T ss_dssp EEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH
T ss_pred EEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHH
Confidence 5566654 579999999997642 33355688999999988 899999999999999999999999999999998854
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
. ..+++..++.++.||+.||.|||++ |++||||||+||+++.++.+||+|||++........ ......||+.
T Consensus 104 ~---~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~--~~~~~~gt~~ 175 (345)
T 3a8x_A 104 Q---RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPN 175 (345)
T ss_dssp H---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC--CBCCCCSCGG
T ss_pred c---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCCCC--cccccCCCcc
Confidence 3 3489999999999999999999998 999999999999999999999999999875332221 1233478999
Q ss_pred CCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcc--cHHHHHHHHhhCCCCcccccccCCCcccHHHHHH
Q 021682 159 YVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESL--NLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMR 236 (309)
Q Consensus 159 y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
|+|||.+.+..++.++|+|||||++|+|++|..||......... ............... .+ . ...+..
T Consensus 176 y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~~-----p----~~~s~~ 245 (345)
T 3a8x_A 176 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RI-----P----RSLSVK 245 (345)
T ss_dssp GCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC-CC-----C----TTSCHH
T ss_pred ccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC-CC-----C----CCCCHH
Confidence 99999999999999999999999999999999999653322111 111111111111111 00 1 112237
Q ss_pred HHHHHhhcccCCCCCCCCH------HHHHHH
Q 021682 237 CMQVALLCVQENAADRPTM------LEILVM 261 (309)
Q Consensus 237 l~~li~~~l~~~p~~Rpt~------~ell~~ 261 (309)
+.++|.+||+.||++||++ +++++.
T Consensus 246 ~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 246 AASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp HHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred HHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 8899999999999999995 677654
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=285.21 Aligned_cols=252 Identities=18% Similarity=0.269 Sum_probs=187.2
Q ss_pred cceEEEEc-CCCcEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRT---SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
+.||++.. .+|+.||||.+... .......+.+|+.++++++||||+++++++..++..++||||+.+++|.+++..
T Consensus 46 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 125 (310)
T 2wqm_A 46 SEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKH 125 (310)
T ss_dssp CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHH
T ss_pred ceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHH
Confidence 35677764 58999999999753 234456788999999999999999999999999999999999999999999864
Q ss_pred hc-cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccccc
Q 021682 79 LR-RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 79 ~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
.. ....+++..++.++.+++.|+.+||+. |++|+||+|+||+++.++.++|+|||++......... .....++.
T Consensus 126 ~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~ 200 (310)
T 2wqm_A 126 FKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTP 200 (310)
T ss_dssp HHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC--------------------CC
T ss_pred hcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCcc--ccccCCCe
Confidence 32 345689999999999999999999998 9999999999999999999999999998765433221 22346788
Q ss_pred CCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHH
Q 021682 158 GYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRC 237 (309)
Q Consensus 158 ~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (309)
.|+|||.+.+..++.++||||||+++|+|++|..||...... ..... ............. ......+
T Consensus 201 ~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~-~~~~~~~~~~~~~--------~~~~~~l 267 (310)
T 2wqm_A 201 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLC-KKIEQCDYPPLPS--------DHYSEEL 267 (310)
T ss_dssp SSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHHH-HHHHTTCSCCCCT--------TTSCHHH
T ss_pred eEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHHH-HHhhcccCCCCcc--------cccCHHH
Confidence 999999999888999999999999999999999998542211 11111 1111111111110 1122378
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHhcccCCCCCC
Q 021682 238 MQVALLCVQENAADRPTMLEILVMLKSETADIKTP 272 (309)
Q Consensus 238 ~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~~~~~ 272 (309)
.+++.+||+.||++|||++++++.|+++.+..+.|
T Consensus 268 ~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~ 302 (310)
T 2wqm_A 268 RQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302 (310)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred HHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence 89999999999999999999999999886644433
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=288.09 Aligned_cols=234 Identities=19% Similarity=0.234 Sum_probs=179.2
Q ss_pred cceEEEE-cCCCcEEEEEEeecCCc--------------------------ccHHHHHHHHHHHhcCCCCCccceeeEEe
Q 021682 3 VAICQGR-LPNGQEMAVKRLSRTSH--------------------------QGLEEFENEVKLTARLQHVNLLPVLGICT 55 (309)
Q Consensus 3 ~~~~~~~-~~~g~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 55 (309)
+.||++. ..+|+.||||++..... ...+.+.+|++++++++||||+++++++.
T Consensus 27 g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 106 (298)
T 2zv2_A 27 GVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLD 106 (298)
T ss_dssp CEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred EEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 3566665 45799999999865421 12356889999999999999999999998
Q ss_pred e--CCeeEEEEeccCCCChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceee
Q 021682 56 Q--REEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKIS 133 (309)
Q Consensus 56 ~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~ 133 (309)
. ....++||||+.+++|.+++ ....+++..+..++.|++.|+.|||++ |++|+||||+||+++.++.+||+
T Consensus 107 ~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~ 179 (298)
T 2zv2_A 107 DPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIA 179 (298)
T ss_dssp CSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEEC
T ss_pred cCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCCEEEe
Confidence 6 56899999999999997754 334589999999999999999999998 99999999999999999999999
Q ss_pred cccccccccCCcccccccccccccCCCCccccccCC---CCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH
Q 021682 134 DFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGI---YSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYG 210 (309)
Q Consensus 134 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 210 (309)
|||++......... .....|++.|+|||.+.+.. .+.++|||||||++|+|++|..||..... ......
T Consensus 180 Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~------~~~~~~ 251 (298)
T 2zv2_A 180 DFGVSNEFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI------MCLHSK 251 (298)
T ss_dssp CCTTCEECSSSSCE--ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHH
T ss_pred cCCCcccccccccc--ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH------HHHHHH
Confidence 99999765543221 22346899999999987654 37889999999999999999999853211 111111
Q ss_pred HhhCCCCcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021682 211 LWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
.... .. .+. ... ..+..+.++|.+||+.||++|||++|+++
T Consensus 252 ~~~~-~~-~~~---~~~----~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 252 IKSQ-AL-EFP---DQP----DIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHHC-CC-CCC---SSS----CCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred Hhcc-cC-CCC---Ccc----ccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 1111 10 000 001 12236889999999999999999999975
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=291.03 Aligned_cols=247 Identities=21% Similarity=0.244 Sum_probs=184.2
Q ss_pred cceEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 3 VAICQGR-LPNGQEMAVKRLSRTSHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 3 ~~~~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
+.||++. ..+|+.||||.+..........+.+|+++++++ +||||+++++++..++..++||||+.+++|.+++...
T Consensus 27 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~- 105 (316)
T 2ac3_A 27 ARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKR- 105 (316)
T ss_dssp EEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHH-
T ss_pred EEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhcc-
Confidence 3567776 458999999999876666678899999999985 7999999999999999999999999999999998543
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCC---ceeecccccccccCCccc-----ccccc
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMN---PKISDFGMARAFTKDECE-----ANTGR 152 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~---~~l~Dfg~~~~~~~~~~~-----~~~~~ 152 (309)
..+++..+..++.|++.|+.|||++ |++||||||+||+++.++. ++|+|||++......... .....
T Consensus 106 --~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~ 180 (316)
T 2ac3_A 106 --RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT 180 (316)
T ss_dssp --SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------------------
T ss_pred --CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcccccccccccc
Confidence 3489999999999999999999999 8999999999999998776 999999998655422111 11122
Q ss_pred cccccCCCCcccccc-----CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccH--------HHHHHHHhhCCCCcc
Q 021682 153 IVGTYGYVPPEYVRK-----GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNL--------LEYAYGLWKNGEGME 219 (309)
Q Consensus 153 ~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~--------~~~~~~~~~~~~~~~ 219 (309)
..|+..|+|||.+.+ ..++.++|||||||++|+|++|..||......+.... ............. .
T Consensus 181 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~-~ 259 (316)
T 2ac3_A 181 PCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKY-E 259 (316)
T ss_dssp -CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCC-C
T ss_pred ccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCc-c
Confidence 358999999999875 4578999999999999999999999965443321100 0001111111110 0
Q ss_pred cccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 220 FIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 220 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
+... ........+.++|.+||+.||++|||++|+++.
T Consensus 260 ~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 260 FPDK-----DWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp CCHH-----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cCch-----hcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0000 000123478899999999999999999999985
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=282.72 Aligned_cols=260 Identities=15% Similarity=0.157 Sum_probs=197.0
Q ss_pred cceEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEE-eeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 3 VAICQGR-LPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGIC-TQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 3 ~~~~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
+.||++. ..+|+.||||.+...... ..+..|+.+++.++|++++..+..+ ..+...++||||+ +++|.+++...
T Consensus 23 g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~- 98 (296)
T 4hgt_A 23 GDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFC- 98 (296)
T ss_dssp SEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT-
T ss_pred eEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHh-
Confidence 4567776 468999999987554322 3578899999999888777766555 6667889999999 89999998532
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEe---CCCCCceeecccccccccCCccc-----ccccc
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL---DYEMNPKISDFGMARAFTKDECE-----ANTGR 152 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~---~~~~~~~l~Dfg~~~~~~~~~~~-----~~~~~ 152 (309)
...+++..+..++.|++.|+.|||++ |++|+||||+||++ +.++.++|+|||++......... .....
T Consensus 99 -~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~ 174 (296)
T 4hgt_A 99 -SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 174 (296)
T ss_dssp -TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCC
T ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccc
Confidence 33489999999999999999999999 89999999999999 78899999999999776543321 11224
Q ss_pred cccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHH
Q 021682 153 IVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAW 232 (309)
Q Consensus 153 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (309)
..|+..|+|||.+.+..++.++|||||||++|+|++|..||............................ ..
T Consensus 175 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~---- 245 (296)
T 4hgt_A 175 LTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC-----KG---- 245 (296)
T ss_dssp CCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHT-----TT----
T ss_pred cCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhh-----cc----
Confidence 568999999999999999999999999999999999999997665554444333322211111100000 00
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccCCCCCCCCCCccc
Q 021682 233 KLMRCMQVALLCVQENAADRPTMLEILVMLKSETADIKTPKKPAFSV 279 (309)
Q Consensus 233 ~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~~~~~~~p~~~~ 279 (309)
.+..+.+++.+||+.||++|||++++++.|+.+.........-.++|
T Consensus 246 ~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw 292 (296)
T 4hgt_A 246 YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDW 292 (296)
T ss_dssp SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGG
T ss_pred CCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccch
Confidence 12378899999999999999999999999998877665554444444
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=295.79 Aligned_cols=233 Identities=23% Similarity=0.300 Sum_probs=184.8
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS---HQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
+.||.+.. .+|+.||||.++... ......+..|..+++.+ +||||+++++++.+....++||||+.+++|.+++.
T Consensus 31 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~ 110 (345)
T 1xjd_A 31 GKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ 110 (345)
T ss_dssp SEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH
T ss_pred eEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHH
Confidence 35666654 579999999997542 33456788899999877 99999999999999999999999999999999985
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
.. ..+++..+..++.||+.|+.|||++ |++||||||+||+++.++.+||+|||++........ ......||+
T Consensus 111 ~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--~~~~~~gt~ 182 (345)
T 1xjd_A 111 SC---HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTP 182 (345)
T ss_dssp HH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--CBCCCCSCG
T ss_pred Hc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCC--cccCCCCCc
Confidence 43 3489999999999999999999998 999999999999999999999999999875432221 123357899
Q ss_pred CCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHH
Q 021682 158 GYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRC 237 (309)
Q Consensus 158 ~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (309)
.|+|||.+.+..++.++|+|||||++|+|++|..||...+..+ .......... . + +......+
T Consensus 183 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~~i~~~~~--~-~--------p~~~s~~~ 245 (345)
T 1xjd_A 183 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE------LFHSIRMDNP--F-Y--------PRWLEKEA 245 (345)
T ss_dssp GGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCC--C-C--------CTTSCHHH
T ss_pred ccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH------HHHHHHhCCC--C-C--------CcccCHHH
Confidence 9999999999999999999999999999999999986432211 1111111110 0 0 11122378
Q ss_pred HHHHhhcccCCCCCCCCHH-HHHH
Q 021682 238 MQVALLCVQENAADRPTML-EILV 260 (309)
Q Consensus 238 ~~li~~~l~~~p~~Rpt~~-ell~ 260 (309)
.++|.+||+.||++||++. ++++
T Consensus 246 ~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 246 KDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp HHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HHHHHHHhcCCHhHcCCChHHHHc
Confidence 8999999999999999997 7764
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=283.11 Aligned_cols=236 Identities=18% Similarity=0.242 Sum_probs=186.3
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
+.||.+.. .+++.||+|.+........+.+.+|++++++++||||+++++++..+...++||||+.+++|.+++..
T Consensus 23 g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--- 99 (277)
T 3f3z_A 23 GEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVH--- 99 (277)
T ss_dssp EEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH---
T ss_pred EEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHH---
Confidence 34566654 56889999999876666678899999999999999999999999999999999999999999988854
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEe---CCCCCceeecccccccccCCcccccccccccccC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL---DYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
...+++..+..++.|++.|+.+||+. |++|+||+|+||++ +.++.++|+|||++........ .....+++.
T Consensus 100 ~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~t~~ 173 (277)
T 3f3z_A 100 KRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM---MRTKVGTPY 173 (277)
T ss_dssp HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC---BCCCCSCTT
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc---hhccCCCCC
Confidence 33489999999999999999999998 99999999999999 7788999999999876554322 223468999
Q ss_pred CCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHH
Q 021682 159 YVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238 (309)
Q Consensus 159 y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (309)
|+|||.+.+. ++.++||||||+++|+|++|..||......+ ....... ..... .. ......+..+.
T Consensus 174 y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~-~~~~~-~~-----~~~~~~~~~~~ 239 (277)
T 3f3z_A 174 YVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE------VMLKIRE-GTFTF-PE-----KDWLNVSPQAE 239 (277)
T ss_dssp TCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHH-CCCCC-CH-----HHHTTSCHHHH
T ss_pred ccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH------HHHHHHh-CCCCC-Cc-----hhhhcCCHHHH
Confidence 9999998664 8999999999999999999999985432111 1111111 11000 00 00001234788
Q ss_pred HHHhhcccCCCCCCCCHHHHHHH
Q 021682 239 QVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 239 ~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
++|.+||+.||++|||+.++++.
T Consensus 240 ~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 240 SLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHHccCChhhCcCHHHHhcC
Confidence 99999999999999999999863
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=284.44 Aligned_cols=238 Identities=21% Similarity=0.337 Sum_probs=188.1
Q ss_pred cceEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEeeC--CeeEEEEeccCCCChhHHHhh
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQR--EEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~ 78 (309)
+.||++.. +|+.||||.++... ....+.+.+|+.++++++||||+++++++... ...++||||+++++|.+++..
T Consensus 24 g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 102 (271)
T 3kmu_A 24 GELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHE 102 (271)
T ss_dssp EEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHS
T ss_pred ceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhh
Confidence 46788887 58999999997543 34456789999999999999999999999887 688999999999999999854
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCc--eeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccc
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLT--IVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGT 156 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~g--i~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 156 (309)
. ....+++..++.++.|++.|+.|||+. | ++|+||+|+||+++.++.++|+|||++..... ....++
T Consensus 103 ~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-------~~~~~t 171 (271)
T 3kmu_A 103 G-TNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-------PGRMYA 171 (271)
T ss_dssp C-SSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-------TTCBSC
T ss_pred c-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeecc-------cCccCC
Confidence 2 233589999999999999999999998 7 99999999999999999999998887643222 123678
Q ss_pred cCCCCccccccCCCCc---cchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHH
Q 021682 157 YGYVPPEYVRKGIYSM---KYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWK 233 (309)
Q Consensus 157 ~~y~aPE~~~~~~~~~---~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
+.|+|||.+.+...+. ++||||||+++|+|++|..||...... ............... +...
T Consensus 172 ~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~~~~---------~~~~ 236 (271)
T 3kmu_A 172 PAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM------EIGMKVALEGLRPTI---------PPGI 236 (271)
T ss_dssp GGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH------HHHHHHHHSCCCCCC---------CTTC
T ss_pred ccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH------HHHHHHHhcCCCCCC---------CCCC
Confidence 8999999998765544 799999999999999999998543221 111122222111111 1112
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccC
Q 021682 234 LMRCMQVALLCVQENAADRPTMLEILVMLKSETA 267 (309)
Q Consensus 234 ~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~ 267 (309)
+..+.+++.+||+.||++|||++++++.|+.+.+
T Consensus 237 ~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 237 SPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 3378899999999999999999999999998754
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=284.14 Aligned_cols=237 Identities=23% Similarity=0.266 Sum_probs=186.9
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCc------ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHH
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSH------QGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFY 75 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (309)
+.||++.. .+|+.||+|.+..... ...+.+.+|+.++++++||||+++++++..+...++||||+.+++|.++
T Consensus 26 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 105 (321)
T 2a2a_A 26 AIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDF 105 (321)
T ss_dssp EEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHH
T ss_pred EEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHH
Confidence 35666654 5799999999975432 1367899999999999999999999999999999999999999999999
Q ss_pred HhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCC----CceeecccccccccCCccccccc
Q 021682 76 IFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM----NPKISDFGMARAFTKDECEANTG 151 (309)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~----~~~l~Dfg~~~~~~~~~~~~~~~ 151 (309)
+.. ...+++..+..++.|++.|+.|||+. |++|+||+|+||+++.++ .++|+|||++........ ..
T Consensus 106 l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~ 176 (321)
T 2a2a_A 106 LAQ---KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FK 176 (321)
T ss_dssp HHT---CSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCC---CC
T ss_pred HHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCccceecCcccc---cc
Confidence 843 34589999999999999999999998 999999999999999887 799999999976554322 22
Q ss_pred ccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccH
Q 021682 152 RIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSA 231 (309)
Q Consensus 152 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (309)
...|++.|+|||.+.+..++.++||||||+++|+|++|..||...... ..... ...... . +.. ....
T Consensus 177 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~-i~~~~~-~-~~~----~~~~ 243 (321)
T 2a2a_A 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLAN-ITSVSY-D-FDE----EFFS 243 (321)
T ss_dssp CCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHH-HHTTCC-C-CCH----HHHT
T ss_pred ccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH------HHHHH-HHhccc-c-cCh----hhhc
Confidence 346899999999999889999999999999999999999998542211 11111 111100 0 000 0001
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 232 WKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 232 ~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
..+..+.++|.+||+.||++|||++|+++.
T Consensus 244 ~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 244 HTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp TCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred ccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 122368899999999999999999999874
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=291.57 Aligned_cols=247 Identities=26% Similarity=0.395 Sum_probs=192.9
Q ss_pred cceEEEE------cCCCcEEEEEEeecCC-cccHHHHHHHHHHHhcC-CCCCccceeeEEeeCC-eeEEEEeccCCCChh
Q 021682 3 VAICQGR------LPNGQEMAVKRLSRTS-HQGLEEFENEVKLTARL-QHVNLLPVLGICTQRE-EKMLIYDYMPNKSLD 73 (309)
Q Consensus 3 ~~~~~~~------~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~-~~~lv~e~~~~~~L~ 73 (309)
+.||++. ..+++.||||.++... ......+.+|+.+++++ +||||+++++++...+ ..++||||+.+++|.
T Consensus 41 g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~ 120 (316)
T 2xir_A 41 GQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLS 120 (316)
T ss_dssp EEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHH
T ss_pred eeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHH
Confidence 4577775 3467899999997653 33456788999999999 7999999999987755 589999999999999
Q ss_pred HHHhhhcc-------------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeeccccccc
Q 021682 74 FYIFDLRR-------------RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARA 140 (309)
Q Consensus 74 ~~~~~~~~-------------~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~ 140 (309)
+++..... ...+++..++.++.|++.|+.|||+. |++|+||||+||+++.++.++|+|||++..
T Consensus 121 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 197 (316)
T 2xir_A 121 TYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARD 197 (316)
T ss_dssp HHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSC
T ss_pred HHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEECCCccccc
Confidence 99865332 12278899999999999999999998 999999999999999999999999999976
Q ss_pred ccCCcccccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcc
Q 021682 141 FTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGME 219 (309)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (309)
..............++..|+|||.+.+..++.++||||||+++|+|++ |..||......... ...........
T Consensus 198 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~------~~~~~~~~~~~ 271 (316)
T 2xir_A 198 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF------CRRLKEGTRMR 271 (316)
T ss_dssp TTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH------HHHHHHTCCCC
T ss_pred cccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHH------HHHhccCccCC
Confidence 654433333334567889999999999899999999999999999998 99998654322211 11111111111
Q ss_pred cccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccC
Q 021682 220 FIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETA 267 (309)
Q Consensus 220 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~ 267 (309)
. +......+.+++.+||+.||++|||+.++++.|+.+.+
T Consensus 272 ~---------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 272 A---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp C---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1 01122378899999999999999999999999988754
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=294.14 Aligned_cols=247 Identities=19% Similarity=0.220 Sum_probs=177.2
Q ss_pred cceEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCC-CCCccceeeEEe--------eCCeeEEEEeccCCCCh
Q 021682 3 VAICQGR-LPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQ-HVNLLPVLGICT--------QREEKMLIYDYMPNKSL 72 (309)
Q Consensus 3 ~~~~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~--------~~~~~~lv~e~~~~~~L 72 (309)
+.||++. ..+|+.||||.+..........+..|+.+++++. ||||+++++++. .....++||||+. ++|
T Consensus 42 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L 120 (337)
T 3ll6_A 42 AFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQL 120 (337)
T ss_dssp EEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEH
T ss_pred eEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecC-CCH
Confidence 3567776 4589999999987776666778899999999995 999999999984 3346899999996 689
Q ss_pred hHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCc--eeecCCCCceEEeCCCCCceeecccccccccCCcccc--
Q 021682 73 DFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLT--IVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEA-- 148 (309)
Q Consensus 73 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~g--i~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~-- 148 (309)
.+++........+++..++.++.|++.|+.|||+. | ++|+||||+||+++.++.++|+|||++..........
T Consensus 121 ~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 197 (337)
T 3ll6_A 121 VEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWS 197 (337)
T ss_dssp HHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-----
T ss_pred HHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecCccceeccccCccccc
Confidence 88886655566799999999999999999999998 8 9999999999999999999999999997665432211
Q ss_pred --------cccccccccCCCCcccc---ccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCC
Q 021682 149 --------NTGRIVGTYGYVPPEYV---RKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEG 217 (309)
Q Consensus 149 --------~~~~~~~~~~y~aPE~~---~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (309)
......+++.|+|||.+ .+..++.++||||||+++|+|++|..||........ ... ..
T Consensus 198 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~~-----~~ 266 (337)
T 3ll6_A 198 AQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI------VNG-----KY 266 (337)
T ss_dssp --------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------------------C
T ss_pred ccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh------hcC-----cc
Confidence 01123578899999998 556788999999999999999999999854222110 000 00
Q ss_pred cccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccCCCCCC
Q 021682 218 MEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETADIKTP 272 (309)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~~~~~ 272 (309)
. . ..... ....+.++|.+||+.||++|||++|+++.|+.+.......
T Consensus 267 ~-~---~~~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~ 313 (337)
T 3ll6_A 267 S-I---PPHDT----QYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVN 313 (337)
T ss_dssp C-C---CTTCC----SSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCC
T ss_pred c-C---Ccccc----cchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCC
Confidence 0 0 00001 1124779999999999999999999999999887654433
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=282.41 Aligned_cols=237 Identities=24% Similarity=0.316 Sum_probs=185.8
Q ss_pred cceEEEEc-CCCcEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
+.||++.. .+|+.||+|.+... .......+.+|+.++++++||||+++++++..+...++||||+.+++|.+.+..
T Consensus 20 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~- 98 (284)
T 3kk8_A 20 SVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA- 98 (284)
T ss_dssp EEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-
T ss_pred eEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHh-
Confidence 35677654 57999999998654 333456788999999999999999999999999999999999999999888744
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCC---ceeecccccccccCCcccccccccccc
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMN---PKISDFGMARAFTKDECEANTGRIVGT 156 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~---~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 156 (309)
...+++..+..++.|++.|+.+||+. |++|+||+|+||+++.++. ++|+|||.+........ .....|+
T Consensus 99 --~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~ 170 (284)
T 3kk8_A 99 --REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGT 170 (284)
T ss_dssp --HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB---CCCSCSC
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc---ccCCCCC
Confidence 34489999999999999999999998 8999999999999987655 99999999976554322 2234689
Q ss_pred cCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHH
Q 021682 157 YGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMR 236 (309)
Q Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
+.|+|||.+.+..++.++||||||+++|+|++|..||....... .. ......... ...+. .......
T Consensus 171 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---~~----~~~~~~~~~-~~~~~-----~~~~~~~ 237 (284)
T 3kk8_A 171 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---LY----AQIKAGAYD-YPSPE-----WDTVTPE 237 (284)
T ss_dssp GGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH----HHHHHTCCC-CCTTT-----TTTSCHH
T ss_pred cCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH---HH----HHHHhcccc-CCchh-----hcccCHH
Confidence 99999999999899999999999999999999999985422111 11 111111110 00000 0112236
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 237 CMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 237 l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
+.++|.+||+.||++|||++|+++.
T Consensus 238 ~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 238 AKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHHcccChhhCCCHHHHhcC
Confidence 8899999999999999999999874
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=285.60 Aligned_cols=246 Identities=23% Similarity=0.403 Sum_probs=178.9
Q ss_pred cceEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
+.||++.. ...||+|.++... ....+.+.+|+.++++++||||+++++++ .....++||||+.+++|.+++..
T Consensus 38 g~Vy~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~-- 112 (289)
T 3og7_A 38 GTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHA-- 112 (289)
T ss_dssp EEEEEEES--SSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTT--
T ss_pred eEEEEEEE--cCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhh--
Confidence 46788875 3469999986543 34456789999999999999999999965 45568999999999999998843
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCC
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYV 160 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 160 (309)
....+++..++.++.|++.|+.+||+. |++|+||||+||+++.++.++|+|||++................|+..|+
T Consensus 113 ~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~ 189 (289)
T 3og7_A 113 SETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 189 (289)
T ss_dssp C---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC------------------CCCTTC
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccccccccccccCCCcccc
Confidence 344589999999999999999999998 99999999999999999999999999987655433222333456899999
Q ss_pred Cccccc---cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHH
Q 021682 161 PPEYVR---KGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRC 237 (309)
Q Consensus 161 aPE~~~---~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (309)
|||.+. +..++.++||||||+++|+|++|..||......+. ................ .. ...+..+
T Consensus 190 aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~~-~~----~~~~~~l 258 (289)
T 3og7_A 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIEMVGRGSLSPDLSK-VR----SNCPKRM 258 (289)
T ss_dssp CHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH------HHHHHHHTSCCCCTTS-SC----TTSCHHH
T ss_pred CchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH------HHHHhcccccCcchhh-cc----ccCCHHH
Confidence 999886 56678899999999999999999999865432221 1111111111111110 01 1122378
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHhcccC
Q 021682 238 MQVALLCVQENAADRPTMLEILVMLKSETA 267 (309)
Q Consensus 238 ~~li~~~l~~~p~~Rpt~~ell~~L~~~~~ 267 (309)
.+++.+||+.||++|||++++++.|+.+.+
T Consensus 259 ~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 259 KRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 899999999999999999999999998754
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=284.01 Aligned_cols=248 Identities=23% Similarity=0.366 Sum_probs=194.9
Q ss_pred cceEEEEc---CCCcEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 3 VAICQGRL---PNGQEMAVKRLSRT-SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 3 ~~~~~~~~---~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
+.||++.. ++++.||||.++.. .....+.+.+|++++++++||||+++++++ ..+..++|||++.+++|.+++..
T Consensus 24 g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~ 102 (287)
T 1u59_A 24 GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG 102 (287)
T ss_dssp EEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTT
T ss_pred eeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHh
Confidence 35777764 36888999999764 334567889999999999999999999998 45678999999999999998843
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccc-cccccccccc
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECE-ANTGRIVGTY 157 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~ 157 (309)
....+++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++......... .......++.
T Consensus 103 --~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~ 177 (287)
T 1u59_A 103 --KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 177 (287)
T ss_dssp --CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCG
T ss_pred --CCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccc
Confidence 344589999999999999999999998 9999999999999999999999999999766543221 1122234678
Q ss_pred CCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHH
Q 021682 158 GYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMR 236 (309)
Q Consensus 158 ~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
.|+|||.+.+..++.++||||||+++|+|++ |..||......+ . ............ +...+..
T Consensus 178 ~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~----~~~i~~~~~~~~---------~~~~~~~ 241 (287)
T 1u59_A 178 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---V----MAFIEQGKRMEC---------PPECPPE 241 (287)
T ss_dssp GGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---H----HHHHHTTCCCCC---------CTTCCHH
T ss_pred cccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---H----HHHHhcCCcCCC---------CCCcCHH
Confidence 8999999988889999999999999999998 999986543221 1 111111111111 1122347
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHHHhcccCCCCCC
Q 021682 237 CMQVALLCVQENAADRPTMLEILVMLKSETADIKTP 272 (309)
Q Consensus 237 l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~~~~~ 272 (309)
+.++|.+||+.||++|||+.++++.|+.+.....++
T Consensus 242 l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 277 (287)
T 1u59_A 242 LYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277 (287)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence 889999999999999999999999998876655444
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=292.82 Aligned_cols=236 Identities=22% Similarity=0.298 Sum_probs=171.8
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
+.||++.. .+++.||||.++... ..+.+..|+.++++++||||+++++++..+...++||||+.+++|.+++..
T Consensus 67 g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--- 141 (349)
T 2w4o_A 67 SIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVE--- 141 (349)
T ss_dssp EEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTT---
T ss_pred EEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHh---
Confidence 45677765 468999999997543 345788999999999999999999999999999999999999999998843
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCC---CCCceeecccccccccCCcccccccccccccC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY---EMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~---~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
...+++..+..++.|++.|+.|||+. |++||||||+||+++. ++.++|+|||++........ .....|++.
T Consensus 142 ~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~ 215 (349)
T 2w4o_A 142 KGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPG 215 (349)
T ss_dssp CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-------------------CGG
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCcccc---cccccCCCC
Confidence 34589999999999999999999998 8999999999999976 78999999999876543321 223468999
Q ss_pred CCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHH
Q 021682 159 YVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238 (309)
Q Consensus 159 y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (309)
|+|||.+.+..++.++|||||||++|+|++|..||....... ........... ....+. .......+.
T Consensus 216 y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~i~~~~~-~~~~~~-----~~~~~~~~~ 283 (349)
T 2w4o_A 216 YCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ------FMFRRILNCEY-YFISPW-----WDEVSLNAK 283 (349)
T ss_dssp GSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH------HHHHHHHTTCC-CCCTTT-----TTTSCHHHH
T ss_pred ccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH------HHHHHHHhCCC-ccCCch-----hhhCCHHHH
Confidence 999999999899999999999999999999999985432211 01111111111 011100 011233788
Q ss_pred HHHhhcccCCCCCCCCHHHHHHH
Q 021682 239 QVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 239 ~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
++|.+||+.||++|||+.++++.
T Consensus 284 ~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 284 DLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHccCChhhCcCHHHHhcC
Confidence 99999999999999999999974
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=289.00 Aligned_cols=249 Identities=22% Similarity=0.358 Sum_probs=183.5
Q ss_pred cceEEEEcC----CCcEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCC-----eeEEEEeccCCCC
Q 021682 3 VAICQGRLP----NGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQRE-----EKMLIYDYMPNKS 71 (309)
Q Consensus 3 ~~~~~~~~~----~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~~ 71 (309)
+.||++... +++.||+|.++.. .....+.+.+|+.++++++||||+++++++.... ..++||||+.+++
T Consensus 48 g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~ 127 (313)
T 3brb_A 48 GSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGD 127 (313)
T ss_dssp CCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCB
T ss_pred eEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCC
Confidence 356776542 4568999998654 2334567899999999999999999999987754 3599999999999
Q ss_pred hhHHHhhh---ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccc
Q 021682 72 LDFYIFDL---RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEA 148 (309)
Q Consensus 72 L~~~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 148 (309)
|.+++... .....+++..++.++.|++.|+.|||+. |++|+||||+||+++.++.++|+|||++..........
T Consensus 128 L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~ 204 (313)
T 3brb_A 128 LHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR 204 (313)
T ss_dssp HHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEECSCSCC----------
T ss_pred HHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEeecCcceecccccccC
Confidence 99988432 2345689999999999999999999998 89999999999999999999999999987654433222
Q ss_pred cccccccccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCC
Q 021682 149 NTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDD 227 (309)
Q Consensus 149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (309)
......++..|+|||.+.+..++.++||||||+++|+|++ |..||........ .. ..........
T Consensus 205 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~----~~~~~~~~~~------- 270 (313)
T 3brb_A 205 QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM---YD----YLLHGHRLKQ------- 270 (313)
T ss_dssp ------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HH----HHHTTCCCCC-------
T ss_pred cccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH---HH----HHHcCCCCCC-------
Confidence 2223456778999999999899999999999999999999 8888864433221 11 1111111111
Q ss_pred cccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccCCCC
Q 021682 228 SSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETADIK 270 (309)
Q Consensus 228 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~~~ 270 (309)
+...+..+.++|.+||+.||++|||++++++.|+.+.+.++
T Consensus 271 --~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 271 --PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp --BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred --CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 11122378899999999999999999999999998876554
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=301.85 Aligned_cols=233 Identities=18% Similarity=0.223 Sum_probs=176.3
Q ss_pred ceEEEE-cCCCcEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGR-LPNGQEMAVKRLSRT---SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
.||.+. ..+|+.||||++... .......+..|+.+++.++||||+++++++...+..++||||+.+++|.+++..
T Consensus 163 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~- 241 (446)
T 4ejn_A 163 KVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR- 241 (446)
T ss_dssp EEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHH-
T ss_pred EEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHh-
Confidence 456554 568999999999753 333445678899999999999999999999999999999999999999988844
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhh-cCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQE-YSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
...+++..+..++.||+.||.|||+ . ||+||||||+||+++.++.+||+|||++........ ......||+.
T Consensus 242 --~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~ 314 (446)
T 4ejn_A 242 --ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPE 314 (446)
T ss_dssp --HSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-------CCSSSCGG
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccCCCc--ccccccCCcc
Confidence 3358999999999999999999998 6 899999999999999999999999999875333221 1233578999
Q ss_pred CCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHH
Q 021682 159 YVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238 (309)
Q Consensus 159 y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (309)
|+|||.+.+..++.++|||||||++|+|++|..||...+... .......... .+ .. .....+.
T Consensus 315 y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~~i~~~~~--~~-----p~----~~~~~~~ 377 (446)
T 4ejn_A 315 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFELILMEEI--RF-----PR----TLGPEAK 377 (446)
T ss_dssp GCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCC--CC-----CT----TSCHHHH
T ss_pred ccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH------HHHHHHhCCC--CC-----Cc----cCCHHHH
Confidence 999999999999999999999999999999999985432211 1111111110 00 11 1123788
Q ss_pred HHHhhcccCCCCCCC-----CHHHHHHH
Q 021682 239 QVALLCVQENAADRP-----TMLEILVM 261 (309)
Q Consensus 239 ~li~~~l~~~p~~Rp-----t~~ell~~ 261 (309)
++|.+||+.||++|| |++|+++.
T Consensus 378 ~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 378 SLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp HHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 999999999999999 99999874
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=293.37 Aligned_cols=238 Identities=21% Similarity=0.224 Sum_probs=176.1
Q ss_pred ceEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHHhc-CCCCCccceeeEEee----CCeeEEEEeccCCCChhHHHh
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTSHQGLEEFENEVKLTAR-LQHVNLLPVLGICTQ----REEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~ 77 (309)
+||.+. ..+|+.||||++.. ...+.+|+.++.+ .+||||+++++++.. ....++||||+.+++|.+++.
T Consensus 77 ~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~ 151 (400)
T 1nxk_A 77 KVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ 151 (400)
T ss_dssp EEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHH
T ss_pred EEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHH
Confidence 455664 45899999999853 2456788888754 489999999999876 567899999999999999985
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCC---CCCceeecccccccccCCcccccccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY---EMNPKISDFGMARAFTKDECEANTGRIV 154 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~---~~~~~l~Dfg~~~~~~~~~~~~~~~~~~ 154 (309)
.. ....+++..+..++.||+.||.|||+. ||+||||||+||+++. ++.+||+|||++........ .....
T Consensus 152 ~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~ 224 (400)
T 1nxk_A 152 DR-GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPC 224 (400)
T ss_dssp CC----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC------------
T ss_pred Hh-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccCCCCc---cccCC
Confidence 42 234589999999999999999999998 9999999999999998 78899999999976543221 22346
Q ss_pred cccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHH
Q 021682 155 GTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKL 234 (309)
Q Consensus 155 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
||..|+|||++.+..++.++|||||||++|+|++|..||................. . +.. .+... ......
T Consensus 225 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~--~-~~~-~~~~~-----~~~~~s 295 (400)
T 1nxk_A 225 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR--M-GQY-EFPNP-----EWSEVS 295 (400)
T ss_dssp --CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH--H-TCC-CCCTT-----TTTTSC
T ss_pred CCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH--c-Ccc-cCCCc-----ccccCC
Confidence 79999999999999999999999999999999999999965443332111111100 0 000 00000 001122
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 021682 235 MRCMQVALLCVQENAADRPTMLEILVML 262 (309)
Q Consensus 235 ~~l~~li~~~l~~~p~~Rpt~~ell~~L 262 (309)
..+.+||.+||+.||++|||++++++.-
T Consensus 296 ~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 296 EEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 3788999999999999999999999863
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=290.37 Aligned_cols=253 Identities=26% Similarity=0.413 Sum_probs=193.2
Q ss_pred cceEEEEc-CCCcEE--EEEEeecC-CcccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 3 VAICQGRL-PNGQEM--AVKRLSRT-SHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 3 ~~~~~~~~-~~g~~v--avK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
+.||++.. .+|+.+ |+|.++.. .......+..|+++++++ +||||+++++++..+...++||||+++++|.+++.
T Consensus 39 g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 118 (327)
T 1fvr_A 39 GQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR 118 (327)
T ss_dssp CEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHH
T ss_pred ceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHH
Confidence 45677765 466654 99988653 333456789999999999 99999999999999999999999999999999985
Q ss_pred hhc-------------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCC
Q 021682 78 DLR-------------RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKD 144 (309)
Q Consensus 78 ~~~-------------~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~ 144 (309)
... ....+++..++.++.|++.|+.+||++ |++|+||+|+||+++.++.++|+|||++......
T Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~ 195 (327)
T 1fvr_A 119 KSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 195 (327)
T ss_dssp TTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEESSCEE
T ss_pred hcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeEEEcccCcCcccccc
Confidence 432 234689999999999999999999998 9999999999999999999999999998643221
Q ss_pred cccccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccc
Q 021682 145 ECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDS 223 (309)
Q Consensus 145 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (309)
. ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+ ............
T Consensus 196 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-------~~~~~~~~~~~~---- 261 (327)
T 1fvr_A 196 V---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYEKLPQGYRLE---- 261 (327)
T ss_dssp C---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHGGGTCCCC----
T ss_pred c---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH-------HHHHhhcCCCCC----
Confidence 1 1122356778999999988888999999999999999998 999985432211 111111111111
Q ss_pred cCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccCCCCCCCCCCc
Q 021682 224 SLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETADIKTPKKPAF 277 (309)
Q Consensus 224 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~~~~~~~p~~ 277 (309)
.+...+..+.++|.+||+.||++|||++++++.|+.+........+...
T Consensus 262 -----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~~ 310 (327)
T 1fvr_A 262 -----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTL 310 (327)
T ss_dssp -----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSBCCBC
T ss_pred -----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCccccch
Confidence 1111223788999999999999999999999999988777665544443
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=277.35 Aligned_cols=236 Identities=20% Similarity=0.289 Sum_probs=180.4
Q ss_pred ceEEEE-cCCCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh-c
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL-R 80 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~ 80 (309)
.||.+. ..+|+.||+|.+.... ....+.+..|++++++++||||+++++++......++||||+.+++|.+++... .
T Consensus 37 ~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 116 (285)
T 3is5_A 37 DVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQA 116 (285)
T ss_dssp EEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHH
T ss_pred EEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhh
Confidence 455554 4679999999987653 345678999999999999999999999999999999999999999999888543 2
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEe---CCCCCceeecccccccccCCccccccccccccc
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL---DYEMNPKISDFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
....+++..++.++.|++.|+.+||+. |++|+||+|+||++ +.++.++|+|||++........ .....++.
T Consensus 117 ~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~ 190 (285)
T 3is5_A 117 RGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTA 190 (285)
T ss_dssp HTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-------------CTTG
T ss_pred cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCccc---CcCccccc
Confidence 345699999999999999999999998 99999999999999 4567899999999976544321 22346889
Q ss_pred CCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHH
Q 021682 158 GYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRC 237 (309)
Q Consensus 158 ~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (309)
.|+|||.+. ..++.++||||||+++|+|++|..||...... ................. .. ....+
T Consensus 191 ~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~------~~~~~~~~~~~~~~~~~----~~----~~~~~ 255 (285)
T 3is5_A 191 LYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE------EVQQKATYKEPNYAVEC----RP----LTPQA 255 (285)
T ss_dssp GGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCCCC------CC----CCHHH
T ss_pred CcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH------HHHhhhccCCccccccc----Cc----CCHHH
Confidence 999999885 46789999999999999999999998543211 11111111111100000 00 12367
Q ss_pred HHHHhhcccCCCCCCCCHHHHHH
Q 021682 238 MQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 238 ~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
.++|.+||+.||++|||++|+++
T Consensus 256 ~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 256 VDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHHT
T ss_pred HHHHHHHccCChhhCcCHHHHhc
Confidence 89999999999999999999985
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=292.28 Aligned_cols=233 Identities=21% Similarity=0.260 Sum_probs=184.9
Q ss_pred ceEEEEc-CCCcEEEEEEeecC---CcccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 4 AICQGRL-PNGQEMAVKRLSRT---SHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
.||.+.. .+|+.||||+++.. .......+..|..++..+ +||+|+++++++......++||||+.+++|.+++..
T Consensus 35 ~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~ 114 (353)
T 2i0e_A 35 KVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ 114 (353)
T ss_dssp EEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH
T ss_pred EEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHh
Confidence 4566654 46899999999754 234457788999999988 899999999999999999999999999999999854
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
. ..+++..++.++.||+.||.|||++ |++||||||+||+++.+|.+||+|||++........ ......||+.
T Consensus 115 ~---~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--~~~~~~gt~~ 186 (353)
T 2i0e_A 115 V---GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKTFCGTPD 186 (353)
T ss_dssp H---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--CBCCCCSCGG
T ss_pred c---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCc--ccccccCCcc
Confidence 3 3489999999999999999999998 999999999999999999999999999875332221 2233468999
Q ss_pred CCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHH
Q 021682 159 YVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238 (309)
Q Consensus 159 y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (309)
|+|||.+.+..++.++|+|||||++|+|++|..||...+.. ......... .. .+ . ...+..+.
T Consensus 187 y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~~-~~-~~-----p----~~~s~~~~ 249 (353)
T 2i0e_A 187 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQSIMEH-NV-AY-----P----KSMSKEAV 249 (353)
T ss_dssp GCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHC-CC-CC-----C----TTSCHHHH
T ss_pred ccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH------HHHHHHHhC-CC-CC-----C----CCCCHHHH
Confidence 99999999999999999999999999999999998643211 111111111 10 01 0 11233788
Q ss_pred HHHhhcccCCCCCCCC-----HHHHHHH
Q 021682 239 QVALLCVQENAADRPT-----MLEILVM 261 (309)
Q Consensus 239 ~li~~~l~~~p~~Rpt-----~~ell~~ 261 (309)
++|.+||+.||++||+ ++++++.
T Consensus 250 ~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 250 AICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp HHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred HHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 9999999999999995 6888764
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=291.86 Aligned_cols=227 Identities=21% Similarity=0.256 Sum_probs=182.9
Q ss_pred cceEEEE-cCCCcEEEEEEeecCCc--------ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCC-Ch
Q 021682 3 VAICQGR-LPNGQEMAVKRLSRTSH--------QGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNK-SL 72 (309)
Q Consensus 3 ~~~~~~~-~~~g~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~-~L 72 (309)
+.||++. ..+|+.||||.+..... .....+..|+.++++++||||+++++++..+...++|||++.++ +|
T Consensus 38 g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l 117 (335)
T 3dls_A 38 GFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDL 117 (335)
T ss_dssp CSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBH
T ss_pred EEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccH
Confidence 3566665 56899999999976421 12345778999999999999999999999999999999998766 89
Q ss_pred hHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccc
Q 021682 73 DFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGR 152 (309)
Q Consensus 73 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 152 (309)
.+++.. ...+++..+..++.|++.|+.|||++ |++||||||+||+++.++.++|+|||++........ ...
T Consensus 118 ~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~---~~~ 188 (335)
T 3dls_A 118 FAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYT 188 (335)
T ss_dssp HHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTCC---BCE
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccceECCCCCc---eec
Confidence 888843 34599999999999999999999999 999999999999999999999999999976554322 223
Q ss_pred cccccCCCCccccccCCC-CccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccH
Q 021682 153 IVGTYGYVPPEYVRKGIY-SMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSA 231 (309)
Q Consensus 153 ~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (309)
..|++.|+|||.+.+..+ +.++|||||||++|+|++|..||....... ...... ..
T Consensus 189 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----------------~~~~~~--~~---- 245 (335)
T 3dls_A 189 FCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV-----------------EAAIHP--PY---- 245 (335)
T ss_dssp ECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT-----------------TTCCCC--SS----
T ss_pred cCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH-----------------hhccCC--Cc----
Confidence 468999999999988776 789999999999999999999985321100 000000 00
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 232 WKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 232 ~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
..+..+.++|.+||+.||++|||++++++.
T Consensus 246 ~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 246 LVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp CCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 122368899999999999999999999986
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=282.44 Aligned_cols=233 Identities=23% Similarity=0.320 Sum_probs=183.3
Q ss_pred cceEEEE-cCCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 3 VAICQGR-LPNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 3 ~~~~~~~-~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
+.||++. ..+++.||||.+.... ......+.+|+.++++++||||+++++++..+...++||||+.+++|.+++..
T Consensus 23 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~ 102 (279)
T 3fdn_A 23 GNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK 102 (279)
T ss_dssp EEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH
T ss_pred eEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHh
Confidence 4567775 4578899999986532 23356788999999999999999999999999999999999999999998854
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
. ..+++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++....... .....++..
T Consensus 103 ~---~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~ 172 (279)
T 3fdn_A 103 L---SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLD 172 (279)
T ss_dssp H---SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC------------CCCCT
T ss_pred c---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCccc----ccccCCCCC
Confidence 3 3489999999999999999999998 99999999999999999999999999885443322 223467899
Q ss_pred CCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHH
Q 021682 159 YVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238 (309)
Q Consensus 159 y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (309)
|+|||.+.+..++.++||||||+++|+|++|..||......+. .. ..... .. . .+......+.
T Consensus 173 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~---~~~~~-~~------~----~~~~~~~~~~ 235 (279)
T 3fdn_A 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET---YK---RISRV-EF------T----FPDFVTEGAR 235 (279)
T ss_dssp TCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HH---HHHHT-CC------C----CCTTSCHHHH
T ss_pred ccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH---HH---HHHhC-CC------C----CCCcCCHHHH
Confidence 9999999998899999999999999999999999864322111 11 11110 00 0 0111223678
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHH
Q 021682 239 QVALLCVQENAADRPTMLEILVML 262 (309)
Q Consensus 239 ~li~~~l~~~p~~Rpt~~ell~~L 262 (309)
++|.+||+.||++|||++|+++.-
T Consensus 236 ~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 236 DLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred HHHHHHhccChhhCCCHHHHhhCc
Confidence 999999999999999999999863
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=282.91 Aligned_cols=240 Identities=24% Similarity=0.370 Sum_probs=185.7
Q ss_pred cceEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 3 VAICQGR-LPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 3 ~~~~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
+.||.+. ..+++.||||.+........+.+.+|+.+++.++||||+++++++......++|||++++++|.+++.....
T Consensus 36 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 115 (295)
T 2clq_A 36 GIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWG 115 (295)
T ss_dssp SEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTC
T ss_pred EEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhcc
Confidence 3567776 467899999999876666678899999999999999999999999999999999999999999999865444
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCC-CCCceeecccccccccCCcccccccccccccCCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY-EMNPKISDFGMARAFTKDECEANTGRIVGTYGYV 160 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 160 (309)
...+++..+..++.|++.|+.+||+. |++|+||+|+||+++. ++.++|+|||++........ ......|+..|+
T Consensus 116 ~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~ 190 (295)
T 2clq_A 116 PLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTETFTGTLQYM 190 (295)
T ss_dssp CCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------CCCCCCGGGC
T ss_pred CCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC--cccccCCCcccc
Confidence 44577889999999999999999998 9999999999999987 89999999999876543221 122346889999
Q ss_pred CccccccCC--CCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHH
Q 021682 161 PPEYVRKGI--YSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238 (309)
Q Consensus 161 aPE~~~~~~--~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (309)
|||.+.+.. ++.++||||||+++|+|++|..||........ ......... ... .. +......+.
T Consensus 191 aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~--~~~-----~~----~~~~~~~~~ 256 (295)
T 2clq_A 191 APEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA---AMFKVGMFK--VHP-----EI----PESMSAEAK 256 (295)
T ss_dssp CHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH---HHHHHHHHC--CCC-----CC----CTTSCHHHH
T ss_pred ChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH---HHHhhcccc--ccc-----cc----cccCCHHHH
Confidence 999987643 78999999999999999999999854322111 111101100 000 11 111223788
Q ss_pred HHHhhcccCCCCCCCCHHHHHHH
Q 021682 239 QVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 239 ~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
++|.+||+.||++|||++++++.
T Consensus 257 ~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 257 AFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp HHHHHTTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHccCChhhCCCHHHHhcC
Confidence 99999999999999999999864
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=283.18 Aligned_cols=250 Identities=25% Similarity=0.334 Sum_probs=190.9
Q ss_pred cceEEEEc-CCC---cEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCee-EEEEeccCCCChhHHH
Q 021682 3 VAICQGRL-PNG---QEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEK-MLIYDYMPNKSLDFYI 76 (309)
Q Consensus 3 ~~~~~~~~-~~g---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-~lv~e~~~~~~L~~~~ 76 (309)
+.||++.. .++ ..||+|.+.... ....+.+.+|+.++++++||||+++++++...+.. ++||||+.+++|.+++
T Consensus 35 g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~ 114 (298)
T 3pls_A 35 GVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI 114 (298)
T ss_dssp EEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHH
T ss_pred ceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHH
Confidence 45677754 233 379999986543 34457789999999999999999999999876654 9999999999999998
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcc--cccccccc
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDEC--EANTGRIV 154 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~ 154 (309)
.. ....+++..+..++.|++.|+.|||++ |++|+||||+||+++.++.++|+|||++........ ........
T Consensus 115 ~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 189 (298)
T 3pls_A 115 RS--PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHAR 189 (298)
T ss_dssp HC--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTT
T ss_pred hc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCC
Confidence 54 344588999999999999999999998 899999999999999999999999999976543321 11222346
Q ss_pred cccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCC-CCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHH
Q 021682 155 GTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRT-SCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWK 233 (309)
Q Consensus 155 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
++..|+|||.+.+..++.++||||||+++|+|++|..| |......+ ..... ....... .+...
T Consensus 190 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~---~~~~~----~~~~~~~---------~~~~~ 253 (298)
T 3pls_A 190 LPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD---LTHFL----AQGRRLP---------QPEYC 253 (298)
T ss_dssp CGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG---HHHHH----HTTCCCC---------CCTTC
T ss_pred CCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH---HHHHh----hcCCCCC---------CCccc
Confidence 78899999999999999999999999999999995554 43222211 11111 1111111 01112
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccCCCCCCC
Q 021682 234 LMRCMQVALLCVQENAADRPTMLEILVMLKSETADIKTPK 273 (309)
Q Consensus 234 ~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~~~~~~ 273 (309)
+..+.+++.+||+.||++|||++++++.|+.+...+....
T Consensus 254 ~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~ 293 (298)
T 3pls_A 254 PDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH 293 (298)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCC
T ss_pred hHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccc
Confidence 2378899999999999999999999999998877665443
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=310.90 Aligned_cols=247 Identities=22% Similarity=0.336 Sum_probs=195.1
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccc
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRR 82 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 82 (309)
+.||++.++++..||||.++... ...+.+.+|++++++++|+||+++++++.. ...++||||+.+++|.+++... .+
T Consensus 281 g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~-~~ 357 (535)
T 2h8h_A 281 GEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TG 357 (535)
T ss_dssp EEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHH-HH
T ss_pred eEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhc-CC
Confidence 46789988888889999997543 345789999999999999999999999876 6789999999999999998542 23
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCc
Q 021682 83 YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPP 162 (309)
Q Consensus 83 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 162 (309)
..+++..++.++.||+.||.|||++ |++||||+|+||+++.++.+||+|||++......... ......++..|+||
T Consensus 358 ~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~~~~y~aP 433 (535)
T 2h8h_A 358 KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAP 433 (535)
T ss_dssp TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHH-TTCSTTSCGGGSCH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCcee-cccCCcCcccccCH
Confidence 4589999999999999999999998 8999999999999999999999999999765432211 11223457789999
Q ss_pred cccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHH
Q 021682 163 EYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241 (309)
Q Consensus 163 E~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 241 (309)
|.+.+..++.++|||||||++|+|++ |..||......+ .......+.... .+......+.+||
T Consensus 434 E~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~-------~~~~i~~~~~~~---------~~~~~~~~l~~li 497 (535)
T 2h8h_A 434 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYRMP---------CPPECPESLHDLM 497 (535)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH-------HHHHHHTTCCCC---------CCTTCCHHHHHHH
T ss_pred HHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCCC---------CCCCCCHHHHHHH
Confidence 99998899999999999999999999 899985432211 111111111111 1112234788999
Q ss_pred hhcccCCCCCCCCHHHHHHHHhcccCCCCCC
Q 021682 242 LLCVQENAADRPTMLEILVMLKSETADIKTP 272 (309)
Q Consensus 242 ~~~l~~~p~~Rpt~~ell~~L~~~~~~~~~~ 272 (309)
.+||+.||++|||+++|++.|+.+.....+.
T Consensus 498 ~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~ 528 (535)
T 2h8h_A 498 CQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 528 (535)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHTSSCCCSCS
T ss_pred HHHcCCChhHCcCHHHHHHHHHHHhhccCcc
Confidence 9999999999999999999999875544433
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=289.23 Aligned_cols=234 Identities=21% Similarity=0.240 Sum_probs=177.0
Q ss_pred cceEEEEc----CCCcEEEEEEeecCC----cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhH
Q 021682 3 VAICQGRL----PNGQEMAVKRLSRTS----HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDF 74 (309)
Q Consensus 3 ~~~~~~~~----~~g~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (309)
+.||.+.. .+|+.||||+++... ......+..|+.++++++||||+++++++..++..++||||+.+++|.+
T Consensus 31 g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 110 (327)
T 3a62_A 31 GKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFM 110 (327)
T ss_dssp EEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHH
T ss_pred EEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHH
Confidence 45676664 589999999997542 2334567889999999999999999999999999999999999999999
Q ss_pred HHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccc
Q 021682 75 YIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIV 154 (309)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~ 154 (309)
++.. ...+++..+..++.||+.|+.|||++ |++||||||+||+++.++.+||+|||++........ ......
T Consensus 111 ~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~ 182 (327)
T 3a62_A 111 QLER---EGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHTFC 182 (327)
T ss_dssp HHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC------------CTTS
T ss_pred HHHh---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcccccccCCc--cccccC
Confidence 8854 33488999999999999999999998 999999999999999999999999999865433221 122346
Q ss_pred cccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHH
Q 021682 155 GTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKL 234 (309)
Q Consensus 155 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
|++.|+|||.+.+..++.++|||||||++|+|++|..||....... .......... . .. ....
T Consensus 183 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~i~~~~~--~-----~p----~~~~ 245 (327)
T 3a62_A 183 GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK------TIDKILKCKL--N-----LP----PYLT 245 (327)
T ss_dssp SCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHTCC--C-----CC----TTSC
T ss_pred CCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhCCC--C-----CC----CCCC
Confidence 8999999999998889999999999999999999999986432211 1111111110 0 01 1122
Q ss_pred HHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 021682 235 MRCMQVALLCVQENAADRP-----TMLEILVM 261 (309)
Q Consensus 235 ~~l~~li~~~l~~~p~~Rp-----t~~ell~~ 261 (309)
..+.++|.+||+.||++|| +++++++.
T Consensus 246 ~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 246 QEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred HHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 3788999999999999999 88898875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=293.03 Aligned_cols=248 Identities=27% Similarity=0.400 Sum_probs=190.6
Q ss_pred cceEEEEc------CCCcEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHH
Q 021682 3 VAICQGRL------PNGQEMAVKRLSRT-SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFY 75 (309)
Q Consensus 3 ~~~~~~~~------~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (309)
+.||++.. .+++.||||.+... .......+..|+.++++++||||+++++++..+...++||||+.+++|.++
T Consensus 44 g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 123 (327)
T 2yfx_A 44 GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSF 123 (327)
T ss_dssp SCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHH
T ss_pred eeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHH
Confidence 35677763 46789999999654 344456788999999999999999999999999999999999999999999
Q ss_pred Hhhhcc----ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCC---CCCceeecccccccccCCcccc
Q 021682 76 IFDLRR----RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY---EMNPKISDFGMARAFTKDECEA 148 (309)
Q Consensus 76 ~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~---~~~~~l~Dfg~~~~~~~~~~~~ 148 (309)
+..... ...+++..++.++.|++.|+.|||+. |++|+||+|+||+++. +..++|+|||++..........
T Consensus 124 l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 200 (327)
T 2yfx_A 124 LRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 200 (327)
T ss_dssp HHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC-----
T ss_pred HHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEECccccccccccccccc
Confidence 865432 24488999999999999999999998 8999999999999984 4469999999987654433332
Q ss_pred cccccccccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCC
Q 021682 149 NTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDD 227 (309)
Q Consensus 149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (309)
......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+ .............
T Consensus 201 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~~~~~~~~~~~------- 266 (327)
T 2yfx_A 201 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-------VLEFVTSGGRMDP------- 266 (327)
T ss_dssp -CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------HHHHHHTTCCCCC-------
T ss_pred cCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH-------HHHHHhcCCCCCC-------
Confidence 3334467889999999988899999999999999999998 888885432111 1111111111111
Q ss_pred cccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccCCC
Q 021682 228 SSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETADI 269 (309)
Q Consensus 228 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~~ 269 (309)
.......+.++|.+||+.||++|||+.++++.|+......
T Consensus 267 --~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 267 --PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp --CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred --CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 1112237889999999999999999999999998776543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=292.87 Aligned_cols=259 Identities=20% Similarity=0.258 Sum_probs=181.9
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCcc-cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSHQ-GLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
+.||++.. .+|+.||||.++..... ....+.+|+.++++++||||+++++++..+...++||||+. ++|.+++...
T Consensus 16 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~- 93 (324)
T 3mtl_A 16 ATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDC- 93 (324)
T ss_dssp EEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHHT-
T ss_pred EEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHhc-
Confidence 35677765 48999999998644321 11234579999999999999999999999999999999997 5888877442
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCC
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYV 160 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 160 (309)
+..+++..+..++.|++.|+.|||+. |++||||||+||+++.++.++|+|||++......... .....++..|+
T Consensus 94 -~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~ 167 (324)
T 3mtl_A 94 -GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT--YDNEVVTLWYR 167 (324)
T ss_dssp -TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC--------------CGGGC
T ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCccc--cccccCccccc
Confidence 34589999999999999999999998 9999999999999999999999999998754433221 22346789999
Q ss_pred Ccccccc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccc---------cCC----
Q 021682 161 PPEYVRK-GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDS---------SLD---- 226 (309)
Q Consensus 161 aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~---- 226 (309)
|||.+.+ ..++.++|||||||++|+|++|..||......+....+.................. ...
T Consensus 168 aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (324)
T 3mtl_A 168 PPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEAL 247 (324)
T ss_dssp CHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCH
T ss_pred ChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhh
Confidence 9999876 56799999999999999999999998654322221111111111111111111000 000
Q ss_pred CcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--HhcccCCC
Q 021682 227 DSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM--LKSETADI 269 (309)
Q Consensus 227 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~--L~~~~~~~ 269 (309)
..........+.+||.+||+.||++|||++|+++. +.+..+..
T Consensus 248 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 292 (324)
T 3mtl_A 248 LSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERI 292 (324)
T ss_dssp HHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTT
T ss_pred hhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccccc
Confidence 00001123467899999999999999999999985 45444433
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=278.13 Aligned_cols=237 Identities=25% Similarity=0.346 Sum_probs=187.1
Q ss_pred cceEEEEcC-CCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEee----------------CCeeEEEEe
Q 021682 3 VAICQGRLP-NGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQ----------------REEKMLIYD 65 (309)
Q Consensus 3 ~~~~~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----------------~~~~~lv~e 65 (309)
+.||++... +|+.||+|.+.... ..+.+|++++++++||||+++++++.. ....++|||
T Consensus 25 g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e 100 (284)
T 2a19_B 25 GQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQME 100 (284)
T ss_dssp CCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEEC
T ss_pred eEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEe
Confidence 456777654 89999999997543 356789999999999999999998854 345899999
Q ss_pred ccCCCChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCc
Q 021682 66 YMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDE 145 (309)
Q Consensus 66 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~ 145 (309)
|+.+++|.+++... ....+++..++.++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++.......
T Consensus 101 ~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 176 (284)
T 2a19_B 101 FCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG 176 (284)
T ss_dssp CCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEESSCCS
T ss_pred ccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCEEECcchhheeccccc
Confidence 99999999998543 234689999999999999999999998 99999999999999999999999999987655432
Q ss_pred ccccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccC
Q 021682 146 CEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSL 225 (309)
Q Consensus 146 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (309)
. .....++..|+|||.+.+..++.++||||||+++|+|++|..|+.. ..............
T Consensus 177 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~---------~~~~~~~~~~~~~~------- 237 (284)
T 2a19_B 177 K---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE---------TSKFFTDLRDGIIS------- 237 (284)
T ss_dssp C---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH---------HHHHHHHHHTTCCC-------
T ss_pred c---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh---------HHHHHHHhhccccc-------
Confidence 2 2223688999999999988899999999999999999999887521 01111111111111
Q ss_pred CCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccCCCCC
Q 021682 226 DDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETADIKT 271 (309)
Q Consensus 226 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~~~~ 271 (309)
.. ....+.++|.+||+.||++|||+.++++.|+........
T Consensus 238 -~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~ 278 (284)
T 2a19_B 238 -DI----FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278 (284)
T ss_dssp -TT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred -cc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence 11 123678999999999999999999999999988665443
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=281.46 Aligned_cols=246 Identities=19% Similarity=0.158 Sum_probs=182.8
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
+.||.+.. .+|+.||||.+.... ....+.+.+|+.++++++||||+++++++..++..++||||+++++|.+++..
T Consensus 48 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 127 (309)
T 2h34_A 48 GDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRR 127 (309)
T ss_dssp SEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHH
T ss_pred eeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHh
Confidence 35677764 479999999996542 22346788999999999999999999999999999999999999999999854
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
. ..+++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++......... ......++..
T Consensus 128 ~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~ 200 (309)
T 2h34_A 128 Q---GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT-QLGNTVGTLY 200 (309)
T ss_dssp H---CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----------------CCGG
T ss_pred c---CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccccccccc-cccccCCCcC
Confidence 3 3489999999999999999999998 8999999999999999999999999998765443211 1223468899
Q ss_pred CCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCC-CcccccccCCCcccHHHHHHH
Q 021682 159 YVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGE-GMEFIDSSLDDSSSAWKLMRC 237 (309)
Q Consensus 159 y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l 237 (309)
|+|||.+.+..++.++||||||+++|+|++|..||..... ........... ....... ..+..+
T Consensus 201 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~~~~~~~--------~~~~~l 265 (309)
T 2h34_A 201 YMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL-------SVMGAHINQAIPRPSTVRP--------GIPVAF 265 (309)
T ss_dssp GCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH-------HHHHHHHHSCCCCGGGTST--------TCCTHH
T ss_pred ccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH-------HHHHHHhccCCCCccccCC--------CCCHHH
Confidence 9999999988899999999999999999999999854211 11111111111 1111111 112268
Q ss_pred HHHHhhcccCCCCCCC-CHHHHHHHHhcccCCCC
Q 021682 238 MQVALLCVQENAADRP-TMLEILVMLKSETADIK 270 (309)
Q Consensus 238 ~~li~~~l~~~p~~Rp-t~~ell~~L~~~~~~~~ 270 (309)
.++|.+||+.||++|| |++++++.|+.......
T Consensus 266 ~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 266 DAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp HHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred HHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 8999999999999999 99999999998755443
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=291.46 Aligned_cols=266 Identities=15% Similarity=0.106 Sum_probs=196.0
Q ss_pred cceEEEEcCC------CcEEEEEEeecCCcccH-----------HHHHHHHHHHhcCCCCCccceeeEEeeC----CeeE
Q 021682 3 VAICQGRLPN------GQEMAVKRLSRTSHQGL-----------EEFENEVKLTARLQHVNLLPVLGICTQR----EEKM 61 (309)
Q Consensus 3 ~~~~~~~~~~------g~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~~~~ 61 (309)
+.||++...+ ++.||||.+........ .....|+..++.++|+||+++++++... ...+
T Consensus 49 g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~ 128 (364)
T 3op5_A 49 GCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRF 128 (364)
T ss_dssp CEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEE
T ss_pred eEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeeeccCCcceEE
Confidence 4578887654 47899999865532111 1223455566778899999999998775 4589
Q ss_pred EEEeccCCCChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeC--CCCCceeecccccc
Q 021682 62 LIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLD--YEMNPKISDFGMAR 139 (309)
Q Consensus 62 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~--~~~~~~l~Dfg~~~ 139 (309)
+||||+ +++|.+++.. ....+++..++.++.||+.||.|||+. |++||||||+||+++ .++.+||+|||++.
T Consensus 129 lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~ 202 (364)
T 3op5_A 129 MIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202 (364)
T ss_dssp EEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESSCTTCEEECCCTTCE
T ss_pred EEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecCCCCeEEEEECCcce
Confidence 999999 8999999854 234599999999999999999999999 999999999999999 88999999999997
Q ss_pred cccCCcccc-----cccccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhC
Q 021682 140 AFTKDECEA-----NTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKN 214 (309)
Q Consensus 140 ~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 214 (309)
......... ......||..|+|||.+.+..++.++|||||||++|+|++|..||......... .........
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~--~~~~~~~~~- 279 (364)
T 3op5_A 203 RYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY--VRDSKIRYR- 279 (364)
T ss_dssp ESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH--HHHHHHHHH-
T ss_pred ecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHH--HHHHHHHhh-
Confidence 654332211 112345899999999999989999999999999999999999999643222111 111111110
Q ss_pred CCCcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccCCCCCCCCCCcccc
Q 021682 215 GEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETADIKTPKKPAFSVK 280 (309)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~~~~~~~p~~~~~ 280 (309)
......++..+.. ...+..+.+++.+||+.||++|||+++|++.|+.+...........++|.
T Consensus 280 ~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~ 342 (364)
T 3op5_A 280 ENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLS 342 (364)
T ss_dssp HCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC-
T ss_pred hhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccceE
Confidence 0111111111100 01123788999999999999999999999999999888777777777764
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=281.48 Aligned_cols=235 Identities=24% Similarity=0.382 Sum_probs=167.5
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
+.||++.. .+|+.||||.+.... ....+.+.+|+.++++++||||+++++++......++||||+.+++|.+++..
T Consensus 25 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 104 (278)
T 3cok_A 25 AGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKN 104 (278)
T ss_dssp EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHT
T ss_pred eEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhh
Confidence 35677764 689999999996542 22357789999999999999999999999999999999999999999998853
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
....+++..++.++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++......... .....++..
T Consensus 105 --~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~ 177 (278)
T 3cok_A 105 --RVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK--HYTLCGTPN 177 (278)
T ss_dssp --CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC----------------
T ss_pred --ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc--ceeccCCCC
Confidence 234589999999999999999999998 9999999999999999999999999998765433221 122467899
Q ss_pred CCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHH
Q 021682 159 YVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238 (309)
Q Consensus 159 y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (309)
|+|||.+.+..++.++||||||+++|+|++|..||........... .. .... . .+......+.
T Consensus 178 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------~~---~~~~---~----~~~~~~~~~~ 240 (278)
T 3cok_A 178 YISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK-------VV---LADY---E----MPSFLSIEAK 240 (278)
T ss_dssp --------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------CC---SSCC---C----CCTTSCHHHH
T ss_pred cCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHH-------Hh---hccc---C----CccccCHHHH
Confidence 9999999888889999999999999999999999865433221100 00 0000 0 1111234788
Q ss_pred HHHhhcccCCCCCCCCHHHHHHH
Q 021682 239 QVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 239 ~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
++|.+||+.||++|||++++++.
T Consensus 241 ~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 241 DLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp HHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHHcccCHhhCCCHHHHhcC
Confidence 99999999999999999999863
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=291.25 Aligned_cols=247 Identities=22% Similarity=0.290 Sum_probs=180.2
Q ss_pred cceEEEE-cCCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCC----eeEEEEeccCCCChhH
Q 021682 3 VAICQGR-LPNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQRE----EKMLIYDYMPNKSLDF 74 (309)
Q Consensus 3 ~~~~~~~-~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~~~~~L~~ 74 (309)
+.||.+. ..+|+.||||+++... ......+.+|+.++++++||||+++++++.... ..++||||+++++|.+
T Consensus 26 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~ 105 (311)
T 3ork_A 26 SEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD 105 (311)
T ss_dssp EEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHH
T ss_pred EEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHH
Confidence 3566665 4689999999997653 233457889999999999999999999987654 3499999999999999
Q ss_pred HHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccc-cccccc
Q 021682 75 YIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECE-ANTGRI 153 (309)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~ 153 (309)
++... ..+++..++.++.|++.|+.|||++ |++|+||||+||+++.++.++|+|||++......... ......
T Consensus 106 ~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 179 (311)
T 3ork_A 106 IVHTE---GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179 (311)
T ss_dssp HHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC----------------
T ss_pred HHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCccccccccccccccccc
Confidence 98543 3489999999999999999999998 8999999999999999999999999999765543221 122234
Q ss_pred ccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHH
Q 021682 154 VGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWK 233 (309)
Q Consensus 154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
.|+..|+|||.+.+..++.++||||||+++|+|++|..||..... ................. .....
T Consensus 180 ~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~~~~~~~-------~~~~~ 246 (311)
T 3ork_A 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPIPPSA-------RHEGL 246 (311)
T ss_dssp --CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCCCHHH-------HSTTC
T ss_pred CcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhcCCCCCccc-------ccCCC
Confidence 689999999999999999999999999999999999999854322 11111111211111000 00012
Q ss_pred HHHHHHHHhhcccCCCCCCCCH-HHHHHHHhcccCC
Q 021682 234 LMRCMQVALLCVQENAADRPTM-LEILVMLKSETAD 268 (309)
Q Consensus 234 ~~~l~~li~~~l~~~p~~Rpt~-~ell~~L~~~~~~ 268 (309)
+..+.++|.+||+.||++||++ +++...|......
T Consensus 247 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 247 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred CHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 2368899999999999999955 4555666655443
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=283.98 Aligned_cols=248 Identities=24% Similarity=0.350 Sum_probs=188.3
Q ss_pred cceEEEEcCC----CcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEe-eCCeeEEEEeccCCCChhHHH
Q 021682 3 VAICQGRLPN----GQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICT-QREEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 3 ~~~~~~~~~~----g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~~~~L~~~~ 76 (309)
+.||++...+ +..||+|.+.... ....+.+.+|+.++++++||||+++++++. .+...++||||+.+++|.+++
T Consensus 39 g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l 118 (298)
T 3f66_A 39 GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 118 (298)
T ss_dssp EEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHH
T ss_pred ceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHH
Confidence 4577776432 2358999986543 344577899999999999999999999864 455789999999999999998
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccc--ccccccc
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECE--ANTGRIV 154 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~ 154 (309)
.. ....+++..++.++.|++.|+.+||++ |++|+||||+||+++.++.++|+|||++......... .......
T Consensus 119 ~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~ 193 (298)
T 3f66_A 119 RN--ETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 193 (298)
T ss_dssp HC--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CC
T ss_pred Hh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCC
Confidence 43 344588999999999999999999998 9999999999999999999999999999765443221 1122335
Q ss_pred cccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHH
Q 021682 155 GTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWK 233 (309)
Q Consensus 155 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
++..|+|||.+.+..++.++||||||+++|+|++ |.+||......+. .... ....... . +...
T Consensus 194 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~---~~~~----~~~~~~~-~--------~~~~ 257 (298)
T 3f66_A 194 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TVYL----LQGRRLL-Q--------PEYC 257 (298)
T ss_dssp BCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH---HHHH----HTTCCCC-C--------CTTC
T ss_pred CCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH---HHHH----hcCCCCC-C--------CccC
Confidence 6778999999999999999999999999999999 5566644333221 1111 1111100 0 0111
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccCCCCC
Q 021682 234 LMRCMQVALLCVQENAADRPTMLEILVMLKSETADIKT 271 (309)
Q Consensus 234 ~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~~~~ 271 (309)
+..+.+++.+||+.||++|||++++++.|+.+...+..
T Consensus 258 ~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 258 PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 23688999999999999999999999999988765543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=291.42 Aligned_cols=242 Identities=20% Similarity=0.228 Sum_probs=182.1
Q ss_pred ceEEEEc-CCCcEEEEEEeecC-----CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 4 AICQGRL-PNGQEMAVKRLSRT-----SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
+||.+.. .+++.||+|++... .....+.+..|++++++++||||+++++++..+...++||||+++++|.+++.
T Consensus 41 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~ 120 (345)
T 3hko_A 41 VVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLN 120 (345)
T ss_dssp EEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEE
T ss_pred EEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHH
Confidence 5666654 58899999998653 34456789999999999999999999999999999999999999999999874
Q ss_pred hhcc-------------------------------------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCc
Q 021682 78 DLRR-------------------------------------RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKAS 120 (309)
Q Consensus 78 ~~~~-------------------------------------~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~ 120 (309)
.... ...+++..++.++.|++.|+.|||+. |++|+||+|+
T Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~ 197 (345)
T 3hko_A 121 VFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPE 197 (345)
T ss_dssp EEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGG
T ss_pred HhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---CccccCCChh
Confidence 2110 11235677888999999999999999 8999999999
Q ss_pred eEEeCCCC--CceeecccccccccCCccc--ccccccccccCCCCcccccc--CCCCccchhhhHHHHHHHHHhCCCCCC
Q 021682 121 NILLDYEM--NPKISDFGMARAFTKDECE--ANTGRIVGTYGYVPPEYVRK--GIYSMKYDVYSYGVLLLQILGGKRTSC 194 (309)
Q Consensus 121 nil~~~~~--~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~ll~g~~p~~ 194 (309)
||+++.++ .++|+|||++......... .......|++.|+|||.+.+ ..++.++|||||||++|+|++|..||.
T Consensus 198 NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 277 (345)
T 3hko_A 198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFP 277 (345)
T ss_dssp GEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred hEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 99998776 8999999999765432211 12233468999999999865 577899999999999999999999985
Q ss_pred CCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 195 YYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
..... .............. ..........+.++|.+||+.||++|||+.++++.
T Consensus 278 ~~~~~------~~~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 278 GVNDA------DTISQVLNKKLCFE-------NPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQH 331 (345)
T ss_dssp CSSHH------HHHHHHHHCCCCTT-------SGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred CCChH------HHHHHHHhcccccC-------CcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 43221 11112222111110 00011123478899999999999999999999874
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=284.55 Aligned_cols=242 Identities=20% Similarity=0.285 Sum_probs=179.3
Q ss_pred cceEEEEcC----CCcEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 3 VAICQGRLP----NGQEMAVKRLSRT-SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 3 ~~~~~~~~~----~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
+.||++... .+..||+|.+... .....+.+.+|+.++++++||||+++++++. ++..++||||+.+++|.+++.
T Consensus 29 g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~ 107 (281)
T 1mp8_A 29 GDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQ 107 (281)
T ss_dssp SEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHH
T ss_pred eeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHH
Confidence 467777653 3557999998654 3344567899999999999999999999985 557889999999999999985
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
.. ...+++..++.++.|++.|+.|||+. |++|+||||+||+++.++.++|+|||++......... ......+++
T Consensus 108 ~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~ 181 (281)
T 1mp8_A 108 VR--KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPI 181 (281)
T ss_dssp HT--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC--------------------CCG
T ss_pred hc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCccccc-ccccCCCcc
Confidence 32 34589999999999999999999998 9999999999999999999999999999765443221 122234677
Q ss_pred CCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHH
Q 021682 158 GYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMR 236 (309)
Q Consensus 158 ~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
.|+|||.+.+..++.++||||||+++|+|++ |..||......+. ... ........ .+...+..
T Consensus 182 ~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~---~~~----i~~~~~~~---------~~~~~~~~ 245 (281)
T 1mp8_A 182 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGR----IENGERLP---------MPPNCPPT 245 (281)
T ss_dssp GGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHH----HHTTCCCC---------CCTTCCHH
T ss_pred cccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH---HHH----HHcCCCCC---------CCCCCCHH
Confidence 8999999998899999999999999999996 8999865433221 111 11111111 11112347
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHHHhcccC
Q 021682 237 CMQVALLCVQENAADRPTMLEILVMLKSETA 267 (309)
Q Consensus 237 l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~ 267 (309)
+.+++.+||+.||++|||+.++++.|+.+.+
T Consensus 246 l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 246 LYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 8899999999999999999999999987643
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=291.24 Aligned_cols=261 Identities=14% Similarity=0.148 Sum_probs=195.8
Q ss_pred cceEEEEcC---------CCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccc---------------eeeEEee-C
Q 021682 3 VAICQGRLP---------NGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLP---------------VLGICTQ-R 57 (309)
Q Consensus 3 ~~~~~~~~~---------~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~---------------~~~~~~~-~ 57 (309)
+.||++... +++.||||.+... ..+.+|++++++++||||++ +++++.. +
T Consensus 56 g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~ 130 (352)
T 2jii_A 56 GILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQD 130 (352)
T ss_dssp EEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETT
T ss_pred eEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCC
Confidence 457788765 3889999998644 35788999999999998887 5677766 6
Q ss_pred CeeEEEEeccCCCChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCC--Cceeecc
Q 021682 58 EEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM--NPKISDF 135 (309)
Q Consensus 58 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~--~~~l~Df 135 (309)
...++||||+ +++|.+++... ....+++..++.++.|++.|+.|||++ |++||||||+||+++.++ .++|+||
T Consensus 131 ~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~~~~~~~~~kl~Df 205 (352)
T 2jii_A 131 KYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGY 205 (352)
T ss_dssp TEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEEETTEEEEEEECCG
T ss_pred cEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEEcCCCCceEEEecC
Confidence 7899999999 89999998543 235699999999999999999999999 999999999999999988 8999999
Q ss_pred cccccccCCcccc-----cccccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH
Q 021682 136 GMARAFTKDECEA-----NTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYG 210 (309)
Q Consensus 136 g~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 210 (309)
|++.......... ......|++.|+|||.+.+..++.++|||||||++|+|++|..||........ .......
T Consensus 206 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~~~~~ 283 (352)
T 2jii_A 206 GFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTE--DIMKQKQ 283 (352)
T ss_dssp GGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH--HHHHHHH
T ss_pred cceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHH--HHHHHHH
Confidence 9997655432211 11234689999999999998999999999999999999999999865432221 1111111
Q ss_pred HhhCCCCcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccCCCCCCCCCCccc
Q 021682 211 LWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETADIKTPKKPAFSV 279 (309)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~~~~~~~p~~~~ 279 (309)
.+.. ....+...... ....+..+.+++.+||+.||++|||++++++.|+.+.+.........++|
T Consensus 284 ~~~~-~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~dw 348 (352)
T 2jii_A 284 KFVD-KPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDPIGL 348 (352)
T ss_dssp HHHH-SCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSCCCC
T ss_pred hccC-Chhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCccccC
Confidence 1111 11111111100 00112378899999999999999999999999999987777665555555
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=286.40 Aligned_cols=251 Identities=19% Similarity=0.219 Sum_probs=182.1
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSH--QGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
+.||++.. .+|+.||||.+..... .....+.+|++++++++||||+++++++..+...++||||+.+++|.+++..
T Consensus 17 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~- 95 (311)
T 4agu_A 17 GVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRY- 95 (311)
T ss_dssp EEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHT-
T ss_pred eEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhh-
Confidence 45677765 4699999999865432 2346678999999999999999999999999999999999999999888733
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
...+++..+..++.|++.|+.|||+. |++|+||+|+||+++.++.++|+|||++......... .....++..|
T Consensus 96 --~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y 168 (311)
T 4agu_A 96 --QRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY--YDDEVATRWY 168 (311)
T ss_dssp --SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--------------GGG
T ss_pred --hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc--cCCCcCCccc
Confidence 34589999999999999999999998 9999999999999999999999999999765533221 2234678899
Q ss_pred CCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH--------HHhhCCCCc---ccccccCCC
Q 021682 160 VPPEYVRK-GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAY--------GLWKNGEGM---EFIDSSLDD 227 (309)
Q Consensus 160 ~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~---~~~~~~~~~ 227 (309)
+|||.+.+ ..++.++||||||+++|+|++|..||......+......... ..+...... ...+.....
T Consensus 169 ~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (311)
T 4agu_A 169 RSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDME 248 (311)
T ss_dssp CCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCC
T ss_pred cChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccc
Confidence 99999876 567999999999999999999999986543322211111100 000000000 000000000
Q ss_pred cc---cHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 228 SS---SAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 228 ~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.. ....+..+.++|.+||+.||++|||++|+++.
T Consensus 249 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 249 PLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred hhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00 01123367899999999999999999999965
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=286.12 Aligned_cols=251 Identities=22% Similarity=0.269 Sum_probs=182.3
Q ss_pred cceEEEE-cCCCcEEEEEEeecCC-----cccHHHHHHHHHHHhcC---CCCCccceeeEEeeCC-----eeEEEEeccC
Q 021682 3 VAICQGR-LPNGQEMAVKRLSRTS-----HQGLEEFENEVKLTARL---QHVNLLPVLGICTQRE-----EKMLIYDYMP 68 (309)
Q Consensus 3 ~~~~~~~-~~~g~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~-----~~~lv~e~~~ 68 (309)
+.||++. ..+|+.||||.+.... ......+.+|+.+++++ +||||+++++++.... ..++|||++.
T Consensus 23 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~ 102 (308)
T 3g33_A 23 GTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD 102 (308)
T ss_dssp CCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC
T ss_pred eEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhh
Confidence 3567776 4689999999986432 11234566777777766 4999999999998765 5899999996
Q ss_pred CCChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccc
Q 021682 69 NKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEA 148 (309)
Q Consensus 69 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 148 (309)
++|.+++... ....+++..+..++.|++.|++|||++ |++|+||||+||+++.++.++|+|||++........
T Consensus 103 -~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-- 175 (308)
T 3g33_A 103 -QDLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-- 175 (308)
T ss_dssp -CBHHHHHHTC-CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCCC--
T ss_pred -cCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEeeCccccccCCCcc--
Confidence 5998888543 233489999999999999999999999 899999999999999999999999999976543322
Q ss_pred cccccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCccc-------c
Q 021682 149 NTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEF-------I 221 (309)
Q Consensus 149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~ 221 (309)
.....||+.|+|||.+.+..++.++|||||||++|+|++|.+||......+....+...........+... +
T Consensus 176 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 254 (308)
T 3g33_A 176 -LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAF 254 (308)
T ss_dssp -SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGS
T ss_pred -cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhcccccc
Confidence 23346899999999999999999999999999999999999998643322211111111111111111000 0
Q ss_pred cccCCC---cccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 222 DSSLDD---SSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 222 ~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
...... .........+.++|.+||+.||++|||+.|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 255 PPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 000000 0001123477899999999999999999999864
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=284.15 Aligned_cols=235 Identities=22% Similarity=0.281 Sum_probs=182.9
Q ss_pred ceEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccc
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRR 82 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 82 (309)
.||.+.. .+|+.||+|.+..........+.+|+.++++++||||+++++++..+...++||||+.+++|.+++...
T Consensus 24 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--- 100 (304)
T 2jam_A 24 EVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILER--- 100 (304)
T ss_dssp EEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH---
T ss_pred eEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHc---
Confidence 4666654 589999999998665545567889999999999999999999999999999999999999999888543
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEe---CCCCCceeecccccccccCCcccccccccccccCC
Q 021682 83 YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL---DYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 83 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
..+++..+..++.|++.|+.+||+. |++|+||+|+||++ +.++.++|+|||++...... ......|+..|
T Consensus 101 ~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~y 173 (304)
T 2jam_A 101 GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACGTPGY 173 (304)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB----TTHHHHSCCCB
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC----ccccccCCCCc
Confidence 3489999999999999999999998 99999999999999 77889999999998654322 12223588999
Q ss_pred CCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHH
Q 021682 160 VPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQ 239 (309)
Q Consensus 160 ~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (309)
+|||.+.+..++.++||||||+++|+|++|..||....... .. ........ .+ .... ....+..+.+
T Consensus 174 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~-~~i~~~~~-~~-~~~~----~~~~~~~~~~ 240 (304)
T 2jam_A 174 VAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK------LF-EKIKEGYY-EF-ESPF----WDDISESAKD 240 (304)
T ss_dssp CCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HH-HHHHHCCC-CC-CTTT----TTTSCHHHHH
T ss_pred cChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH------HH-HHHHcCCC-CC-Cccc----cccCCHHHHH
Confidence 99999999899999999999999999999999985432111 11 11111110 00 0000 1112337889
Q ss_pred HHhhcccCCCCCCCCHHHHHHH
Q 021682 240 VALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 240 li~~~l~~~p~~Rpt~~ell~~ 261 (309)
+|.+||+.||++|||++++++.
T Consensus 241 li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 241 FICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp HHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHHHcCCChhHCcCHHHHhcC
Confidence 9999999999999999999974
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=290.36 Aligned_cols=251 Identities=22% Similarity=0.287 Sum_probs=181.9
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSH--QGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
+.||++.. .+|+.||||.+..... .....+.+|+.++++++||||+++++++..+...++||||+.+++|.++..
T Consensus 39 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-- 116 (331)
T 4aaa_A 39 GMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLEL-- 116 (331)
T ss_dssp SSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHH--
T ss_pred EEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHh--
Confidence 35666654 5699999999865432 234567899999999999999999999999999999999999988888763
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
....+++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++......... .....++..|
T Consensus 117 -~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~t~~y 190 (331)
T 4aaa_A 117 -FPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV--YDDEVATRWY 190 (331)
T ss_dssp -STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC--------------CCCCCTT
T ss_pred -hccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCccc--cCCCcCCccc
Confidence 233489999999999999999999999 9999999999999999999999999998765443221 2234688999
Q ss_pred CCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHH--------HHHhhC------CCCccccccc
Q 021682 160 VPPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYA--------YGLWKN------GEGMEFIDSS 224 (309)
Q Consensus 160 ~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~~------~~~~~~~~~~ 224 (309)
+|||.+.+. .++.++|||||||++|+|++|..||......+........ ...+.. ..........
T Consensus 191 ~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (331)
T 4aaa_A 191 RAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKERE 270 (331)
T ss_dssp CCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCC
T ss_pred cCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccc
Confidence 999998775 6799999999999999999999998653322211111000 000000 0001100000
Q ss_pred CCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 225 LDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 225 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.........+..+.++|.+||+.||++|||++|+++.
T Consensus 271 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 271 PLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp CHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000001123478899999999999999999999864
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=279.62 Aligned_cols=232 Identities=21% Similarity=0.289 Sum_probs=185.8
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
+.||.+.. .+++.||||.+.... ......+.+|++++++++||||+++++++..+...++||||+.+++|.+++..
T Consensus 28 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 107 (284)
T 2vgo_A 28 GNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQK 107 (284)
T ss_dssp EEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH
T ss_pred eEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHh
Confidence 35677765 478899999986532 22356789999999999999999999999999999999999999999998854
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
. ..+++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++....... .....|+..
T Consensus 108 ~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~ 177 (284)
T 2vgo_A 108 H---GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGTLD 177 (284)
T ss_dssp H---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC----BCCCCSCGG
T ss_pred c---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcccc----cccccCCCC
Confidence 3 3489999999999999999999998 99999999999999999999999999986544322 223467899
Q ss_pred CCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHH
Q 021682 159 YVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238 (309)
Q Consensus 159 y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (309)
|+|||.+.+..++.++||||||+++|+|++|..||......+ ..... ..... . .. ......+.
T Consensus 178 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~-~~~~~-~-----~~----~~~~~~~~ 240 (284)
T 2vgo_A 178 YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE------THRRI-VNVDL-K-----FP----PFLSDGSK 240 (284)
T ss_dssp GCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHH-HTTCC-C-----CC----TTSCHHHH
T ss_pred cCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH------HHHHH-hcccc-C-----CC----CcCCHHHH
Confidence 999999999889999999999999999999999985432111 11111 11110 0 01 11223778
Q ss_pred HHHhhcccCCCCCCCCHHHHHHH
Q 021682 239 QVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 239 ~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
++|.+||+.||++|||++++++.
T Consensus 241 ~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 241 DLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTC
T ss_pred HHHHHHhhcCHhhCCCHHHHhhC
Confidence 99999999999999999999974
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=289.68 Aligned_cols=250 Identities=20% Similarity=0.205 Sum_probs=176.0
Q ss_pred cceEEEE-cCCCcEEEEEEeecCCc--ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 3 VAICQGR-LPNGQEMAVKRLSRTSH--QGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 3 ~~~~~~~-~~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
+.||++. ..+|+.||||.++.... .....+.+|+.++++++||||+++++++..+...++||||+.+ +|.+++..
T Consensus 48 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~- 125 (329)
T 3gbz_A 48 GEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDK- 125 (329)
T ss_dssp SEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHH-
T ss_pred eEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCCC-CHHHHHhh-
Confidence 3566665 56899999999965432 2245677999999999999999999999999999999999974 89888843
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeC-----CCCCceeecccccccccCCcccccccccc
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLD-----YEMNPKISDFGMARAFTKDECEANTGRIV 154 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~-----~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~ 154 (309)
...+++..+..++.||+.|+.|||++ |++|+||||+||+++ .++.++|+|||++......... .....
T Consensus 126 --~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~ 198 (329)
T 3gbz_A 126 --NPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQ--FTHEI 198 (329)
T ss_dssp --CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC------------
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcccc--cCCCc
Confidence 33489999999999999999999998 999999999999994 4455999999999766533222 22236
Q ss_pred cccCCCCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCc---------cccccc
Q 021682 155 GTYGYVPPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGM---------EFIDSS 224 (309)
Q Consensus 155 ~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~ 224 (309)
++..|+|||.+.+. .++.++|||||||++|+|++|..||......+.................. ..+...
T Consensus 199 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (329)
T 3gbz_A 199 ITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKF 278 (329)
T ss_dssp -CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCC
T ss_pred CCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhh
Confidence 78999999998774 47999999999999999999999986432222111111110000000000 000000
Q ss_pred CCCc----ccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 225 LDDS----SSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 225 ~~~~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.... ........+.+||.+||+.||++|||++|+++.
T Consensus 279 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 279 RGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp CCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 0000 001123477899999999999999999999863
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=289.89 Aligned_cols=250 Identities=20% Similarity=0.257 Sum_probs=186.2
Q ss_pred cceEEEEc-CCCcEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRT-SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
+.||++.. .+|+.||+|.+... .......+.+|+.++++++||||+++++++..+...++||||+.+++|.+++...
T Consensus 47 g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~- 125 (360)
T 3eqc_A 47 GVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA- 125 (360)
T ss_dssp CEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHH-
T ss_pred eEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHc-
Confidence 35666654 48999999999765 3344567899999999999999999999999999999999999999999998543
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCC
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYV 160 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 160 (309)
..+++..+..++.+++.|+.|||+.+ |++|+||||+||+++.++.++|+|||++....... .....|+..|+
T Consensus 126 --~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~gt~~y~ 197 (360)
T 3eqc_A 126 --GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYM 197 (360)
T ss_dssp --SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC--------CCCCTTC
T ss_pred --CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCccccccc----ccCCCCCCCeE
Confidence 34899999999999999999999853 79999999999999999999999999986543221 22346899999
Q ss_pred CccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH---------HHhhC--------------CCC
Q 021682 161 PPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAY---------GLWKN--------------GEG 217 (309)
Q Consensus 161 aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~---------~~~~~--------------~~~ 217 (309)
|||.+.+..++.++|||||||++|+|++|..||......+......... ..... ...
T Consensus 198 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (360)
T 3eqc_A 198 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAI 277 (360)
T ss_dssp CHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------------CCCH
T ss_pred CHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccc
Confidence 9999999999999999999999999999999986533211100000000 00000 000
Q ss_pred ccc----ccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 218 MEF----IDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 218 ~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.+. .............+..+.++|.+||+.||++|||++|+++.
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 278 FELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp HHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 000 00000000011123368899999999999999999999875
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=294.32 Aligned_cols=239 Identities=16% Similarity=0.158 Sum_probs=183.7
Q ss_pred ceEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
.||.+.. .+|+.||||++++.. ......+..|..++..++||||+++++++.++...++||||+.+++|.+++...
T Consensus 76 ~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~ 155 (412)
T 2vd5_A 76 EVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKF 155 (412)
T ss_dssp EEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH
T ss_pred EEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhc
Confidence 4566654 589999999997532 223345789999999999999999999999999999999999999999998543
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
+..+++..++.++.||+.|+.|||++ |++||||||+||+++.++.+||+|||++......... ......||+.|
T Consensus 156 --~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~-~~~~~~Gt~~Y 229 (412)
T 2vd5_A 156 --GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV-RSLVAVGTPDY 229 (412)
T ss_dssp --SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE-ECSSCCSCGGG
T ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheeccCCCcc-ccceeccccCc
Confidence 23589999999999999999999998 8999999999999999999999999999765543221 12234789999
Q ss_pred CCccccc-------cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHH
Q 021682 160 VPPEYVR-------KGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAW 232 (309)
Q Consensus 160 ~aPE~~~-------~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (309)
+|||++. ...++.++|+|||||++|+|++|+.||...+..+....+ ........... . ...
T Consensus 230 ~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i---~~~~~~~~~p~-----~----~~~ 297 (412)
T 2vd5_A 230 LSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKI---VHYKEHLSLPL-----V----DEG 297 (412)
T ss_dssp CCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH---HTHHHHCCCC-------------C
T ss_pred CCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHH---HhcccCcCCCc-----c----ccC
Confidence 9999987 356799999999999999999999999643222111111 00000000000 0 011
Q ss_pred HHHHHHHHHhhcccCCCCCC---CCHHHHHHH
Q 021682 233 KLMRCMQVALLCVQENAADR---PTMLEILVM 261 (309)
Q Consensus 233 ~~~~l~~li~~~l~~~p~~R---pt~~ell~~ 261 (309)
.+..+.++|.+||+ +|++| |+++|+++.
T Consensus 298 ~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 298 VPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp CCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred CCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 22378899999999 99998 699999876
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=287.37 Aligned_cols=252 Identities=23% Similarity=0.347 Sum_probs=192.7
Q ss_pred cceEEEE-----cCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCC--eeEEEEeccCCCChhHH
Q 021682 3 VAICQGR-----LPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQRE--EKMLIYDYMPNKSLDFY 75 (309)
Q Consensus 3 ~~~~~~~-----~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~ 75 (309)
+.||.+. ..+|+.||||.+..........+.+|++++++++||||+++++++.... ..++||||+++++|.++
T Consensus 55 g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 134 (326)
T 2w1i_A 55 GSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDY 134 (326)
T ss_dssp EEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHH
T ss_pred eEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHH
Confidence 3567776 3479999999997766666778999999999999999999999987654 68999999999999999
Q ss_pred HhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccc-cccccc
Q 021682 76 IFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEA-NTGRIV 154 (309)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~-~~~~~~ 154 (309)
+... ...+++..++.++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++.......... ......
T Consensus 135 l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~ 209 (326)
T 2w1i_A 135 LQKH--KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGE 209 (326)
T ss_dssp HHHS--TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCS
T ss_pred HHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCC
Confidence 8543 33489999999999999999999998 99999999999999999999999999997765433211 122234
Q ss_pred cccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCC--------CCCc-ccHHHHHHHHhhCCCCcccccccC
Q 021682 155 GTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYG--------PNES-LNLLEYAYGLWKNGEGMEFIDSSL 225 (309)
Q Consensus 155 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~--------~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 225 (309)
++..|+|||.+.+..++.++||||||+++|+|++|..|+.... .... ..................
T Consensus 210 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 283 (326)
T 2w1i_A 210 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP------ 283 (326)
T ss_dssp CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCC------
T ss_pred CceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCC------
Confidence 6678999999988888999999999999999999998875310 0000 000001111111111111
Q ss_pred CCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccCC
Q 021682 226 DDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETAD 268 (309)
Q Consensus 226 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~ 268 (309)
.+...+..+.++|.+||+.||++|||+.++++.|+.+...
T Consensus 284 ---~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 284 ---RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp ---CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 1111234788999999999999999999999999987543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=286.23 Aligned_cols=252 Identities=15% Similarity=0.098 Sum_probs=187.6
Q ss_pred cceEEEEcC----CCcEEEEEEeecCCcc-----------cHHHHHHHHHHHhcCCCCCccceeeEEee----CCeeEEE
Q 021682 3 VAICQGRLP----NGQEMAVKRLSRTSHQ-----------GLEEFENEVKLTARLQHVNLLPVLGICTQ----REEKMLI 63 (309)
Q Consensus 3 ~~~~~~~~~----~g~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv 63 (309)
+.||++... ++..||||.+...... ....+..|+..++.++||||+++++++.. ....++|
T Consensus 51 g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv 130 (345)
T 2v62_A 51 GLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMV 130 (345)
T ss_dssp -CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEE
T ss_pred eEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccccCCCcEEEEE
Confidence 367777754 6888999998754321 11235577888999999999999999988 6789999
Q ss_pred EeccCCCChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCC--Cceeecccccccc
Q 021682 64 YDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM--NPKISDFGMARAF 141 (309)
Q Consensus 64 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~--~~~l~Dfg~~~~~ 141 (309)
|||+ +++|.+++.... .+++..++.++.||+.|++|||+. |++||||||+||+++.++ .++|+|||++...
T Consensus 131 ~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~ 203 (345)
T 2v62_A 131 MERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203 (345)
T ss_dssp EECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTTSEEECCCTTCEES
T ss_pred Eecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCCcEEEEeCCCceec
Confidence 9999 899999984432 599999999999999999999998 999999999999999877 9999999999766
Q ss_pred cCCccc-----ccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCC
Q 021682 142 TKDECE-----ANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGE 216 (309)
Q Consensus 142 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 216 (309)
...... .......|+..|+|||.+.+..++.++|||||||++|+|++|..||........ ............
T Consensus 204 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~- 280 (345)
T 2v62_A 204 CPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV--AVQTAKTNLLDE- 280 (345)
T ss_dssp SGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH--HHHHHHHHHHHT-
T ss_pred ccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH--HHHHHHHhhccc-
Confidence 432211 111334689999999999998899999999999999999999999853222111 111111111110
Q ss_pred CcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccC
Q 021682 217 GMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETA 267 (309)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~ 267 (309)
.......... ....+..+.++|.+||+.||++|||+++|++.|+....
T Consensus 281 ~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 281 LPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp TTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred ccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 0110000000 00122378899999999999999999999999998643
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=298.80 Aligned_cols=246 Identities=22% Similarity=0.246 Sum_probs=178.0
Q ss_pred ceEEEE-cCCCcEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeeEEeeC------CeeEEEEeccCCCChhH
Q 021682 4 AICQGR-LPNGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQR------EEKMLIYDYMPNKSLDF 74 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~~L~~ 74 (309)
+||++. ..+|+.||||++... ......++.+|+.+++.++||||+++++++... ...++||||+.++ +.+
T Consensus 77 ~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~~-l~~ 155 (464)
T 3ttj_A 77 IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQ 155 (464)
T ss_dssp EEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEE-HHH
T ss_pred EEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCCC-HHH
Confidence 455554 568999999999754 334456788999999999999999999998654 3579999999764 555
Q ss_pred HHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccc
Q 021682 75 YIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIV 154 (309)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~ 154 (309)
.+. ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||++....... ......
T Consensus 156 ~~~-----~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~ 224 (464)
T 3ttj_A 156 VIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYV 224 (464)
T ss_dssp HHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC-----CC---CC----
T ss_pred HHh-----hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCc---ccCCCc
Confidence 542 2388999999999999999999999 89999999999999999999999999997654432 123347
Q ss_pred cccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH----------------HHhhCC-CC
Q 021682 155 GTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAY----------------GLWKNG-EG 217 (309)
Q Consensus 155 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~----------------~~~~~~-~~ 217 (309)
||+.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+....+.... ...... ..
T Consensus 225 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~ 304 (464)
T 3ttj_A 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKY 304 (464)
T ss_dssp CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCC
T ss_pred ccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhccccc
Confidence 8999999999999999999999999999999999999996543222111111100 000000 00
Q ss_pred -----ccccccc-C--CCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 218 -----MEFIDSS-L--DDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 218 -----~~~~~~~-~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
...+... . ...........+.+||.+||+.||++|||++|+++.
T Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 305 AGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp CCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 0 001111225578899999999999999999999986
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=295.68 Aligned_cols=240 Identities=17% Similarity=0.188 Sum_probs=185.0
Q ss_pred ceEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
.||++.. .+|+.||||++++.. ......+..|..++..++||||+++++++.++...++||||+.+++|.+++...
T Consensus 89 ~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~ 168 (437)
T 4aw2_A 89 EVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKF 168 (437)
T ss_dssp EEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTT
T ss_pred EEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHc
Confidence 4566665 468999999996531 122334789999999999999999999999999999999999999999998542
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
...+++..++.++.|++.|+.|||+. ||+||||||+||+++.++.+||+|||++......... ......||+.|
T Consensus 169 --~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~-~~~~~~GT~~Y 242 (437)
T 4aw2_A 169 --EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-QSSVAVGTPDY 242 (437)
T ss_dssp --TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE-ECCSCCSCGGG
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCc-ccccccCCcCe
Confidence 34599999999999999999999998 8999999999999999999999999999765443222 12234789999
Q ss_pred CCccccc-----cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHH
Q 021682 160 VPPEYVR-----KGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKL 234 (309)
Q Consensus 160 ~aPE~~~-----~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
+|||.+. ...++.++|+|||||++|+|++|..||...+..+....+ ............. .. .+
T Consensus 243 ~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i---~~~~~~~~~p~~~-----~~----~s 310 (437)
T 4aw2_A 243 ISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI---MNHKERFQFPTQV-----TD----VS 310 (437)
T ss_dssp CCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH---HTHHHHCCCCSSC-----CC----SC
T ss_pred eChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhh---hhccccccCCccc-----cc----CC
Confidence 9999986 456899999999999999999999999643222211111 1000000111100 01 12
Q ss_pred HHHHHHHhhcccCCCCC--CCCHHHHHHH
Q 021682 235 MRCMQVALLCVQENAAD--RPTMLEILVM 261 (309)
Q Consensus 235 ~~l~~li~~~l~~~p~~--Rpt~~ell~~ 261 (309)
..+.+||.+||..+|+. ||+++|+++.
T Consensus 311 ~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 311 ENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred HHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 36789999999998888 9999999986
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=289.81 Aligned_cols=237 Identities=21% Similarity=0.283 Sum_probs=180.5
Q ss_pred cceEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHHHHhcCC--CCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQ--HVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
+.||++...+|+.||||.+.... ......+.+|+.++++++ |+||+++++++..+...++||| +.+++|.+++..
T Consensus 70 g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~ 148 (390)
T 2zmd_A 70 SKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK 148 (390)
T ss_dssp EEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHH
T ss_pred eEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHh
Confidence 46788887789999999987542 344577899999999996 5999999999999999999999 557899998854
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
...+++..+..++.||+.||.|||+. ||+||||||+||+++ ++.+||+|||++................||+.
T Consensus 149 ---~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~ 221 (390)
T 2zmd_A 149 ---KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVN 221 (390)
T ss_dssp ---CSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGG
T ss_pred ---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCC
Confidence 33588889999999999999999998 899999999999995 58899999999976654433222334578999
Q ss_pred CCCcccccc-----------CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCC
Q 021682 159 YVPPEYVRK-----------GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDD 227 (309)
Q Consensus 159 y~aPE~~~~-----------~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (309)
|+|||.+.+ ..++.++|||||||++|+|++|..||..... ................+.
T Consensus 222 y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~~~~~~~~~~~~~~~------ 290 (390)
T 2zmd_A 222 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAIIDPNHEIEFP------ 290 (390)
T ss_dssp GCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHHHHHHHCTTSCCCCC------
T ss_pred ccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-----HHHHHHHHhCccccCCCC------
Confidence 999999865 3678999999999999999999999853221 111111111111111111
Q ss_pred cccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 228 SSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 228 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
......+.++|.+||+.||++|||+.|+++.
T Consensus 291 ---~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 291 ---DIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp ---CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---ccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 0112367899999999999999999999976
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=286.77 Aligned_cols=236 Identities=22% Similarity=0.249 Sum_probs=180.6
Q ss_pred ceEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTSHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
.||.+. ..+|+.||||.+...... ..+|++++.++ +||||+++++++.++...++||||+.+++|.+++..
T Consensus 37 ~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~--- 109 (342)
T 2qr7_A 37 VCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILR--- 109 (342)
T ss_dssp EEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT---
T ss_pred EEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHH---
Confidence 456665 457999999999765332 34688888887 799999999999999999999999999999998843
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCC-C---CceeecccccccccCCccccccccccccc
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYE-M---NPKISDFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~-~---~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
...+++..+..++.||+.|+.|||+. |++||||||+||++... + .+||+|||++......... .....+|+
T Consensus 110 ~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~ 184 (342)
T 2qr7_A 110 QKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL--LMTPCYTA 184 (342)
T ss_dssp CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCC--BCCSSCCS
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCc--eeccCCCc
Confidence 34589999999999999999999998 99999999999998543 3 4999999999765443221 22346799
Q ss_pred CCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHH
Q 021682 158 GYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRC 237 (309)
Q Consensus 158 ~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (309)
.|+|||.+.+..++.++|||||||++|+|++|..||............ .....+... + ........+..+
T Consensus 185 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~----~~i~~~~~~-~-----~~~~~~~~s~~~ 254 (342)
T 2qr7_A 185 NFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL----ARIGSGKFS-L-----SGGYWNSVSDTA 254 (342)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHH----HHHHHCCCC-C-----CSTTTTTSCHHH
T ss_pred cccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHH----HHHccCCcc-c-----CccccccCCHHH
Confidence 999999998888899999999999999999999999643222211111 111111111 0 000011123378
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHH
Q 021682 238 MQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 238 ~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.++|.+||+.||++|||+.++++.
T Consensus 255 ~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 255 KDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHCCCChhHCcCHHHHhcC
Confidence 899999999999999999999875
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=300.84 Aligned_cols=238 Identities=23% Similarity=0.298 Sum_probs=189.1
Q ss_pred ceEEEEc-CCCcEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGRL-PNGQEMAVKRLSRT---SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
.||.+.. .+|+.||||.+... .......+..|+.++++++||||+++++++.+....++||||+.+++|.+++...
T Consensus 199 ~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~ 278 (576)
T 2acx_A 199 EVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM 278 (576)
T ss_dssp EEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSS
T ss_pred EEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhc
Confidence 4566654 58999999999653 2334567889999999999999999999999999999999999999999988543
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
. ...+++..+..++.||+.||.|||++ ||+||||||+||+++.+|.+||+|||++........ .....||+.|
T Consensus 279 ~-~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y 351 (576)
T 2acx_A 279 G-QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGY 351 (576)
T ss_dssp S-SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC---EECCCSCGGG
T ss_pred C-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccCcc---ccccCCCccc
Confidence 2 33489999999999999999999998 999999999999999999999999999976544322 1223789999
Q ss_pred CCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHH
Q 021682 160 VPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQ 239 (309)
Q Consensus 160 ~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (309)
+|||++.+..++.++|+|||||++|+|++|..||...........+... ..... ..+ +...+..+.+
T Consensus 352 ~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~--i~~~~--~~~---------p~~~s~~~~d 418 (576)
T 2acx_A 352 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL--VKEVP--EEY---------SERFSPQARS 418 (576)
T ss_dssp CCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHH--HHHCC--CCC---------CTTSCHHHHH
T ss_pred cCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHH--hhccc--ccC---------CccCCHHHHH
Confidence 9999999988999999999999999999999999654332222111111 11110 000 0112237889
Q ss_pred HHhhcccCCCCCCC-----CHHHHHHH
Q 021682 240 VALLCVQENAADRP-----TMLEILVM 261 (309)
Q Consensus 240 li~~~l~~~p~~Rp-----t~~ell~~ 261 (309)
||.+||+.||++|| +++|+++.
T Consensus 419 LI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 419 LCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp HHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred HHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 99999999999999 78999865
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=296.02 Aligned_cols=238 Identities=20% Similarity=0.237 Sum_probs=184.5
Q ss_pred cceEEEEc-CCCcEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRT---SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
+.||.+.. .+|+.||+|++++. .......+.+|+.+++.++||||+++++++.++...++||||+++++|.+++..
T Consensus 83 G~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~ 162 (410)
T 3v8s_A 83 GEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN 162 (410)
T ss_dssp EEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH
T ss_pred EEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHc
Confidence 34566654 57999999999653 122334578999999999999999999999999999999999999999998843
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
..+++..+..++.||+.|+.|||++ ||+||||||+||+++.++.+||+|||++......... ......||+.
T Consensus 163 ----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~-~~~~~~gt~~ 234 (410)
T 3v8s_A 163 ----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPD 234 (410)
T ss_dssp ----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEE-ECCSCCSCGG
T ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcc-cccCCcCCcc
Confidence 2489999999999999999999998 9999999999999999999999999999765543221 1223578999
Q ss_pred CCCccccccCC----CCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHH
Q 021682 159 YVPPEYVRKGI----YSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKL 234 (309)
Q Consensus 159 y~aPE~~~~~~----~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
|+|||++.+.. ++.++|+|||||++|+|++|..||...+...... ..........+.. .. ..+
T Consensus 235 Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~------~i~~~~~~~~~p~---~~----~~s 301 (410)
T 3v8s_A 235 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS------KIMNHKNSLTFPD---DN----DIS 301 (410)
T ss_dssp GCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHHTHHHHCCCCT---TC----CCC
T ss_pred ccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHH------HHHhccccccCCC---cc----ccc
Confidence 99999997655 7899999999999999999999996432221111 1111000000000 00 112
Q ss_pred HHHHHHHhhcccCCCCC--CCCHHHHHHH
Q 021682 235 MRCMQVALLCVQENAAD--RPTMLEILVM 261 (309)
Q Consensus 235 ~~l~~li~~~l~~~p~~--Rpt~~ell~~ 261 (309)
..+.+||.+||+.+|.+ ||+++|+++.
T Consensus 302 ~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 302 KEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred HHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 37889999999999988 9999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=298.53 Aligned_cols=236 Identities=24% Similarity=0.281 Sum_probs=184.0
Q ss_pred cceEEEEc-CCCcEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
++||++.. .+|+.||||++... .......+.+|++++++++||||+++++++......++||||+.+++|.+.+...
T Consensus 36 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 115 (486)
T 3mwu_A 36 GEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR 115 (486)
T ss_dssp SEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH
T ss_pred EEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhc
Confidence 35666654 58999999998653 2345678899999999999999999999999999999999999999998888543
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeC---CCCCceeecccccccccCCcccccccccccc
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLD---YEMNPKISDFGMARAFTKDECEANTGRIVGT 156 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~---~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 156 (309)
..+++..+..++.||+.|+.|||++ |++||||||+||+++ .++.+||+|||++........ .....||
T Consensus 116 ---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt 186 (486)
T 3mwu_A 116 ---KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGT 186 (486)
T ss_dssp ---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-------CCTTG
T ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCc---cCCCcCC
Confidence 3489999999999999999999998 899999999999995 456799999999976544322 2234689
Q ss_pred cCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHH
Q 021682 157 YGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMR 236 (309)
Q Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
+.|+|||++.+ .++.++|||||||++|+|++|.+||......+ ....... ..... ........+..
T Consensus 187 ~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~~-~~~~~------~~~~~~~~s~~ 252 (486)
T 3mwu_A 187 AYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD------ILKRVET-GKYAF------DLPQWRTISDD 252 (486)
T ss_dssp GGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHH-TCCCS------CSGGGGGSCHH
T ss_pred CCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHh-CCCCC------CCcccCCCCHH
Confidence 99999999876 58999999999999999999999985432211 1111111 11100 00011112347
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 237 CMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 237 l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
+.++|.+||+.||++|||+.++++.
T Consensus 253 ~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 253 AKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcC
Confidence 8899999999999999999999986
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=286.50 Aligned_cols=246 Identities=22% Similarity=0.232 Sum_probs=183.1
Q ss_pred ceEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHHhcCC-----CCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQ-----HVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
.||++.. .+|+.||||+++. .......+..|+.+++.++ ||||+++++++......++|||++ +++|.+++.
T Consensus 50 ~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~ 127 (360)
T 3llt_A 50 RVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIIT 127 (360)
T ss_dssp EEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHH
T ss_pred EEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHH
Confidence 5666654 6899999999964 2334566788999999886 999999999999999999999999 889999985
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCC-------------------------CCCcee
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY-------------------------EMNPKI 132 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~-------------------------~~~~~l 132 (309)
.. ....+++..+..++.||+.||.|||+. |++||||||+||+++. ++.+||
T Consensus 128 ~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl 203 (360)
T 3llt_A 128 RN-NYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203 (360)
T ss_dssp HT-TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEE
T ss_pred hc-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEE
Confidence 43 233489999999999999999999998 9999999999999975 788999
Q ss_pred ecccccccccCCcccccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH--
Q 021682 133 SDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYG-- 210 (309)
Q Consensus 133 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~-- 210 (309)
+|||++...... .....||+.|+|||.+.+..++.++|||||||++|+|++|..||......+....+.....
T Consensus 204 ~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 278 (360)
T 3llt_A 204 IDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPI 278 (360)
T ss_dssp CCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCC
T ss_pred EeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCC
Confidence 999999754432 2234689999999999999999999999999999999999999965332221111111000
Q ss_pred ------HhhCCCCcccccc------cCCCcc---------------cHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021682 211 ------LWKNGEGMEFIDS------SLDDSS---------------SAWKLMRCMQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 211 ------~~~~~~~~~~~~~------~~~~~~---------------~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
............. ...... .......+.+||.+||+.||++|||++|+++
T Consensus 279 p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 279 PKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp CHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000000 000000 0001146779999999999999999999985
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=290.11 Aligned_cols=234 Identities=25% Similarity=0.321 Sum_probs=183.2
Q ss_pred cceEEEE-cCCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 3 VAICQGR-LPNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 3 ~~~~~~~-~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
+.||++. ..+|+.||||.+.... ....+.+.+|++++++++||||+++++++..+...++||||+. ++|.+++..
T Consensus 68 g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~ 146 (348)
T 1u5q_A 68 GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEV 146 (348)
T ss_dssp EEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHH
T ss_pred EEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHH
Confidence 3566665 4689999999997543 2234578899999999999999999999999999999999997 577777643
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
....+++..+..++.|++.|+.|||++ |++||||||+||+++.++.+||+|||++...... ....|++.
T Consensus 147 --~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~------~~~~gt~~ 215 (348)
T 1u5q_A 147 --HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPY 215 (348)
T ss_dssp --HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB------CCCCSCGG
T ss_pred --hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC------CcccCCcc
Confidence 234589999999999999999999998 8999999999999999999999999998654432 22468999
Q ss_pred CCCccccc---cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 159 YVPPEYVR---KGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 159 y~aPE~~~---~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
|+|||.+. +..++.++|||||||++|+|++|..||...... .......... ...... ...+.
T Consensus 216 y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~------~~~~~~~~~~-~~~~~~--------~~~~~ 280 (348)
T 1u5q_A 216 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNE-SPALQS--------GHWSE 280 (348)
T ss_dssp GCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSC-CCCCCC--------TTSCH
T ss_pred eeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHhcC-CCCCCC--------CCCCH
Confidence 99999884 467899999999999999999999998543211 1111111111 111111 11123
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHHh
Q 021682 236 RCMQVALLCVQENAADRPTMLEILVMLK 263 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~Rpt~~ell~~L~ 263 (309)
.+.++|.+||+.||++|||++++++..-
T Consensus 281 ~l~~li~~~l~~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 281 YFRNFVDSCLQKIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred HHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 6789999999999999999999997643
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=305.97 Aligned_cols=244 Identities=23% Similarity=0.358 Sum_probs=189.5
Q ss_pred cceEEEEcC---CCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 3 VAICQGRLP---NGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 3 ~~~~~~~~~---~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
+.||+|.+. ++..||||.++... ....+.+.+|++++++++||||+++++++.. +..++||||+.+++|.+++..
T Consensus 350 G~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~ 428 (613)
T 2ozo_A 350 GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVG 428 (613)
T ss_dssp SEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTT
T ss_pred cEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhh
Confidence 467777653 56789999997653 3456789999999999999999999999876 568999999999999999843
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccc-ccccccccc
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEA-NTGRIVGTY 157 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~-~~~~~~~~~ 157 (309)
....+++..+..++.||+.||.|||++ |++||||||+||+++.++.+||+|||++.......... ......++.
T Consensus 429 --~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~ 503 (613)
T 2ozo_A 429 --KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 503 (613)
T ss_dssp --CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CC
T ss_pred --ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCcc
Confidence 344589999999999999999999998 89999999999999999999999999997654332211 112224567
Q ss_pred CCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHH
Q 021682 158 GYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMR 236 (309)
Q Consensus 158 ~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
.|+|||.+.+..++.++|||||||++|+|++ |..||......+ . ......+..... +...+..
T Consensus 504 ~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~----~~~i~~~~~~~~---------p~~~~~~ 567 (613)
T 2ozo_A 504 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---V----MAFIEQGKRMEC---------PPECPPE 567 (613)
T ss_dssp TTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH---H----HHHHHTTCCCCC---------CTTCCHH
T ss_pred ceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---H----HHHHHcCCCCCC---------CCcCCHH
Confidence 8999999998999999999999999999998 999986543322 1 111222221111 1122347
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHHHhcccCC
Q 021682 237 CMQVALLCVQENAADRPTMLEILVMLKSETAD 268 (309)
Q Consensus 237 l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~ 268 (309)
+.+|+.+||+.||++|||+++|++.|+.....
T Consensus 568 l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 568 LYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp HHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 88999999999999999999999999876443
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=278.95 Aligned_cols=231 Identities=19% Similarity=0.138 Sum_probs=175.2
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC--cccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS--HQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
+.||++.. .+|+.||||++.... .........|+..+.++ +|+||+++++++..+...++||||+ +++|.+++..
T Consensus 71 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~ 149 (311)
T 3p1a_A 71 GEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEA 149 (311)
T ss_dssp EEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHH
T ss_pred eEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHh
Confidence 45677765 489999999986542 22333455566555555 9999999999999999999999999 6688888754
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
. +..+++..++.++.|++.||.|||+. |++|+||||+||+++.++.+||+|||++........ .....||+.
T Consensus 150 ~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~ 221 (311)
T 3p1a_A 150 W--GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA---GEVQEGDPR 221 (311)
T ss_dssp H--CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC---------CCCCCGG
T ss_pred c--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccCCC---CcccCCCcc
Confidence 3 34599999999999999999999998 899999999999999999999999999876544322 223368999
Q ss_pred CCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHH
Q 021682 159 YVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238 (309)
Q Consensus 159 y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (309)
|+|||.+.+ .++.++|||||||++|+|++|..++... ..+........... ........+.
T Consensus 222 y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----------~~~~~~~~~~~~~~--------~~~~~~~~l~ 282 (311)
T 3p1a_A 222 YMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----------EGWQQLRQGYLPPE--------FTAGLSSELR 282 (311)
T ss_dssp GCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----------HHHHHHTTTCCCHH--------HHTTSCHHHH
T ss_pred ccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----------cHHHHHhccCCCcc--------cccCCCHHHH
Confidence 999999876 6899999999999999999997665321 01111111111110 1111234788
Q ss_pred HHHhhcccCCCCCCCCHHHHHHH
Q 021682 239 QVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 239 ~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
++|.+||+.||++|||++|+++.
T Consensus 283 ~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 283 SVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHcCCChhhCcCHHHHHhC
Confidence 99999999999999999999863
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=293.51 Aligned_cols=248 Identities=23% Similarity=0.359 Sum_probs=182.5
Q ss_pred cceEEEEcC--C--CcEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeeEEee-CCeeEEEEeccCCCChhHHH
Q 021682 3 VAICQGRLP--N--GQEMAVKRLSRT-SHQGLEEFENEVKLTARLQHVNLLPVLGICTQ-REEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 3 ~~~~~~~~~--~--g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~~ 76 (309)
+.||++... + +..||+|.++.. .....+.+.+|+.++++++||||+++++++.. ++..++||||+.+++|.+++
T Consensus 103 g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l 182 (373)
T 3c1x_A 103 GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 182 (373)
T ss_dssp SEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHH
T ss_pred eEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHH
Confidence 357777652 2 246899998654 33456789999999999999999999998654 45789999999999999998
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccc--cccccc
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEA--NTGRIV 154 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~--~~~~~~ 154 (309)
.. ....+++..+..++.|++.|+.|||++ |++||||||+||+++.++.+||+|||++.......... ......
T Consensus 183 ~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~ 257 (373)
T 3c1x_A 183 RN--ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 257 (373)
T ss_dssp HC--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------------------
T ss_pred hh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccccccccccccccCCCC
Confidence 43 334578899999999999999999998 99999999999999999999999999997654332111 112235
Q ss_pred cccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHH
Q 021682 155 GTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWK 233 (309)
Q Consensus 155 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
++..|+|||.+.+..++.++|||||||++|+|++ |.+||......+. .... ....... .+...
T Consensus 258 ~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~---~~~~----~~~~~~~---------~p~~~ 321 (373)
T 3c1x_A 258 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TVYL----LQGRRLL---------QPEYC 321 (373)
T ss_dssp CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH---HHHH----HTTCCCC---------CCTTC
T ss_pred CcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH---HHHH----HcCCCCC---------CCCCC
Confidence 6778999999999999999999999999999999 6777754433321 1111 1111110 01112
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccCCCCC
Q 021682 234 LMRCMQVALLCVQENAADRPTMLEILVMLKSETADIKT 271 (309)
Q Consensus 234 ~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~~~~ 271 (309)
+..+.+++.+||+.||++|||++++++.|+.+...+..
T Consensus 322 ~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~ 359 (373)
T 3c1x_A 322 PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359 (373)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 23788999999999999999999999999988766553
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=274.20 Aligned_cols=234 Identities=21% Similarity=0.333 Sum_probs=182.5
Q ss_pred cceEEEEc-CCCcEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeeEEee----CCeeEEEEeccCCCChhHH
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQ----REEKMLIYDYMPNKSLDFY 75 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~ 75 (309)
+.||++.. .++..||+|.+... .....+.+.+|+.++++++||||+++++++.. ....++||||+++++|.++
T Consensus 40 g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 119 (290)
T 1t4h_A 40 KTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTY 119 (290)
T ss_dssp EEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHH
T ss_pred eEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHH
Confidence 35677754 57899999998754 34456788999999999999999999998875 3468999999999999999
Q ss_pred HhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCc--eeecCCCCceEEeC-CCCCceeecccccccccCCcccccccc
Q 021682 76 IFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLT--IVHRDLKASNILLD-YEMNPKISDFGMARAFTKDECEANTGR 152 (309)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~g--i~H~di~p~nil~~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 152 (309)
+... ..+++..+..++.|++.|+.|||+. | ++|+||+|+||+++ .++.++|+|||++....... ...
T Consensus 120 l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~----~~~ 189 (290)
T 1t4h_A 120 LKRF---KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKA 189 (290)
T ss_dssp HHHH---SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS----BEE
T ss_pred HHHc---cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccccc----ccc
Confidence 8543 4489999999999999999999998 7 99999999999998 78999999999986544332 222
Q ss_pred cccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHH
Q 021682 153 IVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAW 232 (309)
Q Consensus 153 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (309)
..|++.|+|||.+.+ .++.++||||||+++|+|++|..||....... . .............+. ..
T Consensus 190 ~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----~-~~~~~~~~~~~~~~~--------~~ 254 (290)
T 1t4h_A 190 VIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-----Q-IYRRVTSGVKPASFD--------KV 254 (290)
T ss_dssp SCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-----H-HHHHHTTTCCCGGGG--------GC
T ss_pred ccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH-----H-HHHHHhccCCccccC--------CC
Confidence 468899999998864 58999999999999999999999985432211 1 111111111111111 11
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 233 KLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 233 ~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
....+.++|.+||+.||++|||++++++.
T Consensus 255 ~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 255 AIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 12368899999999999999999999863
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=280.86 Aligned_cols=242 Identities=24% Similarity=0.354 Sum_probs=187.5
Q ss_pred cceEEEEc---CCCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 3 VAICQGRL---PNGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 3 ~~~~~~~~---~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
+.||++.. .+++.||||.++... ....+.+.+|++++++++||||+++++++ .....++||||+.+++|.+++.
T Consensus 31 g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~ 109 (291)
T 1xbb_A 31 GTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQ 109 (291)
T ss_dssp EEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHH
T ss_pred eeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHH
Confidence 45777743 457899999997543 22357789999999999999999999998 5667899999999999999985
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccc-cccccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEA-NTGRIVGT 156 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~-~~~~~~~~ 156 (309)
. ...+++..++.++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++.......... ......++
T Consensus 110 ~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~ 183 (291)
T 1xbb_A 110 Q---NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 183 (291)
T ss_dssp H---CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCC
T ss_pred h---CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCC
Confidence 4 33489999999999999999999998 99999999999999999999999999997665432211 12223456
Q ss_pred cCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 157 YGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
..|+|||.+.+..++.++||||||+++|+|++ |..||......+ ............. +...+.
T Consensus 184 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~~~---------~~~~~~ 247 (291)
T 1xbb_A 184 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGERMGC---------PAGCPR 247 (291)
T ss_dssp GGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCCCCC---------CTTCCH
T ss_pred ceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCCCCC---------CCCCCH
Confidence 78999999988888999999999999999999 999986432211 1111111111111 111234
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHHhcccC
Q 021682 236 RCMQVALLCVQENAADRPTMLEILVMLKSETA 267 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~ 267 (309)
.+.++|.+||+.||++|||+.++++.|+.+..
T Consensus 248 ~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 248 EMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 78899999999999999999999999987644
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=299.51 Aligned_cols=236 Identities=24% Similarity=0.285 Sum_probs=182.5
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
++||++.. .+++.||||++.... ......+.+|+.+++.++||||+++++++......++||||+.+++|.+++...
T Consensus 51 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~ 130 (494)
T 3lij_A 51 GEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR 130 (494)
T ss_dssp -EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH
T ss_pred EEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHc
Confidence 34566654 589999999997542 334678899999999999999999999999999999999999999998887443
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCC---CCceeecccccccccCCcccccccccccc
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYE---MNPKISDFGMARAFTKDECEANTGRIVGT 156 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~---~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 156 (309)
..+++..+..++.||+.|+.|||++ |++||||||+||+++.. +.+||+|||++........ .....||
T Consensus 131 ---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt 201 (494)
T 3lij_A 131 ---MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK---MKERLGT 201 (494)
T ss_dssp ---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBC---BCCCCSC
T ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcc---ccccCCC
Confidence 4489999999999999999999998 99999999999999764 4599999999976654322 2234689
Q ss_pred cCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHH
Q 021682 157 YGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMR 236 (309)
Q Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
+.|+|||.+. ..++.++|||||||++|+|++|.+||......+ ..... ...... +..+ .....+..
T Consensus 202 ~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i-~~~~~~-~~~~-----~~~~~s~~ 267 (494)
T 3lij_A 202 AYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE------ILRKV-EKGKYT-FDSP-----EWKNVSEG 267 (494)
T ss_dssp TTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHH-HHTCCC-CCSG-----GGTTSCHH
T ss_pred cCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHH-HhCCCC-CCch-----hcccCCHH
Confidence 9999999886 468999999999999999999999986432211 11111 111110 0000 00112236
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 237 CMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 237 l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
+.++|.+||+.||++|||++++++.
T Consensus 268 ~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 268 AKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred HHHHHHHHCCCChhhCccHHHHhcC
Confidence 8899999999999999999999864
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=285.78 Aligned_cols=233 Identities=22% Similarity=0.263 Sum_probs=186.4
Q ss_pred ceEEEEc-CCCcEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGRL-PNGQEMAVKRLSRT---SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
.||++.. .+++.||+|++... .....+.+..|+.++++++|+||+++++++..++..++||||+.+++|.+++..
T Consensus 56 ~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~- 134 (335)
T 2owb_A 56 KCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR- 134 (335)
T ss_dssp EEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHH-
T ss_pred EEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhc-
Confidence 4666654 57899999998754 233456788999999999999999999999999999999999999999998743
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
...+++..++.++.|++.|+.|||++ |++|+||+|+||+++.++.++|+|||++......... .....|+..|
T Consensus 135 --~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y 207 (335)
T 2owb_A 135 --RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNY 207 (335)
T ss_dssp --HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCC--BCCCCSCCSS
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCccc--ccccCCCccc
Confidence 34589999999999999999999998 9999999999999999999999999999765433221 2234688999
Q ss_pred CCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHH
Q 021682 160 VPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQ 239 (309)
Q Consensus 160 ~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (309)
+|||.+.+..++.++||||||+++|+|++|..||......+ ......... . . ... .....+.+
T Consensus 208 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~~~-~-~-----~~~----~~~~~~~~ 270 (335)
T 2owb_A 208 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------TYLRIKKNE-Y-S-----IPK----HINPVAAS 270 (335)
T ss_dssp CCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHTC-C-C-----CCT----TSCHHHHH
T ss_pred cCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH------HHHHHhcCC-C-C-----CCc----cCCHHHHH
Confidence 99999998889999999999999999999999985432111 111111110 0 0 011 11236789
Q ss_pred HHhhcccCCCCCCCCHHHHHHH
Q 021682 240 VALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 240 li~~~l~~~p~~Rpt~~ell~~ 261 (309)
+|.+||+.||++|||++++++.
T Consensus 271 li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 271 LIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp HHHHHTCSSGGGSCCGGGGGGS
T ss_pred HHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999974
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=274.24 Aligned_cols=237 Identities=22% Similarity=0.265 Sum_probs=184.1
Q ss_pred cceEEEEcC-CCcEEEEEEeecCC------cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHH
Q 021682 3 VAICQGRLP-NGQEMAVKRLSRTS------HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFY 75 (309)
Q Consensus 3 ~~~~~~~~~-~g~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (309)
+.||.+... +|+.||+|.++... ....+.+.+|+.++++++||||+++++++..+...++||||+.+++|.++
T Consensus 19 g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 98 (283)
T 3bhy_A 19 AIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDF 98 (283)
T ss_dssp EEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHH
T ss_pred eEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHH
Confidence 356777654 79999999987542 12467899999999999999999999999999999999999999999999
Q ss_pred HhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCC----CceeecccccccccCCccccccc
Q 021682 76 IFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM----NPKISDFGMARAFTKDECEANTG 151 (309)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~----~~~l~Dfg~~~~~~~~~~~~~~~ 151 (309)
+.. ...+++..+..++.|++.|+.+||+. |++|+||+|+||+++.++ .++|+|||.+........ ..
T Consensus 99 l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~---~~ 169 (283)
T 3bhy_A 99 LAE---KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FK 169 (283)
T ss_dssp HHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC---------
T ss_pred HHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecccceeccCCCc---cc
Confidence 854 33489999999999999999999998 999999999999998877 799999999876543321 22
Q ss_pred ccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccH
Q 021682 152 RIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSA 231 (309)
Q Consensus 152 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (309)
...+++.|+|||.+.+..++.++||||||+++|+|++|..||......+ .. ......... .......
T Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~-~~~~~~~~~------~~~~~~~ 236 (283)
T 3bhy_A 170 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE------TL-TNISAVNYD------FDEEYFS 236 (283)
T ss_dssp --CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HH-HHHHTTCCC------CCHHHHT
T ss_pred ccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH------HH-HHhHhcccC------Ccchhcc
Confidence 2368899999999998889999999999999999999999985432111 11 111111100 0000001
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 232 WKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 232 ~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
..+..+.+++.+||+.||++|||+.++++.
T Consensus 237 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 237 NTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp TCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred cCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 122368899999999999999999999973
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=300.72 Aligned_cols=235 Identities=24% Similarity=0.275 Sum_probs=185.7
Q ss_pred ceEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
.||.+.. .+|+.||||++.... ......+.+|+.++++++||||+++++++......++||||+.+++|.+++..
T Consensus 41 ~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~- 119 (484)
T 3nyv_A 41 EVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS- 119 (484)
T ss_dssp EEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT-
T ss_pred EEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHh-
Confidence 4566654 589999999996542 34567899999999999999999999999999999999999999999988843
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEe---CCCCCceeecccccccccCCcccccccccccc
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL---DYEMNPKISDFGMARAFTKDECEANTGRIVGT 156 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 156 (309)
...+++..+..++.|++.|+.|||++ |++||||||+||++ +.++.+||+|||++........ .....||
T Consensus 120 --~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt 191 (484)
T 3nyv_A 120 --RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MKDKIGT 191 (484)
T ss_dssp --CSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCS---HHHHTTG
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccc---cccCCCC
Confidence 34589999999999999999999998 99999999999999 4678899999999976654322 2234689
Q ss_pred cCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHH
Q 021682 157 YGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMR 236 (309)
Q Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
+.|+|||.+.+ .++.++|||||||++|+|++|.+||......+ ....... ..... ........+..
T Consensus 192 ~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~~-~~~~~------~~~~~~~~s~~ 257 (484)
T 3nyv_A 192 AYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD------ILKKVEK-GKYTF------ELPQWKKVSES 257 (484)
T ss_dssp GGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHH-CCCCC------CSGGGGGSCHH
T ss_pred ccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHc-CCCCC------CCcccccCCHH
Confidence 99999999876 68999999999999999999999986432211 1111111 11100 00011112347
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 237 CMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 237 l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
+.++|.+||+.||++|||++++++.
T Consensus 258 ~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 258 AKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHCCCChhHCcCHHHHhhC
Confidence 8899999999999999999999975
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=279.98 Aligned_cols=241 Identities=20% Similarity=0.328 Sum_probs=185.4
Q ss_pred cceEEEEcC----CCcEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 3 VAICQGRLP----NGQEMAVKRLSRT-SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 3 ~~~~~~~~~----~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
+.||++... ++..||+|.+... .....+.+.+|+.++++++||||+++++++..+ ..++||||+.+++|.+++.
T Consensus 26 g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~ 104 (281)
T 3cc6_A 26 GEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLE 104 (281)
T ss_dssp SEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHH
T ss_pred eeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEEecCCCCCHHHHHH
Confidence 467777643 2346999998765 344567889999999999999999999998754 5689999999999999985
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
.. ...+++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++......... ......++.
T Consensus 105 ~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~ 178 (281)
T 3cc6_A 105 RN--KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY-KASVTRLPI 178 (281)
T ss_dssp HH--TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC----------CCCCCG
T ss_pred hc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccccccccc-ccccCCCCc
Confidence 42 34489999999999999999999998 9999999999999999999999999998765443221 122235677
Q ss_pred CCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHH
Q 021682 158 GYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMR 236 (309)
Q Consensus 158 ~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
.|+|||.+.+..++.++||||||+++|+|++ |..||......+. .... ........ +...+..
T Consensus 179 ~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~---~~~~----~~~~~~~~---------~~~~~~~ 242 (281)
T 3cc6_A 179 KWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV---IGVL----EKGDRLPK---------PDLCPPV 242 (281)
T ss_dssp GGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH---HHHH----HHTCCCCC---------CTTCCHH
T ss_pred ceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH---HHHH----hcCCCCCC---------CCCCCHH
Confidence 8999999988899999999999999999998 9999864333221 1111 11111110 0112236
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHHHhccc
Q 021682 237 CMQVALLCVQENAADRPTMLEILVMLKSET 266 (309)
Q Consensus 237 l~~li~~~l~~~p~~Rpt~~ell~~L~~~~ 266 (309)
+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 243 l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 243 LYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 889999999999999999999999998763
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=287.66 Aligned_cols=246 Identities=24% Similarity=0.380 Sum_probs=185.7
Q ss_pred cceEEEEcCC-----CcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHH
Q 021682 3 VAICQGRLPN-----GQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 3 ~~~~~~~~~~-----g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 76 (309)
+.||++.... +..||||.++... ......+.+|+.++++++||||+++++++......++||||+.+++|.+++
T Consensus 58 g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 137 (333)
T 1mqb_A 58 GEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL 137 (333)
T ss_dssp SEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHH
T ss_pred eEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHH
Confidence 4577776532 2459999997543 334567889999999999999999999999999999999999999999998
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccc-ccccccc
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEA-NTGRIVG 155 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~-~~~~~~~ 155 (309)
.. ....+++..++.++.|++.|+.+||+. |++|+||||+||+++.++.++|+|||++.......... ......+
T Consensus 138 ~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 212 (333)
T 1mqb_A 138 RE--KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 212 (333)
T ss_dssp HH--TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----------------CC
T ss_pred Hh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCc
Confidence 54 234589999999999999999999998 89999999999999999999999999997665432211 1122345
Q ss_pred ccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHH
Q 021682 156 TYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKL 234 (309)
Q Consensus 156 ~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
+..|+|||.+.+..++.++||||||+++|+|++ |..||......+ ............. +...+
T Consensus 213 ~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-------~~~~~~~~~~~~~---------~~~~~ 276 (333)
T 1mqb_A 213 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-------VMKAINDGFRLPT---------PMDCP 276 (333)
T ss_dssp CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHTTCCCCC---------CTTCB
T ss_pred cccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHHCCCcCCC---------cccCC
Confidence 778999999998899999999999999999998 999985432211 1111111111110 11123
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHHhcccCCC
Q 021682 235 MRCMQVALLCVQENAADRPTMLEILVMLKSETADI 269 (309)
Q Consensus 235 ~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~~ 269 (309)
..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 277 ~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 277 SAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 37889999999999999999999999998876543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=280.45 Aligned_cols=235 Identities=21% Similarity=0.316 Sum_probs=188.9
Q ss_pred cceEEEE-cCCCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 3 VAICQGR-LPNGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 3 ~~~~~~~-~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
+.||++. ..+|+.||||.+.... ....+.+.+|+.++++++||||+++++++..+...++||||+.+++|.+++.
T Consensus 36 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~--- 112 (303)
T 3a7i_A 36 GEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE--- 112 (303)
T ss_dssp SEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHT---
T ss_pred eEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHh---
Confidence 4567775 4579999999997553 3456789999999999999999999999999999999999999999999873
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCC
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYV 160 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 160 (309)
...+++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++......... .....++..|+
T Consensus 113 -~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~ 186 (303)
T 3a7i_A 113 -PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK--RNTFVGTPFWM 186 (303)
T ss_dssp -TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC--BCCCCSCGGGC
T ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccccc--cCccCCCcCcc
Confidence 23589999999999999999999998 9999999999999999999999999998765543221 22346889999
Q ss_pred CccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHH
Q 021682 161 PPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQV 240 (309)
Q Consensus 161 aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 240 (309)
|||.+.+..++.++||||||+++|+|++|..||....... .... ........ .... .+..+.++
T Consensus 187 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~-~~~~~~~~-----~~~~----~~~~l~~l 250 (303)
T 3a7i_A 187 APEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK------VLFL-IPKNNPPT-----LEGN----YSKPLKEF 250 (303)
T ss_dssp CHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHH-HHHSCCCC-----CCSS----CCHHHHHH
T ss_pred CHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH------HHHH-hhcCCCCC-----Cccc----cCHHHHHH
Confidence 9999999889999999999999999999999985432111 1111 11111111 1111 12368899
Q ss_pred HhhcccCCCCCCCCHHHHHHHH
Q 021682 241 ALLCVQENAADRPTMLEILVML 262 (309)
Q Consensus 241 i~~~l~~~p~~Rpt~~ell~~L 262 (309)
|.+||+.||++|||++++++..
T Consensus 251 i~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 251 VEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp HHHHCCSSGGGSCCHHHHTTCH
T ss_pred HHHHcCCChhhCcCHHHHhhCh
Confidence 9999999999999999999754
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=280.38 Aligned_cols=253 Identities=25% Similarity=0.289 Sum_probs=184.6
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhc--CCCCCccceeeEEeeC----CeeEEEEeccCCCChhHHH
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTAR--LQHVNLLPVLGICTQR----EEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~----~~~~lv~e~~~~~~L~~~~ 76 (309)
+.||++.. +|+.||||++.... ......|.+++.. ++||||+++++++... ...++||||+.+++|.+++
T Consensus 51 g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l 126 (337)
T 3mdy_A 51 GEVWMGKW-RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL 126 (337)
T ss_dssp EEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHH
T ss_pred eEEEEEEE-CCceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHh
Confidence 45788876 48999999986432 2344555555554 4999999999999887 6899999999999999998
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhc-----CCCceeecCCCCceEEeCCCCCceeecccccccccCCcccc--c
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEY-----SNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEA--N 149 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~-----~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~--~ 149 (309)
.. ..+++..++.++.|++.|+.|||+. +..|++||||||+||+++.++.+||+|||++.......... .
T Consensus 127 ~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 202 (337)
T 3mdy_A 127 KS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIP 202 (337)
T ss_dssp HH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC---------
T ss_pred hc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccccccCC
Confidence 43 2489999999999999999999976 13379999999999999999999999999997654432221 1
Q ss_pred ccccccccCCCCccccccCCCCcc------chhhhHHHHHHHHHhC----------CCCCCCCCCCCcccHHHHHHHHhh
Q 021682 150 TGRIVGTYGYVPPEYVRKGIYSMK------YDVYSYGVLLLQILGG----------KRTSCYYGPNESLNLLEYAYGLWK 213 (309)
Q Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~------~DvwslG~il~~ll~g----------~~p~~~~~~~~~~~~~~~~~~~~~ 213 (309)
.....|+..|+|||.+.+...... +|||||||++|+|++| ..||........... .......
T Consensus 203 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~--~~~~~~~ 280 (337)
T 3mdy_A 203 PNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYE--DMREIVC 280 (337)
T ss_dssp CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHH--HHHHHHT
T ss_pred CCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchh--hhHHHHh
Confidence 223468999999999987765554 9999999999999999 555543333222111 1111111
Q ss_pred CCCCcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccCC
Q 021682 214 NGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETAD 268 (309)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~ 268 (309)
.......+. ...........+.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus 281 ~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 281 IKKLRPSFP---NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp TSCCCCCCC---GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred hhccCcccc---ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 111111110 1111224566789999999999999999999999999987654
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=293.86 Aligned_cols=246 Identities=24% Similarity=0.296 Sum_probs=180.0
Q ss_pred ceEEEE-cCCCcEEEEEEeecC--CcccHHHHHHHHHHHhcCC-CCCccceeeEEeeCC--eeEEEEeccCCCChhHHHh
Q 021682 4 AICQGR-LPNGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQ-HVNLLPVLGICTQRE--EKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~ 77 (309)
.||++. ..+|+.||||.+... .......+..|+.+++++. ||||+++++++..++ ..++||||+. ++|..++.
T Consensus 24 ~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~ 102 (388)
T 3oz6_A 24 IVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIR 102 (388)
T ss_dssp CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHH
T ss_pred EEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHH
Confidence 456664 568999999998543 3344567889999999996 999999999997544 7899999997 58888774
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcc-----------
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDEC----------- 146 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~----------- 146 (309)
. ..++...+..++.|++.|++|||+. |++||||||+||+++.++.+||+|||++........
T Consensus 103 ~----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~ 175 (388)
T 3oz6_A 103 A----NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINE 175 (388)
T ss_dssp H----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC-
T ss_pred c----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccc
Confidence 3 3588999999999999999999998 999999999999999999999999999976532110
Q ss_pred --------cccccccccccCCCCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCC
Q 021682 147 --------EANTGRIVGTYGYVPPEYVRK-GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEG 217 (309)
Q Consensus 147 --------~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (309)
........||+.|+|||.+.+ ..++.++|||||||++|+|++|.+||...+..+....+ ........
T Consensus 176 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i---~~~~~~p~- 251 (388)
T 3oz6_A 176 NTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI---IGVIDFPS- 251 (388)
T ss_dssp --------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCCCC-
T ss_pred cccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHhcCCCC-
Confidence 111223468999999999876 57899999999999999999999999654322221111 11110000
Q ss_pred cccc----------------------cccCCCccc------------HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 218 MEFI----------------------DSSLDDSSS------------AWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 218 ~~~~----------------------~~~~~~~~~------------~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.+.+ ........+ ......+.+||.+||+.||++|||++|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 252 NEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKH 329 (388)
T ss_dssp HHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCC
Confidence 0000 000000000 0112367899999999999999999999987
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=291.22 Aligned_cols=228 Identities=20% Similarity=0.232 Sum_probs=171.8
Q ss_pred ceEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHH-HhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTS---HQGLEEFENEVKL-TARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
.||.+.. .+++.||||++++.. ......+..|..+ ++.++||||+++++++......++||||+.+++|.+++..
T Consensus 53 ~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~ 132 (373)
T 2r5t_A 53 KVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR 132 (373)
T ss_dssp EEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH
T ss_pred EEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHh
Confidence 4566654 578999999997643 2233456667766 4678999999999999999999999999999999998854
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
...+++..++.++.||+.||.|||++ |++||||||+||+++.+|.+||+|||++........ ......||+.
T Consensus 133 ---~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~--~~~~~~gt~~ 204 (373)
T 2r5t_A 133 ---ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS--TTSTFCGTPE 204 (373)
T ss_dssp ---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCC--CCCSBSCCCC
T ss_pred ---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccCCC--ccccccCCcc
Confidence 33488999999999999999999998 999999999999999999999999999875433221 2333578999
Q ss_pred CCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHH
Q 021682 159 YVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238 (309)
Q Consensus 159 y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (309)
|+|||.+.+..++.++|+|||||++|+|++|..||...+.. ........... .+ ... ....+.
T Consensus 205 y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~~~~--~~-----~~~----~~~~~~ 267 (373)
T 2r5t_A 205 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EMYDNILNKPL--QL-----KPN----ITNSAR 267 (373)
T ss_dssp CCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH------HHHHHHHHSCC--CC-----CSS----SCHHHH
T ss_pred ccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHhccc--CC-----CCC----CCHHHH
Confidence 99999999999999999999999999999999998543211 11111111110 00 111 123678
Q ss_pred HHHhhcccCCCCCCCCHH
Q 021682 239 QVALLCVQENAADRPTML 256 (309)
Q Consensus 239 ~li~~~l~~~p~~Rpt~~ 256 (309)
++|.+||+.||++||++.
T Consensus 268 ~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 268 HLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp HHHHHHTCSSGGGSTTTT
T ss_pred HHHHHHcccCHHhCCCCC
Confidence 999999999999999974
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=286.39 Aligned_cols=252 Identities=22% Similarity=0.233 Sum_probs=182.6
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCcc-----cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHH
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSHQ-----GLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 76 (309)
+.||.+.. .+|+.||||.+...... ....+.+|+.++++++||||+++++++......++||||+.+ +|..++
T Consensus 24 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~ 102 (346)
T 1ua2_A 24 ATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVII 102 (346)
T ss_dssp EEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHH
T ss_pred EEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHH
Confidence 35777765 47999999998653211 124678999999999999999999999999999999999975 787777
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccc
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGT 156 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 156 (309)
.. ....+++..+..++.|++.|+.|||+. |++||||||+||+++.++.+||+|||++......... .....++
T Consensus 103 ~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t 175 (346)
T 1ua2_A 103 KD--NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVVT 175 (346)
T ss_dssp TT--CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC--CCCSCCC
T ss_pred Hh--cCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceeccCCccc--CCccccc
Confidence 43 334588889999999999999999998 8999999999999999999999999999765433221 2234679
Q ss_pred cCCCCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCccc------ccccCCCcc
Q 021682 157 YGYVPPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEF------IDSSLDDSS 229 (309)
Q Consensus 157 ~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~ 229 (309)
+.|+|||.+.+. .++.++|||||||++|+|++|.+||......+....+...........+... .........
T Consensus 176 ~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (346)
T 1ua2_A 176 RWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGI 255 (346)
T ss_dssp CTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCC
T ss_pred ccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCC
Confidence 999999998764 5789999999999999999999998543222111111111000011111110 000000000
Q ss_pred c-----HHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 021682 230 S-----AWKLMRCMQVALLCVQENAADRPTMLEILVML 262 (309)
Q Consensus 230 ~-----~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L 262 (309)
+ ......+.++|.+||+.||++|||++|+++.-
T Consensus 256 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 256 PLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp CHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred ChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 0 11234788999999999999999999999874
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=280.05 Aligned_cols=233 Identities=22% Similarity=0.253 Sum_probs=186.5
Q ss_pred ceEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
.||++.. .+++.||+|.+.... ....+.+.+|+.++++++|+||+++++++..++..++||||+.+++|.+++..
T Consensus 30 ~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~- 108 (294)
T 2rku_A 30 KCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR- 108 (294)
T ss_dssp EEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-
T ss_pred EEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHh-
Confidence 5666654 478999999986542 33456788999999999999999999999999999999999999999988743
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
...+++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++......... .....++..|
T Consensus 109 --~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y 181 (294)
T 2rku_A 109 --RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNY 181 (294)
T ss_dssp --HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCC--BCCCCSCCSS
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCccc--cccccCCCCc
Confidence 33589999999999999999999998 9999999999999999999999999998765433221 2234688999
Q ss_pred CCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHH
Q 021682 160 VPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQ 239 (309)
Q Consensus 160 ~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (309)
+|||.+.+..++.++|+||||+++|+|++|..||......+ .. ........ . ... .....+.+
T Consensus 182 ~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~-~~~~~~~~-~-----~~~----~~~~~~~~ 244 (294)
T 2rku_A 182 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------TY-LRIKKNEY-S-----IPK----HINPVAAS 244 (294)
T ss_dssp CCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HH-HHHHTTCC-C-----CCT----TSCHHHHH
T ss_pred CCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HH-HHHhhccC-C-----Ccc----ccCHHHHH
Confidence 99999988889999999999999999999999985432111 11 11111110 0 001 12236789
Q ss_pred HHhhcccCCCCCCCCHHHHHHH
Q 021682 240 VALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 240 li~~~l~~~p~~Rpt~~ell~~ 261 (309)
++.+||+.||++|||++++++.
T Consensus 245 li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 245 LIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp HHHHHTCSSGGGSCCGGGGGGS
T ss_pred HHHHHcccChhhCcCHHHHhhC
Confidence 9999999999999999999985
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=281.02 Aligned_cols=242 Identities=23% Similarity=0.274 Sum_probs=187.2
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEee--CCeeEEEEeccCCCChhHHHh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQ--REEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~ 77 (309)
+.||++.. .+|+.||+|.+.... ....+.+.+|+.++++++||||+++++++.. +...++||||+++++|.+++.
T Consensus 20 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 99 (279)
T 2w5a_A 20 GRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVIT 99 (279)
T ss_dssp SEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHH
T ss_pred cEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHH
Confidence 35677765 589999999997543 3445678999999999999999999998754 568999999999999999986
Q ss_pred hhc-cccCCCHHHHHHHHHHHHHHHHHHhhcCCCc-----eeecCCCCceEEeCCCCCceeecccccccccCCccccccc
Q 021682 78 DLR-RRYLLDWRTRVHIIEGITQGLLYLQEYSNLT-----IVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTG 151 (309)
Q Consensus 78 ~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~g-----i~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 151 (309)
... ....+++..++.++.|++.|+.+||+. | ++|+||+|+||+++.++.++|+|||++......... ..
T Consensus 100 ~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~--~~ 174 (279)
T 2w5a_A 100 KGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AK 174 (279)
T ss_dssp HHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCHHHHC---CHH--HH
T ss_pred hhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCchheeecccccc--cc
Confidence 533 244589999999999999999999998 7 999999999999999999999999998765433211 12
Q ss_pred ccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccH
Q 021682 152 RIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSA 231 (309)
Q Consensus 152 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (309)
...++..|+|||.+.+..++.++||||||+++|+|++|..||...... .. ......+....+ . .
T Consensus 175 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~-~~~i~~~~~~~~-----~----~ 238 (279)
T 2w5a_A 175 TFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK------EL-AGKIREGKFRRI-----P----Y 238 (279)
T ss_dssp HHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HH-HHHHHHTCCCCC-----C----T
T ss_pred ccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH------HH-HHHHhhcccccC-----C----c
Confidence 246789999999999888999999999999999999999998643211 11 111111111111 1 1
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcc
Q 021682 232 WKLMRCMQVALLCVQENAADRPTMLEILVMLKSE 265 (309)
Q Consensus 232 ~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~ 265 (309)
..+..+.++|.+||+.||++|||++++++.+...
T Consensus 239 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 239 RYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred ccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence 1233788999999999999999999999877643
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=286.19 Aligned_cols=253 Identities=19% Similarity=0.254 Sum_probs=182.6
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEee--------CCeeEEEEeccCCCC
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQ--------REEKMLIYDYMPNKS 71 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--------~~~~~lv~e~~~~~~ 71 (309)
+.||++.. .+|+.||||.+.... ......+.+|+.++++++||||+++++++.. .+..++||||+.+ +
T Consensus 31 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~ 109 (351)
T 3mi9_A 31 GEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-D 109 (351)
T ss_dssp TSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-E
T ss_pred cEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCC-C
Confidence 35666764 689999999986543 2234577899999999999999999999887 3468999999975 6
Q ss_pred hhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccc--cc
Q 021682 72 LDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECE--AN 149 (309)
Q Consensus 72 L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~--~~ 149 (309)
|...+.. ....+++..+..++.|++.|+.|||++ |++||||||+||+++.++.++|+|||++......... ..
T Consensus 110 l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 184 (351)
T 3mi9_A 110 LAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184 (351)
T ss_dssp HHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCC
T ss_pred HHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccc
Confidence 6666533 234489999999999999999999998 9999999999999999999999999999765432211 12
Q ss_pred ccccccccCCCCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCccc-----ccc
Q 021682 150 TGRIVGTYGYVPPEYVRK-GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEF-----IDS 223 (309)
Q Consensus 150 ~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~ 223 (309)
.....|++.|+|||.+.+ ..++.++|||||||++|+|++|.+||...........+............... ...
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 264 (351)
T 3mi9_A 185 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEK 264 (351)
T ss_dssp CCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTS
T ss_pred cCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcc
Confidence 233467999999998876 45799999999999999999999998653322211111111111111100000 000
Q ss_pred ---cCCCcccH-H------HHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 224 ---SLDDSSSA-W------KLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 224 ---~~~~~~~~-~------~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
........ . ....+.+||.+||+.||++|||++|+++.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 265 LELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp SCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 00000000 0 12357899999999999999999999975
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=293.08 Aligned_cols=246 Identities=17% Similarity=0.162 Sum_probs=190.1
Q ss_pred cceEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCC-CCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 3 VAICQGR-LPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQH-VNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 3 ~~~~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
+.||++. ..+|+.||||++...... ..+..|+++++.++| +++..+..++......+|||||+ +++|.+++...
T Consensus 21 G~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~- 96 (483)
T 3sv0_A 21 GEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC- 96 (483)
T ss_dssp CEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT-
T ss_pred EEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhh-
Confidence 3567776 468999999998654332 357889999999976 55666666777778899999999 88999998532
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEe---CCCCCceeecccccccccCCcccc-----cccc
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL---DYEMNPKISDFGMARAFTKDECEA-----NTGR 152 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~---~~~~~~~l~Dfg~~~~~~~~~~~~-----~~~~ 152 (309)
...+++..++.++.||+.||.|||++ ||+||||||+||++ +.++.+||+|||++.......... ....
T Consensus 97 -~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~ 172 (483)
T 3sv0_A 97 -SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN 172 (483)
T ss_dssp -TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCC
T ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccc
Confidence 33589999999999999999999998 99999999999999 578999999999998765443211 1224
Q ss_pred cccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHH
Q 021682 153 IVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAW 232 (309)
Q Consensus 153 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (309)
..|+..|+|||.+.+..++.++|||||||++|+|++|..||..........................+.. .
T Consensus 173 ~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~---------~ 243 (483)
T 3sv0_A 173 LTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCR---------G 243 (483)
T ss_dssp CCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHT---------T
T ss_pred cCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhc---------C
Confidence 5789999999999999999999999999999999999999976555443333322222111111111111 1
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcc
Q 021682 233 KLMRCMQVALLCVQENAADRPTMLEILVMLKSE 265 (309)
Q Consensus 233 ~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~ 265 (309)
.+.++.+++.+||+.+|++||++++|++.|+.+
T Consensus 244 ~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 244 YPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp SCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred CcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 123788999999999999999999999998776
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=279.81 Aligned_cols=236 Identities=25% Similarity=0.368 Sum_probs=181.2
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeC-CeeEEEEeccCCCChhHHHhhhcc
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQR-EEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
+.||.+.. +|+.||||.++.. ...+.+.+|++++++++||||+++++++... ...++||||+.+++|.+++....
T Consensus 35 g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~- 110 (278)
T 1byg_A 35 GDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG- 110 (278)
T ss_dssp CEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHH-
T ss_pred ceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcc-
Confidence 46788876 5899999998644 3457889999999999999999999987554 47899999999999999985432
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP 161 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 161 (309)
...+++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++....... ....++..|+|
T Consensus 111 ~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-----~~~~~~~~y~a 182 (278)
T 1byg_A 111 RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTA 182 (278)
T ss_dssp HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSC
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc-----cCCCccccccC
Confidence 23378899999999999999999998 89999999999999999999999999986544321 12246788999
Q ss_pred ccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHH
Q 021682 162 PEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQV 240 (309)
Q Consensus 162 PE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 240 (309)
||.+.+..++.++||||||+++|+|++ |..||......+ .. .......... .+...+..+.++
T Consensus 183 PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~----~~~~~~~~~~---------~~~~~~~~l~~l 246 (278)
T 1byg_A 183 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV----PRVEKGYKMD---------APDGCPPAVYEV 246 (278)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HH----HHHTTTCCCC---------CCTTCCHHHHHH
T ss_pred HHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHhcCCCCC---------CcccCCHHHHHH
Confidence 999998899999999999999999998 999986543222 11 1111111111 111123478899
Q ss_pred HhhcccCCCCCCCCHHHHHHHHhccc
Q 021682 241 ALLCVQENAADRPTMLEILVMLKSET 266 (309)
Q Consensus 241 i~~~l~~~p~~Rpt~~ell~~L~~~~ 266 (309)
|.+||+.||++|||+.++++.|+.+.
T Consensus 247 i~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 247 MKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 99999999999999999999998764
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=295.59 Aligned_cols=240 Identities=19% Similarity=0.274 Sum_probs=189.2
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
+.||.+.. .+|+.||||++.... ......+..|+.++++++||||+++++++......++||||+.+++|.+++..
T Consensus 199 G~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~ 278 (543)
T 3c4z_A 199 GEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYN 278 (543)
T ss_dssp SEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHT
T ss_pred eEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHH
Confidence 35666665 579999999996542 23456788999999999999999999999999999999999999999998865
Q ss_pred hcc-ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccccc
Q 021682 79 LRR-RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 79 ~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
... ...+++..++.++.||+.|+.|||++ |++||||||+||+++.+|.+||+|||++......... .....||+
T Consensus 279 ~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~--~~~~~GT~ 353 (543)
T 3c4z_A 279 VDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTP 353 (543)
T ss_dssp SSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCC--BCCCCSCT
T ss_pred hhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcc--cccccCCc
Confidence 332 44699999999999999999999998 9999999999999999999999999999765443221 22347899
Q ss_pred CCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHH
Q 021682 158 GYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRC 237 (309)
Q Consensus 158 ~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (309)
.|+|||++.+..++.++|+|||||++|+|++|..||......... ............ .+ +...+..+
T Consensus 354 ~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~--~~~~~~i~~~~~--~~---------p~~~s~~~ 420 (543)
T 3c4z_A 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQRVLEQAV--TY---------PDKFSPAS 420 (543)
T ss_dssp TTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH--HHHHHHHHHCCC--CC---------CTTSCHHH
T ss_pred cccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH--HHHHHHHhhccc--CC---------CcccCHHH
Confidence 999999999999999999999999999999999999654332211 111111111110 00 11123377
Q ss_pred HHHHhhcccCCCCCCCCH-----HHHHH
Q 021682 238 MQVALLCVQENAADRPTM-----LEILV 260 (309)
Q Consensus 238 ~~li~~~l~~~p~~Rpt~-----~ell~ 260 (309)
.++|.+||+.||++||++ +++++
T Consensus 421 ~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 421 KDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp HHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred HHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 899999999999999964 77775
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=292.27 Aligned_cols=180 Identities=23% Similarity=0.356 Sum_probs=143.1
Q ss_pred cceEEEE-cCCCcEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeeEEeeC-----CeeEEEEeccCCCChhH
Q 021682 3 VAICQGR-LPNGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQR-----EEKMLIYDYMPNKSLDF 74 (309)
Q Consensus 3 ~~~~~~~-~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~ 74 (309)
++||++. ..+|+.||||.+... ......++.+|+.++++++||||+++++++... ...++|||++ +++|..
T Consensus 67 g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~ 145 (458)
T 3rp9_A 67 GHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKK 145 (458)
T ss_dssp -CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCC-SEEHHH
T ss_pred eEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEecc-ccchhh
Confidence 3556664 458999999998654 233456788999999999999999999998443 4689999998 468888
Q ss_pred HHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccc-------
Q 021682 75 YIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECE------- 147 (309)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~------- 147 (309)
++. ....+++..+..++.||+.||.|||+. ||+||||||+||+++.++.+||+|||++.........
T Consensus 146 ~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 219 (458)
T 3rp9_A 146 LFR---TPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPIS 219 (458)
T ss_dssp HHH---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC--
T ss_pred hcc---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhccCccccccccccC
Confidence 873 344599999999999999999999998 9999999999999999999999999999765432110
Q ss_pred ------------------ccccccccccCCCCcccc-ccCCCCccchhhhHHHHHHHHHhC
Q 021682 148 ------------------ANTGRIVGTYGYVPPEYV-RKGIYSMKYDVYSYGVLLLQILGG 189 (309)
Q Consensus 148 ------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~il~~ll~g 189 (309)
.......||..|+|||++ .+..++.++|||||||++|+|++|
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 220 PREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp -------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 012234679999999976 556789999999999999999983
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=288.00 Aligned_cols=237 Identities=22% Similarity=0.306 Sum_probs=184.3
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCc--------ccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCCh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSH--------QGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSL 72 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 72 (309)
+.||++.. .+|+.||||++..... ...+.+..|+.+++++ +||||+++++++......++||||+.+++|
T Consensus 108 g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L 187 (365)
T 2y7j_A 108 SVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL 187 (365)
T ss_dssp EEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBH
T ss_pred EEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcH
Confidence 46788876 4799999999875431 1245678899999999 899999999999999999999999999999
Q ss_pred hHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccc
Q 021682 73 DFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGR 152 (309)
Q Consensus 73 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 152 (309)
.+++.. ...+++..+..++.|++.|+.|||+. |++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 188 ~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~~---~~~ 258 (365)
T 2y7j_A 188 FDYLTE---KVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRE 258 (365)
T ss_dssp HHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC---BCC
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecCcccccCCCcc---ccc
Confidence 999854 34589999999999999999999998 999999999999999999999999999876554322 223
Q ss_pred cccccCCCCcccccc------CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCC
Q 021682 153 IVGTYGYVPPEYVRK------GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLD 226 (309)
Q Consensus 153 ~~~~~~y~aPE~~~~------~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (309)
..|++.|+|||.+.+ ..++.++|||||||++|+|++|..||...... ........ ..... ..+.
T Consensus 259 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~------~~~~~i~~-~~~~~-~~~~-- 328 (365)
T 2y7j_A 259 LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI------LMLRMIME-GQYQF-SSPE-- 328 (365)
T ss_dssp CCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHH-TCCCC-CHHH--
T ss_pred CCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHh-CCCCC-CCcc--
Confidence 468999999998864 35788999999999999999999998542211 11111111 11000 0000
Q ss_pred CcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 227 DSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 227 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
....+..+.++|.+||+.||++|||++++++.
T Consensus 329 ---~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 329 ---WDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp ---HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ---cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00112368899999999999999999999863
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=277.13 Aligned_cols=237 Identities=20% Similarity=0.320 Sum_probs=181.4
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
+.||.+.. .+|+.||+|.+........+.+..|++++++++||||+++++++..+...++||||+.+++|.+++...
T Consensus 33 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-- 110 (302)
T 2j7t_A 33 GKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLEL-- 110 (302)
T ss_dssp CCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHH--
T ss_pred eEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhh--
Confidence 35677765 469999999997766667788999999999999999999999999999999999999999999887542
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP 161 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 161 (309)
...+++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++........ ......|+..|+|
T Consensus 111 ~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~a 185 (302)
T 2j7t_A 111 DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ--KRDSFIGTPYWMA 185 (302)
T ss_dssp TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH--C-----CCGGGCC
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccccc--ccccccCChhhcC
Confidence 34489999999999999999999998 999999999999999999999999998754322111 1122467899999
Q ss_pred ccccc-----cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHH
Q 021682 162 PEYVR-----KGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMR 236 (309)
Q Consensus 162 PE~~~-----~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
||.+. +..++.++||||||+++|+|++|..||....... ......... .... ..+...+..
T Consensus 186 PE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~-~~~~-------~~~~~~~~~ 251 (302)
T 2j7t_A 186 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKIAKSD-PPTL-------LTPSKWSVE 251 (302)
T ss_dssp HHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSC-CCCC-------SSGGGSCHH
T ss_pred CeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH------HHHHHhccC-Cccc-------CCccccCHH
Confidence 99883 5678899999999999999999999986432211 111111111 1110 011112347
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHH
Q 021682 237 CMQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 237 l~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
+.++|.+||+.||++|||++++++
T Consensus 252 l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 252 FRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp HHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred HHHHHHHHcccChhhCCCHHHHhc
Confidence 889999999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=276.36 Aligned_cols=233 Identities=21% Similarity=0.329 Sum_probs=178.5
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
+.||.+.. .+|+.||||.+.... ......+.+|+.+++.++||||+++++++..+...++||||+.+++|.+++..
T Consensus 25 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 104 (276)
T 2h6d_A 25 GKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICK 104 (276)
T ss_dssp EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH
T ss_pred eEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhc
Confidence 35677765 489999999986542 23456889999999999999999999999999999999999999999999854
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
. ..+++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++........ .....+++.
T Consensus 105 ~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~ 175 (276)
T 2h6d_A 105 H---GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPN 175 (276)
T ss_dssp H---CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---------------
T ss_pred c---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCcc---eecccCCcc
Confidence 3 3489999999999999999999999 899999999999999999999999999876544321 222367889
Q ss_pred CCCccccccCCC-CccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHH
Q 021682 159 YVPPEYVRKGIY-SMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRC 237 (309)
Q Consensus 159 y~aPE~~~~~~~-~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (309)
|+|||.+.+..+ +.++|+||||+++|+|++|..||...... .. ......... . ... .....+
T Consensus 176 y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~-~~~~~~~~~-~-----~~~----~~~~~l 238 (276)
T 2h6d_A 176 YAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP------TL-FKKIRGGVF-Y-----IPE----YLNRSV 238 (276)
T ss_dssp -CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HH-HHHHHHCCC-C-----CCT----TSCHHH
T ss_pred ccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH------HH-HHHhhcCcc-c-----Cch----hcCHHH
Confidence 999999987765 68999999999999999999998542111 11 111111100 0 011 112367
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHH
Q 021682 238 MQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 238 ~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.++|.+||+.||++|||++++++.
T Consensus 239 ~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 239 ATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHccCChhhCCCHHHHHhC
Confidence 899999999999999999999985
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=278.47 Aligned_cols=236 Identities=22% Similarity=0.318 Sum_probs=187.7
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
+.||.+.. .+|+.||||.+.... ....+.+|+.++++++||||+++++++..+...++||||+.+++|.+++.. .
T Consensus 43 g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~ 118 (314)
T 3com_A 43 GSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRL--R 118 (314)
T ss_dssp CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH--H
T ss_pred eEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHh--c
Confidence 35677765 469999999997543 356789999999999999999999999999999999999999999998843 2
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP 161 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 161 (309)
...+++..+..++.+++.|+.+||+. |++|+||+|+||+++.++.++|+|||.+......... .....++..|+|
T Consensus 119 ~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~a 193 (314)
T 3com_A 119 NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK--RNTVIGTPFWMA 193 (314)
T ss_dssp TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSC--BCCCCSCGGGCC
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccc--cCccCCCCCccC
Confidence 44589999999999999999999998 9999999999999999999999999998765443221 223468899999
Q ss_pred ccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHH
Q 021682 162 PEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241 (309)
Q Consensus 162 PE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 241 (309)
||.+.+..++.++||||||+++|+|++|..||...... ......... ....+ ..+......+.++|
T Consensus 194 PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~-~~~~~-------~~~~~~~~~l~~li 259 (314)
T 3com_A 194 PEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM------RAIFMIPTN-PPPTF-------RKPELWSDNFTDFV 259 (314)
T ss_dssp HHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHS-CCCCC-------SSGGGSCHHHHHHH
T ss_pred hhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhcC-CCccc-------CCcccCCHHHHHHH
Confidence 99999888999999999999999999999998643211 111111111 10000 01111234788999
Q ss_pred hhcccCCCCCCCCHHHHHHH
Q 021682 242 LLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 242 ~~~l~~~p~~Rpt~~ell~~ 261 (309)
.+||+.||++|||+.++++.
T Consensus 260 ~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 260 KQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp HHHTCSCTTTSCCHHHHTTS
T ss_pred HHHccCChhhCcCHHHHHhC
Confidence 99999999999999999874
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=309.32 Aligned_cols=241 Identities=24% Similarity=0.359 Sum_probs=187.4
Q ss_pred cceEEEEc---CCCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 3 VAICQGRL---PNGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 3 ~~~~~~~~---~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
+.||+|.+ ++++.||||+++... ....+.+.+|++++++++||||+++++++.. ...++||||+.+++|.+++.
T Consensus 383 G~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~ 461 (635)
T 4fl3_A 383 GTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQ 461 (635)
T ss_dssp EEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHH
T ss_pred EEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHh
Confidence 35677744 367889999997542 3346789999999999999999999999864 45889999999999999984
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccc-ccccccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECE-ANTGRIVGT 156 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~ 156 (309)
. ...+++..+..++.||+.||.|||++ ||+||||||+||+++.++.+||+|||++......... .......++
T Consensus 462 ~---~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t 535 (635)
T 4fl3_A 462 Q---NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 535 (635)
T ss_dssp H---CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------C
T ss_pred h---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCc
Confidence 3 34589999999999999999999998 8999999999999999999999999999876543221 112223457
Q ss_pred cCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 157 YGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
..|+|||.+.+..++.++|||||||++|+|++ |..||......+ .......+..... +...+.
T Consensus 536 ~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~~~~~~---------p~~~~~ 599 (635)
T 4fl3_A 536 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGERMGC---------PAGCPR 599 (635)
T ss_dssp GGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCCCCC---------CTTCCH
T ss_pred eeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCCCC---------CCCCCH
Confidence 78999999999999999999999999999998 999986433221 1112222211111 111234
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHHhccc
Q 021682 236 RCMQVALLCVQENAADRPTMLEILVMLKSET 266 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~ 266 (309)
.+.+||.+||+.||++|||+++|++.|+...
T Consensus 600 ~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 600 EMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 7889999999999999999999999998764
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=281.73 Aligned_cols=249 Identities=23% Similarity=0.349 Sum_probs=172.1
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
+.||.+.. .+|+.||||.+.... ......+.+|+.++++++||||+++++++..+...++||||+.+++|.+++....
T Consensus 29 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 108 (303)
T 2vwi_A 29 AVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIV 108 (303)
T ss_dssp CCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHH
T ss_pred eEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHh
Confidence 36777764 478999999986442 3345678899999999999999999999999999999999999999999985421
Q ss_pred -----cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccc---ccccc
Q 021682 81 -----RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECE---ANTGR 152 (309)
Q Consensus 81 -----~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~---~~~~~ 152 (309)
....+++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++......... .....
T Consensus 109 ~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 185 (303)
T 2vwi_A 109 AKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 185 (303)
T ss_dssp HTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC-------------
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcc
Confidence 234589999999999999999999998 9999999999999999999999999998765432211 11223
Q ss_pred cccccCCCCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccH
Q 021682 153 IVGTYGYVPPEYVRK-GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSA 231 (309)
Q Consensus 153 ~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (309)
..|+..|+|||.+.+ ..++.++||||||+++|+|++|..||........ ... .... ................
T Consensus 186 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~---~~~~-~~~~~~~~~~~~~~~~ 258 (303)
T 2vwi_A 186 FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV---LML---TLQN-DPPSLETGVQDKEMLK 258 (303)
T ss_dssp --CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---HHH---HHTS-SCCCTTC-----CCCC
T ss_pred cCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH---HHH---Hhcc-CCCccccccccchhhh
Confidence 468899999999876 5679999999999999999999999865433221 111 1111 0000000000000001
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 232 WKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 232 ~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.....+.++|.+||+.||++|||++++++.
T Consensus 259 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 259 KYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 122368899999999999999999999863
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=289.52 Aligned_cols=245 Identities=22% Similarity=0.277 Sum_probs=182.1
Q ss_pred ceEEEE-cCCCcEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCC------eeEEEEeccCCCChhH
Q 021682 4 AICQGR-LPNGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQRE------EKMLIYDYMPNKSLDF 74 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~~L~~ 74 (309)
.||.+. ..+|+.||||.+... ......++.+|++++++++||||+++++++..+. .+++||||+ +++|.+
T Consensus 40 ~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~ 118 (367)
T 1cm8_A 40 AVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGK 118 (367)
T ss_dssp CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHH
T ss_pred EEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHH
Confidence 456665 468999999998543 2333567889999999999999999999997653 469999999 789998
Q ss_pred HHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccc
Q 021682 75 YIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIV 154 (309)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~ 154 (309)
++.. ..+++..+..++.|++.|+.|||+. |++||||||+||+++.++.+||+|||++...... .....
T Consensus 119 ~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-----~~~~~ 186 (367)
T 1cm8_A 119 LMKH----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYV 186 (367)
T ss_dssp HHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSS-----CCSSC
T ss_pred HHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecccccccc-----cCcCc
Confidence 8743 3489999999999999999999998 9999999999999999999999999999765432 22246
Q ss_pred cccCCCCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHH-----hhCCC---Cccccc---
Q 021682 155 GTYGYVPPEYVRK-GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGL-----WKNGE---GMEFID--- 222 (309)
Q Consensus 155 ~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~-----~~~~~---~~~~~~--- 222 (309)
+|..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+..+....+...... +..-. ...++.
T Consensus 187 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 266 (367)
T 1cm8_A 187 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLP 266 (367)
T ss_dssp SCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSC
T ss_pred CCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCC
Confidence 7899999999877 67899999999999999999999998654322211111100000 00000 000000
Q ss_pred ---ccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 223 ---SSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 223 ---~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
..............+.++|.+||+.||++|||++++++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 267 ELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp CCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 000000001123478899999999999999999999985
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=298.27 Aligned_cols=236 Identities=26% Similarity=0.308 Sum_probs=183.7
Q ss_pred cceEEEE-cCCCcEEEEEEeecCCc-------------ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccC
Q 021682 3 VAICQGR-LPNGQEMAVKRLSRTSH-------------QGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMP 68 (309)
Q Consensus 3 ~~~~~~~-~~~g~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 68 (309)
+.||++. ..+++.||||++..... ...+.+.+|+.++++++||||+++++++..+...++||||+.
T Consensus 50 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 129 (504)
T 3q5i_A 50 GEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYE 129 (504)
T ss_dssp EEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred eEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCC
Confidence 3456665 45789999999865421 335678899999999999999999999999999999999999
Q ss_pred CCChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCC---CceeecccccccccCCc
Q 021682 69 NKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM---NPKISDFGMARAFTKDE 145 (309)
Q Consensus 69 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~---~~~l~Dfg~~~~~~~~~ 145 (309)
+++|.+++... ..+++..+..++.||+.|+.|||+. |++||||||+||+++.++ .++|+|||++.......
T Consensus 130 gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 203 (504)
T 3q5i_A 130 GGELFEQIINR---HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY 203 (504)
T ss_dssp TCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTS
T ss_pred CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCC
Confidence 99998888543 3489999999999999999999998 999999999999998876 69999999997665432
Q ss_pred ccccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccC
Q 021682 146 CEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSL 225 (309)
Q Consensus 146 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (309)
. .....|++.|+|||.+.+ .++.++|||||||++|+|++|..||......+ ....... ........
T Consensus 204 ~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~~-~~~~~~~~--- 269 (504)
T 3q5i_A 204 K---LRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD------IIKKVEK-GKYYFDFN--- 269 (504)
T ss_dssp C---BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHH-CCCCCCHH---
T ss_pred c---cccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHc-CCCCCCcc---
Confidence 2 223468999999999864 68999999999999999999999986432211 1111111 11100000
Q ss_pred CCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 226 DDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 226 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.....+..+.++|.+||+.||++|||++|+++.
T Consensus 270 ---~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 270 ---DWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp ---HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000112378899999999999999999999975
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=291.23 Aligned_cols=237 Identities=22% Similarity=0.248 Sum_probs=173.3
Q ss_pred cceEEEE-cCCCcEEEEEEeecCC--------cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChh
Q 021682 3 VAICQGR-LPNGQEMAVKRLSRTS--------HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLD 73 (309)
Q Consensus 3 ~~~~~~~-~~~g~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 73 (309)
+.||++. ..+|+.||||++.... ......+.+|+.++++++||||+++++++. ....++||||+.+++|.
T Consensus 149 g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~e~~~~g~L~ 227 (419)
T 3i6u_A 149 GEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELF 227 (419)
T ss_dssp SEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEEEEEEECCTTCBGG
T ss_pred eEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCceEEEEEcCCCCcHH
Confidence 3456664 4678999999986531 112235789999999999999999999975 45689999999999998
Q ss_pred HHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCC---CceeecccccccccCCcccccc
Q 021682 74 FYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM---NPKISDFGMARAFTKDECEANT 150 (309)
Q Consensus 74 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~---~~~l~Dfg~~~~~~~~~~~~~~ 150 (309)
+++. ....+++..+..++.|++.|+.|||++ |++||||||+||+++.++ .+||+|||++....... ..
T Consensus 228 ~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~---~~ 298 (419)
T 3i6u_A 228 DKVV---GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LM 298 (419)
T ss_dssp GGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC--------
T ss_pred HHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeecccceecCCCc---cc
Confidence 8873 344589999999999999999999998 899999999999997654 49999999997655432 12
Q ss_pred cccccccCCCCcccccc---CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCC
Q 021682 151 GRIVGTYGYVPPEYVRK---GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDD 227 (309)
Q Consensus 151 ~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (309)
....|++.|+|||.+.+ ..++.++|||||||++|+|++|..||........ ..... ...... ...
T Consensus 299 ~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~~i----~~~~~~-~~~----- 366 (419)
T 3i6u_A 299 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQI----TSGKYN-FIP----- 366 (419)
T ss_dssp ------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHHHH----HTTCCC-CCH-----
T ss_pred cccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHHHH----hcCCCC-CCc-----
Confidence 23468999999999853 5678899999999999999999999964332221 11111 111100 000
Q ss_pred cccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 228 SSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 228 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.........+.++|.+||+.||++|||++|+++.
T Consensus 367 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 367 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0001123478899999999999999999999874
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=284.22 Aligned_cols=260 Identities=22% Similarity=0.260 Sum_probs=184.2
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHH--HhcCCCCCccceeeEEee-----CCeeEEEEeccCCCChhHH
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKL--TARLQHVNLLPVLGICTQ-----REEKMLIYDYMPNKSLDFY 75 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~--l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~ 75 (309)
++||++.. +|+.||||++.... ...+..|.++ +..++|+||+++++.+.. ...+++||||+++++|.++
T Consensus 27 g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~ 102 (336)
T 3g2f_A 27 GAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKY 102 (336)
T ss_dssp EEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHH
T ss_pred eEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHH
Confidence 45788876 78999999996543 2334444444 556899999999975543 2367899999999999999
Q ss_pred HhhhccccCCCHHHHHHHHHHHHHHHHHHhhcC------CCceeecCCCCceEEeCCCCCceeecccccccccCCccc--
Q 021682 76 IFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYS------NLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECE-- 147 (309)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~------~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~-- 147 (309)
+... ..++..+..++.|++.||.|||+.. ..|++||||||+||+++.++.+||+|||++.........
T Consensus 103 l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~ 178 (336)
T 3g2f_A 103 LSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRP 178 (336)
T ss_dssp HHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC--
T ss_pred Hhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeecccccccCc
Confidence 8432 2588899999999999999999862 237999999999999999999999999999766533211
Q ss_pred ----ccccccccccCCCCcccccc-------CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccH-HH---------
Q 021682 148 ----ANTGRIVGTYGYVPPEYVRK-------GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNL-LE--------- 206 (309)
Q Consensus 148 ----~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~-~~--------- 206 (309)
.......||..|+|||.+.+ ..++.++|||||||++|+|++|..||........... ..
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 258 (336)
T 3g2f_A 179 GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTF 258 (336)
T ss_dssp -------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCH
T ss_pred cccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchH
Confidence 11223468999999999876 3456789999999999999999777643333222111 10
Q ss_pred -HHHHHhhCCCCcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccCCCCCC
Q 021682 207 -YAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETADIKTP 272 (309)
Q Consensus 207 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~~~~~ 272 (309)
..............+.. ...........+.++|.+||+.||++|||++|+++.|+.+.......
T Consensus 259 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~ 323 (336)
T 3g2f_A 259 EDMQVLVSREKQRPKFPE--AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERN 323 (336)
T ss_dssp HHHHHHHTTSCCCCCCCT--TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC-
T ss_pred HHHHhhhcccccCCCCCc--ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhc
Confidence 01111111111111111 11122335557899999999999999999999999999987665544
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=285.87 Aligned_cols=238 Identities=13% Similarity=0.084 Sum_probs=187.7
Q ss_pred cceEEE------EcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCC---CCCccceeeEEeeCCeeEEEEeccCCCChh
Q 021682 3 VAICQG------RLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQ---HVNLLPVLGICTQREEKMLIYDYMPNKSLD 73 (309)
Q Consensus 3 ~~~~~~------~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 73 (309)
++||++ ...+++.||||.++... ...+..|+++++.++ |+||+.+++++..++..++||||+.+++|.
T Consensus 79 g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~ 155 (365)
T 3e7e_A 79 AQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLL 155 (365)
T ss_dssp EEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHH
T ss_pred EEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcHH
Confidence 367777 45689999999996543 456677777777775 999999999999999999999999999999
Q ss_pred HHHhhhc--cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCC-----------CCCceeeccccccc
Q 021682 74 FYIFDLR--RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY-----------EMNPKISDFGMARA 140 (309)
Q Consensus 74 ~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~-----------~~~~~l~Dfg~~~~ 140 (309)
+++.... ....+++..++.++.||+.||+|||++ ||+||||||+||+++. ++.+||+|||++..
T Consensus 156 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~ 232 (365)
T 3e7e_A 156 NAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID 232 (365)
T ss_dssp HHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEE
T ss_pred HHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhh
Confidence 9986432 345699999999999999999999998 8999999999999998 89999999999976
Q ss_pred ccCCcccccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCccc
Q 021682 141 FTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEF 220 (309)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (309)
..............||..|+|||.+.+..++.++|||||||++|+|++|+.||.........
T Consensus 233 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~------------------ 294 (365)
T 3e7e_A 233 MKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK------------------ 294 (365)
T ss_dssp GGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE------------------
T ss_pred hhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee------------------
Confidence 54332222334457899999999999999999999999999999999999998532221100
Q ss_pred ccccCCCcccHHHHHHHHHHHhhcccCCCCCC-CCHHHHHHHHhcccC
Q 021682 221 IDSSLDDSSSAWKLMRCMQVALLCVQENAADR-PTMLEILVMLKSETA 267 (309)
Q Consensus 221 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R-pt~~ell~~L~~~~~ 267 (309)
........ .....+.+++..||+.+|.+| |+++++.+.|+...+
T Consensus 295 ~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 295 PEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp ECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred echhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 00111111 113366789999999999999 789999998887654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=294.85 Aligned_cols=227 Identities=16% Similarity=0.193 Sum_probs=172.1
Q ss_pred cceEEEEc-CCCcEEEEEEeecC---CcccHHHHHHHHH---HHhcCCCCCcccee-------eEEeeCC----------
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRT---SHQGLEEFENEVK---LTARLQHVNLLPVL-------GICTQRE---------- 58 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~---~l~~l~h~~iv~~~-------~~~~~~~---------- 58 (309)
+.||++.. .+|+.||||++... .....+.+.+|+. .+++++||||++++ +++..++
T Consensus 87 g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (377)
T 3byv_A 87 YAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLD 166 (377)
T ss_dssp EEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC---
T ss_pred EEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccC
Confidence 45777775 57999999999743 3345678889994 55556899999988 6665543
Q ss_pred -------eeEEEEeccCCCChhHHHhhhcc----ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCC
Q 021682 59 -------EKMLIYDYMPNKSLDFYIFDLRR----RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYE 127 (309)
Q Consensus 59 -------~~~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~ 127 (309)
..++||||+ +|+|.+++..... ...+++..++.++.||+.||+|||++ |++||||||+||+++.+
T Consensus 167 ~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~ 242 (377)
T 3byv_A 167 ERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQR 242 (377)
T ss_dssp ---CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTT
T ss_pred CCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC
Confidence 278999999 5799999865322 11233478888999999999999998 89999999999999999
Q ss_pred CCceeecccccccccCCcccccccccccccCCCCccccccC-----------CCCccchhhhHHHHHHHHHhCCCCCCCC
Q 021682 128 MNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKG-----------IYSMKYDVYSYGVLLLQILGGKRTSCYY 196 (309)
Q Consensus 128 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~DvwslG~il~~ll~g~~p~~~~ 196 (309)
+.+||+|||++...... .....| ..|+|||.+.+. .++.++|||||||++|+|++|..||...
T Consensus 243 ~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~ 316 (377)
T 3byv_A 243 GGVFLTGFEHLVRDGAR-----VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKD 316 (377)
T ss_dssp CCEEECCGGGCEETTCE-----EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred CCEEEEechhheecCCc-----ccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCccc
Confidence 99999999999753321 222356 899999999887 7899999999999999999999998643
Q ss_pred CCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021682 197 GPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
......... .... .. .+..+.++|.+||+.||++|||+.++++
T Consensus 317 ~~~~~~~~~---------------~~~~--~~----~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 317 AALGGSEWI---------------FRSC--KN----IPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp ---CCSGGG---------------GSSC--CC----CCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred ccccchhhh---------------hhhc--cC----CCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 332211110 1100 11 1237889999999999999999999986
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=279.87 Aligned_cols=249 Identities=24% Similarity=0.275 Sum_probs=188.4
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhc--CCCCCccceeeEEeeCC----eeEEEEeccCCCChhHHH
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTAR--LQHVNLLPVLGICTQRE----EKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~~----~~~lv~e~~~~~~L~~~~ 76 (309)
+.||++.. +|+.||||.+... ....+..|+++++. ++||||+++++++..+. ..++||||+.+++|.+++
T Consensus 56 g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l 131 (342)
T 1b6c_B 56 GEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL 131 (342)
T ss_dssp EEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHH
T ss_pred cEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHH
Confidence 46788886 6999999998643 34567788888876 79999999999998876 789999999999999998
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHh--------hcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccc
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQ--------EYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEA 148 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh--------~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 148 (309)
.. ..+++..++.++.|++.|+.||| +. |++|+||||+||+++.++.++|+|||++..........
T Consensus 132 ~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 204 (342)
T 1b6c_B 132 NR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 204 (342)
T ss_dssp HH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEE
T ss_pred hc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCCEEEEECCCceecccccccc
Confidence 43 24899999999999999999999 66 99999999999999999999999999997665433211
Q ss_pred --cccccccccCCCCccccccCC------CCccchhhhHHHHHHHHHhC----------CCCCCCCCCCCcccHHHHHHH
Q 021682 149 --NTGRIVGTYGYVPPEYVRKGI------YSMKYDVYSYGVLLLQILGG----------KRTSCYYGPNESLNLLEYAYG 210 (309)
Q Consensus 149 --~~~~~~~~~~y~aPE~~~~~~------~~~~~DvwslG~il~~ll~g----------~~p~~~~~~~~~~~~~~~~~~ 210 (309)
......|+..|+|||.+.+.. ++.++||||||+++|+|++| ..||.......... .....
T Consensus 205 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~--~~~~~ 282 (342)
T 1b6c_B 205 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV--EEMRK 282 (342)
T ss_dssp EECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH--HHHHH
T ss_pred ccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccH--HHHHH
Confidence 123346899999999987652 33789999999999999999 66765433222111 11111
Q ss_pred HhhCCCCcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccC
Q 021682 211 LWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETA 267 (309)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~ 267 (309)
..........+.. ..........+.+++.+||+.||++|||++++++.|+.+.+
T Consensus 283 ~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~ 336 (342)
T 1b6c_B 283 VVCEQKLRPNIPN---RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336 (342)
T ss_dssp HHTTSCCCCCCCG---GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCcc---cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 1111111111110 01123455678899999999999999999999999998754
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=287.95 Aligned_cols=184 Identities=20% Similarity=0.318 Sum_probs=148.6
Q ss_pred cceEEEE-cCCCcEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeeEEeeC-----CeeEEEEeccCCCChhH
Q 021682 3 VAICQGR-LPNGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQR-----EEKMLIYDYMPNKSLDF 74 (309)
Q Consensus 3 ~~~~~~~-~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~ 74 (309)
+.||++. ..+|+.||||.+... ......++.+|++++++++|+||+++++++... ...++|||++. ++|.+
T Consensus 40 g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~ 118 (432)
T 3n9x_A 40 GYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKK 118 (432)
T ss_dssp EEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHH
T ss_pred EEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHH
Confidence 3566665 467999999999754 233456788999999999999999999998776 56899999996 58988
Q ss_pred HHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccc-------
Q 021682 75 YIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECE------- 147 (309)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~------- 147 (309)
++. ....+++..+..++.||+.||+|||+. |++||||||+||+++.++.+||+|||++.........
T Consensus 119 ~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 192 (432)
T 3n9x_A 119 LFK---TPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLE 192 (432)
T ss_dssp HHH---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC-------------
T ss_pred HHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccccccccccccccccc
Confidence 884 344599999999999999999999999 9999999999999999999999999999876543211
Q ss_pred -------------ccccccccccCCCCcccc-ccCCCCccchhhhHHHHHHHHHhCCCCC
Q 021682 148 -------------ANTGRIVGTYGYVPPEYV-RKGIYSMKYDVYSYGVLLLQILGGKRTS 193 (309)
Q Consensus 148 -------------~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~il~~ll~g~~p~ 193 (309)
.......||..|+|||.+ .+..++.++|||||||++|+|++|..||
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 193 ENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp ------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 112345789999999986 5567899999999999999999854443
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=283.62 Aligned_cols=256 Identities=20% Similarity=0.284 Sum_probs=181.7
Q ss_pred cceEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
+.||++..+ ..||+|.++... ....+.+.+|+.++++++|+||+++++++..+...++||||+.+++|.+++..
T Consensus 47 g~V~~~~~~--~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~-- 122 (319)
T 2y4i_B 47 GQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD-- 122 (319)
T ss_dssp SEEEEEEES--SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTS--
T ss_pred eEEEEEEEc--CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHh--
Confidence 467888764 359999986542 33345678899999999999999999999999999999999999999999843
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcc---ccccccccccc
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDEC---EANTGRIVGTY 157 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~~~ 157 (309)
....+++..++.++.|++.|+.+||+. |++|+||+|+||+++ ++.++|+|||++........ ........|+.
T Consensus 123 ~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~ 198 (319)
T 2y4i_B 123 AKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWL 198 (319)
T ss_dssp SCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGG
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcc
Confidence 234589999999999999999999998 999999999999998 68999999999765432211 11122345889
Q ss_pred CCCCcccccc---------CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCc
Q 021682 158 GYVPPEYVRK---------GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDS 228 (309)
Q Consensus 158 ~y~aPE~~~~---------~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (309)
.|+|||.+.+ ..++.++||||||+++|+|++|..||....... .. ...............
T Consensus 199 ~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~-~~~~~~~~~~~~~~~---- 267 (319)
T 2y4i_B 199 CHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA------II-WQMGTGMKPNLSQIG---- 267 (319)
T ss_dssp GTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH------HH-HHHHTTCCCCCCCSS----
T ss_pred cccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HH-HHhccCCCCCCCcCC----
Confidence 9999998864 346889999999999999999999986432211 11 111111111111111
Q ss_pred ccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccCCCCCCCCCCccccC
Q 021682 229 SSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETADIKTPKKPAFSVKR 281 (309)
Q Consensus 229 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~~~~~~~p~~~~~~ 281 (309)
.+..+.+++.+||+.||++|||++++++.|+.+.........|..++..
T Consensus 268 ----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~~~ 316 (319)
T 2y4i_B 268 ----MGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFWKS 316 (319)
T ss_dssp ----CCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----------------
T ss_pred ----CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCcccccc
Confidence 1126789999999999999999999999999999888887888777754
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=305.10 Aligned_cols=233 Identities=21% Similarity=0.263 Sum_probs=185.9
Q ss_pred ceEEEE-cCCCcEEEEEEeecC---CcccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 4 AICQGR-LPNGQEMAVKRLSRT---SHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
.||.+. ..+|+.||||+++.. .......+..|..++..+ +|++|+.+++++.+...+++||||+.+++|..++..
T Consensus 356 ~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~ 435 (674)
T 3pfq_A 356 KVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ 435 (674)
T ss_dssp CEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHH
T ss_pred EEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHh
Confidence 455554 567899999999753 233456788899999988 799999999999999999999999999999999854
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
. ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++.+||+|||++........ ......||+.
T Consensus 436 ~---~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~--~~~~~~GT~~ 507 (674)
T 3pfq_A 436 V---GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKTFCGTPD 507 (674)
T ss_dssp H---SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC--CBCCCCSCSS
T ss_pred c---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccccCCc--ccccccCCCc
Confidence 3 3499999999999999999999999 999999999999999999999999999975433222 2334578999
Q ss_pred CCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHH
Q 021682 159 YVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238 (309)
Q Consensus 159 y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (309)
|+|||++.+..++.++|+|||||++|+|++|..||...+.. ......... .. .+ +.....++.
T Consensus 508 Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~-~~-~~---------p~~~s~~~~ 570 (674)
T 3pfq_A 508 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQSIMEH-NV-AY---------PKSMSKEAV 570 (674)
T ss_dssp SCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHSS-CC-CC---------CTTSCHHHH
T ss_pred ccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH------HHHHHHHhC-CC-CC---------CccCCHHHH
Confidence 99999999999999999999999999999999999643221 111111111 10 11 111233788
Q ss_pred HHHhhcccCCCCCCCCH-----HHHHHH
Q 021682 239 QVALLCVQENAADRPTM-----LEILVM 261 (309)
Q Consensus 239 ~li~~~l~~~p~~Rpt~-----~ell~~ 261 (309)
+||.+||+.||++||++ +||++.
T Consensus 571 ~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 571 AICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp HHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred HHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 99999999999999997 777753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=271.17 Aligned_cols=231 Identities=16% Similarity=0.215 Sum_probs=180.7
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC--cccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS--HQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
+.||.+.. .+|+.||||.++... ......+..|+..+.++ +||||+++++++..+...++||||+++++|.+++..
T Consensus 25 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 104 (289)
T 1x8b_A 25 GSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISE 104 (289)
T ss_dssp EEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH
T ss_pred eEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHh
Confidence 35677765 489999999997642 33456788899999999 999999999999999999999999999999999865
Q ss_pred hcc-ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCC-------------------CCceeeccccc
Q 021682 79 LRR-RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYE-------------------MNPKISDFGMA 138 (309)
Q Consensus 79 ~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~-------------------~~~~l~Dfg~~ 138 (309)
... ...+++..++.++.|++.|+.|||++ |++|+||||+||+++.+ ..++|+|||.+
T Consensus 105 ~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 181 (289)
T 1x8b_A 105 NYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV 181 (289)
T ss_dssp HHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC--------------------CCCEEECCCTTC
T ss_pred hcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccc
Confidence 322 35589999999999999999999998 99999999999999844 47999999998
Q ss_pred ccccCCcccccccccccccCCCCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCC
Q 021682 139 RAFTKDECEANTGRIVGTYGYVPPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEG 217 (309)
Q Consensus 139 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (309)
....... ...++..|+|||.+.+. .++.++|||||||++|+|++|.+++... . . .........
T Consensus 182 ~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---~---~----~~~~~~~~~ 245 (289)
T 1x8b_A 182 TRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG---D---Q----WHEIRQGRL 245 (289)
T ss_dssp EETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS---H---H----HHHHHTTCC
T ss_pred cccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch---h---H----HHHHHcCCC
Confidence 7654432 12578999999998765 5668999999999999999998775321 0 0 111111111
Q ss_pred cccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 218 MEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
..+ ... .+..+.++|.+||+.||++|||+.++++.
T Consensus 246 ~~~-----~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 246 PRI-----PQV----LSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp CCC-----SSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred CCC-----Ccc----cCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 111 111 22378899999999999999999999864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=276.68 Aligned_cols=236 Identities=23% Similarity=0.290 Sum_probs=183.9
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC---------cccHHHHHHHHHHHhcCC-CCCccceeeEEeeCCeeEEEEeccCCCC
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS---------HQGLEEFENEVKLTARLQ-HVNLLPVLGICTQREEKMLIYDYMPNKS 71 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 71 (309)
+.||++.. .+|+.||||.+.... ....+.+.+|+++++++. ||||+++++++..+...++||||+.+++
T Consensus 31 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 110 (298)
T 1phk_A 31 SVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGE 110 (298)
T ss_dssp EEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCB
T ss_pred eEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCc
Confidence 35677765 578999999997543 122456789999999995 9999999999999999999999999999
Q ss_pred hhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccc
Q 021682 72 LDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTG 151 (309)
Q Consensus 72 L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 151 (309)
|.+++.. ...+++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 111 L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~ 181 (298)
T 1phk_A 111 LFDYLTE---KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LR 181 (298)
T ss_dssp HHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC---BC
T ss_pred HHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccchhhcCCCcc---cc
Confidence 9999854 34589999999999999999999998 999999999999999999999999999876544321 22
Q ss_pred ccccccCCCCccccc------cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccC
Q 021682 152 RIVGTYGYVPPEYVR------KGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSL 225 (309)
Q Consensus 152 ~~~~~~~y~aPE~~~------~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (309)
...++..|+|||.+. ...++.++||||||+++|+|++|..||...... ......... ... .
T Consensus 182 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~-~~~-~----- 248 (298)
T 1phk_A 182 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM------LMLRMIMSG-NYQ-F----- 248 (298)
T ss_dssp CCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHT-CCC-C-----
T ss_pred cccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH------HHHHHHhcC-Ccc-c-----
Confidence 346788999999885 446789999999999999999999998542211 111111111 110 0
Q ss_pred CCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021682 226 DDSSSAWKLMRCMQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 226 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
........+..+.++|.+||+.||++|||++++++
T Consensus 249 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 249 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 00011122347889999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=276.96 Aligned_cols=237 Identities=19% Similarity=0.201 Sum_probs=180.6
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC----cccHHHHHHHHHHHhcCCCCCccceeeEEe--eCCeeEEEEeccCCCChhHH
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS----HQGLEEFENEVKLTARLQHVNLLPVLGICT--QREEKMLIYDYMPNKSLDFY 75 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~~~L~~~ 75 (309)
+.||++.. .+|+.||+|.++... ......+.+|+.++++++||||+++++++. .....++||||+.++ |.++
T Consensus 19 g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~ 97 (305)
T 2wtk_C 19 GKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEM 97 (305)
T ss_dssp CEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHH
T ss_pred eEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHH
Confidence 34576764 578999999996542 334578899999999999999999999984 445789999999876 6666
Q ss_pred HhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccc
Q 021682 76 IFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVG 155 (309)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 155 (309)
+... ....+++..+..++.|++.|+.+||++ |++|+||+|+||+++.++.++|+|||++................+
T Consensus 98 ~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 173 (305)
T 2wtk_C 98 LDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQG 173 (305)
T ss_dssp HHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCS
T ss_pred HHhC-cccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCC
Confidence 6432 345689999999999999999999998 999999999999999999999999999976553322222333468
Q ss_pred ccCCCCccccccCC--CCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHH
Q 021682 156 TYGYVPPEYVRKGI--YSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWK 233 (309)
Q Consensus 156 ~~~y~aPE~~~~~~--~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
+..|+|||.+.+.. .+.++||||||+++|+|++|..||...... .. ......... . .... .
T Consensus 174 ~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~-~~~i~~~~~-~-----~~~~----~ 236 (305)
T 2wtk_C 174 SPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY------KL-FENIGKGSY-A-----IPGD----C 236 (305)
T ss_dssp CGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HH-HHHHHHCCC-C-----CCSS----S
T ss_pred CCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH------HH-HHHHhcCCC-C-----CCCc----c
Confidence 99999999987654 377999999999999999999998642211 11 111111110 0 0111 2
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 234 LMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 234 ~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
...+.++|.+||+.||++|||++++++.
T Consensus 237 ~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 237 GPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 2367899999999999999999999975
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=283.18 Aligned_cols=240 Identities=23% Similarity=0.244 Sum_probs=186.1
Q ss_pred cceEEEEc----CCCcEEEEEEeecCC----cccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChh
Q 021682 3 VAICQGRL----PNGQEMAVKRLSRTS----HQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLD 73 (309)
Q Consensus 3 ~~~~~~~~----~~g~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 73 (309)
+.||++.. .+|+.||||+++... ......+..|+.+++++ +||||+++++++..+...++||||+.+++|.
T Consensus 68 g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 147 (355)
T 1vzo_A 68 GKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELF 147 (355)
T ss_dssp EEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHH
T ss_pred EEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHH
Confidence 35677765 479999999986432 23345677899999999 7999999999999999999999999999999
Q ss_pred HHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccc
Q 021682 74 FYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRI 153 (309)
Q Consensus 74 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 153 (309)
+++... ..+++..+..++.|++.||.|||++ |++||||||+||+++.++.+||+|||++......... .....
T Consensus 148 ~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~-~~~~~ 220 (355)
T 1vzo_A 148 THLSQR---ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDF 220 (355)
T ss_dssp HHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGG-GGCGG
T ss_pred HHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCeecccCCCC-cccCc
Confidence 998543 3489999999999999999999998 8999999999999999999999999999765433221 12234
Q ss_pred ccccCCCCccccccC--CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccH
Q 021682 154 VGTYGYVPPEYVRKG--IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSA 231 (309)
Q Consensus 154 ~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (309)
.||..|+|||.+.+. .++.++|||||||++|+|++|..||............ ......... . .+.
T Consensus 221 ~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~--~~~~~~~~~-------~----~~~ 287 (355)
T 1vzo_A 221 CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI--SRRILKSEP-------P----YPQ 287 (355)
T ss_dssp GSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH--HHHHHHCCC-------C----CCT
T ss_pred ccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHH--HHHHhccCC-------C----CCc
Confidence 689999999999763 4689999999999999999999999654433322111 111111110 0 011
Q ss_pred HHHHHHHHHHhhcccCCCCCCC-----CHHHHHHHH
Q 021682 232 WKLMRCMQVALLCVQENAADRP-----TMLEILVML 262 (309)
Q Consensus 232 ~~~~~l~~li~~~l~~~p~~Rp-----t~~ell~~L 262 (309)
.....+.++|.+||+.||++|| |++++++..
T Consensus 288 ~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 288 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 1223678999999999999999 999999875
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=276.77 Aligned_cols=242 Identities=17% Similarity=0.214 Sum_probs=181.9
Q ss_pred cceEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCC-CCCccceeeEEee--CCeeEEEEeccCCCChhHHHhh
Q 021682 3 VAICQGR-LPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQ-HVNLLPVLGICTQ--REEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 3 ~~~~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
+.||++. ..+|+.||||.++.. ....+.+|+.++++++ ||||+++++++.. ....++||||+.+++|..++.
T Consensus 50 g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~- 125 (330)
T 3nsz_A 50 SEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ- 125 (330)
T ss_dssp EEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGG-
T ss_pred eEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHH-
Confidence 3566665 568999999998643 3567899999999996 9999999999987 567899999999999988862
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCC-CceeecccccccccCCccccccccccccc
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM-NPKISDFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
.+++..+..++.|++.|+.|||+. |++||||||+||+++.++ .++|+|||++........ .....++.
T Consensus 126 -----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~ 194 (330)
T 3nsz_A 126 -----TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASR 194 (330)
T ss_dssp -----GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSCCSCG
T ss_pred -----hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc---cccccccc
Confidence 278889999999999999999998 999999999999999776 899999999976544322 22346788
Q ss_pred CCCCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH---------Hhh--------------
Q 021682 158 GYVPPEYVRK-GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYG---------LWK-------------- 213 (309)
Q Consensus 158 ~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~---------~~~-------------- 213 (309)
.|+|||.+.+ ..++.++|||||||++|+|++|..||....... ........ .+.
T Consensus 195 ~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~--~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (330)
T 3nsz_A 195 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY--DQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDIL 272 (330)
T ss_dssp GGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH--HHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHH
T ss_pred cccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH--HHHHHHHHhcCCchhhhHHHHhccccccchhhhh
Confidence 9999999877 678999999999999999999999984322211 11110000 000
Q ss_pred CCCCcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 214 NGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.......................+.++|.+||+.||++|||++|+++.
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 273 GRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp CCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000000111111111112234578899999999999999999999974
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=278.57 Aligned_cols=244 Identities=23% Similarity=0.330 Sum_probs=184.0
Q ss_pred cceEEEEc--CCCc--EEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHH
Q 021682 3 VAICQGRL--PNGQ--EMAVKRLSRT---SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFY 75 (309)
Q Consensus 3 ~~~~~~~~--~~g~--~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (309)
+.||++.+ .+++ .||||.++.. .....+.+.+|++++++++||||+++++++..+. .++|+|++.+++|.++
T Consensus 32 g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~ 110 (291)
T 1u46_A 32 GVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDR 110 (291)
T ss_dssp CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHH
T ss_pred eeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHH
Confidence 46777764 2333 6899998654 2334578899999999999999999999988765 8899999999999998
Q ss_pred HhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccc-cccccc
Q 021682 76 IFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEA-NTGRIV 154 (309)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~-~~~~~~ 154 (309)
+... ...+++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++.......... ......
T Consensus 111 l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 185 (291)
T 1u46_A 111 LRKH--QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 185 (291)
T ss_dssp HHHH--GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----
T ss_pred HHhc--cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCC
Confidence 8543 34489999999999999999999998 99999999999999999999999999987665433221 122335
Q ss_pred cccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHH
Q 021682 155 GTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWK 233 (309)
Q Consensus 155 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
++..|+|||.+.+..++.++||||||+++|+|++ |..||...... .............. .....
T Consensus 186 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~~~~~~---------~~~~~ 250 (291)
T 1u46_A 186 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDKEGERLP---------RPEDC 250 (291)
T ss_dssp CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTSCCCCC---------CCTTC
T ss_pred CCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH------HHHHHHHccCCCCC---------CCcCc
Confidence 6778999999988888999999999999999999 99998543221 11111111111111 01112
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccC
Q 021682 234 LMRCMQVALLCVQENAADRPTMLEILVMLKSETA 267 (309)
Q Consensus 234 ~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~ 267 (309)
+..+.+++.+||+.||++|||+.++++.|+....
T Consensus 251 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 251 PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 3478899999999999999999999999997643
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=278.44 Aligned_cols=236 Identities=22% Similarity=0.253 Sum_probs=177.4
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC--------cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS--------HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLD 73 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 73 (309)
+.||++.. .+|+.||||.+.... ......+.+|++++++++||||+++++++..+. .++||||+.+++|.
T Consensus 24 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~ 102 (322)
T 2ycf_A 24 GEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELF 102 (322)
T ss_dssp EEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETH
T ss_pred EEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHH
Confidence 35677754 578999999986432 122345789999999999999999999987654 89999999999999
Q ss_pred HHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCC---ceeecccccccccCCcccccc
Q 021682 74 FYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMN---PKISDFGMARAFTKDECEANT 150 (309)
Q Consensus 74 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~---~~l~Dfg~~~~~~~~~~~~~~ 150 (309)
+++.. ...+++..+..++.|++.|+.|||++ |++|+||+|+||+++.++. ++|+|||++........ .
T Consensus 103 ~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~---~ 173 (322)
T 2ycf_A 103 DKVVG---NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---M 173 (322)
T ss_dssp HHHST---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHH---H
T ss_pred HHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCccceecccccc---c
Confidence 88843 44589999999999999999999998 9999999999999987665 99999999876543321 1
Q ss_pred cccccccCCCCccccc---cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCC
Q 021682 151 GRIVGTYGYVPPEYVR---KGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDD 227 (309)
Q Consensus 151 ~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (309)
....|+..|+|||.+. ...++.++|||||||++|+|++|..||......... ..... ..... ...
T Consensus 174 ~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~----~~~~~-~~~----- 241 (322)
T 2ycf_A 174 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--KDQIT----SGKYN-FIP----- 241 (322)
T ss_dssp HHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH--HHHHH----HTCCC-CCH-----
T ss_pred ccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH--HHHHH----hCccc-cCc-----
Confidence 2246889999999874 456789999999999999999999998654332211 11111 11000 000
Q ss_pred cccHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021682 228 SSSAWKLMRCMQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 228 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
.........+.++|.+||+.||++|||++++++
T Consensus 242 ~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 242 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 000112347889999999999999999999985
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=286.68 Aligned_cols=238 Identities=12% Similarity=0.055 Sum_probs=164.3
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCc---ccHHHHHHHHH---HHhcCCCCCcccee-------eEEeeC-----------
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSH---QGLEEFENEVK---LTARLQHVNLLPVL-------GICTQR----------- 57 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~---~~~~~~~~e~~---~l~~l~h~~iv~~~-------~~~~~~----------- 57 (309)
++||++.. .+|+.||||++..... ...+.+.+|+. .|+. +||||++++ +++..+
T Consensus 76 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~ 154 (371)
T 3q60_A 76 SVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPG 154 (371)
T ss_dssp EEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEEETTSCSSSBCSCC
T ss_pred EEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehheecCCCCCeeeccCC
Confidence 45677764 5899999999976532 33456778854 4555 799987754 444433
Q ss_pred ------CeeEEEEeccCCCChhHHHhhhccccCCCHHHH------HHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeC
Q 021682 58 ------EEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTR------VHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLD 125 (309)
Q Consensus 58 ------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~------~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~ 125 (309)
...++||||+. ++|.+++..... .++...+ ..++.||+.|++|||++ |++||||||+||+++
T Consensus 155 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivHrDikp~NIll~ 228 (371)
T 3q60_A 155 QDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIM 228 (371)
T ss_dssp ---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGEEEC
T ss_pred cccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCccCcCCHHHEEEC
Confidence 34799999998 899999865422 2454455 67779999999999998 899999999999999
Q ss_pred CCCCceeecccccccccCCcccccccccccccCCCCcccccc--CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCccc
Q 021682 126 YEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRK--GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLN 203 (309)
Q Consensus 126 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~ 203 (309)
.++.+||+|||++........ ...+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||..........
T Consensus 229 ~~~~~kL~DFG~a~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~ 303 (371)
T 3q60_A 229 PDGRLMLGDVSALWKVGTRGP-----ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGS 303 (371)
T ss_dssp TTSCEEECCGGGEEETTCEEE-----GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTC
T ss_pred CCCCEEEEecceeeecCCCcc-----CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccc
Confidence 999999999999976543221 2356799999999987 678999999999999999999999997553322110
Q ss_pred HHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021682 204 LLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
+.....................+..+.++|.+||+.||++|||+.++++
T Consensus 304 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 304 --------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp --------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred --------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000000001011111122347889999999999999999999975
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=284.36 Aligned_cols=244 Identities=23% Similarity=0.321 Sum_probs=186.4
Q ss_pred cceEEEEcCCCcEEEEEEeecCCccc-----------------HHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEe
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQG-----------------LEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYD 65 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 65 (309)
+.||.+.. +|+.||||.+....... .+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 45 g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 123 (348)
T 2pml_X 45 NKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYE 123 (348)
T ss_dssp CCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEESSSEEEEEEE
T ss_pred eEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 46788877 99999999986542111 1789999999999999999999999999999999999
Q ss_pred ccCCCChhHH------HhhhccccCCCHHHHHHHHHHHHHHHHHHhh-cCCCceeecCCCCceEEeCCCCCceeeccccc
Q 021682 66 YMPNKSLDFY------IFDLRRRYLLDWRTRVHIIEGITQGLLYLQE-YSNLTIVHRDLKASNILLDYEMNPKISDFGMA 138 (309)
Q Consensus 66 ~~~~~~L~~~------~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~ 138 (309)
|+++++|.++ +.. .....+++..++.++.|++.|+.|||+ . |++|+||+|+||+++.++.++|+|||.+
T Consensus 124 ~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 199 (348)
T 2pml_X 124 YMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILMDKNGRVKLSDFGES 199 (348)
T ss_dssp CCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred ccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEEcCCCcEEEeccccc
Confidence 9999999888 422 124569999999999999999999999 7 9999999999999999999999999998
Q ss_pred ccccCCcccccccccccccCCCCccccccC-CCCc-cchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCC
Q 021682 139 RAFTKDECEANTGRIVGTYGYVPPEYVRKG-IYSM-KYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGE 216 (309)
Q Consensus 139 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 216 (309)
...... ......++..|+|||.+.+. .++. ++||||||+++|+|++|..||....... . .........
T Consensus 200 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~-~~~~i~~~~ 269 (348)
T 2pml_X 200 EYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV-----E-LFNNIRTKN 269 (348)
T ss_dssp EECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH-----H-HHHHHTSCC
T ss_pred cccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH-----H-HHHHHhccC
Confidence 765443 12234688999999999877 5665 9999999999999999999986543311 1 111111111
Q ss_pred Cccc------ccccC---CCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 217 GMEF------IDSSL---DDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 217 ~~~~------~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
..-. ..... ........+..+.++|.+||+.||++|||++|+++.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 270 IEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp CCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1000 00000 000001223478899999999999999999999873
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=286.28 Aligned_cols=249 Identities=16% Similarity=0.200 Sum_probs=178.2
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCC------eeEEEEeccCCCChhHHH
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQRE------EKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~~L~~~~ 76 (309)
++||.+...++..||+|.+...... ..+|+++++.++||||+++++++.... ..++||||+.++.+....
T Consensus 54 g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~ 129 (394)
T 4e7w_A 54 GVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASR 129 (394)
T ss_dssp EEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHH
T ss_pred eEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHH
Confidence 4678887766777999988644322 236999999999999999999986543 388999999875444443
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeC-CCCCceeecccccccccCCccccccccccc
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLD-YEMNPKISDFGMARAFTKDECEANTGRIVG 155 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 155 (309)
........+++..+..++.||+.|+.|||+. |++||||||+||+++ .++.+||+|||++......... ....+
T Consensus 130 ~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~~---~~~~~ 203 (394)
T 4e7w_A 130 HYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN---VSYIC 203 (394)
T ss_dssp HHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCC---CSSCS
T ss_pred HHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCCC---ccccc
Confidence 3233455699999999999999999999998 999999999999999 7899999999999765443322 22367
Q ss_pred ccCCCCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH--------HHhh----CCCCccccc
Q 021682 156 TYGYVPPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAY--------GLWK----NGEGMEFID 222 (309)
Q Consensus 156 ~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~--------~~~~----~~~~~~~~~ 222 (309)
+..|+|||.+.+. .++.++|||||||++|+|++|+.||......+....+.... .... .........
T Consensus 204 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~ 283 (394)
T 4e7w_A 204 SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRP 283 (394)
T ss_dssp CGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCC
T ss_pred CcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccC
Confidence 8999999998765 58999999999999999999999996543222211111100 0000 000000000
Q ss_pred ccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 223 SSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 223 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
..............+.+||.+||+.||++|||+.|+++.
T Consensus 284 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 284 HPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp CCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 000000001123478899999999999999999999985
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=280.44 Aligned_cols=247 Identities=21% Similarity=0.234 Sum_probs=175.2
Q ss_pred cceEEEE-cCCCcEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCC------eeEEEEeccCCCChh
Q 021682 3 VAICQGR-LPNGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQRE------EKMLIYDYMPNKSLD 73 (309)
Q Consensus 3 ~~~~~~~-~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~~L~ 73 (309)
+.||++. ..+|+.||||.+... .......+.+|+.+++.++||||+++++++.... ..++||||+.+ +|.
T Consensus 39 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~ 117 (371)
T 2xrw_A 39 GIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLC 117 (371)
T ss_dssp EEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSE-EHH
T ss_pred EEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCCC-CHH
Confidence 3566665 457999999999754 2334567889999999999999999999987654 78999999975 677
Q ss_pred HHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccc
Q 021682 74 FYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRI 153 (309)
Q Consensus 74 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 153 (309)
+++. ..+++..+..++.|++.|+.|||++ |++||||||+||+++.++.+||+|||++....... .....
T Consensus 118 ~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~~ 186 (371)
T 2xrw_A 118 QVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPY 186 (371)
T ss_dssp HHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC----------------
T ss_pred HHHh-----hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccccccccc---ccCCc
Confidence 7662 2388999999999999999999998 99999999999999999999999999997654332 12234
Q ss_pred ccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHH----------------HHHHhhC-CC
Q 021682 154 VGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEY----------------AYGLWKN-GE 216 (309)
Q Consensus 154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~----------------~~~~~~~-~~ 216 (309)
.|+..|+|||.+.+..++.++|||||||++|+|++|..||...+..+....+.. ....... ..
T Consensus 187 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (371)
T 2xrw_A 187 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPK 266 (371)
T ss_dssp ---CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCC
T ss_pred eecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCcc
Confidence 688999999999998999999999999999999999999865332111100000 0000000 00
Q ss_pred Cc-----cccccc---CCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 217 GM-----EFIDSS---LDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 217 ~~-----~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.. ..+... ............+.+||.+||+.||++|||++|+++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 267 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp CCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00 000000 0011112235678899999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=286.79 Aligned_cols=247 Identities=17% Similarity=0.229 Sum_probs=177.9
Q ss_pred ceEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEee--------------------------
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQ-------------------------- 56 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-------------------------- 56 (309)
+||++. ..+|+.||||.+...... ..+|+++++.++||||+++++++..
T Consensus 22 ~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 97 (383)
T 3eb0_A 22 IVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVN 97 (383)
T ss_dssp EEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC-------------------------
T ss_pred EEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccccccccccccccccccccccc
Confidence 456664 568999999998654322 2479999999999999999999844
Q ss_pred ------------CCeeEEEEeccCCCChhHHHhh-hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEE
Q 021682 57 ------------REEKMLIYDYMPNKSLDFYIFD-LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNIL 123 (309)
Q Consensus 57 ------------~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil 123 (309)
....++||||+. ++|.+.+.. ...+..+++..+..++.||+.|+.|||+. |++||||||+||+
T Consensus 98 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---gi~H~Dikp~Nil 173 (383)
T 3eb0_A 98 NHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLL 173 (383)
T ss_dssp ------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEE
T ss_pred cccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---cCccCccCHHHEE
Confidence 334889999997 477777654 23455699999999999999999999998 9999999999999
Q ss_pred eC-CCCCceeecccccccccCCcccccccccccccCCCCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCc
Q 021682 124 LD-YEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNES 201 (309)
Q Consensus 124 ~~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~ 201 (309)
++ .++.+||+|||++......... ....++..|+|||.+.+. .++.++||||+||++|+|++|+.||......+.
T Consensus 174 ~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 250 (383)
T 3eb0_A 174 VNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQ 250 (383)
T ss_dssp EETTTTEEEECCCTTCEECCTTSCC---CCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred EcCCCCcEEEEECCCCcccCCCCCC---cCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHH
Confidence 97 6789999999999765443322 223678899999988775 489999999999999999999999865332221
Q ss_pred ccHHHHHHHH-------hhCCCCcccc-----cccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 202 LNLLEYAYGL-------WKNGEGMEFI-----DSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 202 ~~~~~~~~~~-------~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
...+...... -......... ........+...+..+.+||.+||+.||++|||+.|+++.
T Consensus 251 ~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 251 LVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAH 322 (383)
T ss_dssp HHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111100000 0000000000 0000000111123468899999999999999999999864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=271.39 Aligned_cols=236 Identities=23% Similarity=0.277 Sum_probs=183.5
Q ss_pred cceEEEEc-CCCcEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
+.||.+.. .+|+.||||.+... .......+.+|++++++++||||+++++++......++|||++.+++|.+++...
T Consensus 36 g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 115 (287)
T 2wei_A 36 GEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR 115 (287)
T ss_dssp EEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH
T ss_pred EEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhc
Confidence 35677765 48999999998654 2345678999999999999999999999999999999999999999998887543
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCC---CCceeecccccccccCCcccccccccccc
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYE---MNPKISDFGMARAFTKDECEANTGRIVGT 156 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~---~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 156 (309)
..+++..++.++.|++.|+.+||+. |++|+||+|+||+++.+ +.++|+|||++........ .....++
T Consensus 116 ---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~ 186 (287)
T 2wei_A 116 ---KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGT 186 (287)
T ss_dssp ---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS---CSCHHHH
T ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc---cccccCc
Confidence 3489999999999999999999998 99999999999999764 4699999999876544321 1223578
Q ss_pred cCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHH
Q 021682 157 YGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMR 236 (309)
Q Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
..|+|||.+.+. ++.++||||||+++|+|++|..||...... ... .....+...... ......+..
T Consensus 187 ~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~-~~~~~~~~~~~~------~~~~~~~~~ 252 (287)
T 2wei_A 187 AYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEY------DIL-KRVETGKYAFDL------PQWRTISDD 252 (287)
T ss_dssp HTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHH-HHHHHCCCCCCS------GGGTTSCHH
T ss_pred ccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHH------HHH-HHHHcCCCCCCc------hhhhhcCHH
Confidence 899999998764 789999999999999999999998543211 111 111111111000 000112337
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 237 CMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 237 l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
+.++|.+||+.||++|||++++++.
T Consensus 253 ~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 253 AKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHcccChhhCcCHHHHhcC
Confidence 8899999999999999999999973
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=279.23 Aligned_cols=237 Identities=21% Similarity=0.340 Sum_probs=178.5
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCCccceeeEEee------CCeeEEEEeccCCCChhH
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLTARL-QHVNLLPVLGICTQ------REEKMLIYDYMPNKSLDF 74 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~------~~~~~lv~e~~~~~~L~~ 74 (309)
+.||.+.. .+|+.||||.+.... .....+..|+.+++++ +||||+++++++.. ....++||||+.+++|.+
T Consensus 38 g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~ 116 (326)
T 2x7f_A 38 GQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD 116 (326)
T ss_dssp EEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHH
T ss_pred EEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHH
Confidence 35677764 589999999996543 3457889999999999 89999999999977 467899999999999999
Q ss_pred HHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccc
Q 021682 75 YIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIV 154 (309)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~ 154 (309)
++... ....+++..+..++.||+.|+.|||+. |++|+||+|+||+++.++.++|+|||++........ ......
T Consensus 117 ~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~ 190 (326)
T 2x7f_A 117 LIKNT-KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFI 190 (326)
T ss_dssp HHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC---------------
T ss_pred HHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCceecCcCcc--cccccc
Confidence 98543 234589999999999999999999998 899999999999999999999999999876543221 122346
Q ss_pred cccCCCCccccc-----cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcc
Q 021682 155 GTYGYVPPEYVR-----KGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSS 229 (309)
Q Consensus 155 ~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (309)
++..|+|||.+. +..++.++|||||||++|+|++|..||...... ........ ........ .
T Consensus 191 ~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~-~~~~~~~~----~-- 257 (326)
T 2x7f_A 191 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM------RALFLIPR-NPAPRLKS----K-- 257 (326)
T ss_dssp CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHH-SCCCCCSC----S--
T ss_pred CCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH------HHHHHhhc-CccccCCc----c--
Confidence 889999999986 456789999999999999999999998543211 11111111 11111111 1
Q ss_pred cHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 230 SAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 230 ~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.....+.++|.+||..||++|||++++++.
T Consensus 258 --~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 258 --KWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp --CSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred --ccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 112378899999999999999999999874
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=288.45 Aligned_cols=254 Identities=19% Similarity=0.243 Sum_probs=174.5
Q ss_pred cceEEEEcC---CCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEee--CCeeEEEEeccCCCChhHHHh
Q 021682 3 VAICQGRLP---NGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQ--REEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 3 ~~~~~~~~~---~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~ 77 (309)
+.||++... +++.||||.+.... ....+.+|+.++++++||||+++++++.. +...++||||+.+ +|.+++.
T Consensus 35 g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~ 111 (405)
T 3rgf_A 35 GHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIK 111 (405)
T ss_dssp -EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSE-EHHHHHH
T ss_pred eEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCC-CHHHHHH
Confidence 457777654 68899999996543 23567899999999999999999999954 6689999999964 7777764
Q ss_pred hhc------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEe----CCCCCceeecccccccccCCccc
Q 021682 78 DLR------RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL----DYEMNPKISDFGMARAFTKDECE 147 (309)
Q Consensus 78 ~~~------~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~----~~~~~~~l~Dfg~~~~~~~~~~~ 147 (309)
... ....+++..++.++.||+.||.|||+. ||+||||||+||++ +.++.+||+|||++.........
T Consensus 112 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~ 188 (405)
T 3rgf_A 112 FHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP 188 (405)
T ss_dssp HHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC--------
T ss_pred HhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcc
Confidence 322 122489999999999999999999998 89999999999999 67789999999999766543211
Q ss_pred -ccccccccccCCCCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCc------ccHHHHHHHHhhCC---C
Q 021682 148 -ANTGRIVGTYGYVPPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNES------LNLLEYAYGLWKNG---E 216 (309)
Q Consensus 148 -~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~------~~~~~~~~~~~~~~---~ 216 (309)
.......||..|+|||.+.+. .++.++|||||||++|+|++|.+||........ .............. .
T Consensus 189 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~ 268 (405)
T 3rgf_A 189 LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKD 268 (405)
T ss_dssp --------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTT
T ss_pred cccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhh
Confidence 122335689999999998874 589999999999999999999999964433110 01111111111100 0
Q ss_pred Ccccc-------------cccCCCcccH--------HHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 021682 217 GMEFI-------------DSSLDDSSSA--------WKLMRCMQVALLCVQENAADRPTMLEILVML 262 (309)
Q Consensus 217 ~~~~~-------------~~~~~~~~~~--------~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L 262 (309)
+.... .......... .....+.+||.+||+.||++|||++|+++.-
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp 335 (405)
T 3rgf_A 269 WEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 335 (405)
T ss_dssp CGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred cchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 00000 0000000000 0023678999999999999999999999874
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=284.11 Aligned_cols=249 Identities=19% Similarity=0.171 Sum_probs=185.2
Q ss_pred cceEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCC--------CCCccceeeEEe----eCCeeEEEEeccCC
Q 021682 3 VAICQGR-LPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQ--------HVNLLPVLGICT----QREEKMLIYDYMPN 69 (309)
Q Consensus 3 ~~~~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~~iv~~~~~~~----~~~~~~lv~e~~~~ 69 (309)
++||++. ..+|+.||||+++.. ....+.+.+|++++++++ |+||+++++++. .....++||||+ +
T Consensus 51 g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~ 128 (397)
T 1wak_A 51 STVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-G 128 (397)
T ss_dssp EEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCC-C
T ss_pred eeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEecc-C
Confidence 3567775 467999999999643 344567889999999885 788999999987 455899999999 4
Q ss_pred CChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCC---------------------
Q 021682 70 KSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM--------------------- 128 (309)
Q Consensus 70 ~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~--------------------- 128 (309)
+++.+.+... ....+++..++.++.||+.||.|||+++ |++||||||+||+++.++
T Consensus 129 ~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (397)
T 1wak_A 129 HHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPP 205 (397)
T ss_dssp CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHHHHHC----------
T ss_pred ccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCC
Confidence 5665555332 2345899999999999999999999964 799999999999998775
Q ss_pred ----------------------------CceeecccccccccCCcccccccccccccCCCCccccccCCCCccchhhhHH
Q 021682 129 ----------------------------NPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYG 180 (309)
Q Consensus 129 ----------------------------~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG 180 (309)
.++|+|||++...... .....||..|+|||.+.+..++.++||||||
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG 280 (397)
T 1wak_A 206 SGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVLIGSGYNTPADIWSTA 280 (397)
T ss_dssp -----------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHH
T ss_pred CCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhhcCCCCCcHHHHHHHH
Confidence 7999999999765433 2223679999999999998999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCcccHHHHHHHH---hhC--------C-CCccccccc---------C----------CCcc
Q 021682 181 VLLLQILGGKRTSCYYGPNESLNLLEYAYGL---WKN--------G-EGMEFIDSS---------L----------DDSS 229 (309)
Q Consensus 181 ~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~---~~~--------~-~~~~~~~~~---------~----------~~~~ 229 (309)
|++|+|++|..||......+........... ... . ....++... . ....
T Consensus 281 ~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (397)
T 1wak_A 281 CMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEW 360 (397)
T ss_dssp HHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCC
T ss_pred HHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhccc
Confidence 9999999999999765554432222111111 000 0 000011000 0 0112
Q ss_pred cHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 230 SAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 230 ~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.......+.+||.+||+.||++|||++|+++.
T Consensus 361 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 361 SQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred chhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 34456678999999999999999999999863
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=286.40 Aligned_cols=249 Identities=22% Similarity=0.234 Sum_probs=175.8
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcc-----------cHHHHHHHHHHHhcCCCCCccceeeEEee-----CCeeEEEEec
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQ-----------GLEEFENEVKLTARLQHVNLLPVLGICTQ-----REEKMLIYDY 66 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~ 66 (309)
+.||++...+|+.||||.+...... ..+.+.+|++++++++||||+++++++.. ....++||||
T Consensus 36 g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~ 115 (362)
T 3pg1_A 36 GAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTEL 115 (362)
T ss_dssp EEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEEC
T ss_pred EEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEcc
Confidence 4678887778999999998543211 23678999999999999999999999854 3368999999
Q ss_pred cCCCChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcc
Q 021682 67 MPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDEC 146 (309)
Q Consensus 67 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 146 (309)
+. ++|.+++.. ....+++..+..++.|++.|+.|||+. |++|+||||+||+++.++.++|+|||++........
T Consensus 116 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (362)
T 3pg1_A 116 MR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADAN 189 (362)
T ss_dssp CS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCTTC---------
T ss_pred CC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCCEEEEecCcccccccccc
Confidence 97 577777643 344589999999999999999999999 899999999999999999999999999865443321
Q ss_pred cccccccccccCCCCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH---------------
Q 021682 147 EANTGRIVGTYGYVPPEYVRK-GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYG--------------- 210 (309)
Q Consensus 147 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~--------------- 210 (309)
.....++..|+|||.+.+ ..++.++|||||||++|+|++|..||......+....+.....
T Consensus 190 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 266 (362)
T 3pg1_A 190 ---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSA 266 (362)
T ss_dssp ---------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHH
T ss_pred ---cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhh
Confidence 223467889999998877 6789999999999999999999999864332221111100000
Q ss_pred -HhhCCCCcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 211 -LWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 211 -~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.......... ...............+.++|.+||+.||++|||++|+++.
T Consensus 267 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 267 RDYLRNSLSNV-PARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHTTTCCCCC-CCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hHHHHhhcccC-ChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 0000000000 0000000001123468899999999999999999999975
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=279.25 Aligned_cols=251 Identities=17% Similarity=0.195 Sum_probs=179.0
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCe-------eEEEEeccCCCChhH
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREE-------KMLIYDYMPNKSLDF 74 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-------~~lv~e~~~~~~L~~ 74 (309)
+.||++.. .+|+.||||.+.... ........+++.++.++||||+++++++..... .++||||+.+ +|..
T Consensus 37 g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~ 114 (360)
T 3e3p_A 37 GTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHR 114 (360)
T ss_dssp --CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHH
T ss_pred eEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHH
Confidence 35666654 579999999986543 333566778888899999999999999866433 7899999976 4444
Q ss_pred HHh-hhccccCCCHHHHHHHHHHHHHHHHHHh--hcCCCceeecCCCCceEEeCC-CCCceeecccccccccCCcccccc
Q 021682 75 YIF-DLRRRYLLDWRTRVHIIEGITQGLLYLQ--EYSNLTIVHRDLKASNILLDY-EMNPKISDFGMARAFTKDECEANT 150 (309)
Q Consensus 75 ~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~lh--~~~~~gi~H~di~p~nil~~~-~~~~~l~Dfg~~~~~~~~~~~~~~ 150 (309)
.+. .......+++..+..++.|++.|+.+|| +. |++||||||+||+++. ++.++|+|||++.........
T Consensus 115 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~--- 188 (360)
T 3e3p_A 115 CCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN--- 188 (360)
T ss_dssp HHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSCC---
T ss_pred HHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCCc---
Confidence 332 2344556899999999999999999999 66 9999999999999997 899999999999766543322
Q ss_pred cccccccCCCCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHH--------HHHhhCC-CCccc
Q 021682 151 GRIVGTYGYVPPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYA--------YGLWKNG-EGMEF 220 (309)
Q Consensus 151 ~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~-~~~~~ 220 (309)
....|+..|+|||.+.+. .++.++|||||||++|+|++|..||...........+... ...+... .....
T Consensus 189 ~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (360)
T 3e3p_A 189 VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDL 268 (360)
T ss_dssp CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGG
T ss_pred ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccc
Confidence 223678999999998665 4799999999999999999999998653322211111110 0000000 00000
Q ss_pred cccc------CCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 221 IDSS------LDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 221 ~~~~------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.... ............+.+||.+||+.||++|||+.|+++.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 269 YNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp GCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred cccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000 0001111134578899999999999999999999986
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=286.28 Aligned_cols=183 Identities=21% Similarity=0.233 Sum_probs=152.7
Q ss_pred ceEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHHhcC------CCCCccceeeEEeeCCeeEEEEeccCCCChhHHH
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTSHQGLEEFENEVKLTARL------QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 76 (309)
.||++. ..+|+.||||+++.. ......+..|+++++.+ +|+||+++++++......++|||++. ++|.+++
T Consensus 112 ~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l 189 (429)
T 3kvw_A 112 QVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELI 189 (429)
T ss_dssp EEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHH
T ss_pred EEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHH
Confidence 456664 557999999999643 33345677788887766 57799999999999999999999996 6888887
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCC--ceeecccccccccCCcccccccccc
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMN--PKISDFGMARAFTKDECEANTGRIV 154 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~ 154 (309)
... ....+++..+..++.||+.||.|||+. ||+||||||+||+++.++. +||+|||++...... .....
T Consensus 190 ~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~-----~~~~~ 260 (429)
T 3kvw_A 190 KKN-KFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR-----VYTYI 260 (429)
T ss_dssp HHT-TTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC-----CCSSC
T ss_pred Hhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccceecCCc-----ccccC
Confidence 543 233489999999999999999999999 8999999999999999887 999999998654332 22246
Q ss_pred cccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 021682 155 GTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYG 197 (309)
Q Consensus 155 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~ 197 (309)
+++.|+|||.+.+..++.++|||||||++|+|++|.+||...+
T Consensus 261 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 261 QSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp SCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 7899999999999899999999999999999999999986543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=278.36 Aligned_cols=248 Identities=21% Similarity=0.248 Sum_probs=183.5
Q ss_pred cceEEEE-cCCCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeC-----CeeEEEEeccCCCChhHH
Q 021682 3 VAICQGR-LPNGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQR-----EEKMLIYDYMPNKSLDFY 75 (309)
Q Consensus 3 ~~~~~~~-~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~ 75 (309)
+.||++. ..+++.||||.+.... ......+.+|++++++++||||+++++++... ...++|||++. ++|.++
T Consensus 41 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~ 119 (364)
T 3qyz_A 41 GMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKL 119 (364)
T ss_dssp EEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHH
T ss_pred eEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHH
Confidence 3456665 4588999999997543 33456788999999999999999999998765 36899999997 588888
Q ss_pred HhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccc-cccccc
Q 021682 76 IFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEA-NTGRIV 154 (309)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~-~~~~~~ 154 (309)
+.. ..+++..+..++.|++.|+.|||++ |++||||||+||+++.++.++|+|||++.......... ......
T Consensus 120 l~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 192 (364)
T 3qyz_A 120 LKT----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192 (364)
T ss_dssp HHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCC
T ss_pred HHh----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccc
Confidence 732 3489999999999999999999998 99999999999999999999999999997665432211 123347
Q ss_pred cccCCCCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCC-----------ccccc
Q 021682 155 GTYGYVPPEYVRK-GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEG-----------MEFID 222 (309)
Q Consensus 155 ~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~ 222 (309)
||+.|+|||.+.+ ..++.++|||||||++|+|++|..||......+....+.. ....... .....
T Consensus 193 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~---~~~~~~~~~~~~~~~~~~~~~~~ 269 (364)
T 3qyz_A 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG---ILGSPSQEDLNCIINLKARNYLL 269 (364)
T ss_dssp SCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHH---HHCSCCHHHHHTCCCHHHHHHHH
T ss_pred cccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHH---HhCCCCHHHHHHhhhhhHHHHHH
Confidence 8999999998654 4589999999999999999999999965443332222111 1000000 00000
Q ss_pred ccCC-Cc-----ccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 223 SSLD-DS-----SSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 223 ~~~~-~~-----~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.... .. ........+.++|.+||+.||++|||++|+++.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 270 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp TSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 00 001122468899999999999999999999985
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=273.87 Aligned_cols=238 Identities=21% Similarity=0.265 Sum_probs=169.1
Q ss_pred cceEEEE-cCCCcEEEEEEeecCC-ccc-HHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh-
Q 021682 3 VAICQGR-LPNGQEMAVKRLSRTS-HQG-LEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD- 78 (309)
Q Consensus 3 ~~~~~~~-~~~g~~vavK~~~~~~-~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~- 78 (309)
+.||++. ..+|+.||||.++... ... ...+.++...++.++||||+++++++..+...++||||+++ +|.+++..
T Consensus 21 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~ 99 (290)
T 3fme_A 21 GVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDT-SLDKFYKQV 99 (290)
T ss_dssp EEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCSE-EHHHHHHHH
T ss_pred eEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhcc-chHHHHHHH
Confidence 3566665 4689999999996542 222 23344555567888999999999999999999999999974 78777644
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
......+++..+..++.|++.|+.|||++. |++|+||||+||+++.++.++|+|||++........ .....|++.
T Consensus 100 ~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~ 174 (290)
T 3fme_A 100 IDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA---KDIDAGCKP 174 (290)
T ss_dssp HHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC------------------CCCCC
T ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccccccccc---ccccCCCcc
Confidence 234556999999999999999999999853 799999999999999999999999999876544322 222368899
Q ss_pred CCCcccc----ccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHH
Q 021682 159 YVPPEYV----RKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKL 234 (309)
Q Consensus 159 y~aPE~~----~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
|+|||.+ .+..++.++||||||+++|+|++|..||....... .......... ...... ...+
T Consensus 175 y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~-~~~~~~--------~~~~ 240 (290)
T 3fme_A 175 YMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF-----QQLKQVVEEP-SPQLPA--------DKFS 240 (290)
T ss_dssp CSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH-----HHHHHHHHSC-CCCCCT--------TTSC
T ss_pred ccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH-----HHHHHHhccC-CCCccc--------ccCC
Confidence 9999996 45678899999999999999999999986432211 1111111111 111111 1122
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHH
Q 021682 235 MRCMQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 235 ~~l~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
..+.+++.+||+.||++|||++|+++
T Consensus 241 ~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 241 AEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 36889999999999999999999987
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=284.00 Aligned_cols=248 Identities=21% Similarity=0.239 Sum_probs=176.7
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeC------CeeEEEEeccCCCChhHH
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQR------EEKMLIYDYMPNKSLDFY 75 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~~L~~~ 75 (309)
++||++.. .+|+.||||.+..... ...+|++++++++|+||+++++++... ...++||||+.+ ++.+.
T Consensus 68 g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~ 142 (420)
T 1j1b_A 68 GVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRV 142 (420)
T ss_dssp EEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHH
T ss_pred EEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHH
Confidence 35677765 5799999999865422 234699999999999999999988542 246799999975 56555
Q ss_pred Hhh-hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCC-CCceeecccccccccCCccccccccc
Q 021682 76 IFD-LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYE-MNPKISDFGMARAFTKDECEANTGRI 153 (309)
Q Consensus 76 ~~~-~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~~ 153 (309)
+.. ......+++..+..++.||+.||.|||+. ||+||||||+||+++.+ +.+||+|||++........ ....
T Consensus 143 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~---~~~~ 216 (420)
T 1j1b_A 143 ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSY 216 (420)
T ss_dssp HHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSC
T ss_pred HHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhhcccCCC---ceee
Confidence 533 23355689999999999999999999998 99999999999999965 5689999999976543322 1224
Q ss_pred ccccCCCCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH-----HHh--hCCCCcccccccC
Q 021682 154 VGTYGYVPPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAY-----GLW--KNGEGMEFIDSSL 225 (309)
Q Consensus 154 ~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~-----~~~--~~~~~~~~~~~~~ 225 (309)
.++..|+|||.+.+. .++.++|||||||++|+|++|+.||......+....+.... ..+ .......+.-+..
T Consensus 217 ~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~ 296 (420)
T 1j1b_A 217 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 296 (420)
T ss_dssp CSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCC
T ss_pred eeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCcc
Confidence 679999999998765 78999999999999999999999986533222111111100 000 0011111100000
Q ss_pred CCc-----ccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 226 DDS-----SSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 226 ~~~-----~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
... ........+.+||.+||+.||++|||+.|+++.
T Consensus 297 ~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 297 KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp CCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 000 001123478899999999999999999999875
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=280.42 Aligned_cols=246 Identities=24% Similarity=0.293 Sum_probs=170.6
Q ss_pred cceEEEE-cCCCcEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeeEEeeC------CeeEEEEeccCCCChh
Q 021682 3 VAICQGR-LPNGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQR------EEKMLIYDYMPNKSLD 73 (309)
Q Consensus 3 ~~~~~~~-~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~~L~ 73 (309)
+.||++. ..+|+.||||.+... .......+.+|++++++++||||+++++++... ...++|+|++ +++|.
T Consensus 43 g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~ 121 (367)
T 2fst_X 43 GSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLN 121 (367)
T ss_dssp CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC
T ss_pred eEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHH
Confidence 3566665 568999999998653 233456788999999999999999999998654 4679999999 67898
Q ss_pred HHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccc
Q 021682 74 FYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRI 153 (309)
Q Consensus 74 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 153 (309)
+++.. ..+++..+..++.||+.|+.|||+. |++||||||+||+++.++.+||+|||++...... ....
T Consensus 122 ~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~ 189 (367)
T 2fst_X 122 NIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGY 189 (367)
T ss_dssp ---------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-------------------
T ss_pred HHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccccccccc-----CCCc
Confidence 88732 3589999999999999999999998 9999999999999999999999999998764432 2234
Q ss_pred ccccCCCCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHH-----hhCCC---Cccccccc
Q 021682 154 VGTYGYVPPEYVRK-GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGL-----WKNGE---GMEFIDSS 224 (309)
Q Consensus 154 ~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~-----~~~~~---~~~~~~~~ 224 (309)
.+|..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+..+....+....+. +..-. ...++...
T Consensus 190 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~ 269 (367)
T 2fst_X 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 269 (367)
T ss_dssp -CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTS
T ss_pred CcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhcc
Confidence 68999999999877 67899999999999999999999998654332211111110000 00000 00000000
Q ss_pred C---CCccc---HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 225 L---DDSSS---AWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 225 ~---~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
. ..... ......+.+||.+||+.||++|||++++++.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 270 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp CCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0 00000 0112367899999999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=271.42 Aligned_cols=238 Identities=22% Similarity=0.288 Sum_probs=178.8
Q ss_pred cceEEEEcCCCcEEEEEEeecC--CcccHHHHHHHHHHHhcCC--CCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 3 VAICQGRLPNGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQ--HVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
+.||++...+|+.||||.+... .....+.+.+|+.++++++ |+||+++++++..+...++||| +.+++|.+++..
T Consensus 42 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~ 120 (313)
T 3cek_A 42 SKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK 120 (313)
T ss_dssp EEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHH
T ss_pred EEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHh
Confidence 4678888788999999998654 3344577899999999996 5999999999999999999999 457899999854
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
...+++..+..++.|++.|+.|||++ |++|+||+|+||+++ ++.++|+|||++................|+..
T Consensus 121 ---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~ 193 (313)
T 3cek_A 121 ---KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVN 193 (313)
T ss_dssp ---CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCC--------------CCGG
T ss_pred ---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEE-CCeEEEeeccccccccCccccccccCCCCCCC
Confidence 34589999999999999999999998 999999999999996 58899999999976654433222334468999
Q ss_pred CCCcccccc-----------CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCC
Q 021682 159 YVPPEYVRK-----------GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDD 227 (309)
Q Consensus 159 y~aPE~~~~-----------~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (309)
|+|||.+.+ ..++.++||||||+++|+|++|..||..... ................+. .
T Consensus 194 y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~-----~ 263 (313)
T 3cek_A 194 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAIIDPNHEIEFP-----D 263 (313)
T ss_dssp GCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHHHCTTSCCCCC-----C
T ss_pred cCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-----HHHHHHHHHhcccccCCc-----c
Confidence 999999865 4678899999999999999999999853221 111111111111111111 1
Q ss_pred cccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHH
Q 021682 228 SSSAWKLMRCMQVALLCVQENAADRPTMLEILVML 262 (309)
Q Consensus 228 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L 262 (309)
. ....+.++|.+||+.||++|||++++++.-
T Consensus 264 ~----~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 264 I----PEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp C----SCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred c----chHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 1 123688999999999999999999999753
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=285.62 Aligned_cols=240 Identities=21% Similarity=0.273 Sum_probs=174.0
Q ss_pred CccceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 1 MSVAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 1 ~g~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
||+|++++. .+|+.||||.+... ..+.+..|+.+++++ +||||+++++++..+...++||||+. ++|.+++...
T Consensus 28 ~g~V~~~~~-~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~ 102 (434)
T 2rio_A 28 SGTVVFQGS-FQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESK 102 (434)
T ss_dssp TTCEEEEEE-SSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC
T ss_pred CeEEEEEEE-ECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhcc
Confidence 677777665 47999999998653 245678899999876 89999999999999999999999996 5999998543
Q ss_pred cccc----CCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCC-------------CCceeeccccccccc
Q 021682 80 RRRY----LLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYE-------------MNPKISDFGMARAFT 142 (309)
Q Consensus 80 ~~~~----~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~-------------~~~~l~Dfg~~~~~~ 142 (309)
.... ...+..++.++.||+.|+.|||++ |++||||||+||+++.+ +.++|+|||++....
T Consensus 103 ~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~ 179 (434)
T 2rio_A 103 NVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179 (434)
T ss_dssp ------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECC
T ss_pred CCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecC
Confidence 2211 112334577999999999999998 99999999999999754 479999999998765
Q ss_pred CCcccc--cccccccccCCCCcccccc-------CCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHh
Q 021682 143 KDECEA--NTGRIVGTYGYVPPEYVRK-------GIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLW 212 (309)
Q Consensus 143 ~~~~~~--~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~ 212 (309)
...... ......||+.|+|||.+.+ ..++.++|||||||++|+|++ |..||....... . ...
T Consensus 180 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~----~----~i~ 251 (434)
T 2rio_A 180 SGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE----S----NII 251 (434)
T ss_dssp C--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH----H----HHH
T ss_pred CCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH----H----HHh
Confidence 432211 1223468999999999865 567899999999999999998 899985322111 1 111
Q ss_pred hCCCCcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021682 213 KNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
....... ..........+..+.++|.+||+.||++|||+.++++
T Consensus 252 ~~~~~~~----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 252 RGIFSLD----EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HTCCCCC----CCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCCCCcc----cccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1110000 1111223345568889999999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=278.43 Aligned_cols=250 Identities=20% Similarity=0.232 Sum_probs=180.3
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEe--------------eCCeeEEEEecc
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICT--------------QREEKMLIYDYM 67 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--------------~~~~~~lv~e~~ 67 (309)
+.||++.. .+|+.||||.+........+.+.+|++++++++||||+++++++. .....++||||+
T Consensus 25 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~ 104 (320)
T 2i6l_A 25 GLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM 104 (320)
T ss_dssp -CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECC
T ss_pred eEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeecc
Confidence 35677765 469999999998776666788999999999999999999999873 346789999999
Q ss_pred CCCChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeC-CCCCceeecccccccccCCcc
Q 021682 68 PNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLD-YEMNPKISDFGMARAFTKDEC 146 (309)
Q Consensus 68 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~-~~~~~~l~Dfg~~~~~~~~~~ 146 (309)
. ++|.+++. ...+++..++.++.|++.|+++||++ |++|+||||+||+++ .++.++|+|||++........
T Consensus 105 ~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 176 (320)
T 2i6l_A 105 E-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176 (320)
T ss_dssp S-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEECCCTTCBCC-----
T ss_pred C-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcc
Confidence 7 58988873 23488999999999999999999998 999999999999997 567899999999976543211
Q ss_pred c-ccccccccccCCCCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHH--------HHHhhCCC
Q 021682 147 E-ANTGRIVGTYGYVPPEYVRK-GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYA--------YGLWKNGE 216 (309)
Q Consensus 147 ~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~ 216 (309)
. .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||......+........ ...... .
T Consensus 177 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 255 (320)
T 2i6l_A 177 HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLS-V 255 (320)
T ss_dssp ---CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHT-T
T ss_pred cccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhh-c
Confidence 1 11223456889999998765 67899999999999999999999998653321111100000 000000 0
Q ss_pred CcccccccCC-Cc-----ccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 217 GMEFIDSSLD-DS-----SSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 217 ~~~~~~~~~~-~~-----~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.......... .. .....+..+.++|.+||+.||++|||++++++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 256 IPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp SCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 0000000000 00 001123478899999999999999999999874
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=276.56 Aligned_cols=248 Identities=19% Similarity=0.207 Sum_probs=184.4
Q ss_pred cceEEEEc--CCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCC------CccceeeEEeeCCeeEEEEeccCCCChhH
Q 021682 3 VAICQGRL--PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHV------NLLPVLGICTQREEKMLIYDYMPNKSLDF 74 (309)
Q Consensus 3 ~~~~~~~~--~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~------~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (309)
+.||++.. .+|+.||||+++.. ....+.+..|+.+++.++|+ +++++++++..+...++||||+ +++|.+
T Consensus 28 g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~ 105 (339)
T 1z57_A 28 GKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYD 105 (339)
T ss_dssp EEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-CCBHHH
T ss_pred eEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-CCCHHH
Confidence 35677753 47899999999643 34456788999999888655 4999999999999999999999 789988
Q ss_pred HHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCC-------------------CCCceeecc
Q 021682 75 YIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY-------------------EMNPKISDF 135 (309)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~-------------------~~~~~l~Df 135 (309)
++... ....+++..+..++.|++.|+.|||++ |++||||||+||+++. ++.++|+||
T Consensus 106 ~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Df 181 (339)
T 1z57_A 106 FIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF 181 (339)
T ss_dssp HHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCC
T ss_pred HHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeC
Confidence 88543 233588999999999999999999998 9999999999999987 668999999
Q ss_pred cccccccCCcccccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHH----
Q 021682 136 GMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGL---- 211 (309)
Q Consensus 136 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~---- 211 (309)
|++...... .....|+..|+|||.+.+..++.++|||||||++|+|++|..||...+..+...........
T Consensus 182 g~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~ 256 (339)
T 1z57_A 182 GSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKH 256 (339)
T ss_dssp SSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHH
T ss_pred cccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 998754332 22346789999999999989999999999999999999999998654332211111111000
Q ss_pred -hhCCCCccccc-c---------------------cCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 212 -WKNGEGMEFID-S---------------------SLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 212 -~~~~~~~~~~~-~---------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
+........+. . .............+.++|.+||+.||++|||++|+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 257 MIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKH 329 (339)
T ss_dssp HHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcC
Confidence 00000000000 0 00011122345678899999999999999999999864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=275.10 Aligned_cols=248 Identities=21% Similarity=0.253 Sum_probs=180.7
Q ss_pred cceEEEEc--CCCcEEEEEEeecCC--cccHHHHHHHHHHHhcC---CCCCccceeeEEe-----eCCeeEEEEeccCCC
Q 021682 3 VAICQGRL--PNGQEMAVKRLSRTS--HQGLEEFENEVKLTARL---QHVNLLPVLGICT-----QREEKMLIYDYMPNK 70 (309)
Q Consensus 3 ~~~~~~~~--~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~-----~~~~~~lv~e~~~~~ 70 (309)
+.||++.. .+|+.||||.++... ......+.+|+.+++.+ +||||+++++++. .....++||||+. +
T Consensus 25 g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~ 103 (326)
T 1blx_A 25 GKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-Q 103 (326)
T ss_dssp EEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-C
T ss_pred EEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC-C
Confidence 46777765 478999999986432 22233556777776665 8999999999987 4567899999997 5
Q ss_pred ChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccc
Q 021682 71 SLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANT 150 (309)
Q Consensus 71 ~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 150 (309)
+|.+++.... ...+++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 104 ~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~ 176 (326)
T 1blx_A 104 DLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---AL 176 (326)
T ss_dssp BHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG---GG
T ss_pred CHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCcccccccCCC---Cc
Confidence 8988885432 33489999999999999999999998 99999999999999999999999999987654322 12
Q ss_pred cccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCC---CCc-------cc
Q 021682 151 GRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNG---EGM-------EF 220 (309)
Q Consensus 151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~-------~~ 220 (309)
....++..|+|||.+.+..++.++||||||+++|+|++|..||......+. ........... ... ..
T Consensus 177 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~ 253 (326)
T 1blx_A 177 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKILDVIGLPGEEDWPRDVALPRQA 253 (326)
T ss_dssp CCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCGGGSCTTCSSCGGG
T ss_pred cccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHHHcCCCCcccCccccccchhh
Confidence 234678999999999988899999999999999999999999864332211 11111110000 000 00
Q ss_pred ccccC---CCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 221 IDSSL---DDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 221 ~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
+.... ...........+.++|.+||+.||++|||+.++++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 254 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp SCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000 000011123467899999999999999999999953
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=283.47 Aligned_cols=236 Identities=19% Similarity=0.318 Sum_probs=172.6
Q ss_pred CccceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 1 MSVAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 1 ~g~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
||+|++++.. +|+.||||.+...... .+..|+.+++++ +||||+++++++..+...++|||++. ++|.+++...
T Consensus 37 ~G~V~~~~~~-~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~ 111 (432)
T 3p23_A 37 EGTIVYRGMF-DNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQK 111 (432)
T ss_dssp GGCEEEEEES-SSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSS
T ss_pred CEEEEEEEEe-CCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhc
Confidence 5777887765 7899999998654332 356799999999 89999999999999999999999996 5898888543
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCC---C--CCceeecccccccccCCccc-cccccc
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY---E--MNPKISDFGMARAFTKDECE-ANTGRI 153 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~---~--~~~~l~Dfg~~~~~~~~~~~-~~~~~~ 153 (309)
. .......+..++.||+.|+.|||+. |++||||||+||+++. + ..++|+|||++......... ......
T Consensus 112 ~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~ 186 (432)
T 3p23_A 112 D--FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGV 186 (432)
T ss_dssp S--CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------C
T ss_pred C--CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeecccc
Confidence 2 2344456678999999999999998 8999999999999953 2 35779999999766533211 122334
Q ss_pred ccccCCCCcccccc---CCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcc
Q 021682 154 VGTYGYVPPEYVRK---GIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSS 229 (309)
Q Consensus 154 ~~~~~y~aPE~~~~---~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (309)
.||+.|+|||.+.+ ..++.++|||||||++|+|++ |..||....... . ............ ..
T Consensus 187 ~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~----~----~~~~~~~~~~~~------~~ 252 (432)
T 3p23_A 187 PGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ----A----NILLGACSLDCL------HP 252 (432)
T ss_dssp CSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH----H----HHHTTCCCCTTS------CT
T ss_pred CCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH----H----HHHhccCCcccc------Cc
Confidence 68999999999873 566789999999999999999 888884321111 1 111111111111 11
Q ss_pred cHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021682 230 SAWKLMRCMQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 230 ~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
.......+.++|.+||+.||++|||++++++
T Consensus 253 ~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 253 EKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 1233446789999999999999999999994
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=274.50 Aligned_cols=185 Identities=20% Similarity=0.246 Sum_probs=151.6
Q ss_pred cceEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCC-CC-----CccceeeEEeeCCeeEEEEeccCCCChhHH
Q 021682 3 VAICQGR-LPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQ-HV-----NLLPVLGICTQREEKMLIYDYMPNKSLDFY 75 (309)
Q Consensus 3 ~~~~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (309)
+.||++. ..+|+.||||+++.. ......+..|+.+++.++ |+ +|+.+++++......++|||++. ++|.++
T Consensus 68 g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~ 145 (382)
T 2vx3_A 68 GQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDL 145 (382)
T ss_dssp EEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCC-CBHHHH
T ss_pred EEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCC-CCHHHH
Confidence 3567775 457899999999643 334566778888888874 54 49999999999999999999996 589888
Q ss_pred HhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeC--CCCCceeecccccccccCCccccccccc
Q 021682 76 IFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLD--YEMNPKISDFGMARAFTKDECEANTGRI 153 (309)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~--~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 153 (309)
+.... ...+++..+..++.|++.|+.|||+. ..||+||||||+||+++ .++.+||+|||++...... ....
T Consensus 146 l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~-----~~~~ 218 (382)
T 2vx3_A 146 LRNTN-FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR-----IYQY 218 (382)
T ss_dssp HHHTT-TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC-----CCSS
T ss_pred HhhcC-cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCceecccc-----cccc
Confidence 85432 23489999999999999999999952 23899999999999995 4678999999999765432 1224
Q ss_pred ccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCC
Q 021682 154 VGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYY 196 (309)
Q Consensus 154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~ 196 (309)
.+++.|+|||.+.+..++.++|||||||++|+|++|.+||...
T Consensus 219 ~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 219 IQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 6789999999999999999999999999999999999999654
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=279.36 Aligned_cols=248 Identities=21% Similarity=0.269 Sum_probs=180.3
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeC-----CeeEEEEeccCCCChhHH
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQR-----EEKMLIYDYMPNKSLDFY 75 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~ 75 (309)
+.||++.. .+|+.||||.+.... ......+.+|+.++++++||||+++++++..+ ...++|||++. ++|.++
T Consensus 25 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~ 103 (353)
T 2b9h_A 25 GVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRV 103 (353)
T ss_dssp EEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHH
T ss_pred eEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHH
Confidence 35677764 479999999996432 33456788999999999999999999987664 57899999996 588888
Q ss_pred HhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccc-------
Q 021682 76 IFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEA------- 148 (309)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~------- 148 (309)
+.. ..+++..+..++.|++.|+.|||+. |++||||||+||+++.++.++|+|||++..........
T Consensus 104 ~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 176 (353)
T 2b9h_A 104 IST----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176 (353)
T ss_dssp HHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC-------------
T ss_pred Hhh----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccc
Confidence 743 3489999999999999999999998 99999999999999999999999999997654322111
Q ss_pred -cccccccccCCCCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCc---c----
Q 021682 149 -NTGRIVGTYGYVPPEYVRK-GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGM---E---- 219 (309)
Q Consensus 149 -~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~---- 219 (309)
......|+..|+|||.+.+ ..++.++|||||||++|+|++|..||...+.... .............. .
T Consensus 177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 253 (353)
T 2b9h_A 177 SGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ---LLLIFGIIGTPHSDNDLRCIES 253 (353)
T ss_dssp ---CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCSTTTTTTCCC
T ss_pred cchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHHHhCCCchhcccccccc
Confidence 1122467899999998754 6789999999999999999999999864332111 11111111000000 0
Q ss_pred -----cccccC---CC---cccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 220 -----FIDSSL---DD---SSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 220 -----~~~~~~---~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
...... .. .........+.++|.+||+.||++|||++++++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 254 PRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred chhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000 00 0001123477899999999999999999999985
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=274.03 Aligned_cols=241 Identities=22% Similarity=0.289 Sum_probs=177.4
Q ss_pred cceEEEE-cCCCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCee------EEEEeccCCCChh
Q 021682 3 VAICQGR-LPNGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEK------MLIYDYMPNKSLD 73 (309)
Q Consensus 3 ~~~~~~~-~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~------~lv~e~~~~~~L~ 73 (309)
+.||++. ..+|+.||||.+.... ......+.+|+.+++.++||||+++++++...... ++||||+. ++|.
T Consensus 56 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~ 134 (371)
T 4exu_A 56 GSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQ 134 (371)
T ss_dssp EEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHH
T ss_pred eEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHH
Confidence 3566665 4589999999997542 33356788999999999999999999999877654 99999996 5777
Q ss_pred HHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccc
Q 021682 74 FYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRI 153 (309)
Q Consensus 74 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 153 (309)
+++ ...+++..+..++.|++.|+.|||+. |++||||||+||+++.++.++|+|||++...... ....
T Consensus 135 ~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-----~~~~ 201 (371)
T 4exu_A 135 KIM-----GMEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGY 201 (371)
T ss_dssp HHT-----TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC-------------CT
T ss_pred HHh-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcccccccC-----cCCc
Confidence 665 22389999999999999999999999 9999999999999999999999999998754432 2224
Q ss_pred ccccCCCCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccc-----------
Q 021682 154 VGTYGYVPPEYVRK-GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFI----------- 221 (309)
Q Consensus 154 ~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------- 221 (309)
.+++.|+|||.+.+ ..++.++|||||||++|+|++|..||...+..+....+. ... ........
T Consensus 202 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~---~~~-~~~~~~~~~~~~~~~~~~~ 277 (371)
T 4exu_A 202 VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL---KVT-GVPGTEFVQKLNDKAAKSY 277 (371)
T ss_dssp TCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---HHH-CCCCHHHHTTCSCHHHHHH
T ss_pred ccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH---HHh-CCCcHHHHHHhhhhhhhhh
Confidence 67899999999877 678999999999999999999999986433221111110 000 00000000
Q ss_pred -c---ccCCCc---ccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 222 -D---SSLDDS---SSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 222 -~---~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
. ...... ........+.+||.+||+.||++|||++|+++.
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 278 IQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0 000000 001123478899999999999999999999976
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=268.84 Aligned_cols=238 Identities=22% Similarity=0.317 Sum_probs=174.4
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEee-------------CCeeEEEEeccC
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQ-------------REEKMLIYDYMP 68 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-------------~~~~~lv~e~~~ 68 (309)
+.||.+.. .+|+.||||.+... ....+.+.+|+.++++++||||+++++++.. ....++||||++
T Consensus 20 g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~ 98 (303)
T 1zy4_A 20 GQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCE 98 (303)
T ss_dssp EEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCC
T ss_pred EEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCC
Confidence 35677764 58999999999643 3345778899999999999999999998765 356899999999
Q ss_pred CCChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcc--
Q 021682 69 NKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDEC-- 146 (309)
Q Consensus 69 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~-- 146 (309)
+++|.+++.. ....+++..++.++.|++.|+.+||++ |++|+||+|+||+++.++.++|+|||++........
T Consensus 99 ~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 173 (303)
T 1zy4_A 99 NGTLYDLIHS--ENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173 (303)
T ss_dssp SCBHHHHHHH--SCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-----
T ss_pred CCCHHHhhhc--cccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchh
Confidence 9999999854 234478889999999999999999998 899999999999999999999999999876543211
Q ss_pred ----------cccccccccccCCCCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCC
Q 021682 147 ----------EANTGRIVGTYGYVPPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNG 215 (309)
Q Consensus 147 ----------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 215 (309)
........|+..|+|||.+.+. .++.++|||||||++|+|++ ||.. ...... ........
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~-----~~~~~~-~~~~~~~~ 244 (303)
T 1zy4_A 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST-----GMERVN-ILKKLRSV 244 (303)
T ss_dssp --------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS-----HHHHHH-HHHHHHST
T ss_pred ccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC-----chhHHH-HHHhcccc
Confidence 1112234688899999998765 68999999999999999997 3321 011111 11111111
Q ss_pred CCcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 216 EGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
. .. ............+.++|.+||+.||++|||++++++.
T Consensus 245 ~-~~-----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 245 S-IE-----FPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp T-CC-----CCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred c-cc-----cCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 1 00 1111112223367899999999999999999999963
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=272.42 Aligned_cols=238 Identities=19% Similarity=0.210 Sum_probs=156.9
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEee----CCeeEEEEeccCCCChhHHHh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQ----REEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~ 77 (309)
+.||++.. .+|+.||||++... .....+....++.++||||+++++++.. +...++||||+.+++|.+++.
T Consensus 43 g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~ 118 (336)
T 3fhr_A 43 GKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQ 118 (336)
T ss_dssp EEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHH
T ss_pred eEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHH
Confidence 45677765 47999999998643 1222233334566799999999999876 446899999999999999985
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCC---CCceeecccccccccCCcccccccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYE---MNPKISDFGMARAFTKDECEANTGRIV 154 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~---~~~~l~Dfg~~~~~~~~~~~~~~~~~~ 154 (309)
.. ....+++..++.++.|++.|+.|||+. |++||||||+||+++.+ +.++|+|||++....... .....
T Consensus 119 ~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~ 190 (336)
T 3fhr_A 119 ER-GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA----LQTPC 190 (336)
T ss_dssp TC--CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-------------
T ss_pred hc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccceeccccc----cccCC
Confidence 43 234589999999999999999999999 99999999999999864 459999999987654332 22346
Q ss_pred cccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHH
Q 021682 155 GTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKL 234 (309)
Q Consensus 155 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
+++.|+|||.+.+..++.++||||||+++|+|++|..||.............. ...... ..+ ........+
T Consensus 191 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~---~~~~~~-~~~-----~~~~~~~~~ 261 (336)
T 3fhr_A 191 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR---RIRLGQ-YGF-----PNPEWSEVS 261 (336)
T ss_dssp -------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------CC-----CTTTSTTCC
T ss_pred CCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH---hhhccc-ccc-----CchhhccCC
Confidence 78999999999888889999999999999999999999864333221100000 000000 000 000001123
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 235 MRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 235 ~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
..+.++|.+||+.||++|||++++++.
T Consensus 262 ~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 262 EDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 378899999999999999999999985
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=273.26 Aligned_cols=249 Identities=16% Similarity=0.189 Sum_probs=181.7
Q ss_pred cceEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCC-----------CCCccceeeEEeeCC----eeEEEEec
Q 021682 3 VAICQGR-LPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQ-----------HVNLLPVLGICTQRE----EKMLIYDY 66 (309)
Q Consensus 3 ~~~~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~~~~~~~~~~----~~~lv~e~ 66 (309)
+.||.+. ..+|+.||||++... ......+..|+.++++++ |+||+++++++.... ..++|||+
T Consensus 33 g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~ 111 (373)
T 1q8y_A 33 STVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEV 111 (373)
T ss_dssp EEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECC
T ss_pred eEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEec
Confidence 3567776 468999999999643 334567888999988875 889999999988654 78999999
Q ss_pred cCCCChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeC------CCCCceeeccccccc
Q 021682 67 MPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLD------YEMNPKISDFGMARA 140 (309)
Q Consensus 67 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~------~~~~~~l~Dfg~~~~ 140 (309)
+ +++|.+++.... ...+++..+..++.||+.||.|||++. |++|+||||+||+++ ..+.++|+|||++..
T Consensus 112 ~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~ 187 (373)
T 1q8y_A 112 L-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 187 (373)
T ss_dssp C-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEE
T ss_pred C-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcCcceEEEcccccccc
Confidence 9 889999885432 344899999999999999999999964 799999999999995 344799999999976
Q ss_pred ccCCcccccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHh---hC---
Q 021682 141 FTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLW---KN--- 214 (309)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~---~~--- 214 (309)
..... ....+|..|+|||.+.+..++.++|||||||++|+|++|..||................... ..
T Consensus 188 ~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~ 262 (373)
T 1q8y_A 188 YDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPS 262 (373)
T ss_dssp TTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCH
T ss_pred cCCCC-----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCH
Confidence 54321 22367899999999999999999999999999999999999997554332221111111110 00
Q ss_pred -----CC----------Ccccccc----------cCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 215 -----GE----------GMEFIDS----------SLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 215 -----~~----------~~~~~~~----------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.. ....+.. ......+......+.+||.+||+.||++|||++|+++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 263 YLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 334 (373)
T ss_dssp HHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred HHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhC
Confidence 00 0000000 00112234556788999999999999999999999974
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=277.24 Aligned_cols=244 Identities=21% Similarity=0.247 Sum_probs=177.5
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCe------eEEEEeccCCCChh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQREE------KMLIYDYMPNKSLD 73 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------~~lv~e~~~~~~L~ 73 (309)
+.||++.. .+|+.||||.+.... ......+.+|+.++++++||||+++++++..... .++||||+. ++|.
T Consensus 38 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~ 116 (353)
T 3coi_A 38 GSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQ 116 (353)
T ss_dssp EEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGG
T ss_pred eEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHH
Confidence 35677754 589999999996542 3335678899999999999999999999987653 499999997 5777
Q ss_pred HHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccc
Q 021682 74 FYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRI 153 (309)
Q Consensus 74 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 153 (309)
+++. ..+++..+..++.|++.|+.|||++ |++|+||+|+||+++.++.++|+|||++...... ....
T Consensus 117 ~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-----~~~~ 183 (353)
T 3coi_A 117 KIMG-----LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGY 183 (353)
T ss_dssp GTTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC-------------
T ss_pred HHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCCCCC-----cccc
Confidence 6652 2389999999999999999999998 9999999999999999999999999998754432 1223
Q ss_pred ccccCCCCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHH-----hhCC----------CC
Q 021682 154 VGTYGYVPPEYVRK-GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGL-----WKNG----------EG 217 (309)
Q Consensus 154 ~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~-----~~~~----------~~ 217 (309)
.++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+..+....+...... +... ..
T Consensus 184 ~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (353)
T 3coi_A 184 VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSL 263 (353)
T ss_dssp CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTS
T ss_pred ccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhC
Confidence 67899999998877 67899999999999999999999998654322111111000000 0000 00
Q ss_pred cccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 218 MEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
........ ..........+.++|.+||+.||++|||++++++.
T Consensus 264 ~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 264 PQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp CBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred cCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000000 00111223478899999999999999999999975
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=297.55 Aligned_cols=241 Identities=20% Similarity=0.300 Sum_probs=185.5
Q ss_pred cceEEEEcC----CCcEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 3 VAICQGRLP----NGQEMAVKRLSRT-SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 3 ~~~~~~~~~----~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
+.||+|... .+..||||.++.. .....+.+.+|+.++++++||||+++++++. ++..++||||+.+++|.+++.
T Consensus 404 G~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~ 482 (656)
T 2j0j_A 404 GDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQ 482 (656)
T ss_dssp CCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHH
T ss_pred EEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHH
Confidence 467777653 3567999998654 3344578899999999999999999999985 456899999999999999985
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
. ....+++..++.++.|++.|+.|||++ |++||||||+||+++.++.+||+|||++......... ......++.
T Consensus 483 ~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~~t~ 556 (656)
T 2j0j_A 483 V--RKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPI 556 (656)
T ss_dssp H--TTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-----------CCG
T ss_pred h--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecCCCcce-eccCCCCCc
Confidence 3 234589999999999999999999998 9999999999999999999999999999765443221 122235677
Q ss_pred CCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHH
Q 021682 158 GYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMR 236 (309)
Q Consensus 158 ~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
.|+|||.+.+..++.++||||||+++|+|++ |..||......+ ... .......... +...+..
T Consensus 557 ~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---~~~----~i~~~~~~~~---------~~~~~~~ 620 (656)
T 2j0j_A 557 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIG----RIENGERLPM---------PPNCPPT 620 (656)
T ss_dssp GGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHH----HHHHTCCCCC---------CTTCCHH
T ss_pred ceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH---HHH----HHHcCCCCCC---------CccccHH
Confidence 8999999998899999999999999999997 889986432211 111 1111111111 1112347
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHHHhccc
Q 021682 237 CMQVALLCVQENAADRPTMLEILVMLKSET 266 (309)
Q Consensus 237 l~~li~~~l~~~p~~Rpt~~ell~~L~~~~ 266 (309)
+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 621 l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 621 LYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 889999999999999999999999998764
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=271.67 Aligned_cols=242 Identities=22% Similarity=0.296 Sum_probs=162.4
Q ss_pred cceEEEEc-CCCcEEEEEEeecCC-cccHHHHHHHHH-HHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTS-HQGLEEFENEVK-LTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
+.||++.. .+|+.||||.+.... ......+..|+. +++.++||||+++++++..++..++||||+.+ +|.+++...
T Consensus 36 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~ 114 (327)
T 3aln_A 36 GSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYV 114 (327)
T ss_dssp EEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHH
T ss_pred EEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHH
Confidence 35677765 579999999997653 233345555665 67778999999999999999999999999975 777776432
Q ss_pred --ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccccc
Q 021682 80 --RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 80 --~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
.....+++..+..++.+++.|+.+||+.. |++|+||+|+||+++.++.+||+|||++........ .....|+.
T Consensus 115 ~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~ 189 (327)
T 3aln_A 115 YSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA---KTRDAGCR 189 (327)
T ss_dssp HHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC-----------------
T ss_pred HhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceecccccc---cccCCCCc
Confidence 12456899999999999999999999863 799999999999999999999999999876543321 12236889
Q ss_pred CCCCcccc----ccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHH
Q 021682 158 GYVPPEYV----RKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWK 233 (309)
Q Consensus 158 ~y~aPE~~----~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
.|+|||.+ .+..++.++||||||+++|+|++|..||........ .. .......... .........
T Consensus 190 ~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~-~~~~~~~~~~-----~~~~~~~~~ 258 (327)
T 3aln_A 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QL-TQVVKGDPPQ-----LSNSEEREF 258 (327)
T ss_dssp ----------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCCCSCCCC-----CCCCSSCCC
T ss_pred cccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HH-HHHhcCCCCC-----CCCcccccC
Confidence 99999998 456689999999999999999999999864322110 00 0000000001 111111112
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 234 LMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 234 ~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
...+.++|.+||+.||++|||++++++.
T Consensus 259 ~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 259 SPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 3378899999999999999999999763
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=266.21 Aligned_cols=238 Identities=20% Similarity=0.279 Sum_probs=168.6
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCcc-c-HHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSHQ-G-LEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~~-~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
+.||++.. .+|+.||||.+...... . ...+.++..+++.++||||+++++++..+...++||||+ ++.+..+...
T Consensus 39 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~- 116 (318)
T 2dyl_A 39 GQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKR- 116 (318)
T ss_dssp -CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHH-
T ss_pred eeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHH-
Confidence 35677765 47999999999765322 2 233445556678889999999999999999999999999 5556555432
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
....+++..+..++.|++.|+.|||+.+ |++|+||+|+||+++.++.++|+|||++........ .....++..|
T Consensus 117 -~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y 190 (318)
T 2dyl_A 117 -MQGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA---KDRSAGCAAY 190 (318)
T ss_dssp -HTSCCCHHHHHHHHHHHHHHHHHHHHHH--CCCCCCCCGGGEEECTTSCEEECCCTTC-----------------CCTT
T ss_pred -hccCCCHHHHHHHHHHHHHHHHHHHhhC--CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc---ccccCCCccc
Confidence 2345899999999999999999999843 899999999999999999999999999865543321 2223688999
Q ss_pred CCccccc-----cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHH
Q 021682 160 VPPEYVR-----KGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKL 234 (309)
Q Consensus 160 ~aPE~~~-----~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
+|||.+. +..++.++||||||+++|+|++|..||...... ........... ... +... . ..+
T Consensus 191 ~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~-~~~-~~~~--~----~~~ 257 (318)
T 2dyl_A 191 MAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-----FEVLTKVLQEE-PPL-LPGH--M----GFS 257 (318)
T ss_dssp CCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHHSC-CCC-CCSS--S----CCC
T ss_pred cChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----HHHHHHHhccC-CCC-CCcc--C----CCC
Confidence 9999984 456788999999999999999999998642211 11111111111 111 0000 0 112
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 235 MRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 235 ~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
..+.++|.+||+.||.+|||++++++.
T Consensus 258 ~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 258 GDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 368899999999999999999999874
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=271.88 Aligned_cols=248 Identities=17% Similarity=0.216 Sum_probs=180.5
Q ss_pred cceEEEEc-CCC-cEEEEEEeecCCcccHHHHHHHHHHHhcCCCCC------ccceeeEEeeCCeeEEEEeccCCCChhH
Q 021682 3 VAICQGRL-PNG-QEMAVKRLSRTSHQGLEEFENEVKLTARLQHVN------LLPVLGICTQREEKMLIYDYMPNKSLDF 74 (309)
Q Consensus 3 ~~~~~~~~-~~g-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~------iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (309)
+.||++.. .++ +.||||+++.. ....+.+..|+.++++++|++ ++.+++++......++|||++ ++++.+
T Consensus 33 g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~ 110 (355)
T 2eu9_A 33 GKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFE 110 (355)
T ss_dssp EEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECC-CCBHHH
T ss_pred eEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEecc-CCChHH
Confidence 35677754 344 78999999643 344567888999999886555 889999999999999999999 556666
Q ss_pred HHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEe-------------------CCCCCceeecc
Q 021682 75 YIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL-------------------DYEMNPKISDF 135 (309)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~-------------------~~~~~~~l~Df 135 (309)
++... ....+++..+..++.||+.||.|||++ |++|+||||+||++ +.++.++|+||
T Consensus 111 ~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Df 186 (355)
T 2eu9_A 111 FLKEN-NFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 186 (355)
T ss_dssp HHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCC
T ss_pred HHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeec
Confidence 66432 234589999999999999999999998 99999999999999 56788999999
Q ss_pred cccccccCCcccccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH-----
Q 021682 136 GMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYG----- 210 (309)
Q Consensus 136 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~----- 210 (309)
|++....... ....|+..|+|||.+.+..++.++|||||||++|+|++|..||......+..........
T Consensus 187 g~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~ 261 (355)
T 2eu9_A 187 GSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSH 261 (355)
T ss_dssp TTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred Cccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHH
Confidence 9997543322 224689999999999998999999999999999999999999864332221111111100
Q ss_pred HhhCCCCccc-ccc---------------------cCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 211 LWKNGEGMEF-IDS---------------------SLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 211 ~~~~~~~~~~-~~~---------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.+........ ... .............+.+||.+||+.||++|||++|+++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 334 (355)
T 2eu9_A 262 MIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLH 334 (355)
T ss_dssp HHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000000000 000 00011122335578899999999999999999999853
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=273.37 Aligned_cols=226 Identities=22% Similarity=0.310 Sum_probs=179.2
Q ss_pred cceEEEE-cCCCcEEEEEEeecCCcc------cHHHHHHHHHHHhcCC--CCCccceeeEEeeCCeeEEEEeccCC-CCh
Q 021682 3 VAICQGR-LPNGQEMAVKRLSRTSHQ------GLEEFENEVKLTARLQ--HVNLLPVLGICTQREEKMLIYDYMPN-KSL 72 (309)
Q Consensus 3 ~~~~~~~-~~~g~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~-~~L 72 (309)
+.||++. ..+|+.||||.+...... ....+..|+.++++++ |+||+++++++..+...++|+|++.+ ++|
T Consensus 57 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L 136 (320)
T 3a99_A 57 GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDL 136 (320)
T ss_dssp CEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEH
T ss_pred eEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccH
Confidence 3567775 468999999999754211 2245678999999995 59999999999999999999999976 899
Q ss_pred hHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeC-CCCCceeecccccccccCCccccccc
Q 021682 73 DFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLD-YEMNPKISDFGMARAFTKDECEANTG 151 (309)
Q Consensus 73 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~-~~~~~~l~Dfg~~~~~~~~~~~~~~~ 151 (309)
.+++.. ...+++..++.++.|++.||.|||+. |++||||+|+||+++ .++.+||+|||++....... ..
T Consensus 137 ~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~----~~ 206 (320)
T 3a99_A 137 FDFITE---RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YT 206 (320)
T ss_dssp HHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCSSC----BC
T ss_pred HHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCcccccccccc----cc
Confidence 998854 34589999999999999999999998 999999999999999 67899999999987655432 22
Q ss_pred ccccccCCCCccccccCCC-CccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCccc
Q 021682 152 RIVGTYGYVPPEYVRKGIY-SMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSS 230 (309)
Q Consensus 152 ~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (309)
...|+..|+|||.+.+..+ +.++||||||+++|+|++|..||.... . ...... .+ ...
T Consensus 207 ~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--------~----~~~~~~---~~----~~~-- 265 (320)
T 3a99_A 207 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------E----IIRGQV---FF----RQR-- 265 (320)
T ss_dssp CCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------H----HHHCCC---CC----SSC--
T ss_pred CCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--------h----hhcccc---cc----ccc--
Confidence 2468899999999877665 688999999999999999999985310 0 011100 01 111
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 231 AWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 231 ~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
....+.++|.+||+.||++|||++++++.
T Consensus 266 --~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 266 --VSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp --CCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 12378899999999999999999999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=271.17 Aligned_cols=226 Identities=23% Similarity=0.349 Sum_probs=174.1
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCcc------cHHHHHHHHHHHhcC----CCCCccceeeEEeeCCeeEEEEec-cCCC
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSHQ------GLEEFENEVKLTARL----QHVNLLPVLGICTQREEKMLIYDY-MPNK 70 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~~------~~~~~~~e~~~l~~l----~h~~iv~~~~~~~~~~~~~lv~e~-~~~~ 70 (309)
+.||++.. .+|+.||||.+...... ....+..|+.+++++ +|+||+++++++...+..++|+|+ +.++
T Consensus 45 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 124 (312)
T 2iwi_A 45 GTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQ 124 (312)
T ss_dssp EEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEE
T ss_pred EEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCC
Confidence 35677754 57999999999654321 223455788888888 899999999999999999999999 7889
Q ss_pred ChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeC-CCCCceeecccccccccCCccccc
Q 021682 71 SLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLD-YEMNPKISDFGMARAFTKDECEAN 149 (309)
Q Consensus 71 ~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~-~~~~~~l~Dfg~~~~~~~~~~~~~ 149 (309)
+|.+++.. ...+++..++.++.|++.|+.|||+. |++|+||+|+||+++ .++.++|+|||++.......
T Consensus 125 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~---- 194 (312)
T 2iwi_A 125 DLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP---- 194 (312)
T ss_dssp EHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEECCCSSCEECCSSC----
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEEEEcchhhhcccCc----
Confidence 99999854 33489999999999999999999999 899999999999999 78999999999987665432
Q ss_pred ccccccccCCCCccccccCCC-CccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCc
Q 021682 150 TGRIVGTYGYVPPEYVRKGIY-SMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDS 228 (309)
Q Consensus 150 ~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (309)
.....++..|+|||.+.+..+ +.++||||||+++|+|++|..||.... . ..... .. ..
T Consensus 195 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~----~~~~~--~~-----~~-- 253 (312)
T 2iwi_A 195 YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--------E----ILEAE--LH-----FP-- 253 (312)
T ss_dssp BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------H----HHHTC--CC-----CC--
T ss_pred ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--------H----Hhhhc--cC-----Cc--
Confidence 223457899999999877665 458999999999999999999985310 0 00000 00 00
Q ss_pred ccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 229 SSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 229 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
......+.++|.+||+.||++|||++|+++.
T Consensus 254 --~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 254 --AHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp --TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred --ccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122367899999999999999999999975
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=290.99 Aligned_cols=248 Identities=21% Similarity=0.265 Sum_probs=182.0
Q ss_pred ceEEEEc-CCCcEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeeEEee------CCeeEEEEeccCCCChhHH
Q 021682 4 AICQGRL-PNGQEMAVKRLSRT-SHQGLEEFENEVKLTARLQHVNLLPVLGICTQ------REEKMLIYDYMPNKSLDFY 75 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~lv~e~~~~~~L~~~ 75 (309)
.||.+.. .+|+.||||.++.. .....+.+..|++++++++||||+++++++.. +...++||||+.+++|.++
T Consensus 29 ~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~ 108 (676)
T 3qa8_A 29 YVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKY 108 (676)
T ss_dssp BCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHH
T ss_pred EEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHH
Confidence 4566654 57999999998654 34456778999999999999999999998765 5678999999999999999
Q ss_pred HhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCC---ceeecccccccccCCcccccccc
Q 021682 76 IFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMN---PKISDFGMARAFTKDECEANTGR 152 (309)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~---~~l~Dfg~~~~~~~~~~~~~~~~ 152 (309)
+........+++..++.++.+++.|+.|||+. |++||||+|+||+++.++. ++|+|||++........ ...
T Consensus 109 L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~---~~~ 182 (676)
T 3qa8_A 109 LNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTE 182 (676)
T ss_dssp HHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCC---CCC
T ss_pred HHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccccccccccccc---ccc
Confidence 86655455688999999999999999999998 9999999999999997765 89999999976554322 223
Q ss_pred cccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCccc--HHHHHHHH-hhCC--CCccccccc--C
Q 021682 153 IVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLN--LLEYAYGL-WKNG--EGMEFIDSS--L 225 (309)
Q Consensus 153 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~--~~~~~~~~-~~~~--~~~~~~~~~--~ 225 (309)
..|+..|+|||.+.+..++.++||||||+++|+|++|..||.......... ........ .... .....+... .
T Consensus 183 ~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~ 262 (676)
T 3qa8_A 183 FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPT 262 (676)
T ss_dssp CCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCC
T ss_pred ccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCC
Confidence 468999999999999999999999999999999999999985421100000 00000000 0000 000000000 1
Q ss_pred CCcccHHHHHHHHHHHhhcccCCCCCCCCHHH
Q 021682 226 DDSSSAWKLMRCMQVALLCVQENAADRPTMLE 257 (309)
Q Consensus 226 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~e 257 (309)
...........+.++|.+||+.||++|||+++
T Consensus 263 p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 263 PNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp SCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred chhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 11223335568889999999999999999976
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=284.49 Aligned_cols=224 Identities=21% Similarity=0.233 Sum_probs=175.9
Q ss_pred cceEEEEcC--CCcEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCe-----eEEEEeccCCCChhH
Q 021682 3 VAICQGRLP--NGQEMAVKRLSRT-SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREE-----KMLIYDYMPNKSLDF 74 (309)
Q Consensus 3 ~~~~~~~~~--~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-----~~lv~e~~~~~~L~~ 74 (309)
+.||.+... +|+.||||.+... .......+..|++++++++||||+++++++..... .++||||+++++|.+
T Consensus 94 g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~ 173 (681)
T 2pzi_A 94 GWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKR 173 (681)
T ss_dssp EEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC-
T ss_pred eEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHH
Confidence 356777653 6899999998654 33445678899999999999999999999987665 799999999999988
Q ss_pred HHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccc
Q 021682 75 YIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIV 154 (309)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~ 154 (309)
++.. .+++..++.++.||+.+|.|||++ ||+||||||+||+++.+ .+||+|||++...... ....
T Consensus 174 ~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~------~~~~ 238 (681)
T 2pzi_A 174 SKGQ-----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF------GYLY 238 (681)
T ss_dssp ---C-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEETTCC------SCCC
T ss_pred HHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhcccC------CccC
Confidence 7622 589999999999999999999998 99999999999999875 8999999998765433 2346
Q ss_pred cccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHH
Q 021682 155 GTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKL 234 (309)
Q Consensus 155 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
||+.|+|||.+.+.. +.++|||||||++|+|++|.+|+....... ...........
T Consensus 239 gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-----------------------~~~~~~~~~~~ 294 (681)
T 2pzi_A 239 GTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG-----------------------LPEDDPVLKTY 294 (681)
T ss_dssp CCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS-----------------------CCTTCHHHHHC
T ss_pred CCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc-----------------------ccccccccccC
Confidence 899999999987654 889999999999999999988874311110 00111111233
Q ss_pred HHHHHHHhhcccCCCCCCC-CHHHHHHHHhcc
Q 021682 235 MRCMQVALLCVQENAADRP-TMLEILVMLKSE 265 (309)
Q Consensus 235 ~~l~~li~~~l~~~p~~Rp-t~~ell~~L~~~ 265 (309)
..+.++|.+||+.||++|| +++++.+.|...
T Consensus 295 ~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 295 DSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 4788999999999999999 567777766554
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=252.82 Aligned_cols=215 Identities=19% Similarity=0.210 Sum_probs=162.0
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHH-hcCCCCCccceeeEEee----CCeeEEEEeccCCCChhHHH
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLT-ARLQHVNLLPVLGICTQ----REEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~~ 76 (309)
+.||.+.. .+|+.||||.+.. ...+..|+.++ +.++||||+++++++.. +...++||||+.+++|.+++
T Consensus 32 g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 106 (299)
T 3m2w_A 32 GKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 106 (299)
T ss_dssp EEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHH
T ss_pred eEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHH
Confidence 34566654 6899999999853 24567888887 55599999999999887 66899999999999999998
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCC---CCCceeecccccccccCCccccccccc
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY---EMNPKISDFGMARAFTKDECEANTGRI 153 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~---~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 153 (309)
... ....+++..++.++.|++.|+.|||+. |++|+||||+||+++. ++.++|+|||++....
T Consensus 107 ~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~----------- 171 (299)
T 3m2w_A 107 QDR-GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT----------- 171 (299)
T ss_dssp HHC-TTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-----------
T ss_pred Hhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccccccc-----------
Confidence 543 234589999999999999999999998 8999999999999998 7889999999875322
Q ss_pred ccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcc--cH
Q 021682 154 VGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSS--SA 231 (309)
Q Consensus 154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 231 (309)
+..++.++|||||||++|+|++|..||......... ................ ..
T Consensus 172 -------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~ 227 (299)
T 3m2w_A 172 -------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------PGMKTRIRMGQYEFPNPEWS 227 (299)
T ss_dssp -------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCCSSCTTCCSSCHHHHT
T ss_pred -------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----------HHHHHHHhhccccCCchhcc
Confidence 234578899999999999999999998543222100 0000000000000000 01
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 232 WKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 232 ~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
..+..+.++|.+||+.||++|||++|+++.
T Consensus 228 ~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 228 EVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 123478899999999999999999999985
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=250.87 Aligned_cols=216 Identities=12% Similarity=0.051 Sum_probs=165.7
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCc---ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSH---QGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
+.||++.. .+|+.||||++..... .....+.+|+..+++++||||+++++++..++..++||||+.+++|.+++..
T Consensus 45 g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~ 124 (286)
T 3uqc_A 45 LQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT 124 (286)
T ss_dssp CEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTT
T ss_pred eEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhc
Confidence 45677765 4699999999976532 2346788999999999999999999999999999999999999999999832
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
+ .....+..++.|++.||.|||++ |++||||||+||+++.++.++|++++.
T Consensus 125 ---~--~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~~--------------------- 175 (286)
T 3uqc_A 125 ---S--PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPAT--------------------- 175 (286)
T ss_dssp ---C--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCCC---------------------
T ss_pred ---C--CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEeccc---------------------
Confidence 1 34556788999999999999998 999999999999999999999874432
Q ss_pred CCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCC--CcccHHHHHH
Q 021682 159 YVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLD--DSSSAWKLMR 236 (309)
Q Consensus 159 y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 236 (309)
++ .++.++|||||||++|+|++|+.||............ ......... .......+..
T Consensus 176 -~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T 3uqc_A 176 -MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA------------ERDTAGQPIEPADIDRDIPFQ 235 (286)
T ss_dssp -CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC------------CBCTTSCBCCHHHHCTTSCHH
T ss_pred -cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH------------HHHhccCCCChhhcccCCCHH
Confidence 22 2588999999999999999999999754432211000 000000000 0000112346
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHHHhcccCC
Q 021682 237 CMQVALLCVQENAADRPTMLEILVMLKSETAD 268 (309)
Q Consensus 237 l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~ 268 (309)
+.++|.+||+.||++| |++|+++.|+.....
T Consensus 236 l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 236 ISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp HHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred HHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 8899999999999999 999999999886543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-36 Score=267.08 Aligned_cols=226 Identities=16% Similarity=0.175 Sum_probs=163.1
Q ss_pred cceEEEE-cCCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCC-CCc---------cceeeE------------Eee
Q 021682 3 VAICQGR-LPNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQH-VNL---------LPVLGI------------CTQ 56 (309)
Q Consensus 3 ~~~~~~~-~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h-~~i---------v~~~~~------------~~~ 56 (309)
++||++. ..+|+.||||+++... ....+.+++|+.+++.++| .+. +...+. +..
T Consensus 92 G~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (413)
T 3dzo_A 92 YAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLD 171 (413)
T ss_dssp EEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC----------
T ss_pred EEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCC
Confidence 3567776 5689999999987332 2336789999999999976 221 111111 111
Q ss_pred -----CCeeEEEEeccCCCChhHHHhhh----ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCC
Q 021682 57 -----REEKMLIYDYMPNKSLDFYIFDL----RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYE 127 (309)
Q Consensus 57 -----~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~ 127 (309)
....+++|+++ +++|.+++... .....+++..++.++.|++.||.|||++ ||+||||||+||+++.+
T Consensus 172 ~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHrDiKp~NILl~~~ 247 (413)
T 3dzo_A 172 ERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQR 247 (413)
T ss_dssp -----CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTT
T ss_pred CccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcccceEEEecC
Confidence 12467888876 57898887432 1234477888999999999999999998 99999999999999999
Q ss_pred CCceeecccccccccCCcccccccccccccCCCCcccc----------ccCCCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 021682 128 MNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYV----------RKGIYSMKYDVYSYGVLLLQILGGKRTSCYYG 197 (309)
Q Consensus 128 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~ 197 (309)
+.+||+|||++...... .....| ..|+|||.+ .+..++.++|||||||++|+|++|+.||....
T Consensus 248 ~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~ 321 (413)
T 3dzo_A 248 GGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDA 321 (413)
T ss_dssp CCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTG
T ss_pred CeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 99999999998754433 222356 899999998 44567889999999999999999999986433
Q ss_pred CCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 021682 198 PNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEIL 259 (309)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell 259 (309)
...... ..+.... . .+..+.++|.+||+.||++|||+.+++
T Consensus 322 ~~~~~~---------------~~~~~~~--~----~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 322 ALGGSE---------------WIFRSCK--N----IPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp GGSCSG---------------GGGSSCC--C----CCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred hhhhHH---------------HHHhhcc--c----CCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 222111 1111111 1 124788999999999999999966554
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=252.80 Aligned_cols=226 Identities=13% Similarity=0.109 Sum_probs=165.8
Q ss_pred cceEEEEcCCCcEEEEEEeecCC--------cccHHHHHHHHHHHhcCC---------CCCccceeeEE-----------
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTS--------HQGLEEFENEVKLTARLQ---------HVNLLPVLGIC----------- 54 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~~iv~~~~~~----------- 54 (309)
+.||++.. +|+.||||++.... ....+.+.+|+.++++++ |+||+++.+++
T Consensus 34 g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv 112 (336)
T 2vuw_A 34 GEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLL 112 (336)
T ss_dssp EEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHH
T ss_pred eEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHH
Confidence 46788876 78999999997652 223477889999988875 66666665543
Q ss_pred ------ee-------------CCeeEEEEeccCCCChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHh-hcCCCceee
Q 021682 55 ------TQ-------------REEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQ-EYSNLTIVH 114 (309)
Q Consensus 55 ------~~-------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh-~~~~~gi~H 114 (309)
.. +...++||||+.++++.+.+. ...+++..++.++.||+.||.||| +. ||+|
T Consensus 113 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---~ivH 185 (336)
T 2vuw_A 113 KAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----TKLSSLATAKSILHQLTASLAVAEASL---RFEH 185 (336)
T ss_dssp HHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----TTCCCHHHHHHHHHHHHHHHHHHHHHH---CCBC
T ss_pred HHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHhC---CEeE
Confidence 32 678999999999886655542 244899999999999999999999 88 8999
Q ss_pred cCCCCceEEeCCCC--------------------CceeecccccccccCCcccccccccccccCCCCccccccCCCCccc
Q 021682 115 RDLKASNILLDYEM--------------------NPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKY 174 (309)
Q Consensus 115 ~di~p~nil~~~~~--------------------~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 174 (309)
|||||+||+++.++ .+||+|||++...... ...||+.|+|||.+.+.. +.++
T Consensus 186 rDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~aPE~~~g~~-~~~~ 257 (336)
T 2vuw_A 186 RDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSMDEDLFTGDG-DYQF 257 (336)
T ss_dssp SCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTTCSGGGCCCS-SHHH
T ss_pred CCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecccChhhhcCCC-ccce
Confidence 99999999999887 8999999999765432 236899999999998776 8999
Q ss_pred hhhhHHHH-HHHHHhCCCCCCCCCCCCcccHHHHHHHH-hhCCCCcccccccCCCcccHHHHHHHHHHHhhcccCCCCCC
Q 021682 175 DVYSYGVL-LLQILGGKRTSCYYGPNESLNLLEYAYGL-WKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADR 252 (309)
Q Consensus 175 DvwslG~i-l~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 252 (309)
||||+|++ .++++.|..||... ......... ...... ............+.++.+||.+||+.|
T Consensus 258 Diwsl~~~~~~~~~~g~~p~~~~------~~~~~~~~~~~~~~~~----~~~~~~~~~~~~s~~~~dli~~~L~~d---- 323 (336)
T 2vuw_A 258 DIYRLMKKENNNRWGEYHPYSNV------LWLHYLTDKMLKQMTF----KTKCNTPAMKQIKRKIQEFHRTMLNFS---- 323 (336)
T ss_dssp HHHHHHHHHHTTCTTSCCTHHHH------HHHHHHHHHHHHTCCC----SSCCCSHHHHHHHHHHHHHHHHGGGSS----
T ss_pred ehhhhhCCCCcccccccCCCcch------hhhhHHHHhhhhhhcc----CcccchhhhhhcCHHHHHHHHHHhccC----
Confidence 99998777 67788888886210 000001111 111111 111112223345678999999999977
Q ss_pred CCHHHHH
Q 021682 253 PTMLEIL 259 (309)
Q Consensus 253 pt~~ell 259 (309)
|++|++
T Consensus 324 -sa~e~l 329 (336)
T 2vuw_A 324 -SATDLL 329 (336)
T ss_dssp -SHHHHH
T ss_pred -CHHHHH
Confidence 999998
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-31 Score=245.85 Aligned_cols=169 Identities=17% Similarity=0.166 Sum_probs=125.6
Q ss_pred CCCcEEEEEEeecCC----------cccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 11 PNGQEMAVKRLSRTS----------HQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 11 ~~g~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
..|+.+|+|++.... ....+++.+|+++|+++ .|+||++++++++++...||||||++|++|.+++..
T Consensus 257 ~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~- 335 (569)
T 4azs_A 257 FFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAA- 335 (569)
T ss_dssp EECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHT-
T ss_pred cccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHh-
Confidence 368899999997541 22345789999999999 799999999999999999999999999999999954
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
+..++.. .++.||+.||+|+|++ ||+||||||+|||++.+|.+||+|||+++........ .....||+.|
T Consensus 336 --~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~--~~t~vGTp~Y 405 (569)
T 4azs_A 336 --GEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSW--PTNLVQSFFV 405 (569)
T ss_dssp --TCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC---CC--SHHHHHHHHH
T ss_pred --CCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCCCcc--ccCceechhh
Confidence 3346654 4789999999999999 9999999999999999999999999999765543322 2335799999
Q ss_pred CCccccccCCCCccchhhhHHHHHHHHHhCCC
Q 021682 160 VPPEYVRKGIYSMKYDVYSYGVLLLQILGGKR 191 (309)
Q Consensus 160 ~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~ 191 (309)
+|||.+.+. +..++|+|++|++++.+.++..
T Consensus 406 mAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 406 FVNELFAEN-KSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp HHHHHC------------------CCCCTTHH
T ss_pred ccHHHhCCC-CCCcccccccccchhhhccccc
Confidence 999998764 5678999999999887765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.7e-24 Score=199.72 Aligned_cols=174 Identities=18% Similarity=0.179 Sum_probs=138.8
Q ss_pred cceEEEEcCCCcEEEEEEeecCCc--------ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhH
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSH--------QGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDF 74 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (309)
+.||++.. .++.+++|....... ...+++.+|++++++++||||+.+..++......++||||+++++|.+
T Consensus 350 g~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~ 428 (540)
T 3en9_A 350 ADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKD 428 (540)
T ss_dssp EEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHH
T ss_pred EEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHH
Confidence 45788854 688999998644321 113457899999999999999966666667777899999999999999
Q ss_pred HHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccc-----c
Q 021682 75 YIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEA-----N 149 (309)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~-----~ 149 (309)
++.. +..++.|++.++.|||++ ||+||||||+||+++. .+||+|||++.......... .
T Consensus 429 ~l~~-----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~ 492 (540)
T 3en9_A 429 VIED-----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVF 492 (540)
T ss_dssp HSTT-----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHH
T ss_pred HHHH-----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhh
Confidence 8743 457899999999999998 8999999999999998 99999999998765432211 1
Q ss_pred ccccccccCCCCcccccc--CCCCccchhhhHHHHHHHHHhCCCCC
Q 021682 150 TGRIVGTYGYVPPEYVRK--GIYSMKYDVYSYGVLLLQILGGKRTS 193 (309)
Q Consensus 150 ~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~ll~g~~p~ 193 (309)
.....||+.|+|||++.. ..|+...|+|+..+-..+.+.++.++
T Consensus 493 ~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 493 KKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred hhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 224578999999999977 56788899999988888877666554
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=6.6e-21 Score=161.82 Aligned_cols=131 Identities=20% Similarity=0.153 Sum_probs=103.2
Q ss_pred cceEEEEcCCCcEEEEEEeecCCc------------------ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSH------------------QGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIY 64 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 64 (309)
+.||.+...+|+.||||.++.... .....+.+|+.++++++ | +++.+++.. +..++||
T Consensus 104 g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~~-~~~~lvm 179 (282)
T 1zar_A 104 SAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYAW-EGNAVLM 179 (282)
T ss_dssp EEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEEE-ETTEEEE
T ss_pred ceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEec-cceEEEE
Confidence 467888777899999999864321 13456889999999998 4 666665544 4569999
Q ss_pred eccCCCChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCC
Q 021682 65 DYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKD 144 (309)
Q Consensus 65 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~ 144 (309)
||+++++|.+ +. . .....++.|++.|+.+||+. |++||||||.||+++ ++.++|+|||++.
T Consensus 180 E~~~g~~L~~-l~-------~--~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl~DFG~a~----- 240 (282)
T 1zar_A 180 ELIDAKELYR-VR-------V--ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSV----- 240 (282)
T ss_dssp ECCCCEEGGG-CC-------C--SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEECCCTTCE-----
T ss_pred EecCCCcHHH-cc-------h--hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEEEECCCCe-----
Confidence 9999999977 31 1 23456999999999999998 999999999999999 9999999999884
Q ss_pred cccccccccccccCCCCccccc
Q 021682 145 ECEANTGRIVGTYGYVPPEYVR 166 (309)
Q Consensus 145 ~~~~~~~~~~~~~~y~aPE~~~ 166 (309)
.+..+.|||.+.
T Consensus 241 ----------~~~~~~a~e~l~ 252 (282)
T 1zar_A 241 ----------EVGEEGWREILE 252 (282)
T ss_dssp ----------ETTSTTHHHHHH
T ss_pred ----------ECCCCCHHHHHH
Confidence 234567888764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=7.3e-17 Score=135.19 Aligned_cols=123 Identities=19% Similarity=0.166 Sum_probs=91.6
Q ss_pred cceEEEEc-CCCcE--EEEEEeecCCcc------------------------cHHHHHHHHHHHhcCCCCCc--cceeeE
Q 021682 3 VAICQGRL-PNGQE--MAVKRLSRTSHQ------------------------GLEEFENEVKLTARLQHVNL--LPVLGI 53 (309)
Q Consensus 3 ~~~~~~~~-~~g~~--vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~h~~i--v~~~~~ 53 (309)
+.||++.. .+|+. ||||+++..... ....+..|+..++++.|+++ ..++++
T Consensus 61 g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~ 140 (258)
T 1zth_A 61 ANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAGVSVPQPYTY 140 (258)
T ss_dssp EEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTTCCCCCEEEE
T ss_pred EEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCCCCCCeEEEc
Confidence 46788876 68999 999997543111 11367889999999987764 334432
Q ss_pred EeeCCeeEEEEeccCC-C----ChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHh-hcCCCceeecCCCCceEEeCCC
Q 021682 54 CTQREEKMLIYDYMPN-K----SLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQ-EYSNLTIVHRDLKASNILLDYE 127 (309)
Q Consensus 54 ~~~~~~~~lv~e~~~~-~----~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh-~~~~~gi~H~di~p~nil~~~~ 127 (309)
...+|||||+.+ | +|.+.... .++..+..++.|++.++.+|| +. |++||||||.||+++.
T Consensus 141 ----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~---givHrDlkp~NILl~~- 206 (258)
T 1zth_A 141 ----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEA---ELVHADLSEYNIMYID- 206 (258)
T ss_dssp ----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTS---CEECSSCSTTSEEESS-
T ss_pred ----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEEcC-
Confidence 246899999942 3 66655421 224467789999999999999 77 9999999999999988
Q ss_pred CCceeeccccccc
Q 021682 128 MNPKISDFGMARA 140 (309)
Q Consensus 128 ~~~~l~Dfg~~~~ 140 (309)
.++|+|||++..
T Consensus 207 -~~~liDFG~a~~ 218 (258)
T 1zth_A 207 -KVYFIDMGQAVT 218 (258)
T ss_dssp -SEEECCCTTCEE
T ss_pred -cEEEEECccccc
Confidence 899999999854
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.50 E-value=3.1e-14 Score=124.44 Aligned_cols=124 Identities=14% Similarity=0.103 Sum_probs=85.7
Q ss_pred cceEEEEcCCCcEEEEEEeecCCc--------------ccH--------HHHHHHHHHHhcCCCCCccceeeEEeeCCee
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSH--------------QGL--------EEFENEVKLTARLQHVNLLPVLGICTQREEK 60 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~--------------~~~--------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 60 (309)
+.||.+...+|+.||||+++.... ... -....|+..|.++.+.++....-+.. .. .
T Consensus 109 a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp~p~~~-~~-~ 186 (397)
T 4gyi_A 109 SDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVPEPIAQ-SR-H 186 (397)
T ss_dssp EEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCCCEEEE-ET-T
T ss_pred eEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCCeeeec-cC-c
Confidence 468888888999999998753210 000 11235677777775444322221111 22 3
Q ss_pred EEEEeccCCCChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCC----------c
Q 021682 61 MLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMN----------P 130 (309)
Q Consensus 61 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~----------~ 130 (309)
+|||||+.|.+|..+. .......++.|++.++.+||+. |++||||||.|||++.++. +
T Consensus 187 ~LVME~i~G~~L~~l~---------~~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dgd~~d~~~~~~~~ 254 (397)
T 4gyi_A 187 TIVMSLVDALPMRQVS---------SVPDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEKDAEDPSSITLTP 254 (397)
T ss_dssp EEEEECCSCEEGGGCC---------CCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEECSSCTTSEEEEE
T ss_pred eEEEEecCCccHhhhc---------ccHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCCCcccccccccce
Confidence 7999999988875442 1123456789999999999998 9999999999999988763 7
Q ss_pred eeeccccccc
Q 021682 131 KISDFGMARA 140 (309)
Q Consensus 131 ~l~Dfg~~~~ 140 (309)
.++||+.+..
T Consensus 255 ~iID~~Q~V~ 264 (397)
T 4gyi_A 255 IIIXFPQMVS 264 (397)
T ss_dssp EECCCTTCEE
T ss_pred EEEEeCCccc
Confidence 8999987643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=5.1e-12 Score=105.77 Aligned_cols=127 Identities=16% Similarity=0.098 Sum_probs=96.0
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
..||+... +|+.+++|............+..|+.+++.+ .+..+.++++++...+..++|||+++|.++.+.+.
T Consensus 28 ~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~---- 102 (263)
T 3tm0_A 28 AKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE---- 102 (263)
T ss_dssp SEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCC----
T ss_pred CeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccC----
Confidence 44777764 4789999998653222334688899999988 46778889999988889999999999998876531
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcC-----------------------------------------------------
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYS----------------------------------------------------- 108 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~----------------------------------------------------- 108 (309)
+......++.+++.+++.||+..
T Consensus 103 ----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~ 178 (263)
T 3tm0_A 103 ----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEK 178 (263)
T ss_dssp ----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCC
T ss_pred ----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcC
Confidence 11223467888999999999811
Q ss_pred ---CCceeecCCCCceEEeCCCCCceeeccccc
Q 021682 109 ---NLTIVHRDLKASNILLDYEMNPKISDFGMA 138 (309)
Q Consensus 109 ---~~gi~H~di~p~nil~~~~~~~~l~Dfg~~ 138 (309)
..+++|||++|.||+++.++.+.|+||+.+
T Consensus 179 ~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a 211 (263)
T 3tm0_A 179 PEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS 211 (263)
T ss_dssp CCCCEEEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred CCCCceEECCCCCcCcEEEECCcEEEEEEchhc
Confidence 136999999999999987555679999865
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.17 E-value=6.3e-11 Score=98.78 Aligned_cols=123 Identities=18% Similarity=0.203 Sum_probs=88.7
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCC--ccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVN--LLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
..+|+....+|+.+++|..... ....+..|+.+++.+.+.+ +.+++++...++..++|||+++|.++. ..
T Consensus 34 ~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~--- 105 (264)
T 1nd4_A 34 AAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SS--- 105 (264)
T ss_dssp CEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TS---
T ss_pred ceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cC---
Confidence 4678887777888999997543 2245778999988884334 556888888777889999999998874 21
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------------------------
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYS---------------------------------------------------- 108 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~---------------------------------------------------- 108 (309)
. .. ...++.+++..+..||+..
T Consensus 106 ~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 179 (264)
T 1nd4_A 106 H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMP 179 (264)
T ss_dssp C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCC
T ss_pred c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcC
Confidence 1 11 1245666677777777642
Q ss_pred ---CCceeecCCCCceEEeCCCCCceeecccccc
Q 021682 109 ---NLTIVHRDLKASNILLDYEMNPKISDFGMAR 139 (309)
Q Consensus 109 ---~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~ 139 (309)
..+++|+|++|.||+++.++.+.|+||+.+.
T Consensus 180 ~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 180 DGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp SSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1239999999999999876656799998763
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.90 E-value=6.9e-09 Score=90.75 Aligned_cols=132 Identities=14% Similarity=0.214 Sum_probs=94.2
Q ss_pred cceEEEEcCCCcEEEEEEee--cCC-cccHHHHHHHHHHHhcCC--CCCccceeeEEeeC---CeeEEEEeccCCCChhH
Q 021682 3 VAICQGRLPNGQEMAVKRLS--RTS-HQGLEEFENEVKLTARLQ--HVNLLPVLGICTQR---EEKMLIYDYMPNKSLDF 74 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~---~~~~lv~e~~~~~~L~~ 74 (309)
..+|..... +..+++|... ... ......+..|+.+++.+. +..+.+++.++.+. +..++|||+++|..+.+
T Consensus 52 n~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~ 130 (359)
T 3dxp_A 52 NPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWD 130 (359)
T ss_dssp SCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCC
T ss_pred ceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCC
Confidence 356766654 5678888875 321 122356788999999886 44578888888766 34789999999877743
Q ss_pred HHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------------------
Q 021682 75 YIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYS---------------------------------------------- 108 (309)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---------------------------------------------- 108 (309)
.. ...++......++.+++.+++.||+..
T Consensus 131 ~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 205 (359)
T 3dxp_A 131 QS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLP 205 (359)
T ss_dssp TT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGG
T ss_pred Cc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHH
Confidence 21 112567777888999999999999731
Q ss_pred ---------CCceeecCCCCceEEeCCCCC--ceeeccccccc
Q 021682 109 ---------NLTIVHRDLKASNILLDYEMN--PKISDFGMARA 140 (309)
Q Consensus 109 ---------~~gi~H~di~p~nil~~~~~~--~~l~Dfg~~~~ 140 (309)
..+++|||+++.||+++.++. +.|+||+.+..
T Consensus 206 ~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 206 QHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp GCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999987753 58999998754
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.75 E-value=6.5e-09 Score=88.79 Aligned_cols=170 Identities=18% Similarity=0.162 Sum_probs=104.1
Q ss_pred cEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCC--ccceeeEEeeCC---eeEEEEeccCCCChhHHHhhhccccCCCH
Q 021682 14 QEMAVKRLSRTSHQGLEEFENEVKLTARL-QHVN--LLPVLGICTQRE---EKMLIYDYMPNKSLDFYIFDLRRRYLLDW 87 (309)
Q Consensus 14 ~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~--iv~~~~~~~~~~---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 87 (309)
+.+++|.... ......+..|++.++.+ .+.. +..++.....+. ..++||++++|.++..... ..++.
T Consensus 41 ~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~-----~~l~~ 113 (304)
T 3sg8_A 41 RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL-----NNLPK 113 (304)
T ss_dssp TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHH-----HTSCH
T ss_pred CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCcccc-----ccCCH
Confidence 5688888542 23456788999999887 3333 344554433333 3478999999988865331 12555
Q ss_pred HHHHHHHHHHHHHHHHHhhc-------------------------------------------------------CCCce
Q 021682 88 RTRVHIIEGITQGLLYLQEY-------------------------------------------------------SNLTI 112 (309)
Q Consensus 88 ~~~~~~~~~i~~~l~~lh~~-------------------------------------------------------~~~gi 112 (309)
.....++.+++..++.||+. ....+
T Consensus 114 ~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~ 193 (304)
T 3sg8_A 114 QSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCL 193 (304)
T ss_dssp HHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEE
T ss_pred HHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCcee
Confidence 66667777777777777751 11358
Q ss_pred eecCCCCceEEeCC--CCCceeecccccccccCCcccccccccccccCCCCccccc----cC-C---------CCccchh
Q 021682 113 VHRDLKASNILLDY--EMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVR----KG-I---------YSMKYDV 176 (309)
Q Consensus 113 ~H~di~p~nil~~~--~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~----~~-~---------~~~~~Dv 176 (309)
+|||+++.||+++. ++.+.++||+.+............ .....-..|+... .. . ...-.+.
T Consensus 194 ~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~---~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~ 270 (304)
T 3sg8_A 194 IHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISL---MEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKY 270 (304)
T ss_dssp ECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTT---CCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHH
T ss_pred EeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHH---HhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHH
Confidence 99999999999988 456789999987643221111000 0000001222211 00 0 0122588
Q ss_pred hhHHHHHHHHHhCCCCC
Q 021682 177 YSYGVLLLQILGGKRTS 193 (309)
Q Consensus 177 wslG~il~~ll~g~~p~ 193 (309)
|++|.++|.+.+|..++
T Consensus 271 ~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 271 WSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHHHHcCCHHH
Confidence 99999999999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.63 E-value=4.7e-07 Score=75.66 Aligned_cols=126 Identities=15% Similarity=0.144 Sum_probs=89.4
Q ss_pred ceEEEEcC-CCcEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 4 AICQGRLP-NGQEMAVKRLSRTSHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 4 ~~~~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
.+|+-... ++..+++|.-... ....+..|+..|+.+ .+-.+.+++.++..++..++|||+++|.++.+.....
T Consensus 40 ~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~-- 114 (272)
T 4gkh_A 40 TIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY-- 114 (272)
T ss_dssp EEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC--
T ss_pred eEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC--
Confidence 46665443 4677899987533 345678899998887 3445778899999889999999999998887654221
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcC-----------------------------------------------------
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYS----------------------------------------------------- 108 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~----------------------------------------------------- 108 (309)
......+..+++..++.||...
T Consensus 115 -----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 189 (272)
T 4gkh_A 115 -----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPF 189 (272)
T ss_dssp -----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCC
T ss_pred -----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccc
Confidence 1122345566666677776532
Q ss_pred --CCceeecCCCCceEEeCCCCCceeecccccc
Q 021682 109 --NLTIVHRDLKASNILLDYEMNPKISDFGMAR 139 (309)
Q Consensus 109 --~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~ 139 (309)
...++|||+++.||+++.++.+-|+||+.+.
T Consensus 190 ~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 190 SPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp CCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1237999999999999877767799998764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=4.8e-06 Score=71.00 Aligned_cols=121 Identities=18% Similarity=0.219 Sum_probs=75.8
Q ss_pred CcEEEEEEeecCCcccHHHHHHHHHHHhcCCCC---CccceeeEEe-eCCeeEEEEeccCCCChhHHHhhhccccCCCHH
Q 021682 13 GQEMAVKRLSRTSHQGLEEFENEVKLTARLQHV---NLLPVLGICT-QREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWR 88 (309)
Q Consensus 13 g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 88 (309)
|+.+++|+.. .......+..|+++|+.+.+. .+..++.+.. ..+..++||++++|.++...... .++..
T Consensus 39 g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~~-----~l~~~ 111 (306)
T 3tdw_A 39 NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGMA-----VLPDD 111 (306)
T ss_dssp TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHHT-----TSCHH
T ss_pred CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhhh-----hCCHH
Confidence 5668888842 233456788999999998542 3556666664 34467899999999888653110 01222
Q ss_pred HHHHHHHHHHHHHHHHhhc---------------------------------------------------------CCCc
Q 021682 89 TRVHIIEGITQGLLYLQEY---------------------------------------------------------SNLT 111 (309)
Q Consensus 89 ~~~~~~~~i~~~l~~lh~~---------------------------------------------------------~~~g 111 (309)
....++.+++..++.||+. ....
T Consensus 112 ~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~ 191 (306)
T 3tdw_A 112 AKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPR 191 (306)
T ss_dssp HHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCE
T ss_pred HHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCe
Confidence 2223333333333333321 2236
Q ss_pred eeecCCCCceEEeCC---CCC-ceeeccccccc
Q 021682 112 IVHRDLKASNILLDY---EMN-PKISDFGMARA 140 (309)
Q Consensus 112 i~H~di~p~nil~~~---~~~-~~l~Dfg~~~~ 140 (309)
++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 192 ~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 192 LIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp EECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred eEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 799999999999987 355 47999987754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.12 E-value=4e-06 Score=72.99 Aligned_cols=61 Identities=11% Similarity=0.091 Sum_probs=40.6
Q ss_pred CcEEEEEEeecCC---cccHHHHHHHHHHHhcCC-C--CCccceeeEEeeC---CeeEEEEeccCCCChh
Q 021682 13 GQEMAVKRLSRTS---HQGLEEFENEVKLTARLQ-H--VNLLPVLGICTQR---EEKMLIYDYMPNKSLD 73 (309)
Q Consensus 13 g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h--~~iv~~~~~~~~~---~~~~lv~e~~~~~~L~ 73 (309)
|+.+++|...... ......+..|+.+++.+. + ..+.+++.++... ...++|||+++|..+.
T Consensus 52 ~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 52 QQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp EEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCCC
T ss_pred CceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCChh
Confidence 6678888864322 101245678888888873 3 3567788777655 3568999999886654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.98 E-value=4.2e-05 Score=65.84 Aligned_cols=30 Identities=20% Similarity=0.253 Sum_probs=26.8
Q ss_pred CceeecCCCCceEEeCCCCCceeecccccc
Q 021682 110 LTIVHRDLKASNILLDYEMNPKISDFGMAR 139 (309)
Q Consensus 110 ~gi~H~di~p~nil~~~~~~~~l~Dfg~~~ 139 (309)
.+++|||+++.||+++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 489999999999999888889999998763
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.80 E-value=0.00019 Score=56.98 Aligned_cols=102 Identities=12% Similarity=-0.046 Sum_probs=64.9
Q ss_pred CChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccc
Q 021682 70 KSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEAN 149 (309)
Q Consensus 70 ~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 149 (309)
-+|.+.+.. .+.++++.++|.++.|.+.++.-+-..- .-...=+.|..|++..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~--~~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRL--YNQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHH--cCCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc----------
Confidence 468888754 4556999999999999999887762210 111333567899999999888653 1110
Q ss_pred ccccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCC
Q 021682 150 TGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKR 191 (309)
Q Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~ 191 (309)
.....+.|||... ...+.+.-|||||+++|..+--..
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL 134 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL 134 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence 1123566888763 344678899999999999986443
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.74 E-value=0.00026 Score=59.53 Aligned_cols=66 Identities=17% Similarity=0.142 Sum_probs=46.5
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCC-C--CCccceeeEEeeCCeeEEEEeccCCCCh
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQ-H--VNLLPVLGICTQREEKMLIYDYMPNKSL 72 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h--~~iv~~~~~~~~~~~~~lv~e~~~~~~L 72 (309)
..+|+....+|+.|++|............+..|+..|+.|. . ..+.+++.+. + .++|||++.+...
T Consensus 29 ~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 29 WHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--RTLAMEWVDERPP 97 (288)
T ss_dssp EEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--TEEEEECCCCCCC
T ss_pred eEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc--C--ceEEEEeecccCC
Confidence 46788888899999999876554444567888999988873 2 2345555542 2 3689999987654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00029 Score=62.05 Aligned_cols=66 Identities=9% Similarity=0.026 Sum_probs=39.3
Q ss_pred cceEEEEcC-CCcEEEEEEeecCCc-------ccHHHHHHHHHHHhcCC-C-C-CccceeeEEeeCCeeEEEEeccCCC
Q 021682 3 VAICQGRLP-NGQEMAVKRLSRTSH-------QGLEEFENEVKLTARLQ-H-V-NLLPVLGICTQREEKMLIYDYMPNK 70 (309)
Q Consensus 3 ~~~~~~~~~-~g~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~-h-~-~iv~~~~~~~~~~~~~lv~e~~~~~ 70 (309)
..+|+.... +++.|+||....... ...+++..|.++++.+. . + .+..++.+ +....++|||++.+.
T Consensus 44 n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lvmE~l~g~ 120 (397)
T 2olc_A 44 NYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVMEDLSHL 120 (397)
T ss_dssp EEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEECCCTTS
T ss_pred EEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEEEEeCCCc
Confidence 356777543 578899998643211 22345677888888773 2 3 34455543 344568999999763
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00055 Score=58.25 Aligned_cols=64 Identities=22% Similarity=0.165 Sum_probs=48.7
Q ss_pred eEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCC---CCCccceeeEEeeCCeeEEEEeccCCCCh
Q 021682 5 ICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQ---HVNLLPVLGICTQREEKMLIYDYMPNKSL 72 (309)
Q Consensus 5 ~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 72 (309)
+|+-.. +++.+++|..... ....+..|+..|+.|. ...+.+++.+....+..++|||++++..+
T Consensus 52 ~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 52 IWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred eeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 455544 5678899987543 3567889999888873 35788899888877889999999998765
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.40 E-value=0.0029 Score=54.18 Aligned_cols=33 Identities=33% Similarity=0.413 Sum_probs=27.4
Q ss_pred CCceeecCCCCceEEeCCC----CCceeecccccccc
Q 021682 109 NLTIVHRDLKASNILLDYE----MNPKISDFGMARAF 141 (309)
Q Consensus 109 ~~gi~H~di~p~nil~~~~----~~~~l~Dfg~~~~~ 141 (309)
..+++|||+++.||+++.+ +.+.|+||+.+...
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 3489999999999999874 67899999887543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.37 E-value=0.004 Score=53.06 Aligned_cols=68 Identities=7% Similarity=0.082 Sum_probs=42.0
Q ss_pred ceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCC--CccceeeE-----EeeCCeeEEEEeccCCCCh
Q 021682 4 AICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHV--NLLPVLGI-----CTQREEKMLIYDYMPNKSL 72 (309)
Q Consensus 4 ~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~-----~~~~~~~~lv~e~~~~~~L 72 (309)
.+|.....+|+.+++|...... .....+..|...++.+... .+..++.. ...++..++|+++++|..+
T Consensus 40 ~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G~~~ 114 (328)
T 1zyl_A 40 RVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 114 (328)
T ss_dssp EEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred ceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCCCCC
Confidence 4566655567789999986432 2345677788887776321 23444432 2234566889999987543
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.36 E-value=0.0015 Score=57.92 Aligned_cols=31 Identities=13% Similarity=0.254 Sum_probs=26.9
Q ss_pred CceeecCCCCceEEeCCCCCceeecccccccc
Q 021682 110 LTIVHRDLKASNILLDYEMNPKISDFGMARAF 141 (309)
Q Consensus 110 ~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~ 141 (309)
..++|||+++.||+++.++ +.++||+.+...
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 4899999999999998776 999999887543
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.35 E-value=0.00082 Score=58.78 Aligned_cols=123 Identities=19% Similarity=0.223 Sum_probs=72.0
Q ss_pred CcEEEEEEeecCCcccHHHHHHHHHHHhcCC-CCCccceeeEEeeCCeeEEEEeccCCCChhHH--------------Hh
Q 021682 13 GQEMAVKRLSRTSHQGLEEFENEVKLTARLQ-HVNLLPVLGICTQREEKMLIYDYMPNKSLDFY--------------IF 77 (309)
Q Consensus 13 g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~--------------~~ 77 (309)
++.+++|+.-.. ......+..|.++++.+. +.-..++++++.+ .+|+||++|..+..- +.
T Consensus 82 ~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La 156 (379)
T 3feg_A 82 PREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYIPSRPLKTQELREPVLSAAIATKMA 156 (379)
T ss_dssp CSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECCSEEECCGGGGGCHHHHHHHHHHHH
T ss_pred CCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEecCccCChhHhCCHHHHHHHHHHHH
Confidence 578999986332 224556678999988873 3334556766553 289999998665311 00
Q ss_pred hh-cc----ccCCC--HHHHHHHHHHHHH-------------------HHHH----Hhhc-CCCceeecCCCCceEEeCC
Q 021682 78 DL-RR----RYLLD--WRTRVHIIEGITQ-------------------GLLY----LQEY-SNLTIVHRDLKASNILLDY 126 (309)
Q Consensus 78 ~~-~~----~~~~~--~~~~~~~~~~i~~-------------------~l~~----lh~~-~~~gi~H~di~p~nil~~~ 126 (309)
.. .. ..... +.++..+..++.. .+.. |... ....++|+|+.+.||+++.
T Consensus 157 ~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~ 236 (379)
T 3feg_A 157 QFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLS 236 (379)
T ss_dssp HHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEES
T ss_pred HHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcC
Confidence 00 00 11111 2344444443321 1222 2221 2246899999999999987
Q ss_pred C----CCceeeccccccc
Q 021682 127 E----MNPKISDFGMARA 140 (309)
Q Consensus 127 ~----~~~~l~Dfg~~~~ 140 (309)
+ +.+.++||..+..
T Consensus 237 ~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 237 EPENADSLMLVDFEYSSY 254 (379)
T ss_dssp CC---CCEEECCCTTCEE
T ss_pred CCCccCcEEEEecccCCc
Confidence 6 6899999987753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0014 Score=58.30 Aligned_cols=54 Identities=13% Similarity=0.165 Sum_probs=34.3
Q ss_pred CcEEEEEEeecCCcccHHHHHHHHHHHhcCC-CCCccceeeEEeeCCeeEEEEeccCCCCh
Q 021682 13 GQEMAVKRLSRTSHQGLEEFENEVKLTARLQ-HVNLLPVLGICTQREEKMLIYDYMPNKSL 72 (309)
Q Consensus 13 g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 72 (309)
++.+++|+.... .....+..|+.+++.+. +.-..++++.+.+ .+|++|++|.++
T Consensus 105 ~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G~~l 159 (429)
T 1nw1_A 105 PNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL 159 (429)
T ss_dssp CSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred CceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCCccc
Confidence 578999988432 11145557888888874 3333556665542 289999987444
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.00 E-value=0.0026 Score=57.12 Aligned_cols=63 Identities=14% Similarity=0.158 Sum_probs=37.9
Q ss_pred eEEEEcCC-CcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCc-cceeeEEeeCCeeEEEEeccCCCCh
Q 021682 5 ICQGRLPN-GQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNL-LPVLGICTQREEKMLIYDYMPNKSL 72 (309)
Q Consensus 5 ~~~~~~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~~L 72 (309)
+|+....+ ++.+++|+......... ....|+.+++.|...++ .++++++. + .+|++|++|.++
T Consensus 124 ~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 124 LIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 45555443 47889998744322211 12578888888854444 45676663 2 259999987554
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.98 E-value=0.0016 Score=54.97 Aligned_cols=30 Identities=27% Similarity=0.241 Sum_probs=25.2
Q ss_pred CceeecCCCCceEEeCCCCCceeeccccccc
Q 021682 110 LTIVHRDLKASNILLDYEMNPKISDFGMARA 140 (309)
Q Consensus 110 ~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~ 140 (309)
..++|+|+.+.||+ ..++.+.++||+.+..
T Consensus 173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 173 LAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 46899999999999 5667789999987754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0051 Score=52.89 Aligned_cols=31 Identities=26% Similarity=0.374 Sum_probs=27.1
Q ss_pred CceeecCCCCceEEeCCCCCceeeccccccc
Q 021682 110 LTIVHRDLKASNILLDYEMNPKISDFGMARA 140 (309)
Q Consensus 110 ~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~ 140 (309)
.+++|+|+.+.||+++.++.+.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4799999999999999888899999987643
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.73 E-value=0.015 Score=49.30 Aligned_cols=30 Identities=23% Similarity=0.284 Sum_probs=25.3
Q ss_pred CceeecCCCCceEEeCCCCCceeecccccc
Q 021682 110 LTIVHRDLKASNILLDYEMNPKISDFGMAR 139 (309)
Q Consensus 110 ~gi~H~di~p~nil~~~~~~~~l~Dfg~~~ 139 (309)
.+++|+|+++.||+++.++.+.++||+.+.
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 479999999999999876656799998663
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.42 E-value=0.0056 Score=53.22 Aligned_cols=30 Identities=23% Similarity=0.419 Sum_probs=24.6
Q ss_pred CceeecCCCCceEEeCCCCCceeeccccccc
Q 021682 110 LTIVHRDLKASNILLDYEMNPKISDFGMARA 140 (309)
Q Consensus 110 ~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~ 140 (309)
.+++|+|+++.||+++.++ +.|+||+.+..
T Consensus 212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp EEEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred eEEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 3699999999999997654 89999987753
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.28 E-value=0.1 Score=46.15 Aligned_cols=30 Identities=27% Similarity=0.498 Sum_probs=26.1
Q ss_pred CceeecCCCCceEEeCCCCCceeeccccccc
Q 021682 110 LTIVHRDLKASNILLDYEMNPKISDFGMARA 140 (309)
Q Consensus 110 ~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~ 140 (309)
..++|+|+.+.||+ +.++.+.++||..+..
T Consensus 262 ~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 262 LVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp EEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 36899999999999 7778899999988754
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=90.98 E-value=1.3 Score=35.10 Aligned_cols=82 Identities=9% Similarity=0.052 Sum_probs=56.6
Q ss_pred CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccccCCCHHHHHHHHHHHHHHHH-HHhhcCCCceeecCCCCce
Q 021682 43 QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLL-YLQEYSNLTIVHRDLKASN 121 (309)
Q Consensus 43 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~lh~~~~~gi~H~di~p~n 121 (309)
.||++ ...+-..++.+.+.++.-.+ ...+- .-...+....++++.+|+.... +++. -+|--++|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~--~~~f~----~i~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSS--FLTFA----AIRKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTT--CEEHH----HHHTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcc--cCcHH----HHHhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence 57777 44555666677666665322 22221 1122778888898888887766 5544 5888999999
Q ss_pred EEeCCCCCceeecccc
Q 021682 122 ILLDYEMNPKISDFGM 137 (309)
Q Consensus 122 il~~~~~~~~l~Dfg~ 137 (309)
++++.++.+++.-.|+
T Consensus 115 L~f~~~~~p~i~hRGi 130 (219)
T 4ano_A 115 LMFNRALEPFFLHVGV 130 (219)
T ss_dssp EEECTTCCEEESCCEE
T ss_pred EEEeCCCcEEEEEcCC
Confidence 9999999999887765
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=90.30 E-value=0.99 Score=35.64 Aligned_cols=115 Identities=11% Similarity=0.070 Sum_probs=75.4
Q ss_pred CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceE
Q 021682 43 QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNI 122 (309)
Q Consensus 43 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~ni 122 (309)
.||+++.. .+...++.+.+.++.- .....+- .-...+....++++.+|+....+++.. +|--++|+|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~--~~~~~f~----~ik~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL 110 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDIN--DNHTPFD----NIKSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDEL 110 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCC--TTSEEGG----GGGGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGE
T ss_pred cCCcccce-EEEEcccEEEEEEEcC--cccCCHH----HHHhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceE
Confidence 57777766 4556666666666543 2232221 223377888999999998888665543 8889999999
Q ss_pred EeCCCCCceeecccccccccCCcccccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCC
Q 021682 123 LLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTS 193 (309)
Q Consensus 123 l~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~ 193 (309)
+++.++.+++.-.|+... ++|. ..+...=.-.+=|++..++++...|
T Consensus 111 ~f~~~~~p~i~~RGik~~-------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~F 157 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQNV-------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSF 157 (215)
T ss_dssp EECTTSCEEESCCEETTT-------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred EEcCCCCEEEEEccCccC-------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence 999999999876665321 1221 1122222346778888888887776
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=87.32 E-value=0.3 Score=42.78 Aligned_cols=31 Identities=26% Similarity=0.330 Sum_probs=25.4
Q ss_pred ceeecCCCCceEEe------CCCCCceeecccccccc
Q 021682 111 TIVHRDLKASNILL------DYEMNPKISDFGMARAF 141 (309)
Q Consensus 111 gi~H~di~p~nil~------~~~~~~~l~Dfg~~~~~ 141 (309)
.+||+|+.+.||++ ++...+.++||..+...
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n 281 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN 281 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence 46899999999999 44567999999887543
|
| >2lic_A Vitellogenin; lipid transport; HET: SEP; NMR {Apis mellifera} | Back alignment and structure |
|---|
Probab=81.74 E-value=0.74 Score=23.20 Aligned_cols=23 Identities=22% Similarity=0.276 Sum_probs=18.6
Q ss_pred hhhhhccccccccCCccccCCCC
Q 021682 286 ISECMLEANIYSVDDATITQPVP 308 (309)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~ 308 (309)
++.+.++|++.|++.+++-+|+|
T Consensus 12 tdistssssissseendfwqpkp 34 (35)
T 2lic_A 12 TDISTSSSSISSSEENDFWQPKP 34 (35)
T ss_dssp SSSCSCSSCCSTTCSCSSCCCCC
T ss_pred hccccccccccccccccccCCCC
Confidence 55677788888999999988876
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 309 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-60 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-54 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-52 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-50 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-50 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-50 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-50 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-49 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 9e-49 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-48 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-48 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-48 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 9e-48 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-47 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-47 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-47 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-47 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-47 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-47 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-46 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-46 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-45 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-45 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-45 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-45 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-45 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-44 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-43 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-42 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-41 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 9e-41 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-40 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-40 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-39 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-36 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 8e-36 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-35 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-34 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-34 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-33 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-33 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-33 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-33 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-31 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-31 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-31 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-31 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-31 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-30 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-30 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 9e-30 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-29 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-29 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-29 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-28 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-25 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-25 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-22 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-22 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-20 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-20 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-19 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-14 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 4e-60
Identities = 59/260 (22%), Positives = 121/260 (46%), Gaps = 20/260 (7%)
Query: 8 GRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYM 67
G+ + + ++ + Q L+ F+NEV + + +HVN+L +G T + ++ +
Sbjct: 27 GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWC 85
Query: 68 PNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYE 127
SL ++ + + + + I QG+ YL S I+HRDLK++NI L +
Sbjct: 86 EGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHED 140
Query: 128 MNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVR---KGIYSMKYDVYSYGVLLL 184
+ KI DFG+A ++ ++ G+ ++ PE +R K YS + DVY++G++L
Sbjct: 141 LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLY 200
Query: 185 QILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLC 244
+++ G+ P ++N + + G + + A K ++ C
Sbjct: 201 ELMTGQL------PYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK-----RLMAEC 249
Query: 245 VQENAADRPTMLEILVMLKS 264
+++ +RP +IL ++
Sbjct: 250 LKKKRDERPLFPQILASIEL 269
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 6e-54
Identities = 61/259 (23%), Positives = 108/259 (41%), Gaps = 22/259 (8%)
Query: 5 ICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIY 64
+ G N ++A+K + R E+F E ++ +L H L+ + G+C ++ L++
Sbjct: 21 VHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 79
Query: 65 DYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL 124
++M + L Y+ +R L T + + + +G+ YL+E ++HRDL A N L+
Sbjct: 80 EFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLV 134
Query: 125 DYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLL 184
K+SDFGM R D+ ++ + PE YS K DV+S+GVL+
Sbjct: 135 GENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMW 193
Query: 185 QILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLC 244
++ + N + + G L + Q+ C
Sbjct: 194 EVFSEGKIPYENRSNSEV--------VEDISTGFRLYKPRLAST-------HVYQIMNHC 238
Query: 245 VQENAADRPTMLEILVMLK 263
+E DRP +L L
Sbjct: 239 WKERPEDRPAFSRLLRQLA 257
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 1e-52
Identities = 68/256 (26%), Positives = 117/256 (45%), Gaps = 22/256 (8%)
Query: 8 GRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYM 67
G ++AVK L + + F E L +LQH L+ + + TQ E +I +YM
Sbjct: 32 GYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89
Query: 68 PNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYE 127
N SL ++ L + + I +G+ +++E + +HRDL+A+NIL+
Sbjct: 90 ENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDT 145
Query: 128 MNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQIL 187
++ KI+DFG+AR +E A G + PE + G +++K DV+S+G+LL +I+
Sbjct: 146 LSCKIADFGLARLIEDNEYTAREG-AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 204
Query: 188 GGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQE 247
R N + + G M D+ ++ Q+ LC +E
Sbjct: 205 THGRIPYPGMTNPEV------IQNLERGYRMVRPDNCPEE---------LYQLMRLCWKE 249
Query: 248 NAADRPTMLEILVMLK 263
DRPT + +L+
Sbjct: 250 RPEDRPTFDYLRSVLE 265
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 1e-50
Identities = 64/283 (22%), Positives = 107/283 (37%), Gaps = 29/283 (10%)
Query: 12 NGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEK----MLIYDYM 67
G+E+AVK S + E E+ T L+H N+L + + L+ DY
Sbjct: 25 RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 83
Query: 68 PNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQE-----YSNLTIVHRDLKASNI 122
+ SL Y+ RY + + + GL +L I HRDLK+ NI
Sbjct: 84 EHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNI 139
Query: 123 LLDYEMNPKISDFGMARAF--TKDECEANTGRIVGTYGYVPPEYVRKGI------YSMKY 174
L+ I+D G+A D + VGT Y+ PE + I +
Sbjct: 140 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRA 199
Query: 175 DVYSYGVLLLQILGGKRTSCYY----GPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSS 230
D+Y+ G++ +I + P L + + + + + ++ +
Sbjct: 200 DIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQ 259
Query: 231 AWKLMRCM-QVALLCVQENAADRPTMLEILVMLK--SETADIK 270
+ + +R M ++ C N A R T L I L S+ IK
Sbjct: 260 SCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIK 302
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 166 bits (422), Expect = 2e-50
Identities = 60/277 (21%), Positives = 110/277 (39%), Gaps = 40/277 (14%)
Query: 9 RLPNGQEMAVKRLSRTSHQGLE-EFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYM 67
+AVK L + ++ +F+ E L A + N++ +LG+C + L+++YM
Sbjct: 39 PYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYM 98
Query: 68 PNKSLDFYIFDLRRRYL---------------------LDWRTRVHIIEGITQGLLYLQE 106
L+ ++ + + L ++ I + G+ YL E
Sbjct: 99 AYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE 158
Query: 107 YSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVR 166
VHRDL N L+ M KI+DFG++R + G ++PPE +
Sbjct: 159 RK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF 215
Query: 167 KGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLD 226
Y+ + DV++YGV+L +I P + E Y ++G + ++
Sbjct: 216 YNRYTTESDVWAYGVVLWEIFSYGLQ-----PYYGMAHEEVIY-YVRDGNILACPENCPL 269
Query: 227 DSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLK 263
+ + LC + ADRP+ I +L+
Sbjct: 270 E---------LYNLMRLCWSKLPADRPSFCSIHRILQ 297
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 2e-50
Identities = 62/259 (23%), Positives = 114/259 (44%), Gaps = 22/259 (8%)
Query: 5 ICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIY 64
+ G+ ++A+K + +EF E K+ L H L+ + G+CT++ +I
Sbjct: 20 VKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 78
Query: 65 DYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL 124
+YM N L Y+ ++R R + + + + + + + YL+ + +HRDL A N L+
Sbjct: 79 EYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLV 133
Query: 125 DYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLL 184
+ + K+SDFG++R DE ++ G + PPE + +S K D++++GVL+
Sbjct: 134 NDQGVVKVSDFGLSRYVLDDEYTSSVG-SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMW 192
Query: 185 QILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLC 244
+I + Y + N E E I L + + C
Sbjct: 193 EIYSLGKM---------------PYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSC 237
Query: 245 VQENAADRPTMLEILVMLK 263
E A +RPT +L +
Sbjct: 238 WHEKADERPTFKILLSNIL 256
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 3e-50
Identities = 59/269 (21%), Positives = 111/269 (41%), Gaps = 22/269 (8%)
Query: 8 GRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYM 67
G +A+K L + E F E ++ +L+H L+ + + ++ E ++ +YM
Sbjct: 36 GTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93
Query: 68 PNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYE 127
SL ++ +YL V + I G+ Y++ + VHRDL+A+NIL+
Sbjct: 94 SKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGEN 149
Query: 128 MNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQIL 187
+ K++DFG+AR +E A G + PE G +++K DV+S+G+LL ++
Sbjct: 150 LVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 208
Query: 188 GGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQE 247
R Y N E ++ ++ + C ++
Sbjct: 209 TKGRV---------------PYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRK 253
Query: 248 NAADRPTMLEILVMLKSETADIKTPKKPA 276
+RPT + L+ + +P
Sbjct: 254 EPEERPTFEYLQAFLEDYFTSTEPQYQPG 282
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 4e-49
Identities = 64/261 (24%), Positives = 114/261 (43%), Gaps = 31/261 (11%)
Query: 12 NGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKM-LIYDYMPNK 70
G ++AVK + + + F E + +L+H NL+ +LG+ + + + ++ +YM
Sbjct: 29 RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 86
Query: 71 SLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNP 130
SL Y+ R R +L + + + + YL+ + VHRDL A N+L+ +
Sbjct: 87 SLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVA 142
Query: 131 KISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGK 190
K+SDFG+ + E + + PE +R+ +S K DV+S+G+LL +I
Sbjct: 143 KVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFG 197
Query: 191 RTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAA 250
R P + + + G M+ D +V C +AA
Sbjct: 198 RVPYPRIPLKDV------VPRVEKGYKMDAPDGCPPA---------VYEVMKNCWHLDAA 242
Query: 251 DRPTMLEILVMLKSETADIKT 271
RP+ L++ L+ IKT
Sbjct: 243 MRPSFLQLREQLE----HIKT 259
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 9e-49
Identities = 58/253 (22%), Positives = 104/253 (41%), Gaps = 22/253 (8%)
Query: 9 RLPNGQEMAVKRLS-RTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYM 67
+ +AVK + + + E + E+ + L H N++ G + + L +Y
Sbjct: 26 NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 85
Query: 68 PNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYE 127
L I + + G++YL + I HRD+K N+LLD
Sbjct: 86 SGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDER 139
Query: 128 MNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVR-KGIYSMKYDVYSYGVLLLQI 186
N KISDFG+A F + E ++ GT YV PE ++ + ++ DV+S G++L +
Sbjct: 140 DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 199
Query: 187 LGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQ 246
L G+ + P++S E +++ S+ L+ +
Sbjct: 200 LAGEL--PWDQPSDSCQE------YSDWKEKKTYLNPWKKIDSAPLALLHK------ILV 245
Query: 247 ENAADRPTMLEIL 259
EN + R T+ +I
Sbjct: 246 ENPSARITIPDIK 258
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 2e-48
Identities = 56/255 (21%), Positives = 104/255 (40%), Gaps = 23/255 (9%)
Query: 12 NGQEMAVKRLSRTSHQG-LEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNK 70
++A+K L + + + EE E ++ +L + ++ ++G+C Q E ML+ +
Sbjct: 35 KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG 93
Query: 71 SLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNP 130
L ++ R + ++ ++ G+ YL+ VHRDL A N+LL
Sbjct: 94 PLHKFLVGKREE--IPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYA 148
Query: 131 KISDFGMARAFTKDECEAN-TGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGG 189
KISDFG+++A D+ + PE + +S + DV+SYGV + + L
Sbjct: 149 KISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL-- 206
Query: 190 KRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENA 249
S P + + E + G+ ME + + C
Sbjct: 207 ---SYGQKPYKKMKGPE-VMAFIEQGKRMECPPECPPE---------LYALMSDCWIYKW 253
Query: 250 ADRPTMLEILVMLKS 264
DRP L + +++
Sbjct: 254 EDRPDFLTVEQRMRA 268
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 7e-48
Identities = 61/278 (21%), Positives = 114/278 (41%), Gaps = 34/278 (12%)
Query: 8 GRLPNGQEMAVKRLSRTSHQG-LEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYD 65
+ +AVK L ++H E +E+K+ + L H+N++ +LG CT ++I +
Sbjct: 48 IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITE 107
Query: 66 YMPNKSLDFYIFDLRRRYL---------------LDWRTRVHIIEGITQGLLYLQEYSNL 110
Y L ++ R ++ LD + + +G+ +L
Sbjct: 108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---K 164
Query: 111 TIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIY 170
+HRDL A NILL + KI DFG+AR D G ++ PE + +Y
Sbjct: 165 NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY 224
Query: 171 SMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSS 230
+ + DV+SYG+ L ++ + P +S Y + K G M + + +
Sbjct: 225 TFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-----FYKMIKEGFRMLSPEHAPAE--- 276
Query: 231 AWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETAD 268
+ C + RPT +I+ +++ + ++
Sbjct: 277 ------MYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 9e-48
Identities = 65/280 (23%), Positives = 115/280 (41%), Gaps = 39/280 (13%)
Query: 8 GRLPNGQEMAVKRLSRTSHQG-LEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYD 65
+ ++AVK L + E +E+K+ +L H N++ +LG CT LI++
Sbjct: 62 SKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFE 121
Query: 66 YMPNKSLDFYIFDLRRRY--------------------LLDWRTRVHIIEGITQGLLYLQ 105
Y L Y+ R ++ +L + + + +G+ +L+
Sbjct: 122 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE 181
Query: 106 EYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYV 165
S VHRDL A N+L+ + KI DFG+AR D G ++ PE +
Sbjct: 182 FKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL 238
Query: 166 RKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSL 225
+GIY++K DV+SYG+LL +I P + + Y L +NG M+ +
Sbjct: 239 FEGIYTIKSDVWSYGILLWEIFSLGVN-----PYPGIPVDANFYKLIQNGFKMDQPFYAT 293
Query: 226 DDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSE 265
++ + C ++ RP+ + L +
Sbjct: 294 EE---------IYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 324
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 9e-48
Identities = 56/256 (21%), Positives = 108/256 (42%), Gaps = 26/256 (10%)
Query: 9 RLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMP 68
A K + S + LE++ E+ + A H N++ +L ++ ++
Sbjct: 33 NKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 92
Query: 69 NKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM 128
++D + +L R L + + L YL + I+HRDLKA NIL +
Sbjct: 93 GGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDG 147
Query: 129 NPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYV-----RKGIYSMKYDVYSYGVLL 183
+ K++DFG++ T+ ++ +GT ++ PE V + Y K DV+S G+ L
Sbjct: 148 DIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITL 205
Query: 184 LQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALL 243
+++ + P+ LN + + K+ S SS+ ++
Sbjct: 206 IEMAEIEP------PHHELNPMRVLLKIAKSEPPTLAQPSRW--SSNFKDFLKK------ 251
Query: 244 CVQENAADRPTMLEIL 259
C+++N R T ++L
Sbjct: 252 CLEKNVDARWTTSQLL 267
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 159 bits (403), Expect = 1e-47
Identities = 64/253 (25%), Positives = 118/253 (46%), Gaps = 21/253 (8%)
Query: 12 NGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKS 71
+AVK L + + +EEF E + ++H NL+ +LG+CT+ +I ++M +
Sbjct: 41 YSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN 99
Query: 72 LDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPK 131
L Y+ + R + +++ I+ + YL++ + +HRDL A N L+ K
Sbjct: 100 LLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVK 155
Query: 132 ISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKR 191
++DFG++R T D A+ G + PE + +S+K DV+++GVLL +I
Sbjct: 156 VADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM 214
Query: 192 TSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAAD 251
+ P ++L + Y L + ME + + ++ C Q N +D
Sbjct: 215 S-----PYPGIDLSQ-VYELLEKDYRMERPEGCPEK---------VYELMRACWQWNPSD 259
Query: 252 RPTMLEILVMLKS 264
RP+ EI ++
Sbjct: 260 RPSFAEIHQAFET 272
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 2e-47
Identities = 62/284 (21%), Positives = 117/284 (41%), Gaps = 28/284 (9%)
Query: 8 GRLPNGQEMAVKRLSR-TSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDY 66
+ +A+K ++ S + EF NE + +++ +LG+ +Q + ++I +
Sbjct: 45 VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL 104
Query: 67 MPNKSLDFYIFDLRRRYL-------LDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKA 119
M L Y+ LR + + I G+ YL VHRDL A
Sbjct: 105 MTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAA 161
Query: 120 SNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSY 179
N ++ + KI DFGM R + + G+ + ++ PE ++ G+++ DV+S+
Sbjct: 162 RNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF 221
Query: 180 GVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQ 239
GV+L +I P + L+ + G ++ D+ D +
Sbjct: 222 GVVLWEIATLAEQ-----PYQGLSNEQ-VLRFVMEGGLLDKPDNCPDM---------LFE 266
Query: 240 VALLCVQENAADRPTMLEILVMLKSETADIKTPKKPAFSVKRDN 283
+ +C Q N RP+ LEI+ +K E ++ +F +N
Sbjct: 267 LMRMCWQYNPKMRPSFLEIISSIKEEME--PGFREVSFYYSEEN 308
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 2e-47
Identities = 62/258 (24%), Positives = 103/258 (39%), Gaps = 25/258 (9%)
Query: 9 RLPNGQEMAVKRLSRTSH--QGLEEFENEVKLTARLQHVNLLPVLGICTQREEKML--IY 64
R +G+ + K L S + +EV L L+H N++ R L +
Sbjct: 25 RKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 84
Query: 65 DYMPNKSLDFYIFDLRR-RYLLDWRTRVHIIEGITQGLLYL--QEYSNLTIVHRDLKASN 121
+Y L I + R LD + ++ +T L + T++HRDLK +N
Sbjct: 85 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPAN 144
Query: 122 ILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGV 181
+ LD + N K+ DFG+AR D A VGT Y+ PE + + Y+ K D++S G
Sbjct: 145 VFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYMSPEQMNRMSYNEKSDIWSLGC 202
Query: 182 LLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241
LL ++ P + + E G + G+ S +++
Sbjct: 203 LLYELCALMP------PFTAFSQKE-LAGKIREGKFRRIPY---RYSDELNEIITR---- 248
Query: 242 LLCVQENAADRPTMLEIL 259
+ RP++ EIL
Sbjct: 249 --MLNLKDYHRPSVEEIL 264
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 2e-47
Identities = 58/260 (22%), Positives = 109/260 (41%), Gaps = 25/260 (9%)
Query: 13 GQEMAVKRLSRTSHQG--LEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNK 70
+ +AVK L ++ +E E + +L + ++ ++GIC + E ML+ +
Sbjct: 34 VKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELG 92
Query: 71 SLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNP 130
L+ Y+ R + + + ++ ++ G+ YL+ VHRDL A N+LL +
Sbjct: 93 PLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYA 146
Query: 131 KISDFGMARAFTKDECEANTG-RIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGG 189
KISDFG+++A DE + PE + +S K DV+S+GVL+ +
Sbjct: 147 KISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSY 206
Query: 190 KRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENA 249
+ P + E + + GE M + + LC +
Sbjct: 207 GQK-----PYRGMKGSE-VTAMLEKGERMGCPAGCPRE---------MYDLMNLCWTYDV 251
Query: 250 ADRPTMLEILVMLKSETADI 269
+RP + + L++ D+
Sbjct: 252 ENRPGFAAVELRLRNYYYDV 271
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (401), Expect = 4e-47
Identities = 60/257 (23%), Positives = 103/257 (40%), Gaps = 33/257 (12%)
Query: 9 RLPNGQEMAVKRLSRTSHQG---LEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYD 65
+ N + +A+K++S + Q ++ EV+ +L+H N + G + L+ +
Sbjct: 36 DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95
Query: 66 YMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLD 125
Y + D + L + G QGL YL ++ ++HRD+KA NILL
Sbjct: 96 YCLGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLS 149
Query: 126 YEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVR---KGIYSMKYDVYSYGVL 182
K+ DFG A VGT ++ PE + +G Y K DV+S G+
Sbjct: 150 EPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 203
Query: 183 LLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVAL 242
+++ K P ++N + L+ + S S +
Sbjct: 204 CIELAERKP------PLFNMNAMSA---LYHIAQNESPALQSGHWSEYFRNFVDS----- 249
Query: 243 LCVQENAADRPTMLEIL 259
C+Q+ DRPT +L
Sbjct: 250 -CLQKIPQDRPTSEVLL 265
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 5e-47
Identities = 50/281 (17%), Positives = 106/281 (37%), Gaps = 41/281 (14%)
Query: 9 RLPNGQEMAVKRLSRTSHQGL-EEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYM 67
P+G MA K + + + E+++ ++ G E + ++M
Sbjct: 27 HKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 86
Query: 68 PNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYE 127
SLD + ++ + + + + +GL YL I+HRD+K SNIL++
Sbjct: 87 DGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYL--REKHKIMHRDVKPSNILVNSR 141
Query: 128 MNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQIL 187
K+ DFG++ VGT Y+ PE ++ YS++ D++S G+ L+++
Sbjct: 142 GEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA 197
Query: 188 GGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALL---- 243
G+ P+ L + + + + S++ + +A+
Sbjct: 198 VGRYP--IPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLD 255
Query: 244 -------------------------CVQENAADRPTMLEIL 259
C+ +N A+R + +++
Sbjct: 256 YIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 296
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 156 bits (396), Expect = 2e-46
Identities = 57/256 (22%), Positives = 113/256 (44%), Gaps = 24/256 (9%)
Query: 12 NGQEMAVKRL-SRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNK 70
+A+K L S + + +F +E + + H N++ + G+ T+ M+I ++M N
Sbjct: 53 REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENG 112
Query: 71 SLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNP 130
SLD ++ ++ V ++ GI G+ YL +++ VHRDL A NIL++ +
Sbjct: 113 SLDSFLRQNDGQF--TVIQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVC 167
Query: 131 KISDFGMARAFTKDECEANTGRIVG---TYGYVPPEYVRKGIYSMKYDVYSYGVLLLQIL 187
K+SDFG++R D + +G + PE ++ ++ DV+SYG+++ +++
Sbjct: 168 KVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVM 227
Query: 188 GGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQE 247
+ N+ + + I+ Q+ L C Q+
Sbjct: 228 SYGERPYWDMTNQDV---------------INAIEQDYRLPPPMDCPSALHQLMLDCWQK 272
Query: 248 NAADRPTMLEILVMLK 263
+ RP +I+ L
Sbjct: 273 DRNHRPKFGQIVNTLD 288
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 3e-46
Identities = 57/265 (21%), Positives = 107/265 (40%), Gaps = 24/265 (9%)
Query: 4 AICQGRLPNGQEMAVKRLSRTSHQG-LEEFENEVKLTARLQHVNLLPVLGICTQREEK-M 61
AVK L+R + G + +F E + H N+L +LGIC + E +
Sbjct: 46 GTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 105
Query: 62 LIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASN 121
++ YM + L +I + + + ++ ++ VHRDL A N
Sbjct: 106 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK-----GMKFLASKKFVHRDLAARN 160
Query: 122 ILLDYEMNPKISDFGMARAFTKDECEANTGR--IVGTYGYVPPEYVRKGIYSMKYDVYSY 179
+LD + K++DFG+AR E ++ + ++ E ++ ++ K DV+S+
Sbjct: 161 CMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 220
Query: 180 GVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQ 239
GVLL +++ P +N + L + G + + D +
Sbjct: 221 GVLLWELMTRGAP-----PYPDVNTFDITVYLLQ-GRRLLQPEYCPDP---------LYE 265
Query: 240 VALLCVQENAADRPTMLEILVMLKS 264
V L C A RP+ E++ + +
Sbjct: 266 VMLKCWHPKAEMRPSFSELVSRISA 290
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 2e-45
Identities = 54/254 (21%), Positives = 105/254 (41%), Gaps = 22/254 (8%)
Query: 13 GQEMAVKRLSRTSHQG-LEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKS 71
+A+K L + +F E + + H N++ + G+ ++ + M+I +YM N +
Sbjct: 36 EVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGA 95
Query: 72 LDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPK 131
F + V ++ GI G+ Y +N+ VHRDL A NIL++ + K
Sbjct: 96 --LDKFLREKDGEFSVLQLVGMLRGIAAGMKY---LANMNYVHRDLAARNILVNSNLVCK 150
Query: 132 ISDFGMARAFTKDECEANT-GRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGK 190
+SDFG++R D T + PE + ++ DV+S+G+++ +++
Sbjct: 151 VSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYG 210
Query: 191 RTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAA 250
+ N + M+ I+ + Q+ + C Q+ A
Sbjct: 211 ERPYWELSNHEV---------------MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERA 255
Query: 251 DRPTMLEILVMLKS 264
RP +I+ +L
Sbjct: 256 RRPKFADIVSILDK 269
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 2e-45
Identities = 56/251 (22%), Positives = 111/251 (44%), Gaps = 23/251 (9%)
Query: 9 RLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMP 68
+ GQE+A+++++ E NE+ + ++ N++ L +E ++ +Y+
Sbjct: 41 DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100
Query: 69 NKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM 128
SL D+ +D + Q L +L ++HRD+K+ NILL +
Sbjct: 101 GGSL----TDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDG 153
Query: 129 NPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG 188
+ K++DFG T ++ + +T +VGT ++ PE V + Y K D++S G++ ++++
Sbjct: 154 SVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE 211
Query: 189 GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQEN 248
G+ P + N L Y + NG L S+ + C+ +
Sbjct: 212 GEP------PYLNENPLRALYLIATNGTPELQNPEKL--SAIFRDFLNR------CLDMD 257
Query: 249 AADRPTMLEIL 259
R + E+L
Sbjct: 258 VEKRGSAKELL 268
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 2e-45
Identities = 65/273 (23%), Positives = 110/273 (40%), Gaps = 36/273 (13%)
Query: 14 QEMAVKRLSRT-SHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKS 71
+ A+KR+ S +F E+++ +L H N++ +LG C R L +Y P+ +
Sbjct: 38 MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGN 97
Query: 72 LDFYI-------------FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLK 118
L ++ L + +H + +G+ YL + +HRDL
Sbjct: 98 LLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLA 154
Query: 119 ASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYS 178
A NIL+ KI+DFG++R E ++ E + +Y+ DV+S
Sbjct: 155 ARNILVGENYVAKIADFGLSRGQ---EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWS 211
Query: 179 YGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238
YGVLL +I+ T P + E Y G +E + D+
Sbjct: 212 YGVLLWEIVSLGGT-----PYCGMTCAE-LYEKLPQGYRLEKPLNCDDE---------VY 256
Query: 239 QVALLCVQENAADRPTMLEILVMLKSETADIKT 271
+ C +E +RP+ +ILV L + KT
Sbjct: 257 DLMRQCWREKPYERPSFAQILVSLNRMLEERKT 289
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 3e-45
Identities = 59/264 (22%), Positives = 102/264 (38%), Gaps = 24/264 (9%)
Query: 4 AICQGRLPNGQEMAVKRLSR---TSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEK 60
+AVK L + + +++F EV L H NL+ + G+ K
Sbjct: 27 GEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK 86
Query: 61 MLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKAS 120
M + + P SL + + +LL +R + +G+ YL+ +HRDL A
Sbjct: 87 M-VTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLESKR---FIHRDLAAR 140
Query: 121 NILLDYEMNPKISDFGMARAFTKD-ECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSY 179
N+LL KI DFG+ RA ++ + + + PE ++ +S D + +
Sbjct: 141 NLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMF 200
Query: 180 GVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQ 239
GV L ++ + P LN + + + K GE + + D
Sbjct: 201 GVTLWEMF-----TYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD---------IYN 246
Query: 240 VALLCVQENAADRPTMLEILVMLK 263
V + C DRPT + + L
Sbjct: 247 VMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 3e-45
Identities = 64/293 (21%), Positives = 121/293 (41%), Gaps = 28/293 (9%)
Query: 16 MAVKRLSR-TSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDF 74
+A+K L TS + +E +E + A + + ++ +LGIC LI MP L
Sbjct: 41 VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD 99
Query: 75 YIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISD 134
Y+ + + + ++ I +G+ YL++ +VHRDL A N+L+ + KI+D
Sbjct: 100 YVREHKDNI--GSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITD 154
Query: 135 FGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSC 194
FG+A+ +E E + ++ E + IY+ + DV+SYGV + +++
Sbjct: 155 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 214
Query: 195 YYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPT 254
P + + + GE + D + + C +A RP
Sbjct: 215 DGIPASEI------SSILEKGERLPQPPICTID---------VYMIMVKCWMIDADSRPK 259
Query: 255 MLEILVMLKSETAD------IKTPKKPAFSVKRDNDEISECMLEANIYSVDDA 301
E+++ D I+ ++ D++ M E ++ V DA
Sbjct: 260 FRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDA 312
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 1e-44
Identities = 49/255 (19%), Positives = 99/255 (38%), Gaps = 30/255 (11%)
Query: 12 NGQEMAVKRLS--RTSHQGLEEFENEVKLTARLQHVNLLPVLGIC----TQREEKMLIYD 65
E+A L + + + F+ E ++ LQH N++ ++ +L+ +
Sbjct: 33 TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE 92
Query: 66 YMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLD 125
M + +L Y+ +R ++ + I +GL +L I+HRDLK NI +
Sbjct: 93 LMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFIT 148
Query: 126 YE-MNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLL 184
+ KI D G+A ++GT ++ PE + Y DVY++G+ +L
Sbjct: 149 GPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCML 203
Query: 185 QILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLC 244
++ + P Y +G D ++ C
Sbjct: 204 EMATSEY------PYSECQNAAQIYRRVTSGVKPASFDKVAIPE--------VKEIIEGC 249
Query: 245 VQENAADRPTMLEIL 259
+++N +R ++ ++L
Sbjct: 250 IRQNKDERYSIKDLL 264
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 2e-43
Identities = 59/254 (23%), Positives = 101/254 (39%), Gaps = 30/254 (11%)
Query: 9 RLPNGQEMAVKRLSRT---SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYD 65
+ +A+K L + + EV++ + L+H N+L + G LI +
Sbjct: 27 EKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 86
Query: 66 YMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLD 125
Y P ++ + L + D + I + L Y ++HRD+K N+LL
Sbjct: 87 YAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLG 140
Query: 126 YEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQ 185
KI+DFG + + GT Y+PPE + ++ K D++S GVL +
Sbjct: 141 SAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYE 196
Query: 186 ILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCV 245
L GK P E+ E +K +EF + A L+ +
Sbjct: 197 FLVGKP------PFEANTYQE----TYKRISRVEFTFPD-FVTEGARDLISR------LL 239
Query: 246 QENAADRPTMLEIL 259
+ N + RP + E+L
Sbjct: 240 KHNPSQRPMLREVL 253
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 3e-42
Identities = 66/273 (24%), Positives = 110/273 (40%), Gaps = 33/273 (12%)
Query: 8 GRLPNGQEMAVKRLSRTSHQG-LEEFENEVK-LTARLQHVNLLPVLGICTQREEK-MLIY 64
+ + +AVK L + +E+K L H+N++ +LG CT+ M+I
Sbjct: 38 DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 97
Query: 65 DYMPNKSLDFYIFDLRRRYL-------------LDWRTRVHIIEGITQGLLYLQEYSNLT 111
++ +L Y+ R ++ L + + +G+ +L
Sbjct: 98 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--- 154
Query: 112 IVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYS 171
+HRDL A NILL + KI DFG+AR KD G ++ PE + +Y+
Sbjct: 155 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT 214
Query: 172 MKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSA 231
++ DV+S+GVLL +I S P + + E K G M D + +
Sbjct: 215 IQSDVWSFGVLLWEIF-----SLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE---- 265
Query: 232 WKLMRCMQVALLCVQENAADRPTMLEILVMLKS 264
Q L C + RPT E++ L +
Sbjct: 266 -----MYQTMLDCWHGEPSQRPTFSELVEHLGN 293
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 1e-41
Identities = 50/253 (19%), Positives = 101/253 (39%), Gaps = 23/253 (9%)
Query: 13 GQEMAVKRLSRTSHQGL-EEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKS 71
+A+K + + E+F E + H +++ ++G+ T+ +I +
Sbjct: 35 ALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGE 93
Query: 72 LDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPK 131
L ++ R+Y LD + + ++ L YL+ VHRD+ A N+L+ K
Sbjct: 94 LRSFLQ--VRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVK 148
Query: 132 ISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKR 191
+ DFG++R + +D + ++ PE + ++ DV+ +GV + +IL
Sbjct: 149 LGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV 207
Query: 192 TSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAAD 251
N + G +NGE + + + + LM C + +
Sbjct: 208 KPFQGVKNNDV------IGRIENGERLPMPP---NCPPTLYSLMTK------CWAYDPSR 252
Query: 252 RPTMLEILVMLKS 264
RP E+ L +
Sbjct: 253 RPRFTELKAQLST 265
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 9e-41
Identities = 63/272 (23%), Positives = 113/272 (41%), Gaps = 33/272 (12%)
Query: 7 QGRLPNGQEMAVKRLSR-TSHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIY 64
+ + ++AVK L + + L + +E+++ + +H N++ +LG CTQ +I
Sbjct: 39 KDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIV 98
Query: 65 DYMPNKSLDFYIFDLRRRYL-------------LDWRTRVHIIEGITQGLLYLQEYSNLT 111
+Y +L Y+ R L L + V + +G+ YL
Sbjct: 99 EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--- 155
Query: 112 IVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYS 171
+HRDL A N+L+ + KI+DFG+AR + T ++ PE + IY+
Sbjct: 156 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 215
Query: 172 MKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSA 231
+ DV+S+GVLL +I + P E L + L K G M+ + ++
Sbjct: 216 HQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL------FKLLKEGHRMDKPSNCTNE---- 265
Query: 232 WKLMRCMQVALLCVQENAADRPTMLEILVMLK 263
+ C + RPT +++ L
Sbjct: 266 -----LYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 142 bits (360), Expect = 1e-40
Identities = 51/254 (20%), Positives = 90/254 (35%), Gaps = 25/254 (9%)
Query: 9 RLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMP 68
G A K + E E++ + L+H L+ + E ++IY++M
Sbjct: 47 ERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 106
Query: 69 NKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM 128
L + D + + V + + +GL ++ E + VH DLK NI+ +
Sbjct: 107 GGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKR 161
Query: 129 NP--KISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQI 186
+ K+ DFG+ + + GT + PE D++S GVL +
Sbjct: 162 SNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYIL 218
Query: 187 LGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDD-SSSAWKLMRCMQVALLCV 245
L G + G N+ L W DS+ S +R +
Sbjct: 219 LSGLSP--FGGENDDETLRNVKSCDWN------MDDSAFSGISEDGKDFIRK------LL 264
Query: 246 QENAADRPTMLEIL 259
+ R T+ + L
Sbjct: 265 LADPNTRMTIHQAL 278
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 141 bits (357), Expect = 3e-40
Identities = 52/255 (20%), Positives = 94/255 (36%), Gaps = 27/255 (10%)
Query: 9 RLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMP 68
G+ K ++ +NE+ + +L H L+ + + E +LI +++
Sbjct: 50 EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 109
Query: 69 NKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM 128
L I Y + ++ + +GL ++ E +IVH D+K NI+ + +
Sbjct: 110 GGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKK 164
Query: 129 NP--KISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQI 186
KI DFG+A DE T + PE V + D+++ GVL +
Sbjct: 165 ASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVL 221
Query: 187 LGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWK--LMRCMQVALLC 244
L G + G ++ L W EF + + S K + +Q
Sbjct: 222 LSGLSP--FAGEDDLETLQNVKRCDW------EFDEDAFSSVSPEAKDFIKNLLQK---- 269
Query: 245 VQENAADRPTMLEIL 259
R T+ + L
Sbjct: 270 ---EPRKRLTVHDAL 281
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 1e-39
Identities = 54/254 (21%), Positives = 93/254 (36%), Gaps = 26/254 (10%)
Query: 9 RLPNGQEMAVKRLSR---TSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYD 65
L +E A+K L + + E + +RL H + + E+
Sbjct: 29 ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 88
Query: 66 YMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLD 125
Y N L YI + D + + L+ I+HRDLK NILL+
Sbjct: 89 YAKNGELLKYIRKIGS---FDETCTRFYTA---EIVSALEYLHGKGIIHRDLKPENILLN 142
Query: 126 YEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQ 185
+M+ +I+DFG A+ + + +A VGT YV PE + + D+++ G ++ Q
Sbjct: 143 EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQ 202
Query: 186 ILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCV 245
++ G + NE L + + E A L+ +
Sbjct: 203 LVAGLPP--FRAGNEYLIFQKIIKLEYDFPEKF---------FPKARDLVEK------LL 245
Query: 246 QENAADRPTMLEIL 259
+A R E+
Sbjct: 246 VLDATKRLGCEEME 259
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 7e-36
Identities = 48/284 (16%), Positives = 99/284 (34%), Gaps = 26/284 (9%)
Query: 9 RLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMP 68
+ + K + + + E+ + +H N+L + EE ++I++++
Sbjct: 26 ETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84
Query: 69 NKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM 128
+ I + L+ R V + + + L +L ++ I H D++ NI+
Sbjct: 85 GLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRR 139
Query: 129 NP--KISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQI 186
+ KI +FG AR + N + Y PE + + S D++S G L+ +
Sbjct: 140 SSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVL 196
Query: 187 LGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQ 246
L G + + N E ++ + S A + +
Sbjct: 197 LSGINP--FLAETN-----QQIIENIMNAEYTFDEEAFKEISIEAMDFVDR------LLV 243
Query: 247 ENAADRPTMLEILVM--LKSETADIKTPKKPAFSVKRDNDEISE 288
+ R T E L LK + + T +R + +
Sbjct: 244 KERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIK 287
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 8e-36
Identities = 55/268 (20%), Positives = 101/268 (37%), Gaps = 20/268 (7%)
Query: 9 RLPNGQEMAVKRLSRTSHQG-LEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYM 67
N +A+K++S HQ + E+K+ R +H N++ + I + + Y+
Sbjct: 29 DNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL 88
Query: 68 PNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYE 127
+ ++ L + L + + I +GL Y+ ++HRDLK SN+LL+
Sbjct: 89 VTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTT 145
Query: 128 MNPKISDFGMARAFTKDECEANT-GRIVGTYGYVPPEYVRKGI-YSMKYDVYSYGVLLLQ 185
+ KI DFG+AR D V T Y PE + Y+ D++S G +L +
Sbjct: 146 CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAE 205
Query: 186 ILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALL-- 243
+L + + LN + G + I+ + + + L
Sbjct: 206 MLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFP 265
Query: 244 ------------CVQENAADRPTMLEIL 259
+ N R + + L
Sbjct: 266 NADSKALDLLDKMLTFNPHKRIEVEQAL 293
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 127 bits (319), Expect = 5e-35
Identities = 59/255 (23%), Positives = 100/255 (39%), Gaps = 26/255 (10%)
Query: 9 RLPNGQEMAVKRLSRTSHQGLEE-FENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYM 67
+ +A+K +++ + +G E ENE+ + +++H N++ + I LI +
Sbjct: 30 DKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLV 89
Query: 68 PNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL--- 124
L I + R +I + + YL + IVHRDLK N+L
Sbjct: 90 SGGELFDRI---VEKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSL 143
Query: 125 DYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLL 184
D + ISDFG+++ GT GYV PE + + YS D +S GV+
Sbjct: 144 DEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAY 200
Query: 185 QILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLC 244
+L G +Y N+ + E D S SA +R
Sbjct: 201 ILLCGYPP--FYDEND-----AKLFEQILKAEYEFDSPYWDDISDSAKDFIRH------L 247
Query: 245 VQENAADRPTMLEIL 259
++++ R T + L
Sbjct: 248 MEKDPEKRFTCEQAL 262
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 124 bits (312), Expect = 2e-34
Identities = 56/262 (21%), Positives = 100/262 (38%), Gaps = 28/262 (10%)
Query: 10 LPNGQEMAVKRLSR---TSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEK----ML 62
L +++AVK L F E + A L H ++ V +
Sbjct: 29 LRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI 88
Query: 63 IYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNI 122
+ +Y+ +L + + + + +I Q L + + I+HRD+K +NI
Sbjct: 89 VMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANI 142
Query: 123 LLDYEMNPKISDFGMARAFTKD-ECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGV 181
++ K+ DFG+ARA T ++GT Y+ PE R + DVYS G
Sbjct: 143 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 202
Query: 182 LLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241
+L ++L G+ + G + +++ S+ + SA V
Sbjct: 203 VLYEVLTGEPP--FTGDSP-------VSVAYQHVREDPIPPSARHEGLSAD----LDAVV 249
Query: 242 LLCVQENAADRP-TMLEILVML 262
L + +N +R T E+ L
Sbjct: 250 LKALAKNPENRYQTAAEMRADL 271
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 124 bits (311), Expect = 4e-34
Identities = 39/264 (14%), Positives = 79/264 (29%), Gaps = 24/264 (9%)
Query: 9 RLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMP 68
+ G+E+A+K + + E K+ +Q +P + C + ++ +
Sbjct: 28 DIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85
Query: 69 NKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNIL---LD 125
SL+ R+ +T + + + + + Y+ +HRD+K N L
Sbjct: 86 GPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGK 140
Query: 126 YEMNPKISDFGMARAFTKDE-----CEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYG 180
I DFG+A+ + + GT Y S + D+ S G
Sbjct: 141 KGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLG 200
Query: 181 VLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQV 240
+L+ G E + S +
Sbjct: 201 YVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK---GYPSEFATYLNF--- 254
Query: 241 ALLCVQENAADRPTMLEILVMLKS 264
C D+P + + ++
Sbjct: 255 ---CRSLRFDDKPDYSYLRQLFRN 275
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 1e-33
Identities = 58/255 (22%), Positives = 95/255 (37%), Gaps = 29/255 (11%)
Query: 9 RLPNGQEMAVKRLSR---TSHQGLEEFENEVK-LTARLQHVNLLPVLGICTQREEKMLIY 64
Q A+K L + +E E + L+ +H L + +E +
Sbjct: 23 FKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 82
Query: 65 DYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILL 124
+Y+ L ++I + + D I GL +L IV+RDLK NILL
Sbjct: 83 EYLNGGDLMYHI---QSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILL 136
Query: 125 DYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLL 184
D + + KI+DFGM + + + NT GT Y+ PE + Y+ D +S+GVLL
Sbjct: 137 DKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLY 194
Query: 185 QILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALLC 244
++L G+ P + E + + F L A L+
Sbjct: 195 EMLIGQS------PFHGQDEEELFHSIRM---DNPFYPRWL--EKEAKDLLVK------L 237
Query: 245 VQENAADRPTMLEIL 259
R + +
Sbjct: 238 FVREPEKRLGVRGDI 252
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 121 bits (305), Expect = 2e-33
Identities = 65/269 (24%), Positives = 103/269 (38%), Gaps = 42/269 (15%)
Query: 9 RLPNGQEMAVKRLSRTSHQGL---------EEFENEVKLTARLQ-HVNLLPVLGICTQRE 58
P +E AVK + T E EV + ++ H N++ +
Sbjct: 24 HKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 83
Query: 59 EKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLK 118
L++D M L Y+ + L + I+ + + + L + L IVHRDLK
Sbjct: 84 FFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLK 137
Query: 119 ASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVR------KGIYSM 172
NILLD +MN K++DFG + E + GT Y+ PE + Y
Sbjct: 138 PENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGK 194
Query: 173 KYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAW 232
+ D++S GV++ +L G ++ + L L G ++ F DD S
Sbjct: 195 EVDMWSTGVIMYTLLAGSPP--FWHRKQMLMLRMIMSGNYQ------FGSPEWDDYSDTV 246
Query: 233 K--LMRCMQVALLCVQENAADRPTMLEIL 259
K + R + V R T E L
Sbjct: 247 KDLVSRFLVV-------QPQKRYTAEEAL 268
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 122 bits (306), Expect = 3e-33
Identities = 48/195 (24%), Positives = 85/195 (43%), Gaps = 16/195 (8%)
Query: 9 RLPNGQEMAVKRLSR---TSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYD 65
NG+ A+K L + + +E +E + + + H ++ + G ++ +I D
Sbjct: 25 SRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 84
Query: 66 YMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLD 125
Y+ L + +R + + L L+ + I++RDLK NILLD
Sbjct: 85 YIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLALEYLHSKDIIYRDLKPENILLD 138
Query: 126 YEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQ 185
+ KI+DFG A+ T + GT Y+ PE V Y+ D +S+G+L+ +
Sbjct: 139 KNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYE 193
Query: 186 ILGGKRTSCYYGPNE 200
+L G +Y N
Sbjct: 194 MLAGYTP--FYDSNT 206
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 7e-33
Identities = 59/278 (21%), Positives = 99/278 (35%), Gaps = 49/278 (17%)
Query: 9 RLPNGQEMAVKRLSRTSHQGLEE------FENEVKLTARLQ--HVNLLPVLGICTQREEK 60
R+ + +A+K + + E EV L ++ ++ +L + +
Sbjct: 25 RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 84
Query: 61 MLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKAS 120
+LI + F + R L + + + + ++HRD+K
Sbjct: 85 VLILERPEPVQDLFDF--ITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDE 139
Query: 121 NILLDYE-MNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIY-SMKYDVYS 178
NIL+D K+ DFG + GT Y PPE++R Y V+S
Sbjct: 140 NILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWS 195
Query: 179 YGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238
G+LL ++ G + E + G F + SS L+R
Sbjct: 196 LGILLYDMVCGDIP--FEHDEEIIR-------------GQVFFRQRV--SSECQHLIRW- 237
Query: 239 QVALLCVQENAADRPTMLEIL-------VMLKSETADI 269
C+ +DRPT EI V+L ETA+I
Sbjct: 238 -----CLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 270
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 3e-31
Identities = 52/268 (19%), Positives = 98/268 (36%), Gaps = 25/268 (9%)
Query: 9 RLPNGQEMAVKRLSRTSHQGLEE-----FENEVKLTARLQHVNLLPVLGICTQREEKMLI 63
Q +A+K++ ++ E+KL L H N++ +L + L+
Sbjct: 19 DKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLV 78
Query: 64 YDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNIL 123
+D+M +L + QGL YL ++ I+HRDLK +N+L
Sbjct: 79 FDFMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLL 132
Query: 124 LDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRK-GIYSMKYDVYSYGVL 182
LD K++DFG+A++F V T Y PE + +Y + D+++ G +
Sbjct: 133 LDENGVLKLADFGLAKSFGSPNRAYT--HQVVTRWYRAPELLFGARMYGVGVDMWAVGCI 190
Query: 183 LLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA- 241
L ++L + L + G + + + ++ + +
Sbjct: 191 LAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFS 250
Query: 242 --------LL--CVQENAADRPTMLEIL 259
L+ N R T + L
Sbjct: 251 AAGDDLLDLIQGLFLFNPCARITATQAL 278
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 4e-31
Identities = 56/263 (21%), Positives = 100/263 (38%), Gaps = 36/263 (13%)
Query: 9 RLPNGQEMAVKRLSRTSHQG------LEEFENEVKLTARLQHVNLLPVLGICTQREEKML 62
G + A K + + + E+ E EV + +QH N++ + + + + +L
Sbjct: 31 EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 90
Query: 63 IYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNI 122
I + + L ++ + L ++ I L + +L I H DLK NI
Sbjct: 91 ILELVAGGELFDFLA---EKESLTEEEATEFLKQI---LNGVYYLHSLQIAHFDLKPENI 144
Query: 123 LLDYEMNP----KISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYS 178
+L P KI DFG+A I GT +V PE V ++ D++S
Sbjct: 145 MLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWS 201
Query: 179 YGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWK--LMR 236
GV+ +L G + G + L + + EF D ++S+ K + R
Sbjct: 202 IGVITYILLSGAS--PFLGDTKQETLANVSAVNY------EFEDEYFSNTSALAKDFIRR 253
Query: 237 CMQVALLCVQENAADRPTMLEIL 259
+ + R T+ + L
Sbjct: 254 LLVK-------DPKKRMTIQDSL 269
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 4e-31
Identities = 53/276 (19%), Positives = 100/276 (36%), Gaps = 24/276 (8%)
Query: 2 SVAICQGRLPNGQEMAVKRLSRTSHQG--LEEFENEVKLTARL---QHVNLLPVLGICTQ 56
V + G+ +A+KR+ + + EV + L +H N++ + +CT
Sbjct: 22 KVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 81
Query: 57 REEKMLIYDYMPNKSLD---FYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIV 113
+ + +D D + T ++ + +GL +L + +V
Sbjct: 82 SRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VV 138
Query: 114 HRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMK 173
HRDLK NIL+ K++DFG+AR ++ +V T Y PE + + Y+
Sbjct: 139 HRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATP 195
Query: 174 YDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGL-----WKNGEGMEFIDSSLDDS 228
D++S G + ++ K + L + GL W + +
Sbjct: 196 VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSA 255
Query: 229 SSAWKLMRCMQVALL-----CVQENAADRPTMLEIL 259
K + + C+ N A R + L
Sbjct: 256 QPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 117 bits (294), Expect = 4e-31
Identities = 56/256 (21%), Positives = 95/256 (37%), Gaps = 31/256 (12%)
Query: 9 RLPNGQEMAVKRLSR---TSHQGLEEFENEV---KLTARLQHVNLLPVLGICTQREEKML 62
+ G+ A+K L + QG NE L + ++ + ++
Sbjct: 25 KADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 84
Query: 63 IYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNI 122
I D M L +++ + + I GL ++ +V+RDLK +NI
Sbjct: 85 ILDLMNGGDLHYHL---SQHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANI 138
Query: 123 LLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGI-YSMKYDVYSYGV 181
LLD + +ISD G+A F+K + VGT+GY+ PE ++KG+ Y D +S G
Sbjct: 139 LLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGC 194
Query: 182 LLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241
+L ++L G P + + S S L+
Sbjct: 195 MLFKLLRGHS------PFRQHKTKDKHEIDRMTLTMAVELPDSF--SPELRSLLEG---- 242
Query: 242 LLCVQENAADRPTMLE 257
+Q + R L
Sbjct: 243 --LLQRDVNRRLGCLG 256
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 5e-31
Identities = 52/265 (19%), Positives = 99/265 (37%), Gaps = 20/265 (7%)
Query: 9 RLPNGQEMAVK--RLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDY 66
G+ +A+K RL + E+ L L H N++ +L + + L++++
Sbjct: 23 NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 82
Query: 67 MPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY 126
+ F D + + + QGL + + ++HRDLK N+L++
Sbjct: 83 LHQDLKKF--MDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINT 137
Query: 127 EMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQI 186
E K++DFG+ARAF T +V + P + YS D++S G + ++
Sbjct: 138 EGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 196
Query: 187 LGGKRTSCYYGPNESLNLLEYAYG-----LWKNGEGM-----EFIDSSLDDSSSAWKLMR 236
+ + + L + G +W M F + D S +
Sbjct: 197 VTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLD 256
Query: 237 CMQVALL--CVQENAADRPTMLEIL 259
+LL + + R + L
Sbjct: 257 EDGRSLLSQMLHYDPNKRISAKAAL 281
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 3e-30
Identities = 54/270 (20%), Positives = 96/270 (35%), Gaps = 28/270 (10%)
Query: 9 RLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKM------L 62
+G+ +A+K++ + E+++ +L H N++ + EK L
Sbjct: 41 LCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96
Query: 63 IYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNI 122
+ DY+P R + L + + + L Y+ I HRD+K N+
Sbjct: 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNL 153
Query: 123 LLDYE-MNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGV 181
LLD + K+ DFG A+ + E + I Y P Y+ DV+S G
Sbjct: 154 LLDPDTAVLKLCDFGSAKQLVRGEPNVSY--ICSRYYRAPELIFGATDYTSSIDVWSAGC 211
Query: 182 LLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQV- 240
+L ++L G+ + L + G + E + + K +V
Sbjct: 212 VLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVF 271
Query: 241 ---------ALL--CVQENAADRPTMLEIL 259
AL ++ R T LE
Sbjct: 272 RPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 112 bits (280), Expect = 9e-30
Identities = 48/271 (17%), Positives = 102/271 (37%), Gaps = 25/271 (9%)
Query: 5 ICQGRLPNGQEMAVK--RLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKML 62
+ + + G+ A+K RL + E+ + L+H N++ + + ++ +L
Sbjct: 18 VYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVL 77
Query: 63 IYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNI 122
+++++ L+ T + + G+ Y + ++HRDLK N+
Sbjct: 78 VFEHLDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNL 131
Query: 123 LLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVL 182
L++ E KI+DFG+ARAF + IV + P + YS D++S G +
Sbjct: 132 LINREGELKIADFGLARAFGIPVRKYTH-EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCI 190
Query: 183 LLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVAL 242
+++ G + G +E+ L+ L + L + + +
Sbjct: 191 FAEMVNGTP--LFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWES 248
Query: 243 L--------------CVQENAADRPTMLEIL 259
++ + R T + L
Sbjct: 249 FLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 112 bits (281), Expect = 9e-30
Identities = 39/266 (14%), Positives = 78/266 (29%), Gaps = 26/266 (9%)
Query: 9 RLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMP 68
L N Q++A+K R S + +E + L +P + Q ++ +
Sbjct: 26 NLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83
Query: 69 NKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM 128
SL+ + +T + + + + E S +V+RD+K N L+
Sbjct: 84 GPSLEDLL--DLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPN 138
Query: 129 NP-----KISDFGMARAFTKDE-----CEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYS 178
+ + DFGM + + + GT Y+ S + D+ +
Sbjct: 139 SKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEA 198
Query: 179 YGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238
G + + L G + E ++ E +K M
Sbjct: 199 LGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA---GFPEEFYKYMHY- 254
Query: 239 QVALLCVQENAADRPTMLEILVMLKS 264
P + +
Sbjct: 255 -----ARNLAFDATPDYDYLQGLFSK 275
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 2e-29
Identities = 53/279 (18%), Positives = 107/279 (38%), Gaps = 34/279 (12%)
Query: 9 RLPNGQEMAVKRLSRTSHQG--LEEFENEVKLTARLQHVNLLPVLGICTQREEKM----- 61
GQ++A+K++ + + E+K+ L+H N++ ++ IC +
Sbjct: 31 HRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG 90
Query: 62 ---LIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLK 118
L++D+ + L + +++ + GL Y+ I+HRD+K
Sbjct: 91 SIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMK 144
Query: 119 ASNILLDYEMNPKISDFGMARAFT--KDECEANTGRIVGTYGYVPPEYVRKGI-YSMKYD 175
A+N+L+ + K++DFG+ARAF+ K+ V T Y PPE + Y D
Sbjct: 145 AANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPID 204
Query: 176 VYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYG-----LWKNGEGMEFIDSSLDDSSS 230
++ G ++ ++ L L+ G +W N + E +
Sbjct: 205 LWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQ 264
Query: 231 AWKLMRCMQVALL----------CVQENAADRPTMLEIL 259
K+ ++ + + + A R + L
Sbjct: 265 KRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 2e-29
Identities = 57/290 (19%), Positives = 108/290 (37%), Gaps = 31/290 (10%)
Query: 9 RLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARL-QHVNLLPVLGIC----TQREEKMLI 63
++ A+K L + EV+L R Q +++ ++ + R+ +++
Sbjct: 33 NKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 87
Query: 64 YDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNIL 123
+ + L I D R R I++ I + + YL + I HRD+K N+L
Sbjct: 88 MECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLL 143
Query: 124 LDYEMNP---KISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYG 180
+ K++DFG A+ T + T YV PE + Y D++S G
Sbjct: 144 YTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLG 200
Query: 181 VLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQV 240
V++ +L G + N L + + G+ + S L+R
Sbjct: 201 VIMYILLCGYP---PFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN--- 254
Query: 241 ALLCVQENAADRPTMLEILVM--LKSETADIKTPKKPAFSVKRDNDEISE 288
++ R T+ E + + T +TP + +K D + +
Sbjct: 255 ---LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWED 301
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 3e-29
Identities = 45/267 (16%), Positives = 91/267 (34%), Gaps = 24/267 (8%)
Query: 9 RLPNGQEMAVK--RLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDY 66
+ +A+K RL E+ L L+H N++ + + ++ L++++
Sbjct: 23 NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82
Query: 67 MPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY 126
++ + + Q L L + ++HRDLK N+L++
Sbjct: 83 CDQDLKKYFDSCNG------DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINR 136
Query: 127 EMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQI 186
K+++FG+ARAF + +V + P +YS D++S G + ++
Sbjct: 137 NGELKLANFGLARAFGIPV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 195
Query: 187 LGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALL--- 243
R + G + L L E + L D + +
Sbjct: 196 ANAGR-PLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPK 254
Query: 244 -----------CVQENAADRPTMLEIL 259
++ N R + E L
Sbjct: 255 LNATGRDLLQNLLKCNPVQRISAEEAL 281
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 4e-28
Identities = 36/186 (19%), Positives = 74/186 (39%), Gaps = 11/186 (5%)
Query: 9 RLPNGQEMAVKRLSR---TSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYD 65
G+ A+K L + + + E ++ +H L + + + +
Sbjct: 26 EKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85
Query: 66 YMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLD 125
Y L F++ R + + + L+ + +V+RD+K N++LD
Sbjct: 86 YANGGELFFHL---SRERVFTEERARFYG---AEIVSALEYLHSRDVVYRDIKLENLMLD 139
Query: 126 YEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQ 185
+ + KI+DFG+ + D A GT Y+ PE + Y D + GV++ +
Sbjct: 140 KDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 197
Query: 186 ILGGKR 191
++ G+
Sbjct: 198 MMCGRL 203
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 102 bits (254), Expect = 1e-25
Identities = 44/255 (17%), Positives = 92/255 (36%), Gaps = 28/255 (10%)
Query: 9 RLPNGQEMAVKRLSR---TSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYD 65
+G A+K L + + +E NE ++ + L+ + ++ +
Sbjct: 62 HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121
Query: 66 YMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLD 125
Y+ + ++ + R I YL L +++RDLK N+L+D
Sbjct: 122 YVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLID 175
Query: 126 YEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQ 185
+ +++DFG A+ + T + GT + PE + Y+ D ++ GVL+ +
Sbjct: 176 QQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 186 ILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM-RCMQVALLC 244
+ G ++ + G + SS L+ +QV L
Sbjct: 231 MAAGYP--PFFADQPIQIYEKIVSGKVRFPSHF---------SSDLKDLLRNLLQVDLT- 278
Query: 245 VQENAADRPTMLEIL 259
+ + + +I
Sbjct: 279 -KRFGNLKNGVNDIK 292
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (251), Expect = 3e-25
Identities = 61/308 (19%), Positives = 117/308 (37%), Gaps = 26/308 (8%)
Query: 9 RLPNGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYD- 65
G ++A+K+L R S + E++L ++H N++ +L + T E D
Sbjct: 39 DGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 98
Query: 66 YMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLD 125
Y+ + + L + L ++ + +GL Y+ I+HRDLK N+ ++
Sbjct: 99 YLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVN 155
Query: 126 YEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQ 185
+ KI DFG+AR + TG +V + P + Y+ D++S G ++ +
Sbjct: 156 EDCELKILDFGLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAE 211
Query: 186 ILGGKRTSCYYGPNESLNLLEYAYG-----LWKNGEGME-------FIDSSLDDSSSAWK 233
++ GK + L + G + + E + D +S
Sbjct: 212 MITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILT 271
Query: 234 LMRCMQVALL--CVQENAADRPTMLEILVM--LKSETADIKTPKKPAFSVKRDNDEISEC 289
+ V LL + +A R T E L +S P+ + D+ + +
Sbjct: 272 NASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLD 331
Query: 290 MLEANIYS 297
+ Y
Sbjct: 332 EWKRVTYK 339
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.2 bits (233), Expect = 1e-22
Identities = 56/309 (18%), Positives = 114/309 (36%), Gaps = 30/309 (9%)
Query: 9 RLPNGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYD- 65
G +AVK+LSR S + E++L ++H N++ +L + T D
Sbjct: 39 DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 98
Query: 66 YMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLD 125
Y+ + + ++ + L +I I +GL Y+ +HRDLK SN+ ++
Sbjct: 99 YLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAVN 155
Query: 126 YEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQ 185
+ KI DFG+AR + TG + + P + Y+ D++S G ++ +
Sbjct: 156 EDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 211
Query: 186 ILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALL-- 243
+L G+ + + G + L + G + SS + L + ++
Sbjct: 212 LLTGR--TLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV 269
Query: 244 --------------CVQENAADRPTMLEILVM--LKSETADIKTPKKPAFSVKRDNDEIS 287
+ ++ R T + L P + ++ ++
Sbjct: 270 FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLL 329
Query: 288 ECMLEANIY 296
++ Y
Sbjct: 330 IDEWKSLTY 338
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.2 bits (228), Expect = 4e-22
Identities = 54/259 (20%), Positives = 100/259 (38%), Gaps = 27/259 (10%)
Query: 4 AICQGRLPNGQEMAVKRLSRTS----HQGLEEFENEVKLTARLQHVNLLPVL-GICTQRE 58
G+ A+K L + + + E E ++ ++ L L
Sbjct: 43 VRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102
Query: 59 EKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLK 118
+ LI DY+ L ++ +R + + + +L L+ L I++RD+K
Sbjct: 103 KLHLILDYINGGELFTHL---SQRERFTEH---EVQIYVGEIVLALEHLHKLGIIYRDIK 156
Query: 119 ASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGI--YSMKYDV 176
NILLD + ++DFG+++ F DE E GT Y+ P+ VR G + D
Sbjct: 157 LENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDW 215
Query: 177 YSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMR 236
+S GVL+ ++L G + E + E + + K + S+ A L++
Sbjct: 216 WSLGVLMYELLTGAS--PFTVDGEKNSQAEISRRILK-----SEPPYPQEMSALAKDLIQ 268
Query: 237 CMQVALLCVQENAADRPTM 255
+ ++ R
Sbjct: 269 R------LLMKDPKKRLGC 281
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.5 bits (218), Expect = 1e-20
Identities = 62/320 (19%), Positives = 114/320 (35%), Gaps = 37/320 (11%)
Query: 9 RLPNGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDY 66
+ +A+K+LSR + + E+ L + H N++ +L + T ++ D
Sbjct: 38 DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 97
Query: 67 MPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY 126
L + LD +++ + G+ +L +HRDLK SNI++
Sbjct: 98 YLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKS 154
Query: 127 EMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQI 186
+ KI DFG+AR V T Y PE + Y D++S G ++ ++
Sbjct: 155 DCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 211
Query: 187 LGGKRTSCYYGPNESLNLLEYAYG-----LWKNGEGME------------------FIDS 223
+ K + N + G K + F DS
Sbjct: 212 VRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDS 271
Query: 224 SLDDSSSAWKLMRCMQVALL--CVQENAADRPTMLEIL----VMLKSETADIKTPKKPAF 277
S KL LL + + A R ++ + L + + + A+++ P +
Sbjct: 272 LFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIY 331
Query: 278 SVKRDNDEISECMLEANIYS 297
+ D E + + IY
Sbjct: 332 DKQLDEREHTIEEWKELIYK 351
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 87.2 bits (215), Expect = 3e-20
Identities = 37/187 (19%), Positives = 79/187 (42%), Gaps = 18/187 (9%)
Query: 9 RLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQ-HVNLLPVLGICTQREEKM--LIYD 65
+ N +++ VK L ++ + E+K+ L+ N++ + I + L+++
Sbjct: 56 NITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112
Query: 66 YMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLD 125
++ N L + L + I + L Y + I+HRD+K N+++D
Sbjct: 113 HVNNTDF----KQLYQT--LTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMID 163
Query: 126 YE-MNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLL 184
+E ++ D+G+A + + R+ Y P V +Y D++S G +L
Sbjct: 164 HEHRKLRLIDWGLAEFYHPG--QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 221
Query: 185 QILGGKR 191
++ K
Sbjct: 222 SMIFRKE 228
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 84.7 bits (208), Expect = 3e-19
Identities = 31/196 (15%), Positives = 66/196 (33%), Gaps = 17/196 (8%)
Query: 9 RLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMP 68
+ N +A+K + R E E+E+KL R+ + + K+L +
Sbjct: 34 DMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92
Query: 69 NKSLDFY-------------IFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHR 115
+ + + I + + GL Y+ I+H
Sbjct: 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHT 150
Query: 116 DLKASNILLDYE-MNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKY 174
D+K N+L++ + +A + + + T Y PE + +
Sbjct: 151 DIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGA 210
Query: 175 DVYSYGVLLLQILGGK 190
D++S L+ +++ G
Sbjct: 211 DIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 68.3 bits (166), Expect = 2e-14
Identities = 33/181 (18%), Positives = 56/181 (30%), Gaps = 25/181 (13%)
Query: 8 GRLPNGQEMAVK--RLSRTS--------HQGLEEFENEVKLTARLQHVNLLPVLGICTQR 57
E VK ++ TS G F +AR + L + G+ +
Sbjct: 19 CYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPK 78
Query: 58 EEKMLIYDYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDL 117
+Y + N L I + +++ I + + IVH DL
Sbjct: 79 -----VYAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAKFYHR---GIVHGDL 129
Query: 118 KASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVY 177
N+L+ E I DF + ++ R V Y + Y + D+
Sbjct: 130 SQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDV----RNIITYFSRT-YRTEKDIN 183
Query: 178 S 178
S
Sbjct: 184 S 184
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 309 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.8 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.7 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.28 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.67 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.61 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.75 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.12 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-51 Score=342.70 Aligned_cols=237 Identities=23% Similarity=0.285 Sum_probs=186.5
Q ss_pred ceEEEEc-CCCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
+||++.. .+|+.||||++.... ....+.+.+|++++++++||||+++++++.+++..++||||+++++|.+++. .
T Consensus 20 ~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~---~ 96 (271)
T d1nvra_ 20 EVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---P 96 (271)
T ss_dssp EEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSB---T
T ss_pred EEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHh---c
Confidence 5677654 689999999987543 3334678899999999999999999999999999999999999999998883 3
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP 161 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 161 (309)
...+++..++.++.||+.|+.|||++ ||+||||||+||+++.++.+||+|||++................||+.|+|
T Consensus 97 ~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~A 173 (271)
T d1nvra_ 97 DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 173 (271)
T ss_dssp TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSC
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccC
Confidence 44599999999999999999999998 999999999999999999999999999987654433333444579999999
Q ss_pred ccccccCCC-CccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHH
Q 021682 162 PEYVRKGIY-SMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQV 240 (309)
Q Consensus 162 PE~~~~~~~-~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 240 (309)
||.+.+..+ +.++|||||||++|+|++|+.||......... .. ......... ......+.++.+|
T Consensus 174 PE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~--~~----~~~~~~~~~--------~~~~~~s~~~~~l 239 (271)
T d1nvra_ 174 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YS----DWKEKKTYL--------NPWKKIDSAPLAL 239 (271)
T ss_dssp THHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH--HH----HHHTTCTTS--------TTGGGSCHHHHHH
T ss_pred HhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH--HH----HHhcCCCCC--------CccccCCHHHHHH
Confidence 999988776 57899999999999999999999654332211 11 111111000 0011122477899
Q ss_pred HhhcccCCCCCCCCHHHHHH
Q 021682 241 ALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 241 i~~~l~~~p~~Rpt~~ell~ 260 (309)
|.+||+.||++|||++|+++
T Consensus 240 i~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 240 LHKILVENPSARITIPDIKK 259 (271)
T ss_dssp HHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHcCCChhHCcCHHHHhc
Confidence 99999999999999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-50 Score=342.25 Aligned_cols=236 Identities=22% Similarity=0.337 Sum_probs=191.5
Q ss_pred cceEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 3 VAICQGR-LPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 3 ~~~~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
++||++. ..+|+.||||.++.......+.+.+|+.++++++||||+++++++.+++..++||||+++++|.+++..
T Consensus 34 g~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~--- 110 (293)
T d1yhwa1 34 GTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--- 110 (293)
T ss_dssp CEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH---
T ss_pred cEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhc---
Confidence 3567775 468999999999876656678899999999999999999999999999999999999999999987632
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP 161 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 161 (309)
..+++..+..++.||+.||.|||++ ||+||||||+||+++.++.+||+|||++......... .....||+.|+|
T Consensus 111 -~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~--~~~~~gt~~Y~a 184 (293)
T d1yhwa1 111 -TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMA 184 (293)
T ss_dssp -SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC--BCCCCSCGGGCC
T ss_pred -cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccccc--ccccccCCCccC
Confidence 3489999999999999999999998 9999999999999999999999999999876543322 233479999999
Q ss_pred ccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHH
Q 021682 162 PEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241 (309)
Q Consensus 162 PE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 241 (309)
||.+.+..++.++|||||||++|+|++|..||......+ .......... .. ...+...+..+.+||
T Consensus 185 PE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~~~~~~~-~~-------~~~~~~~s~~~~~li 250 (293)
T d1yhwa1 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNGT-PE-------LQNPEKLSAIFRDFL 250 (293)
T ss_dssp HHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHHCS-CC-------CSSGGGSCHHHHHHH
T ss_pred hhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH------HHHHHHhCCC-CC-------CCCcccCCHHHHHHH
Confidence 999999999999999999999999999999985432211 1111111111 00 011112234788999
Q ss_pred hhcccCCCCCCCCHHHHHHH
Q 021682 242 LLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 242 ~~~l~~~p~~Rpt~~ell~~ 261 (309)
.+||+.||++|||++|+++.
T Consensus 251 ~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 251 NRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp HHHTCSSTTTSCCHHHHTTC
T ss_pred HHHccCChhHCcCHHHHhcC
Confidence 99999999999999999863
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-50 Score=337.25 Aligned_cols=230 Identities=23% Similarity=0.322 Sum_probs=187.7
Q ss_pred ceEEEEc-CCCcEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGRL-PNGQEMAVKRLSRT---SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
+||++.. .+|+.||+|++... .......+.+|++++++++||||+++++++.+++..++||||+++|+|.+++..
T Consensus 21 ~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~- 99 (263)
T d2j4za1 21 NVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK- 99 (263)
T ss_dssp EEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-
T ss_pred EEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhh-
Confidence 5667754 58999999998643 233467789999999999999999999999999999999999999999999854
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
...+++..+..++.||+.|++|||++ |++||||||+||+++.++.+||+|||++....... .....||+.|
T Consensus 100 --~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~----~~~~~Gt~~Y 170 (263)
T d2j4za1 100 --LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDY 170 (263)
T ss_dssp --HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC----CEETTEEGGG
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCCc----ccccCCCCcc
Confidence 33499999999999999999999998 99999999999999999999999999997654432 2234689999
Q ss_pred CCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHH
Q 021682 160 VPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQ 239 (309)
Q Consensus 160 ~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (309)
+|||.+.+..++.++|||||||++|+|++|+.||......+ . ......... . .. ...+.++.+
T Consensus 171 ~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~-~~~i~~~~~-~-----~p----~~~s~~~~~ 233 (263)
T d2j4za1 171 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE------T-YKRISRVEF-T-----FP----DFVTEGARD 233 (263)
T ss_dssp CCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------H-HHHHHTTCC-C-----CC----TTSCHHHHH
T ss_pred cCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH------H-HHHHHcCCC-C-----CC----ccCCHHHHH
Confidence 99999999999999999999999999999999985432111 1 111111111 0 01 112337889
Q ss_pred HHhhcccCCCCCCCCHHHHHH
Q 021682 240 VALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 240 li~~~l~~~p~~Rpt~~ell~ 260 (309)
+|.+||+.||++|||++|+++
T Consensus 234 li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 234 LISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp HHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHccCCHhHCcCHHHHHc
Confidence 999999999999999999986
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-50 Score=338.79 Aligned_cols=248 Identities=23% Similarity=0.379 Sum_probs=188.1
Q ss_pred cceEEEEcCCCcEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 3 VAICQGRLPNGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
+.||+|.++ ..||||+++.. .....+.+.+|+.++++++||||+++++++.. ...++||||+++|+|.+++..
T Consensus 22 g~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~L~~~l~~-- 96 (276)
T d1uwha_ 22 GTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHI-- 96 (276)
T ss_dssp CEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEEHHHHHHT--
T ss_pred cEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCCHHHHHhh--
Confidence 367899864 46999998654 34456789999999999999999999998754 568999999999999999853
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCC
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYV 160 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 160 (309)
....+++..+..++.||+.|++|||++ ||+||||||+||+++.++.+||+|||++................||+.|+
T Consensus 97 ~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~ 173 (276)
T d1uwha_ 97 IETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173 (276)
T ss_dssp SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGC
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccC
Confidence 234589999999999999999999998 89999999999999999999999999997765443333344457899999
Q ss_pred CccccccC---CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHH
Q 021682 161 PPEYVRKG---IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRC 237 (309)
Q Consensus 161 aPE~~~~~---~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (309)
|||++.+. .++.++|||||||++|+|++|+.||........ . ......+....... . .....+..+
T Consensus 174 APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~---~---~~~~~~~~~~p~~~-~----~~~~~~~~l 242 (276)
T d1uwha_ 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---I---IFMVGRGYLSPDLS-K----VRSNCPKAM 242 (276)
T ss_dssp CHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH---H---HHHHHHTSCCCCGG-G----SCTTCCHHH
T ss_pred CHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH---H---HHHHhcCCCCCcch-h----ccccchHHH
Confidence 99998643 478999999999999999999999864332221 1 11111111111110 0 111123478
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHHhcccCCC
Q 021682 238 MQVALLCVQENAADRPTMLEILVMLKSETADI 269 (309)
Q Consensus 238 ~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~~ 269 (309)
.+|+.+||+.||++|||++||++.|+.+.+.+
T Consensus 243 ~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 243 KRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 89999999999999999999999999886644
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-50 Score=338.30 Aligned_cols=241 Identities=25% Similarity=0.389 Sum_probs=184.6
Q ss_pred ceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcccc
Q 021682 4 AICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRY 83 (309)
Q Consensus 4 ~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~ 83 (309)
.||+|.+.+++.||||.++.. ....+.+.+|++++++++||||+++++++..++..++||||+++|+|.+++.. ...
T Consensus 20 ~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~--~~~ 96 (263)
T d1sm2a_ 20 LVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT--QRG 96 (263)
T ss_dssp CEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHT--TTT
T ss_pred EEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhc--ccc
Confidence 689999888999999999654 34457899999999999999999999999999999999999999999998743 344
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCcc
Q 021682 84 LLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPE 163 (309)
Q Consensus 84 ~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 163 (309)
.+++..+..++.|++.|+.|||++ +++||||||+||+++.++.+||+|||++.......... .....||..|+|||
T Consensus 97 ~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE 172 (263)
T d1sm2a_ 97 LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPE 172 (263)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-------------------CTTSCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCcee-ecceecCcccCChH
Confidence 588999999999999999999998 89999999999999999999999999997665433222 22346889999999
Q ss_pred ccccCCCCccchhhhHHHHHHHHHhC-CCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHHh
Q 021682 164 YVRKGIYSMKYDVYSYGVLLLQILGG-KRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVAL 242 (309)
Q Consensus 164 ~~~~~~~~~~~DvwslG~il~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 242 (309)
.+.+..++.++|||||||++|||+++ .+|+..... ..... ....+.... .+...+.++.+++.
T Consensus 173 ~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~---~~~~~----~i~~~~~~~---------~p~~~~~~l~~li~ 236 (263)
T d1sm2a_ 173 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVE----DISTGFRLY---------KPRLASTHVYQIMN 236 (263)
T ss_dssp HHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH---HHHHH----HHHHTCCCC---------CCTTSCHHHHHHHH
T ss_pred HhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH---HHHHH----HHHhcCCCC---------CccccCHHHHHHHH
Confidence 99999999999999999999999995 555432211 11111 111111110 01112247889999
Q ss_pred hcccCCCCCCCCHHHHHHHHhcccC
Q 021682 243 LCVQENAADRPTMLEILVMLKSETA 267 (309)
Q Consensus 243 ~~l~~~p~~Rpt~~ell~~L~~~~~ 267 (309)
+||+.||++|||++||++.|+++.+
T Consensus 237 ~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 237 HCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHccCCHhHCcCHHHHHHHHHHHHh
Confidence 9999999999999999999998753
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-50 Score=339.07 Aligned_cols=238 Identities=22% Similarity=0.298 Sum_probs=190.8
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
+.||++.. .+|+.||||.+........+.+.+|++++++++||||+++++++.+++..++||||+++++|.+++...
T Consensus 26 g~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~-- 103 (288)
T d2jfla1 26 GKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL-- 103 (288)
T ss_dssp EEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHH--
T ss_pred cEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhc--
Confidence 35677764 589999999998776667788999999999999999999999999999999999999999999987442
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP 161 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 161 (309)
...+++..+..++.||+.||.|||++ ||+||||||+||+++.++.+||+|||++........ ......||+.|+|
T Consensus 104 ~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~--~~~~~~Gt~~y~A 178 (288)
T d2jfla1 104 ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RRDSFIGTPYWMA 178 (288)
T ss_dssp TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH--HHTCCCSCCTTCC
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCcc--cccccccccccCC
Confidence 34599999999999999999999998 899999999999999999999999999865443221 1223478999999
Q ss_pred ccccc-----cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHH
Q 021682 162 PEYVR-----KGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMR 236 (309)
Q Consensus 162 PE~~~-----~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
||++. +..++.++|||||||++|+|++|+.||......+.. . ..... .... ...+...+.+
T Consensus 179 PE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~---~---~i~~~-~~~~-------~~~~~~~s~~ 244 (288)
T d2jfla1 179 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL---L---KIAKS-EPPT-------LAQPSRWSSN 244 (288)
T ss_dssp HHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH---H---HHHHS-CCCC-------CSSGGGSCHH
T ss_pred HHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHH---H---HHHcC-CCCC-------CCccccCCHH
Confidence 99884 456789999999999999999999999654332211 1 11111 1110 1111223347
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 237 CMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 237 l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
+.+||.+||+.||++|||++|+++.
T Consensus 245 ~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 245 FKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHHccCChhHCcCHHHHhcC
Confidence 8899999999999999999999763
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.2e-50 Score=338.95 Aligned_cols=244 Identities=25% Similarity=0.341 Sum_probs=195.2
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
++||+|.. .+|+.||||.++.. ....+++.+|++++++++||||+++++++.+++..++||||+++|+|.+++.. ..
T Consensus 31 g~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~-~~ 108 (287)
T d1opja_ 31 GEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CN 108 (287)
T ss_dssp SSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHH-SC
T ss_pred eEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhh-cc
Confidence 35788865 47899999998654 34567899999999999999999999999999999999999999999998854 23
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP 161 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 161 (309)
...+++..+..++.|++.|++|||++ ||+||||||+||+++.++.+||+|||++.......... .....|+..|+|
T Consensus 109 ~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~-~~~~~g~~~y~a 184 (287)
T d1opja_ 109 RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA-HAGAKFPIKWTA 184 (287)
T ss_dssp TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEE-ETTEEECGGGCC
T ss_pred ccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCcee-eccccccccccC
Confidence 45689999999999999999999998 89999999999999999999999999998765443222 223457889999
Q ss_pred ccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHH
Q 021682 162 PEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241 (309)
Q Consensus 162 PE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 241 (309)
||.+.+..++.++|||||||++|+|++|..|+....... ........+..... +...+.++.+|+
T Consensus 185 PE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~------~~~~~i~~~~~~~~---------~~~~~~~l~~li 249 (287)
T d1opja_ 185 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKDYRMER---------PEGCPEKVYELM 249 (287)
T ss_dssp HHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HHHHHHHTTCCCCC---------CTTCCHHHHHHH
T ss_pred hHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH------HHHHHHhcCCCCCC---------CccchHHHHHHH
Confidence 999999999999999999999999999766653221111 11122222211111 112234788999
Q ss_pred hhcccCCCCCCCCHHHHHHHHhcccC
Q 021682 242 LLCVQENAADRPTMLEILVMLKSETA 267 (309)
Q Consensus 242 ~~~l~~~p~~Rpt~~ell~~L~~~~~ 267 (309)
.+||+.||++|||++|+++.|+.+.+
T Consensus 250 ~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 250 RACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred HHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 99999999999999999999988744
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-49 Score=340.33 Aligned_cols=249 Identities=20% Similarity=0.244 Sum_probs=187.8
Q ss_pred ceEEEEc-CCCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
+||++.. .+|+.||+|.++... .....++.+|+.+|++++||||++++++|.++.+.++||||+.+++|.+++...
T Consensus 21 ~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~-- 98 (322)
T d1s9ja_ 21 VVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-- 98 (322)
T ss_dssp CEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHH--
T ss_pred EEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhc--
Confidence 4677764 589999999997653 344578899999999999999999999999999999999999999999998543
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP 161 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 161 (309)
..+++..+..++.|++.|+.|||+.+ ||+||||||+||+++.++.+||+|||+|....... .....||..|+|
T Consensus 99 -~~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~----~~~~~GT~~Y~A 171 (322)
T d1s9ja_ 99 -GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMS 171 (322)
T ss_dssp -SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT----C---CCSSCCCC
T ss_pred -CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCCCc----cccccCCccccC
Confidence 34999999999999999999999743 89999999999999999999999999997654322 223579999999
Q ss_pred ccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHH-HHHH---------hhCCCCc-ccc---------
Q 021682 162 PEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEY-AYGL---------WKNGEGM-EFI--------- 221 (309)
Q Consensus 162 PE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~-~~~~---------~~~~~~~-~~~--------- 221 (309)
||++.+..++.++||||+||++|+|++|+.||...+..+....... .... ....... ...
T Consensus 172 PEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (322)
T d1s9ja_ 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIF 251 (322)
T ss_dssp HHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------------CCCCHH
T ss_pred chHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHH
Confidence 9999999999999999999999999999999965433221100000 0000 0000000 000
Q ss_pred -------cccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 222 -------DSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 222 -------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
............+.++.++|.+||+.||++|||++|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 252 ELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp HHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0000000001123468899999999999999999999874
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-50 Score=339.60 Aligned_cols=235 Identities=23% Similarity=0.265 Sum_probs=186.5
Q ss_pred cceEEEEc-CCCcEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRT---SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
++||++.. .+|+.||||++... .....+.+.+|++++++++||||+++++++.+++..++||||+++++|.+++..
T Consensus 22 g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~ 101 (288)
T d1uu3a_ 22 STVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK 101 (288)
T ss_dssp CEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH
T ss_pred eEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhc
Confidence 35777764 68999999999653 234457899999999999999999999999999999999999999999998744
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
...+++..++.++.|++.|+.|||++ ||+||||||+||+++.++.+||+|||++................||+.
T Consensus 102 ---~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~ 175 (288)
T d1uu3a_ 102 ---IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 175 (288)
T ss_dssp ---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGG
T ss_pred ---cCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCCcccccccccCCcc
Confidence 34599999999999999999999999 999999999999999999999999999987654433333344579999
Q ss_pred CCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHH
Q 021682 159 YVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238 (309)
Q Consensus 159 y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (309)
|+|||++.+..++.++|||||||++|+|++|..||...+..+ ..... ..... .+ .. ..+.++.
T Consensus 176 Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~~~i-~~~~~-~~-----p~----~~s~~~~ 238 (288)
T d1uu3a_ 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL------IFQKI-IKLEY-DF-----PE----KFFPKAR 238 (288)
T ss_dssp GCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHH-HTTCC-CC-----CT----TCCHHHH
T ss_pred ccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH------HHHHH-HcCCC-CC-----Cc----cCCHHHH
Confidence 999999999999999999999999999999999996432111 11111 11111 11 11 1223788
Q ss_pred HHHhhcccCCCCCCCCHHHHHH
Q 021682 239 QVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 239 ~li~~~l~~~p~~Rpt~~ell~ 260 (309)
+||.+||+.||++|||++|+++
T Consensus 239 ~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 239 DLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp HHHHTTSCSSGGGSTTSGGGTC
T ss_pred HHHHHHccCCHhHCcCHHHHcC
Confidence 9999999999999999998754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-50 Score=335.25 Aligned_cols=239 Identities=24% Similarity=0.303 Sum_probs=178.3
Q ss_pred ceEEEEc-CCCcEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeeEEee--CCeeEEEEeccCCCChhHHHhh
Q 021682 4 AICQGRL-PNGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQ--REEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
+||++.. .+|+.||||.+... .....+.+.+|++++++++||||+++++++.+ +..+++||||+++|+|.+++..
T Consensus 19 ~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~ 98 (269)
T d2java1 19 RCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITK 98 (269)
T ss_dssp EEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHH
T ss_pred EEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHh
Confidence 5778864 58999999998654 33445678999999999999999999998864 4568999999999999999865
Q ss_pred h-ccccCCCHHHHHHHHHHHHHHHHHHhhcC--CCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccc
Q 021682 79 L-RRRYLLDWRTRVHIIEGITQGLLYLQEYS--NLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVG 155 (309)
Q Consensus 79 ~-~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 155 (309)
. ..+..+++..++.++.||+.|+.|||++. ..+|+||||||+||+++.++.+||+|||++......... .....|
T Consensus 99 ~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~--~~~~~g 176 (269)
T d2java1 99 GTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKAFVG 176 (269)
T ss_dssp HHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-------------C
T ss_pred ccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCCCc--cccCCC
Confidence 3 23556999999999999999999999872 124999999999999999999999999999876543322 223578
Q ss_pred ccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 156 TYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 156 ~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
|+.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+ . ...........+ . ...+.
T Consensus 177 t~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~------~-~~~i~~~~~~~~-----~----~~~s~ 240 (269)
T d2java1 177 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE------L-AGKIREGKFRRI-----P----YRYSD 240 (269)
T ss_dssp CCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------H-HHHHHHTCCCCC-----C----TTSCH
T ss_pred CcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH------H-HHHHHcCCCCCC-----C----cccCH
Confidence 999999999999999999999999999999999999985432211 1 111111111111 1 11233
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHH
Q 021682 236 RCMQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
++.+||.+||+.||++|||++|+++
T Consensus 241 ~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 241 ELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHh
Confidence 7889999999999999999999985
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-48 Score=325.66 Aligned_cols=232 Identities=21% Similarity=0.328 Sum_probs=182.8
Q ss_pred ceEEEEc-CCCcEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeeEEee----CCeeEEEEeccCCCChhHHH
Q 021682 4 AICQGRL-PNGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQ----REEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~~ 76 (309)
+||++.. .+++.||+|.+... .....+.+.+|++++++++||||+++++++.. +..+++||||+++++|.+++
T Consensus 24 ~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l 103 (270)
T d1t4ha_ 24 TVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL 103 (270)
T ss_dssp EEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHH
T ss_pred EEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHH
Confidence 5677764 57999999998654 34456788999999999999999999999865 34689999999999999998
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCc--eeecCCCCceEEeC-CCCCceeecccccccccCCccccccccc
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLT--IVHRDLKASNILLD-YEMNPKISDFGMARAFTKDECEANTGRI 153 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~g--i~H~di~p~nil~~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 153 (309)
.. ...+++..+..++.||+.|++|||++ | |+||||||+||+++ .++.+||+|||++....... ....
T Consensus 104 ~~---~~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~----~~~~ 173 (270)
T d1t4ha_ 104 KR---FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAV 173 (270)
T ss_dssp HH---HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS----BEES
T ss_pred hc---cccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCc----cCCc
Confidence 54 34589999999999999999999998 6 99999999999997 47899999999997544332 2234
Q ss_pred ccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHH
Q 021682 154 VGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWK 233 (309)
Q Consensus 154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
.||+.|+|||.+.+ .++.++|||||||++|+|++|+.||....... ........+.....+. ...
T Consensus 174 ~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~------~~~~~i~~~~~~~~~~--------~~~ 238 (270)
T d1t4ha_ 174 IGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA------QIYRRVTSGVKPASFD--------KVA 238 (270)
T ss_dssp CSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH------HHHHHHTTTCCCGGGG--------GCC
T ss_pred ccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH------HHHHHHHcCCCCcccC--------ccC
Confidence 78999999999865 58999999999999999999999985322111 1112222211111111 112
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021682 234 LMRCMQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 234 ~~~l~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
..++.+||.+||+.||++|||++|+++
T Consensus 239 ~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 239 IPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 236889999999999999999999986
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-49 Score=329.57 Aligned_cols=239 Identities=25% Similarity=0.388 Sum_probs=195.3
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccc
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRR 82 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 82 (309)
++||+|.+++++.||||.++.... ..+.+++|+.++++++||||+++++++.+++.+++||||+.+|+|..++.. ..
T Consensus 18 g~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~--~~ 94 (258)
T d1k2pa_ 18 GVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE--MR 94 (258)
T ss_dssp EEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHS--GG
T ss_pred eEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhc--cc
Confidence 358999998899999999976543 457899999999999999999999999999999999999999999888743 34
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCc
Q 021682 83 YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPP 162 (309)
Q Consensus 83 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 162 (309)
..+++..+..++.|+++|++|||+. |++||||||+||+++.++.+||+|||++......... ......+|..|+||
T Consensus 95 ~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~t~~y~aP 170 (258)
T d1k2pa_ 95 HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPP 170 (258)
T ss_dssp GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-CCCCSCCCGGGCCH
T ss_pred cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCce-eecccCCCCCcCCc
Confidence 4588999999999999999999998 8999999999999999999999999999766544332 22234688999999
Q ss_pred cccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHH
Q 021682 163 EYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVA 241 (309)
Q Consensus 163 E~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 241 (309)
|.+.+..++.++|||||||++|||++ |+.||......+ .......+..... +...+..+.++|
T Consensus 171 E~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~-------~~~~i~~~~~~~~---------p~~~~~~l~~li 234 (258)
T d1k2pa_ 171 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-------TAEHIAQGLRLYR---------PHLASEKVYTIM 234 (258)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-------HHHHHHTTCCCCC---------CTTCCHHHHHHH
T ss_pred HHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH-------HHHHHHhCCCCCC---------cccccHHHHHHH
Confidence 99999999999999999999999998 788886543221 1112222211111 111224788999
Q ss_pred hhcccCCCCCCCCHHHHHHHHhc
Q 021682 242 LLCVQENAADRPTMLEILVMLKS 264 (309)
Q Consensus 242 ~~~l~~~p~~Rpt~~ell~~L~~ 264 (309)
.+||+.||++|||++++++.|..
T Consensus 235 ~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 235 YSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp HHTTCSSGGGSCCHHHHHHHHHC
T ss_pred HHHccCCHhHCcCHHHHHHHhhC
Confidence 99999999999999999999864
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-49 Score=331.58 Aligned_cols=241 Identities=28% Similarity=0.377 Sum_probs=190.1
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccc
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRR 82 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 82 (309)
+.||+|.+++++.||||.++.. ....+.+.+|++++++++||||+++++++.. +..++||||+++|+|.+++... ..
T Consensus 27 g~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~-~~ 103 (272)
T d1qpca_ 27 GEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SG 103 (272)
T ss_dssp EEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSH-HH
T ss_pred cEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhc-CC
Confidence 4689999888899999999654 3456789999999999999999999998754 5678999999999999887432 23
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCc
Q 021682 83 YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPP 162 (309)
Q Consensus 83 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 162 (309)
..+++..+..++.||+.|+.|||++ |++||||||+||+++.++.+||+|||++.......... .....|+..|+||
T Consensus 104 ~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~-~~~~~gt~~y~AP 179 (272)
T d1qpca_ 104 IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA-REGAKFPIKWTAP 179 (272)
T ss_dssp HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC-CTTCCCCTTTSCH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCcccc-ccccCCcccccCh
Confidence 4589999999999999999999998 89999999999999999999999999998765433222 2234688899999
Q ss_pred cccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHHh
Q 021682 163 EYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVAL 242 (309)
Q Consensus 163 E~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 242 (309)
|.+.+..++.++|||||||++|+|++|..|+...... .. .......+..... +...+.++.+|+.
T Consensus 180 E~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~-----~~-~~~~i~~~~~~~~---------p~~~~~~l~~li~ 244 (272)
T d1qpca_ 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-----PE-VIQNLERGYRMVR---------PDNCPEELYQLMR 244 (272)
T ss_dssp HHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HH-HHHHHHTTCCCCC---------CTTCCHHHHHHHH
T ss_pred HHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH-----HH-HHHHHHhcCCCCC---------cccChHHHHHHHH
Confidence 9999889999999999999999999965554221111 11 1111122111111 1112337889999
Q ss_pred hcccCCCCCCCCHHHHHHHHhcc
Q 021682 243 LCVQENAADRPTMLEILVMLKSE 265 (309)
Q Consensus 243 ~~l~~~p~~Rpt~~ell~~L~~~ 265 (309)
+||+.||++|||+++|++.|+..
T Consensus 245 ~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 245 LCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHHHhhhh
Confidence 99999999999999999999863
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.6e-49 Score=337.79 Aligned_cols=244 Identities=24% Similarity=0.409 Sum_probs=182.7
Q ss_pred cceEEEEcC-CCc---EEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 3 VAICQGRLP-NGQ---EMAVKRLSRT-SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 3 ~~~~~~~~~-~g~---~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
+.||+|... +|+ .||||.+... .....+.+.+|++++++++||||+++++++..++..++||||+++|+|.+++.
T Consensus 40 g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~ 119 (299)
T d1jpaa_ 40 GEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR 119 (299)
T ss_dssp SEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHH
T ss_pred eEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeec
Confidence 367888764 333 5899988654 34456789999999999999999999999999999999999999999999874
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccc---ccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEAN---TGRIV 154 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~---~~~~~ 154 (309)
. ....+++..+..++.||+.|+.|||++ |++||||||+||+++.++.+||+|||+++.......... .....
T Consensus 120 ~--~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~ 194 (299)
T d1jpaa_ 120 Q--NDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGK 194 (299)
T ss_dssp T--TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----------------------
T ss_pred c--ccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccCCCCcceeeeccccc
Confidence 3 334589999999999999999999998 899999999999999999999999999987654322211 11235
Q ss_pred cccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHH
Q 021682 155 GTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWK 233 (309)
Q Consensus 155 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
+|+.|+|||.+.+..++.++|||||||++|||++ |.+||......+ .. .....+.... .+...
T Consensus 195 ~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~---~~----~~i~~~~~~~---------~~~~~ 258 (299)
T d1jpaa_ 195 IPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD---VI----NAIEQDYRLP---------PPMDC 258 (299)
T ss_dssp -CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HH----HHHHTTCCCC---------CCTTC
T ss_pred CCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH---HH----HHHHcCCCCC---------CCccc
Confidence 7889999999999999999999999999999998 899986432211 11 1111111111 11122
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccC
Q 021682 234 LMRCMQVALLCVQENAADRPTMLEILVMLKSETA 267 (309)
Q Consensus 234 ~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~ 267 (309)
+..+.+|+.+||+.||++|||++||++.|+++.+
T Consensus 259 ~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 259 PSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 3478899999999999999999999999988754
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.1e-48 Score=340.23 Aligned_cols=237 Identities=20% Similarity=0.233 Sum_probs=191.0
Q ss_pred ceEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccc
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRR 82 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 82 (309)
.||++. ..+|+.||||++........+.+.+|+.++++++||||+++++++.+++..++||||+++|+|.+++.. ..
T Consensus 41 ~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~--~~ 118 (350)
T d1koaa2 41 VVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EH 118 (350)
T ss_dssp EEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTC--TT
T ss_pred EEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHh--hc
Confidence 567776 468999999999777666678899999999999999999999999999999999999999999998843 23
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCC--CCCceeecccccccccCCcccccccccccccCCC
Q 021682 83 YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY--EMNPKISDFGMARAFTKDECEANTGRIVGTYGYV 160 (309)
Q Consensus 83 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~--~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 160 (309)
..+++..+..++.||+.||.|||++ |++||||||+||+++. ++.+||+|||++........ .....||+.|+
T Consensus 119 ~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gT~~Y~ 192 (350)
T d1koaa2 119 NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFA 192 (350)
T ss_dssp SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC---EEEECSCTTTC
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccccc---cceecCccccc
Confidence 4599999999999999999999998 9999999999999964 57899999999977654332 22347899999
Q ss_pred CccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHH
Q 021682 161 PPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQV 240 (309)
Q Consensus 161 aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 240 (309)
|||++.+..++.++|||||||++|+|++|+.||...+..+ ........... .........+..+.+|
T Consensus 193 aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~i~~~~~~-------~~~~~~~~~s~~~~~l 259 (350)
T d1koaa2 193 APEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------TLRNVKSCDWN-------MDDSAFSGISEDGKDF 259 (350)
T ss_dssp CHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHTCCC-------SCCGGGGGCCHHHHHH
T ss_pred CHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCCC-------CCcccccCCCHHHHHH
Confidence 9999999999999999999999999999999985432111 11111111100 0111111123478899
Q ss_pred HhhcccCCCCCCCCHHHHHHH
Q 021682 241 ALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 241 i~~~l~~~p~~Rpt~~ell~~ 261 (309)
|.+||+.||++|||++|+++.
T Consensus 260 i~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 260 IRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHHHCCSSGGGSCCHHHHHHS
T ss_pred HHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999985
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.1e-48 Score=340.58 Aligned_cols=241 Identities=21% Similarity=0.251 Sum_probs=192.2
Q ss_pred ceEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccc
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRR 82 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 82 (309)
+||++. ..+|+.||||+++.........+.+|+.++++++||||+++++++.++...++|||||++++|.+++.. .+
T Consensus 44 ~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~--~~ 121 (352)
T d1koba_ 44 VVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA--ED 121 (352)
T ss_dssp EEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTC--TT
T ss_pred EEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHh--cC
Confidence 456665 468999999999876666667889999999999999999999999999999999999999999887632 34
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeC--CCCCceeecccccccccCCcccccccccccccCCC
Q 021682 83 YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLD--YEMNPKISDFGMARAFTKDECEANTGRIVGTYGYV 160 (309)
Q Consensus 83 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~--~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 160 (309)
..+++..++.++.||+.||+|||++ ||+||||||+|||++ .++.+||+|||++........ .....|++.|+
T Consensus 122 ~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~ 195 (352)
T d1koba_ 122 YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFA 195 (352)
T ss_dssp CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC---EEEECSSGGGC
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCCc---eeeccCccccc
Confidence 4599999999999999999999998 999999999999998 568999999999987654432 22346899999
Q ss_pred CccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHH
Q 021682 161 PPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQV 240 (309)
Q Consensus 161 aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 240 (309)
|||++.+..++.++|||||||++|+|++|..||......+ ......... .. + ........+.++.+|
T Consensus 196 aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~i~~~~-~~-~-----~~~~~~~~s~~~~~l 262 (352)
T d1koba_ 196 APEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE------TLQNVKRCD-WE-F-----DEDAFSSVSPEAKDF 262 (352)
T ss_dssp CHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHHHCC-CC-C-----CSSTTTTSCHHHHHH
T ss_pred CHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCC-CC-C-----CcccccCCCHHHHHH
Confidence 9999999999999999999999999999999995432211 111111111 00 0 011111123378899
Q ss_pred HhhcccCCCCCCCCHHHHHHH--Hhcc
Q 021682 241 ALLCVQENAADRPTMLEILVM--LKSE 265 (309)
Q Consensus 241 i~~~l~~~p~~Rpt~~ell~~--L~~~ 265 (309)
|.+||+.||.+|||++|+++. +++.
T Consensus 263 i~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 263 IKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp HHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred HHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 999999999999999999885 5443
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.5e-49 Score=336.17 Aligned_cols=236 Identities=22% Similarity=0.249 Sum_probs=172.6
Q ss_pred ceEEEEc-CCCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
+||++.. .+|+.||||.+.... ......+.+|+.++++++||||+++++++.+++..++||||++|++|.+++..
T Consensus 24 ~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~--- 100 (307)
T d1a06a_ 24 EVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE--- 100 (307)
T ss_dssp GEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT---
T ss_pred EEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhc---
Confidence 5677754 589999999997553 23345678999999999999999999999999999999999999999999843
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeC---CCCCceeecccccccccCCcccccccccccccC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLD---YEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~---~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
...+++..+..++.||+.|+.|||++ |++||||||+||++. .++.+||+|||++........ .....||+.
T Consensus 101 ~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~GT~~ 174 (307)
T d1a06a_ 101 KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPG 174 (307)
T ss_dssp CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC---------------------CT
T ss_pred ccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccCCCe---eeeeeeCcc
Confidence 44599999999999999999999998 999999999999995 478899999999976543322 223468999
Q ss_pred CCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHH
Q 021682 159 YVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238 (309)
Q Consensus 159 y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (309)
|+|||++.+..++.++|||||||++|+|++|.+||...... ........ .... +. .......+.++.
T Consensus 175 y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~~~i~~-~~~~--~~----~~~~~~~s~~~~ 241 (307)
T d1a06a_ 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA------KLFEQILK-AEYE--FD----SPYWDDISDSAK 241 (307)
T ss_dssp TSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHT-TCCC--CC----TTTTTTSCHHHH
T ss_pred ccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH------HHHHHHhc-cCCC--CC----CccccCCCHHHH
Confidence 99999999999999999999999999999999998532211 11111111 1110 00 011111234788
Q ss_pred HHHhhcccCCCCCCCCHHHHHHH
Q 021682 239 QVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 239 ~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
+||.+||+.||++|||++|+++.
T Consensus 242 ~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 242 DFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHccCCHhHCcCHHHHhcC
Confidence 99999999999999999999874
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-48 Score=329.73 Aligned_cols=241 Identities=24% Similarity=0.375 Sum_probs=192.2
Q ss_pred cceEEEEcC---CCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 3 VAICQGRLP---NGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 3 ~~~~~~~~~---~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
++||+|.++ ++..||||.++... ....+.+.+|++++++++||||+++++++.. +..++||||+++|+|.+++..
T Consensus 23 g~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~ 101 (285)
T d1u59a_ 23 GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVG 101 (285)
T ss_dssp EEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHTT
T ss_pred eEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhhc
Confidence 357888653 45679999997553 4456789999999999999999999999865 468899999999999998743
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccc-cccccccccc
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECE-ANTGRIVGTY 157 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~ 157 (309)
.+..+++..+..++.|++.|++|||++ |++||||||+||+++.++.+||+|||++......... .......||+
T Consensus 102 --~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~ 176 (285)
T d1u59a_ 102 --KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176 (285)
T ss_dssp --CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCG
T ss_pred --cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCc
Confidence 334589999999999999999999998 8999999999999999999999999999876543322 2223346788
Q ss_pred CCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHH
Q 021682 158 GYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMR 236 (309)
Q Consensus 158 ~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
.|+|||.+.+..++.++|||||||++|||++ |+.||......+ . ......+..... +...+.+
T Consensus 177 ~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~---~----~~~i~~~~~~~~---------p~~~~~~ 240 (285)
T d1u59a_ 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---V----MAFIEQGKRMEC---------PPECPPE 240 (285)
T ss_dssp GGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---H----HHHHHTTCCCCC---------CTTCCHH
T ss_pred cccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH---H----HHHHHcCCCCCC---------CCcCCHH
Confidence 9999999999999999999999999999998 899986543221 1 112222222211 1122347
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHHHhcc
Q 021682 237 CMQVALLCVQENAADRPTMLEILVMLKSE 265 (309)
Q Consensus 237 l~~li~~~l~~~p~~Rpt~~ell~~L~~~ 265 (309)
+.+||.+||+.||++|||+.+|++.|+..
T Consensus 241 l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 241 LYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 88999999999999999999999998765
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-49 Score=332.82 Aligned_cols=240 Identities=25% Similarity=0.363 Sum_probs=187.6
Q ss_pred cceEEEEcC---CCcEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 3 VAICQGRLP---NGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 3 ~~~~~~~~~---~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
+.||+|.++ +++.||||.++.. +....+.+.+|++++++++||||+++++++.. +..+|||||+++|+|.+++.
T Consensus 21 G~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~g~L~~~l~ 99 (277)
T d1xbba_ 21 GTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQ 99 (277)
T ss_dssp EEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHH
T ss_pred eEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCCCcHHHHHh
Confidence 357888653 4578999998654 23345679999999999999999999999865 45789999999999999984
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccc-ccccccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECE-ANTGRIVGT 156 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~ 156 (309)
. ...+++..+..++.||+.|+.|||++ |++||||||+||+++.++.+||+|||+++........ .......||
T Consensus 100 ~---~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt 173 (277)
T d1xbba_ 100 Q---NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 173 (277)
T ss_dssp H---CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCC
T ss_pred h---ccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccccccccccccccCCC
Confidence 3 34599999999999999999999998 8999999999999999999999999999876543322 222334688
Q ss_pred cCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 157 YGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
+.|+|||.+.+..++.++|||||||++|||++ |+.||......+ .......+..... +...+.
T Consensus 174 ~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~-------~~~~i~~~~~~~~---------p~~~~~ 237 (277)
T d1xbba_ 174 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGERMGC---------PAGCPR 237 (277)
T ss_dssp GGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCCCCC---------CTTCCH
T ss_pred ceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH-------HHHHHHcCCCCCC---------CcccCH
Confidence 99999999999999999999999999999998 899986432211 1112222221111 111234
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHHhcc
Q 021682 236 RCMQVALLCVQENAADRPTMLEILVMLKSE 265 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~Rpt~~ell~~L~~~ 265 (309)
++.+|+.+||+.||++|||+++|++.|+..
T Consensus 238 ~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 238 EMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 788999999999999999999999988753
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=330.84 Aligned_cols=252 Identities=23% Similarity=0.333 Sum_probs=192.7
Q ss_pred ceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcccc
Q 021682 4 AICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRRY 83 (309)
Q Consensus 4 ~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~ 83 (309)
.||+|..++++.||||.++.. ....+.+.+|+.++++++||||+++++++.+ +..++||||+++|+|..++... ...
T Consensus 32 ~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~-~~~ 108 (285)
T d1fmka3 32 EVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGK 108 (285)
T ss_dssp EEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHH-HHT
T ss_pred EEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhhc-ccc
Confidence 689999888889999999644 3456789999999999999999999999854 5678999999999998887543 234
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCCcc
Q 021682 84 LLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVPPE 163 (309)
Q Consensus 84 ~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 163 (309)
.+++..++.++.||+.|++|||++ |++||||||+||+++.++.+||+|||++......... ......+++.|+|||
T Consensus 109 ~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE 184 (285)
T d1fmka3 109 YLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPE 184 (285)
T ss_dssp TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHH
T ss_pred cchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCce-eeccccccccccChH
Confidence 589999999999999999999998 8999999999999999999999999999765443322 222346889999999
Q ss_pred ccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHHHhh
Q 021682 164 YVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQVALL 243 (309)
Q Consensus 164 ~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 243 (309)
.+....++.++|||||||++|+|++|..|+...... .. ............ .+...+.++.++|.+
T Consensus 185 ~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-----~~-~~~~i~~~~~~~---------~~~~~~~~l~~li~~ 249 (285)
T d1fmka3 185 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----RE-VLDQVERGYRMP---------CPPECPESLHDLMCQ 249 (285)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HH-HHHHHHTTCCCC---------CCTTSCHHHHHHHHH
T ss_pred HHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-----HH-HHHHHHhcCCCC---------CCcccCHHHHHHHHH
Confidence 999999999999999999999999976654332111 11 111122111111 111123478899999
Q ss_pred cccCCCCCCCCHHHHHHHHhcccCCCCCCCCCCc
Q 021682 244 CVQENAADRPTMLEILVMLKSETADIKTPKKPAF 277 (309)
Q Consensus 244 ~l~~~p~~Rpt~~ell~~L~~~~~~~~~~~~p~~ 277 (309)
||+.||++|||+++|+++|+.......++..|+.
T Consensus 250 cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p~~ 283 (285)
T d1fmka3 250 CWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGE 283 (285)
T ss_dssp HTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCCSC
T ss_pred HcccCHhHCcCHHHHHHHHhhhhcCCCCCCCCCC
Confidence 9999999999999999999987666655555543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=337.55 Aligned_cols=243 Identities=26% Similarity=0.402 Sum_probs=190.2
Q ss_pred ceEEEEcC-CC-----cEEEEEEeecC-CcccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHH
Q 021682 4 AICQGRLP-NG-----QEMAVKRLSRT-SHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFY 75 (309)
Q Consensus 4 ~~~~~~~~-~g-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (309)
+||+|... .+ ..||+|.+... .......+.+|+.+++++ +||||+++++++.+++..++||||+++|+|.++
T Consensus 52 ~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~ 131 (325)
T d1rjba_ 52 KVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNY 131 (325)
T ss_dssp EEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHH
T ss_pred EEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHH
Confidence 46777653 22 36999998654 344456789999999998 899999999999999999999999999999999
Q ss_pred Hhhhcc--------------------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecc
Q 021682 76 IFDLRR--------------------RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDF 135 (309)
Q Consensus 76 ~~~~~~--------------------~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Df 135 (309)
+..... ...+++..++.++.|++.|++|||++ ||+||||||+||+++.++.+||+||
T Consensus 132 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~Nill~~~~~~Kl~DF 208 (325)
T d1rjba_ 132 LRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDF 208 (325)
T ss_dssp HHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGEEEETTTEEEECCC
T ss_pred HHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchhccccccCCeEEEeec
Confidence 854321 23588999999999999999999998 8999999999999999999999999
Q ss_pred cccccccCCcccccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhC
Q 021682 136 GMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKN 214 (309)
Q Consensus 136 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 214 (309)
|+++...............||+.|+|||.+.+..++.++|||||||++|+|++ |.+||......... ......
T Consensus 209 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~------~~~~~~ 282 (325)
T d1rjba_ 209 GLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF------YKLIQN 282 (325)
T ss_dssp GGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH------HHHHHT
T ss_pred cccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHH------HHHHhc
Confidence 99977655444333444568999999999999999999999999999999997 89998654332211 111112
Q ss_pred CCCcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhc
Q 021682 215 GEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKS 264 (309)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~ 264 (309)
+.... .+...+.++.+||.+||+.||++|||++||+++|..
T Consensus 283 ~~~~~---------~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 283 GFKMD---------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp TCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCC---------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 11111 111223478899999999999999999999999964
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-48 Score=334.42 Aligned_cols=232 Identities=25% Similarity=0.353 Sum_probs=184.9
Q ss_pred cceEEEE-cCCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 3 VAICQGR-LPNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 3 ~~~~~~~-~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
++||++. ..+|+.||||.+.... ....+.+.+|++++++++||||+++++++.+++..++|||||.+++|..++.
T Consensus 29 g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~- 107 (309)
T d1u5ra_ 29 GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV- 107 (309)
T ss_dssp SEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHH-
T ss_pred eEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHH-
Confidence 3677776 4689999999997553 2234568899999999999999999999999999999999999998876653
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
....+++..++.++.||+.||.|||++ ||+||||||+||+++.++.+||+|||++...... ....||+.
T Consensus 108 --~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~------~~~~GT~~ 176 (309)
T d1u5ra_ 108 --HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPY 176 (309)
T ss_dssp --HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB------CCCCSCGG
T ss_pred --hCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC------CccccCcc
Confidence 334599999999999999999999998 8999999999999999999999999999754432 23468999
Q ss_pred CCCcccccc---CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 159 YVPPEYVRK---GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 159 y~aPE~~~~---~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
|+|||++.+ ..++.++|||||||++|+|++|..||...... ......... ....... ...+.
T Consensus 177 Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~------~~~~~i~~~-~~~~~~~--------~~~s~ 241 (309)
T d1u5ra_ 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQN-ESPALQS--------GHWSE 241 (309)
T ss_dssp GCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHS-CCCCCSC--------TTSCH
T ss_pred ccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhC-CCCCCCC--------CCCCH
Confidence 999999864 45789999999999999999999998543211 111111111 1111111 11223
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 236 RCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.+.+||.+||+.||++|||++|+++.
T Consensus 242 ~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 242 YFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred HHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 78899999999999999999999873
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-48 Score=328.67 Aligned_cols=245 Identities=23% Similarity=0.371 Sum_probs=184.9
Q ss_pred cceEEEEcCCC-----cEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHH
Q 021682 3 VAICQGRLPNG-----QEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 3 ~~~~~~~~~~g-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 76 (309)
+.||+|.++++ ..||||.++... ......+.+|++++++++||||+++++++......++||||+.++++.+++
T Consensus 21 G~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~ 100 (283)
T d1mqba_ 21 GEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL 100 (283)
T ss_dssp SEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHH
T ss_pred eEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhh
Confidence 35888876432 369999986543 334567889999999999999999999999999999999999999998877
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccc-ccccccc
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEA-NTGRIVG 155 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~-~~~~~~~ 155 (309)
.. ....+++..+..++.|++.|+.|||++ ||+||||||+||+++.++.+||+|||+++......... ......|
T Consensus 101 ~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~g 175 (283)
T d1mqba_ 101 RE--KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175 (283)
T ss_dssp HH--TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----------------CC
T ss_pred hc--ccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCC
Confidence 43 334589999999999999999999998 89999999999999999999999999998765432221 2223457
Q ss_pred ccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 156 TYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 156 ~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
|..|+|||.+.+..++.++|||||||++|||+++..|+...... .. .......+.... .+...+.
T Consensus 176 t~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~----~~~~i~~~~~~~---------~~~~~~~ 240 (283)
T d1mqba_ 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HE----VMKAINDGFRLP---------TPMDCPS 240 (283)
T ss_dssp CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HH----HHHHHHTTCCCC---------CCTTCBH
T ss_pred CccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HH----HHHHHhccCCCC---------CchhhHH
Confidence 88999999999999999999999999999999966654322111 11 112222221111 1111234
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHHhcccC
Q 021682 236 RCMQVALLCVQENAADRPTMLEILVMLKSETA 267 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~ 267 (309)
.+.+||.+||+.||++|||+.||++.|+++.+
T Consensus 241 ~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 241 AIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 78899999999999999999999999988755
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=326.69 Aligned_cols=236 Identities=22% Similarity=0.259 Sum_probs=187.8
Q ss_pred ceEEEEc-CCCcEEEEEEeecCC------cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHH
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTS------HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 76 (309)
+||++.. .+|+.||||+++... ....+.+.+|+.++++++||||+++++++.++...+||||||++++|.+++
T Consensus 25 ~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i 104 (293)
T d1jksa_ 25 VVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 104 (293)
T ss_dssp EEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHH
T ss_pred EEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchh
Confidence 6777765 589999999986532 224678999999999999999999999999999999999999999999998
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCC----CceeecccccccccCCcccccccc
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM----NPKISDFGMARAFTKDECEANTGR 152 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~----~~~l~Dfg~~~~~~~~~~~~~~~~ 152 (309)
... ..+++..++.++.|++.|++|||++ |++||||||+||+++.++ .+||+|||++........ ...
T Consensus 105 ~~~---~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~---~~~ 175 (293)
T d1jksa_ 105 AEK---ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKN 175 (293)
T ss_dssp HHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCB---CSC
T ss_pred ccc---cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhhhhcCCCcc---ccc
Confidence 543 3599999999999999999999999 899999999999998776 499999999976654322 223
Q ss_pred cccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHH
Q 021682 153 IVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAW 232 (309)
Q Consensus 153 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (309)
..|++.|+|||.+.+..++.++|||||||++|+|++|..||......+ .. ......... ........
T Consensus 176 ~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~-~~i~~~~~~------~~~~~~~~ 242 (293)
T d1jksa_ 176 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TL-ANVSAVNYE------FEDEYFSN 242 (293)
T ss_dssp CCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HH-HHHHTTCCC------CCHHHHTT
T ss_pred cCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH------HH-HHHHhcCCC------CCchhcCC
Confidence 468899999999999999999999999999999999999986432111 11 111111110 00000011
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 233 KLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 233 ~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.+..+.+||.+||+.||++|||++|+++.
T Consensus 243 ~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 243 TSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 23377899999999999999999999863
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-47 Score=327.99 Aligned_cols=233 Identities=18% Similarity=0.237 Sum_probs=188.8
Q ss_pred ceEEEE-cCCCcEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGR-LPNGQEMAVKRLSRT---SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
.||++. ..+|+.||||++++. .......+.+|+.+|++++||||+++++++.++..+++||||+++|+|.+++..
T Consensus 20 ~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~- 98 (337)
T d1o6la_ 20 KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR- 98 (337)
T ss_dssp EEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-
T ss_pred EEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhc-
Confidence 567765 468999999999754 233467789999999999999999999999999999999999999999998854
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
...+++..++.++.||+.|+.|||++ |++||||||+||+++.+|.+||+|||++........ ......||+.|
T Consensus 99 --~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~--~~~~~~GT~~Y 171 (337)
T d1o6la_ 99 --ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEY 171 (337)
T ss_dssp --HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC--CBCCCEECGGG
T ss_pred --ccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCCc--ccccceeCHHH
Confidence 34489999999999999999999999 999999999999999999999999999976543322 22335799999
Q ss_pred CCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHH
Q 021682 160 VPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQ 239 (309)
Q Consensus 160 ~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (309)
+|||++.+..++.++|+|||||++|+|++|.+||...+..+ ....... .. ..+ . ...+.++.+
T Consensus 172 ~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~------~~~~i~~-~~-~~~-----p----~~~s~~~~d 234 (337)
T d1o6la_ 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFELILM-EE-IRF-----P----RTLSPEAKS 234 (337)
T ss_dssp CCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHH-CC-CCC-----C----TTSCHHHHH
T ss_pred hhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH------HHHHHhc-CC-CCC-----C----ccCCHHHHH
Confidence 99999999999999999999999999999999986433211 1111111 11 111 1 112236789
Q ss_pred HHhhcccCCCCCCCC-----HHHHHHH
Q 021682 240 VALLCVQENAADRPT-----MLEILVM 261 (309)
Q Consensus 240 li~~~l~~~p~~Rpt-----~~ell~~ 261 (309)
||.+||+.||++|++ ++|+++.
T Consensus 235 li~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 235 LLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHhhccCCchhhcccccccHHHHHcC
Confidence 999999999999994 8888874
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.8e-47 Score=325.27 Aligned_cols=230 Identities=20% Similarity=0.259 Sum_probs=187.4
Q ss_pred ceEEEEc-CCCcEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGRL-PNGQEMAVKRLSRT---SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
+||++.. .+|+.||||+++.. .....+.+.+|+.++++++||||+++++++.++...++||||+.|++|..++.
T Consensus 19 ~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~-- 96 (316)
T d1fota_ 19 RVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR-- 96 (316)
T ss_dssp EEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH--
T ss_pred EEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCcccccccc--
Confidence 5677764 67999999999753 23446788999999999999999999999999999999999999999988874
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
....+++..+..++.||+.|+.|||++ ||+||||||+||+++.+|.+||+|||++....... ....||+.|
T Consensus 97 -~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~-----~~~~Gt~~Y 167 (316)
T d1fota_ 97 -KSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTPDY 167 (316)
T ss_dssp -HTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB-----CCCCSCTTT
T ss_pred -ccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecccc-----ccccCcccc
Confidence 344588999999999999999999998 99999999999999999999999999997765432 234789999
Q ss_pred CCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHH
Q 021682 160 VPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQ 239 (309)
Q Consensus 160 ~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (309)
+|||.+.+..++.++|||||||++|+|++|+.||...+..+ ......... . . ... ..+.++.+
T Consensus 168 ~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~i~~~~-~-~-----~p~----~~s~~~~~ 230 (316)
T d1fota_ 168 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK------TYEKILNAE-L-R-----FPP----FFNEDVKD 230 (316)
T ss_dssp CCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHCC-C-C-----CCT----TSCHHHHH
T ss_pred cCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH------HHHHHHcCC-C-C-----CCC----CCCHHHHH
Confidence 99999999999999999999999999999999996432211 111111111 0 0 011 12236889
Q ss_pred HHhhcccCCCCCCC-----CHHHHHHH
Q 021682 240 VALLCVQENAADRP-----TMLEILVM 261 (309)
Q Consensus 240 li~~~l~~~p~~Rp-----t~~ell~~ 261 (309)
++.+||+.||++|+ |++++++.
T Consensus 231 li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 231 LLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp HHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHHhhhCHHhccccchhhHHHHHcC
Confidence 99999999999996 99999874
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.8e-47 Score=323.98 Aligned_cols=245 Identities=24% Similarity=0.377 Sum_probs=193.2
Q ss_pred cceEEEEc------CCCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHH
Q 021682 3 VAICQGRL------PNGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFY 75 (309)
Q Consensus 3 ~~~~~~~~------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (309)
++||+|.+ .+++.||||+++... ....+++.+|++++++++||||+++++++......+++||++.+++|.++
T Consensus 27 G~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~ 106 (301)
T d1lufa_ 27 GRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEF 106 (301)
T ss_dssp CEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHH
T ss_pred eEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHH
Confidence 45777864 356789999987543 33456799999999999999999999999999999999999999999999
Q ss_pred Hhhhcc---------------------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeec
Q 021682 76 IFDLRR---------------------RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISD 134 (309)
Q Consensus 76 ~~~~~~---------------------~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~D 134 (309)
+..... ...+++..++.++.|++.|++|||++ |++||||||+||+++.++.+||+|
T Consensus 107 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~NILld~~~~~Kl~D 183 (301)
T d1lufa_ 107 LRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIAD 183 (301)
T ss_dssp HHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECC
T ss_pred HHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcccceEECCCCcEEEcc
Confidence 854321 23478889999999999999999998 899999999999999999999999
Q ss_pred ccccccccCCcccccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCC-CCCCCCCCCCcccHHHHHHHHhh
Q 021682 135 FGMARAFTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGK-RTSCYYGPNESLNLLEYAYGLWK 213 (309)
Q Consensus 135 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~ 213 (309)
||++............+...+++.|+|||.+.+..++.++|||||||++|||++|. +||......+ .. ....
T Consensus 184 FGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e------~~-~~v~ 256 (301)
T d1lufa_ 184 FGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE------VI-YYVR 256 (301)
T ss_dssp CSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HH-HHHH
T ss_pred chhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHH------HH-HHHH
Confidence 99997665443333344456788999999999999999999999999999999985 5654332211 11 1222
Q ss_pred CCCCcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhccc
Q 021682 214 NGEGMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSET 266 (309)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~ 266 (309)
.+...... ...+.++.+|+.+||+.||++|||+.||+++|+++.
T Consensus 257 ~~~~~~~p---------~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 257 DGNILACP---------ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cCCCCCCC---------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 22222111 112237889999999999999999999999999875
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-47 Score=324.83 Aligned_cols=253 Identities=21% Similarity=0.211 Sum_probs=184.3
Q ss_pred ceEEEEc-CCCcEEEEEEeecCCcc-----cHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTSHQ-----GLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
+||++.. .+|+.||||+++..... ....+.+|+.++++++||||+++++++..+++.++||||+.++++..+.
T Consensus 13 ~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~- 91 (299)
T d1ua2a_ 13 TVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIK- 91 (299)
T ss_dssp EEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHT-
T ss_pred EEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhh-
Confidence 5788765 57999999998654221 1346889999999999999999999999999999999999887666554
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
.....+++..+..++.||+.||+|||++ |++||||||+||+++.++.+||+|||++......... .....||+
T Consensus 92 --~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~--~~~~~gt~ 164 (299)
T d1ua2a_ 92 --DNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVVTR 164 (299)
T ss_dssp --TCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC--CCCSCCCC
T ss_pred --hcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCccc--ccceecCh
Confidence 3345588999999999999999999998 9999999999999999999999999999765543322 22346899
Q ss_pred CCCCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCccc------ccccCCCccc
Q 021682 158 GYVPPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEF------IDSSLDDSSS 230 (309)
Q Consensus 158 ~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~ 230 (309)
.|+|||.+.+. .++.++|||||||++|+|++|.+||......+....+............... .........+
T Consensus 165 ~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (299)
T d1ua2a_ 165 WYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIP 244 (299)
T ss_dssp TTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCC
T ss_pred hhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCC
Confidence 99999988654 5799999999999999999999998643322211111111000000000000 0000000000
Q ss_pred -----HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--Hhc
Q 021682 231 -----AWKLMRCMQVALLCVQENAADRPTMLEILVM--LKS 264 (309)
Q Consensus 231 -----~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~--L~~ 264 (309)
......+.+||.+||+.||++|||++|+++. ++.
T Consensus 245 ~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 285 (299)
T d1ua2a_ 245 LHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285 (299)
T ss_dssp HHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred hHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence 0123478899999999999999999999974 544
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.7e-46 Score=325.40 Aligned_cols=229 Identities=17% Similarity=0.192 Sum_probs=186.9
Q ss_pred ceEEEE-cCCCcEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGR-LPNGQEMAVKRLSRT---SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
.||++. ..+|+.||||++... .....+.+.+|++++++++||||+++++++......++||||+.+++|..++...
T Consensus 56 ~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~ 135 (350)
T d1rdqe_ 56 RVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI 135 (350)
T ss_dssp EEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH
T ss_pred EEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccccchhhhHhhc
Confidence 566665 468999999998643 2344577899999999999999999999999999999999999999999888543
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
..+++..+..++.||+.||.|||++ ||+||||||+||+++.+|.+||+|||++....... ....||+.|
T Consensus 136 ---~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~-----~~~~Gt~~Y 204 (350)
T d1rdqe_ 136 ---GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WTLCGTPEA 204 (350)
T ss_dssp ---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB-----CCCEECGGG
T ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccccc-----ccccCcccc
Confidence 3499999999999999999999998 89999999999999999999999999998765432 234789999
Q ss_pred CCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHH
Q 021682 160 VPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQ 239 (309)
Q Consensus 160 ~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (309)
+|||++.+..++.++|||||||++|+|++|..||..... ........... . .+ +...+.++.+
T Consensus 205 ~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~i~~~~-~-~~---------p~~~s~~~~~ 267 (350)
T d1rdqe_ 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYEKIVSGK-V-RF---------PSHFSSDLKD 267 (350)
T ss_dssp CCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCC-C-CC---------CTTCCHHHHH
T ss_pred CCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH------HHHHHHHhcCC-C-CC---------CccCCHHHHH
Confidence 999999999999999999999999999999999954221 11111111111 0 00 0112237889
Q ss_pred HHhhcccCCCCCCC-----CHHHHHH
Q 021682 240 VALLCVQENAADRP-----TMLEILV 260 (309)
Q Consensus 240 li~~~l~~~p~~Rp-----t~~ell~ 260 (309)
+|.+||+.||.+|+ |++++++
T Consensus 268 li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 268 LLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHHHhhhCHHhccccccccHHHHHc
Confidence 99999999999994 9999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-47 Score=315.72 Aligned_cols=236 Identities=25% Similarity=0.368 Sum_probs=182.4
Q ss_pred cceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEee-CCeeEEEEeccCCCChhHHHhhhcc
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQ-REEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
++||+|.+ +|+.||||.++.. ...+.+.+|++++++++||||+++++++.. ++.+++||||+++|+|.+++... .
T Consensus 21 g~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~ 96 (262)
T d1byga_ 21 GDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-G 96 (262)
T ss_dssp CEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHH-H
T ss_pred eEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhc-C
Confidence 46899987 5889999999643 345789999999999999999999998854 45689999999999999998543 2
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCCC
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYVP 161 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 161 (309)
...+++..++.++.||+.|+.|||+. +++||||+|+||+++.++.++|+|||++....... ....++..|+|
T Consensus 97 ~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~-----~~~~~~~~y~a 168 (262)
T d1byga_ 97 RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTA 168 (262)
T ss_dssp HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSC
T ss_pred CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCC-----ccccccccCCC
Confidence 33489999999999999999999998 89999999999999999999999999987644332 22356889999
Q ss_pred ccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHH
Q 021682 162 PEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQV 240 (309)
Q Consensus 162 PE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 240 (309)
||.+.+..++.++|||||||++|||++ |.+||......+ .... ...+....+ +...+.++.+|
T Consensus 169 PE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~----i~~~~~~~~---------~~~~~~~~~~l 232 (262)
T d1byga_ 169 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR----VEKGYKMDA---------PDGCPPAVYEV 232 (262)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHH----HTTTCCCCC---------CTTCCHHHHHH
T ss_pred hHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHHH----HHcCCCCCC---------CccCCHHHHHH
Confidence 999999999999999999999999998 677765432222 1111 111111111 11122478899
Q ss_pred HhhcccCCCCCCCCHHHHHHHHhccc
Q 021682 241 ALLCVQENAADRPTMLEILVMLKSET 266 (309)
Q Consensus 241 i~~~l~~~p~~Rpt~~ell~~L~~~~ 266 (309)
|.+||+.||++|||+.+++++|+.+.
T Consensus 233 i~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 233 MKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 99999999999999999999998753
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-47 Score=327.62 Aligned_cols=242 Identities=24% Similarity=0.384 Sum_probs=184.9
Q ss_pred ceEEEEc-CCCc----EEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 4 AICQGRL-PNGQ----EMAVKRLSRT-SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 4 ~~~~~~~-~~g~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
.||+|.. .+|+ +||+|.++.. .....+.+.+|++++++++||||+++++++.++ ..+++++++.+++|.+++.
T Consensus 24 ~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~ 102 (317)
T d1xkka_ 24 TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVR 102 (317)
T ss_dssp EEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHH
T ss_pred EEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEeccCCccccccc
Confidence 5788865 3555 5888888643 344567899999999999999999999999865 5677888898999988774
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
. ....+++..++.++.||+.|+.|||++ |++||||||+||+++.++.+||+|||++................||.
T Consensus 103 ~--~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 177 (317)
T d1xkka_ 103 E--HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177 (317)
T ss_dssp H--TSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCT
T ss_pred c--cccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceecccccccccccccccCc
Confidence 3 345689999999999999999999998 89999999999999999999999999998766544433333446899
Q ss_pred CCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHH
Q 021682 158 GYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMR 236 (309)
Q Consensus 158 ~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
.|+|||.+.+..++.++|||||||++|+|++ |.+||......+. ... ...+.... .+...+..
T Consensus 178 ~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~---~~~----i~~~~~~~---------~p~~~~~~ 241 (317)
T d1xkka_ 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---SSI----LEKGERLP---------QPPICTID 241 (317)
T ss_dssp TTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH---HHH----HHHTCCCC---------CCTTBCHH
T ss_pred cccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH---HHH----HHcCCCCC---------CCcccCHH
Confidence 9999999999999999999999999999998 7888765433221 111 11111111 11112337
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHHHhcccC
Q 021682 237 CMQVALLCVQENAADRPTMLEILVMLKSETA 267 (309)
Q Consensus 237 l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~ 267 (309)
+.+|+.+||+.||++|||+.|+++.|+.+..
T Consensus 242 ~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 242 VYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 8899999999999999999999999887643
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=9.5e-47 Score=319.07 Aligned_cols=244 Identities=23% Similarity=0.297 Sum_probs=184.8
Q ss_pred ceEEEE-cCCCcEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeeEEeeCC----eeEEEEeccCCCChhHH
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTS---HQGLEEFENEVKLTARLQHVNLLPVLGICTQRE----EKMLIYDYMPNKSLDFY 75 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~~~~~L~~~ 75 (309)
.||++. ..+|+.||||+++... ......+.+|++++++++||||+++++++.... ..++||||+++++|..+
T Consensus 22 ~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~ 101 (277)
T d1o6ya_ 22 EVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDI 101 (277)
T ss_dssp EEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHH
T ss_pred EEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhh
Confidence 567775 4689999999997543 333457899999999999999999999987654 47899999999999988
Q ss_pred HhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcc-cccccccc
Q 021682 76 IFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDEC-EANTGRIV 154 (309)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~ 154 (309)
+.. ...+++..++.++.||+.|+.|||++ |++||||||+||+++.++..+++|||.+........ ........
T Consensus 102 ~~~---~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 175 (277)
T d1o6ya_ 102 VHT---EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 175 (277)
T ss_dssp HHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEECC-------------
T ss_pred hcc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhhcccccccccccccc
Confidence 744 33599999999999999999999998 999999999999999999999999998865543322 12233457
Q ss_pred cccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHH
Q 021682 155 GTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKL 234 (309)
Q Consensus 155 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
||+.|+|||.+.+..++.++|||||||++|+|++|++||..... ................ .... ..+
T Consensus 176 Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~~~~~~~~~~~---~~~~----~~s 242 (277)
T d1o6ya_ 176 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPIPPS---ARHE----GLS 242 (277)
T ss_dssp ---TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCCCGG---GTSS----SCC
T ss_pred CcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH------HHHHHHHHhcCCCCCc---hhcc----CCC
Confidence 89999999999999999999999999999999999999854221 1222222222211110 0011 122
Q ss_pred HHHHHHHhhcccCCCCCCC-CHHHHHHHHhccc
Q 021682 235 MRCMQVALLCVQENAADRP-TMLEILVMLKSET 266 (309)
Q Consensus 235 ~~l~~li~~~l~~~p~~Rp-t~~ell~~L~~~~ 266 (309)
..+.++|.+||+.||++|| |++++++.|.++.
T Consensus 243 ~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 243 ADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 3788999999999999999 8999999988753
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.5e-46 Score=314.62 Aligned_cols=237 Identities=23% Similarity=0.278 Sum_probs=186.3
Q ss_pred cceEEEEc-CCCcEEEEEEeecCCc---------ccHHHHHHHHHHHhcCC-CCCccceeeEEeeCCeeEEEEeccCCCC
Q 021682 3 VAICQGRL-PNGQEMAVKRLSRTSH---------QGLEEFENEVKLTARLQ-HVNLLPVLGICTQREEKMLIYDYMPNKS 71 (309)
Q Consensus 3 ~~~~~~~~-~~g~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 71 (309)
++||+++. .+|+.||||++..... ...+++.+|+.++++++ ||||+++++++.+++..+|||||+++++
T Consensus 17 g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~ 96 (277)
T d1phka_ 17 SVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGE 96 (277)
T ss_dssp EEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCB
T ss_pred eEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCch
Confidence 35777764 6899999999976431 12346789999999996 9999999999999999999999999999
Q ss_pred hhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccc
Q 021682 72 LDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTG 151 (309)
Q Consensus 72 L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 151 (309)
|.+++.. ...+++..++.++.||+.|++|||++ |++||||||+||+++.++.+||+|||++........ ..
T Consensus 97 L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~---~~ 167 (277)
T d1phka_ 97 LFDYLTE---KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LR 167 (277)
T ss_dssp HHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC---BC
T ss_pred HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchheeEccCCCc---ee
Confidence 9999854 34599999999999999999999998 899999999999999999999999999987654332 22
Q ss_pred ccccccCCCCcccccc------CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccC
Q 021682 152 RIVGTYGYVPPEYVRK------GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSL 225 (309)
Q Consensus 152 ~~~~~~~y~aPE~~~~------~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (309)
...||..|+|||.+.+ ..++.++||||+||++|+|++|+.||...... ......... ... .
T Consensus 168 ~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~------~~~~~i~~~-~~~-~----- 234 (277)
T d1phka_ 168 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM------LMLRMIMSG-NYQ-F----- 234 (277)
T ss_dssp CCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHT-CCC-C-----
T ss_pred eeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH------HHHHHHHhC-CCC-C-----
Confidence 3478999999998853 34678999999999999999999999643211 111111111 111 0
Q ss_pred CCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 226 DDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 226 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
........+.++.+++.+||+.||++|||++|+++.
T Consensus 235 ~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 235 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 011111223478899999999999999999999764
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-46 Score=315.15 Aligned_cols=242 Identities=21% Similarity=0.298 Sum_probs=180.8
Q ss_pred cceEEEEcC----CCcEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 3 VAICQGRLP----NGQEMAVKRLSRT-SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 3 ~~~~~~~~~----~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
+.||+|... .+..||||.++.. .....+.+.+|+.++++++||||+++++++. ++..++||||+.+++|.+++.
T Consensus 21 g~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~ 99 (273)
T d1mp8a_ 21 GDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQ 99 (273)
T ss_dssp SEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHH
T ss_pred cEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhh
Confidence 357788653 2456889988654 3444677999999999999999999999986 467899999999999988864
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTY 157 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 157 (309)
. ....+++..++.++.||+.|+.|||++ |++||||||+||+++.++.+||+|||++......... ......||+
T Consensus 100 ~--~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~-~~~~~~gt~ 173 (273)
T d1mp8a_ 100 V--RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPI 173 (273)
T ss_dssp H--TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC--------------------CCG
T ss_pred c--cCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCCcce-eccceecCc
Confidence 3 344589999999999999999999998 8999999999999999999999999999765443222 223346789
Q ss_pred CCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHH
Q 021682 158 GYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMR 236 (309)
Q Consensus 158 ~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
.|+|||.+.+..++.++|||||||++|+|++ |.+||......+. .. ....+....+ +...+..
T Consensus 174 ~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~---~~----~i~~~~~~~~---------~~~~~~~ 237 (273)
T d1mp8a_ 174 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IG----RIENGERLPM---------PPNCPPT 237 (273)
T ss_dssp GGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HH----HHHTTCCCCC---------CTTCCHH
T ss_pred ccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH---HH----HHHcCCCCCC---------CCCCCHH
Confidence 9999999999999999999999999999998 8888865443321 11 1112211111 1112347
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHHHhcccC
Q 021682 237 CMQVALLCVQENAADRPTMLEILVMLKSETA 267 (309)
Q Consensus 237 l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~ 267 (309)
+.+||.+||+.||++|||++||++.|+.+.+
T Consensus 238 ~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 238 LYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 8899999999999999999999999987643
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=323.79 Aligned_cols=232 Identities=23% Similarity=0.305 Sum_probs=184.4
Q ss_pred ceEEEEc-CCCcEEEEEEeecC---CcccHHHHHHHHHHHh-cCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhh
Q 021682 4 AICQGRL-PNGQEMAVKRLSRT---SHQGLEEFENEVKLTA-RLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFD 78 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 78 (309)
+||++.. .+|+.||||++++. .....+.+..|..++. .++||||+++++++.+++..++||||+++|+|.+++..
T Consensus 17 ~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~ 96 (320)
T d1xjda_ 17 KVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS 96 (320)
T ss_dssp EEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH
T ss_pred EEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhc
Confidence 4677754 58999999999753 2334556677777765 68999999999999999999999999999999999854
Q ss_pred hccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccC
Q 021682 79 LRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
...+++..+..++.||+.||.|||++ |++||||||+||+++.++.+||+|||++........ ......||+.
T Consensus 97 ---~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~ 168 (320)
T d1xjda_ 97 ---CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPD 168 (320)
T ss_dssp ---HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--CBCCCCSCGG
T ss_pred ---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcccccc--cccccCCCCC
Confidence 33489999999999999999999999 899999999999999999999999999976544322 2233478999
Q ss_pred CCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHH
Q 021682 159 YVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCM 238 (309)
Q Consensus 159 y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (309)
|+|||.+.+..++.++|||||||++|+|++|+.||...+..+ ......... .. ... ..+.++.
T Consensus 169 y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~------~~~~i~~~~--~~-----~p~----~~s~~~~ 231 (320)
T d1xjda_ 169 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE------LFHSIRMDN--PF-----YPR----WLEKEAK 231 (320)
T ss_dssp GCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCC--CC-----CCT----TSCHHHH
T ss_pred cCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH------HHHHHHcCC--CC-----CCc----cCCHHHH
Confidence 999999999999999999999999999999999996432211 111111111 00 011 1223688
Q ss_pred HHHhhcccCCCCCCCCHH-HHHH
Q 021682 239 QVALLCVQENAADRPTML-EILV 260 (309)
Q Consensus 239 ~li~~~l~~~p~~Rpt~~-ell~ 260 (309)
+||.+||+.||++|||+. ++++
T Consensus 232 dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 232 DLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp HHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HHHHHhcccCCCCCcCHHHHHHh
Confidence 999999999999999996 7764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-46 Score=318.74 Aligned_cols=246 Identities=26% Similarity=0.376 Sum_probs=182.5
Q ss_pred ceEEEEcC------CCcEEEEEEeecCC-cccHHHHHHHHHHHhcC-CCCCccceeeEEeeC-CeeEEEEeccCCCChhH
Q 021682 4 AICQGRLP------NGQEMAVKRLSRTS-HQGLEEFENEVKLTARL-QHVNLLPVLGICTQR-EEKMLIYDYMPNKSLDF 74 (309)
Q Consensus 4 ~~~~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~ 74 (309)
.||+|... +++.||||.++... ......+..|...+.++ +|+||+.+++++..+ ...++||||+++|+|.+
T Consensus 28 ~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~ 107 (299)
T d1ywna1 28 QVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLST 107 (299)
T ss_dssp EEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHH
T ss_pred EEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHH
Confidence 57777642 45789999987543 33456677888888877 789999999987664 46899999999999999
Q ss_pred HHhhhcc-------------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccc
Q 021682 75 YIFDLRR-------------RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAF 141 (309)
Q Consensus 75 ~~~~~~~-------------~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~ 141 (309)
++..... ...+++..+..++.||+.|+.|||++ ||+||||||+||+++.++.+||+|||+++..
T Consensus 108 ~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~ 184 (299)
T d1ywna1 108 YLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDI 184 (299)
T ss_dssp HHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECC------C
T ss_pred HHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECCCCcEEEccCcchhhc
Confidence 9865322 33588999999999999999999998 8999999999999999999999999999876
Q ss_pred cCCcccccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCC-CCCCCCCCCCcccHHHHHHHHhhCCCCccc
Q 021682 142 TKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGK-RTSCYYGPNESLNLLEYAYGLWKNGEGMEF 220 (309)
Q Consensus 142 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (309)
.............||+.|+|||.+.+..++.++|||||||++|+|++|. +||......+. . ......+.....
T Consensus 185 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~---~---~~~~~~~~~~~~ 258 (299)
T d1ywna1 185 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---F---CRRLKEGTRMRA 258 (299)
T ss_dssp CSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH---H---HHHHHHTCCCCC
T ss_pred cccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH---H---HHHHhcCCCCCC
Confidence 5544444444557899999999999999999999999999999999864 56654322221 1 111111111111
Q ss_pred ccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccC
Q 021682 221 IDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETA 267 (309)
Q Consensus 221 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~ 267 (309)
. ...+.++.+++.+||+.||++|||++|++++|+++.+
T Consensus 259 ~---------~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 259 P---------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp C---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C---------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1 1122378899999999999999999999999998753
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-46 Score=322.28 Aligned_cols=236 Identities=17% Similarity=0.208 Sum_probs=186.4
Q ss_pred ceEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccc
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRR 82 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 82 (309)
+||++.. .+|+.||||.++.... ....+.+|+++|++++||||+++++++.+++.+|+|||||.|++|.+++.. .+
T Consensus 20 ~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~--~~ 96 (321)
T d1tkia_ 20 IVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINT--SA 96 (321)
T ss_dssp EEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTS--SS
T ss_pred EEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHh--cC
Confidence 4677754 5899999999976543 346788999999999999999999999999999999999999999998843 23
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCC--CCceeecccccccccCCcccccccccccccCCC
Q 021682 83 YLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYE--MNPKISDFGMARAFTKDECEANTGRIVGTYGYV 160 (309)
Q Consensus 83 ~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~--~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 160 (309)
..+++..+..++.||+.|+.|||++ ||+||||||+||+++.+ +.++|+|||++........ .....+++.|+
T Consensus 97 ~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~---~~~~~~t~~y~ 170 (321)
T d1tkia_ 97 FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYY 170 (321)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE---EEEEESCGGGS
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCCc---ccccccccccc
Confidence 3589999999999999999999998 99999999999999854 4799999999976544322 22346889999
Q ss_pred CccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHHHHHHH
Q 021682 161 PPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLMRCMQV 240 (309)
Q Consensus 161 aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 240 (309)
|||.+.+..++.++|||||||++|+|++|..||......+ ............ ........+.++.+|
T Consensus 171 ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~------~~~~i~~~~~~~-------~~~~~~~~s~~~~~l 237 (321)
T d1tkia_ 171 APEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ------IIENIMNAEYTF-------DEEAFKEISIEAMDF 237 (321)
T ss_dssp CHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHTCCCC-------CHHHHTTSCHHHHHH
T ss_pred cchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCCCC-------ChhhccCCCHHHHHH
Confidence 9999999999999999999999999999999986432211 111111111000 000000123368899
Q ss_pred HhhcccCCCCCCCCHHHHHHH
Q 021682 241 ALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 241 i~~~l~~~p~~Rpt~~ell~~ 261 (309)
|.+||+.||++|||++|+++.
T Consensus 238 i~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 238 VDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999984
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-46 Score=320.44 Aligned_cols=246 Identities=24% Similarity=0.397 Sum_probs=195.1
Q ss_pred ceEEEEc------CCCcEEEEEEeecCC-cccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHH
Q 021682 4 AICQGRL------PNGQEMAVKRLSRTS-HQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFY 75 (309)
Q Consensus 4 ~~~~~~~------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (309)
.||+|.+ .+++.||||.++... ......+.+|+.+++++ +||||+++++++..+...++||||+++++|.++
T Consensus 38 ~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~ 117 (311)
T d1t46a_ 38 KVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNF 117 (311)
T ss_dssp EEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHH
T ss_pred EEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHH
Confidence 5788764 467889999997643 34456789999999999 799999999999999999999999999999999
Q ss_pred Hhhhc---------------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeeccccccc
Q 021682 76 IFDLR---------------RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARA 140 (309)
Q Consensus 76 ~~~~~---------------~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~ 140 (309)
+.... ....+++..+..++.||+.|++|||++ |++||||||+||+++.++.++++|||.+..
T Consensus 118 l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~ 194 (311)
T d1t46a_ 118 LRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARD 194 (311)
T ss_dssp HHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETTTEEEECCCGGGSC
T ss_pred HHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccccccccccccCcccccccchhee
Confidence 85432 123588999999999999999999999 899999999999999999999999999987
Q ss_pred ccCCcccccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcc
Q 021682 141 FTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGME 219 (309)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (309)
..............||+.|+|||.+.+..++.++|||||||++|+|++ |.+|+......+. . ......+....
T Consensus 195 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~---~---~~~i~~~~~~~ 268 (311)
T d1t46a_ 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK---F---YKMIKEGFRML 268 (311)
T ss_dssp TTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH---H---HHHHHHTCCCC
T ss_pred ccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH---H---HHHHhcCCCCC
Confidence 765544444445678999999999999999999999999999999998 5555543322221 1 11111111111
Q ss_pred cccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccC
Q 021682 220 FIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETA 267 (309)
Q Consensus 220 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~ 267 (309)
.+...+..+.+||.+||+.||++|||+++|+++|+++..
T Consensus 269 ---------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 269 ---------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp ---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 111123478899999999999999999999999987644
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-46 Score=320.39 Aligned_cols=237 Identities=19% Similarity=0.214 Sum_probs=182.4
Q ss_pred ceEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCCccceeeEEee----CCeeEEEEeccCCCChhHHHh
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTSHQGLEEFENEVKLTARL-QHVNLLPVLGICTQ----REEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~ 77 (309)
+||++. ..+|+.||||+++. ...+.+|+.++.++ +||||+++++++.+ +..+|+|||||+||+|.+++.
T Consensus 27 ~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~ 101 (335)
T d2ozaa1 27 KVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ 101 (335)
T ss_dssp EEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHH
T ss_pred EEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHH
Confidence 466665 46899999999853 24677899887654 89999999999875 457899999999999999985
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCC---CCCceeecccccccccCCcccccccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY---EMNPKISDFGMARAFTKDECEANTGRIV 154 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~---~~~~~l~Dfg~~~~~~~~~~~~~~~~~~ 154 (309)
.. ....+++..++.++.||+.|++|||++ ||+||||||+||+++. .+.+||+|||++........ .....
T Consensus 102 ~~-~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~---~~~~~ 174 (335)
T d2ozaa1 102 DR-GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPC 174 (335)
T ss_dssp SC-SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCC---CCCCS
T ss_pred hc-CCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceeeeccCCCc---ccccc
Confidence 42 234599999999999999999999998 9999999999999986 45799999999976654332 22347
Q ss_pred cccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHH
Q 021682 155 GTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKL 234 (309)
Q Consensus 155 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
||+.|+|||++.+..++.++|||||||++|+|++|++||............. .... ..............+
T Consensus 175 gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~---~~i~------~~~~~~~~~~~~~~s 245 (335)
T d2ozaa1 175 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK---TRIR------MGQYEFPNPEWSEVS 245 (335)
T ss_dssp CCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCC------SCSSSCCTTHHHHSC
T ss_pred CCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHH---HHHh------cCCCCCCCcccccCC
Confidence 8999999999999999999999999999999999999996543322111110 0000 000011111122334
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 235 MRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 235 ~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.++.+||.+||+.||++|||++|+++.
T Consensus 246 ~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 246 EEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 578899999999999999999999984
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.6e-45 Score=322.15 Aligned_cols=234 Identities=23% Similarity=0.240 Sum_probs=182.2
Q ss_pred ceEEEEc-CCCcEEEEEEeecCC---cccHHHHH---HHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHH
Q 021682 4 AICQGRL-PNGQEMAVKRLSRTS---HQGLEEFE---NEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 4 ~~~~~~~-~~g~~vavK~~~~~~---~~~~~~~~---~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 76 (309)
.||++.. .+|+.||||++.... ......+. .++.+++.++||||+++++++..++..++||||+.+++|.+++
T Consensus 19 ~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l 98 (364)
T d1omwa3 19 EVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL 98 (364)
T ss_dssp EEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHH
T ss_pred EEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHH
Confidence 4677764 589999999986431 22223333 4467788889999999999999999999999999999999998
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccc
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGT 156 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 156 (309)
.. ...+++..++.++.||+.||.|||++ |++||||||+||+++.+|.+||+|||++....... .....||
T Consensus 99 ~~---~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~----~~~~~GT 168 (364)
T d1omwa3 99 SQ---HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGT 168 (364)
T ss_dssp HH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC----CCSCCSC
T ss_pred Hh---cccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecCCCc----ccccccc
Confidence 54 34588999999999999999999999 99999999999999999999999999998665432 2234689
Q ss_pred cCCCCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 157 YGYVPPEYVRK-GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 157 ~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
+.|+|||.+.. ..++.++|||||||++|+|++|+.||......+.. ... ..... .... + .. ..+.
T Consensus 169 ~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~~~-~~~~~-~~~~-~----~~----~~s~ 234 (364)
T d1omwa3 169 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EID-RMTLT-MAVE-L----PD----SFSP 234 (364)
T ss_dssp GGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH---HHH-HHSSS-CCCC-C----CS----SSCH
T ss_pred cccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH---HHH-Hhccc-CCCC-C----CC----CCCH
Confidence 99999999864 56899999999999999999999999654433321 111 11000 0000 0 11 1223
Q ss_pred HHHHHHhhcccCCCCCCCC-----HHHHHHH
Q 021682 236 RCMQVALLCVQENAADRPT-----MLEILVM 261 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~Rpt-----~~ell~~ 261 (309)
++.+||.+||+.||++||| ++|+++.
T Consensus 235 ~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 235 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp HHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred HHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 7889999999999999999 7999863
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-46 Score=316.27 Aligned_cols=245 Identities=25% Similarity=0.341 Sum_probs=195.8
Q ss_pred ceEEEEcC--------CCcEEEEEEeecCC-cccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChh
Q 021682 4 AICQGRLP--------NGQEMAVKRLSRTS-HQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLD 73 (309)
Q Consensus 4 ~~~~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 73 (309)
.||++... ++..||||.++... ......+..|+..+.++ +||||+++++++.++...++||||+.+|+|.
T Consensus 28 ~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~ 107 (299)
T d1fgka_ 28 QVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 107 (299)
T ss_dssp CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHH
T ss_pred EEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcHH
Confidence 56776542 23479999997653 34456788899999888 8999999999999999999999999999999
Q ss_pred HHHhhhcc-------------ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeeccccccc
Q 021682 74 FYIFDLRR-------------RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARA 140 (309)
Q Consensus 74 ~~~~~~~~-------------~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~ 140 (309)
+++..... ...+++..++.++.||+.|+.|||+. |++||||||+||+++.++.+||+|||++..
T Consensus 108 ~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~ 184 (299)
T d1fgka_ 108 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARD 184 (299)
T ss_dssp HHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSTTCCCC
T ss_pred HHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeecCCCCeEeccchhhcc
Confidence 99854321 34589999999999999999999999 899999999999999999999999999987
Q ss_pred ccCCcccccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcc
Q 021682 141 FTKDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGME 219 (309)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (309)
..............+++.|+|||.+.+..++.++|||||||++|+|++ |.+||...... .....+..+....
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~-------~~~~~i~~~~~~~ 257 (299)
T d1fgka_ 185 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-------ELFKLLKEGHRMD 257 (299)
T ss_dssp GGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-------HHHHHHHTTCCCC
T ss_pred ccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH-------HHHHHHHcCCCCC
Confidence 765544444445578899999999999999999999999999999998 68887532221 1222233322222
Q ss_pred cccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccC
Q 021682 220 FIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETA 267 (309)
Q Consensus 220 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~ 267 (309)
.. ...+.++.+||.+||+.||++|||++||++.|+++.+
T Consensus 258 ~p---------~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 258 KP---------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp CC---------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CC---------ccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 11 1122378899999999999999999999999998743
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=315.78 Aligned_cols=247 Identities=23% Similarity=0.347 Sum_probs=191.2
Q ss_pred ceEEEEcCCC----cEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeeEEee-CCeeEEEEeccCCCChhHHHh
Q 021682 4 AICQGRLPNG----QEMAVKRLSRT-SHQGLEEFENEVKLTARLQHVNLLPVLGICTQ-REEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 4 ~~~~~~~~~g----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~ 77 (309)
+||+|.+.++ ..||||.++.. .....+++.+|++++++++||||+++++++.. +...++||||+++++|.+++.
T Consensus 42 ~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~ 121 (311)
T d1r0pa_ 42 CVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR 121 (311)
T ss_dssp EEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHH
T ss_pred EEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhc
Confidence 5888876432 25899998643 45556789999999999999999999999876 458899999999999999874
Q ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccc--ccccccc
Q 021682 78 DLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEA--NTGRIVG 155 (309)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~--~~~~~~~ 155 (309)
. .....++..+..++.|++.|+.|+|+. |++||||||+||++++++.+||+|||++.......... ......|
T Consensus 122 ~--~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~g 196 (311)
T d1r0pa_ 122 N--ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 196 (311)
T ss_dssp C--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSC
T ss_pred c--ccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccc
Confidence 3 344577888999999999999999998 89999999999999999999999999997765432221 2223468
Q ss_pred ccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHHH
Q 021682 156 TYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKLM 235 (309)
Q Consensus 156 ~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
|..|+|||.+....++.++||||||+++|||++|..||....... .... ....+..... +...+.
T Consensus 197 t~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~----~i~~g~~~~~---------p~~~~~ 261 (311)
T d1r0pa_ 197 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITV----YLLQGRRLLQ---------PEYCPD 261 (311)
T ss_dssp CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHH----HHHTTCCCCC---------CTTCCH
T ss_pred cccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHH----HHHcCCCCCC---------cccCcH
Confidence 899999999999999999999999999999999877764322111 1111 1111111111 111234
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHHhcccCCCC
Q 021682 236 RCMQVALLCVQENAADRPTMLEILVMLKSETADIK 270 (309)
Q Consensus 236 ~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~~~ 270 (309)
.+.+|+.+||+.||++|||+.||++.|+++...+.
T Consensus 262 ~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~ 296 (311)
T d1r0pa_ 262 PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296 (311)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhh
Confidence 78899999999999999999999999999866433
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=316.13 Aligned_cols=241 Identities=22% Similarity=0.322 Sum_probs=183.5
Q ss_pred ceEEEEcC--CC--cEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHH
Q 021682 4 AICQGRLP--NG--QEMAVKRLSRT---SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYI 76 (309)
Q Consensus 4 ~~~~~~~~--~g--~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 76 (309)
.||+|.+. ++ ..||||.++.. .....+.+.+|+.++++++||||+++++++.+ ...++||||++++++.+++
T Consensus 23 ~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~ 101 (273)
T d1u46a_ 23 VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRL 101 (273)
T ss_dssp CCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHH
T ss_pred EEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeeeecCcchhhhh
Confidence 57888652 33 36899988654 23345688999999999999999999999975 4678999999999998887
Q ss_pred hhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccc-ccccccc
Q 021682 77 FDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEA-NTGRIVG 155 (309)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~-~~~~~~~ 155 (309)
.. ....+++..+..++.||+.|+.|||++ |++||||||+||+++.++.+||+|||++.......... ......+
T Consensus 102 ~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~ 176 (273)
T d1u46a_ 102 RK--HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176 (273)
T ss_dssp HH--HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----C
T ss_pred hc--ccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCcccc
Confidence 54 334599999999999999999999998 89999999999999999999999999998765443222 2223457
Q ss_pred ccCCCCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHHH
Q 021682 156 TYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILG-GKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWKL 234 (309)
Q Consensus 156 ~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
+..|+|||.+.+..++.++||||||+++|||++ |..||...... .........+..... +...+
T Consensus 177 ~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~------~~~~~i~~~~~~~~~---------~~~~~ 241 (273)
T d1u46a_ 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDKEGERLPR---------PEDCP 241 (273)
T ss_dssp CGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTSCCCCCC---------CTTCC
T ss_pred CcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH------HHHHHHHhCCCCCCC---------ccccc
Confidence 789999999999999999999999999999998 89998533222 112222222211111 11122
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHHhcc
Q 021682 235 MRCMQVALLCVQENAADRPTMLEILVMLKSE 265 (309)
Q Consensus 235 ~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~ 265 (309)
..+.+||.+||+.||++|||+++|++.|+..
T Consensus 242 ~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 242 QDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 3788999999999999999999999999753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=314.35 Aligned_cols=255 Identities=17% Similarity=0.180 Sum_probs=185.9
Q ss_pred cceEEEE-cCCCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhh
Q 021682 3 VAICQGR-LPNGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 3 ~~~~~~~-~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
++||++. ..+|+.||||+++... ....+++.+|++++++++||||+++++++.++...++||||+.++.+ .++..
T Consensus 16 g~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~~~-~~~~~- 93 (298)
T d1gz8a_ 16 GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLK-KFMDA- 93 (298)
T ss_dssp SEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHH-HHHHH-
T ss_pred eEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCCchh-hhhhh-
Confidence 3567775 4689999999986542 23457889999999999999999999999999999999999976544 44322
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGY 159 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y 159 (309)
.....+++..+..++.||+.||.|||++ ||+||||||+||+++.++.+||+|||.+......... .....|++.|
T Consensus 94 ~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~--~~~~~gt~~y 168 (298)
T d1gz8a_ 94 SALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWY 168 (298)
T ss_dssp TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC--TTCCBCCCTT
T ss_pred hcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCccc--ceeeccccee
Confidence 2345599999999999999999999998 8999999999999999999999999999776543322 2234789999
Q ss_pred CCccccccCC-CCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhC---CCCccc---------ccccCC
Q 021682 160 VPPEYVRKGI-YSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKN---GEGMEF---------IDSSLD 226 (309)
Q Consensus 160 ~aPE~~~~~~-~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~---------~~~~~~ 226 (309)
+|||.+.... ++.++|+|||||++|+|++|+.||...+..+ ........... ...... ......
T Consensus 169 ~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (298)
T d1gz8a_ 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID---QLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWAR 245 (298)
T ss_dssp CCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCC
T ss_pred eehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH---HHHHHHHhcCCCchhhccccccccccccccccccc
Confidence 9999877665 4789999999999999999999986432211 11111111000 000000 000000
Q ss_pred Cc---ccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--HhcccC
Q 021682 227 DS---SSAWKLMRCMQVALLCVQENAADRPTMLEILVM--LKSETA 267 (309)
Q Consensus 227 ~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~--L~~~~~ 267 (309)
.. .....+.++.+||.+||+.||++|||++|+++. ++.+.+
T Consensus 246 ~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~ 291 (298)
T d1gz8a_ 246 QDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291 (298)
T ss_dssp CCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence 00 001122467899999999999999999999986 655433
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=314.99 Aligned_cols=247 Identities=23% Similarity=0.358 Sum_probs=195.7
Q ss_pred CccceEEEEcC------CCcEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChh
Q 021682 1 MSVAICQGRLP------NGQEMAVKRLSRT-SHQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLD 73 (309)
Q Consensus 1 ~g~~~~~~~~~------~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 73 (309)
|| .||+|.+. +++.||||.++.. .......+.+|+.++++++||||+++++++..+...++||||+.+|+|.
T Consensus 33 fG-~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~ 111 (308)
T d1p4oa_ 33 FG-MVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLK 111 (308)
T ss_dssp SS-EEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHH
T ss_pred Ce-EEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHH
Confidence 44 47877652 3678999999754 3344557899999999999999999999999999999999999999999
Q ss_pred HHHhhhc-------cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcc
Q 021682 74 FYIFDLR-------RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDEC 146 (309)
Q Consensus 74 ~~~~~~~-------~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 146 (309)
+++.... ....+++..+..++.+++.|+.|||++ +++||||||+||+++.++++||+|||++........
T Consensus 112 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~ 188 (308)
T d1p4oa_ 112 SYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 188 (308)
T ss_dssp HHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGC
T ss_pred HHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEeecccceeccCCcc
Confidence 9885432 123468889999999999999999998 899999999999999999999999999987655444
Q ss_pred cccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCC-CCCCCCCCCCcccHHHHHHHHhhCCCCcccccccC
Q 021682 147 EANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGK-RTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSL 225 (309)
Q Consensus 147 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (309)
........+++.|+|||.+.+..++.++|||||||++|+|++|. +||..... .... .....+......
T Consensus 189 ~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~------~~~~-~~i~~~~~~~~p---- 257 (308)
T d1p4oa_ 189 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------EQVL-RFVMEGGLLDKP---- 257 (308)
T ss_dssp EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH------HHHH-HHHHTTCCCCCC----
T ss_pred eeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH------HHHH-HHHHhCCCCCCc----
Confidence 43444456899999999999999999999999999999999985 66543211 1111 112222221111
Q ss_pred CCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccC
Q 021682 226 DDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETA 267 (309)
Q Consensus 226 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~ 267 (309)
...+..+.+++.+||+.||++|||+++|+++|++..+
T Consensus 258 -----~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 258 -----DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp -----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred -----ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1122378899999999999999999999999998755
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-46 Score=317.47 Aligned_cols=247 Identities=26% Similarity=0.397 Sum_probs=189.7
Q ss_pred cceEEEEcC-CCc--EEEEEEeecC-CcccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCChhHHHh
Q 021682 3 VAICQGRLP-NGQ--EMAVKRLSRT-SHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIF 77 (309)
Q Consensus 3 ~~~~~~~~~-~g~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 77 (309)
++||+|.++ +|. .||||.++.. .....+.+.+|+++++++ +||||+++++++.+++..++||||+++|+|.+++.
T Consensus 24 g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~ 103 (309)
T d1fvra_ 24 GQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR 103 (309)
T ss_dssp CEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHH
T ss_pred cEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHh
Confidence 357888764 444 4778887644 344566899999999999 79999999999999999999999999999999985
Q ss_pred hh-------------ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCC
Q 021682 78 DL-------------RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKD 144 (309)
Q Consensus 78 ~~-------------~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~ 144 (309)
.. .....+++..+..++.||+.|+.|+|++ |++||||||+|||++.++.+||+|||++......
T Consensus 104 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~ 180 (309)
T d1fvra_ 104 KSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 180 (309)
T ss_dssp TTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEESSCEE
T ss_pred hccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCceEEcccccccccccc
Confidence 43 2245689999999999999999999998 8999999999999999999999999998654432
Q ss_pred cccccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCC-CCCCCCCCCCcccHHHHHHHHhhCCCCcccccc
Q 021682 145 ECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGK-RTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDS 223 (309)
Q Consensus 145 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (309)
.. .....||..|+|||.+.+..++.++|||||||++|+|++|. +||......+ . ......+....
T Consensus 181 ~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~------~-~~~i~~~~~~~---- 246 (309)
T d1fvra_ 181 VK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------L-YEKLPQGYRLE---- 246 (309)
T ss_dssp CC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------H-HHHGGGTCCCC----
T ss_pred cc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH------H-HHHHHhcCCCC----
Confidence 22 22336789999999999999999999999999999999975 4554322111 1 11112211111
Q ss_pred cCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccCCCCC
Q 021682 224 SLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSETADIKT 271 (309)
Q Consensus 224 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~~~~ 271 (309)
.+...+.++.+||.+||+.||++|||++||++.|+++.+....
T Consensus 247 -----~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~ 289 (309)
T d1fvra_ 247 -----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 289 (309)
T ss_dssp -----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred -----CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCcC
Confidence 1111234788999999999999999999999999988765443
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-45 Score=312.02 Aligned_cols=253 Identities=23% Similarity=0.247 Sum_probs=185.2
Q ss_pred ceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeCC----eeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQRE----EKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~ 79 (309)
.||+|.+ +|+.||||.++.... .....+.|+..+.+++||||+++++++..+. ..++||||+++++|.+++..
T Consensus 18 ~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~- 94 (303)
T d1vjya_ 18 EVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR- 94 (303)
T ss_dssp EEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-
T ss_pred EEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhc-
Confidence 6899986 789999999864322 1222344555667789999999999997654 58999999999999999943
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhc-----CCCceeecCCCCceEEeCCCCCceeecccccccccCCccc--ccccc
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEY-----SNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECE--ANTGR 152 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~-----~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~ 152 (309)
..+++..++.++.+++.|+.|+|+. +.+||+||||||+||+++.++.+||+|||++......... .....
T Consensus 95 ---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~ 171 (303)
T d1vjya_ 95 ---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 171 (303)
T ss_dssp ---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----
T ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccc
Confidence 2488999999999999999999973 2359999999999999999999999999999876543322 22334
Q ss_pred cccccCCCCccccccCC------CCccchhhhHHHHHHHHHhCCCCCCCCCCCCcc--------cHHHHHHHHhhCCCCc
Q 021682 153 IVGTYGYVPPEYVRKGI------YSMKYDVYSYGVLLLQILGGKRTSCYYGPNESL--------NLLEYAYGLWKNGEGM 218 (309)
Q Consensus 153 ~~~~~~y~aPE~~~~~~------~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~~ 218 (309)
..||+.|+|||.+.+.. ++.++|||||||++|+|++|..|+......... ...............
T Consensus 172 ~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 250 (303)
T d1vjya_ 172 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL- 250 (303)
T ss_dssp CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCC-
T ss_pred eecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhcccc-
Confidence 57899999999987643 567899999999999999998887543222110 011111111111111
Q ss_pred ccccccCC-CcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhccc
Q 021682 219 EFIDSSLD-DSSSAWKLMRCMQVALLCVQENAADRPTMLEILVMLKSET 266 (309)
Q Consensus 219 ~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~ 266 (309)
++... ..........+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 251 ---~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 251 ---RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp ---CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 11111 1112334457889999999999999999999999998764
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.2e-44 Score=305.95 Aligned_cols=250 Identities=18% Similarity=0.212 Sum_probs=184.8
Q ss_pred cceEEEEcCCCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
+.||++..++|+.||||+++... ....+++.+|+.++++++||||+++++++..++..+++++++.++++..+. .
T Consensus 16 g~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~---~ 92 (286)
T d1ob3a_ 16 GVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD---V 92 (286)
T ss_dssp EEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHH---T
T ss_pred cEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHH---h
Confidence 35789988899999999996542 333578999999999999999999999999999999999999877666665 3
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCC
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYV 160 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 160 (309)
....+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||.+......... .....+++.|+
T Consensus 93 ~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~~~~~y~ 167 (286)
T d1ob3a_ 93 CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--YTHEIVTLWYR 167 (286)
T ss_dssp STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTC
T ss_pred hcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCccc--cceecccchhh
Confidence 345599999999999999999999998 9999999999999999999999999999776543222 22236788999
Q ss_pred CccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCccc---------c---cccCCC
Q 021682 161 PPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEF---------I---DSSLDD 227 (309)
Q Consensus 161 aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~---~~~~~~ 227 (309)
|||.+.+. .++.++|||||||++|+|++|+.||......+....+............... . ......
T Consensus 168 ~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (286)
T d1ob3a_ 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWE 247 (286)
T ss_dssp CHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGG
T ss_pred hHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchh
Confidence 99998764 5689999999999999999999999643322211111111000000000000 0 000000
Q ss_pred cccHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021682 228 SSSAWKLMRCMQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 228 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
.........+.++|.+||+.||++|||++|+++
T Consensus 248 ~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 248 SFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp GTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 001112347789999999999999999999985
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-45 Score=308.83 Aligned_cols=225 Identities=21% Similarity=0.311 Sum_probs=177.3
Q ss_pred ceEEEE-cCCCcEEEEEEeecCCc------ccHHHHHHHHHHHhcCC--CCCccceeeEEeeCCeeEEEEeccCC-CChh
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTSH------QGLEEFENEVKLTARLQ--HVNLLPVLGICTQREEKMLIYDYMPN-KSLD 73 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~-~~L~ 73 (309)
+||++. ..+|+.||||.+..... ....++..|+.++++++ ||||+++++++.+++..++|||++.+ +++.
T Consensus 19 ~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~ 98 (273)
T d1xwsa_ 19 SVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 98 (273)
T ss_dssp EEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHH
T ss_pred EEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHH
Confidence 567776 46899999999865321 11234668999999986 89999999999999999999999976 5677
Q ss_pred HHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCC-CCceeecccccccccCCcccccccc
Q 021682 74 FYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYE-MNPKISDFGMARAFTKDECEANTGR 152 (309)
Q Consensus 74 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~ 152 (309)
+++.. ...+++..++.++.||+.|+.|||++ |++||||||+||+++.+ +.+||+|||++....... ...
T Consensus 99 ~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~~----~~~ 168 (273)
T d1xwsa_ 99 DFITE---RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTD 168 (273)
T ss_dssp HHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCSSC----BCC
T ss_pred HHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccccceeccccc----ccc
Confidence 77643 34599999999999999999999998 99999999999999855 789999999997654432 223
Q ss_pred cccccCCCCccccccCCC-CccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccH
Q 021682 153 IVGTYGYVPPEYVRKGIY-SMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSA 231 (309)
Q Consensus 153 ~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (309)
..||+.|+|||.+.+..+ +.++|||||||++|+|++|+.||.... ...... ..+.. .
T Consensus 169 ~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------~i~~~~---~~~~~----~--- 226 (273)
T d1xwsa_ 169 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRGQ---VFFRQ----R--- 226 (273)
T ss_dssp CCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHCC---CCCSS----C---
T ss_pred cccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------------HHhhcc---cCCCC----C---
Confidence 478999999999987665 577899999999999999999985311 011110 01111 1
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 232 WKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 232 ~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.+.++.++|.+||+.||++|||++|+++.
T Consensus 227 -~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 227 -VSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp -CCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -CCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 12378899999999999999999999864
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-43 Score=307.10 Aligned_cols=250 Identities=20% Similarity=0.228 Sum_probs=179.6
Q ss_pred CccceEEEEc-CCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeeEEeeC------CeeEEEEeccCCCChh
Q 021682 1 MSVAICQGRL-PNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLPVLGICTQR------EEKMLIYDYMPNKSLD 73 (309)
Q Consensus 1 ~g~~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~~L~ 73 (309)
||+ ||++.. .+|+.||||++..... ...+|++++++++|+||++++++|... .+.++||||+.++++.
T Consensus 33 fg~-Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~ 107 (350)
T d1q5ka_ 33 FGV-VYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR 107 (350)
T ss_dssp TEE-EEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHH
T ss_pred CeE-EEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHH
Confidence 444 667664 5899999999965432 234799999999999999999998543 3579999999766544
Q ss_pred HHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCC-CceeecccccccccCCcccccccc
Q 021682 74 FYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM-NPKISDFGMARAFTKDECEANTGR 152 (309)
Q Consensus 74 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~ 152 (309)
.+.........+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++........ ...
T Consensus 108 ~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~---~~~ 181 (350)
T d1q5ka_ 108 VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVS 181 (350)
T ss_dssp HHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC---CCS
T ss_pred HHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhccCCcc---ccc
Confidence 4443334556699999999999999999999998 999999999999999775 899999999976654332 222
Q ss_pred cccccCCCCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHH--------HHHhhCC----CCcc
Q 021682 153 IVGTYGYVPPEYVRK-GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYA--------YGLWKNG----EGME 219 (309)
Q Consensus 153 ~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~----~~~~ 219 (309)
..|+..|+|||.+.+ ..++.++||||+||++|+|++|.+||......+....+... ....... ....
T Consensus 182 ~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 261 (350)
T d1q5ka_ 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 261 (350)
T ss_dssp CCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCC
T ss_pred ccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccc
Confidence 468999999998765 46899999999999999999999999654322221111110 0001100 0000
Q ss_pred cccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 220 FIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 220 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
................++.+||.+||+.||++|||++|+++.
T Consensus 262 ~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 262 IKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp CCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000111223468899999999999999999999974
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-44 Score=306.13 Aligned_cols=251 Identities=22% Similarity=0.264 Sum_probs=178.4
Q ss_pred cceEEEEc-CC-CcEEEEEEeecCC--cccHHHHHHHHHHHhcC---CCCCccceeeEEee-----CCeeEEEEeccCCC
Q 021682 3 VAICQGRL-PN-GQEMAVKRLSRTS--HQGLEEFENEVKLTARL---QHVNLLPVLGICTQ-----REEKMLIYDYMPNK 70 (309)
Q Consensus 3 ~~~~~~~~-~~-g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~ 70 (309)
++||++.. .+ ++.||||.++... ......+.+|+.+++.+ +||||++++++|.. ....+++||++.++
T Consensus 21 g~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~ 100 (305)
T d1blxa_ 21 GKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD 100 (305)
T ss_dssp EEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCB
T ss_pred eEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCC
Confidence 35677764 44 6779999986542 22233456677776655 79999999999853 34689999999887
Q ss_pred ChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccc
Q 021682 71 SLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANT 150 (309)
Q Consensus 71 ~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 150 (309)
++..... .....+++..++.++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++....... ..
T Consensus 101 ~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~~---~~ 172 (305)
T d1blxa_ 101 LTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---AL 172 (305)
T ss_dssp HHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG---GG
T ss_pred chhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchhhhhhhcccc---cC
Confidence 6654432 3455589999999999999999999998 89999999999999999999999999986544332 23
Q ss_pred cccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHH-----hhCCCC-c-ccccc
Q 021682 151 GRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGL-----WKNGEG-M-EFIDS 223 (309)
Q Consensus 151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~-~-~~~~~ 223 (309)
....||+.|+|||.+.+..++.++||||+||++|+|++|++||......+....+...... +..... . ..+..
T Consensus 173 ~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (305)
T d1blxa_ 173 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHS 252 (305)
T ss_dssp CCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCC
T ss_pred CCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhcc
Confidence 3457899999999999999999999999999999999999999643322211111111000 000000 0 00000
Q ss_pred cC---CCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 224 SL---DDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 224 ~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.. ...........+.+||.+||+.||++|||++|+++.
T Consensus 253 ~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 253 KSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 000011123467899999999999999999999874
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-42 Score=301.37 Aligned_cols=251 Identities=22% Similarity=0.264 Sum_probs=183.3
Q ss_pred CccceEEEE-cCCCcEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeeEEeeCC------eeEEEEeccCCCC
Q 021682 1 MSVAICQGR-LPNGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQRE------EKMLIYDYMPNKS 71 (309)
Q Consensus 1 ~g~~~~~~~-~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~~ 71 (309)
||+ ||++. ..+|+.||||+++.. .....+.+.+|+++|++++||||++++++|...+ .+++||||+ +.+
T Consensus 31 fg~-V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~ 108 (346)
T d1cm8a_ 31 YGA-VCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTD 108 (346)
T ss_dssp --C-EEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEE
T ss_pred CeE-EEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-ccc
Confidence 444 56665 568999999999754 2334567889999999999999999999997654 579999999 567
Q ss_pred hhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccc
Q 021682 72 LDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTG 151 (309)
Q Consensus 72 L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 151 (309)
|..+.. ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++.+|++|||++....... .
T Consensus 109 l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~~-----~ 176 (346)
T d1cm8a_ 109 LGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM-----T 176 (346)
T ss_dssp HHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSSC-----C
T ss_pred HHHHHH----hccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceeccCCcc-----c
Confidence 776652 23499999999999999999999998 99999999999999999999999999997655432 2
Q ss_pred ccccccCCCCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH-----HhhCCC---------
Q 021682 152 RIVGTYGYVPPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYG-----LWKNGE--------- 216 (309)
Q Consensus 152 ~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~--------- 216 (309)
...|++.|+|||.+.+. .++.++||||+||++|+|++|++||...+............. .+....
T Consensus 177 ~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (346)
T d1cm8a_ 177 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMK 256 (346)
T ss_dssp SSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHH
T ss_pred cccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhc
Confidence 34689999999988764 568999999999999999999999865432221111110000 000000
Q ss_pred -CcccccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--Hhccc
Q 021682 217 -GMEFIDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM--LKSET 266 (309)
Q Consensus 217 -~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~--L~~~~ 266 (309)
........ ...........+.+||.+||+.||++|||++|+++. ++.+.
T Consensus 257 ~~~~~~~~~-~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 257 GLPELEKKD-FASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HSCCCCCCC-GGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred cCCcccccc-hHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 00000000 000001122367799999999999999999999986 55543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.3e-42 Score=293.12 Aligned_cols=259 Identities=16% Similarity=0.127 Sum_probs=197.9
Q ss_pred ceEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCC-CCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQH-VNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
+||+|. ..+|+.||||+++.... ...+.+|++.++.++| +|++.+++++..+...++|||++ +++|.+++.. .
T Consensus 20 ~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~--~ 94 (293)
T d1csna_ 20 VIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDL--C 94 (293)
T ss_dssp EEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH--T
T ss_pred EEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHh--h
Confidence 567776 45899999999865432 2456789999999964 89999999999999999999999 6789888743 3
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCC-----CCCceeecccccccccCCccc-----cccc
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY-----EMNPKISDFGMARAFTKDECE-----ANTG 151 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~-----~~~~~l~Dfg~~~~~~~~~~~-----~~~~ 151 (309)
+..++...+..++.|++.|+.+||++ |++||||||+||+++. ++.++|+|||+++........ ....
T Consensus 95 ~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~ 171 (293)
T d1csna_ 95 GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKK 171 (293)
T ss_dssp TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCC
T ss_pred ccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccC
Confidence 34589999999999999999999999 9999999999999974 567999999999876543221 1223
Q ss_pred ccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccH
Q 021682 152 RIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSA 231 (309)
Q Consensus 152 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (309)
...||+.|+|||.+.+..++.++|||||||++|+|++|..||.........................++. ..
T Consensus 172 ~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~-----~~--- 243 (293)
T d1csna_ 172 NLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC-----AG--- 243 (293)
T ss_dssp CCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHT-----TT---
T ss_pred ceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhc-----CC---
Confidence 4579999999999999999999999999999999999999997655544333222221111111111111 11
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHHHHHHHhcccCCCCCCCCCCccc
Q 021682 232 WKLMRCMQVALLCVQENAADRPTMLEILVMLKSETADIKTPKKPAFSV 279 (309)
Q Consensus 232 ~~~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~~~~~~~~~p~~~~ 279 (309)
.+.++.+++..|+..+|++||+++.+.+.|+.+.+.........|+|
T Consensus 244 -~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw 290 (293)
T d1csna_ 244 -FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDW 290 (293)
T ss_dssp -SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGG
T ss_pred -CCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 12368899999999999999999999999988766655554444554
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-43 Score=300.45 Aligned_cols=254 Identities=19% Similarity=0.254 Sum_probs=180.5
Q ss_pred CccceEEEEc-CCCcEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeeEEee--------CCeeEEEEeccCC
Q 021682 1 MSVAICQGRL-PNGQEMAVKRLSRT--SHQGLEEFENEVKLTARLQHVNLLPVLGICTQ--------REEKMLIYDYMPN 69 (309)
Q Consensus 1 ~g~~~~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--------~~~~~lv~e~~~~ 69 (309)
|| +||++.. .+|+.||||++... ......++.+|+++|++++|+||+++++++.. +...++|||++.+
T Consensus 23 fg-~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~ 101 (318)
T d3blha1 23 FG-EVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH 101 (318)
T ss_dssp SS-EEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCE
T ss_pred Ce-EEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCC
Confidence 44 5777764 68999999998544 33445678899999999999999999998755 3468999999987
Q ss_pred CChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccc--
Q 021682 70 KSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECE-- 147 (309)
Q Consensus 70 ~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~-- 147 (309)
+++.... .....+++..++.++.|++.|+.|||++ ||+||||||+||+++.++.+||+|||++.........
T Consensus 102 ~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~ 175 (318)
T d3blha1 102 DLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 175 (318)
T ss_dssp EHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----C
T ss_pred Cccchhh---hcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecceeeeccccccccc
Confidence 6665443 3345589999999999999999999998 9999999999999999999999999999766543222
Q ss_pred ccccccccccCCCCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcc-------
Q 021682 148 ANTGRIVGTYGYVPPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGME------- 219 (309)
Q Consensus 148 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 219 (309)
.......||..|+|||.+.+. .++.++|||||||++|+|++|+.||..........................
T Consensus 176 ~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 255 (318)
T d3blha1 176 NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELY 255 (318)
T ss_dssp CCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC---
T ss_pred ccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhh
Confidence 122234689999999998765 679999999999999999999999864322221111111111000000000
Q ss_pred -cccccCCCcccHH-------HHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 220 -FIDSSLDDSSSAW-------KLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 220 -~~~~~~~~~~~~~-------~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.+........... ....+.+||.+||+.||++|||++|+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 256 EKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp ----CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0000011111111 12356789999999999999999999976
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-42 Score=298.99 Aligned_cols=252 Identities=21% Similarity=0.228 Sum_probs=181.5
Q ss_pred CccceEEEE-cCCCcEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeeEEeeCC-----eeEEEEeccCCCChh
Q 021682 1 MSVAICQGR-LPNGQEMAVKRLSRTS-HQGLEEFENEVKLTARLQHVNLLPVLGICTQRE-----EKMLIYDYMPNKSLD 73 (309)
Q Consensus 1 ~g~~~~~~~-~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~~L~ 73 (309)
|| +||++. ..+|+.||||++.... ....+++++|+.+|++++||||+++++++..+. ..+++ +++.+++|.
T Consensus 21 fg-~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~-~~~~~g~L~ 98 (345)
T d1pmea_ 21 YG-MVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV-THLMGADLY 98 (345)
T ss_dssp CC-CEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE-EECCCEEHH
T ss_pred Ce-EEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEE-EeecCCchh
Confidence 44 577775 4689999999996543 334567899999999999999999999987653 34555 456689999
Q ss_pred HHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccc-ccccc
Q 021682 74 FYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECE-ANTGR 152 (309)
Q Consensus 74 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~ 152 (309)
+++.. ..+++..++.++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++......... .....
T Consensus 99 ~~l~~----~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 171 (345)
T d1pmea_ 99 KLLKT----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 171 (345)
T ss_dssp HHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCC
T ss_pred hhhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeecc
Confidence 99843 2489999999999999999999998 9999999999999999999999999999765443222 22334
Q ss_pred cccccCCCCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHh-----hCCCC---cccccc
Q 021682 153 IVGTYGYVPPEYVRK-GIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLW-----KNGEG---MEFIDS 223 (309)
Q Consensus 153 ~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~---~~~~~~ 223 (309)
..|++.|+|||.+.. ..++.++||||+||++|+|++|..||......+............ ..... ......
T Consensus 172 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (345)
T d1pmea_ 172 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 251 (345)
T ss_dssp CCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHT
T ss_pred ccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhccccc
Confidence 568999999998844 567899999999999999999999985433221111110000000 00000 000000
Q ss_pred cCC-Ccc-----cHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 224 SLD-DSS-----SAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 224 ~~~-~~~-----~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
... ... ......++.+||.+||+.||++|||++|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 252 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp SCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 000 00112367899999999999999999999985
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-42 Score=294.74 Aligned_cols=246 Identities=15% Similarity=0.152 Sum_probs=181.7
Q ss_pred ceEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccc-eeeEEeeCCeeEEEEeccCCCChhHHHhhhcc
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVNLLP-VLGICTQREEKMLIYDYMPNKSLDFYIFDLRR 81 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~-~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 81 (309)
+||+|. ..+|+.||||++...... ..+..|++++++++|++++. +..++..+...++||||+. +++.+.+.. .
T Consensus 22 ~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~-~~l~~~~~~--~ 96 (299)
T d1ckia_ 22 DIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG-PSLEDLFNF--C 96 (299)
T ss_dssp EEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC-CBHHHHHHH--T
T ss_pred EEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC-Cchhhhhhh--c
Confidence 567775 468999999998754332 45788999999997776554 5566677788999999994 566665533 3
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCC---CCCceeecccccccccCCccc-----cccccc
Q 021682 82 RYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDY---EMNPKISDFGMARAFTKDECE-----ANTGRI 153 (309)
Q Consensus 82 ~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~---~~~~~l~Dfg~~~~~~~~~~~-----~~~~~~ 153 (309)
...+++..+..++.|++.|++|||++ ||+||||||+||+++. +..++|+|||++......... ......
T Consensus 97 ~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~ 173 (299)
T d1ckia_ 97 SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL 173 (299)
T ss_dssp TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSC
T ss_pred cCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCc
Confidence 34599999999999999999999998 8999999999999864 457999999999876543322 122345
Q ss_pred ccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHHH
Q 021682 154 VGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAWK 233 (309)
Q Consensus 154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
.||+.|+|||.+.+..++.++|||||||++|+|++|..||............................ .. .
T Consensus 174 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~----~ 244 (299)
T d1ckia_ 174 TGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC-----KG----Y 244 (299)
T ss_dssp CCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHT-----TT----S
T ss_pred CCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhc-----cC----C
Confidence 79999999999999999999999999999999999999997655544333322221111111111110 01 1
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHHHhccc
Q 021682 234 LMRCMQVALLCVQENAADRPTMLEILVMLKSET 266 (309)
Q Consensus 234 ~~~l~~li~~~l~~~p~~Rpt~~ell~~L~~~~ 266 (309)
+.++.+++.+||+.+|++||+++++.+.|+...
T Consensus 245 p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 245 PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp CHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 236889999999999999999999999888653
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-42 Score=291.64 Aligned_cols=248 Identities=18% Similarity=0.197 Sum_probs=185.9
Q ss_pred ceEEEE-cCCCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhc
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLR 80 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 80 (309)
+||++. ..+|+.||||+++... .....++.+|+.++++++||||+++++++......++|++++.++++..++.
T Consensus 17 ~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~--- 93 (292)
T d1unla_ 17 TVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--- 93 (292)
T ss_dssp EEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHH---
T ss_pred EEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccccccccccc---
Confidence 566665 5689999999996543 3346788999999999999999999999999999999999999888877763
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccccccCCC
Q 021682 81 RRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVGTYGYV 160 (309)
Q Consensus 81 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 160 (309)
....+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||.+......... .....++..|.
T Consensus 94 ~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~--~~~~~~~~~~~ 168 (292)
T d1unla_ 94 CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--YSAEVVTLWYR 168 (292)
T ss_dssp TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC--CCSCCSCGGGC
T ss_pred cccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCcc--ceeeccccchh
Confidence 344589999999999999999999998 9999999999999999999999999999876544322 22235677899
Q ss_pred CccccccCC-CCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCC---CCcc---c--------c-ccc
Q 021682 161 PPEYVRKGI-YSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNG---EGME---F--------I-DSS 224 (309)
Q Consensus 161 aPE~~~~~~-~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~---~--------~-~~~ 224 (309)
|||.+.+.. ++.++|||||||++|+|++|+.||..... ............... .... . . ...
T Consensus 169 ~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (292)
T d1unla_ 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATT 246 (292)
T ss_dssp CHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTC
T ss_pred hhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC--HHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccc
Confidence 999887665 68999999999999999999998743221 111111111111110 0000 0 0 000
Q ss_pred CCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 225 LDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 225 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
............+.+||.+||+.||++|||++|+++.
T Consensus 247 ~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 247 SLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0011111223467899999999999999999999864
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-42 Score=296.71 Aligned_cols=255 Identities=22% Similarity=0.256 Sum_probs=193.4
Q ss_pred ceEEEEc----CCCcEEEEEEeecC----CcccHHHHHHHHHHHhcCCC-CCccceeeEEeeCCeeEEEEeccCCCChhH
Q 021682 4 AICQGRL----PNGQEMAVKRLSRT----SHQGLEEFENEVKLTARLQH-VNLLPVLGICTQREEKMLIYDYMPNKSLDF 74 (309)
Q Consensus 4 ~~~~~~~----~~g~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (309)
.||++.. .+|+.||||.++.. .....+.+.+|++++++++| |||+++++++.+....+++|||+.+++|.+
T Consensus 39 ~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~ 118 (322)
T d1vzoa_ 39 KVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFT 118 (322)
T ss_dssp EEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHH
T ss_pred EEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHH
Confidence 4677753 36899999998543 22345678899999999966 899999999999999999999999999999
Q ss_pred HHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccc
Q 021682 75 YIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIV 154 (309)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~ 154 (309)
++... ..+++..+..++.||+.|+.|+|++ |++||||||+||+++.++.++|+|||++.......... .....
T Consensus 119 ~i~~~---~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~-~~~~~ 191 (322)
T d1vzoa_ 119 HLSQR---ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFC 191 (322)
T ss_dssp HHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGG-GCGGG
T ss_pred HHHhc---ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhhccccccc-ccccc
Confidence 98543 3478899999999999999999998 89999999999999999999999999997665433222 23347
Q ss_pred cccCCCCccccccC--CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhCCCCcccccccCCCcccHH
Q 021682 155 GTYGYVPPEYVRKG--IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGLWKNGEGMEFIDSSLDDSSSAW 232 (309)
Q Consensus 155 ~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (309)
|++.|++||.+.+. .++.++|||||||++|+|++|..||......+....+... ...... ..+..
T Consensus 192 g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~--~~~~~~-----------~~~~~ 258 (322)
T d1vzoa_ 192 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR--ILKSEP-----------PYPQE 258 (322)
T ss_dssp SCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH--HHHCCC-----------CCCTT
T ss_pred cccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh--cccCCC-----------CCccc
Confidence 89999999998764 4688999999999999999999999765544433332221 111100 01111
Q ss_pred HHHHHHHHHhhcccCCCCCCC-----CHHHHHHH--Hhc------ccCCCCCCCCCCcc
Q 021682 233 KLMRCMQVALLCVQENAADRP-----TMLEILVM--LKS------ETADIKTPKKPAFS 278 (309)
Q Consensus 233 ~~~~l~~li~~~l~~~p~~Rp-----t~~ell~~--L~~------~~~~~~~~~~p~~~ 278 (309)
.+.++.++|.+||+.||++|| |++|+++. ++. .....++|-+|...
T Consensus 259 ~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~~p~~p~~~ 317 (322)
T d1vzoa_ 259 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIR 317 (322)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC
T ss_pred CCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCCcCCCCCCC
Confidence 234788999999999999999 58999863 222 22345556666543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.9e-41 Score=293.31 Aligned_cols=242 Identities=17% Similarity=0.215 Sum_probs=178.5
Q ss_pred ceEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCC-CCCccceeeEEeeC--CeeEEEEeccCCCChhHHHhhh
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQ-HVNLLPVLGICTQR--EEKMLIYDYMPNKSLDFYIFDL 79 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~ 79 (309)
+||++. ..+|+.||||+++.. ..+++.+|+.+|++++ ||||+++++++... ...++||||+.+++|..+.
T Consensus 50 ~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~--- 123 (328)
T d3bqca1 50 EVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY--- 123 (328)
T ss_dssp EEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT---
T ss_pred EEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh---
Confidence 566665 468999999998643 3467889999999995 99999999998754 4689999999999986553
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCC-CceeecccccccccCCcccccccccccccC
Q 021682 80 RRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEM-NPKISDFGMARAFTKDECEANTGRIVGTYG 158 (309)
Q Consensus 80 ~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~ 158 (309)
..+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .++|+|||++........ .....+|..
T Consensus 124 ---~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~---~~~~~~t~~ 194 (328)
T d3bqca1 124 ---QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRY 194 (328)
T ss_dssp ---TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC---CCSCCSCGG
T ss_pred ---cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCCCc---ccccccCcc
Confidence 2389999999999999999999999 999999999999998655 589999999976554332 223467899
Q ss_pred CCCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcc-cHHHHHH------HHh---hCCCCccc-------
Q 021682 159 YVPPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESL-NLLEYAY------GLW---KNGEGMEF------- 220 (309)
Q Consensus 159 y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~-~~~~~~~------~~~---~~~~~~~~------- 220 (309)
|+|||.+.+. .++.++||||+||++|+|++|..||......... ..+.... ... .......+
T Consensus 195 y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (328)
T d3bqca1 195 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRH 274 (328)
T ss_dssp GCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCC
T ss_pred ccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccc
Confidence 9999998765 4799999999999999999999998643322111 0000000 000 00000000
Q ss_pred ----ccccCCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021682 221 ----IDSSLDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILV 260 (309)
Q Consensus 221 ----~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~ 260 (309)
...............++.+||.+||+.||++|||++|+++
T Consensus 275 ~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 275 SRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0001111111222346889999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-42 Score=298.04 Aligned_cols=246 Identities=21% Similarity=0.232 Sum_probs=175.6
Q ss_pred ceEEEE-cCCCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEee------CCeeEEEEeccCCCChhH
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQ------REEKMLIYDYMPNKSLDF 74 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~lv~e~~~~~~L~~ 74 (309)
+||++. ..+|+.||||+++... .....++.+|+.++++++||||++++++|.. ..+.|+||||+.++++..
T Consensus 32 ~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~ 111 (355)
T d2b1pa1 32 IVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQV 111 (355)
T ss_dssp EEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHH
T ss_pred EEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchHHHHh
Confidence 466665 4589999999997543 3345578899999999999999999999864 358899999997765543
Q ss_pred HHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCcccccccccc
Q 021682 75 YIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIV 154 (309)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~ 154 (309)
+ ...+++..++.++.|++.|+.|||++ |++||||||+||+++.++.++++|||++........ .....
T Consensus 112 ~------~~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~~---~~~~~ 179 (355)
T d2b1pa1 112 I------QMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYV 179 (355)
T ss_dssp H------TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----------------
T ss_pred h------hcCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhccccccc---ccccc
Confidence 3 12389999999999999999999999 999999999999999999999999998876554332 22346
Q ss_pred cccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH-----HHh-----------hCC---
Q 021682 155 GTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAY-----GLW-----------KNG--- 215 (309)
Q Consensus 155 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~-----~~~-----------~~~--- 215 (309)
+|..|+|||.+.+..++.++||||+||++|+|++|.+||...+.......+.... ..+ ...
T Consensus 180 ~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (355)
T d2b1pa1 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKY 259 (355)
T ss_dssp -CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCC
T ss_pred ccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccc
Confidence 8899999999999999999999999999999999999985432111111000000 000 000
Q ss_pred ---CCccccccc---CCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 216 ---EGMEFIDSS---LDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 216 ---~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.....+... ............+.+||.+||+.||++||||+|+++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 260 AGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp CCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000001000 0111223345678899999999999999999999976
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-41 Score=291.50 Aligned_cols=246 Identities=23% Similarity=0.273 Sum_probs=174.8
Q ss_pred ceEEEE-cCCCcEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeeEEeeC-----CeeEEEEeccCCCChhHH
Q 021682 4 AICQGR-LPNGQEMAVKRLSRTS--HQGLEEFENEVKLTARLQHVNLLPVLGICTQR-----EEKMLIYDYMPNKSLDFY 75 (309)
Q Consensus 4 ~~~~~~-~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~ 75 (309)
+||++. ..+|+.||||+++... ....+++.+|+++|++++|||++++++++... ...+++++++.+++|.++
T Consensus 33 ~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~ 112 (348)
T d2gfsa1 33 SVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 112 (348)
T ss_dssp SEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHH
T ss_pred EEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhh
Confidence 466665 5689999999997543 33445788999999999999999999998643 234556667779999998
Q ss_pred HhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCCccccccccccc
Q 021682 76 IFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKDECEANTGRIVG 155 (309)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 155 (309)
+. ...+++..++.++.||+.||+|||++ ||+||||||+||+++.++.++++|||.+...... .....|
T Consensus 113 ~~----~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~-----~~~~~g 180 (348)
T d2gfsa1 113 VK----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVA 180 (348)
T ss_dssp HT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCTGG-----GSSSCH
T ss_pred cc----cccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcccCcc-----cccccc
Confidence 73 23499999999999999999999998 9999999999999999999999999998654332 223468
Q ss_pred ccCCCCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHH-----hhCCCC---cccccccCC
Q 021682 156 TYGYVPPEYVRKG-IYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGL-----WKNGEG---MEFIDSSLD 226 (309)
Q Consensus 156 ~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~---~~~~~~~~~ 226 (309)
+..|+|||.+.+. .++.++|||||||++|+|++|.+||...+.......+...... ...... .........
T Consensus 181 ~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (348)
T d2gfsa1 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 260 (348)
T ss_dssp HHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCC
T ss_pred cccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhccc
Confidence 8899999987665 4689999999999999999999998643222211111110000 000000 000000000
Q ss_pred -Ccc-----cHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 227 -DSS-----SAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 227 -~~~-----~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
... .......+.+||.+||+.||++|||++|+++.
T Consensus 261 ~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 261 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 000 00122367899999999999999999999984
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.1e-36 Score=262.52 Aligned_cols=251 Identities=16% Similarity=0.140 Sum_probs=174.8
Q ss_pred cceEEEE-cCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCC-----------CCCccceeeEEeeC--CeeEEEEeccC
Q 021682 3 VAICQGR-LPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQ-----------HVNLLPVLGICTQR--EEKMLIYDYMP 68 (309)
Q Consensus 3 ~~~~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~~~~~~~~~--~~~~lv~e~~~ 68 (309)
++||++. ..+|+.||||+++... ...+.+.+|+++++.++ |+||+++++++... ...++++.++.
T Consensus 27 g~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~ 105 (362)
T d1q8ya_ 27 STVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEV 105 (362)
T ss_dssp EEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECC
T ss_pred eEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeecc
Confidence 3567776 4689999999996542 23467788998888774 57899999887653 45666666665
Q ss_pred CCChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCC------ceeeccccccccc
Q 021682 69 NKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMN------PKISDFGMARAFT 142 (309)
Q Consensus 69 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~------~~l~Dfg~~~~~~ 142 (309)
................+++..+..++.|++.|+.|||+.. ||+||||||+||+++.++. ++++|||.+....
T Consensus 106 ~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~ 183 (362)
T d1q8ya_ 106 LGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD 183 (362)
T ss_dssp CCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETT
T ss_pred cccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeeeeccCcccccceeeEeecccccccc
Confidence 5444333333445566899999999999999999999843 8999999999999987654 8999999986543
Q ss_pred CCcccccccccccccCCCCccccccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHH---h-------
Q 021682 143 KDECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVLLLQILGGKRTSCYYGPNESLNLLEYAYGL---W------- 212 (309)
Q Consensus 143 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~---~------- 212 (309)
.. .....|++.|+|||.+.+..++.++|+||+||++++|++|+.||.................. .
T Consensus 184 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~ 258 (362)
T d1q8ya_ 184 EH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYL 258 (362)
T ss_dssp BC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHH
T ss_pred cc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHH
Confidence 32 22346899999999999999999999999999999999999998654433222211111110 0
Q ss_pred -hC----------CCCccccccc----------CCCcccHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021682 213 -KN----------GEGMEFIDSS----------LDDSSSAWKLMRCMQVALLCVQENAADRPTMLEILVM 261 (309)
Q Consensus 213 -~~----------~~~~~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ell~~ 261 (309)
.. ......+... ............+.+||.+||++||++|||++|+++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 259 LRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 328 (362)
T ss_dssp HHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred hhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 0000000000 0111233456688999999999999999999999875
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.80 E-value=2.7e-20 Score=147.11 Aligned_cols=157 Identities=17% Similarity=0.107 Sum_probs=107.2
Q ss_pred cceEEEEcCCCcEEEEEEeecCCc------------------ccHHHHHHHHHHHhcCCCCCccceeeEEeeCCeeEEEE
Q 021682 3 VAICQGRLPNGQEMAVKRLSRTSH------------------QGLEEFENEVKLTARLQHVNLLPVLGICTQREEKMLIY 64 (309)
Q Consensus 3 ~~~~~~~~~~g~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 64 (309)
++||+|...+|+.||||+++.... ........|+..+.++.|.+++..+++.. .+++|
T Consensus 14 g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~~----~~lvm 89 (191)
T d1zara2 14 SAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEG----NAVLM 89 (191)
T ss_dssp EEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEET----TEEEE
T ss_pred eEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEecC----CEEEE
Confidence 468888878899999998753210 01123456788899999999988876532 37999
Q ss_pred eccCCCChhHHHhhhccccCCCHHHHHHHHHHHHHHHHHHhhcCCCceeecCCCCceEEeCCCCCceeecccccccccCC
Q 021682 65 DYMPNKSLDFYIFDLRRRYLLDWRTRVHIIEGITQGLLYLQEYSNLTIVHRDLKASNILLDYEMNPKISDFGMARAFTKD 144 (309)
Q Consensus 65 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~~~~~~ 144 (309)
|++++..+.. ++......++.|++.++++||++ |++||||||+||++++++ ++|+|||++......
T Consensus 90 e~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~~-~~liDFG~a~~~~~~ 155 (191)
T d1zara2 90 ELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEE 155 (191)
T ss_dssp ECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETTE-EEECCCTTCEETTST
T ss_pred Eeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCCC-EEEEECCCcccCCCC
Confidence 9998755422 34445677899999999999998 999999999999998654 899999998654432
Q ss_pred cccccccccccccCCCCccccccCCCCccchhhhHHHH
Q 021682 145 ECEANTGRIVGTYGYVPPEYVRKGIYSMKYDVYSYGVL 182 (309)
Q Consensus 145 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~i 182 (309)
....... ..... -.+.+ ...++.++|+||+.--
T Consensus 156 ~~~~~l~---rd~~~-~~~~f-~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 156 GWREILE---RDVRN-IITYF-SRTYRTEKDINSAIDR 188 (191)
T ss_dssp THHHHHH---HHHHH-HHHHH-HHHHCCCCCHHHHHHH
T ss_pred CcHHHHH---HHHHH-HHHHH-cCCCCCcccHHHHHHH
Confidence 2110000 00000 00111 3456888999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.70 E-value=3.8e-08 Score=79.99 Aligned_cols=127 Identities=16% Similarity=0.102 Sum_probs=87.0
Q ss_pred ceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCC-CCCccceeeEEeeCCeeEEEEeccCCCChhHHHhhhccc
Q 021682 4 AICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQ-HVNLLPVLGICTQREEKMLIYDYMPNKSLDFYIFDLRRR 82 (309)
Q Consensus 4 ~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 82 (309)
.+|+... +++.++||............+..|...+..+. +-.+.+++.+...++..++||++++|.++......
T Consensus 29 ~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~---- 103 (263)
T d1j7la_ 29 KVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED---- 103 (263)
T ss_dssp EEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT----
T ss_pred cEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc----
Confidence 4676654 56778889876554444445678888877763 44567788888888899999999998877554311
Q ss_pred cCCCHHHHHHHHHHHHHHHHHHhhcC------------------------------------------------------
Q 021682 83 YLLDWRTRVHIIEGITQGLLYLQEYS------------------------------------------------------ 108 (309)
Q Consensus 83 ~~~~~~~~~~~~~~i~~~l~~lh~~~------------------------------------------------------ 108 (309)
......++.+++..++.||+..
T Consensus 104 ----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 179 (263)
T d1j7la_ 104 ----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKP 179 (263)
T ss_dssp ----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCC
T ss_pred ----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCC
Confidence 1112234455555666666421
Q ss_pred --CCceeecCCCCceEEeCCCCCceeecccccc
Q 021682 109 --NLTIVHRDLKASNILLDYEMNPKISDFGMAR 139 (309)
Q Consensus 109 --~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~ 139 (309)
...++|+|+.|.||+++.++.+-|+||+.+.
T Consensus 180 ~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 180 EEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1247999999999999876666799998763
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.28 E-value=2.5e-06 Score=68.51 Aligned_cols=67 Identities=19% Similarity=0.189 Sum_probs=48.2
Q ss_pred ceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCC--CCCccceeeEEeeCCeeEEEEeccCCCChh
Q 021682 4 AICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQ--HVNLLPVLGICTQREEKMLIYDYMPNKSLD 73 (309)
Q Consensus 4 ~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 73 (309)
.+|+....+|..+++|....... ..+..|+..++.+. .-.+.+++.+..+++..++||++++|.++.
T Consensus 26 ~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 26 AVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp EEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred eEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 46877777788899998654432 34667777777663 334666788888888899999999886653
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.67 E-value=0.0002 Score=61.02 Aligned_cols=29 Identities=28% Similarity=0.334 Sum_probs=25.1
Q ss_pred ceeecCCCCceEEeCCCCCceeeccccccc
Q 021682 111 TIVHRDLKASNILLDYEMNPKISDFGMARA 140 (309)
Q Consensus 111 gi~H~di~p~nil~~~~~~~~l~Dfg~~~~ 140 (309)
.++|||+++.|||++.++ ++++||..+..
T Consensus 224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~ 252 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFY 252 (392)
T ss_dssp EEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred ceeccCCcCCceeEcCCc-eEEechhhccc
Confidence 699999999999998765 89999987754
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.61 E-value=0.00037 Score=57.68 Aligned_cols=67 Identities=7% Similarity=0.083 Sum_probs=44.4
Q ss_pred ceEEEEcCCCcEEEEEEeecCCcccHHHHHHHHHHHhcCCCCC--cccee-----eEEeeCCeeEEEEeccCCCC
Q 021682 4 AICQGRLPNGQEMAVKRLSRTSHQGLEEFENEVKLTARLQHVN--LLPVL-----GICTQREEKMLIYDYMPNKS 71 (309)
Q Consensus 4 ~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~-----~~~~~~~~~~lv~e~~~~~~ 71 (309)
.||....++|+.|++|+.++.. ...+++..|...+..|.... ++..+ ..+..+...+.+++++.|..
T Consensus 37 ~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 37 RVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp EEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred eeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 4788888899999999986542 24567888888887763222 22221 12344567888999987633
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.75 E-value=0.0031 Score=53.34 Aligned_cols=54 Identities=13% Similarity=0.170 Sum_probs=34.9
Q ss_pred CcEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCCccceeeEEeeCCeeEEEEeccCCCCh
Q 021682 13 GQEMAVKRLSRTSHQGLEEFENEVKLTARL-QHVNLLPVLGICTQREEKMLIYDYMPNKSL 72 (309)
Q Consensus 13 g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 72 (309)
++.|.+++.- ... .......|..+++.+ .+.-..++++++.+ .+|++|++|..+
T Consensus 74 ~~~vllRi~g-~~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 74 PNKVLLRVYF-NPE-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL 128 (395)
T ss_dssp CSEEEEEEEC-SCC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred CCcEEEEecC-Ccc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence 4567777764 222 234566888888888 34444567777653 478999987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.12 E-value=0.0071 Score=49.22 Aligned_cols=31 Identities=23% Similarity=0.265 Sum_probs=26.8
Q ss_pred CCceeecCCCCceEEeCCCCCceeecccccc
Q 021682 109 NLTIVHRDLKASNILLDYEMNPKISDFGMAR 139 (309)
Q Consensus 109 ~~gi~H~di~p~nil~~~~~~~~l~Dfg~~~ 139 (309)
..|++|+|+.++|++++.+...-++||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 3589999999999999988767899998764
|